<corpus source="DS">
    <document id="DS.d0" origId="17003041">
        <sentence id="DS.d0.s0" origId="17003041-302" text="Bestrophin-1 enables Ca2+-activated Cl-conductance in epithelia.">
            <entity id="DS.d0.s0.e0" origId="O76090,O88870,Q21973,Q6UY87,Q8WMR7" charOffset="0-12" type="protein" text="Bestrophin-1"/>
            <entity id="DS.d0.s0.e1" origId="312" charOffset="36-38" type="compound" text="Cl"/>
            <pair e1="DS.d0.s0.e1" e2="DS.d0.s0.e0" id="DS.d0.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d0.s1" origId="17003041-304" text="Calcium-dependent Cl (-) currents were activated by ATP in HEK293 cells expressing BEST1.">
            <entity id="DS.d0.s1.e0" origId="312" charOffset="18-20" type="compound" text="Cl"/>
            <entity id="DS.d0.s1.e1" origId="5957" charOffset="52-55" type="compound" text="ATP"/>
            <entity id="DS.d0.s1.e2" origId="O76090,Q6UY87,Q8WMR7" charOffset="83-88" type="protein" text="BEST1"/>
            <pair e1="DS.d0.s1.e1" e2="DS.d0.s1.e2" id="DS.d0.s1.i0" interaction="False"/>
            <pair e1="DS.d0.s1.e0" e2="DS.d0.s1.e2" id="DS.d0.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1" origId="17321121">
        <sentence id="DS.d1.s0" origId="17321121-703" text="The absorption spectrum of the hydrogenase enzyme showed an absorption peak at 425nm indicating that the enzyme had iron-sulfur clusters.">
            <entity id="DS.d1.s0.e0" origId="P80509,P80510" charOffset="31-42" type="protein" text="hydrogenase"/>
            <entity id="DS.d1.s0.e1" origId="402" charOffset="121-127" type="compound" text="sulfur"/>
            <pair e1="DS.d1.s0.e1" e2="DS.d1.s0.e0" id="DS.d1.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d2" origId="17403602">
        <sentence id="DS.d2.s0" origId="17403602-1067" text="When Vitreoscilla were grown in medium containing 60mM sodium nitrite under both normal and limited aeration conditions, the levels of Vitreoscilla hemoglobin (VHb) were decreased by greater than 90%, while the levels of the terminal respiratory oxidase, cytochrome bo, were increased 350% under normal aeration and 7-23% under limited aeration.">
            <entity id="DS.d2.s0.e0" origId="23668193" charOffset="55-69" type="compound" text="sodium nitrite"/>
            <entity id="DS.d2.s0.e1" origId="P15160,P17724,P73925,Q03459" charOffset="148-158" type="protein" text="hemoglobin"/>
            <pair e1="DS.d2.s0.e0" e2="DS.d2.s0.e1" id="DS.d2.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d3" origId="17590240">
        <sentence id="DS.d3.s0" origId="17590240-1233" text="Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation.">
            <entity id="DS.d3.s0.e0" origId="65064" charOffset="0-30" type="compound" text="Epigallocatechin gallate (EGCG"/>
            <entity id="DS.d3.s0.e1" origId="P00520,P00522" charOffset="99-102" type="protein" text="Abl"/>
            <entity id="DS.d3.s0.e2" origId="O00213" charOffset="103-107" type="protein" text="FE65"/>
            <entity id="DS.d3.s0.e3" origId="P18266,P49841,Q5YJC2,Q9WV60" charOffset="134-143" type="protein" text="GSK3 beta"/>
            <pair e1="DS.d3.s0.e0" e2="DS.d3.s0.e3" id="DS.d3.s0.i0" interaction="True"/>
            <pair e1="DS.d3.s0.e0" e2="DS.d3.s0.e1" id="DS.d3.s0.i1" interaction="True"/>
            <pair e1="DS.d3.s0.e0" e2="DS.d3.s0.e2" id="DS.d3.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d3.s1" origId="17590240-1234" text="Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (APP-C99) to investigate the protection mechanism of epigallocatechin gallate (EGCG), the main constituent of green tea.">
            <entity id="DS.d3.s1.e0" origId="P12023" charOffset="111-118" type="protein" text="APP-C99"/>
            <entity id="DS.d3.s1.e1" origId="65064" charOffset="163-193" type="compound" text="epigallocatechin gallate (EGCG"/>
            <entity id="DS.d3.s1.e2" origId="4630" charOffset="220-229" type="compound" text="green tea"/>
            <pair e1="DS.d3.s1.e2" e2="DS.d3.s1.e0" id="DS.d3.s1.i0" interaction="False"/>
            <pair e1="DS.d3.s1.e1" e2="DS.d3.s1.e0" id="DS.d3.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d4" origId="17616381">
        <sentence id="DS.d4.s0" origId="17616381-938" text="The protease was purified to homogeneity using ammonium sulfate precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.">
            <entity id="DS.d4.s0.e0" origId="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0" charOffset="4-12" type="protein" text="protease"/>
            <entity id="DS.d4.s0.e1" origId="223" charOffset="47-55" type="compound" text="ammonium"/>
            <entity id="DS.d4.s0.e2" origId="1117" charOffset="56-63" type="compound" text="sulfate"/>
            <pair e1="DS.d4.s0.e2" e2="DS.d4.s0.e0" id="DS.d4.s0.i0" interaction="False"/>
            <pair e1="DS.d4.s0.e1" e2="DS.d4.s0.e0" id="DS.d4.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d5" origId="17629591">
        <sentence id="DS.d5.s0" origId="17629591-228" text="In addition, we demonstrated that Hsp20, HspB2 and HspB8 induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by dexamethasone, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.">
            <entity id="DS.d5.s0.e0" origId="O35878,Q16082,Q99PR8" charOffset="41-46" type="protein" text="HspB2"/>
            <entity id="DS.d5.s0.e1" origId="Q5EAC9,Q5RAB0,Q6SJQ8,Q8MJ36,Q9EPX0,Q9JK92,Q9UJY1" charOffset="51-56" type="protein" text="HspB8"/>
            <entity id="DS.d5.s0.e2" origId="P41693" charOffset="65-78" type="protein" text="interleukin-6"/>
            <entity id="DS.d5.s0.e3" origId="5743" charOffset="158-171" type="compound" text="dexamethasone"/>
            <pair e1="DS.d5.s0.e3" e2="DS.d5.s0.e0" id="DS.d5.s0.i0" interaction="False"/>
            <pair e1="DS.d5.s0.e3" e2="DS.d5.s0.e2" id="DS.d5.s0.i1" interaction="True"/>
            <pair e1="DS.d5.s0.e3" e2="DS.d5.s0.e1" id="DS.d5.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d6" origId="17692997">
        <sentence id="DS.d6.s0" origId="17692997-193" text="Furthermore, dithiothreitol was found to be capable of significantly preventing the inhibitory effect of insulin on Abeta oligomer formation.">
            <entity id="DS.d6.s0.e0" origId="19001,439196,446094" charOffset="13-27" type="compound" text="dithiothreitol"/>
            <entity id="DS.d6.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="105-112" type="protein" text="insulin"/>
            <pair e1="DS.d6.s0.e0" e2="DS.d6.s0.e1" id="DS.d6.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d7" origId="17719144">
        <sentence id="DS.d7.s0" origId="17719144-1171" text="The scavenger receptor, class B, type I (SR-BI) is critical in maintaining the homeostasis of cholesterol and alpha-tocopherol.">
            <entity id="DS.d7.s0.e1" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="41-46" type="protein" text="SR-BI"/>
            <entity id="DS.d7.s0.e2" origId="304,5997,6432564,11025495" charOffset="94-105" type="compound" text="cholesterol"/>
            <entity id="DS.d7.s0.e3" origId="2116,14985" charOffset="110-126" type="compound" text="alpha-tocopherol"/>
            <pair e1="DS.d7.s0.e3" e2="DS.d7.s0.e1" id="DS.d7.s0.i1" interaction="True"/>
            <pair e1="DS.d7.s0.e2" e2="DS.d7.s0.e1" id="DS.d7.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d7.s1" origId="17719144-1172" text="SR-BI binds high-density lipoproteins (HDL) and mediates the selective transfer of cholesteryl esters and alpha-tocopherol from circulating HDL to cells.">
            <entity id="DS.d7.s1.e0" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="0-5" type="protein" text="SR-BI"/>
            <entity id="DS.d7.s1.e1" origId="P81182" charOffset="12-37" type="protein" text="high-density lipoproteins"/>
            <entity id="DS.d7.s1.e2" origId="2116,14985" charOffset="106-122" type="compound" text="alpha-tocopherol"/>
            <pair e1="DS.d7.s1.e2" e2="DS.d7.s1.e1" id="DS.d7.s1.i0" interaction="False"/>
            <pair e1="DS.d7.s1.e2" e2="DS.d7.s1.e0" id="DS.d7.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d7.s2" origId="17719144-1173" text="Thus, SR-BI influences neural and cognitive processes, a finding that highlights the contribution of cholesterol and alpha-tocopherol homeostasis in proper cognitive function.">
            <entity id="DS.d7.s2.e0" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="6-11" type="protein" text="SR-BI"/>
            <entity id="DS.d7.s2.e1" origId="304,5997,6432564,11025495" charOffset="101-112" type="compound" text="cholesterol"/>
            <entity id="DS.d7.s2.e2" origId="2116,14985" charOffset="117-133" type="compound" text="alpha-tocopherol"/>
            <pair e1="DS.d7.s2.e1" e2="DS.d7.s2.e0" id="DS.d7.s2.i0" interaction="False"/>
            <pair e1="DS.d7.s2.e2" e2="DS.d7.s2.e0" id="DS.d7.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d8" origId="17768029">
        <sentence id="DS.d8.s0" origId="17768029-984" text="Alloxan is believed to confer its diabetogenic effect by inhibiting pancreatic glucokinase activity, leading to pancreatic beta-cell death.">
            <entity id="DS.d8.s0.e0" origId="5781" charOffset="0-7" type="compound" text="Alloxan"/>
            <entity id="DS.d8.s0.e1" origId="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0" charOffset="79-90" type="protein" text="glucokinase"/>
            <pair e1="DS.d8.s0.e0" e2="DS.d8.s0.e1" id="DS.d8.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d9" origId="17882129">
        <sentence id="DS.d9.s0" origId="17882129-602" text="Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1/arylesterase activities in healthy individuals.">
            <entity id="DS.d9.s0.e0" origId="2116,14985" charOffset="0-16" type="compound" text="Alpha-tocopherol"/>
            <entity id="DS.d9.s0.e1" origId="P22862" charOffset="96-108" type="protein" text="arylesterase"/>
            <pair e1="DS.d9.s0.e0" e2="DS.d9.s0.e1" id="DS.d9.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d10" origId="17888544">
        <sentence id="DS.d10.s0" origId="17888544-779" text="Although ApoE4 has been repeatedly associated with altered sphingomyelin and cholesterol levels in tissue culture and rodent models, there has not been a direct quantification of sphingomyelin or sterol levels in the brains of patients with different forms of ApoE.">
            <entity id="DS.d10.s0.e0" origId="304,5997,6432564,11025495" charOffset="77-88" type="compound" text="cholesterol"/>
            <entity id="DS.d10.s0.e1" origId="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8" charOffset="9-13" type="protein" text="ApoE"/>
            <pair e1="DS.d10.s0.e0" e2="DS.d10.s0.e1" id="DS.d10.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d11" origId="17888546">
        <sentence id="DS.d11.s0" origId="17888546-781" text="ApoE modified the association between cholesterol and cognitive decline, and the association between the ratio of 27-hydroxycholesterol to cholesterol and cognitive functioning.">
            <entity id="DS.d11.s0.e0" origId="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8" charOffset="0-4" type="protein" text="ApoE"/>
            <entity id="DS.d11.s0.e1" origId="304,5997,6432564,11025495" charOffset="38-49" type="compound" text="cholesterol"/>
            <entity id="DS.d11.s0.e2" origId="99470,123976,50990021" charOffset="114-135" type="compound" text="27-hydroxycholesterol"/>
            <entity id="DS.d11.s0.e3" origId="304,5997,6432564,11025495" charOffset="124-135" type="compound" text="cholesterol"/>
            <pair e1="DS.d11.s0.e2" e2="DS.d11.s0.e0" id="DS.d11.s0.i0" interaction="True"/>
            <pair e1="DS.d11.s0.e1" e2="DS.d11.s0.e0" id="DS.d11.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d12" origId="17890844">
        <sentence id="DS.d12.s0" origId="17890844-955" text="Here we show that during growth in media containing glucose and in complex medium without glucose RamB activates expression of the aceE gene, encoding the E1p subunit of the pyruvate dehydrogenase complex.">
            <entity id="DS.d12.s0.e0" origId="206,5793,64689,79025" charOffset="52-59" type="compound" text="glucose"/>
            <entity id="DS.d12.s0.e1" origId="206,5793,64689,79025" charOffset="90-97" type="compound" text="glucose"/>
            <entity id="DS.d12.s0.e2" origId="P0AFG8,P0AFG9,P45119,P57301,Q10504,Q59637,Q89AR0,Q8K9T9" charOffset="131-135" type="protein" text="aceE"/>
            <pair e1="DS.d12.s0.e0" e2="DS.d12.s0.e2" id="DS.d12.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d13" origId="17925795">
        <sentence id="DS.d13.s0" origId="17925795-1037" text="The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.">
            <entity id="DS.d13.s0.e0" origId="28486,3028194" charOffset="21-28" type="compound" text="lithium"/>
            <entity id="DS.d13.s0.e1" origId="3121" charOffset="33-42" type="compound" text="valproate"/>
            <entity id="DS.d13.s0.e2" origId="P25430,P25431,P25432,Q06225" charOffset="83-116" type="protein" text="brain-derived neurotrophic factor"/>
            <pair e1="DS.d13.s0.e0" e2="DS.d13.s0.e2" id="DS.d13.s0.i0" interaction="True"/>
            <pair e1="DS.d13.s0.e1" e2="DS.d13.s0.e2" id="DS.d13.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d13.s1" origId="17925795-1038" text="Treatment of cultured rat cortical neurons with therapeutic concentrations of LiCl or VPA selectively increased the levels of exon IV (formerly rat exon III)-containing BDNF mRNA, and the activity of BDNF promoter IV.">
            <entity id="DS.d13.s1.e0" origId="433294" charOffset="78-82" type="compound" text="LiCl"/>
            <entity id="DS.d13.s1.e1" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="169-173" type="protein" text="BDNF"/>
            <entity id="DS.d13.s1.e2" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="200-204" type="protein" text="BDNF"/>
            <pair e1="DS.d13.s1.e0" e2="DS.d13.s1.e1" id="DS.d13.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d13.s2" origId="17925795-1039" text="We showed that lithium-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or GSK-3beta isoforms.">
            <entity id="DS.d13.s2.e0" origId="28486,3028194" charOffset="15-22" type="compound" text="lithium"/>
            <entity id="DS.d13.s2.e1" origId="P51136,P83101" charOffset="103-108" type="protein" text="GSK-3"/>
            <entity id="DS.d13.s2.e2" origId="P18265,P49840" charOffset="169-179" type="protein" text="GSK-3alpha"/>
            <entity id="DS.d13.s2.e3" origId="P18266,P49841,Q5YJC2,Q9WV60" charOffset="183-192" type="protein" text="GSK-3beta"/>
            <pair e1="DS.d13.s2.e0" e2="DS.d13.s2.e2" id="DS.d13.s2.i0" interaction="True"/>
            <pair e1="DS.d13.s2.e0" e2="DS.d13.s2.e3" id="DS.d13.s2.i1" interaction="True"/>
            <pair e1="DS.d13.s2.e0" e2="DS.d13.s2.e1" id="DS.d13.s2.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d13.s3" origId="17925795-1040" text="Furthermore, treatment with other HDAC inhibitors, sodium butyrate and trichostatin A, or transfection with an HDAC1-specific siRNA also activated BDNF promoter IV.">
            <entity id="DS.d13.s3.e0" origId="264" charOffset="51-66" type="compound" text="sodium butyrate"/>
            <entity id="DS.d13.s3.e1" origId="444732" charOffset="71-85" type="compound" text="trichostatin A"/>
            <entity id="DS.d13.s3.e2" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="147-151" type="protein" text="BDNF"/>
            <pair e1="DS.d13.s3.e0" e2="DS.d13.s3.e2" id="DS.d13.s3.i0" interaction="True"/>
            <pair e1="DS.d13.s3.e1" e2="DS.d13.s3.e2" id="DS.d13.s3.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d13.s4" origId="17925795-1041" text="Our study demonstrates for the first time that GSK-3 and HDAC are respective initial targets for lithium and VPA to activate BDNF promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.">
            <entity id="DS.d13.s4.e0" origId="P51136,P83101" charOffset="47-52" type="protein" text="GSK-3"/>
            <entity id="DS.d13.s4.e1" origId="28486,3028194" charOffset="97-104" type="compound" text="lithium"/>
            <entity id="DS.d13.s4.e2" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="125-129" type="protein" text="BDNF"/>
            <entity id="DS.d13.s4.e3" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="157-161" type="protein" text="BDNF"/>
            <entity id="DS.d13.s4.e4" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="157-161" type="protein" text="BDNF"/>
            <pair e1="DS.d13.s4.e1" e2="DS.d13.s4.e0" id="DS.d13.s4.i0" interaction="True"/>
            <pair e1="DS.d13.s4.e1" e2="DS.d13.s4.e2" id="DS.d13.s4.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d14" origId="17941873">
        <sentence id="DS.d14.s0" origId="17941873-845" text="Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).">
            <entity id="DS.d14.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="21-28" type="protein" text="insulin"/>
            <entity id="DS.d14.s0.e1" origId="4091" charOffset="52-61" type="compound" text="metformin"/>
            <entity id="DS.d14.s0.e2" origId="4829" charOffset="66-78" type="compound" text="pioglitazone"/>
            <entity id="DS.d14.s0.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="162-169" type="protein" text="Insulin"/>
            <pair e1="DS.d14.s0.e2" e2="DS.d14.s0.e0" id="DS.d14.s0.i0" interaction="False"/>
            <pair e1="DS.d14.s0.e1" e2="DS.d14.s0.e0" id="DS.d14.s0.i1" interaction="False"/>
            <pair e1="DS.d14.s0.e2" e2="DS.d14.s0.e3" id="DS.d14.s0.i2" interaction="False"/>
            <pair e1="DS.d14.s0.e1" e2="DS.d14.s0.e3" id="DS.d14.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d14.s1" origId="17941873-846" text="Efficacy and safety of biphasic insulin aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of metformin and pioglitazone (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.">
            <entity id="DS.d14.s1.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="32-39" type="protein" text="insulin"/>
            <entity id="DS.d14.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="103-110" type="protein" text="insulin"/>
            <entity id="DS.d14.s1.e2" origId="4091" charOffset="154-163" type="compound" text="metformin"/>
            <entity id="DS.d14.s1.e3" origId="4829" charOffset="168-180" type="compound" text="pioglitazone"/>
            <pair e1="DS.d14.s1.e3" e2="DS.d14.s1.e0" id="DS.d14.s1.i0" interaction="False"/>
            <pair e1="DS.d14.s1.e2" e2="DS.d14.s1.e0" id="DS.d14.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d15" origId="17943458">
        <sentence id="DS.d15.s0" origId="17943458-544" text="N-acetylaspartic acid (NAA) is converted into aspartate and acetate by aspartoacylase.">
            <entity id="DS.d15.s0.e0" origId="65065" charOffset="0-21" type="compound" text="N-acetylaspartic acid"/>
            <entity id="DS.d15.s0.e1" origId="5960" charOffset="46-55" type="compound" text="aspartate"/>
            <entity id="DS.d15.s0.e2" origId="53627460" charOffset="60-67" type="compound" text="acetate"/>
            <entity id="DS.d15.s0.e3" origId="P45381,P46446,Q60HH2,Q8R3P0,Q9R1T5" charOffset="71-85" type="protein" text="aspartoacylase"/>
            <pair e1="DS.d15.s0.e0" e2="DS.d15.s0.e3" id="DS.d15.s0.i0" interaction="True"/>
            <pair e1="DS.d15.s0.e1" e2="DS.d15.s0.e3" id="DS.d15.s0.i1" interaction="True"/>
            <pair e1="DS.d15.s0.e2" e2="DS.d15.s0.e3" id="DS.d15.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d16" origId="17950491">
        <sentence id="DS.d16.s0" origId="17950491-1121" text="In addition, treatment with rosiglitazone increased interleukin-4 (IL-4) mRNA and reversed the age-related decrease in hippocampal IL-4 concentration.">
            <entity id="DS.d16.s0.e0" origId="77999" charOffset="28-41" type="compound" text="rosiglitazone"/>
            <entity id="DS.d16.s0.e1" origId="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58" charOffset="67-71" type="protein" text="IL-4"/>
            <entity id="DS.d16.s0.e2" origId="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58" charOffset="131-135" type="protein" text="IL-4"/>
            <pair e1="DS.d16.s0.e0" e2="DS.d16.s0.e1" id="DS.d16.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d17" origId="17965987">
        <sentence id="DS.d17.s0" origId="17965987-545" text="Serum BDNF levels were increased and plasma levels of HVA and MHPG were decreased according to the recovery from the active phase of the disease.">
            <entity id="DS.d17.s0.e0" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="6-10" type="protein" text="BDNF"/>
            <entity id="DS.d17.s0.e1" origId="1738" charOffset="54-57" type="compound" text="HVA"/>
            <entity id="DS.d17.s0.e2" origId="10805" charOffset="62-66" type="compound" text="MHPG"/>
            <pair e1="DS.d17.s0.e1" e2="DS.d17.s0.e0" id="DS.d17.s0.i0" interaction="False"/>
            <pair e1="DS.d17.s0.e2" e2="DS.d17.s0.e0" id="DS.d17.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d17.s1" origId="17965987-546" text="These results suggest that dysfunctions of catecholaminergic neurons and neurotrophic factors might exist in Sydenham's chorea, and the decreasing catecholamine activities in response to risperidone might be associated with the improvement of the disease.">
            <entity id="DS.d17.s1.e0" origId="P18280,P20181,P20783,P25433,P25434,P25435,Q9TST2" charOffset="73-93" type="protein" text="neurotrophic factors"/>
            <entity id="DS.d17.s1.e1" origId="5073" charOffset="187-198" type="compound" text="risperidone"/>
            <pair e1="DS.d17.s1.e1" e2="DS.d17.s1.e0" id="DS.d17.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d18" origId="17968352">
        <sentence id="DS.d18.s0" origId="17968352-734" text="Based on these validities we identified alterations in the Wolframin gene in the CA1 and amygdala regions, specifically in exposed PTSD-like rats, which were normalized after treatment with citalopram.">
            <entity id="DS.d18.s0.e0" origId="O76024,P56695" charOffset="59-68" type="protein" text="Wolframin"/>
            <entity id="DS.d18.s0.e1" origId="2771,146570" charOffset="190-200" type="compound" text="citalopram"/>
            <pair e1="DS.d18.s0.e1" e2="DS.d18.s0.e0" id="DS.d18.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d19" origId="17968676">
        <sentence id="DS.d19.s0" origId="17968676-958" text="Cyclooxygenase-2 (Cox-2) is a key enzyme in the conversion of arachidonic acid to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).">
            <entity id="DS.d19.s0.e0" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="0-16" type="protein" text="Cyclooxygenase-2"/>
            <entity id="DS.d19.s0.e1" origId="P00411,P24894,P35355,Q05769,Q8HEC3,Q8SEM9" charOffset="18-23" type="protein" text="Cox-2"/>
            <entity id="DS.d19.s0.e2" origId="444899" charOffset="62-78" type="compound" text="arachidonic acid"/>
            <pair e1="DS.d19.s0.e2" e2="DS.d19.s0.e0" id="DS.d19.s0.i0" interaction="True"/>
            <pair e1="DS.d19.s0.e2" e2="DS.d19.s0.e1" id="DS.d19.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d20" origId="17976762">
        <sentence id="DS.d20.s0" origId="17976762-900" text="Other potential treatments discussed for possible use with long-acting insulin overdoses include incision and drainage of the injection site, glucagon, and octreotide.">
            <entity id="DS.d20.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="71-78" type="protein" text="insulin"/>
            <entity id="DS.d20.s0.e2" origId="383414,448601" charOffset="156-166" type="compound" text="octreotide"/>
            <pair e1="DS.d20.s0.e2" e2="DS.d20.s0.e0" id="DS.d20.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d21" origId="18037312">
        <sentence id="DS.d21.s0" origId="18037312-321" text="Cadmium inhalation induced: (1) a transient bronchial inflammation, dominated by neutrophils; (2) a neutrophilia of the blood that persisted for up to 4 weeks; (3) a transient increased bronchial reactivity, and (4) a significant increase in MMP-9 activity in the BALF.">
            <entity id="DS.d21.s0.e0" origId="23973" charOffset="0-7" type="compound" text="Cadmium"/>
            <entity id="DS.d21.s0.e1" origId="O18733,P14780,P41245,P41246,P50282,P52176" charOffset="242-247" type="protein" text="MMP-9"/>
            <pair e1="DS.d21.s0.e0" e2="DS.d21.s0.e1" id="DS.d21.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d22" origId="18042181">
        <sentence id="DS.d22.s0" origId="18042181-811" text="To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate GSH production in Sertoli cells by regulating the expression of GCLC, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.">
            <entity id="DS.d22.s0.e0" origId="P03969,P09038,P12226,P13109,P15655,P20003,P48798,P48799,P48800,Q60487" charOffset="57-87" type="protein" text="basic fibroblast growth factor"/>
            <entity id="DS.d22.s0.e1" origId="124886" charOffset="104-107" type="compound" text="GSH"/>
            <entity id="DS.d22.s0.e2" origId="P48506" charOffset="168-172" type="protein" text="GCLC"/>
            <entity id="DS.d22.s0.e3" origId="P48507,Q2T9Y6" charOffset="174-178" type="protein" text="GCLM"/>
            <pair e1="DS.d22.s0.e1" e2="DS.d22.s0.e3" id="DS.d22.s0.i0" interaction="False"/>
            <pair e1="DS.d22.s0.e1" e2="DS.d22.s0.e0" id="DS.d22.s0.i1" interaction="False"/>
            <pair e1="DS.d22.s0.e1" e2="DS.d22.s0.e2" id="DS.d22.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d22.s1" origId="18042181-812" text="In conclusion, our results show that FSH and bFGF increase GSH levels in Sertoli cells through stimulation of the de novo synthesis and recycling by upregulating GCLM and GR expression respectively.">
            <entity id="DS.d22.s1.e0" origId="124886" charOffset="59-62" type="compound" text="GSH"/>
            <entity id="DS.d22.s1.e1" origId="P48507,Q2T9Y6" charOffset="162-166" type="protein" text="GCLM"/>
            <pair e1="DS.d22.s1.e0" e2="DS.d22.s1.e1" id="DS.d22.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d23" origId="18061671">
        <sentence id="DS.d23.s0" origId="18061671-207" text="Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.">
            <entity id="DS.d23.s0.e0" origId="54670067,54690394" charOffset="132-145" type="compound" text="ascorbic acid"/>
            <entity id="DS.d23.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="147-155" type="protein" text="catalase"/>
            <entity id="DS.d23.s0.e2" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="157-160" type="protein" text="CAT"/>
            <entity id="DS.d23.s0.e3" origId="614,8988,145742" charOffset="246-253" type="compound" text="proline"/>
            <entity id="DS.d23.s0.e4" origId="O50258" charOffset="264-284" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d23.s0.e5" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="286-289" type="protein" text="SOD"/>
            <entity id="DS.d23.s0.e6" origId="P15984,P16147,P84714" charOffset="295-305" type="protein" text="peroxidase"/>
            <entity id="DS.d23.s0.e7" origId="P59097,P79076,Q5B2E9,Q5G234,Q6QWR1,Q6UG02,Q75ZP8,Q8J136,Q8J2V8" charOffset="307-310" type="protein" text="POD"/>
            <entity id="DS.d23.s0.e8" origId="P22079,P80025" charOffset="328-331" type="protein" text="LPO"/>
            <pair e1="DS.d23.s0.e0" e2="DS.d23.s0.e6" id="DS.d23.s0.i0" interaction="False"/>
            <pair e1="DS.d23.s0.e3" e2="DS.d23.s0.e6" id="DS.d23.s0.i1" interaction="False"/>
            <pair e1="DS.d23.s0.e3" e2="DS.d23.s0.e2" id="DS.d23.s0.i2" interaction="False"/>
            <pair e1="DS.d23.s0.e0" e2="DS.d23.s0.e1" id="DS.d23.s0.i3" interaction="False"/>
            <pair e1="DS.d23.s0.e3" e2="DS.d23.s0.e5" id="DS.d23.s0.i4" interaction="False"/>
            <pair e1="DS.d23.s0.e0" e2="DS.d23.s0.e7" id="DS.d23.s0.i5" interaction="False"/>
            <pair e1="DS.d23.s0.e0" e2="DS.d23.s0.e2" id="DS.d23.s0.i6" interaction="False"/>
            <pair e1="DS.d23.s0.e0" e2="DS.d23.s0.e5" id="DS.d23.s0.i7" interaction="False"/>
            <pair e1="DS.d23.s0.e3" e2="DS.d23.s0.e8" id="DS.d23.s0.i8" interaction="False"/>
            <pair e1="DS.d23.s0.e3" e2="DS.d23.s0.e4" id="DS.d23.s0.i9" interaction="False"/>
            <pair e1="DS.d23.s0.e3" e2="DS.d23.s0.e7" id="DS.d23.s0.i10" interaction="False"/>
            <pair e1="DS.d23.s0.e3" e2="DS.d23.s0.e1" id="DS.d23.s0.i11" interaction="False"/>
            <pair e1="DS.d23.s0.e0" e2="DS.d23.s0.e8" id="DS.d23.s0.i12" interaction="False"/>
            <pair e1="DS.d23.s0.e0" e2="DS.d23.s0.e4" id="DS.d23.s0.i13" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d24" origId="18068270">
        <sentence id="DS.d24.s0" origId="18068270-465" text="Selenium and aluminum levels were not associated to CSF Abeta42.">
            <entity id="DS.d24.s0.e0" origId="5359268" charOffset="13-21" type="compound" text="aluminum"/>
            <entity id="DS.d24.s0.e1" origId="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481" charOffset="52-55" type="protein" text="CSF"/>
            <pair e1="DS.d24.s0.e0" e2="DS.d24.s0.e1" id="DS.d24.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d24.s1" origId="18068270-466" text="In vitro, the degradation of synthetic Abeta substrate added to CSF was markedly accelerated by low levels (2microM) of exogenous zinc and copper.">
            <entity id="DS.d24.s1.e0" origId="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481" charOffset="64-67" type="protein" text="CSF"/>
            <entity id="DS.d24.s1.e1" origId="23978" charOffset="139-145" type="compound" text="copper"/>
            <pair e1="DS.d24.s1.e1" e2="DS.d24.s1.e0" id="DS.d24.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d25" origId="18068871">
        <sentence id="DS.d25.s0" origId="18068871-859" text="Presenilin-1 mutation impairs cholinergic modulation of synaptic plasticity and suppresses NMDA currents in hippocampus slices.">
            <entity id="DS.d25.s0.e0" origId="O12976,P49768,P49769,P79802,P97887,Q4JIM4,Q5R780,Q6RH31,Q8HXW5,Q9W6T7,Q9XT97" charOffset="0-12" type="protein" text="Presenilin-1"/>
            <entity id="DS.d25.s0.e1" origId="22880" charOffset="91-95" type="compound" text="NMDA"/>
            <pair e1="DS.d25.s0.e1" e2="DS.d25.s0.e0" id="DS.d25.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d25.s1" origId="18068871-860" text="Similarly, mutant PS1 impairs the ability of the cholinesterase inhibitor phenserine to enhance LTP.">
            <entity id="DS.d25.s1.e0" origId="P49768,P79802,Q8HXW5,Q9W6T7" charOffset="18-21" type="protein" text="PS1"/>
            <entity id="DS.d25.s1.e1" origId="192706,9905831,10337156" charOffset="74-84" type="compound" text="phenserine"/>
            <pair e1="DS.d25.s1.e1" e2="DS.d25.s1.e0" id="DS.d25.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d26" origId="18077014">
        <sentence id="DS.d26.s0" origId="18077014-827" text="It was found that the expression of SSAT and ODC were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while putrescine concentration was significantly increased.">
            <entity id="DS.d26.s0.e0" origId="P21673,P48026,P49431,Q01612,Q28999,Q3T0Q0,Q8AXL1,Q9JHW6" charOffset="36-40" type="protein" text="SSAT"/>
            <entity id="DS.d26.s0.e1" origId="O22616,P00860,P07805,P08432,P09057,P11926,P14019,P27116,P27117,P27118,P27119,P27121,P40807,P40808,P41931,P43099,P49725,P50134,P78599,Q5RFB7,Q8S3N2,Q92445,Q9BQT8,Q9UQW9" charOffset="45-48" type="protein" text="ODC"/>
            <entity id="DS.d26.s0.e2" origId="1102" charOffset="110-120" type="compound" text="spermidine"/>
            <entity id="DS.d26.s0.e3" origId="1103" charOffset="125-133" type="compound" text="spermine"/>
            <entity id="DS.d26.s0.e4" origId="1045" charOffset="170-180" type="compound" text="putrescine"/>
            <pair e1="DS.d26.s0.e3" e2="DS.d26.s0.e1" id="DS.d26.s0.i0" interaction="True"/>
            <pair e1="DS.d26.s0.e4" e2="DS.d26.s0.e0" id="DS.d26.s0.i1" interaction="True"/>
            <pair e1="DS.d26.s0.e3" e2="DS.d26.s0.e0" id="DS.d26.s0.i2" interaction="True"/>
            <pair e1="DS.d26.s0.e4" e2="DS.d26.s0.e1" id="DS.d26.s0.i3" interaction="True"/>
            <pair e1="DS.d26.s0.e2" e2="DS.d26.s0.e0" id="DS.d26.s0.i4" interaction="True"/>
            <pair e1="DS.d26.s0.e2" e2="DS.d26.s0.e1" id="DS.d26.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d27" origId="18079026">
        <sentence id="DS.d27.s0" origId="18079026-797" text="In the present study, we investigated the effects of quetiapine on memory impairment and pathological changes in an amyloid precursor protein (APP)/presenilin-1 (PS-1) double transgenic mouse model of Alzheimer's disease (AD).">
            <entity id="DS.d27.s0.e0" origId="5002" charOffset="53-63" type="compound" text="quetiapine"/>
            <entity id="DS.d27.s0.e1" origId="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241" charOffset="143-146" type="protein" text="APP"/>
            <entity id="DS.d27.s0.e2" origId="O12976,P49768,P49769,P79802,P97887,Q4JIM4,Q5R780,Q6RH31,Q8HXW5,Q9W6T7,Q9XT97" charOffset="148-160" type="protein" text="presenilin-1"/>
            <entity id="DS.d27.s0.e3" origId="P49768,P49769,P79802,P84566,P97887,Q5R780,Q6RH31,Q8HXW5,Q9XT97" charOffset="162-166" type="protein" text="PS-1"/>
            <pair e1="DS.d27.s0.e0" e2="DS.d27.s0.e2" id="DS.d27.s0.i0" interaction="False"/>
            <pair e1="DS.d27.s0.e0" e2="DS.d27.s0.e3" id="DS.d27.s0.i1" interaction="False"/>
            <pair e1="DS.d27.s0.e0" e2="DS.d27.s0.e1" id="DS.d27.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d27.s1" origId="18079026-798" text="Quetiapine also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of C99 (an APP C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.">
            <entity id="DS.d27.s1.e0" origId="5002" charOffset="0-10" type="compound" text="Quetiapine"/>
            <entity id="DS.d27.s1.e1" origId="P05067,P08592,P12023,P53601,P79307,Q5IS80,Q95241" charOffset="105-108" type="protein" text="C99"/>
            <entity id="DS.d27.s1.e2" origId="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241" charOffset="113-116" type="protein" text="APP"/>
            <pair e1="DS.d27.s1.e0" e2="DS.d27.s1.e1" id="DS.d27.s1.i0" interaction="True"/>
            <pair e1="DS.d27.s1.e0" e2="DS.d27.s1.e2" id="DS.d27.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d27.s2" origId="18079026-799" text="Furthermore, quetiapine attenuated anxiety-like behavior, up-regulated cerebral Bcl-2 protein, and decreased cerebral nitrotyrosine in the transgenic mice.">
            <entity id="DS.d27.s2.e0" origId="5002" charOffset="13-23" type="compound" text="quetiapine"/>
            <entity id="DS.d27.s2.e1" origId="P10417,P49950" charOffset="80-85" type="protein" text="Bcl-2"/>
            <pair e1="DS.d27.s2.e0" e2="DS.d27.s2.e1" id="DS.d27.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d28" origId="18162361">
        <sentence id="DS.d28.s0" origId="18162361-61" text="Rosuvastatin rapidly phosphorylated Akt and endothelial nitric oxide synthase (eNOS) in human endothelial cells.">
            <entity id="DS.d28.s0.e0" origId="446157" charOffset="0-12" type="compound" text="Rosuvastatin"/>
            <entity id="DS.d28.s0.e1" origId="P31750,Q8INB9" charOffset="36-39" type="protein" text="Akt"/>
            <entity id="DS.d28.s0.e2" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="56-77" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d28.s0.e3" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="79-83" type="protein" text="eNOS"/>
            <pair e1="DS.d28.s0.e0" e2="DS.d28.s0.e2" id="DS.d28.s0.i0" interaction="True"/>
            <pair e1="DS.d28.s0.e0" e2="DS.d28.s0.e3" id="DS.d28.s0.i1" interaction="True"/>
            <pair e1="DS.d28.s0.e0" e2="DS.d28.s0.e1" id="DS.d28.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d28.s1" origId="18162361-62" text="Our findings indicate that rosuvastatin protects endothelial cells from death with phosphorylation of Akt and eNOS.">
            <entity id="DS.d28.s1.e0" origId="446157" charOffset="27-39" type="compound" text="rosuvastatin"/>
            <entity id="DS.d28.s1.e1" origId="P31750,Q8INB9" charOffset="102-105" type="protein" text="Akt"/>
            <entity id="DS.d28.s1.e2" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="110-114" type="protein" text="eNOS"/>
            <pair e1="DS.d28.s1.e0" e2="DS.d28.s1.e2" id="DS.d28.s1.i0" interaction="True"/>
            <pair e1="DS.d28.s1.e0" e2="DS.d28.s1.e1" id="DS.d28.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d29" origId="18164165">
        <sentence id="DS.d29.s0" origId="18164165-377" text="Superoxide dismutase and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.">
            <entity id="DS.d29.s0.e0" origId="O50258" charOffset="0-20" type="protein" text="Superoxide dismutase"/>
            <entity id="DS.d29.s0.e1" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="25-47" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d29.s0.e2" origId="10964" charOffset="82-97" type="compound" text="malondialdehyde"/>
            <entity id="DS.d29.s0.e3" origId="5280489" charOffset="142-155" type="compound" text="beta-carotene"/>
            <entity id="DS.d29.s0.e4" origId="445354" charOffset="157-164" type="compound" text="retinol"/>
            <entity id="DS.d29.s0.e5" origId="54670067" charOffset="166-175" type="compound" text="vitamin C"/>
            <entity id="DS.d29.s0.e6" origId="2116,14985,1548900,1742129" charOffset="177-186" type="compound" text="vitamin E"/>
            <entity id="DS.d29.s0.e7" origId="124886" charOffset="188-207" type="compound" text="reduced glutathione"/>
            <pair e1="DS.d29.s0.e4" e2="DS.d29.s0.e0" id="DS.d29.s0.i0" interaction="False"/>
            <pair e1="DS.d29.s0.e5" e2="DS.d29.s0.e0" id="DS.d29.s0.i1" interaction="False"/>
            <pair e1="DS.d29.s0.e2" e2="DS.d29.s0.e1" id="DS.d29.s0.i2" interaction="False"/>
            <pair e1="DS.d29.s0.e7" e2="DS.d29.s0.e0" id="DS.d29.s0.i3" interaction="False"/>
            <pair e1="DS.d29.s0.e6" e2="DS.d29.s0.e1" id="DS.d29.s0.i4" interaction="False"/>
            <pair e1="DS.d29.s0.e6" e2="DS.d29.s0.e0" id="DS.d29.s0.i5" interaction="False"/>
            <pair e1="DS.d29.s0.e5" e2="DS.d29.s0.e1" id="DS.d29.s0.i6" interaction="False"/>
            <pair e1="DS.d29.s0.e4" e2="DS.d29.s0.e1" id="DS.d29.s0.i7" interaction="False"/>
            <pair e1="DS.d29.s0.e7" e2="DS.d29.s0.e1" id="DS.d29.s0.i8" interaction="False"/>
            <pair e1="DS.d29.s0.e2" e2="DS.d29.s0.e0" id="DS.d29.s0.i9" interaction="False"/>
            <pair e1="DS.d29.s0.e3" e2="DS.d29.s0.e0" id="DS.d29.s0.i10" interaction="False"/>
            <pair e1="DS.d29.s0.e3" e2="DS.d29.s0.e1" id="DS.d29.s0.i11" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d30" origId="18172601">
        <sentence id="DS.d30.s0" origId="18172601-392" text="Structure-function studies of nitrated SERCA2 in aging heart and skeletal muscle demonstrate stoichiometric nitration of vicinal tyrosines, Tyr (294) and Tyr (295), on the lumenal side of the membrane-spanning helix, M4, which correlates with partial inhibition of Ca(2+)-ATPase activity suggesting a possible regulatory function in down-regulating mitochondrial energy production and the associated generation of reactive oxygen/nitrogen species.">
            <entity id="DS.d30.s0.e0" origId="O46674,O55143,P11507,P11607,P16615,P20647,Q00779,Q03669" charOffset="39-45" type="protein" text="SERCA2"/>
            <entity id="DS.d30.s0.e1" origId="16682741" charOffset="217-219" type="compound" text="M4"/>
            <entity id="DS.d30.s0.e2" origId="977" charOffset="423-429" type="compound" text="oxygen"/>
            <entity id="DS.d30.s0.e3" origId="947,123329" charOffset="430-438" type="compound" text="nitrogen"/>
            <pair e1="DS.d30.s0.e1" e2="DS.d30.s0.e0" id="DS.d30.s0.i0" interaction="False"/>
            <pair e1="DS.d30.s0.e2" e2="DS.d30.s0.e0" id="DS.d30.s0.i1" interaction="False"/>
            <pair e1="DS.d30.s0.e3" e2="DS.d30.s0.e0" id="DS.d30.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d31" origId="18177531">
        <sentence id="DS.d31.s0" origId="18177531-936" text="Carbon monoxide is an endogenous vasodilator gas produced by the enzyme heme oxygenase (HO).">
            <entity id="DS.d31.s0.e0" origId="281" charOffset="0-15" type="compound" text="Carbon monoxide"/>
            <entity id="DS.d31.s0.e1" origId="O19998,O73688,O78497,P51271,P71119" charOffset="72-86" type="protein" text="heme oxygenase"/>
            <pair e1="DS.d31.s0.e0" e2="DS.d31.s0.e1" id="DS.d31.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d32" origId="18179560">
        <sentence id="DS.d32.s0" origId="18179560-930" text="The long pentraxin 3 (PTX3) is a multifunctional soluble pattern recognition receptor, involved in several processes ranging from innate resistance and inflammation to clearance of apoptotic cells and organization of hyaluronic acid-rich extracellular matrices.">
            <entity id="DS.d32.s0.e0" origId="O75364,P26022" charOffset="22-26" type="protein" text="PTX3"/>
            <entity id="DS.d32.s0.e1" origId="24759,453618,3084050,24728612" charOffset="217-232" type="compound" text="hyaluronic acid"/>
            <pair e1="DS.d32.s0.e1" e2="DS.d32.s0.e0" id="DS.d32.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d33" origId="18180755">
        <sentence id="DS.d33.s0" origId="18180755-369" text="The FKBP5 gene product forms part of a complex with the glucocorticoid receptor and can modulate cortisol-binding affinity.">
            <entity id="DS.d33.s0.e0" origId="P0C1J7,Q13451,Q5RF88,Q95L05,Q9XSH5,Q9XSI2,Q9XT11" charOffset="4-9" type="protein" text="FKBP5"/>
            <entity id="DS.d33.s0.e1" origId="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3" charOffset="56-79" type="protein" text="glucocorticoid receptor"/>
            <entity id="DS.d33.s0.e2" origId="5754" charOffset="97-105" type="compound" text="cortisol"/>
            <pair e1="DS.d33.s0.e2" e2="DS.d33.s0.e0" id="DS.d33.s0.i0" interaction="True"/>
            <pair e1="DS.d33.s0.e2" e2="DS.d33.s0.e1" id="DS.d33.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d34" origId="18190985">
        <sentence id="DS.d34.s0" origId="18190985-361" text="Several studies have shown that epsilon 2 carriers have lower low-density lipoprotein and apo B levels and higher high-density lipoprotein cholesterol and apo A-I levels than epsilon 3 carriers.">
            <entity id="DS.d34.s0.e0" origId="P05463" charOffset="32-39" type="protein" text="epsilon"/>
            <entity id="DS.d34.s0.e1" origId="P81182" charOffset="114-138" type="protein" text="high-density lipoprotein"/>
            <entity id="DS.d34.s0.e2" origId="304,5997,6432564,11025495" charOffset="139-150" type="compound" text="cholesterol"/>
            <entity id="DS.d34.s0.e3" origId="P05463" charOffset="175-182" type="protein" text="epsilon"/>
            <pair e1="DS.d34.s0.e2" e2="DS.d34.s0.e1" id="DS.d34.s0.i0" interaction="True"/>
            <pair e1="DS.d34.s0.e2" e2="DS.d34.s0.e0" id="DS.d34.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d35" origId="18191451">
        <sentence id="DS.d35.s0" origId="18191451-670" text="Toxicity and characterization of cholinesterase-inhibition induced by diisopropyl fluorophosphate in Artemia salina larvae.">
            <entity id="DS.d35.s0.e0" origId="P32749,P32750,P32751,P32752,P32753,P81908" charOffset="33-47" type="protein" text="cholinesterase"/>
            <entity id="DS.d35.s0.e1" origId="5936" charOffset="70-97" type="compound" text="diisopropyl fluorophosphate"/>
            <pair e1="DS.d35.s0.e1" e2="DS.d35.s0.e0" id="DS.d35.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d36" origId="18195714">
        <sentence id="DS.d36.s0" origId="18195714-756" text="Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.">
            <entity id="DS.d36.s0.e0" origId="11970143" charOffset="0-18" type="compound" text="Lipopolysaccharide"/>
            <entity id="DS.d36.s0.e1" origId="P14902,P28776" charOffset="67-94" type="protein" text="indoleamine 2,3-dioxygenase"/>
            <pair e1="DS.d36.s0.e0" e2="DS.d36.s0.e1" id="DS.d36.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d36.s1" origId="18195714-757" text="We report that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests.">
            <entity id="DS.d36.s1.e0" origId="11970143" charOffset="44-62" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d36.s1.e1" origId="P14902,P28776" charOffset="79-82" type="protein" text="IDO"/>
            <pair e1="DS.d36.s1.e0" e2="DS.d36.s1.e1" id="DS.d36.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d36.s2" origId="18195714-758" text="Administration of L-kynurenine, a metabolite of tryptophan that is generated by IDO, to naive mice dose dependently induces depressive-like behavior.">
            <entity id="DS.d36.s2.e0" origId="846" charOffset="20-30" type="compound" text="kynurenine"/>
            <entity id="DS.d36.s2.e1" origId="1148,6305,9060,5460840" charOffset="48-58" type="compound" text="tryptophan"/>
            <entity id="DS.d36.s2.e2" origId="P14902,P28776" charOffset="80-83" type="protein" text="IDO"/>
            <pair e1="DS.d36.s2.e0" e2="DS.d36.s2.e2" id="DS.d36.s2.i0" interaction="True"/>
            <pair e1="DS.d36.s2.e1" e2="DS.d36.s2.e2" id="DS.d36.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d37" origId="18198986">
        <sentence id="DS.d37.s0" origId="18198986-243" text="Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment.">
            <entity id="DS.d37.s0.e0" origId="O42494,O45035,O76821,P80547,Q17284,Q8MUC1,Q9U5P1" charOffset="16-42" type="protein" text="fatty acid binding protein"/>
            <entity id="DS.d37.s0.e1" origId="3339" charOffset="122-133" type="compound" text="fenofibrate"/>
            <pair e1="DS.d37.s0.e1" e2="DS.d37.s0.e0" id="DS.d37.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d37.s1" origId="18198986-245" text="Serum FABP levels were 2.5-fold higher in T2DM group relative to C and were not affected by fenofibrate treatment (C: 20.6+/-2.1 microg/l, T2DM before F: 55.6+/-5.7 microg/l, T2DM after F: 54.2+/-5.4 microg/l, p 0.0001 for C vs. T2DM before F).">
            <entity id="DS.d37.s1.e0" origId="P80565" charOffset="6-10" type="protein" text="FABP"/>
            <entity id="DS.d37.s1.e1" origId="3339" charOffset="92-103" type="compound" text="fenofibrate"/>
            <pair e1="DS.d37.s1.e1" e2="DS.d37.s1.e0" id="DS.d37.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d37.s2" origId="18198986-246" text="FABP levels positively correlated with BMI, triglyceride levels, blood glucose, glycated hemoglobin, atherogenic index and insulin levels.">
            <entity id="DS.d37.s2.e0" origId="P80565" charOffset="0-4" type="protein" text="FABP"/>
            <entity id="DS.d37.s2.e1" origId="206,5793,64689,79025" charOffset="71-78" type="compound" text="glucose"/>
            <entity id="DS.d37.s2.e2" origId="P15160,P17724,P73925,Q03459" charOffset="89-99" type="protein" text="hemoglobin"/>
            <entity id="DS.d37.s2.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="123-130" type="protein" text="insulin"/>
            <pair e1="DS.d37.s2.e1" e2="DS.d37.s2.e2" id="DS.d37.s2.i0" interaction="False"/>
            <pair e1="DS.d37.s2.e1" e2="DS.d37.s2.e0" id="DS.d37.s2.i1" interaction="True"/>
            <pair e1="DS.d37.s2.e1" e2="DS.d37.s2.e3" id="DS.d37.s2.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d38" origId="18198997">
        <sentence id="DS.d38.s0" origId="18198997-256" text="Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon.">
            <entity id="DS.d38.s0.e0" origId="264" charOffset="0-8" type="compound" text="Butyrate"/>
            <entity id="DS.d38.s0.e1" origId="P0A9M0" charOffset="27-30" type="protein" text="Muc"/>
            <pair e1="DS.d38.s0.e0" e2="DS.d38.s0.e1" id="DS.d38.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d38.s1" origId="18198997-257" text="We demonstrated that butyrate stimulated the gene expression of both secreted (Muc2) and membrane-linked (Muc1, Muc3, Muc4) mucins.">
            <entity id="DS.d38.s1.e0" origId="264" charOffset="21-29" type="compound" text="butyrate"/>
            <entity id="DS.d38.s1.e1" origId="Q62635" charOffset="79-83" type="protein" text="Muc2"/>
            <entity id="DS.d38.s1.e2" origId="Q02496" charOffset="106-110" type="protein" text="Muc1"/>
            <pair e1="DS.d38.s1.e0" e2="DS.d38.s1.e1" id="DS.d38.s1.i0" interaction="True"/>
            <pair e1="DS.d38.s1.e0" e2="DS.d38.s1.e2" id="DS.d38.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d38.s2" origId="18198997-258" text="Butyrate especially induced a 6-fold increase in Muc2 gene expression in proximal colon.">
            <entity id="DS.d38.s2.e0" origId="264" charOffset="0-8" type="compound" text="Butyrate"/>
            <entity id="DS.d38.s2.e1" origId="Q62635" charOffset="49-53" type="protein" text="Muc2"/>
            <pair e1="DS.d38.s2.e0" e2="DS.d38.s2.e1" id="DS.d38.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d38.s3" origId="18198997-259" text="However, butyrate enemas did not modify the number of epithelial cells containing the protein Muc2, and caused a 2-fold decrease in the thickness of adherent mucus layer.">
            <entity id="DS.d38.s3.e0" origId="264" charOffset="9-17" type="compound" text="butyrate"/>
            <entity id="DS.d38.s3.e1" origId="Q62635" charOffset="94-98" type="protein" text="Muc2"/>
            <pair e1="DS.d38.s3.e0" e2="DS.d38.s3.e1" id="DS.d38.s3.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d39" origId="18204887">
        <sentence id="DS.d39.s0" origId="18204887-141" text="We examined the association of MTHFR C677T and A1298C, and changes in plasma homocysteine in 352 Tunisian patients with angiographically-demonstrated CAD, and 390 age and gender-matched healthy subjects.">
            <entity id="DS.d39.s0.e0" origId="P42898,Q5I598,Q60HE5" charOffset="31-36" type="protein" text="MTHFR"/>
            <entity id="DS.d39.s0.e1" origId="778" charOffset="77-89" type="compound" text="homocysteine"/>
            <pair e1="DS.d39.s0.e1" e2="DS.d39.s0.e0" id="DS.d39.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d40" origId="18205042">
        <sentence id="DS.d40.s0" origId="18205042-213" text="However, we also observed that clotrimazol (1alpha-hydroxylase inhibitor) enhanced 25(OH)D(3)-induced CYP24 expression in breast cancer cells.">
            <entity id="DS.d40.s0.e0" origId="2812" charOffset="31-42" type="compound" text="clotrimazol"/>
            <entity id="DS.d40.s0.e1" origId="Q07973" charOffset="102-107" type="protein" text="CYP24"/>
            <pair e1="DS.d40.s0.e0" e2="DS.d40.s0.e1" id="DS.d40.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d41" origId="18207583">
        <sentence id="DS.d41.s0" origId="18207583-646" text="Expression of senescence-associated beta-galactosidase (SA-beta-Gal) by human skin fibroblasts, effect of advanced glycation end-products and fucose or rhamnose-rich polysaccharides.">
            <entity id="DS.d41.s0.e0" origId="O33815,O52629,O52847,P00722,P00723,P06219,P0C1Y0,P14288,P22498,P23989,P24131,P26257,P30812,P50388,P70753,P77989,P81650,Q1G9Z4,Q47077,Q48727,Q56307,Q59140,Q59750,Q9K9C6" charOffset="36-54" type="protein" text="beta-galactosidase"/>
            <entity id="DS.d41.s0.e1" origId="P10683,P11886,P47212" charOffset="64-67" type="protein" text="Gal"/>
            <entity id="DS.d41.s0.e2" origId="840,17106,19466,94270,439554" charOffset="142-148" type="compound" text="fucose"/>
            <pair e1="DS.d41.s0.e2" e2="DS.d41.s0.e1" id="DS.d41.s0.i0" interaction="False"/>
            <pair e1="DS.d41.s0.e2" e2="DS.d41.s0.e0" id="DS.d41.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d42" origId="18221806">
        <sentence id="DS.d42.s0" origId="18221806-436" text="Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial nitric oxide synthase.">
            <entity id="DS.d42.s0.e0" origId="54454,4677798" charOffset="25-36" type="compound" text="simvastatin"/>
            <entity id="DS.d42.s0.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="159-180" type="protein" text="nitric oxide synthase"/>
            <pair e1="DS.d42.s0.e0" e2="DS.d42.s0.e1" id="DS.d42.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d43" origId="18222028">
        <sentence id="DS.d43.s0" origId="18222028-559" text="It has been shown that the removal efficiency of COD increased with the increasing applied current density and increasing PAC and Na (2)SO(4) dosage and the most effective removal capacity was achieved at the pH 7.">
            <entity id="DS.d43.s0.e0" origId="P14678" charOffset="49-52" type="protein" text="COD"/>
            <entity id="DS.d43.s0.e1" origId="923,373840" charOffset="130-132" type="compound" text="Na"/>
            <pair e1="DS.d43.s0.e1" e2="DS.d43.s0.e0" id="DS.d43.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d44" origId="18222543">
        <sentence id="DS.d44.s0" origId="18222543-918" text="The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.">
            <entity id="DS.d44.s0.e0" origId="6001" charOffset="92-96" type="compound" text="DMBA"/>
            <entity id="DS.d44.s0.e1" origId="O50258" charOffset="132-152" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d44.s0.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="154-157" type="protein" text="SOD"/>
            <entity id="DS.d44.s0.e3" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="160-168" type="protein" text="catalase"/>
            <entity id="DS.d44.s0.e4" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="170-173" type="protein" text="CAT"/>
            <entity id="DS.d44.s0.e5" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="176-198" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d44.s0.e6" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="210-231" type="protein" text="glutathione reductase"/>
            <entity id="DS.d44.s0.e7" origId="124886" charOffset="176-187" type="compound" text="glutathione"/>
            <entity id="DS.d44.s0.e8" origId="124886" charOffset="271-274" type="compound" text="GSH"/>
            <pair e1="DS.d44.s0.e7" e2="DS.d44.s0.e4" id="DS.d44.s0.i0" interaction="False"/>
            <pair e1="DS.d44.s0.e0" e2="DS.d44.s0.e5" id="DS.d44.s0.i1" interaction="False"/>
            <pair e1="DS.d44.s0.e8" e2="DS.d44.s0.e2" id="DS.d44.s0.i2" interaction="False"/>
            <pair e1="DS.d44.s0.e8" e2="DS.d44.s0.e5" id="DS.d44.s0.i3" interaction="False"/>
            <pair e1="DS.d44.s0.e7" e2="DS.d44.s0.e2" id="DS.d44.s0.i4" interaction="False"/>
            <pair e1="DS.d44.s0.e0" e2="DS.d44.s0.e6" id="DS.d44.s0.i5" interaction="False"/>
            <pair e1="DS.d44.s0.e7" e2="DS.d44.s0.e5" id="DS.d44.s0.i6" interaction="False"/>
            <pair e1="DS.d44.s0.e8" e2="DS.d44.s0.e1" id="DS.d44.s0.i7" interaction="False"/>
            <pair e1="DS.d44.s0.e0" e2="DS.d44.s0.e2" id="DS.d44.s0.i8" interaction="False"/>
            <pair e1="DS.d44.s0.e0" e2="DS.d44.s0.e1" id="DS.d44.s0.i9" interaction="False"/>
            <pair e1="DS.d44.s0.e0" e2="DS.d44.s0.e3" id="DS.d44.s0.i10" interaction="False"/>
            <pair e1="DS.d44.s0.e8" e2="DS.d44.s0.e4" id="DS.d44.s0.i11" interaction="False"/>
            <pair e1="DS.d44.s0.e7" e2="DS.d44.s0.e1" id="DS.d44.s0.i12" interaction="False"/>
            <pair e1="DS.d44.s0.e7" e2="DS.d44.s0.e6" id="DS.d44.s0.i13" interaction="False"/>
            <pair e1="DS.d44.s0.e8" e2="DS.d44.s0.e3" id="DS.d44.s0.i14" interaction="False"/>
            <pair e1="DS.d44.s0.e8" e2="DS.d44.s0.e6" id="DS.d44.s0.i15" interaction="False"/>
            <pair e1="DS.d44.s0.e0" e2="DS.d44.s0.e4" id="DS.d44.s0.i16" interaction="False"/>
            <pair e1="DS.d44.s0.e7" e2="DS.d44.s0.e3" id="DS.d44.s0.i17" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d45" origId="18226951">
        <sentence id="DS.d45.s0" origId="18226951-1110" text="Abnormally high CSF 3-OMD occurs frequently for RLS patients indicating either increased l-dopa synthesis, limitations in l-dopa decarboxylation or increased MAT/COMT activity, or some combination of these.">
            <entity id="DS.d45.s0.e0" origId="6047" charOffset="89-95" type="compound" text="l-dopa"/>
            <entity id="DS.d45.s0.e1" origId="6047" charOffset="122-128" type="compound" text="l-dopa"/>
            <entity id="DS.d45.s0.e2" origId="O50163,O67222,O83772,P0A817,P0A818,P0A819,P0A820,P24752,P43762,P47293,P50307,P54419,P56460,P56878,P57486,P57897,P61945,P61946,P66764,P66765,P66766,P66767,P72871,P77899,P78003,Q1QCH2,Q21NJ5,Q21RM4,Q28UI9,Q2A1N2,Q2FFV6,Q2GBP1,Q2IM98,Q2IZR2,Q2JIN3,Q2JV74,Q2NRD1,Q2NZF1,Q2RK28,Q2RYY4,Q2SLT3,Q2SS11,Q2T267,Q2VYQ2,Q2Y5Z1,Q2YTK1,Q30PN0,Q311V1,Q31CL7,Q31EL0,Q31KC6,Q31WK4,Q32C11,Q38YF8,Q39BZ1,Q39W48,Q3A388,Q3AFS4,Q3AME2,Q3AQC3,Q3AWE6,Q3B531,Q3BXB7,Q3IDQ1,Q3IW86,Q3J7R5,Q3JX94,Q3K1M7,Q3K5E8,Q3MF32,Q3SFY2,Q3YXS9,Q3Z943,Q3ZZN7,Q46H57,Q476V0,Q47JN4,Q47R14,Q486L6,Q48CH3,Q48SU7,Q493F2,Q49YL6,Q4A5F4,Q4FNN1,Q4FTH7,Q4JVH7,Q4K4I7,Q4L7C7,Q4QLC5,Q4UR08,Q4ZM01,Q57K26,Q5E7R2,Q5FAC0,Q5FIN8,Q5FSK6,Q5GW76,Q5HEY9,Q5HNB8,Q5KW02,Q5LJ26,Q5LLL2,Q5LZI0,Q5M434,Q5N1I9,Q5NIC7,Q5NQV7,Q5P2V5,Q5PJJ2,Q5QVM7,Q5SHT8,Q5WDZ8,Q5WV18,Q5X3N0,Q5XBJ6,Q5YTN0,Q5ZTY6,Q60CG7,Q62EZ1,Q632S5,Q63YH5,Q650L4,Q65FV8,Q65UT4,Q661P3,Q666P5,Q67T90,Q6A8H3,Q6AF79,Q6AQ43,Q6D081,Q6F1M6,Q6FAQ6,Q6G8E3,Q6GFR6,Q6HCB4,Q6LMM8,Q6MPK2,Q6MTB6,Q71Z03,Q729A3,Q72I53,Q72SM5,Q72YV6,Q73JR4,Q741G5,Q74KS4,Q7M7Z2,Q7MHK6,Q7MTQ0,Q7N119,Q7NHG0,Q7NZF9,Q7U051,Q7U4S6,Q7URU7,Q7V2Y8,Q7V5A2,Q7VDM7,Q7VFY5,Q7VNG7,Q7VRG5,Q7VUL5,Q7W200,Q7WQX8,Q7WYG5,Q7WYN1,Q816Q8,Q81KI0,Q827Q0,Q82WL2,Q837P9,Q83A78,Q83GE4,Q83HT7,Q84FD3,Q87AY6,Q87LK6,Q88AK7,Q88D60,Q88XB8,Q898W7,Q89HP5,Q8A2T6,Q8CNT5,Q8CXS7,Q8D2N8,Q8DCA3,Q8DK88,Q8DQH0,Q8DT23,Q8E0A3,Q8E5Y0,Q8EIB4,Q8EP05,Q8FT48,Q8G3H4,Q8K715,Q8K9E5,Q8KEG7,Q8NVZ9,Q8P0G6,Q8PCH3,Q8PP75,Q8RCE4,Q8RGE5,Q8Y347,Q8Y6M0,Q8ZHG7,Q92AZ5,Q938W7,Q97F85,Q97RN9,Q98A80,Q98PM0,Q99Z77,Q9CCQ4,Q9CEE0,Q9I5Z0,Q9JVV6,Q9JY09,Q9K5E4,Q9K7Q9,Q9KUP3,Q9L0Y3,Q9PGB0,Q9RL99,Q9RWM6,Q9X1Y8,Q9X4Q2,Q9ZMN5" charOffset="158-161" type="protein" text="MAT"/>
            <entity id="DS.d45.s0.e3" origId="O23760,O81646,O82054,P21964,P28002,P46484,Q06509,Q06528,Q43239,Q43609,Q6ZD89,Q8GU25,Q8LL87,Q8W013,Q99028,Q9FQY8,Q9SWC2" charOffset="162-166" type="protein" text="COMT"/>
            <pair e1="DS.d45.s0.e0" e2="DS.d45.s0.e2" id="DS.d45.s0.i0" interaction="False"/>
            <pair e1="DS.d45.s0.e0" e2="DS.d45.s0.e3" id="DS.d45.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d46" origId="18227836">
        <sentence id="DS.d46.s0" origId="18227836-349" text="To test this hypothesis, we investigated whether disruption of the oxytocin gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and phencyclidine (PCP).">
            <entity id="DS.d46.s0.e0" origId="P01175,P01176,P01177,P01178,P01179,P13389,P32005,P35454,P69043,P69044,P69056,P69057,P69058" charOffset="67-75" type="protein" text="oxytocin"/>
            <entity id="DS.d46.s0.e1" origId="P01179,P35454,Q5QQ53,Q7KVA1" charOffset="82-85" type="protein" text="Oxt"/>
            <entity id="DS.d46.s0.e2" origId="3007,5826,32893" charOffset="153-164" type="compound" text="amphetamine"/>
            <entity id="DS.d46.s0.e3" origId="6083" charOffset="166-169" type="compound" text="Amp"/>
            <entity id="DS.d46.s0.e4" origId="6005" charOffset="172-183" type="compound" text="apomorphine"/>
            <entity id="DS.d46.s0.e5" origId="6468" charOffset="194-207" type="compound" text="phencyclidine"/>
            <pair e1="DS.d46.s0.e4" e2="DS.d46.s0.e1" id="DS.d46.s0.i0" interaction="False"/>
            <pair e1="DS.d46.s0.e3" e2="DS.d46.s0.e0" id="DS.d46.s0.i1" interaction="False"/>
            <pair e1="DS.d46.s0.e4" e2="DS.d46.s0.e0" id="DS.d46.s0.i2" interaction="False"/>
            <pair e1="DS.d46.s0.e2" e2="DS.d46.s0.e0" id="DS.d46.s0.i3" interaction="False"/>
            <pair e1="DS.d46.s0.e2" e2="DS.d46.s0.e1" id="DS.d46.s0.i4" interaction="False"/>
            <pair e1="DS.d46.s0.e5" e2="DS.d46.s0.e1" id="DS.d46.s0.i5" interaction="False"/>
            <pair e1="DS.d46.s0.e5" e2="DS.d46.s0.e0" id="DS.d46.s0.i6" interaction="False"/>
            <pair e1="DS.d46.s0.e3" e2="DS.d46.s0.e1" id="DS.d46.s0.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d47" origId="18227838">
        <sentence id="DS.d47.s0" origId="18227838-352" text="The mood stabilizers lithium and valproate activate the ERK pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.">
            <entity id="DS.d47.s0.e0" origId="28486,3028194" charOffset="21-28" type="compound" text="lithium"/>
            <entity id="DS.d47.s0.e1" origId="3121" charOffset="33-42" type="compound" text="valproate"/>
            <entity id="DS.d47.s0.e2" origId="P29323" charOffset="56-59" type="protein" text="ERK"/>
            <entity id="DS.d47.s0.e3" origId="P29323" charOffset="120-123" type="protein" text="ERK"/>
            <pair e1="DS.d47.s0.e0" e2="DS.d47.s0.e2" id="DS.d47.s0.i0" interaction="True"/>
            <pair e1="DS.d47.s0.e1" e2="DS.d47.s0.e2" id="DS.d47.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d48" origId="18227970">
        <sentence id="DS.d48.s0" origId="18227970-442" text="In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-lysine suppressed the activity of lysine decarboxylase and of ornithine decarboxylase to the same extent, but had no effect on arginine decarboxylase activity.">
            <entity id="DS.d48.s0.e0" origId="137670" charOffset="58-72" type="compound" text="difluoromethyl"/>
            <entity id="DS.d48.s0.e1" origId="866,5962" charOffset="73-79" type="compound" text="lysine"/>
            <entity id="DS.d48.s0.e2" origId="P05033" charOffset="107-127" type="protein" text="lysine decarboxylase"/>
            <entity id="DS.d48.s0.e3" origId="O22616,P00860,P07805,P08432,P09057,P11926,P14019,P27116,P27117,P27118,P27119,P27121,P41931,P44317,P49725,P50134,P78599,Q8S3N2,Q92445,Q9UQW9" charOffset="135-158" type="protein" text="ornithine decarboxylase"/>
            <entity id="DS.d48.s0.e4" origId="O81160,O82475,P21885,P22220,P49726,Q39827,Q43075,Q819L4,Q81MS2,Q96412,Q96A70,Q9K9K5,Q9SNN0" charOffset="200-222" type="protein" text="arginine decarboxylase"/>
            <pair e1="DS.d48.s0.e0" e2="DS.d48.s0.e4" id="DS.d48.s0.i0" interaction="False"/>
            <pair e1="DS.d48.s0.e1" e2="DS.d48.s0.e4" id="DS.d48.s0.i1" interaction="False"/>
            <pair e1="DS.d48.s0.e0" e2="DS.d48.s0.e3" id="DS.d48.s0.i2" interaction="True"/>
            <pair e1="DS.d48.s0.e1" e2="DS.d48.s0.e3" id="DS.d48.s0.i3" interaction="True"/>
            <pair e1="DS.d48.s0.e0" e2="DS.d48.s0.e2" id="DS.d48.s0.i4" interaction="True"/>
            <pair e1="DS.d48.s0.e1" e2="DS.d48.s0.e2" id="DS.d48.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d49" origId="18228136">
        <sentence id="DS.d49.s0" origId="18228136-547" text="RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or 2ME treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, P53 and Cyclin D1.">
            <entity id="DS.d49.s0.e0" origId="10903" charOffset="91-94" type="compound" text="2ME"/>
            <entity id="DS.d49.s0.e1" origId="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72" charOffset="169-173" type="protein" text="MDR1"/>
            <entity id="DS.d49.s0.e2" origId="P10417,P49950" charOffset="175-179" type="protein" text="Bcl2"/>
            <entity id="DS.d49.s0.e3" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="181-184" type="protein" text="P53"/>
            <entity id="DS.d49.s0.e4" origId="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268" charOffset="189-195" type="protein" text="Cyclin"/>
            <pair e1="DS.d49.s0.e0" e2="DS.d49.s0.e4" id="DS.d49.s0.i0" interaction="True"/>
            <pair e1="DS.d49.s0.e0" e2="DS.d49.s0.e3" id="DS.d49.s0.i1" interaction="True"/>
            <pair e1="DS.d49.s0.e0" e2="DS.d49.s0.e1" id="DS.d49.s0.i2" interaction="True"/>
            <pair e1="DS.d49.s0.e0" e2="DS.d49.s0.e2" id="DS.d49.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d49.s1" origId="18228136-548" text="The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of 2ME with Dox.">
            <entity id="DS.d49.s1.e0" origId="P10417,P49950" charOffset="43-47" type="protein" text="Bcl2"/>
            <entity id="DS.d49.s1.e1" origId="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268" charOffset="52-58" type="protein" text="Cyclin"/>
            <entity id="DS.d49.s1.e2" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="94-97" type="protein" text="P53"/>
            <entity id="DS.d49.s1.e3" origId="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72" charOffset="132-136" type="protein" text="MDR1"/>
            <entity id="DS.d49.s1.e4" origId="10903" charOffset="174-177" type="compound" text="2ME"/>
            <pair e1="DS.d49.s1.e4" e2="DS.d49.s1.e1" id="DS.d49.s1.i0" interaction="True"/>
            <pair e1="DS.d49.s1.e4" e2="DS.d49.s1.e3" id="DS.d49.s1.i1" interaction="True"/>
            <pair e1="DS.d49.s1.e4" e2="DS.d49.s1.e2" id="DS.d49.s1.i2" interaction="False"/>
            <pair e1="DS.d49.s1.e4" e2="DS.d49.s1.e0" id="DS.d49.s1.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d49.s2" origId="18228136-549" text="In conclusion, 2ME chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of Bcl2 and Cyclin D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.">
            <entity id="DS.d49.s2.e0" origId="10903" charOffset="15-18" type="compound" text="2ME"/>
            <entity id="DS.d49.s2.e1" origId="P10417,P49950" charOffset="118-122" type="protein" text="Bcl2"/>
            <entity id="DS.d49.s2.e2" origId="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268" charOffset="127-133" type="protein" text="Cyclin"/>
            <pair e1="DS.d49.s2.e0" e2="DS.d49.s2.e2" id="DS.d49.s2.i0" interaction="True"/>
            <pair e1="DS.d49.s2.e0" e2="DS.d49.s2.e1" id="DS.d49.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d50" origId="18230627">
        <sentence id="DS.d50.s0" origId="18230627-837" text="Randomised trials have demonstrated that the efficacy of anti-tumour necrosis factor (TNF) agents is significantly increased by concomitant methotrexate (MTX) in rheumatoid arthritis (RA).">
            <entity id="DS.d50.s0.e0" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="86-89" type="protein" text="TNF"/>
            <entity id="DS.d50.s0.e1" origId="126941" charOffset="140-152" type="compound" text="methotrexate"/>
            <pair e1="DS.d50.s0.e1" e2="DS.d50.s0.e0" id="DS.d50.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d51" origId="18243311">
        <sentence id="DS.d51.s0" origId="18243311-231" text="Neither apyrase nor ATP altered production of reactive oxygen intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.">
            <entity id="DS.d51.s0.e0" origId="P52914" charOffset="8-15" type="protein" text="apyrase"/>
            <entity id="DS.d51.s0.e1" origId="5957" charOffset="20-23" type="compound" text="ATP"/>
            <entity id="DS.d51.s0.e2" origId="977" charOffset="55-61" type="compound" text="oxygen"/>
            <entity id="DS.d51.s0.e3" origId="947,123329" charOffset="94-102" type="compound" text="nitrogen"/>
            <pair e1="DS.d51.s0.e3" e2="DS.d51.s0.e0" id="DS.d51.s0.i0" interaction="False"/>
            <pair e1="DS.d51.s0.e2" e2="DS.d51.s0.e0" id="DS.d51.s0.i1" interaction="False"/>
            <pair e1="DS.d51.s0.e1" e2="DS.d51.s0.e0" id="DS.d51.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d52" origId="18243368">
        <sentence id="DS.d52.s0" origId="18243368-1130" text="In this systematic review, we have analyzed the results of 52 clinical trials, including 72 intervention groups and 6290 patients, on vitamin D supplementation in order to evaluate the experimental evidence and the effects of age and chronic immobility on responses of parathyroid hormone (PTH).">
            <entity id="DS.d52.s0.e0" origId="5280795" charOffset="134-143" type="compound" text="vitamin D"/>
            <entity id="DS.d52.s0.e1" origId="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3" charOffset="290-293" type="protein" text="PTH"/>
            <pair e1="DS.d52.s0.e0" e2="DS.d52.s0.e1" id="DS.d52.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d52.s1" origId="18243368-1131" text="The vitamin D supplementation of the chronically immobile patients resulted in a smaller decrease in PTH 0.001).">
            <entity id="DS.d52.s1.e0" origId="5280795" charOffset="4-13" type="compound" text="vitamin D"/>
            <entity id="DS.d52.s1.e1" origId="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3" charOffset="101-104" type="protein" text="PTH"/>
            <pair e1="DS.d52.s1.e0" e2="DS.d52.s1.e1" id="DS.d52.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d52.s2" origId="18243368-1132" text="Our results also suggest that PTH decreases quite linearly during vitamin D supplementation at any given 25-OHD level.">
            <entity id="DS.d52.s2.e0" origId="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3" charOffset="30-33" type="protein" text="PTH"/>
            <entity id="DS.d52.s2.e1" origId="5280795" charOffset="66-75" type="compound" text="vitamin D"/>
            <pair e1="DS.d52.s2.e1" e2="DS.d52.s2.e0" id="DS.d52.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d53" origId="18248398">
        <sentence id="DS.d53.s0" origId="18248398-140" text="Leptin did not show any effect in long photoperiod but decreased proliferation by stimulating melatonin in short photoperiod.">
            <entity id="DS.d53.s0.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="0-6" type="protein" text="Leptin"/>
            <entity id="DS.d53.s0.e1" origId="896" charOffset="94-103" type="compound" text="melatonin"/>
            <pair e1="DS.d53.s0.e1" e2="DS.d53.s0.e0" id="DS.d53.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d54" origId="18249383">
        <sentence id="DS.d54.s0" origId="18249383-1046" text="To compare the changes in body composition and in leptin levels in postmenopausal women receiving hormone therapy (HT) or tibolone.">
            <entity id="DS.d54.s0.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="50-56" type="protein" text="leptin"/>
            <entity id="DS.d54.s0.e1" origId="444008" charOffset="122-130" type="compound" text="tibolone"/>
            <pair e1="DS.d54.s0.e1" e2="DS.d54.s0.e0" id="DS.d54.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d55" origId="18249399">
        <sentence id="DS.d55.s0" origId="18249399-1054" text="Common 677C--&amp;gt;T mutation of the 5,10-methylenetetrahydrofolate reductase gene affects follicular estradiol synthesis.">
            <entity id="DS.d55.s0.e0" origId="O54235,O67422,P0AEZ1,P0AEZ2,P11003,P45208,P57154,P71319,Q89B13,Q8KA62" charOffset="35-75" type="protein" text="5,10-methylenetetrahydrofolate reductase"/>
            <entity id="DS.d55.s0.e1" origId="5757" charOffset="100-109" type="compound" text="estradiol"/>
            <pair e1="DS.d55.s0.e1" e2="DS.d55.s0.e0" id="DS.d55.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d56" origId="18253022">
        <sentence id="DS.d56.s0" origId="18253022-733" text="Surprisingly, a deletion of the pilR gene affected not only insoluble Fe(III) reduction, which requires pili, but also soluble Fe(III) reduction, which, in contrast, does not require pili.">
            <entity id="DS.d56.s0.e0" origId="Q00934" charOffset="32-36" type="protein" text="pilR"/>
            <entity id="DS.d56.s0.e1" origId="29936" charOffset="70-76" type="compound" text="Fe(III"/>
            <entity id="DS.d56.s0.e2" origId="29936" charOffset="127-133" type="compound" text="Fe(III"/>
            <pair e1="DS.d56.s0.e1" e2="DS.d56.s0.e0" id="DS.d56.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d57" origId="18253697">
        <sentence id="DS.d57.s0" origId="18253697-765" text="Furthermore, the suppressive effects of P on cytochrome c release and caspase-9 and caspase-3 activation in serum-deprived MC3T3-E1 cells were also reversed by RU486.">
            <entity id="DS.d57.s0.e0" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="45-57" type="protein" text="cytochrome c"/>
            <entity id="DS.d57.s0.e1" origId="55245" charOffset="160-165" type="compound" text="RU486"/>
            <pair e1="DS.d57.s0.e1" e2="DS.d57.s0.e0" id="DS.d57.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d58" origId="18256928">
        <sentence id="DS.d58.s0" origId="18256928-624" text="Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.">
            <entity id="DS.d58.s0.e0" origId="4091" charOffset="12-21" type="compound" text="metformin"/>
            <entity id="DS.d58.s0.e1" origId="P54646,Q09136,Q9Y478" charOffset="22-26" type="protein" text="AMPK"/>
            <pair e1="DS.d58.s0.e0" e2="DS.d58.s0.e1" id="DS.d58.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d58.s1" origId="18256928-625" text="However, when ERalpha negative MDA-MB-435 cells were treated with metformin, they demonstrated increased expression of vascular endothelial growth factor (VEGF) in an AMPK dependent manner; while the ERalpha positive MCF-7 cells did not.">
            <entity id="DS.d58.s1.e0" origId="4091" charOffset="66-75" type="compound" text="metformin"/>
            <entity id="DS.d58.s1.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="155-159" type="protein" text="VEGF"/>
            <entity id="DS.d58.s1.e2" origId="P54646,Q09136,Q9Y478" charOffset="167-171" type="protein" text="AMPK"/>
            <pair e1="DS.d58.s1.e0" e2="DS.d58.s1.e2" id="DS.d58.s1.i0" interaction="True"/>
            <pair e1="DS.d58.s1.e0" e2="DS.d58.s1.e1" id="DS.d58.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d58.s2" origId="18256928-626" text="The metformin-treated group showed increased VEGF expression, intratumoral microvascular density and reduced necrosis.">
            <entity id="DS.d58.s2.e0" origId="4091" charOffset="4-13" type="compound" text="metformin"/>
            <entity id="DS.d58.s2.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="45-49" type="protein" text="VEGF"/>
            <pair e1="DS.d58.s2.e0" e2="DS.d58.s2.e1" id="DS.d58.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d58.s3" origId="18256928-627" text="Metformin treatment was sufficient, however, to reduce systemic IGF-1 and the proliferation rate of tumor cells in vascularized regions.">
            <entity id="DS.d58.s3.e0" origId="4091" charOffset="0-9" type="compound" text="Metformin"/>
            <entity id="DS.d58.s3.e1" origId="Q95222" charOffset="64-69" type="protein" text="IGF-1"/>
            <pair e1="DS.d58.s3.e0" e2="DS.d58.s3.e1" id="DS.d58.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d59" origId="18260130">
        <sentence id="DS.d59.s0" origId="18260130-109" text="TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.">
            <entity id="DS.d59.s0.e0" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="0-9" type="protein" text="TNF-alpha"/>
            <entity id="DS.d59.s0.e1" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="11-16" type="protein" text="MCP-1"/>
            <entity id="DS.d59.s0.e2" origId="P10147,P10855,P50229,Q5I1Z0,Q8HYQ3,Q8SQA6" charOffset="18-28" type="protein" text="MIP-1alpha"/>
            <entity id="DS.d59.s0.e3" origId="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5" charOffset="30-34" type="protein" text="IL-8"/>
            <entity id="DS.d59.s0.e4" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="36-40" type="protein" text="IL-6"/>
            <entity id="DS.d59.s0.e5" origId="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77" charOffset="42-50" type="protein" text="IL-1beta"/>
            <entity id="DS.d59.s0.e6" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="52-56" type="protein" text="VEGF"/>
            <entity id="DS.d59.s0.e7" origId="O18999,O77482,P18510,P25085,P25086,P26890,Q29056,Q866R8,Q9BEH0,Q9GMZ4" charOffset="58-64" type="protein" text="IL-1ra"/>
            <entity id="DS.d59.s0.e8" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="70-75" type="protein" text="IL-10"/>
            <entity id="DS.d59.s0.e9" origId="12254" charOffset="204-216" type="compound" text="polyurethane"/>
            <entity id="DS.d59.s0.e10" origId="6658" charOffset="252-275" type="compound" text="polymethyl methacrylate"/>
            <entity id="DS.d59.s0.e11" origId="13360" charOffset="305-332" type="compound" text="2-hydroxyethyl methacrylate"/>
            <entity id="DS.d59.s0.e12" origId="6917" charOffset="334-357" type="compound" text="1-vinyl-2-pyrrolidinone"/>
            <entity id="DS.d59.s0.e13" origId="7501" charOffset="410-421" type="compound" text="polystyrene"/>
            <pair e1="DS.d59.s0.e10" e2="DS.d59.s0.e0" id="DS.d59.s0.i0" interaction="False"/>
            <pair e1="DS.d59.s0.e12" e2="DS.d59.s0.e8" id="DS.d59.s0.i1" interaction="False"/>
            <pair e1="DS.d59.s0.e9" e2="DS.d59.s0.e6" id="DS.d59.s0.i2" interaction="False"/>
            <pair e1="DS.d59.s0.e9" e2="DS.d59.s0.e4" id="DS.d59.s0.i3" interaction="False"/>
            <pair e1="DS.d59.s0.e10" e2="DS.d59.s0.e1" id="DS.d59.s0.i4" interaction="False"/>
            <pair e1="DS.d59.s0.e13" e2="DS.d59.s0.e7" id="DS.d59.s0.i5" interaction="False"/>
            <pair e1="DS.d59.s0.e12" e2="DS.d59.s0.e0" id="DS.d59.s0.i6" interaction="False"/>
            <pair e1="DS.d59.s0.e11" e2="DS.d59.s0.e2" id="DS.d59.s0.i7" interaction="False"/>
            <pair e1="DS.d59.s0.e11" e2="DS.d59.s0.e1" id="DS.d59.s0.i8" interaction="False"/>
            <pair e1="DS.d59.s0.e13" e2="DS.d59.s0.e1" id="DS.d59.s0.i9" interaction="False"/>
            <pair e1="DS.d59.s0.e10" e2="DS.d59.s0.e7" id="DS.d59.s0.i10" interaction="False"/>
            <pair e1="DS.d59.s0.e13" e2="DS.d59.s0.e4" id="DS.d59.s0.i11" interaction="False"/>
            <pair e1="DS.d59.s0.e13" e2="DS.d59.s0.e6" id="DS.d59.s0.i12" interaction="False"/>
            <pair e1="DS.d59.s0.e9" e2="DS.d59.s0.e1" id="DS.d59.s0.i13" interaction="False"/>
            <pair e1="DS.d59.s0.e12" e2="DS.d59.s0.e5" id="DS.d59.s0.i14" interaction="False"/>
            <pair e1="DS.d59.s0.e9" e2="DS.d59.s0.e8" id="DS.d59.s0.i15" interaction="False"/>
            <pair e1="DS.d59.s0.e9" e2="DS.d59.s0.e3" id="DS.d59.s0.i16" interaction="False"/>
            <pair e1="DS.d59.s0.e13" e2="DS.d59.s0.e0" id="DS.d59.s0.i17" interaction="False"/>
            <pair e1="DS.d59.s0.e12" e2="DS.d59.s0.e6" id="DS.d59.s0.i18" interaction="False"/>
            <pair e1="DS.d59.s0.e13" e2="DS.d59.s0.e8" id="DS.d59.s0.i19" interaction="False"/>
            <pair e1="DS.d59.s0.e10" e2="DS.d59.s0.e5" id="DS.d59.s0.i20" interaction="False"/>
            <pair e1="DS.d59.s0.e10" e2="DS.d59.s0.e4" id="DS.d59.s0.i21" interaction="False"/>
            <pair e1="DS.d59.s0.e10" e2="DS.d59.s0.e2" id="DS.d59.s0.i22" interaction="False"/>
            <pair e1="DS.d59.s0.e12" e2="DS.d59.s0.e2" id="DS.d59.s0.i23" interaction="False"/>
            <pair e1="DS.d59.s0.e12" e2="DS.d59.s0.e7" id="DS.d59.s0.i24" interaction="False"/>
            <pair e1="DS.d59.s0.e9" e2="DS.d59.s0.e7" id="DS.d59.s0.i25" interaction="False"/>
            <pair e1="DS.d59.s0.e10" e2="DS.d59.s0.e6" id="DS.d59.s0.i26" interaction="False"/>
            <pair e1="DS.d59.s0.e9" e2="DS.d59.s0.e0" id="DS.d59.s0.i27" interaction="False"/>
            <pair e1="DS.d59.s0.e11" e2="DS.d59.s0.e5" id="DS.d59.s0.i28" interaction="False"/>
            <pair e1="DS.d59.s0.e9" e2="DS.d59.s0.e2" id="DS.d59.s0.i29" interaction="False"/>
            <pair e1="DS.d59.s0.e11" e2="DS.d59.s0.e6" id="DS.d59.s0.i30" interaction="False"/>
            <pair e1="DS.d59.s0.e10" e2="DS.d59.s0.e8" id="DS.d59.s0.i31" interaction="False"/>
            <pair e1="DS.d59.s0.e12" e2="DS.d59.s0.e3" id="DS.d59.s0.i32" interaction="False"/>
            <pair e1="DS.d59.s0.e11" e2="DS.d59.s0.e4" id="DS.d59.s0.i33" interaction="False"/>
            <pair e1="DS.d59.s0.e9" e2="DS.d59.s0.e5" id="DS.d59.s0.i34" interaction="False"/>
            <pair e1="DS.d59.s0.e11" e2="DS.d59.s0.e0" id="DS.d59.s0.i35" interaction="False"/>
            <pair e1="DS.d59.s0.e10" e2="DS.d59.s0.e3" id="DS.d59.s0.i36" interaction="False"/>
            <pair e1="DS.d59.s0.e12" e2="DS.d59.s0.e1" id="DS.d59.s0.i37" interaction="False"/>
            <pair e1="DS.d59.s0.e11" e2="DS.d59.s0.e3" id="DS.d59.s0.i38" interaction="False"/>
            <pair e1="DS.d59.s0.e12" e2="DS.d59.s0.e4" id="DS.d59.s0.i39" interaction="False"/>
            <pair e1="DS.d59.s0.e13" e2="DS.d59.s0.e5" id="DS.d59.s0.i40" interaction="False"/>
            <pair e1="DS.d59.s0.e11" e2="DS.d59.s0.e7" id="DS.d59.s0.i41" interaction="False"/>
            <pair e1="DS.d59.s0.e13" e2="DS.d59.s0.e3" id="DS.d59.s0.i42" interaction="False"/>
            <pair e1="DS.d59.s0.e13" e2="DS.d59.s0.e2" id="DS.d59.s0.i43" interaction="False"/>
            <pair e1="DS.d59.s0.e11" e2="DS.d59.s0.e8" id="DS.d59.s0.i44" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d60" origId="18262559">
        <sentence id="DS.d60.s0" origId="18262559-301" text="Systemic administration of hemoglobin vesicle elevates tumor tissue oxygen tension and modifies tumor response to irradiation.">
            <entity id="DS.d60.s0.e0" origId="P15160,P17724,P73925,Q03459" charOffset="27-37" type="protein" text="hemoglobin"/>
            <entity id="DS.d60.s0.e1" origId="977" charOffset="68-74" type="compound" text="oxygen"/>
            <pair e1="DS.d60.s0.e1" e2="DS.d60.s0.e0" id="DS.d60.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d61" origId="18262738">
        <sentence id="DS.d61.s0" origId="18262738-416" text="The participation of protein kinase A (PKA), protein kinase C (PKC) and protein tyrosine kinase (PTK) in capacitation induced by ONOO (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM bisindolylmaleimide I, and 3 microM genistein, respectively).">
            <entity id="DS.d61.s0.e0" origId="Q05608,Q9RI12" charOffset="21-37" type="protein" text="protein kinase A"/>
            <entity id="DS.d61.s0.e1" origId="P13678,Q25378" charOffset="45-61" type="protein" text="protein kinase C"/>
            <entity id="DS.d61.s0.e2" origId="P05130,P13677,P13678,P34722" charOffset="63-66" type="protein" text="PKC"/>
            <entity id="DS.d61.s0.e3" origId="5460609" charOffset="129-133" type="compound" text="ONOO"/>
            <entity id="DS.d61.s0.e4" origId="2396" charOffset="219-240" type="compound" text="bisindolylmaleimide I"/>
            <entity id="DS.d61.s0.e5" origId="5280961" charOffset="255-264" type="compound" text="genistein"/>
            <pair e1="DS.d61.s0.e4" e2="DS.d61.s0.e2" id="DS.d61.s0.i0" interaction="False"/>
            <pair e1="DS.d61.s0.e4" e2="DS.d61.s0.e0" id="DS.d61.s0.i1" interaction="False"/>
            <pair e1="DS.d61.s0.e3" e2="DS.d61.s0.e0" id="DS.d61.s0.i2" interaction="False"/>
            <pair e1="DS.d61.s0.e3" e2="DS.d61.s0.e1" id="DS.d61.s0.i3" interaction="False"/>
            <pair e1="DS.d61.s0.e5" e2="DS.d61.s0.e0" id="DS.d61.s0.i4" interaction="False"/>
            <pair e1="DS.d61.s0.e5" e2="DS.d61.s0.e1" id="DS.d61.s0.i5" interaction="False"/>
            <pair e1="DS.d61.s0.e3" e2="DS.d61.s0.e2" id="DS.d61.s0.i6" interaction="False"/>
            <pair e1="DS.d61.s0.e5" e2="DS.d61.s0.e2" id="DS.d61.s0.i7" interaction="False"/>
            <pair e1="DS.d61.s0.e4" e2="DS.d61.s0.e1" id="DS.d61.s0.i8" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d62" origId="18266054">
        <sentence id="DS.d62.s0" origId="18266054-1214" text="At the time, glutathione reductase activity was significantly inhibited and gamma-glutamyl cysteine increased by ACA exposure.">
            <entity id="DS.d62.s0.e0" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="13-34" type="protein" text="glutathione reductase"/>
            <entity id="DS.d62.s0.e1" origId="594,5862,5360637" charOffset="91-99" type="compound" text="cysteine"/>
            <pair e1="DS.d62.s0.e1" e2="DS.d62.s0.e0" id="DS.d62.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d63" origId="18268501">
        <sentence id="DS.d63.s0" origId="18268501-1260" text="The effect of the polymorphism is non-conservative and results in a glutamine to arginine change (Gln460Arg), which is likely to affect P2RX7 dimerization and protein-protein interactions.">
            <entity id="DS.d63.s0.e0" origId="738,5961" charOffset="68-77" type="compound" text="glutamine"/>
            <entity id="DS.d63.s0.e1" origId="232,4367,6322" charOffset="81-89" type="compound" text="arginine"/>
            <entity id="DS.d63.s0.e2" origId="Q99572" charOffset="136-141" type="protein" text="P2RX7"/>
            <pair e1="DS.d63.s0.e1" e2="DS.d63.s0.e2" id="DS.d63.s0.i0" interaction="True"/>
            <pair e1="DS.d63.s0.e0" e2="DS.d63.s0.e2" id="DS.d63.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d64" origId="18270841">
        <sentence id="DS.d64.s0" origId="18270841-348" text="Increased somatostatin tone and decreased ghrelin concentrations may also contribute to reduced GH levels.">
            <entity id="DS.d64.s0.e0" origId="16129681,16129706" charOffset="10-22" type="compound" text="somatostatin"/>
            <entity id="DS.d64.s0.e1" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="42-49" type="protein" text="ghrelin"/>
            <pair e1="DS.d64.s0.e0" e2="DS.d64.s0.e1" id="DS.d64.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d65" origId="18272254">
        <sentence id="DS.d65.s0" origId="18272254-1258" text="Inhibition of LTP by beta-amyloid is prevented by activation of beta2 adrenoceptors and stimulation of the cAMP/PKA signalling pathway.">
            <entity id="DS.d65.s0.e0" origId="O70431,P04274,P07550,P10608,P18762,P54833,Q28044,Q28509,Q28997,Q4KWL2,Q8UUY8,Q9TST5" charOffset="64-83" type="protein" text="beta2 adrenoceptors"/>
            <entity id="DS.d65.s0.e1" origId="6076" charOffset="107-111" type="compound" text="cAMP"/>
            <pair e1="DS.d65.s0.e1" e2="DS.d65.s0.e0" id="DS.d65.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d66" origId="18274872">
        <sentence id="DS.d66.s0" origId="18274872-320" text=") O2 (-) and H2O2 in H. plumaeforme was respectively related to the low activity of SOD and the decreased activity of CAT.">
            <entity id="DS.d66.s0.e0" origId="977,5359597" charOffset="2-4" type="compound" text="O2"/>
            <entity id="DS.d66.s0.e1" origId="784" charOffset="13-17" type="compound" text="H2O2"/>
            <entity id="DS.d66.s0.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="84-87" type="protein" text="SOD"/>
            <entity id="DS.d66.s0.e3" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="118-121" type="protein" text="CAT"/>
            <pair e1="DS.d66.s0.e0" e2="DS.d66.s0.e2" id="DS.d66.s0.i0" interaction="True"/>
            <pair e1="DS.d66.s0.e1" e2="DS.d66.s0.e3" id="DS.d66.s0.i1" interaction="True"/>
            <pair e1="DS.d66.s0.e1" e2="DS.d66.s0.e2" id="DS.d66.s0.i2" interaction="True"/>
            <pair e1="DS.d66.s0.e0" e2="DS.d66.s0.e3" id="DS.d66.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d67" origId="18279956">
        <sentence id="DS.d67.s0" origId="18279956-684" text="A novel oligodeoxynuleotides containing 11 CpG motifs was synthesized and inserted into the VR1020 plasmid containing pig interleukin-6 (IL-6) gene (VPIL6) to construct recombinant plasmid, VPIL6C.">
            <entity id="DS.d67.s0.e0" origId="6804" charOffset="43-46" type="compound" text="CpG"/>
            <entity id="DS.d67.s0.e1" origId="P41693" charOffset="122-135" type="protein" text="interleukin-6"/>
            <entity id="DS.d67.s0.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="137-141" type="protein" text="IL-6"/>
            <pair e1="DS.d67.s0.e0" e2="DS.d67.s0.e1" id="DS.d67.s0.i0" interaction="False"/>
            <pair e1="DS.d67.s0.e0" e2="DS.d67.s0.e2" id="DS.d67.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d68" origId="18280595">
        <sentence id="DS.d68.s0" origId="18280595-101" text="Furthermore, it has also been reported that capsaicin-treated pigs significantly increase mean arterial blood pressure compared with controls and that the decrease in CGRP synthesis and release contributes to the elevated blood pressure.">
            <entity id="DS.d68.s0.e0" origId="1548943" charOffset="44-53" type="compound" text="capsaicin"/>
            <entity id="DS.d68.s0.e1" origId="P10286,P30880,P30881,P31888,P80511" charOffset="167-171" type="protein" text="CGRP"/>
            <pair e1="DS.d68.s0.e0" e2="DS.d68.s0.e1" id="DS.d68.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d69" origId="18283487">
        <sentence id="DS.d69.s0" origId="18283487-569" text="Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the ATP-dependent and-coupled transport of Na (+) and K(+) across the plasma membrane of a living cell in which such a process (sodium pump) is detected.">
            <entity id="DS.d69.s0.e0" origId="5957" charOffset="145-148" type="compound" text="ATP"/>
            <entity id="DS.d69.s0.e1" origId="923,373840" charOffset="184-186" type="compound" text="Na"/>
            <entity id="DS.d69.s0.e2" origId="P13607,P17326,P28774,P35317" charOffset="269-280" type="protein" text="sodium pump"/>
            <pair e1="DS.d69.s0.e0" e2="DS.d69.s0.e2" id="DS.d69.s0.i0" interaction="True"/>
            <pair e1="DS.d69.s0.e1" e2="DS.d69.s0.e2" id="DS.d69.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d70" origId="18286621">
        <sentence id="DS.d70.s0" origId="18286621-29" text="Affinity electrophoresis analysis provided evidence that carboxymethylated dextran polymers grafted with high amounts of benzylamide groups (named DMCB) interact with BMP-2.">
            <entity id="DS.d70.s0.e0" origId="4125253,5460037" charOffset="75-82" type="compound" text="dextran"/>
            <entity id="DS.d70.s0.e1" origId="10391" charOffset="121-132" type="compound" text="benzylamide"/>
            <entity id="DS.d70.s0.e2" origId="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751" charOffset="167-172" type="protein" text="BMP-2"/>
            <pair e1="DS.d70.s0.e1" e2="DS.d70.s0.e2" id="DS.d70.s0.i0" interaction="True"/>
            <pair e1="DS.d70.s0.e0" e2="DS.d70.s0.e2" id="DS.d70.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d70.s1" origId="18286621-30" text="A screening study provided evidence that the potentiating effects of the dextran derivatives on the BMP-2-induced alkaline phosphatase activity improved with their benzylamide groups content and, therefore, with their affinity for the growth factor.">
            <entity id="DS.d70.s1.e0" origId="4125253,5460037" charOffset="73-80" type="compound" text="dextran"/>
            <entity id="DS.d70.s1.e1" origId="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751" charOffset="100-105" type="protein" text="BMP-2"/>
            <entity id="DS.d70.s1.e2" origId="O60109,P81800,P83456" charOffset="114-134" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d70.s1.e3" origId="10391" charOffset="164-175" type="compound" text="benzylamide"/>
            <pair e1="DS.d70.s1.e3" e2="DS.d70.s1.e2" id="DS.d70.s1.i0" interaction="True"/>
            <pair e1="DS.d70.s1.e0" e2="DS.d70.s1.e1" id="DS.d70.s1.i1" interaction="True"/>
            <pair e1="DS.d70.s1.e0" e2="DS.d70.s1.e2" id="DS.d70.s1.i2" interaction="True"/>
            <pair e1="DS.d70.s1.e3" e2="DS.d70.s1.e1" id="DS.d70.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d71" origId="18294936">
        <sentence id="DS.d71.s0" origId="18294936-104" text="Since buprenorphine is metabolized through cytochrome P450 3A4, we genotyped six genetic polymorphisms previously described in poor metabolizers but could not confirm these pharmacogenetic bases in this case.">
            <entity id="DS.d71.s0.e0" origId="40400,644073,5311033,6321408,24838065" charOffset="6-19" type="compound" text="buprenorphine"/>
            <entity id="DS.d71.s0.e1" origId="P08684" charOffset="43-62" type="protein" text="cytochrome P450 3A4"/>
            <pair e1="DS.d71.s0.e0" e2="DS.d71.s0.e1" id="DS.d71.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d72" origId="18295378">
        <sentence id="DS.d72.s0" origId="18295378-334" text="Mitochondrial dysfunction was associated with higher levels of reactive oxygen species, an altered Bcl-xL/Bax ratio and reduction of COX IV activity.">
            <entity id="DS.d72.s0.e0" origId="977" charOffset="72-78" type="compound" text="oxygen"/>
            <entity id="DS.d72.s0.e1" origId="P27297,Q07813,Q63690" charOffset="106-109" type="protein" text="Bax"/>
            <entity id="DS.d72.s0.e2" origId="P11353,P36551,P36552,Q9UTE2,Q9V3D2" charOffset="133-136" type="protein" text="COX"/>
            <pair e1="DS.d72.s0.e0" e2="DS.d72.s0.e2" id="DS.d72.s0.i0" interaction="False"/>
            <pair e1="DS.d72.s0.e0" e2="DS.d72.s0.e1" id="DS.d72.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d73" origId="18298568">
        <sentence id="DS.d73.s0" origId="18298568-1058" text="Peripheral venous levels of testosterone, prolactin, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), malondialdehyde and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.">
            <entity id="DS.d73.s0.e0" origId="6013" charOffset="28-40" type="compound" text="testosterone"/>
            <entity id="DS.d73.s0.e1" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="42-51" type="protein" text="prolactin"/>
            <entity id="DS.d73.s0.e2" origId="10964" charOffset="150-165" type="compound" text="malondialdehyde"/>
            <pair e1="DS.d73.s0.e0" e2="DS.d73.s0.e1" id="DS.d73.s0.i0" interaction="False"/>
            <pair e1="DS.d73.s0.e2" e2="DS.d73.s0.e1" id="DS.d73.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d74" origId="18298570">
        <sentence id="DS.d74.s0" origId="18298570-1059" text="Our results showed that catalase abolished the effect of the oxidant, protecting spermatozoa against reactive oxygen species, and improving both sperm motility and chromatin status during incubation.">
            <entity id="DS.d74.s0.e0" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="24-32" type="protein" text="catalase"/>
            <entity id="DS.d74.s0.e1" origId="977" charOffset="110-116" type="compound" text="oxygen"/>
            <pair e1="DS.d74.s0.e1" e2="DS.d74.s0.e0" id="DS.d74.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d75" origId="18298659">
        <sentence id="DS.d75.s0" origId="18298659-1127" text="Intranasal and intravenous administration of live Cpn and Aa, respectively induced an accumulation of activated mast cells in the aortic sinus of apolipoprotein E-deficient mice, however, with varying responses in the systemic levels of lipopolysaccharide (LPS) and TNF-alpha.">
            <entity id="DS.d75.s0.e0" origId="11970143" charOffset="237-255" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d75.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="266-275" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d75.s0.e0" e2="DS.d75.s0.e1" id="DS.d75.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d76" origId="18304632">
        <sentence id="DS.d76.s0" origId="18304632-1001" text="MnSOD and two additional catalase isozymes were induced by quinclorac or bensulfuron-methyl in S. maltophilia WZ2, but not in E. coli K12.">
            <entity id="DS.d76.s0.e0" origId="P00448,P66828,P66829,Q8Z2V9,Q9RUV2" charOffset="0-5" type="protein" text="MnSOD"/>
            <entity id="DS.d76.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="25-33" type="protein" text="catalase"/>
            <entity id="DS.d76.s0.e2" origId="91739" charOffset="59-69" type="compound" text="quinclorac"/>
            <entity id="DS.d76.s0.e3" origId="54960" charOffset="73-91" type="compound" text="bensulfuron-methyl"/>
            <pair e1="DS.d76.s0.e2" e2="DS.d76.s0.e0" id="DS.d76.s0.i0" interaction="True"/>
            <pair e1="DS.d76.s0.e2" e2="DS.d76.s0.e1" id="DS.d76.s0.i1" interaction="True"/>
            <pair e1="DS.d76.s0.e3" e2="DS.d76.s0.e0" id="DS.d76.s0.i2" interaction="True"/>
            <pair e1="DS.d76.s0.e3" e2="DS.d76.s0.e1" id="DS.d76.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d76.s1" origId="18304632-1002" text="Results indicate that catalase has a much weakly role in the defense against quinclorac or bensulfuron-methyl induced oxidative stress, whereas SOD could be critical.">
            <entity id="DS.d76.s1.e0" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="22-30" type="protein" text="catalase"/>
            <entity id="DS.d76.s1.e1" origId="91739" charOffset="77-87" type="compound" text="quinclorac"/>
            <entity id="DS.d76.s1.e2" origId="54960" charOffset="91-109" type="compound" text="bensulfuron-methyl"/>
            <entity id="DS.d76.s1.e3" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="144-147" type="protein" text="SOD"/>
            <pair e1="DS.d76.s1.e1" e2="DS.d76.s1.e0" id="DS.d76.s1.i0" interaction="True"/>
            <pair e1="DS.d76.s1.e2" e2="DS.d76.s1.e3" id="DS.d76.s1.i1" interaction="True"/>
            <pair e1="DS.d76.s1.e2" e2="DS.d76.s1.e0" id="DS.d76.s1.i2" interaction="True"/>
            <pair e1="DS.d76.s1.e1" e2="DS.d76.s1.e3" id="DS.d76.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d77" origId="18304748">
        <sentence id="DS.d77.s0" origId="18304748-1077" text="Moreover, TARPs (except gamma4) reduce the ion channel block by the synthetic Joro spider toxin analog 1-naphthylacetyl spermine (NASP).">
            <entity id="DS.d77.s0.e0" origId="Q99JR5" charOffset="10-15" type="protein" text="TARPs"/>
            <entity id="DS.d77.s0.e1" origId="119582,5311197" charOffset="78-95" type="compound" text="Joro spider toxin"/>
            <entity id="DS.d77.s0.e2" origId="129695" charOffset="103-128" type="compound" text="1-naphthylacetyl spermine"/>
            <pair e1="DS.d77.s0.e2" e2="DS.d77.s0.e0" id="DS.d77.s0.i0" interaction="True"/>
            <pair e1="DS.d77.s0.e1" e2="DS.d77.s0.e0" id="DS.d77.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d78" origId="18306310">
        <sentence id="DS.d78.s0" origId="18306310-763" text="SMC cultured on P(100/0) films modified by covalently attached fibronectin or fibrin layers proliferated at a rate comparable to that observed on control tissue culture polystyrene.">
            <entity id="DS.d78.s0.e0" origId="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400" charOffset="63-74" type="protein" text="fibronectin"/>
            <entity id="DS.d78.s0.e1" origId="7501" charOffset="169-180" type="compound" text="polystyrene"/>
            <pair e1="DS.d78.s0.e1" e2="DS.d78.s0.e0" id="DS.d78.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d78.s1" origId="18306310-764" text="However, prewetting P(70/30) with a phosphate buffer prior to aminolysis significantly improved cell numbers following immobilization of fibronectin.">
            <entity id="DS.d78.s1.e0" origId="1061,167704,644102" charOffset="36-45" type="compound" text="phosphate"/>
            <entity id="DS.d78.s1.e1" origId="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400" charOffset="137-148" type="protein" text="fibronectin"/>
            <pair e1="DS.d78.s1.e0" e2="DS.d78.s1.e1" id="DS.d78.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d79" origId="18308488">
        <sentence id="DS.d79.s0" origId="18308488-862" text="The dose of ACTH (2.5 microg/kg) was chosen to mimic the cortisol concentrations seen during mixing of unfamiliar sows.">
            <entity id="DS.d79.s0.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="12-16" type="protein" text="ACTH"/>
            <entity id="DS.d79.s0.e1" origId="5754" charOffset="57-65" type="compound" text="cortisol"/>
            <pair e1="DS.d79.s0.e1" e2="DS.d79.s0.e0" id="DS.d79.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d80" origId="18311594">
        <sentence id="DS.d80.s0" origId="18311594-236" text="Our data suggest HumDN1 genotypes are related to total cholesterol levels in Han Chinese MI patients, but deoxyribonuclease I gene polymorphisms are not associated with susceptibility to MI in Han Chinese.">
            <entity id="DS.d80.s0.e0" origId="304,5997,6432564,11025495" charOffset="55-66" type="compound" text="cholesterol"/>
            <entity id="DS.d80.s0.e1" origId="O18998,O42446,P00639,P11936,P11937,P21704,P24855,P49183,Q4AEE3,Q767J3,Q9YGI5" charOffset="106-125" type="protein" text="deoxyribonuclease I"/>
            <pair e1="DS.d80.s0.e0" e2="DS.d80.s0.e1" id="DS.d80.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d81" origId="18314895">
        <sentence id="DS.d81.s0" origId="18314895-1018" text="Specifically, TEG was shown to alter S. mutans gene expression levels of gtfB, a known virulence factor, and yfiV, a putative transcriptional regulator of cell-surface fatty acid genes.">
            <entity id="DS.d81.s0.e0" origId="8172" charOffset="14-17" type="compound" text="TEG"/>
            <entity id="DS.d81.s0.e1" origId="P08987" charOffset="73-77" type="protein" text="gtfB"/>
            <entity id="DS.d81.s0.e2" origId="Q9CJ45" charOffset="126-151" type="protein" text="transcriptional regulator"/>
            <pair e1="DS.d81.s0.e0" e2="DS.d81.s0.e2" id="DS.d81.s0.i0" interaction="True"/>
            <pair e1="DS.d81.s0.e0" e2="DS.d81.s0.e1" id="DS.d81.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d82" origId="18314898">
        <sentence id="DS.d82.s0" origId="18314898-1022" text="Degradation analysis over 8 weeks in the presence of 10 mg/L lysozyme showed a 50% decrease in total weight and an 80% decrease in PLGA molecular weight.">
            <entity id="DS.d82.s0.e0" origId="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7" charOffset="61-69" type="protein" text="lysozyme"/>
            <entity id="DS.d82.s0.e1" origId="36797" charOffset="131-135" type="compound" text="PLGA"/>
            <pair e1="DS.d82.s0.e1" e2="DS.d82.s0.e0" id="DS.d82.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d83" origId="18317936">
        <sentence id="DS.d83.s0" origId="18317936-346" text="Fluo-3 staining used in flow cytometry and video microscopy revealed an oxysterol-induced Ca(2+) influx, varying according to the oxysterol studied, leading to the activation of the MEK/ERK1/2 pathway as demonstrated by Western blot analysis.">
            <entity id="DS.d83.s0.e0" origId="271" charOffset="90-94" type="compound" text="Ca(2"/>
            <entity id="DS.d83.s0.e1" origId="P27361,P28869,P42525,Q07176" charOffset="186-190" type="protein" text="ERK1"/>
            <pair e1="DS.d83.s0.e0" e2="DS.d83.s0.e1" id="DS.d83.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d84" origId="18327670">
        <sentence id="DS.d84.s0" origId="18327670-82" text="To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic &quot;flare reaction&quot; detected by positron emission tomography (PET) with 2-((18)F)-fluoro-2-deoxyglucose (FDG), induced by an estradiol challenge, or by estrogen-receptor (ER) status, determined by PET with the estrogen analog 16alpha-((18)F)fluoroestradiol-17beta (FES).">
            <entity id="DS.d84.s0.e0" origId="108223" charOffset="188-202" type="compound" text="2-deoxyglucose"/>
            <entity id="DS.d84.s0.e1" origId="5757" charOffset="224-233" type="compound" text="estradiol"/>
            <entity id="DS.d84.s0.e2" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="251-268" type="protein" text="estrogen-receptor"/>
            <pair e1="DS.d84.s0.e0" e2="DS.d84.s0.e2" id="DS.d84.s0.i0" interaction="False"/>
            <pair e1="DS.d84.s0.e1" e2="DS.d84.s0.e2" id="DS.d84.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d85" origId="18328561">
        <sentence id="DS.d85.s0" origId="18328561-582" text="Depletion of GSH levels was accompanied by the induction of glutathione reductase (GR) after 24h exposure with each of the four carbamates to CHO-K1 cells.">
            <entity id="DS.d85.s0.e0" origId="124886" charOffset="13-16" type="compound" text="GSH"/>
            <entity id="DS.d85.s0.e1" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="60-81" type="protein" text="glutathione reductase"/>
            <pair e1="DS.d85.s0.e0" e2="DS.d85.s0.e1" id="DS.d85.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d86" origId="18330498">
        <sentence id="DS.d86.s0" origId="18330498-512" text="Chloroquine and wortmannin inhibited the upregulation induced by insulin stimulation and amino acid deprivation but not that induced by osmotic shock.">
            <entity id="DS.d86.s0.e0" origId="2719" charOffset="0-11" type="compound" text="Chloroquine"/>
            <entity id="DS.d86.s0.e1" origId="312145" charOffset="16-26" type="compound" text="wortmannin"/>
            <entity id="DS.d86.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="65-72" type="protein" text="insulin"/>
            <pair e1="DS.d86.s0.e0" e2="DS.d86.s0.e2" id="DS.d86.s0.i0" interaction="True"/>
            <pair e1="DS.d86.s0.e1" e2="DS.d86.s0.e2" id="DS.d86.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d86.s1" origId="18330498-513" text="Moreover, PD98059 and SP600125 inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only insulin-induced upregulation.">
            <entity id="DS.d86.s1.e0" origId="4713" charOffset="10-17" type="compound" text="PD98059"/>
            <entity id="DS.d86.s1.e1" origId="8515" charOffset="22-30" type="compound" text="SP600125"/>
            <entity id="DS.d86.s1.e2" origId="5353940" charOffset="94-102" type="compound" text="SB202190"/>
            <entity id="DS.d86.s1.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="118-125" type="protein" text="insulin"/>
            <pair e1="DS.d86.s1.e2" e2="DS.d86.s1.e3" id="DS.d86.s1.i0" interaction="True"/>
            <pair e1="DS.d86.s1.e1" e2="DS.d86.s1.e3" id="DS.d86.s1.i1" interaction="False"/>
            <pair e1="DS.d86.s1.e0" e2="DS.d86.s1.e3" id="DS.d86.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d87" origId="18331557">
        <sentence id="DS.d87.s0" origId="18331557-1201" text="The role of phosphorylated Akt (p-Akt) in oral carcinogenesis induced by nicotine and alkaline environments was investigated.">
            <entity id="DS.d87.s0.e0" origId="P31750,Q8INB9" charOffset="27-30" type="protein" text="Akt"/>
            <entity id="DS.d87.s0.e1" origId="P31750,Q8INB9" charOffset="34-37" type="protein" text="Akt"/>
            <entity id="DS.d87.s0.e2" origId="942,89594,157672" charOffset="73-81" type="compound" text="nicotine"/>
            <pair e1="DS.d87.s0.e2" e2="DS.d87.s0.e0" id="DS.d87.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d88" origId="18336537">
        <sentence id="DS.d88.s0" origId="18336537-456" text="Sera from a population sample of infants with cryptorchidism (n = 43), hypospadias (n = 41) and controls (n = 113) were analyzed for inhibin B, anti-M&#252;llerian hormone (AMH), testosterone, luteinizing hormone (LH), follicle stimulating hormone (FSH) and sex hormone binding globulin (SHBG).">
            <entity id="DS.d88.s0.e0" origId="P03971,P03972,P27106,P49000,P79295" charOffset="168-171" type="protein" text="AMH"/>
            <entity id="DS.d88.s0.e1" origId="6013" charOffset="174-186" type="compound" text="testosterone"/>
            <entity id="DS.d88.s0.e2" origId="P04278,P08689,P15196,P97497,Q62588" charOffset="283-287" type="protein" text="SHBG"/>
            <pair e1="DS.d88.s0.e1" e2="DS.d88.s0.e0" id="DS.d88.s0.i0" interaction="False"/>
            <pair e1="DS.d88.s0.e1" e2="DS.d88.s0.e2" id="DS.d88.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d89" origId="18340529">
        <sentence id="DS.d89.s0" origId="18340529-389" text="Myeloperoxidase (MPO) is an endogenous oxidant enzyme that generates reactive oxygen species (ROS).">
            <entity id="DS.d89.s0.e0" origId="P05164,P11247" charOffset="17-20" type="protein" text="MPO"/>
            <entity id="DS.d89.s0.e1" origId="977" charOffset="78-84" type="compound" text="oxygen"/>
            <pair e1="DS.d89.s0.e1" e2="DS.d89.s0.e0" id="DS.d89.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d90" origId="18343629">
        <sentence id="DS.d90.s0" origId="18343629-1064" text="In present study, we investigated the combined effect of emodin and baicalin on pancreatic damage and pancreatitis associated lung injury, as well as tissue TLR4 expression in the setting of AP.">
            <entity id="DS.d90.s0.e0" origId="3220" charOffset="57-63" type="compound" text="emodin"/>
            <entity id="DS.d90.s0.e1" origId="64982" charOffset="68-76" type="compound" text="baicalin"/>
            <entity id="DS.d90.s0.e2" origId="O00206,P58727,Q2V898,Q68Y56,Q8SPE8,Q8SPE9,Q9GL65,Q9MYW3,Q9TSP2,Q9TTN0,Q9WV82" charOffset="157-161" type="protein" text="TLR4"/>
            <pair e1="DS.d90.s0.e0" e2="DS.d90.s0.e2" id="DS.d90.s0.i0" interaction="False"/>
            <pair e1="DS.d90.s0.e1" e2="DS.d90.s0.e2" id="DS.d90.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d90.s1" origId="18343629-1065" text="The results showed that combination of emodin and baicalin significantly reduced serum amylase, tumor necrosis factor-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.">
            <entity id="DS.d90.s1.e0" origId="3220" charOffset="39-45" type="compound" text="emodin"/>
            <entity id="DS.d90.s1.e1" origId="64982" charOffset="50-58" type="compound" text="baicalin"/>
            <entity id="DS.d90.s1.e2" origId="Q8JFG3" charOffset="96-117" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d90.s1.e3" origId="P41693" charOffset="128-141" type="protein" text="interleukin-6"/>
            <entity id="DS.d90.s1.e4" origId="O00206,P58727,Q2V898,Q68Y56,Q8SPE8,Q8SPE9,Q9GL65,Q9MYW3,Q9TSP2,Q9TTN0,Q9WV82" charOffset="203-207" type="protein" text="TLR4"/>
            <pair e1="DS.d90.s1.e1" e2="DS.d90.s1.e4" id="DS.d90.s1.i0" interaction="True"/>
            <pair e1="DS.d90.s1.e0" e2="DS.d90.s1.e4" id="DS.d90.s1.i1" interaction="True"/>
            <pair e1="DS.d90.s1.e0" e2="DS.d90.s1.e2" id="DS.d90.s1.i2" interaction="True"/>
            <pair e1="DS.d90.s1.e1" e2="DS.d90.s1.e3" id="DS.d90.s1.i3" interaction="True"/>
            <pair e1="DS.d90.s1.e0" e2="DS.d90.s1.e3" id="DS.d90.s1.i4" interaction="True"/>
            <pair e1="DS.d90.s1.e1" e2="DS.d90.s1.e2" id="DS.d90.s1.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d91" origId="18346857">
        <sentence id="DS.d91.s0" origId="18346857-498" text="Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma 17beta-estradiol (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and estrogen receptor-beta (ER-beta).">
            <entity id="DS.d91.s0.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="39-45" type="protein" text="leptin"/>
            <entity id="DS.d91.s0.e1" origId="5757" charOffset="282-298" type="compound" text="17beta-estradiol"/>
            <entity id="DS.d91.s0.e2" origId="P23945,P32212,P35376,P35379,P47799,P49059,P79763,Q5GJ04,Q6R6L8,Q6YNB6,Q7ZTV5,Q8R428,Q95179" charOffset="393-397" type="protein" text="FSHR"/>
            <entity id="DS.d91.s0.e3" origId="O02721,P16235,P16582,P22888,P30730,Q28005,Q28585,Q90674" charOffset="400-428" type="protein" text="luteinizing hormone receptor"/>
            <entity id="DS.d91.s0.e4" origId="P16070,P22888,Q28585" charOffset="430-433" type="protein" text="LHR"/>
            <entity id="DS.d91.s0.e5" origId="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32" charOffset="439-461" type="protein" text="estrogen receptor-beta"/>
            <entity id="DS.d91.s0.e6" origId="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32" charOffset="463-470" type="protein" text="ER-beta"/>
            <pair e1="DS.d91.s0.e1" e2="DS.d91.s0.e4" id="DS.d91.s0.i0" interaction="False"/>
            <pair e1="DS.d91.s0.e1" e2="DS.d91.s0.e5" id="DS.d91.s0.i1" interaction="False"/>
            <pair e1="DS.d91.s0.e1" e2="DS.d91.s0.e3" id="DS.d91.s0.i2" interaction="False"/>
            <pair e1="DS.d91.s0.e1" e2="DS.d91.s0.e6" id="DS.d91.s0.i3" interaction="False"/>
            <pair e1="DS.d91.s0.e1" e2="DS.d91.s0.e2" id="DS.d91.s0.i4" interaction="False"/>
            <pair e1="DS.d91.s0.e1" e2="DS.d91.s0.e0" id="DS.d91.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d92" origId="18357521">
        <sentence id="DS.d92.s0" origId="18357521-771" text="The anti-neoplastic drug taxol binds to beta-tubulin to prevent tumor cell division, promoting cell death.">
            <entity id="DS.d92.s0.e0" origId="4666,36314,441276" charOffset="25-30" type="compound" text="taxol"/>
            <entity id="DS.d92.s0.e1" origId="O04386,O42786,O44388,O59837,P02554,P02556,P02557,P04107,P05219,P05220,P05304,P08562,P10875,P10876,P10878,P11482,P11833,P11857,P12457,P14140,P14643,P16040,P17938,P18699,P18700,P20365,P20802,P21148,P22012,P22852,P24637,P28551,P30668,P32256,P33127,P34108,P35394,P41352,P41385,P41386,P41387,P41388,P41741,P41742,P41799,P53373,P53374,P53375,P53376,P79008,P93176,Q00264,Q04709,Q08115,Q24829,Q27380,Q2U2U3,Q39445,Q3KVN1,Q4HZS8,Q4P235,Q4R9N3,Q4WA70,Q52NY7,Q5UBX3,Q6QDC9,Q7KQL5,Q86ZP5,Q8SS99,Q8WZE0,Q91240,Q92268,Q96TU8,Q9GSR5,Q9HFQ3,Q9LKI8,Q9N2N6,Q9UV72" charOffset="40-52" type="protein" text="beta-tubulin"/>
            <pair e1="DS.d92.s0.e0" e2="DS.d92.s0.e1" id="DS.d92.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d92.s1" origId="18357521-772" text="In the current study, we knocked down Bcl-2 expression using cognate siRNA during low-dose taxol treatment to induce apoptosis in two human glioblastoma U138MG and U251MG cell lines.">
            <entity id="DS.d92.s1.e0" origId="P10417,P49950" charOffset="38-43" type="protein" text="Bcl-2"/>
            <entity id="DS.d92.s1.e1" origId="4666,36314,441276" charOffset="91-96" type="compound" text="taxol"/>
            <pair e1="DS.d92.s1.e1" e2="DS.d92.s1.e0" id="DS.d92.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d92.s2" origId="18357521-773" text="The cells were treated with either 100 nM taxol or 100 nM Bcl-2 siRNA or both for 72 h. Immunofluorescent stainings for calpain and active caspase-3 showed increases in expression and co-localization of these proteases in apoptotic cells.">
            <entity id="DS.d92.s2.e0" origId="4666,36314,441276" charOffset="42-47" type="compound" text="taxol"/>
            <entity id="DS.d92.s2.e1" origId="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0" charOffset="209-218" type="protein" text="proteases"/>
            <pair e1="DS.d92.s2.e0" e2="DS.d92.s2.e1" id="DS.d92.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d92.s3" origId="18357521-774" text="Our current study demonstrated that Bcl-2 siRNA significantly augmented taxol mediated apoptosis in different human glioblastoma cells through induction of calpain and caspase proteolytic activities.">
            <entity id="DS.d92.s3.e0" origId="4666,36314,441276" charOffset="72-77" type="compound" text="taxol"/>
            <entity id="DS.d92.s3.e1" origId="P27730" charOffset="156-163" type="protein" text="calpain"/>
            <pair e1="DS.d92.s3.e0" e2="DS.d92.s3.e1" id="DS.d92.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d93" origId="18357522">
        <sentence id="DS.d93.s0" origId="18357522-775" text="Based on these findings, altered expression of PLP1 in most areas of the striatum suggests that widespread changes to the myelin structure could be associated with the adaptive changes following chronic cocaine abuse.">
            <entity id="DS.d93.s0.e0" origId="P04116,P23289,P23294,P47789,P47790,P60201,Q04004,Q08868,Q8HXW7" charOffset="47-51" type="protein" text="PLP1"/>
            <entity id="DS.d93.s0.e1" origId="2826,5760,439497,446220,644017,54613779" charOffset="203-210" type="compound" text="cocaine"/>
            <pair e1="DS.d93.s0.e1" e2="DS.d93.s0.e0" id="DS.d93.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d94" origId="18359113">
        <sentence id="DS.d94.s0" origId="18359113-478" text="No correlation was detected between serum leptin level and vitamin D-25(OH)D3, which was under normal range in 60% of the patients.">
            <entity id="DS.d94.s0.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="42-48" type="protein" text="leptin"/>
            <entity id="DS.d94.s0.e1" origId="5280795" charOffset="59-68" type="compound" text="vitamin D"/>
            <pair e1="DS.d94.s0.e1" e2="DS.d94.s0.e0" id="DS.d94.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d94.s1" origId="18359113-479" text="The higher leptin levels in women was accompanied by higher serum levels of glucose, albumin, Ca, cholesterol, Na and FT4.">
            <entity id="DS.d94.s1.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="11-17" type="protein" text="leptin"/>
            <entity id="DS.d94.s1.e1" origId="206,5793,64689,79025" charOffset="76-83" type="compound" text="glucose"/>
            <entity id="DS.d94.s1.e2" origId="304,5997,6432564,11025495" charOffset="98-109" type="compound" text="cholesterol"/>
            <entity id="DS.d94.s1.e3" origId="923,373840" charOffset="111-113" type="compound" text="Na"/>
            <pair e1="DS.d94.s1.e2" e2="DS.d94.s1.e0" id="DS.d94.s1.i0" interaction="True"/>
            <pair e1="DS.d94.s1.e3" e2="DS.d94.s1.e0" id="DS.d94.s1.i1" interaction="True"/>
            <pair e1="DS.d94.s1.e1" e2="DS.d94.s1.e0" id="DS.d94.s1.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d94.s2" origId="18359113-480" text="Comparison of 50 patients with the lowest leptin levels (mean of 3.4ng/ml) to 50 patients with highest leptin levels (mean of 34ng/ml), did not indicate differences in both 25(OH)D3 and ICTP between these two populations in spite of the highly significant difference in leptin levels.">
            <entity id="DS.d94.s2.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="42-48" type="protein" text="leptin"/>
            <entity id="DS.d94.s2.e1" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="103-109" type="protein" text="leptin"/>
            <entity id="DS.d94.s2.e2" origId="5283731" charOffset="173-181" type="compound" text="25(OH)D3"/>
            <entity id="DS.d94.s2.e3" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="103-109" type="protein" text="leptin"/>
            <pair e1="DS.d94.s2.e2" e2="DS.d94.s2.e0" id="DS.d94.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d95" origId="18363836">
        <sentence id="DS.d95.s0" origId="18363836-902" text="The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after Brefeldin A treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.">
            <entity id="DS.d95.s0.e0" origId="P08163" charOffset="146-158" type="protein" text="glycoprotein"/>
            <entity id="DS.d95.s0.e1" origId="5287620" charOffset="243-254" type="compound" text="Brefeldin A"/>
            <entity id="DS.d95.s0.e2" origId="P31597,P43005,P51906,P51907,Q95135" charOffset="341-372" type="protein" text="excitatory amino-acid carrier 1"/>
            <entity id="DS.d95.s0.e3" origId="P31597,P43005,Q95135" charOffset="374-379" type="protein" text="EAAC1"/>
            <entity id="DS.d95.s0.e4" origId="P62821,Q4UB16,Q6NYB7,Q9TVU5" charOffset="498-502" type="protein" text="Rab1"/>
            <pair e1="DS.d95.s0.e1" e2="DS.d95.s0.e2" id="DS.d95.s0.i0" interaction="False"/>
            <pair e1="DS.d95.s0.e1" e2="DS.d95.s0.e0" id="DS.d95.s0.i1" interaction="False"/>
            <pair e1="DS.d95.s0.e1" e2="DS.d95.s0.e4" id="DS.d95.s0.i2" interaction="False"/>
            <pair e1="DS.d95.s0.e1" e2="DS.d95.s0.e3" id="DS.d95.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d96" origId="18367388">
        <sentence id="DS.d96.s0" origId="18367388-537" text="Resveratrol did not attenuate GA-induced generation of hydrogen peroxide, but it did block GA-induced phosphorylation of connexin 43 (Cx43), a key modulator of GJIC.">
            <entity id="DS.d96.s0.e0" origId="445154" charOffset="0-11" type="compound" text="Resveratrol"/>
            <entity id="DS.d96.s0.e1" origId="784" charOffset="55-72" type="compound" text="hydrogen peroxide"/>
            <entity id="DS.d96.s0.e2" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="121-132" type="protein" text="connexin 43"/>
            <entity id="DS.d96.s0.e3" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="134-138" type="protein" text="Cx43"/>
            <pair e1="DS.d96.s0.e1" e2="DS.d96.s0.e3" id="DS.d96.s0.i0" interaction="False"/>
            <pair e1="DS.d96.s0.e0" e2="DS.d96.s0.e3" id="DS.d96.s0.i1" interaction="True"/>
            <pair e1="DS.d96.s0.e1" e2="DS.d96.s0.e2" id="DS.d96.s0.i2" interaction="False"/>
            <pair e1="DS.d96.s0.e0" e2="DS.d96.s0.e2" id="DS.d96.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d96.s1" origId="18367388-538" text="Furthermore, resveratrol down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (ERK)1/2, one of the critical regulators of Cx43.">
            <entity id="DS.d96.s1.e0" origId="445154" charOffset="13-24" type="compound" text="resveratrol"/>
            <entity id="DS.d96.s1.e1" origId="P29323" charOffset="109-112" type="protein" text="ERK"/>
            <entity id="DS.d96.s1.e2" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="152-156" type="protein" text="Cx43"/>
            <pair e1="DS.d96.s1.e0" e2="DS.d96.s1.e1" id="DS.d96.s1.i0" interaction="True"/>
            <pair e1="DS.d96.s1.e0" e2="DS.d96.s1.e2" id="DS.d96.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d97" origId="18368465">
        <sentence id="DS.d97.s0" origId="18368465-1220" text="DFMO accumulated cells in S phase of the cell cycle and reduced cyclin A expression.">
            <entity id="DS.d97.s0.e0" origId="3009" charOffset="0-4" type="compound" text="DFMO"/>
            <entity id="DS.d97.s0.e1" origId="P20248,P30274,P37881,P43449,P51943,Q92161" charOffset="64-72" type="protein" text="cyclin A"/>
            <pair e1="DS.d97.s0.e0" e2="DS.d97.s0.e1" id="DS.d97.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d98" origId="18368485">
        <sentence id="DS.d98.s0" origId="18368485-1240" text="Indeed, treatment of cells with 1 muM all-trans retinoic acid (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (GFAP) and down regulation of telomerase activity.">
            <entity id="DS.d98.s0.e0" origId="444795" charOffset="38-61" type="compound" text="all-trans retinoic acid"/>
            <entity id="DS.d98.s0.e1" origId="444795" charOffset="63-67" type="compound" text="ATRA"/>
            <entity id="DS.d98.s0.e2" origId="444795" charOffset="48-61" type="compound" text="retinoic acid"/>
            <entity id="DS.d98.s0.e3" origId="P01538,P01543,P01544,P01545,P08772,P08943,P09617,P09618,P21742,P32032,Q05806,Q42596,Q42597,Q42838,Q8H0Q5,Q8VZK8,Q9C8D6,Q9SBK8" charOffset="192-206" type="protein" text="acidic protein"/>
            <entity id="DS.d98.s0.e4" origId="P03995,P14136,P47819,Q28115" charOffset="208-212" type="protein" text="GFAP"/>
            <pair e1="DS.d98.s0.e0" e2="DS.d98.s0.e3" id="DS.d98.s0.i0" interaction="True"/>
            <pair e1="DS.d98.s0.e2" e2="DS.d98.s0.e4" id="DS.d98.s0.i1" interaction="True"/>
            <pair e1="DS.d98.s0.e0" e2="DS.d98.s0.e4" id="DS.d98.s0.i2" interaction="True"/>
            <pair e1="DS.d98.s0.e1" e2="DS.d98.s0.e3" id="DS.d98.s0.i3" interaction="True"/>
            <pair e1="DS.d98.s0.e2" e2="DS.d98.s0.e3" id="DS.d98.s0.i4" interaction="True"/>
            <pair e1="DS.d98.s0.e1" e2="DS.d98.s0.e4" id="DS.d98.s0.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d98.s1" origId="18368485-1241" text="Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml IFN-gamma for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible nitric oxide synthase (iNOS), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.">
            <entity id="DS.d98.s1.e0" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="165-174" type="protein" text="IFN-gamma"/>
            <entity id="DS.d98.s1.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="302-323" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d98.s1.e2" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="325-329" type="protein" text="iNOS"/>
            <entity id="DS.d98.s1.e3" origId="145068" charOffset="302-314" type="compound" text="nitric oxide"/>
            <entity id="DS.d98.s1.e4" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="401-410" type="protein" text="IFN-gamma"/>
            <pair e1="DS.d98.s1.e3" e2="DS.d98.s1.e1" id="DS.d98.s1.i0" interaction="False"/>
            <pair e1="DS.d98.s1.e3" e2="DS.d98.s1.e0" id="DS.d98.s1.i1" interaction="False"/>
            <pair e1="DS.d98.s1.e3" e2="DS.d98.s1.e2" id="DS.d98.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d99" origId="18371961">
        <sentence id="DS.d99.s0" origId="18371961-849" text="Because annexin V binds phosphatidylserine, this study is using this feature to select functional spermatozoa.">
            <entity id="DS.d99.s0.e0" origId="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0" charOffset="8-17" type="protein" text="annexin V"/>
            <entity id="DS.d99.s0.e1" origId="445141,6323481,44147587" charOffset="24-42" type="compound" text="phosphatidylserine"/>
            <pair e1="DS.d99.s0.e1" e2="DS.d99.s0.e0" id="DS.d99.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d100" origId="18373731">
        <sentence id="DS.d100.s0" origId="18373731-672" text="Cyclo(His-Pro) promotes cytoprotection by activating Nrf2-mediated up-regulation of antioxidant defence.">
            <entity id="DS.d100.s0.e0" origId="65137" charOffset="0-13" type="compound" text="Cyclo(His-Pro"/>
            <entity id="DS.d100.s0.e1" origId="O54968,Q60795" charOffset="53-57" type="protein" text="Nrf2"/>
            <pair e1="DS.d100.s0.e0" e2="DS.d100.s0.e1" id="DS.d100.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d100.s1" origId="18373731-674" text="Here, we addressed this issue and found that cyclo(His-Pro) triggered nuclear accumulation of NF-E2-related factor-2 (Nrf2), a transcription factor that up-regulates antioxidant-/electrophile-responsive element (ARE-EpRE)-related genes, in PC12 cells.">
            <entity id="DS.d100.s1.e0" origId="65137" charOffset="45-58" type="compound" text="cyclo(His-Pro"/>
            <entity id="DS.d100.s1.e1" origId="O54968,Q16236,Q60795" charOffset="94-116" type="protein" text="NF-E2-related factor-2"/>
            <entity id="DS.d100.s1.e2" origId="O54968,Q60795" charOffset="118-122" type="protein" text="Nrf2"/>
            <pair e1="DS.d100.s1.e0" e2="DS.d100.s1.e1" id="DS.d100.s1.i0" interaction="True"/>
            <pair e1="DS.d100.s1.e0" e2="DS.d100.s1.e2" id="DS.d100.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d101" origId="18374997">
        <sentence id="DS.d101.s0" origId="18374997-195" text="In women, Plg levels were higher in individuals with diagnosed ischemic heart disease (IHD) and increased with triglycerides (TG) and glucose level.">
            <entity id="DS.d101.s0.e0" origId="P20918,Q01177" charOffset="10-13" type="protein" text="Plg"/>
            <entity id="DS.d101.s0.e1" origId="206,5793,64689,79025" charOffset="134-141" type="compound" text="glucose"/>
            <pair e1="DS.d101.s0.e1" e2="DS.d101.s0.e0" id="DS.d101.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d102" origId="18375536">
        <sentence id="DS.d102.s0" origId="18375536-500" text="To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (IL6) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood cortisol.">
            <entity id="DS.d102.s0.e0" origId="P41693" charOffset="91-104" type="protein" text="interleukin 6"/>
            <entity id="DS.d102.s0.e1" origId="O35736,P05231,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="106-109" type="protein" text="IL6"/>
            <entity id="DS.d102.s0.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="145-153" type="protein" text="TNFalpha"/>
            <entity id="DS.d102.s0.e3" origId="5754" charOffset="239-247" type="compound" text="cortisol"/>
            <pair e1="DS.d102.s0.e3" e2="DS.d102.s0.e1" id="DS.d102.s0.i0" interaction="False"/>
            <pair e1="DS.d102.s0.e3" e2="DS.d102.s0.e2" id="DS.d102.s0.i1" interaction="False"/>
            <pair e1="DS.d102.s0.e3" e2="DS.d102.s0.e0" id="DS.d102.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d103" origId="18378405">
        <sentence id="DS.d103.s0" origId="18378405-1044" text="Using a cell culture model of synaptic NMDA receptor-dependent synaptic potentiation, we find that this is mediated exclusively by NR2B-containing N-methyl-D-aspartate receptors, as implicated by NR2B-specific antagonists and the use of selective vs. non-selective doses of the NR2A-preferring antagonist NVP-AAM077.">
            <entity id="DS.d103.s0.e0" origId="P35439,Q9R1M7" charOffset="147-177" type="protein" text="N-methyl-D-aspartate receptors"/>
            <entity id="DS.d103.s0.e1" origId="4463" charOffset="305-308" type="compound" text="NVP"/>
            <pair e1="DS.d103.s0.e1" e2="DS.d103.s0.e0" id="DS.d103.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d104" origId="18379782">
        <sentence id="DS.d104.s0" origId="18379782-593" text="Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.">
            <entity id="DS.d104.s0.e0" origId="30623,71384" charOffset="0-11" type="compound" text="Dexrazoxane"/>
            <entity id="DS.d104.s0.e1" origId="P31750,Q8INB9" charOffset="81-84" type="protein" text="Akt"/>
            <pair e1="DS.d104.s0.e0" e2="DS.d104.s0.e1" id="DS.d104.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d105" origId="18380536">
        <sentence id="DS.d105.s0" origId="18380536-252" text="Intracellular oxidative status was assessed by analysis of GSH/GSSG levels and time course of ROS production and glutathione reductase (GR) activity.">
            <entity id="DS.d105.s0.e0" origId="124886" charOffset="59-62" type="compound" text="GSH"/>
            <entity id="DS.d105.s0.e1" origId="65359" charOffset="63-67" type="compound" text="GSSG"/>
            <entity id="DS.d105.s0.e2" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="113-134" type="protein" text="glutathione reductase"/>
            <pair e1="DS.d105.s0.e0" e2="DS.d105.s0.e2" id="DS.d105.s0.i0" interaction="False"/>
            <pair e1="DS.d105.s0.e1" e2="DS.d105.s0.e2" id="DS.d105.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d106" origId="18380539">
        <sentence id="DS.d106.s0" origId="18380539-1099" text="A recently discussed cardiovascular risk factor, asymmetric dimethylarginine (ADMA), is known to act as an endogenous inhibitor of endothelial nitric oxide synthase.">
            <entity id="DS.d106.s0.e0" origId="123831" charOffset="49-76" type="compound" text="asymmetric dimethylarginine"/>
            <entity id="DS.d106.s0.e1" origId="123831" charOffset="78-82" type="compound" text="ADMA"/>
            <entity id="DS.d106.s0.e2" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="143-164" type="protein" text="nitric oxide synthase"/>
            <pair e1="DS.d106.s0.e1" e2="DS.d106.s0.e2" id="DS.d106.s0.i0" interaction="True"/>
            <pair e1="DS.d106.s0.e0" e2="DS.d106.s0.e2" id="DS.d106.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d107" origId="18380542">
        <sentence id="DS.d107.s0" origId="18380542-1100" text="The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma lactate, IL-6 or TNF-alpha concentrations).">
            <entity id="DS.d107.s0.e0" origId="P49763,Q9XS47" charOffset="44-47" type="protein" text="PGF"/>
            <entity id="DS.d107.s0.e1" origId="612" charOffset="418-425" type="compound" text="lactate"/>
            <entity id="DS.d107.s0.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="427-431" type="protein" text="IL-6"/>
            <entity id="DS.d107.s0.e3" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="435-444" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d107.s0.e1" e2="DS.d107.s0.e3" id="DS.d107.s0.i0" interaction="False"/>
            <pair e1="DS.d107.s0.e1" e2="DS.d107.s0.e2" id="DS.d107.s0.i1" interaction="False"/>
            <pair e1="DS.d107.s0.e1" e2="DS.d107.s0.e0" id="DS.d107.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d108" origId="18380545">
        <sentence id="DS.d108.s0" origId="18380545-1104" text="Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (IB-MECA) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.">
            <entity id="DS.d108.s0.e0" origId="123683" charOffset="85-92" type="compound" text="IB-MECA"/>
            <entity id="DS.d108.s0.e1" origId="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4" charOffset="164-192" type="protein" text="hematopoietic growth factors"/>
            <entity id="DS.d108.s0.e2" origId="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4" charOffset="208-212" type="protein" text="IL-3"/>
            <entity id="DS.d108.s0.e3" origId="P20826,P21581,P21583,P79169,P79368,Q06220,Q09108,Q28132,Q29030,Q90314,Q95M19,Q95MD2,Q95N18" charOffset="215-231" type="protein" text="stem cell factor"/>
            <entity id="DS.d108.s0.e4" origId="P20826,P21581,P21583,P79169,P79368,Q06220,Q09108,Q28132,Q29030,Q90314,Q95M19,Q95MD2,Q95N18" charOffset="233-236" type="protein" text="SCF"/>
            <entity id="DS.d108.s0.e5" origId="P48750" charOffset="239-287" type="protein" text="granulocyte-macrophage colony-stimulating factor"/>
            <entity id="DS.d108.s0.e6" origId="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481" charOffset="289-295" type="protein" text="GM-CSF"/>
            <entity id="DS.d108.s0.e7" origId="P35834,Q28746" charOffset="302-339" type="protein" text="granulocyte colony-stimulating factor"/>
            <entity id="DS.d108.s0.e8" origId="O02708,O02837,P09919,P09920,P35833,P35834,Q28746" charOffset="341-346" type="protein" text="G-CSF"/>
            <pair e1="DS.d108.s0.e0" e2="DS.d108.s0.e5" id="DS.d108.s0.i0" interaction="False"/>
            <pair e1="DS.d108.s0.e0" e2="DS.d108.s0.e1" id="DS.d108.s0.i1" interaction="False"/>
            <pair e1="DS.d108.s0.e0" e2="DS.d108.s0.e8" id="DS.d108.s0.i2" interaction="False"/>
            <pair e1="DS.d108.s0.e0" e2="DS.d108.s0.e7" id="DS.d108.s0.i3" interaction="False"/>
            <pair e1="DS.d108.s0.e0" e2="DS.d108.s0.e2" id="DS.d108.s0.i4" interaction="False"/>
            <pair e1="DS.d108.s0.e0" e2="DS.d108.s0.e4" id="DS.d108.s0.i5" interaction="False"/>
            <pair e1="DS.d108.s0.e0" e2="DS.d108.s0.e3" id="DS.d108.s0.i6" interaction="False"/>
            <pair e1="DS.d108.s0.e0" e2="DS.d108.s0.e6" id="DS.d108.s0.i7" interaction="False"/>
        </sentence>
        <sentence id="DS.d108.s1" origId="18380545-1105" text="Significant elevation of numbers of GM-CFC evoked by the combinations of IB-MECA with IL-3, SCF, or GM-CSF as compared with these growth factors alone has been noted.">
            <entity id="DS.d108.s1.e0" origId="123683" charOffset="73-80" type="compound" text="IB-MECA"/>
            <entity id="DS.d108.s1.e1" origId="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4" charOffset="86-90" type="protein" text="IL-3"/>
            <entity id="DS.d108.s1.e2" origId="P20826,P21581,P21583,P79169,P79368,Q06220,Q09108,Q28132,Q29030,Q90314,Q95M19,Q95MD2,Q95N18" charOffset="92-95" type="protein" text="SCF"/>
            <pair e1="DS.d108.s1.e0" e2="DS.d108.s1.e2" id="DS.d108.s1.i0" interaction="False"/>
            <pair e1="DS.d108.s1.e0" e2="DS.d108.s1.e1" id="DS.d108.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d108.s2" origId="18380545-1106" text="Combination of IB-MECA with G-CSF did not induce significantly higher numbers of GM-CFC in comparison with G-CSF alone.">
            <entity id="DS.d108.s2.e0" origId="123683" charOffset="15-22" type="compound" text="IB-MECA"/>
            <entity id="DS.d108.s2.e1" origId="O02708,O02837,P09919,P09920,P35833,P35834,Q28746" charOffset="28-33" type="protein" text="G-CSF"/>
            <entity id="DS.d108.s2.e2" origId="O02708,O02837,P09919,P09920,P35833,P35834,Q28746" charOffset="107-112" type="protein" text="G-CSF"/>
            <pair e1="DS.d108.s2.e0" e2="DS.d108.s2.e1" id="DS.d108.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d108.s3" origId="18380545-1107" text="Joint action of three drugs, namely of IB-MECA+ IL-3+ GM-CSF, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.">
            <entity id="DS.d108.s3.e0" origId="123683" charOffset="39-46" type="compound" text="IB-MECA"/>
            <entity id="DS.d108.s3.e1" origId="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4" charOffset="48-52" type="protein" text="IL-3"/>
            <entity id="DS.d108.s3.e2" origId="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481" charOffset="54-60" type="protein" text="GM-CSF"/>
            <entity id="DS.d108.s3.e3" origId="123683" charOffset="149-156" type="compound" text="IB-MECA"/>
            <entity id="DS.d108.s3.e4" origId="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4" charOffset="158-162" type="protein" text="IL-3"/>
            <entity id="DS.d108.s3.e5" origId="123683" charOffset="149-156" type="compound" text="IB-MECA"/>
            <entity id="DS.d108.s3.e6" origId="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481" charOffset="173-179" type="protein" text="GM-CSF"/>
            <entity id="DS.d108.s3.e7" origId="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4" charOffset="158-162" type="protein" text="IL-3"/>
            <entity id="DS.d108.s3.e8" origId="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481" charOffset="173-179" type="protein" text="GM-CSF"/>
            <pair e1="DS.d108.s3.e0" e2="DS.d108.s3.e2" id="DS.d108.s3.i0" interaction="False"/>
            <pair e1="DS.d108.s3.e0" e2="DS.d108.s3.e1" id="DS.d108.s3.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d109" origId="18381637">
        <sentence id="DS.d109.s0" origId="18381637-476" text="Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (IGF-1), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.">
            <entity id="DS.d109.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="89-96" type="protein" text="insulin"/>
            <entity id="DS.d109.s0.e1" origId="Q95222" charOffset="119-124" type="protein" text="IGF-1"/>
            <entity id="DS.d109.s0.e2" origId="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6" charOffset="161-170" type="protein" text="TGF-beta1"/>
            <entity id="DS.d109.s0.e3" origId="16212859" charOffset="236-268" type="compound" text="poly(ethylene glycol)-diacrylate"/>
            <entity id="DS.d109.s0.e4" origId="8037" charOffset="332-368" type="compound" text="N,N,N',N'-tetramethylethylenediamine"/>
            <pair e1="DS.d109.s0.e4" e2="DS.d109.s0.e2" id="DS.d109.s0.i0" interaction="False"/>
            <pair e1="DS.d109.s0.e4" e2="DS.d109.s0.e1" id="DS.d109.s0.i1" interaction="False"/>
            <pair e1="DS.d109.s0.e3" e2="DS.d109.s0.e2" id="DS.d109.s0.i2" interaction="False"/>
            <pair e1="DS.d109.s0.e4" e2="DS.d109.s0.e0" id="DS.d109.s0.i3" interaction="False"/>
            <pair e1="DS.d109.s0.e3" e2="DS.d109.s0.e1" id="DS.d109.s0.i4" interaction="False"/>
            <pair e1="DS.d109.s0.e3" e2="DS.d109.s0.e0" id="DS.d109.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d110" origId="18381638">
        <sentence id="DS.d110.s0" origId="18381638-477" text="Fibronectin modulates osteoblast behavior on Nitinol.">
            <entity id="DS.d110.s0.e0" origId="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400" charOffset="0-11" type="protein" text="Fibronectin"/>
            <entity id="DS.d110.s0.e1" origId="3081502" charOffset="45-52" type="compound" text="Nitinol"/>
            <pair e1="DS.d110.s0.e1" e2="DS.d110.s0.e0" id="DS.d110.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d111" origId="18384163">
        <sentence id="DS.d111.s0" origId="18384163-783" text="Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and alkaline phosphatase was increased in hyaluronic acid-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, RGD peptide, and BMP-2.">
            <entity id="DS.d111.s0.e0" origId="Q08775,Q13950,Q9XSB7,Q9Z2J9" charOffset="79-88" type="protein" text="CBFalpha1"/>
            <entity id="DS.d111.s0.e1" origId="O60109,P81800,P83456" charOffset="93-113" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d111.s0.e2" origId="24759,453618,3084050,24728612" charOffset="131-146" type="compound" text="hyaluronic acid"/>
            <entity id="DS.d111.s0.e3" origId="24759,453618,3084050,24728612" charOffset="229-244" type="compound" text="hyaluronic acid"/>
            <entity id="DS.d111.s0.e4" origId="104802" charOffset="246-257" type="compound" text="RGD peptide"/>
            <entity id="DS.d111.s0.e5" origId="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751" charOffset="263-268" type="protein" text="BMP-2"/>
            <pair e1="DS.d111.s0.e4" e2="DS.d111.s0.e1" id="DS.d111.s0.i0" interaction="True"/>
            <pair e1="DS.d111.s0.e4" e2="DS.d111.s0.e5" id="DS.d111.s0.i1" interaction="False"/>
            <pair e1="DS.d111.s0.e2" e2="DS.d111.s0.e1" id="DS.d111.s0.i2" interaction="True"/>
            <pair e1="DS.d111.s0.e4" e2="DS.d111.s0.e0" id="DS.d111.s0.i3" interaction="True"/>
            <pair e1="DS.d111.s0.e2" e2="DS.d111.s0.e5" id="DS.d111.s0.i4" interaction="False"/>
            <pair e1="DS.d111.s0.e2" e2="DS.d111.s0.e0" id="DS.d111.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d112" origId="18386138">
        <sentence id="DS.d112.s0" origId="18386138-732" text="Treatment of H9c2 cell with low concentrations of Dox causes alterations in fibrous structural proteins including the nuclear lamina and sarcomeric cardiac myosin, as well as mitochondrial depolarization and fragmentation, membrane blebbing with cell shape changes, and phosphatidylserine externalization.">
            <entity id="DS.d112.s0.e0" origId="Q04765,Q04766" charOffset="84-103" type="protein" text="structural proteins"/>
            <entity id="DS.d112.s0.e1" origId="445141,6323481,44147587" charOffset="270-288" type="compound" text="phosphatidylserine"/>
            <pair e1="DS.d112.s0.e1" e2="DS.d112.s0.e0" id="DS.d112.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d113" origId="18387753">
        <sentence id="DS.d113.s0" origId="18387753-460" text="We monitored bcr-abl transcript levels by quantitative real time PCR in 50 tunisian patients treated with imatinib for chronic myeloid leukemia in chronic phase for a median of 29 months (3-60) after they started imatinib.">
            <entity id="DS.d113.s0.e0" origId="P28246,P45123" charOffset="13-16" type="protein" text="bcr"/>
            <entity id="DS.d113.s0.e1" origId="P00520,P00522" charOffset="17-20" type="protein" text="abl"/>
            <entity id="DS.d113.s0.e2" origId="5291" charOffset="106-114" type="compound" text="imatinib"/>
            <entity id="DS.d113.s0.e3" origId="5291" charOffset="213-221" type="compound" text="imatinib"/>
            <pair e1="DS.d113.s0.e2" e2="DS.d113.s0.e1" id="DS.d113.s0.i0" interaction="False"/>
            <pair e1="DS.d113.s0.e2" e2="DS.d113.s0.e0" id="DS.d113.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d114" origId="18389169">
        <sentence id="DS.d114.s0" origId="18389169-121" text="The non-covalent interaction of brilliant red (BR) with lysozyme was investigated by the UV spectrometry, circular dichroism (CD) and isothermal titration calorimetry (ITC).">
            <entity id="DS.d114.s0.e0" origId="5483782,6085493" charOffset="32-45" type="compound" text="brilliant red"/>
            <entity id="DS.d114.s0.e1" origId="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7" charOffset="56-64" type="protein" text="lysozyme"/>
            <pair e1="DS.d114.s0.e0" e2="DS.d114.s0.e1" id="DS.d114.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d115" origId="18390571">
        <sentence id="DS.d115.s0" origId="18390571-968" text="Recent studies suggest that crystals of monosodium urate (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, leucine-rich repeat and pyrin domain-containing protein (NALP)3 inflammasome.">
            <entity id="DS.d115.s0.e0" origId="1175" charOffset="40-56" type="compound" text="monosodium urate"/>
            <entity id="DS.d115.s0.e1" origId="857,6106,439524" charOffset="151-158" type="compound" text="leucine"/>
            <entity id="DS.d115.s0.e2" origId="O15553,Q9JJ25,Q9JJ26" charOffset="175-180" type="protein" text="pyrin"/>
            <pair e1="DS.d115.s0.e1" e2="DS.d115.s0.e2" id="DS.d115.s0.i0" interaction="False"/>
            <pair e1="DS.d115.s0.e0" e2="DS.d115.s0.e2" id="DS.d115.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d116" origId="18393628">
        <sentence id="DS.d116.s0" origId="18393628-298" text="Nicotine, muscarine, and chlorpyrifos induced the phosphorylation of extracellular signal-regulated kinases 1 and 2.">
            <entity id="DS.d116.s0.e0" origId="942,89594,157672" charOffset="0-8" type="compound" text="Nicotine"/>
            <entity id="DS.d116.s0.e1" origId="9308" charOffset="10-19" type="compound" text="muscarine"/>
            <entity id="DS.d116.s0.e2" origId="2730" charOffset="25-37" type="compound" text="chlorpyrifos"/>
            <entity id="DS.d116.s0.e3" origId="P21708,P27361,P28869,P42525,Q63844" charOffset="69-109" type="protein" text="extracellular signal-regulated kinases 1"/>
            <pair e1="DS.d116.s0.e1" e2="DS.d116.s0.e3" id="DS.d116.s0.i0" interaction="True"/>
            <pair e1="DS.d116.s0.e2" e2="DS.d116.s0.e3" id="DS.d116.s0.i1" interaction="True"/>
            <pair e1="DS.d116.s0.e0" e2="DS.d116.s0.e3" id="DS.d116.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d117" origId="18393672">
        <sentence id="DS.d117.s0" origId="18393672-326" text="Adult bone marrow (BM)-derived insulin-producing cells (IPCs) are capable of regulating blood glucose levels in chemically induced hyperglycemic mice.">
            <entity id="DS.d117.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="31-38" type="protein" text="insulin"/>
            <entity id="DS.d117.s0.e1" origId="206,5793,64689,79025" charOffset="94-101" type="compound" text="glucose"/>
            <pair e1="DS.d117.s0.e1" e2="DS.d117.s0.e0" id="DS.d117.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d117.s1" origId="18393672-328" text="Treatment with benfotiamine activated glucose metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize insulin.">
            <entity id="DS.d117.s1.e0" origId="3032771" charOffset="15-27" type="compound" text="benfotiamine"/>
            <entity id="DS.d117.s1.e1" origId="206,5793,64689,79025" charOffset="38-45" type="compound" text="glucose"/>
            <entity id="DS.d117.s1.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="175-182" type="protein" text="insulin"/>
            <pair e1="DS.d117.s1.e0" e2="DS.d117.s1.e2" id="DS.d117.s1.i0" interaction="True"/>
            <pair e1="DS.d117.s1.e1" e2="DS.d117.s1.e2" id="DS.d117.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d117.s2" origId="18393672-329" text="Benfotiamine was not shown to induce the glucose receptor Glut-2, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to glucose-6-phosphate.">
            <entity id="DS.d117.s2.e0" origId="3032771" charOffset="0-12" type="compound" text="Benfotiamine"/>
            <entity id="DS.d117.s2.e1" origId="P12336,P14246" charOffset="58-64" type="protein" text="Glut-2"/>
            <entity id="DS.d117.s2.e2" origId="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0" charOffset="99-110" type="protein" text="glucokinase"/>
            <entity id="DS.d117.s2.e3" origId="5958,439284,439427,439958" charOffset="164-183" type="compound" text="glucose-6-phosphate"/>
            <pair e1="DS.d117.s2.e3" e2="DS.d117.s2.e2" id="DS.d117.s2.i0" interaction="True"/>
            <pair e1="DS.d117.s2.e3" e2="DS.d117.s2.e1" id="DS.d117.s2.i1" interaction="False"/>
            <pair e1="DS.d117.s2.e0" e2="DS.d117.s2.e2" id="DS.d117.s2.i2" interaction="True"/>
            <pair e1="DS.d117.s2.e0" e2="DS.d117.s2.e1" id="DS.d117.s2.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d117.s3" origId="18393672-330" text="However, in cells where the pentose phosphate pathway was blocked by oxythiamine treatment, there was a clear downregulation of Glut-2, glucokinase, insulin, and GAPDH.">
            <entity id="DS.d117.s3.e0" origId="8682" charOffset="69-80" type="compound" text="oxythiamine"/>
            <entity id="DS.d117.s3.e1" origId="P12336,P14246" charOffset="128-134" type="protein" text="Glut-2"/>
            <entity id="DS.d117.s3.e2" origId="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0" charOffset="136-147" type="protein" text="glucokinase"/>
            <entity id="DS.d117.s3.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="149-156" type="protein" text="insulin"/>
            <entity id="DS.d117.s3.e4" origId="O01360,O13507,O27090,O28542,O32755,O34425,O42259,O52631,O57479,O57672,O59494,O59841,O67161,O83816,O96423,P00355,P00356,P00357,P00361,P00362,P04406,P04797,P08439,P09124,P09316,P09317,P0A1P0,P0A1P1,P0C0G6,P0C0G7,P10096,P10097,P10618,P15115,P16858,P17244,P17721,P19089,P19314,P19315,P20287,P20445,P22512,P22513,P23722,P24163,P24164,P24166,P24746,P24748,P24749,P24750,P24751,P24753,P25861,P26518,P26519,P26520,P26521,P26988,P27726,P28844,P29272,P29497,P32637,P32638,P34783,P35143,P39460,P44304,P46406,P46713,P46795,P46796,P47543,P48812,P51009,P51469,P51640,P52694,P52987,P53429,P53430,P54117,P54118,P54226,P55070,P55071,P55971,P56649,P57384,P58839,P61879,P61880,P64178,P64179,P68777,P70685,P75358,P80447,P80534,P83601,P87197,P94915,Q00301,Q00584,Q00640,Q01558,Q01597,Q01651,Q01982,Q05025,Q07234,Q12552,Q1DTF9,Q27652,Q27890,Q28259,Q28554,Q2NEN0,Q3IUT3,Q46450,Q48335,Q4J940,Q4KYY3,Q58546,Q59199,Q59309,Q59800,Q59906,Q5JHB5,Q5R2J2,Q5RAB4,Q5V061,Q5XDW3,Q6BMK0,Q6CCU7,Q6L125,Q6M0E6,Q757I2,Q89AK1,Q8J1H3,Q8K8M9,Q8NK47,Q8PTD3,Q8TFJ2,Q8WZN0,Q8X1X3,Q8ZWK7,Q92211,Q92243,Q92263,Q94469,Q96US8,Q971K2,Q97BJ8,Q9HFX1,Q9HGY7,Q9HJ69,Q9HSS7,Q9N2D5,Q9N655,Q9P8C0,Q9PJN6,Q9UR38,Q9UVC0,Q9UW96,Q9V1P1,Q9Y796,Q9Y8E9,Q9YFS9,Q9Z518,Q9Z7T0,Q9ZKT0" charOffset="162-167" type="protein" text="GAPDH"/>
            <pair e1="DS.d117.s3.e0" e2="DS.d117.s3.e4" id="DS.d117.s3.i0" interaction="True"/>
            <pair e1="DS.d117.s3.e0" e2="DS.d117.s3.e2" id="DS.d117.s3.i1" interaction="True"/>
            <pair e1="DS.d117.s3.e0" e2="DS.d117.s3.e3" id="DS.d117.s3.i2" interaction="True"/>
            <pair e1="DS.d117.s3.e0" e2="DS.d117.s3.e1" id="DS.d117.s3.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d118" origId="18394828">
        <sentence id="DS.d118.s0" origId="18394828-1061" text=") and two oxygen tensions (5 and 20%) were compared for their ability to sustain blastocyst survival and IFNT production from days 8 to 11 post-insemination.">
            <entity id="DS.d118.s0.e0" origId="977" charOffset="10-16" type="compound" text="oxygen"/>
            <entity id="DS.d118.s0.e1" origId="O46633,P28171,P28172,Q95187" charOffset="105-109" type="protein" text="IFNT"/>
            <pair e1="DS.d118.s0.e0" e2="DS.d118.s0.e1" id="DS.d118.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d118.s1" origId="18394828-1062" text="In conclusion, culturing blastocysts of cattle in a 5% oxygen environment with M199 containing serum sustains embryo viability and permits constitutive and inducible IFNT production.">
            <entity id="DS.d118.s1.e0" origId="977" charOffset="55-61" type="compound" text="oxygen"/>
            <entity id="DS.d118.s1.e1" origId="O46633,P28171,P28172,Q95187" charOffset="166-170" type="protein" text="IFNT"/>
            <pair e1="DS.d118.s1.e0" e2="DS.d118.s1.e1" id="DS.d118.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d118.s2" origId="18394828-1063" text="Incubation in 20% oxygen increases IFNT production.">
            <entity id="DS.d118.s2.e0" origId="977" charOffset="18-24" type="compound" text="oxygen"/>
            <entity id="DS.d118.s2.e1" origId="O46633,P28171,P28172,Q95187" charOffset="35-39" type="protein" text="IFNT"/>
            <pair e1="DS.d118.s2.e0" e2="DS.d118.s2.e1" id="DS.d118.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d119" origId="18395421">
        <sentence id="DS.d119.s0" origId="18395421-172" text="Histologic examination investigated deposition of extracellular matrix (ECM) including collagen, elastin, hyaluronic acid (HA), fibronectin, and decorin in the lamina propria of the scarred vocal folds.">
            <entity id="DS.d119.s0.e0" origId="Q13201" charOffset="72-75" type="protein" text="ECM"/>
            <entity id="DS.d119.s0.e1" origId="P11547" charOffset="97-104" type="protein" text="elastin"/>
            <entity id="DS.d119.s0.e2" origId="24759,453618,3084050,24728612" charOffset="106-121" type="compound" text="hyaluronic acid"/>
            <entity id="DS.d119.s0.e3" origId="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400" charOffset="128-139" type="protein" text="fibronectin"/>
            <pair e1="DS.d119.s0.e2" e2="DS.d119.s0.e3" id="DS.d119.s0.i0" interaction="False"/>
            <pair e1="DS.d119.s0.e2" e2="DS.d119.s0.e1" id="DS.d119.s0.i1" interaction="False"/>
            <pair e1="DS.d119.s0.e2" e2="DS.d119.s0.e0" id="DS.d119.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d120" origId="18396353">
        <sentence id="DS.d120.s0" origId="18396353-715" text="A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (AChE) and compared with the established antidote 2-PAM and obidoxime.">
            <entity id="DS.d120.s0.e0" origId="10869" charOffset="57-78" type="compound" text="methoxymethyl benzene"/>
            <entity id="DS.d120.s0.e1" origId="5936" charOffset="242-273" type="compound" text="diisopropyl phosphorofluoridate"/>
            <entity id="DS.d120.s0.e2" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="290-310" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d120.s0.e3" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="312-316" type="protein" text="AChE"/>
            <entity id="DS.d120.s0.e4" origId="107688" charOffset="371-380" type="compound" text="obidoxime"/>
            <pair e1="DS.d120.s0.e0" e2="DS.d120.s0.e2" id="DS.d120.s0.i0" interaction="False"/>
            <pair e1="DS.d120.s0.e0" e2="DS.d120.s0.e3" id="DS.d120.s0.i1" interaction="False"/>
            <pair e1="DS.d120.s0.e1" e2="DS.d120.s0.e3" id="DS.d120.s0.i2" interaction="False"/>
            <pair e1="DS.d120.s0.e4" e2="DS.d120.s0.e2" id="DS.d120.s0.i3" interaction="False"/>
            <pair e1="DS.d120.s0.e4" e2="DS.d120.s0.e3" id="DS.d120.s0.i4" interaction="False"/>
            <pair e1="DS.d120.s0.e1" e2="DS.d120.s0.e2" id="DS.d120.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d121" origId="18396355">
        <sentence id="DS.d121.s0" origId="18396355-716" text="In-vitro regeneration of sarin inhibited electric eel acetylcholinesterase by bis-pyridinium oximes bearing xylene linker.">
            <entity id="DS.d121.s0.e0" origId="7871" charOffset="25-30" type="compound" text="sarin"/>
            <entity id="DS.d121.s0.e1" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="54-74" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d121.s0.e2" origId="7237" charOffset="108-114" type="compound" text="xylene"/>
            <pair e1="DS.d121.s0.e0" e2="DS.d121.s0.e1" id="DS.d121.s0.i0" interaction="True"/>
            <pair e1="DS.d121.s0.e2" e2="DS.d121.s0.e1" id="DS.d121.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d121.s1" origId="18396355-717" text="A series of bis-pyridinium oximes connected by xylene linker were synthesized and their in-vitro reactivation potential was evaluated against acetylcholinesterase (AChE) inhibited by nerve agent, sarin.">
            <entity id="DS.d121.s1.e0" origId="7237" charOffset="47-53" type="compound" text="xylene"/>
            <entity id="DS.d121.s1.e1" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="142-162" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d121.s1.e2" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="164-168" type="protein" text="AChE"/>
            <entity id="DS.d121.s1.e3" origId="7871" charOffset="196-201" type="compound" text="sarin"/>
            <pair e1="DS.d121.s1.e0" e2="DS.d121.s1.e1" id="DS.d121.s1.i0" interaction="False"/>
            <pair e1="DS.d121.s1.e3" e2="DS.d121.s1.e1" id="DS.d121.s1.i1" interaction="False"/>
            <pair e1="DS.d121.s1.e0" e2="DS.d121.s1.e2" id="DS.d121.s1.i2" interaction="False"/>
            <pair e1="DS.d121.s1.e3" e2="DS.d121.s1.e2" id="DS.d121.s1.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d121.s2" origId="18396355-718" text="Among the synthesized compounds, alpha,alpha'xylene-bis-(3,3'-(hydroxyiminomethyl) pyridinium) dibromide (3b) was found to be most potent reactivator for AChE inhibited by sarin.">
            <entity id="DS.d121.s2.e0" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="154-158" type="protein" text="AChE"/>
            <entity id="DS.d121.s2.e1" origId="7871" charOffset="172-177" type="compound" text="sarin"/>
            <pair e1="DS.d121.s2.e1" e2="DS.d121.s2.e0" id="DS.d121.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d122" origId="18396356">
        <sentence id="DS.d122.s0" origId="18396356-720" text="Of the compounds synthesized, compound 2a, which has a primary amide at warhead region of the inhibitor most potently inhibited mu-calpain with an IC(50) value of 2.81+/-1.26 microM, which is ca.">
            <entity id="DS.d122.s0.e0" origId="398803" charOffset="30-41" type="compound" text="compound 2a"/>
            <entity id="DS.d122.s0.e1" origId="P27730" charOffset="131-138" type="protein" text="calpain"/>
            <pair e1="DS.d122.s0.e0" e2="DS.d122.s0.e1" id="DS.d122.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d123" origId="18397836">
        <sentence id="DS.d123.s0" origId="18397836-365" text="Recent studies have focused on possible functional disorders of the enteric nervous system within the abomasal wall, since cattle with abomasal displacement have an increased activity of neuronal nitric oxide synthase, as well as decreased acetylcholine sensitivity.">
            <entity id="DS.d123.s0.e0" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="196-217" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d123.s0.e1" origId="187" charOffset="240-253" type="compound" text="acetylcholine"/>
            <pair e1="DS.d123.s0.e1" e2="DS.d123.s0.e0" id="DS.d123.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d124" origId="18397960">
        <sentence id="DS.d124.s0" origId="18397960-447" text="Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite A771726 (teriflunomide).">
            <entity id="DS.d124.s0.e0" origId="Q9UNQ0" charOffset="79-111" type="protein" text="breast cancer resistance protein"/>
            <entity id="DS.d124.s0.e1" origId="Q9UNQ0" charOffset="113-117" type="protein" text="BCRP"/>
            <entity id="DS.d124.s0.e2" origId="3899" charOffset="200-211" type="compound" text="leflunomide"/>
            <entity id="DS.d124.s0.e3" origId="54684141" charOffset="231-238" type="compound" text="A771726"/>
            <entity id="DS.d124.s0.e4" origId="54684141" charOffset="240-253" type="compound" text="teriflunomide"/>
            <pair e1="DS.d124.s0.e4" e2="DS.d124.s0.e1" id="DS.d124.s0.i0" interaction="True"/>
            <pair e1="DS.d124.s0.e2" e2="DS.d124.s0.e1" id="DS.d124.s0.i1" interaction="True"/>
            <pair e1="DS.d124.s0.e3" e2="DS.d124.s0.e0" id="DS.d124.s0.i2" interaction="True"/>
            <pair e1="DS.d124.s0.e2" e2="DS.d124.s0.e0" id="DS.d124.s0.i3" interaction="True"/>
            <pair e1="DS.d124.s0.e4" e2="DS.d124.s0.e0" id="DS.d124.s0.i4" interaction="True"/>
            <pair e1="DS.d124.s0.e3" e2="DS.d124.s0.e1" id="DS.d124.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d125" origId="18398609">
        <sentence id="DS.d125.s0" origId="18398609-866" text="Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.">
            <entity id="DS.d125.s0.e0" origId="P0ABF6,P0ABF7,P19079,P32320,P44325,P47298,P47718,P56389,P75051,Q06549,Q322V3,Q32EM3,Q3IBX5,Q3Z062,Q4QK60,Q57MF5,Q5E4R6,Q5PE68,Q65RG8,Q66C79,Q6D3B4,Q6LRI0,Q7MK48,Q7N6K3,Q7VMJ6,Q87Q52,Q8DA31,Q8EDG1,Q8FFV3,Q8X648,Q8Z5A8,Q8ZG08,Q8ZNM0,Q9CP11,Q9KD53,Q9KSM5,Q9S3M0" charOffset="14-32" type="protein" text="cytidine deaminase"/>
            <entity id="DS.d125.s0.e1" origId="100016,328839,16760709,46783268" charOffset="36-46" type="compound" text="zebularine"/>
            <entity id="DS.d125.s0.e2" origId="451668" charOffset="85-107" type="compound" text="5-aza-2'-deoxycytidine"/>
            <pair e1="DS.d125.s0.e2" e2="DS.d125.s0.e0" id="DS.d125.s0.i0" interaction="False"/>
            <pair e1="DS.d125.s0.e1" e2="DS.d125.s0.e0" id="DS.d125.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d126" origId="18398611">
        <sentence id="DS.d126.s0" origId="18398611-867" text="An individual's response to fludarabine may be influenced by the amount of CD4 (+) and CD8(+) T-lymphocyte suppression.">
            <entity id="DS.d126.s0.e0" origId="657237" charOffset="28-39" type="compound" text="fludarabine"/>
            <entity id="DS.d126.s0.e1" origId="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78" charOffset="75-78" type="protein" text="CD4"/>
            <pair e1="DS.d126.s0.e0" e2="DS.d126.s0.e1" id="DS.d126.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d127" origId="18398624">
        <sentence id="DS.d127.s0" origId="18398624-876" text="We hypothesise that arginine aspartate acts as a chemical or pharmacological chaperone, and suggest amino acid supplementation as a possible therapy in PDHA1 mutations with mild phenotypes.">
            <entity id="DS.d127.s0.e0" origId="24325" charOffset="20-38" type="compound" text="arginine aspartate"/>
            <entity id="DS.d127.s0.e1" origId="P08559,P29804,P49823,Q5R490,Q8HXW9" charOffset="152-157" type="protein" text="PDHA1"/>
            <pair e1="DS.d127.s0.e0" e2="DS.d127.s0.e1" id="DS.d127.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d128" origId="18400050">
        <sentence id="DS.d128.s0" origId="18400050-469" text="mRNA expressions of matrix metallopeptidase-9, inducible nitric oxide synthase and pro-inflammatory cytokines interleukin-1 beta and tumour necrosis factor-alpha in EAN sciatic nerves were greatly decreased by administration of minocycline as well.">
            <entity id="DS.d128.s0.e0" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="57-78" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d128.s0.e1" origId="54675783" charOffset="228-239" type="compound" text="minocycline"/>
            <pair e1="DS.d128.s0.e1" e2="DS.d128.s0.e0" id="DS.d128.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d129" origId="18400404">
        <sentence id="DS.d129.s0" origId="18400404-699" text="Then the review evaluates the involvement of KARs activated by the endogenous agonist glutamate in the generation and propagation of epileptiform activity.">
            <entity id="DS.d129.s0.e0" origId="O70503,Q4R5G7,Q53GQ0,Q5E9H7,Q6P7R8" charOffset="45-49" type="protein" text="KARs"/>
            <entity id="DS.d129.s0.e1" origId="611,23327,33032" charOffset="86-95" type="compound" text="glutamate"/>
            <pair e1="DS.d129.s0.e1" e2="DS.d129.s0.e0" id="DS.d129.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d130" origId="18403016">
        <sentence id="DS.d130.s0" origId="18403016-272" text="Glutamate cysteine ligase (GCL), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.">
            <entity id="DS.d130.s0.e0" origId="O68838,P0A6W9,P0A6X0,P32477,P57485,P58994,P61379,Q09768,Q20117,Q57KV3,Q5E7F8,Q5LYY5,Q5M3J8,Q5PF10,Q65RX0,Q66E64,Q6ANW2,Q6D1T4,Q6LMV1,Q71VZ1,Q72RD4,Q7MHS5,Q7N7A4,Q7W3F2,Q7WES2,Q82ZG8,Q87LS2,Q88AR1,Q88R90,Q88UW5,Q89AD8,Q8D2V5,Q8DC38,Q8DW15,Q8DXM9,Q8E399,Q8EBF9,Q8F4D5,Q8X0X0,Q8X900,Q8XK30,Q8Y3R3,Q8Z4D6,Q8ZBU2,Q926X7,Q97IV1,Q9CM00,Q9HF78,Q9HTY6,Q9KUG5,Q9NFN6,Q9W3K5" charOffset="0-25" type="protein" text="Glutamate cysteine ligase"/>
            <entity id="DS.d130.s0.e1" origId="P28676,Q8NEA9,Q96IK5" charOffset="27-30" type="protein" text="GCL"/>
            <entity id="DS.d130.s0.e2" origId="123938" charOffset="46-68" type="compound" text="gamma-glutamylcysteine"/>
            <entity id="DS.d130.s0.e3" origId="611,23327,33032" charOffset="74-83" type="compound" text="glutamate"/>
            <entity id="DS.d130.s0.e4" origId="594,5862,5360637" charOffset="10-18" type="compound" text="cysteine"/>
            <entity id="DS.d130.s0.e5" origId="124886" charOffset="129-140" type="compound" text="glutathione"/>
            <entity id="DS.d130.s0.e6" origId="124886" charOffset="142-145" type="compound" text="GSH"/>
            <pair e1="DS.d130.s0.e4" e2="DS.d130.s0.e1" id="DS.d130.s0.i0" interaction="True"/>
            <pair e1="DS.d130.s0.e6" e2="DS.d130.s0.e1" id="DS.d130.s0.i1" interaction="True"/>
            <pair e1="DS.d130.s0.e3" e2="DS.d130.s0.e0" id="DS.d130.s0.i2" interaction="True"/>
            <pair e1="DS.d130.s0.e2" e2="DS.d130.s0.e1" id="DS.d130.s0.i3" interaction="True"/>
            <pair e1="DS.d130.s0.e2" e2="DS.d130.s0.e0" id="DS.d130.s0.i4" interaction="True"/>
            <pair e1="DS.d130.s0.e3" e2="DS.d130.s0.e1" id="DS.d130.s0.i5" interaction="True"/>
            <pair e1="DS.d130.s0.e4" e2="DS.d130.s0.e0" id="DS.d130.s0.i6" interaction="True"/>
            <pair e1="DS.d130.s0.e5" e2="DS.d130.s0.e0" id="DS.d130.s0.i7" interaction="True"/>
            <pair e1="DS.d130.s0.e5" e2="DS.d130.s0.e1" id="DS.d130.s0.i8" interaction="True"/>
            <pair e1="DS.d130.s0.e6" e2="DS.d130.s0.e0" id="DS.d130.s0.i9" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d131" origId="18403053">
        <sentence id="DS.d131.s0" origId="18403053-226" text="We observed that lactacystin inhibited the proteasome activities and increased the level and insolubility of different tau species, including phosphorylated tau.">
            <entity id="DS.d131.s0.e0" origId="3870,3034764,6610292" charOffset="17-28" type="compound" text="lactacystin"/>
            <entity id="DS.d131.s0.e1" origId="P10637,P16525,P19332,P58384" charOffset="119-122" type="protein" text="tau"/>
            <entity id="DS.d131.s0.e2" origId="P10637,P16525,P19332,P58384" charOffset="157-160" type="protein" text="tau"/>
            <pair e1="DS.d131.s0.e0" e2="DS.d131.s0.e1" id="DS.d131.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d132" origId="18404246">
        <sentence id="DS.d132.s0" origId="18404246-532" text="Serine and cysteine proteases proved to be suitable tools for the production of amino acids and peptides conjugated to 4-aminoantipyrine, whereas metalloproteases do not seem to be very qualified for accepting this nucleophile.">
            <entity id="DS.d132.s0.e0" origId="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0" charOffset="20-29" type="protein" text="proteases"/>
            <entity id="DS.d132.s0.e1" origId="2151" charOffset="119-136" type="compound" text="4-aminoantipyrine"/>
            <pair e1="DS.d132.s0.e1" e2="DS.d132.s0.e0" id="DS.d132.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d133" origId="18405417">
        <sentence id="DS.d133.s0" origId="18405417-151" text="Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice.">
            <entity id="DS.d133.s0.e0" origId="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298" charOffset="18-24" type="protein" text="5-HT1A"/>
            <entity id="DS.d133.s0.e1" origId="5656" charOffset="103-114" type="compound" text="venlafaxine"/>
            <pair e1="DS.d133.s0.e1" e2="DS.d133.s0.e0" id="DS.d133.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d133.s1" origId="18405417-152" text="The present study was undertaken to evaluate the potential role of 5-HT1A receptors in the antidepressant-like effect and antinociceptive effect of venlafaxine.">
            <entity id="DS.d133.s1.e0" origId="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298" charOffset="67-73" type="protein" text="5-HT1A"/>
            <entity id="DS.d133.s1.e1" origId="5656" charOffset="148-159" type="compound" text="venlafaxine"/>
            <pair e1="DS.d133.s1.e1" e2="DS.d133.s1.e0" id="DS.d133.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d133.s2" origId="18405417-154" text="These findings show that 5-HT1A receptors play differing roles in modulating the antidepressant-like and antinociceptive effects of venlafaxine in the models investigated.">
            <entity id="DS.d133.s2.e0" origId="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298" charOffset="25-31" type="protein" text="5-HT1A"/>
            <entity id="DS.d133.s2.e1" origId="5656" charOffset="132-143" type="compound" text="venlafaxine"/>
            <pair e1="DS.d133.s2.e1" e2="DS.d133.s2.e0" id="DS.d133.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d133.s3" origId="18405417-155" text="In contrast, the antinociceptive effect of venlafaxine is probably potentiated due to the blockade of somatodendritic 5-HT1A receptors in the same raphe nuclei, facilitating the descending monoaminergic pain control system.">
            <entity id="DS.d133.s3.e0" origId="5656" charOffset="43-54" type="compound" text="venlafaxine"/>
            <entity id="DS.d133.s3.e1" origId="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298" charOffset="118-124" type="protein" text="5-HT1A"/>
            <pair e1="DS.d133.s3.e0" e2="DS.d133.s3.e1" id="DS.d133.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d134" origId="18407279">
        <sentence id="DS.d134.s0" origId="18407279-655" text="Moreover, beta-glucuronidase hydrolysis of baicalin sequentially yielded glucuronic acid and baicalein as confirmed by co-TLC with authentic samples.">
            <entity id="DS.d134.s0.e0" origId="P05804" charOffset="10-28" type="protein" text="beta-glucuronidase"/>
            <entity id="DS.d134.s0.e1" origId="64982" charOffset="43-51" type="compound" text="baicalin"/>
            <entity id="DS.d134.s0.e2" origId="5281605" charOffset="93-102" type="compound" text="baicalein"/>
            <pair e1="DS.d134.s0.e2" e2="DS.d134.s0.e0" id="DS.d134.s0.i0" interaction="True"/>
            <pair e1="DS.d134.s0.e1" e2="DS.d134.s0.e0" id="DS.d134.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d135" origId="18407527">
        <sentence id="DS.d135.s0" origId="18407527-68" text="The effect of this diet alone or after 2 weeks of treatment with rosiglitazone or glimepiride on glucose homeostasis, lipid profile, and levels of resistin and leptin was studied.">
            <entity id="DS.d135.s0.e0" origId="77999" charOffset="65-78" type="compound" text="rosiglitazone"/>
            <entity id="DS.d135.s0.e1" origId="3476" charOffset="82-93" type="compound" text="glimepiride"/>
            <entity id="DS.d135.s0.e2" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="160-166" type="protein" text="leptin"/>
            <pair e1="DS.d135.s0.e0" e2="DS.d135.s0.e2" id="DS.d135.s0.i0" interaction="False"/>
            <pair e1="DS.d135.s0.e1" e2="DS.d135.s0.e2" id="DS.d135.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d135.s1" origId="18407527-71" text="Rosiglitazone corrected the altered parameters measured, except for liver TGs ; similarly, glimepiride reinstated the inverted parameters but raised insulin level and, consequently, the HOMA index.">
            <entity id="DS.d135.s1.e0" origId="77999" charOffset="0-13" type="compound" text="Rosiglitazone"/>
            <entity id="DS.d135.s1.e1" origId="2724387" charOffset="74-77" type="compound" text="TGs"/>
            <entity id="DS.d135.s1.e2" origId="3476" charOffset="91-102" type="compound" text="glimepiride"/>
            <entity id="DS.d135.s1.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="149-156" type="protein" text="insulin"/>
            <pair e1="DS.d135.s1.e2" e2="DS.d135.s1.e3" id="DS.d135.s1.i0" interaction="True"/>
            <pair e1="DS.d135.s1.e0" e2="DS.d135.s1.e3" id="DS.d135.s1.i1" interaction="False"/>
            <pair e1="DS.d135.s1.e1" e2="DS.d135.s1.e3" id="DS.d135.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d136" origId="18409068">
        <sentence id="DS.d136.s0" origId="18409068-1012" text="AZD0530 inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of FAK and paxillin in a dose-dependent manner in a Calu-6 xenograft model.">
            <entity id="DS.d136.s0.e0" origId="10302451" charOffset="0-7" type="compound" text="AZD0530"/>
            <entity id="DS.d136.s0.e1" origId="Q00944,Q05397" charOffset="96-99" type="protein" text="FAK"/>
            <entity id="DS.d136.s0.e2" origId="P49023,P49024,Q5R7I1,Q66H76,Q8VI36" charOffset="104-112" type="protein" text="paxillin"/>
            <pair e1="DS.d136.s0.e0" e2="DS.d136.s0.e1" id="DS.d136.s0.i0" interaction="True"/>
            <pair e1="DS.d136.s0.e0" e2="DS.d136.s0.e2" id="DS.d136.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d137" origId="18409071">
        <sentence id="DS.d137.s0" origId="18409071-995" text="Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant.">
            <entity id="DS.d137.s0.e0" origId="P00533,P13387,P55245" charOffset="21-25" type="protein" text="EGFR"/>
            <entity id="DS.d137.s0.e1" origId="104741" charOffset="120-131" type="compound" text="fulvestrant"/>
            <pair e1="DS.d137.s0.e1" e2="DS.d137.s0.e0" id="DS.d137.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d137.s1" origId="18409071-997" text="Treatment with the EGFR inhibitor gefitinib preferentially inhibited growth and reduced the S phase fraction in the resistant cell lines concomitant with inhibition of Erk and unaltered Akt activation.">
            <entity id="DS.d137.s1.e0" origId="123631" charOffset="34-43" type="compound" text="gefitinib"/>
            <entity id="DS.d137.s1.e1" origId="P31750,Q8INB9" charOffset="186-189" type="protein" text="Akt"/>
            <pair e1="DS.d137.s1.e0" e2="DS.d137.s1.e1" id="DS.d137.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d138" origId="18410309">
        <sentence id="DS.d138.s0" origId="18410309-540" text="Melatonin protects from hepatic reperfusion injury through inhibition of IKK and JNK pathways and modification of cell proliferation.">
            <entity id="DS.d138.s0.e0" origId="896" charOffset="0-9" type="compound" text="Melatonin"/>
            <entity id="DS.d138.s0.e1" origId="P92208,Q966Y3" charOffset="81-84" type="protein" text="JNK"/>
            <pair e1="DS.d138.s0.e0" e2="DS.d138.s0.e1" id="DS.d138.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d138.s1" origId="18410309-541" text="Melatonin significantly improved animal survival and decreased transaminase levels, the indices for necrosis, liver damage, leukocyte infiltration, and iNOS expression.">
            <entity id="DS.d138.s1.e0" origId="896" charOffset="0-9" type="compound" text="Melatonin"/>
            <entity id="DS.d138.s1.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="152-156" type="protein" text="iNOS"/>
            <pair e1="DS.d138.s1.e0" e2="DS.d138.s1.e1" id="DS.d138.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d138.s2" origId="18410309-542" text="At the same time, melatonin reduced the expression of both PCNA 0.05).">
            <entity id="DS.d138.s2.e0" origId="896" charOffset="18-27" type="compound" text="melatonin"/>
            <entity id="DS.d138.s2.e1" origId="O01377,O02115,O10308,O16852,O27367,O29912,O58398,O73947,O82134,O82797,P04961,P11038,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00265,Q00268,Q03392,Q43124,Q43266,Q57697,Q6B6N4,Q6KZF1,Q6LWJ8,Q74MV1,Q7T6Y0,Q8PX25,Q8TUF7,Q8TWK3,Q979S2,Q9DDF1,Q9DEA3,Q9HJQ0,Q9HN45,Q9M7Q7,Q9MAY3,Q9P9H8,Q9PTP1,Q9UWR9,Q9UYX8,Q9W644" charOffset="59-63" type="protein" text="PCNA"/>
            <pair e1="DS.d138.s2.e0" e2="DS.d138.s2.e1" id="DS.d138.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d138.s3" origId="18410309-543" text="Melatonin is hepatoprotective most likely via mechanisms including inhibition of IKK and JNK pathways and regulation of cell proliferation.">
            <entity id="DS.d138.s3.e0" origId="896" charOffset="0-9" type="compound" text="Melatonin"/>
            <entity id="DS.d138.s3.e1" origId="P92208,Q966Y3" charOffset="89-92" type="protein" text="JNK"/>
            <pair e1="DS.d138.s3.e0" e2="DS.d138.s3.e1" id="DS.d138.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d139" origId="18410522">
        <sentence id="DS.d139.s0" origId="18410522-611" text="Here, we report that the citrus bioflavonoid luteolin reduces amyloid-beta (Abeta) peptide generation in both human 'Swedish' mutant APP transgene-bearing neuron-like cells and primary neurons.">
            <entity id="DS.d139.s0.e0" origId="5280805" charOffset="32-44" type="compound" text="bioflavonoid"/>
            <entity id="DS.d139.s0.e1" origId="5280445" charOffset="45-53" type="compound" text="luteolin"/>
            <entity id="DS.d139.s0.e2" origId="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241" charOffset="133-136" type="protein" text="APP"/>
            <pair e1="DS.d139.s0.e1" e2="DS.d139.s0.e2" id="DS.d139.s0.i0" interaction="True"/>
            <pair e1="DS.d139.s0.e0" e2="DS.d139.s0.e2" id="DS.d139.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d139.s1" origId="18410522-612" text="We also find that luteolin induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote presenilin-1 (PS1) carboxyl-terminal fragment (CTF) phosphorylation.">
            <entity id="DS.d139.s1.e0" origId="5280445" charOffset="18-26" type="compound" text="luteolin"/>
            <entity id="DS.d139.s1.e1" origId="P51136,P83101" charOffset="59-64" type="protein" text="GSK-3"/>
            <entity id="DS.d139.s1.e2" origId="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241" charOffset="124-127" type="protein" text="APP"/>
            <entity id="DS.d139.s1.e3" origId="O12976,P49768,P49769,P79802,P97887,Q4JIM4,Q5R780,Q6RH31,Q8HXW5,Q9W6T7,Q9XT97" charOffset="157-169" type="protein" text="presenilin-1"/>
            <entity id="DS.d139.s1.e4" origId="P49768,P79802,Q8HXW5,Q9W6T7" charOffset="171-174" type="protein" text="PS1"/>
            <pair e1="DS.d139.s1.e0" e2="DS.d139.s1.e2" id="DS.d139.s1.i0" interaction="True"/>
            <pair e1="DS.d139.s1.e0" e2="DS.d139.s1.e3" id="DS.d139.s1.i1" interaction="True"/>
            <pair e1="DS.d139.s1.e0" e2="DS.d139.s1.e4" id="DS.d139.s1.i2" interaction="True"/>
            <pair e1="DS.d139.s1.e0" e2="DS.d139.s1.e1" id="DS.d139.s1.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d139.s2" origId="18410522-613" text="As validation of these findings in vivo, we find that luteolin, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces GSK-3 activity, and disrupts PS1-APP association.">
            <entity id="DS.d139.s2.e0" origId="5280445" charOffset="54-62" type="compound" text="luteolin"/>
            <entity id="DS.d139.s2.e1" origId="P51136,P83101" charOffset="150-155" type="protein" text="GSK-3"/>
            <entity id="DS.d139.s2.e2" origId="P49768,P79802,Q8HXW5,Q9W6T7" charOffset="179-182" type="protein" text="PS1"/>
            <entity id="DS.d139.s2.e3" origId="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241" charOffset="183-186" type="protein" text="APP"/>
            <pair e1="DS.d139.s2.e0" e2="DS.d139.s2.e3" id="DS.d139.s2.i0" interaction="True"/>
            <pair e1="DS.d139.s2.e0" e2="DS.d139.s2.e2" id="DS.d139.s2.i1" interaction="True"/>
            <pair e1="DS.d139.s2.e0" e2="DS.d139.s2.e1" id="DS.d139.s2.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d140" origId="18410527">
        <sentence id="DS.d140.s0" origId="18410527-619" text="Since biliverdin and bilirubin are downstream products of heme degradation by heme oxygenase (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.">
            <entity id="DS.d140.s0.e0" origId="5280353,5315455,5353439,6183357" charOffset="6-16" type="compound" text="biliverdin"/>
            <entity id="DS.d140.s0.e1" origId="5280352" charOffset="21-30" type="compound" text="bilirubin"/>
            <entity id="DS.d140.s0.e2" origId="4971" charOffset="58-62" type="compound" text="heme"/>
            <entity id="DS.d140.s0.e3" origId="O19998,O73688,O78497,P51271,P71119" charOffset="78-92" type="protein" text="heme oxygenase"/>
            <pair e1="DS.d140.s0.e1" e2="DS.d140.s0.e3" id="DS.d140.s0.i0" interaction="True"/>
            <pair e1="DS.d140.s0.e2" e2="DS.d140.s0.e3" id="DS.d140.s0.i1" interaction="False"/>
            <pair e1="DS.d140.s0.e0" e2="DS.d140.s0.e3" id="DS.d140.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d141" origId="18410529">
        <sentence id="DS.d141.s0" origId="18410529-629" text="Here, we examine the effect of resistin on glucose uptake in human trophoblast cells and we demonstrate that transplacental glucose transport is mediated by glucose transporter (GLUT)-1.">
            <entity id="DS.d141.s0.e0" origId="206,5793,64689,79025" charOffset="43-50" type="compound" text="glucose"/>
            <entity id="DS.d141.s0.e1" origId="P23586" charOffset="157-176" type="protein" text="glucose transporter"/>
            <pair e1="DS.d141.s0.e0" e2="DS.d141.s0.e1" id="DS.d141.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d141.s1" origId="18410529-630" text="ERK1 and 2 activation stimulated GLUT-1 synthesis and resulted in increase of placental glucose uptake.">
            <entity id="DS.d141.s1.e0" origId="P27361,P28869,P42525,Q07176" charOffset="0-4" type="protein" text="ERK1"/>
            <entity id="DS.d141.s1.e1" origId="P79365" charOffset="33-39" type="protein" text="GLUT-1"/>
            <entity id="DS.d141.s1.e2" origId="206,5793,64689,79025" charOffset="88-95" type="compound" text="glucose"/>
            <pair e1="DS.d141.s1.e2" e2="DS.d141.s1.e1" id="DS.d141.s1.i0" interaction="True"/>
            <pair e1="DS.d141.s1.e2" e2="DS.d141.s1.e0" id="DS.d141.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d141.s2" origId="18410529-631" text="High resistin levels (50-100 ng/ml) seem able to affect glucose-uptake, presumably by decreasing the cell surface glucose transporter.">
            <entity id="DS.d141.s2.e0" origId="206,5793,64689,79025" charOffset="56-63" type="compound" text="glucose"/>
            <entity id="DS.d141.s2.e1" origId="P23586" charOffset="114-133" type="protein" text="glucose transporter"/>
            <pair e1="DS.d141.s2.e0" e2="DS.d141.s2.e1" id="DS.d141.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d142" origId="18410530">
        <sentence id="DS.d142.s0" origId="18410530-134" text="CpG methylation as well as histone H3 methylation of lysines 9 and 27 contribute independently to ARF gene silencing in adenocarcinoma cell lines and can be reversed by 5-aza-2'-deoxycytidine.">
            <entity id="DS.d142.s0.e0" origId="6804" charOffset="0-3" type="compound" text="CpG"/>
            <entity id="DS.d142.s0.e1" origId="O48920,P34727,P34728,P51823,Q94650" charOffset="98-101" type="protein" text="ARF"/>
            <entity id="DS.d142.s0.e2" origId="451668" charOffset="169-191" type="compound" text="5-aza-2'-deoxycytidine"/>
            <pair e1="DS.d142.s0.e0" e2="DS.d142.s0.e1" id="DS.d142.s0.i0" interaction="True"/>
            <pair e1="DS.d142.s0.e2" e2="DS.d142.s0.e1" id="DS.d142.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d143" origId="18410982">
        <sentence id="DS.d143.s0" origId="18410982-929" text="Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and tripeptidyl peptidase I activities in mammalian tissue sections.">
            <entity id="DS.d143.s0.e0" origId="79101" charOffset="0-7" type="compound" text="Gly-Pro"/>
            <entity id="DS.d143.s0.e1" origId="79101" charOffset="10-17" type="compound" text="Gly-Pro"/>
            <entity id="DS.d143.s0.e2" origId="3520" charOffset="133-144" type="compound" text="guanidinium"/>
            <entity id="DS.d143.s0.e3" origId="P14740,P22411,P27487,P28843,P81425,Q9N2I7" charOffset="224-247" type="protein" text="dipeptidyl peptidase IV"/>
            <entity id="DS.d143.s0.e4" origId="O14773,O89023,Q5IS74,Q5RFL1,Q60HH1,Q71JP6,Q9EQV6,Q9XSB8" charOffset="252-275" type="protein" text="tripeptidyl peptidase I"/>
            <pair e1="DS.d143.s0.e0" e2="DS.d143.s0.e3" id="DS.d143.s0.i0" interaction="True"/>
            <pair e1="DS.d143.s0.e2" e2="DS.d143.s0.e3" id="DS.d143.s0.i1" interaction="True"/>
            <pair e1="DS.d143.s0.e0" e2="DS.d143.s0.e4" id="DS.d143.s0.i2" interaction="True"/>
            <pair e1="DS.d143.s0.e2" e2="DS.d143.s0.e4" id="DS.d143.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d144" origId="18413191">
        <sentence id="DS.d144.s0" origId="18413191-1010" text="However, increased blood glucose (200 mg/dl) significantly impaired the inhibitory effect of ASA (84% for GPIIb.005; 48% for P-selectin, P=NS).">
            <entity id="DS.d144.s0.e0" origId="206,5793,64689,79025" charOffset="25-32" type="compound" text="glucose"/>
            <entity id="DS.d144.s0.e1" origId="P08514,P53711,Q9QUM0" charOffset="106-111" type="protein" text="GPIIb"/>
            <pair e1="DS.d144.s0.e0" e2="DS.d144.s0.e1" id="DS.d144.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d145" origId="18413206">
        <sentence id="DS.d145.s0" origId="18413206-1026" text="The expressions of MCP-1 mRNA in renal tissues were markedly up-regulated in untreated diabetic rats, and these could be notably reduced by rosiglitazone treatment.">
            <entity id="DS.d145.s0.e0" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="19-24" type="protein" text="MCP-1"/>
            <entity id="DS.d145.s0.e1" origId="77999" charOffset="140-153" type="compound" text="rosiglitazone"/>
            <pair e1="DS.d145.s0.e1" e2="DS.d145.s0.e0" id="DS.d145.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d145.s1" origId="18413206-1027" text="In conclusion, rosiglitazone may have a potential therapeutic target in DN, which may be partly attributed to lowering of the expression of MCP-1 in the local kidney and the urinary excretion of MCP-1.">
            <entity id="DS.d145.s1.e0" origId="77999" charOffset="15-28" type="compound" text="rosiglitazone"/>
            <entity id="DS.d145.s1.e1" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="140-145" type="protein" text="MCP-1"/>
            <entity id="DS.d145.s1.e2" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="195-200" type="protein" text="MCP-1"/>
            <pair e1="DS.d145.s1.e0" e2="DS.d145.s1.e1" id="DS.d145.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d146" origId="18414844">
        <sentence id="DS.d146.s0" origId="18414844-751" text="The homomeric P2X (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, magnesium, zinc and copper.">
            <entity id="DS.d146.s0.e0" origId="P13900,P16604" charOffset="14-17" type="protein" text="P2X"/>
            <entity id="DS.d146.s0.e1" origId="5462224" charOffset="247-256" type="compound" text="magnesium"/>
            <entity id="DS.d146.s0.e2" origId="23978" charOffset="267-273" type="compound" text="copper"/>
            <pair e1="DS.d146.s0.e2" e2="DS.d146.s0.e0" id="DS.d146.s0.i0" interaction="True"/>
            <pair e1="DS.d146.s0.e1" e2="DS.d146.s0.e0" id="DS.d146.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d147" origId="18414894">
        <sentence id="DS.d147.s0" origId="18414894-793" text="Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (ACTH), and testosterone levels remained high.">
            <entity id="DS.d147.s0.e0" origId="5754" charOffset="21-35" type="compound" text="hydrocortisone"/>
            <entity id="DS.d147.s0.e1" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="99-126" type="protein" text="adrenocorticotropic hormone"/>
            <entity id="DS.d147.s0.e2" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="128-132" type="protein" text="ACTH"/>
            <entity id="DS.d147.s0.e3" origId="6013" charOffset="139-151" type="compound" text="testosterone"/>
            <pair e1="DS.d147.s0.e3" e2="DS.d147.s0.e1" id="DS.d147.s0.i0" interaction="False"/>
            <pair e1="DS.d147.s0.e0" e2="DS.d147.s0.e2" id="DS.d147.s0.i1" interaction="False"/>
            <pair e1="DS.d147.s0.e3" e2="DS.d147.s0.e2" id="DS.d147.s0.i2" interaction="False"/>
            <pair e1="DS.d147.s0.e0" e2="DS.d147.s0.e1" id="DS.d147.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d148" origId="18414974">
        <sentence id="DS.d148.s0" origId="18414974-853" text="Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.">
            <entity id="DS.d148.s0.e0" origId="23973" charOffset="0-7" type="compound" text="Cadmium"/>
            <entity id="DS.d148.s0.e1" origId="O50258" charOffset="70-90" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d148.s0.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="92-95" type="protein" text="SOD"/>
            <entity id="DS.d148.s0.e3" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="98-106" type="protein" text="catalase"/>
            <entity id="DS.d148.s0.e4" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="108-111" type="protein" text="CAT"/>
            <entity id="DS.d148.s0.e5" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="114-139" type="protein" text="glutathione-S-transferase"/>
            <entity id="DS.d148.s0.e6" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="141-144" type="protein" text="GST"/>
            <entity id="DS.d148.s0.e7" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="147-168" type="protein" text="glutathione reductase"/>
            <entity id="DS.d148.s0.e8" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="175-197" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d148.s0.e9" origId="O00091,O24357,O51581,O54537,O55044,O68282,O83491,O84188,P05370,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11410,P11411,P11412,P11413,P12646,P15588,P21907,P29686,P37830,P37986,P41571,P41764,P44311,P48826,P48828,P48848,P48992,P54547,P54996,P56110,P57405,P73411,P77809,P80619,P97324,Q00612,Q23711,Q24625,Q25019,Q25537,Q27464,Q27638,Q29492,Q42919,Q43793,Q43839,Q7YS37,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2" charOffset="243-247" type="protein" text="G6PD"/>
            <entity id="DS.d148.s0.e10" origId="124886" charOffset="287-306" type="compound" text="reduced glutathione"/>
            <entity id="DS.d148.s0.e11" origId="124886" charOffset="308-311" type="compound" text="GSH"/>
            <pair e1="DS.d148.s0.e11" e2="DS.d148.s0.e6" id="DS.d148.s0.i0" interaction="False"/>
            <pair e1="DS.d148.s0.e10" e2="DS.d148.s0.e6" id="DS.d148.s0.i1" interaction="False"/>
            <pair e1="DS.d148.s0.e0" e2="DS.d148.s0.e3" id="DS.d148.s0.i2" interaction="True"/>
            <pair e1="DS.d148.s0.e11" e2="DS.d148.s0.e1" id="DS.d148.s0.i3" interaction="False"/>
            <pair e1="DS.d148.s0.e10" e2="DS.d148.s0.e5" id="DS.d148.s0.i4" interaction="False"/>
            <pair e1="DS.d148.s0.e10" e2="DS.d148.s0.e4" id="DS.d148.s0.i5" interaction="False"/>
            <pair e1="DS.d148.s0.e10" e2="DS.d148.s0.e3" id="DS.d148.s0.i6" interaction="False"/>
            <pair e1="DS.d148.s0.e10" e2="DS.d148.s0.e2" id="DS.d148.s0.i7" interaction="False"/>
            <pair e1="DS.d148.s0.e11" e2="DS.d148.s0.e4" id="DS.d148.s0.i8" interaction="False"/>
            <pair e1="DS.d148.s0.e0" e2="DS.d148.s0.e6" id="DS.d148.s0.i9" interaction="True"/>
            <pair e1="DS.d148.s0.e11" e2="DS.d148.s0.e7" id="DS.d148.s0.i10" interaction="False"/>
            <pair e1="DS.d148.s0.e0" e2="DS.d148.s0.e9" id="DS.d148.s0.i11" interaction="True"/>
            <pair e1="DS.d148.s0.e11" e2="DS.d148.s0.e2" id="DS.d148.s0.i12" interaction="False"/>
            <pair e1="DS.d148.s0.e0" e2="DS.d148.s0.e2" id="DS.d148.s0.i13" interaction="True"/>
            <pair e1="DS.d148.s0.e11" e2="DS.d148.s0.e8" id="DS.d148.s0.i14" interaction="False"/>
            <pair e1="DS.d148.s0.e10" e2="DS.d148.s0.e9" id="DS.d148.s0.i15" interaction="False"/>
            <pair e1="DS.d148.s0.e10" e2="DS.d148.s0.e1" id="DS.d148.s0.i16" interaction="False"/>
            <pair e1="DS.d148.s0.e0" e2="DS.d148.s0.e1" id="DS.d148.s0.i17" interaction="True"/>
            <pair e1="DS.d148.s0.e10" e2="DS.d148.s0.e8" id="DS.d148.s0.i18" interaction="False"/>
            <pair e1="DS.d148.s0.e0" e2="DS.d148.s0.e7" id="DS.d148.s0.i19" interaction="True"/>
            <pair e1="DS.d148.s0.e0" e2="DS.d148.s0.e8" id="DS.d148.s0.i20" interaction="True"/>
            <pair e1="DS.d148.s0.e11" e2="DS.d148.s0.e5" id="DS.d148.s0.i21" interaction="False"/>
            <pair e1="DS.d148.s0.e0" e2="DS.d148.s0.e5" id="DS.d148.s0.i22" interaction="True"/>
            <pair e1="DS.d148.s0.e10" e2="DS.d148.s0.e7" id="DS.d148.s0.i23" interaction="False"/>
            <pair e1="DS.d148.s0.e0" e2="DS.d148.s0.e4" id="DS.d148.s0.i24" interaction="True"/>
            <pair e1="DS.d148.s0.e11" e2="DS.d148.s0.e3" id="DS.d148.s0.i25" interaction="False"/>
            <pair e1="DS.d148.s0.e11" e2="DS.d148.s0.e9" id="DS.d148.s0.i26" interaction="False"/>
        </sentence>
        <sentence id="DS.d148.s1" origId="18414974-854" text="On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (CYP P450s) have been found to increase due to cadmium intoxication.">
            <entity id="DS.d148.s1.e0" origId="975,65359" charOffset="33-53" type="compound" text="oxidized glutathione"/>
            <entity id="DS.d148.s1.e1" origId="65359" charOffset="55-59" type="compound" text="GSSG"/>
            <entity id="DS.d148.s1.e2" origId="5359597" charOffset="141-151" type="compound" text="superoxide"/>
            <entity id="DS.d148.s1.e3" origId="O08469" charOffset="179-194" type="protein" text="cytochrome P450"/>
            <entity id="DS.d148.s1.e4" origId="P21568,P21569,P24525,P34887,Q26551" charOffset="204-207" type="protein" text="CYP"/>
            <entity id="DS.d148.s1.e5" origId="23973" charOffset="250-257" type="compound" text="cadmium"/>
            <pair e1="DS.d148.s1.e1" e2="DS.d148.s1.e4" id="DS.d148.s1.i0" interaction="False"/>
            <pair e1="DS.d148.s1.e5" e2="DS.d148.s1.e4" id="DS.d148.s1.i1" interaction="True"/>
            <pair e1="DS.d148.s1.e1" e2="DS.d148.s1.e3" id="DS.d148.s1.i2" interaction="False"/>
            <pair e1="DS.d148.s1.e0" e2="DS.d148.s1.e3" id="DS.d148.s1.i3" interaction="False"/>
            <pair e1="DS.d148.s1.e5" e2="DS.d148.s1.e3" id="DS.d148.s1.i4" interaction="True"/>
            <pair e1="DS.d148.s1.e2" e2="DS.d148.s1.e4" id="DS.d148.s1.i5" interaction="False"/>
            <pair e1="DS.d148.s1.e0" e2="DS.d148.s1.e4" id="DS.d148.s1.i6" interaction="False"/>
            <pair e1="DS.d148.s1.e2" e2="DS.d148.s1.e3" id="DS.d148.s1.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d149" origId="18415015">
        <sentence id="DS.d149.s0" origId="18415015-878" text="This paper describes (1) the preparation of the intact oligosaccharides from GM1 (II(3)NeuAcGgOse(4) Cer) and GbOse(4) Cer as examples to show the use of CGase to prepare intact glycan chains from GSLs, and (2) the specificity and detergent requirements of Rhodococcal EGCases for the release of glycan chains from different GSLs.">
            <entity id="DS.d149.s0.e0" origId="P48648" charOffset="77-80" type="protein" text="GM1"/>
            <entity id="DS.d149.s0.e1" origId="871" charOffset="178-184" type="compound" text="glycan"/>
            <entity id="DS.d149.s0.e2" origId="871" charOffset="296-302" type="compound" text="glycan"/>
            <pair e1="DS.d149.s0.e1" e2="DS.d149.s0.e0" id="DS.d149.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d150" origId="18415121">
        <sentence id="DS.d150.s0" origId="18415121-949" text="The discovery of the PLN/HAX-1 interaction therefore unveils an important new link between Ca(2+) homeostasis and cell survival, with significant therapeutic potential.">
            <entity id="DS.d150.s0.e0" origId="P26677,P26678,P61012,P61013,P61015" charOffset="21-24" type="protein" text="PLN"/>
            <entity id="DS.d150.s0.e1" origId="O00165,O35387" charOffset="25-30" type="protein" text="HAX-1"/>
            <entity id="DS.d150.s0.e2" origId="271" charOffset="91-95" type="compound" text="Ca(2"/>
            <pair e1="DS.d150.s0.e2" e2="DS.d150.s0.e1" id="DS.d150.s0.i0" interaction="False"/>
            <pair e1="DS.d150.s0.e2" e2="DS.d150.s0.e0" id="DS.d150.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d151" origId="18418358">
        <sentence id="DS.d151.s0" origId="18418358-391" text="UFP-101 alone evoked effects similar to low N/OFQ doses, suggesting tonic inhibitory control over forelimb movement by endogenous N/OFQ.">
            <entity id="DS.d151.s0.e0" origId="25081457" charOffset="0-7" type="compound" text="UFP-101"/>
            <entity id="DS.d151.s0.e1" origId="Q13519" charOffset="46-49" type="protein" text="OFQ"/>
            <entity id="DS.d151.s0.e2" origId="Q13519" charOffset="132-135" type="protein" text="OFQ"/>
            <pair e1="DS.d151.s0.e0" e2="DS.d151.s0.e1" id="DS.d151.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d152" origId="18418709">
        <sentence id="DS.d152.s0" origId="18418709-605" text="Treating MCF-7 cells with AVE-1642 Qdots, but not unconjugated Qdots alone, downregulated IGF1R levels and rendered cells refractory to IGF-I stimulation.">
            <entity id="DS.d152.s0.e0" origId="16070039" charOffset="26-29" type="compound" text="AVE"/>
            <entity id="DS.d152.s0.e1" origId="P08069,Q05688,Q29000" charOffset="90-95" type="protein" text="IGF1R"/>
            <entity id="DS.d152.s0.e2" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="136-141" type="protein" text="IGF-I"/>
            <pair e1="DS.d152.s0.e0" e2="DS.d152.s0.e1" id="DS.d152.s0.i0" interaction="True"/>
            <pair e1="DS.d152.s0.e0" e2="DS.d152.s0.e2" id="DS.d152.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d152.s1" origId="18418709-606" text="Our data suggest that AVE-1642 Qdots can be used to detect IGF1R expression and measure changes in cell surface receptor levels.">
            <entity id="DS.d152.s1.e0" origId="16070039" charOffset="22-25" type="compound" text="AVE"/>
            <entity id="DS.d152.s1.e1" origId="P08069,Q05688,Q29000" charOffset="59-64" type="protein" text="IGF1R"/>
            <pair e1="DS.d152.s1.e0" e2="DS.d152.s1.e1" id="DS.d152.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d153" origId="18420260">
        <sentence id="DS.d153.s0" origId="18420260-309" text="Although previous studies indicated reduced levels of sialic acid residues during apoptosis, elevated Sambucus nigra agglutinin (SNA) reactivity might be due to the degradation of high molecular weight glycoproteins (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.">
            <entity id="DS.d153.s0.e0" origId="906,444885,445063" charOffset="54-65" type="compound" text="sialic acid"/>
            <entity id="DS.d153.s0.e1" origId="P02872,P05046,P11218,P11219,P30617,P42088,P49329,P82859,P82953" charOffset="117-127" type="protein" text="agglutinin"/>
            <entity id="DS.d153.s0.e2" origId="P08163" charOffset="202-215" type="protein" text="glycoproteins"/>
            <pair e1="DS.d153.s0.e0" e2="DS.d153.s0.e2" id="DS.d153.s0.i0" interaction="False"/>
            <pair e1="DS.d153.s0.e0" e2="DS.d153.s0.e1" id="DS.d153.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d154" origId="18423787">
        <sentence id="DS.d154.s0" origId="18423787-1115" text="We detected a marked decrease in target mRNA, an accumulation of short interfering RNAs (siRNAs), and a decrease in quercetin content relative to kaempferol in leaf tissues, indicating that sequence-specific mRNA degradation of the F3'H gene was induced.">
            <entity id="DS.d154.s0.e0" origId="5280343" charOffset="116-133" type="compound" text="quercetin content"/>
            <entity id="DS.d154.s0.e1" origId="5280863" charOffset="146-156" type="compound" text="kaempferol"/>
            <entity id="DS.d154.s0.e2" origId="Q9SD85" charOffset="232-236" type="protein" text="F3'H"/>
            <pair e1="DS.d154.s0.e1" e2="DS.d154.s0.e2" id="DS.d154.s0.i0" interaction="False"/>
            <pair e1="DS.d154.s0.e0" e2="DS.d154.s0.e2" id="DS.d154.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d155" origId="18423943">
        <sentence id="DS.d155.s0" origId="18423943-93" text="Polyhydroxy phenolic compounds, such as flavonoids, vitamin E, rosmarinic acid and aristolochic acid, are able to inhibit PLA (2) from different sources.">
            <entity id="DS.d155.s0.e0" origId="2116,14985,1548900,1742129" charOffset="52-61" type="compound" text="vitamin E"/>
            <entity id="DS.d155.s0.e1" origId="5281792" charOffset="63-78" type="compound" text="rosmarinic acid"/>
            <entity id="DS.d155.s0.e2" origId="2236" charOffset="83-100" type="compound" text="aristolochic acid"/>
            <entity id="DS.d155.s0.e3" origId="P0C1C0,Q01172,Q6CZT4" charOffset="122-125" type="protein" text="PLA"/>
            <pair e1="DS.d155.s0.e1" e2="DS.d155.s0.e3" id="DS.d155.s0.i0" interaction="True"/>
            <pair e1="DS.d155.s0.e0" e2="DS.d155.s0.e3" id="DS.d155.s0.i1" interaction="True"/>
            <pair e1="DS.d155.s0.e2" e2="DS.d155.s0.e3" id="DS.d155.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d156" origId="18425600">
        <sentence id="DS.d156.s0" origId="18425600-1102" text="Analysis of the protein domain features indicated typical conserved cysteine residues containing a single whey acidic protein (WAP) domain at the C-terminus.">
            <entity id="DS.d156.s0.e0" origId="594,5862,5360637" charOffset="68-76" type="compound" text="cysteine"/>
            <entity id="DS.d156.s0.e1" origId="P09837" charOffset="106-125" type="protein" text="whey acidic protein"/>
            <entity id="DS.d156.s0.e2" origId="O46655,P01173,P01174,P09412,P09837,Q9N0L8" charOffset="127-130" type="protein" text="WAP"/>
            <pair e1="DS.d156.s0.e0" e2="DS.d156.s0.e2" id="DS.d156.s0.i0" interaction="False"/>
            <pair e1="DS.d156.s0.e0" e2="DS.d156.s0.e1" id="DS.d156.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d157" origId="18427801">
        <sentence id="DS.d157.s0" origId="18427801-1197" text="Cross-linked P2X (1/2) heteromers showed strongly reduced or absent function that was selectively recovered upon treatment with DTT.">
            <entity id="DS.d157.s0.e0" origId="P13900,P16604" charOffset="13-16" type="protein" text="P2X"/>
            <entity id="DS.d157.s0.e1" origId="439196,439352,446094" charOffset="128-131" type="compound" text="DTT"/>
            <pair e1="DS.d157.s0.e1" e2="DS.d157.s0.e0" id="DS.d157.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d158" origId="18431601">
        <sentence id="DS.d158.s0" origId="18431601-998" text="Permeabilization of K. marxianus cells in relation to beta-galactosidase activity was carried out using cetyltrimethyl ammonium bromide (CTAB) to avoid the problem of enzyme extraction.">
            <entity id="DS.d158.s0.e0" origId="O33815,O52629,O52847,P00722,P00723,P06219,P0C1Y0,P14288,P22498,P23989,P24131,P26257,P30812,P50388,P70753,P77989,P81650,Q1G9Z4,Q47077,Q48727,Q56307,Q59140,Q59750,Q9K9C6" charOffset="54-72" type="protein" text="beta-galactosidase"/>
            <entity id="DS.d158.s0.e1" origId="25514" charOffset="119-135" type="compound" text="ammonium bromide"/>
            <entity id="DS.d158.s0.e2" origId="2681" charOffset="137-141" type="compound" text="CTAB"/>
            <pair e1="DS.d158.s0.e2" e2="DS.d158.s0.e0" id="DS.d158.s0.i0" interaction="True"/>
            <pair e1="DS.d158.s0.e1" e2="DS.d158.s0.e0" id="DS.d158.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d159" origId="18431759">
        <sentence id="DS.d159.s0" origId="18431759-1114" text="Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with PEU and SR, materials that do not promote fusion.">
            <entity id="DS.d159.s0.e0" origId="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58" charOffset="23-27" type="protein" text="IL-4"/>
            <entity id="DS.d159.s0.e1" origId="P20109,P35225,P42203,P61126,Q5I6E4,Q864V6,Q865W5,Q865X3,Q95J68,Q9N0W9,Q9XSV9" charOffset="29-34" type="protein" text="IL-13"/>
            <entity id="DS.d159.s0.e2" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="36-41" type="protein" text="IL-10"/>
            <entity id="DS.d159.s0.e3" origId="O46678,O55235,P09340,P09341" charOffset="47-50" type="protein" text="GRO"/>
            <entity id="DS.d159.s0.e4" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="134-138" type="protein" text="IL-6"/>
            <entity id="DS.d159.s0.e5" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="143-151" type="protein" text="TNFalpha"/>
            <entity id="DS.d159.s0.e6" origId="5327147" charOffset="211-214" type="compound" text="PEU"/>
            <pair e1="DS.d159.s0.e6" e2="DS.d159.s0.e3" id="DS.d159.s0.i0" interaction="False"/>
            <pair e1="DS.d159.s0.e6" e2="DS.d159.s0.e0" id="DS.d159.s0.i1" interaction="False"/>
            <pair e1="DS.d159.s0.e6" e2="DS.d159.s0.e1" id="DS.d159.s0.i2" interaction="False"/>
            <pair e1="DS.d159.s0.e6" e2="DS.d159.s0.e5" id="DS.d159.s0.i3" interaction="False"/>
            <pair e1="DS.d159.s0.e6" e2="DS.d159.s0.e2" id="DS.d159.s0.i4" interaction="False"/>
            <pair e1="DS.d159.s0.e6" e2="DS.d159.s0.e4" id="DS.d159.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d160" origId="18431773">
        <sentence id="DS.d160.s0" origId="18431773-1123" text="Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of vinculin, beta-actin, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.">
            <entity id="DS.d160.s0.e0" origId="6035" charOffset="17-34" type="compound" text="bromodeoxyuridine"/>
            <entity id="DS.d160.s0.e1" origId="O46037,P12003,P18206,P19826,P26234,Q04615,Q17162,Q64727" charOffset="87-95" type="protein" text="vinculin"/>
            <entity id="DS.d160.s0.e2" origId="O18840,O42161,O93400,P15475,P29751,P48975,P60706,P60707,P60708,P60709,P60710,P60711,P60712,P60713,P68143,P79818,P83750,P83751,P84336,P84856,Q0PGG4,Q4L0Y2,Q5R1X3,Q711N9,Q71FK5,Q76N69,Q91ZK5,Q9Y702" charOffset="97-107" type="protein" text="beta-actin"/>
            <entity id="DS.d160.s0.e3" origId="P02819,P02821,P02823,P0C225,P0C226,P15504,P28317,P39056,P81455,P83005,P83238,P83473,P83489,P84348,P84349,P84350,P84351,Q7LZI4,Q8HYY9" charOffset="126-137" type="protein" text="osteocalcin"/>
            <entity id="DS.d160.s0.e4" origId="7501" charOffset="245-256" type="compound" text="polystyrene"/>
            <pair e1="DS.d160.s0.e4" e2="DS.d160.s0.e3" id="DS.d160.s0.i0" interaction="False"/>
            <pair e1="DS.d160.s0.e0" e2="DS.d160.s0.e1" id="DS.d160.s0.i1" interaction="False"/>
            <pair e1="DS.d160.s0.e4" e2="DS.d160.s0.e1" id="DS.d160.s0.i2" interaction="False"/>
            <pair e1="DS.d160.s0.e0" e2="DS.d160.s0.e2" id="DS.d160.s0.i3" interaction="False"/>
            <pair e1="DS.d160.s0.e0" e2="DS.d160.s0.e3" id="DS.d160.s0.i4" interaction="False"/>
            <pair e1="DS.d160.s0.e4" e2="DS.d160.s0.e2" id="DS.d160.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d161" origId="18431776">
        <sentence id="DS.d161.s0" origId="18431776-1124" text="To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine serum albumin (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), poly(lactide-co-glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV.">
            <entity id="DS.d161.s0.e0" origId="P21847,P83517" charOffset="186-199" type="protein" text="serum albumin"/>
            <entity id="DS.d161.s0.e1" origId="P02769" charOffset="201-204" type="protein" text="BSA"/>
            <entity id="DS.d161.s0.e2" origId="107801" charOffset="277-320" type="compound" text="poly(3-hydroxybutyrate-co-3-hydroxyvalerate"/>
            <entity id="DS.d161.s0.e3" origId="23111554" charOffset="338-363" type="compound" text="poly(lactide-co-glycolide"/>
            <entity id="DS.d161.s0.e4" origId="36797" charOffset="371-375" type="compound" text="PLGA"/>
            <entity id="DS.d161.s0.e5" origId="36797" charOffset="398-402" type="compound" text="PLGA"/>
            <pair e1="DS.d161.s0.e4" e2="DS.d161.s0.e1" id="DS.d161.s0.i0" interaction="False"/>
            <pair e1="DS.d161.s0.e2" e2="DS.d161.s0.e0" id="DS.d161.s0.i1" interaction="False"/>
            <pair e1="DS.d161.s0.e4" e2="DS.d161.s0.e0" id="DS.d161.s0.i2" interaction="False"/>
            <pair e1="DS.d161.s0.e3" e2="DS.d161.s0.e1" id="DS.d161.s0.i3" interaction="False"/>
            <pair e1="DS.d161.s0.e2" e2="DS.d161.s0.e1" id="DS.d161.s0.i4" interaction="False"/>
            <pair e1="DS.d161.s0.e3" e2="DS.d161.s0.e0" id="DS.d161.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d162" origId="18433938">
        <sentence id="DS.d162.s0" origId="18433938-1194" text="Prediction of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas based on the heuristic method, support vector machine and projection pursuit regression.">
            <entity id="DS.d162.s0.e0" origId="O62743,O97878,O97879,O97880,O97881,O97882,O97883,O97962,O97975,P51681,P56439,P56440,P56493,P60574,P61755,P61756,P61757,P61813,P61814,P61815,P68269,P68270,Q1ZY22,Q2HJ17,Q5ECR9,Q6WN98,Q71UI8,Q8HZT9,Q95NC0,Q95NC1,Q95NC2,Q95NC3,Q95NC4,Q95NC5,Q95NC6,Q95NC7,Q95NC8,Q95NC9,Q95ND0,Q95ND1,Q95ND2,Q95NE8,Q9BGN6,Q9TV42,Q9TV43,Q9TV45,Q9TV47,Q9TV48,Q9TV49,Q9XT76" charOffset="14-18" type="protein" text="CCR5"/>
            <entity id="DS.d162.s0.e1" origId="5376415" charOffset="83-94" type="compound" text="piperidinyl"/>
            <pair e1="DS.d162.s0.e1" e2="DS.d162.s0.e0" id="DS.d162.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d162.s1" origId="18433938-1195" text="Quantitative structure-activity relationship (QSAR) models were developed to predict for CCR5 binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas using linear free energy relationship (LFER).">
            <entity id="DS.d162.s1.e0" origId="O62743,O97878,O97879,O97880,O97881,O97882,O97883,O97962,O97975,P51681,P56439,P56440,P56493,P60574,P61755,P61756,P61757,P61813,P61814,P61815,P68269,P68270,Q1ZY22,Q2HJ17,Q5ECR9,Q6WN98,Q71UI8,Q8HZT9,Q95NC0,Q95NC1,Q95NC2,Q95NC3,Q95NC4,Q95NC5,Q95NC6,Q95NC7,Q95NC8,Q95NC9,Q95ND0,Q95ND1,Q95ND2,Q95NE8,Q9BGN6,Q9TV42,Q9TV43,Q9TV45,Q9TV47,Q9TV48,Q9TV49,Q9XT76" charOffset="89-93" type="protein" text="CCR5"/>
            <entity id="DS.d162.s1.e1" origId="5376415" charOffset="149-160" type="compound" text="piperidinyl"/>
            <pair e1="DS.d162.s1.e1" e2="DS.d162.s1.e0" id="DS.d162.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d163" origId="18434046">
        <sentence id="DS.d163.s0" origId="18434046-291" text="It is suggested that GABA acting through the GABA(A) receptor mechanism on the expression of GnRH gene and GnRH-R gene in the hypothalamus may be involved in two processes: the biosynthesis of GnRH and the release of this neurohormone in the hypothalamus.">
            <entity id="DS.d163.s0.e0" origId="119" charOffset="21-25" type="compound" text="GABA"/>
            <entity id="DS.d163.s0.e1" origId="P26714,Q08832,Q9BLY8" charOffset="45-61" type="protein" text="GABA(A) receptor"/>
            <entity id="DS.d163.s0.e2" origId="P27429" charOffset="93-97" type="protein" text="GnRH"/>
            <entity id="DS.d163.s0.e3" origId="O18821,P30968,P30969,P32236,P32237,P49922,Q01776,Q19PY9,Q8CH60,Q8SPZ1,Q9MZI6,Q9TTI8" charOffset="107-113" type="protein" text="GnRH-R"/>
            <entity id="DS.d163.s0.e4" origId="P27429" charOffset="107-111" type="protein" text="GnRH"/>
            <pair e1="DS.d163.s0.e0" e2="DS.d163.s0.e3" id="DS.d163.s0.i0" interaction="True"/>
            <pair e1="DS.d163.s0.e0" e2="DS.d163.s0.e2" id="DS.d163.s0.i1" interaction="True"/>
            <pair e1="DS.d163.s0.e0" e2="DS.d163.s0.e1" id="DS.d163.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d164" origId="18435693">
        <sentence id="DS.d164.s0" origId="18435693-994" text="TT-induced increases in cortisol, adrenocorticotropic hormone and prolactin were reduced only after 3-h REC.">
            <entity id="DS.d164.s0.e0" origId="5754" charOffset="24-32" type="compound" text="cortisol"/>
            <entity id="DS.d164.s0.e1" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="34-61" type="protein" text="adrenocorticotropic hormone"/>
            <entity id="DS.d164.s0.e2" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="66-75" type="protein" text="prolactin"/>
            <entity id="DS.d164.s0.e3" origId="Q9UIJ5" charOffset="104-107" type="protein" text="REC"/>
            <pair e1="DS.d164.s0.e0" e2="DS.d164.s0.e3" id="DS.d164.s0.i0" interaction="False"/>
            <pair e1="DS.d164.s0.e0" e2="DS.d164.s0.e1" id="DS.d164.s0.i1" interaction="False"/>
            <pair e1="DS.d164.s0.e0" e2="DS.d164.s0.e2" id="DS.d164.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d165" origId="18436224">
        <sentence id="DS.d165.s0" origId="18436224-84" text="Quercetin inhibits vascular superoxide production induced by endothelin-1 : Role of NADPH oxidase, uncoupled eNOS and PKC.">
            <entity id="DS.d165.s0.e0" origId="5280343" charOffset="0-9" type="compound" text="Quercetin"/>
            <entity id="DS.d165.s0.e1" origId="5359597" charOffset="28-38" type="compound" text="superoxide"/>
            <entity id="DS.d165.s0.e2" origId="P05305,Q28469" charOffset="61-73" type="protein" text="endothelin-1"/>
            <entity id="DS.d165.s0.e3" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="109-113" type="protein" text="eNOS"/>
            <entity id="DS.d165.s0.e4" origId="P05130,P13677,P13678,P34722" charOffset="118-121" type="protein" text="PKC"/>
            <pair e1="DS.d165.s0.e0" e2="DS.d165.s0.e4" id="DS.d165.s0.i0" interaction="False"/>
            <pair e1="DS.d165.s0.e0" e2="DS.d165.s0.e3" id="DS.d165.s0.i1" interaction="False"/>
            <pair e1="DS.d165.s0.e1" e2="DS.d165.s0.e4" id="DS.d165.s0.i2" interaction="False"/>
            <pair e1="DS.d165.s0.e1" e2="DS.d165.s0.e3" id="DS.d165.s0.i3" interaction="False"/>
            <pair e1="DS.d165.s0.e1" e2="DS.d165.s0.e2" id="DS.d165.s0.i4" interaction="True"/>
            <pair e1="DS.d165.s0.e0" e2="DS.d165.s0.e2" id="DS.d165.s0.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d165.s3" origId="18436224-87" text="Furthermore, ET-1 increased intracellular O(2*)(-) production in all layers of the vessel, protein expression of NADPH oxidase subunit p47 (phox) without affecting p22 (phox) expression and lucigenin-enhanced chemiluminescence signal stimulated by calcium ionophore A23187.">
            <entity id="DS.d165.s3.e1" origId="O10300,P08567,P26642,P34051,Q12802,Q91375,Q9SZB9,Q9Y240" charOffset="135-138" type="protein" text="p47"/>
            <entity id="DS.d165.s3.e2" origId="O75935,P03304,P11691,P15961,P16342,P17593,P17594,P19751,P23169,P24102,P50629,P50630,P50631,P50632,P50633,P50634,P82796,Q05903,Q66198,Q8V439,Q8V6W7,Q91A29,Q9PYA3" charOffset="164-167" type="protein" text="p22"/>
            <entity id="DS.d165.s3.e3" origId="1959,11957499" charOffset="248-272" type="compound" text="calcium ionophore A23187"/>
            <pair e1="DS.d165.s3.e3" e2="DS.d165.s3.e1" id="DS.d165.s3.i0" interaction="False"/>
            <pair e1="DS.d165.s3.e3" e2="DS.d165.s3.e2" id="DS.d165.s3.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d165.s5" origId="18436224-89" text="Moreover, quercetin but not isorhamnetin, inhibited the increased PKC activity induced by ET-1.">
            <entity id="DS.d165.s5.e0" origId="5280343" charOffset="10-19" type="compound" text="quercetin"/>
            <entity id="DS.d165.s5.e1" origId="5281654" charOffset="28-40" type="compound" text="isorhamnetin"/>
            <entity id="DS.d165.s5.e2" origId="P05130,P13677,P13678,P34722" charOffset="66-69" type="protein" text="PKC"/>
            <pair e1="DS.d165.s5.e1" e2="DS.d165.s5.e2" id="DS.d165.s5.i0" interaction="False"/>
            <pair e1="DS.d165.s5.e0" e2="DS.d165.s5.e2" id="DS.d165.s5.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d165.s6" origId="18436224-90" text="Taken together these results indicate that ET-1-induced NADPH oxidase up-regulation and eNOS uncoupling via PKC leading to endothelial dysfunction and these effects were prevented by quercetin and isorhamnetin.">
            <entity id="DS.d165.s6.e1" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="88-92" type="protein" text="eNOS"/>
            <entity id="DS.d165.s6.e2" origId="P05130,P13677,P13678,P34722" charOffset="108-111" type="protein" text="PKC"/>
            <entity id="DS.d165.s6.e3" origId="5280343" charOffset="183-192" type="compound" text="quercetin"/>
            <entity id="DS.d165.s6.e4" origId="5281654" charOffset="197-209" type="compound" text="isorhamnetin"/>
            <pair e1="DS.d165.s6.e4" e2="DS.d165.s6.e1" id="DS.d165.s6.i1" interaction="True"/>
            <pair e1="DS.d165.s6.e4" e2="DS.d165.s6.e2" id="DS.d165.s6.i2" interaction="True"/>
            <pair e1="DS.d165.s6.e3" e2="DS.d165.s6.e1" id="DS.d165.s6.i3" interaction="True"/>
            <pair e1="DS.d165.s6.e3" e2="DS.d165.s6.e2" id="DS.d165.s6.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d166" origId="18436227">
        <sentence id="DS.d166.s0" origId="18436227-91" text="We hypothesized that variants in PCSK9 that lower LDL cholesterol levels are associated with reduced prevalence and incidence of peripheral artery disease (PAD).">
            <entity id="DS.d166.s0.e0" origId="Q8NBP7" charOffset="33-38" type="protein" text="PCSK9"/>
            <entity id="DS.d166.s0.e1" origId="304,5997,6432564,11025495" charOffset="54-65" type="compound" text="cholesterol"/>
            <pair e1="DS.d166.s0.e1" e2="DS.d166.s0.e0" id="DS.d166.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d167" origId="18436346">
        <sentence id="DS.d167.s0" origId="18436346-156" text="A series of 2-aryl-naphtho(1,2-d) oxazole derivatives have been synthesized and evaluated for PTP-1B inhibitory activity.">
            <entity id="DS.d167.s0.e0" origId="9255" charOffset="34-41" type="compound" text="oxazole"/>
            <entity id="DS.d167.s0.e1" origId="O13016,P18031,P20417,P35821" charOffset="94-100" type="protein" text="PTP-1B"/>
            <pair e1="DS.d167.s0.e0" e2="DS.d167.s0.e1" id="DS.d167.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d168" origId="18436348">
        <sentence id="DS.d168.s0" origId="18436348-931" text="A new series of indanone and aurone derivatives have been synthesized and tested for in vitro AChE inhibitory activity by modified Ellman method.">
            <entity id="DS.d168.s0.e0" origId="6735" charOffset="16-24" type="compound" text="indanone"/>
            <entity id="DS.d168.s0.e1" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="94-98" type="protein" text="AChE"/>
            <pair e1="DS.d168.s0.e0" e2="DS.d168.s0.e1" id="DS.d168.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d169" origId="18436399">
        <sentence id="DS.d169.s0" origId="18436399-180" text="Polyunsaturated fatty acids differentially alter PGF (2alpha) and PGE (2) release from bovine trophoblast and endometrial tissues during short-term culture.">
            <entity id="DS.d169.s0.e0" origId="56842239" charOffset="0-27" type="compound" text="Polyunsaturated fatty acids"/>
            <entity id="DS.d169.s0.e1" origId="P49763,Q9XS47" charOffset="49-52" type="protein" text="PGF"/>
            <entity id="DS.d169.s0.e2" origId="Q29458" charOffset="66-69" type="protein" text="PGE"/>
            <pair e1="DS.d169.s0.e0" e2="DS.d169.s0.e1" id="DS.d169.s0.i0" interaction="True"/>
            <pair e1="DS.d169.s0.e0" e2="DS.d169.s0.e2" id="DS.d169.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d169.s1" origId="18436399-181" text="Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.">
            <entity id="DS.d169.s1.e0" origId="6433873" charOffset="75-96" type="compound" text="docosahexaenoic acids"/>
            <entity id="DS.d169.s1.e1" origId="5280450" charOffset="118-131" type="compound" text="linoleic acid"/>
            <entity id="DS.d169.s1.e2" origId="96" charOffset="147-150" type="compound" text="LIN"/>
            <entity id="DS.d169.s1.e3" origId="P49763,Q9XS47" charOffset="220-223" type="protein" text="PGF"/>
            <entity id="DS.d169.s1.e4" origId="Q29458" charOffset="258-261" type="protein" text="PGE"/>
            <pair e1="DS.d169.s1.e2" e2="DS.d169.s1.e4" id="DS.d169.s1.i0" interaction="True"/>
            <pair e1="DS.d169.s1.e2" e2="DS.d169.s1.e3" id="DS.d169.s1.i1" interaction="True"/>
            <pair e1="DS.d169.s1.e0" e2="DS.d169.s1.e4" id="DS.d169.s1.i2" interaction="True"/>
            <pair e1="DS.d169.s1.e1" e2="DS.d169.s1.e4" id="DS.d169.s1.i3" interaction="True"/>
            <pair e1="DS.d169.s1.e1" e2="DS.d169.s1.e3" id="DS.d169.s1.i4" interaction="True"/>
            <pair e1="DS.d169.s1.e0" e2="DS.d169.s1.e3" id="DS.d169.s1.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d170" origId="18437529">
        <sentence id="DS.d170.s0" origId="18437529-872" text="1-Deoxy-D-xylulose-5-phosphate synthase (DXS) catalyses the first committed step of the 2C-methyl-D-erythritol-4-phosphate (MEP) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.">
            <entity id="DS.d170.s0.e0" origId="O25121,O67036,O83796,O84335,P0A554,P0A555,P26242,P45205,P54523,P57536,P57848,P73067,P77488,Q0S1H1,Q0SS05,Q0TKM1,Q0TPD8,Q0VMI4,Q11KE0,Q11NY7,Q12CQ9,Q13RX1,Q18B68,Q1BLY7,Q1C4I9,Q1CL87,Q1CUF6,Q1D3G4,Q1GCG4,Q1GQK9,Q1GZD7,Q1IZP0,Q1LK34,Q1LTI9,Q1MKN4,Q1MRB3,Q1QE74,Q1QQ40,Q1R1E5,Q1RFC0,Q21A74,Q21F93,Q21UG7,Q24V05,Q253R7,Q2A3D3,Q2GC13,Q2IPZ2,Q2IRL7,Q2JDD9,Q2JK64,Q2JTX2,Q2KBR2,Q2KZ15,Q2LUA7,Q2NV94,Q2P472,Q2RIB9,Q2SA08,Q2T7N5,Q2W367,Q2YCH7,Q2YMF0,Q30TC5,Q30Z99,Q31AZ2,Q325I1,Q32JH8,Q393P4,Q3A3Z6,Q3AAN0,Q3AJP8,Q3AXZ4,Q3B5P3,Q3BRW8,Q3II09,Q3JAD1,Q3JKA3,Q3K660,Q3KM28,Q3M4F6,Q3SKF1,Q3SUZ1,Q3Z4Y9,Q3Z8G9,Q3ZXC2,Q46L36,Q474C2,Q47BJ0,Q47NL9,Q487D3,Q48NX0,Q493G7,Q4FN07,Q4FV64,Q4JVB5,Q4K5A5,Q4QKG6,Q4UW29,Q4ZYU8,Q50000,Q57ET1,Q57SE2,Q5E6Z0,Q5FAI2,Q5FUB1,Q5H1A0,Q5HWF0,Q5L6H4,Q5LH44,Q5LX42,Q5NG39,Q5P228,Q5PFR6,Q5QVE8,Q5SMD7,Q5WF63,Q5YTA2,Q60AN1,Q62DU1,Q635A7,Q63JF4,Q64Y02,Q65HJ2,Q65TP4,Q66DV4,Q67NB6,Q6A8V3,Q6AFD5,Q6AJQ1,Q6D844,Q6F7N5,Q6G0D4,Q6G4D1,Q6HDY8,Q6LU07,Q6MDK6,Q6NB76,Q6NGV3,Q71ZV7,Q72CD3,Q72H81,Q72U01,Q731B7,Q73LF4,Q73W57,Q75TB7,Q7M7Z0,Q7MN49,Q7MSZ3,Q7N0J7,Q7NP63,Q7NUK5,Q7U6P6,Q7UWB7,Q7V1G6,Q7V7Q3,Q7VC14,Q7VIJ7,Q7VNP7,Q7VRH9,Q7VV87,Q7W7Q0,Q7WL37,Q818R9,Q81M54,Q823V1,Q82VD3,Q83G46,Q83I20,Q83SG2,Q87C03,Q87RU0,Q889Q1,Q88QG7,Q894H0,Q89RW1,Q8A0C2,Q8D357,Q8DFA3,Q8DL74,Q8EGR9,Q8EWX7,Q8F153,Q8FKB9,Q8FPI2,Q8G292,Q8GAA0,Q8K9A1,Q8KFI9,Q8NPB2,Q8P815,Q8PJG7,Q8R639,Q8RAC5,Q8UHD7,Q8XE76,Q8XJE1,Q8XX95,Q8Y7C1,Q8YFM2,Q8YZ80,Q8Z8X3,Q8ZC45,Q8ZRD1,Q92BZ0,Q92RJ1,Q97HD5,Q985Y3,Q9A6M5,Q9JW13,Q9JXV7,Q9K971,Q9KGU7,Q9KTL3,Q9PB95,Q9PIH8,Q9PK62,Q9R6S7,Q9RBN6,Q9RUB5,Q9X291,Q9Z6J9,Q9ZM94" charOffset="0-39" type="protein" text="1-Deoxy-D-xylulose-5-phosphate synthase"/>
            <entity id="DS.d170.s0.e1" origId="192838,3262721" charOffset="98-122" type="compound" text="D-erythritol-4-phosphate"/>
            <entity id="DS.d170.s0.e2" origId="7728" charOffset="124-127" type="compound" text="MEP"/>
            <pair e1="DS.d170.s0.e2" e2="DS.d170.s0.e0" id="DS.d170.s0.i0" interaction="True"/>
            <pair e1="DS.d170.s0.e1" e2="DS.d170.s0.e0" id="DS.d170.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d171" origId="18437557">
        <sentence id="DS.d171.s0" origId="18437557-896" text="To get insight into the underlying mechanisms, we compared the ability of recombinant wild type and variant (D327N) SHBG to influence estradiol effects in MCF-7 breast cancer cells.">
            <entity id="DS.d171.s0.e0" origId="P04278,P08689,P15196,P97497,Q62588" charOffset="116-120" type="protein" text="SHBG"/>
            <entity id="DS.d171.s0.e1" origId="5757" charOffset="134-143" type="compound" text="estradiol"/>
            <pair e1="DS.d171.s0.e1" e2="DS.d171.s0.e0" id="DS.d171.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d171.s1" origId="18437557-897" text="D327N SHBG was more effective than wild type protein in inhibiting estradiol-induced cell proliferation and anti-apoptosis.">
            <entity id="DS.d171.s1.e0" origId="P04278,P08689,P15196,P97497,Q62588" charOffset="6-10" type="protein" text="SHBG"/>
            <entity id="DS.d171.s1.e1" origId="5757" charOffset="67-76" type="compound" text="estradiol"/>
            <pair e1="DS.d171.s1.e1" e2="DS.d171.s1.e0" id="DS.d171.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d172" origId="18437699">
        <sentence id="DS.d172.s0" origId="18437699-978" text="Our results suggest that Ni(II)-induced changes in cytokine secretion by monocytes are diverse and may be influenced by Nrf2 but are not likely influenced by changes in whole-cell Trx1 levels.">
            <entity id="DS.d172.s0.e0" origId="934" charOffset="25-30" type="compound" text="Ni(II"/>
            <entity id="DS.d172.s0.e1" origId="O54968,Q60795" charOffset="120-124" type="protein" text="Nrf2"/>
            <entity id="DS.d172.s0.e2" origId="O14463,P29445,Q8KEA4" charOffset="180-184" type="protein" text="Trx1"/>
            <pair e1="DS.d172.s0.e0" e2="DS.d172.s0.e2" id="DS.d172.s0.i0" interaction="True"/>
            <pair e1="DS.d172.s0.e0" e2="DS.d172.s0.e1" id="DS.d172.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d173" origId="18439591">
        <sentence id="DS.d173.s0" origId="18439591-271" text="To test the hypothesis that increasing DHEAS levels is associated with improved insulin resistance in patients with polycystic ovary syndrome (PCOS).">
            <entity id="DS.d173.s0.e0" origId="12594" charOffset="39-44" type="compound" text="DHEAS"/>
            <entity id="DS.d173.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="80-87" type="protein" text="insulin"/>
            <pair e1="DS.d173.s0.e0" e2="DS.d173.s0.e1" id="DS.d173.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d174" origId="18440842">
        <sentence id="DS.d174.s0" origId="18440842-362" text="Packed cell volume, total protein, creatinine, blood urea nitrogen, and sorbitol dehydrogenase concentrations decreased while foals were on PN, while serum chloride concentration increased.">
            <entity id="DS.d174.s0.e0" origId="588" charOffset="35-45" type="compound" text="creatinine"/>
            <entity id="DS.d174.s0.e1" origId="1176,265993" charOffset="53-57" type="compound" text="urea"/>
            <entity id="DS.d174.s0.e2" origId="947,123329" charOffset="58-66" type="compound" text="nitrogen"/>
            <entity id="DS.d174.s0.e3" origId="P07846,P27867,Q00796,Q02912,Q06004,Q29318,Q4R639,Q58D31,Q59787,Q64442,Q9Z9U1" charOffset="72-94" type="protein" text="sorbitol dehydrogenase"/>
            <entity id="DS.d174.s0.e4" origId="312" charOffset="156-164" type="compound" text="chloride"/>
            <pair e1="DS.d174.s0.e1" e2="DS.d174.s0.e3" id="DS.d174.s0.i0" interaction="False"/>
            <pair e1="DS.d174.s0.e4" e2="DS.d174.s0.e3" id="DS.d174.s0.i1" interaction="False"/>
            <pair e1="DS.d174.s0.e2" e2="DS.d174.s0.e3" id="DS.d174.s0.i2" interaction="False"/>
            <pair e1="DS.d174.s0.e0" e2="DS.d174.s0.e3" id="DS.d174.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d175" origId="18442069">
        <sentence id="DS.d175.s0" origId="18442069-1161" text="The gene expressions of CYP1A1 and CYP2E1 in the placenta increased significantly in nicotine-treated groups on GD 15 and GD 18, but returned to the level similar to the corresponding control on GD 21.">
            <entity id="DS.d175.s0.e0" origId="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64" charOffset="24-30" type="protein" text="CYP1A1"/>
            <entity id="DS.d175.s0.e1" origId="O18963,P05181,P08682,P33266,P51581,P79383,Q6GUQ4" charOffset="35-41" type="protein" text="CYP2E1"/>
            <entity id="DS.d175.s0.e2" origId="942,89594,157672" charOffset="85-93" type="compound" text="nicotine"/>
            <pair e1="DS.d175.s0.e2" e2="DS.d175.s0.e1" id="DS.d175.s0.i0" interaction="True"/>
            <pair e1="DS.d175.s0.e2" e2="DS.d175.s0.e0" id="DS.d175.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d175.s1" origId="18442069-1162" text="In nicotine group, there was a decrease of mdr1a expression on GD 15, GD 18, and GD 21, with the most significant decrease on GD 15.">
            <entity id="DS.d175.s1.e0" origId="942,89594,157672" charOffset="3-11" type="compound" text="nicotine"/>
            <entity id="DS.d175.s1.e1" origId="P21447" charOffset="43-48" type="protein" text="mdr1a"/>
            <pair e1="DS.d175.s1.e0" e2="DS.d175.s1.e1" id="DS.d175.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d176" origId="18442070">
        <sentence id="DS.d176.s0" origId="18442070-1163" text="The present study was designed to understand the effects of sublethal concentrations of dichlorvos (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (aspartate aminotransferase, alanin aminotransferase, alkaline phosphatase, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.">
            <entity id="DS.d176.s0.e0" origId="3039" charOffset="88-98" type="compound" text="dichlorvos"/>
            <entity id="DS.d176.s0.e1" origId="P15160,P17724,P73925,Q03459" charOffset="222-232" type="protein" text="hemoglobin"/>
            <entity id="DS.d176.s0.e2" origId="P15160,P17724,P73925,Q03459" charOffset="251-261" type="protein" text="hemoglobin"/>
            <entity id="DS.d176.s0.e3" origId="P15160,P17724,P73925,Q03459" charOffset="251-261" type="protein" text="hemoglobin"/>
            <entity id="DS.d176.s0.e4" origId="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56" charOffset="362-388" type="protein" text="aspartate aminotransferase"/>
            <entity id="DS.d176.s0.e5" origId="O60109,P81800,P83456" charOffset="415-435" type="protein" text="alkaline phosphatase"/>
            <pair e1="DS.d176.s0.e0" e2="DS.d176.s0.e4" id="DS.d176.s0.i0" interaction="False"/>
            <pair e1="DS.d176.s0.e0" e2="DS.d176.s0.e5" id="DS.d176.s0.i1" interaction="False"/>
            <pair e1="DS.d176.s0.e0" e2="DS.d176.s0.e1" id="DS.d176.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d177" origId="18442075">
        <sentence id="DS.d177.s0" origId="18442075-634" text="Melatonin altered PHZ-induced responses significantly to a greater degree than vitamin E as evidenced by LPO status, SOD activity, and ABTS radical cation scavenging activity of antioxidants.">
            <entity id="DS.d177.s0.e0" origId="896" charOffset="0-9" type="compound" text="Melatonin"/>
            <entity id="DS.d177.s0.e1" origId="7516" charOffset="18-21" type="compound" text="PHZ"/>
            <entity id="DS.d177.s0.e2" origId="2116,14985,1548900,1742129" charOffset="79-88" type="compound" text="vitamin E"/>
            <entity id="DS.d177.s0.e3" origId="P22079,P80025" charOffset="105-108" type="protein" text="LPO"/>
            <entity id="DS.d177.s0.e4" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="117-120" type="protein" text="SOD"/>
            <entity id="DS.d177.s0.e5" origId="5464076" charOffset="135-154" type="compound" text="ABTS radical cation"/>
            <pair e1="DS.d177.s0.e2" e2="DS.d177.s0.e4" id="DS.d177.s0.i0" interaction="False"/>
            <pair e1="DS.d177.s0.e0" e2="DS.d177.s0.e4" id="DS.d177.s0.i1" interaction="True"/>
            <pair e1="DS.d177.s0.e0" e2="DS.d177.s0.e3" id="DS.d177.s0.i2" interaction="True"/>
            <pair e1="DS.d177.s0.e1" e2="DS.d177.s0.e4" id="DS.d177.s0.i3" interaction="False"/>
            <pair e1="DS.d177.s0.e5" e2="DS.d177.s0.e3" id="DS.d177.s0.i4" interaction="False"/>
            <pair e1="DS.d177.s0.e5" e2="DS.d177.s0.e4" id="DS.d177.s0.i5" interaction="False"/>
            <pair e1="DS.d177.s0.e1" e2="DS.d177.s0.e3" id="DS.d177.s0.i6" interaction="False"/>
            <pair e1="DS.d177.s0.e2" e2="DS.d177.s0.e3" id="DS.d177.s0.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d178" origId="18443829">
        <sentence id="DS.d178.s0" origId="18443829-973" text="The hydrolysis reaction of p-nitrophenyl butyrate catalyzed by lipases was followed with in situ UV/vis diode array spectrophotometry.">
            <entity id="DS.d178.s0.e0" origId="75834" charOffset="27-49" type="compound" text="p-nitrophenyl butyrate"/>
            <entity id="DS.d178.s0.e1" origId="Q7M4U7" charOffset="63-70" type="protein" text="lipases"/>
            <pair e1="DS.d178.s0.e0" e2="DS.d178.s0.e1" id="DS.d178.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d178.s1" origId="18443829-974" text="Five enzymes-Candida antarctica lipase B and Fusarium solani pisi cutinase wild-type and three single-mutation variants-were tested as catalysts in homogeneous conditions and immobilized on zeolite NaY, on a polyacrylate support and as cross-linked aggregates.">
            <entity id="DS.d178.s1.e0" origId="Q7M4U7" charOffset="32-38" type="protein" text="lipase"/>
            <entity id="DS.d178.s1.e1" origId="445523" charOffset="198-201" type="compound" text="NaY"/>
            <entity id="DS.d178.s1.e2" origId="6581" charOffset="208-220" type="compound" text="polyacrylate"/>
            <pair e1="DS.d178.s1.e2" e2="DS.d178.s1.e0" id="DS.d178.s1.i0" interaction="False"/>
            <pair e1="DS.d178.s1.e1" e2="DS.d178.s1.e0" id="DS.d178.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d179" origId="18443843">
        <sentence id="DS.d179.s0" origId="18443843-1157" text="At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.">
            <entity id="DS.d179.s0.e0" origId="P22079,P80025" charOffset="87-90" type="protein" text="LPO"/>
            <entity id="DS.d179.s0.e1" origId="O50258" charOffset="107-127" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d179.s0.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="129-132" type="protein" text="SOD"/>
            <entity id="DS.d179.s0.e3" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="135-143" type="protein" text="catalase"/>
            <entity id="DS.d179.s0.e4" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="145-167" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d179.s0.e5" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="175-200" type="protein" text="glutathione-S-transferase"/>
            <entity id="DS.d179.s0.e6" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="202-205" type="protein" text="GST"/>
            <entity id="DS.d179.s0.e7" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="230-250" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d179.s0.e8" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="252-256" type="protein" text="AChE"/>
            <entity id="DS.d179.s0.e9" origId="206,5793,64689,79025" charOffset="281-288" type="compound" text="glucose"/>
            <entity id="DS.d179.s0.e10" origId="124886" charOffset="145-156" type="compound" text="glutathione"/>
            <entity id="DS.d179.s0.e11" origId="124886" charOffset="317-320" type="compound" text="GSH"/>
            <entity id="DS.d179.s0.e12" origId="P15160,P17724,P73925,Q03459" charOffset="339-349" type="protein" text="hemoglobin"/>
            <pair e1="DS.d179.s0.e11" e2="DS.d179.s0.e6" id="DS.d179.s0.i0" interaction="False"/>
            <pair e1="DS.d179.s0.e10" e2="DS.d179.s0.e6" id="DS.d179.s0.i1" interaction="False"/>
            <pair e1="DS.d179.s0.e9" e2="DS.d179.s0.e3" id="DS.d179.s0.i2" interaction="False"/>
            <pair e1="DS.d179.s0.e11" e2="DS.d179.s0.e1" id="DS.d179.s0.i3" interaction="False"/>
            <pair e1="DS.d179.s0.e11" e2="DS.d179.s0.e12" id="DS.d179.s0.i4" interaction="False"/>
            <pair e1="DS.d179.s0.e11" e2="DS.d179.s0.e2" id="DS.d179.s0.i5" interaction="False"/>
            <pair e1="DS.d179.s0.e10" e2="DS.d179.s0.e8" id="DS.d179.s0.i6" interaction="False"/>
            <pair e1="DS.d179.s0.e11" e2="DS.d179.s0.e0" id="DS.d179.s0.i7" interaction="False"/>
            <pair e1="DS.d179.s0.e9" e2="DS.d179.s0.e5" id="DS.d179.s0.i8" interaction="False"/>
            <pair e1="DS.d179.s0.e9" e2="DS.d179.s0.e7" id="DS.d179.s0.i9" interaction="False"/>
            <pair e1="DS.d179.s0.e10" e2="DS.d179.s0.e2" id="DS.d179.s0.i10" interaction="False"/>
            <pair e1="DS.d179.s0.e9" e2="DS.d179.s0.e1" id="DS.d179.s0.i11" interaction="False"/>
            <pair e1="DS.d179.s0.e9" e2="DS.d179.s0.e4" id="DS.d179.s0.i12" interaction="False"/>
            <pair e1="DS.d179.s0.e10" e2="DS.d179.s0.e3" id="DS.d179.s0.i13" interaction="False"/>
            <pair e1="DS.d179.s0.e10" e2="DS.d179.s0.e7" id="DS.d179.s0.i14" interaction="False"/>
            <pair e1="DS.d179.s0.e9" e2="DS.d179.s0.e12" id="DS.d179.s0.i15" interaction="False"/>
            <pair e1="DS.d179.s0.e11" e2="DS.d179.s0.e4" id="DS.d179.s0.i16" interaction="False"/>
            <pair e1="DS.d179.s0.e10" e2="DS.d179.s0.e0" id="DS.d179.s0.i17" interaction="False"/>
            <pair e1="DS.d179.s0.e9" e2="DS.d179.s0.e8" id="DS.d179.s0.i18" interaction="False"/>
            <pair e1="DS.d179.s0.e11" e2="DS.d179.s0.e5" id="DS.d179.s0.i19" interaction="False"/>
            <pair e1="DS.d179.s0.e10" e2="DS.d179.s0.e1" id="DS.d179.s0.i20" interaction="False"/>
            <pair e1="DS.d179.s0.e10" e2="DS.d179.s0.e4" id="DS.d179.s0.i21" interaction="False"/>
            <pair e1="DS.d179.s0.e9" e2="DS.d179.s0.e2" id="DS.d179.s0.i22" interaction="False"/>
            <pair e1="DS.d179.s0.e9" e2="DS.d179.s0.e0" id="DS.d179.s0.i23" interaction="False"/>
            <pair e1="DS.d179.s0.e11" e2="DS.d179.s0.e7" id="DS.d179.s0.i24" interaction="False"/>
            <pair e1="DS.d179.s0.e11" e2="DS.d179.s0.e8" id="DS.d179.s0.i25" interaction="False"/>
            <pair e1="DS.d179.s0.e10" e2="DS.d179.s0.e5" id="DS.d179.s0.i26" interaction="False"/>
            <pair e1="DS.d179.s0.e10" e2="DS.d179.s0.e12" id="DS.d179.s0.i27" interaction="False"/>
            <pair e1="DS.d179.s0.e11" e2="DS.d179.s0.e3" id="DS.d179.s0.i28" interaction="False"/>
            <pair e1="DS.d179.s0.e9" e2="DS.d179.s0.e6" id="DS.d179.s0.i29" interaction="False"/>
        </sentence>
        <sentence id="DS.d179.s1" origId="18443843-1158" text="Catalase was decreased with endosulfan and the coexposure, but not with arsenic, whereas GSH was decreased with arsenic and endosulfan, but not with the coexposure.">
            <entity id="DS.d179.s1.e0" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="0-8" type="protein" text="Catalase"/>
            <entity id="DS.d179.s1.e1" origId="3224" charOffset="28-38" type="compound" text="endosulfan"/>
            <entity id="DS.d179.s1.e2" origId="124886" charOffset="89-92" type="compound" text="GSH"/>
            <entity id="DS.d179.s1.e3" origId="3224" charOffset="124-134" type="compound" text="endosulfan"/>
            <pair e1="DS.d179.s1.e1" e2="DS.d179.s1.e0" id="DS.d179.s1.i0" interaction="True"/>
            <pair e1="DS.d179.s1.e2" e2="DS.d179.s1.e0" id="DS.d179.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d179.s2" origId="18443843-1159" text="Na+-K+-ATPase activity was decreased in the endosulfan-treated and the coexposed birds.">
            <entity id="DS.d179.s2.e0" origId="P13607,P17326,P28774,P35317" charOffset="0-13" type="protein" text="Na+-K+-ATPase"/>
            <entity id="DS.d179.s2.e1" origId="3224" charOffset="44-54" type="compound" text="endosulfan"/>
            <pair e1="DS.d179.s2.e1" e2="DS.d179.s2.e0" id="DS.d179.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d180" origId="18443897">
        <sentence id="DS.d180.s0" origId="18443897-1003" text="mRNA and protein levels of TNF-alpha, Fas, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by L-carnitine treatment.">
            <entity id="DS.d180.s0.e0" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="27-36" type="protein" text="TNF-alpha"/>
            <entity id="DS.d180.s0.e1" origId="P25446,Q63199" charOffset="38-41" type="protein" text="Fas"/>
            <entity id="DS.d180.s0.e2" origId="10918" charOffset="176-187" type="compound" text="L-carnitine"/>
            <pair e1="DS.d180.s0.e2" e2="DS.d180.s0.e0" id="DS.d180.s0.i0" interaction="True"/>
            <pair e1="DS.d180.s0.e2" e2="DS.d180.s0.e1" id="DS.d180.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d180.s1" origId="18443897-1004" text="In addition, L-carnitine treatment regulated mitochondria-dependent apoptosis pathways by inducing the up-regulation of caspase-9 and caspase-3 and the down-regulation of Bcl-2 in hepa1c1c 7 cells.">
            <entity id="DS.d180.s1.e0" origId="10918" charOffset="13-24" type="compound" text="L-carnitine"/>
            <entity id="DS.d180.s1.e1" origId="P10417,P49950" charOffset="171-176" type="protein" text="Bcl-2"/>
            <pair e1="DS.d180.s1.e0" e2="DS.d180.s1.e1" id="DS.d180.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d180.s2" origId="18443897-1005" text="Taken together, the findings of this study have demonstrated that L-carnitine could induce apoptosis in hepa1c1c7 cells by regulating Fas ligands and inhibiting the expression of Bcl-2.">
            <entity id="DS.d180.s2.e0" origId="10918" charOffset="66-77" type="compound" text="L-carnitine"/>
            <entity id="DS.d180.s2.e1" origId="P36940,P41047,P48023,P63306,P63307,P63308,Q861W5,Q9BDN1,Q9BEA8" charOffset="134-145" type="protein" text="Fas ligands"/>
            <entity id="DS.d180.s2.e2" origId="P10417,P49950" charOffset="179-184" type="protein" text="Bcl-2"/>
            <pair e1="DS.d180.s2.e0" e2="DS.d180.s2.e1" id="DS.d180.s2.i0" interaction="True"/>
            <pair e1="DS.d180.s2.e0" e2="DS.d180.s2.e2" id="DS.d180.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d181" origId="18445079">
        <sentence id="DS.d181.s0" origId="18445079-363" text="Merlin is known to bind paxillin, beta1 integrin and focal adhesion kinase, members of focal contacts, multi-protein complexes that mediate cell adhesion to the extracellular matrix.">
            <entity id="DS.d181.s0.e0" origId="84098" charOffset="0-6" type="compound" text="Merlin"/>
            <entity id="DS.d181.s0.e1" origId="P49023,P49024,Q5R7I1,Q66H76,Q8VI36" charOffset="24-32" type="protein" text="paxillin"/>
            <pair e1="DS.d181.s0.e0" e2="DS.d181.s0.e1" id="DS.d181.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d182" origId="18445307">
        <sentence id="DS.d182.s0" origId="18445307-585" text="Furthermore, free radical overproduction and oxidative stress were associated with a significant decrease in hepatic glutathione levels in septic mice, and with an excessive NO production attributed to the induction of the inducible isoform of NO synthase (iNOS).">
            <entity id="DS.d182.s0.e0" origId="124886" charOffset="117-128" type="compound" text="glutathione"/>
            <entity id="DS.d182.s0.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="257-261" type="protein" text="iNOS"/>
            <pair e1="DS.d182.s0.e0" e2="DS.d182.s0.e1" id="DS.d182.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d182.s1" origId="18445307-586" text="In fact, hepatic glutathione levels were significantly increased in the group of mice receiving the probiotic, and the increased iNOS expression both in the colon and lungs was down-regulated in those mice treated with L. fermentum.">
            <entity id="DS.d182.s1.e0" origId="124886" charOffset="17-28" type="compound" text="glutathione"/>
            <entity id="DS.d182.s1.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="129-133" type="protein" text="iNOS"/>
            <pair e1="DS.d182.s1.e0" e2="DS.d182.s1.e1" id="DS.d182.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d183" origId="18448193">
        <sentence id="DS.d183.s0" origId="18448193-1146" text="Furthermore, supplementation of specific inhibitors of PAL, C4H and 4CL in elicited cell cultures led to suppressed accumulation of p-hydroxybenzoic acid, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.">
            <entity id="DS.d183.s0.e0" origId="O03979,O04058,O93967,P10248,P10731,P11544,P14166,P14717,P14925,P19021,P26600,P35511,P35512,P45726,P45727,P45730,P45731,P45735,P52777,P83388,P91268,P97467,Q42609,Q43210,Q9P2V4,Q9PSN0" charOffset="55-58" type="protein" text="PAL"/>
            <entity id="DS.d183.s0.e1" origId="O24312,O81928,P37114,P37115,P48522,P92994,Q04468,Q42797,Q43033,Q43054,Q43067,Q43240,Q96423,Q9AR74" charOffset="60-63" type="protein" text="C4H"/>
            <entity id="DS.d183.s0.e2" origId="O11451,O11452,O11453,O24540,O54075,O69140,P17814,P41636,P42516,P68763,P68764,P68765,P69180,P69181,P69182,P69183,P69184" charOffset="68-71" type="protein" text="4CL"/>
            <entity id="DS.d183.s0.e3" origId="135" charOffset="132-153" type="compound" text="p-hydroxybenzoic acid"/>
            <pair e1="DS.d183.s0.e3" e2="DS.d183.s0.e0" id="DS.d183.s0.i0" interaction="True"/>
            <pair e1="DS.d183.s0.e3" e2="DS.d183.s0.e2" id="DS.d183.s0.i1" interaction="True"/>
            <pair e1="DS.d183.s0.e3" e2="DS.d183.s0.e1" id="DS.d183.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d184" origId="18449471">
        <sentence id="DS.d184.s0" origId="18449471-648" text="Imatinib is transported by P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.">
            <entity id="DS.d184.s0.e0" origId="5291" charOffset="0-8" type="compound" text="Imatinib"/>
            <entity id="DS.d184.s0.e1" origId="P08163" charOffset="29-41" type="protein" text="glycoprotein"/>
            <entity id="DS.d184.s0.e2" origId="Q9UNQ0" charOffset="53-85" type="protein" text="Breast Cancer Resistance Protein"/>
            <entity id="DS.d184.s0.e3" origId="Q9UNQ0" charOffset="87-91" type="protein" text="BCRP"/>
            <entity id="DS.d184.s0.e4" origId="5291" charOffset="206-214" type="compound" text="imatinib"/>
            <pair e1="DS.d184.s0.e4" e2="DS.d184.s0.e3" id="DS.d184.s0.i0" interaction="True"/>
            <pair e1="DS.d184.s0.e4" e2="DS.d184.s0.e2" id="DS.d184.s0.i1" interaction="True"/>
            <pair e1="DS.d184.s0.e0" e2="DS.d184.s0.e1" id="DS.d184.s0.i2" interaction="True"/>
            <pair e1="DS.d184.s0.e0" e2="DS.d184.s0.e3" id="DS.d184.s0.i3" interaction="True"/>
            <pair e1="DS.d184.s0.e0" e2="DS.d184.s0.e2" id="DS.d184.s0.i4" interaction="True"/>
            <pair e1="DS.d184.s0.e4" e2="DS.d184.s0.e1" id="DS.d184.s0.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d184.s1" origId="18449471-650" text="In conclusion, P-gp and BCRP have only a modest effect on the ADME of imatinib in comparison to metabolic elimination.">
            <entity id="DS.d184.s1.e0" origId="Q9UNQ0" charOffset="24-28" type="protein" text="BCRP"/>
            <entity id="DS.d184.s1.e1" origId="5291" charOffset="70-78" type="compound" text="imatinib"/>
            <pair e1="DS.d184.s1.e1" e2="DS.d184.s1.e0" id="DS.d184.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d184.s2" origId="18449471-651" text="The considerable drug-drug interaction observed with elacridar or pantoprazole is only partly mediated by inhibition of P-gp and BCRP and far more by the inhibition of other elimination pathways.">
            <entity id="DS.d184.s2.e0" origId="119373" charOffset="53-62" type="compound" text="elacridar"/>
            <entity id="DS.d184.s2.e1" origId="4679" charOffset="66-78" type="compound" text="pantoprazole"/>
            <entity id="DS.d184.s2.e2" origId="Q9UNQ0" charOffset="129-133" type="protein" text="BCRP"/>
            <pair e1="DS.d184.s2.e1" e2="DS.d184.s2.e2" id="DS.d184.s2.i0" interaction="True"/>
            <pair e1="DS.d184.s2.e0" e2="DS.d184.s2.e2" id="DS.d184.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d185" origId="18449536">
        <sentence id="DS.d185.s0" origId="18449536-687" text="There is clear evidence for TREK-1 and TASK-1 in the heart and these channels are likely to regulate cardiac action potential duration through their regulation by stretch, polyunsaturated fatty acids, pH, and neurotransmitters.">
            <entity id="DS.d185.s0.e0" origId="O95069" charOffset="28-32" type="protein" text="TREK"/>
            <entity id="DS.d185.s0.e1" origId="O14649" charOffset="39-43" type="protein" text="TASK"/>
            <entity id="DS.d185.s0.e2" origId="56842239" charOffset="172-199" type="compound" text="polyunsaturated fatty acids"/>
            <pair e1="DS.d185.s0.e2" e2="DS.d185.s0.e1" id="DS.d185.s0.i0" interaction="True"/>
            <pair e1="DS.d185.s0.e2" e2="DS.d185.s0.e0" id="DS.d185.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d185.s1" origId="18449536-688" text="TREK-1 may also have a critical role in mediating the vasodilator response of resistance arteries to polyunsaturated fatty acids, thus contributing to their protective effect on the cardiovascular system.">
            <entity id="DS.d185.s1.e0" origId="O95069" charOffset="0-4" type="protein" text="TREK"/>
            <entity id="DS.d185.s1.e1" origId="56842239" charOffset="101-128" type="compound" text="polyunsaturated fatty acids"/>
            <pair e1="DS.d185.s1.e1" e2="DS.d185.s1.e0" id="DS.d185.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d186" origId="18449944">
        <sentence id="DS.d186.s0" origId="18449944-953" text="Alumina ceramic particles, in comparison with titanium particles, hardly affect the expression of RANK-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line.">
            <entity id="DS.d186.s0.e0" origId="23963" charOffset="46-54" type="compound" text="titanium"/>
            <entity id="DS.d186.s0.e1" origId="Q9Y6Q6" charOffset="98-102" type="protein" text="RANK"/>
            <entity id="DS.d186.s0.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="105-114" type="protein" text="TNF-alpha"/>
            <entity id="DS.d186.s0.e3" origId="O00300" charOffset="121-124" type="protein" text="OPG"/>
            <pair e1="DS.d186.s0.e0" e2="DS.d186.s0.e2" id="DS.d186.s0.i0" interaction="False"/>
            <pair e1="DS.d186.s0.e0" e2="DS.d186.s0.e1" id="DS.d186.s0.i1" interaction="False"/>
            <pair e1="DS.d186.s0.e0" e2="DS.d186.s0.e3" id="DS.d186.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d187" origId="18450412">
        <sentence id="DS.d187.s0" origId="18450412-1248" text="Indirubin-3-oxime-induced growth inhibition was associated with induction of Cdk inhibitor p21, inhibition of cyclin D1 and activation of caspase-3.">
            <entity id="DS.d187.s0.e0" origId="5326739" charOffset="0-17" type="compound" text="Indirubin-3-oxime"/>
            <entity id="DS.d187.s0.e1" origId="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268" charOffset="110-116" type="protein" text="cyclin"/>
            <pair e1="DS.d187.s0.e0" e2="DS.d187.s0.e1" id="DS.d187.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d188" origId="18452177">
        <sentence id="DS.d188.s0" origId="18452177-145" text="Three proteins, porcine somatotropin, bovine serum albumin, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, indomethacin and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).">
            <entity id="DS.d188.s0.e0" origId="P10766,P20391,P20392,P33092,P34005,P34006,P34747,P37885,P55755" charOffset="24-36" type="protein" text="somatotropin"/>
            <entity id="DS.d188.s0.e1" origId="P21847,P83517" charOffset="45-58" type="protein" text="serum albumin"/>
            <entity id="DS.d188.s0.e2" origId="3715" charOffset="162-174" type="compound" text="indomethacin"/>
            <pair e1="DS.d188.s0.e2" e2="DS.d188.s0.e1" id="DS.d188.s0.i0" interaction="False"/>
            <pair e1="DS.d188.s0.e2" e2="DS.d188.s0.e0" id="DS.d188.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d189" origId="18454352">
        <sentence id="DS.d189.s0" origId="18454352-1155" text="The recombinant protein exhibited high PAL activity and could catalyze the conversion of L:-Phe to trans-cinnamic acid.">
            <entity id="DS.d189.s0.e0" origId="O03979,O04058,O93967,P10248,P10731,P11544,P14166,P14717,P14925,P19021,P26600,P35511,P35512,P45726,P45727,P45730,P45731,P45735,P52777,P83388,P91268,P97467,Q42609,Q43210,Q9P2V4,Q9PSN0" charOffset="39-42" type="protein" text="PAL"/>
            <entity id="DS.d189.s0.e1" origId="444539" charOffset="99-118" type="compound" text="trans-cinnamic acid"/>
            <pair e1="DS.d189.s0.e1" e2="DS.d189.s0.e0" id="DS.d189.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d190" origId="18456422">
        <sentence id="DS.d190.s0" origId="18456422-1170" text="Only the beta-lactamases of pI 5.4 and superior to 7.6 hydrolyze the cefotaxime.">
            <entity id="DS.d190.s0.e0" origId="P80298,P80545,P81173" charOffset="9-24" type="protein" text="beta-lactamases"/>
            <entity id="DS.d190.s0.e1" origId="5479527,5742673,6540461" charOffset="69-79" type="compound" text="cefotaxime"/>
            <pair e1="DS.d190.s0.e1" e2="DS.d190.s0.e0" id="DS.d190.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d191" origId="18457934">
        <sentence id="DS.d191.s0" origId="18457934-815" text="To investigate this relationship, we used actively growing young Sprague-Dawley rats and CKD-732, one of the angiogenesis inhibitor (AI) to reveal the relationship of angiogenesis in the effect of PTH.">
            <entity id="DS.d191.s0.e0" origId="6918502" charOffset="89-96" type="compound" text="CKD-732"/>
            <entity id="DS.d191.s0.e1" origId="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3" charOffset="197-200" type="protein" text="PTH"/>
            <pair e1="DS.d191.s0.e0" e2="DS.d191.s0.e1" id="DS.d191.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d192" origId="18458677">
        <sentence id="DS.d192.s0" origId="18458677-190" text="Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.">
            <entity id="DS.d192.s0.e0" origId="P41693" charOffset="32-45" type="protein" text="interleukin-6"/>
            <entity id="DS.d192.s0.e1" origId="37542" charOffset="138-147" type="compound" text="ribavirin"/>
            <pair e1="DS.d192.s0.e1" e2="DS.d192.s0.e0" id="DS.d192.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d193" origId="18458952">
        <sentence id="DS.d193.s0" origId="18458952-1204" text="An alpha-numeric code for representing N-linked glycan structures in secreted glycoproteins.">
            <entity id="DS.d193.s0.e0" origId="871" charOffset="48-54" type="compound" text="glycan"/>
            <entity id="DS.d193.s0.e1" origId="P08163" charOffset="78-91" type="protein" text="glycoproteins"/>
            <pair e1="DS.d193.s0.e0" e2="DS.d193.s0.e1" id="DS.d193.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d193.s1" origId="18458952-1205" text="Towards this end, we propose a fixed-length alpha-numeric code for representing N-linked glycan structures commonly found in secreted glycoproteins from mammalian cell cultures.">
            <entity id="DS.d193.s1.e0" origId="871" charOffset="89-95" type="compound" text="glycan"/>
            <entity id="DS.d193.s1.e1" origId="P08163" charOffset="134-147" type="protein" text="glycoproteins"/>
            <pair e1="DS.d193.s1.e0" e2="DS.d193.s1.e1" id="DS.d193.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d194" origId="18458994">
        <sentence id="DS.d194.s0" origId="18458994-119" text="There was a significant increase in cytochrome-c oxidase activity at 2.5 mg/L, which might indicate irgarol's disruption of the mitochondrial membrane and subsequently ATP synthesis.">
            <entity id="DS.d194.s0.e0" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="36-48" type="protein" text="cytochrome-c"/>
            <entity id="DS.d194.s0.e1" origId="91590" charOffset="100-107" type="compound" text="irgarol"/>
            <entity id="DS.d194.s0.e2" origId="5957" charOffset="168-171" type="compound" text="ATP"/>
            <pair e1="DS.d194.s0.e1" e2="DS.d194.s0.e0" id="DS.d194.s0.i0" interaction="True"/>
            <pair e1="DS.d194.s0.e2" e2="DS.d194.s0.e0" id="DS.d194.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d195" origId="18459128">
        <sentence id="DS.d195.s0" origId="18459128-282" text="Treatment of A549, which express wild-type p53, and H1299, which are p53-deficient, human lung cancer cells with berberine resulted in inhibition of cell proliferation and an increase in apoptotic cell death ; however, A549 cells were more sensitive to the berberine-induced cytotoxic effects than H1299 cells.">
            <entity id="DS.d195.s0.e0" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="43-46" type="protein" text="p53"/>
            <entity id="DS.d195.s0.e1" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="69-72" type="protein" text="p53"/>
            <entity id="DS.d195.s0.e2" origId="2353" charOffset="113-122" type="compound" text="berberine"/>
            <entity id="DS.d195.s0.e3" origId="2353" charOffset="257-266" type="compound" text="berberine"/>
            <pair e1="DS.d195.s0.e2" e2="DS.d195.s0.e0" id="DS.d195.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d196" origId="18459941">
        <sentence id="DS.d196.s0" origId="18459941-785" text="Furthermore atorvastatin treatment markedly decreased the levels of TNF-alpha, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.">
            <entity id="DS.d196.s0.e0" origId="60823" charOffset="12-24" type="compound" text="atorvastatin"/>
            <entity id="DS.d196.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="68-77" type="protein" text="TNF-alpha"/>
            <entity id="DS.d196.s0.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="79-83" type="protein" text="IL-6"/>
            <entity id="DS.d196.s0.e3" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="88-93" type="protein" text="MCP-1"/>
            <entity id="DS.d196.s0.e4" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="232-237" type="protein" text="IL-10"/>
            <pair e1="DS.d196.s0.e0" e2="DS.d196.s0.e4" id="DS.d196.s0.i0" interaction="True"/>
            <pair e1="DS.d196.s0.e0" e2="DS.d196.s0.e3" id="DS.d196.s0.i1" interaction="True"/>
            <pair e1="DS.d196.s0.e0" e2="DS.d196.s0.e2" id="DS.d196.s0.i2" interaction="True"/>
            <pair e1="DS.d196.s0.e0" e2="DS.d196.s0.e1" id="DS.d196.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d196.s1" origId="18459941-787" text="Our study suggests that the modulation of the balance between pro- and anti-inflammatory cytokines towards the anti-inflammatory cytokine IL-10 is one salutary mechanism underlying how atorvastatin influences post-MI remodelling and thus improves LV function.">
            <entity id="DS.d196.s1.e0" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="138-143" type="protein" text="IL-10"/>
            <entity id="DS.d196.s1.e1" origId="60823" charOffset="185-197" type="compound" text="atorvastatin"/>
            <pair e1="DS.d196.s1.e1" e2="DS.d196.s1.e0" id="DS.d196.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d197" origId="18459944">
        <sentence id="DS.d197.s0" origId="18459944-788" text="In addition, AUDA treatment attenuated macrophage infiltration and inhibited urinary excretion of MCP-1 (monocyte chemoattractant protein-1) and kidney cortex MCP-1 gene expression.">
            <entity id="DS.d197.s0.e0" origId="10069117" charOffset="13-17" type="compound" text="AUDA"/>
            <entity id="DS.d197.s0.e1" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="98-103" type="protein" text="MCP-1"/>
            <entity id="DS.d197.s0.e2" origId="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="105-139" type="protein" text="monocyte chemoattractant protein-1"/>
            <entity id="DS.d197.s0.e3" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="159-164" type="protein" text="MCP-1"/>
            <pair e1="DS.d197.s0.e0" e2="DS.d197.s0.e1" id="DS.d197.s0.i0" interaction="True"/>
            <pair e1="DS.d197.s0.e0" e2="DS.d197.s0.e2" id="DS.d197.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d198" origId="18462831">
        <sentence id="DS.d198.s0" origId="18462831-74" text="Exogenous spermidine, arsenic and beta-aminobutyric acid modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and arginine decarboxylase gene expression in tobacco leaves.">
            <entity id="DS.d198.s0.e0" origId="1102" charOffset="10-20" type="compound" text="spermidine"/>
            <entity id="DS.d198.s0.e1" origId="10932" charOffset="34-56" type="compound" text="beta-aminobutyric acid"/>
            <entity id="DS.d198.s0.e2" origId="O81160,O82475,P21885,P22220,P49726,Q39827,Q43075,Q819L4,Q81MS2,Q96412,Q96A70,Q9K9K5,Q9SNN0" charOffset="174-196" type="protein" text="arginine decarboxylase"/>
            <pair e1="DS.d198.s0.e1" e2="DS.d198.s0.e2" id="DS.d198.s0.i0" interaction="True"/>
            <pair e1="DS.d198.s0.e0" e2="DS.d198.s0.e2" id="DS.d198.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d198.s1" origId="18462831-75" text="Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule salicylic acid and in transcript levels of some pathogenesis/stress-related genes (pathogenesis-related proteins PR-1a and PR-2 and arginine decarboxylase (ADC)).">
            <entity id="DS.d198.s1.e0" origId="338" charOffset="123-137" type="compound" text="salicylic acid"/>
            <entity id="DS.d198.s1.e1" origId="P83834" charOffset="206-235" type="protein" text="pathogenesis-related proteins"/>
            <entity id="DS.d198.s1.e2" origId="P33157,P51525" charOffset="246-250" type="protein" text="PR-2"/>
            <entity id="DS.d198.s1.e3" origId="O81160,O82475,P21885,P22220,P49726,Q39827,Q43075,Q819L4,Q81MS2,Q96412,Q96A70,Q9K9K5,Q9SNN0" charOffset="255-277" type="protein" text="arginine decarboxylase"/>
            <entity id="DS.d198.s1.e4" origId="O81160,O82475,P21170,P22220,P23670,P28629,P49726,P60658,P60659,P81336,Q39827,Q43075,Q7MK24,Q7N121,Q7NE10,Q7NSA6,Q7NU27,Q7TUJ9,Q7U3S0,Q7UTS2,Q7V3M9,Q7VEG4,Q83Q93,Q87F25,Q87JS8,Q87VU3,Q88QC7,Q8A2B1,Q8BVM4,Q8DA54,Q8DHY6,Q8EFU5,Q8FE34,Q8P448,Q8PFQ5,Q8XCX9,Q8XR10,Q8YRP3,Q8ZHG8,Q96412,Q96A70,Q9CL60,Q9EYI7,Q9HUX1,Q9JT25,Q9K0U3,Q9KLD1,Q9PH02,Q9RPK1,Q9RXR4,Q9SNN0" charOffset="279-282" type="protein" text="ADC"/>
            <pair e1="DS.d198.s1.e0" e2="DS.d198.s1.e3" id="DS.d198.s1.i0" interaction="True"/>
            <pair e1="DS.d198.s1.e0" e2="DS.d198.s1.e1" id="DS.d198.s1.i1" interaction="True"/>
            <pair e1="DS.d198.s1.e0" e2="DS.d198.s1.e4" id="DS.d198.s1.i2" interaction="True"/>
            <pair e1="DS.d198.s1.e0" e2="DS.d198.s1.e2" id="DS.d198.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d199" origId="18462962">
        <sentence id="DS.d199.s0" origId="18462962-149" text="She had a mutation in PANK2 gene consisting of an aminoacid change of Alanine to Valine in exon 5 (A382V).">
            <entity id="DS.d199.s0.e0" origId="Q9BZ23" charOffset="22-27" type="protein" text="PANK2"/>
            <entity id="DS.d199.s0.e1" origId="602,4580,5950,71080" charOffset="70-77" type="compound" text="Alanine"/>
            <entity id="DS.d199.s0.e2" origId="6287" charOffset="81-87" type="compound" text="Valine"/>
            <pair e1="DS.d199.s0.e2" e2="DS.d199.s0.e0" id="DS.d199.s0.i0" interaction="True"/>
            <pair e1="DS.d199.s0.e1" e2="DS.d199.s0.e0" id="DS.d199.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d200" origId="18466349">
        <sentence id="DS.d200.s0" origId="18466349-969" text="Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.">
            <entity id="DS.d200.s0.e0" origId="P02753,P06912,P18902,P27485,P41263,P61641,Q28369" charOffset="18-22" type="protein" text="RBP4"/>
            <entity id="DS.d200.s0.e1" origId="206,5793,64689,79025" charOffset="68-75" type="compound" text="glucose"/>
            <entity id="DS.d200.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="114-121" type="protein" text="insulin"/>
            <pair e1="DS.d200.s0.e1" e2="DS.d200.s0.e0" id="DS.d200.s0.i0" interaction="True"/>
            <pair e1="DS.d200.s0.e1" e2="DS.d200.s0.e2" id="DS.d200.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d201" origId="18466352">
        <sentence id="DS.d201.s0" origId="18466352-971" text="RAD001-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.">
            <entity id="DS.d201.s0.e0" origId="6442177" charOffset="0-6" type="compound" text="RAD001"/>
            <entity id="DS.d201.s0.e1" origId="P42345,P42346,Q9JLN9" charOffset="92-96" type="protein" text="mTOR"/>
            <entity id="DS.d201.s0.e2" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="111-115" type="protein" text="VEGF"/>
            <entity id="DS.d201.s0.e3" origId="O11451,O11452,O11453,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P06934,P16342,P19751,P25880,P25881,P25882,P25884,P25989,P26660,P26661,P26662,P26663,P26664,P27958,P29833,P29846,P29996,P29997,P40305,P68763,P68764,P68765,P69180,P69181,P69182,P69183,P69184,P69618,P69619,Q00269,Q43735,Q5I2N3,Q66198,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q81835,Q81842,Q8V439,Q8V6W7,Q913D4,Q91A29,Q91DH7,Q91DH8,Q91DH9,Q99IB8,Q9DHD6,Q9E925,Q9PYA3,Q9QAX1,Q9WMX2" charOffset="203-206" type="protein" text="p27"/>
            <entity id="DS.d201.s0.e4" origId="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2" charOffset="237-240" type="protein" text="p21"/>
            <entity id="DS.d201.s0.e5" origId="O42923,P39689" charOffset="242-246" type="protein" text="Cip1"/>
            <entity id="DS.d201.s0.e6" origId="P39689" charOffset="247-251" type="protein" text="Waf1"/>
            <entity id="DS.d201.s0.e7" origId="O05982" charOffset="254-257" type="protein" text="Cdk"/>
            <entity id="DS.d201.s0.e8" origId="O05982" charOffset="261-264" type="protein" text="Cdk"/>
            <entity id="DS.d201.s0.e9" origId="O05982" charOffset="261-264" type="protein" text="Cdk"/>
            <entity id="DS.d201.s0.e10" origId="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268" charOffset="284-290" type="protein" text="cyclin"/>
            <entity id="DS.d201.s0.e11" origId="P01109,P06646,P49709,P52160,Q17103" charOffset="298-303" type="protein" text="c-Myc"/>
            <pair e1="DS.d201.s0.e0" e2="DS.d201.s0.e5" id="DS.d201.s0.i0" interaction="True"/>
            <pair e1="DS.d201.s0.e0" e2="DS.d201.s0.e3" id="DS.d201.s0.i1" interaction="True"/>
            <pair e1="DS.d201.s0.e0" e2="DS.d201.s0.e2" id="DS.d201.s0.i2" interaction="True"/>
            <pair e1="DS.d201.s0.e0" e2="DS.d201.s0.e7" id="DS.d201.s0.i3" interaction="True"/>
            <pair e1="DS.d201.s0.e0" e2="DS.d201.s0.e11" id="DS.d201.s0.i4" interaction="True"/>
            <pair e1="DS.d201.s0.e0" e2="DS.d201.s0.e6" id="DS.d201.s0.i5" interaction="True"/>
            <pair e1="DS.d201.s0.e0" e2="DS.d201.s0.e4" id="DS.d201.s0.i6" interaction="True"/>
            <pair e1="DS.d201.s0.e0" e2="DS.d201.s0.e10" id="DS.d201.s0.i7" interaction="True"/>
            <pair e1="DS.d201.s0.e0" e2="DS.d201.s0.e1" id="DS.d201.s0.i8" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d202" origId="18467006">
        <sentence id="DS.d202.s0" origId="18467006-128" text="A series of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles have been synthesized and evaluated for their ALK5 inhibitory activity in cell-based luciferase reporter assays.">
            <entity id="DS.d202.s0.e0" origId="7370" charOffset="12-30" type="compound" text="benzenesulfonamide"/>
            <entity id="DS.d202.s0.e1" origId="P36897" charOffset="143-147" type="protein" text="ALK5"/>
            <pair e1="DS.d202.s0.e0" e2="DS.d202.s0.e1" id="DS.d202.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d203" origId="18468607">
        <sentence id="DS.d203.s0" origId="18468607-1101" text="Genetic variation in CETP (cholesteryl ester transfer protein) has been clearly associated with HDL cholesterol levels but its association with cardiovascular disease and related phenotypes has been more controversial, possibly due to variability of polymorphisms and their frequencies across different ethnic populations.">
            <entity id="DS.d203.s0.e0" origId="P11597,P22687,P25914,P47896" charOffset="21-25" type="protein" text="CETP"/>
            <entity id="DS.d203.s0.e1" origId="P25914" charOffset="27-61" type="protein" text="cholesteryl ester transfer protein"/>
            <entity id="DS.d203.s0.e2" origId="304,5997,6432564,11025495" charOffset="100-111" type="compound" text="cholesterol"/>
            <pair e1="DS.d203.s0.e2" e2="DS.d203.s0.e0" id="DS.d203.s0.i0" interaction="True"/>
            <pair e1="DS.d203.s0.e2" e2="DS.d203.s0.e1" id="DS.d203.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d204" origId="18470629">
        <sentence id="DS.d204.s0" origId="18470629-1072" text="However, methomyl exhibited more potency in reducing AChE activity than methiocarb.">
            <entity id="DS.d204.s0.e0" origId="5353758" charOffset="9-17" type="compound" text="methomyl"/>
            <entity id="DS.d204.s0.e1" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="53-57" type="protein" text="AChE"/>
            <entity id="DS.d204.s0.e2" origId="16248" charOffset="72-82" type="compound" text="methiocarb"/>
            <pair e1="DS.d204.s0.e0" e2="DS.d204.s0.e1" id="DS.d204.s0.i0" interaction="True"/>
            <pair e1="DS.d204.s0.e2" e2="DS.d204.s0.e1" id="DS.d204.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d205" origId="18470874">
        <sentence id="DS.d205.s0" origId="18470874-1230" text="Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-uridine incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, UBF and nucleophosmin, B23).">
            <entity id="DS.d205.s0.e0" origId="6029" charOffset="277-284" type="compound" text="uridine"/>
            <entity id="DS.d205.s0.e1" origId="P17480" charOffset="443-446" type="protein" text="UBF"/>
            <entity id="DS.d205.s0.e2" origId="P06748,P07222,P13084,P16039,Q3T160,Q61937" charOffset="451-464" type="protein" text="nucleophosmin"/>
            <entity id="DS.d205.s0.e3" origId="P51472" charOffset="466-469" type="protein" text="B23"/>
            <pair e1="DS.d205.s0.e0" e2="DS.d205.s0.e2" id="DS.d205.s0.i0" interaction="False"/>
            <pair e1="DS.d205.s0.e0" e2="DS.d205.s0.e1" id="DS.d205.s0.i1" interaction="False"/>
            <pair e1="DS.d205.s0.e0" e2="DS.d205.s0.e3" id="DS.d205.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d206" origId="18471929">
        <sentence id="DS.d206.s0" origId="18471929-584" text="Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming peroxidase (POX) were found to be increased by proline and betaine under salt stress.">
            <entity id="DS.d206.s0.e0" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="125-133" type="protein" text="catalase"/>
            <entity id="DS.d206.s0.e1" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="135-138" type="protein" text="CAT"/>
            <entity id="DS.d206.s0.e2" origId="P15984,P16147,P84714" charOffset="159-169" type="protein" text="peroxidase"/>
            <entity id="DS.d206.s0.e3" origId="P07003,P37063,P92983,Q54970" charOffset="171-174" type="protein" text="POX"/>
            <entity id="DS.d206.s0.e4" origId="614,8988,145742" charOffset="206-213" type="compound" text="proline"/>
            <entity id="DS.d206.s0.e5" origId="248" charOffset="218-225" type="compound" text="betaine"/>
            <pair e1="DS.d206.s0.e5" e2="DS.d206.s0.e2" id="DS.d206.s0.i0" interaction="True"/>
            <pair e1="DS.d206.s0.e4" e2="DS.d206.s0.e3" id="DS.d206.s0.i1" interaction="True"/>
            <pair e1="DS.d206.s0.e4" e2="DS.d206.s0.e2" id="DS.d206.s0.i2" interaction="True"/>
            <pair e1="DS.d206.s0.e4" e2="DS.d206.s0.e1" id="DS.d206.s0.i3" interaction="True"/>
            <pair e1="DS.d206.s0.e5" e2="DS.d206.s0.e1" id="DS.d206.s0.i4" interaction="True"/>
            <pair e1="DS.d206.s0.e4" e2="DS.d206.s0.e0" id="DS.d206.s0.i5" interaction="True"/>
            <pair e1="DS.d206.s0.e5" e2="DS.d206.s0.e0" id="DS.d206.s0.i6" interaction="True"/>
            <pair e1="DS.d206.s0.e5" e2="DS.d206.s0.e3" id="DS.d206.s0.i7" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d207" origId="18472163">
        <sentence id="DS.d207.s0" origId="18472163-737" text="Significant ALP activity changes, sensitivity of isozyme patterns (Mr of 60, 64, and 85kDa) and increased variation in ALP plasticity during acute exposure to cadmium point to its possible aplication as an exposure biomarker.">
            <entity id="DS.d207.s0.e0" origId="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0" charOffset="12-15" type="protein" text="ALP"/>
            <entity id="DS.d207.s0.e1" origId="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0" charOffset="119-122" type="protein" text="ALP"/>
            <entity id="DS.d207.s0.e2" origId="23973" charOffset="159-166" type="compound" text="cadmium"/>
            <pair e1="DS.d207.s0.e2" e2="DS.d207.s0.e0" id="DS.d207.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d208" origId="18472187">
        <sentence id="DS.d208.s0" origId="18472187-928" text="To decrease the level of androgen testosterone in the prostate, we are interested in developing inhibitors of 17beta-hydroxysteroid dehydrogenase type 5 (17beta-HSD5).">
            <entity id="DS.d208.s0.e0" origId="6013" charOffset="34-46" type="compound" text="testosterone"/>
            <entity id="DS.d208.s0.e1" origId="P42330,Q5R7C9" charOffset="110-152" type="protein" text="17beta-hydroxysteroid dehydrogenase type 5"/>
            <entity id="DS.d208.s0.e2" origId="P42330,P70694,Q5R7C9" charOffset="154-165" type="protein" text="17beta-HSD5"/>
            <pair e1="DS.d208.s0.e0" e2="DS.d208.s0.e2" id="DS.d208.s0.i0" interaction="False"/>
            <pair e1="DS.d208.s0.e0" e2="DS.d208.s0.e1" id="DS.d208.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d209" origId="18472342">
        <sentence id="DS.d209.s0" origId="18472342-221" text="A role for guanosine 3',5'-cyclic monophosphate (cGMP) and the protein kinase G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic glutamate release.">
            <entity id="DS.d209.s0.e0" origId="24316" charOffset="11-47" type="compound" text="guanosine 3',5'-cyclic monophosphate"/>
            <entity id="DS.d209.s0.e1" origId="24316" charOffset="49-53" type="compound" text="cGMP"/>
            <entity id="DS.d209.s0.e2" origId="P00513,P25848" charOffset="63-77" type="protein" text="protein kinase"/>
            <entity id="DS.d209.s0.e3" origId="24316" charOffset="248-252" type="compound" text="cGMP"/>
            <entity id="DS.d209.s0.e4" origId="611,23327,33032" charOffset="332-341" type="compound" text="glutamate"/>
            <pair e1="DS.d209.s0.e4" e2="DS.d209.s0.e2" id="DS.d209.s0.i0" interaction="False"/>
            <pair e1="DS.d209.s0.e0" e2="DS.d209.s0.e2" id="DS.d209.s0.i1" interaction="False"/>
            <pair e1="DS.d209.s0.e1" e2="DS.d209.s0.e2" id="DS.d209.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d209.s1" origId="18472342-222" text="Application of an inhibitor of soluble guanylate cyclase prevented LTD induced by low-frequency stimulation (LFS), and impaired LFS-STD elicited in the presence of Zaprinast.">
            <entity id="DS.d209.s1.e0" origId="O94303,P33734,Q9P4P9,Q9SZ30" charOffset="49-56" type="protein" text="cyclase"/>
            <entity id="DS.d209.s1.e3" origId="P50234,P52842,Q06520" charOffset="132-135" type="protein" text="STD"/>
            <entity id="DS.d209.s1.e4" origId="5722" charOffset="164-173" type="compound" text="Zaprinast"/>
            <pair e1="DS.d209.s1.e4" e2="DS.d209.s1.e0" id="DS.d209.s1.i0" interaction="False"/>
            <pair e1="DS.d209.s1.e4" e2="DS.d209.s1.e3" id="DS.d209.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d210" origId="18473163">
        <sentence id="DS.d210.s0" origId="18473163-133" text="beta-Hexosaminidases (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound N-acetylglucosamine and N-acetylgalactosamine residues from a number of glycoconjugates.">
            <entity id="DS.d210.s0.e0" origId="O60502,P44955,P49010,P58067,P75949,P96155,P96157,Q04786,Q0TR53,Q2KXM7,Q2P4L0,Q2Y863,Q31G32,Q31ZG4,Q32EW7,Q3BVU6,Q3J953,Q3SKU2,Q3Z310,Q4QLU8,Q4USG7,Q57QE6,Q5FA94,Q5H1Q0,Q5P081,Q5PGT0,Q5QUZ5,Q606N2,Q65VK7,Q669N5,Q6D674,Q6LJ30,Q7N397,Q7NWB7,Q7UCW4,Q7VNI8,Q7VWV8,Q7W9J5,Q7WH65,Q82SJ8,Q87BR5,Q89ZI2,Q8EEW2,Q8FIN2,Q8PB42,Q8PMU1,Q8VIJ5,Q8XL08,Q8Z7I6,Q8ZFS3,Q8ZQ06,Q9CPH0,Q9EQQ9,Q9HZK0,Q9JVT3,Q9K0Q4,Q9KU37,Q9PAZ0" charOffset="0-20" type="protein" text="beta-Hexosaminidases"/>
            <entity id="DS.d210.s0.e1" origId="24139" charOffset="104-123" type="compound" text="N-acetylglucosamine"/>
            <entity id="DS.d210.s0.e2" origId="899,35717,84265,439174" charOffset="128-149" type="compound" text="N-acetylgalactosamine"/>
            <pair e1="DS.d210.s0.e2" e2="DS.d210.s0.e0" id="DS.d210.s0.i0" interaction="True"/>
            <pair e1="DS.d210.s0.e1" e2="DS.d210.s0.e0" id="DS.d210.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d211" origId="18473182">
        <sentence id="DS.d211.s0" origId="18473182-143" text="Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).">
            <entity id="DS.d211.s0.e0" origId="O18963,P05181,P08682,P33266,P51581,P79383,Q6GUQ4" charOffset="18-24" type="protein" text="CYP2E1"/>
            <entity id="DS.d211.s0.e1" origId="16078949" charOffset="79-134" type="compound" text="5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside"/>
            <pair e1="DS.d211.s0.e1" e2="DS.d211.s0.e0" id="DS.d211.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d212" origId="18474445">
        <sentence id="DS.d212.s0" origId="18474445-915" text="Distribution of the androgen receptor in the diencephalon and the pituitary gland in goats: Co-localisation with corticotrophin releasing hormone, arginine vasopressin and corticotrophs.">
            <entity id="DS.d212.s0.e0" origId="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90" charOffset="20-37" type="protein" text="androgen receptor"/>
            <entity id="DS.d212.s0.e1" origId="8230,644077,44285245" charOffset="147-167" type="compound" text="arginine vasopressin"/>
            <pair e1="DS.d212.s0.e1" e2="DS.d212.s0.e0" id="DS.d212.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d213" origId="18475288">
        <sentence id="DS.d213.s0" origId="18475288-1020" text="Bicalutamide induced apoptosis in androgen-dependent PWR-1E cells via a caspase-dependent and calpain-independent mechanism.">
            <entity id="DS.d213.s0.e0" origId="2375" charOffset="0-12" type="compound" text="Bicalutamide"/>
            <entity id="DS.d213.s0.e1" origId="P27730" charOffset="94-101" type="protein" text="calpain"/>
            <pair e1="DS.d213.s0.e0" e2="DS.d213.s0.e1" id="DS.d213.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d213.s1" origId="18475288-1021" text="In androgen-independent PC-3 cells, bicalutamide also induced apoptosis by mechanisms that were partially inhibited by pan-caspase inhibition but were partially calpain dependent.">
            <entity id="DS.d213.s1.e0" origId="2375" charOffset="36-48" type="compound" text="bicalutamide"/>
            <entity id="DS.d213.s1.e1" origId="P27730" charOffset="161-168" type="protein" text="calpain"/>
            <pair e1="DS.d213.s1.e0" e2="DS.d213.s1.e1" id="DS.d213.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d214" origId="18477686">
        <sentence id="DS.d214.s0" origId="18477686-347" text="A differential regulation of the two GABA synthesizing enzymes (GAD65 and GAD67) parallels GABAergic neuron differentiation.">
            <entity id="DS.d214.s0.e0" origId="119" charOffset="37-41" type="compound" text="GABA"/>
            <entity id="DS.d214.s0.e1" origId="P48321,Q05329,Q4PRC2" charOffset="64-69" type="protein" text="GAD65"/>
            <entity id="DS.d214.s0.e2" origId="P14748,P48319,Q5IS68,Q99259" charOffset="74-79" type="protein" text="GAD67"/>
            <pair e1="DS.d214.s0.e0" e2="DS.d214.s0.e2" id="DS.d214.s0.i0" interaction="True"/>
            <pair e1="DS.d214.s0.e0" e2="DS.d214.s0.e1" id="DS.d214.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d215" origId="18479249">
        <sentence id="DS.d215.s0" origId="18479249-96" text="The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and TGF-beta1, protein expression of iNOS and TXS, and production of TXA2 in liver perfusates were significantly decreased in UDCA-treated BDL rats.">
            <entity id="DS.d215.s0.e0" origId="Q08398" charOffset="129-135" type="protein" text="alpha1"/>
            <entity id="DS.d215.s0.e1" origId="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6" charOffset="140-149" type="protein" text="TGF-beta1"/>
            <entity id="DS.d215.s0.e2" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="173-177" type="protein" text="iNOS"/>
            <entity id="DS.d215.s0.e3" origId="P24557,P36423,P47787,P49430,Q2KIG5" charOffset="182-185" type="protein" text="TXS"/>
            <entity id="DS.d215.s0.e4" origId="5280497" charOffset="205-209" type="compound" text="TXA2"/>
            <pair e1="DS.d215.s0.e4" e2="DS.d215.s0.e2" id="DS.d215.s0.i0" interaction="False"/>
            <pair e1="DS.d215.s0.e4" e2="DS.d215.s0.e0" id="DS.d215.s0.i1" interaction="False"/>
            <pair e1="DS.d215.s0.e4" e2="DS.d215.s0.e1" id="DS.d215.s0.i2" interaction="False"/>
            <pair e1="DS.d215.s0.e4" e2="DS.d215.s0.e3" id="DS.d215.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d215.s1" origId="18479249-97" text="The increased levels of hepatic GSH and SOD activity and decreased levels of TBARS and nitrite were also observed in UDCA-treated BDL rats.">
            <entity id="DS.d215.s1.e0" origId="124886" charOffset="32-35" type="compound" text="GSH"/>
            <entity id="DS.d215.s1.e1" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="40-43" type="protein" text="SOD"/>
            <pair e1="DS.d215.s1.e0" e2="DS.d215.s1.e1" id="DS.d215.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d216" origId="18479251">
        <sentence id="DS.d216.s0" origId="18479251-501" text="The production of rhG-CSF was induced by switching from growth on glycerol to growth on methanol.">
            <entity id="DS.d216.s0.e0" origId="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481" charOffset="22-25" type="protein" text="CSF"/>
            <entity id="DS.d216.s0.e1" origId="753" charOffset="66-74" type="compound" text="glycerol"/>
            <entity id="DS.d216.s0.e2" origId="887,19314" charOffset="88-96" type="compound" text="methanol"/>
            <pair e1="DS.d216.s0.e1" e2="DS.d216.s0.e0" id="DS.d216.s0.i0" interaction="False"/>
            <pair e1="DS.d216.s0.e2" e2="DS.d216.s0.e0" id="DS.d216.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d216.s1" origId="18479251-502" text="In the induction phase, the methanol feed rate had a significant effect on the specific expression rate of rhG-CSF.">
            <entity id="DS.d216.s1.e0" origId="887,19314" charOffset="28-36" type="compound" text="methanol"/>
            <entity id="DS.d216.s1.e1" origId="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481" charOffset="111-114" type="protein" text="CSF"/>
            <pair e1="DS.d216.s1.e0" e2="DS.d216.s1.e1" id="DS.d216.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d216.s2" origId="18479251-503" text="Under this condition, a maximum concentration of 300 mg/l of rhG-CSF and the expression yield of 0.6 mg of rhG-CSF/g of methanol were attained.">
            <entity id="DS.d216.s2.e0" origId="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481" charOffset="65-68" type="protein" text="CSF"/>
            <entity id="DS.d216.s2.e1" origId="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481" charOffset="111-114" type="protein" text="CSF"/>
            <entity id="DS.d216.s2.e2" origId="887,19314" charOffset="120-128" type="compound" text="methanol"/>
            <pair e1="DS.d216.s2.e2" e2="DS.d216.s2.e0" id="DS.d216.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d216.s3" origId="18479251-504" text="Among seven additives tested, Tween 20, Tween 80 and betaine exhibited the best results in respect of preventing the formation of rhG-CSF protein aggregates.">
            <entity id="DS.d216.s3.e0" origId="443314" charOffset="30-38" type="compound" text="Tween 20"/>
            <entity id="DS.d216.s3.e1" origId="248" charOffset="53-60" type="compound" text="betaine"/>
            <entity id="DS.d216.s3.e2" origId="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481" charOffset="134-137" type="protein" text="CSF"/>
            <pair e1="DS.d216.s3.e0" e2="DS.d216.s3.e2" id="DS.d216.s3.i0" interaction="True"/>
            <pair e1="DS.d216.s3.e1" e2="DS.d216.s3.e2" id="DS.d216.s3.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d217" origId="18479686">
        <sentence id="DS.d217.s0" origId="18479686-323" text="Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice.">
            <entity id="DS.d217.s0.e0" origId="150311" charOffset="0-9" type="compound" text="Ezetimibe"/>
            <entity id="DS.d217.s0.e1" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="73-77" type="protein" text="eNOS"/>
            <pair e1="DS.d217.s0.e0" e2="DS.d217.s0.e1" id="DS.d217.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d217.s1" origId="18479686-324" text="Hypercholesterolemia is associated with decreased vascular nitric oxide bioavailability and deletion of endothelial nitric oxide synthase (eNOS) markedly accelerates atherosclerosis development in apolipoprotein E knockout (apoE ko) mice.">
            <entity id="DS.d217.s1.e0" origId="145068" charOffset="59-71" type="compound" text="nitric oxide"/>
            <entity id="DS.d217.s1.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="116-137" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d217.s1.e2" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="139-143" type="protein" text="eNOS"/>
            <pair e1="DS.d217.s1.e0" e2="DS.d217.s1.e2" id="DS.d217.s1.i0" interaction="False"/>
            <pair e1="DS.d217.s1.e0" e2="DS.d217.s1.e1" id="DS.d217.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d218" origId="18479896">
        <sentence id="DS.d218.s0" origId="18479896-454" text="Docosahexaenoic acid induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and p38 MAPK pathways.">
            <entity id="DS.d218.s0.e0" origId="445580" charOffset="0-20" type="compound" text="Docosahexaenoic acid"/>
            <entity id="DS.d218.s0.e1" origId="P42347,P42348,P54673,P54674,P54675,P54676" charOffset="87-97" type="protein" text="PI3 kinase"/>
            <entity id="DS.d218.s0.e2" origId="O62618" charOffset="102-110" type="protein" text="p38 MAPK"/>
            <pair e1="DS.d218.s0.e0" e2="DS.d218.s0.e1" id="DS.d218.s0.i0" interaction="True"/>
            <pair e1="DS.d218.s0.e0" e2="DS.d218.s0.e2" id="DS.d218.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d218.s1" origId="18479896-455" text="The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the p38 MAPK protein, were used to investigate cross-talk between signalling pathways.">
            <entity id="DS.d218.s1.e0" origId="312145" charOffset="23-33" type="compound" text="wortmannin"/>
            <entity id="DS.d218.s1.e1" origId="16738692" charOffset="35-51" type="compound" text="phosphoinositide"/>
            <entity id="DS.d218.s1.e2" origId="4713" charOffset="73-81" type="compound" text="PD 98059"/>
            <entity id="DS.d218.s1.e3" origId="176155" charOffset="102-111" type="compound" text="SB 203580"/>
            <entity id="DS.d218.s1.e4" origId="O62618" charOffset="192-200" type="protein" text="p38 MAPK"/>
            <pair e1="DS.d218.s1.e3" e2="DS.d218.s1.e4" id="DS.d218.s1.i0" interaction="False"/>
            <pair e1="DS.d218.s1.e1" e2="DS.d218.s1.e4" id="DS.d218.s1.i1" interaction="False"/>
            <pair e1="DS.d218.s1.e0" e2="DS.d218.s1.e4" id="DS.d218.s1.i2" interaction="False"/>
            <pair e1="DS.d218.s1.e2" e2="DS.d218.s1.e4" id="DS.d218.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d219" origId="18479897">
        <sentence id="DS.d219.s0" origId="18479897-371" text="Feeding long-chain n-3 polyunsaturated fatty acids during gestation increases intestinal glucose absorption potentially via the acute activation of AMPK.">
            <entity id="DS.d219.s0.e0" origId="56842239" charOffset="23-50" type="compound" text="polyunsaturated fatty acids"/>
            <entity id="DS.d219.s0.e1" origId="206,5793,64689,79025" charOffset="89-96" type="compound" text="glucose"/>
            <entity id="DS.d219.s0.e2" origId="P54646,Q09136,Q9Y478" charOffset="148-152" type="protein" text="AMPK"/>
            <pair e1="DS.d219.s0.e1" e2="DS.d219.s0.e2" id="DS.d219.s0.i0" interaction="False"/>
            <pair e1="DS.d219.s0.e0" e2="DS.d219.s0.e2" id="DS.d219.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d219.s1" origId="18479897-373" text="Furthermore, adding docosahexaenoic acid (DHA) or an AMP-activated protein kinase (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.">
            <entity id="DS.d219.s1.e0" origId="445580" charOffset="20-40" type="compound" text="docosahexaenoic acid"/>
            <entity id="DS.d219.s1.e1" origId="O24006" charOffset="53-56" type="protein" text="AMP"/>
            <entity id="DS.d219.s1.e2" origId="P00513,P25848" charOffset="67-81" type="protein" text="protein kinase"/>
            <entity id="DS.d219.s1.e3" origId="P54646,Q09136,Q9Y478" charOffset="83-87" type="protein" text="AMPK"/>
            <pair e1="DS.d219.s1.e0" e2="DS.d219.s1.e3" id="DS.d219.s1.i0" interaction="False"/>
            <pair e1="DS.d219.s1.e0" e2="DS.d219.s1.e2" id="DS.d219.s1.i1" interaction="False"/>
            <pair e1="DS.d219.s1.e0" e2="DS.d219.s1.e1" id="DS.d219.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d220" origId="18479950">
        <sentence id="DS.d220.s0" origId="18479950-485" text="Prior to vitamin E supplementation, exercise induced a significant decrease in PON1 activity, EMF, vitamin E concentration and a significant increase in MDA concentration at t+1d.">
            <entity id="DS.d220.s0.e0" origId="2116,14985,1548900,1742129" charOffset="9-18" type="compound" text="vitamin E"/>
            <entity id="DS.d220.s0.e1" origId="P27169,P27170" charOffset="79-83" type="protein" text="PON1"/>
            <entity id="DS.d220.s0.e2" origId="23644574" charOffset="94-97" type="compound" text="EMF"/>
            <entity id="DS.d220.s0.e3" origId="2116,14985,1548900,1742129" charOffset="99-108" type="compound" text="vitamin E"/>
            <pair e1="DS.d220.s0.e0" e2="DS.d220.s0.e1" id="DS.d220.s0.i0" interaction="False"/>
            <pair e1="DS.d220.s0.e2" e2="DS.d220.s0.e1" id="DS.d220.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d220.s1" origId="18479950-486" text="After a 10 week vitamin E supplementation period, these exercise-induced changes in PON1 activity, EMF and MDA concentration were still significant in the control group, but not in the supplemented group.">
            <entity id="DS.d220.s1.e0" origId="2116,14985,1548900,1742129" charOffset="16-25" type="compound" text="vitamin E"/>
            <entity id="DS.d220.s1.e1" origId="P27169,P27170" charOffset="84-88" type="protein" text="PON1"/>
            <entity id="DS.d220.s1.e2" origId="23644574" charOffset="99-102" type="compound" text="EMF"/>
            <pair e1="DS.d220.s1.e2" e2="DS.d220.s1.e1" id="DS.d220.s1.i0" interaction="False"/>
            <pair e1="DS.d220.s1.e0" e2="DS.d220.s1.e1" id="DS.d220.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d221" origId="18481266">
        <sentence id="DS.d221.s0" origId="18481266-77" text="In adulthood, testosterone secreted by the testes is converted into estrogens by the preoptic aromatase.">
            <entity id="DS.d221.s0.e0" origId="6013" charOffset="14-26" type="compound" text="testosterone"/>
            <entity id="DS.d221.s0.e1" origId="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28" charOffset="94-103" type="protein" text="aromatase"/>
            <pair e1="DS.d221.s0.e0" e2="DS.d221.s0.e1" id="DS.d221.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d222" origId="18481276">
        <sentence id="DS.d222.s0" origId="18481276-83" text="The model was used to investigate how on-treatment CRP related to baseline CRP and estimated treatment effects with rosuvastatin.">
            <entity id="DS.d222.s0.e0" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="51-54" type="protein" text="CRP"/>
            <entity id="DS.d222.s0.e1" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="75-78" type="protein" text="CRP"/>
            <entity id="DS.d222.s0.e2" origId="446157" charOffset="116-128" type="compound" text="rosuvastatin"/>
            <pair e1="DS.d222.s0.e2" e2="DS.d222.s0.e0" id="DS.d222.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d223" origId="18481313">
        <sentence id="DS.d223.s0" origId="18481313-107" text="Hepatocyte growth factor, keratinocyte growth factor or insulin prevented the effect of ethanol on cell permeability, but not on PGE (2) release.">
            <entity id="DS.d223.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="56-63" type="protein" text="insulin"/>
            <entity id="DS.d223.s0.e1" origId="702" charOffset="88-95" type="compound" text="ethanol"/>
            <entity id="DS.d223.s0.e2" origId="Q29458" charOffset="129-132" type="protein" text="PGE"/>
            <pair e1="DS.d223.s0.e1" e2="DS.d223.s0.e0" id="DS.d223.s0.i0" interaction="True"/>
            <pair e1="DS.d223.s0.e1" e2="DS.d223.s0.e2" id="DS.d223.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d223.s1" origId="18481313-108" text="Cyclooxygenase-2 stimulated PGE (2) release mediated the reversible effect of ethanol on tight junctions and, meanwhile, contributed to cell survival.">
            <entity id="DS.d223.s1.e0" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="0-16" type="protein" text="Cyclooxygenase-2"/>
            <entity id="DS.d223.s1.e1" origId="Q29458" charOffset="28-31" type="protein" text="PGE"/>
            <entity id="DS.d223.s1.e2" origId="702" charOffset="78-85" type="compound" text="ethanol"/>
            <pair e1="DS.d223.s1.e2" e2="DS.d223.s1.e0" id="DS.d223.s1.i0" interaction="True"/>
            <pair e1="DS.d223.s1.e2" e2="DS.d223.s1.e1" id="DS.d223.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d224" origId="18482727">
        <sentence id="DS.d224.s0" origId="18482727-966" text="Interestingly, atorvastatin inhibited the expression of ICAM and MCP-1, followed by the suppression of macrophage recruitment into the aortic wall at 1 week after operation.">
            <entity id="DS.d224.s0.e0" origId="60823" charOffset="15-27" type="compound" text="atorvastatin"/>
            <entity id="DS.d224.s0.e1" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="65-70" type="protein" text="MCP-1"/>
            <pair e1="DS.d224.s0.e0" e2="DS.d224.s0.e1" id="DS.d224.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d224.s1" origId="18482727-967" text="In addition, synthesis of collagen and elastin in the vascular wall were significantly increased by atorvastatin.">
            <entity id="DS.d224.s1.e0" origId="P11547" charOffset="39-46" type="protein" text="elastin"/>
            <entity id="DS.d224.s1.e1" origId="60823" charOffset="100-112" type="compound" text="atorvastatin"/>
            <pair e1="DS.d224.s1.e1" e2="DS.d224.s1.e0" id="DS.d224.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d225" origId="18484100">
        <sentence id="DS.d225.s0" origId="18484100-516" text="Organic cations (OCs) are primarily excreted via vectorial transport by various renal organic cation transporters (OCTs).">
            <entity id="DS.d225.s0.e0" origId="72886" charOffset="17-20" type="compound" text="OCs"/>
            <entity id="DS.d225.s0.e1" origId="O75051" charOffset="115-119" type="protein" text="OCTs"/>
            <pair e1="DS.d225.s0.e0" e2="DS.d225.s0.e1" id="DS.d225.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d225.s1" origId="18484100-517" text="In a rat ARF model, induction of ARF by uranyl nitrate (UN) treatment significantly decreased the levels of Oct2 (slc22a2) mRNA and protein in the kidney medulla.">
            <entity id="DS.d225.s1.e0" origId="24933" charOffset="40-54" type="compound" text="uranyl nitrate"/>
            <entity id="DS.d225.s1.e1" origId="Q00196" charOffset="108-112" type="protein" text="Oct2"/>
            <pair e1="DS.d225.s1.e0" e2="DS.d225.s1.e1" id="DS.d225.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d226" origId="18484622">
        <sentence id="DS.d226.s0" origId="18484622-1118" text="In all final products, dimethylsulfoxide used to prepare the insulin/lipid mixture was below 20 ppm.">
            <entity id="DS.d226.s0.e0" origId="679" charOffset="23-40" type="compound" text="dimethylsulfoxide"/>
            <entity id="DS.d226.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="61-68" type="protein" text="insulin"/>
            <pair e1="DS.d226.s0.e0" e2="DS.d226.s0.e1" id="DS.d226.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d227" origId="18485500">
        <sentence id="DS.d227.s0" origId="18485500-951" text="Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene.">
            <entity id="DS.d227.s0.e0" origId="2806,60606" charOffset="24-35" type="compound" text="clopidogrel"/>
            <entity id="DS.d227.s0.e1" origId="Q95KC3,Q9CPV9,Q9EPX4,Q9H244" charOffset="91-96" type="protein" text="P2Y12"/>
            <entity id="DS.d227.s0.e2" origId="P02783" charOffset="97-100" type="protein" text="ADP"/>
            <pair e1="DS.d227.s0.e0" e2="DS.d227.s0.e2" id="DS.d227.s0.i0" interaction="True"/>
            <pair e1="DS.d227.s0.e0" e2="DS.d227.s0.e1" id="DS.d227.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d228" origId="18486150">
        <sentence id="DS.d228.s0" origId="18486150-336" text="Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells.">
            <entity id="DS.d228.s0.e0" origId="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938" charOffset="0-13" type="compound" text="Cyclosporin A"/>
            <entity id="DS.d228.s0.e1" origId="P13678,Q25378" charOffset="41-57" type="protein" text="protein kinase C"/>
            <pair e1="DS.d228.s0.e0" e2="DS.d228.s0.e1" id="DS.d228.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d228.s1" origId="18486150-337" text="We have proposed that cyclosporin A (CsA), despite being a calcineurin inhibitor, will activate PKC in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.">
            <entity id="DS.d228.s1.e0" origId="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938" charOffset="22-35" type="compound" text="cyclosporin A"/>
            <entity id="DS.d228.s1.e1" origId="O88480,Q9Y6J0" charOffset="59-80" type="protein" text="calcineurin inhibitor"/>
            <entity id="DS.d228.s1.e2" origId="P05130,P13677,P13678,P34722" charOffset="96-99" type="protein" text="PKC"/>
            <pair e1="DS.d228.s1.e0" e2="DS.d228.s1.e1" id="DS.d228.s1.i0" interaction="True"/>
            <pair e1="DS.d228.s1.e0" e2="DS.d228.s1.e2" id="DS.d228.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d229" origId="18486994">
        <sentence id="DS.d229.s0" origId="18486994-189" text="Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse transcriptase catalytic activity with cytotoxicity lower than AZT and SI higher than DDC and DDI.">
            <entity id="DS.d229.s0.e0" origId="O55528,O89344,P03523,P06447,P06829,P11205,P11213,P12576,P12577,P13179,P13615,P16289,P16379,P20894,P24658,P26676,P28887,P30929,P31332,P31352,P35262,P35341,P35946,P35975,P41357,Q03396,Q05318,Q06996,Q5XX01,Q66802,Q6V1Q2,Q88434,Q8JPX5,Q91DD4,Q997F0,Q9DUD8" charOffset="95-108" type="protein" text="transcriptase"/>
            <entity id="DS.d229.s0.e1" origId="35370" charOffset="157-160" type="compound" text="AZT"/>
            <pair e1="DS.d229.s0.e1" e2="DS.d229.s0.e0" id="DS.d229.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d230" origId="18487053">
        <sentence id="DS.d230.s0" origId="18487053-332" text="Resveratrol (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB.">
            <entity id="DS.d230.s0.e0" origId="445154" charOffset="0-11" type="compound" text="Resveratrol"/>
            <entity id="DS.d230.s0.e1" origId="O62664,O97554,P05979,P22437,P23219,Q63921" charOffset="92-108" type="protein" text="cyclooxygenase-1"/>
            <entity id="DS.d230.s0.e2" origId="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8" charOffset="110-115" type="protein" text="COX-1"/>
            <entity id="DS.d230.s0.e3" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="118-134" type="protein" text="cyclooxygenase-2"/>
            <entity id="DS.d230.s0.e4" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="136-141" type="protein" text="COX-2"/>
            <pair e1="DS.d230.s0.e0" e2="DS.d230.s0.e3" id="DS.d230.s0.i0" interaction="True"/>
            <pair e1="DS.d230.s0.e0" e2="DS.d230.s0.e1" id="DS.d230.s0.i1" interaction="True"/>
            <pair e1="DS.d230.s0.e0" e2="DS.d230.s0.e2" id="DS.d230.s0.i2" interaction="True"/>
            <pair e1="DS.d230.s0.e0" e2="DS.d230.s0.e4" id="DS.d230.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d231" origId="18489490">
        <sentence id="DS.d231.s0" origId="18489490-99" text="After NMDA stimulation of SV-FHAS and neoplastic astrocytes, real-time polymerase chain reaction showed an increase of the CPE, containing EGR-1 splice variant only in astrocytoma cells.">
            <entity id="DS.d231.s0.e0" origId="22880" charOffset="6-10" type="compound" text="NMDA"/>
            <entity id="DS.d231.s0.e1" origId="O73691,O73692,O73693,O73694,P08046,P08154,P18146,P26632,Q29W20" charOffset="139-144" type="protein" text="EGR-1"/>
            <pair e1="DS.d231.s0.e0" e2="DS.d231.s0.e1" id="DS.d231.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d232" origId="18489909">
        <sentence id="DS.d232.s0" origId="18489909-317" text="Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of quercetin and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).">
            <entity id="DS.d232.s0.e0" origId="5280343" charOffset="131-140" type="compound" text="quercetin"/>
            <entity id="DS.d232.s0.e1" origId="P19320,P29533,P29534,Q28260" charOffset="245-251" type="protein" text="VCAM-1"/>
            <entity id="DS.d232.s0.e2" origId="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132" charOffset="289-295" type="protein" text="ICAM-1"/>
            <entity id="DS.d232.s0.e3" origId="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="301-335" type="protein" text="monocyte chemoattractant protein-1"/>
            <entity id="DS.d232.s0.e4" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="337-342" type="protein" text="MCP-1"/>
            <entity id="DS.d232.s0.e5" origId="Q8JFG3" charOffset="412-433" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d232.s0.e6" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="441-449" type="protein" text="TNFalpha"/>
            <pair e1="DS.d232.s0.e0" e2="DS.d232.s0.e6" id="DS.d232.s0.i0" interaction="False"/>
            <pair e1="DS.d232.s0.e0" e2="DS.d232.s0.e3" id="DS.d232.s0.i1" interaction="False"/>
            <pair e1="DS.d232.s0.e0" e2="DS.d232.s0.e5" id="DS.d232.s0.i2" interaction="False"/>
            <pair e1="DS.d232.s0.e0" e2="DS.d232.s0.e2" id="DS.d232.s0.i3" interaction="False"/>
            <pair e1="DS.d232.s0.e0" e2="DS.d232.s0.e4" id="DS.d232.s0.i4" interaction="False"/>
            <pair e1="DS.d232.s0.e0" e2="DS.d232.s0.e1" id="DS.d232.s0.i5" interaction="False"/>
        </sentence>
        <sentence id="DS.d232.s1" origId="18489909-318" text="Quercetin was able to reduce TNFalpha-induced upregulation of VCAM-1, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.">
            <entity id="DS.d232.s1.e0" origId="5280343" charOffset="0-9" type="compound" text="Quercetin"/>
            <entity id="DS.d232.s1.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="29-37" type="protein" text="TNFalpha"/>
            <entity id="DS.d232.s1.e2" origId="P19320,P29533,P29534,Q28260" charOffset="62-68" type="protein" text="VCAM-1"/>
            <entity id="DS.d232.s1.e3" origId="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132" charOffset="70-76" type="protein" text="ICAM-1"/>
            <entity id="DS.d232.s1.e4" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="81-86" type="protein" text="MCP-1"/>
            <pair e1="DS.d232.s1.e0" e2="DS.d232.s1.e1" id="DS.d232.s1.i0" interaction="True"/>
            <pair e1="DS.d232.s1.e0" e2="DS.d232.s1.e3" id="DS.d232.s1.i1" interaction="True"/>
            <pair e1="DS.d232.s1.e0" e2="DS.d232.s1.e4" id="DS.d232.s1.i2" interaction="True"/>
            <pair e1="DS.d232.s1.e0" e2="DS.d232.s1.e2" id="DS.d232.s1.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d232.s2" origId="18489909-319" text="However the quercetin metabolites, quercetin 3'-sulfate, quercetin 3-glucuronide and 3'-methylquercetin 3-glucuronide, had no effect on TNFalpha-induced up regulation of adhesion molecule or chemokine expression, at either concentration tested.">
            <entity id="DS.d232.s2.e0" origId="5280362" charOffset="35-55" type="compound" text="quercetin 3'-sulfate"/>
            <entity id="DS.d232.s2.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="136-144" type="protein" text="TNFalpha"/>
            <pair e1="DS.d232.s2.e0" e2="DS.d232.s2.e1" id="DS.d232.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d233" origId="18490188">
        <sentence id="DS.d233.s0" origId="18490188-482" text="In its active form, thiamin pyrophosphate (TPP), it is a co-enzyme for several enzymes, including transketolase.">
            <entity id="DS.d233.s0.e0" origId="1132" charOffset="20-41" type="compound" text="thiamin pyrophosphate"/>
            <entity id="DS.d233.s0.e1" origId="O06811,O67642,O83571,P29277,P29401,P34736,P40142,P43757,P45694,P46708,P47312,P50137,P51010,P56900,P57195,P58333,P59956,P66962,P66963,P75611,P84540,P99161,Q12630,Q52723,Q5HG77,Q5HPJ9,Q5R1W6,Q5R4C1,Q60HC7,Q6B855,Q6G9L6,Q6GH64,Q89AY2,Q8CPC7,Q8KA26,Q9KAD7" charOffset="98-111" type="protein" text="transketolase"/>
            <pair e1="DS.d233.s0.e0" e2="DS.d233.s0.e1" id="DS.d233.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d234" origId="18492032">
        <sentence id="DS.d234.s0" origId="18492032-354" text="Coexpression pattern with VDR provides an indication that calcitriol could be the modulator of these adaptive responses to involution and dietary P restriction.">
            <entity id="DS.d234.s0.e0" origId="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5" charOffset="26-29" type="protein" text="VDR"/>
            <entity id="DS.d234.s0.e1" origId="5280453" charOffset="58-68" type="compound" text="calcitriol"/>
            <pair e1="DS.d234.s0.e1" e2="DS.d234.s0.e0" id="DS.d234.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d235" origId="18492301">
        <sentence id="DS.d235.s0" origId="18492301-527" text="Dietary chia seed (Salvia hispanica L.) rich in alpha-linolenic acid improves adiposity and normalises hypertriacylglycerolaemia and insulin resistance in dyslipaemic rats.">
            <entity id="DS.d235.s0.e0" origId="5280934" charOffset="48-68" type="compound" text="alpha-linolenic acid"/>
            <entity id="DS.d235.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="133-140" type="protein" text="insulin"/>
            <pair e1="DS.d235.s0.e0" e2="DS.d235.s0.e1" id="DS.d235.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d235.s1" origId="18492301-528" text="The present study investigates the benefits of the dietary intake of chia seed (Salvia hispanica L.) rich in alpha-linolenic acid and fibre upon dyslipidaemia and insulin resistance (IR), induced by intake of a sucrose-rich (62.5 %) diet (SRD).">
            <entity id="DS.d235.s1.e0" origId="5280934" charOffset="109-129" type="compound" text="alpha-linolenic acid"/>
            <entity id="DS.d235.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="163-170" type="protein" text="insulin"/>
            <entity id="DS.d235.s1.e2" origId="5988" charOffset="211-218" type="compound" text="sucrose"/>
            <pair e1="DS.d235.s1.e0" e2="DS.d235.s1.e1" id="DS.d235.s1.i0" interaction="False"/>
            <pair e1="DS.d235.s1.e2" e2="DS.d235.s1.e1" id="DS.d235.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d236" origId="18492302">
        <sentence id="DS.d236.s0" origId="18492302-529" text="Pigs fed the high-lysine diet moreover had an increased concentration of trimethyllysine (TML), a reduced mRNA abundance of TML dioxygenase and reduced concentrations of gamma-butyrobetaine (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.">
            <entity id="DS.d236.s0.e0" origId="866,5962" charOffset="18-24" type="compound" text="lysine"/>
            <entity id="DS.d236.s0.e1" origId="440121" charOffset="73-88" type="compound" text="trimethyllysine"/>
            <entity id="DS.d236.s0.e2" origId="Q0VC74,Q5F4B3,Q91ZE0,Q91ZW6,Q96UB1,Q9NVH6" charOffset="124-139" type="protein" text="TML dioxygenase"/>
            <entity id="DS.d236.s0.e3" origId="134" charOffset="170-189" type="compound" text="gamma-butyrobetaine"/>
            <pair e1="DS.d236.s0.e0" e2="DS.d236.s0.e2" id="DS.d236.s0.i0" interaction="False"/>
            <pair e1="DS.d236.s0.e1" e2="DS.d236.s0.e2" id="DS.d236.s0.i1" interaction="False"/>
            <pair e1="DS.d236.s0.e3" e2="DS.d236.s0.e2" id="DS.d236.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d237" origId="18494609">
        <sentence id="DS.d237.s0" origId="18494609-496" text="The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.">
            <entity id="DS.d237.s0.e0" origId="5280893" charOffset="32-42" type="compound" text="15S)-HPETE"/>
            <entity id="DS.d237.s0.e1" origId="5280724" charOffset="68-77" type="compound" text="15S)-HETE"/>
            <entity id="DS.d237.s0.e2" origId="P36940,P41047,P48023,P63306,P63307,P63308,Q861W5,Q9BDN1,Q9BEA8" charOffset="117-127" type="protein" text="Fas ligand"/>
            <entity id="DS.d237.s0.e3" origId="P46310,Q13158" charOffset="132-136" type="protein" text="FADD"/>
            <entity id="DS.d237.s0.e4" origId="P25446,Q63199" charOffset="117-120" type="protein" text="Fas"/>
            <entity id="DS.d237.s0.e5" origId="P55957,P70444,Q4JHS0,Q8JGM8,Q9JLT6" charOffset="195-231" type="protein" text="BH3-interacting domain death agonist"/>
            <entity id="DS.d237.s0.e6" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="289-301" type="protein" text="cytochrome c"/>
            <entity id="DS.d237.s0.e7" origId="P09874,P11103,P18493,P26446,P27008,Q7EYV7,Q9R152,Q9ZP54,Q9ZSV1" charOffset="333-339" type="protein" text="PARP-1"/>
            <entity id="DS.d237.s0.e8" origId="P02783" charOffset="346-349" type="protein" text="ADP"/>
            <pair e1="DS.d237.s0.e0" e2="DS.d237.s0.e3" id="DS.d237.s0.i0" interaction="True"/>
            <pair e1="DS.d237.s0.e0" e2="DS.d237.s0.e4" id="DS.d237.s0.i1" interaction="True"/>
            <pair e1="DS.d237.s0.e1" e2="DS.d237.s0.e5" id="DS.d237.s0.i2" interaction="True"/>
            <pair e1="DS.d237.s0.e1" e2="DS.d237.s0.e4" id="DS.d237.s0.i3" interaction="True"/>
            <pair e1="DS.d237.s0.e1" e2="DS.d237.s0.e8" id="DS.d237.s0.i4" interaction="True"/>
            <pair e1="DS.d237.s0.e1" e2="DS.d237.s0.e6" id="DS.d237.s0.i5" interaction="True"/>
            <pair e1="DS.d237.s0.e1" e2="DS.d237.s0.e2" id="DS.d237.s0.i6" interaction="True"/>
            <pair e1="DS.d237.s0.e0" e2="DS.d237.s0.e2" id="DS.d237.s0.i7" interaction="True"/>
            <pair e1="DS.d237.s0.e1" e2="DS.d237.s0.e3" id="DS.d237.s0.i8" interaction="True"/>
            <pair e1="DS.d237.s0.e0" e2="DS.d237.s0.e8" id="DS.d237.s0.i9" interaction="True"/>
            <pair e1="DS.d237.s0.e1" e2="DS.d237.s0.e7" id="DS.d237.s0.i10" interaction="True"/>
            <pair e1="DS.d237.s0.e0" e2="DS.d237.s0.e6" id="DS.d237.s0.i11" interaction="True"/>
            <pair e1="DS.d237.s0.e0" e2="DS.d237.s0.e5" id="DS.d237.s0.i12" interaction="True"/>
            <pair e1="DS.d237.s0.e0" e2="DS.d237.s0.e7" id="DS.d237.s0.i13" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d238" origId="18495128">
        <sentence id="DS.d238.s0" origId="18495128-1028" text="3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE (-/-)/LDL(-/-) double knockout mice.">
            <entity id="DS.d238.s0.e0" origId="1651,23190" charOffset="0-16" type="compound" text="3-Deazaadenosine"/>
            <entity id="DS.d238.s0.e1" origId="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8" charOffset="71-75" type="protein" text="ApoE"/>
            <pair e1="DS.d238.s0.e0" e2="DS.d238.s0.e1" id="DS.d238.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d239" origId="18495129">
        <sentence id="DS.d239.s0" origId="18495129-1029" text="Anthocyanin attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation.">
            <entity id="DS.d239.s0.e0" origId="145858" charOffset="0-11" type="compound" text="Anthocyanin"/>
            <entity id="DS.d239.s0.e1" origId="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34" charOffset="23-27" type="protein" text="CD40"/>
            <entity id="DS.d239.s0.e2" origId="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34" charOffset="93-97" type="protein" text="CD40"/>
            <entity id="DS.d239.s0.e3" origId="O42781,P27638,Q00859" charOffset="106-110" type="protein" text="MAPK"/>
            <pair e1="DS.d239.s0.e0" e2="DS.d239.s0.e3" id="DS.d239.s0.i0" interaction="True"/>
            <pair e1="DS.d239.s0.e0" e2="DS.d239.s0.e1" id="DS.d239.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d239.s1" origId="18495129-1030" text="Treatment of ECs with anthocyanins cyanidin-3-O-beta-glucoside (Cy-3-g) and peonidin-3-O-beta-glucoside (Pn-3-g) prevents CD40-induced endothelial activation by inhibiting production of proinflammatory cytokines and matrix metalloproteinases (MMPs).">
            <entity id="DS.d239.s1.e0" origId="53398755" charOffset="76-103" type="compound" text="peonidin-3-O-beta-glucoside"/>
            <entity id="DS.d239.s1.e1" origId="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34" charOffset="122-126" type="protein" text="CD40"/>
            <pair e1="DS.d239.s1.e0" e2="DS.d239.s1.e1" id="DS.d239.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d239.s2" origId="18495129-1031" text="Collectively, our findings suggested that the inhibition of JNK and p38 activation interrupts CD40 induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of anthocyanin and its athero-protective function.">
            <entity id="DS.d239.s2.e0" origId="P92208,Q966Y3" charOffset="60-63" type="protein" text="JNK"/>
            <entity id="DS.d239.s2.e1" origId="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7" charOffset="68-71" type="protein" text="p38"/>
            <entity id="DS.d239.s2.e2" origId="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34" charOffset="94-98" type="protein" text="CD40"/>
            <entity id="DS.d239.s2.e3" origId="145858" charOffset="243-254" type="compound" text="anthocyanin"/>
            <pair e1="DS.d239.s2.e3" e2="DS.d239.s2.e1" id="DS.d239.s2.i0" interaction="True"/>
            <pair e1="DS.d239.s2.e3" e2="DS.d239.s2.e0" id="DS.d239.s2.i1" interaction="True"/>
            <pair e1="DS.d239.s2.e3" e2="DS.d239.s2.e2" id="DS.d239.s2.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d240" origId="18495357">
        <sentence id="DS.d240.s0" origId="18495357-1187" text="Postsynaptic action of ATP is mediated through metabotropic P2Y and ionotropic P2X receptors abundantly expressed in neural cells.">
            <entity id="DS.d240.s0.e0" origId="5957" charOffset="23-26" type="compound" text="ATP"/>
            <entity id="DS.d240.s0.e1" origId="P13900,P16604" charOffset="79-82" type="protein" text="P2X"/>
            <pair e1="DS.d240.s0.e0" e2="DS.d240.s0.e1" id="DS.d240.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d241" origId="18495456">
        <sentence id="DS.d241.s0" origId="18495456-706" text="However, the MTHFR C677T genotype, alone or together with a diet, influenced betaine (P=.03) and phosphatidylcholine (P=.03).">
            <entity id="DS.d241.s0.e0" origId="P42898,Q5I598,Q60HE5" charOffset="13-18" type="protein" text="MTHFR"/>
            <entity id="DS.d241.s0.e1" origId="248" charOffset="77-84" type="compound" text="betaine"/>
            <pair e1="DS.d241.s0.e1" e2="DS.d241.s0.e0" id="DS.d241.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d241.s1" origId="18495456-707" text="In addition, the MTHFR C677T genotype appears to influence the direction and use of choline moieties in this group of women.">
            <entity id="DS.d241.s1.e0" origId="P42898,Q5I598,Q60HE5" charOffset="17-22" type="protein" text="MTHFR"/>
            <entity id="DS.d241.s1.e1" origId="305" charOffset="84-91" type="compound" text="choline"/>
            <pair e1="DS.d241.s1.e1" e2="DS.d241.s1.e0" id="DS.d241.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d242" origId="18495458">
        <sentence id="DS.d242.s0" origId="18495458-1236" text="Epicatechin-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).">
            <entity id="DS.d242.s0.e0" origId="1203,72276,182232" charOffset="0-11" type="compound" text="Epicatechin"/>
            <entity id="DS.d242.s0.e1" origId="P13678,Q25378" charOffset="260-276" type="protein" text="protein kinase C"/>
            <entity id="DS.d242.s0.e2" origId="P05130,P13677,P13678,P34722" charOffset="278-281" type="protein" text="PKC"/>
            <entity id="DS.d242.s0.e3" origId="P05627,P17325,P18289" charOffset="335-338" type="protein" text="jun"/>
            <entity id="DS.d242.s0.e4" origId="P10829" charOffset="427-436" type="protein" text="PKC-delta"/>
            <pair e1="DS.d242.s0.e0" e2="DS.d242.s0.e3" id="DS.d242.s0.i0" interaction="True"/>
            <pair e1="DS.d242.s0.e0" e2="DS.d242.s0.e2" id="DS.d242.s0.i1" interaction="True"/>
            <pair e1="DS.d242.s0.e0" e2="DS.d242.s0.e4" id="DS.d242.s0.i2" interaction="True"/>
            <pair e1="DS.d242.s0.e0" e2="DS.d242.s0.e1" id="DS.d242.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d243" origId="18495460">
        <sentence id="DS.d243.s0" origId="18495460-1238" text="Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis.">
            <entity id="DS.d243.s0.e0" origId="P19957" charOffset="44-47" type="protein" text="PI3"/>
            <entity id="DS.d243.s0.e1" origId="P22221,Q42736" charOffset="50-53" type="protein" text="PDK"/>
            <entity id="DS.d243.s0.e2" origId="P31750,Q8INB9" charOffset="56-59" type="protein" text="Akt"/>
            <entity id="DS.d243.s0.e3" origId="2116,14985,1548900,1742129" charOffset="83-92" type="compound" text="vitamin E"/>
            <pair e1="DS.d243.s0.e3" e2="DS.d243.s0.e0" id="DS.d243.s0.i0" interaction="True"/>
            <pair e1="DS.d243.s0.e3" e2="DS.d243.s0.e2" id="DS.d243.s0.i1" interaction="True"/>
            <pair e1="DS.d243.s0.e3" e2="DS.d243.s0.e1" id="DS.d243.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d244" origId="18495461">
        <sentence id="DS.d244.s0" origId="18495461-1165" text="Lack of vitamin A significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell &quot;cup&quot; area relative to controls; decreased MUC2 mRNA expression in the jejunum, ileum and colon of VAD rats and increased MUC3 mRNA expression in the ileum and colon of these rats.">
            <entity id="DS.d244.s0.e0" origId="445354" charOffset="8-17" type="compound" text="vitamin A"/>
            <entity id="DS.d244.s0.e1" origId="Q02817" charOffset="146-150" type="protein" text="MUC2"/>
            <entity id="DS.d244.s0.e2" origId="Q02505" charOffset="225-229" type="protein" text="MUC3"/>
            <pair e1="DS.d244.s0.e0" e2="DS.d244.s0.e1" id="DS.d244.s0.i0" interaction="True"/>
            <pair e1="DS.d244.s0.e0" e2="DS.d244.s0.e2" id="DS.d244.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d244.s1" origId="18495461-1166" text="In addition, vitamin A deficiency down-regulated defensin 6 mRNA expression while up-regulating toll-like receptors 2 and 5 mRNA expressions.">
            <entity id="DS.d244.s1.e0" origId="445354" charOffset="13-22" type="compound" text="vitamin A"/>
            <entity id="DS.d244.s1.e1" origId="P17722,P37364,P80154,P80407,P81462,Q10745" charOffset="49-57" type="protein" text="defensin"/>
            <pair e1="DS.d244.s1.e0" e2="DS.d244.s1.e1" id="DS.d244.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d245" origId="18495463">
        <sentence id="DS.d245.s0" origId="18495463-1243" text="Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA.">
            <entity id="DS.d245.s0.e0" origId="969516" charOffset="0-8" type="compound" text="Curcumin"/>
            <entity id="DS.d245.s0.e1" origId="5324476" charOffset="10-27" type="compound" text="demethoxycurcumin"/>
            <entity id="DS.d245.s0.e2" origId="5315472" charOffset="32-52" type="compound" text="bisdemethoxycurcumin"/>
            <entity id="DS.d245.s0.e3" origId="P00749,P04185,P06869,P15120,P16227,P29598,Q05589" charOffset="137-140" type="protein" text="uPA"/>
            <pair e1="DS.d245.s0.e0" e2="DS.d245.s0.e3" id="DS.d245.s0.i0" interaction="True"/>
            <pair e1="DS.d245.s0.e2" e2="DS.d245.s0.e3" id="DS.d245.s0.i1" interaction="True"/>
            <pair e1="DS.d245.s0.e1" e2="DS.d245.s0.e3" id="DS.d245.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d246" origId="18496518">
        <sentence id="DS.d246.s0" origId="18496518-35" text="Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter.">
            <entity id="DS.d246.s0.e0" origId="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3" charOffset="0-23" type="protein" text="Glucocorticoid receptor"/>
            <entity id="DS.d246.s0.e1" origId="3386" charOffset="44-54" type="compound" text="fluoxetine"/>
            <pair e1="DS.d246.s0.e1" e2="DS.d246.s0.e0" id="DS.d246.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d246.s1" origId="18496518-37" text="In contrast, chronic fluoxetine markedly decreased 5-HTT levels in all regions.">
            <entity id="DS.d246.s1.e0" origId="3386" charOffset="21-31" type="compound" text="fluoxetine"/>
            <entity id="DS.d246.s1.e1" origId="P31645" charOffset="53-56" type="protein" text="HTT"/>
            <pair e1="DS.d246.s1.e0" e2="DS.d246.s1.e1" id="DS.d246.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d246.s2" origId="18496518-38" text="This downregulation of 5-HTT by fluoxetine and its enhancement by Org 34850 can explain our recent observation that GR antagonists augment the SSRI-induced increase in extracellular 5-HT.">
            <entity id="DS.d246.s2.e0" origId="P31645" charOffset="25-28" type="protein" text="HTT"/>
            <entity id="DS.d246.s2.e1" origId="3386" charOffset="32-42" type="compound" text="fluoxetine"/>
            <entity id="DS.d246.s2.e2" origId="5202" charOffset="23-27" type="compound" text="5-HT"/>
            <pair e1="DS.d246.s2.e2" e2="DS.d246.s2.e0" id="DS.d246.s2.i0" interaction="False"/>
            <pair e1="DS.d246.s2.e1" e2="DS.d246.s2.e0" id="DS.d246.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d247" origId="18496650">
        <sentence id="DS.d247.s0" origId="18496650-691" text="Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.">
            <entity id="DS.d247.s0.e0" origId="O50258" charOffset="83-103" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d247.s0.e1" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="105-108" type="protein" text="SOD"/>
            <entity id="DS.d247.s0.e2" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="111-119" type="protein" text="catalase"/>
            <entity id="DS.d247.s0.e3" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="121-124" type="protein" text="CAT"/>
            <entity id="DS.d247.s0.e4" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="127-152" type="protein" text="glutathione S-transferase"/>
            <entity id="DS.d247.s0.e5" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="154-157" type="protein" text="GST"/>
            <entity id="DS.d247.s0.e6" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="160-182" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d247.s0.e7" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="190-211" type="protein" text="glutathione reductase"/>
            <entity id="DS.d247.s0.e8" origId="124886" charOffset="221-240" type="compound" text="reduced glutathione"/>
            <entity id="DS.d247.s0.e9" origId="124886" charOffset="242-245" type="compound" text="GSH"/>
            <entity id="DS.d247.s0.e10" origId="5281670" charOffset="315-320" type="compound" text="morin"/>
            <pair e1="DS.d247.s0.e9" e2="DS.d247.s0.e5" id="DS.d247.s0.i0" interaction="False"/>
            <pair e1="DS.d247.s0.e10" e2="DS.d247.s0.e5" id="DS.d247.s0.i1" interaction="True"/>
            <pair e1="DS.d247.s0.e10" e2="DS.d247.s0.e3" id="DS.d247.s0.i2" interaction="True"/>
            <pair e1="DS.d247.s0.e9" e2="DS.d247.s0.e0" id="DS.d247.s0.i3" interaction="False"/>
            <pair e1="DS.d247.s0.e10" e2="DS.d247.s0.e7" id="DS.d247.s0.i4" interaction="True"/>
            <pair e1="DS.d247.s0.e9" e2="DS.d247.s0.e1" id="DS.d247.s0.i5" interaction="False"/>
            <pair e1="DS.d247.s0.e8" e2="DS.d247.s0.e3" id="DS.d247.s0.i6" interaction="False"/>
            <pair e1="DS.d247.s0.e9" e2="DS.d247.s0.e4" id="DS.d247.s0.i7" interaction="False"/>
            <pair e1="DS.d247.s0.e8" e2="DS.d247.s0.e2" id="DS.d247.s0.i8" interaction="False"/>
            <pair e1="DS.d247.s0.e8" e2="DS.d247.s0.e1" id="DS.d247.s0.i9" interaction="False"/>
            <pair e1="DS.d247.s0.e8" e2="DS.d247.s0.e5" id="DS.d247.s0.i10" interaction="False"/>
            <pair e1="DS.d247.s0.e9" e2="DS.d247.s0.e3" id="DS.d247.s0.i11" interaction="False"/>
            <pair e1="DS.d247.s0.e9" e2="DS.d247.s0.e7" id="DS.d247.s0.i12" interaction="False"/>
            <pair e1="DS.d247.s0.e10" e2="DS.d247.s0.e2" id="DS.d247.s0.i13" interaction="True"/>
            <pair e1="DS.d247.s0.e8" e2="DS.d247.s0.e4" id="DS.d247.s0.i14" interaction="False"/>
            <pair e1="DS.d247.s0.e10" e2="DS.d247.s0.e4" id="DS.d247.s0.i15" interaction="True"/>
            <pair e1="DS.d247.s0.e9" e2="DS.d247.s0.e6" id="DS.d247.s0.i16" interaction="False"/>
            <pair e1="DS.d247.s0.e8" e2="DS.d247.s0.e0" id="DS.d247.s0.i17" interaction="False"/>
            <pair e1="DS.d247.s0.e10" e2="DS.d247.s0.e0" id="DS.d247.s0.i18" interaction="True"/>
            <pair e1="DS.d247.s0.e8" e2="DS.d247.s0.e6" id="DS.d247.s0.i19" interaction="False"/>
            <pair e1="DS.d247.s0.e10" e2="DS.d247.s0.e6" id="DS.d247.s0.i20" interaction="True"/>
            <pair e1="DS.d247.s0.e8" e2="DS.d247.s0.e7" id="DS.d247.s0.i21" interaction="False"/>
            <pair e1="DS.d247.s0.e10" e2="DS.d247.s0.e1" id="DS.d247.s0.i22" interaction="True"/>
            <pair e1="DS.d247.s0.e9" e2="DS.d247.s0.e2" id="DS.d247.s0.i23" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d248" origId="18496767">
        <sentence id="DS.d248.s0" origId="18496767-753" text="Using in vitro binding assays we have demonstrated that transcription factors Sp3, ZBP-89 and NF-Y are capable of binding to the SOX18 promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by mithramycin A.">
            <entity id="DS.d248.s0.e0" origId="O70494,Q02447,Q90WR8" charOffset="56-81" type="protein" text="transcription factors Sp3"/>
            <entity id="DS.d248.s0.e1" origId="P35713" charOffset="129-134" type="protein" text="SOX18"/>
            <entity id="DS.d248.s0.e2" origId="29051,163659,230076,6326719" charOffset="264-277" type="compound" text="mithramycin A"/>
            <pair e1="DS.d248.s0.e2" e2="DS.d248.s0.e1" id="DS.d248.s0.i0" interaction="True"/>
            <pair e1="DS.d248.s0.e2" e2="DS.d248.s0.e0" id="DS.d248.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d249" origId="18496861">
        <sentence id="DS.d249.s0" origId="18496861-830" text="Treatment with hyaluronidase indicates that the dimensions of the small fibrils may be dependent upon the presence of hyaluronan within the matrix.">
            <entity id="DS.d249.s0.e0" origId="P15316,P26831,P49370,P49371,Q08169,Q53591,Q54699,Q54873,Q59634,Q59801,Q9U6V9" charOffset="15-28" type="protein" text="hyaluronidase"/>
            <entity id="DS.d249.s0.e1" origId="24759" charOffset="118-128" type="compound" text="hyaluronan"/>
            <pair e1="DS.d249.s0.e1" e2="DS.d249.s0.e0" id="DS.d249.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d250" origId="18496865">
        <sentence id="DS.d250.s0" origId="18496865-833" text="Tetraglyme coatings reduce fibrinogen and von Willebrand factor adsorption and platelet adhesion under both static and flow conditions.">
            <entity id="DS.d250.s0.e0" origId="8925" charOffset="0-10" type="compound" text="Tetraglyme"/>
            <entity id="DS.d250.s0.e1" origId="P22775,P81070" charOffset="27-37" type="protein" text="fibrinogen"/>
            <entity id="DS.d250.s0.e2" origId="Q62935" charOffset="42-63" type="protein" text="von Willebrand factor"/>
            <pair e1="DS.d250.s0.e0" e2="DS.d250.s0.e1" id="DS.d250.s0.i0" interaction="True"/>
            <pair e1="DS.d250.s0.e0" e2="DS.d250.s0.e2" id="DS.d250.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d250.s1" origId="18496865-834" text="Previous studies have showed that radio-frequency plasma deposited tetraglyme coatings greatly reduced fibrinogen adsorption (Gamma(Fg)) from highly diluted plasmas (0.1 and 1%) and subsequent platelet adhesion under static conditions.">
            <entity id="DS.d250.s1.e0" origId="8925" charOffset="67-77" type="compound" text="tetraglyme"/>
            <entity id="DS.d250.s1.e1" origId="P22775,P81070" charOffset="103-113" type="protein" text="fibrinogen"/>
            <pair e1="DS.d250.s1.e0" e2="DS.d250.s1.e1" id="DS.d250.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d251" origId="18497703">
        <sentence id="DS.d251.s0" origId="18497703-873" text="Effects of inhibition of NOS, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.">
            <entity id="DS.d251.s0.e0" origId="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2" charOffset="25-28" type="protein" text="NOS"/>
            <entity id="DS.d251.s0.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="30-34" type="protein" text="iNOS"/>
            <entity id="DS.d251.s0.e2" origId="O19132,O61309,P29475,P29476,Q9Z0J4" charOffset="40-44" type="protein" text="nNOS"/>
            <entity id="DS.d251.s0.e3" origId="92932,550788" charOffset="56-79" type="compound" text="L-arginine methyl ester"/>
            <entity id="DS.d251.s0.e4" origId="2146" charOffset="90-104" type="compound" text="aminoguanidine"/>
            <entity id="DS.d251.s0.e5" origId="1893" charOffset="110-125" type="compound" text="7-nitroindazole"/>
            <pair e1="DS.d251.s0.e5" e2="DS.d251.s0.e0" id="DS.d251.s0.i0" interaction="False"/>
            <pair e1="DS.d251.s0.e4" e2="DS.d251.s0.e1" id="DS.d251.s0.i1" interaction="False"/>
            <pair e1="DS.d251.s0.e3" e2="DS.d251.s0.e0" id="DS.d251.s0.i2" interaction="False"/>
            <pair e1="DS.d251.s0.e3" e2="DS.d251.s0.e2" id="DS.d251.s0.i3" interaction="False"/>
            <pair e1="DS.d251.s0.e4" e2="DS.d251.s0.e2" id="DS.d251.s0.i4" interaction="False"/>
            <pair e1="DS.d251.s0.e4" e2="DS.d251.s0.e0" id="DS.d251.s0.i5" interaction="False"/>
            <pair e1="DS.d251.s0.e3" e2="DS.d251.s0.e1" id="DS.d251.s0.i6" interaction="False"/>
            <pair e1="DS.d251.s0.e5" e2="DS.d251.s0.e2" id="DS.d251.s0.i7" interaction="False"/>
            <pair e1="DS.d251.s0.e5" e2="DS.d251.s0.e1" id="DS.d251.s0.i8" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d252" origId="18497707">
        <sentence id="DS.d252.s0" origId="18497707-589" text="Differential gene expression of interleukin-1 receptor associated kinase-1 and interleukin-1 receptor associated kinase-M in peripheral blood mononuclear cells of young and aged rats following preconditioning with endotoxin.">
            <entity id="DS.d252.s0.e0" origId="P51617,Q62406" charOffset="32-74" type="protein" text="interleukin-1 receptor associated kinase-1"/>
            <entity id="DS.d252.s0.e1" origId="44268108" charOffset="214-223" type="compound" text="endotoxin"/>
            <pair e1="DS.d252.s0.e1" e2="DS.d252.s0.e0" id="DS.d252.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d252.s1" origId="18497707-590" text="The IL-1 receptor-associated kinase 1 (IRAK-1) and IRAK-M are key signaling molecules in cellular responses to endotoxin initiated through the Toll-like receptors (TLRs).">
            <entity id="DS.d252.s1.e0" origId="P51617,Q62406" charOffset="39-45" type="protein" text="IRAK-1"/>
            <entity id="DS.d252.s1.e1" origId="Q8K4B2,Q9Y616" charOffset="51-57" type="protein" text="IRAK-M"/>
            <entity id="DS.d252.s1.e2" origId="44268108" charOffset="111-120" type="compound" text="endotoxin"/>
            <entity id="DS.d252.s1.e3" origId="P23799" charOffset="164-168" type="protein" text="TLRs"/>
            <pair e1="DS.d252.s1.e2" e2="DS.d252.s1.e1" id="DS.d252.s1.i0" interaction="True"/>
            <pair e1="DS.d252.s1.e2" e2="DS.d252.s1.e3" id="DS.d252.s1.i1" interaction="True"/>
            <pair e1="DS.d252.s1.e2" e2="DS.d252.s1.e0" id="DS.d252.s1.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d252.s2" origId="18497707-591" text="The aim of this study was to evaluate the effect of age on the modulation of TLRs and IRAK-1 and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to endotoxin under conditions that could induce endotoxin tolerance.">
            <entity id="DS.d252.s2.e0" origId="P23799" charOffset="77-81" type="protein" text="TLRs"/>
            <entity id="DS.d252.s2.e1" origId="P51617,Q62406" charOffset="86-92" type="protein" text="IRAK-1"/>
            <entity id="DS.d252.s2.e2" origId="Q8K4B2,Q9Y616" charOffset="97-103" type="protein" text="IRAK-M"/>
            <entity id="DS.d252.s2.e3" origId="44268108" charOffset="170-179" type="compound" text="endotoxin"/>
            <entity id="DS.d252.s2.e4" origId="44268108" charOffset="215-224" type="compound" text="endotoxin"/>
            <pair e1="DS.d252.s2.e3" e2="DS.d252.s2.e2" id="DS.d252.s2.i0" interaction="False"/>
            <pair e1="DS.d252.s2.e3" e2="DS.d252.s2.e1" id="DS.d252.s2.i1" interaction="False"/>
            <pair e1="DS.d252.s2.e3" e2="DS.d252.s2.e0" id="DS.d252.s2.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d253" origId="18497709">
        <sentence id="DS.d253.s0" origId="18497709-959" text="We also previously demonstrated that glutamine (GLN) significantly induced HO-1 in the lower intestinal tract.">
            <entity id="DS.d253.s0.e0" origId="738,5961" charOffset="37-46" type="compound" text="glutamine"/>
            <entity id="DS.d253.s0.e1" origId="P06762,P09601,P14791,P14901,P32394,Q5E9F2" charOffset="75-79" type="protein" text="HO-1"/>
            <pair e1="DS.d253.s0.e0" e2="DS.d253.s0.e1" id="DS.d253.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d253.s1" origId="18497709-961" text="Glutamine treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.">
            <entity id="DS.d253.s1.e0" origId="738,5961" charOffset="0-9" type="compound" text="Glutamine"/>
            <entity id="DS.d253.s1.e1" origId="5047209,46173182" charOffset="27-29" type="compound" text="HS"/>
            <entity id="DS.d253.s1.e2" origId="5047209,46173182" charOffset="84-86" type="compound" text="HS"/>
            <entity id="DS.d253.s1.e3" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="212-221" type="protein" text="TNF-alpha"/>
            <entity id="DS.d253.s1.e4" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="223-227" type="protein" text="iNOS"/>
            <entity id="DS.d253.s1.e5" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="494-499" type="protein" text="IL-10"/>
            <entity id="DS.d253.s1.e6" origId="P10417,P49950" charOffset="504-509" type="protein" text="Bcl-2"/>
            <pair e1="DS.d253.s1.e0" e2="DS.d253.s1.e5" id="DS.d253.s1.i0" interaction="True"/>
            <pair e1="DS.d253.s1.e0" e2="DS.d253.s1.e3" id="DS.d253.s1.i1" interaction="True"/>
            <pair e1="DS.d253.s1.e1" e2="DS.d253.s1.e5" id="DS.d253.s1.i2" interaction="False"/>
            <pair e1="DS.d253.s1.e0" e2="DS.d253.s1.e4" id="DS.d253.s1.i3" interaction="True"/>
            <pair e1="DS.d253.s1.e1" e2="DS.d253.s1.e4" id="DS.d253.s1.i4" interaction="False"/>
            <pair e1="DS.d253.s1.e0" e2="DS.d253.s1.e6" id="DS.d253.s1.i5" interaction="True"/>
            <pair e1="DS.d253.s1.e1" e2="DS.d253.s1.e6" id="DS.d253.s1.i6" interaction="False"/>
            <pair e1="DS.d253.s1.e1" e2="DS.d253.s1.e3" id="DS.d253.s1.i7" interaction="False"/>
        </sentence>
        <sentence id="DS.d253.s2" origId="18497709-964" text="Glutamine treatment may thus protect mucosal cells from HS-induced oxidative damage via the anti-inflammatory and antiapoptotic properties of HO-1.">
            <entity id="DS.d253.s2.e0" origId="738,5961" charOffset="0-9" type="compound" text="Glutamine"/>
            <entity id="DS.d253.s2.e1" origId="P06762,P09601,P14791,P14901,P32394,Q5E9F2" charOffset="142-146" type="protein" text="HO-1"/>
            <pair e1="DS.d253.s2.e0" e2="DS.d253.s2.e1" id="DS.d253.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d254" origId="18498083">
        <sentence id="DS.d254.s0" origId="18498083-305" text="In this work, we identified a high affinity and potency metallocene-containing triazole peptide conjugate that suppresses the interactions of HIV-1 envelope gp120 at both its CD4 and co-receptor binding sites.">
            <entity id="DS.d254.s0.e0" origId="67516" charOffset="79-87" type="compound" text="triazole"/>
            <entity id="DS.d254.s0.e1" origId="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69" charOffset="157-162" type="protein" text="gp120"/>
            <entity id="DS.d254.s0.e2" origId="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78" charOffset="175-178" type="protein" text="CD4"/>
            <pair e1="DS.d254.s0.e0" e2="DS.d254.s0.e2" id="DS.d254.s0.i0" interaction="True"/>
            <pair e1="DS.d254.s0.e0" e2="DS.d254.s0.e1" id="DS.d254.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d254.s1" origId="18498083-306" text="Surface plasmon resonance interaction analysis revealed that, compared to a previously reported phenyl-containing triazole conjugate HNG-105 (105), peptide 156 had a higher direct binding affinity for several subtypes of HIV-1 gp120 due mainly to the decreased dissociation rate of the conjugate-gp120 complex.">
            <entity id="DS.d254.s1.e0" origId="67516" charOffset="114-122" type="compound" text="triazole"/>
            <entity id="DS.d254.s1.e1" origId="25085904" charOffset="133-140" type="compound" text="HNG-105"/>
            <entity id="DS.d254.s1.e2" origId="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69" charOffset="227-232" type="protein" text="gp120"/>
            <pair e1="DS.d254.s1.e1" e2="DS.d254.s1.e2" id="DS.d254.s1.i0" interaction="True"/>
            <pair e1="DS.d254.s1.e0" e2="DS.d254.s1.e2" id="DS.d254.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d254.s2" origId="18498083-307" text="The ferrocene triazole conjugate bound to gp120 of both clade A (92UG037-08) and clade B (YU-2 and SF162) virus subtypes with nanomolar KD in direct binding and inhibited the binding of gp120 to soluble CD4 and to antibodies that bind to HIV-1YU-2 gp120 at both the CD4 binding site and CD4-induced binding sites.">
            <entity id="DS.d254.s2.e0" origId="67516" charOffset="14-22" type="compound" text="triazole"/>
            <entity id="DS.d254.s2.e1" origId="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69" charOffset="42-47" type="protein" text="gp120"/>
            <entity id="DS.d254.s2.e2" origId="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69" charOffset="186-191" type="protein" text="gp120"/>
            <entity id="DS.d254.s2.e3" origId="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78" charOffset="203-206" type="protein" text="CD4"/>
            <entity id="DS.d254.s2.e4" origId="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78" charOffset="266-269" type="protein" text="CD4"/>
            <entity id="DS.d254.s2.e5" origId="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78" charOffset="266-269" type="protein" text="CD4"/>
            <pair e1="DS.d254.s2.e0" e2="DS.d254.s2.e3" id="DS.d254.s2.i0" interaction="True"/>
            <pair e1="DS.d254.s2.e0" e2="DS.d254.s2.e1" id="DS.d254.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d255" origId="18498357">
        <sentence id="DS.d255.s0" origId="18498357-470" text="Screening of risk factors for thromboembolism revealed that all patients carried a methylenetetrahydrofolate reductase 677C--&amp;gt;T (MTHFR) mutation in a gene involved in folate metabolism, and either borderline or elevated homocysteine levels.">
            <entity id="DS.d255.s0.e0" origId="P42898,Q5I598,Q60HE5,Q9WU20" charOffset="83-118" type="protein" text="methylenetetrahydrofolate reductase"/>
            <entity id="DS.d255.s0.e1" origId="P42898,Q5I598,Q60HE5" charOffset="132-137" type="protein" text="MTHFR"/>
            <entity id="DS.d255.s0.e2" origId="778" charOffset="223-235" type="compound" text="homocysteine"/>
            <pair e1="DS.d255.s0.e2" e2="DS.d255.s0.e0" id="DS.d255.s0.i0" interaction="False"/>
            <pair e1="DS.d255.s0.e2" e2="DS.d255.s0.e1" id="DS.d255.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d256" origId="18498673">
        <sentence id="DS.d256.s0" origId="18498673-382" text="Circulating leptin was negatively correlated with mRNA expression of adiponectin, LEPR and LPL, whereas thyroxine was positively correlated with levels of PPARGC1A.">
            <entity id="DS.d256.s0.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="12-18" type="protein" text="leptin"/>
            <entity id="DS.d256.s0.e1" origId="O02671,O15243,P48357,Q9MYL0" charOffset="82-86" type="protein" text="LEPR"/>
            <entity id="DS.d256.s0.e2" origId="O46647,P06858,P11151,P11152,P11153,P11602,P49060,P49923,P55031,Q06000,Q29524" charOffset="91-94" type="protein" text="LPL"/>
            <entity id="DS.d256.s0.e3" origId="853,5819" charOffset="104-113" type="compound" text="thyroxine"/>
            <entity id="DS.d256.s0.e4" origId="Q865B6,Q865B7,Q9UBK2" charOffset="155-163" type="protein" text="PPARGC1A"/>
            <pair e1="DS.d256.s0.e3" e2="DS.d256.s0.e2" id="DS.d256.s0.i0" interaction="False"/>
            <pair e1="DS.d256.s0.e3" e2="DS.d256.s0.e0" id="DS.d256.s0.i1" interaction="False"/>
            <pair e1="DS.d256.s0.e3" e2="DS.d256.s0.e4" id="DS.d256.s0.i2" interaction="True"/>
            <pair e1="DS.d256.s0.e3" e2="DS.d256.s0.e1" id="DS.d256.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d257" origId="18500430">
        <sentence id="DS.d257.s0" origId="18500430-564" text="In the absence of exogenous Ca(2+) and Mg(2+) and in the presence of EGTA, which favours the release of endogenous Ca(2+), the polyamine spermine is able to stimulate the activity of pyruvate dehydrogenase complex (PDC) of energized rat liver mitochondria (RLM).">
            <entity id="DS.d257.s0.e0" origId="271" charOffset="28-32" type="compound" text="Ca(2"/>
            <entity id="DS.d257.s0.e1" origId="6207" charOffset="69-73" type="compound" text="EGTA"/>
            <entity id="DS.d257.s0.e2" origId="271" charOffset="115-119" type="compound" text="Ca(2"/>
            <entity id="DS.d257.s0.e3" origId="1103" charOffset="137-145" type="compound" text="spermine"/>
            <entity id="DS.d257.s0.e4" origId="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39" charOffset="215-218" type="protein" text="PDC"/>
            <pair e1="DS.d257.s0.e3" e2="DS.d257.s0.e4" id="DS.d257.s0.i0" interaction="True"/>
            <pair e1="DS.d257.s0.e0" e2="DS.d257.s0.e4" id="DS.d257.s0.i1" interaction="False"/>
            <pair e1="DS.d257.s0.e1" e2="DS.d257.s0.e4" id="DS.d257.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d257.s1" origId="18500430-565" text="At concentrations higher than 0.5 mM, spermine still stimulates PDC, when compared with the control, but shows a slight dose-dependent decrease.">
            <entity id="DS.d257.s1.e0" origId="1103" charOffset="38-46" type="compound" text="spermine"/>
            <entity id="DS.d257.s1.e1" origId="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39" charOffset="64-67" type="protein" text="PDC"/>
            <pair e1="DS.d257.s1.e0" e2="DS.d257.s1.e1" id="DS.d257.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d257.s2" origId="18500430-566" text="Changes in PDC stimulation are very close to the phosphorylation level of the E(1alpha) subunit of PDC, which regulates the activity of the complex, but it is also the target of spermine.">
            <entity id="DS.d257.s2.e0" origId="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39" charOffset="11-14" type="protein" text="PDC"/>
            <entity id="DS.d257.s2.e1" origId="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39" charOffset="99-102" type="protein" text="PDC"/>
            <entity id="DS.d257.s2.e2" origId="1103" charOffset="178-186" type="compound" text="spermine"/>
            <pair e1="DS.d257.s2.e2" e2="DS.d257.s2.e0" id="DS.d257.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d257.s3" origId="18500430-567" text="These results provide the first evidence that, when transported in RLM, spermine can interact in various ways with PDC, showing dose-dependent behaviour.">
            <entity id="DS.d257.s3.e0" origId="1103" charOffset="72-80" type="compound" text="spermine"/>
            <entity id="DS.d257.s3.e1" origId="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39" charOffset="115-118" type="protein" text="PDC"/>
            <pair e1="DS.d257.s3.e0" e2="DS.d257.s3.e1" id="DS.d257.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d258" origId="18500522">
        <sentence id="DS.d258.s0" origId="18500522-58" text="This study assessed relationships between hNT levels and fludarabine uptake and cytotoxicity in cultures of human renal proximal tubule cells (hRPTCs) that produce multiple transporter types.">
            <entity id="DS.d258.s0.e0" origId="Q9P121" charOffset="42-45" type="protein" text="hNT"/>
            <entity id="DS.d258.s0.e1" origId="657237" charOffset="57-68" type="compound" text="fludarabine"/>
            <pair e1="DS.d258.s0.e1" e2="DS.d258.s0.e0" id="DS.d258.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d259" origId="18502597">
        <sentence id="DS.d259.s0" origId="18502597-1034" text="Multiple metabolic and neuroendocrine mechanisms are responsible for the CR-mediated anti-inflammatory effects, including reduced adiposity and secretion of pro-inflammatory adipokines, enhanced glucocorticoid production, reduced plasma glucose and advanced glycation end-product concentrations, increased parasympathetic tone, and increased ghrelin production.">
            <entity id="DS.d259.s0.e0" origId="206,5793,64689,79025" charOffset="237-244" type="compound" text="glucose"/>
            <entity id="DS.d259.s0.e1" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="342-349" type="protein" text="ghrelin"/>
            <pair e1="DS.d259.s0.e0" e2="DS.d259.s0.e1" id="DS.d259.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d260" origId="18503570">
        <sentence id="DS.d260.s0" origId="18503570-926" text="From the known regulatory mechanisms of Arc expression, HFD reduced N-methyl-D-aspartate receptor (NMDAR) activity, as seen by decreases in tyrosine phosphorylation of NMDAR2A and levels of NMDAR1.">
            <entity id="DS.d260.s0.e0" origId="P35439,Q9R1M7" charOffset="68-97" type="protein" text="N-methyl-D-aspartate receptor"/>
            <entity id="DS.d260.s0.e1" origId="1153,6057,5460803" charOffset="140-148" type="compound" text="tyrosine"/>
            <entity id="DS.d260.s0.e2" origId="P35436,Q00959,Q12879,Q5IS45" charOffset="168-175" type="protein" text="NMDAR2A"/>
            <entity id="DS.d260.s0.e3" origId="Q05586,Q5R1P0" charOffset="190-196" type="protein" text="NMDAR1"/>
            <pair e1="DS.d260.s0.e1" e2="DS.d260.s0.e2" id="DS.d260.s0.i0" interaction="True"/>
            <pair e1="DS.d260.s0.e1" e2="DS.d260.s0.e0" id="DS.d260.s0.i1" interaction="True"/>
            <pair e1="DS.d260.s0.e1" e2="DS.d260.s0.e3" id="DS.d260.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d260.s1" origId="18503570-927" text="Additionally, we demonstrated that 27-hydroxycholesterol, a cholesterol metabolite that enters the brain from the blood, decreases Arc levels as well as NMDAR and Src kinase activities in rat primary hippocampal neurons.">
            <entity id="DS.d260.s1.e0" origId="99470,123976,50990021" charOffset="35-56" type="compound" text="27-hydroxycholesterol"/>
            <entity id="DS.d260.s1.e1" origId="304,5997,6432564,11025495" charOffset="45-56" type="compound" text="cholesterol"/>
            <entity id="DS.d260.s1.e2" origId="P05480,Q9WUD9" charOffset="163-166" type="protein" text="Src"/>
            <pair e1="DS.d260.s1.e1" e2="DS.d260.s1.e2" id="DS.d260.s1.i0" interaction="True"/>
            <pair e1="DS.d260.s1.e0" e2="DS.d260.s1.e2" id="DS.d260.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d261" origId="18505747">
        <sentence id="DS.d261.s0" origId="18505747-21" text="Cyclooxygenase-2, an inducible enzyme important in inflammation, catalyzes the production of prostanoids from arachidonic acid.">
            <entity id="DS.d261.s0.e0" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="0-16" type="protein" text="Cyclooxygenase-2"/>
            <entity id="DS.d261.s0.e1" origId="444899" charOffset="110-126" type="compound" text="arachidonic acid"/>
            <pair e1="DS.d261.s0.e1" e2="DS.d261.s0.e0" id="DS.d261.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d262" origId="18506596">
        <sentence id="DS.d262.s0" origId="18506596-495" text="cDNA probes have been developed for subsequent use in monitoring the cadmium exposure of the clam Ruditapes decussatus and the cockle Cerastoderma glaucum using metallothionein (MT) gene expression in different tissues of these species.">
            <entity id="DS.d262.s0.e0" origId="23973" charOffset="69-76" type="compound" text="cadmium"/>
            <entity id="DS.d262.s0.e1" origId="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568" charOffset="161-176" type="protein" text="metallothionein"/>
            <pair e1="DS.d262.s0.e0" e2="DS.d262.s0.e1" id="DS.d262.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d263" origId="18506630">
        <sentence id="DS.d263.s0" origId="18506630-727" text="Purified lignin peroxidase was able to oxidize a variety of substrates including Mn2+, tryptophan, mimosine, L-Dopa, hydroquinone, xylidine, n-propanol, veratryl alcohol, and ten textile dyes of various groups indicating as a versatile peroxidase.">
            <entity id="DS.d263.s0.e0" origId="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622" charOffset="9-26" type="protein" text="lignin peroxidase"/>
            <entity id="DS.d263.s0.e1" origId="27854" charOffset="81-84" type="compound" text="Mn2"/>
            <entity id="DS.d263.s0.e2" origId="1148,6305,9060,5460840" charOffset="87-97" type="compound" text="tryptophan"/>
            <entity id="DS.d263.s0.e3" origId="3862" charOffset="99-107" type="compound" text="mimosine"/>
            <entity id="DS.d263.s0.e4" origId="6047" charOffset="109-115" type="compound" text="L-Dopa"/>
            <entity id="DS.d263.s0.e5" origId="785" charOffset="117-129" type="compound" text="hydroquinone"/>
            <entity id="DS.d263.s0.e6" origId="1031" charOffset="141-151" type="compound" text="n-propanol"/>
            <entity id="DS.d263.s0.e7" origId="7118" charOffset="153-169" type="compound" text="veratryl alcohol"/>
            <pair e1="DS.d263.s0.e6" e2="DS.d263.s0.e0" id="DS.d263.s0.i0" interaction="True"/>
            <pair e1="DS.d263.s0.e5" e2="DS.d263.s0.e0" id="DS.d263.s0.i2" interaction="True"/>
            <pair e1="DS.d263.s0.e1" e2="DS.d263.s0.e0" id="DS.d263.s0.i3" interaction="True"/>
            <pair e1="DS.d263.s0.e3" e2="DS.d263.s0.e0" id="DS.d263.s0.i7" interaction="True"/>
            <pair e1="DS.d263.s0.e4" e2="DS.d263.s0.e0" id="DS.d263.s0.i9" interaction="True"/>
            <pair e1="DS.d263.s0.e7" e2="DS.d263.s0.e0" id="DS.d263.s0.i10" interaction="True"/>
            <pair e1="DS.d263.s0.e2" e2="DS.d263.s0.e0" id="DS.d263.s0.i13" interaction="True"/>
        </sentence>
        <sentence id="DS.d263.s1" origId="18506630-728" text="Tryptophan stabilizes the lignin peroxidase activity during decolorization of dyes.">
            <entity id="DS.d263.s1.e0" origId="1148,6305,9060,5460840" charOffset="0-10" type="compound" text="Tryptophan"/>
            <entity id="DS.d263.s1.e1" origId="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622" charOffset="26-43" type="protein" text="lignin peroxidase"/>
            <pair e1="DS.d263.s1.e0" e2="DS.d263.s1.e1" id="DS.d263.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d264" origId="18506631">
        <sentence id="DS.d264.s0" origId="18506631-523" text="To achieve enzymatic production of calcium-stearate at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable lipase was selected and reaction conditions were optimized using calcium hydroxide and hydrogenated beef tallow as substrates.">
            <entity id="DS.d264.s0.e0" origId="5281" charOffset="35-51" type="compound" text="calcium-stearate"/>
            <entity id="DS.d264.s0.e1" origId="Q7M4U7" charOffset="118-124" type="protein" text="lipase"/>
            <entity id="DS.d264.s0.e2" origId="961" charOffset="191-200" type="compound" text="hydroxide"/>
            <pair e1="DS.d264.s0.e2" e2="DS.d264.s0.e1" id="DS.d264.s0.i0" interaction="True"/>
            <pair e1="DS.d264.s0.e0" e2="DS.d264.s0.e1" id="DS.d264.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d264.s1" origId="18506631-524" text="Under optimum conditions, 95% of beef tallow, in 2.5 h, was converted into calcium-stearate by using commercial lipase SDL 451.">
            <entity id="DS.d264.s1.e0" origId="5281" charOffset="75-91" type="compound" text="calcium-stearate"/>
            <entity id="DS.d264.s1.e1" origId="Q7M4U7" charOffset="112-118" type="protein" text="lipase"/>
            <pair e1="DS.d264.s1.e0" e2="DS.d264.s1.e1" id="DS.d264.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d265" origId="18506760">
        <sentence id="DS.d265.s0" origId="18506760-597" text="Celecoxib could selectively inhibited COX-2 expression and PGE2 production.">
            <entity id="DS.d265.s0.e0" origId="2662" charOffset="0-9" type="compound" text="Celecoxib"/>
            <entity id="DS.d265.s0.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="38-43" type="protein" text="COX-2"/>
            <entity id="DS.d265.s0.e2" origId="5280360" charOffset="59-63" type="compound" text="PGE2"/>
            <pair e1="DS.d265.s0.e0" e2="DS.d265.s0.e1" id="DS.d265.s0.i0" interaction="True"/>
            <pair e1="DS.d265.s0.e2" e2="DS.d265.s0.e1" id="DS.d265.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d265.s1" origId="18506760-598" text="Celecoxib also inhibited p(473Ser) Akt, raf and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.">
            <entity id="DS.d265.s1.e0" origId="2662" charOffset="0-9" type="compound" text="Celecoxib"/>
            <entity id="DS.d265.s1.e1" origId="P31750,Q8INB9" charOffset="35-38" type="protein" text="Akt"/>
            <entity id="DS.d265.s1.e2" origId="P09560,P11345,Q80VX4,Q8C0C0" charOffset="40-43" type="protein" text="raf"/>
            <entity id="DS.d265.s1.e3" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="48-51" type="protein" text="p53"/>
            <entity id="DS.d265.s1.e4" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="100-112" type="protein" text="cytochrome c"/>
            <pair e1="DS.d265.s1.e0" e2="DS.d265.s1.e4" id="DS.d265.s1.i0" interaction="True"/>
            <pair e1="DS.d265.s1.e0" e2="DS.d265.s1.e1" id="DS.d265.s1.i1" interaction="True"/>
            <pair e1="DS.d265.s1.e0" e2="DS.d265.s1.e2" id="DS.d265.s1.i2" interaction="True"/>
            <pair e1="DS.d265.s1.e0" e2="DS.d265.s1.e3" id="DS.d265.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d268" origId="18509327">
        <sentence id="DS.d268.s0" origId="18509327-948" text="However, the simultaneous presence of the CYP3A4 *1B and CYP3A5 *1A alleles was associated with a 64% increase in docetaxel clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).">
            <entity id="DS.d268.s0.e0" origId="P08684" charOffset="42-48" type="protein" text="CYP3A4"/>
            <entity id="DS.d268.s0.e1" origId="P20815" charOffset="57-63" type="protein" text="CYP3A5"/>
            <entity id="DS.d268.s0.e2" origId="148124" charOffset="114-123" type="compound" text="docetaxel"/>
            <pair e1="DS.d268.s0.e2" e2="DS.d268.s0.e0" id="DS.d268.s0.i0" interaction="True"/>
            <pair e1="DS.d268.s0.e2" e2="DS.d268.s0.e1" id="DS.d268.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d269" origId="18509591">
        <sentence id="DS.d269.s0" origId="18509591-45" text="It was found that taurine administration produced lower levels of aspartate aminotransferase and alkaline aminotransferase than that of the untreated group.">
            <entity id="DS.d269.s0.e0" origId="1123" charOffset="18-25" type="compound" text="taurine"/>
            <entity id="DS.d269.s0.e1" origId="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56" charOffset="66-92" type="protein" text="aspartate aminotransferase"/>
            <pair e1="DS.d269.s0.e0" e2="DS.d269.s0.e1" id="DS.d269.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d269.s1" origId="18509591-46" text="In addition, the levels of hepatic total protein, glutathione and superoxide dismutase were higher in the taurine treated groups than those in the untreated control or the taurine depleted groups, while hepatic malondialdehyde content exhibited the negative effect.">
            <entity id="DS.d269.s1.e0" origId="124886" charOffset="50-61" type="compound" text="glutathione"/>
            <entity id="DS.d269.s1.e1" origId="O50258" charOffset="66-86" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d269.s1.e2" origId="1123" charOffset="106-113" type="compound" text="taurine"/>
            <entity id="DS.d269.s1.e3" origId="1123" charOffset="172-179" type="compound" text="taurine"/>
            <entity id="DS.d269.s1.e4" origId="10964" charOffset="211-226" type="compound" text="malondialdehyde"/>
            <pair e1="DS.d269.s1.e2" e2="DS.d269.s1.e1" id="DS.d269.s1.i0" interaction="True"/>
            <pair e1="DS.d269.s1.e4" e2="DS.d269.s1.e1" id="DS.d269.s1.i1" interaction="True"/>
            <pair e1="DS.d269.s1.e0" e2="DS.d269.s1.e1" id="DS.d269.s1.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d269.s2" origId="18509591-47" text="Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.">
            <entity id="DS.d269.s2.e0" origId="825,5810,69248,440015" charOffset="40-54" type="compound" text="hydroxyproline"/>
            <entity id="DS.d269.s2.e1" origId="24759,453618,3084050,24728612" charOffset="62-77" type="compound" text="hyaluronic acid"/>
            <entity id="DS.d269.s2.e2" origId="P41693" charOffset="94-107" type="protein" text="interleukin-6"/>
            <entity id="DS.d269.s2.e3" origId="Q8JFG3" charOffset="109-130" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d269.s2.e4" origId="44342165" charOffset="141-148" type="compound" text="laminin"/>
            <entity id="DS.d269.s2.e5" origId="1123" charOffset="175-182" type="compound" text="taurine"/>
            <pair e1="DS.d269.s2.e4" e2="DS.d269.s2.e2" id="DS.d269.s2.i0" interaction="False"/>
            <pair e1="DS.d269.s2.e1" e2="DS.d269.s2.e2" id="DS.d269.s2.i1" interaction="False"/>
            <pair e1="DS.d269.s2.e5" e2="DS.d269.s2.e3" id="DS.d269.s2.i2" interaction="True"/>
            <pair e1="DS.d269.s2.e0" e2="DS.d269.s2.e2" id="DS.d269.s2.i3" interaction="False"/>
            <pair e1="DS.d269.s2.e5" e2="DS.d269.s2.e2" id="DS.d269.s2.i4" interaction="True"/>
            <pair e1="DS.d269.s2.e4" e2="DS.d269.s2.e3" id="DS.d269.s2.i5" interaction="False"/>
            <pair e1="DS.d269.s2.e0" e2="DS.d269.s2.e3" id="DS.d269.s2.i6" interaction="False"/>
            <pair e1="DS.d269.s2.e1" e2="DS.d269.s2.e3" id="DS.d269.s2.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d270" origId="18509644">
        <sentence id="DS.d270.s0" origId="18509644-1152" text="Pharmacological (flavopiridol) and molecular (shRNA) transcription inhibitor were used to impede formation of MET transcripts.">
            <entity id="DS.d270.s0.e0" origId="5287969" charOffset="17-29" type="compound" text="flavopiridol"/>
            <entity id="DS.d270.s0.e1" origId="P08581,Q07DV8,Q07DY1,Q07DZ1,Q07E01,Q07E24,Q07E37,Q07E48,Q09YH7,Q09YI9,Q09YK0,Q09YL1,Q09YN5,Q108U6,Q2IBA6,Q2IBC0,Q2IBD8,Q2IBF2,Q2IBG7,Q2QL89,Q2QLA9,Q2QLC0,Q2QLE0,Q2QLF1,Q2QLG5,Q2QLH6,Q42662,Q75ZY9" charOffset="110-113" type="protein" text="MET"/>
            <pair e1="DS.d270.s0.e0" e2="DS.d270.s0.e1" id="DS.d270.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d271" origId="18509748">
        <sentence id="DS.d271.s0" origId="18509748-1206" text="Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L:-ascorbate on pancreatic tumors in athymic mice.">
            <entity id="DS.d271.s0.e0" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="43-53" type="protein" text="HIF-1alpha"/>
            <entity id="DS.d271.s0.e1" origId="54690394" charOffset="80-92" type="compound" text="L:-ascorbate"/>
            <pair e1="DS.d271.s0.e1" e2="DS.d271.s0.e0" id="DS.d271.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d272" origId="18511076">
        <sentence id="DS.d272.s0" origId="18511076-738" text="Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.">
            <entity id="DS.d272.s0.e0" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="11-15" type="protein" text="BDNF"/>
            <entity id="DS.d272.s0.e1" origId="68617" charOffset="108-118" type="compound" text="sertraline"/>
            <entity id="DS.d272.s0.e2" origId="146570" charOffset="120-132" type="compound" text="escitalopram"/>
            <entity id="DS.d272.s0.e3" origId="5656" charOffset="137-148" type="compound" text="venlafaxine"/>
            <pair e1="DS.d272.s0.e3" e2="DS.d272.s0.e0" id="DS.d272.s0.i0" interaction="True"/>
            <pair e1="DS.d272.s0.e1" e2="DS.d272.s0.e0" id="DS.d272.s0.i1" interaction="True"/>
            <pair e1="DS.d272.s0.e2" e2="DS.d272.s0.e0" id="DS.d272.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d272.s1" origId="18511076-739" text="We assessed serum BDNF levels in 21 patients with major depressive episode treated with sertraline, escitalopram, or venlafaxine and 20 healthy controls.">
            <entity id="DS.d272.s1.e0" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="18-22" type="protein" text="BDNF"/>
            <entity id="DS.d272.s1.e1" origId="68617" charOffset="88-98" type="compound" text="sertraline"/>
            <entity id="DS.d272.s1.e2" origId="146570" charOffset="100-112" type="compound" text="escitalopram"/>
            <entity id="DS.d272.s1.e3" origId="5656" charOffset="117-128" type="compound" text="venlafaxine"/>
            <pair e1="DS.d272.s1.e3" e2="DS.d272.s1.e0" id="DS.d272.s1.i0" interaction="True"/>
            <pair e1="DS.d272.s1.e1" e2="DS.d272.s1.e0" id="DS.d272.s1.i1" interaction="True"/>
            <pair e1="DS.d272.s1.e2" e2="DS.d272.s1.e0" id="DS.d272.s1.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d272.s2" origId="18511076-740" text="Sertraline increased BDNF levels after 5 weeks and 6 months of treatment.">
            <entity id="DS.d272.s2.e0" origId="68617" charOffset="0-10" type="compound" text="Sertraline"/>
            <entity id="DS.d272.s2.e1" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="21-25" type="protein" text="BDNF"/>
            <pair e1="DS.d272.s2.e0" e2="DS.d272.s2.e1" id="DS.d272.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d272.s3" origId="18511076-741" text="Venlafaxine increased BDNF levels only after 6 months.">
            <entity id="DS.d272.s3.e0" origId="5656" charOffset="0-11" type="compound" text="Venlafaxine"/>
            <entity id="DS.d272.s3.e1" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="22-26" type="protein" text="BDNF"/>
            <pair e1="DS.d272.s3.e0" e2="DS.d272.s3.e1" id="DS.d272.s3.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d272.s4" origId="18511076-742" text="Escitalopram did not affect BDNF levels at either time point.">
            <entity id="DS.d272.s4.e0" origId="146570" charOffset="0-12" type="compound" text="Escitalopram"/>
            <entity id="DS.d272.s4.e1" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="28-32" type="protein" text="BDNF"/>
            <pair e1="DS.d272.s4.e0" e2="DS.d272.s4.e1" id="DS.d272.s4.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d273" origId="18513727">
        <sentence id="DS.d273.s0" origId="18513727-1142" text="The increase of cholesterol was accompanied by a marked posttranslational down-regulation of liver SR-BI expression.">
            <entity id="DS.d273.s0.e0" origId="304,5997,6432564,11025495" charOffset="16-27" type="compound" text="cholesterol"/>
            <entity id="DS.d273.s0.e1" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="99-104" type="protein" text="SR-BI"/>
            <pair e1="DS.d273.s0.e0" e2="DS.d273.s0.e1" id="DS.d273.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d273.s1" origId="18513727-1143" text="Taken together, a diet-induced increase of plasma and hepatic cholesterol levels leads to a posttranscriptional down-regulation of SR-BI in mouse liver via a mechanism likely involving PDZK1.">
            <entity id="DS.d273.s1.e0" origId="304,5997,6432564,11025495" charOffset="62-73" type="compound" text="cholesterol"/>
            <entity id="DS.d273.s1.e1" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="131-136" type="protein" text="SR-BI"/>
            <entity id="DS.d273.s1.e2" origId="Q3T0X8,Q5RCF7,Q5T2W1,Q865P3" charOffset="185-190" type="protein" text="PDZK1"/>
            <pair e1="DS.d273.s1.e0" e2="DS.d273.s1.e2" id="DS.d273.s1.i0" interaction="False"/>
            <pair e1="DS.d273.s1.e0" e2="DS.d273.s1.e1" id="DS.d273.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d274" origId="18513857">
        <sentence id="DS.d274.s0" origId="18513857-1213" text="A 5.5 kilobase-pair (kbp) Pst1-Kpn1 fragment containing gene(s) encoding for zearalenone degradation was cloned.">
            <entity id="DS.d274.s0.e0" origId="Q09750" charOffset="26-30" type="protein" text="Pst1"/>
            <entity id="DS.d274.s0.e1" origId="5281576" charOffset="77-88" type="compound" text="zearalenone"/>
            <pair e1="DS.d274.s0.e1" e2="DS.d274.s0.e0" id="DS.d274.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d275" origId="18514659">
        <sentence id="DS.d275.s0" origId="18514659-430" text="However, TXA(2) formation remains elevated in patients with cardiovascular disease on doses of aspirin that fully suppress platelet COX-1, suggesting other tissue sources for TXA(2) formation.">
            <entity id="DS.d275.s0.e0" origId="5280497" charOffset="9-14" type="compound" text="TXA(2"/>
            <entity id="DS.d275.s0.e1" origId="2244" charOffset="95-102" type="compound" text="aspirin"/>
            <entity id="DS.d275.s0.e2" origId="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8" charOffset="132-137" type="protein" text="COX-1"/>
            <entity id="DS.d275.s0.e3" origId="5280497" charOffset="175-180" type="compound" text="TXA(2"/>
            <pair e1="DS.d275.s0.e1" e2="DS.d275.s0.e2" id="DS.d275.s0.i0" interaction="True"/>
            <pair e1="DS.d275.s0.e0" e2="DS.d275.s0.e2" id="DS.d275.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d276" origId="18514900">
        <sentence id="DS.d276.s0" origId="18514900-1098" text=") production increased; metallothionein (MT) and glutathione levels increased in most cases, and acetylcholinesterase (AChE) activity decreased in summer.">
            <entity id="DS.d276.s0.e0" origId="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568" charOffset="24-39" type="protein" text="metallothionein"/>
            <entity id="DS.d276.s0.e1" origId="124886" charOffset="49-60" type="compound" text="glutathione"/>
            <entity id="DS.d276.s0.e2" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="97-117" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d276.s0.e3" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="119-123" type="protein" text="AChE"/>
            <pair e1="DS.d276.s0.e1" e2="DS.d276.s0.e3" id="DS.d276.s0.i1" interaction="False"/>
            <pair e1="DS.d276.s0.e1" e2="DS.d276.s0.e2" id="DS.d276.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d277" origId="18515453">
        <sentence id="DS.d277.s0" origId="18515453-577" text="From these findings, it is suggested that distigmine bromide may produce centrally mediated behavioural signs by increasing the ACh levels in the brain, resulting from its AChE and BuChE inhibitions.">
            <entity id="DS.d277.s0.e0" origId="3116" charOffset="42-60" type="compound" text="distigmine bromide"/>
            <entity id="DS.d277.s0.e1" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="172-176" type="protein" text="AChE"/>
            <pair e1="DS.d277.s0.e0" e2="DS.d277.s0.e1" id="DS.d277.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d278" origId="18515457">
        <sentence id="DS.d278.s0" origId="18515457-594" text="Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with R121919/NBI 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (AVP) and CRH mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.">
            <entity id="DS.d278.s0.e0" origId="9821250" charOffset="108-115" type="compound" text="R121919"/>
            <entity id="DS.d278.s0.e2" origId="P01180,P01181,P01182,P01183,P01184,P01185,P10769,P31414,P81768" charOffset="268-271" type="protein" text="AVP"/>
            <entity id="DS.d278.s0.e3" origId="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1" charOffset="277-280" type="protein" text="CRH"/>
            <pair e1="DS.d278.s0.e0" e2="DS.d278.s0.e3" id="DS.d278.s0.i2" interaction="False"/>
            <pair e1="DS.d278.s0.e0" e2="DS.d278.s0.e2" id="DS.d278.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d279" origId="18515973">
        <sentence id="DS.d279.s0" origId="18515973-10" text="7-Ketocholesterol also enhanced IL-6 release from VSMC.">
            <entity id="DS.d279.s0.e0" origId="91474" charOffset="0-17" type="compound" text="7-Ketocholesterol"/>
            <entity id="DS.d279.s0.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="32-36" type="protein" text="IL-6"/>
            <pair e1="DS.d279.s0.e0" e2="DS.d279.s0.e1" id="DS.d279.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d279.s1" origId="18515973-11" text="IL-6 release by 7-ketocholesterol, although significant, was not as remarkable as that induced by TNF-alpha.">
            <entity id="DS.d279.s1.e0" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="0-4" type="protein" text="IL-6"/>
            <entity id="DS.d279.s1.e1" origId="91474" charOffset="16-33" type="compound" text="7-ketocholesterol"/>
            <entity id="DS.d279.s1.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="98-107" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d279.s1.e1" e2="DS.d279.s1.e0" id="DS.d279.s1.i0" interaction="True"/>
            <pair e1="DS.d279.s1.e1" e2="DS.d279.s1.e2" id="DS.d279.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d279.s2" origId="18515973-12" text="These data suggest that 7-ketocholesterol upregulates IL-6 via mechanisms distinct from TNF-alpha and contributes to the intra- and extracellular IL-6 deposits within the vasculature.">
            <entity id="DS.d279.s2.e0" origId="91474" charOffset="24-41" type="compound" text="7-ketocholesterol"/>
            <entity id="DS.d279.s2.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="54-58" type="protein" text="IL-6"/>
            <entity id="DS.d279.s2.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="88-97" type="protein" text="TNF-alpha"/>
            <entity id="DS.d279.s2.e3" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="146-150" type="protein" text="IL-6"/>
            <pair e1="DS.d279.s2.e0" e2="DS.d279.s2.e1" id="DS.d279.s2.i0" interaction="True"/>
            <pair e1="DS.d279.s2.e0" e2="DS.d279.s2.e2" id="DS.d279.s2.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d279.s3" origId="18515973-3" text="7-Ketocholesterol upregulates interleukin-6 via mechanisms that are distinct from those of tumor necrosis factor-alpha, in vascular smooth muscle cells.">
            <entity id="DS.d279.s3.e0" origId="91474" charOffset="0-17" type="compound" text="7-Ketocholesterol"/>
            <entity id="DS.d279.s3.e1" origId="P41693" charOffset="30-43" type="protein" text="interleukin-6"/>
            <entity id="DS.d279.s3.e2" origId="Q8JFG3" charOffset="91-112" type="protein" text="tumor necrosis factor"/>
            <pair e1="DS.d279.s3.e0" e2="DS.d279.s3.e1" id="DS.d279.s3.i0" interaction="True"/>
            <pair e1="DS.d279.s3.e0" e2="DS.d279.s3.e2" id="DS.d279.s3.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d279.s4" origId="18515973-4" text="Among the 7 IL examined, only IL-6 transcript was increased by 7-ketocholesterol treatment in human aorta smooth muscle cells.">
            <entity id="DS.d279.s4.e0" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="30-34" type="protein" text="IL-6"/>
            <entity id="DS.d279.s4.e1" origId="91474" charOffset="63-80" type="compound" text="7-ketocholesterol"/>
            <pair e1="DS.d279.s4.e1" e2="DS.d279.s4.e0" id="DS.d279.s4.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d279.s5" origId="18515973-5" text="IL-6 transcripts increased up to 24 h after treatment with 7-ketocholesterol, and this effect was profoundly repressed by treatment with p38 MAPK inhibitors and to a lesser extent JNK inhibitors.">
            <entity id="DS.d279.s5.e0" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="0-4" type="protein" text="IL-6"/>
            <entity id="DS.d279.s5.e1" origId="91474" charOffset="59-76" type="compound" text="7-ketocholesterol"/>
            <pair e1="DS.d279.s5.e1" e2="DS.d279.s5.e0" id="DS.d279.s5.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d279.s6" origId="18515973-6" text="7alpha-Hydroxycholesterol, 27-hydroxycholesterol or cholesterol, however, did not induce IL-6 expression.">
            <entity id="DS.d279.s6.e0" origId="107722" charOffset="0-25" type="compound" text="7alpha-Hydroxycholesterol"/>
            <entity id="DS.d279.s6.e1" origId="99470,123976,50990021" charOffset="27-48" type="compound" text="27-hydroxycholesterol"/>
            <entity id="DS.d279.s6.e2" origId="304,5997,6432564,11025495" charOffset="14-25" type="compound" text="cholesterol"/>
            <entity id="DS.d279.s6.e3" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="89-93" type="protein" text="IL-6"/>
            <pair e1="DS.d279.s6.e0" e2="DS.d279.s6.e3" id="DS.d279.s6.i0" interaction="False"/>
            <pair e1="DS.d279.s6.e2" e2="DS.d279.s6.e3" id="DS.d279.s6.i1" interaction="False"/>
            <pair e1="DS.d279.s6.e1" e2="DS.d279.s6.e3" id="DS.d279.s6.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d279.s7" origId="18515973-7" text="Mechanisms of IL-6 induction by 7-ketocholesterol were investigated in comparison with tumor necrosis factor (TNF)-alpha.">
            <entity id="DS.d279.s7.e0" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="14-18" type="protein" text="IL-6"/>
            <entity id="DS.d279.s7.e1" origId="91474" charOffset="32-49" type="compound" text="7-ketocholesterol"/>
            <entity id="DS.d279.s7.e2" origId="Q8JFG3" charOffset="87-108" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d279.s7.e3" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="110-113" type="protein" text="TNF"/>
            <pair e1="DS.d279.s7.e1" e2="DS.d279.s7.e0" id="DS.d279.s7.i0" interaction="True"/>
            <pair e1="DS.d279.s7.e1" e2="DS.d279.s7.e3" id="DS.d279.s7.i1" interaction="False"/>
            <pair e1="DS.d279.s7.e1" e2="DS.d279.s7.e2" id="DS.d279.s7.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d279.s8" origId="18515973-8" text="Whereas TNF-alpha activated IL-6 promoter, which was impaired by p38 MAPK inhibitors or by mutation in the NF-kappaB-binding site within the promoter region, 7-ketocholesterol did not affect IL-6 promoter activity.">
            <entity id="DS.d279.s8.e0" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="8-17" type="protein" text="TNF-alpha"/>
            <entity id="DS.d279.s8.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="28-32" type="protein" text="IL-6"/>
            <entity id="DS.d279.s8.e2" origId="91474" charOffset="158-175" type="compound" text="7-ketocholesterol"/>
            <entity id="DS.d279.s8.e3" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="191-195" type="protein" text="IL-6"/>
            <pair e1="DS.d279.s8.e2" e2="DS.d279.s8.e0" id="DS.d279.s8.i0" interaction="False"/>
            <pair e1="DS.d279.s8.e2" e2="DS.d279.s8.e1" id="DS.d279.s8.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d279.s9" origId="18515973-9" text="7-ketocholesterol significantly increased the amount of intracellular IL-6 protein in the presence of brefeldin A.">
            <entity id="DS.d279.s9.e0" origId="91474" charOffset="0-17" type="compound" text="7-ketocholesterol"/>
            <entity id="DS.d279.s9.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="70-74" type="protein" text="IL-6"/>
            <entity id="DS.d279.s9.e2" origId="5287620" charOffset="102-113" type="compound" text="brefeldin A"/>
            <pair e1="DS.d279.s9.e0" e2="DS.d279.s9.e1" id="DS.d279.s9.i0" interaction="True"/>
            <pair e1="DS.d279.s9.e2" e2="DS.d279.s9.e1" id="DS.d279.s9.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d280" origId="18521540">
        <sentence id="DS.d280.s0" origId="18521540-51" text="AGI-1067 is a novel, phenolic antioxidant, and vascular protectant which dose-dependently inhibits PEA biomarkers in vitro.">
            <entity id="DS.d280.s0.e0" origId="216325" charOffset="0-8" type="compound" text="AGI-1067"/>
            <entity id="DS.d280.s0.e1" origId="P0C1A8,P0C1A9" charOffset="99-102" type="protein" text="PEA"/>
            <pair e1="DS.d280.s0.e0" e2="DS.d280.s0.e1" id="DS.d280.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d281" origId="18521605">
        <sentence id="DS.d281.s0" origId="18521605-224" text="Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.">
            <entity id="DS.d281.s0.e0" origId="3637" charOffset="0-11" type="compound" text="Hydralazine"/>
            <entity id="DS.d281.s0.e1" origId="P25054" charOffset="84-87" type="protein" text="APC"/>
            <pair e1="DS.d281.s0.e0" e2="DS.d281.s0.e1" id="DS.d281.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d281.s1" origId="18521605-225" text="Clinically, it has been approved that DNA methylation inhibitors, such as 5-aza-2'-deoxycytidine (5-Aza-dC), can reverse APC promoter methylation, but widespread clinical use of these inhibitors is limited by their toxicity and instability in aqueous solution.">
            <entity id="DS.d281.s1.e0" origId="451668" charOffset="74-96" type="compound" text="5-aza-2'-deoxycytidine"/>
            <entity id="DS.d281.s1.e1" origId="451668" charOffset="98-106" type="compound" text="5-Aza-dC"/>
            <entity id="DS.d281.s1.e2" origId="P25054" charOffset="121-124" type="protein" text="APC"/>
            <pair e1="DS.d281.s1.e0" e2="DS.d281.s1.e2" id="DS.d281.s1.i0" interaction="True"/>
            <pair e1="DS.d281.s1.e1" e2="DS.d281.s1.e2" id="DS.d281.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d282" origId="18521740">
        <sentence id="DS.d282.s1" origId="18521740-1015" text="Lastly, we found that the downstream metabolite of 5alpha-dihydrotestosterone, 5alpha- androstane-3beta,17beta-diol (3betaAdiol), is estrogenic in breast cancer cells, and induces growth and ER-signaling via activation of ERalpha.">
            <entity id="DS.d282.s1.e0" origId="10635" charOffset="51-77" type="compound" text="5alpha-dihydrotestosterone"/>
            <entity id="DS.d282.s1.e2" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="222-229" type="protein" text="ERalpha"/>
            <pair e1="DS.d282.s1.e0" e2="DS.d282.s1.e2" id="DS.d282.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d283" origId="18521741">
        <sentence id="DS.d283.s0" origId="18521741-219" text="Here we demonstrate that an AR ligand, 5-alpha-dihydrotestosterone (DHT), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (IGF-I).">
            <entity id="DS.d283.s0.e0" origId="15,10635" charOffset="39-66" type="compound" text="5-alpha-dihydrotestosterone"/>
            <entity id="DS.d283.s0.e1" origId="10635" charOffset="68-71" type="compound" text="DHT"/>
            <entity id="DS.d283.s0.e3" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="156-161" type="protein" text="IGF-I"/>
            <pair e1="DS.d283.s0.e0" e2="DS.d283.s0.e3" id="DS.d283.s0.i0" interaction="True"/>
            <pair e1="DS.d283.s0.e1" e2="DS.d283.s0.e3" id="DS.d283.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d284" origId="18521748">
        <sentence id="DS.d284.s0" origId="18521748-1184" text="Here, we constructed variants to test whether any of these motifs may explain why TRPM2-DeltaN does not respond to stimulation with either ADP ribose or hydrogen peroxide.">
            <entity id="DS.d284.s0.e0" origId="O94759" charOffset="82-87" type="protein" text="TRPM2"/>
            <entity id="DS.d284.s0.e1" origId="784" charOffset="153-170" type="compound" text="hydrogen peroxide"/>
            <pair e1="DS.d284.s0.e1" e2="DS.d284.s0.e0" id="DS.d284.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d285" origId="18521846">
        <sentence id="DS.d285.s0" origId="18521846-1089" text="We found that 2-methoxyestradiol induced the activation of JNK, ERK, and p38 MAPKs.">
            <entity id="DS.d285.s0.e0" origId="66414" charOffset="14-32" type="compound" text="2-methoxyestradiol"/>
            <entity id="DS.d285.s0.e1" origId="P92208,Q966Y3" charOffset="59-62" type="protein" text="JNK"/>
            <entity id="DS.d285.s0.e2" origId="P29323" charOffset="64-67" type="protein" text="ERK"/>
            <entity id="DS.d285.s0.e3" origId="O62618" charOffset="73-82" type="protein" text="p38 MAPKs"/>
            <pair e1="DS.d285.s0.e0" e2="DS.d285.s0.e2" id="DS.d285.s0.i0" interaction="True"/>
            <pair e1="DS.d285.s0.e0" e2="DS.d285.s0.e3" id="DS.d285.s0.i1" interaction="True"/>
            <pair e1="DS.d285.s0.e0" e2="DS.d285.s0.e1" id="DS.d285.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d285.s1" origId="18521846-1090" text="2-methoxyestradiol-induced JNK activation was associated with the induction of apoptosis through the mitochondrial pathways as a result of increased phosphorylation (inactivation) of the anti-apoptotic Bcl-2 and Bcl-xL proteins.">
            <entity id="DS.d285.s1.e0" origId="66414" charOffset="0-18" type="compound" text="2-methoxyestradiol"/>
            <entity id="DS.d285.s1.e1" origId="P92208,Q966Y3" charOffset="27-30" type="protein" text="JNK"/>
            <entity id="DS.d285.s1.e2" origId="P10417,P49950" charOffset="202-207" type="protein" text="Bcl-2"/>
            <pair e1="DS.d285.s1.e0" e2="DS.d285.s1.e2" id="DS.d285.s1.i0" interaction="True"/>
            <pair e1="DS.d285.s1.e0" e2="DS.d285.s1.e1" id="DS.d285.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d285.s2" origId="18521846-1091" text="In comparison, 2-methoxyestradiol-induced activation of ERK and p38 in these cells was found to have a protective effect against 2-MeO-E(2)-induced apoptosis.">
            <entity id="DS.d285.s2.e0" origId="66414" charOffset="15-33" type="compound" text="2-methoxyestradiol"/>
            <entity id="DS.d285.s2.e1" origId="P29323" charOffset="56-59" type="protein" text="ERK"/>
            <entity id="DS.d285.s2.e2" origId="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7" charOffset="64-67" type="protein" text="p38"/>
            <pair e1="DS.d285.s2.e0" e2="DS.d285.s2.e1" id="DS.d285.s2.i0" interaction="True"/>
            <pair e1="DS.d285.s2.e0" e2="DS.d285.s2.e2" id="DS.d285.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d285.s3" origId="18521846-1093" text="Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during 2-methoxyestradiol treatment.">
            <entity id="DS.d285.s3.e0" origId="P29323" charOffset="31-34" type="protein" text="ERK"/>
            <entity id="DS.d285.s3.e1" origId="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7" charOffset="39-42" type="protein" text="p38"/>
            <entity id="DS.d285.s3.e2" origId="O50017,P08469,P14043,P31669,P35875,P55057,Q08824,Q11208" charOffset="107-111" type="protein" text="PARP"/>
            <entity id="DS.d285.s3.e3" origId="P27297" charOffset="163-175" type="protein" text="proteins Bax"/>
            <entity id="DS.d285.s3.e4" origId="O54918,O88498" charOffset="180-183" type="protein" text="Bim"/>
            <entity id="DS.d285.s3.e5" origId="66414" charOffset="233-251" type="compound" text="2-methoxyestradiol"/>
            <pair e1="DS.d285.s3.e5" e2="DS.d285.s3.e0" id="DS.d285.s3.i0" interaction="False"/>
            <pair e1="DS.d285.s3.e5" e2="DS.d285.s3.e3" id="DS.d285.s3.i1" interaction="False"/>
            <pair e1="DS.d285.s3.e5" e2="DS.d285.s3.e2" id="DS.d285.s3.i2" interaction="False"/>
            <pair e1="DS.d285.s3.e5" e2="DS.d285.s3.e4" id="DS.d285.s3.i3" interaction="False"/>
            <pair e1="DS.d285.s3.e5" e2="DS.d285.s3.e1" id="DS.d285.s3.i4" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d286" origId="18521859">
        <sentence id="DS.d286.s0" origId="18521859-1108" text="Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of DA transporter, which is a target of methamphetamine (METH).">
            <entity id="DS.d286.s0.e0" origId="53477912" charOffset="36-56" type="compound" text="phosphatidylinositol"/>
            <entity id="DS.d286.s0.e1" origId="681" charOffset="110-118" type="compound" text="dopamine"/>
            <entity id="DS.d286.s0.e2" origId="P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6" charOffset="146-160" type="protein" text="DA transporter"/>
            <entity id="DS.d286.s0.e3" origId="1206,10836,36604" charOffset="183-198" type="compound" text="methamphetamine"/>
            <pair e1="DS.d286.s0.e1" e2="DS.d286.s0.e2" id="DS.d286.s0.i0" interaction="False"/>
            <pair e1="DS.d286.s0.e3" e2="DS.d286.s0.e2" id="DS.d286.s0.i1" interaction="True"/>
            <pair e1="DS.d286.s0.e0" e2="DS.d286.s0.e2" id="DS.d286.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d287" origId="18522674">
        <sentence id="DS.d287.s0" origId="18522674-789" text="Celecoxib caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (PGE (2)) concentrations, accompanied by a compensatory increase in COX-2 mRNA expression.">
            <entity id="DS.d287.s0.e0" origId="2662" charOffset="0-9" type="compound" text="Celecoxib"/>
            <entity id="DS.d287.s0.e1" origId="Q29458" charOffset="91-94" type="protein" text="PGE"/>
            <entity id="DS.d287.s0.e2" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="158-163" type="protein" text="COX-2"/>
            <pair e1="DS.d287.s0.e0" e2="DS.d287.s0.e2" id="DS.d287.s0.i0" interaction="True"/>
            <pair e1="DS.d287.s0.e0" e2="DS.d287.s0.e1" id="DS.d287.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d287.s1" origId="18522674-790" text="However, celecoxib had no effect on COX-2 protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible nitric-oxide synthase.">
            <entity id="DS.d287.s1.e0" origId="2662" charOffset="9-18" type="compound" text="celecoxib"/>
            <entity id="DS.d287.s1.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="36-41" type="protein" text="COX-2"/>
            <entity id="DS.d287.s1.e2" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="174-195" type="protein" text="nitric-oxide synthase"/>
            <pair e1="DS.d287.s1.e0" e2="DS.d287.s1.e1" id="DS.d287.s1.i0" interaction="False"/>
            <pair e1="DS.d287.s1.e0" e2="DS.d287.s1.e2" id="DS.d287.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d287.s2" origId="18522674-791" text="These data indicate that celecoxib reduces intratesticular activity of COX-2 (as indicated by PGE (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.">
            <entity id="DS.d287.s2.e0" origId="2662" charOffset="25-34" type="compound" text="celecoxib"/>
            <entity id="DS.d287.s2.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="71-76" type="protein" text="COX-2"/>
            <entity id="DS.d287.s2.e2" origId="Q29458" charOffset="94-97" type="protein" text="PGE"/>
            <pair e1="DS.d287.s2.e0" e2="DS.d287.s2.e1" id="DS.d287.s2.i0" interaction="True"/>
            <pair e1="DS.d287.s2.e0" e2="DS.d287.s2.e2" id="DS.d287.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d287.s3" origId="18522674-792" text="These results indicate significant roles for products of the COX-2 pathway in testicular vascular control and steroidogenesis, which may have implications for men with marginal fertility taking celecoxib for extended periods, but also highlight the potential of this drug to ameliorate testicular damage caused by systemic or local inflammation.">
            <entity id="DS.d287.s3.e0" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="61-66" type="protein" text="COX-2"/>
            <entity id="DS.d287.s3.e1" origId="2662" charOffset="194-203" type="compound" text="celecoxib"/>
            <pair e1="DS.d287.s3.e1" e2="DS.d287.s3.e0" id="DS.d287.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d288" origId="18528683">
        <sentence id="DS.d288.s0" origId="18528683-286" text="At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of glutathione reductase (GR) and contents of reduced glutathione (GSH) and hydroxyproline (Hpr) in the lung as well as serum level of tumor necrosis factor-alpha (TNF-alpha) were evaluated.">
            <entity id="DS.d288.s0.e0" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="108-129" type="protein" text="glutathione reductase"/>
            <entity id="DS.d288.s0.e1" origId="124886" charOffset="151-170" type="compound" text="reduced glutathione"/>
            <entity id="DS.d288.s0.e2" origId="124886" charOffset="172-175" type="compound" text="GSH"/>
            <entity id="DS.d288.s0.e3" origId="825,5810,69248,440015" charOffset="181-195" type="compound" text="hydroxyproline"/>
            <entity id="DS.d288.s0.e4" origId="Q8JFG3" charOffset="240-261" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d288.s0.e5" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="269-278" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d288.s0.e3" e2="DS.d288.s0.e5" id="DS.d288.s0.i0" interaction="False"/>
            <pair e1="DS.d288.s0.e1" e2="DS.d288.s0.e5" id="DS.d288.s0.i1" interaction="False"/>
            <pair e1="DS.d288.s0.e1" e2="DS.d288.s0.e0" id="DS.d288.s0.i2" interaction="False"/>
            <pair e1="DS.d288.s0.e2" e2="DS.d288.s0.e5" id="DS.d288.s0.i3" interaction="False"/>
            <pair e1="DS.d288.s0.e1" e2="DS.d288.s0.e4" id="DS.d288.s0.i4" interaction="False"/>
            <pair e1="DS.d288.s0.e2" e2="DS.d288.s0.e0" id="DS.d288.s0.i5" interaction="False"/>
            <pair e1="DS.d288.s0.e3" e2="DS.d288.s0.e4" id="DS.d288.s0.i6" interaction="False"/>
            <pair e1="DS.d288.s0.e3" e2="DS.d288.s0.e0" id="DS.d288.s0.i7" interaction="False"/>
            <pair e1="DS.d288.s0.e2" e2="DS.d288.s0.e4" id="DS.d288.s0.i8" interaction="False"/>
        </sentence>
        <sentence id="DS.d288.s1" origId="18528683-287" text="The obtained data revealed that BCNU induced pathological changes and markedly increased lung collagen and level of Hpr but decreased GSH content and GR activity and increased serum TNF-alpha compared to both control and MT-administered rats.">
            <entity id="DS.d288.s1.e0" origId="2578" charOffset="32-36" type="compound" text="BCNU"/>
            <entity id="DS.d288.s1.e1" origId="P0AA04,P0AA07,P11065,P77335" charOffset="116-119" type="protein" text="Hpr"/>
            <entity id="DS.d288.s1.e2" origId="124886" charOffset="134-137" type="compound" text="GSH"/>
            <entity id="DS.d288.s1.e3" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="182-191" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d288.s1.e2" e2="DS.d288.s1.e1" id="DS.d288.s1.i0" interaction="False"/>
            <pair e1="DS.d288.s1.e0" e2="DS.d288.s1.e1" id="DS.d288.s1.i1" interaction="True"/>
            <pair e1="DS.d288.s1.e0" e2="DS.d288.s1.e3" id="DS.d288.s1.i2" interaction="True"/>
            <pair e1="DS.d288.s1.e2" e2="DS.d288.s1.e3" id="DS.d288.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d289" origId="18528747">
        <sentence id="DS.d289.s0" origId="18528747-574" text="Collectively, HMB supplementation increased concentrations of short-chain fatty acids in intestinal lumen, expression of proglucagon, GLP-2R, and eNOS genes, and net portal absorption of AA.">
            <entity id="DS.d289.s0.e0" origId="P06116" charOffset="14-17" type="protein" text="HMB"/>
            <entity id="DS.d289.s0.e1" origId="176" charOffset="62-85" type="compound" text="short-chain fatty acids"/>
            <entity id="DS.d289.s0.e2" origId="O95838,Q9Z0W0" charOffset="134-140" type="protein" text="GLP-2R"/>
            <entity id="DS.d289.s0.e3" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="146-150" type="protein" text="eNOS"/>
            <pair e1="DS.d289.s0.e1" e2="DS.d289.s0.e0" id="DS.d289.s0.i0" interaction="True"/>
            <pair e1="DS.d289.s0.e1" e2="DS.d289.s0.e2" id="DS.d289.s0.i1" interaction="False"/>
            <pair e1="DS.d289.s0.e1" e2="DS.d289.s0.e3" id="DS.d289.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d290" origId="18528783">
        <sentence id="DS.d290.s0" origId="18528783-293" text="In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of RB-2, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, 1-amino-4-bromoanthraquinone 2-sulfonic acid esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat NTPDase1, 2, and 3 using a capillary electrophoresis assay.">
            <entity id="DS.d290.s0.e0" origId="656725" charOffset="144-148" type="compound" text="RB-2"/>
            <entity id="DS.d290.s0.e1" origId="22628" charOffset="252-296" type="compound" text="1-amino-4-bromoanthraquinone 2-sulfonic acid"/>
            <entity id="DS.d290.s0.e2" origId="O18956,O93295,P49961,P55772,P97687,Q9MYU4" charOffset="420-428" type="protein" text="NTPDase1"/>
            <pair e1="DS.d290.s0.e1" e2="DS.d290.s0.e2" id="DS.d290.s0.i0" interaction="False"/>
            <pair e1="DS.d290.s0.e0" e2="DS.d290.s0.e2" id="DS.d290.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d291" origId="18533896">
        <sentence id="DS.d291.s0" origId="18533896-944" text="Plasma insulin 0.05) following ingestion of GluF than after Glu alone, without any differences between the effects of either intervention on plasma glucose concentrations.">
            <entity id="DS.d291.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="7-14" type="protein" text="insulin"/>
            <entity id="DS.d291.s0.e1" origId="206,5793,64689,79025" charOffset="148-155" type="compound" text="glucose"/>
            <pair e1="DS.d291.s0.e1" e2="DS.d291.s0.e0" id="DS.d291.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d292" origId="18534791">
        <sentence id="DS.d292.s0" origId="18534791-223" text="No significant differences were observed in plasma concentrations of glucose, NEFA, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease beta hydroxybutyrate postpartum compared to CTL cows.">
            <entity id="DS.d292.s0.e0" origId="206,5793,64689,79025" charOffset="69-76" type="compound" text="glucose"/>
            <entity id="DS.d292.s0.e1" origId="P80303" charOffset="78-82" type="protein" text="NEFA"/>
            <entity id="DS.d292.s0.e3" origId="441" charOffset="187-207" type="compound" text="beta hydroxybutyrate"/>
            <pair e1="DS.d292.s0.e0" e2="DS.d292.s0.e1" id="DS.d292.s0.i0" interaction="False"/>
            <pair e1="DS.d292.s0.e3" e2="DS.d292.s0.e1" id="DS.d292.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d293" origId="18534811">
        <sentence id="DS.d293.s0" origId="18534811-234" text="The results showed that colchicine augmented splenic-specific IgG1 and IL-4 as well as cell proliferation but suppressed specific IgG2a and IFN-gamma levels.">
            <entity id="DS.d293.s0.e0" origId="2833,6167,53278" charOffset="24-34" type="compound" text="colchicine"/>
            <entity id="DS.d293.s0.e1" origId="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58" charOffset="71-75" type="protein" text="IL-4"/>
            <entity id="DS.d293.s0.e2" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="140-149" type="protein" text="IFN-gamma"/>
            <pair e1="DS.d293.s0.e0" e2="DS.d293.s0.e2" id="DS.d293.s0.i0" interaction="True"/>
            <pair e1="DS.d293.s0.e0" e2="DS.d293.s0.e1" id="DS.d293.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d294" origId="18534874">
        <sentence id="DS.d294.s0" origId="18534874-957" text="Sunitinib malate (Pfizer, Inc.) is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor (VEGF) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, Flt3, RET, and Kit.">
            <entity id="DS.d294.s0.e0" origId="5329102" charOffset="0-16" type="compound" text="Sunitinib malate"/>
            <entity id="DS.d294.s0.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="118-122" type="protein" text="VEGF"/>
            <entity id="DS.d294.s0.e2" origId="Q00342" charOffset="214-218" type="protein" text="Flt3"/>
            <entity id="DS.d294.s0.e3" origId="P07949" charOffset="220-223" type="protein" text="RET"/>
            <pair e1="DS.d294.s0.e0" e2="DS.d294.s0.e3" id="DS.d294.s0.i0" interaction="True"/>
            <pair e1="DS.d294.s0.e0" e2="DS.d294.s0.e2" id="DS.d294.s0.i1" interaction="True"/>
            <pair e1="DS.d294.s0.e0" e2="DS.d294.s0.e1" id="DS.d294.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d295" origId="18536700">
        <sentence id="DS.d295.s0" origId="18536700-664" text="Narp deletion blocks extinction of morphine place preference conditioning.">
            <entity id="DS.d295.s0.e0" origId="P97738" charOffset="0-4" type="protein" text="Narp"/>
            <entity id="DS.d295.s0.e1" origId="5288826,5479215" charOffset="35-43" type="compound" text="morphine"/>
            <pair e1="DS.d295.s0.e1" e2="DS.d295.s0.e0" id="DS.d295.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d295.s1" origId="18536700-665" text="Accordingly, to assess its potential role in the long-lasting behavioral effects of drugs of abuse, we have investigated the impact of Narp deletion on sustained behavioral responses elicited by repeated morphine administration.">
            <entity id="DS.d295.s1.e0" origId="P97738" charOffset="135-139" type="protein" text="Narp"/>
            <entity id="DS.d295.s1.e1" origId="5288826,5479215" charOffset="204-212" type="compound" text="morphine"/>
            <pair e1="DS.d295.s1.e1" e2="DS.d295.s1.e0" id="DS.d295.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d296" origId="18536704">
        <sentence id="DS.d296.s0" origId="18536704-162" text="Decreased dopamine D4 receptor expression increases extracellular glutamate and alters its regulation in mouse striatum.">
            <entity id="DS.d296.s0.e0" origId="P21917,P30729,P51436,Q6TLJ0" charOffset="10-30" type="protein" text="dopamine D4 receptor"/>
            <entity id="DS.d296.s0.e1" origId="611,23327,33032" charOffset="66-75" type="compound" text="glutamate"/>
            <pair e1="DS.d296.s0.e1" e2="DS.d296.s0.e0" id="DS.d296.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d297" origId="18536705">
        <sentence id="DS.d297.s0" origId="18536705-163" text="injection of PACAP provoked a significant increase in plasma glucose level.">
            <entity id="DS.d297.s0.e0" origId="O70176,P13589,P16613,P18509,P41535,P41585,P48144,P81039,Q29W19" charOffset="13-18" type="protein" text="PACAP"/>
            <entity id="DS.d297.s0.e1" origId="206,5793,64689,79025" charOffset="61-68" type="compound" text="glucose"/>
            <pair e1="DS.d297.s0.e1" e2="DS.d297.s0.e0" id="DS.d297.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d298" origId="18536954">
        <sentence id="DS.d298.s0" origId="18536954-285" text="In 17 adults on a fixed metabolic diet, an 11-day course of cinacalcet increased serum gastrin and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.">
            <entity id="DS.d298.s0.e0" origId="156419" charOffset="60-70" type="compound" text="cinacalcet"/>
            <entity id="DS.d298.s0.e1" origId="O02686,P01350,P01351,P01352,P01353,P01354,P04563,P04564,P06885,P10034,P33713,P33714,P48757,P55885" charOffset="87-94" type="protein" text="gastrin"/>
            <pair e1="DS.d298.s0.e0" e2="DS.d298.s0.e1" id="DS.d298.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d299" origId="18537150">
        <sentence id="DS.d299.s0" origId="18537150-81" text="Since PSC-833 was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on esterases, phenol sulfotransferases, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.">
            <entity id="DS.d299.s0.e0" origId="5281884" charOffset="6-13" type="compound" text="PSC-833"/>
            <entity id="DS.d299.s0.e1" origId="P16397,P18773" charOffset="95-104" type="protein" text="esterases"/>
            <entity id="DS.d299.s0.e2" origId="P17988,P50227,P52840,P52846,P82609,Q29476,Q80VR3" charOffset="106-130" type="protein" text="phenol sulfotransferases"/>
            <entity id="DS.d299.s0.e3" origId="5281884" charOffset="176-183" type="compound" text="PSC-833"/>
            <pair e1="DS.d299.s0.e0" e2="DS.d299.s0.e2" id="DS.d299.s0.i0" interaction="False"/>
            <pair e1="DS.d299.s0.e0" e2="DS.d299.s0.e1" id="DS.d299.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d300" origId="18538372">
        <sentence id="DS.d300.s0" origId="18538372-777" text="We showed that after treatment of HCT116 cells with a low dose of doxorubicin most of them stopped proliferation as documented by SA-beta-galactosidase activity and the lack of Ki67 expression.">
            <entity id="DS.d300.s0.e0" origId="31703" charOffset="66-77" type="compound" text="doxorubicin"/>
            <entity id="DS.d300.s0.e1" origId="O33815,O52629,O52847,P00722,P00723,P06219,P0C1Y0,P14288,P22498,P23989,P24131,P26257,P30812,P50388,P70753,P77989,P81650,Q1G9Z4,Q47077,Q48727,Q56307,Q59140,Q59750,Q9K9C6" charOffset="133-151" type="protein" text="beta-galactosidase"/>
            <pair e1="DS.d300.s0.e0" e2="DS.d300.s0.e1" id="DS.d300.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d302" origId="18539357">
        <sentence id="DS.d302.s0" origId="18539357-492" text="Tumor MUC1 differs from normal MUC1 by modified glycan side chains.">
            <entity id="DS.d302.s0.e0" origId="P08640,P15941,Q29435,Q60528" charOffset="6-10" type="protein" text="MUC1"/>
            <entity id="DS.d302.s0.e1" origId="P08640,P15941,Q29435,Q60528" charOffset="31-35" type="protein" text="MUC1"/>
            <entity id="DS.d302.s0.e2" origId="871" charOffset="48-54" type="compound" text="glycan"/>
            <pair e1="DS.d302.s0.e2" e2="DS.d302.s0.e0" id="DS.d302.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d303" origId="18539387">
        <sentence id="DS.d303.s0" origId="18539387-509" text="Mineralization and dehalogenation of 2,4,6-TCP was evidenced by high COD removal efficiencies (approximately 95%), and by the stoichiometric release of chloride ions from the halogenated compound (approximately 80%).">
            <entity id="DS.d303.s0.e0" origId="6914" charOffset="37-46" type="compound" text="2,4,6-TCP"/>
            <entity id="DS.d303.s0.e1" origId="P14678" charOffset="69-72" type="protein" text="COD"/>
            <entity id="DS.d303.s0.e2" origId="312" charOffset="152-160" type="compound" text="chloride"/>
            <pair e1="DS.d303.s0.e0" e2="DS.d303.s0.e1" id="DS.d303.s0.i0" interaction="True"/>
            <pair e1="DS.d303.s0.e2" e2="DS.d303.s0.e1" id="DS.d303.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d305" origId="18541345">
        <sentence id="DS.d305.s0" origId="18541345-459" text="Gliclazide can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in CYP2C9 and CYP2C19.">
            <entity id="DS.d305.s0.e0" origId="3475" charOffset="0-10" type="compound" text="Gliclazide"/>
            <entity id="DS.d305.s0.e1" origId="3475" charOffset="105-115" type="compound" text="gliclazide"/>
            <entity id="DS.d305.s0.e2" origId="P11712" charOffset="195-201" type="protein" text="CYP2C9"/>
            <entity id="DS.d305.s0.e3" origId="P33261" charOffset="206-213" type="protein" text="CYP2C19"/>
            <pair e1="DS.d305.s0.e0" e2="DS.d305.s0.e3" id="DS.d305.s0.i0" interaction="True"/>
            <pair e1="DS.d305.s0.e1" e2="DS.d305.s0.e2" id="DS.d305.s0.i1" interaction="True"/>
            <pair e1="DS.d305.s0.e0" e2="DS.d305.s0.e2" id="DS.d305.s0.i2" interaction="True"/>
            <pair e1="DS.d305.s0.e1" e2="DS.d305.s0.e3" id="DS.d305.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d306" origId="18543297">
        <sentence id="DS.d306.s0" origId="18543297-399" text="Metabolism of dextrorphan by CYP2D6 in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism.">
            <entity id="DS.d306.s0.e0" origId="3918,5360697" charOffset="14-25" type="compound" text="dextrorphan"/>
            <entity id="DS.d306.s0.e1" origId="P10635,Q2XNC8,Q2XNC9" charOffset="29-35" type="protein" text="CYP2D6"/>
            <entity id="DS.d306.s0.e2" origId="3008,5360696,5362449,12305042" charOffset="133-149" type="compound" text="dextromethorphan"/>
            <pair e1="DS.d306.s0.e0" e2="DS.d306.s0.e1" id="DS.d306.s0.i0" interaction="True"/>
            <pair e1="DS.d306.s0.e2" e2="DS.d306.s0.e1" id="DS.d306.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d306.s1" origId="18543297-400" text="Cytochrome P450 2D6 (CYP2D6) mediated formation of dextrorphan (DOR) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.">
            <entity id="DS.d306.s1.e0" origId="P10635,Q2XNC8,Q2XNC9" charOffset="0-19" type="protein" text="Cytochrome P450 2D6"/>
            <entity id="DS.d306.s1.e1" origId="P10635,Q2XNC8,Q2XNC9" charOffset="21-27" type="protein" text="CYP2D6"/>
            <entity id="DS.d306.s1.e2" origId="3918,5360697" charOffset="51-62" type="compound" text="dextrorphan"/>
            <entity id="DS.d306.s1.e3" origId="439216" charOffset="64-67" type="compound" text="DOR"/>
            <entity id="DS.d306.s1.e4" origId="3008,5360696,5362449,12305042" charOffset="74-90" type="compound" text="dextromethorphan"/>
            <pair e1="DS.d306.s1.e4" e2="DS.d306.s1.e0" id="DS.d306.s1.i0" interaction="True"/>
            <pair e1="DS.d306.s1.e2" e2="DS.d306.s1.e0" id="DS.d306.s1.i1" interaction="True"/>
            <pair e1="DS.d306.s1.e2" e2="DS.d306.s1.e1" id="DS.d306.s1.i2" interaction="True"/>
            <pair e1="DS.d306.s1.e4" e2="DS.d306.s1.e1" id="DS.d306.s1.i3" interaction="True"/>
            <pair e1="DS.d306.s1.e3" e2="DS.d306.s1.e0" id="DS.d306.s1.i4" interaction="True"/>
            <pair e1="DS.d306.s1.e3" e2="DS.d306.s1.e1" id="DS.d306.s1.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d306.s2" origId="18543297-401" text="The sequential metabolism of DOR during in vitro studies, particularly using recombinant systems (rCYPs) expressing human CYP2D6, is assumed to be negligible.">
            <entity id="DS.d306.s2.e0" origId="439216" charOffset="29-32" type="compound" text="DOR"/>
            <entity id="DS.d306.s2.e1" origId="P10635,Q2XNC8,Q2XNC9" charOffset="122-128" type="protein" text="CYP2D6"/>
            <pair e1="DS.d306.s2.e0" e2="DS.d306.s2.e1" id="DS.d306.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d306.s3" origId="18543297-402" text="The extent of metabolism was investigated for a range of DEX and DOR concentrations in microsomal preparations from three different rCYPs expressing human CYP2D6 (yeast, Supersomes and Bactosomes) containing 10 pmol of the enzyme.">
            <entity id="DS.d306.s3.e0" origId="439216" charOffset="65-68" type="compound" text="DOR"/>
            <entity id="DS.d306.s3.e1" origId="P10635,Q2XNC8,Q2XNC9" charOffset="155-161" type="protein" text="CYP2D6"/>
            <pair e1="DS.d306.s3.e0" e2="DS.d306.s3.e1" id="DS.d306.s3.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d306.s4" origId="18543297-403" text="Two novel CYP2D6 related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of DOR and HYM using ion-trap mass spectrometry.">
            <entity id="DS.d306.s4.e0" origId="P10635,Q2XNC8,Q2XNC9" charOffset="10-16" type="protein" text="CYP2D6"/>
            <entity id="DS.d306.s4.e1" origId="439216" charOffset="129-132" type="compound" text="DOR"/>
            <entity id="DS.d306.s4.e2" origId="11840954" charOffset="137-140" type="compound" text="HYM"/>
            <pair e1="DS.d306.s4.e1" e2="DS.d306.s4.e0" id="DS.d306.s4.i0" interaction="True"/>
            <pair e1="DS.d306.s4.e2" e2="DS.d306.s4.e0" id="DS.d306.s4.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d307" origId="18543330">
        <sentence id="DS.d307.s0" origId="18543330-427" text="The metal-coordinating residues in the active site of ILL2 include a conserved cysteine that clearly distinguishes this protein from previously structurally characterized members of the M20 peptidase family.">
            <entity id="DS.d307.s0.e0" origId="P54970" charOffset="54-58" type="protein" text="ILL2"/>
            <entity id="DS.d307.s0.e1" origId="594,5862,5360637" charOffset="79-87" type="compound" text="cysteine"/>
            <pair e1="DS.d307.s0.e1" e2="DS.d307.s0.e0" id="DS.d307.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d307.s1" origId="18543330-428" text="Finally, the active site of ILL2 harbors an absolutely conserved glutamate (Glu172), which is well positioned to act as a general acid-base residue.">
            <entity id="DS.d307.s1.e0" origId="P54970" charOffset="28-32" type="protein" text="ILL2"/>
            <entity id="DS.d307.s1.e1" origId="611,23327,33032" charOffset="65-74" type="compound" text="glutamate"/>
            <pair e1="DS.d307.s1.e1" e2="DS.d307.s1.e0" id="DS.d307.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d308" origId="18544044">
        <sentence id="DS.d308.s0" origId="18544044-880" text="In this study, we tested the hypothesis that the Angiopoietin 1 (Ang1)/Tie2 pathway mediates simvastatin-induced vascular integrity and migration of neuroblasts after stroke.">
            <entity id="DS.d308.s0.e0" origId="P21570" charOffset="65-69" type="protein" text="Ang1"/>
            <entity id="DS.d308.s0.e1" origId="O73791,Q02858" charOffset="71-75" type="protein" text="Tie2"/>
            <entity id="DS.d308.s0.e2" origId="54454,4677798" charOffset="93-104" type="compound" text="simvastatin"/>
            <pair e1="DS.d308.s0.e2" e2="DS.d308.s0.e1" id="DS.d308.s0.i0" interaction="False"/>
            <pair e1="DS.d308.s0.e2" e2="DS.d308.s0.e0" id="DS.d308.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d308.s1" origId="18544044-881" text="Simvastatin treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased Ang1, Tie2 and Occludin expression in the ischaemic border (IBZ) compared to the MCAo control group.">
            <entity id="DS.d308.s1.e0" origId="54454,4677798" charOffset="0-11" type="compound" text="Simvastatin"/>
            <entity id="DS.d308.s1.e1" origId="P21570" charOffset="109-113" type="protein" text="Ang1"/>
            <entity id="DS.d308.s1.e2" origId="O73791,Q02858" charOffset="115-119" type="protein" text="Tie2"/>
            <entity id="DS.d308.s1.e3" origId="Q16625,Q28269,Q28793,Q5RFS5,Q61146,Q6P6T5,Q91049,Q9PUN1" charOffset="124-132" type="protein" text="Occludin"/>
            <pair e1="DS.d308.s1.e0" e2="DS.d308.s1.e2" id="DS.d308.s1.i0" interaction="True"/>
            <pair e1="DS.d308.s1.e0" e2="DS.d308.s1.e3" id="DS.d308.s1.i1" interaction="True"/>
            <pair e1="DS.d308.s1.e0" e2="DS.d308.s1.e1" id="DS.d308.s1.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d308.s2" origId="18544044-882" text="Simvastatin also significantly increased doublecortin (DCX, a marker of migrating neuroblasts) expression in the IBZ compared to control MCAo rats.">
            <entity id="DS.d308.s2.e0" origId="54454,4677798" charOffset="0-11" type="compound" text="Simvastatin"/>
            <entity id="DS.d308.s2.e1" origId="O43602" charOffset="55-58" type="protein" text="DCX"/>
            <pair e1="DS.d308.s2.e0" e2="DS.d308.s2.e1" id="DS.d308.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d308.s3" origId="18544044-883" text="The data show that simvastatin treatment of RBMEC increased Ang1 and Tie2 gene and protein expression and promoted phosphorylated-Tie2 activity.">
            <entity id="DS.d308.s3.e0" origId="54454,4677798" charOffset="19-30" type="compound" text="simvastatin"/>
            <entity id="DS.d308.s3.e1" origId="P21570" charOffset="60-64" type="protein" text="Ang1"/>
            <entity id="DS.d308.s3.e2" origId="O73791,Q02858" charOffset="69-73" type="protein" text="Tie2"/>
            <entity id="DS.d308.s3.e3" origId="O73791,Q02858" charOffset="130-134" type="protein" text="Tie2"/>
            <pair e1="DS.d308.s3.e0" e2="DS.d308.s3.e2" id="DS.d308.s3.i0" interaction="True"/>
            <pair e1="DS.d308.s3.e0" e2="DS.d308.s3.e1" id="DS.d308.s3.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d308.s4" origId="18544044-884" text="Simvastatin treatment of stroke increases Ang1/Tie2 expression and thereby reduces BBB leakage and promotes vascular stabilization.">
            <entity id="DS.d308.s4.e0" origId="54454,4677798" charOffset="0-11" type="compound" text="Simvastatin"/>
            <entity id="DS.d308.s4.e1" origId="P21570" charOffset="42-46" type="protein" text="Ang1"/>
            <entity id="DS.d308.s4.e2" origId="O73791,Q02858" charOffset="47-51" type="protein" text="Tie2"/>
            <pair e1="DS.d308.s4.e0" e2="DS.d308.s4.e2" id="DS.d308.s4.i0" interaction="True"/>
            <pair e1="DS.d308.s4.e0" e2="DS.d308.s4.e1" id="DS.d308.s4.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d308.s5" origId="18544044-885" text="Ang1/Tie2 expression induced by simvastatin treatment promotes neuroblast micro-vascular coupling after stroke.">
            <entity id="DS.d308.s5.e0" origId="P21570" charOffset="0-4" type="protein" text="Ang1"/>
            <entity id="DS.d308.s5.e1" origId="O73791,Q02858" charOffset="5-9" type="protein" text="Tie2"/>
            <entity id="DS.d308.s5.e2" origId="54454,4677798" charOffset="32-43" type="compound" text="simvastatin"/>
            <pair e1="DS.d308.s5.e2" e2="DS.d308.s5.e1" id="DS.d308.s5.i0" interaction="True"/>
            <pair e1="DS.d308.s5.e2" e2="DS.d308.s5.e0" id="DS.d308.s5.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d309" origId="18544047">
        <sentence id="DS.d309.s0" origId="18544047-888" text="Suppressing the activity of ERRalpha in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal glucose uptake.">
            <entity id="DS.d309.s0.e0" origId="O08580,P11474" charOffset="28-36" type="protein" text="ERRalpha"/>
            <entity id="DS.d309.s0.e1" origId="206,5793,64689,79025" charOffset="125-132" type="compound" text="glucose"/>
            <pair e1="DS.d309.s0.e1" e2="DS.d309.s0.e0" id="DS.d309.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d309.s2" origId="18544047-891" text="Therefore, ERRalpha stands at the crossroad of glucose and fatty acid utilization and acts as a homeostatic switch to regulate the flux of TCA cycle, mitochondrial membrane potential and glycolysis to maintain a steady level of ATP production, particularly, when mitochondrial biogenesis is reduced.">
            <entity id="DS.d309.s2.e0" origId="O08580,P11474" charOffset="11-19" type="protein" text="ERRalpha"/>
            <entity id="DS.d309.s2.e1" origId="206,5793,64689,79025" charOffset="47-54" type="compound" text="glucose"/>
            <entity id="DS.d309.s2.e2" origId="5957" charOffset="228-231" type="compound" text="ATP"/>
            <pair e1="DS.d309.s2.e2" e2="DS.d309.s2.e0" id="DS.d309.s2.i0" interaction="True"/>
            <pair e1="DS.d309.s2.e1" e2="DS.d309.s2.e0" id="DS.d309.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d310" origId="18544592">
        <sentence id="DS.d310.s0" origId="18544592-1218" text="A significant decrease in mean total nitric oxide (NOx), nitrite, and nitrate levels was also found after G-CSF plus dexamethasone administration.">
            <entity id="DS.d310.s0.e0" origId="145068" charOffset="37-49" type="compound" text="nitric oxide"/>
            <entity id="DS.d310.s0.e1" origId="943" charOffset="70-77" type="compound" text="nitrate"/>
            <entity id="DS.d310.s0.e2" origId="O02708,O02837,P09919,P09920,P35833,P35834,Q28746" charOffset="106-111" type="protein" text="G-CSF"/>
            <entity id="DS.d310.s0.e3" origId="5743" charOffset="117-130" type="compound" text="dexamethasone"/>
            <pair e1="DS.d310.s0.e1" e2="DS.d310.s0.e2" id="DS.d310.s0.i0" interaction="True"/>
            <pair e1="DS.d310.s0.e3" e2="DS.d310.s0.e2" id="DS.d310.s0.i1" interaction="False"/>
            <pair e1="DS.d310.s0.e0" e2="DS.d310.s0.e2" id="DS.d310.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d310.s1" origId="18544592-1219" text="Even if partially compensated with u-PA and protein C, increased FVIII and vWF activity, and decreased nitric oxide levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus dexamethasone administered healthy granulocyte donors.">
            <entity id="DS.d310.s1.e0" origId="O55527,O55779,P02810,P03314,P03424,P04861,P04862,P06022,P06164,P06165,P06941,P07602,P08097,P10030,P14253,P14254,P14340,P26035,P26779,P27384,P28055,P29165,P32533,P32534,P32535,P35940,P35948,P35977,P69738,Q00794,Q03339,Q074N0,Q1X880,Q1X881,Q6DV88,Q6J3P1,Q89277,Q98803,Q997F1,Q9DUE0,Q9WS38,Q9YRV3" charOffset="44-53" type="protein" text="protein C"/>
            <entity id="DS.d310.s1.e1" origId="P04275,P80012,Q28295,Q28833,Q8CIZ8" charOffset="75-78" type="protein" text="vWF"/>
            <entity id="DS.d310.s1.e2" origId="145068" charOffset="103-115" type="compound" text="nitric oxide"/>
            <entity id="DS.d310.s1.e3" origId="5743" charOffset="201-214" type="compound" text="dexamethasone"/>
            <pair e1="DS.d310.s1.e3" e2="DS.d310.s1.e0" id="DS.d310.s1.i0" interaction="False"/>
            <pair e1="DS.d310.s1.e2" e2="DS.d310.s1.e1" id="DS.d310.s1.i1" interaction="False"/>
            <pair e1="DS.d310.s1.e3" e2="DS.d310.s1.e1" id="DS.d310.s1.i2" interaction="False"/>
            <pair e1="DS.d310.s1.e2" e2="DS.d310.s1.e0" id="DS.d310.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d312" origId="18547170">
        <sentence id="DS.d312.s0" origId="18547170-484" text="Amyloglucosidase from Rhizopus mould and beta-glucosidase from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).">
            <entity id="DS.d312.s0.e0" origId="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684" charOffset="41-57" type="protein" text="beta-glucosidase"/>
            <entity id="DS.d312.s0.e1" origId="1183" charOffset="148-156" type="compound" text="vanillin"/>
            <entity id="DS.d312.s0.e2" origId="2998" charOffset="158-178" type="compound" text="N-vanillylnonanamide"/>
            <entity id="DS.d312.s0.e3" origId="836" charOffset="180-187" type="compound" text="DL-dopa"/>
            <entity id="DS.d312.s0.e4" origId="681" charOffset="189-197" type="compound" text="dopamine"/>
            <entity id="DS.d312.s0.e5" origId="969516" charOffset="199-207" type="compound" text="curcumin"/>
            <entity id="DS.d312.s0.e6" origId="2116,14985" charOffset="209-225" type="compound" text="alpha-tocopherol"/>
            <entity id="DS.d312.s0.e7" origId="2116,14985,1548900,1742129" charOffset="227-236" type="compound" text="vitamin E"/>
            <entity id="DS.d312.s0.e8" origId="1054" charOffset="239-249" type="compound" text="pyridoxine"/>
            <entity id="DS.d312.s0.e9" origId="3249" charOffset="266-291" type="compound" text="ergocalciferol (vitamin D"/>
            <entity id="DS.d312.s0.e10" origId="1130" charOffset="298-305" type="compound" text="thiamin"/>
            <entity id="DS.d312.s0.e11" origId="1072,6759,493570" charOffset="325-335" type="compound" text="riboflavin"/>
            <pair e1="DS.d312.s0.e10" e2="DS.d312.s0.e0" id="DS.d312.s0.i0" interaction="True"/>
            <pair e1="DS.d312.s0.e4" e2="DS.d312.s0.e0" id="DS.d312.s0.i1" interaction="True"/>
            <pair e1="DS.d312.s0.e6" e2="DS.d312.s0.e0" id="DS.d312.s0.i2" interaction="True"/>
            <pair e1="DS.d312.s0.e5" e2="DS.d312.s0.e0" id="DS.d312.s0.i3" interaction="True"/>
            <pair e1="DS.d312.s0.e3" e2="DS.d312.s0.e0" id="DS.d312.s0.i4" interaction="True"/>
            <pair e1="DS.d312.s0.e8" e2="DS.d312.s0.e0" id="DS.d312.s0.i5" interaction="True"/>
            <pair e1="DS.d312.s0.e7" e2="DS.d312.s0.e0" id="DS.d312.s0.i6" interaction="True"/>
            <pair e1="DS.d312.s0.e2" e2="DS.d312.s0.e0" id="DS.d312.s0.i7" interaction="True"/>
            <pair e1="DS.d312.s0.e1" e2="DS.d312.s0.e0" id="DS.d312.s0.i8" interaction="True"/>
            <pair e1="DS.d312.s0.e9" e2="DS.d312.s0.e0" id="DS.d312.s0.i9" interaction="True"/>
            <pair e1="DS.d312.s0.e11" e2="DS.d312.s0.e0" id="DS.d312.s0.i10" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d313" origId="18547363">
        <sentence id="DS.d313.s0" origId="18547363-1222" text="Ochratoxin A impairs Nrf2-dependent gene expression in porcine kidney tubulus cells.">
            <entity id="DS.d313.s0.e0" origId="442530" charOffset="0-12" type="compound" text="Ochratoxin A"/>
            <entity id="DS.d313.s0.e1" origId="O54968,Q60795" charOffset="21-25" type="protein" text="Nrf2"/>
            <pair e1="DS.d313.s0.e0" e2="DS.d313.s0.e1" id="DS.d313.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d313.s1" origId="18547363-1223" text="Therefore, in the present study, the effects of OTA on the nuclear translocation and transactivation of the transcription factor Nrf2 as well as mRNA levels of Nrf2 target genes including glutathione-S-transferase and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).">
            <entity id="DS.d313.s1.e0" origId="444766" charOffset="48-51" type="compound" text="OTA"/>
            <entity id="DS.d313.s1.e1" origId="O54968,Q60795" charOffset="129-133" type="protein" text="Nrf2"/>
            <entity id="DS.d313.s1.e2" origId="O54968,Q60795" charOffset="160-164" type="protein" text="Nrf2"/>
            <entity id="DS.d313.s1.e3" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="188-213" type="protein" text="glutathione-S-transferase"/>
            <pair e1="DS.d313.s1.e0" e2="DS.d313.s1.e1" id="DS.d313.s1.i0" interaction="False"/>
            <pair e1="DS.d313.s1.e0" e2="DS.d313.s1.e3" id="DS.d313.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d313.s2" origId="18547363-1224" text="Nrf2 was induced by sulforaphane, a well-known activator of this transcription factor.">
            <entity id="DS.d313.s2.e0" origId="O54968,Q60795" charOffset="0-4" type="protein" text="Nrf2"/>
            <entity id="DS.d313.s2.e1" origId="5350" charOffset="20-32" type="compound" text="sulforaphane"/>
            <pair e1="DS.d313.s2.e1" e2="DS.d313.s2.e0" id="DS.d313.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d313.s3" origId="18547363-1225" text="Ochratoxin A significantly decreased gamma-glutamylcysteinyl synthetase and glutathione-S-transferase mRNA levels in LLC-PK1 cells.">
            <entity id="DS.d313.s3.e0" origId="442530" charOffset="0-12" type="compound" text="Ochratoxin A"/>
            <entity id="DS.d313.s3.e1" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="76-101" type="protein" text="glutathione-S-transferase"/>
            <pair e1="DS.d313.s3.e0" e2="DS.d313.s3.e1" id="DS.d313.s3.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d313.s4" origId="18547363-1226" text="Furthermore, OTA also lowered Nrf2 mRNA levels.">
            <entity id="DS.d313.s4.e0" origId="444766" charOffset="13-16" type="compound" text="OTA"/>
            <entity id="DS.d313.s4.e1" origId="O54968,Q60795" charOffset="30-34" type="protein" text="Nrf2"/>
            <pair e1="DS.d313.s4.e0" e2="DS.d313.s4.e1" id="DS.d313.s4.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d313.s5" origId="18547363-1227" text="Current data indicate that OTA nephrotoxicity may be, at least partly, mediated by an Nrf2-dependent signal transduction pathway.">
            <entity id="DS.d313.s5.e0" origId="444766" charOffset="27-30" type="compound" text="OTA"/>
            <entity id="DS.d313.s5.e1" origId="O54968,Q60795" charOffset="86-90" type="protein" text="Nrf2"/>
            <pair e1="DS.d313.s5.e0" e2="DS.d313.s5.e1" id="DS.d313.s5.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d314" origId="18547754">
        <sentence id="DS.d314.s0" origId="18547754-637" text="Parthenogenetic porcine blastocysts were generated by the following methods: (1) electroporation followed by blocking the activity of specific protein kinases with butyrolactone I ; (2) electroporation followed by inhibition of protein synthesis using cycloheximide ; and (3) electroporation only (control).">
            <entity id="DS.d314.s0.e0" origId="P00513,P25848" charOffset="143-158" type="protein" text="protein kinases"/>
            <entity id="DS.d314.s0.e1" origId="123740,5235506,51340302" charOffset="164-179" type="compound" text="butyrolactone I"/>
            <entity id="DS.d314.s0.e2" origId="6197" charOffset="252-265" type="compound" text="cycloheximide"/>
            <pair e1="DS.d314.s0.e1" e2="DS.d314.s0.e0" id="DS.d314.s0.i0" interaction="True"/>
            <pair e1="DS.d314.s0.e2" e2="DS.d314.s0.e0" id="DS.d314.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d315" origId="18547755">
        <sentence id="DS.d315.s0" origId="18547755-125" text="The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and progesterone.">
            <entity id="DS.d315.s0.e0" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="91-98" type="protein" text="ERalpha"/>
            <entity id="DS.d315.s0.e1" origId="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32" charOffset="100-106" type="protein" text="ERbeta"/>
            <entity id="DS.d315.s0.e2" origId="5757" charOffset="310-319" type="compound" text="estradiol"/>
            <entity id="DS.d315.s0.e3" origId="5994" charOffset="324-336" type="compound" text="progesterone"/>
            <pair e1="DS.d315.s0.e3" e2="DS.d315.s0.e0" id="DS.d315.s0.i0" interaction="False"/>
            <pair e1="DS.d315.s0.e2" e2="DS.d315.s0.e0" id="DS.d315.s0.i1" interaction="False"/>
            <pair e1="DS.d315.s0.e3" e2="DS.d315.s0.e1" id="DS.d315.s0.i2" interaction="False"/>
            <pair e1="DS.d315.s0.e2" e2="DS.d315.s0.e1" id="DS.d315.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d316" origId="18547796">
        <sentence id="DS.d316.s0" origId="18547796-661" text="Increased incorporation of dietary plant sterols and cholesterol correlates with decreased expression of hepatic and intestinal Abcg5 and Abcg8 in diabetic BB rats.">
            <entity id="DS.d316.s0.e0" origId="304,5997,6432564,11025495" charOffset="53-64" type="compound" text="cholesterol"/>
            <entity id="DS.d316.s0.e1" origId="Q99PE7,Q99PE8" charOffset="128-133" type="protein" text="Abcg5"/>
            <entity id="DS.d316.s0.e2" origId="P58428,Q9DBM0" charOffset="138-143" type="protein" text="Abcg8"/>
            <pair e1="DS.d316.s0.e0" e2="DS.d316.s0.e2" id="DS.d316.s0.i0" interaction="True"/>
            <pair e1="DS.d316.s0.e0" e2="DS.d316.s0.e1" id="DS.d316.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d316.s1" origId="18547796-662" text="This increase in cholesterol and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal Abcg5 (ATP-binding cassette transporter G5) and Abcg8 (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.">
            <entity id="DS.d316.s1.e0" origId="304,5997,6432564,11025495" charOffset="17-28" type="compound" text="cholesterol"/>
            <entity id="DS.d316.s1.e1" origId="Q99PE7,Q99PE8" charOffset="123-128" type="protein" text="Abcg5"/>
            <entity id="DS.d316.s1.e2" origId="P58428,Q9DBM0" charOffset="171-176" type="protein" text="Abcg8"/>
            <pair e1="DS.d316.s1.e0" e2="DS.d316.s1.e2" id="DS.d316.s1.i0" interaction="True"/>
            <pair e1="DS.d316.s1.e0" e2="DS.d316.s1.e1" id="DS.d316.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d316.s2" origId="18547796-663" text="Therefore, lower expression levels of Abcg5/Abcg8 in diabetic rats may account for the increased accumulation of plant sterols and cholesterol in these rats.">
            <entity id="DS.d316.s2.e0" origId="Q99PE7,Q99PE8" charOffset="38-43" type="protein" text="Abcg5"/>
            <entity id="DS.d316.s2.e1" origId="P58428,Q9DBM0" charOffset="44-49" type="protein" text="Abcg8"/>
            <entity id="DS.d316.s2.e2" origId="304,5997,6432564,11025495" charOffset="131-142" type="compound" text="cholesterol"/>
            <pair e1="DS.d316.s2.e2" e2="DS.d316.s2.e1" id="DS.d316.s2.i0" interaction="True"/>
            <pair e1="DS.d316.s2.e2" e2="DS.d316.s2.e0" id="DS.d316.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d317" origId="18547798">
        <sentence id="DS.d317.s0" origId="18547798-666" text="Gallic acid, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (CAT.05).">
            <entity id="DS.d317.s0.e0" origId="370" charOffset="0-11" type="compound" text="Gallic acid"/>
            <entity id="DS.d317.s0.e1" origId="445858" charOffset="13-25" type="compound" text="ferulic acid"/>
            <entity id="DS.d317.s0.e2" origId="637542" charOffset="30-45" type="compound" text="p-coumaric acid"/>
            <entity id="DS.d317.s0.e3" origId="O50258" charOffset="137-157" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d317.s0.e4" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="159-181" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d317.s0.e5" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="192-200" type="protein" text="catalase"/>
            <entity id="DS.d317.s0.e6" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="202-205" type="protein" text="CAT"/>
            <pair e1="DS.d317.s0.e1" e2="DS.d317.s0.e4" id="DS.d317.s0.i0" interaction="True"/>
            <pair e1="DS.d317.s0.e0" e2="DS.d317.s0.e4" id="DS.d317.s0.i1" interaction="True"/>
            <pair e1="DS.d317.s0.e2" e2="DS.d317.s0.e3" id="DS.d317.s0.i2" interaction="True"/>
            <pair e1="DS.d317.s0.e2" e2="DS.d317.s0.e4" id="DS.d317.s0.i3" interaction="True"/>
            <pair e1="DS.d317.s0.e1" e2="DS.d317.s0.e6" id="DS.d317.s0.i4" interaction="True"/>
            <pair e1="DS.d317.s0.e0" e2="DS.d317.s0.e6" id="DS.d317.s0.i5" interaction="True"/>
            <pair e1="DS.d317.s0.e0" e2="DS.d317.s0.e5" id="DS.d317.s0.i6" interaction="True"/>
            <pair e1="DS.d317.s0.e0" e2="DS.d317.s0.e3" id="DS.d317.s0.i7" interaction="True"/>
            <pair e1="DS.d317.s0.e2" e2="DS.d317.s0.e6" id="DS.d317.s0.i8" interaction="True"/>
            <pair e1="DS.d317.s0.e2" e2="DS.d317.s0.e5" id="DS.d317.s0.i9" interaction="True"/>
            <pair e1="DS.d317.s0.e1" e2="DS.d317.s0.e5" id="DS.d317.s0.i10" interaction="True"/>
            <pair e1="DS.d317.s0.e1" e2="DS.d317.s0.e3" id="DS.d317.s0.i11" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d318" origId="18547799">
        <sentence id="DS.d318.s0" origId="18547799-292" text="These effects of genistein during the differentiation period were associated with down-regulation of ERalpha and ERbeta expression.">
            <entity id="DS.d318.s0.e0" origId="5280961" charOffset="17-26" type="compound" text="genistein"/>
            <entity id="DS.d318.s0.e1" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="101-108" type="protein" text="ERalpha"/>
            <entity id="DS.d318.s0.e2" origId="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32" charOffset="113-119" type="protein" text="ERbeta"/>
            <pair e1="DS.d318.s0.e0" e2="DS.d318.s0.e1" id="DS.d318.s0.i0" interaction="True"/>
            <pair e1="DS.d318.s0.e0" e2="DS.d318.s0.e2" id="DS.d318.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d319" origId="18548182">
        <sentence id="DS.d319.s0" origId="18548182-922" text="Activities of microbial extracellular enzymes involved in carbon, nitrogen, and phosphorus cycling declined appreciably with depth, the only exception being peroxidase.">
            <entity id="DS.d319.s0.e0" origId="947,123329" charOffset="66-74" type="compound" text="nitrogen"/>
            <entity id="DS.d319.s0.e1" origId="24404,139579" charOffset="80-90" type="compound" text="phosphorus"/>
            <entity id="DS.d319.s0.e2" origId="P15984,P16147,P84714" charOffset="157-167" type="protein" text="peroxidase"/>
            <pair e1="DS.d319.s0.e0" e2="DS.d319.s0.e2" id="DS.d319.s0.i0" interaction="False"/>
            <pair e1="DS.d319.s0.e1" e2="DS.d319.s0.e2" id="DS.d319.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d320" origId="18548275">
        <sentence id="DS.d320.s0" origId="18548275-801" text="Sulfonylurea (SU) treatment restores insulin secretion in patients with KCNJ11 mutations.">
            <entity id="DS.d320.s0.e0" origId="104818" charOffset="0-12" type="compound" text="Sulfonylurea"/>
            <entity id="DS.d320.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="37-44" type="protein" text="insulin"/>
            <entity id="DS.d320.s0.e2" origId="O02822,Q14654,Q9JHJ9" charOffset="72-78" type="protein" text="KCNJ11"/>
            <pair e1="DS.d320.s0.e0" e2="DS.d320.s0.e2" id="DS.d320.s0.i0" interaction="False"/>
            <pair e1="DS.d320.s0.e0" e2="DS.d320.s0.e1" id="DS.d320.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d321" origId="18548615">
        <sentence id="DS.d321.s0" origId="18548615-1193" text="The purpose of this study was to investigate the effect of three zinc salts (i.e., zinc oxide, zinc carbonate, and zinc acetate) on insulin encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (PLGA) microspheres.">
            <entity id="DS.d321.s0.e0" origId="14806" charOffset="83-93" type="compound" text="zinc oxide"/>
            <entity id="DS.d321.s0.e1" origId="767" charOffset="95-109" type="compound" text="zinc carbonate"/>
            <entity id="DS.d321.s0.e2" origId="176" charOffset="115-127" type="compound" text="zinc acetate"/>
            <entity id="DS.d321.s0.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="132-139" type="protein" text="insulin"/>
            <entity id="DS.d321.s0.e5" origId="36797" charOffset="248-252" type="compound" text="PLGA"/>
            <pair e1="DS.d321.s0.e1" e2="DS.d321.s0.e3" id="DS.d321.s0.i0" interaction="False"/>
            <pair e1="DS.d321.s0.e2" e2="DS.d321.s0.e3" id="DS.d321.s0.i1" interaction="False"/>
            <pair e1="DS.d321.s0.e5" e2="DS.d321.s0.e3" id="DS.d321.s0.i2" interaction="False"/>
            <pair e1="DS.d321.s0.e0" e2="DS.d321.s0.e3" id="DS.d321.s0.i4" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d322" origId="18550063">
        <sentence id="DS.d322.s0" origId="18550063-794" text="Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation.">
            <entity id="DS.d322.s0.e0" origId="Q8JFG3" charOffset="0-21" type="protein" text="Tumor necrosis factor"/>
            <entity id="DS.d322.s0.e1" origId="44268108" charOffset="56-65" type="compound" text="endotoxin"/>
            <pair e1="DS.d322.s0.e1" e2="DS.d322.s0.e0" id="DS.d322.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d322.s1" origId="18550063-795" text="In the present study, we investigated whether endotoxin-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether tumor necrosis factor-alpha (TNFalpha) plays a role in this process.">
            <entity id="DS.d322.s1.e0" origId="44268108" charOffset="46-55" type="compound" text="endotoxin"/>
            <entity id="DS.d322.s1.e1" origId="Q8JFG3" charOffset="164-185" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d322.s1.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="193-201" type="protein" text="TNFalpha"/>
            <pair e1="DS.d322.s1.e0" e2="DS.d322.s1.e1" id="DS.d322.s1.i0" interaction="False"/>
            <pair e1="DS.d322.s1.e0" e2="DS.d322.s1.e2" id="DS.d322.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d323" origId="18550164">
        <sentence id="DS.d323.s0" origId="18550164-868" text="The amino acid sequence deduced from the coding sequence encodes for a protein of 73 amino acids containing 21 cysteine residues.">
            <entity id="DS.d323.s0.e0" origId="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005" charOffset="69-78" type="protein" text="a protein"/>
            <entity id="DS.d323.s0.e1" origId="594,5862,5360637" charOffset="111-119" type="compound" text="cysteine"/>
            <pair e1="DS.d323.s0.e1" e2="DS.d323.s0.e0" id="DS.d323.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d324" origId="18550594">
        <sentence id="DS.d324.s0" origId="18550594-1147" text="Ultrastructural analysis in the macaque mediodorsal nucleus revealed that thalamic interneurons are a main postsynaptic target of DAT-ir axons ; this suggests that the marked expansion of the dopamine innervation in the primate in comparison to the rodent thalamus may be related to the presence of a sizable interneuron population in primates.">
            <entity id="DS.d324.s0.e0" origId="P13483,P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6" charOffset="130-133" type="protein" text="DAT"/>
            <entity id="DS.d324.s0.e1" origId="681" charOffset="192-200" type="compound" text="dopamine"/>
            <pair e1="DS.d324.s0.e1" e2="DS.d324.s0.e0" id="DS.d324.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d325" origId="18550596">
        <sentence id="DS.d325.s0" origId="18550596-1150" text="Synapsin-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-actin polymerization with cytochalasin B in hippocampal slices.">
            <entity id="DS.d325.s0.e0" origId="Q24546" charOffset="0-8" type="protein" text="Synapsin"/>
            <entity id="DS.d325.s0.e1" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="87-92" type="protein" text="actin"/>
            <entity id="DS.d325.s0.e2" origId="2919,5311281,5368686,5836499,6364615,6433621" charOffset="113-127" type="compound" text="cytochalasin B"/>
            <pair e1="DS.d325.s0.e2" e2="DS.d325.s0.e0" id="DS.d325.s0.i0" interaction="True"/>
            <pair e1="DS.d325.s0.e2" e2="DS.d325.s0.e1" id="DS.d325.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d326" origId="18551377">
        <sentence id="DS.d326.s0" origId="18551377-641" text="Transformation was achieved using a vector that targets genes to the rrn16/rps12 intergenic region of the sugar beet plastome, employing the aadA gene as a selectable marker against spectinomycin and the gfp gene for visual screening of plastid transformants.">
            <entity id="DS.d326.s0.e0" origId="O14062,P02368,P06368,P11524,P13576,P14149,P17293,P17294,P19461,P29161,P39573,P41196,P42344,P46296,P46308,P47333,P47840,P48856,P49168,P49500,P51289,P52762,P56354,P59168,P61941,P62127,P63196,P63199,P63200,P63323,P63324,P74230,Q2JMY0,Q2JUX7,Q318N2,Q3AMT3,Q3AW56,Q3MDM2,Q46IW1,Q5F1R7,Q68S28,Q6B8X8,Q6ENC0,Q6L3C7,Q6YXM6,Q70XU7,Q7NAV1,Q7NEF4,Q7U4D4,Q7UZY4,Q7V503,Q7VA02,Q85BW6,Q85FG4,Q85X49,Q8KTP6,Q8MA18,Q8RUK6,Q8VMU2,Q8YP60,Q9AIG9,Q9CL86,Q9MUP2,Q9PPW5,Q9TJR0,Q9TKZ7,Q9TLV6,Q9XQE1" charOffset="75-80" type="protein" text="rps12"/>
            <entity id="DS.d326.s0.e1" origId="P08881,P0AG05,P0AG06" charOffset="141-145" type="protein" text="aadA"/>
            <entity id="DS.d326.s0.e2" origId="15541" charOffset="182-195" type="compound" text="spectinomycin"/>
            <pair e1="DS.d326.s0.e2" e2="DS.d326.s0.e1" id="DS.d326.s0.i0" interaction="True"/>
            <pair e1="DS.d326.s0.e2" e2="DS.d326.s0.e0" id="DS.d326.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d327" origId="18552508">
        <sentence id="DS.d327.s0" origId="18552508-1057" text="Celecoxib inhibits serum amyloid a-induced matrix metalloproteinase-10 expression in human endothelial cells.">
            <entity id="DS.d327.s0.e0" origId="2662" charOffset="0-9" type="compound" text="Celecoxib"/>
            <entity id="DS.d327.s0.e1" origId="O55123,P07152,P09238" charOffset="43-70" type="protein" text="matrix metalloproteinase-10"/>
            <pair e1="DS.d327.s0.e0" e2="DS.d327.s0.e1" id="DS.d327.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d328" origId="18553142">
        <sentence id="DS.d328.s0" origId="18553142-185" text="This article investigated the effect of sulfite on total antioxidant capacity (TAC), total oxidant status, lipid hydroperoxide (LOOH), and total free sulfydryl groups (-SH) levels in normal and SOX-deficient male albino rat plasma.">
            <entity id="DS.d328.s0.e0" origId="784" charOffset="113-126" type="compound" text="hydroperoxide"/>
            <entity id="DS.d328.s0.e1" origId="P79371,Q8JGM4,Q9S850" charOffset="194-197" type="protein" text="SOX"/>
            <pair e1="DS.d328.s0.e0" e2="DS.d328.s0.e1" id="DS.d328.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d328.s1" origId="18553142-186" text="SOX deficiency was established by feeding rats a low molybdenum diet and adding to their drinking water 200 ppm tungsten.">
            <entity id="DS.d328.s1.e0" origId="P79371,Q8JGM4,Q9S850" charOffset="0-3" type="protein" text="SOX"/>
            <entity id="DS.d328.s1.e1" origId="6422,23932" charOffset="53-63" type="compound" text="molybdenum"/>
            <entity id="DS.d328.s1.e2" origId="23964" charOffset="112-120" type="compound" text="tungsten"/>
            <pair e1="DS.d328.s1.e2" e2="DS.d328.s1.e0" id="DS.d328.s1.i0" interaction="True"/>
            <pair e1="DS.d328.s1.e1" e2="DS.d328.s1.e0" id="DS.d328.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d330" origId="18554595">
        <sentence id="DS.d330.s0" origId="18554595-1071" text="To test the hypothesis that DHEAS production from DHEA occurs in hepatic cells and that this production is augmented by the presence of sex steroids or insulin.">
            <entity id="DS.d330.s0.e0" origId="12594" charOffset="28-33" type="compound" text="DHEAS"/>
            <entity id="DS.d330.s0.e1" origId="5881" charOffset="28-32" type="compound" text="DHEA"/>
            <entity id="DS.d330.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="152-159" type="protein" text="insulin"/>
            <pair e1="DS.d330.s0.e1" e2="DS.d330.s0.e2" id="DS.d330.s0.i0" interaction="False"/>
            <pair e1="DS.d330.s0.e0" e2="DS.d330.s0.e2" id="DS.d330.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d331" origId="18554598">
        <sentence id="DS.d331.s0" origId="18554598-1073" text="Changes in tumor necrosis factor (TNF) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.">
            <entity id="DS.d331.s0.e0" origId="Q8JFG3" charOffset="11-32" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d331.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="34-37" type="protein" text="TNF"/>
            <entity id="DS.d331.s0.e2" origId="11970143" charOffset="53-71" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d331.s0.e3" origId="10631" charOffset="209-228" type="compound" text="medroxyprogesterone"/>
            <pair e1="DS.d331.s0.e3" e2="DS.d331.s0.e0" id="DS.d331.s0.i0" interaction="False"/>
            <pair e1="DS.d331.s0.e2" e2="DS.d331.s0.e1" id="DS.d331.s0.i1" interaction="True"/>
            <pair e1="DS.d331.s0.e2" e2="DS.d331.s0.e0" id="DS.d331.s0.i2" interaction="True"/>
            <pair e1="DS.d331.s0.e3" e2="DS.d331.s0.e1" id="DS.d331.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d332" origId="18554690">
        <sentence id="DS.d332.s0" origId="18554690-393" text="The differences in tissue distribution and protein levels of EcR-B1 during the programmed cell death indicate that the receptor plays a major role in the modulation and function of ecdysone activity in Bombyx anterior silk glands.">
            <entity id="DS.d332.s0.e0" origId="O18473,O18531,P34021,P49880,P49881,P49882,P49883" charOffset="61-64" type="protein" text="EcR"/>
            <entity id="DS.d332.s0.e1" origId="19212,4233007,5316996" charOffset="181-189" type="compound" text="ecdysone"/>
            <pair e1="DS.d332.s0.e1" e2="DS.d332.s0.e0" id="DS.d332.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d333" origId="18555241">
        <sentence id="DS.d333.s0" origId="18555241-208" text="Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression.">
            <entity id="DS.d333.s0.e0" origId="969516" charOffset="0-8" type="compound" text="Curcumin"/>
            <entity id="DS.d333.s0.e1" origId="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400" charOffset="113-124" type="protein" text="fibronectin"/>
            <pair e1="DS.d333.s0.e0" e2="DS.d333.s0.e1" id="DS.d333.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d334" origId="18555557">
        <sentence id="DS.d334.s0" origId="18555557-379" text="Methylthioadenosine phosphorylase (MTAP) is involved in the metabolism of purines and converts methylthioadenosine (MTA) to adenine.">
            <entity id="DS.d334.s0.e0" origId="Q13126" charOffset="35-39" type="protein" text="MTAP"/>
            <entity id="DS.d334.s0.e1" origId="190" charOffset="124-131" type="compound" text="adenine"/>
            <pair e1="DS.d334.s0.e1" e2="DS.d334.s0.e0" id="DS.d334.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d334.s1" origId="18555557-380" text="Methylation-specific primers were used to analyze methylation of the MTAP promoter, using DNA treated with sodium bisulfite.">
            <entity id="DS.d334.s1.e0" origId="Q13126" charOffset="69-73" type="protein" text="MTAP"/>
            <entity id="DS.d334.s1.e1" origId="23665763" charOffset="107-123" type="compound" text="sodium bisulfite"/>
            <pair e1="DS.d334.s1.e1" e2="DS.d334.s1.e0" id="DS.d334.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d335" origId="18555679">
        <sentence id="DS.d335.s0" origId="18555679-458" text="Long-chain fatty alcohols also reduced tumor necrosis factor-alpha and prostaglandin E(2) production, although the potency of inhibition for the latter was lower.">
            <entity id="DS.d335.s0.e0" origId="62238" charOffset="11-25" type="compound" text="fatty alcohols"/>
            <entity id="DS.d335.s0.e1" origId="Q8JFG3" charOffset="39-60" type="protein" text="tumor necrosis factor"/>
            <pair e1="DS.d335.s0.e0" e2="DS.d335.s0.e1" id="DS.d335.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d336" origId="18556000">
        <sentence id="DS.d336.s0" origId="18556000-671" text="Neopterin is released from human monocyte-derived macrophages upon stimulation with interferon-gamma and is a sensitive indicator for cellular immune activation.">
            <entity id="DS.d336.s0.e0" origId="4455" charOffset="0-9" type="compound" text="Neopterin"/>
            <entity id="DS.d336.s0.e1" origId="Q9TTB0" charOffset="84-100" type="protein" text="interferon-gamma"/>
            <pair e1="DS.d336.s0.e0" e2="DS.d336.s0.e1" id="DS.d336.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d337" origId="18556087">
        <sentence id="DS.d337.s0" origId="18556087-712" text="Both activity and expression of sulfate transporters and APS reductase in plants are modulated by the sulfur status of the plant.">
            <entity id="DS.d337.s0.e0" origId="O70531,P50443,Q62273" charOffset="32-52" type="protein" text="sulfate transporters"/>
            <entity id="DS.d337.s0.e2" origId="402" charOffset="102-108" type="compound" text="sulfur"/>
            <pair e1="DS.d337.s0.e2" e2="DS.d337.s0.e0" id="DS.d337.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d338" origId="18560889">
        <sentence id="DS.d338.s0" origId="18560889-729" text="Complex I deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of adenosine triphosphate (ATP) needed for the maintenance of ion gradients across membranes.">
            <entity id="DS.d338.s0.e0" origId="Q07842" charOffset="0-9" type="protein" text="Complex I"/>
            <entity id="DS.d338.s0.e1" origId="5957" charOffset="101-123" type="compound" text="adenosine triphosphate"/>
            <entity id="DS.d338.s0.e2" origId="5957" charOffset="125-128" type="compound" text="ATP"/>
            <pair e1="DS.d338.s0.e1" e2="DS.d338.s0.e0" id="DS.d338.s0.i0" interaction="True"/>
            <pair e1="DS.d338.s0.e2" e2="DS.d338.s0.e0" id="DS.d338.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d339" origId="18561093">
        <sentence id="DS.d339.s0" origId="18561093-53" text="This prospective cross-sectional study was performed to investigate the influence of GH excess on leptin and ghrelin levels at baseline and after glucose load in a large group of acromegalic patients.">
            <entity id="DS.d339.s0.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="98-104" type="protein" text="leptin"/>
            <entity id="DS.d339.s0.e1" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="109-116" type="protein" text="ghrelin"/>
            <entity id="DS.d339.s0.e2" origId="206,5793,64689,79025" charOffset="146-153" type="compound" text="glucose"/>
            <pair e1="DS.d339.s0.e2" e2="DS.d339.s0.e0" id="DS.d339.s0.i0" interaction="False"/>
            <pair e1="DS.d339.s0.e2" e2="DS.d339.s0.e1" id="DS.d339.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d340" origId="18561170">
        <sentence id="DS.d340.s0" origId="18561170-499" text="Trypsin digestion, fluorescence anisotropy, and NMR experiments presented here were designed to resolve the issue and show that in arm-dimerization domain, the arms are structured, although differently, in the presence and absence of arabinose.">
            <entity id="DS.d340.s0.e0" origId="P23916,P24664,P35050,P83348,Q59149" charOffset="0-7" type="protein" text="Trypsin"/>
            <entity id="DS.d340.s0.e1" origId="66308" charOffset="234-243" type="compound" text="arabinose"/>
            <pair e1="DS.d340.s0.e1" e2="DS.d340.s0.e0" id="DS.d340.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d341" origId="18561187">
        <sentence id="DS.d341.s0" origId="18561187-110" text="DNA array studies have revealed that YhaK is strongly up-regulated by nitroso-glutathione (GSNO) and also displays a 12-fold increase in expression during biofilm growth of E. coli 83972 and VR50 in human urine.">
            <entity id="DS.d341.s0.e0" origId="P42624,P58115" charOffset="37-41" type="protein" text="YhaK"/>
            <entity id="DS.d341.s0.e2" origId="3514,104858,10404739" charOffset="91-95" type="compound" text="GSNO"/>
            <pair e1="DS.d341.s0.e2" e2="DS.d341.s0.e0" id="DS.d341.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d341.s1" origId="18561187-111" text="We found that the third cysteine in YhaK, Cys122, is oxidized to a sulfenic acid.">
            <entity id="DS.d341.s1.e0" origId="594,5862,5360637" charOffset="24-32" type="compound" text="cysteine"/>
            <entity id="DS.d341.s1.e1" origId="P42624,P58115" charOffset="36-40" type="protein" text="YhaK"/>
            <entity id="DS.d341.s1.e2" origId="447587" charOffset="67-80" type="compound" text="sulfenic acid"/>
            <pair e1="DS.d341.s1.e0" e2="DS.d341.s1.e1" id="DS.d341.s1.i0" interaction="False"/>
            <pair e1="DS.d341.s1.e2" e2="DS.d341.s1.e1" id="DS.d341.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d341.s2" origId="18561187-112" text="E. coli thioredoxin reductase and NADPH produced ROS and caused oxidation and oligomerization of reduced YhaK.">
            <entity id="DS.d341.s2.e0" origId="O14313,O22711,O30973,O32823,O43099,O66790,O69777,O83790,O84101,P0A9P4,P0A9P5,P0AE52,P0AE53,P0AE54,P0AE55,P14292,P14293,P21762,P26830,P30044,P34227,P39916,P40553,P43496,P43788,P44411,P44758,P46843,P47348,P49537,P50971,P51272,P51978,P52213,P52214,P52215,P55979,P56431,P56577,P56578,P56876,P57279,P57399,P61076,P65688,P65689,P66010,P66011,P73728,P75531,P80880,P80892,P81433,P94284,P99029,P99101,Q01116,Q05741,Q25861,Q53212,Q55624,Q5HHQ4,Q5HQW4,Q6BIS1,Q6C7L4,Q6FR39,Q6GB66,Q6GIM7,Q75CM8,Q7Z7S3,Q89AJ2,Q89AS1,Q8CPY8,Q8J0U0,Q8K9W0,Q8T6Z1,Q92375,Q928B5,Q92I02,Q98PK9,Q9BGI1,Q9GLW7,Q9GLW9,Q9KSS4,Q9M7T0,Q9PKT7,Q9PR71,Q9R063,Q9Z8M4,Q9ZD97,Q9ZHF0,Q9ZL18,Q9ZMU4" charOffset="8-29" type="protein" text="thioredoxin reductase"/>
            <entity id="DS.d341.s2.e1" origId="5884" charOffset="34-39" type="compound" text="NADPH"/>
            <entity id="DS.d341.s2.e2" origId="P42624,P58115" charOffset="105-109" type="protein" text="YhaK"/>
            <pair e1="DS.d341.s2.e1" e2="DS.d341.s2.e2" id="DS.d341.s2.i0" interaction="True"/>
            <pair e1="DS.d341.s2.e1" e2="DS.d341.s2.e0" id="DS.d341.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d342" origId="18562331">
        <sentence id="DS.d342.s0" origId="18562331-1081" text="In this report, we investigated the possible role of LA and vmPFC NR2Bs in the consolidation of fear extinction using the NR2B-selective antagonist ifenprodil.">
            <entity id="DS.d342.s0.e0" origId="Q00960,Q01097,Q13224" charOffset="66-71" type="protein" text="NR2Bs"/>
            <entity id="DS.d342.s0.e1" origId="Q00960,Q01097,Q13224" charOffset="66-70" type="protein" text="NR2B"/>
            <entity id="DS.d342.s0.e2" origId="3689,6604117,11198145,11771731" charOffset="148-158" type="compound" text="ifenprodil"/>
            <pair e1="DS.d342.s0.e2" e2="DS.d342.s0.e1" id="DS.d342.s0.i0" interaction="False"/>
            <pair e1="DS.d342.s0.e2" e2="DS.d342.s0.e0" id="DS.d342.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d343" origId="18562423">
        <sentence id="DS.d343.s0" origId="18562423-1156" text="Patients under clozapine-risperidone therapy developed a rise of serum prolactin levels.">
            <entity id="DS.d343.s0.e0" origId="2818" charOffset="15-24" type="compound" text="clozapine"/>
            <entity id="DS.d343.s0.e1" origId="5073" charOffset="25-36" type="compound" text="risperidone"/>
            <entity id="DS.d343.s0.e2" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="71-80" type="protein" text="prolactin"/>
            <pair e1="DS.d343.s0.e1" e2="DS.d343.s0.e2" id="DS.d343.s0.i0" interaction="True"/>
            <pair e1="DS.d343.s0.e0" e2="DS.d343.s0.e2" id="DS.d343.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d344" origId="18562442">
        <sentence id="DS.d344.s0" origId="18562442-1178" text="In experiment 3, administration of E(2) or DPN to ovariectomised wildtype, but not betaERKO, mice decreased immobility compared with vehicle administration, these data suggest that ERbeta may be required for some of the anti-depressant-like effects of E(2).">
            <entity id="DS.d344.s0.e0" origId="926,5893,447862" charOffset="43-46" type="compound" text="DPN"/>
            <entity id="DS.d344.s0.e1" origId="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32" charOffset="181-187" type="protein" text="ERbeta"/>
            <pair e1="DS.d344.s0.e0" e2="DS.d344.s0.e1" id="DS.d344.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d345" origId="18563306">
        <sentence id="DS.d345.s0" origId="18563306-164" text="Simvastatin treatment significantly increased the number of peripheral blood CD34+ CD133+ cells, and serum concentration of vascular endothelial growth factor (VEGF) and AKT was markedly increased in vivo.">
            <entity id="DS.d345.s0.e0" origId="54454,4677798" charOffset="0-11" type="compound" text="Simvastatin"/>
            <entity id="DS.d345.s0.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="160-164" type="protein" text="VEGF"/>
            <pair e1="DS.d345.s0.e0" e2="DS.d345.s0.e1" id="DS.d345.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d345.s1" origId="18563306-165" text="In cultured EPC, simvastatin increased the concentrations of VEGF, AKT and eNOS.">
            <entity id="DS.d345.s1.e0" origId="54454,4677798" charOffset="17-28" type="compound" text="simvastatin"/>
            <entity id="DS.d345.s1.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="61-65" type="protein" text="VEGF"/>
            <entity id="DS.d345.s1.e2" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="75-79" type="protein" text="eNOS"/>
            <pair e1="DS.d345.s1.e0" e2="DS.d345.s1.e1" id="DS.d345.s1.i0" interaction="True"/>
            <pair e1="DS.d345.s1.e0" e2="DS.d345.s1.e2" id="DS.d345.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d345.s2" origId="18563306-166" text="Western blots analysis showed that simvastatin increased the phosphorylation of eNOS and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker LY294002.">
            <entity id="DS.d345.s2.e0" origId="54454,4677798" charOffset="35-46" type="compound" text="simvastatin"/>
            <entity id="DS.d345.s2.e1" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="80-84" type="protein" text="eNOS"/>
            <entity id="DS.d345.s2.e2" origId="O43524" charOffset="89-95" type="protein" text="FKHRL1"/>
            <entity id="DS.d345.s2.e3" origId="3973" charOffset="150-158" type="compound" text="LY294002"/>
            <pair e1="DS.d345.s2.e3" e2="DS.d345.s2.e1" id="DS.d345.s2.i0" interaction="True"/>
            <pair e1="DS.d345.s2.e3" e2="DS.d345.s2.e2" id="DS.d345.s2.i1" interaction="True"/>
            <pair e1="DS.d345.s2.e0" e2="DS.d345.s2.e1" id="DS.d345.s2.i2" interaction="True"/>
            <pair e1="DS.d345.s2.e0" e2="DS.d345.s2.e2" id="DS.d345.s2.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d345.s3" origId="18563306-167" text="In in vitro study, simvastatin increases the phosphorylation of eNOS and of FKHRL1 through the PI3K/AKT signaling pathway.">
            <entity id="DS.d345.s3.e0" origId="54454,4677798" charOffset="19-30" type="compound" text="simvastatin"/>
            <entity id="DS.d345.s3.e1" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="64-68" type="protein" text="eNOS"/>
            <entity id="DS.d345.s3.e2" origId="O43524" charOffset="76-82" type="protein" text="FKHRL1"/>
            <entity id="DS.d345.s3.e3" origId="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0" charOffset="95-99" type="protein" text="PI3K"/>
            <pair e1="DS.d345.s3.e0" e2="DS.d345.s3.e3" id="DS.d345.s3.i0" interaction="True"/>
            <pair e1="DS.d345.s3.e0" e2="DS.d345.s3.e1" id="DS.d345.s3.i1" interaction="True"/>
            <pair e1="DS.d345.s3.e0" e2="DS.d345.s3.e2" id="DS.d345.s3.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d346" origId="18563517">
        <sentence id="DS.d346.s0" origId="18563517-342" text="Only the intracellular IL-2 response in the lower tertile of IL-2 production was improved with glutamine indicating a small influence.">
            <entity id="DS.d346.s0.e0" origId="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84" charOffset="23-27" type="protein" text="IL-2"/>
            <entity id="DS.d346.s0.e1" origId="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84" charOffset="61-65" type="protein" text="IL-2"/>
            <entity id="DS.d346.s0.e2" origId="738,5961" charOffset="95-104" type="compound" text="glutamine"/>
            <pair e1="DS.d346.s0.e2" e2="DS.d346.s0.e0" id="DS.d346.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d346.s1" origId="18563517-343" text="The elevation of glutamine plasma levels by a perioperative intravenous infusion of L-alanyl-L-glutamine influenced the intracellular expression of IL-2 in the lower tertile only slightly.">
            <entity id="DS.d346.s1.e0" origId="738,5961" charOffset="17-26" type="compound" text="glutamine"/>
            <entity id="DS.d346.s1.e2" origId="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84" charOffset="148-152" type="protein" text="IL-2"/>
            <pair e1="DS.d346.s1.e0" e2="DS.d346.s1.e2" id="DS.d346.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d347" origId="18563542">
        <sentence id="DS.d347.s0" origId="18563542-358" text="Determination of bioactive matter by affinity adsorption solid substrate-room temperature phosphorimetry based on lectin labeled with self-ordered ring of eosin Y.">
            <entity id="DS.d347.s0.e0" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="114-120" type="protein" text="lectin"/>
            <entity id="DS.d347.s0.e1" origId="11049,27020" charOffset="155-162" type="compound" text="eosin Y"/>
            <pair e1="DS.d347.s0.e1" e2="DS.d347.s0.e0" id="DS.d347.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d347.s1" origId="18563542-359" text="Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), glucose (G), respectively.">
            <entity id="DS.d347.s1.e0" origId="P02872,P05046,P11218,P11219,P30617,P42088,P49329,P82859,P82953" charOffset="102-112" type="protein" text="agglutinin"/>
            <entity id="DS.d347.s1.e1" origId="P02866,P14894,P81460,P81461" charOffset="114-119" type="protein" text="Con A"/>
            <entity id="DS.d347.s1.e2" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="140-146" type="protein" text="lectin"/>
            <entity id="DS.d347.s1.e3" origId="O80994,O80995,P02771,P05140,P07835,P09031,P23699,P28050,P49066,P83128,P84407,Q01758,Q08617,Q12899,Q28789,Q3SZ57,Q8MJU5" charOffset="202-205" type="protein" text="AFP"/>
            <entity id="DS.d347.s1.e4" origId="O60109,P81800,P83456" charOffset="210-230" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d347.s1.e5" origId="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0" charOffset="232-235" type="protein" text="ALP"/>
            <entity id="DS.d347.s1.e6" origId="206,5793,64689,79025" charOffset="238-245" type="compound" text="glucose"/>
            <pair e1="DS.d347.s1.e6" e2="DS.d347.s1.e0" id="DS.d347.s1.i0" interaction="False"/>
            <pair e1="DS.d347.s1.e6" e2="DS.d347.s1.e5" id="DS.d347.s1.i1" interaction="False"/>
            <pair e1="DS.d347.s1.e6" e2="DS.d347.s1.e2" id="DS.d347.s1.i2" interaction="False"/>
            <pair e1="DS.d347.s1.e6" e2="DS.d347.s1.e3" id="DS.d347.s1.i3" interaction="False"/>
            <pair e1="DS.d347.s1.e6" e2="DS.d347.s1.e4" id="DS.d347.s1.i4" interaction="False"/>
            <pair e1="DS.d347.s1.e6" e2="DS.d347.s1.e1" id="DS.d347.s1.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d348" origId="18563554">
        <sentence id="DS.d348.s0" origId="18563554-369" text="In this paper we demonstrate that hedgehog signaling antagonists, including cyclopamine, and a second compound, CUR0199691, can inhibit growth of estrogen receptor (ER)-positive and ER-negative tumorigenic breast cancer cells at elevated doses.">
            <entity id="DS.d348.s0.e0" origId="442972" charOffset="76-87" type="compound" text="cyclopamine"/>
            <entity id="DS.d348.s0.e1" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="146-163" type="protein" text="estrogen receptor"/>
            <pair e1="DS.d348.s0.e0" e2="DS.d348.s0.e1" id="DS.d348.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d349" origId="18563559">
        <sentence id="DS.d349.s0" origId="18563559-375" text="The equality of K (D) of paroxetine binding to blood platelet membranes and to membranes from nerve endings appears to encourage the use of such membranes as a model for brain SERT.">
            <entity id="DS.d349.s0.e0" origId="43815" charOffset="25-35" type="compound" text="paroxetine"/>
            <entity id="DS.d349.s0.e1" origId="P31645,Q9XT49" charOffset="176-180" type="protein" text="SERT"/>
            <pair e1="DS.d349.s0.e0" e2="DS.d349.s0.e1" id="DS.d349.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d350" origId="18563560">
        <sentence id="DS.d350.s0" origId="18563560-376" text="With supplementation of taurine in diet, lower expression of GFAP and VEGF while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).">
            <entity id="DS.d350.s0.e0" origId="1123" charOffset="24-31" type="compound" text="taurine"/>
            <entity id="DS.d350.s0.e1" origId="P03995,P14136,P47819,Q28115" charOffset="61-65" type="protein" text="GFAP"/>
            <entity id="DS.d350.s0.e2" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="70-74" type="protein" text="VEGF"/>
            <entity id="DS.d350.s0.e3" origId="P24942,P56564" charOffset="102-107" type="protein" text="GLAST"/>
            <entity id="DS.d350.s0.e4" origId="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20" charOffset="116-119" type="protein" text="GAD"/>
            <pair e1="DS.d350.s0.e0" e2="DS.d350.s0.e2" id="DS.d350.s0.i0" interaction="True"/>
            <pair e1="DS.d350.s0.e0" e2="DS.d350.s0.e1" id="DS.d350.s0.i1" interaction="True"/>
            <pair e1="DS.d350.s0.e0" e2="DS.d350.s0.e4" id="DS.d350.s0.i2" interaction="True"/>
            <pair e1="DS.d350.s0.e0" e2="DS.d350.s0.e3" id="DS.d350.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d350.s1" origId="18563560-377" text="GFAP, VEGF, GLAST, GS and GAD expressions in normal controls were not altered by taurine treatment.">
            <entity id="DS.d350.s1.e0" origId="P03995,P14136,P47819,Q28115" charOffset="0-4" type="protein" text="GFAP"/>
            <entity id="DS.d350.s1.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="6-10" type="protein" text="VEGF"/>
            <entity id="DS.d350.s1.e2" origId="P24942,P56564" charOffset="12-17" type="protein" text="GLAST"/>
            <entity id="DS.d350.s1.e3" origId="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20" charOffset="26-29" type="protein" text="GAD"/>
            <entity id="DS.d350.s1.e4" origId="1123" charOffset="81-88" type="compound" text="taurine"/>
            <pair e1="DS.d350.s1.e4" e2="DS.d350.s1.e0" id="DS.d350.s1.i0" interaction="False"/>
            <pair e1="DS.d350.s1.e4" e2="DS.d350.s1.e2" id="DS.d350.s1.i1" interaction="False"/>
            <pair e1="DS.d350.s1.e4" e2="DS.d350.s1.e3" id="DS.d350.s1.i2" interaction="False"/>
            <pair e1="DS.d350.s1.e4" e2="DS.d350.s1.e1" id="DS.d350.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d351" origId="18563561">
        <sentence id="DS.d351.s0" origId="18563561-378" text="Malondialdehyde (MDA), glutathione (GSH), nitric oxide (NO) levels and myeloperoxidase activity (MPO) were examined in plasma, liver and brain tissues.">
            <entity id="DS.d351.s0.e0" origId="10964" charOffset="0-15" type="compound" text="Malondialdehyde"/>
            <entity id="DS.d351.s0.e1" origId="124886" charOffset="23-34" type="compound" text="glutathione"/>
            <entity id="DS.d351.s0.e2" origId="124886" charOffset="36-39" type="compound" text="GSH"/>
            <entity id="DS.d351.s0.e3" origId="145068" charOffset="42-54" type="compound" text="nitric oxide"/>
            <entity id="DS.d351.s0.e4" origId="P05164,P11247" charOffset="97-100" type="protein" text="MPO"/>
            <pair e1="DS.d351.s0.e2" e2="DS.d351.s0.e4" id="DS.d351.s0.i0" interaction="False"/>
            <pair e1="DS.d351.s0.e0" e2="DS.d351.s0.e4" id="DS.d351.s0.i1" interaction="False"/>
            <pair e1="DS.d351.s0.e3" e2="DS.d351.s0.e4" id="DS.d351.s0.i2" interaction="False"/>
            <pair e1="DS.d351.s0.e1" e2="DS.d351.s0.e4" id="DS.d351.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d352" origId="18563616">
        <sentence id="DS.d352.s0" origId="18563616-418" text="Glutathione peroxidase 1 (GPX1) is a ubiquitously expressed selenium-dependent enzyme that protects cells against oxidative damage by reducing hydrogen peroxide and a wide range of organic peroxides.">
            <entity id="DS.d352.s0.e0" origId="O23970,P00435,P04041,P07203,P11352,P11909,P36014,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14" charOffset="0-24" type="protein" text="Glutathione peroxidase 1"/>
            <entity id="DS.d352.s0.e1" origId="O48646,P00435,P07203,P11909,P36014,P52032,Q00277,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14" charOffset="26-30" type="protein" text="GPX1"/>
            <entity id="DS.d352.s0.e2" origId="784" charOffset="143-160" type="compound" text="hydrogen peroxide"/>
            <pair e1="DS.d352.s0.e2" e2="DS.d352.s0.e0" id="DS.d352.s0.i0" interaction="True"/>
            <pair e1="DS.d352.s0.e2" e2="DS.d352.s0.e1" id="DS.d352.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d353" origId="18563708">
        <sentence id="DS.d353.s0" origId="18563708-512" text="Nitric oxide (NO), which is produced by nitric oxide synthase (NOS), may play a role in the development of ASD.">
            <entity id="DS.d353.s0.e0" origId="145068" charOffset="0-12" type="compound" text="Nitric oxide"/>
            <entity id="DS.d353.s0.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="40-61" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d353.s0.e2" origId="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2" charOffset="63-66" type="protein" text="NOS"/>
            <pair e1="DS.d353.s0.e0" e2="DS.d353.s0.e2" id="DS.d353.s0.i0" interaction="True"/>
            <pair e1="DS.d353.s0.e0" e2="DS.d353.s0.e1" id="DS.d353.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d354" origId="18563803">
        <sentence id="DS.d354.s0" origId="18563803-210" text="In conclusion, TAD-A has sufficient bonding strength and comparatively low toxicity in clinical use of 0.3 mmol or less of TAD and 0.8 mL of 44 w/w % HSA solution.">
            <entity id="DS.d354.s0.e0" origId="124886,128225" charOffset="15-18" type="compound" text="TAD"/>
            <entity id="DS.d354.s0.e1" origId="124886,128225" charOffset="123-126" type="compound" text="TAD"/>
            <entity id="DS.d354.s0.e2" origId="P24807,Q07490" charOffset="150-153" type="protein" text="HSA"/>
            <pair e1="DS.d354.s0.e0" e2="DS.d354.s0.e2" id="DS.d354.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d355" origId="18563826">
        <sentence id="DS.d355.s0" origId="18563826-616" text="Long intercalated defects in canine ribs can be repaired successfully using porous beta-tricalcium phosphate (beta-TCP) cylinders, infused with a biodegradable polymer (poly D,L-lactic acid-polyethylene block copolymer) containing recombinant human bone morphogenetic protein-2 (rhBMP-2).">
            <entity id="DS.d355.s0.e0" origId="24456" charOffset="83-108" type="compound" text="beta-tricalcium phosphate"/>
            <entity id="DS.d355.s0.e1" origId="P07580" charOffset="254-275" type="protein" text="morphogenetic protein"/>
            <pair e1="DS.d355.s0.e0" e2="DS.d355.s0.e1" id="DS.d355.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d356" origId="18564056">
        <sentence id="DS.d356.s0" origId="18564056-810" text="In the present study we explored the possibility of using genetic engineering to increase the artemisinin content of A. annua by suppressing the expression of SQS (squalene synthase), a key enzyme of sterol pathway (a pathway competitive with that of artemisinin biosynthesis) by means of a hairpin-RNA-mediated RNAi (RNA interference) technique.">
            <entity id="DS.d356.s0.e0" origId="2240,68827,452191,641602,5458876,9838675,11836791,23757058,44266427,49796325" charOffset="94-105" type="compound" text="artemisinin"/>
            <entity id="DS.d356.s0.e1" origId="O74165,P29704,P36596,P37268,P53798,P53799,P53800,P78589,Q02769,Q752X9,Q7S4Z6,Q92459,Q9HGZ6,Q9Y753" charOffset="159-162" type="protein" text="SQS"/>
            <entity id="DS.d356.s0.e2" origId="2240,68827,452191,641602,5458876,9838675,11836791,23757058,44266427,49796325" charOffset="251-262" type="compound" text="artemisinin"/>
            <pair e1="DS.d356.s0.e0" e2="DS.d356.s0.e1" id="DS.d356.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d357" origId="18564176">
        <sentence id="DS.d357.s0" origId="18564176-915" text="Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway.">
            <entity id="DS.d357.s0.e0" origId="3476" charOffset="0-11" type="compound" text="Glimepiride"/>
            <entity id="DS.d357.s0.e1" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="24-28" type="protein" text="eNOS"/>
            <pair e1="DS.d357.s0.e0" e2="DS.d357.s0.e1" id="DS.d357.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d358" origId="18564211">
        <sentence id="DS.d358.s0" origId="18564211-943" text="It has been reported that tamoxifen may affect hepatoma cell growth in vitro by suppressing transforming growth factor beta-1 (TGF-beta1) expression, suggesting that tamoxifen might also retard fibrogenesis.">
            <entity id="DS.d358.s0.e0" origId="2733526" charOffset="26-35" type="compound" text="tamoxifen"/>
            <entity id="DS.d358.s0.e1" origId="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6" charOffset="127-136" type="protein" text="TGF-beta1"/>
            <entity id="DS.d358.s0.e2" origId="2733526" charOffset="166-175" type="compound" text="tamoxifen"/>
            <pair e1="DS.d358.s0.e0" e2="DS.d358.s0.e1" id="DS.d358.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d358.s1" origId="18564211-944" text="Thus, we examined whether tamoxifen might suppress TGF-beta1 expression and consequently inhibit the process of hepatic fibrosis in vivo.">
            <entity id="DS.d358.s1.e0" origId="2733526" charOffset="26-35" type="compound" text="tamoxifen"/>
            <entity id="DS.d358.s1.e1" origId="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6" charOffset="51-60" type="protein" text="TGF-beta1"/>
            <pair e1="DS.d358.s1.e0" e2="DS.d358.s1.e1" id="DS.d358.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d359" origId="18564281">
        <sentence id="DS.d359.s0" origId="18564281-1010" text="We also explored the effect of substance P released by capsaicin because this neuropeptide is known to affect the microvasculature environment.">
            <entity id="DS.d359.s0.e0" origId="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541" charOffset="31-42" type="protein" text="substance P"/>
            <entity id="DS.d359.s0.e1" origId="1548943" charOffset="55-64" type="compound" text="capsaicin"/>
            <entity id="DS.d359.s0.e2" origId="P21259" charOffset="78-90" type="protein" text="neuropeptide"/>
            <pair e1="DS.d359.s0.e1" e2="DS.d359.s0.e0" id="DS.d359.s0.i0" interaction="False"/>
            <pair e1="DS.d359.s0.e1" e2="DS.d359.s0.e2" id="DS.d359.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d360" origId="18565553">
        <sentence id="DS.d360.s0" origId="18565553-422" text="Leukotriene C4 release and gene expressions of IL-8 and MCP-1 in porcine alveolar epithelial type II cells.">
            <entity id="DS.d360.s0.e0" origId="3907,5280493,5283121,5353716" charOffset="0-14" type="compound" text="Leukotriene C4"/>
            <entity id="DS.d360.s0.e1" origId="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5" charOffset="47-51" type="protein" text="IL-8"/>
            <entity id="DS.d360.s0.e2" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="56-61" type="protein" text="MCP-1"/>
            <pair e1="DS.d360.s0.e0" e2="DS.d360.s0.e1" id="DS.d360.s0.i0" interaction="False"/>
            <pair e1="DS.d360.s0.e0" e2="DS.d360.s0.e2" id="DS.d360.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d360.s1" origId="18565553-424" text="These findings suggest that AEC IIs play an important role in initial inflammatory reactions of the lung by releasing LTC4, and that they also modulate later inflammatory reactions, evidenced by consistent elevation of MCP-1 gene expression after and during exogenous challenge in pigs.">
            <entity id="DS.d360.s1.e0" origId="5280493" charOffset="118-122" type="compound" text="LTC4"/>
            <entity id="DS.d360.s1.e1" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="219-224" type="protein" text="MCP-1"/>
            <pair e1="DS.d360.s1.e0" e2="DS.d360.s1.e1" id="DS.d360.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d361" origId="18565581">
        <sentence id="DS.d361.s0" origId="18565581-347" text="Whereas their toxicity is due to acetylcholinesterase inhibition, their secondary toxic effects have been related to free oxygen radicals.">
            <entity id="DS.d361.s0.e0" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="33-53" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d361.s0.e1" origId="977" charOffset="122-128" type="compound" text="oxygen"/>
            <pair e1="DS.d361.s0.e1" e2="DS.d361.s0.e0" id="DS.d361.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d361.s1" origId="18565581-348" text="Diazinon diminished the plasma acetylcholinesterase activity on day 1 post-treatment, although testosterone levels remained unaffected.">
            <entity id="DS.d361.s1.e0" origId="3017" charOffset="0-8" type="compound" text="Diazinon"/>
            <entity id="DS.d361.s1.e1" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="31-51" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d361.s1.e2" origId="6013" charOffset="95-107" type="compound" text="testosterone"/>
            <pair e1="DS.d361.s1.e0" e2="DS.d361.s1.e1" id="DS.d361.s1.i0" interaction="True"/>
            <pair e1="DS.d361.s1.e2" e2="DS.d361.s1.e1" id="DS.d361.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d361.s2" origId="18565581-349" text="Melatonin pretreatment prevented every alteration induced by diazinon, except the diminution of acetylcholinesterase plasmatic activity.">
            <entity id="DS.d361.s2.e0" origId="896" charOffset="0-9" type="compound" text="Melatonin"/>
            <entity id="DS.d361.s2.e1" origId="3017" charOffset="61-69" type="compound" text="diazinon"/>
            <entity id="DS.d361.s2.e2" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="96-116" type="protein" text="acetylcholinesterase"/>
            <pair e1="DS.d361.s2.e1" e2="DS.d361.s2.e2" id="DS.d361.s2.i0" interaction="True"/>
            <pair e1="DS.d361.s2.e0" e2="DS.d361.s2.e2" id="DS.d361.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d362" origId="18566887">
        <sentence id="DS.d362.s0" origId="18566887-1426" text="Sialic acid-specific O-acetyltransferases and O-acetylesterases are responsible for the metabolism of esterified sialic acids.">
            <entity id="DS.d362.s0.e0" origId="P16966" charOffset="23-41" type="protein" text="acetyltransferases"/>
            <entity id="DS.d362.s0.e1" origId="P23553,P23872,Q325C0,Q3Z4S3,Q57S73,Q5PFJ2,Q83M39,Q8FK82,Q8XD38,Q8Z8T1,Q8ZRA1" charOffset="48-63" type="protein" text="acetylesterases"/>
            <entity id="DS.d362.s0.e2" origId="349960" charOffset="113-125" type="compound" text="sialic acids"/>
            <pair e1="DS.d362.s0.e2" e2="DS.d362.s0.e0" id="DS.d362.s0.i0" interaction="True"/>
            <pair e1="DS.d362.s0.e2" e2="DS.d362.s0.e1" id="DS.d362.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d363" origId="18567517">
        <sentence id="DS.d363.s0" origId="18567517-267" text="Endomorphin-2 vector injection also reduced spontaneous pain-related behaviors in the delayed phase of the formalin test and in both CFA and formalin models suppressed spinal c-fos expression.">
            <entity id="DS.d363.s0.e0" origId="5311081" charOffset="0-13" type="compound" text="Endomorphin-2"/>
            <entity id="DS.d363.s0.e1" origId="O04350,O75347,P48427,P48428,P48606,P80584,P80585,Q9Y703" charOffset="133-136" type="protein" text="CFA"/>
            <entity id="DS.d363.s0.e2" origId="P01101,P12841,Q56415" charOffset="177-180" type="protein" text="fos"/>
            <pair e1="DS.d363.s0.e0" e2="DS.d363.s0.e2" id="DS.d363.s0.i0" interaction="True"/>
            <pair e1="DS.d363.s0.e0" e2="DS.d363.s0.e1" id="DS.d363.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d364" origId="18568363">
        <sentence id="DS.d364.s0" origId="18568363-1000" text="Furthermore, 8-bromo-cGMP and peroxynitrite failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on TonEBP rather than through classical NO signaling pathways.">
            <entity id="DS.d364.s0.e0" origId="104767" charOffset="13-25" type="compound" text="8-bromo-cGMP"/>
            <entity id="DS.d364.s0.e1" origId="104806" charOffset="30-43" type="compound" text="peroxynitrite"/>
            <entity id="DS.d364.s0.e2" origId="O94916" charOffset="129-135" type="protein" text="TonEBP"/>
            <pair e1="DS.d364.s0.e1" e2="DS.d364.s0.e2" id="DS.d364.s0.i0" interaction="False"/>
            <pair e1="DS.d364.s0.e0" e2="DS.d364.s0.e2" id="DS.d364.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d364.s1" origId="18568363-998" text="Nitric oxide decreases expression of osmoprotective genes via direct inhibition of TonEBP transcriptional activity.">
            <entity id="DS.d364.s1.e0" origId="145068" charOffset="0-12" type="compound" text="Nitric oxide"/>
            <entity id="DS.d364.s1.e1" origId="O94916" charOffset="83-89" type="protein" text="TonEBP"/>
            <pair e1="DS.d364.s1.e0" e2="DS.d364.s1.e1" id="DS.d364.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d364.s2" origId="18568363-999" text="Because nitric oxide (NO) is abundantly produced in the renal medulla, the present studies addressed the effect of NO on expression of osmoprotective genes and TonEBP activation in MDCK cells.">
            <entity id="DS.d364.s2.e0" origId="145068" charOffset="8-20" type="compound" text="nitric oxide"/>
            <entity id="DS.d364.s2.e1" origId="O94916" charOffset="160-166" type="protein" text="TonEBP"/>
            <pair e1="DS.d364.s2.e0" e2="DS.d364.s2.e1" id="DS.d364.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d365" origId="18568422">
        <sentence id="DS.d365.s0" origId="18568422-1042" text="Ran GTPase guanine nucleotide exchange factor RCC1 is phosphorylated on serine 11 by cdc2 kinase in vitro.">
            <entity id="DS.d365.s0.e0" origId="P18754,P23800,P52499" charOffset="46-50" type="protein" text="RCC1"/>
            <entity id="DS.d365.s0.e1" origId="5951" charOffset="72-78" type="compound" text="serine"/>
            <entity id="DS.d365.s0.e2" origId="P04551,P11440,P23572,P39951" charOffset="85-89" type="protein" text="cdc2"/>
            <pair e1="DS.d365.s0.e1" e2="DS.d365.s0.e0" id="DS.d365.s0.i0" interaction="False"/>
            <pair e1="DS.d365.s0.e1" e2="DS.d365.s0.e2" id="DS.d365.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d365.s1" origId="18568422-1043" text="An RCC1 mutant in which all N-terminal serine and threonine residues were substituted with glutamate residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, KPNA4, compared with wild type RCC1.">
            <entity id="DS.d365.s1.e0" origId="5951" charOffset="39-45" type="compound" text="serine"/>
            <entity id="DS.d365.s1.e1" origId="6288" charOffset="50-59" type="compound" text="threonine"/>
            <entity id="DS.d365.s1.e2" origId="611,23327,33032" charOffset="91-100" type="compound" text="glutamate"/>
            <entity id="DS.d365.s1.e3" origId="O00629" charOffset="198-203" type="protein" text="KPNA4"/>
            <pair e1="DS.d365.s1.e1" e2="DS.d365.s1.e3" id="DS.d365.s1.i0" interaction="False"/>
            <pair e1="DS.d365.s1.e0" e2="DS.d365.s1.e3" id="DS.d365.s1.i1" interaction="False"/>
            <pair e1="DS.d365.s1.e2" e2="DS.d365.s1.e3" id="DS.d365.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d366" origId="18568426">
        <sentence id="DS.d366.s0" origId="18568426-1046" text="ATP, acting on P2X (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (IL-1beta), and following prolonged agonist exposure, cell death.">
            <entity id="DS.d366.s0.e0" origId="5957" charOffset="0-3" type="compound" text="ATP"/>
            <entity id="DS.d366.s0.e1" origId="P13900,P16604" charOffset="15-18" type="protein" text="P2X"/>
            <entity id="DS.d366.s0.e2" origId="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77" charOffset="140-148" type="protein" text="IL-1beta"/>
            <pair e1="DS.d366.s0.e0" e2="DS.d366.s0.e2" id="DS.d366.s0.i0" interaction="True"/>
            <pair e1="DS.d366.s0.e0" e2="DS.d366.s0.e1" id="DS.d366.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d368" origId="18570315">
        <sentence id="DS.d368.s0" origId="18570315-909" text="While the total insulin released during a 1 h glucose stimulation period was the same from islets in each sample, increasing hydrogel crosslinking density contributed to delays in insulin release from hydrogel samples within the 1 h stimulation period.">
            <entity id="DS.d368.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="16-23" type="protein" text="insulin"/>
            <entity id="DS.d368.s0.e1" origId="206,5793,64689,79025" charOffset="46-53" type="compound" text="glucose"/>
            <entity id="DS.d368.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="180-187" type="protein" text="insulin"/>
            <pair e1="DS.d368.s0.e1" e2="DS.d368.s0.e0" id="DS.d368.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d369" origId="18570630">
        <sentence id="DS.d369.s0" origId="18570630-1172" text="Ischaemia and insulin, but not ischaemia and contraction, act synergistically in stimulating muscle glucose uptake in vivo in humans.">
            <entity id="DS.d369.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="14-21" type="protein" text="insulin"/>
            <entity id="DS.d369.s0.e1" origId="206,5793,64689,79025" charOffset="100-107" type="compound" text="glucose"/>
            <pair e1="DS.d369.s0.e1" e2="DS.d369.s0.e0" id="DS.d369.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d369.s1" origId="18570630-1173" text="In summary, ischaemia and insulin independently stimulate skeletal muscle glucose uptake in vivo in humans, whereas ischaemia and contraction do not.">
            <entity id="DS.d369.s1.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="26-33" type="protein" text="insulin"/>
            <entity id="DS.d369.s1.e1" origId="206,5793,64689,79025" charOffset="74-81" type="compound" text="glucose"/>
            <pair e1="DS.d369.s1.e1" e2="DS.d369.s1.e0" id="DS.d369.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d370" origId="18570631">
        <sentence id="DS.d370.s0" origId="18570631-224" text="A comparison of the inhibitory effect of paraoxon on soluble and immobilized AChE showed that immobilization increased the linearity of the inhibition plot particularly in the range 0.1 nM-0.1 microM.">
            <entity id="DS.d370.s0.e0" origId="9395" charOffset="41-49" type="compound" text="paraoxon"/>
            <entity id="DS.d370.s0.e1" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="77-81" type="protein" text="AChE"/>
            <pair e1="DS.d370.s0.e0" e2="DS.d370.s0.e1" id="DS.d370.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d371" origId="18570695">
        <sentence id="DS.d371.s0" origId="18570695-1236" text="7,12-Dimethyl-benz(a) anthracene (DMBA) can induce expressions of CYP1A1 and CYP1B1 which are known to be responsive to PAH.">
            <entity id="DS.d371.s0.e1" origId="6001" charOffset="34-38" type="compound" text="DMBA"/>
            <entity id="DS.d371.s0.e2" origId="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64" charOffset="66-72" type="protein" text="CYP1A1"/>
            <entity id="DS.d371.s0.e3" origId="Q16678" charOffset="77-83" type="protein" text="CYP1B1"/>
            <pair e1="DS.d371.s0.e1" e2="DS.d371.s0.e3" id="DS.d371.s0.i0" interaction="True"/>
            <pair e1="DS.d371.s0.e1" e2="DS.d371.s0.e2" id="DS.d371.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d372" origId="18571801">
        <sentence id="DS.d372.s0" origId="18571801-413" text="Extracellular lipase LIP prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic ibuprofen.">
            <entity id="DS.d372.s0.e0" origId="Q7M4U7" charOffset="14-20" type="protein" text="lipase"/>
            <entity id="DS.d372.s0.e1" origId="O59952,P21764,P49081,Q06383,Q96Q15" charOffset="21-24" type="protein" text="LIP"/>
            <entity id="DS.d372.s0.e2" origId="3672,39912" charOffset="119-128" type="compound" text="ibuprofen"/>
            <pair e1="DS.d372.s0.e2" e2="DS.d372.s0.e1" id="DS.d372.s0.i0" interaction="True"/>
            <pair e1="DS.d372.s0.e2" e2="DS.d372.s0.e0" id="DS.d372.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d372.s1" origId="18571801-414" text="The high purity (S)-ibuprofen (ee = 0.98) was obtained using lipase LIP to catalyze hydrolysis of (S)-ester in 0.1 M phosphate buffer (pH = 8).">
            <entity id="DS.d372.s1.e0" origId="39912" charOffset="17-29" type="compound" text="S)-ibuprofen"/>
            <entity id="DS.d372.s1.e1" origId="Q7M4U7" charOffset="61-67" type="protein" text="lipase"/>
            <entity id="DS.d372.s1.e2" origId="O59952,P21764,P49081,Q06383,Q96Q15" charOffset="68-71" type="protein" text="LIP"/>
            <entity id="DS.d372.s1.e3" origId="1061,167704,644102" charOffset="117-126" type="compound" text="phosphate"/>
            <pair e1="DS.d372.s1.e0" e2="DS.d372.s1.e2" id="DS.d372.s1.i0" interaction="True"/>
            <pair e1="DS.d372.s1.e3" e2="DS.d372.s1.e2" id="DS.d372.s1.i1" interaction="False"/>
            <pair e1="DS.d372.s1.e0" e2="DS.d372.s1.e1" id="DS.d372.s1.i2" interaction="True"/>
            <pair e1="DS.d372.s1.e3" e2="DS.d372.s1.e1" id="DS.d372.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d373" origId="18571950">
        <sentence id="DS.d373.s0" origId="18571950-552" text="The potential action of galactose as a &quot;chemical chaperone&quot;: increase of beta galactosidase activity in fibroblasts from an adult GM1-gangliosidosis patient.">
            <entity id="DS.d373.s0.e0" origId="6036,439353,439357" charOffset="24-33" type="compound" text="galactose"/>
            <entity id="DS.d373.s0.e1" origId="O33815,O52629,O52847,P00722,P00723,P06219,P0C1Y0,P14288,P22498,P23989,P24131,P26257,P30812,P50388,P70753,P77989,P81650,Q1G9Z4,Q47077,Q48727,Q56307,Q59140,Q59750,Q9K9C6" charOffset="73-91" type="protein" text="beta galactosidase"/>
            <pair e1="DS.d373.s0.e0" e2="DS.d373.s0.e1" id="DS.d373.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d374" origId="18571954">
        <sentence id="DS.d374.s0" origId="18571954-554" text="Citric acid perfusion marginally increased NGF levels to 7.3 fg/microg/ml on average in the upper arm and control axilla.">
            <entity id="DS.d374.s0.e0" origId="311" charOffset="0-11" type="compound" text="Citric acid"/>
            <entity id="DS.d374.s0.e1" origId="P21617,P34129,Q6YBR5,Q90W38" charOffset="43-46" type="protein" text="NGF"/>
            <pair e1="DS.d374.s0.e0" e2="DS.d374.s0.e1" id="DS.d374.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d374.s1" origId="18571954-555" text="In contrast, perfusion of the inflamed axilla with citric acid significantly enhanced the release of both NGF and BDNF.">
            <entity id="DS.d374.s1.e0" origId="311" charOffset="51-62" type="compound" text="citric acid"/>
            <entity id="DS.d374.s1.e1" origId="P21617,P34129,Q6YBR5,Q90W38" charOffset="106-109" type="protein" text="NGF"/>
            <entity id="DS.d374.s1.e2" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="114-118" type="protein" text="BDNF"/>
            <pair e1="DS.d374.s1.e0" e2="DS.d374.s1.e1" id="DS.d374.s1.i0" interaction="True"/>
            <pair e1="DS.d374.s1.e0" e2="DS.d374.s1.e2" id="DS.d374.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d375" origId="18572174">
        <sentence id="DS.d375.s0" origId="18572174-747" text="Pitavastatin induces PON1 expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.">
            <entity id="DS.d375.s0.e0" origId="5282452" charOffset="0-12" type="compound" text="Pitavastatin"/>
            <entity id="DS.d375.s0.e1" origId="P27169,P27170" charOffset="21-25" type="protein" text="PON1"/>
            <entity id="DS.d375.s0.e2" origId="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3" charOffset="45-48" type="protein" text="p44"/>
            <entity id="DS.d375.s0.e3" origId="P00513,P25848" charOffset="70-84" type="protein" text="protein kinase"/>
            <pair e1="DS.d375.s0.e0" e2="DS.d375.s0.e3" id="DS.d375.s0.i0" interaction="True"/>
            <pair e1="DS.d375.s0.e0" e2="DS.d375.s0.e2" id="DS.d375.s0.i1" interaction="True"/>
            <pair e1="DS.d375.s0.e0" e2="DS.d375.s0.e1" id="DS.d375.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d375.s1" origId="18572174-748" text="Both PON1 gene promoter activity and PON1 protein expression were elevated by pitavastatin stimulation.">
            <entity id="DS.d375.s1.e0" origId="P27169,P27170" charOffset="5-9" type="protein" text="PON1"/>
            <entity id="DS.d375.s1.e1" origId="P27169,P27170" charOffset="37-41" type="protein" text="PON1"/>
            <entity id="DS.d375.s1.e2" origId="5282452" charOffset="78-90" type="compound" text="pitavastatin"/>
            <pair e1="DS.d375.s1.e2" e2="DS.d375.s1.e0" id="DS.d375.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d375.s2" origId="18572174-749" text="Pitavastatin phosphorylated p44/42 MAP kinase.">
            <entity id="DS.d375.s2.e0" origId="5282452" charOffset="0-12" type="compound" text="Pitavastatin"/>
            <entity id="DS.d375.s2.e1" origId="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3" charOffset="28-31" type="protein" text="p44"/>
            <pair e1="DS.d375.s2.e0" e2="DS.d375.s2.e1" id="DS.d375.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d375.s3" origId="18572174-751" text="Pitavastatin increased the Sp1-PON1 DNA complex and this effect was attenuated by PD98059.">
            <entity id="DS.d375.s3.e0" origId="5282452" charOffset="0-12" type="compound" text="Pitavastatin"/>
            <entity id="DS.d375.s3.e1" origId="O14300,O89090,P17379,Q01714,Q85439,Q85449,Q85451" charOffset="27-30" type="protein" text="Sp1"/>
            <entity id="DS.d375.s3.e2" origId="P27169,P27170" charOffset="31-35" type="protein" text="PON1"/>
            <entity id="DS.d375.s3.e3" origId="4713" charOffset="82-89" type="compound" text="PD98059"/>
            <pair e1="DS.d375.s3.e0" e2="DS.d375.s3.e1" id="DS.d375.s3.i0" interaction="True"/>
            <pair e1="DS.d375.s3.e3" e2="DS.d375.s3.e2" id="DS.d375.s3.i1" interaction="True"/>
            <pair e1="DS.d375.s3.e3" e2="DS.d375.s3.e1" id="DS.d375.s3.i2" interaction="True"/>
            <pair e1="DS.d375.s3.e0" e2="DS.d375.s3.e2" id="DS.d375.s3.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d375.s4" origId="18572174-752" text="These observations suggest that pitavastatin phosphorylates p44/42 MAP kinase and then activates the transcription of PON1 gene and increases the PON1 protein expression in Huh7 cells.">
            <entity id="DS.d375.s4.e0" origId="5282452" charOffset="32-44" type="compound" text="pitavastatin"/>
            <entity id="DS.d375.s4.e1" origId="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3" charOffset="60-63" type="protein" text="p44"/>
            <entity id="DS.d375.s4.e2" origId="P27169,P27170" charOffset="118-122" type="protein" text="PON1"/>
            <entity id="DS.d375.s4.e3" origId="P27169,P27170" charOffset="146-150" type="protein" text="PON1"/>
            <pair e1="DS.d375.s4.e0" e2="DS.d375.s4.e1" id="DS.d375.s4.i0" interaction="True"/>
            <pair e1="DS.d375.s4.e0" e2="DS.d375.s4.e2" id="DS.d375.s4.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d375.s5" origId="18572174-753" text="Furthermore, we speculate that pitavastatin affects both the phosphorylation of SREBP-2 and the Sp1 binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.">
            <entity id="DS.d375.s5.e0" origId="5282452" charOffset="31-43" type="compound" text="pitavastatin"/>
            <entity id="DS.d375.s5.e1" origId="Q12772,Q60429" charOffset="80-87" type="protein" text="SREBP-2"/>
            <entity id="DS.d375.s5.e2" origId="O14300,O89090,P17379,Q01714,Q85439,Q85449,Q85451" charOffset="96-99" type="protein" text="Sp1"/>
            <entity id="DS.d375.s5.e3" origId="P27169,P27170" charOffset="111-115" type="protein" text="PON1"/>
            <entity id="DS.d375.s5.e4" origId="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3" charOffset="146-149" type="protein" text="p44"/>
            <pair e1="DS.d375.s5.e0" e2="DS.d375.s5.e4" id="DS.d375.s5.i0" interaction="True"/>
            <pair e1="DS.d375.s5.e0" e2="DS.d375.s5.e1" id="DS.d375.s5.i1" interaction="False"/>
            <pair e1="DS.d375.s5.e0" e2="DS.d375.s5.e2" id="DS.d375.s5.i2" interaction="True"/>
            <pair e1="DS.d375.s5.e0" e2="DS.d375.s5.e3" id="DS.d375.s5.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d376" origId="18573668">
        <sentence id="DS.d376.s0" origId="18573668-277" text="Inhibition of cyclooxygenase 2 expression by diallyl sulfide on joint inflammation induced by urate crystal and IL-1beta.">
            <entity id="DS.d376.s0.e0" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="14-30" type="protein" text="cyclooxygenase 2"/>
            <entity id="DS.d376.s0.e1" origId="11617" charOffset="45-60" type="compound" text="diallyl sulfide"/>
            <entity id="DS.d376.s0.e2" origId="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77" charOffset="112-120" type="protein" text="IL-1beta"/>
            <pair e1="DS.d376.s0.e1" e2="DS.d376.s0.e2" id="DS.d376.s0.i0" interaction="False"/>
            <pair e1="DS.d376.s0.e1" e2="DS.d376.s0.e0" id="DS.d376.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d376.s1" origId="18573668-278" text="Investigation of the effects of diallyl sulfide (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by monosodium urate (MSU) crystals and interleukin-1beta (IL-1beta).">
            <entity id="DS.d376.s1.e0" origId="11617" charOffset="32-47" type="compound" text="diallyl sulfide"/>
            <entity id="DS.d376.s1.e2" origId="1175" charOffset="131-147" type="compound" text="monosodium urate"/>
            <entity id="DS.d376.s1.e3" origId="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77" charOffset="186-194" type="protein" text="IL-1beta"/>
            <pair e1="DS.d376.s1.e0" e2="DS.d376.s1.e3" id="DS.d376.s1.i1" interaction="False"/>
            <pair e1="DS.d376.s1.e2" e2="DS.d376.s1.e3" id="DS.d376.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d377" origId="18574025">
        <sentence id="DS.d377.s0" origId="18574025-577" text="Genetic variants of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) are known to influence warfarin dose, but the effect of other genes has not been fully elucidated.">
            <entity id="DS.d377.s0.e0" origId="P11712" charOffset="20-39" type="protein" text="cytochrome P450 2C9"/>
            <entity id="DS.d377.s0.e1" origId="P11712" charOffset="41-47" type="protein" text="CYP2C9"/>
            <entity id="DS.d377.s0.e2" origId="Q6B4J2,Q9BQB6" charOffset="82-88" type="protein" text="VKORC1"/>
            <entity id="DS.d377.s0.e3" origId="54678486" charOffset="113-121" type="compound" text="warfarin"/>
            <pair e1="DS.d377.s0.e3" e2="DS.d377.s0.e0" id="DS.d377.s0.i0" interaction="True"/>
            <pair e1="DS.d377.s0.e3" e2="DS.d377.s0.e2" id="DS.d377.s0.i1" interaction="True"/>
            <pair e1="DS.d377.s0.e3" e2="DS.d377.s0.e1" id="DS.d377.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d377.s1" origId="18574025-578" text="In conclusion, CYP2C9 and VKORC1 significantly influenced warfarin dose and predicted individuals predisposed to unstable anticoagulation.">
            <entity id="DS.d377.s1.e0" origId="P11712" charOffset="15-21" type="protein" text="CYP2C9"/>
            <entity id="DS.d377.s1.e1" origId="Q6B4J2,Q9BQB6" charOffset="26-32" type="protein" text="VKORC1"/>
            <entity id="DS.d377.s1.e2" origId="54678486" charOffset="58-66" type="compound" text="warfarin"/>
            <pair e1="DS.d377.s1.e2" e2="DS.d377.s1.e1" id="DS.d377.s1.i0" interaction="True"/>
            <pair e1="DS.d377.s1.e2" e2="DS.d377.s1.e0" id="DS.d377.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d378" origId="18574490">
        <sentence id="DS.d378.s0" origId="18574490-986" text="BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (PSA) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and prednisone compared with mitoxantrone and prednisone.">
            <entity id="DS.d378.s0.e0" origId="6013" charOffset="8-20" type="compound" text="testosterone"/>
            <entity id="DS.d378.s0.e1" origId="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617" charOffset="125-128" type="protein" text="PSA"/>
            <entity id="DS.d378.s0.e2" origId="148124" charOffset="244-253" type="compound" text="docetaxel"/>
            <entity id="DS.d378.s0.e3" origId="5865" charOffset="258-268" type="compound" text="prednisone"/>
            <entity id="DS.d378.s0.e4" origId="4212" charOffset="283-295" type="compound" text="mitoxantrone"/>
            <entity id="DS.d378.s0.e5" origId="5865" charOffset="300-310" type="compound" text="prednisone"/>
            <pair e1="DS.d378.s0.e2" e2="DS.d378.s0.e1" id="DS.d378.s0.i0" interaction="False"/>
            <pair e1="DS.d378.s0.e0" e2="DS.d378.s0.e1" id="DS.d378.s0.i1" interaction="False"/>
            <pair e1="DS.d378.s0.e4" e2="DS.d378.s0.e1" id="DS.d378.s0.i2" interaction="False"/>
            <pair e1="DS.d378.s0.e3" e2="DS.d378.s0.e1" id="DS.d378.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d378.s1" origId="18574490-987" text="In multivariate analysis, neither BMI, presence of obesity, nor baseline testosterone was significantly associated with OS or PSA declines.">
            <entity id="DS.d378.s1.e0" origId="6013" charOffset="73-85" type="compound" text="testosterone"/>
            <entity id="DS.d378.s1.e1" origId="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617" charOffset="126-129" type="protein" text="PSA"/>
            <pair e1="DS.d378.s1.e0" e2="DS.d378.s1.e1" id="DS.d378.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d379" origId="18574670">
        <sentence id="DS.d379.s0" origId="18574670-1109" text="The interaction between PAF and the platelet agonists ADP, thrombin and convulxin was analyzed in vitro in whole blood with the use of flow cytometry and was further characterized with the use of receptor antagonists to PAF (ABT-491), P2Y1 (MRS-2179), and P2Y12 (cangrelor) as well as a monoclonal anti-PSGL-1 antibody (anti-CD162).">
            <entity id="DS.d379.s0.e0" origId="P84122" charOffset="59-67" type="protein" text="thrombin"/>
            <entity id="DS.d379.s0.e1" origId="5311303" charOffset="241-249" type="compound" text="MRS-2179"/>
            <entity id="DS.d379.s0.e2" origId="9854012" charOffset="263-272" type="compound" text="cangrelor"/>
            <pair e1="DS.d379.s0.e2" e2="DS.d379.s0.e0" id="DS.d379.s0.i0" interaction="False"/>
            <pair e1="DS.d379.s0.e1" e2="DS.d379.s0.e0" id="DS.d379.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d380" origId="18575957">
        <sentence id="DS.d380.s0" origId="18575957-472" text="Aim The present study sought insight into the effects of remifentanyl and fentanyl on LPS-induced release of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) and IL-10 in human whole blood.">
            <entity id="DS.d380.s0.e0" origId="60815" charOffset="57-69" type="compound" text="remifentanyl"/>
            <entity id="DS.d380.s0.e2" origId="P41693" charOffset="109-122" type="protein" text="interleukin-6"/>
            <entity id="DS.d380.s0.e3" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="124-128" type="protein" text="IL-6"/>
            <entity id="DS.d380.s0.e4" origId="Q8JFG3" charOffset="131-152" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d380.s0.e5" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="160-169" type="protein" text="TNF-alpha"/>
            <entity id="DS.d380.s0.e6" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="175-180" type="protein" text="IL-10"/>
            <pair e1="DS.d380.s0.e0" e2="DS.d380.s0.e5" id="DS.d380.s0.i0" interaction="False"/>
            <pair e1="DS.d380.s0.e0" e2="DS.d380.s0.e3" id="DS.d380.s0.i3" interaction="False"/>
            <pair e1="DS.d380.s0.e0" e2="DS.d380.s0.e4" id="DS.d380.s0.i4" interaction="False"/>
            <pair e1="DS.d380.s0.e0" e2="DS.d380.s0.e2" id="DS.d380.s0.i6" interaction="False"/>
            <pair e1="DS.d380.s0.e0" e2="DS.d380.s0.e6" id="DS.d380.s0.i9" interaction="False"/>
        </sentence>
        <sentence id="DS.d380.s1" origId="18575957-473" text="Effects of remifentanyl and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, TNF-alpha and IL-10 0.01).">
            <entity id="DS.d380.s1.e0" origId="60815" charOffset="11-23" type="compound" text="remifentanyl"/>
            <entity id="DS.d380.s1.e2" origId="53481793" charOffset="56-85" type="compound" text="endotoxin (lipopolysaccharide"/>
            <entity id="DS.d380.s1.e3" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="210-214" type="protein" text="IL-6"/>
            <entity id="DS.d380.s1.e4" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="216-225" type="protein" text="TNF-alpha"/>
            <entity id="DS.d380.s1.e5" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="230-235" type="protein" text="IL-10"/>
            <pair e1="DS.d380.s1.e0" e2="DS.d380.s1.e5" id="DS.d380.s1.i1" interaction="False"/>
            <pair e1="DS.d380.s1.e0" e2="DS.d380.s1.e4" id="DS.d380.s1.i3" interaction="False"/>
            <pair e1="DS.d380.s1.e2" e2="DS.d380.s1.e4" id="DS.d380.s1.i4" interaction="False"/>
            <pair e1="DS.d380.s1.e2" e2="DS.d380.s1.e3" id="DS.d380.s1.i5" interaction="False"/>
            <pair e1="DS.d380.s1.e2" e2="DS.d380.s1.e5" id="DS.d380.s1.i6" interaction="False"/>
            <pair e1="DS.d380.s1.e0" e2="DS.d380.s1.e3" id="DS.d380.s1.i8" interaction="False"/>
        </sentence>
        <sentence id="DS.d380.s2" origId="18575957-475" text="Remifentanyl and fentanyl could inhibit the expressions of IL-6, TNF-alpha and IL-10 induced by LPS.">
            <entity id="DS.d380.s2.e0" origId="60815" charOffset="0-12" type="compound" text="Remifentanyl"/>
            <entity id="DS.d380.s2.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="59-63" type="protein" text="IL-6"/>
            <entity id="DS.d380.s2.e3" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="65-74" type="protein" text="TNF-alpha"/>
            <entity id="DS.d380.s2.e4" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="79-84" type="protein" text="IL-10"/>
            <pair e1="DS.d380.s2.e0" e2="DS.d380.s2.e3" id="DS.d380.s2.i0" interaction="True"/>
            <pair e1="DS.d380.s2.e0" e2="DS.d380.s2.e2" id="DS.d380.s2.i2" interaction="True"/>
            <pair e1="DS.d380.s2.e0" e2="DS.d380.s2.e4" id="DS.d380.s2.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d381" origId="18577298">
        <sentence id="DS.d381.s0" origId="18577298-1601" text="This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (PKB, Akt).">
            <entity id="DS.d381.s0.e0" origId="439177" charOffset="78-86" type="compound" text="glycogen"/>
            <entity id="DS.d381.s0.e1" origId="1153,6057,5460803" charOffset="119-127" type="compound" text="tyrosine"/>
            <entity id="DS.d381.s0.e2" origId="P31749,P31750,P47196,Q01314,Q8INB9" charOffset="215-231" type="protein" text="protein kinase B"/>
            <entity id="DS.d381.s0.e3" origId="P31749,P31750,P47196,Q01314,Q8INB9" charOffset="233-236" type="protein" text="PKB"/>
            <entity id="DS.d381.s0.e4" origId="P31750,Q8INB9" charOffset="238-241" type="protein" text="Akt"/>
            <pair e1="DS.d381.s0.e1" e2="DS.d381.s0.e3" id="DS.d381.s0.i0" interaction="False"/>
            <pair e1="DS.d381.s0.e0" e2="DS.d381.s0.e4" id="DS.d381.s0.i1" interaction="False"/>
            <pair e1="DS.d381.s0.e0" e2="DS.d381.s0.e2" id="DS.d381.s0.i2" interaction="True"/>
            <pair e1="DS.d381.s0.e0" e2="DS.d381.s0.e3" id="DS.d381.s0.i3" interaction="True"/>
            <pair e1="DS.d381.s0.e1" e2="DS.d381.s0.e4" id="DS.d381.s0.i4" interaction="False"/>
            <pair e1="DS.d381.s0.e1" e2="DS.d381.s0.e2" id="DS.d381.s0.i5" interaction="False"/>
        </sentence>
        <sentence id="DS.d381.s1" origId="18577298-1602" text="Improved hepatic insulin signalling led to decreased phosphoenolpyruvate carboxykinase expression and reduced hepatic glucose output accordingly.">
            <entity id="DS.d381.s1.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="17-24" type="protein" text="insulin"/>
            <entity id="DS.d381.s1.e1" origId="206,5793,64689,79025" charOffset="118-125" type="compound" text="glucose"/>
            <pair e1="DS.d381.s1.e1" e2="DS.d381.s1.e0" id="DS.d381.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d382" origId="18577871">
        <sentence id="DS.d382.s0" origId="18577871-351" text="These data provide evidence that CMEC express CaSR, which is able to respond to physiological agonists by mobilizing Ca(2+) from intracellular InsP(3)-sensitive stores.">
            <entity id="DS.d382.s0.e0" origId="O62714,P35384,P41180,P48442,Q9QY96" charOffset="46-50" type="protein" text="CaSR"/>
            <entity id="DS.d382.s0.e1" origId="271" charOffset="117-121" type="compound" text="Ca(2"/>
            <pair e1="DS.d382.s0.e1" e2="DS.d382.s0.e0" id="DS.d382.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d383" origId="18579232">
        <sentence id="DS.d383.s0" origId="18579232-1493" text="Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of COX-2/iNOS mRNA level is under the control of endogenous iNO/cGMP signaling system.">
            <entity id="DS.d383.s0.e0" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="80-85" type="protein" text="COX-2"/>
            <entity id="DS.d383.s0.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="86-90" type="protein" text="iNOS"/>
            <entity id="DS.d383.s0.e3" origId="24316" charOffset="141-145" type="compound" text="cGMP"/>
            <pair e1="DS.d383.s0.e3" e2="DS.d383.s0.e0" id="DS.d383.s0.i1" interaction="True"/>
            <pair e1="DS.d383.s0.e3" e2="DS.d383.s0.e1" id="DS.d383.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d384" origId="18580872">
        <sentence id="DS.d384.s0" origId="18580872-1175" text="Pre-synaptic CB1Rs inhibit neurotransmitter release, suggesting that CB1R activation during extinction may decrease CCK peptide release as well as GABA release.">
            <entity id="DS.d384.s0.e0" origId="P52451" charOffset="13-18" type="protein" text="CB1Rs"/>
            <entity id="DS.d384.s0.e1" origId="P52451" charOffset="13-17" type="protein" text="CB1R"/>
            <entity id="DS.d384.s0.e2" origId="O57312,O93464,P01355,P01356,P06307,P09240,P0C229,P23362,P41520,P50144,P50145,P68125,P68126,P80344,P80345,Q9PU29,Q9PU41" charOffset="116-119" type="protein" text="CCK"/>
            <entity id="DS.d384.s0.e3" origId="119" charOffset="147-151" type="compound" text="GABA"/>
            <pair e1="DS.d384.s0.e3" e2="DS.d384.s0.e1" id="DS.d384.s0.i0" interaction="True"/>
            <pair e1="DS.d384.s0.e3" e2="DS.d384.s0.e2" id="DS.d384.s0.i1" interaction="False"/>
            <pair e1="DS.d384.s0.e3" e2="DS.d384.s0.e0" id="DS.d384.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d385" origId="18580876">
        <sentence id="DS.d385.s0" origId="18580876-1179" text="Acute cocaine, through D(2) dopamine receptors, induced a dose-response increase in FADD protein in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).">
            <entity id="DS.d385.s0.e0" origId="2826,5760,439497,446220,644017,54613779" charOffset="6-13" type="compound" text="cocaine"/>
            <entity id="DS.d385.s0.e1" origId="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1" charOffset="23-46" type="protein" text="D(2) dopamine receptors"/>
            <entity id="DS.d385.s0.e2" origId="Q13158,Q61160" charOffset="84-96" type="protein" text="FADD protein"/>
            <pair e1="DS.d385.s0.e0" e2="DS.d385.s0.e2" id="DS.d385.s0.i0" interaction="True"/>
            <pair e1="DS.d385.s0.e0" e2="DS.d385.s0.e1" id="DS.d385.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d385.s1" origId="18580876-1180" text="FADD was increased by cocaine in cytosol (approximately 142%), membranes (approximately 23%) and nucleus (approximately 54%).">
            <entity id="DS.d385.s1.e0" origId="P46310,Q13158" charOffset="0-4" type="protein" text="FADD"/>
            <entity id="DS.d385.s1.e1" origId="2826,5760,439497,446220,644017,54613779" charOffset="22-29" type="compound" text="cocaine"/>
            <pair e1="DS.d385.s1.e1" e2="DS.d385.s1.e0" id="DS.d385.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d385.s2" origId="18580876-1181" text="In a second experiment, possible FADD differences were investigated in rats selectively bred for differential responsiveness to novelty, propensity for drug-seeking and cocaine sensitization.">
            <entity id="DS.d385.s2.e0" origId="P46310,Q13158" charOffset="33-37" type="protein" text="FADD"/>
            <entity id="DS.d385.s2.e1" origId="2826,5760,439497,446220,644017,54613779" charOffset="169-176" type="compound" text="cocaine"/>
            <pair e1="DS.d385.s2.e1" e2="DS.d385.s2.e0" id="DS.d385.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d386" origId="18581264">
        <sentence id="DS.d386.s0" origId="18581264-1465" text="Lignin peroxidases have the unique ability to catalyze oxidative cleavage of C-C bonds and ether (C-O-C) bonds in non-phenolic aromatic substrates of high redox potential.">
            <entity id="DS.d386.s0.e0" origId="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622" charOffset="0-18" type="protein" text="Lignin peroxidases"/>
            <entity id="DS.d386.s0.e1" origId="3283,5382654" charOffset="91-96" type="compound" text="ether"/>
            <pair e1="DS.d386.s0.e1" e2="DS.d386.s0.e0" id="DS.d386.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d386.s1" origId="18581264-1466" text="Manganese peroxidases oxidize Mn(II) to Mn(III), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.">
            <entity id="DS.d386.s1.e0" origId="P15984,P16147,P84714" charOffset="10-21" type="protein" text="peroxidases"/>
            <entity id="DS.d386.s1.e1" origId="27854" charOffset="30-35" type="compound" text="Mn(II"/>
            <entity id="DS.d386.s1.e2" origId="105130" charOffset="40-46" type="compound" text="Mn(III"/>
            <pair e1="DS.d386.s1.e2" e2="DS.d386.s1.e0" id="DS.d386.s1.i0" interaction="True"/>
            <pair e1="DS.d386.s1.e1" e2="DS.d386.s1.e0" id="DS.d386.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d386.s2" origId="18581264-1467" text="Laccases are multi-copper-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular oxygen to water.">
            <entity id="DS.d386.s2.e0" origId="Q12570" charOffset="0-8" type="protein" text="Laccases"/>
            <entity id="DS.d386.s2.e1" origId="23978" charOffset="19-25" type="compound" text="copper"/>
            <entity id="DS.d386.s2.e2" origId="977" charOffset="137-143" type="compound" text="oxygen"/>
            <pair e1="DS.d386.s2.e1" e2="DS.d386.s2.e0" id="DS.d386.s2.i0" interaction="True"/>
            <pair e1="DS.d386.s2.e2" e2="DS.d386.s2.e0" id="DS.d386.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d387" origId="18581270">
        <sentence id="DS.d387.s0" origId="18581270-1477" text="The co-expression of SERT with M6B results in a significant decrease in SERT-mediated serotonin uptake caused by a down-regulation of SERT surface expression.">
            <entity id="DS.d387.s0.e0" origId="P31645,Q9XT49" charOffset="21-25" type="protein" text="SERT"/>
            <entity id="DS.d387.s0.e1" origId="Q13491,Q5R603" charOffset="31-34" type="protein" text="M6B"/>
            <entity id="DS.d387.s0.e2" origId="P31645,Q9XT49" charOffset="72-76" type="protein" text="SERT"/>
            <entity id="DS.d387.s0.e3" origId="5202" charOffset="86-95" type="compound" text="serotonin"/>
            <entity id="DS.d387.s0.e4" origId="P31645,Q9XT49" charOffset="72-76" type="protein" text="SERT"/>
            <pair e1="DS.d387.s0.e3" e2="DS.d387.s0.e0" id="DS.d387.s0.i0" interaction="True"/>
            <pair e1="DS.d387.s0.e3" e2="DS.d387.s0.e1" id="DS.d387.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d388" origId="18582556">
        <sentence id="DS.d388.s0" origId="18582556-870" text="Hence, resistance to cancer in old Snell dwarf mice may be mediated by neuroendocrine factors that reduce glucose utilization besides elevated adiponectin, reduced IGF-I and a lack of GH, PRL and TSH, seen in both Snell and Ames dwarf mice.">
            <entity id="DS.d388.s0.e0" origId="206,5793,64689,79025" charOffset="106-113" type="compound" text="glucose"/>
            <entity id="DS.d388.s0.e1" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="164-169" type="protein" text="IGF-I"/>
            <entity id="DS.d388.s0.e2" origId="O62781,O62819,O93337,P01236,P01237,P01238,P01239,P01240,P06879,P09585,P10765,P12420,P14676,P17572,P21993,P22393,P29234,P29235,P33089,P33090,P33091,P33096,P34181,P35395,P37884,P40424,P43001,P43299,P46403,P48096,P48249,P51904,P55151,P87495,Q28318,Q28632,Q3Y4G6,Q6UC74,Q7ZZV3,Q8HXS1,Q9QZL1,Q9YGV6" charOffset="188-191" type="protein" text="PRL"/>
            <pair e1="DS.d388.s0.e0" e2="DS.d388.s0.e2" id="DS.d388.s0.i0" interaction="False"/>
            <pair e1="DS.d388.s0.e0" e2="DS.d388.s0.e1" id="DS.d388.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d389" origId="18582992">
        <sentence id="DS.d389.s0" origId="18582992-1242" text="Therefore, cinacalcet, which inhibit the production of parathormone by negative feedback, was considered a treatment option to control the evolution of calciphylaxis in a dialysed patient suffering from cholangiocarcinoma.">
            <entity id="DS.d389.s0.e0" origId="156419" charOffset="11-21" type="compound" text="cinacalcet"/>
            <entity id="DS.d389.s0.e1" origId="P01270" charOffset="55-67" type="protein" text="parathormone"/>
            <pair e1="DS.d389.s0.e0" e2="DS.d389.s0.e1" id="DS.d389.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d390" origId="18583434">
        <sentence id="DS.d390.s0" origId="18583434-1596" text="Glucose levels and hormones (Peptide YY(3-36), glucagon-like peptide-1 (GLP-1), leptin, ghrelin, insulin) that regulate EI were measured.">
            <entity id="DS.d390.s0.e0" origId="206,5793,64689,79025" charOffset="0-7" type="compound" text="Glucose"/>
            <entity id="DS.d390.s0.e1" origId="P10082,P68004,Q9TR93" charOffset="29-45" type="protein" text="Peptide YY(3-36)"/>
            <entity id="DS.d390.s0.e2" origId="O12956,P01272,P01273,P01274,P01275,P01278,P05110,P06883,P15438,P22890,P29794,P55095,P68259,Q8MJ25" charOffset="47-70" type="protein" text="glucagon-like peptide-1"/>
            <entity id="DS.d390.s0.e3" origId="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25" charOffset="72-77" type="protein" text="GLP-1"/>
            <entity id="DS.d390.s0.e4" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="80-86" type="protein" text="leptin"/>
            <entity id="DS.d390.s0.e5" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="88-95" type="protein" text="ghrelin"/>
            <entity id="DS.d390.s0.e6" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="97-104" type="protein" text="insulin"/>
            <pair e1="DS.d390.s0.e0" e2="DS.d390.s0.e2" id="DS.d390.s0.i0" interaction="False"/>
            <pair e1="DS.d390.s0.e0" e2="DS.d390.s0.e6" id="DS.d390.s0.i1" interaction="False"/>
            <pair e1="DS.d390.s0.e0" e2="DS.d390.s0.e5" id="DS.d390.s0.i2" interaction="False"/>
            <pair e1="DS.d390.s0.e0" e2="DS.d390.s0.e4" id="DS.d390.s0.i3" interaction="False"/>
            <pair e1="DS.d390.s0.e0" e2="DS.d390.s0.e3" id="DS.d390.s0.i4" interaction="False"/>
            <pair e1="DS.d390.s0.e0" e2="DS.d390.s0.e1" id="DS.d390.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d392" origId="18584285">
        <sentence id="DS.d392.s0" origId="18584285-592" text="Transglutaminases catalyze a calcium-dependent transamidation reaction that produces covalent cross-linking of available substrate glutamine residues and modifies the extracellular matrix.">
            <entity id="DS.d392.s0.e0" origId="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7" charOffset="0-17" type="protein" text="Transglutaminases"/>
            <entity id="DS.d392.s0.e1" origId="738,5961" charOffset="131-140" type="compound" text="glutamine"/>
            <pair e1="DS.d392.s0.e1" e2="DS.d392.s0.e0" id="DS.d392.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d393" origId="18584286">
        <sentence id="DS.d393.s0" origId="18584286-593" text="We fed rats lysine or valine deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, PHGDH) and serine/threonine degrading enzymes (serine dehydratase, SDS) in the liver.">
            <entity id="DS.d393.s0.e0" origId="866,5962" charOffset="12-18" type="compound" text="lysine"/>
            <entity id="DS.d393.s0.e1" origId="6287" charOffset="22-28" type="compound" text="valine"/>
            <entity id="DS.d393.s0.e2" origId="O43175,Q5EAD2,Q5R7M2,Q60HD7" charOffset="148-153" type="protein" text="PHGDH"/>
            <entity id="DS.d393.s0.e3" origId="P20132" charOffset="215-218" type="protein" text="SDS"/>
            <pair e1="DS.d393.s0.e0" e2="DS.d393.s0.e2" id="DS.d393.s0.i0" interaction="False"/>
            <pair e1="DS.d393.s0.e1" e2="DS.d393.s0.e2" id="DS.d393.s0.i1" interaction="False"/>
            <pair e1="DS.d393.s0.e1" e2="DS.d393.s0.e3" id="DS.d393.s0.i2" interaction="False"/>
            <pair e1="DS.d393.s0.e0" e2="DS.d393.s0.e3" id="DS.d393.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d393.s1" origId="18584286-594" text="Dietary deficiency induced marked elevation of hepatic serine and threonine levels associated with enhancement of PHGDH mRNA expression and repression of SDS mRNA expression.">
            <entity id="DS.d393.s1.e0" origId="5951" charOffset="55-61" type="compound" text="serine"/>
            <entity id="DS.d393.s1.e1" origId="6288" charOffset="66-75" type="compound" text="threonine"/>
            <entity id="DS.d393.s1.e2" origId="O43175,Q5EAD2,Q5R7M2,Q60HD7" charOffset="114-119" type="protein" text="PHGDH"/>
            <entity id="DS.d393.s1.e3" origId="P20132" charOffset="154-157" type="protein" text="SDS"/>
            <pair e1="DS.d393.s1.e1" e2="DS.d393.s1.e2" id="DS.d393.s1.i0" interaction="False"/>
            <pair e1="DS.d393.s1.e0" e2="DS.d393.s1.e2" id="DS.d393.s1.i1" interaction="False"/>
            <pair e1="DS.d393.s1.e1" e2="DS.d393.s1.e3" id="DS.d393.s1.i2" interaction="False"/>
            <pair e1="DS.d393.s1.e0" e2="DS.d393.s1.e3" id="DS.d393.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d394" origId="18584306">
        <sentence id="DS.d394.s0" origId="18584306-333" text="Site-directed mutation test and mithramycin A treatment demonstrated that the ZNF230 promoter contained a functional Sp1 site.">
            <entity id="DS.d394.s0.e0" origId="29051,163659,230076,6326719" charOffset="32-45" type="compound" text="mithramycin A"/>
            <entity id="DS.d394.s0.e1" origId="Q8WVD5,Q9UIE0" charOffset="78-84" type="protein" text="ZNF230"/>
            <entity id="DS.d394.s0.e2" origId="O14300,O89090,P17379,Q01714,Q85439,Q85449,Q85451" charOffset="117-120" type="protein" text="Sp1"/>
            <pair e1="DS.d394.s0.e0" e2="DS.d394.s0.e2" id="DS.d394.s0.i0" interaction="True"/>
            <pair e1="DS.d394.s0.e0" e2="DS.d394.s0.e1" id="DS.d394.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d395" origId="18584320">
        <sentence id="DS.d395.s0" origId="18584320-630" text="Progesterone effects on neuronal ultrastructure and expression of microtubule-associated protein 2 (MAP2) in rats with acute spinal cord injury.">
            <entity id="DS.d395.s0.e0" origId="5994" charOffset="0-12" type="compound" text="Progesterone"/>
            <entity id="DS.d395.s0.e1" origId="P11137,P15146,P20357" charOffset="66-98" type="protein" text="microtubule-associated protein 2"/>
            <entity id="DS.d395.s0.e2" origId="P11137,P38174,Q5Z859,Q6XMH6,Q6XMH7,Q8SR45" charOffset="100-104" type="protein" text="MAP2"/>
            <pair e1="DS.d395.s0.e0" e2="DS.d395.s0.e1" id="DS.d395.s0.i0" interaction="True"/>
            <pair e1="DS.d395.s0.e0" e2="DS.d395.s0.e2" id="DS.d395.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d395.s1" origId="18584320-631" text="(4) Our data indicated that progesterone maintained in part neuronal ultrastructure, attenuated chromatolysis, and preclude the loss of MAP2, suggesting a protective effect during the early phases of spinal cord injury.">
            <entity id="DS.d395.s1.e0" origId="5994" charOffset="28-40" type="compound" text="progesterone"/>
            <entity id="DS.d395.s1.e1" origId="P11137,P38174,Q5Z859,Q6XMH6,Q6XMH7,Q8SR45" charOffset="136-140" type="protein" text="MAP2"/>
            <pair e1="DS.d395.s1.e0" e2="DS.d395.s1.e1" id="DS.d395.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d396" origId="18584336">
        <sentence id="DS.d396.s0" origId="18584336-637" text="In conclusion, our results indicate that chronic THC modulates the expression and subcellular localization of proteins implicated in Ras signaling, calcium-buffering potential, and trafficking.">
            <entity id="DS.d396.s0.e0" origId="16078,134740" charOffset="49-52" type="compound" text="THC"/>
            <entity id="DS.d396.s0.e1" origId="P03967,P22126,Q07152" charOffset="133-136" type="protein" text="Ras"/>
            <pair e1="DS.d396.s0.e0" e2="DS.d396.s0.e1" id="DS.d396.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d397" origId="18584896">
        <sentence id="DS.d397.s0" origId="18584896-1102" text="For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), capsaicin (CAP) to deplete CGRP from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).">
            <entity id="DS.d397.s0.e0" origId="2703,411938" charOffset="130-143" type="compound" text="chelerythrine"/>
            <entity id="DS.d397.s0.e1" origId="1548943" charOffset="151-160" type="compound" text="capsaicin"/>
            <entity id="DS.d397.s0.e2" origId="P10286,P30880,P30881,P31888,P80511" charOffset="178-182" type="protein" text="CGRP"/>
            <entity id="DS.d397.s0.e3" origId="25058136" charOffset="254-257" type="compound" text="5HD"/>
            <pair e1="DS.d397.s0.e0" e2="DS.d397.s0.e2" id="DS.d397.s0.i0" interaction="False"/>
            <pair e1="DS.d397.s0.e3" e2="DS.d397.s0.e2" id="DS.d397.s0.i1" interaction="False"/>
            <pair e1="DS.d397.s0.e1" e2="DS.d397.s0.e2" id="DS.d397.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d398" origId="18585399">
        <sentence id="DS.d398.s0" origId="18585399-1508" text="The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator.">
            <entity id="DS.d398.s0.e0" origId="5311454" charOffset="20-31" type="compound" text="stiripentol"/>
            <entity id="DS.d398.s0.e1" origId="P26714,Q08832,Q9BLY8" charOffset="53-69" type="protein" text="GABA(A) receptor"/>
            <pair e1="DS.d398.s0.e0" e2="DS.d398.s0.e1" id="DS.d398.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d399" origId="18585720">
        <sentence id="DS.d399.s0" origId="18585720-96" text="Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies.">
            <entity id="DS.d399.s0.e0" origId="5885531" charOffset="3-9" type="compound" text="oleoyl"/>
            <entity id="DS.d399.s0.e1" origId="P27169,P27170" charOffset="66-70" type="protein" text="PON1"/>
            <pair e1="DS.d399.s0.e0" e2="DS.d399.s0.e1" id="DS.d399.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d400" origId="18585721">
        <sentence id="DS.d400.s0" origId="18585721-97" text="With the exception of specific genetic defects in purine metabolism, increased uric acid is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, insulin resistance, the metabolic syndrome and renal failure.">
            <entity id="DS.d400.s0.e0" origId="1044" charOffset="50-56" type="compound" text="purine"/>
            <entity id="DS.d400.s0.e1" origId="1175" charOffset="79-88" type="compound" text="uric acid"/>
            <entity id="DS.d400.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="199-206" type="protein" text="insulin"/>
            <pair e1="DS.d400.s0.e1" e2="DS.d400.s0.e2" id="DS.d400.s0.i0" interaction="True"/>
            <pair e1="DS.d400.s0.e0" e2="DS.d400.s0.e2" id="DS.d400.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d401" origId="18585744">
        <sentence id="DS.d401.s0" origId="18585744-108" text="The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different fluorescein isothiocyanate (FITC) conjugated lectins.">
            <entity id="DS.d401.s0.e0" origId="18730" charOffset="120-146" type="compound" text="fluorescein isothiocyanate"/>
            <entity id="DS.d401.s0.e1" origId="18730" charOffset="148-152" type="compound" text="FITC"/>
            <entity id="DS.d401.s0.e2" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="165-172" type="protein" text="lectins"/>
            <pair e1="DS.d401.s0.e0" e2="DS.d401.s0.e2" id="DS.d401.s0.i0" interaction="False"/>
            <pair e1="DS.d401.s0.e1" e2="DS.d401.s0.e2" id="DS.d401.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d402" origId="18586252">
        <sentence id="DS.d402.s0" origId="18586252-521" text="High glucose and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity.">
            <entity id="DS.d402.s0.e0" origId="206,5793,64689,79025" charOffset="5-12" type="compound" text="glucose"/>
            <entity id="DS.d402.s0.e1" origId="Q9TTB0" charOffset="17-33" type="protein" text="interferon gamma"/>
            <entity id="DS.d402.s0.e2" origId="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5" charOffset="60-65" type="protein" text="MMP-1"/>
            <entity id="DS.d402.s0.e3" origId="P42224,Q764M5" charOffset="132-137" type="protein" text="STAT1"/>
            <pair e1="DS.d402.s0.e0" e2="DS.d402.s0.e1" id="DS.d402.s0.i0" interaction="False"/>
            <pair e1="DS.d402.s0.e0" e2="DS.d402.s0.e3" id="DS.d402.s0.i1" interaction="True"/>
            <pair e1="DS.d402.s0.e0" e2="DS.d402.s0.e2" id="DS.d402.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d402.s1" origId="18586252-522" text="To test our hypothesis that hyperglycemia interplays with interferon gamma (IFN gamma), a key factor involved in atherosclerosis, to up-regulate the expression of genes such as matrix metalloproteinases (MMPs) and cytokines that are involved in plaque destabilization, U937 macrophages cultured in medium containing either normal or high glucose were challenged with IFN gamma and the expression of MMPs and cytokines were then quantified by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).">
            <entity id="DS.d402.s1.e0" origId="Q9TTB0" charOffset="58-74" type="protein" text="interferon gamma"/>
            <entity id="DS.d402.s1.e1" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="76-85" type="protein" text="IFN gamma"/>
            <entity id="DS.d402.s1.e2" origId="206,5793,64689,79025" charOffset="338-345" type="compound" text="glucose"/>
            <entity id="DS.d402.s1.e3" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="367-376" type="protein" text="IFN gamma"/>
            <pair e1="DS.d402.s1.e2" e2="DS.d402.s1.e0" id="DS.d402.s1.i0" interaction="False"/>
            <pair e1="DS.d402.s1.e2" e2="DS.d402.s1.e1" id="DS.d402.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d402.s2" origId="18586252-523" text="Results showed that high glucose and IFN gamma had a synergistic effect on the expression of MMP-1, MMP-9 and IL-1 beta.">
            <entity id="DS.d402.s2.e0" origId="206,5793,64689,79025" charOffset="25-32" type="compound" text="glucose"/>
            <entity id="DS.d402.s2.e1" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="37-46" type="protein" text="IFN gamma"/>
            <entity id="DS.d402.s2.e2" origId="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5" charOffset="93-98" type="protein" text="MMP-1"/>
            <entity id="DS.d402.s2.e3" origId="O18733,P14780,P41245,P41246,P50282,P52176" charOffset="100-105" type="protein" text="MMP-9"/>
            <entity id="DS.d402.s2.e4" origId="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77" charOffset="110-119" type="protein" text="IL-1 beta"/>
            <pair e1="DS.d402.s2.e0" e2="DS.d402.s2.e4" id="DS.d402.s2.i0" interaction="True"/>
            <pair e1="DS.d402.s2.e0" e2="DS.d402.s2.e2" id="DS.d402.s2.i1" interaction="True"/>
            <pair e1="DS.d402.s2.e0" e2="DS.d402.s2.e1" id="DS.d402.s2.i2" interaction="False"/>
            <pair e1="DS.d402.s2.e0" e2="DS.d402.s2.e3" id="DS.d402.s2.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d402.s3" origId="18586252-525" text="Furthermore, high glucose and IFN gamma exert the synergistic effect on MMP-1 expression by enhancing STAT1 phosphorylation and STAT1 transcriptional activity.">
            <entity id="DS.d402.s3.e0" origId="206,5793,64689,79025" charOffset="18-25" type="compound" text="glucose"/>
            <entity id="DS.d402.s3.e1" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="30-39" type="protein" text="IFN gamma"/>
            <entity id="DS.d402.s3.e2" origId="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5" charOffset="72-77" type="protein" text="MMP-1"/>
            <entity id="DS.d402.s3.e3" origId="P42224,Q764M5" charOffset="102-107" type="protein" text="STAT1"/>
            <entity id="DS.d402.s3.e4" origId="P42224,Q764M5" charOffset="128-133" type="protein" text="STAT1"/>
            <pair e1="DS.d402.s3.e0" e2="DS.d402.s3.e3" id="DS.d402.s3.i0" interaction="True"/>
            <pair e1="DS.d402.s3.e0" e2="DS.d402.s3.e1" id="DS.d402.s3.i1" interaction="False"/>
            <pair e1="DS.d402.s3.e0" e2="DS.d402.s3.e2" id="DS.d402.s3.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d403" origId="18586420">
        <sentence id="DS.d403.s0" origId="18586420-663" text="In Experiment 2, lactoferrin (10 mg/mL) combined with cidofovir (62.5 microg/mL) inhibited up to 100,200 PFU/mL of virus in cell culture.">
            <entity id="DS.d403.s0.e0" origId="O77698,O77811,P02788,P08071,P14632,P24627,Q29477,Q9TUM0" charOffset="17-28" type="protein" text="lactoferrin"/>
            <entity id="DS.d403.s0.e1" origId="60613" charOffset="54-63" type="compound" text="cidofovir"/>
            <pair e1="DS.d403.s0.e1" e2="DS.d403.s0.e0" id="DS.d403.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d404" origId="18586549">
        <sentence id="DS.d404.s0" origId="18586549-790" text="We systematically investigated whether PD-related stresses including MG132 and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and rotenone (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 ubiquitin ligases (dorfin, SIAH-1).">
            <entity id="DS.d404.s0.e0" origId="462382" charOffset="69-74" type="compound" text="MG132"/>
            <entity id="DS.d404.s0.e1" origId="6758" charOffset="159-167" type="compound" text="rotenone"/>
            <entity id="DS.d404.s0.e2" origId="O46543,P08565,P08618,P0C014,P0C072,P13117,P14624,P14792,P15174,P19848,P20685,P22589,P23324,P23398,P42739,P42740,P46574,P49634,P49635,P59263,P59669,P61862,P61863,P61864,P62972,P62973,P62974,P62975,P62976,P62977,P62988,P62989,P62990,P62991,P63049,P63051,P68195,P68196,P68197,P68198,P68199,P68201,P68204,P69308,P69309,P69310,P69311,P69312,P69313,P69314,P69315,P69316,P69317,P69318,P69319,P69320,P69321,P69322,P69323,P69324,P69325,P69326,P84589,Q05550,Q865C5,Q867C2,Q867C3,Q867C4,Q8MKD1,Q9Y848" charOffset="252-261" type="protein" text="ubiquitin"/>
            <entity id="DS.d404.s0.e3" origId="Q9NV58" charOffset="271-277" type="protein" text="dorfin"/>
            <pair e1="DS.d404.s0.e1" e2="DS.d404.s0.e2" id="DS.d404.s0.i0" interaction="False"/>
            <pair e1="DS.d404.s0.e1" e2="DS.d404.s0.e3" id="DS.d404.s0.i1" interaction="False"/>
            <pair e1="DS.d404.s0.e0" e2="DS.d404.s0.e3" id="DS.d404.s0.i2" interaction="False"/>
            <pair e1="DS.d404.s0.e0" e2="DS.d404.s0.e2" id="DS.d404.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d405" origId="18587580">
        <sentence id="DS.d405.s0" origId="18587580-1638" text="CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.">
            <entity id="DS.d405.s0.e0" origId="400769" charOffset="0-7" type="compound" text="CDDO-Me"/>
            <entity id="DS.d405.s0.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="58-62" type="protein" text="IL-6"/>
            <entity id="DS.d405.s0.e2" origId="P42227,P52631" charOffset="67-72" type="protein" text="Stat3"/>
            <pair e1="DS.d405.s0.e0" e2="DS.d405.s0.e2" id="DS.d405.s0.i0" interaction="True"/>
            <pair e1="DS.d405.s0.e0" e2="DS.d405.s0.e1" id="DS.d405.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d405.s1" origId="18587580-1639" text="To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit IL-6 secretion, Stat3 phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.">
            <entity id="DS.d405.s1.e0" origId="400769" charOffset="120-127" type="compound" text="CDDO-Me"/>
            <entity id="DS.d405.s1.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="166-170" type="protein" text="IL-6"/>
            <entity id="DS.d405.s1.e2" origId="P42227,P52631" charOffset="182-187" type="protein" text="Stat3"/>
            <entity id="DS.d405.s1.e3" origId="P42227,P52631" charOffset="205-210" type="protein" text="Stat3"/>
            <entity id="DS.d405.s1.e4" origId="4666,36314,441276,5352019,6713921,6915727,44155032,53313247" charOffset="237-247" type="compound" text="paclitaxel"/>
            <pair e1="DS.d405.s1.e4" e2="DS.d405.s1.e2" id="DS.d405.s1.i0" interaction="False"/>
            <pair e1="DS.d405.s1.e0" e2="DS.d405.s1.e1" id="DS.d405.s1.i1" interaction="False"/>
            <pair e1="DS.d405.s1.e4" e2="DS.d405.s1.e1" id="DS.d405.s1.i2" interaction="False"/>
            <pair e1="DS.d405.s1.e0" e2="DS.d405.s1.e2" id="DS.d405.s1.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d405.s2" origId="18587580-1640" text="These studies demonstrated that CDDO-Me significantly inhibits IL-6 secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced Stat3 nuclear translocation.">
            <entity id="DS.d405.s2.e0" origId="400769" charOffset="32-39" type="compound" text="CDDO-Me"/>
            <entity id="DS.d405.s2.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="63-67" type="protein" text="IL-6"/>
            <entity id="DS.d405.s2.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="151-155" type="protein" text="IL-6"/>
            <entity id="DS.d405.s2.e3" origId="P42227,P52631" charOffset="180-185" type="protein" text="Stat3"/>
            <pair e1="DS.d405.s2.e0" e2="DS.d405.s2.e3" id="DS.d405.s2.i0" interaction="True"/>
            <pair e1="DS.d405.s2.e0" e2="DS.d405.s2.e1" id="DS.d405.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d405.s3" origId="18587580-1641" text="Treatment with CDDO-Me significantly decreases the levels of Stat3, Jak2, and Src phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.">
            <entity id="DS.d405.s3.e0" origId="400769" charOffset="15-22" type="compound" text="CDDO-Me"/>
            <entity id="DS.d405.s3.e1" origId="Q62120,Q62689" charOffset="68-72" type="protein" text="Jak2"/>
            <entity id="DS.d405.s3.e2" origId="P05480,Q9WUD9" charOffset="78-81" type="protein" text="Src"/>
            <pair e1="DS.d405.s3.e0" e2="DS.d405.s3.e1" id="DS.d405.s3.i0" interaction="True"/>
            <pair e1="DS.d405.s3.e0" e2="DS.d405.s3.e2" id="DS.d405.s3.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d405.s4" origId="18587580-1642" text="Our data confirm that CDDO-Me interrupts the signaling of multiple kinases involved in the IL-6-Stat3 and Src signaling pathways.">
            <entity id="DS.d405.s4.e0" origId="400769" charOffset="22-29" type="compound" text="CDDO-Me"/>
            <entity id="DS.d405.s4.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="91-95" type="protein" text="IL-6"/>
            <entity id="DS.d405.s4.e2" origId="P42227,P52631" charOffset="96-101" type="protein" text="Stat3"/>
            <entity id="DS.d405.s4.e3" origId="P05480,Q9WUD9" charOffset="106-109" type="protein" text="Src"/>
            <pair e1="DS.d405.s4.e0" e2="DS.d405.s4.e2" id="DS.d405.s4.i0" interaction="True"/>
            <pair e1="DS.d405.s4.e0" e2="DS.d405.s4.e3" id="DS.d405.s4.i1" interaction="True"/>
            <pair e1="DS.d405.s4.e0" e2="DS.d405.s4.e1" id="DS.d405.s4.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d406" origId="18587601">
        <sentence id="DS.d406.s0" origId="18587601-1586" text="The anti-hyperlipemia effect of EPS and intracellular polysaccharide (IPS) extracted from mycelia were observed that both EPS and IPS can obviously reduce the serum triglyceride (TG), the blood cholesterol (TC) and serum low density lipoprotein (LDL) level, and increase the high density lipoprotein (HDL) level of the hyperlipemia mice.">
            <entity id="DS.d406.s0.e0" origId="304,5997,6432564,11025495" charOffset="194-205" type="compound" text="cholesterol"/>
            <entity id="DS.d406.s0.e1" origId="P81182" charOffset="275-299" type="protein" text="high density lipoprotein"/>
            <pair e1="DS.d406.s0.e0" e2="DS.d406.s0.e1" id="DS.d406.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d407" origId="18587610">
        <sentence id="DS.d407.s0" origId="18587610-1674" text="On a molar basis, streptomycin yields a signal that is approximately 0.67 times that of MurA.">
            <entity id="DS.d407.s0.e0" origId="5999,19649,6426892,6602485" charOffset="18-30" type="compound" text="streptomycin"/>
            <entity id="DS.d407.s0.e1" origId="O32849,O32857,O32858,O33159,O33160,O51428,O54312,O67315,O84461,P0A5L2,P0A5L3,P0A749,P0A750,P0A751,P19670,P33038,P33986,P45025,P45821,P56189,P57466,P57821,P65452,P65453,P65454,P65455,P65458,P65459,P70965,P84058,P84059,Q2RQ67,Q2YAN2,Q2YPB6,Q30T46,Q315P9,Q319I9,Q31GZ1,Q31W66,Q32BE4,Q39K93,Q39YP9,Q3A131,Q3A949,Q3AR32,Q3B5D7,Q3BQX2,Q3IG20,Q3J077,Q3J7G9,Q3JMZ4,Q3KHZ4,Q3KLP3,Q3MD78,Q3SHP2,Q3SW27,Q3YX52,Q46JH1,Q46WL0,Q47AK9,Q47KH3,Q47VJ4,Q48EC7,Q48UD0,Q493Y9,Q4FNE4,Q4FQF6,Q4JXA4,Q4KI75,Q4L7Y1,Q4QLK7,Q4UKX7,Q4UX36,Q4ZNV7,Q55673,Q57F97,Q57JG1,Q59561,Q5E7V0,Q5F5K6,Q5FME5,Q5FSM2,Q5GRP6,Q5H3C7,Q5HEA0,Q5HMC2,Q5HUT8,Q5L6U5,Q5L9P3,Q5LL90,Q5LZI4,Q5M439,Q5NLR2,Q5P787,Q5PBP4,Q5PLD1,Q5R0J5,Q5SM03,Q5WB82,Q5WY61,Q5X6Q6,Q5XCX7,Q5Z0X7,Q5ZX85,Q606Q0,Q62GD7,Q630W1,Q63Q84,Q64PY6,Q65RU6,Q661E8,Q665K4,Q68WF7,Q6AJM7,Q6DAF2,Q6FED0,Q6FYT1,Q6G226,Q6G7L0,Q6GEX5,Q6HAZ8,Q6LMC9,Q6MEP6,Q6MRK7,Q6N176,Q6NFK1,Q71WQ2,Q726D3,Q72GJ4,Q73FX6,Q73Q03,Q73X63,Q748B3,Q74LG1,Q7MAC1,Q7MPA3,Q7MUW1,Q7N068,Q7NGP3,Q7P0X5,Q7U5R6,Q7V0G1,Q7V8L0,Q7VAC5,Q7VAT0,Q7VIM8,Q7VP51,Q7VQS0,Q7VSZ3,Q7W2Y6,Q7WDY6,Q82TN2,Q83DI0,Q87DN8,Q87LF4,Q87WV2,Q88P88,Q89AE9,Q89W71,Q8A681,Q8CRN6,Q8D2M5,Q8DEB6,Q8DKS7,Q8DNE8,Q8E5U6,Q8EAF7,Q8EM86,Q8FMR0,Q8K825,Q8K9G4,Q8KEX7,Q8NML5,Q8P719,Q8PID3,Q8RIQ1,Q8UHW9,Q8X9J9,Q8XID7,Q8XV78,Q8Y4C4,Q8Z0C4,Q8ZB56,Q927W7,Q92H88,Q92S27,Q931H5,Q97F79,Q97NQ4,Q9A5U7,Q9CI17,Q9HVW7,Q9JWS7,Q9K1Q9,Q9K6I0,Q9KP62,Q9PDG4,Q9PJT7,Q9PP65,Q9RVA6,Q9WXW3,Q9Z3Z6,Q9Z7Y2,Q9ZCX3,Q9ZH21,Q9ZLI6" charOffset="88-92" type="protein" text="MurA"/>
            <pair e1="DS.d407.s0.e0" e2="DS.d407.s0.e1" id="DS.d407.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d408" origId="18587665">
        <sentence id="DS.d408.s0" origId="18587665-16" text="Puerarin regulates expressions of VEGF and HIF-1alpha stimulated by STZ.">
            <entity id="DS.d408.s0.e0" origId="5281807,5385074,5486172,44257207,53384442" charOffset="0-8" type="compound" text="Puerarin"/>
            <entity id="DS.d408.s0.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="34-38" type="protein" text="VEGF"/>
            <entity id="DS.d408.s0.e2" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="43-53" type="protein" text="HIF-1alpha"/>
            <pair e1="DS.d408.s0.e0" e2="DS.d408.s0.e2" id="DS.d408.s0.i0" interaction="True"/>
            <pair e1="DS.d408.s0.e0" e2="DS.d408.s0.e1" id="DS.d408.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d409" origId="18588512">
        <sentence id="DS.d409.s0" origId="18588512-710" text="In patients with hypertension and diabetes, ARB, ACEi and diuretic treatment increased Ras activation only during the first week.">
            <entity id="DS.d409.s0.e0" origId="439764" charOffset="44-47" type="compound" text="ARB"/>
            <entity id="DS.d409.s0.e1" origId="P03967,P22126,Q07152" charOffset="87-90" type="protein" text="Ras"/>
            <pair e1="DS.d409.s0.e0" e2="DS.d409.s0.e1" id="DS.d409.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d410" origId="18590515">
        <sentence id="DS.d410.s0" origId="18590515-661" text="Although the co-expression of alpha2,3-ST and CMP-SAS did not further increase sialylation, an increase in the intracellular pool of CMP-sialic acid was noted.">
            <entity id="DS.d410.s0.e0" origId="P54751,P61130,P61131,P72074,P72097,Q02745,Q11200,Q11201,Q11204,Q11205,Q11206,Q16842,Q48211,Q6KB58,Q6KB59,Q91Y74,Q9CNC4,Q9JUV5" charOffset="30-41" type="protein" text="alpha2,3-ST"/>
            <entity id="DS.d410.s0.e1" origId="906,444885,445063" charOffset="137-148" type="compound" text="sialic acid"/>
            <pair e1="DS.d410.s0.e1" e2="DS.d410.s0.e0" id="DS.d410.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d411" origId="18590587">
        <sentence id="DS.d411.s0" origId="18590587-733" text="NOPE-EGCG treatment improved insulin 0.0001).">
            <entity id="DS.d411.s0.e0" origId="65064" charOffset="5-9" type="compound" text="EGCG"/>
            <entity id="DS.d411.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="29-36" type="protein" text="insulin"/>
            <pair e1="DS.d411.s0.e0" e2="DS.d411.s0.e1" id="DS.d411.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d412" origId="18590597">
        <sentence id="DS.d412.s0" origId="18590597-739" text="A 23.5-fold increase in 7-ethoxy-4-trifluoromethylcoumarin O-deethylation activity suggested that metabolic resistance through elevated levels of cytochrome P450 dependent monooxygenase-activity is a possible resistance mechanism.However, synergism studies with different metabolic inhibitors revealed some contrasting resistance mechanisms between the METI-acaricides.">
            <entity id="DS.d412.s0.e0" origId="130779" charOffset="24-58" type="compound" text="7-ethoxy-4-trifluoromethylcoumarin"/>
            <entity id="DS.d412.s0.e1" origId="O08469" charOffset="146-161" type="protein" text="cytochrome P450"/>
            <pair e1="DS.d412.s0.e0" e2="DS.d412.s0.e1" id="DS.d412.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d413" origId="18592271">
        <sentence id="DS.d413.s0" origId="18592271-409" text="The activities of Rho GTPases are predominantly controlled by guanine nucleotide exchange factors (GEFs), which activate GTPases by catalyzing the exchange of bound GDP for GTP.">
            <entity id="DS.d413.s0.e1" origId="Q9NR83" charOffset="99-103" type="protein" text="GEFs"/>
            <entity id="DS.d413.s0.e2" origId="8977" charOffset="165-168" type="compound" text="GDP"/>
            <pair e1="DS.d413.s0.e2" e2="DS.d413.s0.e1" id="DS.d413.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d414" origId="18592327">
        <sentence id="DS.d414.s0" origId="18592327-379" text="11beta-Hydroxysteroid dehydrogenase type 1 (11beta-HSD1) enzyme catalyzes interconversion of inactive cortisone to active cortisol.">
            <entity id="DS.d414.s0.e0" origId="P16232,P28845,P50172,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4" charOffset="44-55" type="protein" text="11beta-HSD1"/>
            <entity id="DS.d414.s0.e1" origId="222786" charOffset="102-111" type="compound" text="cortisone"/>
            <entity id="DS.d414.s0.e2" origId="5754" charOffset="122-130" type="compound" text="cortisol"/>
            <pair e1="DS.d414.s0.e2" e2="DS.d414.s0.e0" id="DS.d414.s0.i0" interaction="True"/>
            <pair e1="DS.d414.s0.e1" e2="DS.d414.s0.e0" id="DS.d414.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d415" origId="18592344">
        <sentence id="DS.d415.s0" origId="18592344-477" text="Rebinding experiments with Lys-Gly-Asp, an analogue of Arg-Gly-Asp, and other different peptides, such as cholecystokinin C-terminal tri- and pentapeptide and gramicidin, further indicated the selectivity of methacrylic acid-trimethylpropane trimethacrylate copolymer for Arg-Gly-Asp giving specific selectivity factor values 1.27, 1.98, 1.31 and 1.67, respectively.">
            <entity id="DS.d415.s0.e2" origId="P0C229,P50144,P50145,P68125,P68126" charOffset="106-121" type="protein" text="cholecystokinin"/>
            <entity id="DS.d415.s0.e4" origId="16130140" charOffset="159-169" type="compound" text="gramicidin"/>
            <pair e1="DS.d415.s0.e4" e2="DS.d415.s0.e2" id="DS.d415.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d416" origId="18592367">
        <sentence id="DS.d416.s0" origId="18592367-499" text="Parents (N = 19) of children with autism spectrum disorders (ASD) and adult controls (N = 17) underwent positron emission tomography (PET) using ((18)F) setoperone to image cortical serotonin type-2 (5-HT2) receptors.">
            <entity id="DS.d416.s0.e0" origId="68604" charOffset="153-163" type="compound" text="setoperone"/>
            <entity id="DS.d416.s0.e1" origId="O46635,P14842,P18599,P28223,P35363,P35382,P50128,P50129,Q5R4Q6,Q75Z89" charOffset="200-205" type="protein" text="5-HT2"/>
            <pair e1="DS.d416.s0.e0" e2="DS.d416.s0.e1" id="DS.d416.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d417" origId="18592408">
        <sentence id="DS.d417.s0" origId="18592408-535" text="Natural anacardic acid was enzymatically polymerized using soybean peroxidase.">
            <entity id="DS.d417.s0.e0" origId="167551" charOffset="8-22" type="compound" text="anacardic acid"/>
            <entity id="DS.d417.s0.e1" origId="P15984,P16147,P84714" charOffset="67-77" type="protein" text="peroxidase"/>
            <pair e1="DS.d417.s0.e0" e2="DS.d417.s0.e1" id="DS.d417.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d418" origId="18592416">
        <sentence id="DS.d418.s0" origId="18592416-542" text="Vesicle mobilization requires Ca(2+)-induced Ca2+ release by presynaptic endoplasmic reticulum (ER) ryanodine receptors (RyRs) that in turn stimulates Ca2+/calmodulin-dependent kinase II (CamKII).">
            <entity id="DS.d418.s0.e0" origId="271" charOffset="30-34" type="compound" text="Ca(2"/>
            <entity id="DS.d418.s0.e1" origId="Q24498" charOffset="121-125" type="protein" text="RyRs"/>
            <pair e1="DS.d418.s0.e0" e2="DS.d418.s0.e1" id="DS.d418.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d419" origId="18593507">
        <sentence id="DS.d419.s0" origId="18593507-1421" text="These results highlight both the interactions between mGluR5 and NMDA receptors in the determination of schizophreniform behaviours and the potential for the effects of clozapine to be mediated by NMDA receptor regulation.">
            <entity id="DS.d419.s0.e0" origId="P31424,P41594" charOffset="54-60" type="protein" text="mGluR5"/>
            <entity id="DS.d419.s0.e1" origId="2818" charOffset="169-178" type="compound" text="clozapine"/>
            <pair e1="DS.d419.s0.e1" e2="DS.d419.s0.e0" id="DS.d419.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d420" origId="18594129">
        <sentence id="DS.d420.s0" origId="18594129-259" text="Expression of rhtC reduced the intracellular L-threonine concentration from 140 to 11 mM and resulted in maximal excretion rates of 11.2 nmol min(-1) mg(-1) as compared to 2.3 nmol min(-1) mg(-1) obtained without rhtC expression.">
            <entity id="DS.d420.s0.e0" origId="P0AG38,P0AG39,Q8Z3B3,Q9L6N7" charOffset="14-18" type="protein" text="rhtC"/>
            <entity id="DS.d420.s0.e1" origId="6288" charOffset="45-56" type="compound" text="L-threonine"/>
            <entity id="DS.d420.s0.e2" origId="P0AG38,P0AG39,Q8Z3B3,Q9L6N7" charOffset="213-217" type="protein" text="rhtC"/>
            <pair e1="DS.d420.s0.e1" e2="DS.d420.s0.e0" id="DS.d420.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d420.s1" origId="18594129-260" text="In combination with an ilvA mutation generated and introduced into the chromosome, an accumulation of up to 54 mM L-threonine was achieved as compared to 21 mM obtained with the ancestor strain.">
            <entity id="DS.d420.s1.e0" origId="P04968,P20506,P37946,P46493,P53607,P66897,P66898,Q02145,Q04513,Q2FF63,Q2YUE8,Q3V7T4,Q3V7T5,Q49Z16,Q4L7U4,Q5HEE0,Q5HMF5,Q7A4H2,Q8CNK9,Q8NVI8,Q99SJ1,Q9CKJ2,Q9KC63,Q9X7F1" charOffset="23-27" type="protein" text="ilvA"/>
            <entity id="DS.d420.s1.e1" origId="6288" charOffset="114-125" type="compound" text="L-threonine"/>
            <pair e1="DS.d420.s1.e1" e2="DS.d420.s1.e0" id="DS.d420.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d421" origId="18594817">
        <sentence id="DS.d421.s0" origId="18594817-847" text="This additive effect was not observed when glioma cells were pre-treated with temozolomide, which was unable to increase Fas expression in tumor.">
            <entity id="DS.d421.s0.e0" origId="5394" charOffset="78-90" type="compound" text="temozolomide"/>
            <entity id="DS.d421.s0.e1" origId="P25446,Q63199" charOffset="121-124" type="protein" text="Fas"/>
            <pair e1="DS.d421.s0.e0" e2="DS.d421.s0.e1" id="DS.d421.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d421.s1" origId="18594817-848" text="Furthermore, the CD3(+) T cells co-cultured with topotecan treated U-87 and autologous GBM tumor cells showed a significant increase in expression in IFN-gamma, a key cytokine produced by activated T cells, and accordingly enhanced tumor cytotoxicity.">
            <entity id="DS.d421.s1.e0" origId="60700" charOffset="49-58" type="compound" text="topotecan"/>
            <entity id="DS.d421.s1.e1" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="150-159" type="protein" text="IFN-gamma"/>
            <pair e1="DS.d421.s1.e0" e2="DS.d421.s1.e1" id="DS.d421.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d422" origId="18594856">
        <sentence id="DS.d422.s0" origId="18594856-883" text="Hypergravity also induced a transient reorganization of actin fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (herbimycin A and tyrphostin 46).">
            <entity id="DS.d422.s0.e0" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="56-61" type="protein" text="actin"/>
            <entity id="DS.d422.s0.e1" origId="448042" charOffset="124-130" type="compound" text="Y27632"/>
            <entity id="DS.d422.s0.e2" origId="3591,5311102,6436247" charOffset="164-176" type="compound" text="herbimycin A"/>
            <entity id="DS.d422.s0.e3" origId="5328768" charOffset="181-194" type="compound" text="tyrphostin 46"/>
            <pair e1="DS.d422.s0.e1" e2="DS.d422.s0.e0" id="DS.d422.s0.i0" interaction="True"/>
            <pair e1="DS.d422.s0.e2" e2="DS.d422.s0.e0" id="DS.d422.s0.i1" interaction="True"/>
            <pair e1="DS.d422.s0.e3" e2="DS.d422.s0.e0" id="DS.d422.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d422.s1" origId="18594856-886" text="Collectively, these results indicate that hypergravity induces ATP release and actin reorganization via RhoA activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.">
            <entity id="DS.d422.s1.e0" origId="5957" charOffset="63-66" type="compound" text="ATP"/>
            <entity id="DS.d422.s1.e1" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="79-84" type="protein" text="actin"/>
            <entity id="DS.d422.s1.e2" origId="Q9C3Y4" charOffset="104-108" type="protein" text="RhoA"/>
            <entity id="DS.d422.s1.e3" origId="Q00944,Q05397" charOffset="124-127" type="protein" text="FAK"/>
            <pair e1="DS.d422.s1.e0" e2="DS.d422.s1.e3" id="DS.d422.s1.i0" interaction="True"/>
            <pair e1="DS.d422.s1.e0" e2="DS.d422.s1.e2" id="DS.d422.s1.i1" interaction="True"/>
            <pair e1="DS.d422.s1.e0" e2="DS.d422.s1.e1" id="DS.d422.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d423" origId="18594946">
        <sentence id="DS.d423.s0" origId="18594946-953" text="Cell exposure to 250 microM homocysteine was able to induce transglutaminase 2 up-regulation and increased in situ transglutaminase activity.">
            <entity id="DS.d423.s0.e0" origId="778" charOffset="28-40" type="compound" text="homocysteine"/>
            <entity id="DS.d423.s0.e1" origId="P08587,P21980,P21981,P51176,P52181,Q01841" charOffset="60-78" type="protein" text="transglutaminase 2"/>
            <entity id="DS.d423.s0.e2" origId="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7" charOffset="60-76" type="protein" text="transglutaminase"/>
            <pair e1="DS.d423.s0.e0" e2="DS.d423.s0.e2" id="DS.d423.s0.i0" interaction="True"/>
            <pair e1="DS.d423.s0.e0" e2="DS.d423.s0.e1" id="DS.d423.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d423.s1" origId="18594946-954" text="Homocysteine also induced NF-kappaB activation that seemed associated with transglutaminase 2 up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.">
            <entity id="DS.d423.s1.e0" origId="778" charOffset="0-12" type="compound" text="Homocysteine"/>
            <entity id="DS.d423.s1.e1" origId="P08587,P21980,P21981,P51176,P52181,Q01841" charOffset="75-93" type="protein" text="transglutaminase 2"/>
            <entity id="DS.d423.s1.e2" origId="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7" charOffset="75-91" type="protein" text="transglutaminase"/>
            <pair e1="DS.d423.s1.e0" e2="DS.d423.s1.e2" id="DS.d423.s1.i0" interaction="True"/>
            <pair e1="DS.d423.s1.e0" e2="DS.d423.s1.e1" id="DS.d423.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d424" origId="18594965">
        <sentence id="DS.d424.s0" origId="18594965-980" text="Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytes.">
            <entity id="DS.d424.s0.e0" origId="3988,5311263,5497152" charOffset="0-21" type="compound" text="Lysophosphatidic acid"/>
            <entity id="DS.d424.s0.e1" origId="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1" charOffset="92-95" type="protein" text="MBP"/>
            <pair e1="DS.d424.s0.e0" e2="DS.d424.s0.e1" id="DS.d424.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d425" origId="18594989">
        <sentence id="DS.d425.s0" origId="18594989-1002" text="There was no correlation between the presence of significant heart-valve regurgitation and cabergoline cumulative dose, duration of cabergoline treatment, prior use of bromocriptine, age, adenoma size, or prolactin levels.">
            <entity id="DS.d425.s0.e0" origId="54746" charOffset="91-102" type="compound" text="cabergoline"/>
            <entity id="DS.d425.s0.e1" origId="54746" charOffset="132-143" type="compound" text="cabergoline"/>
            <entity id="DS.d425.s0.e2" origId="31101" charOffset="168-181" type="compound" text="bromocriptine"/>
            <entity id="DS.d425.s0.e3" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="205-214" type="protein" text="prolactin"/>
            <pair e1="DS.d425.s0.e0" e2="DS.d425.s0.e3" id="DS.d425.s0.i0" interaction="False"/>
            <pair e1="DS.d425.s0.e2" e2="DS.d425.s0.e3" id="DS.d425.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d426" origId="18595002">
        <sentence id="DS.d426.s0" origId="18595002-930" text="CHH elevates glucose levels in the hemolymph by stimulating glycogenolysis in target tissues.">
            <entity id="DS.d426.s0.e0" origId="O77220,P14944,P30814,P55845,P56687,P59685,P81032,P83800,Q25588,Q25589,Q25683,Q26181" charOffset="0-3" type="protein" text="CHH"/>
            <entity id="DS.d426.s0.e1" origId="206,5793,64689,79025" charOffset="13-20" type="compound" text="glucose"/>
            <pair e1="DS.d426.s0.e1" e2="DS.d426.s0.e0" id="DS.d426.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d427" origId="18596195">
        <sentence id="DS.d427.s0" origId="18596195-276" text="Here, we assessed the regulation of pancreatic cytochrome c release by Ca(2+), mitochondrial membrane potential (Delta Psi m), and reactive oxygen species (ROS), the signals involved in acute pancreatitis.">
            <entity id="DS.d427.s0.e0" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="47-59" type="protein" text="cytochrome c"/>
            <entity id="DS.d427.s0.e1" origId="271" charOffset="71-75" type="compound" text="Ca(2"/>
            <pair e1="DS.d427.s0.e1" e2="DS.d427.s0.e0" id="DS.d427.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d428" origId="18596687">
        <sentence id="DS.d428.s0" origId="18596687-690" text="Here, we report the efficacy of betaxolol in reducing increases in gene expression of amygdalar corticotropin-releasing factor (CRF), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of cocaine abstinence.">
            <entity id="DS.d428.s0.e0" origId="2369,60657" charOffset="32-41" type="compound" text="betaxolol"/>
            <entity id="DS.d428.s0.e1" origId="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1" charOffset="96-126" type="protein" text="corticotropin-releasing factor"/>
            <entity id="DS.d428.s0.e2" origId="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1" charOffset="128-131" type="protein" text="CRF"/>
            <entity id="DS.d428.s0.e3" origId="2826,5760,439497,446220,644017,54613779" charOffset="228-235" type="compound" text="cocaine"/>
            <pair e1="DS.d428.s0.e3" e2="DS.d428.s0.e2" id="DS.d428.s0.i0" interaction="True"/>
            <pair e1="DS.d428.s0.e0" e2="DS.d428.s0.e1" id="DS.d428.s0.i1" interaction="True"/>
            <pair e1="DS.d428.s0.e0" e2="DS.d428.s0.e2" id="DS.d428.s0.i2" interaction="True"/>
            <pair e1="DS.d428.s0.e3" e2="DS.d428.s0.e1" id="DS.d428.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d428.s1" origId="18596687-691" text="Results showed that betaxolol treatment during early cocaine withdrawal attenuated increases in amygdalar CRF gene expression and cyclic adenosine monophosphate-dependent protein kinase regulatory and catalytic subunit (nuclear fraction) protein expression.">
            <entity id="DS.d428.s1.e0" origId="2369,60657" charOffset="20-29" type="compound" text="betaxolol"/>
            <entity id="DS.d428.s1.e1" origId="2826,5760,439497,446220,644017,54613779" charOffset="53-60" type="compound" text="cocaine"/>
            <entity id="DS.d428.s1.e2" origId="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1" charOffset="106-109" type="protein" text="CRF"/>
            <entity id="DS.d428.s1.e3" origId="P00513,P25848" charOffset="171-185" type="protein" text="protein kinase"/>
            <pair e1="DS.d428.s1.e0" e2="DS.d428.s1.e3" id="DS.d428.s1.i0" interaction="True"/>
            <pair e1="DS.d428.s1.e1" e2="DS.d428.s1.e2" id="DS.d428.s1.i1" interaction="False"/>
            <pair e1="DS.d428.s1.e0" e2="DS.d428.s1.e2" id="DS.d428.s1.i2" interaction="True"/>
            <pair e1="DS.d428.s1.e1" e2="DS.d428.s1.e3" id="DS.d428.s1.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d428.s2" origId="18596687-692" text="The present findings suggest that the efficacy of betaxolol treatment on cocaine withdrawal-induced anxiety may be related, in part, to its effect on amygdalar beta(1)-adrenergic receptor, modulation of its downstream cell-signaling elements and CRF gene expression.">
            <entity id="DS.d428.s2.e0" origId="2369,60657" charOffset="50-59" type="compound" text="betaxolol"/>
            <entity id="DS.d428.s2.e1" origId="2826,5760,439497,446220,644017,54613779" charOffset="73-80" type="compound" text="cocaine"/>
            <entity id="DS.d428.s2.e2" origId="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1" charOffset="246-249" type="protein" text="CRF"/>
            <pair e1="DS.d428.s2.e1" e2="DS.d428.s2.e2" id="DS.d428.s2.i0" interaction="False"/>
            <pair e1="DS.d428.s2.e0" e2="DS.d428.s2.e2" id="DS.d428.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d429" origId="18597051">
        <sentence id="DS.d429.s0" origId="18597051-1012" text="Furthermore, it is demonstrated that this strain has xylanase activity, and the activity can be optimized under suitable growing conditions where wheat bran and urea are the primary sources of carbon and nitrogen.">
            <entity id="DS.d429.s0.e0" origId="O43097,O59859,O60206,P07529,P09850,P17137,P23360,P23557,P29417,P40943,P45703,P48793,P56588,P81536,Q53317" charOffset="53-61" type="protein" text="xylanase"/>
            <entity id="DS.d429.s0.e1" origId="1176,265993" charOffset="161-165" type="compound" text="urea"/>
            <entity id="DS.d429.s0.e2" origId="947,123329" charOffset="204-212" type="compound" text="nitrogen"/>
            <pair e1="DS.d429.s0.e1" e2="DS.d429.s0.e0" id="DS.d429.s0.i0" interaction="False"/>
            <pair e1="DS.d429.s0.e2" e2="DS.d429.s0.e0" id="DS.d429.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d430" origId="18597073">
        <sentence id="DS.d430.s0" origId="18597073-1033" text="Glutathione S-transferase (GST) isozymes catalyze nucleophilic attack by reduced Glutathione (GSH) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).">
            <entity id="DS.d430.s0.e0" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="0-25" type="protein" text="Glutathione S-transferase"/>
            <entity id="DS.d430.s0.e1" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="27-30" type="protein" text="GST"/>
            <entity id="DS.d430.s0.e2" origId="124886" charOffset="73-92" type="compound" text="reduced Glutathione"/>
            <entity id="DS.d430.s0.e3" origId="124886" charOffset="94-97" type="compound" text="GSH"/>
            <pair e1="DS.d430.s0.e3" e2="DS.d430.s0.e1" id="DS.d430.s0.i0" interaction="True"/>
            <pair e1="DS.d430.s0.e2" e2="DS.d430.s0.e0" id="DS.d430.s0.i1" interaction="True"/>
            <pair e1="DS.d430.s0.e2" e2="DS.d430.s0.e1" id="DS.d430.s0.i2" interaction="True"/>
            <pair e1="DS.d430.s0.e3" e2="DS.d430.s0.e0" id="DS.d430.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d431" origId="18597869">
        <sentence id="DS.d431.s0" origId="18597869-1683" text="Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.">
            <entity id="DS.d431.s0.e0" origId="4091" charOffset="0-9" type="compound" text="Metformin"/>
            <entity id="DS.d431.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="19-28" type="protein" text="TNF-alpha"/>
            <entity id="DS.d431.s0.e2" origId="O15111,Q60680" charOffset="37-51" type="protein" text="IkappaB kinase"/>
            <entity id="DS.d431.s0.e3" origId="P25963,Q08353,Q63746,Q91974,Q9Z1E3" charOffset="69-82" type="protein" text="IkappaB-alpha"/>
            <entity id="DS.d431.s0.e4" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="99-103" type="protein" text="IL-6"/>
            <entity id="DS.d431.s0.e5" origId="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0" charOffset="144-148" type="protein" text="PI3K"/>
            <entity id="DS.d431.s0.e6" origId="P54646,Q09136,Q9Y478" charOffset="159-163" type="protein" text="AMPK"/>
            <pair e1="DS.d431.s0.e0" e2="DS.d431.s0.e6" id="DS.d431.s0.i0" interaction="True"/>
            <pair e1="DS.d431.s0.e0" e2="DS.d431.s0.e1" id="DS.d431.s0.i1" interaction="False"/>
            <pair e1="DS.d431.s0.e0" e2="DS.d431.s0.e5" id="DS.d431.s0.i2" interaction="True"/>
            <pair e1="DS.d431.s0.e0" e2="DS.d431.s0.e3" id="DS.d431.s0.i3" interaction="True"/>
            <pair e1="DS.d431.s0.e0" e2="DS.d431.s0.e4" id="DS.d431.s0.i4" interaction="True"/>
            <pair e1="DS.d431.s0.e0" e2="DS.d431.s0.e2" id="DS.d431.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d432" origId="18599066">
        <sentence id="DS.d432.s0" origId="18599066-769" text="Palmitate phosphorylated p38 and JNK kinases, and blocking of these kinases with specific inhibitors diminished the palmitate-induced cytokine secretion.">
            <entity id="DS.d432.s0.e0" origId="985" charOffset="0-9" type="compound" text="Palmitate"/>
            <entity id="DS.d432.s0.e1" origId="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7" charOffset="25-28" type="protein" text="p38"/>
            <entity id="DS.d432.s0.e2" origId="P92208,Q966Y3" charOffset="33-36" type="protein" text="JNK"/>
            <entity id="DS.d432.s0.e3" origId="985" charOffset="116-125" type="compound" text="palmitate"/>
            <pair e1="DS.d432.s0.e0" e2="DS.d432.s0.e2" id="DS.d432.s0.i0" interaction="False"/>
            <pair e1="DS.d432.s0.e3" e2="DS.d432.s0.e1" id="DS.d432.s0.i1" interaction="False"/>
            <pair e1="DS.d432.s0.e0" e2="DS.d432.s0.e1" id="DS.d432.s0.i2" interaction="True"/>
            <pair e1="DS.d432.s0.e3" e2="DS.d432.s0.e2" id="DS.d432.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d432.s1" origId="18599066-770" text="Palmitate also activated the AP-1 (c-Jun) transcription factor.">
            <entity id="DS.d432.s1.e0" origId="985" charOffset="0-9" type="compound" text="Palmitate"/>
            <entity id="DS.d432.s1.e1" origId="P21525" charOffset="29-33" type="protein" text="AP-1"/>
            <pair e1="DS.d432.s1.e0" e2="DS.d432.s1.e1" id="DS.d432.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d433" origId="18599093">
        <sentence id="DS.d433.s0" origId="18599093-1004" text="Characterisation of ATP analogues to cross-link and label P2X receptors.">
            <entity id="DS.d433.s0.e0" origId="5957" charOffset="20-23" type="compound" text="ATP"/>
            <entity id="DS.d433.s0.e1" origId="P13900,P16604" charOffset="58-61" type="protein" text="P2X"/>
            <pair e1="DS.d433.s0.e0" e2="DS.d433.s0.e1" id="DS.d433.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d433.s1" origId="18599093-1005" text="In this study we determined whether the UV light-reactive ATP analogues 2-azido ATP, ATP azidoanilide (ATP-AA) and 2', 3'-O-(4-benzoylbenzoyl)-ATP (BzATP) can be used to label the ATP binding site of P2X1 receptors.">
            <entity id="DS.d433.s1.e0" origId="5957" charOffset="58-61" type="compound" text="ATP"/>
            <entity id="DS.d433.s1.e1" origId="123645,189791" charOffset="72-83" type="compound" text="2-azido ATP"/>
            <entity id="DS.d433.s1.e2" origId="5957" charOffset="80-83" type="compound" text="ATP"/>
            <entity id="DS.d433.s1.e3" origId="5957" charOffset="80-83" type="compound" text="ATP"/>
            <entity id="DS.d433.s1.e4" origId="115205" charOffset="119-146" type="compound" text="3'-O-(4-benzoylbenzoyl)-ATP"/>
            <entity id="DS.d433.s1.e5" origId="115205" charOffset="148-153" type="compound" text="BzATP"/>
            <entity id="DS.d433.s1.e6" origId="P47824,P51575,P51576" charOffset="200-204" type="protein" text="P2X1"/>
            <pair e1="DS.d433.s1.e0" e2="DS.d433.s1.e6" id="DS.d433.s1.i0" interaction="True"/>
            <pair e1="DS.d433.s1.e1" e2="DS.d433.s1.e6" id="DS.d433.s1.i1" interaction="True"/>
            <pair e1="DS.d433.s1.e5" e2="DS.d433.s1.e6" id="DS.d433.s1.i2" interaction="True"/>
            <pair e1="DS.d433.s1.e4" e2="DS.d433.s1.e6" id="DS.d433.s1.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d433.s2" origId="18599093-1006" text="cross-linked to P2X1 receptors and this binding was reduced by co-incubation with ATP.">
            <entity id="DS.d433.s2.e0" origId="P47824,P51575,P51576" charOffset="16-20" type="protein" text="P2X1"/>
            <entity id="DS.d433.s2.e1" origId="5957" charOffset="82-85" type="compound" text="ATP"/>
            <pair e1="DS.d433.s2.e1" e2="DS.d433.s2.e0" id="DS.d433.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d433.s3" origId="18599093-1007" text="These studies demonstrate that photo-reactive ATP analogues can be used to label P2X receptor and may prove useful in elucidating the ATP binding site at this novel class of ATP binding proteins.">
            <entity id="DS.d433.s3.e0" origId="5957" charOffset="46-49" type="compound" text="ATP"/>
            <entity id="DS.d433.s3.e1" origId="P13900,P16604" charOffset="81-84" type="protein" text="P2X"/>
            <pair e1="DS.d433.s3.e0" e2="DS.d433.s3.e1" id="DS.d433.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d434" origId="18599154">
        <sentence id="DS.d434.s0" origId="18599154-1053" text="TGF-beta1 treatment for 72 h also induced EMT in the A549 cells and this transition led to resistance to gefitinib.">
            <entity id="DS.d434.s0.e0" origId="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6" charOffset="0-9" type="protein" text="TGF-beta1"/>
            <entity id="DS.d434.s0.e1" origId="123631" charOffset="105-114" type="compound" text="gefitinib"/>
            <pair e1="DS.d434.s0.e1" e2="DS.d434.s0.e0" id="DS.d434.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d435" origId="18599191">
        <sentence id="DS.d435.s0" origId="18599191-1078" text="Insulin-antagonistic effects of hormones, cytokines and excess metabolic substrates such as glucose and fatty acids may be exerted via common mechanisms involving for example reactive oxygen species (ROS) accumulation and associated inflammatory responses.">
            <entity id="DS.d435.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="0-7" type="protein" text="Insulin"/>
            <entity id="DS.d435.s0.e1" origId="206,5793,64689,79025" charOffset="92-99" type="compound" text="glucose"/>
            <pair e1="DS.d435.s0.e1" e2="DS.d435.s0.e0" id="DS.d435.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d436" origId="18599210">
        <sentence id="DS.d436.s0" origId="18599210-1087" text="Optimization of decolorization of methylene blue (MB) dye by lignin peroxidase (LiP) enzyme produced by white-rot fungus Phanerochaete chrysosporium using sewage treatment plant (STP) sludge as a major substrate was carried out in the laboratory.">
            <entity id="DS.d436.s0.e0" origId="4139" charOffset="34-48" type="compound" text="methylene blue"/>
            <entity id="DS.d436.s0.e1" origId="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622" charOffset="61-78" type="protein" text="lignin peroxidase"/>
            <pair e1="DS.d436.s0.e0" e2="DS.d436.s0.e1" id="DS.d436.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d437" origId="18600448">
        <sentence id="DS.d437.s0" origId="18600448-401" text="Glycine release was potentiated by the activation of protein kinase C and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, zaprinast.">
            <entity id="DS.d437.s0.e0" origId="750" charOffset="0-7" type="compound" text="Glycine"/>
            <entity id="DS.d437.s0.e1" origId="P13678,Q25378" charOffset="53-69" type="protein" text="protein kinase C"/>
            <entity id="DS.d437.s0.e2" origId="24316" charOffset="99-129" type="compound" text="cyclic guanosine monophosphate"/>
            <entity id="DS.d437.s0.e3" origId="5722" charOffset="173-182" type="compound" text="zaprinast"/>
            <pair e1="DS.d437.s0.e3" e2="DS.d437.s0.e1" id="DS.d437.s0.i0" interaction="False"/>
            <pair e1="DS.d437.s0.e2" e2="DS.d437.s0.e1" id="DS.d437.s0.i1" interaction="False"/>
            <pair e1="DS.d437.s0.e0" e2="DS.d437.s0.e1" id="DS.d437.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d438" origId="18600455">
        <sentence id="DS.d438.s0" origId="18600455-406" text="Our study demonstrates that taurocholate causes evident damage to acinar cells, impairing both calcium homeostasis and secretory response to CCK.">
            <entity id="DS.d438.s0.e0" origId="6675" charOffset="28-40" type="compound" text="taurocholate"/>
            <entity id="DS.d438.s0.e1" origId="O57312,O93464,P01355,P01356,P06307,P09240,P0C229,P23362,P41520,P50144,P50145,P68125,P68126,P80344,P80345,Q9PU29,Q9PU41" charOffset="141-144" type="protein" text="CCK"/>
            <pair e1="DS.d438.s0.e0" e2="DS.d438.s0.e1" id="DS.d438.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d439" origId="18600456">
        <sentence id="DS.d439.s0" origId="18600456-407" text="Enteric neuronal dopamine (DA) inhibits acetylcholine release and gastric motility; this has been thought to be mediated via neuronal dopamine-2 receptor (D2R).">
            <entity id="DS.d439.s0.e0" origId="187" charOffset="40-53" type="compound" text="acetylcholine"/>
            <entity id="DS.d439.s0.e1" origId="Q8IS44" charOffset="155-158" type="protein" text="D2R"/>
            <pair e1="DS.d439.s0.e0" e2="DS.d439.s0.e1" id="DS.d439.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d440" origId="18600473">
        <sentence id="DS.d440.s0" origId="18600473-984" text="As compared with parental B16 cells, the inhibitory effects of TGF-beta1 and activin A on melanin content were relative smaller in B16 F10 cells, a subline of B16 cells that contain more pigment.">
            <entity id="DS.d440.s0.e0" origId="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6" charOffset="63-72" type="protein" text="TGF-beta1"/>
            <entity id="DS.d440.s0.e1" origId="6325610" charOffset="90-97" type="compound" text="melanin"/>
            <pair e1="DS.d440.s0.e1" e2="DS.d440.s0.e0" id="DS.d440.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d441" origId="18601937">
        <sentence id="DS.d441.s0" origId="18601937-1660" text="ATP-gated P2X receptors on excitatory nerve terminals onto interneurons initiate a form of asynchronous glutamate release.">
            <entity id="DS.d441.s0.e0" origId="P13900,P16604" charOffset="10-13" type="protein" text="P2X"/>
            <entity id="DS.d441.s0.e1" origId="611,23327,33032" charOffset="104-113" type="compound" text="glutamate"/>
            <pair e1="DS.d441.s0.e1" e2="DS.d441.s0.e0" id="DS.d441.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d441.s1" origId="18601937-1662" text="However asynchronous EPSCs were increased following synaptic depression and a component of these appeared to be initiated by endogenously released ATP acting on presynaptic P2X receptors.">
            <entity id="DS.d441.s1.e0" origId="5957" charOffset="147-150" type="compound" text="ATP"/>
            <entity id="DS.d441.s1.e1" origId="P13900,P16604" charOffset="173-176" type="protein" text="P2X"/>
            <pair e1="DS.d441.s1.e0" e2="DS.d441.s1.e1" id="DS.d441.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d441.s2" origId="18601937-1663" text="Unexpectedly, the data suggest P2X receptor activation initiates a form of asynchronous glutamate release, rather than detectably affecting the vesicles underlying action potential evoked release.">
            <entity id="DS.d441.s2.e0" origId="P13900,P16604" charOffset="31-34" type="protein" text="P2X"/>
            <entity id="DS.d441.s2.e1" origId="611,23327,33032" charOffset="88-97" type="compound" text="glutamate"/>
            <pair e1="DS.d441.s2.e1" e2="DS.d441.s2.e0" id="DS.d441.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d442" origId="18601945">
        <sentence id="DS.d442.s0" origId="18601945-1673" text="The second enzyme of GSH synthesis, GSH synthase (GS) is also regulated in a coordinated manner as GCL subunits and its up-regulation can further enhance the capacity of the cell to synthesize GSH.">
            <entity id="DS.d442.s0.e0" origId="124886" charOffset="21-24" type="compound" text="GSH"/>
            <entity id="DS.d442.s0.e1" origId="124886" charOffset="36-39" type="compound" text="GSH"/>
            <entity id="DS.d442.s0.e2" origId="P28676,Q8NEA9,Q96IK5" charOffset="99-102" type="protein" text="GCL"/>
            <entity id="DS.d442.s0.e3" origId="124886" charOffset="36-39" type="compound" text="GSH"/>
            <pair e1="DS.d442.s0.e0" e2="DS.d442.s0.e2" id="DS.d442.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d443" origId="18602447">
        <sentence id="DS.d443.s0" origId="18602447-1075" text="The rise in (Ca(2+))(i) elicited by hGH is associated with an enhanced insulin secretion, effects that are mediated mainly through the prolactin receptor.">
            <entity id="DS.d443.s0.e0" origId="271" charOffset="13-17" type="compound" text="Ca(2"/>
            <entity id="DS.d443.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="71-78" type="protein" text="insulin"/>
            <entity id="DS.d443.s0.e2" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="135-144" type="protein" text="prolactin"/>
            <pair e1="DS.d443.s0.e0" e2="DS.d443.s0.e2" id="DS.d443.s0.i0" interaction="True"/>
            <pair e1="DS.d443.s0.e0" e2="DS.d443.s0.e1" id="DS.d443.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d443.s1" origId="18602447-1076" text="These mechanisms indicate that a rise in (Ca(2+))(i) elicited by activation of PRLR is JAK2-dependent and is associated with enhanced insulin secretion.">
            <entity id="DS.d443.s1.e0" origId="271" charOffset="42-46" type="compound" text="Ca(2"/>
            <entity id="DS.d443.s1.e1" origId="O46561,P14787,P16471,Q04594,Q28172,Q28235,Q6JTA8,Q90374,Q91094,Q91513" charOffset="79-83" type="protein" text="PRLR"/>
            <entity id="DS.d443.s1.e2" origId="O60674" charOffset="87-91" type="protein" text="JAK2"/>
            <entity id="DS.d443.s1.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="134-141" type="protein" text="insulin"/>
            <pair e1="DS.d443.s1.e0" e2="DS.d443.s1.e2" id="DS.d443.s1.i0" interaction="True"/>
            <pair e1="DS.d443.s1.e0" e2="DS.d443.s1.e3" id="DS.d443.s1.i1" interaction="True"/>
            <pair e1="DS.d443.s1.e0" e2="DS.d443.s1.e1" id="DS.d443.s1.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d443.s2" origId="18602447-1077" text="In contrast, GH receptor-mediated increase in (Ca(2+))(i) is JAK2-independent and is dissociated from insulin secretion.">
            <entity id="DS.d443.s2.e0" origId="O46600,P10912,P16310,P16882,P19756,P19941,P79108,P79194,Q02092,Q28575,Q90375,Q95JF2,Q95ML5,Q9JI97,Q9TU69,Q9XSZ1" charOffset="13-24" type="protein" text="GH receptor"/>
            <entity id="DS.d443.s2.e1" origId="271" charOffset="47-51" type="compound" text="Ca(2"/>
            <entity id="DS.d443.s2.e2" origId="O60674" charOffset="61-65" type="protein" text="JAK2"/>
            <entity id="DS.d443.s2.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="102-109" type="protein" text="insulin"/>
            <pair e1="DS.d443.s2.e1" e2="DS.d443.s2.e2" id="DS.d443.s2.i0" interaction="True"/>
            <pair e1="DS.d443.s2.e1" e2="DS.d443.s2.e3" id="DS.d443.s2.i1" interaction="False"/>
            <pair e1="DS.d443.s2.e1" e2="DS.d443.s2.e0" id="DS.d443.s2.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d444" origId="18602691">
        <sentence id="DS.d444.s0" origId="18602691-569" text="SEMG I expression is upregulated by IL-4, IL-6 and 5-azacytidine.">
            <entity id="DS.d444.s0.e0" origId="P04279" charOffset="0-4" type="protein" text="SEMG"/>
            <entity id="DS.d444.s0.e1" origId="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58" charOffset="36-40" type="protein" text="IL-4"/>
            <entity id="DS.d444.s0.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="42-46" type="protein" text="IL-6"/>
            <entity id="DS.d444.s0.e3" origId="9444" charOffset="51-64" type="compound" text="5-azacytidine"/>
            <pair e1="DS.d444.s0.e3" e2="DS.d444.s0.e1" id="DS.d444.s0.i0" interaction="False"/>
            <pair e1="DS.d444.s0.e3" e2="DS.d444.s0.e0" id="DS.d444.s0.i1" interaction="True"/>
            <pair e1="DS.d444.s0.e3" e2="DS.d444.s0.e2" id="DS.d444.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d445" origId="18602794">
        <sentence id="DS.d445.s0" origId="18602794-652" text="Trichostatin A down-regulates CYP19 transcript and protein levels in MCF-7 breast cancer cells.">
            <entity id="DS.d445.s0.e0" origId="444732" charOffset="0-14" type="compound" text="Trichostatin A"/>
            <entity id="DS.d445.s0.e1" origId="O46512,P11511,P19098,P46194,P70091,P79690,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28" charOffset="30-35" type="protein" text="CYP19"/>
            <pair e1="DS.d445.s0.e0" e2="DS.d445.s0.e1" id="DS.d445.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d446" origId="18602807">
        <sentence id="DS.d446.s0" origId="18602807-667" text="Consumption of the trichothecene mycotoxin deoxynivalenol (DON) induces interleukin-6 (IL-6)-dependent IgA nephropathy (IgAN) in mice.">
            <entity id="DS.d446.s0.e1" origId="40024,430147,442408,6321385,6432495,49868109" charOffset="43-57" type="compound" text="deoxynivalenol"/>
            <entity id="DS.d446.s0.e2" origId="P41693" charOffset="72-85" type="protein" text="interleukin-6"/>
            <entity id="DS.d446.s0.e3" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="87-91" type="protein" text="IL-6"/>
            <pair e1="DS.d446.s0.e1" e2="DS.d446.s0.e2" id="DS.d446.s0.i0" interaction="True"/>
            <pair e1="DS.d446.s0.e1" e2="DS.d446.s0.e3" id="DS.d446.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d446.s1" origId="18602807-668" text="The purpose of this study was to identify the signal transduction pathways by which DON up-regulates IL-6 in the peritoneal macrophage and how consumption of fish oil enriched with the n-3 PUFA docosahexaenoic acid (DHA) suppresses these processes.">
            <entity id="DS.d446.s1.e0" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="101-105" type="protein" text="IL-6"/>
            <entity id="DS.d446.s1.e1" origId="445580" charOffset="194-214" type="compound" text="docosahexaenoic acid"/>
            <pair e1="DS.d446.s1.e1" e2="DS.d446.s1.e0" id="DS.d446.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d448" origId="18602814">
        <sentence id="DS.d448.s0" origId="18602814-672" text="The aim of the present study was to determine the effects of niacin and chromium on HDL formation by investigating the changes in ABCA1 and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).">
            <entity id="DS.d448.s0.e0" origId="938" charOffset="61-67" type="compound" text="niacin"/>
            <entity id="DS.d448.s0.e1" origId="23976" charOffset="72-80" type="compound" text="chromium"/>
            <entity id="DS.d448.s0.e2" origId="O95477" charOffset="130-135" type="protein" text="ABCA1"/>
            <pair e1="DS.d448.s0.e1" e2="DS.d448.s0.e2" id="DS.d448.s0.i0" interaction="False"/>
            <pair e1="DS.d448.s0.e0" e2="DS.d448.s0.e2" id="DS.d448.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d448.s1" origId="18602814-674" text="Niacin and chromium cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (PPARalpha) mRNA by approximately 1.3-1.8-fold.">
            <entity id="DS.d448.s1.e0" origId="938" charOffset="0-6" type="compound" text="Niacin"/>
            <entity id="DS.d448.s1.e1" origId="23976" charOffset="11-19" type="compound" text="chromium"/>
            <entity id="DS.d448.s1.e2" origId="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78" charOffset="72-120" type="protein" text="peroxisome proliferator-activated receptor-alpha"/>
            <entity id="DS.d448.s1.e3" origId="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78" charOffset="122-131" type="protein" text="PPARalpha"/>
            <pair e1="DS.d448.s1.e1" e2="DS.d448.s1.e2" id="DS.d448.s1.i0" interaction="True"/>
            <pair e1="DS.d448.s1.e1" e2="DS.d448.s1.e3" id="DS.d448.s1.i1" interaction="True"/>
            <pair e1="DS.d448.s1.e0" e2="DS.d448.s1.e2" id="DS.d448.s1.i2" interaction="True"/>
            <pair e1="DS.d448.s1.e0" e2="DS.d448.s1.e3" id="DS.d448.s1.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d448.s2" origId="18602814-675" text="A combination of niacin and chromium chloride did not significantly increase (3+1 mM) but instead reduced (1+3 mM) ABCA1 gene expression.">
            <entity id="DS.d448.s2.e0" origId="938" charOffset="17-23" type="compound" text="niacin"/>
            <entity id="DS.d448.s2.e1" origId="24808,24871" charOffset="28-45" type="compound" text="chromium chloride"/>
            <entity id="DS.d448.s2.e2" origId="O95477" charOffset="115-120" type="protein" text="ABCA1"/>
            <pair e1="DS.d448.s2.e0" e2="DS.d448.s2.e2" id="DS.d448.s2.i0" interaction="True"/>
            <pair e1="DS.d448.s2.e1" e2="DS.d448.s2.e2" id="DS.d448.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d448.s3" origId="18602814-676" text="We hypothesize that the stimulation of ABCA1 gene expression causes an enhanced cholesterol efflux, perhaps mediated by PPARalpha pathway(s).">
            <entity id="DS.d448.s3.e0" origId="O95477" charOffset="39-44" type="protein" text="ABCA1"/>
            <entity id="DS.d448.s3.e1" origId="304,5997,6432564,11025495" charOffset="80-91" type="compound" text="cholesterol"/>
            <entity id="DS.d448.s3.e2" origId="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78" charOffset="120-129" type="protein" text="PPARalpha"/>
            <pair e1="DS.d448.s3.e1" e2="DS.d448.s3.e0" id="DS.d448.s3.i0" interaction="True"/>
            <pair e1="DS.d448.s3.e1" e2="DS.d448.s3.e2" id="DS.d448.s3.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d450" origId="18602823">
        <sentence id="DS.d450.s0" origId="18602823-684" text="Sulforaphane inhibited cell proliferation with IC(50) values at 24 and 48 h of 12.5 and 7.5 muM doses, respectively, and decreased ERalpha protein expression at concentrations between 2.5 and 30 muM.">
            <entity id="DS.d450.s0.e0" origId="5350" charOffset="0-12" type="compound" text="Sulforaphane"/>
            <entity id="DS.d450.s0.e1" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="131-138" type="protein" text="ERalpha"/>
            <pair e1="DS.d450.s0.e0" e2="DS.d450.s0.e1" id="DS.d450.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d450.s1" origId="18602823-685" text="30 muM, the SUL-induced suppression of ERalpha protein was reversed by preincubation with the proteasome inhibitor MG132 and was accompanied by an increase in protein levels of the 20S catalytic core subunit PSMB5.">
            <entity id="DS.d450.s1.e0" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="39-46" type="protein" text="ERalpha"/>
            <entity id="DS.d450.s1.e1" origId="462382" charOffset="115-120" type="compound" text="MG132"/>
            <entity id="DS.d450.s1.e2" origId="P28074,P34065" charOffset="208-213" type="protein" text="PSMB5"/>
            <pair e1="DS.d450.s1.e1" e2="DS.d450.s1.e0" id="DS.d450.s1.i0" interaction="True"/>
            <pair e1="DS.d450.s1.e1" e2="DS.d450.s1.e2" id="DS.d450.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d452" origId="18603252">
        <sentence id="DS.d452.s0" origId="18603252-1055" text="Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.">
            <entity id="DS.d452.s0.e0" origId="150311" charOffset="30-39" type="compound" text="ezetimibe"/>
            <entity id="DS.d452.s0.e1" origId="187" charOffset="130-143" type="compound" text="acetylcholine"/>
            <entity id="DS.d452.s0.e2" origId="P41693" charOffset="174-187" type="protein" text="interleukin-6"/>
            <entity id="DS.d452.s0.e3" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="224-245" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d452.s0.e4" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="247-251" type="protein" text="eNOS"/>
            <pair e1="DS.d452.s0.e0" e2="DS.d452.s0.e4" id="DS.d452.s0.i0" interaction="True"/>
            <pair e1="DS.d452.s0.e1" e2="DS.d452.s0.e2" id="DS.d452.s0.i1" interaction="False"/>
            <pair e1="DS.d452.s0.e1" e2="DS.d452.s0.e3" id="DS.d452.s0.i2" interaction="False"/>
            <pair e1="DS.d452.s0.e0" e2="DS.d452.s0.e2" id="DS.d452.s0.i3" interaction="True"/>
            <pair e1="DS.d452.s0.e1" e2="DS.d452.s0.e4" id="DS.d452.s0.i4" interaction="False"/>
            <pair e1="DS.d452.s0.e0" e2="DS.d452.s0.e3" id="DS.d452.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d453" origId="18603333">
        <sentence id="DS.d453.s0" origId="18603333-1106" text="A series of adamantane derivatives of thiazolyl-N-substituted amides were synthesized in a three-step reaction and tested for anti-inflammatory activity as well as lipoxygenase and cycloxygenase inhibitory actions.">
            <entity id="DS.d453.s0.e0" origId="9238" charOffset="12-22" type="compound" text="adamantane"/>
            <entity id="DS.d453.s0.e1" origId="P27481,P38414" charOffset="164-176" type="protein" text="lipoxygenase"/>
            <pair e1="DS.d453.s0.e0" e2="DS.d453.s0.e1" id="DS.d453.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d454" origId="18604600">
        <sentence id="DS.d454.s0" origId="18604600-443" text="Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.">
            <entity id="DS.d454.s0.e0" origId="P21917,P30729,P51436,Q6TLJ0" charOffset="0-20" type="protein" text="Dopamine D4 receptor"/>
            <entity id="DS.d454.s0.e1" origId="5761" charOffset="83-86" type="compound" text="LSD"/>
            <entity id="DS.d454.s0.e2" origId="1001,31016" charOffset="100-114" type="compound" text="phenethylamine"/>
            <entity id="DS.d454.s0.e4" origId="1229,6603801,9840090" charOffset="128-131" type="compound" text="DOI"/>
            <pair e1="DS.d454.s0.e2" e2="DS.d454.s0.e0" id="DS.d454.s0.i0" interaction="False"/>
            <pair e1="DS.d454.s0.e1" e2="DS.d454.s0.e0" id="DS.d454.s0.i1" interaction="True"/>
            <pair e1="DS.d454.s0.e4" e2="DS.d454.s0.e0" id="DS.d454.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d455" origId="18606045">
        <sentence id="DS.d455.s0" origId="18606045-1675" text="Plasma levels of magnesium, zinc and carotenoids did not vary across quintiles, but weak negative correlations were observed with serum ferritin and transferrin saturation.">
            <entity id="DS.d455.s0.e0" origId="5462224" charOffset="17-26" type="compound" text="magnesium"/>
            <entity id="DS.d455.s0.e1" origId="Q26061" charOffset="136-144" type="protein" text="ferritin"/>
            <entity id="DS.d455.s0.e2" origId="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1" charOffset="149-160" type="protein" text="transferrin"/>
            <pair e1="DS.d455.s0.e0" e2="DS.d455.s0.e2" id="DS.d455.s0.i0" interaction="True"/>
            <pair e1="DS.d455.s0.e0" e2="DS.d455.s0.e1" id="DS.d455.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d456" origId="18606396">
        <sentence id="DS.d456.s0" origId="18606396-239" text="Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as rifampicin, carbamazepin and phenytoin.">
            <entity id="DS.d456.s0.e0" origId="O02747,P30561,P35869,P41738,Q8R4S2,Q8R4S4,Q8R4S5,Q8R4S6,Q8R4S7,Q95LD9" charOffset="80-91" type="protein" text="Ah receptor"/>
            <entity id="DS.d456.s0.e1" origId="4594,9579578" charOffset="142-152" type="compound" text="omeprazole"/>
            <entity id="DS.d456.s0.e2" origId="O75469,Q8SQ01" charOffset="191-194" type="protein" text="PXR"/>
            <entity id="DS.d456.s0.e3" origId="5381226,5388984,5458213,6243627,6842115,6913622,16043998,17753751,25141428,45356263,56947149" charOffset="231-241" type="compound" text="rifampicin"/>
            <entity id="DS.d456.s0.e4" origId="1775" charOffset="260-269" type="compound" text="phenytoin"/>
            <pair e1="DS.d456.s0.e4" e2="DS.d456.s0.e2" id="DS.d456.s0.i0" interaction="True"/>
            <pair e1="DS.d456.s0.e3" e2="DS.d456.s0.e0" id="DS.d456.s0.i1" interaction="False"/>
            <pair e1="DS.d456.s0.e3" e2="DS.d456.s0.e2" id="DS.d456.s0.i2" interaction="True"/>
            <pair e1="DS.d456.s0.e1" e2="DS.d456.s0.e2" id="DS.d456.s0.i3" interaction="False"/>
            <pair e1="DS.d456.s0.e4" e2="DS.d456.s0.e0" id="DS.d456.s0.i4" interaction="False"/>
            <pair e1="DS.d456.s0.e1" e2="DS.d456.s0.e0" id="DS.d456.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d457" origId="18607531">
        <sentence id="DS.d457.s0" origId="18607531-1203" text="The structure-activity relationship between oxycoumarin derivatives showing inhibitory effects on iNOS in mouse macrophage RAW264.7 cells.">
            <entity id="DS.d457.s0.e0" origId="5281426" charOffset="44-55" type="compound" text="oxycoumarin"/>
            <entity id="DS.d457.s0.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="98-102" type="protein" text="iNOS"/>
            <pair e1="DS.d457.s0.e0" e2="DS.d457.s0.e1" id="DS.d457.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d457.s1" origId="18607531-1204" text="We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-nitric oxide synthase (iNOS) induced by lipopolysaccharide.">
            <entity id="DS.d457.s1.e0" origId="5281426" charOffset="76-87" type="compound" text="oxycoumarin"/>
            <entity id="DS.d457.s1.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="149-170" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d457.s1.e2" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="172-176" type="protein" text="iNOS"/>
            <entity id="DS.d457.s1.e3" origId="11970143" charOffset="189-207" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d457.s1.e0" e2="DS.d457.s1.e2" id="DS.d457.s1.i0" interaction="False"/>
            <pair e1="DS.d457.s1.e3" e2="DS.d457.s1.e2" id="DS.d457.s1.i1" interaction="True"/>
            <pair e1="DS.d457.s1.e3" e2="DS.d457.s1.e1" id="DS.d457.s1.i2" interaction="True"/>
            <pair e1="DS.d457.s1.e0" e2="DS.d457.s1.e1" id="DS.d457.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d458" origId="18607542">
        <sentence id="DS.d458.s0" origId="18607542-1212" text="Inhibition of protein synthesis by imexon reduces HIF-1alpha expression in normoxic and hypoxic pancreatic cancer cells.">
            <entity id="DS.d458.s0.e0" origId="68791" charOffset="35-41" type="compound" text="imexon"/>
            <entity id="DS.d458.s0.e1" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="50-60" type="protein" text="HIF-1alpha"/>
            <pair e1="DS.d458.s0.e0" e2="DS.d458.s0.e1" id="DS.d458.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d458.s1" origId="18607542-1213" text="Western blot analyses of imexon-treated cells demonstrated that imexon reduces HIF-1alpha protein levels in both normoxic and hypoxic conditions in a time- and concentration-dependant fashion.">
            <entity id="DS.d458.s1.e0" origId="68791" charOffset="25-31" type="compound" text="imexon"/>
            <entity id="DS.d458.s1.e1" origId="68791" charOffset="64-70" type="compound" text="imexon"/>
            <entity id="DS.d458.s1.e2" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="79-89" type="protein" text="HIF-1alpha"/>
            <pair e1="DS.d458.s1.e0" e2="DS.d458.s1.e2" id="DS.d458.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d458.s2" origId="18607542-1214" text="Gemcitabine did not similarly affect HIF-1alpha levels.">
            <entity id="DS.d458.s2.e0" origId="60750" charOffset="0-11" type="compound" text="Gemcitabine"/>
            <entity id="DS.d458.s2.e1" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="37-47" type="protein" text="HIF-1alpha"/>
            <pair e1="DS.d458.s2.e0" e2="DS.d458.s2.e1" id="DS.d458.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d458.s3" origId="18607542-1216" text="Concurrently, the half-life of existing HIF-1alpha protein was increased by imexon, in association with a marked inhibition of chymotryptic activity in the 20S proteasome.">
            <entity id="DS.d458.s3.e0" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="40-50" type="protein" text="HIF-1alpha"/>
            <entity id="DS.d458.s3.e1" origId="68791" charOffset="76-82" type="compound" text="imexon"/>
            <pair e1="DS.d458.s3.e1" e2="DS.d458.s3.e0" id="DS.d458.s3.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d458.s4" origId="18607542-1217" text="The inhibition of HIF-1alpha translation was not specific, rather it was part of a general decrease in protein translation caused by imexon.">
            <entity id="DS.d458.s4.e0" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="18-28" type="protein" text="HIF-1alpha"/>
            <entity id="DS.d458.s4.e1" origId="68791" charOffset="133-139" type="compound" text="imexon"/>
            <pair e1="DS.d458.s4.e1" e2="DS.d458.s4.e0" id="DS.d458.s4.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d459" origId="18607689">
        <sentence id="DS.d459.s0" origId="18607689-1312" text="To determine whether a regimen of aspirin pretreatment, bivalirudin during the procedure and clopidogrel (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to thrombin (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and platelet activating factor (10 nM).">
            <entity id="DS.d459.s0.e0" origId="2244" charOffset="34-41" type="compound" text="aspirin"/>
            <entity id="DS.d459.s0.e1" origId="16129704" charOffset="56-67" type="compound" text="bivalirudin"/>
            <entity id="DS.d459.s0.e2" origId="2806,60606" charOffset="93-104" type="compound" text="clopidogrel"/>
            <entity id="DS.d459.s0.e3" origId="P84122" charOffset="381-389" type="protein" text="thrombin"/>
            <entity id="DS.d459.s0.e4" origId="108157" charOffset="461-487" type="compound" text="platelet activating factor"/>
            <pair e1="DS.d459.s0.e0" e2="DS.d459.s0.e3" id="DS.d459.s0.i0" interaction="False"/>
            <pair e1="DS.d459.s0.e4" e2="DS.d459.s0.e3" id="DS.d459.s0.i1" interaction="False"/>
            <pair e1="DS.d459.s0.e2" e2="DS.d459.s0.e3" id="DS.d459.s0.i2" interaction="False"/>
            <pair e1="DS.d459.s0.e1" e2="DS.d459.s0.e3" id="DS.d459.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d460" origId="18607722">
        <sentence id="DS.d460.s0" origId="18607722-1326" text="Brainstem concentrations of cholesterol are not influenced by genetic ablation of the low-density lipoprotein receptor.">
            <entity id="DS.d460.s0.e0" origId="304,5997,6432564,11025495" charOffset="28-39" type="compound" text="cholesterol"/>
            <entity id="DS.d460.s0.e1" origId="P01131,P20063,Q28832" charOffset="86-118" type="protein" text="low-density lipoprotein receptor"/>
            <pair e1="DS.d460.s0.e0" e2="DS.d460.s0.e1" id="DS.d460.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d460.s1" origId="18607722-1327" text="The low-density lipoprotein receptor (LDLr) mediates the uptake of LDL particles enriched with cholesterol, into several tissues.">
            <entity id="DS.d460.s1.e0" origId="P01131,P20063,Q28832" charOffset="4-36" type="protein" text="low-density lipoprotein receptor"/>
            <entity id="DS.d460.s1.e1" origId="304,5997,6432564,11025495" charOffset="95-106" type="compound" text="cholesterol"/>
            <pair e1="DS.d460.s1.e1" e2="DS.d460.s1.e0" id="DS.d460.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d461" origId="18607918">
        <sentence id="DS.d461.s0" origId="18607918-1505" text="Under the condition of delayed intervention (30 days after deafening) following gentamicin+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.">
            <entity id="DS.d461.s0.e0" origId="3467" charOffset="80-90" type="compound" text="gentamicin"/>
            <entity id="DS.d461.s0.e1" origId="3440" charOffset="92-102" type="compound" text="furosemide"/>
            <entity id="DS.d461.s0.e2" origId="P25430,P25431,P25432,Q06225" charOffset="236-269" type="protein" text="brain-derived neurotrophic factor"/>
            <entity id="DS.d461.s0.e3" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="271-275" type="protein" text="BDNF"/>
            <pair e1="DS.d461.s0.e0" e2="DS.d461.s0.e2" id="DS.d461.s0.i0" interaction="False"/>
            <pair e1="DS.d461.s0.e0" e2="DS.d461.s0.e3" id="DS.d461.s0.i1" interaction="False"/>
            <pair e1="DS.d461.s0.e1" e2="DS.d461.s0.e2" id="DS.d461.s0.i2" interaction="False"/>
            <pair e1="DS.d461.s0.e1" e2="DS.d461.s0.e3" id="DS.d461.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d463" origId="18608753">
        <sentence id="DS.d463.s0" origId="18608753-1365" text="For this purpose, human erythrocyte glutathione reductase was initially purified 2139-fold in a yield of 29% by using 2', 5'-ADP Sepharose 4B affinity gel and Sephadex G-200 gel filtration chromatography.">
            <entity id="DS.d463.s0.e0" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="36-57" type="protein" text="glutathione reductase"/>
            <entity id="DS.d463.s0.e1" origId="11966311" charOffset="129-138" type="compound" text="Sepharose"/>
            <pair e1="DS.d463.s0.e1" e2="DS.d463.s0.e0" id="DS.d463.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d464" origId="18608754">
        <sentence id="DS.d464.s0" origId="18608754-503" text="The enzyme deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase) catalyses the hydrolysis of dUTP to dUMP and PPi thus controlling the incorporation of uracil into DNA genomes.">
            <entity id="DS.d464.s0.e0" origId="O25536,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8RA46,Q8RER7,Q8SRS0,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3" charOffset="11-59" type="protein" text="deoxyuridine 5'-triphosphate nucleotidohydrolase"/>
            <entity id="DS.d464.s0.e1" origId="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3" charOffset="61-68" type="protein" text="dUTPase"/>
            <entity id="DS.d464.s0.e3" origId="1174" charOffset="157-163" type="compound" text="uracil"/>
            <pair e1="DS.d464.s0.e3" e2="DS.d464.s0.e1" id="DS.d464.s0.i0" interaction="True"/>
            <pair e1="DS.d464.s0.e3" e2="DS.d464.s0.e0" id="DS.d464.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d464.s1" origId="18608754-504" text="In the present study we perform a kinetic analysis of Campylobacter dUTPase using the continuous spectrophotometric method and show that the enzyme is highly specific for deoxyuridine nucleotides.">
            <entity id="DS.d464.s1.e0" origId="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3" charOffset="68-75" type="protein" text="dUTPase"/>
            <entity id="DS.d464.s1.e1" origId="13712" charOffset="171-183" type="compound" text="deoxyuridine"/>
            <pair e1="DS.d464.s1.e1" e2="DS.d464.s1.e0" id="DS.d464.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d465" origId="18608755">
        <sentence id="DS.d465.s0" origId="18608755-505" text="Tryptophanase (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan pyruvate, ammonia and indole.">
            <entity id="DS.d465.s0.e0" origId="O07674,O30971,P0A853,P0A854,P21643,P28796,P48775,P48776,Q09474,Q2KIQ5,Q59342,Q5EBG2,Q5U4U6,Q7MCR1,Q7N8C9,Q7NYV9,Q7SY53,Q87JQ6,Q894M8,Q8D5Q4,Q8FBV2,Q8R9K5,Q8XB34,Q9CL27,Q9KN05,Q9ZNA8" charOffset="0-13" type="protein" text="Tryptophanase"/>
            <entity id="DS.d465.s0.e1" origId="4802,6305,5460850" charOffset="135-147" type="compound" text="L-tryptophan"/>
            <entity id="DS.d465.s0.e2" origId="1060" charOffset="148-156" type="compound" text="pyruvate"/>
            <entity id="DS.d465.s0.e3" origId="222" charOffset="158-165" type="compound" text="ammonia"/>
            <pair e1="DS.d465.s0.e3" e2="DS.d465.s0.e0" id="DS.d465.s0.i0" interaction="True"/>
            <pair e1="DS.d465.s0.e1" e2="DS.d465.s0.e0" id="DS.d465.s0.i1" interaction="True"/>
            <pair e1="DS.d465.s0.e2" e2="DS.d465.s0.e0" id="DS.d465.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d468" origId="18608766">
        <sentence id="DS.d468.s0" origId="18608766-514" text="Urease allows soil microorganisms to use urea as a source of nitrogen and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.">
            <entity id="DS.d468.s0.e0" origId="O00084,O13465,P07374,P08298,Q5KCQ6,Q6A3P9" charOffset="0-6" type="protein" text="Urease"/>
            <entity id="DS.d468.s0.e1" origId="1176,265993" charOffset="41-45" type="compound" text="urea"/>
            <entity id="DS.d468.s0.e2" origId="947,123329" charOffset="61-69" type="compound" text="nitrogen"/>
            <entity id="DS.d468.s0.e3" origId="1176,265993" charOffset="105-109" type="compound" text="urea"/>
            <pair e1="DS.d468.s0.e1" e2="DS.d468.s0.e0" id="DS.d468.s0.i0" interaction="True"/>
            <pair e1="DS.d468.s0.e2" e2="DS.d468.s0.e0" id="DS.d468.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d469" origId="18608782">
        <sentence id="DS.d469.s0" origId="18608782-527" text="Adenosine deaminase (ADA), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of adenosine into inosine and free ammonia.">
            <entity id="DS.d469.s0.e0" origId="O83085,P00813,P03958,P22333,P53909,P53984,P56658,P63907,P63908,P63909,P63910,Q2TZN9,Q4IMJ1,Q4X1Q4,Q59ZB1,Q5ZKP6,Q63ZU0,Q6CM42,Q6DG22,Q6FP78,Q6GP70,Q7M9R5,Q7MDL6,Q7N4H5,Q7VNV1,Q7WBG5,Q7WMY6,Q839J4,Q83RC0,Q889J2,Q88QA3,Q8D6Q8,Q8DTN8,Q8E8D4,Q8FH99,Q8UJ05,Q8X1T6,Q8X661,Q8XHH8,Q8XXL5,Q8Z6R2,Q8ZPL9,Q920P6,Q92T48,Q97EV1,Q98GV2,Q9A3M3,Q9CCL9,Q9CIR9,Q9I6Y4,Q9KNI7,Q9P6I7" charOffset="0-19" type="protein" text="Adenosine deaminase"/>
            <entity id="DS.d469.s0.e1" origId="P00813,P56658,Q5ZKP6" charOffset="21-24" type="protein" text="ADA"/>
            <entity id="DS.d469.s0.e2" origId="60961" charOffset="106-115" type="compound" text="adenosine"/>
            <entity id="DS.d469.s0.e3" origId="6021" charOffset="121-128" type="compound" text="inosine"/>
            <entity id="DS.d469.s0.e4" origId="222" charOffset="138-145" type="compound" text="ammonia"/>
            <pair e1="DS.d469.s0.e2" e2="DS.d469.s0.e1" id="DS.d469.s0.i0" interaction="True"/>
            <pair e1="DS.d469.s0.e3" e2="DS.d469.s0.e1" id="DS.d469.s0.i1" interaction="True"/>
            <pair e1="DS.d469.s0.e4" e2="DS.d469.s0.e1" id="DS.d469.s0.i2" interaction="True"/>
            <pair e1="DS.d469.s0.e2" e2="DS.d469.s0.e0" id="DS.d469.s0.i3" interaction="True"/>
            <pair e1="DS.d469.s0.e4" e2="DS.d469.s0.e0" id="DS.d469.s0.i4" interaction="True"/>
            <pair e1="DS.d469.s0.e3" e2="DS.d469.s0.e0" id="DS.d469.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d470" origId="18609042">
        <sentence id="DS.d470.s0" origId="18609042-761" text="Diastolic function and BNP changes during exercise predict oxygen consumption in chronic heart failure patients.">
            <entity id="DS.d470.s0.e0" origId="P40753,P83965,Q805D7,Q805E8,Q9GLK4" charOffset="23-26" type="protein" text="BNP"/>
            <entity id="DS.d470.s0.e1" origId="977" charOffset="59-65" type="compound" text="oxygen"/>
            <pair e1="DS.d470.s0.e1" e2="DS.d470.s0.e0" id="DS.d470.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d471" origId="18609294">
        <sentence id="DS.d471.s0" origId="18609294-966" text="Although incubation with prolactin (PRL) and/or adrenocorticotrophic hormone (ACTH) resulted in a dose-dependent increase of corticosterone and progesterone release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.">
            <entity id="DS.d471.s0.e0" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="25-34" type="protein" text="prolactin"/>
            <entity id="DS.d471.s0.e1" origId="O62781,O62819,O93337,P01236,P01237,P01238,P01239,P01240,P06879,P09585,P10765,P12420,P14676,P17572,P21993,P22393,P29234,P29235,P33089,P33090,P33091,P33096,P34181,P35395,P37884,P40424,P43001,P43299,P46403,P48096,P48249,P51904,P55151,P87495,Q28318,Q28632,Q3Y4G6,Q6UC74,Q7ZZV3,Q8HXS1,Q9QZL1,Q9YGV6" charOffset="36-39" type="protein" text="PRL"/>
            <entity id="DS.d471.s0.e2" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="78-82" type="protein" text="ACTH"/>
            <entity id="DS.d471.s0.e3" origId="5753" charOffset="125-139" type="compound" text="corticosterone"/>
            <entity id="DS.d471.s0.e4" origId="5994" charOffset="144-156" type="compound" text="progesterone"/>
            <pair e1="DS.d471.s0.e3" e2="DS.d471.s0.e2" id="DS.d471.s0.i0" interaction="True"/>
            <pair e1="DS.d471.s0.e3" e2="DS.d471.s0.e0" id="DS.d471.s0.i1" interaction="True"/>
            <pair e1="DS.d471.s0.e4" e2="DS.d471.s0.e2" id="DS.d471.s0.i2" interaction="True"/>
            <pair e1="DS.d471.s0.e3" e2="DS.d471.s0.e1" id="DS.d471.s0.i3" interaction="True"/>
            <pair e1="DS.d471.s0.e4" e2="DS.d471.s0.e1" id="DS.d471.s0.i4" interaction="True"/>
            <pair e1="DS.d471.s0.e4" e2="DS.d471.s0.e0" id="DS.d471.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d472" origId="18609433">
        <sentence id="DS.d472.s0" origId="18609433-1079" text="Fluvoxamine, a SSRI, is mainly metabolized by cytochrome P450 (CYP) 2D6 and 1A2.">
            <entity id="DS.d472.s0.e0" origId="5324346" charOffset="0-11" type="compound" text="Fluvoxamine"/>
            <entity id="DS.d472.s0.e1" origId="O08469" charOffset="46-61" type="protein" text="cytochrome P450"/>
            <entity id="DS.d472.s0.e2" origId="P21568,P21569,P24525,P34887,Q26551" charOffset="63-66" type="protein" text="CYP"/>
            <pair e1="DS.d472.s0.e0" e2="DS.d472.s0.e2" id="DS.d472.s0.i0" interaction="True"/>
            <pair e1="DS.d472.s0.e0" e2="DS.d472.s0.e1" id="DS.d472.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d474" origId="18612599">
        <sentence id="DS.d474.s0" origId="18612599-292" text="GCK is expressed in the rat DVC, where mRNA is localized to neurons that exhibit electrophysiological sensitivity to glucose imbalance.">
            <entity id="DS.d474.s0.e0" origId="P35557,Q12851,Q61161" charOffset="0-3" type="protein" text="GCK"/>
            <entity id="DS.d474.s0.e1" origId="206,5793,64689,79025" charOffset="117-124" type="compound" text="glucose"/>
            <pair e1="DS.d474.s0.e1" e2="DS.d474.s0.e0" id="DS.d474.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d476" origId="18612775">
        <sentence id="DS.d476.s0" origId="18612775-1047" text="Indoleamine 2,3-dioxygenase (IDO) catalyzes the first and rate-limiting step of Kynurenine pathway along the major route of Tryptophan catabolism.">
            <entity id="DS.d476.s0.e0" origId="P14902,P28776" charOffset="0-27" type="protein" text="Indoleamine 2,3-dioxygenase"/>
            <entity id="DS.d476.s0.e1" origId="P14902,P28776" charOffset="29-32" type="protein" text="IDO"/>
            <entity id="DS.d476.s0.e2" origId="846" charOffset="80-90" type="compound" text="Kynurenine"/>
            <pair e1="DS.d476.s0.e2" e2="DS.d476.s0.e1" id="DS.d476.s0.i0" interaction="True"/>
            <pair e1="DS.d476.s0.e2" e2="DS.d476.s0.e0" id="DS.d476.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d477" origId="18612777">
        <sentence id="DS.d477.s0" origId="18612777-425" text="Type I transglutaminase (TG1), an enzyme that catalyzes the formation of epsilon-(gamma-glutamyl) lysine bonds, is the key protein responsible for generation of the crosslinks.">
            <entity id="DS.d477.s0.e0" origId="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7" charOffset="7-23" type="protein" text="transglutaminase"/>
            <entity id="DS.d477.s0.e1" origId="866,5962" charOffset="98-104" type="compound" text="lysine"/>
            <pair e1="DS.d477.s0.e1" e2="DS.d477.s0.e0" id="DS.d477.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d478" origId="18612811">
        <sentence id="DS.d478.s0" origId="18612811-461" text="Myc-oncogene inactivating effect by proline rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.">
            <entity id="DS.d478.s0.e0" origId="P01108,P09416,P52160" charOffset="0-3" type="protein" text="Myc"/>
            <entity id="DS.d478.s0.e1" origId="614,8988,145742" charOffset="36-43" type="compound" text="proline"/>
            <pair e1="DS.d478.s0.e1" e2="DS.d478.s0.e0" id="DS.d478.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d479" origId="18612819">
        <sentence id="DS.d479.s0" origId="18612819-471" text="Like PSC, DSL6A cells secrete less ET-1 when cultured with bosentan.">
            <entity id="DS.d479.s0.e0" origId="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76" charOffset="35-39" type="protein" text="ET-1"/>
            <entity id="DS.d479.s0.e1" origId="104865" charOffset="59-67" type="compound" text="bosentan"/>
            <pair e1="DS.d479.s0.e1" e2="DS.d479.s0.e0" id="DS.d479.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d480" origId="18612824">
        <sentence id="DS.d480.s0" origId="18612824-1284" text="Caspase inhibition with z-VAD was unable to prevent AIF localization to the nucleus and subsequently unable to prevent cell death.">
            <entity id="DS.d480.s0.e0" origId="5289545" charOffset="26-29" type="compound" text="VAD"/>
            <entity id="DS.d480.s0.e1" origId="O95831" charOffset="52-55" type="protein" text="AIF"/>
            <pair e1="DS.d480.s0.e0" e2="DS.d480.s0.e1" id="DS.d480.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d481" origId="18614168">
        <sentence id="DS.d481.s0" origId="18614168-1607" text="Purinergic receptor agonists ATP and UTP selectively activate certain Src family tyrosine kinases and stimulate Na,K-ATPase activity.">
            <entity id="DS.d481.s0.e0" origId="5957" charOffset="29-32" type="compound" text="ATP"/>
            <entity id="DS.d481.s0.e1" origId="6133" charOffset="37-40" type="compound" text="UTP"/>
            <entity id="DS.d481.s0.e2" origId="P05480,Q9WUD9" charOffset="70-73" type="protein" text="Src"/>
            <pair e1="DS.d481.s0.e0" e2="DS.d481.s0.e2" id="DS.d481.s0.i0" interaction="True"/>
            <pair e1="DS.d481.s0.e1" e2="DS.d481.s0.e2" id="DS.d481.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d482" origId="18615010">
        <sentence id="DS.d482.s0" origId="18615010-596" text="Early deprivation led to decreases in hippocampal growth-associated protein-43 (GAP-43) mRNA, serotonin 1A receptor (5-HT(1A)R) mRNA and binding ((3H)WAY100635), and to increased vesicular GABA transporter mRNA.">
            <entity id="DS.d482.s0.e0" origId="P06836,P06837,P07936,P17677,P17691,P35001,P55860,Q5IS67,Q5NVP7,Q6S9D9,Q95K78,Q98987" charOffset="50-78" type="protein" text="growth-associated protein-43"/>
            <entity id="DS.d482.s0.e1" origId="P09851,P20936,P50904,P74851,P74873,Q5PEA9,Q92211,Q92263" charOffset="80-83" type="protein" text="GAP"/>
            <entity id="DS.d482.s0.e2" origId="5684" charOffset="147-159" type="compound" text="3H)WAY100635"/>
            <entity id="DS.d482.s0.e3" origId="O35458,O35633,P34579,Q95KE2,Q9H598" charOffset="179-205" type="protein" text="vesicular GABA transporter"/>
            <pair e1="DS.d482.s0.e3" e2="DS.d482.s0.e1" id="DS.d482.s0.i0" interaction="False"/>
            <pair e1="DS.d482.s0.e3" e2="DS.d482.s0.e0" id="DS.d482.s0.i1" interaction="False"/>
            <pair e1="DS.d482.s0.e3" e2="DS.d482.s0.e3" id="DS.d482.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d483" origId="18615011">
        <sentence id="DS.d483.s0" origId="18615011-597" text="We measured the ability to increase GABA in eight healthy subjects by comparing the binding of ((11)C) flumazenil, a positron emission tomography (PET) radiotracer specific for the benzodiazepine (BDZ) site, at baseline and in the presence of an acute elevation in GABA levels through the blockade of the GABA membrane transporter (GAT1).">
            <entity id="DS.d483.s0.e0" origId="3373" charOffset="103-113" type="compound" text="flumazenil"/>
            <entity id="DS.d483.s0.e1" origId="P30531,P36148,P43574" charOffset="332-336" type="protein" text="GAT1"/>
            <pair e1="DS.d483.s0.e0" e2="DS.d483.s0.e1" id="DS.d483.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d483.s1" origId="18615011-598" text="GAT1 blockade resulted in significant increases in mean (+/-SD) ((11)C) flumazenil-binding potential (BP(ND)) over baseline in brain regions representing the major functional domains of the cerebral cortex: association cortex+15.2+/-20.2% (p=0.05), sensory cortex+13.5+/-15.5% (p=0.03) and limbic (medial temporal lobe, MTL)+16.4+/-20.2% (p=0.03).">
            <entity id="DS.d483.s1.e0" origId="P30531,P36148,P43574" charOffset="0-4" type="protein" text="GAT1"/>
            <entity id="DS.d483.s1.e1" origId="3373" charOffset="72-82" type="compound" text="flumazenil"/>
            <pair e1="DS.d483.s1.e1" e2="DS.d483.s1.e0" id="DS.d483.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d484" origId="18615280">
        <sentence id="DS.d484.s0" origId="18615280-830" text="alpha-Glucosidase inhibitory activity of cyanidin-3-galactoside and synergistic effect with acarbose.">
            <entity id="DS.d484.s0.e0" origId="O33830,O43451,O59645,P21517,P43473,Q02751" charOffset="0-17" type="protein" text="alpha-Glucosidase"/>
            <entity id="DS.d484.s0.e1" origId="44256700" charOffset="41-63" type="compound" text="cyanidin-3-galactoside"/>
            <entity id="DS.d484.s0.e2" origId="41774,441184,444254,445421,4432690" charOffset="92-100" type="compound" text="acarbose"/>
            <pair e1="DS.d484.s0.e1" e2="DS.d484.s0.e0" id="DS.d484.s0.i0" interaction="True"/>
            <pair e1="DS.d484.s0.e2" e2="DS.d484.s0.e0" id="DS.d484.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d484.s1" origId="18615280-831" text="Cyanidin-3-galactoside, a natural anthocyanin, was investigated for its alpha-glucosidase inhibitory activity.">
            <entity id="DS.d484.s1.e0" origId="44256700" charOffset="0-22" type="compound" text="Cyanidin-3-galactoside"/>
            <entity id="DS.d484.s1.e1" origId="145858" charOffset="34-45" type="compound" text="anthocyanin"/>
            <entity id="DS.d484.s1.e2" origId="O33830,O43451,O59645,P21517,P43473,Q02751" charOffset="72-89" type="protein" text="alpha-glucosidase"/>
            <pair e1="DS.d484.s1.e1" e2="DS.d484.s1.e2" id="DS.d484.s1.i0" interaction="False"/>
            <pair e1="DS.d484.s1.e0" e2="DS.d484.s1.e2" id="DS.d484.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d486" origId="18615705">
        <sentence id="DS.d486.s0" origId="18615705-81" text="The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).">
            <entity id="DS.d486.s0.e0" origId="4004" charOffset="65-74" type="compound" text="malathion"/>
            <entity id="DS.d486.s0.e1" origId="2730" charOffset="76-88" type="compound" text="chlorpyrifos"/>
            <entity id="DS.d486.s0.e2" origId="9570290" charOffset="94-100" type="compound" text="phoxim"/>
            <entity id="DS.d486.s0.e3" origId="8289" charOffset="144-163" type="compound" text="triphenyl phosphate"/>
            <entity id="DS.d486.s0.e4" origId="5794" charOffset="171-189" type="compound" text="piperonyl butoxide"/>
            <entity id="DS.d486.s0.e5" origId="5271566" charOffset="201-216" type="compound" text="diethyl maleate"/>
            <entity id="DS.d486.s0.e6" origId="P16397,P18773" charOffset="277-286" type="protein" text="esterases"/>
            <entity id="DS.d486.s0.e7" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="295-321" type="protein" text="glutathione S-transferases"/>
            <entity id="DS.d486.s0.e8" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="323-327" type="protein" text="GSTs"/>
            <entity id="DS.d486.s0.e9" origId="O08469" charOffset="334-349" type="protein" text="cytochrome P450"/>
            <entity id="DS.d486.s0.e10" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="412-432" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d486.s0.e11" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="434-438" type="protein" text="AChE"/>
            <pair e1="DS.d486.s0.e3" e2="DS.d486.s0.e10" id="DS.d486.s0.i0" interaction="False"/>
            <pair e1="DS.d486.s0.e2" e2="DS.d486.s0.e10" id="DS.d486.s0.i1" interaction="False"/>
            <pair e1="DS.d486.s0.e2" e2="DS.d486.s0.e11" id="DS.d486.s0.i2" interaction="False"/>
            <pair e1="DS.d486.s0.e3" e2="DS.d486.s0.e8" id="DS.d486.s0.i3" interaction="False"/>
            <pair e1="DS.d486.s0.e2" e2="DS.d486.s0.e6" id="DS.d486.s0.i4" interaction="False"/>
            <pair e1="DS.d486.s0.e4" e2="DS.d486.s0.e8" id="DS.d486.s0.i5" interaction="False"/>
            <pair e1="DS.d486.s0.e3" e2="DS.d486.s0.e7" id="DS.d486.s0.i6" interaction="False"/>
            <pair e1="DS.d486.s0.e2" e2="DS.d486.s0.e8" id="DS.d486.s0.i7" interaction="False"/>
            <pair e1="DS.d486.s0.e1" e2="DS.d486.s0.e8" id="DS.d486.s0.i8" interaction="False"/>
            <pair e1="DS.d486.s0.e4" e2="DS.d486.s0.e7" id="DS.d486.s0.i9" interaction="False"/>
            <pair e1="DS.d486.s0.e4" e2="DS.d486.s0.e6" id="DS.d486.s0.i10" interaction="False"/>
            <pair e1="DS.d486.s0.e5" e2="DS.d486.s0.e9" id="DS.d486.s0.i11" interaction="False"/>
            <pair e1="DS.d486.s0.e5" e2="DS.d486.s0.e10" id="DS.d486.s0.i12" interaction="False"/>
            <pair e1="DS.d486.s0.e0" e2="DS.d486.s0.e10" id="DS.d486.s0.i13" interaction="False"/>
            <pair e1="DS.d486.s0.e0" e2="DS.d486.s0.e8" id="DS.d486.s0.i14" interaction="False"/>
            <pair e1="DS.d486.s0.e1" e2="DS.d486.s0.e9" id="DS.d486.s0.i15" interaction="False"/>
            <pair e1="DS.d486.s0.e1" e2="DS.d486.s0.e6" id="DS.d486.s0.i16" interaction="False"/>
            <pair e1="DS.d486.s0.e0" e2="DS.d486.s0.e9" id="DS.d486.s0.i17" interaction="False"/>
            <pair e1="DS.d486.s0.e4" e2="DS.d486.s0.e10" id="DS.d486.s0.i18" interaction="False"/>
            <pair e1="DS.d486.s0.e3" e2="DS.d486.s0.e6" id="DS.d486.s0.i19" interaction="False"/>
            <pair e1="DS.d486.s0.e4" e2="DS.d486.s0.e9" id="DS.d486.s0.i20" interaction="False"/>
            <pair e1="DS.d486.s0.e5" e2="DS.d486.s0.e11" id="DS.d486.s0.i21" interaction="False"/>
            <pair e1="DS.d486.s0.e5" e2="DS.d486.s0.e8" id="DS.d486.s0.i22" interaction="False"/>
            <pair e1="DS.d486.s0.e4" e2="DS.d486.s0.e11" id="DS.d486.s0.i23" interaction="False"/>
            <pair e1="DS.d486.s0.e1" e2="DS.d486.s0.e11" id="DS.d486.s0.i24" interaction="False"/>
            <pair e1="DS.d486.s0.e0" e2="DS.d486.s0.e6" id="DS.d486.s0.i25" interaction="False"/>
            <pair e1="DS.d486.s0.e3" e2="DS.d486.s0.e11" id="DS.d486.s0.i26" interaction="False"/>
            <pair e1="DS.d486.s0.e0" e2="DS.d486.s0.e11" id="DS.d486.s0.i27" interaction="False"/>
            <pair e1="DS.d486.s0.e2" e2="DS.d486.s0.e9" id="DS.d486.s0.i28" interaction="False"/>
            <pair e1="DS.d486.s0.e1" e2="DS.d486.s0.e10" id="DS.d486.s0.i29" interaction="False"/>
            <pair e1="DS.d486.s0.e5" e2="DS.d486.s0.e7" id="DS.d486.s0.i30" interaction="False"/>
            <pair e1="DS.d486.s0.e5" e2="DS.d486.s0.e6" id="DS.d486.s0.i31" interaction="False"/>
            <pair e1="DS.d486.s0.e2" e2="DS.d486.s0.e7" id="DS.d486.s0.i32" interaction="False"/>
            <pair e1="DS.d486.s0.e0" e2="DS.d486.s0.e7" id="DS.d486.s0.i33" interaction="False"/>
            <pair e1="DS.d486.s0.e1" e2="DS.d486.s0.e7" id="DS.d486.s0.i34" interaction="False"/>
            <pair e1="DS.d486.s0.e3" e2="DS.d486.s0.e9" id="DS.d486.s0.i35" interaction="False"/>
        </sentence>
        <sentence id="DS.d486.s1" origId="18615705-83" text="All these results clearly indicated that the observed malathion resistance in the FR was conferred by multiple mechanisms, including increased detoxification by ESTs and GSTs, and increased activity and reduced sensitivity of AChE to OP inhibition.">
            <entity id="DS.d486.s1.e0" origId="4004" charOffset="54-63" type="compound" text="malathion"/>
            <entity id="DS.d486.s1.e1" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="170-174" type="protein" text="GSTs"/>
            <entity id="DS.d486.s1.e2" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="226-230" type="protein" text="AChE"/>
            <pair e1="DS.d486.s1.e0" e2="DS.d486.s1.e1" id="DS.d486.s1.i0" interaction="True"/>
            <pair e1="DS.d486.s1.e0" e2="DS.d486.s1.e2" id="DS.d486.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d487" origId="18615707">
        <sentence id="DS.d487.s0" origId="18615707-1194" text="Lysozymes act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&amp;gt;4) bonds between N-acetylglucosamine and N-acetylmuramic acid in the peptidoglycan of prokaryotic cell walls.">
            <entity id="DS.d487.s0.e0" origId="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7" charOffset="0-9" type="protein" text="Lysozymes"/>
            <entity id="DS.d487.s0.e1" origId="24139" charOffset="120-139" type="compound" text="N-acetylglucosamine"/>
            <entity id="DS.d487.s0.e2" origId="440822,542212,5462244,6323218" charOffset="144-164" type="compound" text="N-acetylmuramic acid"/>
            <entity id="DS.d487.s0.e3" origId="9816401" charOffset="172-185" type="compound" text="peptidoglycan"/>
            <pair e1="DS.d487.s0.e1" e2="DS.d487.s0.e0" id="DS.d487.s0.i0" interaction="True"/>
            <pair e1="DS.d487.s0.e2" e2="DS.d487.s0.e0" id="DS.d487.s0.i1" interaction="True"/>
            <pair e1="DS.d487.s0.e3" e2="DS.d487.s0.e0" id="DS.d487.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d488" origId="18615734">
        <sentence id="DS.d488.s0" origId="18615734-449" text="These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the &quot; membrane activation model&quot; of gephyrin clustering.">
            <entity id="DS.d488.s0.e0" origId="P08567,Q4KM33,Q6Q308,Q9JHK5" charOffset="33-43" type="protein" text="pleckstrin"/>
            <entity id="DS.d488.s0.e1" origId="O43307,Q3UTH8,Q58DL7,Q5RDK0,Q9QX73" charOffset="68-79" type="protein" text="collybistin"/>
            <entity id="DS.d488.s0.e2" origId="6857403,9776841" charOffset="105-137" type="compound" text="phosphatidylinositol-3-phosphate"/>
            <entity id="DS.d488.s0.e3" origId="643964,24755494" charOffset="144-154" type="compound" text="PtdIns-3-P"/>
            <entity id="DS.d488.s0.e4" origId="16738692" charOffset="159-175" type="compound" text="phosphoinositide"/>
            <entity id="DS.d488.s0.e5" origId="643963" charOffset="259-299" type="compound" text="phosphatidylinositol 3,4,5-trisphosphate"/>
            <entity id="DS.d488.s0.e6" origId="643963" charOffset="306-320" type="compound" text="PtdIns-3,4,5-P"/>
            <entity id="DS.d488.s0.e7" origId="Q03555,Q9NQX3" charOffset="385-393" type="protein" text="gephyrin"/>
            <pair e1="DS.d488.s0.e2" e2="DS.d488.s0.e0" id="DS.d488.s0.i0" interaction="True"/>
            <pair e1="DS.d488.s0.e4" e2="DS.d488.s0.e1" id="DS.d488.s0.i1" interaction="True"/>
            <pair e1="DS.d488.s0.e3" e2="DS.d488.s0.e1" id="DS.d488.s0.i2" interaction="True"/>
            <pair e1="DS.d488.s0.e5" e2="DS.d488.s0.e1" id="DS.d488.s0.i3" interaction="True"/>
            <pair e1="DS.d488.s0.e5" e2="DS.d488.s0.e0" id="DS.d488.s0.i4" interaction="True"/>
            <pair e1="DS.d488.s0.e6" e2="DS.d488.s0.e1" id="DS.d488.s0.i5" interaction="True"/>
            <pair e1="DS.d488.s0.e3" e2="DS.d488.s0.e0" id="DS.d488.s0.i6" interaction="True"/>
            <pair e1="DS.d488.s0.e6" e2="DS.d488.s0.e0" id="DS.d488.s0.i7" interaction="True"/>
            <pair e1="DS.d488.s0.e6" e2="DS.d488.s0.e7" id="DS.d488.s0.i8" interaction="False"/>
            <pair e1="DS.d488.s0.e2" e2="DS.d488.s0.e1" id="DS.d488.s0.i9" interaction="True"/>
            <pair e1="DS.d488.s0.e4" e2="DS.d488.s0.e0" id="DS.d488.s0.i10" interaction="True"/>
            <pair e1="DS.d488.s0.e3" e2="DS.d488.s0.e7" id="DS.d488.s0.i11" interaction="False"/>
            <pair e1="DS.d488.s0.e2" e2="DS.d488.s0.e7" id="DS.d488.s0.i12" interaction="False"/>
            <pair e1="DS.d488.s0.e4" e2="DS.d488.s0.e7" id="DS.d488.s0.i13" interaction="False"/>
            <pair e1="DS.d488.s0.e5" e2="DS.d488.s0.e7" id="DS.d488.s0.i14" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d489" origId="18616717">
        <sentence id="DS.d489.s0" origId="18616717-310" text="We investigated whether several different inflammatory markers including C-reactive protein (CRP) and fibrinogen and white blood cells (WBCs) count, are associated with maximal oxygen consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).">
            <entity id="DS.d489.s0.e0" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="93-96" type="protein" text="CRP"/>
            <entity id="DS.d489.s0.e1" origId="P22775,P81070" charOffset="102-112" type="protein" text="fibrinogen"/>
            <entity id="DS.d489.s0.e2" origId="977" charOffset="177-183" type="compound" text="oxygen"/>
            <pair e1="DS.d489.s0.e2" e2="DS.d489.s0.e0" id="DS.d489.s0.i0" interaction="False"/>
            <pair e1="DS.d489.s0.e2" e2="DS.d489.s0.e1" id="DS.d489.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d491" origId="18617682">
        <sentence id="DS.d491.s0" origId="18617682-1119" text="CSE activated the MMP-1 promoter, and this induction was prevented by PD98059 blockade of ERK1/2 phosphorylation.">
            <entity id="DS.d491.s0.e0" origId="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5" charOffset="18-23" type="protein" text="MMP-1"/>
            <entity id="DS.d491.s0.e1" origId="4713" charOffset="70-77" type="compound" text="PD98059"/>
            <entity id="DS.d491.s0.e2" origId="P27361,P28869,P42525,Q07176" charOffset="90-94" type="protein" text="ERK1"/>
            <pair e1="DS.d491.s0.e1" e2="DS.d491.s0.e2" id="DS.d491.s0.i0" interaction="True"/>
            <pair e1="DS.d491.s0.e1" e2="DS.d491.s0.e0" id="DS.d491.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d491.s1" origId="18617682-1120" text="Cotransfection, mithramycin, and electrophoretic mobility shift assay studies identified activating and repressive roles for Sp1 and PEA3 transcription factors, respectively.">
            <entity id="DS.d491.s1.e0" origId="29051,163659,230076,457831,6326719" charOffset="16-27" type="compound" text="mithramycin"/>
            <entity id="DS.d491.s1.e1" origId="O14300,O89090,P17379,Q01714,Q85439,Q85449,Q85451" charOffset="125-128" type="protein" text="Sp1"/>
            <pair e1="DS.d491.s1.e0" e2="DS.d491.s1.e1" id="DS.d491.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d492" origId="18617751">
        <sentence id="DS.d492.s0" origId="18617751-1188" text="We have previously demonstrated that iloprost, a stable prostacyclin (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (VEGF)-dependent mechanism.">
            <entity id="DS.d492.s0.e0" origId="5311181,6435378,6443959,53394043,53486260" charOffset="37-45" type="compound" text="iloprost"/>
            <entity id="DS.d492.s0.e1" origId="5280427,5282411,6434194" charOffset="56-68" type="compound" text="prostacyclin"/>
            <entity id="DS.d492.s0.e2" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="165-169" type="protein" text="VEGF"/>
            <pair e1="DS.d492.s0.e0" e2="DS.d492.s0.e2" id="DS.d492.s0.i0" interaction="True"/>
            <pair e1="DS.d492.s0.e1" e2="DS.d492.s0.e2" id="DS.d492.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d492.s1" origId="18617751-1189" text="In this study, we demonstrate that iloprost-induced angiogenesis and VEGF upregulation are modulated by peroxisome proliferator-activated receptor-alpha (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.">
            <entity id="DS.d492.s1.e0" origId="5311181,6435378,6443959,53394043,53486260" charOffset="35-43" type="compound" text="iloprost"/>
            <entity id="DS.d492.s1.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="69-73" type="protein" text="VEGF"/>
            <entity id="DS.d492.s1.e2" origId="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78" charOffset="104-152" type="protein" text="peroxisome proliferator-activated receptor-alpha"/>
            <entity id="DS.d492.s1.e3" origId="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78" charOffset="154-163" type="protein" text="PPARalpha"/>
            <pair e1="DS.d492.s1.e0" e2="DS.d492.s1.e1" id="DS.d492.s1.i0" interaction="True"/>
            <pair e1="DS.d492.s1.e0" e2="DS.d492.s1.e3" id="DS.d492.s1.i1" interaction="True"/>
            <pair e1="DS.d492.s1.e0" e2="DS.d492.s1.e2" id="DS.d492.s1.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d492.s2" origId="18617751-1191" text="In contrast, iloprost induces a robust angiogenic response in wild-type mice, along with local upregulation of VEGF.">
            <entity id="DS.d492.s2.e0" origId="5311181,6435378,6443959,53394043,53486260" charOffset="13-21" type="compound" text="iloprost"/>
            <entity id="DS.d492.s2.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="111-115" type="protein" text="VEGF"/>
            <pair e1="DS.d492.s2.e0" e2="DS.d492.s2.e1" id="DS.d492.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d492.s3" origId="18617751-1192" text="Importantly, mice lacking the PPARalpha gene exhibit a normal angiogenic response to VEGF, indicating that the absence of PPARalpha does not result in a general impairment of angiogenesis, but specifically affects the ability of iloprost to induce angiogenesis.">
            <entity id="DS.d492.s3.e0" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="85-89" type="protein" text="VEGF"/>
            <entity id="DS.d492.s3.e1" origId="5311181,6435378,6443959,53394043,53486260" charOffset="229-237" type="compound" text="iloprost"/>
            <pair e1="DS.d492.s3.e1" e2="DS.d492.s3.e0" id="DS.d492.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d493" origId="18618086">
        <sentence id="DS.d493.s1" origId="18618086-1425" text="The proportion of APP molecules that are directed to the novel cleavage pathway is regulated by the ratio of free cholesterol and cholesteryl esters in cells.">
            <entity id="DS.d493.s1.e0" origId="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241" charOffset="18-21" type="protein" text="APP"/>
            <entity id="DS.d493.s1.e1" origId="304,5997,6432564,11025495" charOffset="114-125" type="compound" text="cholesterol"/>
            <pair e1="DS.d493.s1.e1" e2="DS.d493.s1.e0" id="DS.d493.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d494" origId="18618240">
        <sentence id="DS.d494.s0" origId="18618240-1582" text="In the hormone receptor-positive breast cancer cell line T47-D expression of hCAR and its soluble isoforms was increased by treatment with estradiol and tamoxifen.">
            <entity id="DS.d494.s0.e0" origId="P78310" charOffset="77-81" type="protein" text="hCAR"/>
            <entity id="DS.d494.s0.e1" origId="5757" charOffset="139-148" type="compound" text="estradiol"/>
            <entity id="DS.d494.s0.e2" origId="2733526" charOffset="153-162" type="compound" text="tamoxifen"/>
            <pair e1="DS.d494.s0.e2" e2="DS.d494.s0.e0" id="DS.d494.s0.i0" interaction="True"/>
            <pair e1="DS.d494.s0.e1" e2="DS.d494.s0.e0" id="DS.d494.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d495" origId="18618241">
        <sentence id="DS.d495.s0" origId="18618241-1584" text="In contrast to the behavior in aqueous solution, lactose binding in DMSO resulted in an increase of the lectin's radius of gyration from 49+/-1 to 55.5+/-1 A.">
            <entity id="DS.d495.s0.e0" origId="679" charOffset="68-72" type="compound" text="DMSO"/>
            <entity id="DS.d495.s0.e1" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="104-110" type="protein" text="lectin"/>
            <pair e1="DS.d495.s0.e0" e2="DS.d495.s0.e1" id="DS.d495.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d496" origId="18618243">
        <sentence id="DS.d496.s0" origId="18618243-1587" text="Tumor necrosis factor-alpha (TNF-alpha) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the caffeine-treated rats groups and the control rats.">
            <entity id="DS.d496.s0.e0" origId="Q8JFG3" charOffset="0-21" type="protein" text="Tumor necrosis factor"/>
            <entity id="DS.d496.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="29-38" type="protein" text="TNF-alpha"/>
            <entity id="DS.d496.s0.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="150-159" type="protein" text="TNF-alpha"/>
            <entity id="DS.d496.s0.e3" origId="2519" charOffset="174-182" type="compound" text="caffeine"/>
            <pair e1="DS.d496.s0.e3" e2="DS.d496.s0.e0" id="DS.d496.s0.i0" interaction="False"/>
            <pair e1="DS.d496.s0.e3" e2="DS.d496.s0.e1" id="DS.d496.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d496.s1" origId="18618243-1588" text="Our study indicates that brain arginase activity decreases after caffeine administration at doses of 30 mg/kg and 100 mg/kg.">
            <entity id="DS.d496.s1.e0" origId="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3" charOffset="31-39" type="protein" text="arginase"/>
            <entity id="DS.d496.s1.e1" origId="2519" charOffset="65-73" type="compound" text="caffeine"/>
            <pair e1="DS.d496.s1.e1" e2="DS.d496.s1.e0" id="DS.d496.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d497" origId="18618245">
        <sentence id="DS.d497.s0" origId="18618245-1590" text="Comparison of the PTM's of MBP's isolated from several vertebrate species reveals marked differences in their phosphate content.">
            <entity id="DS.d497.s0.e0" origId="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1" charOffset="27-30" type="protein" text="MBP"/>
            <entity id="DS.d497.s0.e1" origId="1061,167704,644102" charOffset="110-119" type="compound" text="phosphate"/>
            <pair e1="DS.d497.s0.e1" e2="DS.d497.s0.e0" id="DS.d497.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d497.s1" origId="18618245-1591" text="Chicken MBP does not share any phosphorylated sites with dogfish MBP ; However, it does contain phosphorylated serine and threonine residues in common with mammalian MBP.">
            <entity id="DS.d497.s1.e0" origId="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1" charOffset="8-11" type="protein" text="MBP"/>
            <entity id="DS.d497.s1.e1" origId="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1" charOffset="65-68" type="protein" text="MBP"/>
            <entity id="DS.d497.s1.e2" origId="5951" charOffset="111-117" type="compound" text="serine"/>
            <entity id="DS.d497.s1.e3" origId="6288" charOffset="122-131" type="compound" text="threonine"/>
            <entity id="DS.d497.s1.e4" origId="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1" charOffset="65-68" type="protein" text="MBP"/>
            <pair e1="DS.d497.s1.e3" e2="DS.d497.s1.e0" id="DS.d497.s1.i0" interaction="True"/>
            <pair e1="DS.d497.s1.e2" e2="DS.d497.s1.e0" id="DS.d497.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d498" origId="18618304">
        <sentence id="DS.d498.s0" origId="18618304-1646" text="Riluzole/NaPB administration increased acetylation at H4 and increased NF-kappaB p50 translocation to the nucleus in G93A mice, consistent with a therapeutic effect.">
            <entity id="DS.d498.s0.e0" origId="5070" charOffset="0-8" type="compound" text="Riluzole"/>
            <entity id="DS.d498.s0.e1" origId="4775" charOffset="9-13" type="compound" text="NaPB"/>
            <entity id="DS.d498.s0.e2" origId="P23061,P38644,P83939,Q05894,Q28618,Q43731" charOffset="81-84" type="protein" text="p50"/>
            <pair e1="DS.d498.s0.e0" e2="DS.d498.s0.e2" id="DS.d498.s0.i0" interaction="True"/>
            <pair e1="DS.d498.s0.e1" e2="DS.d498.s0.e2" id="DS.d498.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d499" origId="18618472">
        <sentence id="DS.d499.s0" origId="18618472-1060" text="Due to the absence of hydrophobic solute-material interactions, which limit the scope of microstructures fabricated from poly(dimethylsiloxane) for biocatalytic applications, the new microreactor was fully compatible with the alternate enzyme substrate 2-nitro-phenyl-beta-D-galactoside and the 2-nitro-phenol product resulting from its hydrolysis catalyzed by CelB.">
            <entity id="DS.d499.s0.e1" origId="6947" charOffset="295-309" type="compound" text="2-nitro-phenol"/>
            <entity id="DS.d499.s0.e2" origId="P04956,P06565,P06963,P10474,P17334,P18126,P22698,P23550,P23661,P26222,P37701,P38569,P46317,Q45400" charOffset="361-365" type="protein" text="CelB"/>
            <pair e1="DS.d499.s0.e1" e2="DS.d499.s0.e2" id="DS.d499.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d500" origId="18618621">
        <sentence id="DS.d500.s0" origId="18618621-1255" text="These findings suggest that multiple variations in the SLC6A4 gene are associated with remission in white non-Hispanic depressed adults treated with citalopram.">
            <entity id="DS.d500.s0.e0" origId="O35899,P31645,Q9MYX0,Q9XT49" charOffset="55-61" type="protein" text="SLC6A4"/>
            <entity id="DS.d500.s0.e1" origId="2771,146570" charOffset="149-159" type="compound" text="citalopram"/>
            <pair e1="DS.d500.s0.e1" e2="DS.d500.s0.e0" id="DS.d500.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d501" origId="18618694">
        <sentence id="DS.d501.s0" origId="18618694-248" text="The planar angle between the carbamoyl phosphate and aspartate domains of the catalytic chain is more open at pH 8.5 than in ATCase structures determined at lower pH values.">
            <entity id="DS.d501.s0.e0" origId="278" charOffset="29-48" type="compound" text="carbamoyl phosphate"/>
            <entity id="DS.d501.s0.e1" origId="5960" charOffset="53-62" type="compound" text="aspartate"/>
            <entity id="DS.d501.s0.e2" origId="O25716,O27464,O30130,O58451,O66726,P05654,P0A1Z4,P0A1Z5,P0A786,P0A787,P0A788,P0A789,P19910,P41008,P49077,P56585,P57450,P65611,P65612,P65613,P65614,P65615,P65616,P65617,P65618,P65619,P65620,P65621,P74163,P77883,P77918,P96079,P96111,P96174,Q04595,Q2W156,Q55338,Q58976,Q59653,Q59711,Q5E7U5,Q5FGW9,Q5FJB7,Q5FRG8,Q5H2Z0,Q5HBA3,Q5HGN2,Q5HPZ1,Q5HU06,Q5JHM9,Q5L0U6,Q5LX75,Q5M0X1,Q5M5F8,Q5N3S1,Q5NPE5,Q5P6I4,Q5PAN5,Q5PJB2,Q5SK66,Q5V2T3,Q5WFI9,Q5WYW3,Q5X7G7,Q5XCR9,Q5YTM0,Q5ZXZ2,Q60252,Q605F1,Q62I89,Q636D7,Q63RI2,Q64U74,Q65JV0,Q665I6,Q67Q01,Q6A917,Q6AF88,Q6AS40,Q6DA73,Q6FCR5,Q6FZS5,Q6G3F3,Q6GA13,Q6GHN5,Q6HES5,Q6L0F2,Q6LUX0,Q6LWQ0,Q6N565,Q6NH13,Q71YH8,Q727F4,Q72KU0,Q72NJ5,Q732I0,Q73GP1,Q741H5,Q74DP5,Q74J31,Q7M9Y9,Q7MHF1,Q7MX58,Q7MZ16,Q7NCV1,Q7P145,Q7U9G2,Q7UNR3,Q7V355,Q7V4X7,Q7VDV6,Q7VIT3,Q7W044,Q7W3U7,Q7WF77,Q819S0,Q81WE9,Q827R1,Q82U44,Q83A16,Q87C22,Q87LF8,Q87V99,Q88D30,Q89K19,Q8A9S3,Q8CPJ7,Q8D293,Q8DCF6,Q8DIM4,Q8DPH9,Q8DUP5,Q8DZQ5,Q8E5F3,Q8ER38,Q8EUX9,Q8F812,Q8FT39,Q8G655,Q8K9H9,Q8KBI7,Q8NQ38,Q8P1G1,Q8P767,Q8PII1,Q8PXK5,Q8R9R5,Q8RG89,Q8THL2,Q8TVB2,Q8U373,Q8UFT9,Q8XL59,Q8Y1L2,Q8Y662,Q8YWD2,Q8ZB39,Q8ZYH7,Q92AH0,Q92QL5,Q934T0,Q970X2,Q97B29,Q97FS3,Q97QE2,Q98M86,Q9A5K4,Q9CCR5,Q9CF79,Q9HHN4,Q9HKM2,Q9K9V6,Q9KP66,Q9KXR2,Q9L4N6,Q9L4T8,Q9PBB8,Q9PNJ6,Q9RVC0,Q9UX08,Q9YBD4,Q9ZM81" charOffset="125-131" type="protein" text="ATCase"/>
            <pair e1="DS.d501.s0.e1" e2="DS.d501.s0.e2" id="DS.d501.s0.i0" interaction="True"/>
            <pair e1="DS.d501.s0.e0" e2="DS.d501.s0.e2" id="DS.d501.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d502" origId="18618700">
        <sentence id="DS.d502.s0" origId="18618700-254" text="At 0.15 microM Ca(2+), ((35)S) CaM bound to RyR2 with decreased affinity and binding enthalpy compared with RyR1.">
            <entity id="DS.d502.s0.e0" origId="271" charOffset="15-19" type="compound" text="Ca(2"/>
            <entity id="DS.d502.s0.e1" origId="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0" charOffset="31-34" type="protein" text="CaM"/>
            <entity id="DS.d502.s0.e2" origId="P30957,Q92736" charOffset="44-48" type="protein" text="RyR2"/>
            <entity id="DS.d502.s0.e3" origId="P11716,P16960,P21817" charOffset="108-112" type="protein" text="RyR1"/>
            <pair e1="DS.d502.s0.e0" e2="DS.d502.s0.e2" id="DS.d502.s0.i0" interaction="False"/>
            <pair e1="DS.d502.s0.e0" e2="DS.d502.s0.e1" id="DS.d502.s0.i1" interaction="False"/>
            <pair e1="DS.d502.s0.e0" e2="DS.d502.s0.e3" id="DS.d502.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d502.s1" origId="18618700-255" text="The rates of ((35)S) CaM dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM Ca(2+) the rate from RyR2 was little affected.">
            <entity id="DS.d502.s1.e0" origId="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0" charOffset="21-24" type="protein" text="CaM"/>
            <entity id="DS.d502.s1.e1" origId="P11716,P16960,P21817" charOffset="43-47" type="protein" text="RyR1"/>
            <entity id="DS.d502.s1.e2" origId="271" charOffset="112-116" type="compound" text="Ca(2"/>
            <entity id="DS.d502.s1.e3" origId="P30957,Q92736" charOffset="133-137" type="protein" text="RyR2"/>
            <pair e1="DS.d502.s1.e2" e2="DS.d502.s1.e3" id="DS.d502.s1.i0" interaction="False"/>
            <pair e1="DS.d502.s1.e2" e2="DS.d502.s1.e1" id="DS.d502.s1.i1" interaction="False"/>
            <pair e1="DS.d502.s1.e2" e2="DS.d502.s1.e0" id="DS.d502.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d503" origId="18619522">
        <sentence id="DS.d503.s0" origId="18619522-636" text="In rats, infusion of angiotensin II increases ferritin levels and arterial thickness which are reversed by treatment with the iron chelator deferoxamine.">
            <entity id="DS.d503.s0.e0" origId="Q26061" charOffset="46-54" type="protein" text="ferritin"/>
            <entity id="DS.d503.s0.e1" origId="2973" charOffset="140-152" type="compound" text="deferoxamine"/>
            <pair e1="DS.d503.s0.e1" e2="DS.d503.s0.e0" id="DS.d503.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d504" origId="18619705">
        <sentence id="DS.d504.s0" origId="18619705-1094" text="Furthermore, ellipticine regulated endogenous survival signaling by up-regulating phosphorylated Akt that returned to its basal level later.">
            <entity id="DS.d504.s0.e0" origId="3213" charOffset="13-24" type="compound" text="ellipticine"/>
            <entity id="DS.d504.s0.e1" origId="P31750,Q8INB9" charOffset="97-100" type="protein" text="Akt"/>
            <pair e1="DS.d504.s0.e0" e2="DS.d504.s0.e1" id="DS.d504.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d504.s1" origId="18619705-1095" text="Furthermore, ellipticine induced nucleus translocalization of p53 and Akt and recruitment of autophagosomes.">
            <entity id="DS.d504.s1.e0" origId="3213" charOffset="13-24" type="compound" text="ellipticine"/>
            <entity id="DS.d504.s1.e1" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="62-65" type="protein" text="p53"/>
            <entity id="DS.d504.s1.e2" origId="P31750,Q8INB9" charOffset="70-73" type="protein" text="Akt"/>
            <pair e1="DS.d504.s1.e0" e2="DS.d504.s1.e2" id="DS.d504.s1.i0" interaction="True"/>
            <pair e1="DS.d504.s1.e0" e2="DS.d504.s1.e1" id="DS.d504.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d505" origId="18619713">
        <sentence id="DS.d505.s0" origId="18619713-1104" text="The ubiquitous enzyme dUTP nucleotidohydrolase (dUTPase) catalyses the hydrolysis of dUTP to dUMP and can be considered as the first line of defence against incorporation of uracil into DNA.">
            <entity id="DS.d505.s0.e0" origId="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3" charOffset="48-55" type="protein" text="dUTPase"/>
            <entity id="DS.d505.s0.e1" origId="1174" charOffset="174-180" type="compound" text="uracil"/>
            <pair e1="DS.d505.s0.e1" e2="DS.d505.s0.e0" id="DS.d505.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d506" origId="18621093">
        <sentence id="DS.d506.s0" origId="18621093-545" text="Recent findings indicate that the polypyrimidine tract-binding protein (PTB), also named hnRNP I, by binding to the 3'-UTR (untranslated region) of the preproinsulin mRNA molecule, stabilizes the messenger, thereby participating in the glucose-induced increase in preproinsulin mRNA.">
            <entity id="DS.d506.s0.e0" origId="P17225,P26599,Q00438,Q29099,Q8WN55,Q9MAC5,Q9UKA9" charOffset="72-75" type="protein" text="PTB"/>
            <entity id="DS.d506.s0.e1" origId="P17225,P26599,Q00438,Q29099" charOffset="89-96" type="protein" text="hnRNP I"/>
            <entity id="DS.d506.s0.e2" origId="206,5793,64689,79025" charOffset="236-243" type="compound" text="glucose"/>
            <pair e1="DS.d506.s0.e2" e2="DS.d506.s0.e0" id="DS.d506.s0.i0" interaction="True"/>
            <pair e1="DS.d506.s0.e2" e2="DS.d506.s0.e1" id="DS.d506.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d507" origId="18621373">
        <sentence id="DS.d507.s0" origId="18621373-794" text="Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (p38MAPK) significantly decreased CRP-induced superoxide anion release from macrophages in vivo.">
            <entity id="DS.d507.s0.e0" origId="O62618" charOffset="152-159" type="protein" text="p38MAPK"/>
            <entity id="DS.d507.s0.e1" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="185-188" type="protein" text="CRP"/>
            <entity id="DS.d507.s0.e2" origId="5359597" charOffset="197-207" type="compound" text="superoxide"/>
            <pair e1="DS.d507.s0.e2" e2="DS.d507.s0.e1" id="DS.d507.s0.i0" interaction="True"/>
            <pair e1="DS.d507.s0.e2" e2="DS.d507.s0.e0" id="DS.d507.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d508" origId="18621413">
        <sentence id="DS.d508.s0" origId="18621413-823" text="The free radicals produced are thought to be generated during the production of uric acid, a reaction catalyzed by xanthine oxidase.">
            <entity id="DS.d508.s0.e0" origId="1175" charOffset="80-89" type="compound" text="uric acid"/>
            <entity id="DS.d508.s0.e1" origId="P22985,P47989,P47990,P80457,Q00519,Q9MYW6" charOffset="115-131" type="protein" text="xanthine oxidase"/>
            <pair e1="DS.d508.s0.e0" e2="DS.d508.s0.e1" id="DS.d508.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d509" origId="18621448">
        <sentence id="DS.d509.s0" origId="18621448-855" text="In the diabetic group, a decrease in the pancreatic glutathione levels, glutathione peroxidase and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed.">
            <entity id="DS.d509.s0.e0" origId="124886" charOffset="52-63" type="compound" text="glutathione"/>
            <entity id="DS.d509.s0.e1" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="72-94" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d509.s0.e2" origId="O50258" charOffset="99-119" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d509.s0.e3" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="194-202" type="protein" text="catalase"/>
            <pair e1="DS.d509.s0.e0" e2="DS.d509.s0.e3" id="DS.d509.s0.i0" interaction="False"/>
            <pair e1="DS.d509.s0.e0" e2="DS.d509.s0.e2" id="DS.d509.s0.i1" interaction="False"/>
            <pair e1="DS.d509.s0.e0" e2="DS.d509.s0.e1" id="DS.d509.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d510" origId="18621563">
        <sentence id="DS.d510.s0" origId="18621563-947" text="The immunomodulatory effects of thalidomide are at least partially mediated through its ability to down-regulate the pathogenic over-production of tumor necrosis factor-alpha (TNF-alpha).">
            <entity id="DS.d510.s0.e0" origId="5426,75792,92142" charOffset="32-43" type="compound" text="thalidomide"/>
            <entity id="DS.d510.s0.e1" origId="Q8JFG3" charOffset="147-168" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d510.s0.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="176-185" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d510.s0.e0" e2="DS.d510.s0.e2" id="DS.d510.s0.i0" interaction="True"/>
            <pair e1="DS.d510.s0.e0" e2="DS.d510.s0.e1" id="DS.d510.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d510.s1" origId="18621563-948" text="In the central nervous system, TNF-alpha is involved in induction of a fever response and triggers the release of other cytokines, and may also influence transport of compounds into the brain, leading to cerebrospinal fluid leukocytosis, increased protein influx, and lactate accumulation.">
            <entity id="DS.d510.s1.e0" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="31-40" type="protein" text="TNF-alpha"/>
            <entity id="DS.d510.s1.e1" origId="612" charOffset="268-275" type="compound" text="lactate"/>
            <pair e1="DS.d510.s1.e1" e2="DS.d510.s1.e0" id="DS.d510.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d510.s2" origId="18621563-949" text="Thalidomide has been shown to down-regulate the production of TNF-alpha.">
            <entity id="DS.d510.s2.e0" origId="5426,75792,92142" charOffset="0-11" type="compound" text="Thalidomide"/>
            <entity id="DS.d510.s2.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="62-71" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d510.s2.e0" e2="DS.d510.s2.e1" id="DS.d510.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d511" origId="18622696">
        <sentence id="DS.d511.s0" origId="18622696-162" text="Both cell types expressed estrogen and progesterone receptors, although only the epithelial LM05-E cells were stimulated by estradiol and inhibited by tamoxifen.">
            <entity id="DS.d511.s0.e0" origId="P06186,P06401,P07812,P79373,Q00175,Q28590,Q63449,Q8AYI2,Q9GLW0" charOffset="39-61" type="protein" text="progesterone receptors"/>
            <entity id="DS.d511.s0.e1" origId="5757" charOffset="124-133" type="compound" text="estradiol"/>
            <entity id="DS.d511.s0.e2" origId="2733526" charOffset="151-160" type="compound" text="tamoxifen"/>
            <pair e1="DS.d511.s0.e1" e2="DS.d511.s0.e0" id="DS.d511.s0.i0" interaction="False"/>
            <pair e1="DS.d511.s0.e2" e2="DS.d511.s0.e0" id="DS.d511.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d512" origId="18622720">
        <sentence id="DS.d512.s0" origId="18622720-185" text="This study was performed to investigate the effect of combined treatment with niacin and chromium on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and LOX-1.">
            <entity id="DS.d512.s0.e0" origId="938" charOffset="78-84" type="compound" text="niacin"/>
            <entity id="DS.d512.s0.e1" origId="23976" charOffset="89-97" type="compound" text="chromium"/>
            <entity id="DS.d512.s0.e2" origId="O70156,P78380,P79391,Q9EQ09,Q9TTK7,Q9XTA8" charOffset="234-239" type="protein" text="LOX-1"/>
            <pair e1="DS.d512.s0.e0" e2="DS.d512.s0.e2" id="DS.d512.s0.i0" interaction="False"/>
            <pair e1="DS.d512.s0.e1" e2="DS.d512.s0.e2" id="DS.d512.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d512.s1" origId="18622720-186" text="In HF group, the serum levels of total cholesterol (TC), low-density lipoprotein (LDL), oxidized low-density lipoprotein (ox-LDL) and endothelin (ET) were higher, whereas the levels of high-density lipoprotein (HDL), serum NO were lower than those in CG group.">
            <entity id="DS.d512.s1.e0" origId="304,5997,6432564,11025495" charOffset="39-50" type="compound" text="cholesterol"/>
            <entity id="DS.d512.s1.e1" origId="P81182" charOffset="185-209" type="protein" text="high-density lipoprotein"/>
            <pair e1="DS.d512.s1.e0" e2="DS.d512.s1.e1" id="DS.d512.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d512.s2" origId="18622720-187" text="These findings indicated that combined treatment with niacin and chromium has potential therapeutic protection of endothelial function by down-regulating ox-LDL/LOX-1 signaling pathway.">
            <entity id="DS.d512.s2.e0" origId="938" charOffset="54-60" type="compound" text="niacin"/>
            <entity id="DS.d512.s2.e1" origId="23976" charOffset="65-73" type="compound" text="chromium"/>
            <entity id="DS.d512.s2.e2" origId="O70156,P78380,P79391,Q9EQ09,Q9TTK7,Q9XTA8" charOffset="161-166" type="protein" text="LOX-1"/>
            <pair e1="DS.d512.s2.e1" e2="DS.d512.s2.e2" id="DS.d512.s2.i0" interaction="True"/>
            <pair e1="DS.d512.s2.e0" e2="DS.d512.s2.e2" id="DS.d512.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d513" origId="18622759">
        <sentence id="DS.d513.s0" origId="18622759-218" text="The deduced amino acid sequence of Ai Lec was highly similar to those of the C-type lectins from other animals and contained a typical carbohydrate-recognition domain (CRD) of 131 residues, which has four conserved disulfide-bonded cysteine residues that define the CRD and two additional cysteine residues at the amino terminus.">
            <entity id="DS.d513.s0.e0" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="84-91" type="protein" text="lectins"/>
            <entity id="DS.d513.s0.e1" origId="594,5862,5360637" charOffset="232-240" type="compound" text="cysteine"/>
            <entity id="DS.d513.s0.e2" origId="594,5862,5360637" charOffset="289-297" type="compound" text="cysteine"/>
            <pair e1="DS.d513.s0.e1" e2="DS.d513.s0.e0" id="DS.d513.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d514" origId="18623061">
        <sentence id="DS.d514.s0" origId="18623061-1275" text="Src kinases can be activated by trans-phosphorylation of a tyrosine located in the central activation loop of the catalytic domain.">
            <entity id="DS.d514.s0.e0" origId="P05480,Q9WUD9" charOffset="0-3" type="protein" text="Src"/>
            <entity id="DS.d514.s0.e1" origId="1153,6057,5460803" charOffset="59-67" type="compound" text="tyrosine"/>
            <pair e1="DS.d514.s0.e1" e2="DS.d514.s0.e0" id="DS.d514.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d514.s1" origId="18623061-1276" text="However, because the required exposure of this tyrosine is not observed in the down-regulated X-ray structures of Src kinases, transient partial opening of the activation loop appears to be necessary for such processes.">
            <entity id="DS.d514.s1.e0" origId="1153,6057,5460803" charOffset="47-55" type="compound" text="tyrosine"/>
            <entity id="DS.d514.s1.e1" origId="P05480,Q9WUD9" charOffset="114-117" type="protein" text="Src"/>
            <pair e1="DS.d514.s1.e0" e2="DS.d514.s1.e1" id="DS.d514.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d515" origId="18623078">
        <sentence id="DS.d515.s0" origId="18623078-486" text="The growth of L. minor (as fresh weight) and chlorophyll a content were significantly reduced and superoxide dismutase (SOD) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.">
            <entity id="DS.d515.s0.e0" origId="5351507,5459387,6326752,6433193,6914133,9600410" charOffset="45-58" type="compound" text="chlorophyll a"/>
            <entity id="DS.d515.s0.e1" origId="O50258" charOffset="98-118" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d515.s0.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="120-123" type="protein" text="SOD"/>
            <pair e1="DS.d515.s0.e0" e2="DS.d515.s0.e1" id="DS.d515.s0.i0" interaction="False"/>
            <pair e1="DS.d515.s0.e0" e2="DS.d515.s0.e2" id="DS.d515.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d515.s1" origId="18623078-487" text="The experiment also indicated that catalase (CAT) activity was not significantly influenced by microcystin for both the two tested aquatic plants.">
            <entity id="DS.d515.s1.e0" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="35-43" type="protein" text="catalase"/>
            <entity id="DS.d515.s1.e1" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="45-48" type="protein" text="CAT"/>
            <entity id="DS.d515.s1.e2" origId="56841897" charOffset="95-106" type="compound" text="microcystin"/>
            <pair e1="DS.d515.s1.e2" e2="DS.d515.s1.e1" id="DS.d515.s1.i0" interaction="False"/>
            <pair e1="DS.d515.s1.e2" e2="DS.d515.s1.e0" id="DS.d515.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d516" origId="18623211">
        <sentence id="DS.d516.s0" origId="18623211-610" text="The purpose of this study was to investigate the solid-state properties of lyophilized formulations of protein (ribonuclease A) containing sucrose or trehalose across a wide range of compositions, both in the presence or absence of hydroxyethylstarch (HES).">
            <entity id="DS.d516.s0.e0" origId="P27043" charOffset="112-126" type="protein" text="ribonuclease A"/>
            <entity id="DS.d516.s0.e1" origId="5988" charOffset="139-146" type="compound" text="sucrose"/>
            <entity id="DS.d516.s0.e2" origId="7427" charOffset="150-159" type="compound" text="trehalose"/>
            <pair e1="DS.d516.s0.e1" e2="DS.d516.s0.e0" id="DS.d516.s0.i0" interaction="False"/>
            <pair e1="DS.d516.s0.e2" e2="DS.d516.s0.e0" id="DS.d516.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d517" origId="18624726">
        <sentence id="DS.d517.s0" origId="18624726-1067" text="The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of stearic acid on MCP-1 secretion are mediated via TLR-4.">
            <entity id="DS.d517.s0.e0" origId="5281" charOffset="119-131" type="compound" text="stearic acid"/>
            <entity id="DS.d517.s0.e1" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="135-140" type="protein" text="MCP-1"/>
            <entity id="DS.d517.s0.e2" origId="P23799" charOffset="168-171" type="protein" text="TLR"/>
            <pair e1="DS.d517.s0.e0" e2="DS.d517.s0.e1" id="DS.d517.s0.i0" interaction="True"/>
            <pair e1="DS.d517.s0.e0" e2="DS.d517.s0.e2" id="DS.d517.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d518" origId="18624760">
        <sentence id="DS.d518.s0" origId="18624760-178" text="Acitretin increased the levels of CD95 (Fas), CD95-ligand and Fas-associated death domain.">
            <entity id="DS.d518.s0.e0" origId="5284513" charOffset="0-9" type="compound" text="Acitretin"/>
            <entity id="DS.d518.s0.e1" origId="P25446,Q63199" charOffset="40-43" type="protein" text="Fas"/>
            <entity id="DS.d518.s0.e2" origId="P25446,Q63199" charOffset="62-65" type="protein" text="Fas"/>
            <pair e1="DS.d518.s0.e0" e2="DS.d518.s0.e1" id="DS.d518.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d519" origId="18624766">
        <sentence id="DS.d519.s0" origId="18624766-181" text="Since lithium and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).">
            <entity id="DS.d519.s0.e0" origId="28486,3028194" charOffset="6-13" type="compound" text="lithium"/>
            <entity id="DS.d519.s0.e1" origId="4210951" charOffset="18-27" type="compound" text="SB-415286"/>
            <entity id="DS.d519.s0.e2" origId="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268" charOffset="136-142" type="protein" text="cyclin"/>
            <entity id="DS.d519.s0.e3" origId="P04551,P11440,P23572,P39951" charOffset="146-150" type="protein" text="cdc2"/>
            <entity id="DS.d519.s0.e4" origId="P04551,P11440,P23572,P39951" charOffset="202-206" type="protein" text="cdc2"/>
            <pair e1="DS.d519.s0.e1" e2="DS.d519.s0.e2" id="DS.d519.s0.i0" interaction="False"/>
            <pair e1="DS.d519.s0.e0" e2="DS.d519.s0.e3" id="DS.d519.s0.i1" interaction="False"/>
            <pair e1="DS.d519.s0.e1" e2="DS.d519.s0.e3" id="DS.d519.s0.i2" interaction="False"/>
            <pair e1="DS.d519.s0.e0" e2="DS.d519.s0.e2" id="DS.d519.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d519.s1" origId="18624766-182" text="On the other hand, SB-415286 increased the expression of SIRT2, involved in the regulation of proliferation.">
            <entity id="DS.d519.s1.e0" origId="4210951" charOffset="19-28" type="compound" text="SB-415286"/>
            <entity id="DS.d519.s1.e1" origId="Q4R834,Q5RBF1,Q8IXJ6" charOffset="57-62" type="protein" text="SIRT2"/>
            <pair e1="DS.d519.s1.e0" e2="DS.d519.s1.e1" id="DS.d519.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d519.s2" origId="18624766-184" text="We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of cdc2 and, in the case of SB-415286, SIRT2 expression, which induced apoptosis in a caspase-independent manner.">
            <entity id="DS.d519.s2.e0" origId="P04551,P11440,P23572,P39951" charOffset="99-103" type="protein" text="cdc2"/>
            <entity id="DS.d519.s2.e1" origId="4210951" charOffset="124-133" type="compound" text="SB-415286"/>
            <entity id="DS.d519.s2.e2" origId="Q4R834,Q5RBF1,Q8IXJ6" charOffset="135-140" type="protein" text="SIRT2"/>
            <pair e1="DS.d519.s2.e1" e2="DS.d519.s2.e2" id="DS.d519.s2.i0" interaction="True"/>
            <pair e1="DS.d519.s2.e1" e2="DS.d519.s2.e0" id="DS.d519.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d520" origId="18624772">
        <sentence id="DS.d520.s1" origId="18624772-192" text="Reduction of intracellular Ca(2+) levels abolished eNOS reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).">
            <entity id="DS.d520.s1.e0" origId="271" charOffset="27-31" type="compound" text="Ca(2"/>
            <entity id="DS.d520.s1.e1" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="51-55" type="protein" text="eNOS"/>
            <entity id="DS.d520.s1.e2" origId="104751" charOffset="165-170" type="compound" text="BAPTA"/>
            <entity id="DS.d520.s1.e3" origId="2214" charOffset="210-218" type="compound" text="apocynin"/>
            <pair e1="DS.d520.s1.e0" e2="DS.d520.s1.e1" id="DS.d520.s1.i0" interaction="True"/>
            <pair e1="DS.d520.s1.e2" e2="DS.d520.s1.e1" id="DS.d520.s1.i1" interaction="True"/>
            <pair e1="DS.d520.s1.e3" e2="DS.d520.s1.e1" id="DS.d520.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d521" origId="18624794">
        <sentence id="DS.d521.s0" origId="18624794-206" text="In addition to transporting glutamate, EAAC1 plays other roles in regulating GABA synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.">
            <entity id="DS.d521.s0.e0" origId="611,23327,33032" charOffset="28-37" type="compound" text="glutamate"/>
            <entity id="DS.d521.s0.e1" origId="P31597,P43005,Q95135" charOffset="39-44" type="protein" text="EAAC1"/>
            <entity id="DS.d521.s0.e2" origId="119" charOffset="77-81" type="compound" text="GABA"/>
            <pair e1="DS.d521.s0.e0" e2="DS.d521.s0.e1" id="DS.d521.s0.i0" interaction="True"/>
            <pair e1="DS.d521.s0.e2" e2="DS.d521.s0.e1" id="DS.d521.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d522" origId="18625283">
        <sentence id="DS.d522.s0" origId="18625283-633" text="Whereas both peptides lactoferricin (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of lactoferrin chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic gentamicin.">
            <entity id="DS.d522.s0.e0" origId="44567785" charOffset="22-35" type="compound" text="lactoferricin"/>
            <entity id="DS.d522.s0.e1" origId="O77698,O77811,P02788,P08071,P14632,P24627,Q29477,Q9TUM0" charOffset="122-133" type="protein" text="lactoferrin"/>
            <entity id="DS.d522.s0.e2" origId="3467" charOffset="252-262" type="compound" text="gentamicin"/>
            <pair e1="DS.d522.s0.e0" e2="DS.d522.s0.e1" id="DS.d522.s0.i0" interaction="False"/>
            <pair e1="DS.d522.s0.e2" e2="DS.d522.s0.e1" id="DS.d522.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d523" origId="18625298">
        <sentence id="DS.d523.s0" origId="18625298-638" text="We have recently shown that the antidepressant fluoxetine enhances T cell proliferation and T(H)1 cytokine production in vivo, without changes on CD4/CD8 subsets.">
            <entity id="DS.d523.s0.e0" origId="3386" charOffset="47-57" type="compound" text="fluoxetine"/>
            <entity id="DS.d523.s0.e1" origId="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78" charOffset="146-149" type="protein" text="CD4"/>
            <pair e1="DS.d523.s0.e0" e2="DS.d523.s0.e1" id="DS.d523.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d523.s1" origId="18625298-639" text="We found that fluoxetine restored T cell proliferation and interleukin-2, interferon-gamma and tumor necrosis factor-alpha production by compensatory mechanisms.">
            <entity id="DS.d523.s1.e0" origId="3386" charOffset="14-24" type="compound" text="fluoxetine"/>
            <entity id="DS.d523.s1.e1" origId="Q9TTB0" charOffset="74-90" type="protein" text="interferon-gamma"/>
            <entity id="DS.d523.s1.e2" origId="Q8JFG3" charOffset="95-116" type="protein" text="tumor necrosis factor"/>
            <pair e1="DS.d523.s1.e0" e2="DS.d523.s1.e1" id="DS.d523.s1.i0" interaction="True"/>
            <pair e1="DS.d523.s1.e0" e2="DS.d523.s1.e2" id="DS.d523.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d524" origId="18625569">
        <sentence id="DS.d524.s0" origId="18625569-874" text="Here we report a case of intragenic EGFR microdeletion in renal cell carcinoma (RCC) associated with the effect of treatment by gefitinib.">
            <entity id="DS.d524.s0.e0" origId="P00533,P13387,P55245" charOffset="36-40" type="protein" text="EGFR"/>
            <entity id="DS.d524.s0.e1" origId="123631" charOffset="128-137" type="compound" text="gefitinib"/>
            <pair e1="DS.d524.s0.e1" e2="DS.d524.s0.e0" id="DS.d524.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d525" origId="18626508">
        <sentence id="DS.d525.s0" origId="18626508-1659" text="Taking advantage of this prostate cancer-specific property of PSMA (E/P), we successfully introduced bacterial UPRT into LNCaP cells where the tumoricidal effect of 5-fluorouracil (5-FU) was significantly increased when compared with the cells without the exogenous UPRT.">
            <entity id="DS.d525.s0.e0" origId="Q26998" charOffset="111-115" type="protein" text="UPRT"/>
            <entity id="DS.d525.s0.e1" origId="3385" charOffset="165-179" type="compound" text="5-fluorouracil"/>
            <entity id="DS.d525.s0.e2" origId="3385" charOffset="181-185" type="compound" text="5-FU"/>
            <entity id="DS.d525.s0.e3" origId="Q26998" charOffset="266-270" type="protein" text="UPRT"/>
            <pair e1="DS.d525.s0.e2" e2="DS.d525.s0.e0" id="DS.d525.s0.i0" interaction="True"/>
            <pair e1="DS.d525.s0.e1" e2="DS.d525.s0.e0" id="DS.d525.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d526" origId="18626658">
        <sentence id="DS.d526.s0" origId="18626658-281" text="UCP2 is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate glucose-induced changes in ATP/ADP ratio and insulin secretion.">
            <entity id="DS.d526.s0.e0" origId="O97562,P55851,Q9N2J1,Q9W725" charOffset="0-4" type="protein" text="UCP2"/>
            <entity id="DS.d526.s0.e1" origId="206,5793,64689,79025" charOffset="98-105" type="compound" text="glucose"/>
            <entity id="DS.d526.s0.e2" origId="5957" charOffset="125-128" type="compound" text="ATP"/>
            <entity id="DS.d526.s0.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="143-150" type="protein" text="insulin"/>
            <pair e1="DS.d526.s0.e1" e2="DS.d526.s0.e0" id="DS.d526.s0.i0" interaction="True"/>
            <pair e1="DS.d526.s0.e1" e2="DS.d526.s0.e3" id="DS.d526.s0.i1" interaction="True"/>
            <pair e1="DS.d526.s0.e2" e2="DS.d526.s0.e0" id="DS.d526.s0.i2" interaction="True"/>
            <pair e1="DS.d526.s0.e2" e2="DS.d526.s0.e3" id="DS.d526.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d526.s2" origId="18626658-283" text="Neither UCP1 expression nor UCP2 overexpression modified basal or glucose-stimulated metabolic changes.">
            <entity id="DS.d526.s2.e0" origId="P04575,P10861,P14271,P25874,Q18P97,Q8K404,Q9ER18,Q9GMZ1" charOffset="8-12" type="protein" text="UCP1"/>
            <entity id="DS.d526.s2.e1" origId="O97562,P55851,Q9N2J1,Q9W725" charOffset="28-32" type="protein" text="UCP2"/>
            <entity id="DS.d526.s2.e2" origId="206,5793,64689,79025" charOffset="66-73" type="compound" text="glucose"/>
            <pair e1="DS.d526.s2.e2" e2="DS.d526.s2.e0" id="DS.d526.s2.i0" interaction="False"/>
            <pair e1="DS.d526.s2.e2" e2="DS.d526.s2.e1" id="DS.d526.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d527" origId="18626709">
        <sentence id="DS.d527.s0" origId="18626709-112" text="The chitinase activity was increased by Mn(2+), Cu(2+), and Mg(2+), while strongly inhibited by Fe(2+) and Ba(2+).">
            <entity id="DS.d527.s0.e0" origId="P13656,P14529,P23472,P23473,P81241,P84754" charOffset="4-13" type="protein" text="chitinase"/>
            <entity id="DS.d527.s0.e1" origId="27854" charOffset="40-44" type="compound" text="Mn(2"/>
            <entity id="DS.d527.s0.e2" origId="27099" charOffset="48-52" type="compound" text="Cu(2"/>
            <entity id="DS.d527.s0.e3" origId="27284" charOffset="96-100" type="compound" text="Fe(2"/>
            <entity id="DS.d527.s0.e4" origId="104810" charOffset="107-111" type="compound" text="Ba(2"/>
            <pair e1="DS.d527.s0.e2" e2="DS.d527.s0.e0" id="DS.d527.s0.i0" interaction="True"/>
            <pair e1="DS.d527.s0.e1" e2="DS.d527.s0.e0" id="DS.d527.s0.i1" interaction="True"/>
            <pair e1="DS.d527.s0.e4" e2="DS.d527.s0.e0" id="DS.d527.s0.i2" interaction="True"/>
            <pair e1="DS.d527.s0.e3" e2="DS.d527.s0.e0" id="DS.d527.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d527.s1" origId="18626709-113" text="Meanwhile, SDS, ethyleneglycoltetraacetic acid, urea, and ethylenediaminetetraacetic acid were found to have significantly inhibitory effect on chitinase activity.">
            <entity id="DS.d527.s1.e0" origId="1176,265993" charOffset="48-52" type="compound" text="urea"/>
            <entity id="DS.d527.s1.e1" origId="6049" charOffset="58-89" type="compound" text="ethylenediaminetetraacetic acid"/>
            <entity id="DS.d527.s1.e2" origId="P13656,P14529,P23472,P23473,P81241,P84754" charOffset="144-153" type="protein" text="chitinase"/>
            <pair e1="DS.d527.s1.e1" e2="DS.d527.s1.e2" id="DS.d527.s1.i0" interaction="True"/>
            <pair e1="DS.d527.s1.e0" e2="DS.d527.s1.e2" id="DS.d527.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d528" origId="18626726">
        <sentence id="DS.d528.s0" origId="18626726-122" text="In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-nitric oxide synthase (iNOS) expression induced by lipopolysaccharide (LPS) in mouse macrophages RAW 264.7.">
            <entity id="DS.d528.s0.e0" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="117-138" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d528.s0.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="140-144" type="protein" text="iNOS"/>
            <entity id="DS.d528.s0.e2" origId="11970143" charOffset="168-186" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d528.s0.e2" e2="DS.d528.s0.e1" id="DS.d528.s0.i0" interaction="True"/>
            <pair e1="DS.d528.s0.e2" e2="DS.d528.s0.e0" id="DS.d528.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d529" origId="18626791">
        <sentence id="DS.d529.s0" origId="18626791-1140" text="Following thermal denaturation, rabbit reticulocyte lysate and ATP were added and luciferase activity measured.">
            <entity id="DS.d529.s0.e0" origId="5957" charOffset="63-66" type="compound" text="ATP"/>
            <entity id="DS.d529.s0.e1" origId="P08659,P13129,Q01158,Q26304,Q27757" charOffset="82-92" type="protein" text="luciferase"/>
            <pair e1="DS.d529.s0.e0" e2="DS.d529.s0.e1" id="DS.d529.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d530" origId="18626794">
        <sentence id="DS.d530.s0" origId="18626794-227" text="These results are in contrast to postmortem findings in schizophrenia and suggest that reduced synaptophysin protein levels in schizophrenia patients' postmortem brain do not result from perinatal oxygen deprivation.">
            <entity id="DS.d530.s0.e0" origId="P07825,P08247,P20488,Q5YJC1,Q62277" charOffset="95-108" type="protein" text="synaptophysin"/>
            <entity id="DS.d530.s0.e1" origId="977" charOffset="197-203" type="compound" text="oxygen"/>
            <pair e1="DS.d530.s0.e1" e2="DS.d530.s0.e0" id="DS.d530.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d531" origId="18627006">
        <sentence id="DS.d531.s0" origId="18627006-344" text="We found that the acetylated histone H3 at lysine 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.">
            <entity id="DS.d531.s0.e0" origId="P02299,P07041,P08437,P08898,P22843,P23753,P40285,P50564,P61830,P61831,P61832,P61833,P61834,P61835,P61836,P80553,P83864,P84235,P84236,P84237,P84238,P84239,P90543,Q06196,Q2UCQ0,Q5DWI3,Q757N1,Q7XYZ0,Q98RY4,Q9HDN1,Q9P427,Q9U7D1" charOffset="29-39" type="protein" text="histone H3"/>
            <entity id="DS.d531.s0.e1" origId="866,5962" charOffset="43-49" type="compound" text="lysine"/>
            <entity id="DS.d531.s0.e2" origId="866,5962" charOffset="56-62" type="compound" text="lysine"/>
            <entity id="DS.d531.s0.e3" origId="P02686,P02687,P04370,P06906,P15720,P20939,P25188,P25274,P81558,P83487,P87346,P98190,Q91325,Q91439" charOffset="102-122" type="protein" text="myelin basic protein"/>
            <entity id="DS.d531.s0.e4" origId="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1" charOffset="124-127" type="protein" text="MBP"/>
            <entity id="DS.d531.s0.e5" origId="P04116,P13085,P22858,P23289,P23294,P30044,P47789,P47790,P60201,P60202,P60203,P79826,P80145,P99029,Q8HXW7,Q96GD0,Q9R063" charOffset="154-157" type="protein" text="PLP"/>
            <entity id="DS.d531.s0.e6" origId="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1" charOffset="268-271" type="protein" text="MBP"/>
            <entity id="DS.d531.s0.e7" origId="P04116,P13085,P22858,P23289,P23294,P30044,P47789,P47790,P60201,P60202,P60203,P79826,P80145,P99029,Q8HXW7,Q96GD0,Q9R063" charOffset="273-276" type="protein" text="PLP"/>
            <entity id="DS.d531.s0.e8" origId="O22446" charOffset="282-301" type="protein" text="histone deacetylase"/>
            <pair e1="DS.d531.s0.e1" e2="DS.d531.s0.e0" id="DS.d531.s0.i0" interaction="True"/>
            <pair e1="DS.d531.s0.e1" e2="DS.d531.s0.e4" id="DS.d531.s0.i1" interaction="True"/>
            <pair e1="DS.d531.s0.e1" e2="DS.d531.s0.e8" id="DS.d531.s0.i2" interaction="False"/>
            <pair e1="DS.d531.s0.e1" e2="DS.d531.s0.e3" id="DS.d531.s0.i3" interaction="True"/>
            <pair e1="DS.d531.s0.e1" e2="DS.d531.s0.e5" id="DS.d531.s0.i4" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d532" origId="18627414">
        <sentence id="DS.d532.s0" origId="18627414-696" text="Although the current studies associating particular genes and their variants with seizure control or adverse events have inherent weaknesses and have not provided unifying conclusions, several results, for example that Asian patients with a particular HLA allele, HLA-B *1502, are at a higher risk for Stevens-Johnson syndrome when using carbamazepine, are helpful to increase our knowledge how genetic variation affects the treatment of epilepsy.">
            <entity id="DS.d532.s0.e0" origId="P01889,P03989,P10319,P18463,P18464,P18465,P30460,P30461,P30462,P30464,P30466,P30475,P30479,P30480,P30481,P30483,P30484,P30485,P30486,P30487,P30488,P30490,P30491,P30492,P30493,P30495,P30498,P30685,Q04826,Q29718,Q29836,Q29940,Q31610,Q31612,Q95365" charOffset="264-269" type="protein" text="HLA-B"/>
            <entity id="DS.d532.s0.e1" origId="2554" charOffset="338-351" type="compound" text="carbamazepine"/>
            <pair e1="DS.d532.s0.e1" e2="DS.d532.s0.e0" id="DS.d532.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d533" origId="18627421">
        <sentence id="DS.d533.s0" origId="18627421-707" text="However, OPN-(/-) mice showed increased serum levels of tumour necrosis factor (TNF)-alpha, which could be due to systemically present lipopolysaccharide translocated to the gut.">
            <entity id="DS.d533.s0.e0" origId="P10451,P14287,P31096,Q9XSY9" charOffset="9-12" type="protein" text="OPN"/>
            <entity id="DS.d533.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="80-83" type="protein" text="TNF"/>
            <entity id="DS.d533.s0.e2" origId="11970143" charOffset="135-153" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d533.s0.e2" e2="DS.d533.s0.e1" id="DS.d533.s0.i0" interaction="True"/>
            <pair e1="DS.d533.s0.e2" e2="DS.d533.s0.e0" id="DS.d533.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d534" origId="18627475">
        <sentence id="DS.d534.s0" origId="18627475-762" text="The expression of the ERG1, ERG3, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with fluconazole and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.">
            <entity id="DS.d534.s0.e0" origId="O08703,O08962,O13306,O35219,P32476,Q12809,Q14534,Q75F69,Q7GC09,Q86QT3,Q86QU1,Q86QU6,Q86QV0,Q86QV3,Q86QV6,Q8WNY2,Q92206,Q9PT84,Q9TSZ3,Q9TUI4" charOffset="22-26" type="protein" text="ERG1"/>
            <entity id="DS.d534.s0.e1" origId="O13597,O93875,P32353,P50860,P78575,Q754B9,Q7F9X0,Q86QT9,Q86QU4,Q86QU8,Q86QV1,Q86QV4,Q86QV9,Q8J207,Q8NJ57,Q9NS40" charOffset="28-32" type="protein" text="ERG3"/>
            <entity id="DS.d534.s0.e2" origId="P38604,Q04782,Q96WJ0" charOffset="34-38" type="protein" text="ERG7"/>
            <entity id="DS.d534.s0.e3" origId="O74165,P29704,P78589,Q752X9,Q92459,Q9HGZ6" charOffset="40-44" type="protein" text="ERG9"/>
            <entity id="DS.d534.s0.e4" origId="P10613,P10614,P14263,P49602,P50859,Q759W0" charOffset="46-51" type="protein" text="ERG11"/>
            <entity id="DS.d534.s0.e5" origId="O59933,P53045,Q15800" charOffset="56-61" type="protein" text="ERG25"/>
            <entity id="DS.d534.s0.e6" origId="3365" charOffset="99-110" type="compound" text="fluconazole"/>
            <pair e1="DS.d534.s0.e6" e2="DS.d534.s0.e3" id="DS.d534.s0.i0" interaction="True"/>
            <pair e1="DS.d534.s0.e6" e2="DS.d534.s0.e4" id="DS.d534.s0.i1" interaction="True"/>
            <pair e1="DS.d534.s0.e6" e2="DS.d534.s0.e5" id="DS.d534.s0.i2" interaction="True"/>
            <pair e1="DS.d534.s0.e6" e2="DS.d534.s0.e1" id="DS.d534.s0.i3" interaction="True"/>
            <pair e1="DS.d534.s0.e6" e2="DS.d534.s0.e0" id="DS.d534.s0.i4" interaction="True"/>
            <pair e1="DS.d534.s0.e6" e2="DS.d534.s0.e2" id="DS.d534.s0.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d534.s1" origId="18627475-763" text="Expression of the ERG11 gene was found to be low or moderate and it was regulated by fluconazole addition more so than by biofilm formation.">
            <entity id="DS.d534.s1.e0" origId="P10613,P10614,P14263,P49602,P50859,Q759W0" charOffset="18-23" type="protein" text="ERG11"/>
            <entity id="DS.d534.s1.e1" origId="3365" charOffset="85-96" type="compound" text="fluconazole"/>
            <pair e1="DS.d534.s1.e1" e2="DS.d534.s1.e0" id="DS.d534.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d534.s2" origId="18627475-764" text="The expression of the ERG9 increased in the presence of fluconazole in some isolates.">
            <entity id="DS.d534.s2.e0" origId="O74165,P29704,P78589,Q752X9,Q92459,Q9HGZ6" charOffset="22-26" type="protein" text="ERG9"/>
            <entity id="DS.d534.s2.e1" origId="3365" charOffset="56-67" type="compound" text="fluconazole"/>
            <pair e1="DS.d534.s2.e1" e2="DS.d534.s2.e0" id="DS.d534.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d535" origId="18629545">
        <sentence id="DS.d535.s0" origId="18629545-780" text="Concentrations of polyethylene glycol 1000 and Na2SO4 were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of pectinase, purification factor and pectinase yield.">
            <entity id="DS.d535.s0.e0" origId="174" charOffset="18-37" type="compound" text="polyethylene glycol"/>
            <entity id="DS.d535.s0.e1" origId="24436" charOffset="47-53" type="compound" text="Na2SO4"/>
            <entity id="DS.d535.s0.e2" origId="O42824,O59925,O93883,P05117,P20041,P24548,P26215,P26216,P27644,P35335,P35336,P35337,P35338,P35339,P41749,P41750,P43212,P47180,P48978,P48979,P49062,P49063,P49575,P58598,Q00446,Q02096,Q05967,Q07181,Q12708,Q39766,Q39786,Q40312,Q7M1E7,Q9FY19,Q9LW07,Q9Y718" charOffset="206-215" type="protein" text="pectinase"/>
            <entity id="DS.d535.s0.e3" origId="O42824,O59925,O93883,P05117,P20041,P24548,P26215,P26216,P27644,P35335,P35336,P35337,P35338,P35339,P41749,P41750,P43212,P47180,P48978,P48979,P49062,P49063,P49575,P58598,Q00446,Q02096,Q05967,Q07181,Q12708,Q39766,Q39786,Q40312,Q7M1E7,Q9FY19,Q9LW07,Q9Y718" charOffset="241-250" type="protein" text="pectinase"/>
            <pair e1="DS.d535.s0.e0" e2="DS.d535.s0.e2" id="DS.d535.s0.i0" interaction="False"/>
            <pair e1="DS.d535.s0.e1" e2="DS.d535.s0.e2" id="DS.d535.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d536" origId="18629605">
        <sentence id="DS.d536.s0" origId="18629605-1551" text="In aged animals, administration of L-carnitine for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase.">
            <entity id="DS.d536.s0.e0" origId="10918" charOffset="35-46" type="compound" text="L-carnitine"/>
            <entity id="DS.d536.s0.e1" origId="O50258" charOffset="169-189" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d536.s0.e2" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="191-199" type="protein" text="catalase"/>
            <entity id="DS.d536.s0.e3" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="201-223" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d536.s0.e4" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="228-249" type="protein" text="glutathione reductase"/>
            <pair e1="DS.d536.s0.e0" e2="DS.d536.s0.e2" id="DS.d536.s0.i0" interaction="True"/>
            <pair e1="DS.d536.s0.e0" e2="DS.d536.s0.e4" id="DS.d536.s0.i1" interaction="True"/>
            <pair e1="DS.d536.s0.e0" e2="DS.d536.s0.e3" id="DS.d536.s0.i2" interaction="True"/>
            <pair e1="DS.d536.s0.e0" e2="DS.d536.s0.e1" id="DS.d536.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d536.s1" origId="18629605-1552" text="L-Carnitine enhanced T-cell proliferative responses as evaluated by T-cell proliferation assay using (3H) thymidine incorporation and also significantly reduced DNA damage, apoptosis and TNF-alpha level in lymphocytes of aged animals.">
            <entity id="DS.d536.s1.e0" origId="10918" charOffset="0-11" type="compound" text="L-Carnitine"/>
            <entity id="DS.d536.s1.e1" origId="5789" charOffset="106-115" type="compound" text="thymidine"/>
            <entity id="DS.d536.s1.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="187-196" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d536.s1.e1" e2="DS.d536.s1.e2" id="DS.d536.s1.i0" interaction="False"/>
            <pair e1="DS.d536.s1.e0" e2="DS.d536.s1.e2" id="DS.d536.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d537" origId="18629630">
        <sentence id="DS.d537.s0" origId="18629630-845" text="In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (SIAH2) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line tamoxifen therapy.">
            <entity id="DS.d537.s0.e0" origId="O43255,Q06986,Q8R4T2,Q9I8X5,Q9M2P4" charOffset="44-71" type="protein" text="Seven-in-Absentia Homolog 2"/>
            <entity id="DS.d537.s0.e1" origId="O43255" charOffset="73-78" type="protein" text="SIAH2"/>
            <entity id="DS.d537.s0.e2" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="99-116" type="protein" text="estrogen receptor"/>
            <entity id="DS.d537.s0.e3" origId="2733526" charOffset="181-190" type="compound" text="tamoxifen"/>
            <pair e1="DS.d537.s0.e3" e2="DS.d537.s0.e2" id="DS.d537.s0.i0" interaction="True"/>
            <pair e1="DS.d537.s0.e3" e2="DS.d537.s0.e0" id="DS.d537.s0.i1" interaction="True"/>
            <pair e1="DS.d537.s0.e3" e2="DS.d537.s0.e1" id="DS.d537.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d538" origId="18629637">
        <sentence id="DS.d538.s0" origId="18629637-851" text="Fluorocitrate, an inhibitor of glial metabolism, inhibits the up-regulation of NOS expression, activity and NO production in the spinal cord induced by formalin test in rats.">
            <entity id="DS.d538.s0.e0" origId="107647" charOffset="0-13" type="compound" text="Fluorocitrate"/>
            <entity id="DS.d538.s0.e1" origId="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2" charOffset="79-82" type="protein" text="NOS"/>
            <pair e1="DS.d538.s0.e0" e2="DS.d538.s0.e1" id="DS.d538.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d538.s1" origId="18629637-852" text="In order to explore the involvement of glia in the NO-mediated nociceptive transmission, the present study was undertaken to investigate the effect of fluorocitrate (FC), an inhibitor of glial metabolism, on NOS expression and activity and NO production in the spinal cord during the process of peripheral inflammatory pain and hyperalgesia induced by formalin test in rats.">
            <entity id="DS.d538.s1.e0" origId="107647" charOffset="151-164" type="compound" text="fluorocitrate"/>
            <entity id="DS.d538.s1.e1" origId="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2" charOffset="208-211" type="protein" text="NOS"/>
            <pair e1="DS.d538.s1.e0" e2="DS.d538.s1.e1" id="DS.d538.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d539" origId="18629640">
        <sentence id="DS.d539.s0" origId="18629640-41" text="Oral administration of morin remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (AST), and total bilirubin levels.">
            <entity id="DS.d539.s0.e0" origId="5281670" charOffset="23-28" type="compound" text="morin"/>
            <entity id="DS.d539.s0.e1" origId="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67" charOffset="182-185" type="protein" text="AST"/>
            <entity id="DS.d539.s0.e2" origId="5280352" charOffset="198-207" type="compound" text="bilirubin"/>
            <pair e1="DS.d539.s0.e0" e2="DS.d539.s0.e1" id="DS.d539.s0.i0" interaction="True"/>
            <pair e1="DS.d539.s0.e2" e2="DS.d539.s0.e1" id="DS.d539.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d540" origId="18631247">
        <sentence id="DS.d540.s0" origId="18631247-468" text="Green tea extract reduces induction of p53 and apoptosis in UVB-irradiated human skin independent of transcriptional controls.">
            <entity id="DS.d540.s0.e0" origId="65064" charOffset="0-17" type="compound" text="Green tea extract"/>
            <entity id="DS.d540.s0.e1" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="39-42" type="protein" text="p53"/>
            <pair e1="DS.d540.s0.e0" e2="DS.d540.s0.e1" id="DS.d540.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d540.s1" origId="18631247-469" text="We found that while OM24 treatment did not significantly affect UV-induced erythema and thymidine dimer formation, OM24 treatment significantly reduced UV-induced p53 expression in keratinocytes.">
            <entity id="DS.d540.s1.e0" origId="5789" charOffset="88-97" type="compound" text="thymidine"/>
            <entity id="DS.d540.s1.e1" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="163-166" type="protein" text="p53"/>
            <pair e1="DS.d540.s1.e0" e2="DS.d540.s1.e1" id="DS.d540.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d542" origId="18632742">
        <sentence id="DS.d542.s0" origId="18632742-27" text="Here we show that NRG-1 selectively increases the power of kainate-induced, but not carbachol-induced, gamma oscillations in acute hippocampal slices.">
            <entity id="DS.d542.s0.e0" origId="Q99988,Q9JKM5" charOffset="18-23" type="protein" text="NRG-1"/>
            <entity id="DS.d542.s0.e1" origId="10255" charOffset="59-66" type="compound" text="kainate"/>
            <entity id="DS.d542.s0.e2" origId="2551" charOffset="84-93" type="compound" text="carbachol"/>
            <pair e1="DS.d542.s0.e1" e2="DS.d542.s0.e0" id="DS.d542.s0.i0" interaction="True"/>
            <pair e1="DS.d542.s0.e2" e2="DS.d542.s0.e0" id="DS.d542.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d542.s1" origId="18632742-28" text="These effects of NRG-1beta are blocked by PD158780, a pan-specific antagonist of ErbB receptors, and are mediated specifically via ErbB4 receptors, because mice harboring a targeted mutation of ErbB4 do not respond to NRG-1.">
            <entity id="DS.d542.s1.e0" origId="4707" charOffset="42-50" type="compound" text="PD158780"/>
            <entity id="DS.d542.s1.e1" origId="Q99988,Q9JKM5" charOffset="17-22" type="protein" text="NRG-1"/>
            <pair e1="DS.d542.s1.e0" e2="DS.d542.s1.e1" id="DS.d542.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d543" origId="18633436">
        <sentence id="DS.d543.s0" origId="18633436-86" text="Of various agents tested in HaCaT cell cultures, only retinoic acid (10(-6) M) and staurosporine (2.5 x 10(-8) M) upregulated MMP-21 mRNA and protein expression, whereas tumor promoters, hormones, or dexamethasone were without effect.">
            <entity id="DS.d543.s0.e0" origId="444795" charOffset="54-67" type="compound" text="retinoic acid"/>
            <entity id="DS.d543.s0.e1" origId="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148" charOffset="83-96" type="compound" text="staurosporine"/>
            <entity id="DS.d543.s0.e2" origId="O75900,O93470,Q8K3F2,Q8N119,Q90YC2,Q9R0S2" charOffset="126-132" type="protein" text="MMP-21"/>
            <entity id="DS.d543.s0.e3" origId="5743" charOffset="200-213" type="compound" text="dexamethasone"/>
            <pair e1="DS.d543.s0.e0" e2="DS.d543.s0.e2" id="DS.d543.s0.i0" interaction="True"/>
            <pair e1="DS.d543.s0.e1" e2="DS.d543.s0.e2" id="DS.d543.s0.i1" interaction="True"/>
            <pair e1="DS.d543.s0.e3" e2="DS.d543.s0.e2" id="DS.d543.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d544" origId="18633446">
        <sentence id="DS.d544.s0" origId="18633446-279" text="We have generated two novel chimeric VEGF-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of Flt-1 fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a polyglycine linker 9Gly.">
            <entity id="DS.d544.s0.e0" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="37-41" type="protein" text="VEGF"/>
            <entity id="DS.d544.s0.e1" origId="P17948,P53767" charOffset="144-149" type="protein" text="Flt-1"/>
            <entity id="DS.d544.s0.e3" origId="750" charOffset="231-242" type="compound" text="polyglycine"/>
            <pair e1="DS.d544.s0.e3" e2="DS.d544.s0.e0" id="DS.d544.s0.i1" interaction="False"/>
            <pair e1="DS.d544.s0.e3" e2="DS.d544.s0.e1" id="DS.d544.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d545" origId="18633600">
        <sentence id="DS.d545.s0" origId="18633600-1063" text="By contrast, treatment of N2a cells with 1-10 microM DZO resulted in marked reductions in the expression of the axon growth-associated protein GAP-43.">
            <entity id="DS.d545.s0.e0" origId="6419789" charOffset="53-56" type="compound" text="DZO"/>
            <entity id="DS.d545.s0.e1" origId="P09851,P20936,P50904,P74851,P74873,Q5PEA9,Q92211,Q92263" charOffset="143-146" type="protein" text="GAP"/>
            <pair e1="DS.d545.s0.e0" e2="DS.d545.s0.e1" id="DS.d545.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d545.s1" origId="18633600-1064" text="DZO-treated cells also showed an increased expression of the heat shock protein HSP-70 compared to controls.">
            <entity id="DS.d545.s1.e0" origId="6419789" charOffset="0-3" type="compound" text="DZO"/>
            <entity id="DS.d545.s1.e1" origId="P27894" charOffset="80-86" type="protein" text="HSP-70"/>
            <pair e1="DS.d545.s1.e0" e2="DS.d545.s1.e1" id="DS.d545.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d547" origId="18633701">
        <sentence id="DS.d547.s0" origId="18633701-1577" text="We showed that in comparison to stage VI, stages I-V oocytes expressed higher levels of O-GlcNAc correlating changes in OGT expression, but not in UDP-GlcNAc pools.">
            <entity id="DS.d547.s0.e0" origId="O18158" charOffset="88-96" type="protein" text="O-GlcNAc"/>
            <entity id="DS.d547.s0.e1" origId="O15294,O18158,P81436" charOffset="120-123" type="protein" text="OGT"/>
            <entity id="DS.d547.s0.e2" origId="445675,643981,9547196" charOffset="147-157" type="compound" text="UDP-GlcNAc"/>
            <pair e1="DS.d547.s0.e2" e2="DS.d547.s0.e1" id="DS.d547.s0.i0" interaction="False"/>
            <pair e1="DS.d547.s0.e2" e2="DS.d547.s0.e0" id="DS.d547.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d547.s1" origId="18633701-1578" text="Upon progesterone stimulation, an O-GlcNAc level burst occurred during meiotic resumption long before MPF and Mos-Erk2 pathways activations.">
            <entity id="DS.d547.s1.e0" origId="5994" charOffset="5-17" type="compound" text="progesterone"/>
            <entity id="DS.d547.s1.e1" origId="O18158" charOffset="34-42" type="protein" text="O-GlcNAc"/>
            <entity id="DS.d547.s1.e2" origId="Q13421,Q61468,Q9ERA7" charOffset="102-105" type="protein" text="MPF"/>
            <entity id="DS.d547.s1.e3" origId="P00536,P00539,P12965" charOffset="110-113" type="protein" text="Mos"/>
            <entity id="DS.d547.s1.e4" origId="P63085,P63086" charOffset="114-118" type="protein" text="Erk2"/>
            <pair e1="DS.d547.s1.e0" e2="DS.d547.s1.e2" id="DS.d547.s1.i0" interaction="True"/>
            <pair e1="DS.d547.s1.e0" e2="DS.d547.s1.e3" id="DS.d547.s1.i1" interaction="True"/>
            <pair e1="DS.d547.s1.e0" e2="DS.d547.s1.e4" id="DS.d547.s1.i2" interaction="True"/>
            <pair e1="DS.d547.s1.e0" e2="DS.d547.s1.e1" id="DS.d547.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d548" origId="18633707">
        <sentence id="DS.d548.s0" origId="18633707-828" text="Mean plasma levels of folic acid, homocysteine, and vitamin B12 did not change, but there was a significant decrease of CRP at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.">
            <entity id="DS.d548.s0.e0" origId="6037" charOffset="22-32" type="compound" text="folic acid"/>
            <entity id="DS.d548.s0.e1" origId="778" charOffset="34-46" type="compound" text="homocysteine"/>
            <entity id="DS.d548.s0.e2" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="120-123" type="protein" text="CRP"/>
            <pair e1="DS.d548.s0.e1" e2="DS.d548.s0.e2" id="DS.d548.s0.i0" interaction="False"/>
            <pair e1="DS.d548.s0.e0" e2="DS.d548.s0.e2" id="DS.d548.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d549" origId="18634065">
        <sentence id="DS.d549.s0" origId="18634065-1113" text="Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), insulin-like growth factor-I (IGF-I), C3 Transferase, Y27632, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).">
            <entity id="DS.d549.s0.e0" origId="O46612,O46613,P01582,P01583,P04822,P08831,P16598,P18430,P46647,P48089,P79161,P79340,Q28385,Q28579,Q3HWU1,Q60480,Q865X7" charOffset="70-79" type="protein" text="IL-1alpha"/>
            <entity id="DS.d549.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="82-89" type="protein" text="insulin"/>
            <entity id="DS.d549.s0.e2" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="112-117" type="protein" text="IGF-I"/>
            <entity id="DS.d549.s0.e3" origId="448042" charOffset="136-142" type="compound" text="Y27632"/>
            <pair e1="DS.d549.s0.e3" e2="DS.d549.s0.e0" id="DS.d549.s0.i0" interaction="False"/>
            <pair e1="DS.d549.s0.e3" e2="DS.d549.s0.e1" id="DS.d549.s0.i1" interaction="False"/>
            <pair e1="DS.d549.s0.e3" e2="DS.d549.s0.e2" id="DS.d549.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d549.s1" origId="18634065-1115" text="Affinity assays were performed to measure endogenous GTP-bound Rho, and confocal microscopy was used to assess changes in organization of the actin cytoskeleton.">
            <entity id="DS.d549.s1.e0" origId="6830" charOffset="53-56" type="compound" text="GTP"/>
            <entity id="DS.d549.s1.e1" origId="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9" charOffset="63-66" type="protein" text="Rho"/>
            <entity id="DS.d549.s1.e2" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="142-147" type="protein" text="actin"/>
            <pair e1="DS.d549.s1.e0" e2="DS.d549.s1.e1" id="DS.d549.s1.i0" interaction="True"/>
            <pair e1="DS.d549.s1.e0" e2="DS.d549.s1.e2" id="DS.d549.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d549.s2" origId="18634065-1116" text="IL-1alpha and RhoG14V increased cytoplasmic actin stress fiber formation, which was blocked by C3 Transferase, and Y27632.">
            <entity id="DS.d549.s2.e0" origId="O46612,O46613,P01582,P01583,P04822,P08831,P16598,P18430,P46647,P48089,P79161,P79340,Q28385,Q28579,Q3HWU1,Q60480,Q865X7" charOffset="0-9" type="protein" text="IL-1alpha"/>
            <entity id="DS.d549.s2.e1" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="44-49" type="protein" text="actin"/>
            <entity id="DS.d549.s2.e2" origId="448042" charOffset="115-121" type="compound" text="Y27632"/>
            <pair e1="DS.d549.s2.e2" e2="DS.d549.s2.e1" id="DS.d549.s2.i0" interaction="True"/>
            <pair e1="DS.d549.s2.e2" e2="DS.d549.s2.e0" id="DS.d549.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d549.s3" origId="18634065-1118" text="Expression of RhoQ63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with Y27632 was unable to inhibit IL-1alpha-induced MMP-13 expression.">
            <entity id="DS.d549.s3.e0" origId="O18927,O62806,O77656,P23097,P33435,P45452,Q10835" charOffset="55-61" type="protein" text="MMP-13"/>
            <entity id="DS.d549.s3.e1" origId="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9" charOffset="14-17" type="protein" text="Rho"/>
            <entity id="DS.d549.s3.e2" origId="448042" charOffset="106-112" type="compound" text="Y27632"/>
            <entity id="DS.d549.s3.e3" origId="O46612,O46613,P01582,P01583,P04822,P08831,P16598,P18430,P46647,P48089,P79161,P79340,Q28385,Q28579,Q3HWU1,Q60480,Q865X7" charOffset="135-144" type="protein" text="IL-1alpha"/>
            <entity id="DS.d549.s3.e4" origId="O18927,O62806,O77656,P23097,P33435,P45452,Q10835" charOffset="153-159" type="protein" text="MMP-13"/>
            <pair e1="DS.d549.s3.e2" e2="DS.d549.s3.e3" id="DS.d549.s3.i0" interaction="False"/>
            <pair e1="DS.d549.s3.e2" e2="DS.d549.s3.e1" id="DS.d549.s3.i1" interaction="True"/>
            <pair e1="DS.d549.s3.e2" e2="DS.d549.s3.e0" id="DS.d549.s3.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d550" origId="18634706">
        <sentence id="DS.d550.s0" origId="18634706-392" text="Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.">
            <entity id="DS.d550.s0.e0" origId="304,5997,6432564,11025495" charOffset="13-24" type="compound" text="cholesterol"/>
            <entity id="DS.d550.s0.e1" origId="P44321" charOffset="26-29" type="protein" text="TAG"/>
            <entity id="DS.d550.s0.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="73-77" type="protein" text="IL-6"/>
            <entity id="DS.d550.s0.e3" origId="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0" charOffset="79-84" type="protein" text="IL-18"/>
            <entity id="DS.d550.s0.e4" origId="977" charOffset="135-141" type="compound" text="oxygen"/>
            <entity id="DS.d550.s0.e5" origId="24247" charOffset="176-191" type="compound" text="perchloric acid"/>
            <pair e1="DS.d550.s0.e0" e2="DS.d550.s0.e2" id="DS.d550.s0.i0" interaction="False"/>
            <pair e1="DS.d550.s0.e0" e2="DS.d550.s0.e3" id="DS.d550.s0.i1" interaction="False"/>
            <pair e1="DS.d550.s0.e5" e2="DS.d550.s0.e1" id="DS.d550.s0.i2" interaction="False"/>
            <pair e1="DS.d550.s0.e4" e2="DS.d550.s0.e3" id="DS.d550.s0.i3" interaction="False"/>
            <pair e1="DS.d550.s0.e5" e2="DS.d550.s0.e3" id="DS.d550.s0.i4" interaction="False"/>
            <pair e1="DS.d550.s0.e0" e2="DS.d550.s0.e1" id="DS.d550.s0.i5" interaction="False"/>
            <pair e1="DS.d550.s0.e5" e2="DS.d550.s0.e2" id="DS.d550.s0.i6" interaction="False"/>
            <pair e1="DS.d550.s0.e4" e2="DS.d550.s0.e2" id="DS.d550.s0.i7" interaction="False"/>
            <pair e1="DS.d550.s0.e4" e2="DS.d550.s0.e1" id="DS.d550.s0.i8" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d551" origId="18634843">
        <sentence id="DS.d551.s0" origId="18634843-1147" text="The increase of mature IL-18 by macrophages was inhibited by caspase-1 inhibitor : caspase-1 is known to cleave the proform of IL-18 to produce active mature IL-18.">
            <entity id="DS.d551.s0.e0" origId="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0" charOffset="23-28" type="protein" text="IL-18"/>
            <entity id="DS.d551.s0.e1" origId="44134608" charOffset="61-80" type="compound" text="caspase-1 inhibitor"/>
            <entity id="DS.d551.s0.e2" origId="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0" charOffset="127-132" type="protein" text="IL-18"/>
            <entity id="DS.d551.s0.e3" origId="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0" charOffset="127-132" type="protein" text="IL-18"/>
            <pair e1="DS.d551.s0.e1" e2="DS.d551.s0.e0" id="DS.d551.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d552" origId="18635261">
        <sentence id="DS.d552.s0" origId="18635261-398" text="In absence of stretch, we could activate Gns and deactivate GK1 by 1-oleoyl-2-acetyl-sn-glycerol (OAG) and other amphipaths.">
            <entity id="DS.d552.s0.e0" origId="P64267,P64268" charOffset="41-44" type="protein" text="Gns"/>
            <entity id="DS.d552.s0.e1" origId="Q9GTW9" charOffset="60-63" type="protein" text="GK1"/>
            <entity id="DS.d552.s0.e2" origId="1394,5353264,6437055" charOffset="67-96" type="compound" text="1-oleoyl-2-acetyl-sn-glycerol"/>
            <entity id="DS.d552.s0.e3" origId="5353264" charOffset="98-101" type="compound" text="OAG"/>
            <pair e1="DS.d552.s0.e3" e2="DS.d552.s0.e0" id="DS.d552.s0.i0" interaction="True"/>
            <pair e1="DS.d552.s0.e2" e2="DS.d552.s0.e0" id="DS.d552.s0.i1" interaction="True"/>
            <pair e1="DS.d552.s0.e2" e2="DS.d552.s0.e1" id="DS.d552.s0.i2" interaction="True"/>
            <pair e1="DS.d552.s0.e3" e2="DS.d552.s0.e1" id="DS.d552.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d553" origId="18635336">
        <sentence id="DS.d553.s0" origId="18635336-453" text="Using enzyme-linked immunosorbent assays, we showed DHMEQ to inhibit LPS-induced secretion of IL-6 and TNF-alpha.">
            <entity id="DS.d553.s0.e0" origId="9881652" charOffset="52-57" type="compound" text="DHMEQ"/>
            <entity id="DS.d553.s0.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="94-98" type="protein" text="IL-6"/>
            <entity id="DS.d553.s0.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="103-112" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d553.s0.e0" e2="DS.d553.s0.e1" id="DS.d553.s0.i0" interaction="True"/>
            <pair e1="DS.d553.s0.e0" e2="DS.d553.s0.e2" id="DS.d553.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d554" origId="18635390">
        <sentence id="DS.d554.s0" origId="18635390-1443" text="The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and GSH, elevated buccal mucosa GSH as well as induction of bax and PARP, and inhibition of bcl-2.">
            <entity id="DS.d554.s0.e0" origId="124886" charOffset="104-107" type="compound" text="GSH"/>
            <entity id="DS.d554.s0.e1" origId="124886" charOffset="132-135" type="compound" text="GSH"/>
            <entity id="DS.d554.s0.e2" origId="P27297,Q07813,Q63690" charOffset="160-163" type="protein" text="bax"/>
            <entity id="DS.d554.s0.e3" origId="O50017,P08469,P14043,P31669,P35875,P55057,Q08824,Q11208" charOffset="168-172" type="protein" text="PARP"/>
            <entity id="DS.d554.s0.e4" origId="P10417,P49950" charOffset="192-197" type="protein" text="bcl-2"/>
            <pair e1="DS.d554.s0.e0" e2="DS.d554.s0.e2" id="DS.d554.s0.i0" interaction="False"/>
            <pair e1="DS.d554.s0.e0" e2="DS.d554.s0.e4" id="DS.d554.s0.i1" interaction="False"/>
            <pair e1="DS.d554.s0.e0" e2="DS.d554.s0.e3" id="DS.d554.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d555" origId="18635693">
        <sentence id="DS.d555.s0" origId="18635693-781" text="Dopamine release and direct stimulation of dopamine D2 and serotonin 5-HT2A receptors also contributes to the overall action of MDMA.">
            <entity id="DS.d555.s0.e0" origId="P50129" charOffset="69-75" type="protein" text="5-HT2A"/>
            <entity id="DS.d555.s0.e1" origId="1615" charOffset="128-132" type="compound" text="MDMA"/>
            <pair e1="DS.d555.s0.e1" e2="DS.d555.s0.e0" id="DS.d555.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d555.s1" origId="18635693-783" text="Our findings suggest that MDMA differentially affects higher cognitive functions, but does not support the hypothesis from animal studies, that some of the MDMA effects are causally mediated through action at the 5-HT1A receptor system.">
            <entity id="DS.d555.s1.e0" origId="1615" charOffset="26-30" type="compound" text="MDMA"/>
            <entity id="DS.d555.s1.e1" origId="1615" charOffset="156-160" type="compound" text="MDMA"/>
            <entity id="DS.d555.s1.e2" origId="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298" charOffset="213-219" type="protein" text="5-HT1A"/>
            <pair e1="DS.d555.s1.e0" e2="DS.d555.s1.e2" id="DS.d555.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d556" origId="18635704">
        <sentence id="DS.d556.s0" origId="18635704-791" text="These results suggest that AKT1 does not play a significant role in clinical and functional manifestations in patients with schizophrenia who receive risperidone treatment.">
            <entity id="DS.d556.s0.e0" origId="P31749,Q01314,Q38998,Q8VYX2" charOffset="27-31" type="protein" text="AKT1"/>
            <entity id="DS.d556.s0.e1" origId="5073" charOffset="150-161" type="compound" text="risperidone"/>
            <pair e1="DS.d556.s0.e1" e2="DS.d556.s0.e0" id="DS.d556.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d557" origId="18635814">
        <sentence id="DS.d557.s0" origId="18635814-879" text="Urethane is a chemical carcinogen found in tobacco smoke that causes activating mutations in Kras and induces lung tumors in mice.">
            <entity id="DS.d557.s0.e0" origId="5641" charOffset="0-8" type="compound" text="Urethane"/>
            <entity id="DS.d557.s0.e1" origId="P08644,P32883,Q05147" charOffset="93-97" type="protein" text="Kras"/>
            <pair e1="DS.d557.s0.e0" e2="DS.d557.s0.e1" id="DS.d557.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d558" origId="18636040">
        <sentence id="DS.d558.s0" origId="18636040-1068" text="In the present study, we measured plasma GSTA1-1 levels by enzyme-linked immunosorbent assay in seven healthy volunteers after repeated experimental endotoxemia induced by 2 ng kg Escherichia coli endotoxin per day (to investigate inflammation-induced hepatic injury) and in 21 patients within 12 h after the occurrence of severe sepsis/septic shock (to investigate its ability to predict an increase of transaminases on day 7).">
            <entity id="DS.d558.s0.e0" origId="P08263,Q08863" charOffset="41-48" type="protein" text="GSTA1-1"/>
            <entity id="DS.d558.s0.e1" origId="44268108" charOffset="197-206" type="compound" text="endotoxin"/>
            <pair e1="DS.d558.s0.e1" e2="DS.d558.s0.e0" id="DS.d558.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d558.s1" origId="18636040-1069" text="Furthermore, GSTA1-1 levels did not correlate with IL-6 levels but did with dobutamine infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.">
            <entity id="DS.d558.s1.e0" origId="P08263,Q08863" charOffset="13-20" type="protein" text="GSTA1-1"/>
            <entity id="DS.d558.s1.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="51-55" type="protein" text="IL-6"/>
            <entity id="DS.d558.s1.e2" origId="36811" charOffset="76-86" type="compound" text="dobutamine"/>
            <pair e1="DS.d558.s1.e2" e2="DS.d558.s1.e0" id="DS.d558.s1.i0" interaction="True"/>
            <pair e1="DS.d558.s1.e2" e2="DS.d558.s1.e1" id="DS.d558.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d559" origId="18636042">
        <sentence id="DS.d559.s0" origId="18636042-1310" text="Heparin (H), argatroban (A), antithrombin III (ATIII), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.">
            <entity id="DS.d559.s0.e0" origId="2232,92722,152951,440542,445156" charOffset="13-23" type="compound" text="argatroban"/>
            <entity id="DS.d559.s0.e1" origId="P81050" charOffset="29-45" type="protein" text="antithrombin III"/>
            <entity id="DS.d559.s0.e2" origId="P01008,P32261,P32262,P41361,P81050,Q03352,Q5R5A3" charOffset="47-52" type="protein" text="ATIII"/>
            <entity id="DS.d559.s0.e3" origId="O55527,O55779,P02810,P03314,P03424,P04861,P04862,P06022,P06164,P06165,P06941,P07602,P08097,P10030,P14253,P14254,P14340,P26035,P26779,P27384,P28055,P29165,P32533,P32534,P32535,P35940,P35948,P35977,P69738,Q00794,Q03339,Q074N0,Q1X880,Q1X881,Q6DV88,Q6J3P1,Q89277,Q98803,Q997F1,Q9DUE0,Q9WS38,Q9YRV3" charOffset="87-96" type="protein" text="protein C"/>
            <entity id="DS.d559.s0.e4" origId="P84122" charOffset="33-41" type="protein" text="thrombin"/>
            <pair e1="DS.d559.s0.e0" e2="DS.d559.s0.e4" id="DS.d559.s0.i0" interaction="False"/>
            <pair e1="DS.d559.s0.e0" e2="DS.d559.s0.e3" id="DS.d559.s0.i1" interaction="False"/>
            <pair e1="DS.d559.s0.e0" e2="DS.d559.s0.e2" id="DS.d559.s0.i2" interaction="False"/>
            <pair e1="DS.d559.s0.e0" e2="DS.d559.s0.e1" id="DS.d559.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d560" origId="18636044">
        <sentence id="DS.d560.s0" origId="18636044-1070" text="Hydrogen sulfide (H2S) is a novel gaseous mediator produced by cystathionine-beta-synthase and cystathionine-gamma-lyase in the cardiovascular system, including the heart.">
            <entity id="DS.d560.s0.e0" origId="402,108196" charOffset="0-16" type="compound" text="Hydrogen sulfide"/>
            <entity id="DS.d560.s0.e1" origId="6857678" charOffset="18-21" type="compound" text="H2S"/>
            <entity id="DS.d560.s0.e2" origId="P32232,P32582,P35520,P46794,Q58H57,Q91WT9,Q9N0V7,Q9YBL2" charOffset="63-90" type="protein" text="cystathionine-beta-synthase"/>
            <entity id="DS.d560.s0.e3" origId="P18757,P31373,P32929,Q58DW2,Q60HG7,Q8VCN5" charOffset="95-120" type="protein" text="cystathionine-gamma-lyase"/>
            <pair e1="DS.d560.s0.e0" e2="DS.d560.s0.e2" id="DS.d560.s0.i0" interaction="True"/>
            <pair e1="DS.d560.s0.e1" e2="DS.d560.s0.e2" id="DS.d560.s0.i1" interaction="True"/>
            <pair e1="DS.d560.s0.e0" e2="DS.d560.s0.e3" id="DS.d560.s0.i2" interaction="True"/>
            <pair e1="DS.d560.s0.e1" e2="DS.d560.s0.e3" id="DS.d560.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d561" origId="18636221">
        <sentence id="DS.d561.s0" origId="18636221-1488" text="Chemotaxis, lysozyme release and superoxide anion production have been measured.">
            <entity id="DS.d561.s0.e0" origId="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7" charOffset="12-20" type="protein" text="lysozyme"/>
            <entity id="DS.d561.s0.e1" origId="5359597" charOffset="33-43" type="compound" text="superoxide"/>
            <pair e1="DS.d561.s0.e1" e2="DS.d561.s0.e0" id="DS.d561.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d562" origId="18636241">
        <sentence id="DS.d562.s0" origId="18636241-1243" text="According to annexin V-binding, arsenic trioxide (7 microM) within 48 h significantly increased phosphatidylserine exposure of human erythrocytes without inducing hemolysis.">
            <entity id="DS.d562.s0.e0" origId="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0" charOffset="13-22" type="protein" text="annexin V"/>
            <entity id="DS.d562.s0.e1" origId="445141,6323481,44147587" charOffset="96-114" type="compound" text="phosphatidylserine"/>
            <pair e1="DS.d562.s0.e1" e2="DS.d562.s0.e0" id="DS.d562.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d562.s1" origId="18636241-1244" text="Removal of extracellular Ca2+ or inhibition of the Ca2+-permeable cation channels with amiloride blunted the effects of arsenic on annexin V-binding and cell shrinkage.">
            <entity id="DS.d562.s1.e0" origId="16231" charOffset="87-96" type="compound" text="amiloride"/>
            <entity id="DS.d562.s1.e1" origId="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0" charOffset="131-140" type="protein" text="annexin V"/>
            <pair e1="DS.d562.s1.e0" e2="DS.d562.s1.e1" id="DS.d562.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d563" origId="18636311">
        <sentence id="DS.d563.s0" origId="18636311-1287" text="In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.">
            <entity id="DS.d563.s0.e0" origId="10228" charOffset="101-107" type="compound" text="osthol"/>
            <entity id="DS.d563.s0.e1" origId="66548" charOffset="117-130" type="compound" text="xanthoxyletin"/>
            <entity id="DS.d563.s0.e2" origId="5318015" charOffset="225-238" type="compound" text="heptaphylline"/>
            <entity id="DS.d563.s0.e3" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="287-308" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d563.s0.e4" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="310-314" type="protein" text="iNOS"/>
            <entity id="DS.d563.s0.e5" origId="11970143" charOffset="338-356" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d563.s0.e0" e2="DS.d563.s0.e4" id="DS.d563.s0.i0" interaction="False"/>
            <pair e1="DS.d563.s0.e1" e2="DS.d563.s0.e4" id="DS.d563.s0.i1" interaction="False"/>
            <pair e1="DS.d563.s0.e2" e2="DS.d563.s0.e4" id="DS.d563.s0.i2" interaction="False"/>
            <pair e1="DS.d563.s0.e0" e2="DS.d563.s0.e3" id="DS.d563.s0.i3" interaction="False"/>
            <pair e1="DS.d563.s0.e5" e2="DS.d563.s0.e3" id="DS.d563.s0.i4" interaction="False"/>
            <pair e1="DS.d563.s0.e5" e2="DS.d563.s0.e4" id="DS.d563.s0.i5" interaction="False"/>
            <pair e1="DS.d563.s0.e2" e2="DS.d563.s0.e3" id="DS.d563.s0.i6" interaction="False"/>
            <pair e1="DS.d563.s0.e1" e2="DS.d563.s0.e3" id="DS.d563.s0.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d564" origId="18636399">
        <sentence id="DS.d564.s0" origId="18636399-1328" text="Cell viability and reactive oxygen species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the GST and GPx activity as well as the concentration of reduced glutathione.">
            <entity id="DS.d564.s0.e0" origId="977" charOffset="28-34" type="compound" text="oxygen"/>
            <entity id="DS.d564.s0.e1" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="171-174" type="protein" text="GST"/>
            <entity id="DS.d564.s0.e2" origId="124886" charOffset="224-243" type="compound" text="reduced glutathione"/>
            <pair e1="DS.d564.s0.e2" e2="DS.d564.s0.e1" id="DS.d564.s0.i0" interaction="False"/>
            <pair e1="DS.d564.s0.e0" e2="DS.d564.s0.e1" id="DS.d564.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d565" origId="18636508">
        <sentence id="DS.d565.s0" origId="18636508-1410" text="Fibril growth was a second-order process with an enthalpy of activation (27+/-5 kcal mol(-1)), which is indistinguishable from that of tetramer formation by cystatins, which involves limited conformational changes including proline trans to cis isomerization.">
            <entity id="DS.d565.s0.e0" origId="P08935,P25973,P81061,P81714,Q06445" charOffset="157-166" type="protein" text="cystatins"/>
            <entity id="DS.d565.s0.e1" origId="614,8988,145742" charOffset="224-231" type="compound" text="proline"/>
            <pair e1="DS.d565.s0.e1" e2="DS.d565.s0.e0" id="DS.d565.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d566" origId="18636565">
        <sentence id="DS.d566.s0" origId="18636565-515" text="Mutations in MCT8 are associated with severe psychomotor retardation, high serum T3 and low 3,3',5'-triiodothyronine (rT3) levels.">
            <entity id="DS.d566.s0.e0" origId="P36021" charOffset="13-17" type="protein" text="MCT8"/>
            <entity id="DS.d566.s0.e1" origId="5920,644280" charOffset="92-116" type="compound" text="3,3',5'-triiodothyronine"/>
            <entity id="DS.d566.s0.e2" origId="644280" charOffset="118-121" type="compound" text="rT3"/>
            <pair e1="DS.d566.s0.e1" e2="DS.d566.s0.e0" id="DS.d566.s0.i0" interaction="True"/>
            <pair e1="DS.d566.s0.e2" e2="DS.d566.s0.e0" id="DS.d566.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d567" origId="18637152">
        <sentence id="DS.d567.s0" origId="18637152-268" text="Results showed that MENT treatments increased PSA secretion and proliferation rate with a potency ranged between T and DHT.">
            <entity id="DS.d567.s0.e0" origId="19582,9838899" charOffset="20-24" type="compound" text="MENT"/>
            <entity id="DS.d567.s0.e1" origId="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617" charOffset="46-49" type="protein" text="PSA"/>
            <entity id="DS.d567.s0.e2" origId="10635" charOffset="119-122" type="compound" text="DHT"/>
            <pair e1="DS.d567.s0.e2" e2="DS.d567.s0.e1" id="DS.d567.s0.i0" interaction="True"/>
            <pair e1="DS.d567.s0.e0" e2="DS.d567.s0.e1" id="DS.d567.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d567.s1" origId="18637152-269" text="The studies with finasteride showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and PSA secretion, and corroborated the resistance of MENT to the 5-AR.">
            <entity id="DS.d567.s1.e0" origId="57363" charOffset="17-28" type="compound" text="finasteride"/>
            <entity id="DS.d567.s1.e1" origId="10635" charOffset="88-91" type="compound" text="DHT"/>
            <entity id="DS.d567.s1.e2" origId="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617" charOffset="157-160" type="protein" text="PSA"/>
            <entity id="DS.d567.s1.e3" origId="19582,9838899" charOffset="207-211" type="compound" text="MENT"/>
            <pair e1="DS.d567.s1.e0" e2="DS.d567.s1.e2" id="DS.d567.s1.i0" interaction="False"/>
            <pair e1="DS.d567.s1.e3" e2="DS.d567.s1.e2" id="DS.d567.s1.i1" interaction="False"/>
            <pair e1="DS.d567.s1.e1" e2="DS.d567.s1.e2" id="DS.d567.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d568" origId="18637154">
        <sentence id="DS.d568.s0" origId="18637154-273" text="Pregnant Sprague-Dawley female rats were treated once with TCDD (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.">
            <entity id="DS.d568.s0.e0" origId="15625" charOffset="59-63" type="compound" text="TCDD"/>
            <entity id="DS.d568.s0.e1" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="170-188" type="protein" text="estrogen receptors"/>
            <entity id="DS.d568.s0.e2" origId="O46516,O57245,P14893,P21097,P26670,P27365,Q5IFP1,Q67477,Q9N119" charOffset="230-239" type="protein" text="3beta-HSD"/>
            <entity id="DS.d568.s0.e3" origId="O46689,P49675,P51557,P58864,P70114,P79245,P97826,Q28918,Q28996,Q9DE06,Q9DEB4,Q9DG08,Q9DG09,Q9DG10" charOffset="270-274" type="protein" text="StAR"/>
            <entity id="DS.d568.s0.e4" origId="P33242,P50569,P79387,Q04752,Q13285,Q95L87,Q9GKL2" charOffset="276-280" type="protein" text="SF-1"/>
            <entity id="DS.d568.s0.e5" origId="P49604" charOffset="282-286" type="protein" text="GATA"/>
            <pair e1="DS.d568.s0.e0" e2="DS.d568.s0.e1" id="DS.d568.s0.i0" interaction="False"/>
            <pair e1="DS.d568.s0.e0" e2="DS.d568.s0.e4" id="DS.d568.s0.i1" interaction="False"/>
            <pair e1="DS.d568.s0.e0" e2="DS.d568.s0.e2" id="DS.d568.s0.i2" interaction="False"/>
            <pair e1="DS.d568.s0.e0" e2="DS.d568.s0.e5" id="DS.d568.s0.i3" interaction="False"/>
            <pair e1="DS.d568.s0.e0" e2="DS.d568.s0.e3" id="DS.d568.s0.i4" interaction="False"/>
        </sentence>
        <sentence id="DS.d568.s1" origId="18637154-274" text="In utero exposure to TCDD reduced intratesticular T of foetal males (significant at 0.3 microg/kg TCDD) and tended to reduce the protein expression of ERalpha and AR of foetal male rat testis.">
            <entity id="DS.d568.s1.e0" origId="15625" charOffset="21-25" type="compound" text="TCDD"/>
            <entity id="DS.d568.s1.e1" origId="15625" charOffset="98-102" type="compound" text="TCDD"/>
            <entity id="DS.d568.s1.e2" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="151-158" type="protein" text="ERalpha"/>
            <pair e1="DS.d568.s1.e0" e2="DS.d568.s1.e2" id="DS.d568.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d568.s2" origId="18637154-275" text="mRNA expression of developmental regulatory factors was not influenced by foetal TCDD exposure, except for significantly reduced adrenal SF-1.">
            <entity id="DS.d568.s2.e0" origId="15625" charOffset="81-85" type="compound" text="TCDD"/>
            <entity id="DS.d568.s2.e1" origId="P33242,P50569,P79387,Q04752,Q13285,Q95L87,Q9GKL2" charOffset="137-141" type="protein" text="SF-1"/>
            <pair e1="DS.d568.s2.e0" e2="DS.d568.s2.e1" id="DS.d568.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d569" origId="18637708">
        <sentence id="DS.d569.s0" origId="18637708-746" text="Nitrogen-containing bisphosphonates were found to inhibit farnesyl diphosphate synthase-an essential enzyme in the cholesterol biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.">
            <entity id="DS.d569.s0.e0" origId="947,123329" charOffset="0-8" type="compound" text="Nitrogen"/>
            <entity id="DS.d569.s0.e1" origId="O66126,O66952,P22939,P45204,P54383,P55539,P57537,Q08291,Q45220,Q8K9A0" charOffset="58-87" type="protein" text="farnesyl diphosphate synthase"/>
            <entity id="DS.d569.s0.e2" origId="304,5997,6432564,11025495" charOffset="115-126" type="compound" text="cholesterol"/>
            <pair e1="DS.d569.s0.e0" e2="DS.d569.s0.e1" id="DS.d569.s0.i0" interaction="False"/>
            <pair e1="DS.d569.s0.e2" e2="DS.d569.s0.e1" id="DS.d569.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d570" origId="18637712">
        <sentence id="DS.d570.s0" origId="18637712-756" text="hsBAFF-upregulated intracellular free Ca(2+) homeostasis regulates ERK1/2 activity and cell proliferation in B cells in vitro.">
            <entity id="DS.d570.s0.e0" origId="271" charOffset="38-42" type="compound" text="Ca(2"/>
            <entity id="DS.d570.s0.e1" origId="P27361,P28869,P42525,Q07176" charOffset="67-71" type="protein" text="ERK1"/>
            <pair e1="DS.d570.s0.e0" e2="DS.d570.s0.e1" id="DS.d570.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d570.s1" origId="18637712-757" text="Using immunocytochemistry and Western blot analysis, we found that the activation of ERK1/2 due to hsBAFF was triggered by a (Ca(2+))(i)-dependent pathway, leading to elevation of B cell proliferation.">
            <entity id="DS.d570.s1.e0" origId="P27361,P28869,P42525,Q07176" charOffset="85-89" type="protein" text="ERK1"/>
            <entity id="DS.d570.s1.e1" origId="271" charOffset="126-130" type="compound" text="Ca(2"/>
            <pair e1="DS.d570.s1.e1" e2="DS.d570.s1.e0" id="DS.d570.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d570.s2" origId="18637712-758" text="This is supported by the findings that intracellular Ca(2+) chelator BAPTA/AM attenuated phosphorylated ERK1/2 expression and cell proliferation in hsBAFF-stimulated B cells.">
            <entity id="DS.d570.s2.e0" origId="2293" charOffset="69-77" type="compound" text="BAPTA/AM"/>
            <entity id="DS.d570.s2.e1" origId="P27361,P28869,P42525,Q07176" charOffset="104-108" type="protein" text="ERK1"/>
            <pair e1="DS.d570.s2.e0" e2="DS.d570.s2.e1" id="DS.d570.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d570.s3" origId="18637712-759" text="Taken together, the main finding of this study is that hsBAFF elicits higher but homeostatic (Ca(2+))(i) levels, which regulates ERK1/2 activity and cell proliferation in in vitro B cells.">
            <entity id="DS.d570.s3.e0" origId="271" charOffset="94-98" type="compound" text="Ca(2"/>
            <entity id="DS.d570.s3.e1" origId="P27361,P28869,P42525,Q07176" charOffset="129-133" type="protein" text="ERK1"/>
            <pair e1="DS.d570.s3.e0" e2="DS.d570.s3.e1" id="DS.d570.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d571" origId="18637714">
        <sentence id="DS.d571.s0" origId="18637714-1311" text="Surgical removal of pheochromocytoma significantly increased body weight, decreased both systolic and diastolic blood pressure, fasting blood glucose and glycated hemoglobin levels.">
            <entity id="DS.d571.s0.e0" origId="206,5793,64689,79025" charOffset="142-149" type="compound" text="glucose"/>
            <entity id="DS.d571.s0.e1" origId="P15160,P17724,P73925,Q03459" charOffset="163-173" type="protein" text="hemoglobin"/>
            <pair e1="DS.d571.s0.e0" e2="DS.d571.s0.e1" id="DS.d571.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d572" origId="18637715">
        <sentence id="DS.d572.s0" origId="18637715-1322" text="In this study we have investigated a long-term pattern of expression and production of spinal COX-1 and COX-2 in the model of osteoarthritis induced in rats by injection of monoiodoacetate (MIA) into the knee joint.">
            <entity id="DS.d572.s0.e0" origId="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8" charOffset="94-99" type="protein" text="COX-1"/>
            <entity id="DS.d572.s0.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="104-109" type="protein" text="COX-2"/>
            <entity id="DS.d572.s0.e2" origId="5240" charOffset="173-188" type="compound" text="monoiodoacetate"/>
            <pair e1="DS.d572.s0.e2" e2="DS.d572.s0.e1" id="DS.d572.s0.i0" interaction="False"/>
            <pair e1="DS.d572.s0.e2" e2="DS.d572.s0.e0" id="DS.d572.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d573" origId="18639339">
        <sentence id="DS.d573.s0" origId="18639339-380" text="The enzyme indoleamine 2,3-dioxygenase (IDO) converts tryptophan to kynurenine, blocking T-cell activation and inducing immunosuppression.">
            <entity id="DS.d573.s0.e0" origId="P14902,P28776" charOffset="11-38" type="protein" text="indoleamine 2,3-dioxygenase"/>
            <entity id="DS.d573.s0.e1" origId="P14902,P28776" charOffset="40-43" type="protein" text="IDO"/>
            <entity id="DS.d573.s0.e2" origId="1148,6305,9060,5460840" charOffset="54-64" type="compound" text="tryptophan"/>
            <entity id="DS.d573.s0.e3" origId="846" charOffset="68-78" type="compound" text="kynurenine"/>
            <pair e1="DS.d573.s0.e2" e2="DS.d573.s0.e0" id="DS.d573.s0.i0" interaction="True"/>
            <pair e1="DS.d573.s0.e3" e2="DS.d573.s0.e1" id="DS.d573.s0.i1" interaction="True"/>
            <pair e1="DS.d573.s0.e2" e2="DS.d573.s0.e1" id="DS.d573.s0.i2" interaction="True"/>
            <pair e1="DS.d573.s0.e3" e2="DS.d573.s0.e0" id="DS.d573.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d574" origId="18639341">
        <sentence id="DS.d574.s0" origId="18639341-381" text="Serum l-kynurenine (l-KYN) concentrations, l-KYN/l-TRP ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.">
            <entity id="DS.d574.s0.e0" origId="846" charOffset="8-18" type="compound" text="kynurenine"/>
            <entity id="DS.d574.s0.e1" origId="161166" charOffset="22-25" type="compound" text="KYN"/>
            <entity id="DS.d574.s0.e2" origId="161166" charOffset="45-48" type="compound" text="KYN"/>
            <entity id="DS.d574.s0.e3" origId="P07147,P17643" charOffset="51-54" type="protein" text="TRP"/>
            <entity id="DS.d574.s0.e4" origId="P14902,P28776" charOffset="79-82" type="protein" text="IDO"/>
            <pair e1="DS.d574.s0.e0" e2="DS.d574.s0.e3" id="DS.d574.s0.i0" interaction="False"/>
            <pair e1="DS.d574.s0.e1" e2="DS.d574.s0.e3" id="DS.d574.s0.i1" interaction="False"/>
            <pair e1="DS.d574.s0.e1" e2="DS.d574.s0.e4" id="DS.d574.s0.i2" interaction="False"/>
            <pair e1="DS.d574.s0.e0" e2="DS.d574.s0.e4" id="DS.d574.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d575" origId="18639629">
        <sentence id="DS.d575.s0" origId="18639629-311" text="Peripheral administration of the acetylcholinesterase inhibitor galantamine significantly reduced serum TNF levels through vagus nerve signaling, and protected against lethality during murine endotoxemia.">
            <entity id="DS.d575.s0.e0" origId="9651" charOffset="64-75" type="compound" text="galantamine"/>
            <entity id="DS.d575.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="104-107" type="protein" text="TNF"/>
            <pair e1="DS.d575.s0.e0" e2="DS.d575.s0.e1" id="DS.d575.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d575.s1" origId="18639629-312" text="Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of TNF by galantamine, indicating that suppressing acetylcholinesterase activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.">
            <entity id="DS.d575.s1.e0" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="97-100" type="protein" text="TNF"/>
            <entity id="DS.d575.s1.e1" origId="9651" charOffset="104-115" type="compound" text="galantamine"/>
            <entity id="DS.d575.s1.e2" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="145-165" type="protein" text="acetylcholinesterase"/>
            <pair e1="DS.d575.s1.e1" e2="DS.d575.s1.e2" id="DS.d575.s1.i0" interaction="True"/>
            <pair e1="DS.d575.s1.e1" e2="DS.d575.s1.e0" id="DS.d575.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d575.s2" origId="18639629-313" text="Administration of galantamine to alpha7nAChR knockout mice failed to suppress TNF levels, indicating that the alpha7nAChR-mediated cholinergic anti-inflammatory pathway is required for the anti-inflammatory effect of galantamine.">
            <entity id="DS.d575.s2.e0" origId="9651" charOffset="18-29" type="compound" text="galantamine"/>
            <entity id="DS.d575.s2.e1" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="78-81" type="protein" text="TNF"/>
            <entity id="DS.d575.s2.e2" origId="9651" charOffset="217-228" type="compound" text="galantamine"/>
            <pair e1="DS.d575.s2.e0" e2="DS.d575.s2.e1" id="DS.d575.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d576" origId="18639930">
        <sentence id="DS.d576.s0" origId="18639930-897" text="The involvement of superoxide and nitric oxide was verified by the block of MSC using specific scavengers (tiron and PTIO, respectively).">
            <entity id="DS.d576.s0.e0" origId="5359597" charOffset="19-29" type="compound" text="superoxide"/>
            <entity id="DS.d576.s0.e1" origId="145068" charOffset="34-46" type="compound" text="nitric oxide"/>
            <entity id="DS.d576.s0.e2" origId="O60682" charOffset="76-79" type="protein" text="MSC"/>
            <entity id="DS.d576.s0.e3" origId="9002" charOffset="107-112" type="compound" text="tiron"/>
            <pair e1="DS.d576.s0.e0" e2="DS.d576.s0.e2" id="DS.d576.s0.i0" interaction="False"/>
            <pair e1="DS.d576.s0.e3" e2="DS.d576.s0.e2" id="DS.d576.s0.i1" interaction="True"/>
            <pair e1="DS.d576.s0.e1" e2="DS.d576.s0.e2" id="DS.d576.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d576.s1" origId="18639930-898" text="Accordingly, MSC were blocked by the peroxynitrite scavenger uric acid and could be mimicked by application of exogenous peroxynitrite.">
            <entity id="DS.d576.s1.e0" origId="O60682" charOffset="13-16" type="protein" text="MSC"/>
            <entity id="DS.d576.s1.e2" origId="1175" charOffset="61-70" type="compound" text="uric acid"/>
            <pair e1="DS.d576.s1.e2" e2="DS.d576.s1.e0" id="DS.d576.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d576.s2" origId="18639930-899" text="This conclusion is supported by our findings that MSC were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (oleic acid, Triton X-100).">
            <entity id="DS.d576.s2.e0" origId="O60682" charOffset="50-53" type="protein" text="MSC"/>
            <entity id="DS.d576.s2.e1" origId="445639" charOffset="170-180" type="compound" text="oleic acid"/>
            <entity id="DS.d576.s2.e2" origId="5590" charOffset="182-194" type="compound" text="Triton X-100"/>
            <pair e1="DS.d576.s2.e2" e2="DS.d576.s2.e0" id="DS.d576.s2.i0" interaction="True"/>
            <pair e1="DS.d576.s2.e1" e2="DS.d576.s2.e0" id="DS.d576.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d577" origId="18640003">
        <sentence id="DS.d577.s0" origId="18640003-956" text="In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), annexin V-FITC/propidium iodide (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.">
            <entity id="DS.d577.s0.e0" origId="64966" charOffset="277-338" type="compound" text="3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide"/>
            <entity id="DS.d577.s0.e1" origId="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0" charOffset="346-355" type="protein" text="annexin V"/>
            <entity id="DS.d577.s0.e2" origId="18730" charOffset="356-360" type="compound" text="FITC"/>
            <entity id="DS.d577.s0.e3" origId="4939" charOffset="361-377" type="compound" text="propidium iodide"/>
            <pair e1="DS.d577.s0.e0" e2="DS.d577.s0.e1" id="DS.d577.s0.i0" interaction="False"/>
            <pair e1="DS.d577.s0.e3" e2="DS.d577.s0.e1" id="DS.d577.s0.i1" interaction="False"/>
            <pair e1="DS.d577.s0.e2" e2="DS.d577.s0.e1" id="DS.d577.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d578" origId="18640059">
        <sentence id="DS.d578.s0" origId="18640059-934" text="To investigate the role of adenosine analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE (2)) release and cyclooxygenase-2 (COX-2) expression in bovine synovial fibroblasts (SFs).">
            <entity id="DS.d578.s0.e0" origId="60961" charOffset="27-36" type="compound" text="adenosine"/>
            <entity id="DS.d578.s0.e1" origId="Q29458" charOffset="112-115" type="protein" text="PGE"/>
            <entity id="DS.d578.s0.e2" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="133-149" type="protein" text="cyclooxygenase-2"/>
            <entity id="DS.d578.s0.e3" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="151-156" type="protein" text="COX-2"/>
            <pair e1="DS.d578.s0.e0" e2="DS.d578.s0.e1" id="DS.d578.s0.i0" interaction="False"/>
            <pair e1="DS.d578.s0.e0" e2="DS.d578.s0.e3" id="DS.d578.s0.i1" interaction="False"/>
            <pair e1="DS.d578.s0.e0" e2="DS.d578.s0.e2" id="DS.d578.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d579" origId="18640663">
        <sentence id="DS.d579.s0" origId="18640663-1479" text="In this study, we compared the effects of insulin-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and glucosamine sulphate on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.">
            <entity id="DS.d579.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="42-49" type="protein" text="insulin"/>
            <entity id="DS.d579.s0.e1" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="72-77" type="protein" text="IGF-I"/>
            <entity id="DS.d579.s0.e2" origId="P03969,P09038,P12226,P13109,P15655,P20003,P48798,P48799,P48800,Q60487" charOffset="80-110" type="protein" text="basic fibroblast growth factor"/>
            <entity id="DS.d579.s0.e3" origId="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6" charOffset="153-162" type="protein" text="TGF-beta1"/>
            <entity id="DS.d579.s0.e4" origId="3034366" charOffset="169-189" type="compound" text="glucosamine sulphate"/>
            <pair e1="DS.d579.s0.e4" e2="DS.d579.s0.e0" id="DS.d579.s0.i0" interaction="False"/>
            <pair e1="DS.d579.s0.e4" e2="DS.d579.s0.e3" id="DS.d579.s0.i1" interaction="False"/>
            <pair e1="DS.d579.s0.e4" e2="DS.d579.s0.e1" id="DS.d579.s0.i2" interaction="False"/>
            <pair e1="DS.d579.s0.e4" e2="DS.d579.s0.e2" id="DS.d579.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d580" origId="18640679">
        <sentence id="DS.d580.s0" origId="18640679-288" text="Meanwhile, both the enhanced expression of VCAM-1 and increased activation of NF-kappaB induced by CRH in aortas of LDLr-/-mice were also largely suppressed by NBI27914, whereas these inhibitory effects were not observed in anti-Svg-30 group.">
            <entity id="DS.d580.s0.e0" origId="P19320,P29533,P29534,Q28260" charOffset="43-49" type="protein" text="VCAM-1"/>
            <entity id="DS.d580.s0.e1" origId="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1" charOffset="99-102" type="protein" text="CRH"/>
            <entity id="DS.d580.s0.e2" origId="176157" charOffset="160-168" type="compound" text="NBI27914"/>
            <pair e1="DS.d580.s0.e2" e2="DS.d580.s0.e0" id="DS.d580.s0.i0" interaction="True"/>
            <pair e1="DS.d580.s0.e2" e2="DS.d580.s0.e1" id="DS.d580.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d581" origId="18640717">
        <sentence id="DS.d581.s0" origId="18640717-1523" text="PI3K/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or LY294002 improved apoptosis in the resistant cell lines.">
            <entity id="DS.d581.s0.e0" origId="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0" charOffset="0-4" type="protein" text="PI3K"/>
            <entity id="DS.d581.s0.e1" origId="53477912" charOffset="31-51" type="compound" text="phosphatidylinositol"/>
            <entity id="DS.d581.s0.e2" origId="312145" charOffset="205-215" type="compound" text="wortmannin"/>
            <entity id="DS.d581.s0.e3" origId="3973" charOffset="219-227" type="compound" text="LY294002"/>
            <pair e1="DS.d581.s0.e2" e2="DS.d581.s0.e0" id="DS.d581.s0.i0" interaction="True"/>
            <pair e1="DS.d581.s0.e3" e2="DS.d581.s0.e0" id="DS.d581.s0.i1" interaction="True"/>
            <pair e1="DS.d581.s0.e1" e2="DS.d581.s0.e0" id="DS.d581.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d581.s1" origId="18640717-1524" text="Vincristine but not doxorubicin increased p-Akt expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.">
            <entity id="DS.d581.s1.e0" origId="5978" charOffset="0-11" type="compound" text="Vincristine"/>
            <entity id="DS.d581.s1.e1" origId="31703" charOffset="20-31" type="compound" text="doxorubicin"/>
            <entity id="DS.d581.s1.e2" origId="P31750,Q8INB9" charOffset="44-47" type="protein" text="Akt"/>
            <entity id="DS.d581.s1.e3" origId="5978" charOffset="105-116" type="compound" text="vincristine"/>
            <pair e1="DS.d581.s1.e1" e2="DS.d581.s1.e2" id="DS.d581.s1.i0" interaction="False"/>
            <pair e1="DS.d581.s1.e0" e2="DS.d581.s1.e2" id="DS.d581.s1.i1" interaction="True"/>
            <pair e1="DS.d581.s1.e3" e2="DS.d581.s1.e2" id="DS.d581.s1.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d581.s2" origId="18640717-1525" text="Wortmannin and LY294002 inhibited P-glycoprotein (Pgp) function and also increased NF-kappaB activity.">
            <entity id="DS.d581.s2.e0" origId="312145" charOffset="0-10" type="compound" text="Wortmannin"/>
            <entity id="DS.d581.s2.e1" origId="3973" charOffset="15-23" type="compound" text="LY294002"/>
            <entity id="DS.d581.s2.e2" origId="P08163" charOffset="36-48" type="protein" text="glycoprotein"/>
            <pair e1="DS.d581.s2.e1" e2="DS.d581.s2.e2" id="DS.d581.s2.i0" interaction="True"/>
            <pair e1="DS.d581.s2.e0" e2="DS.d581.s2.e2" id="DS.d581.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d582" origId="18640746">
        <sentence id="DS.d582.s0" origId="18640746-1557" text="Namely, the results obtained for the most active compounds, 5-(chloroacetylamino) uracil (2) and its acyclic sugar analogue 18, suggest that formation of a covalent bond between reactive substituent and several possible targets within the thymidylate synthase mechanism (sulphur of the cysteine residue, basic part of the enzyme, N,N-methylene tetrahydrofolate or its reactive iminium forms) is the most probable mode of action.">
            <entity id="DS.d582.s0.e1" origId="O02604,O26868,O33380,O66108,O76511,O81395,O96650,P00469,P00471,P04818,P06785,P06854,P07382,P07606,P07607,P09249,P0A0M5,P0A884,P0A885,P0A886,P0C0M4,P0C0M5,P12461,P12462,P13100,P13922,P16126,P19368,P20712,P44420,P45350,P45351,P45352,P46103,P47469,P48464,P51820,P57515,P57808,P59427,P67042,P67043,P67044,P67045,P67046,P67047,P67048,P67049,P67050,P67051,P67052,P78029,P80305,P90463,Q05762,Q05763,Q07422,Q23695,Q27713,Q27783,Q27793,Q27828,Q2QRX6,Q4QM04,Q57931,Q5D189,Q5E7P1,Q5FKL6,Q5GWB5,Q5HFZ6,Q5HMP6,Q5KZ25,Q5M0S7,Q5M5B3,Q5NFK5,Q5P233,Q5PEN6,Q5R064,Q5UQG3,Q5WDS1,Q5WSU5,Q5X119,Q5XCM3,Q5YPL7,Q5ZRL3,Q603S2,Q63BV5,Q64PV5,Q65J44,Q65VJ8,Q667F9,Q67JQ1,Q6A761,Q6AFI0,Q6D8I6,Q6F145,Q6FER7,Q6FZ91,Q6G2S8,Q6G9D4,Q6GGY0,Q6HJC7,Q6KIQ6,Q6LUM1,Q6MID2,Q6N447,Q6NIF2,Q6REU8,Q6YQT0,Q71YE1,Q738X7,Q73VZ2,Q74IU3,Q7MNN6,Q7MTB5,Q7N8U4,Q7NZ95,Q7UID0,Q7VMH2,Q7VUE3,Q7W1A9,Q7WP13,Q81E05,Q81R23,Q82WU3,Q834R3,Q83BG2,Q87BT4,Q87SA0,Q87UL4,Q88CN9,Q88W05,Q89940,Q89G35,Q8A639,Q8D2N4,Q8DER9,Q8DUI4,Q8DZ07,Q8E4L6,Q8EH94,Q8EQG0,Q8EV81,Q8FR47,Q8G3T9,Q8K9C3,Q8NS38,Q8P1D1,Q8PCE7,Q8PP46,Q8PXI1,Q8RGP6,Q8THH4,Q8TVL9,Q8UDS3,Q8Y0U6,Q8Y626,Q8Z412,Q8ZHV1,Q8ZMA9,Q92AD4,Q92NQ5,Q97EV3,Q98KH9,Q98Q31,Q9A6H0,Q9CBW0,Q9I6F1,Q9JT57,Q9JY72,Q9K7B5,Q9P4T7,Q9PB13,Q9RAM7,Q9XC19,Q9Z671" charOffset="239-259" type="protein" text="thymidylate synthase"/>
            <entity id="DS.d582.s0.e2" origId="594,5862,5360637" charOffset="286-294" type="compound" text="cysteine"/>
            <pair e1="DS.d582.s0.e2" e2="DS.d582.s0.e1" id="DS.d582.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d583" origId="18641920">
        <sentence id="DS.d583.s0" origId="18641920-846" text="PTK787/ZK222584, a potent orally active angiogenesis inhibitor capable of inhibiting all known isoforms of Vascular Endothelial Growth Factor (VEGF) receptor, belongs to the class of aminophthalazines.">
            <entity id="DS.d583.s0.e0" origId="151194" charOffset="0-15" type="compound" text="PTK787/ZK222584"/>
            <entity id="DS.d583.s0.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="143-147" type="protein" text="VEGF"/>
            <pair e1="DS.d583.s0.e0" e2="DS.d583.s0.e1" id="DS.d583.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d584" origId="18642040">
        <sentence id="DS.d584.s0" origId="18642040-946" text="Recent evidence for toxic superoxide (O(2)(-)) production by marine microalgae is afforded particular attention given that release of O(2)(-) anions can be exacerbated by the binding of mannose-specific lectins to the microalgal cell wall ; a novel model for grazing-activated chemical defence is proposed.">
            <entity id="DS.d584.s0.e0" origId="5359597" charOffset="26-36" type="compound" text="superoxide"/>
            <entity id="DS.d584.s0.e1" origId="P82953" charOffset="186-210" type="protein" text="mannose-specific lectins"/>
            <pair e1="DS.d584.s0.e0" e2="DS.d584.s0.e1" id="DS.d584.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d585" origId="18642088">
        <sentence id="DS.d585.s0" origId="18642088-995" text="Activation of these receptors can inhibit ACTH-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or SOM230) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.">
            <entity id="DS.d585.s0.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="42-46" type="protein" text="ACTH"/>
            <entity id="DS.d585.s0.e1" origId="56603683" charOffset="139-150" type="compound" text="pasireotide"/>
            <entity id="DS.d585.s0.e2" origId="56841596" charOffset="155-161" type="compound" text="SOM230"/>
            <entity id="DS.d585.s0.e3" origId="54746" charOffset="172-183" type="compound" text="cabergoline"/>
            <pair e1="DS.d585.s0.e1" e2="DS.d585.s0.e0" id="DS.d585.s0.i0" interaction="False"/>
            <pair e1="DS.d585.s0.e3" e2="DS.d585.s0.e0" id="DS.d585.s0.i1" interaction="False"/>
            <pair e1="DS.d585.s0.e2" e2="DS.d585.s0.e0" id="DS.d585.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d586" origId="18642106">
        <sentence id="DS.d586.s0" origId="18642106-1330" text="The glutamate induced chemotaxis was accompanied by polarization of the actin cytoskeleton, and by polymerization of F-actin.">
            <entity id="DS.d586.s0.e0" origId="611,23327,33032" charOffset="4-13" type="compound" text="glutamate"/>
            <entity id="DS.d586.s0.e1" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="72-77" type="protein" text="actin"/>
            <entity id="DS.d586.s0.e2" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="119-124" type="protein" text="actin"/>
            <pair e1="DS.d586.s0.e0" e2="DS.d586.s0.e1" id="DS.d586.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d587" origId="18642386">
        <sentence id="DS.d587.s0" origId="18642386-611" text="SD4 in anionic DSPG liposomes stimulated murine IL-6 production in RAW 264 cells at concentrations 25-to 30-fold lower than free drug.">
            <entity id="DS.d587.s0.e0" origId="97663" charOffset="0-3" type="compound" text="SD4"/>
            <entity id="DS.d587.s0.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="48-52" type="protein" text="IL-6"/>
            <pair e1="DS.d587.s0.e0" e2="DS.d587.s0.e1" id="DS.d587.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d588" origId="18643838">
        <sentence id="DS.d588.s0" origId="18643838-993" text="To elucidate the mechanism by which rosiglitazone regulates adipose triglyceride lipase (ATGL).">
            <entity id="DS.d588.s0.e0" origId="77999" charOffset="36-49" type="compound" text="rosiglitazone"/>
            <entity id="DS.d588.s0.e1" origId="Q7M4U7" charOffset="81-87" type="protein" text="lipase"/>
            <pair e1="DS.d588.s0.e0" e2="DS.d588.s0.e1" id="DS.d588.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d589" origId="18643908">
        <sentence id="DS.d589.s0" origId="18643908-800" text="Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a GDP-GTP exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.">
            <entity id="DS.d589.s0.e0" origId="O16005,O16017,O16018,O16019,O16020,O18312,O18315,O18481,O18485,O18486,O18766,O42268,O42294,O42300,O42301,O42307,O42327,O42328,O42330,O42427,O42431,O42451,O42452,O42466,O42604,O62791,O62792,O62793,O62794,O62795,O62796,O62798,O93441,O93459,P02699,P02700,P08100,P09241,P15409,P22328,P22671,P24603,P28681,P29403,P31355,P31356,P32308,P32309,P35356,P35359,P35362,P35403,P41590,P41591,P49912,P51470,P51488,P51489,P52202,P56514,P56515,P56516,P79756,P79798,P79807,P79808,P79809,P79812,P79848,P79863,P79898,P79901,P79902,P79903,P79911,P79914,P87369,Q17094,Q17292,Q17296,Q28886,Q68J47,Q6W3E1,Q769E8,Q8HY69,Q90245,Q90305,Q90373,Q95KU1,Q98980,Q9DGG4,Q9YGY9,Q9YGZ0,Q9YGZ1,Q9YGZ2,Q9YGZ3,Q9YGZ4,Q9YGZ5,Q9YGZ6,Q9YGZ7,Q9YGZ8,Q9YGZ9,Q9YH00,Q9YH01,Q9YH02,Q9YH03,Q9YH04,Q9YH05" charOffset="0-9" type="protein" text="Rhodopsin"/>
            <entity id="DS.d589.s0.e1" origId="8977" charOffset="93-96" type="compound" text="GDP"/>
            <entity id="DS.d589.s0.e2" origId="6830" charOffset="97-100" type="compound" text="GTP"/>
            <entity id="DS.d589.s0.e3" origId="P49177" charOffset="144-154" type="protein" text="transducin"/>
            <pair e1="DS.d589.s0.e2" e2="DS.d589.s0.e0" id="DS.d589.s0.i0" interaction="True"/>
            <pair e1="DS.d589.s0.e1" e2="DS.d589.s0.e3" id="DS.d589.s0.i1" interaction="True"/>
            <pair e1="DS.d589.s0.e2" e2="DS.d589.s0.e3" id="DS.d589.s0.i2" interaction="True"/>
            <pair e1="DS.d589.s0.e1" e2="DS.d589.s0.e0" id="DS.d589.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d590" origId="18644606">
        <sentence id="DS.d590.s0" origId="18644606-1339" text="Olanzapine was associated with a lower frequency of extrapyramidal symptoms than other antipsychotics, fewer prolactin-related adverse events than risperidone and other atypical antipsychotics, but greater weight gain than typicals and risperidone.">
            <entity id="DS.d590.s0.e0" origId="4585" charOffset="0-10" type="compound" text="Olanzapine"/>
            <entity id="DS.d590.s0.e1" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="109-118" type="protein" text="prolactin"/>
            <pair e1="DS.d590.s0.e0" e2="DS.d590.s0.e1" id="DS.d590.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d591" origId="18646192">
        <sentence id="DS.d591.s0" origId="18646192-1003" text="In our earlier method, glutathione disulfide (GSSG) was measured by first reducing it to GSH with glutathione reductase (GR) in the presence of NADPH.">
            <entity id="DS.d591.s0.e0" origId="65359" charOffset="23-44" type="compound" text="glutathione disulfide"/>
            <entity id="DS.d591.s0.e1" origId="65359" charOffset="46-50" type="compound" text="GSSG"/>
            <entity id="DS.d591.s0.e2" origId="124886" charOffset="89-92" type="compound" text="GSH"/>
            <entity id="DS.d591.s0.e3" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="98-119" type="protein" text="glutathione reductase"/>
            <entity id="DS.d591.s0.e4" origId="5884" charOffset="144-149" type="compound" text="NADPH"/>
            <pair e1="DS.d591.s0.e1" e2="DS.d591.s0.e3" id="DS.d591.s0.i0" interaction="True"/>
            <pair e1="DS.d591.s0.e0" e2="DS.d591.s0.e3" id="DS.d591.s0.i1" interaction="True"/>
            <pair e1="DS.d591.s0.e4" e2="DS.d591.s0.e3" id="DS.d591.s0.i2" interaction="True"/>
            <pair e1="DS.d591.s0.e2" e2="DS.d591.s0.e3" id="DS.d591.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d593" origId="18647135">
        <sentence id="DS.d593.s0" origId="18647135-78" text="The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: potential implication in hypertension.">
            <entity id="DS.d593.s0.e0" origId="Q10751" charOffset="4-33" type="protein" text="angiotensin-converting enzyme"/>
            <entity id="DS.d593.s0.e1" origId="5359597" charOffset="120-130" type="compound" text="superoxide"/>
            <pair e1="DS.d593.s0.e1" e2="DS.d593.s0.e0" id="DS.d593.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d594" origId="18648748">
        <sentence id="DS.d594.s0" origId="18648748-1370" text="Administration of hesperetin to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, SOD, and CAT activities.">
            <entity id="DS.d594.s0.e0" origId="72281" charOffset="18-28" type="compound" text="hesperetin"/>
            <entity id="DS.d594.s0.e1" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="188-191" type="protein" text="GST"/>
            <entity id="DS.d594.s0.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="198-201" type="protein" text="SOD"/>
            <entity id="DS.d594.s0.e3" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="207-210" type="protein" text="CAT"/>
            <pair e1="DS.d594.s0.e0" e2="DS.d594.s0.e2" id="DS.d594.s0.i0" interaction="True"/>
            <pair e1="DS.d594.s0.e0" e2="DS.d594.s0.e1" id="DS.d594.s0.i1" interaction="True"/>
            <pair e1="DS.d594.s0.e0" e2="DS.d594.s0.e3" id="DS.d594.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d595" origId="18648826">
        <sentence id="DS.d595.s0" origId="18648826-1446" text="Culture of mid-segments of hair follicles in low calcium culture medium kept on agarose increased expression of filaggrin and Kdap, but downregulated expression of involucrin.">
            <entity id="DS.d595.s0.e0" origId="11966311" charOffset="80-87" type="compound" text="agarose"/>
            <entity id="DS.d595.s0.e1" origId="P11088,P20930" charOffset="112-121" type="protein" text="filaggrin"/>
            <entity id="DS.d595.s0.e2" origId="O09043" charOffset="126-130" type="protein" text="Kdap"/>
            <entity id="DS.d595.s0.e3" origId="P07476,P14590,P14591,P14708,P17941,P18174,P18175,P24708,P24709,P24710,P24711,P24712,P48997,P48998,Q95337" charOffset="164-174" type="protein" text="involucrin"/>
            <pair e1="DS.d595.s0.e0" e2="DS.d595.s0.e3" id="DS.d595.s0.i0" interaction="False"/>
            <pair e1="DS.d595.s0.e0" e2="DS.d595.s0.e1" id="DS.d595.s0.i1" interaction="False"/>
            <pair e1="DS.d595.s0.e0" e2="DS.d595.s0.e2" id="DS.d595.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d596" origId="18648877">
        <sentence id="DS.d596.s0" origId="18648877-1504" text="The p-hydroxyphenylpyruvate produced by the Escherichia coli host was converted to HGA through the oxidation reaction of introduced HPPD.">
            <entity id="DS.d596.s0.e0" origId="979" charOffset="4-27" type="compound" text="p-hydroxyphenylpyruvate"/>
            <entity id="DS.d596.s0.e1" origId="449178" charOffset="83-86" type="compound" text="HGA"/>
            <entity id="DS.d596.s0.e2" origId="O42764" charOffset="132-136" type="protein" text="HPPD"/>
            <pair e1="DS.d596.s0.e1" e2="DS.d596.s0.e2" id="DS.d596.s0.i0" interaction="True"/>
            <pair e1="DS.d596.s0.e0" e2="DS.d596.s0.e2" id="DS.d596.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d597" origId="18649000">
        <sentence id="DS.d597.s0" origId="18649000-1622" text="The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to creatinine (CR), PD to CR, the plasma urea-N (PUN) and insulin increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.">
            <entity id="DS.d597.s0.e0" origId="947,123329" charOffset="77-85" type="compound" text="nitrogen"/>
            <entity id="DS.d597.s0.e1" origId="1044" charOffset="114-120" type="compound" text="purine"/>
            <entity id="DS.d597.s0.e2" origId="204" charOffset="163-172" type="compound" text="allantoin"/>
            <entity id="DS.d597.s0.e3" origId="588" charOffset="176-186" type="compound" text="creatinine"/>
            <entity id="DS.d597.s0.e4" origId="23976" charOffset="188-190" type="compound" text="CR"/>
            <entity id="DS.d597.s0.e5" origId="23976" charOffset="199-201" type="compound" text="CR"/>
            <entity id="DS.d597.s0.e6" origId="1176,265993" charOffset="214-218" type="compound" text="urea"/>
            <entity id="DS.d597.s0.e7" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="231-238" type="protein" text="insulin"/>
            <pair e1="DS.d597.s0.e6" e2="DS.d597.s0.e7" id="DS.d597.s0.i0" interaction="False"/>
            <pair e1="DS.d597.s0.e0" e2="DS.d597.s0.e7" id="DS.d597.s0.i1" interaction="False"/>
            <pair e1="DS.d597.s0.e1" e2="DS.d597.s0.e7" id="DS.d597.s0.i2" interaction="False"/>
            <pair e1="DS.d597.s0.e4" e2="DS.d597.s0.e7" id="DS.d597.s0.i3" interaction="False"/>
            <pair e1="DS.d597.s0.e3" e2="DS.d597.s0.e7" id="DS.d597.s0.i4" interaction="False"/>
            <pair e1="DS.d597.s0.e2" e2="DS.d597.s0.e7" id="DS.d597.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d598" origId="18649135">
        <sentence id="DS.d598.s0" origId="18649135-39" text="Activation of interleukin-6/STAT3 in rat cholangiocyte proliferation induced by lipopolysaccharide.">
            <entity id="DS.d598.s0.e0" origId="P41693" charOffset="14-27" type="protein" text="interleukin-6"/>
            <entity id="DS.d598.s0.e1" origId="P40763,P61635" charOffset="28-33" type="protein" text="STAT3"/>
            <entity id="DS.d598.s0.e2" origId="11970143" charOffset="80-98" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d598.s0.e2" e2="DS.d598.s0.e1" id="DS.d598.s0.i0" interaction="True"/>
            <pair e1="DS.d598.s0.e2" e2="DS.d598.s0.e0" id="DS.d598.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d599" origId="18650080">
        <sentence id="DS.d599.s1" origId="18650080-816" text="To investigate the activation pathways triggered by laccase, ESR spin-trapping techniques using N-tert-butyl-alpha-phenylnitrone (PBN) as spin trap followed by ethyl acetate extraction were employed to identify and quantify the free radical intermediates.">
            <entity id="DS.d599.s1.e0" origId="Q12570" charOffset="52-59" type="protein" text="laccase"/>
            <entity id="DS.d599.s1.e1" origId="8857" charOffset="160-173" type="compound" text="ethyl acetate"/>
            <pair e1="DS.d599.s1.e1" e2="DS.d599.s1.e0" id="DS.d599.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d600" origId="18650805">
        <sentence id="DS.d600.s0" origId="18650805-1377" text="Methylation of these CpG sites may lead to reduced OPRM1 expression in the lymphocytes of these former heroin addicts.">
            <entity id="DS.d600.s0.e0" origId="6804" charOffset="21-24" type="compound" text="CpG"/>
            <entity id="DS.d600.s0.e1" origId="P35372,P79350,P97266,Q5IS39,Q5IS84,Q95247,Q95M54,Q9MYW9" charOffset="51-56" type="protein" text="OPRM1"/>
            <pair e1="DS.d600.s0.e0" e2="DS.d600.s0.e1" id="DS.d600.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d601" origId="18651093">
        <sentence id="DS.d601.s0" origId="18651093-1447" text="Two infants with elevated serum gamma-GT had a decreased serum glutamine.">
            <entity id="DS.d601.s0.e0" origId="Q05902" charOffset="32-40" type="protein" text="gamma-GT"/>
            <entity id="DS.d601.s0.e1" origId="738,5961" charOffset="63-72" type="compound" text="glutamine"/>
            <pair e1="DS.d601.s0.e1" e2="DS.d601.s0.e0" id="DS.d601.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d602" origId="18651113">
        <sentence id="DS.d602.s0" origId="18651113-1681" text="Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on titanium with surface-grafted chitosan and immobilized bone morphogenetic protein-2.">
            <entity id="DS.d602.s0.e0" origId="23963" charOffset="83-91" type="compound" text="titanium"/>
            <entity id="DS.d602.s0.e1" origId="P07580" charOffset="143-164" type="protein" text="morphogenetic protein"/>
            <pair e1="DS.d602.s0.e0" e2="DS.d602.s0.e1" id="DS.d602.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d603" origId="18651133">
        <sentence id="DS.d603.s0" origId="18651133-1703" text="None of the compounds altered Cyp11b1 gene expression, indicating that 3-MeSO2-DDE inhibits CYP11B1 activity on the protein level.">
            <entity id="DS.d603.s0.e0" origId="P15393" charOffset="30-37" type="protein" text="Cyp11b1"/>
            <entity id="DS.d603.s0.e1" origId="119115" charOffset="73-82" type="compound" text="MeSO2-DDE"/>
            <entity id="DS.d603.s0.e2" origId="P15150,P15538,P51663,P97720,Q29527,Q29552,Q64408" charOffset="92-99" type="protein" text="CYP11B1"/>
            <pair e1="DS.d603.s0.e1" e2="DS.d603.s0.e0" id="DS.d603.s0.i0" interaction="False"/>
            <pair e1="DS.d603.s0.e1" e2="DS.d603.s0.e2" id="DS.d603.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d604" origId="18651191">
        <sentence id="DS.d604.s0" origId="18651191-669" text="Functional analysis demonstrated that elkj encoded a C20-elongase that mediated the elongation of EPA into docosapentaenoic acid (22:5n-3), confirming the two-step conversion from EPA to DHA in marine microalga.">
            <entity id="DS.d604.s0.e0" origId="Q9SDN0" charOffset="53-56" type="protein" text="C20"/>
            <entity id="DS.d604.s0.e1" origId="3145,5497182,6441454" charOffset="107-128" type="compound" text="docosapentaenoic acid"/>
            <pair e1="DS.d604.s0.e1" e2="DS.d604.s0.e0" id="DS.d604.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d605" origId="18651838">
        <sentence id="DS.d605.s0" origId="18651838-564" text="ANP (atrial natriuretic peptide) exerts its biological effects by binding to GC (guanylate cyclase)-A/NPR (natriuretic peptide receptor)-A, which generates the second messenger cGMP.">
            <entity id="DS.d605.s0.e0" origId="O46540,P01160,P01161,P05125,P07499,P07500,P07501,P09196,P18144,P18908,P18909,P24259,P27104,P27596,P83964,Q805D8,Q805E9,Q9GLD0" charOffset="0-3" type="protein" text="ANP"/>
            <entity id="DS.d605.s0.e1" origId="O46540,P01160,P01161,P05125,P07499,P07500,P07501,P09196,P18144,P18908,P18909,P24259,P27104,P27596,P83964,Q805D8,Q805E9,Q9GLD0" charOffset="5-31" type="protein" text="atrial natriuretic peptide"/>
            <entity id="DS.d605.s0.e2" origId="O94303,P33734,Q9P4P9,Q9SZ30" charOffset="91-98" type="protein" text="cyclase"/>
            <entity id="DS.d605.s0.e3" origId="P20910,Q41249" charOffset="102-105" type="protein" text="NPR"/>
            <entity id="DS.d605.s0.e4" origId="P28374" charOffset="12-31" type="protein" text="natriuretic peptide"/>
            <entity id="DS.d605.s0.e5" origId="24316" charOffset="177-181" type="compound" text="cGMP"/>
            <pair e1="DS.d605.s0.e5" e2="DS.d605.s0.e2" id="DS.d605.s0.i0" interaction="True"/>
            <pair e1="DS.d605.s0.e5" e2="DS.d605.s0.e0" id="DS.d605.s0.i1" interaction="True"/>
            <pair e1="DS.d605.s0.e5" e2="DS.d605.s0.e3" id="DS.d605.s0.i2" interaction="True"/>
            <pair e1="DS.d605.s0.e5" e2="DS.d605.s0.e4" id="DS.d605.s0.i3" interaction="True"/>
            <pair e1="DS.d605.s0.e5" e2="DS.d605.s0.e1" id="DS.d605.s0.i4" interaction="True"/>
        </sentence>
        <sentence id="DS.d605.s1" origId="18651838-565" text="Overexpression of Ets-1 enhanced significantly Npr1 mRNA levels, protein expression, GC activity and ANP-stimulated intracellular accumulation of cGMP in transfected cells.">
            <entity id="DS.d605.s1.e0" origId="P27577,P41156" charOffset="18-23" type="protein" text="Ets-1"/>
            <entity id="DS.d605.s1.e1" origId="P18293,P18910" charOffset="47-51" type="protein" text="Npr1"/>
            <entity id="DS.d605.s1.e2" origId="O46540,P01160,P01161,P05125,P07499,P07500,P07501,P09196,P18144,P18908,P18909,P24259,P27104,P27596,P83964,Q805D8,Q805E9,Q9GLD0" charOffset="101-104" type="protein" text="ANP"/>
            <entity id="DS.d605.s1.e3" origId="24316" charOffset="146-150" type="compound" text="cGMP"/>
            <pair e1="DS.d605.s1.e3" e2="DS.d605.s1.e1" id="DS.d605.s1.i0" interaction="False"/>
            <pair e1="DS.d605.s1.e3" e2="DS.d605.s1.e2" id="DS.d605.s1.i1" interaction="True"/>
            <pair e1="DS.d605.s1.e3" e2="DS.d605.s1.e0" id="DS.d605.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d606" origId="18652538">
        <sentence id="DS.d606.s0" origId="18652538-1158" text="In the current study, these cells were cultured with three different media: &quot; BMP-plus&quot; medium containing dexamethasone and 100 ng/mL of rhBMP-2, &quot;odontogenic&quot; medium containing dexamethasone, and &quot;control&quot; medium without supplements.">
            <entity id="DS.d606.s0.e0" origId="P35855" charOffset="78-81" type="protein" text="BMP"/>
            <entity id="DS.d606.s0.e1" origId="5743" charOffset="106-119" type="compound" text="dexamethasone"/>
            <entity id="DS.d606.s0.e2" origId="5743" charOffset="178-191" type="compound" text="dexamethasone"/>
            <pair e1="DS.d606.s0.e1" e2="DS.d606.s0.e0" id="DS.d606.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d607" origId="18652864">
        <sentence id="DS.d607.s0" origId="18652864-1389" text="The allatostatins (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit juvenile hormone (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.">
            <entity id="DS.d607.s0.e0" origId="P42559" charOffset="4-17" type="protein" text="allatostatins"/>
            <entity id="DS.d607.s0.e1" origId="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67" charOffset="19-23" type="protein" text="ASTs"/>
            <entity id="DS.d607.s0.e2" origId="P21259" charOffset="83-96" type="protein" text="neuropeptides"/>
            <entity id="DS.d607.s0.e3" origId="6439662" charOffset="160-176" type="compound" text="juvenile hormone"/>
            <pair e1="DS.d607.s0.e3" e2="DS.d607.s0.e1" id="DS.d607.s0.i0" interaction="True"/>
            <pair e1="DS.d607.s0.e3" e2="DS.d607.s0.e0" id="DS.d607.s0.i1" interaction="True"/>
            <pair e1="DS.d607.s0.e3" e2="DS.d607.s0.e2" id="DS.d607.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d608" origId="18652909">
        <sentence id="DS.d608.s0" origId="18652909-1018" text="Lecithin:retinol acyltransferase (LRAT) catalyzes the esterification of retinol (vitamin A).">
            <entity id="DS.d608.s0.e1" origId="O95237,Q9BGL2" charOffset="34-38" type="protein" text="LRAT"/>
            <entity id="DS.d608.s0.e2" origId="445354" charOffset="81-90" type="compound" text="vitamin A"/>
            <pair e1="DS.d608.s0.e2" e2="DS.d608.s0.e1" id="DS.d608.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d608.s1" origId="18652909-1019" text="Retinoic acid (RA) treatment increased this LRAT promoter-luciferase activity in PrEC cells, but not in PC-3 cells.">
            <entity id="DS.d608.s1.e0" origId="444795" charOffset="0-13" type="compound" text="Retinoic acid"/>
            <entity id="DS.d608.s1.e1" origId="O95237,Q9BGL2" charOffset="44-48" type="protein" text="LRAT"/>
            <entity id="DS.d608.s1.e2" origId="P08659,P13129,Q01158,Q26304,Q27757" charOffset="58-68" type="protein" text="luciferase"/>
            <pair e1="DS.d608.s1.e0" e2="DS.d608.s1.e1" id="DS.d608.s1.i0" interaction="True"/>
            <pair e1="DS.d608.s1.e0" e2="DS.d608.s1.e2" id="DS.d608.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d609" origId="18654608">
        <sentence id="DS.d609.s0" origId="18654608-1184" text="As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-REIC treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to doxorubicin and of the P-glycoprotein expression.">
            <entity id="DS.d609.s0.e0" origId="Q9UBP4" charOffset="126-130" type="protein" text="REIC"/>
            <entity id="DS.d609.s0.e1" origId="31703" charOffset="228-239" type="compound" text="doxorubicin"/>
            <entity id="DS.d609.s0.e2" origId="P08163" charOffset="253-265" type="protein" text="glycoprotein"/>
            <pair e1="DS.d609.s0.e1" e2="DS.d609.s0.e2" id="DS.d609.s0.i0" interaction="False"/>
            <pair e1="DS.d609.s0.e1" e2="DS.d609.s0.e0" id="DS.d609.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d609.s1" origId="18654608-1185" text="Ad-REIC treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through JNK activation, and sensitized its drug resistance against doxorubicin.">
            <entity id="DS.d609.s1.e0" origId="Q9UBP4" charOffset="3-7" type="protein" text="REIC"/>
            <entity id="DS.d609.s1.e1" origId="P08163" charOffset="57-69" type="protein" text="glycoprotein"/>
            <entity id="DS.d609.s1.e2" origId="P92208,Q966Y3" charOffset="90-93" type="protein" text="JNK"/>
            <entity id="DS.d609.s1.e3" origId="31703" charOffset="149-160" type="compound" text="doxorubicin"/>
            <pair e1="DS.d609.s1.e3" e2="DS.d609.s1.e2" id="DS.d609.s1.i0" interaction="False"/>
            <pair e1="DS.d609.s1.e3" e2="DS.d609.s1.e1" id="DS.d609.s1.i1" interaction="False"/>
            <pair e1="DS.d609.s1.e3" e2="DS.d609.s1.e0" id="DS.d609.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d610" origId="18654747">
        <sentence id="DS.d610.s0" origId="18654747-1289" text="Diflomotecan, a homocamptothecin, targets DNA topoisomerase I.">
            <entity id="DS.d610.s0.e0" origId="219023" charOffset="0-12" type="compound" text="Diflomotecan"/>
            <entity id="DS.d610.s0.e1" origId="O27661,O28469,O34204,O51768,O58356,O66893,O69548,O73954,O83409,P04786,P06612,P07799,P0A2I1,P0A2I2,P0A620,P0A621,P11387,P16472,P30181,P30189,P32989,P34184,P34185,P39814,P40114,P41511,P41512,P43012,P46155,P46799,P47368,P55991,P57371,P68697,P68698,P73810,P78032,P93119,Q00313,Q04750,Q07050,Q59046,Q76ZS7,Q7YR26,Q87AQ6,Q8K9P7,Q92IH1,Q9CG80,Q9CN30,Q9HM08,Q9HZJ5,Q9JN65,Q9KA23,Q9KRB2,Q9PEV8,Q9PLZ2,Q9UYS8,Q9WUL0,Q9X3X7,Q9X909,Q9YB01,Q9ZDK2,Q9ZMV7" charOffset="42-61" type="protein" text="DNA topoisomerase I"/>
            <pair e1="DS.d610.s0.e0" e2="DS.d610.s0.e1" id="DS.d610.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d611" origId="18654835">
        <sentence id="DS.d611.s0" origId="18654835-1331" text="Both MudPIT and cDNA microarray analyses indicate that H2O2 treatment caused elevated levels of thioredoxin reductase 1.">
            <entity id="DS.d611.s0.e0" origId="784" charOffset="55-59" type="compound" text="H2O2"/>
            <entity id="DS.d611.s0.e1" origId="P29509,Q17745,Q39243" charOffset="96-119" type="protein" text="thioredoxin reductase 1"/>
            <pair e1="DS.d611.s0.e0" e2="DS.d611.s0.e1" id="DS.d611.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d612" origId="18655070">
        <sentence id="DS.d612.s0" origId="18655070-1550" text="Altogether these changes offer a straightforward explanation for how following the addition of Ca(2+), the coelenterazine could escape and become available for bioluminescence on Renilla luciferase.">
            <entity id="DS.d612.s0.e0" origId="271" charOffset="95-99" type="compound" text="Ca(2"/>
            <entity id="DS.d612.s0.e1" origId="2830" charOffset="107-121" type="compound" text="coelenterazine"/>
            <entity id="DS.d612.s0.e2" origId="P08659,P13129,Q01158,Q26304,Q27757" charOffset="187-197" type="protein" text="luciferase"/>
            <pair e1="DS.d612.s0.e1" e2="DS.d612.s0.e2" id="DS.d612.s0.i0" interaction="True"/>
            <pair e1="DS.d612.s0.e0" e2="DS.d612.s0.e2" id="DS.d612.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d613" origId="18655138">
        <sentence id="DS.d613.s0" origId="18655138-1615" text="The APTS functionalization was then used to immobilize bone morphogenetic protein on the bioactive glasses.">
            <entity id="DS.d613.s0.e0" origId="4346576" charOffset="4-8" type="compound" text="APTS"/>
            <entity id="DS.d613.s0.e1" origId="P07580" charOffset="60-81" type="protein" text="morphogenetic protein"/>
            <pair e1="DS.d613.s0.e0" e2="DS.d613.s0.e1" id="DS.d613.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d614" origId="18655158">
        <sentence id="DS.d614.s0" origId="18655158-1630" text="L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (KAT) I and KAT II.">
            <entity id="DS.d614.s0.e0" origId="846" charOffset="2-12" type="compound" text="Kynurenine"/>
            <entity id="DS.d614.s0.e1" origId="161166" charOffset="14-17" type="compound" text="KYN"/>
            <entity id="DS.d614.s0.e2" origId="1148,6305,9060,5460840" charOffset="22-32" type="compound" text="tryptophan"/>
            <entity id="DS.d614.s0.e3" origId="3845" charOffset="63-77" type="compound" text="kynurenic acid"/>
            <entity id="DS.d614.s0.e4" origId="3845" charOffset="79-83" type="compound" text="KYNA"/>
            <entity id="DS.d614.s0.e5" origId="846" charOffset="182-192" type="compound" text="kynurenine"/>
            <entity id="DS.d614.s0.e6" origId="Q8NFU3" charOffset="211-214" type="protein" text="KAT"/>
            <entity id="DS.d614.s0.e7" origId="Q8NFU3" charOffset="222-225" type="protein" text="KAT"/>
            <pair e1="DS.d614.s0.e4" e2="DS.d614.s0.e6" id="DS.d614.s0.i0" interaction="True"/>
            <pair e1="DS.d614.s0.e1" e2="DS.d614.s0.e6" id="DS.d614.s0.i1" interaction="True"/>
            <pair e1="DS.d614.s0.e0" e2="DS.d614.s0.e6" id="DS.d614.s0.i2" interaction="True"/>
            <pair e1="DS.d614.s0.e3" e2="DS.d614.s0.e6" id="DS.d614.s0.i3" interaction="True"/>
            <pair e1="DS.d614.s0.e2" e2="DS.d614.s0.e6" id="DS.d614.s0.i4" interaction="False"/>
            <pair e1="DS.d614.s0.e5" e2="DS.d614.s0.e6" id="DS.d614.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d615" origId="18655176">
        <sentence id="DS.d615.s0" origId="18655176-1654" text="Exposure to benzo(a)pyrene (BaP) by intraperitoneal injection increased biliary BaP metabolites and liver CYP1A gene expression.">
            <entity id="DS.d615.s0.e0" origId="2336" charOffset="12-26" type="compound" text="benzo(a)pyrene"/>
            <entity id="DS.d615.s0.e1" origId="Q6JZS3,Q92039,Q9YH64" charOffset="106-111" type="protein" text="CYP1A"/>
            <pair e1="DS.d615.s0.e0" e2="DS.d615.s0.e1" id="DS.d615.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d616" origId="18655177">
        <sentence id="DS.d616.s0" origId="18655177-1378" text="We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.">
            <entity id="DS.d616.s0.e0" origId="4004" charOffset="53-62" type="compound" text="malathion"/>
            <entity id="DS.d616.s0.e1" origId="4004" charOffset="88-97" type="compound" text="malathion"/>
            <entity id="DS.d616.s0.e2" origId="54670067" charOffset="118-127" type="compound" text="vitamin C"/>
            <entity id="DS.d616.s0.e3" origId="2116,14985,1548900,1742129" charOffset="147-156" type="compound" text="vitamin E"/>
            <entity id="DS.d616.s0.e4" origId="10964" charOffset="191-206" type="compound" text="malondialdehyde"/>
            <entity id="DS.d616.s0.e5" origId="O50258" charOffset="218-238" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d616.s0.e6" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="240-243" type="protein" text="SOD"/>
            <entity id="DS.d616.s0.e7" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="246-254" type="protein" text="catalase"/>
            <entity id="DS.d616.s0.e8" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="256-259" type="protein" text="CAT"/>
            <entity id="DS.d616.s0.e9" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="266-288" type="protein" text="glutathione peroxidase"/>
            <pair e1="DS.d616.s0.e3" e2="DS.d616.s0.e8" id="DS.d616.s0.i0" interaction="False"/>
            <pair e1="DS.d616.s0.e4" e2="DS.d616.s0.e7" id="DS.d616.s0.i1" interaction="False"/>
            <pair e1="DS.d616.s0.e2" e2="DS.d616.s0.e8" id="DS.d616.s0.i2" interaction="False"/>
            <pair e1="DS.d616.s0.e0" e2="DS.d616.s0.e9" id="DS.d616.s0.i3" interaction="False"/>
            <pair e1="DS.d616.s0.e3" e2="DS.d616.s0.e5" id="DS.d616.s0.i4" interaction="False"/>
            <pair e1="DS.d616.s0.e3" e2="DS.d616.s0.e7" id="DS.d616.s0.i5" interaction="False"/>
            <pair e1="DS.d616.s0.e2" e2="DS.d616.s0.e6" id="DS.d616.s0.i6" interaction="False"/>
            <pair e1="DS.d616.s0.e3" e2="DS.d616.s0.e6" id="DS.d616.s0.i7" interaction="False"/>
            <pair e1="DS.d616.s0.e0" e2="DS.d616.s0.e5" id="DS.d616.s0.i8" interaction="False"/>
            <pair e1="DS.d616.s0.e4" e2="DS.d616.s0.e6" id="DS.d616.s0.i9" interaction="False"/>
            <pair e1="DS.d616.s0.e4" e2="DS.d616.s0.e9" id="DS.d616.s0.i10" interaction="False"/>
            <pair e1="DS.d616.s0.e2" e2="DS.d616.s0.e7" id="DS.d616.s0.i11" interaction="False"/>
            <pair e1="DS.d616.s0.e0" e2="DS.d616.s0.e8" id="DS.d616.s0.i12" interaction="False"/>
            <pair e1="DS.d616.s0.e0" e2="DS.d616.s0.e6" id="DS.d616.s0.i13" interaction="False"/>
            <pair e1="DS.d616.s0.e4" e2="DS.d616.s0.e8" id="DS.d616.s0.i14" interaction="False"/>
            <pair e1="DS.d616.s0.e0" e2="DS.d616.s0.e7" id="DS.d616.s0.i15" interaction="False"/>
            <pair e1="DS.d616.s0.e4" e2="DS.d616.s0.e5" id="DS.d616.s0.i16" interaction="False"/>
            <pair e1="DS.d616.s0.e2" e2="DS.d616.s0.e9" id="DS.d616.s0.i17" interaction="False"/>
            <pair e1="DS.d616.s0.e3" e2="DS.d616.s0.e9" id="DS.d616.s0.i18" interaction="False"/>
            <pair e1="DS.d616.s0.e2" e2="DS.d616.s0.e5" id="DS.d616.s0.i19" interaction="False"/>
        </sentence>
        <sentence id="DS.d616.s1" origId="18655177-1379" text="Erythrocytes were incubated under various treatment conditions (malathion alone, vitamins alone, or malathion plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and SOD, CAT and GPx activities, were determined.">
            <entity id="DS.d616.s1.e0" origId="4004" charOffset="64-73" type="compound" text="malathion"/>
            <entity id="DS.d616.s1.e1" origId="4004" charOffset="100-109" type="compound" text="malathion"/>
            <entity id="DS.d616.s1.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="179-182" type="protein" text="SOD"/>
            <entity id="DS.d616.s1.e3" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="184-187" type="protein" text="CAT"/>
            <pair e1="DS.d616.s1.e0" e2="DS.d616.s1.e3" id="DS.d616.s1.i0" interaction="True"/>
            <pair e1="DS.d616.s1.e0" e2="DS.d616.s1.e2" id="DS.d616.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d616.s2" origId="18655177-1380" text="Treatment with malathion alone increased the levels of MDA and decreased SOD, CAT 0.05).">
            <entity id="DS.d616.s2.e0" origId="4004" charOffset="15-24" type="compound" text="malathion"/>
            <entity id="DS.d616.s2.e1" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="73-76" type="protein" text="SOD"/>
            <entity id="DS.d616.s2.e2" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="78-81" type="protein" text="CAT"/>
            <pair e1="DS.d616.s2.e0" e2="DS.d616.s2.e2" id="DS.d616.s2.i0" interaction="True"/>
            <pair e1="DS.d616.s2.e0" e2="DS.d616.s2.e1" id="DS.d616.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d617" origId="18655190">
        <sentence id="DS.d617.s0" origId="18655190-1668" text="Adrenomedullin reduces antioxidant defense system and enhances kidney tissue damage in cadmium and lead exposed rats.">
            <entity id="DS.d617.s0.e0" origId="O62827,O77559,P35318,P43145,P53366,P97297" charOffset="0-14" type="protein" text="Adrenomedullin"/>
            <entity id="DS.d617.s0.e1" origId="23973" charOffset="87-94" type="compound" text="cadmium"/>
            <pair e1="DS.d617.s0.e1" e2="DS.d617.s0.e0" id="DS.d617.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d617.s1" origId="18655190-1669" text="In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.">
            <entity id="DS.d617.s1.e0" origId="O50258" charOffset="92-112" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d617.s1.e1" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="114-117" type="protein" text="SOD"/>
            <entity id="DS.d617.s1.e2" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="120-128" type="protein" text="catalase"/>
            <entity id="DS.d617.s1.e3" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="130-133" type="protein" text="CAT"/>
            <entity id="DS.d617.s1.e4" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="140-162" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d617.s1.e5" origId="124886" charOffset="164-167" type="compound" text="GSH"/>
            <entity id="DS.d617.s1.e6" origId="10964" charOffset="207-222" type="compound" text="malondialdehyde"/>
            <pair e1="DS.d617.s1.e5" e2="DS.d617.s1.e1" id="DS.d617.s1.i0" interaction="False"/>
            <pair e1="DS.d617.s1.e5" e2="DS.d617.s1.e4" id="DS.d617.s1.i1" interaction="False"/>
            <pair e1="DS.d617.s1.e5" e2="DS.d617.s1.e0" id="DS.d617.s1.i2" interaction="False"/>
            <pair e1="DS.d617.s1.e6" e2="DS.d617.s1.e1" id="DS.d617.s1.i3" interaction="False"/>
            <pair e1="DS.d617.s1.e6" e2="DS.d617.s1.e4" id="DS.d617.s1.i4" interaction="False"/>
            <pair e1="DS.d617.s1.e5" e2="DS.d617.s1.e3" id="DS.d617.s1.i5" interaction="False"/>
            <pair e1="DS.d617.s1.e6" e2="DS.d617.s1.e3" id="DS.d617.s1.i6" interaction="False"/>
            <pair e1="DS.d617.s1.e5" e2="DS.d617.s1.e2" id="DS.d617.s1.i7" interaction="False"/>
            <pair e1="DS.d617.s1.e6" e2="DS.d617.s1.e0" id="DS.d617.s1.i8" interaction="False"/>
            <pair e1="DS.d617.s1.e6" e2="DS.d617.s1.e2" id="DS.d617.s1.i9" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d618" origId="18655797">
        <sentence id="DS.d618.s0" origId="18655797-440" text="We found that Fos expression in LH orexin neurons varied in proportion to preference for morphine, cocaine or food.">
            <entity id="DS.d618.s0.e0" origId="P01101,P12841,Q56415" charOffset="14-17" type="protein" text="Fos"/>
            <entity id="DS.d618.s0.e1" origId="5288826,5479215" charOffset="89-97" type="compound" text="morphine"/>
            <entity id="DS.d618.s0.e2" origId="2826,5760,439497,446220,644017,54613779" charOffset="99-106" type="compound" text="cocaine"/>
            <pair e1="DS.d618.s0.e2" e2="DS.d618.s0.e0" id="DS.d618.s0.i0" interaction="True"/>
            <pair e1="DS.d618.s0.e1" e2="DS.d618.s0.e0" id="DS.d618.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d618.s1" origId="18655797-441" text="Recent studies showed that LH orexin neurons that project to ventral tegmental area (VTA) have greater Fos induction in association with elevated morphine preference during protracted withdrawal than non-VTA-projecting orexin neurons, indicating that the VTA is an important site of action for orexin's role in reward processing.">
            <entity id="DS.d618.s1.e0" origId="P01101,P12841,Q56415" charOffset="103-106" type="protein" text="Fos"/>
            <entity id="DS.d618.s1.e1" origId="5288826,5479215" charOffset="146-154" type="compound" text="morphine"/>
            <pair e1="DS.d618.s1.e1" e2="DS.d618.s1.e0" id="DS.d618.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d619" origId="18655808">
        <sentence id="DS.d619.s0" origId="18655808-447" text="Cytochromes c are metalloproteins that function in electron transfer reactions and contain a heme moiety covalently attached via thioether linkages between the co-factor and a CXXCH motif in the protein.">
            <entity id="DS.d619.s0.e0" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="0-13" type="protein" text="Cytochromes c"/>
            <entity id="DS.d619.s0.e1" origId="4971" charOffset="93-97" type="compound" text="heme"/>
            <pair e1="DS.d619.s0.e1" e2="DS.d619.s0.e0" id="DS.d619.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d620" origId="18655848">
        <sentence id="DS.d620.s0" origId="18655848-489" text="The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.">
            <entity id="DS.d620.s0.e0" origId="6326970" charOffset="25-33" type="compound" text="selenium"/>
            <entity id="DS.d620.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="170-178" type="protein" text="Catalase"/>
            <entity id="DS.d620.s0.e2" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="180-183" type="protein" text="CAT"/>
            <entity id="DS.d620.s0.e3" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="186-208" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d620.s0.e4" origId="O50258" charOffset="216-236" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d620.s0.e5" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="238-241" type="protein" text="SOD"/>
            <entity id="DS.d620.s0.e6" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="244-269" type="protein" text="glutathione S-transferase"/>
            <entity id="DS.d620.s0.e7" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="271-274" type="protein" text="GST"/>
            <entity id="DS.d620.s0.e8" origId="124886" charOffset="277-296" type="compound" text="reduced glutathione"/>
            <entity id="DS.d620.s0.e9" origId="124886" charOffset="298-301" type="compound" text="GSH"/>
            <pair e1="DS.d620.s0.e0" e2="DS.d620.s0.e6" id="DS.d620.s0.i0" interaction="False"/>
            <pair e1="DS.d620.s0.e9" e2="DS.d620.s0.e6" id="DS.d620.s0.i1" interaction="False"/>
            <pair e1="DS.d620.s0.e8" e2="DS.d620.s0.e1" id="DS.d620.s0.i2" interaction="False"/>
            <pair e1="DS.d620.s0.e9" e2="DS.d620.s0.e5" id="DS.d620.s0.i3" interaction="False"/>
            <pair e1="DS.d620.s0.e9" e2="DS.d620.s0.e3" id="DS.d620.s0.i4" interaction="False"/>
            <pair e1="DS.d620.s0.e0" e2="DS.d620.s0.e1" id="DS.d620.s0.i5" interaction="False"/>
            <pair e1="DS.d620.s0.e8" e2="DS.d620.s0.e3" id="DS.d620.s0.i6" interaction="False"/>
            <pair e1="DS.d620.s0.e8" e2="DS.d620.s0.e7" id="DS.d620.s0.i7" interaction="False"/>
            <pair e1="DS.d620.s0.e0" e2="DS.d620.s0.e2" id="DS.d620.s0.i8" interaction="False"/>
            <pair e1="DS.d620.s0.e9" e2="DS.d620.s0.e4" id="DS.d620.s0.i9" interaction="False"/>
            <pair e1="DS.d620.s0.e0" e2="DS.d620.s0.e7" id="DS.d620.s0.i10" interaction="False"/>
            <pair e1="DS.d620.s0.e8" e2="DS.d620.s0.e5" id="DS.d620.s0.i11" interaction="False"/>
            <pair e1="DS.d620.s0.e9" e2="DS.d620.s0.e2" id="DS.d620.s0.i12" interaction="False"/>
            <pair e1="DS.d620.s0.e0" e2="DS.d620.s0.e3" id="DS.d620.s0.i13" interaction="False"/>
            <pair e1="DS.d620.s0.e8" e2="DS.d620.s0.e2" id="DS.d620.s0.i14" interaction="False"/>
            <pair e1="DS.d620.s0.e9" e2="DS.d620.s0.e1" id="DS.d620.s0.i15" interaction="False"/>
            <pair e1="DS.d620.s0.e9" e2="DS.d620.s0.e7" id="DS.d620.s0.i16" interaction="False"/>
            <pair e1="DS.d620.s0.e0" e2="DS.d620.s0.e4" id="DS.d620.s0.i17" interaction="False"/>
            <pair e1="DS.d620.s0.e0" e2="DS.d620.s0.e5" id="DS.d620.s0.i18" interaction="False"/>
            <pair e1="DS.d620.s0.e8" e2="DS.d620.s0.e6" id="DS.d620.s0.i19" interaction="False"/>
            <pair e1="DS.d620.s0.e8" e2="DS.d620.s0.e4" id="DS.d620.s0.i20" interaction="False"/>
        </sentence>
        <sentence id="DS.d620.s1" origId="18655848-490" text="MPc also increased GST activity in all tissues with a concurrent decrease in GSH levels.">
            <entity id="DS.d620.s1.e0" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="19-22" type="protein" text="GST"/>
            <entity id="DS.d620.s1.e1" origId="124886" charOffset="77-80" type="compound" text="GSH"/>
            <pair e1="DS.d620.s1.e1" e2="DS.d620.s1.e0" id="DS.d620.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d621" origId="18656273">
        <sentence id="DS.d621.s0" origId="18656273-863" text="Resveratrol reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes.">
            <entity id="DS.d621.s0.e0" origId="445154" charOffset="0-11" type="compound" text="Resveratrol"/>
            <entity id="DS.d621.s0.e1" origId="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76" charOffset="21-25" type="protein" text="ET-1"/>
            <entity id="DS.d621.s0.e2" origId="P29323" charOffset="122-125" type="protein" text="ERK"/>
            <pair e1="DS.d621.s0.e0" e2="DS.d621.s0.e2" id="DS.d621.s0.i0" interaction="True"/>
            <pair e1="DS.d621.s0.e0" e2="DS.d621.s0.e1" id="DS.d621.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d621.s1" origId="18656273-864" text="Pretreatment with the MEK-ERK inhibitor (PD98059) appreciably reversed the mitogenic effects of ET-1.">
            <entity id="DS.d621.s1.e0" origId="4713" charOffset="41-48" type="compound" text="PD98059"/>
            <entity id="DS.d621.s1.e1" origId="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76" charOffset="96-100" type="protein" text="ET-1"/>
            <pair e1="DS.d621.s1.e0" e2="DS.d621.s1.e1" id="DS.d621.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d621.s2" origId="18656273-865" text="On the other hand, pretreatment with the polyphenolic stilbene resveratrol (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and ERK1/2 activation.">
            <entity id="DS.d621.s2.e0" origId="638088" charOffset="54-62" type="compound" text="stilbene"/>
            <entity id="DS.d621.s2.e1" origId="445154" charOffset="63-74" type="compound" text="resveratrol"/>
            <entity id="DS.d621.s2.e2" origId="P27361,P28869,P42525,Q07176" charOffset="170-174" type="protein" text="ERK1"/>
            <pair e1="DS.d621.s2.e0" e2="DS.d621.s2.e2" id="DS.d621.s2.i0" interaction="False"/>
            <pair e1="DS.d621.s2.e1" e2="DS.d621.s2.e2" id="DS.d621.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d621.s3" origId="18656273-866" text="Further, pretreatment with the specific cGMP-phosphodiesterase inhibitor, zaprinast (10 microM) appreciably augmented RSVL-evoked cGMP formation, ERK inhibition, and cytostatic response.">
            <entity id="DS.d621.s3.e0" origId="5722" charOffset="74-83" type="compound" text="zaprinast"/>
            <entity id="DS.d621.s3.e1" origId="P29323" charOffset="146-149" type="protein" text="ERK"/>
            <pair e1="DS.d621.s3.e0" e2="DS.d621.s3.e1" id="DS.d621.s3.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d621.s4" origId="18656273-867" text="Moreover, the RSVL-induced ERK-inhibitory effects were significantly reversed by the kinase-G inhibitor, KT-5823 (10 microM; 69%), but not by the kinase-A inhibitor (KT-5720).">
            <entity id="DS.d621.s4.e0" origId="P29323" charOffset="27-30" type="protein" text="ERK"/>
            <entity id="DS.d621.s4.e1" origId="108152" charOffset="105-112" type="compound" text="KT-5823"/>
            <entity id="DS.d621.s4.e2" origId="3844,454202,16219545" charOffset="166-173" type="compound" text="KT-5720"/>
            <pair e1="DS.d621.s4.e2" e2="DS.d621.s4.e0" id="DS.d621.s4.i0" interaction="False"/>
            <pair e1="DS.d621.s4.e1" e2="DS.d621.s4.e0" id="DS.d621.s4.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d622" origId="18656335">
        <sentence id="DS.d622.s0" origId="18656335-913" text="Adding beta-carotene to the diet of the mice during the period of irradiation suppressed the activity and expression of MMP-9 as well as the wrinkling and sagging formation.">
            <entity id="DS.d622.s0.e0" origId="5280489" charOffset="7-20" type="compound" text="beta-carotene"/>
            <entity id="DS.d622.s0.e1" origId="O18733,P14780,P41245,P41246,P50282,P52176" charOffset="120-125" type="protein" text="MMP-9"/>
            <pair e1="DS.d622.s0.e0" e2="DS.d622.s0.e1" id="DS.d622.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d622.s1" origId="18656335-914" text="Dietary beta-carotene prevents the expression of MMP-9, at least partly, by inhibiting photodynamic action involved in the formation of Chol-OOHs.">
            <entity id="DS.d622.s1.e0" origId="5280489" charOffset="8-21" type="compound" text="beta-carotene"/>
            <entity id="DS.d622.s1.e1" origId="O18733,P14780,P41245,P41246,P50282,P52176" charOffset="49-54" type="protein" text="MMP-9"/>
            <pair e1="DS.d622.s1.e0" e2="DS.d622.s1.e1" id="DS.d622.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d623" origId="18656337">
        <sentence id="DS.d623.s0" origId="18656337-916" text="Exposure to linoleic acid for 6 h induced expression of both caveolin-1 and cyclooxygenase (COX)-2.">
            <entity id="DS.d623.s0.e0" origId="5280450" charOffset="12-25" type="compound" text="linoleic acid"/>
            <entity id="DS.d623.s0.e1" origId="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8" charOffset="61-71" type="protein" text="caveolin-1"/>
            <entity id="DS.d623.s0.e2" origId="P11353,P36551,P36552,Q9UTE2,Q9V3D2" charOffset="92-95" type="protein" text="COX"/>
            <pair e1="DS.d623.s0.e0" e2="DS.d623.s0.e2" id="DS.d623.s0.i0" interaction="True"/>
            <pair e1="DS.d623.s0.e0" e2="DS.d623.s0.e1" id="DS.d623.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d623.s1" origId="18656337-917" text="Pretreatment with EGCG blocked fatty-acid-induced caveolin-1 and COX-2 expression in a time- and concentration-dependent manner.">
            <entity id="DS.d623.s1.e0" origId="65064" charOffset="18-22" type="compound" text="EGCG"/>
            <entity id="DS.d623.s1.e1" origId="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8" charOffset="50-60" type="protein" text="caveolin-1"/>
            <entity id="DS.d623.s1.e2" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="65-70" type="protein" text="COX-2"/>
            <pair e1="DS.d623.s1.e0" e2="DS.d623.s1.e1" id="DS.d623.s1.i0" interaction="True"/>
            <pair e1="DS.d623.s1.e0" e2="DS.d623.s1.e2" id="DS.d623.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d623.s2" origId="18656337-918" text="Exposure to linoleic acid rapidly increased phosphorylation of several kinases, including p38 MAPK, extracellular signal regulated kinase 1/2 (ERK1/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.">
            <entity id="DS.d623.s2.e0" origId="5280450" charOffset="12-25" type="compound" text="linoleic acid"/>
            <entity id="DS.d623.s2.e1" origId="O62618" charOffset="90-98" type="protein" text="p38 MAPK"/>
            <entity id="DS.d623.s2.e2" origId="P21708,P27361,P28869,P42525,Q63844" charOffset="100-139" type="protein" text="extracellular signal regulated kinase 1"/>
            <entity id="DS.d623.s2.e3" origId="P27361,P28869,P42525,Q07176" charOffset="143-147" type="protein" text="ERK1"/>
            <entity id="DS.d623.s2.e4" origId="P31750,Q8INB9" charOffset="178-181" type="protein" text="Akt"/>
            <pair e1="DS.d623.s2.e0" e2="DS.d623.s2.e1" id="DS.d623.s2.i0" interaction="True"/>
            <pair e1="DS.d623.s2.e0" e2="DS.d623.s2.e4" id="DS.d623.s2.i1" interaction="True"/>
            <pair e1="DS.d623.s2.e0" e2="DS.d623.s2.e2" id="DS.d623.s2.i2" interaction="True"/>
            <pair e1="DS.d623.s2.e0" e2="DS.d623.s2.e3" id="DS.d623.s2.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d623.s3" origId="18656337-919" text="Inhibitors of ERK1/2 and Akt down-regulated the linoleic-acid-induced increase in COX-2 protein, which also occurred after pretreatment with EGCG.">
            <entity id="DS.d623.s3.e0" origId="5280450" charOffset="48-61" type="compound" text="linoleic-acid"/>
            <entity id="DS.d623.s3.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="82-87" type="protein" text="COX-2"/>
            <entity id="DS.d623.s3.e2" origId="65064" charOffset="141-145" type="compound" text="EGCG"/>
            <pair e1="DS.d623.s3.e0" e2="DS.d623.s3.e1" id="DS.d623.s3.i0" interaction="True"/>
            <pair e1="DS.d623.s3.e2" e2="DS.d623.s3.e1" id="DS.d623.s3.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d623.s4" origId="18656337-920" text="Caveolin-1 silencing blocked linoleic-acid-induced phosphorylation of ERK1/2 and protein expression of COX-2, suggesting that specific MAPK signaling is caveolae dependent.">
            <entity id="DS.d623.s4.e0" origId="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8" charOffset="0-10" type="protein" text="Caveolin-1"/>
            <entity id="DS.d623.s4.e1" origId="5280450" charOffset="29-42" type="compound" text="linoleic-acid"/>
            <entity id="DS.d623.s4.e2" origId="P27361,P28869,P42525,Q07176" charOffset="70-74" type="protein" text="ERK1"/>
            <entity id="DS.d623.s4.e3" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="103-108" type="protein" text="COX-2"/>
            <entity id="DS.d623.s4.e4" origId="O42781,P27638,Q00859" charOffset="135-139" type="protein" text="MAPK"/>
            <pair e1="DS.d623.s4.e1" e2="DS.d623.s4.e2" id="DS.d623.s4.i0" interaction="True"/>
            <pair e1="DS.d623.s4.e1" e2="DS.d623.s4.e0" id="DS.d623.s4.i1" interaction="False"/>
            <pair e1="DS.d623.s4.e1" e2="DS.d623.s4.e4" id="DS.d623.s4.i2" interaction="True"/>
            <pair e1="DS.d623.s4.e1" e2="DS.d623.s4.e3" id="DS.d623.s4.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d624" origId="18656338">
        <sentence id="DS.d624.s0" origId="18656338-921" text="Apigenin causes G(2)/M arrest associated with the modulation of p21 (Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.">
            <entity id="DS.d624.s0.e0" origId="5280443" charOffset="0-8" type="compound" text="Apigenin"/>
            <entity id="DS.d624.s0.e1" origId="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2" charOffset="64-67" type="protein" text="p21"/>
            <entity id="DS.d624.s0.e2" origId="O42923,P39689" charOffset="69-73" type="protein" text="Cip1"/>
            <entity id="DS.d624.s0.e3" origId="P04551,P11440,P23572,P39951" charOffset="79-83" type="protein" text="Cdc2"/>
            <entity id="DS.d624.s0.e4" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="98-101" type="protein" text="p53"/>
            <pair e1="DS.d624.s0.e0" e2="DS.d624.s0.e3" id="DS.d624.s0.i0" interaction="True"/>
            <pair e1="DS.d624.s0.e0" e2="DS.d624.s0.e4" id="DS.d624.s0.i1" interaction="True"/>
            <pair e1="DS.d624.s0.e0" e2="DS.d624.s0.e1" id="DS.d624.s0.i2" interaction="True"/>
            <pair e1="DS.d624.s0.e0" e2="DS.d624.s0.e2" id="DS.d624.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d624.s1" origId="18656338-922" text="To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and CDK4.">
            <entity id="DS.d624.s1.e0" origId="5280443" charOffset="72-80" type="compound" text="apigenin"/>
            <entity id="DS.d624.s1.e1" origId="5280443" charOffset="122-130" type="compound" text="apigenin"/>
            <entity id="DS.d624.s1.e2" origId="5280443" charOffset="141-149" type="compound" text="Apigenin"/>
            <entity id="DS.d624.s1.e3" origId="Q5SCB5" charOffset="178-186" type="protein" text="cyclin D"/>
            <entity id="DS.d624.s1.e5" origId="O55076,P24941,P43450,P48963,Q5E9Y0" charOffset="230-234" type="protein" text="CDK2"/>
            <entity id="DS.d624.s1.e6" origId="P11802,P79432" charOffset="239-243" type="protein" text="CDK4"/>
            <pair e1="DS.d624.s1.e0" e2="DS.d624.s1.e3" id="DS.d624.s1.i0" interaction="True"/>
            <pair e1="DS.d624.s1.e2" e2="DS.d624.s1.e5" id="DS.d624.s1.i2" interaction="False"/>
            <pair e1="DS.d624.s1.e0" e2="DS.d624.s1.e6" id="DS.d624.s1.i4" interaction="False"/>
            <pair e1="DS.d624.s1.e2" e2="DS.d624.s1.e3" id="DS.d624.s1.i5" interaction="True"/>
            <pair e1="DS.d624.s1.e0" e2="DS.d624.s1.e5" id="DS.d624.s1.i6" interaction="False"/>
            <pair e1="DS.d624.s1.e2" e2="DS.d624.s1.e6" id="DS.d624.s1.i7" interaction="False"/>
        </sentence>
        <sentence id="DS.d624.s2" origId="18656338-923" text="In addition, the apigenin-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in CDK1 together with cyclin A and cyclin B.">
            <entity id="DS.d624.s2.e0" origId="5280443" charOffset="17-25" type="compound" text="apigenin"/>
            <entity id="DS.d624.s2.e1" origId="P00546,P06493,P11440,P13863,P39951,P43063,P48734,P51958,Q5RCH1,Q9DG98,Q9DGA2,Q9DGA5,Q9DGD3" charOffset="116-120" type="protein" text="CDK1"/>
            <entity id="DS.d624.s2.e2" origId="P20248,P30274,P37881,P43449,P51943,Q92161" charOffset="135-143" type="protein" text="cyclin A"/>
            <entity id="DS.d624.s2.e3" origId="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268" charOffset="135-141" type="protein" text="cyclin"/>
            <pair e1="DS.d624.s2.e0" e2="DS.d624.s2.e2" id="DS.d624.s2.i1" interaction="True"/>
            <pair e1="DS.d624.s2.e0" e2="DS.d624.s2.e1" id="DS.d624.s2.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d624.s3" origId="18656338-924" text="In an additional study, apigenin also increased the accumulation of p53 and further enhanced the level of p21 (Cip1), with no change in p27 (Kip1).">
            <entity id="DS.d624.s3.e0" origId="5280443" charOffset="24-32" type="compound" text="apigenin"/>
            <entity id="DS.d624.s3.e1" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="68-71" type="protein" text="p53"/>
            <entity id="DS.d624.s3.e2" origId="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2" charOffset="106-109" type="protein" text="p21"/>
            <entity id="DS.d624.s3.e3" origId="O42923,P39689" charOffset="111-115" type="protein" text="Cip1"/>
            <entity id="DS.d624.s3.e4" origId="O11451,O11452,O11453,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P06934,P16342,P19751,P25880,P25881,P25882,P25884,P25989,P26660,P26661,P26662,P26663,P26664,P27958,P29833,P29846,P29996,P29997,P40305,P68763,P68764,P68765,P69180,P69181,P69182,P69183,P69184,P69618,P69619,Q00269,Q43735,Q5I2N3,Q66198,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q81835,Q81842,Q8V439,Q8V6W7,Q913D4,Q91A29,Q91DH7,Q91DH8,Q91DH9,Q99IB8,Q9DHD6,Q9E925,Q9PYA3,Q9QAX1,Q9WMX2" charOffset="136-139" type="protein" text="p27"/>
            <pair e1="DS.d624.s3.e0" e2="DS.d624.s3.e2" id="DS.d624.s3.i0" interaction="True"/>
            <pair e1="DS.d624.s3.e0" e2="DS.d624.s3.e3" id="DS.d624.s3.i1" interaction="True"/>
            <pair e1="DS.d624.s3.e0" e2="DS.d624.s3.e4" id="DS.d624.s3.i2" interaction="False"/>
            <pair e1="DS.d624.s3.e0" e2="DS.d624.s3.e1" id="DS.d624.s3.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d624.s4" origId="18656338-925" text="The expression of Bax and cytochrome c of p53 downstream target was increased markedly at high concentration treatment over 50 microM apigenin.">
            <entity id="DS.d624.s4.e0" origId="P27297,Q07813,Q63690" charOffset="18-21" type="protein" text="Bax"/>
            <entity id="DS.d624.s4.e1" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="26-38" type="protein" text="cytochrome c"/>
            <entity id="DS.d624.s4.e2" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="42-45" type="protein" text="p53"/>
            <entity id="DS.d624.s4.e3" origId="5280443" charOffset="134-142" type="compound" text="apigenin"/>
            <pair e1="DS.d624.s4.e3" e2="DS.d624.s4.e1" id="DS.d624.s4.i0" interaction="True"/>
            <pair e1="DS.d624.s4.e3" e2="DS.d624.s4.e2" id="DS.d624.s4.i1" interaction="True"/>
            <pair e1="DS.d624.s4.e3" e2="DS.d624.s4.e0" id="DS.d624.s4.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d625" origId="18656400">
        <sentence id="DS.d625.s0" origId="18656400-711" text="Therefore, we next examined whether 5-HT2A and 5-HT2C receptors are involved, and from where 5-HT is released in the formalin test.">
            <entity id="DS.d625.s0.e0" origId="P50129" charOffset="36-42" type="protein" text="5-HT2A"/>
            <entity id="DS.d625.s0.e1" origId="P08909,P28335,P34968,Q5IS66,Q60F97" charOffset="47-53" type="protein" text="5-HT2C"/>
            <entity id="DS.d625.s0.e2" origId="5202" charOffset="36-40" type="compound" text="5-HT"/>
            <entity id="DS.d625.s0.e3" origId="712" charOffset="117-125" type="compound" text="formalin"/>
            <pair e1="DS.d625.s0.e3" e2="DS.d625.s0.e0" id="DS.d625.s0.i0" interaction="False"/>
            <pair e1="DS.d625.s0.e2" e2="DS.d625.s0.e1" id="DS.d625.s0.i1" interaction="False"/>
            <pair e1="DS.d625.s0.e2" e2="DS.d625.s0.e0" id="DS.d625.s0.i2" interaction="False"/>
            <pair e1="DS.d625.s0.e3" e2="DS.d625.s0.e1" id="DS.d625.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d625.s1" origId="18656400-713" text="These results indicate that 5-HT released into peripheral tissue and its receptors, 5-HT2A as well as 5-HT2C, at the periphery have an important role in pain-related behaviors during acute peripheral inflammation.">
            <entity id="DS.d625.s1.e0" origId="5202" charOffset="28-32" type="compound" text="5-HT"/>
            <entity id="DS.d625.s1.e1" origId="P50129" charOffset="84-90" type="protein" text="5-HT2A"/>
            <entity id="DS.d625.s1.e2" origId="P08909,P28335,P34968,Q5IS66,Q60F97" charOffset="102-108" type="protein" text="5-HT2C"/>
            <pair e1="DS.d625.s1.e0" e2="DS.d625.s1.e1" id="DS.d625.s1.i0" interaction="True"/>
            <pair e1="DS.d625.s1.e0" e2="DS.d625.s1.e2" id="DS.d625.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d626" origId="18656896">
        <sentence id="DS.d626.s0" origId="18656896-1449" text="Haloperidol strongly decreased the expression of BDNF 0.01).">
            <entity id="DS.d626.s0.e0" origId="3559" charOffset="0-11" type="compound" text="Haloperidol"/>
            <entity id="DS.d626.s0.e1" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="49-53" type="protein" text="BDNF"/>
            <pair e1="DS.d626.s0.e0" e2="DS.d626.s0.e1" id="DS.d626.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d626.s1" origId="18656896-1450" text="In contrast, the administration of ziprasidone significantly attenuated the immobilization stress-induced decrease in BDNF 0.01).">
            <entity id="DS.d626.s1.e0" origId="60854" charOffset="35-46" type="compound" text="ziprasidone"/>
            <entity id="DS.d626.s1.e1" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="118-122" type="protein" text="BDNF"/>
            <pair e1="DS.d626.s1.e0" e2="DS.d626.s1.e1" id="DS.d626.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d626.s2" origId="18656896-1451" text="Ziprasidone exhibited differential effects on BDNF mRNA expression in the rat hippocampus and neocortex.">
            <entity id="DS.d626.s2.e0" origId="60854" charOffset="0-11" type="compound" text="Ziprasidone"/>
            <entity id="DS.d626.s2.e1" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="46-50" type="protein" text="BDNF"/>
            <pair e1="DS.d626.s2.e0" e2="DS.d626.s2.e1" id="DS.d626.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d626.s3" origId="18656896-1452" text="These results suggest that ziprasidone might have a neuroprotective effect by recovering stress-induced decreases in BDNF mRNA expression.">
            <entity id="DS.d626.s3.e0" origId="60854" charOffset="27-38" type="compound" text="ziprasidone"/>
            <entity id="DS.d626.s3.e1" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="117-121" type="protein" text="BDNF"/>
            <pair e1="DS.d626.s3.e0" e2="DS.d626.s3.e1" id="DS.d626.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d627" origId="18657000">
        <sentence id="DS.d627.s0" origId="18657000-1427" text="In conclusion, fructose overload in rats induced hypertriglyceridemia and insulin resistance associated with an enhanced oxidative stress.">
            <entity id="DS.d627.s0.e0" origId="5984" charOffset="15-23" type="compound" text="fructose"/>
            <entity id="DS.d627.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="74-81" type="protein" text="insulin"/>
            <pair e1="DS.d627.s0.e0" e2="DS.d627.s0.e1" id="DS.d627.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d628" origId="18657005">
        <sentence id="DS.d628.s0" origId="18657005-297" text="Clinical and biochemical parameters including fructosamine (FAM), glycated hemoglobin (HbA1c) and serum AGEs were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.">
            <entity id="DS.d628.s0.e0" origId="20484" charOffset="46-58" type="compound" text="fructosamine"/>
            <entity id="DS.d628.s0.e1" origId="P15160,P17724,P73925,Q03459" charOffset="75-85" type="protein" text="hemoglobin"/>
            <entity id="DS.d628.s0.e2" origId="O18921,P17560,P51606,P51607,P82343" charOffset="104-108" type="protein" text="AGEs"/>
            <pair e1="DS.d628.s0.e0" e2="DS.d628.s0.e2" id="DS.d628.s0.i0" interaction="False"/>
            <pair e1="DS.d628.s0.e0" e2="DS.d628.s0.e1" id="DS.d628.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d629" origId="18657007">
        <sentence id="DS.d629.s0" origId="18657007-1437" text="Leptin and soluble leptin receptor changes after pulmonary endarterectomy: relations to cortisol and cytokine network.">
            <entity id="DS.d629.s0.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="0-6" type="protein" text="Leptin"/>
            <entity id="DS.d629.s0.e1" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="19-25" type="protein" text="leptin"/>
            <entity id="DS.d629.s0.e2" origId="5754" charOffset="88-96" type="compound" text="cortisol"/>
            <pair e1="DS.d629.s0.e2" e2="DS.d629.s0.e1" id="DS.d629.s0.i0" interaction="True"/>
            <pair e1="DS.d629.s0.e2" e2="DS.d629.s0.e0" id="DS.d629.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d629.s1" origId="18657007-1438" text="Leptin and soluble leptin receptor (SLR) were compared with evolution of cortisol and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).">
            <entity id="DS.d629.s1.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="0-6" type="protein" text="Leptin"/>
            <entity id="DS.d629.s1.e1" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="19-25" type="protein" text="leptin"/>
            <entity id="DS.d629.s1.e2" origId="5754" charOffset="73-81" type="compound" text="cortisol"/>
            <pair e1="DS.d629.s1.e2" e2="DS.d629.s1.e1" id="DS.d629.s1.i0" interaction="False"/>
            <pair e1="DS.d629.s1.e2" e2="DS.d629.s1.e0" id="DS.d629.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d630" origId="18657009">
        <sentence id="DS.d630.s0" origId="18657009-1440" text="Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of CAV-1, and evaluated the effects of tight metabolic control (insulin, 12 IU/day) and angiotensin receptor blocker, losartan (4 weeks, 20 mg/kg/day).">
            <entity id="DS.d630.s0.e0" origId="Q9YGM8" charOffset="149-154" type="protein" text="CAV-1"/>
            <entity id="DS.d630.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="210-217" type="protein" text="insulin"/>
            <entity id="DS.d630.s0.e2" origId="3961" charOffset="264-272" type="compound" text="losartan"/>
            <pair e1="DS.d630.s0.e2" e2="DS.d630.s0.e0" id="DS.d630.s0.i0" interaction="False"/>
            <pair e1="DS.d630.s0.e2" e2="DS.d630.s0.e1" id="DS.d630.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d631" origId="18657194">
        <sentence id="DS.d631.s0" origId="18657194-724" text="Androgenic action correlates inversely with a polymorphic CAG repeat region in the AR gene encoding for glutamine residues the length of which appears to influence high density lipoprotein (HDL) cholesterol levels.">
            <entity id="DS.d631.s0.e0" origId="738,5961" charOffset="104-113" type="compound" text="glutamine"/>
            <entity id="DS.d631.s0.e1" origId="P81182" charOffset="164-188" type="protein" text="high density lipoprotein"/>
            <entity id="DS.d631.s0.e2" origId="304,5997,6432564,11025495" charOffset="195-206" type="compound" text="cholesterol"/>
            <pair e1="DS.d631.s0.e2" e2="DS.d631.s0.e1" id="DS.d631.s0.i0" interaction="True"/>
            <pair e1="DS.d631.s0.e0" e2="DS.d631.s0.e1" id="DS.d631.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d632" origId="18657228">
        <sentence id="DS.d632.s0" origId="18657228-1396" text="These vessels are formed by proliferating cells that incorporate bromodeoxyuridine and express the endothelial cell markers vegfr2/kdr and fli1.">
            <entity id="DS.d632.s0.e0" origId="6035" charOffset="65-82" type="compound" text="bromodeoxyuridine"/>
            <entity id="DS.d632.s0.e1" origId="O08775,P35918,Q8AXB3" charOffset="131-134" type="protein" text="kdr"/>
            <entity id="DS.d632.s0.e2" origId="P26323,P41157,Q9JJ28" charOffset="139-143" type="protein" text="fli1"/>
            <pair e1="DS.d632.s0.e0" e2="DS.d632.s0.e1" id="DS.d632.s0.i0" interaction="False"/>
            <pair e1="DS.d632.s0.e0" e2="DS.d632.s0.e2" id="DS.d632.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d632.s1" origId="18657228-1398" text="Moreover, similar to rFGF2, injection of the zebrafish form of vascular endothelial growth factor-A (VEGF-A) induces a significant angiogenic response in the ZFYM assay that is suppressed by the VEGF receptor-2/KDR TK inhibitor SU5416.">
            <entity id="DS.d632.s1.e0" origId="P26617" charOffset="63-99" type="protein" text="vascular endothelial growth factor-A"/>
            <entity id="DS.d632.s1.e1" origId="P15691,P15692,P16612,P26617,P49151,P50412,P67860,P67964,P67965,P83906,Q00731,Q99PS1,Q9GKR0,Q9MYV3" charOffset="101-107" type="protein" text="VEGF-A"/>
            <entity id="DS.d632.s1.e2" origId="5329098" charOffset="228-234" type="compound" text="SU5416"/>
            <pair e1="DS.d632.s1.e2" e2="DS.d632.s1.e0" id="DS.d632.s1.i0" interaction="True"/>
            <pair e1="DS.d632.s1.e2" e2="DS.d632.s1.e1" id="DS.d632.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d633" origId="18657961">
        <sentence id="DS.d633.s0" origId="18657961-1695" text="In this study, we examined ferulate for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/IkappaB kinase (IKK) and mitogen-activated protein kinases (MAPKs) by reducing oxidative stress in aged rats.">
            <entity id="DS.d633.s0.e0" origId="445858" charOffset="27-35" type="compound" text="ferulate"/>
            <entity id="DS.d633.s0.e1" origId="O95819,Q99558" charOffset="149-152" type="protein" text="NIK"/>
            <entity id="DS.d633.s0.e2" origId="O15111,Q60680" charOffset="154-168" type="protein" text="IkappaB kinase"/>
            <entity id="DS.d633.s0.e3" origId="Q00859" charOffset="179-212" type="protein" text="mitogen-activated protein kinases"/>
            <entity id="DS.d633.s0.e4" origId="O42781,P27638,Q00859" charOffset="214-219" type="protein" text="MAPKs"/>
            <pair e1="DS.d633.s0.e0" e2="DS.d633.s0.e2" id="DS.d633.s0.i0" interaction="True"/>
            <pair e1="DS.d633.s0.e0" e2="DS.d633.s0.e3" id="DS.d633.s0.i1" interaction="True"/>
            <pair e1="DS.d633.s0.e0" e2="DS.d633.s0.e4" id="DS.d633.s0.i2" interaction="True"/>
            <pair e1="DS.d633.s0.e0" e2="DS.d633.s0.e1" id="DS.d633.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d633.s1" origId="18657961-1696" text="Data show that in aged kidney tissue, ferulate exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, iNOS, VCAM-1 and ICAM-1.">
            <entity id="DS.d633.s1.e0" origId="445858" charOffset="38-46" type="compound" text="ferulate"/>
            <entity id="DS.d633.s1.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="216-221" type="protein" text="COX-2"/>
            <entity id="DS.d633.s1.e2" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="223-227" type="protein" text="iNOS"/>
            <entity id="DS.d633.s1.e3" origId="P19320,P29533,P29534,Q28260" charOffset="229-235" type="protein" text="VCAM-1"/>
            <entity id="DS.d633.s1.e4" origId="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132" charOffset="240-246" type="protein" text="ICAM-1"/>
            <pair e1="DS.d633.s1.e0" e2="DS.d633.s1.e1" id="DS.d633.s1.i0" interaction="True"/>
            <pair e1="DS.d633.s1.e0" e2="DS.d633.s1.e3" id="DS.d633.s1.i1" interaction="True"/>
            <pair e1="DS.d633.s1.e0" e2="DS.d633.s1.e2" id="DS.d633.s1.i2" interaction="True"/>
            <pair e1="DS.d633.s1.e0" e2="DS.d633.s1.e4" id="DS.d633.s1.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d633.s2" origId="18657961-1698" text="The molecular modulation of NF-kappaB by ferulate was further revealed in endothelial YPEN-1 cells through ferulate's ability to suppress the activation of NIK/IKK and MAPKs.">
            <entity id="DS.d633.s2.e0" origId="445858" charOffset="41-49" type="compound" text="ferulate"/>
            <entity id="DS.d633.s2.e1" origId="445858" charOffset="107-115" type="compound" text="ferulate"/>
            <entity id="DS.d633.s2.e2" origId="O95819,Q99558" charOffset="156-159" type="protein" text="NIK"/>
            <entity id="DS.d633.s2.e3" origId="O42781,P27638,Q00859" charOffset="168-173" type="protein" text="MAPKs"/>
            <pair e1="DS.d633.s2.e0" e2="DS.d633.s2.e2" id="DS.d633.s2.i0" interaction="True"/>
            <pair e1="DS.d633.s2.e0" e2="DS.d633.s2.e3" id="DS.d633.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d633.s3" origId="18657961-1699" text="Based on these results, we conclude that ferulate's antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of NIK/IKK and MAPKs in vivo.">
            <entity id="DS.d633.s3.e0" origId="445858" charOffset="41-49" type="compound" text="ferulate"/>
            <entity id="DS.d633.s3.e1" origId="O95819,Q99558" charOffset="155-158" type="protein" text="NIK"/>
            <entity id="DS.d633.s3.e2" origId="O42781,P27638,Q00859" charOffset="167-172" type="protein" text="MAPKs"/>
            <pair e1="DS.d633.s3.e0" e2="DS.d633.s3.e1" id="DS.d633.s3.i0" interaction="True"/>
            <pair e1="DS.d633.s3.e0" e2="DS.d633.s3.e2" id="DS.d633.s3.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d634" origId="18658095">
        <sentence id="DS.d634.s0" origId="18658095-656" text="Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).">
            <entity id="DS.d634.s0.e0" origId="5957" charOffset="153-156" type="compound" text="ATP"/>
            <entity id="DS.d634.s0.e1" origId="3988,5311263,5497152" charOffset="161-182" type="compound" text="lysophosphatidic acid"/>
            <entity id="DS.d634.s0.e2" origId="P01132,P01133,P07522,Q00968,Q95ND4,Q9BEA0" charOffset="218-241" type="protein" text="epidermal growth factor"/>
            <entity id="DS.d634.s0.e3" origId="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0" charOffset="243-246" type="protein" text="EGF"/>
            <entity id="DS.d634.s0.e4" origId="P00533,P13387,P55245" charOffset="258-262" type="protein" text="EGFR"/>
            <entity id="DS.d634.s0.e5" origId="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0" charOffset="258-261" type="protein" text="EGF"/>
            <entity id="DS.d634.s0.e6" origId="Q01580,Q06175,Q06186,Q09118,Q99075" charOffset="335-341" type="protein" text="HB-EGF"/>
            <pair e1="DS.d634.s0.e0" e2="DS.d634.s0.e4" id="DS.d634.s0.i0" interaction="True"/>
            <pair e1="DS.d634.s0.e1" e2="DS.d634.s0.e6" id="DS.d634.s0.i1" interaction="True"/>
            <pair e1="DS.d634.s0.e0" e2="DS.d634.s0.e2" id="DS.d634.s0.i2" interaction="True"/>
            <pair e1="DS.d634.s0.e1" e2="DS.d634.s0.e4" id="DS.d634.s0.i3" interaction="True"/>
            <pair e1="DS.d634.s0.e1" e2="DS.d634.s0.e3" id="DS.d634.s0.i4" interaction="True"/>
            <pair e1="DS.d634.s0.e1" e2="DS.d634.s0.e2" id="DS.d634.s0.i5" interaction="True"/>
            <pair e1="DS.d634.s0.e0" e2="DS.d634.s0.e3" id="DS.d634.s0.i6" interaction="True"/>
            <pair e1="DS.d634.s0.e0" e2="DS.d634.s0.e6" id="DS.d634.s0.i7" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d635" origId="18660796">
        <sentence id="DS.d635.s0" origId="18660796-396" text="Nitric oxide is a free radical molecule synthesized from L-arginine by nitric oxide synthases that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.">
            <entity id="DS.d635.s0.e0" origId="145068" charOffset="0-12" type="compound" text="Nitric oxide"/>
            <entity id="DS.d635.s0.e1" origId="6322" charOffset="57-67" type="compound" text="L-arginine"/>
            <entity id="DS.d635.s0.e2" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="71-93" type="protein" text="nitric oxide synthases"/>
            <pair e1="DS.d635.s0.e0" e2="DS.d635.s0.e2" id="DS.d635.s0.i0" interaction="True"/>
            <pair e1="DS.d635.s0.e1" e2="DS.d635.s0.e2" id="DS.d635.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d636" origId="18661133">
        <sentence id="DS.d636.s0" origId="18661133-1463" text="Furthermore, restoration of KSR1 expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and cytochalasin H and decreased ERK1/2 activation following exposure to these drugs.">
            <entity id="DS.d636.s0.e0" origId="Q8IVT5" charOffset="28-32" type="protein" text="KSR1"/>
            <entity id="DS.d636.s0.e1" origId="Q8IVT5" charOffset="108-112" type="protein" text="KSR1"/>
            <entity id="DS.d636.s0.e2" origId="5351303,6434468,13892272,17751001" charOffset="181-195" type="compound" text="cytochalasin H"/>
            <entity id="DS.d636.s0.e3" origId="P27361,P28869,P42525,Q07176" charOffset="210-214" type="protein" text="ERK1"/>
            <pair e1="DS.d636.s0.e2" e2="DS.d636.s0.e3" id="DS.d636.s0.i0" interaction="False"/>
            <pair e1="DS.d636.s0.e2" e2="DS.d636.s0.e0" id="DS.d636.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d638" origId="18661233">
        <sentence id="DS.d638.s0" origId="18661233-1568" text="We demonstrated the increase in the levels of p53, Bax, and cytochrome c and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with baicalein in N18 cells.">
            <entity id="DS.d638.s0.e0" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="46-49" type="protein" text="p53"/>
            <entity id="DS.d638.s0.e1" origId="P27297,Q07813,Q63690" charOffset="51-54" type="protein" text="Bax"/>
            <entity id="DS.d638.s0.e2" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="60-72" type="protein" text="cytochrome c"/>
            <entity id="DS.d638.s0.e3" origId="P10417,P49950" charOffset="102-107" type="protein" text="Bcl-2"/>
            <entity id="DS.d638.s0.e4" origId="5281605" charOffset="199-208" type="compound" text="baicalein"/>
            <pair e1="DS.d638.s0.e4" e2="DS.d638.s0.e2" id="DS.d638.s0.i0" interaction="True"/>
            <pair e1="DS.d638.s0.e4" e2="DS.d638.s0.e3" id="DS.d638.s0.i1" interaction="True"/>
            <pair e1="DS.d638.s0.e4" e2="DS.d638.s0.e1" id="DS.d638.s0.i2" interaction="True"/>
            <pair e1="DS.d638.s0.e4" e2="DS.d638.s0.e0" id="DS.d638.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d639" origId="18661547">
        <sentence id="DS.d639.s0" origId="18661547-124" text="GFP-fluorescent cells were slowly cycling, as shown by their long-term retention of BrdU, and less than 10% expressed the proliferative markers Ki67 and Mcm2.">
            <entity id="DS.d639.s0.e0" origId="6035" charOffset="84-88" type="compound" text="BrdU"/>
            <entity id="DS.d639.s0.e1" origId="P07759,P40377,P49735,P55861,P97310,Q6DIH3" charOffset="153-157" type="protein" text="Mcm2"/>
            <pair e1="DS.d639.s0.e0" e2="DS.d639.s0.e1" id="DS.d639.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d640" origId="18662278">
        <sentence id="DS.d640.s0" origId="18662278-741" text="MTHFR gene polymorphisms and high levels of homocysteine are associated with a high degree of steatosis and fibrosis, conditions associated with a low sustained virological response (SVR) rate.">
            <entity id="DS.d640.s0.e0" origId="P42898,Q5I598,Q60HE5" charOffset="0-5" type="protein" text="MTHFR"/>
            <entity id="DS.d640.s0.e1" origId="778" charOffset="44-56" type="compound" text="homocysteine"/>
            <pair e1="DS.d640.s0.e1" e2="DS.d640.s0.e0" id="DS.d640.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d641" origId="18662930">
        <sentence id="DS.d641.s0" origId="18662930-1285" text="Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes.">
            <entity id="DS.d641.s0.e0" origId="24759" charOffset="0-10" type="compound" text="Hyaluronan"/>
            <entity id="DS.d641.s0.e1" origId="O75173,Q5RFQ8,Q9TT93" charOffset="34-41" type="protein" text="ADAMTS4"/>
            <entity id="DS.d641.s0.e2" origId="O75173,Q5RFQ8,Q8BNJ2,Q9ESP7,Q9TT93" charOffset="43-56" type="protein" text="aggrecanase-1"/>
            <pair e1="DS.d641.s0.e0" e2="DS.d641.s0.e2" id="DS.d641.s0.i0" interaction="True"/>
            <pair e1="DS.d641.s0.e0" e2="DS.d641.s0.e1" id="DS.d641.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d642" origId="18663366">
        <sentence id="DS.d642.s0" origId="18663366-1650" text="The discovery that a common polymorphism (5-HTTLPR, short variant) in the human serotonin transporter gene (SLC6A4) can influence personality traits and increase the risk for depression in adulthood has led to the hypothesis that a relative increase in the extracellular levels of serotonin (5-HT) during development could be critical for the establishment of brain circuits.">
            <entity id="DS.d642.s0.e0" origId="O35899,P31645,Q9MYX0,Q9XT49" charOffset="108-114" type="protein" text="SLC6A4"/>
            <entity id="DS.d642.s0.e1" origId="5202" charOffset="42-46" type="compound" text="5-HT"/>
            <pair e1="DS.d642.s0.e1" e2="DS.d642.s0.e0" id="DS.d642.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d643" origId="18663367">
        <sentence id="DS.d643.s0" origId="18663367-1653" text="Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, beta-estradiol, calmodulin and tumour necrosis factor.">
            <entity id="DS.d643.s0.e1" origId="Q96EV8" charOffset="132-138" type="protein" text="DTNBP1"/>
            <entity id="DS.d643.s0.e2" origId="Q96EV8" charOffset="187-193" type="protein" text="DTNBP1"/>
            <entity id="DS.d643.s0.e3" origId="444795" charOffset="217-230" type="compound" text="retinoic acid"/>
            <entity id="DS.d643.s0.e4" origId="5757" charOffset="232-246" type="compound" text="beta-estradiol"/>
            <entity id="DS.d643.s0.e5" origId="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0" charOffset="248-258" type="protein" text="calmodulin"/>
            <pair e1="DS.d643.s0.e3" e2="DS.d643.s0.e5" id="DS.d643.s0.i1" interaction="False"/>
            <pair e1="DS.d643.s0.e3" e2="DS.d643.s0.e1" id="DS.d643.s0.i3" interaction="True"/>
            <pair e1="DS.d643.s0.e4" e2="DS.d643.s0.e5" id="DS.d643.s0.i4" interaction="False"/>
            <pair e1="DS.d643.s0.e4" e2="DS.d643.s0.e1" id="DS.d643.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d644" origId="18663553">
        <sentence id="DS.d644.s0" origId="18663553-101" text="Prior to the first dose of leflunomide, serum concentrations of studied chemokines correlated with marker of RA activity such as the erythrocyte sedimentation rate and IL-8 level with DAS.">
            <entity id="DS.d644.s0.e0" origId="3899" charOffset="27-38" type="compound" text="leflunomide"/>
            <entity id="DS.d644.s0.e1" origId="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5" charOffset="168-172" type="protein" text="IL-8"/>
            <pair e1="DS.d644.s0.e0" e2="DS.d644.s0.e1" id="DS.d644.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d645" origId="18663559">
        <sentence id="DS.d645.s0" origId="18663559-103" text="Hypothetically, cytochrome P450 2D6 influences the transport of taurine across the blood-brain barrier.">
            <entity id="DS.d645.s0.e0" origId="P10635,Q2XNC8,Q2XNC9" charOffset="16-35" type="protein" text="cytochrome P450 2D6"/>
            <entity id="DS.d645.s0.e1" origId="1123" charOffset="64-71" type="compound" text="taurine"/>
            <pair e1="DS.d645.s0.e1" e2="DS.d645.s0.e0" id="DS.d645.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d646" origId="18663659">
        <sentence id="DS.d646.s0" origId="18663659-168" text="Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to itraconazole, including ERG6, ERG7, ERG11, ERG24, ERG25 and ERG26.">
            <entity id="DS.d646.s0.e0" origId="3793,55283,6917738,14179013" charOffset="115-127" type="compound" text="itraconazole"/>
            <entity id="DS.d646.s0.e1" origId="O74198,P25087,Q5EN22,Q6BRB7,Q6C2D9,Q6CYB3,Q6FRZ7,Q759S7,Q875K1" charOffset="139-143" type="protein" text="ERG6"/>
            <entity id="DS.d646.s0.e2" origId="P38604,Q04782,Q96WJ0" charOffset="145-149" type="protein" text="ERG7"/>
            <entity id="DS.d646.s0.e3" origId="P10613,P10614,P14263,P49602,P50859,Q759W0" charOffset="151-156" type="protein" text="ERG11"/>
            <entity id="DS.d646.s0.e4" origId="P32462" charOffset="158-163" type="protein" text="ERG24"/>
            <entity id="DS.d646.s0.e5" origId="O59933,P53045,Q15800" charOffset="165-170" type="protein" text="ERG25"/>
            <entity id="DS.d646.s0.e6" origId="P53199" charOffset="175-180" type="protein" text="ERG26"/>
            <pair e1="DS.d646.s0.e0" e2="DS.d646.s0.e2" id="DS.d646.s0.i0" interaction="True"/>
            <pair e1="DS.d646.s0.e0" e2="DS.d646.s0.e3" id="DS.d646.s0.i1" interaction="True"/>
            <pair e1="DS.d646.s0.e0" e2="DS.d646.s0.e1" id="DS.d646.s0.i2" interaction="True"/>
            <pair e1="DS.d646.s0.e0" e2="DS.d646.s0.e5" id="DS.d646.s0.i3" interaction="True"/>
            <pair e1="DS.d646.s0.e0" e2="DS.d646.s0.e6" id="DS.d646.s0.i4" interaction="True"/>
            <pair e1="DS.d646.s0.e0" e2="DS.d646.s0.e4" id="DS.d646.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d647" origId="18665046">
        <sentence id="DS.d647.s0" origId="18665046-1318" text="In prolonged OJ with LPS administration, hepatocyte apoptosis depending on Fas ligand expression significantly increased in association with a decrease in ATP contents, thus resulting in liver necrapoptosis.">
            <entity id="DS.d647.s0.e0" origId="P36940,P41047,P48023,P63306,P63307,P63308,Q861W5,Q9BDN1,Q9BEA8" charOffset="75-85" type="protein" text="Fas ligand"/>
            <entity id="DS.d647.s0.e1" origId="5957" charOffset="155-158" type="compound" text="ATP"/>
            <pair e1="DS.d647.s0.e1" e2="DS.d647.s0.e0" id="DS.d647.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d648" origId="18665051">
        <sentence id="DS.d648.s0" origId="18665051-1321" text="Administration of ethyl pyruvate to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of CTLA-4, Foxp3 on Tregs, and IL-10 production after burns.">
            <entity id="DS.d648.s0.e0" origId="12041" charOffset="18-32" type="compound" text="ethyl pyruvate"/>
            <entity id="DS.d648.s0.e1" origId="P09793,P16410,P42072,Q9MYX7,Q9XSI1" charOffset="122-128" type="protein" text="CTLA-4"/>
            <entity id="DS.d648.s0.e2" origId="Q99JB6" charOffset="130-135" type="protein" text="Foxp3"/>
            <entity id="DS.d648.s0.e3" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="150-155" type="protein" text="IL-10"/>
            <pair e1="DS.d648.s0.e0" e2="DS.d648.s0.e2" id="DS.d648.s0.i0" interaction="True"/>
            <pair e1="DS.d648.s0.e0" e2="DS.d648.s0.e3" id="DS.d648.s0.i1" interaction="True"/>
            <pair e1="DS.d648.s0.e0" e2="DS.d648.s0.e1" id="DS.d648.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d649" origId="18665052">
        <sentence id="DS.d649.s0" origId="18665052-290" text="In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).">
            <entity id="DS.d649.s0.e0" origId="6022" charOffset="123-144" type="compound" text="adenosine diphosphate"/>
            <entity id="DS.d649.s0.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="174-178" type="protein" text="iNOS"/>
            <entity id="DS.d649.s0.e2" origId="O02789,O57486,P04053,P06526,P09838,P36195,P42118,Q92089" charOffset="248-284" type="protein" text="terminal deoxynucleotidyltransferase"/>
            <entity id="DS.d649.s0.e3" origId="P27297,Q07813,Q63690" charOffset="320-323" type="protein" text="Bax"/>
            <entity id="DS.d649.s0.e4" origId="P10417,P49950" charOffset="329-334" type="protein" text="Bcl-2"/>
            <entity id="DS.d649.s0.e5" origId="3495,14982,128229,44260118,45358130,46878350" charOffset="411-423" type="compound" text="glycyrrhizin"/>
            <pair e1="DS.d649.s0.e0" e2="DS.d649.s0.e1" id="DS.d649.s0.i0" interaction="False"/>
            <pair e1="DS.d649.s0.e5" e2="DS.d649.s0.e3" id="DS.d649.s0.i1" interaction="True"/>
            <pair e1="DS.d649.s0.e0" e2="DS.d649.s0.e4" id="DS.d649.s0.i2" interaction="False"/>
            <pair e1="DS.d649.s0.e5" e2="DS.d649.s0.e1" id="DS.d649.s0.i3" interaction="True"/>
            <pair e1="DS.d649.s0.e0" e2="DS.d649.s0.e3" id="DS.d649.s0.i4" interaction="False"/>
            <pair e1="DS.d649.s0.e0" e2="DS.d649.s0.e2" id="DS.d649.s0.i5" interaction="False"/>
            <pair e1="DS.d649.s0.e5" e2="DS.d649.s0.e2" id="DS.d649.s0.i6" interaction="True"/>
            <pair e1="DS.d649.s0.e5" e2="DS.d649.s0.e4" id="DS.d649.s0.i7" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d650" origId="18665326">
        <sentence id="DS.d650.s0" origId="18665326-1562" text="Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis.">
            <entity id="DS.d650.s0.e0" origId="5213,31553,1548994,3086637,24832061,44147684" charOffset="0-9" type="compound" text="Silymarin"/>
            <entity id="DS.d650.s0.e1" origId="P08253,P33434,P33436,P50757,Q90611,Q9GLE5" charOffset="80-107" type="protein" text="matrix metalloproteinases-2"/>
            <pair e1="DS.d650.s0.e0" e2="DS.d650.s0.e1" id="DS.d650.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d650.s1" origId="18665326-1563" text="NDEA administered rats showed increased MCD as revealed by toluidine blue staining along with upregulated expressions of MMP-2 and MMP-9.">
            <entity id="DS.d650.s1.e0" origId="5921" charOffset="0-4" type="compound" text="NDEA"/>
            <entity id="DS.d650.s1.e1" origId="P08253,P33434,P33436,P50757,Q90611,Q9GLE5" charOffset="121-126" type="protein" text="MMP-2"/>
            <entity id="DS.d650.s1.e2" origId="O18733,P14780,P41245,P41246,P50282,P52176" charOffset="131-136" type="protein" text="MMP-9"/>
            <pair e1="DS.d650.s1.e0" e2="DS.d650.s1.e2" id="DS.d650.s1.i0" interaction="True"/>
            <pair e1="DS.d650.s1.e0" e2="DS.d650.s1.e1" id="DS.d650.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d650.s2" origId="18665326-1564" text="Silymarin treatment inhibited this increase in MCD and downregulated the expressions of MMP-2 and MMP-9 as revealed by Western blotting and immunohistochemistry.">
            <entity id="DS.d650.s2.e0" origId="5213,31553,1548994,3086637,24832061,44147684" charOffset="0-9" type="compound" text="Silymarin"/>
            <entity id="DS.d650.s2.e1" origId="P08253,P33434,P33436,P50757,Q90611,Q9GLE5" charOffset="88-93" type="protein" text="MMP-2"/>
            <entity id="DS.d650.s2.e2" origId="O18733,P14780,P41245,P41246,P50282,P52176" charOffset="98-103" type="protein" text="MMP-9"/>
            <pair e1="DS.d650.s2.e0" e2="DS.d650.s2.e1" id="DS.d650.s2.i0" interaction="True"/>
            <pair e1="DS.d650.s2.e0" e2="DS.d650.s2.e2" id="DS.d650.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d650.s3" origId="18665326-1565" text="In conclusion, silymarin exerted beneficial effects on liver carcinogenesis by attenuating the recruitment of mast cells and thereby decreased the expressions of MMP-2 and MMP-9.">
            <entity id="DS.d650.s3.e0" origId="5213,31553,1548994,3086637,24832061,44147684" charOffset="15-24" type="compound" text="silymarin"/>
            <entity id="DS.d650.s3.e1" origId="P08253,P33434,P33436,P50757,Q90611,Q9GLE5" charOffset="162-167" type="protein" text="MMP-2"/>
            <entity id="DS.d650.s3.e2" origId="O18733,P14780,P41245,P41246,P50282,P52176" charOffset="172-177" type="protein" text="MMP-9"/>
            <pair e1="DS.d650.s3.e0" e2="DS.d650.s3.e1" id="DS.d650.s3.i0" interaction="True"/>
            <pair e1="DS.d650.s3.e0" e2="DS.d650.s3.e2" id="DS.d650.s3.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d651" origId="18665390">
        <sentence id="DS.d651.s0" origId="18665390-1624" text="As a result, combined glucose and insulin infusion significantly decreased plasma K+ concentration despite a significant decrease of urinary K+ excretion in sgk1+/+ but not in sgk1-/-mice.">
            <entity id="DS.d651.s0.e0" origId="206,5793,64689,79025" charOffset="22-29" type="compound" text="glucose"/>
            <entity id="DS.d651.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="34-41" type="protein" text="insulin"/>
            <pair e1="DS.d651.s0.e0" e2="DS.d651.s0.e1" id="DS.d651.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d652" origId="18665391">
        <sentence id="DS.d652.s0" origId="18665391-1625" text="While it is clearly demonstrated that members of the TRPC3/6/7 subfamily are activated by diacylglycerol, the mechanism by which phospholipase C activates members of the TRPC1/4/5 subfamily remains a mystery.">
            <entity id="DS.d652.s0.e0" origId="Q13507" charOffset="53-58" type="protein" text="TRPC3"/>
            <entity id="DS.d652.s0.e1" origId="6026790" charOffset="90-104" type="compound" text="diacylglycerol"/>
            <entity id="DS.d652.s0.e2" origId="O18784,P48995,Q9TUN9" charOffset="170-175" type="protein" text="TRPC1"/>
            <pair e1="DS.d652.s0.e1" e2="DS.d652.s0.e0" id="DS.d652.s0.i0" interaction="True"/>
            <pair e1="DS.d652.s0.e1" e2="DS.d652.s0.e2" id="DS.d652.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d652.s1" origId="18665391-1626" text="Depletion of polyphosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in TRPC5-expressing but not in TRPC3-or TRPC7-expressing cells.">
            <entity id="DS.d652.s1.e1" origId="5311358" charOffset="54-91" type="compound" text="phosphatidylinositol 4,5-bisphosphate"/>
            <entity id="DS.d652.s1.e2" origId="P54677" charOffset="121-150" type="protein" text="phosphatidylinositol 4-kinase"/>
            <entity id="DS.d652.s1.e3" origId="O62852,Q9MYV9,Q9UL62" charOffset="200-205" type="protein" text="TRPC5"/>
            <entity id="DS.d652.s1.e4" origId="Q13507" charOffset="228-233" type="protein" text="TRPC3"/>
            <entity id="DS.d652.s1.e5" origId="O94759,Q9HCX4" charOffset="237-242" type="protein" text="TRPC7"/>
            <pair e1="DS.d652.s1.e1" e2="DS.d652.s1.e2" id="DS.d652.s1.i0" interaction="True"/>
            <pair e1="DS.d652.s1.e1" e2="DS.d652.s1.e4" id="DS.d652.s1.i1" interaction="False"/>
            <pair e1="DS.d652.s1.e1" e2="DS.d652.s1.e5" id="DS.d652.s1.i2" interaction="False"/>
            <pair e1="DS.d652.s1.e1" e2="DS.d652.s1.e3" id="DS.d652.s1.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d652.s2" origId="18665391-1627" text="Inclusion of polyphosphatidylinositol 4-phosphate or PIP2, but not phosphatidylinositol 3,4,5-trisphosphate, in the patch pipette inhibited TRPC5 currents.">
            <entity id="DS.d652.s2.e1" origId="643963" charOffset="67-107" type="compound" text="phosphatidylinositol 3,4,5-trisphosphate"/>
            <entity id="DS.d652.s2.e2" origId="O62852,Q9MYV9,Q9UL62" charOffset="140-145" type="protein" text="TRPC5"/>
            <pair e1="DS.d652.s2.e1" e2="DS.d652.s2.e2" id="DS.d652.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d653" origId="18665432">
        <sentence id="DS.d653.s0" origId="18665432-1672" text="Osteogenic differentiation was enhanced after treatment with alendronate as confirmed by Alizarin Red S staining, elevated alkaline phosphatase activity and osteocalcin mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence staining against CD44 by flow cytometric analysis.">
            <entity id="DS.d653.s0.e0" origId="2088" charOffset="61-72" type="compound" text="alendronate"/>
            <entity id="DS.d653.s0.e1" origId="O60109,P81800,P83456" charOffset="123-143" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d653.s0.e2" origId="P02819,P02821,P02823,P0C225,P0C226,P15504,P28317,P39056,P81455,P83005,P83238,P83473,P83489,P84348,P84349,P84350,P84351,Q7LZI4,Q8HYY9" charOffset="157-168" type="protein" text="osteocalcin"/>
            <entity id="DS.d653.s0.e3" origId="P14745,P16070,P20944,Q05078,Q28284,Q29423,Q60522" charOffset="297-301" type="protein" text="CD44"/>
            <pair e1="DS.d653.s0.e0" e2="DS.d653.s0.e2" id="DS.d653.s0.i0" interaction="True"/>
            <pair e1="DS.d653.s0.e0" e2="DS.d653.s0.e1" id="DS.d653.s0.i1" interaction="True"/>
            <pair e1="DS.d653.s0.e0" e2="DS.d653.s0.e3" id="DS.d653.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d654" origId="18667202">
        <sentence id="DS.d654.s0" origId="18667202-1391" text="Ghrelin inhibits contraction and proliferation of human aortic smooth muscle cells by cAMP/PKA pathway activation.">
            <entity id="DS.d654.s0.e0" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="0-7" type="protein" text="Ghrelin"/>
            <entity id="DS.d654.s0.e1" origId="6076" charOffset="86-90" type="compound" text="cAMP"/>
            <pair e1="DS.d654.s0.e1" e2="DS.d654.s0.e0" id="DS.d654.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d654.s1" origId="18667202-1393" text="Ghrelin was able to inhibit angiotensin II-induced proliferation and contraction in a dose-response fashion via the cAMP/PKA pathway.">
            <entity id="DS.d654.s1.e0" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="0-7" type="protein" text="Ghrelin"/>
            <entity id="DS.d654.s1.e1" origId="6076" charOffset="116-120" type="compound" text="cAMP"/>
            <pair e1="DS.d654.s1.e1" e2="DS.d654.s1.e0" id="DS.d654.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d655" origId="18667302">
        <sentence id="DS.d655.s0" origId="18667302-1496" text="The results indicated that the backbone of POP was composed of (1--&amp;gt;6)-linked-alpha-D-galactopyranosyl and (1--&amp;gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&amp;gt;)-beta-D-glucose residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.">
            <entity id="DS.d655.s0.e0" origId="Q9XF19" charOffset="43-46" type="protein" text="POP"/>
            <entity id="DS.d655.s0.e1" origId="439271" charOffset="87-105" type="compound" text="D-galactopyranosyl"/>
            <entity id="DS.d655.s0.e2" origId="439271" charOffset="136-154" type="compound" text="D-galactopyranosyl"/>
            <entity id="DS.d655.s0.e3" origId="206,64689" charOffset="220-234" type="compound" text="beta-D-glucose"/>
            <pair e1="DS.d655.s0.e3" e2="DS.d655.s0.e0" id="DS.d655.s0.i0" interaction="True"/>
            <pair e1="DS.d655.s0.e1" e2="DS.d655.s0.e0" id="DS.d655.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d655.s1" origId="18667302-1497" text="Preliminary tests in vitro showed POP is capable of enhancing concanavalin A (ConA)-or lipopolysaccharide (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.">
            <entity id="DS.d655.s1.e0" origId="Q9XF19" charOffset="34-37" type="protein" text="POP"/>
            <entity id="DS.d655.s1.e1" origId="P81460,P81461" charOffset="62-76" type="protein" text="concanavalin A"/>
            <entity id="DS.d655.s1.e2" origId="P02866,P14894,P81460,P81461" charOffset="78-82" type="protein" text="ConA"/>
            <entity id="DS.d655.s1.e3" origId="11970143" charOffset="87-105" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d655.s1.e4" origId="Q9XF19" charOffset="167-170" type="protein" text="POP"/>
            <pair e1="DS.d655.s1.e3" e2="DS.d655.s1.e2" id="DS.d655.s1.i0" interaction="False"/>
            <pair e1="DS.d655.s1.e3" e2="DS.d655.s1.e0" id="DS.d655.s1.i1" interaction="True"/>
            <pair e1="DS.d655.s1.e3" e2="DS.d655.s1.e1" id="DS.d655.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d656" origId="18668138">
        <sentence id="DS.d656.s0" origId="18668138-492" text="Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by wortmannin and specific abrogation of Akt1 protein using small-interfering RNA revealed a regulatory function of Akt1 in insulin-mediated VEGF biosynthesis in keratinocytes.">
            <entity id="DS.d656.s0.e0" origId="312145" charOffset="64-74" type="compound" text="wortmannin"/>
            <entity id="DS.d656.s0.e1" origId="P31750,P47196,Q8INB9,Q98TY9" charOffset="102-106" type="protein" text="Akt1"/>
            <entity id="DS.d656.s0.e2" origId="P31750,P47196,Q8INB9,Q98TY9" charOffset="177-181" type="protein" text="Akt1"/>
            <entity id="DS.d656.s0.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="185-192" type="protein" text="insulin"/>
            <entity id="DS.d656.s0.e4" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="202-206" type="protein" text="VEGF"/>
            <pair e1="DS.d656.s0.e0" e2="DS.d656.s0.e3" id="DS.d656.s0.i0" interaction="False"/>
            <pair e1="DS.d656.s0.e0" e2="DS.d656.s0.e4" id="DS.d656.s0.i1" interaction="False"/>
            <pair e1="DS.d656.s0.e0" e2="DS.d656.s0.e1" id="DS.d656.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d657" origId="18668211">
        <sentence id="DS.d657.s0" origId="18668211-556" text="Cross-linked hydrogels showed increased resistance to digestion by testicular hyaluronidase and hyaluronidase SD with increasing hyaluronan concentration.">
            <entity id="DS.d657.s0.e0" origId="P15316,P26831,P49370,P49371,Q08169,Q53591,Q54699,Q54873,Q59634,Q59801,Q9U6V9" charOffset="78-91" type="protein" text="hyaluronidase"/>
            <entity id="DS.d657.s0.e1" origId="P15316,P26831,P49370,P49371,Q08169,Q53591,Q54699,Q54873,Q59634,Q59801,Q9U6V9" charOffset="96-109" type="protein" text="hyaluronidase"/>
            <entity id="DS.d657.s0.e2" origId="24759" charOffset="129-139" type="compound" text="hyaluronan"/>
            <pair e1="DS.d657.s0.e2" e2="DS.d657.s0.e0" id="DS.d657.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d658" origId="18668222">
        <sentence id="DS.d658.s0" origId="18668222-95" text="Chlorpyrifos (CPF), a commonly used organophosphorus insecticide, induces acetylcholinesterase inhibition and cholinergic toxicity.">
            <entity id="DS.d658.s0.e0" origId="2730" charOffset="0-12" type="compound" text="Chlorpyrifos"/>
            <entity id="DS.d658.s0.e1" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="74-94" type="protein" text="acetylcholinesterase"/>
            <pair e1="DS.d658.s0.e0" e2="DS.d658.s0.e1" id="DS.d658.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d659" origId="18668243">
        <sentence id="DS.d659.s0" origId="18668243-580" text="Role of RNase L in apoptosis induced by 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine.">
            <entity id="DS.d659.s0.e0" origId="Q05823,Q05921" charOffset="8-15" type="protein" text="RNase L"/>
            <entity id="DS.d659.s0.e1" origId="56841052" charOffset="40-90" type="compound" text="1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine"/>
            <pair e1="DS.d659.s0.e1" e2="DS.d659.s0.e0" id="DS.d659.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d660" origId="18668351">
        <sentence id="DS.d660.s0" origId="18668351-55" text="It was observed that administration of the PKC inhibitor chelerythrine chloride (5 mg/kg) suppressed the activation of three exercise-induced PKC isoforms (PKCalpha, PKCdelta, and PKCepsilon) and attenuated the exercise-mediated reduction of myocardial infarct size during ischemia-reperfusion injury.">
            <entity id="DS.d660.s0.e0" origId="2703" charOffset="57-79" type="compound" text="chelerythrine chloride"/>
            <entity id="DS.d660.s0.e1" origId="P04409,P05696,P10102,P17252,P20444" charOffset="156-164" type="protein" text="PKCalpha"/>
            <entity id="DS.d660.s0.e2" origId="P10829" charOffset="166-174" type="protein" text="PKCdelta"/>
            <pair e1="DS.d660.s0.e0" e2="DS.d660.s0.e2" id="DS.d660.s0.i0" interaction="True"/>
            <pair e1="DS.d660.s0.e0" e2="DS.d660.s0.e1" id="DS.d660.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d661" origId="18668366">
        <sentence id="DS.d661.s0" origId="18668366-689" text="Capsaicin is known to have regulatory effects on gastrointestinal functions via the vanilloid receptor (VR1).">
            <entity id="DS.d661.s0.e0" origId="1548943" charOffset="0-9" type="compound" text="Capsaicin"/>
            <entity id="DS.d661.s0.e1" origId="Q8NER1" charOffset="104-107" type="protein" text="VR1"/>
            <pair e1="DS.d661.s0.e0" e2="DS.d661.s0.e1" id="DS.d661.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d662" origId="18670196">
        <sentence id="DS.d662.s0" origId="18670196-1382" text="Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein cholesterol (HDL-C).">
            <entity id="DS.d662.s0.e0" origId="P25914" charOffset="0-34" type="protein" text="Cholesteryl ester transfer protein"/>
            <entity id="DS.d662.s0.e1" origId="P11597,P22687,P25914,P47896" charOffset="36-40" type="protein" text="CETP"/>
            <entity id="DS.d662.s0.e2" origId="P08163" charOffset="54-66" type="protein" text="glycoprotein"/>
            <entity id="DS.d662.s0.e3" origId="P81182" charOffset="219-243" type="protein" text="high density lipoprotein"/>
            <entity id="DS.d662.s0.e4" origId="304,5997,6432564,11025495" charOffset="244-255" type="compound" text="cholesterol"/>
            <pair e1="DS.d662.s0.e4" e2="DS.d662.s0.e1" id="DS.d662.s0.i0" interaction="True"/>
            <pair e1="DS.d662.s0.e4" e2="DS.d662.s0.e3" id="DS.d662.s0.i1" interaction="True"/>
            <pair e1="DS.d662.s0.e4" e2="DS.d662.s0.e2" id="DS.d662.s0.i2" interaction="True"/>
            <pair e1="DS.d662.s0.e4" e2="DS.d662.s0.e0" id="DS.d662.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d663" origId="18670732">
        <sentence id="DS.d663.s0" origId="18670732-960" text="These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum brain natriuretic peptide levels, and the inflammatory markers C reactive protein and Interleukin 6, and an improvement in New York Heart Association class, exercise capacity, oxygen utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.">
            <entity id="DS.d663.s0.e0" origId="P40753" charOffset="379-404" type="protein" text="brain natriuretic peptide"/>
            <entity id="DS.d663.s0.e1" origId="P41693" charOffset="465-478" type="protein" text="Interleukin 6"/>
            <entity id="DS.d663.s0.e2" origId="977" charOffset="555-561" type="compound" text="oxygen"/>
            <pair e1="DS.d663.s0.e2" e2="DS.d663.s0.e1" id="DS.d663.s0.i0" interaction="False"/>
            <pair e1="DS.d663.s0.e2" e2="DS.d663.s0.e0" id="DS.d663.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d664" origId="18670809">
        <sentence id="DS.d664.s0" origId="18670809-1037" text="DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and NADH 2 genes, were obtained from 49 Acropora species.">
            <entity id="DS.d664.s0.e0" origId="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0" charOffset="19-29" type="protein" text="calmodulin"/>
            <entity id="DS.d664.s0.e1" origId="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0" charOffset="31-34" type="protein" text="CaM"/>
            <entity id="DS.d664.s0.e2" origId="O03176,O03207,O03363,O03473,O03474,O03478,O03503,O03520,O03522,O03523,O03538,O03543,O03545,O03548,O03553,O03713,O03810,O03811,O03812,O20433,O20434,O20435,O20539,O20540,O20544,O20546,O20547,O20549,O20603,O20604,O20611,O20612,O20613,O20644,O20645,O20672,O20964,O20965,O20968,O20998,O21159,O21163,O21166,O21167,O21175,O21205,O21217,O21220,O21223,O21224,O21298,O21337,O21366,O21411,O21414,O21416,O21424,O21425,O21764,O21789,O21795,O21804,O21807,O21816,O31215,O47414,O47415,O47419,O47420,O47421,O47431,O47477,O47488,O47499,O47554,O47555,O47556,O47557,O47558,O47560,O47561,O47583,O47584,O47714,O47716,O47718,O47721,O47723,O47885,O47890,O47892,O47893,O47922,O47923,O47924,O47926,O47930,O47976,O47993,O48001,O48009,O48010,O48012,O48014,O48017,O48023,O48025,O48027,O48039,O48041,O48043,O48047,O48049,O48052,O48053,O48055,O48057,O48060,O48062,O48063,O48065,O48066,O48067,O48073,O48076,O48079,O48080,O48085,O48087,O48089,O48090,O48092,O48093,O48094,O48096,O48098,O48100,O48101,O48102,O48106,O48109,O48111,O48114,O48277,O48285,O48309,O48321,O48334,O48336,O48350,O48372,O54070,O63534,O63535,O63536,O63537,O63696,O63699,O63848,O78690,O78742,O78761,O78773,O78774,O78775,O78776,O78777,O78778,O78779,O78780,O78781,O78782,O78783,O78784,O78785,O78786,O78787,O78788,O78789,O78790,O78858,O78927,O78928,O78929,O78930,O78931,O78932,O78933,O78934,O78935,O78936,O78937,O79122,O79195,O79196,O79197,O79198,O79199,O79200,O79201,O79202,O79203,O79204,O79205,O79206,O79207,O79208,O79209,O79210,O79211,O79212,O79213,O79215,O79216,O79217,O79218,O79219,O79220,O79221,O79222,O79223,O79224,O79225,O79226,O79227,O79228,O79229,O79230,O79274,O79311,O79327,O79360,O79386,O79413,O79426,O79440,O79445,O79446,O79447,O79448,O79450,O79451,O79452,O79453,O79454,O79455,O79460,O79461,O79462,O79463,O79464,O79465,O79468,O79512,O79520,O79524,O79558,O79648,O79652,O79657,O79659,O79660,O79680,O79785,O79925,O79927,O79936,O79967,O79969,O79980,O79993,O79996,O79997,O80005,O80019,O99240,O99253,O99256,O99257,O99258,O99338,O99342,O99343,O99345,O99468,O99655,O99795,O99797,O99798,O99799,O99800,O99828,P00156,P00157,P00158,P00159,P00160,P00161,P00162,P00163,P00164,P04165,P05418,P05501,P05718,P07704,P07747,P08502,P09843,P11669,P12778,P14548,P14833,P15547,P15585,P16357,P16358,P16359,P16360,P16362,P16363,P16364,P16366,P16367,P16674,P18935,P18946,P21713,P21714,P21715,P21716,P21717,P21718,P21719,P21720,P21721,P21722,P21723,P23134,P23662,P23663,P24878,P24890,P24950,P24951,P24952,P24953,P24954,P24955,P24956,P24957,P24958,P24959,P24960,P24962,P24964,P24965,P24966,P24992,P26852,P29630,P29631,P29632,P29633,P29634,P29635,P29636,P29637,P29638,P29639,P29640,P29641,P29642,P29663,P29664,P29665,P29666,P29667,P29668,P29669,P29670,P29671,P29672,P29757,P33501,P34197,P34844,P34845,P34860,P34861,P34862,P34863,P34864,P34865,P34866,P34867,P34868,P34869,P34870,P34871,P34872,P34873,P34874,P34875,P34876,P35075,P38593,P38594,P39480,P41280,P41281,P41282,P41283,P41284,P41285,P41286,P41287,P41288,P41289,P41290,P41303,P42792,P48173,P48517,P48518,P48519,P48520,P48521,P48665,P48875,P48876,P48877,P48884,P48885,P48886,P49341,P49390,P50663,P51131,P51941,P56629,P56630,P56631,P56697,P56731,P62513,P68090,P68091,P68092,P68093,P68094,P68095,P68533,P68534,P69219,P69220,P69221,P81376,P81378,P81381,P82045,P82046,P82047,P82048,P82049,P87410,P87416,P87419,P87421,P92472,P92487,P92493,P92509,P92583,P92584,P92592,P92599,P92600,P92605,P92651,P92657,P92658,P92671,P92701,P92717,P92723,P92845,P92846,P92847,P92848,P92849,P92850,P92852,P92853,P92857,P92870,Q00228,Q00530,Q02655,Q02761,Q02768,Q04910,Q04911,Q104Y0,Q104Y1,Q104Y3,Q1EG05,Q1H8Y8,Q1HUU1,Q1HUV6,Q1KTB0,Q1MWH4,Q1MWK0,Q1PG50,Q1PG51,Q1PG54,Q1PG55,Q1PG56,Q1PG57,Q1PG58,Q1X6J6,Q1X6K1,Q1XA12,Q1XA32,Q1XII1,Q1XII7,Q1XII9,Q1XIJ0,Q1XIJ4,Q1XIK7,Q1XIK9,Q1XIL4,Q1XIM0,Q1XIM1,Q1XIM5,Q1XIM8,Q1XIN0,Q1XIN1,Q1XIN6,Q1XIP1,Q1XIP3,Q1XIP4,Q1XIP7,Q1XIP8,Q1XIQ2,Q1XIQ3,Q1XIQ4,Q1ZYR2,Q20FQ1,Q20FQ2,Q20FQ7,Q20FR3,Q20FR8,Q20FS0,Q20K40,Q20K43,Q25CF7,Q288H1,Q288H2,Q288H4,Q288H5,Q2N2B5,Q2N2B8,Q2N2J6,Q2N2J7,Q2Q1V7,Q2TVN0,Q2TVN1,Q2Y060,Q2Y067,Q31652,Q31684,Q33377,Q33401,Q33452,Q33487,Q33500,Q33537,Q33568,Q33607,Q33629,Q33645,Q33688,Q33695,Q33697,Q33706,Q33723,Q33754,Q33772,Q33782,Q33784,Q33798,Q33800,Q33818,Q33842,Q33865,Q33887,Q33941,Q33950,Q33954,Q33976,Q33987,Q33989,Q34028,Q34045,Q34070,Q34101,Q34106,Q34107,Q34108,Q34161,Q34169,Q34172,Q34179,Q34235,Q34253,Q34254,Q34260,Q34261,Q34279,Q34289,Q34300,Q34301,Q34302,Q34306,Q34321,Q34340,Q34341,Q34376,Q34382,Q34399,Q34409,Q34459,Q34462,Q34471,Q34473,Q34501,Q34534,Q34607,Q34653,Q34677,Q34683,Q34717,Q34724,Q34732,Q34760,Q34814,Q34876,Q34889,Q34890,Q34891,Q34893,Q34900,Q34902,Q34916,Q34945,Q34952,Q34957,Q34972,Q34973,Q35000,Q35019,Q35020,Q35038,Q35054,Q35065,Q35066,Q35075,Q35076,Q35078,Q35083,Q35111,Q35113,Q35117,Q35118,Q35130,Q35131,Q35157,Q35160,Q35172,Q35196,Q35273,Q35350,Q35377,Q35380,Q35409,Q35425,Q35438,Q35457,Q35459,Q35467,Q35468,Q35485,Q35505,Q35506,Q35516,Q35518,Q35522,Q35532,Q35533,Q35534,Q35553,Q35558,Q35614,Q35618,Q35621,Q35630,Q35653,Q35673,Q35675,Q35677,Q35695,Q35727,Q35805,Q35810,Q35819,Q35861,Q35873,Q35877,Q35886,Q35895,Q35925,Q35930,Q35942,Q35966,Q35968,Q35994,Q36012,Q36035,Q36055,Q36058,Q36082,Q36089,Q36096,Q36099,Q36118,Q36128,Q36192,Q36194,Q36201,Q36209,Q36222,Q36227,Q36229,Q36262,Q36266,Q36291,Q36294,Q36311,Q36319,Q36324,Q36368,Q36427,Q36445,Q36461,Q36507,Q36548,Q36549,Q36551,Q36572,Q36590,Q36644,Q36654,Q36659,Q36922,Q36976,Q37006,Q37064,Q37078,Q37080,Q37311,Q37378,Q37395,Q37713,Q3L2T5,Q3L6X7,Q3L701,Q3LTW2,Q3LZS3,Q3T4C8,Q3T4F1,Q3YLA8,Q3YLC2,Q3ZEC1,Q3ZEC3,Q3ZEC9,Q3ZED1,Q3ZEG3,Q4FBI3,Q4JQH5,Q4QXK3,Q4UJ67,Q4VGP8,Q4VKI6,Q4VKI7,Q4VUT8,Q4VUU0,Q4VUU2,Q4VUU4,Q4VUV4,Q4VUV8,Q4VUV9,Q4VUY0,Q4VUY6,Q4VUY8,Q4VUY9,Q4VWH4,Q4VWH9,Q508J0,Q508J1,Q508J2,Q508J3,Q508J4,Q508J5,Q508J7,Q508J9,Q508K1,Q508K2,Q508K4,Q508K5,Q508K6,Q508K7,Q508K8,Q508K9,Q508L0,Q508L1,Q508L2,Q508L3,Q508L4,Q508L6,Q508L8,Q508M1,Q508M2,Q508M3,Q508M4,Q508M6,Q508M8,Q508M9,Q508N0,Q508N1,Q508N2,Q508N3,Q508N6,Q508P2,Q50DL8,Q539B4,Q539Z1,Q53AJ7,Q53AK6,Q53AK8,Q53AL7,Q53AM3,Q564N6,Q564N8,Q564P1,Q564P2,Q58F56,Q58F69,Q58F82,Q597C5,Q597C7,Q597E2,Q597E3,Q597E4,Q597E6,Q597E7,Q597E8,Q597E9,Q597F0,Q597F1,Q597F2,Q598T9,Q598V2,Q599A4,Q5BQG8,Q5BQG9,Q5BU73,Q5C9H5,Q5DWG5,Q5DX17,Q5F4E4,Q5F4E8,Q5F4F1,Q5F4F4,Q5F4F5,Q5F4G0,Q5F4G2,Q5F4G3,Q5F4G7,Q5F4G9,Q5I191,Q5J1T0,Q5J1T3,Q5J1T4,Q5J1T5,Q5NUR5,Q5NUR7,Q5QD74,Q5QD76,Q5QFW4,Q5QFW5,Q5QFW6,Q5QS02,Q5QS15,Q5QS28,Q5QS41,Q5QS67,Q5S1V3,Q5UVI3,Q5UVI4,Q5UVI5,Q5UVI6,Q5UVI8,Q5UVJ0,Q5VJ36,Q5VJ37,Q5VJ39,Q5VJ41,Q5VJ42,Q5VJ44,Q5VJ45,Q5VJ46,Q5VJ49,Q5VJ50,Q5VJ52,Q5VJ55,Q5VJ57,Q5VJ58,Q5VJ59,Q5VJ60,Q5VJ61,Q5VJ65,Q5VJ67,Q5Y4Q0,Q5YBK0,Q5YJ58,Q5YJ78,Q5YJ93,Q5YKK4,Q5ZN98,Q64GI8,Q64GJ1,Q64J97,Q64JA0,Q678S1,Q678S2,Q678S3,Q678S5,Q678S8,Q678S9,Q692W3,Q698P7,Q6DUL2,Q6ED58,Q6ELU6,Q6ELU7,Q6ELU8,Q6ELU9,Q6ELV2,Q6ELV4,Q6ELV5,Q6ELV7,Q6ELV8,Q6ELV9,Q6ELW1,Q6ELW2,Q6ELW3,Q6ELW6,Q6IYG6,Q6JDN5,Q6JDP8,Q6JDQ6,Q6JDS2,Q6JDS4,Q6JDS5,Q6JDS6,Q6JDS8,Q6JDT0,Q6JDT3,Q6JDT4,Q6JDT8,Q6JDU0,Q6JDU8,Q6JWX5,Q6KF39,Q6KF53,Q6RSH5,Q6RSH6,Q6SQI7,Q6U1P6,Q6V8Y0,Q6V8Y1,Q6V9D6,Q6W6K7,Q6W6L7,Q6WRG2,Q6WRG3,Q6WRG4,Q6WRG7,Q6WRH2,Q6WRH4,Q6WRH5,Q6X2M0,Q6X9S4,Q6XBV1,Q6XBV6,Q6XBW1,Q6XBW4,Q6XBW5,Q6XBW7,Q6XBW8,Q6XZH2,Q6XZH3,Q6XZN8,Q6XZN9,Q6XZP4,Q6Y8J2,Q6Y8J6,Q6Y8J7,Q6YDK5,Q6YDK7,Q6YDL2,Q6YDL6,Q6YDL7,Q6YLN1,Q70RT7,Q70RV0,Q70RW3,Q70XG0,Q70XI6,Q710S3,Q711L6,Q71E87,Q71E89,Q71E95,Q71E97,Q71E99,Q71EA6,Q71EB0,Q71FH1,Q71FH2,Q71FI6,Q71FI8,Q71FI9,Q71FJ0,Q71FJ2,Q71MR3,Q71MR6,Q71RU1,Q75R30,Q76LN6,Q76MX5,Q7GEV4,Q7GGQ9,Q7GI23,Q7HEI2,Q7HFF9,Q7HFG0,Q7HKW1,Q7IY93,Q7IY99,Q7IYN8,Q7IYZ1,Q7J370,Q7J6I1,Q7JE02,Q7Y5X9,Q7Y778,Q7Y779,Q7Y7B2,Q7Y8F6,Q7Y8I2,Q7Y8J5,Q7Y8K8,Q7Y8L0,Q7Y8L4,Q7Y8L5,Q7Y8L6,Q7Y8L9,Q7Y8M0,Q7YA49,Q7YBY4,Q7YBY6,Q7YC63,Q7YC71,Q7YC73,Q7YC74,Q7YC75,Q7YC76,Q7YD12,Q7YD13,Q7YD16,Q7YD72,Q7YD73,Q7YD75,Q7YEV2,Q7YGD4,Q85AG5,Q85AV3,Q85C06,Q85C43,Q85DD9,Q85DE4,Q85DF2,Q85DF5,Q85DF8,Q85IN3,Q85IN4,Q85IN5,Q85IN6,Q85IN7,Q85IN8,Q85IN9,Q85PK7,Q85PM6,Q85PN0,Q85PN4,Q85PN6,Q85PN7,Q85PN8,Q85PP0,Q85PP1,Q85Q58,Q85QA4,Q85RV3,Q8HCJ4,Q8HD57,Q8HD60,Q8HEC2,Q8HEM1,Q8HF67,Q8HG55,Q8HL81,Q8HL93,Q8HLB9,Q8HLD2,Q8HLR2,Q8HMZ7,Q8HQ92,Q8HQE6,Q8HQE7,Q8HQE8,Q8HQE9,Q8HQF0,Q8HQF1,Q8HQF2,Q8LW83,Q8LWM2,Q8LWM4,Q8LWN0,Q8LWP6,Q8LWU4,Q8LX87,Q8LZ88,Q8LZ94,Q8LZ97,Q8M0A6,Q8M0E7,Q8M0K7,Q8M0K9,Q8M354,Q8M3J6,Q8M4C6,Q8M4C7,Q8M4D6,Q8M4E2,Q8M4E6,Q8M5M3,Q8M6Z3,Q8M700,Q8M703,Q8M706,Q8M708,Q8SE00,Q8SE72,Q8SE77,Q8SE89,Q8SEH7,Q8SEJ1,Q8SEL4,Q8SEP4,Q8SET9,Q8SFK5,Q8SFK7,Q8SG72,Q8SGA0,Q8SGQ9,Q8SJB6,Q8SJK5,Q8SJK6,Q8SJK7,Q8SJK8,Q8SJK9,Q8SJL1,Q8SJL2,Q8SJL3,Q8SJX4,Q8SJX5,Q8SJZ1,Q8SJZ2,Q8SJZ3,Q8SJZ4,Q8W7G4,Q8W822,Q8W8Q1,Q8W8W1,Q8W8Y1,Q8W926,Q8W9E4,Q8W9F5,Q8W9F9,Q8W9J6,Q8W9L2,Q8W9N7,Q8WA39,Q8WA47,Q8WB03,Q8WB05,Q8WBP9,Q8WBV2,Q8WCJ7,Q8WCK9,Q8WCL1,Q8WDK6,Q8WDU1,Q8WDV0,Q8WDV2,Q8WDV6,Q8WE97,Q8WEK2,Q8WEK7,Q8WEW8,Q8WFX3,Q8WGF6,Q8WGF7,Q8WGF8,Q8WGG5,Q8WGG8,Q8WGL0,Q94ND7,Q94NF7,Q94NM3,Q94P21,Q94PA3,Q94PB4,Q94Q38,Q94Q45,Q94Q84,Q94QD3,Q94QP2,Q94QQ7,Q94S37,Q94S78,Q94SA4,Q94SD0,Q94SJ5,Q94SK8,Q94SZ7,Q94T21,Q94T42,Q94T68,Q94TE4,Q94TI3,Q94UZ9,Q94V00,Q94V01,Q94V02,Q94VK4,Q94WP7,Q94WQ8,Q94WW5,Q94WW7,Q94WW9,Q94WX2,Q94WX4,Q94WX5,Q94WY6,Q94WY7,Q94Y46,Q94Y47,Q94Y50,Q94Y51,Q94Y56,Q94Y62,Q94Y64,Q94Y66,Q94Y71,Q94Y72,Q94YE5,Q94YL4,Q94YL5,Q94YL9,Q94ZD1,Q94ZJ2,Q94ZK8,Q950B9,Q950C2,Q950C6,Q950C7,Q950S3,Q951T4,Q951T6,Q953G9,Q953J5,Q953K8,Q955G5,Q955G6,Q956S6,Q956Y7,Q956Y9,Q956Z1,Q956Z2,Q956Z3,Q956Z5,Q956Z6,Q956Z7,Q956Z8,Q956Z9,Q95711,Q95718,Q95719,Q95723,Q95726,Q95727,Q95728,Q95729,Q95730,Q95731,Q95734,Q95735,Q95736,Q95737,Q95738,Q95739,Q95741,Q95744,Q95745,Q95750,Q95776,Q957A1,Q957A2,Q957A4,Q957A7,Q957A8,Q957A9,Q957B0,Q957B1,Q957B2,Q957B3,Q957B4,Q957B5,Q957B6,Q957B7,Q957B8,Q957B9,Q957C1,Q957C3,Q957C6,Q957C7,Q957C8,Q957D1,Q95920,Q959V6,Q96071,Q9B0S2,Q9B0Y1,Q9B106,Q9B161,Q9B167,Q9B1D2,Q9B1N0,Q9B1X4,Q9B1Z4,Q9B203,Q9B205,Q9B2C4,Q9B2F7,Q9B365,Q9B506,Q9B5Q1,Q9B5Q3,Q9B5Q4,Q9B5Q5,Q9B5Q6,Q9B5Q7,Q9B5Q8,Q9B5Q9,Q9B5R0,Q9B5R1,Q9B5R2,Q9B5R3,Q9B5R7,Q9B5R8,Q9B5S0,Q9B5S1,Q9B6D0,Q9B6F0,Q9B7V7,Q9B7W1,Q9B7W3,Q9B9E4,Q9B9E8,Q9B9F5,Q9B9F6,Q9B9F9,Q9B9G0,Q9B9Z1,Q9BA02,Q9G0M4,Q9G0S9,Q9G0W6,Q9G156,Q9G1B9,Q9G1C4,Q9G1F7,Q9G1R4,Q9G1Z0,Q9G210,Q9G215,Q9G250,Q9G273,Q9G2R8,Q9G2S5,Q9G2U4,Q9G2U7,Q9G2W6,Q9G396,Q9G3M2,Q9G3M7,Q9G3M9,Q9G3N1,Q9G3N2,Q9G3N4,Q9G3R1,Q9G3S4,Q9G3T7,Q9G4Q1,Q9G6G2,Q9G6G3,Q9G6M3,Q9G7T9,Q9G7U1,Q9G946,Q9G964,Q9G9J4,Q9G9J6,Q9G9J7,Q9GA18,Q9GAM6,Q9GAM7,Q9GAM9,Q9GAN2,Q9GAN4,Q9GAP0,Q9GAR5,Q9GAR6,Q9GAW0,Q9GAW3,Q9GAW6,Q9GBG9,Q9GBY1,Q9GBY4,Q9GBY5,Q9GBY6,Q9GBY8,Q9GBZ0,Q9GBZ1,Q9GBZ2,Q9GBZ4,Q9GBZ5,Q9GBZ6,Q9GBZ7,Q9MDF2,Q9MDZ9,Q9MED6,Q9MFN3,Q9MFN9,Q9MG84,Q9MGL5,Q9MGM4,Q9MI31,Q9MI32,Q9MI35,Q9MI36,Q9MI37,Q9MI38,Q9MI39,Q9MI64,Q9MI97,Q9MIX8,Q9MIZ2,Q9MJ99,Q9MJA1,Q9MJA2,Q9MJV1,Q9MLD6,Q9MLD7,Q9MLI3,Q9MLI6,Q9MLI7,Q9MLI8,Q9MLI9,Q9MLJ0,Q9MLJ1,Q9MLJ2,Q9MLJ3,Q9MLJ4,Q9MLJ5,Q9MLJ6,Q9MLJ7,Q9MLJ8,Q9MLJ9,Q9MLK0,Q9MLK1,Q9MLK2,Q9MLK3,Q9MLK4,Q9MLK5,Q9MLK6,Q9MLK7,Q9MLK8,Q9MLK9,Q9MLL0,Q9MLL3,Q9MLL4,Q9MLL5,Q9MLL6,Q9MMZ2,Q9MQX1,Q9MQX8,Q9MQY0,Q9MQY1,Q9MQY3,Q9MQY5,Q9MQY6,Q9MR49,Q9T3H9,Q9T3Q2,Q9T3R3,Q9T3S9,Q9T3Y0,Q9T3Y2,Q9T3Y3,Q9T443,Q9T469,Q9T475,Q9T4A7,Q9T4B2,Q9T4N0,Q9T4P2,Q9T4R0,Q9T4U3,Q9T5N4,Q9T6I4,Q9T6J0,Q9T6R2,Q9T6R3,Q9T6R5,Q9T6R8,Q9T6R9,Q9T7L5,Q9T7L6,Q9T7L7,Q9T7L8,Q9T7L9,Q9T7M0,Q9T7M3,Q9T7N2,Q9T7N5,Q9T7P0,Q9T7P1,Q9T7Q0,Q9T7Q5,Q9T7Q6,Q9T7Q8,Q9T7Q9,Q9T7S2,Q9T7T7,Q9T7T8,Q9T7T9,Q9T9A5,Q9T9A6,Q9T9A7,Q9T9A8,Q9T9B2,Q9T9B6,Q9T9B7,Q9T9B9,Q9T9C0,Q9T9C1,Q9T9C8,Q9T9I2,Q9T9I7,Q9T9J2,Q9T9J5,Q9T9V5,Q9T9W4,Q9T9Y3,Q9TA00,Q9TAB1,Q9TAD3,Q9TDJ6,Q9TDJ9,Q9TDK1,Q9TDK2,Q9TDK4,Q9TDK6,Q9TDK7,Q9TDK9,Q9TDL0,Q9TDL1,Q9TDL2,Q9TDL3,Q9TDL4,Q9TDL5,Q9TDL6,Q9TDL7,Q9TDL8,Q9TDL9,Q9TDM0,Q9TDM1,Q9TDM3,Q9TDM5,Q9TDM6,Q9TDM7,Q9TDN0,Q9TDN1,Q9TDN2,Q9TDQ5,Q9TDQ7,Q9TDT5,Q9TEB4,Q9TEB5,Q9TEC1,Q9TEU7,Q9TEX8,Q9TEY4,Q9TEY5,Q9TEY6,Q9TEY7,Q9TEY8,Q9TEZ5,Q9TF10,Q9TF12,Q9TF14,Q9TF17,Q9TF20,Q9TF27,Q9TF30,Q9TF31,Q9TF32,Q9TF34,Q9TF37,Q9TF45,Q9TF46,Q9TF47,Q9TF49,Q9TF50,Q9TF51,Q9TF52,Q9TF55,Q9TF57,Q9TF61,Q9TF73,Q9TF74,Q9TF80,Q9TF86,Q9TF89,Q9TF91,Q9TF93,Q9TF95,Q9TFA0,Q9TFX4,Q9TFX5,Q9TFX6,Q9TG16,Q9TGH6,Q9TGH8,Q9TGL9,Q9TH43,Q9TH45,Q9TH46,Q9TH47,Q9TH52,Q9TH56,Q9THD6,Q9XK52,Q9XK70,Q9XKC0,Q9XKK0,Q9XKK2,Q9XKK5,Q9XLE0,Q9XLE1,Q9XLE2,Q9XM10,Q9XMC1,Q9XMC2,Q9XNM0,Q9XNM1,Q9XNM5,Q9XNN0,Q9XNN1,Q9XNN3,Q9XNN4,Q9XNT9,Q9XNU0,Q9XNU2,Q9XNU4,Q9XNU5,Q9XNU6,Q9XNU9,Q9XNV3,Q9XNV4,Q9XNV7,Q9XNW3,Q9XNW4,Q9XNW5,Q9XNW7,Q9XNW8,Q9XNW9,Q9XNX0,Q9XNX1,Q9XNX3,Q9XNX4,Q9XNX6,Q9XNX7,Q9XNX8,Q9XP34,Q9XP68,Q9XP73,Q9XP76,Q9XP77,Q9XP78,Q9XP81,Q9XP82,Q9XP83,Q9XP84,Q9XP86,Q9XP87,Q9XP88,Q9XP89,Q9ZY14,Q9ZY15,Q9ZY46,Q9ZY49,Q9ZZ40,Q9ZZ42,Q9ZZD2,Q9ZZD4,Q9ZZD8,Q9ZZE3,Q9ZZE4,Q9ZZF6,Q9ZZR4,Q9ZZT5,Q9ZZT6,Q9ZZT7,Q9ZZT8,Q9ZZU1" charOffset="146-158" type="protein" text="cytochrome b"/>
            <entity id="DS.d664.s0.e3" origId="P00158,P00159,P00160,P00162,P05501,P07704,P18935,P24890,P51941,Q8HEC2,Q8HMZ7,Q8HQ92,Q8WA47,Q9MDZ9,Q9MGL5,Q9MGM4,Q9MIX8" charOffset="160-164" type="protein" text="cytb"/>
            <entity id="DS.d664.s0.e4" origId="439153" charOffset="170-174" type="compound" text="NADH"/>
            <pair e1="DS.d664.s0.e4" e2="DS.d664.s0.e1" id="DS.d664.s0.i0" interaction="False"/>
            <pair e1="DS.d664.s0.e4" e2="DS.d664.s0.e2" id="DS.d664.s0.i1" interaction="False"/>
            <pair e1="DS.d664.s0.e4" e2="DS.d664.s0.e3" id="DS.d664.s0.i2" interaction="False"/>
            <pair e1="DS.d664.s0.e4" e2="DS.d664.s0.e0" id="DS.d664.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d665" origId="18670810">
        <sentence id="DS.d665.s0" origId="18670810-1039" text="Both expression of tac and tac2 were induced by 2% sucrose.">
            <entity id="DS.d665.s0.e0" origId="P06767,P08435,P41539,P55099" charOffset="27-31" type="protein" text="tac2"/>
            <entity id="DS.d665.s0.e1" origId="5988" charOffset="51-58" type="compound" text="sucrose"/>
            <pair e1="DS.d665.s0.e1" e2="DS.d665.s0.e0" id="DS.d665.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d666" origId="18670880">
        <sentence id="DS.d666.s0" origId="18670880-1082" text="Contaminants of current high use in the LRGV, such as atrazine, and some of the highly persistent organochlorines, such as toxaphene and DDE, could be potentially associated with modulation of aromatase activity in avian tissues.">
            <entity id="DS.d666.s0.e0" origId="2256" charOffset="54-62" type="compound" text="atrazine"/>
            <entity id="DS.d666.s0.e1" origId="5284469" charOffset="123-132" type="compound" text="toxaphene"/>
            <entity id="DS.d666.s0.e2" origId="3035" charOffset="137-140" type="compound" text="DDE"/>
            <entity id="DS.d666.s0.e3" origId="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28" charOffset="193-202" type="protein" text="aromatase"/>
            <pair e1="DS.d666.s0.e1" e2="DS.d666.s0.e3" id="DS.d666.s0.i0" interaction="True"/>
            <pair e1="DS.d666.s0.e0" e2="DS.d666.s0.e3" id="DS.d666.s0.i1" interaction="True"/>
            <pair e1="DS.d666.s0.e2" e2="DS.d666.s0.e3" id="DS.d666.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d667" origId="18670892">
        <sentence id="DS.d667.s0" origId="18670892-1460" text="In this view, this study aimed at the investigating the use of a crude peroxidase preparation from onion solid by-products for oxidising caffeic acid, a widespread o-diphenol, whose various derivatives may occur in food industry wastes, such as olive mill waste waters.">
            <entity id="DS.d667.s0.e0" origId="P15984,P16147,P84714" charOffset="71-81" type="protein" text="peroxidase"/>
            <entity id="DS.d667.s0.e1" origId="689043" charOffset="137-149" type="compound" text="caffeic acid"/>
            <pair e1="DS.d667.s0.e1" e2="DS.d667.s0.e0" id="DS.d667.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d668" origId="18670896">
        <sentence id="DS.d668.s0" origId="18670896-1090" text="Ziram exposures that caused a loss of binding function were examined for effects on expression of key NK cell-surface proteins needed for binding to targets.">
            <entity id="DS.d668.s0.e0" origId="6599" charOffset="0-5" type="compound" text="Ziram"/>
            <entity id="DS.d668.s0.e1" origId="O12164,O41803,O42043,O56861,O70902,O71037,O89292,O91086,P03374,P03375,P03377,P03378,P03379,P03380,P03381,P03383,P03385,P03386,P03387,P03388,P03390,P03391,P03392,P03395,P03396,P03397,P03399,P04027,P04502,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P06445,P06751,P06752,P07575,P08359,P08360,P08810,P0C212,P10259,P10267,P10269,P11261,P11267,P11268,P11306,P12449,P12487,P12488,P12489,P12492,P14075,P14351,P15073,P15831,P16082,P16090,P16899,P17281,P17755,P18040,P18094,P18799,P19030,P19503,P19549,P19550,P19551,P19556,P19557,P20871,P20872,P20888,P21412,P21415,P21436,P21443,P21444,P21445,P22380,P22427,P22428,P22429,P22430,P23064,P23073,P23422,P23423,P24105,P25057,P25504,P25505,P25506,P25507,P26803,P26804,P27399,P27757,P27977,P31621,P31626,P31627,P31789,P31791,P31794,P31796,P31819,P31872,P32536,P32541,P33498,P35954,P35961,P51515,P51519,P51520,P60507,P60508,P60608,P61549,P61550,P61552,P61553,P61554,P61555,P61556,P61557,P61558,P61559,P61561,P61562,P61563,P61564,P61565,P61566,P61567,P61570,Q02076,Q02077,Q02282,Q02837,Q03804,Q03816,Q03817,Q04993,Q04995,Q05312,Q09SZ7,Q0R5Q9,Q14264,Q1A243,Q1A261,Q69384,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q85646,Q89607,Q8AIH5,Q8MIB6,Q902F8,Q902F9,Q96L62,Q9IDV2,Q9N2J8,Q9N2J9,Q9N2K0,Q9NX77,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9TTC0,Q9UKH3,Q9UQF0,Q9WC60,Q9WC69" charOffset="110-126" type="protein" text="surface proteins"/>
            <pair e1="DS.d668.s0.e0" e2="DS.d668.s0.e1" id="DS.d668.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d669" origId="18670905">
        <sentence id="DS.d669.s0" origId="18670905-814" text="Here, we have investigated how the post-synthetic acetylation of HMGB1 affects its interaction with negatively supercoiled DNA by employing monoacetylated at Lys2 protein, isolated from butyrate-treated cells.">
            <entity id="DS.d669.s0.e0" origId="P07156,P09429,P10103,P12682,P36194,Q4R844,Q6YKA4" charOffset="65-70" type="protein" text="HMGB1"/>
            <entity id="DS.d669.s0.e1" origId="264" charOffset="186-194" type="compound" text="butyrate"/>
            <pair e1="DS.d669.s0.e1" e2="DS.d669.s0.e0" id="DS.d669.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d670" origId="18670906">
        <sentence id="DS.d670.s0" origId="18670906-1096" text="KAP8.1 protein contains high glycine and tyrosine, which concerns regulation and function of the matrix structure fiber.">
            <entity id="DS.d670.s0.e0" origId="Q8IUC2" charOffset="0-6" type="protein" text="KAP8.1"/>
            <entity id="DS.d670.s0.e1" origId="750" charOffset="29-36" type="compound" text="glycine"/>
            <entity id="DS.d670.s0.e2" origId="1153,6057,5460803" charOffset="41-49" type="compound" text="tyrosine"/>
            <pair e1="DS.d670.s0.e2" e2="DS.d670.s0.e0" id="DS.d670.s0.i0" interaction="True"/>
            <pair e1="DS.d670.s0.e1" e2="DS.d670.s0.e0" id="DS.d670.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d671" origId="18671273">
        <sentence id="DS.d671.s0" origId="18671273-1368" text="Cycloheximide inhibited MIH induced Mos expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.">
            <entity id="DS.d671.s0.e0" origId="6197" charOffset="0-13" type="compound" text="Cycloheximide"/>
            <entity id="DS.d671.s0.e1" origId="O61389,O96605,P19806,P55321,P55846,P55847,P55848,P83220,P83636,Q10987,Q27225" charOffset="24-27" type="protein" text="MIH"/>
            <entity id="DS.d671.s0.e2" origId="P00536,P00539,P12965" charOffset="36-39" type="protein" text="Mos"/>
            <entity id="DS.d671.s0.e3" origId="P70047,Q8CFC2,Q91618,Q9ESG9,Q9NI63" charOffset="98-102" type="protein" text="Myt1"/>
            <pair e1="DS.d671.s0.e0" e2="DS.d671.s0.e3" id="DS.d671.s0.i0" interaction="True"/>
            <pair e1="DS.d671.s0.e0" e2="DS.d671.s0.e2" id="DS.d671.s0.i1" interaction="True"/>
            <pair e1="DS.d671.s0.e0" e2="DS.d671.s0.e1" id="DS.d671.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d672" origId="18671672">
        <sentence id="DS.d672.s0" origId="18671672-48" text="CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).">
            <entity id="DS.d672.s0.e0" origId="11984615" charOffset="0-5" type="compound" text="CLNO2"/>
            <entity id="DS.d672.s0.e1" origId="11970143" charOffset="113-131" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d672.s0.e2" origId="Q9TTB0" charOffset="137-153" type="protein" text="interferon-gamma"/>
            <entity id="DS.d672.s0.e3" origId="O19114,O46660,O54705,O62699,P35228,P60321,P79290,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="223-227" type="protein" text="NOS2"/>
            <entity id="DS.d672.s0.e4" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="239-260" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d672.s0.e6" origId="39836" charOffset="326-360" type="compound" text="N(G)-nitro-L-arginine methyl ester"/>
            <pair e1="DS.d672.s0.e0" e2="DS.d672.s0.e2" id="DS.d672.s0.i0" interaction="True"/>
            <pair e1="DS.d672.s0.e6" e2="DS.d672.s0.e2" id="DS.d672.s0.i1" interaction="False"/>
            <pair e1="DS.d672.s0.e0" e2="DS.d672.s0.e4" id="DS.d672.s0.i2" interaction="True"/>
            <pair e1="DS.d672.s0.e1" e2="DS.d672.s0.e3" id="DS.d672.s0.i4" interaction="True"/>
            <pair e1="DS.d672.s0.e6" e2="DS.d672.s0.e3" id="DS.d672.s0.i5" interaction="False"/>
            <pair e1="DS.d672.s0.e1" e2="DS.d672.s0.e4" id="DS.d672.s0.i6" interaction="False"/>
            <pair e1="DS.d672.s0.e0" e2="DS.d672.s0.e3" id="DS.d672.s0.i8" interaction="True"/>
            <pair e1="DS.d672.s0.e1" e2="DS.d672.s0.e2" id="DS.d672.s0.i10" interaction="False"/>
            <pair e1="DS.d672.s0.e6" e2="DS.d672.s0.e4" id="DS.d672.s0.i11" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d673" origId="18671761">
        <sentence id="DS.d673.s0" origId="18671761-109" text="Parkin-mediated ubiquitination regulates phospholipase C-gamma1.">
            <entity id="DS.d673.s0.e0" origId="3290" charOffset="0-6" type="compound" text="Parkin"/>
            <entity id="DS.d673.s0.e1" origId="P08487,P10686,P19174,Q62077" charOffset="41-63" type="protein" text="phospholipase C-gamma1"/>
            <pair e1="DS.d673.s0.e0" e2="DS.d673.s0.e1" id="DS.d673.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d674" origId="18671795">
        <sentence id="DS.d674.s0" origId="18671795-129" text="Short-acting insulin analogues, in comparison with regular human insulin (HRI), provide a greater control of postprandial glucose, while their superiority on haemoglobin A1c (HbA1c) is controversial.">
            <entity id="DS.d674.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="13-20" type="protein" text="insulin"/>
            <entity id="DS.d674.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="65-72" type="protein" text="insulin"/>
            <entity id="DS.d674.s0.e2" origId="P33279,Q9BQI3" charOffset="74-77" type="protein" text="HRI"/>
            <entity id="DS.d674.s0.e3" origId="206,5793,64689,79025" charOffset="122-129" type="compound" text="glucose"/>
            <pair e1="DS.d674.s0.e3" e2="DS.d674.s0.e0" id="DS.d674.s0.i0" interaction="True"/>
            <pair e1="DS.d674.s0.e3" e2="DS.d674.s0.e2" id="DS.d674.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d675" origId="18671897">
        <sentence id="DS.d675.s0" origId="18671897-205" text="Western blotting showed that carbenoxolone down-regulated Cx43 protein expression in the BA, which in the SAH-only group was significantly higher than that of the normal group.">
            <entity id="DS.d675.s0.e0" origId="21913,636403,5311038" charOffset="29-42" type="compound" text="carbenoxolone"/>
            <entity id="DS.d675.s0.e1" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="58-62" type="protein" text="Cx43"/>
            <pair e1="DS.d675.s0.e0" e2="DS.d675.s0.e1" id="DS.d675.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d676" origId="18672341">
        <sentence id="DS.d676.s0" origId="18672341-581" text="Hepatocytes exposed to resistin, but only in the presence of insulin, show a decrease in insulin-stimulated glycogen content.">
            <entity id="DS.d676.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="61-68" type="protein" text="insulin"/>
            <entity id="DS.d676.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="89-96" type="protein" text="insulin"/>
            <entity id="DS.d676.s0.e2" origId="439177" charOffset="108-116" type="compound" text="glycogen"/>
            <pair e1="DS.d676.s0.e2" e2="DS.d676.s0.e0" id="DS.d676.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d678" origId="18673089">
        <sentence id="DS.d678.s0" origId="18673089-1229" text="Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with oil red-O, and expressed adipocyte-specific genes (lipoprotein lipase (LPL), peroxisome proliferator activated receptor gamma2, and adipocyte-specific fatty acid binding protein (alphaP2)).">
            <entity id="DS.d678.s0.e0" origId="6046885,6821284" charOffset="162-171" type="compound" text="oil red-O"/>
            <entity id="DS.d678.s0.e1" origId="Q7M4U7" charOffset="225-231" type="protein" text="lipase"/>
            <entity id="DS.d678.s0.e2" origId="O46647,P06858,P11151,P11152,P11153,P11602,P49060,P49923,P55031,Q06000,Q29524" charOffset="233-236" type="protein" text="LPL"/>
            <entity id="DS.d678.s0.e3" origId="P02528" charOffset="282-288" type="protein" text="gamma2"/>
            <entity id="DS.d678.s0.e4" origId="O42494,O45035,O76821,P80547,Q17284,Q8MUC1,Q9U5P1" charOffset="313-339" type="protein" text="fatty acid binding protein"/>
            <pair e1="DS.d678.s0.e0" e2="DS.d678.s0.e1" id="DS.d678.s0.i0" interaction="False"/>
            <pair e1="DS.d678.s0.e0" e2="DS.d678.s0.e4" id="DS.d678.s0.i1" interaction="False"/>
            <pair e1="DS.d678.s0.e0" e2="DS.d678.s0.e2" id="DS.d678.s0.i2" interaction="False"/>
            <pair e1="DS.d678.s0.e0" e2="DS.d678.s0.e3" id="DS.d678.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d679" origId="18673303">
        <sentence id="DS.d679.s0" origId="18673303-1358" text="In addition, AIT induced a more favourable regulation of blood glucose and insulin compared with MTG.">
            <entity id="DS.d679.s0.e0" origId="206,5793,64689,79025" charOffset="63-70" type="compound" text="glucose"/>
            <entity id="DS.d679.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="75-82" type="protein" text="insulin"/>
            <pair e1="DS.d679.s0.e0" e2="DS.d679.s0.e1" id="DS.d679.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d680" origId="18673333">
        <sentence id="DS.d680.s0" origId="18673333-52" text="Beta1,4-galactosyltransferase-I (B4GALT1), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds galactose to oligosaccharides.">
            <entity id="DS.d680.s0.e0" origId="P14769,P23336,P50127" charOffset="8-29" type="protein" text="galactosyltransferase"/>
            <entity id="DS.d680.s0.e1" origId="P08037,P15291" charOffset="33-40" type="protein" text="B4GALT1"/>
            <entity id="DS.d680.s0.e2" origId="P14769,P23336,P50127" charOffset="64-86" type="protein" text="galactosyltransferases"/>
            <entity id="DS.d680.s0.e3" origId="6036,439353,439357" charOffset="153-162" type="compound" text="galactose"/>
            <pair e1="DS.d680.s0.e3" e2="DS.d680.s0.e0" id="DS.d680.s0.i0" interaction="True"/>
            <pair e1="DS.d680.s0.e3" e2="DS.d680.s0.e1" id="DS.d680.s0.i1" interaction="True"/>
            <pair e1="DS.d680.s0.e3" e2="DS.d680.s0.e2" id="DS.d680.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d680.s1" origId="18673333-53" text="When compared to the other mammalian B4GALT1 genes, the porcine coding sequence contained a single threonine codon inserted into the region encoding the cytoplasmic domain.">
            <entity id="DS.d680.s1.e0" origId="P08037,P15291" charOffset="37-44" type="protein" text="B4GALT1"/>
            <entity id="DS.d680.s1.e1" origId="6288" charOffset="99-108" type="compound" text="threonine"/>
            <pair e1="DS.d680.s1.e1" e2="DS.d680.s1.e0" id="DS.d680.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d681" origId="18674953">
        <sentence id="DS.d681.s0" origId="18674953-1307" text="Gyp inhibited the levels of the anti-apoptotic proteins Bcl-2 and Bcl-xl, but promoted the levels of the pro-apoptotic protein Bax.">
            <entity id="DS.d681.s0.e0" origId="64947" charOffset="0-3" type="compound" text="Gyp"/>
            <entity id="DS.d681.s0.e1" origId="P10417,P49950" charOffset="56-61" type="protein" text="Bcl-2"/>
            <entity id="DS.d681.s0.e2" origId="P27297" charOffset="119-130" type="protein" text="protein Bax"/>
            <pair e1="DS.d681.s0.e0" e2="DS.d681.s0.e1" id="DS.d681.s0.i0" interaction="True"/>
            <pair e1="DS.d681.s0.e0" e2="DS.d681.s0.e2" id="DS.d681.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d681.s1" origId="18674953-1308" text="In conclusion, Gyp induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.">
            <entity id="DS.d681.s1.e0" origId="64947" charOffset="15-18" type="compound" text="Gyp"/>
            <entity id="DS.d681.s1.e1" origId="977" charOffset="64-70" type="compound" text="oxygen"/>
            <entity id="DS.d681.s1.e2" origId="271" charOffset="83-87" type="compound" text="Ca(2"/>
            <entity id="DS.d681.s1.e3" origId="P10417,P49950" charOffset="111-116" type="protein" text="Bcl-2"/>
            <entity id="DS.d681.s1.e4" origId="P27297,Q07813,Q63690" charOffset="121-124" type="protein" text="Bax"/>
            <entity id="DS.d681.s1.e5" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="178-190" type="protein" text="cytochrome c"/>
            <pair e1="DS.d681.s1.e1" e2="DS.d681.s1.e3" id="DS.d681.s1.i0" interaction="False"/>
            <pair e1="DS.d681.s1.e2" e2="DS.d681.s1.e4" id="DS.d681.s1.i1" interaction="False"/>
            <pair e1="DS.d681.s1.e2" e2="DS.d681.s1.e3" id="DS.d681.s1.i2" interaction="False"/>
            <pair e1="DS.d681.s1.e1" e2="DS.d681.s1.e5" id="DS.d681.s1.i3" interaction="False"/>
            <pair e1="DS.d681.s1.e0" e2="DS.d681.s1.e3" id="DS.d681.s1.i4" interaction="True"/>
            <pair e1="DS.d681.s1.e2" e2="DS.d681.s1.e5" id="DS.d681.s1.i5" interaction="False"/>
            <pair e1="DS.d681.s1.e0" e2="DS.d681.s1.e5" id="DS.d681.s1.i6" interaction="True"/>
            <pair e1="DS.d681.s1.e1" e2="DS.d681.s1.e4" id="DS.d681.s1.i7" interaction="False"/>
            <pair e1="DS.d681.s1.e0" e2="DS.d681.s1.e4" id="DS.d681.s1.i8" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d682" origId="18675966">
        <sentence id="DS.d682.s0" origId="18675966-641" text="To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and pinopodes in Indian women using ormeloxifene as a contraceptive with fertile and infertile subjects during the window of implantation.">
            <entity id="DS.d682.s0.e0" origId="O62728,P09056,P15018,P17777,Q27956" charOffset="138-141" type="protein" text="LIF"/>
            <entity id="DS.d682.s0.e1" origId="P41693" charOffset="144-157" type="protein" text="interleukin-6"/>
            <entity id="DS.d682.s0.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="159-163" type="protein" text="IL-6"/>
            <entity id="DS.d682.s0.e3" origId="35805,154413" charOffset="202-214" type="compound" text="ormeloxifene"/>
            <pair e1="DS.d682.s0.e3" e2="DS.d682.s0.e2" id="DS.d682.s0.i0" interaction="True"/>
            <pair e1="DS.d682.s0.e3" e2="DS.d682.s0.e1" id="DS.d682.s0.i1" interaction="True"/>
            <pair e1="DS.d682.s0.e3" e2="DS.d682.s0.e0" id="DS.d682.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d683" origId="18676014">
        <sentence id="DS.d683.s0" origId="18676014-229" text="We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or Mcl 1.">
            <entity id="DS.d683.s0.e0" origId="20279" charOffset="188-198" type="compound" text="cladribine"/>
            <entity id="DS.d683.s0.e1" origId="657237" charOffset="202-213" type="compound" text="fludarabine"/>
            <entity id="DS.d683.s0.e2" origId="2907,9554282" charOffset="228-244" type="compound" text="cyclophosphamide"/>
            <entity id="DS.d683.s0.e3" origId="P10417,P49950" charOffset="352-357" type="protein" text="Bcl-2"/>
            <entity id="DS.d683.s0.e4" origId="Q69FH1,Q9Z2H6" charOffset="365-368" type="protein" text="Mcl"/>
            <pair e1="DS.d683.s0.e0" e2="DS.d683.s0.e3" id="DS.d683.s0.i0" interaction="False"/>
            <pair e1="DS.d683.s0.e2" e2="DS.d683.s0.e3" id="DS.d683.s0.i1" interaction="False"/>
            <pair e1="DS.d683.s0.e1" e2="DS.d683.s0.e4" id="DS.d683.s0.i2" interaction="False"/>
            <pair e1="DS.d683.s0.e2" e2="DS.d683.s0.e4" id="DS.d683.s0.i3" interaction="False"/>
            <pair e1="DS.d683.s0.e1" e2="DS.d683.s0.e3" id="DS.d683.s0.i4" interaction="False"/>
            <pair e1="DS.d683.s0.e0" e2="DS.d683.s0.e4" id="DS.d683.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d684" origId="18676199">
        <sentence id="DS.d684.s0" origId="18676199-799" text="Exposure of erythrocytes to PGNs increased cytosolic Ca(2+) concentration, increased ceramide formation, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration.">
            <entity id="DS.d684.s0.e0" origId="Q9UQ90" charOffset="28-32" type="protein" text="PGNs"/>
            <entity id="DS.d684.s0.e1" origId="271" charOffset="53-57" type="compound" text="Ca(2"/>
            <entity id="DS.d684.s0.e2" origId="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0" charOffset="132-141" type="protein" text="annexin V"/>
            <entity id="DS.d684.s0.e3" origId="5957" charOffset="233-236" type="compound" text="ATP"/>
            <pair e1="DS.d684.s0.e3" e2="DS.d684.s0.e2" id="DS.d684.s0.i0" interaction="False"/>
            <pair e1="DS.d684.s0.e3" e2="DS.d684.s0.e0" id="DS.d684.s0.i1" interaction="True"/>
            <pair e1="DS.d684.s0.e1" e2="DS.d684.s0.e2" id="DS.d684.s0.i2" interaction="False"/>
            <pair e1="DS.d684.s0.e1" e2="DS.d684.s0.e0" id="DS.d684.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d685" origId="18676776">
        <sentence id="DS.d685.s0" origId="18676776-233" text="Inhibition of mitogen-activated protein kinase (MAPK) and Akt prevented the antiapoptotic effects of nicotine and decreased chemotherapy-induced apoptosis.">
            <entity id="DS.d685.s0.e0" origId="Q00859" charOffset="14-46" type="protein" text="mitogen-activated protein kinase"/>
            <entity id="DS.d685.s0.e1" origId="O42781,P27638,Q00859" charOffset="48-52" type="protein" text="MAPK"/>
            <entity id="DS.d685.s0.e2" origId="P31750,Q8INB9" charOffset="58-61" type="protein" text="Akt"/>
            <entity id="DS.d685.s0.e3" origId="942,89594,157672" charOffset="101-109" type="compound" text="nicotine"/>
            <pair e1="DS.d685.s0.e3" e2="DS.d685.s0.e2" id="DS.d685.s0.i0" interaction="True"/>
            <pair e1="DS.d685.s0.e3" e2="DS.d685.s0.e1" id="DS.d685.s0.i1" interaction="True"/>
            <pair e1="DS.d685.s0.e3" e2="DS.d685.s0.e0" id="DS.d685.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d685.s1" origId="18676776-235" text="Nicotine up-regulated Akt-mediated antiapoptotic X-linked inhibitor of apoptosis protein and phosphorylated proapoptotic Bcl2-antagonist of cell death.">
            <entity id="DS.d685.s1.e0" origId="942,89594,157672" charOffset="0-8" type="compound" text="Nicotine"/>
            <entity id="DS.d685.s1.e3" origId="O35147,Q61337,Q92934" charOffset="121-150" type="protein" text="Bcl2-antagonist of cell death"/>
            <pair e1="DS.d685.s1.e0" e2="DS.d685.s1.e3" id="DS.d685.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d686" origId="18677478">
        <sentence id="DS.d686.s0" origId="18677478-391" text="Induction of NY-ESO-1 expression on tumor targets using the demethylating agent 5-aza-2'-deoxycytidine (alone or in combination with the histone deacetylase inhibitor depsipeptide) resulted in enhanced interferon-gamma secretion by the TCR-transduced PBL on culture with treated targets.">
            <entity id="DS.d686.s0.e0" origId="451668" charOffset="80-102" type="compound" text="5-aza-2'-deoxycytidine"/>
            <entity id="DS.d686.s0.e1" origId="5352062" charOffset="167-179" type="compound" text="depsipeptide"/>
            <entity id="DS.d686.s0.e2" origId="Q9TTB0" charOffset="202-218" type="protein" text="interferon-gamma"/>
            <pair e1="DS.d686.s0.e1" e2="DS.d686.s0.e2" id="DS.d686.s0.i0" interaction="True"/>
            <pair e1="DS.d686.s0.e0" e2="DS.d686.s0.e2" id="DS.d686.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d687" origId="18677521">
        <sentence id="DS.d687.s0" origId="18677521-1468" text="In the absence of OmcB, cells lost the ability to reduce soluble or insoluble Fe(III).">
            <entity id="DS.d687.s0.e0" origId="P18151,P21354,P23603,P23700,P23701,P26758,P94664,Q253E5,Q3KLQ7,Q548P6,Q933I7,Q9AIS7,Q9PJV0" charOffset="18-22" type="protein" text="OmcB"/>
            <entity id="DS.d687.s0.e1" origId="29936" charOffset="78-84" type="compound" text="Fe(III"/>
            <pair e1="DS.d687.s0.e1" e2="DS.d687.s0.e0" id="DS.d687.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d687.s1" origId="18677521-1470" text="DNA sequences of upstream regions of coregulated operons in the adapted mutant are divergent, suggesting the presence of recognition sites for different transcriptional regulators and indicating that adaptation of the omcB mutant to growth on soluble Fe(III) has shifted the relevant expression networks involved to a more diverse molecular basis.">
            <entity id="DS.d687.s1.e0" origId="Q9CJ45" charOffset="153-179" type="protein" text="transcriptional regulators"/>
            <entity id="DS.d687.s1.e1" origId="29936" charOffset="251-257" type="compound" text="Fe(III"/>
            <pair e1="DS.d687.s1.e1" e2="DS.d687.s1.e0" id="DS.d687.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d688" origId="18677561">
        <sentence id="DS.d688.s0" origId="18677561-697" text="Elevated beta1,4-galactosyltransferase-I induced by the intraspinal injection of lipopolysaccharide.">
            <entity id="DS.d688.s0.e0" origId="P14769,P23336,P50127" charOffset="17-38" type="protein" text="galactosyltransferase"/>
            <entity id="DS.d688.s0.e1" origId="11970143" charOffset="81-99" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d688.s0.e1" e2="DS.d688.s0.e0" id="DS.d688.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d688.s1" origId="18677561-698" text="E-selectin, which ligand was modified by beta1,4-GalT-I, was correlated with galactose-containing glycans following injecting LPS into spinal cord.">
            <entity id="DS.d688.s1.e0" origId="O33836,O84904,P09148,P13212,P22714,P31764,P39575,P45981,P96994,Q00054,Q5LYY8,Q5M3K1,Q836N8,Q88SF0,Q8R8R6,Q8RHC9,Q8VS92,Q8XKP8,Q93MM1,Q97EZ4,Q9CE63,Q9KDV2,Q9RGR9,Q9S6S3,Q9ZB09" charOffset="49-53" type="protein" text="GalT"/>
            <entity id="DS.d688.s1.e1" origId="6036,439353,439357" charOffset="77-86" type="compound" text="galactose"/>
            <pair e1="DS.d688.s1.e1" e2="DS.d688.s1.e0" id="DS.d688.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d689" origId="18677571">
        <sentence id="DS.d689.s0" origId="18677571-1520" text="Effects of P85 on amino acid transporters were examined using their substrates: (3)H-phenylalanine, (3)H-lysine, and (3)H-methylaminoisobutyric acid, respectively.">
            <entity id="DS.d689.s0.e0" origId="O43439,P46655,P49846,Q14155" charOffset="11-14" type="protein" text="P85"/>
            <entity id="DS.d689.s0.e1" origId="994,6140,71567" charOffset="85-98" type="compound" text="phenylalanine"/>
            <entity id="DS.d689.s0.e2" origId="866,5962" charOffset="105-111" type="compound" text="lysine"/>
            <pair e1="DS.d689.s0.e1" e2="DS.d689.s0.e0" id="DS.d689.s0.i0" interaction="False"/>
            <pair e1="DS.d689.s0.e2" e2="DS.d689.s0.e0" id="DS.d689.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d690" origId="18677583">
        <sentence id="DS.d690.s0" origId="18677583-1526" text="Valproate, an anticonvulsant and mood stabilizer, up-regulates Bcl-2, a neurotrophic/neuroprotective protein.">
            <entity id="DS.d690.s0.e0" origId="3121" charOffset="0-9" type="compound" text="Valproate"/>
            <entity id="DS.d690.s0.e1" origId="P10417,P49950" charOffset="63-68" type="protein" text="Bcl-2"/>
            <pair e1="DS.d690.s0.e0" e2="DS.d690.s0.e1" id="DS.d690.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d690.s1" origId="18677583-1527" text="In this study, we investigated the molecular mechanism through which Bcl-2 is up-regulated by valproate using cultured human neuron-like cells.">
            <entity id="DS.d690.s1.e0" origId="P10417,P49950" charOffset="69-74" type="protein" text="Bcl-2"/>
            <entity id="DS.d690.s1.e1" origId="3121" charOffset="94-103" type="compound" text="valproate"/>
            <pair e1="DS.d690.s1.e1" e2="DS.d690.s1.e0" id="DS.d690.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d690.s2" origId="18677583-1528" text="Valproate, within therapeutically relevant ranges, induced time- and concentration-dependent up-regulations of both Bcl-2 messenger RNA and protein implicating an underlying gene transcriptional-mediated mechanism.">
            <entity id="DS.d690.s2.e0" origId="3121" charOffset="0-9" type="compound" text="Valproate"/>
            <entity id="DS.d690.s2.e1" origId="P10417,P49950" charOffset="116-121" type="protein" text="Bcl-2"/>
            <pair e1="DS.d690.s2.e0" e2="DS.d690.s2.e1" id="DS.d690.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d690.s3" origId="18677583-1529" text="Valproate increased transcriptional activity of a human bcl-2 promoter-reporter gene construct.">
            <entity id="DS.d690.s3.e0" origId="3121" charOffset="0-9" type="compound" text="Valproate"/>
            <entity id="DS.d690.s3.e1" origId="P10417,P49950" charOffset="56-61" type="protein" text="bcl-2"/>
            <pair e1="DS.d690.s3.e0" e2="DS.d690.s3.e1" id="DS.d690.s3.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d690.s4" origId="18677583-1530" text="ERK and/or PI3K pathway inhibitors and RSK1 small hairpin RNA knockdown reduced, but did not abolish, baseline and valproate-induced promoter activities and lowered Bcl-2 protein levels.">
            <entity id="DS.d690.s4.e0" origId="3121" charOffset="115-124" type="compound" text="valproate"/>
            <entity id="DS.d690.s4.e1" origId="P10417,P49950" charOffset="165-170" type="protein" text="Bcl-2"/>
            <pair e1="DS.d690.s4.e0" e2="DS.d690.s4.e1" id="DS.d690.s4.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d690.s5" origId="18677583-1531" text="These data collectively suggest that valproate induces Bcl-2 regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.">
            <entity id="DS.d690.s5.e0" origId="3121" charOffset="37-46" type="compound" text="valproate"/>
            <entity id="DS.d690.s5.e1" origId="P10417,P49950" charOffset="55-60" type="protein" text="Bcl-2"/>
            <entity id="DS.d690.s5.e2" origId="P29323" charOffset="109-112" type="protein" text="ERK"/>
            <entity id="DS.d690.s5.e3" origId="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0" charOffset="117-121" type="protein" text="PI3K"/>
            <entity id="DS.d690.s5.e4" origId="P18652" charOffset="160-163" type="protein" text="RSK"/>
            <pair e1="DS.d690.s5.e0" e2="DS.d690.s5.e3" id="DS.d690.s5.i0" interaction="True"/>
            <pair e1="DS.d690.s5.e0" e2="DS.d690.s5.e4" id="DS.d690.s5.i1" interaction="True"/>
            <pair e1="DS.d690.s5.e0" e2="DS.d690.s5.e1" id="DS.d690.s5.i2" interaction="True"/>
            <pair e1="DS.d690.s5.e0" e2="DS.d690.s5.e2" id="DS.d690.s5.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d690.s6" origId="18677583-1532" text="Given the known roles of Bcl-2 in the central nervous system, the current findings offer a partial yet complex molecular mechanistic explanation for the known neurobiological effects of valproate including neurite growth, neuronal survival, and neurogenesis.">
            <entity id="DS.d690.s6.e0" origId="P10417,P49950" charOffset="25-30" type="protein" text="Bcl-2"/>
            <entity id="DS.d690.s6.e1" origId="3121" charOffset="186-195" type="compound" text="valproate"/>
            <pair e1="DS.d690.s6.e1" e2="DS.d690.s6.e0" id="DS.d690.s6.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d691" origId="18679593">
        <sentence id="DS.d691.s0" origId="18679593-620" text="With covalent method, glutaraldehyde was introduced to immobilize cellobiase.">
            <entity id="DS.d691.s0.e0" origId="3485" charOffset="22-36" type="compound" text="glutaraldehyde"/>
            <entity id="DS.d691.s0.e1" origId="O33843,P06835,P07337,P10482,P12614,P14002,P15885,P16084,P22073,P22505,P22506,P22507,P26208,P27034,P29090,P29091,P33363,P38645,P40740,P42403,P48825,P49235,Q03506,Q08638,Q46684,Q56078" charOffset="66-76" type="protein" text="cellobiase"/>
            <pair e1="DS.d691.s0.e0" e2="DS.d691.s0.e1" id="DS.d691.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d692" origId="18679731">
        <sentence id="DS.d692.s0" origId="18679731-726" text="As metabolic flux for the operation of the flavonoid pathway is maintained through the activities of PAL and C4H, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.">
            <entity id="DS.d692.s0.e0" origId="10251" charOffset="43-52" type="compound" text="flavonoid"/>
            <entity id="DS.d692.s0.e1" origId="O03979,O04058,O93967,P10248,P10731,P11544,P14166,P14717,P14925,P19021,P26600,P35511,P35512,P45726,P45727,P45730,P45731,P45735,P52777,P83388,P91268,P97467,Q42609,Q43210,Q9P2V4,Q9PSN0" charOffset="101-104" type="protein" text="PAL"/>
            <entity id="DS.d692.s0.e2" origId="O24312,O81928,P37114,P37115,P48522,P92994,Q04468,Q42797,Q43033,Q43054,Q43067,Q43240,Q96423,Q9AR74" charOffset="109-112" type="protein" text="C4H"/>
            <pair e1="DS.d692.s0.e0" e2="DS.d692.s0.e1" id="DS.d692.s0.i0" interaction="True"/>
            <pair e1="DS.d692.s0.e0" e2="DS.d692.s0.e2" id="DS.d692.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d693" origId="18679812">
        <sentence id="DS.d693.s0" origId="18679812-4" text="Activities of antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutatione-S-transferase, and reduced glutathione) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.">
            <entity id="DS.d693.s0.e0" origId="O50258" charOffset="35-55" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d693.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="57-65" type="protein" text="catalase"/>
            <entity id="DS.d693.s0.e2" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="67-89" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d693.s0.e3" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="91-112" type="protein" text="glutathione reductase"/>
            <entity id="DS.d693.s0.e4" origId="124886" charOffset="144-163" type="compound" text="reduced glutathione"/>
            <pair e1="DS.d693.s0.e4" e2="DS.d693.s0.e0" id="DS.d693.s0.i0" interaction="False"/>
            <pair e1="DS.d693.s0.e4" e2="DS.d693.s0.e2" id="DS.d693.s0.i1" interaction="False"/>
            <pair e1="DS.d693.s0.e4" e2="DS.d693.s0.e1" id="DS.d693.s0.i2" interaction="False"/>
            <pair e1="DS.d693.s0.e4" e2="DS.d693.s0.e3" id="DS.d693.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d694" origId="18679831">
        <sentence id="DS.d694.s0" origId="18679831-20" text="In this study, we report that AR-M1896, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and calcitonin gene-related peptide in a manner similar to galanin, confirming a non-GalR1-mediated effect.">
            <entity id="DS.d694.s0.e0" origId="77681" charOffset="33-38" type="compound" text="M1896"/>
            <entity id="DS.d694.s0.e1" origId="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541" charOffset="103-114" type="protein" text="substance P"/>
            <entity id="DS.d694.s0.e2" origId="P30880,P30881,P31888" charOffset="119-150" type="protein" text="calcitonin gene-related peptide"/>
            <entity id="DS.d694.s0.e3" origId="P07480,P10683,P11242,P22466,P30802,P31234,P33710,P47212,P47213,P47214,P47215,P47216,Q9W6M9" charOffset="174-181" type="protein" text="galanin"/>
            <pair e1="DS.d694.s0.e0" e2="DS.d694.s0.e2" id="DS.d694.s0.i0" interaction="False"/>
            <pair e1="DS.d694.s0.e0" e2="DS.d694.s0.e3" id="DS.d694.s0.i1" interaction="False"/>
            <pair e1="DS.d694.s0.e0" e2="DS.d694.s0.e1" id="DS.d694.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d695" origId="18680102">
        <sentence id="DS.d695.s0" origId="18680102-211" text="Inhibition of non-small cell lung cancer cell migration by grape seed proanthocyanidins is mediated through the inhibition of nitric oxide, guanylate cyclase, and ERK1/2.">
            <entity id="DS.d695.s0.e0" origId="108065" charOffset="70-87" type="compound" text="proanthocyanidins"/>
            <entity id="DS.d695.s0.e1" origId="O94303,P33734,Q9P4P9,Q9SZ30" charOffset="150-157" type="protein" text="cyclase"/>
            <entity id="DS.d695.s0.e2" origId="P27361,P28869,P42525,Q07176" charOffset="163-167" type="protein" text="ERK1"/>
            <pair e1="DS.d695.s0.e0" e2="DS.d695.s0.e2" id="DS.d695.s0.i0" interaction="True"/>
            <pair e1="DS.d695.s0.e0" e2="DS.d695.s0.e1" id="DS.d695.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d695.s1" origId="18680102-215" text="Additionally, UO126 and ODQ inhibited the migration restoring effects of L-arginine in L-NAME-treated cells, suggesting the involvement of cGMP and MAPK pathways in NO-mediated migration.">
            <entity id="DS.d695.s1.e0" origId="1456" charOffset="24-27" type="compound" text="ODQ"/>
            <entity id="DS.d695.s1.e1" origId="6322" charOffset="73-83" type="compound" text="L-arginine"/>
            <entity id="DS.d695.s1.e2" origId="24316" charOffset="139-143" type="compound" text="cGMP"/>
            <entity id="DS.d695.s1.e3" origId="O42781,P27638,Q00859" charOffset="148-152" type="protein" text="MAPK"/>
            <pair e1="DS.d695.s1.e0" e2="DS.d695.s1.e3" id="DS.d695.s1.i0" interaction="True"/>
            <pair e1="DS.d695.s1.e1" e2="DS.d695.s1.e3" id="DS.d695.s1.i1" interaction="True"/>
            <pair e1="DS.d695.s1.e2" e2="DS.d695.s1.e3" id="DS.d695.s1.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d695.s2" origId="18680102-216" text="GSPs inhibited L-arginine and 8-Br-cGMP-induced activation of ERK1/2 in A549 cells.">
            <entity id="DS.d695.s2.e0" origId="6322" charOffset="15-25" type="compound" text="L-arginine"/>
            <entity id="DS.d695.s2.e1" origId="104767" charOffset="30-39" type="compound" text="8-Br-cGMP"/>
            <entity id="DS.d695.s2.e2" origId="P27361,P28869,P42525,Q07176" charOffset="62-66" type="protein" text="ERK1"/>
            <pair e1="DS.d695.s2.e0" e2="DS.d695.s2.e2" id="DS.d695.s2.i0" interaction="True"/>
            <pair e1="DS.d695.s2.e1" e2="DS.d695.s2.e2" id="DS.d695.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d696" origId="18680106">
        <sentence id="DS.d696.s0" origId="18680106-970" text="Enhancement of p53 expression in keratinocytes by the bioflavonoid apigenin is associated with RNA-binding protein HuR.">
            <entity id="DS.d696.s0.e0" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="15-18" type="protein" text="p53"/>
            <entity id="DS.d696.s0.e1" origId="5280805" charOffset="54-66" type="compound" text="bioflavonoid"/>
            <entity id="DS.d696.s0.e2" origId="5280443" charOffset="67-75" type="compound" text="apigenin"/>
            <entity id="DS.d696.s0.e3" origId="P03526,P04487,P07940,P12002,P56958,P82866" charOffset="95-114" type="protein" text="RNA-binding protein"/>
            <entity id="DS.d696.s0.e4" origId="P70372,Q15717" charOffset="115-118" type="protein" text="HuR"/>
            <pair e1="DS.d696.s0.e1" e2="DS.d696.s0.e4" id="DS.d696.s0.i0" interaction="False"/>
            <pair e1="DS.d696.s0.e1" e2="DS.d696.s0.e0" id="DS.d696.s0.i1" interaction="False"/>
            <pair e1="DS.d696.s0.e2" e2="DS.d696.s0.e3" id="DS.d696.s0.i2" interaction="False"/>
            <pair e1="DS.d696.s0.e2" e2="DS.d696.s0.e4" id="DS.d696.s0.i3" interaction="True"/>
            <pair e1="DS.d696.s0.e2" e2="DS.d696.s0.e0" id="DS.d696.s0.i4" interaction="True"/>
            <pair e1="DS.d696.s0.e1" e2="DS.d696.s0.e3" id="DS.d696.s0.i5" interaction="False"/>
        </sentence>
        <sentence id="DS.d696.s1" origId="18680106-971" text="We have reported previously that apigenin, a naturally occurring nonmutagenic flavonoid, increased wild-type p53 protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.">
            <entity id="DS.d696.s1.e0" origId="5280443" charOffset="33-41" type="compound" text="apigenin"/>
            <entity id="DS.d696.s1.e1" origId="10251" charOffset="78-87" type="compound" text="flavonoid"/>
            <entity id="DS.d696.s1.e2" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="109-112" type="protein" text="p53"/>
            <entity id="DS.d696.s1.e3" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="197-200" type="protein" text="p53"/>
            <pair e1="DS.d696.s1.e0" e2="DS.d696.s1.e2" id="DS.d696.s1.i0" interaction="True"/>
            <pair e1="DS.d696.s1.e1" e2="DS.d696.s1.e2" id="DS.d696.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d696.s2" origId="18680106-973" text="Instead, biosynthetic labeling showed that apigenin increased nascent p53 protein synthesis by enhancing p53 translation.">
            <entity id="DS.d696.s2.e0" origId="5280443" charOffset="43-51" type="compound" text="apigenin"/>
            <entity id="DS.d696.s2.e1" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="70-73" type="protein" text="p53"/>
            <entity id="DS.d696.s2.e2" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="105-108" type="protein" text="p53"/>
            <pair e1="DS.d696.s2.e0" e2="DS.d696.s2.e1" id="DS.d696.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d696.s3" origId="18680106-975" text="Furthermore, apigenin treatment increased the level of association of the RNA binding protein HuR with endogenous p53 mRNA.">
            <entity id="DS.d696.s3.e0" origId="5280443" charOffset="13-21" type="compound" text="apigenin"/>
            <entity id="DS.d696.s3.e1" origId="P03526,P04487,P07940,P12002,P56958,P82866" charOffset="74-93" type="protein" text="RNA binding protein"/>
            <entity id="DS.d696.s3.e2" origId="P70372,Q15717" charOffset="94-97" type="protein" text="HuR"/>
            <entity id="DS.d696.s3.e3" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="114-117" type="protein" text="p53"/>
            <pair e1="DS.d696.s3.e0" e2="DS.d696.s3.e3" id="DS.d696.s3.i0" interaction="True"/>
            <pair e1="DS.d696.s3.e0" e2="DS.d696.s3.e2" id="DS.d696.s3.i1" interaction="True"/>
            <pair e1="DS.d696.s3.e0" e2="DS.d696.s3.e1" id="DS.d696.s3.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d696.s4" origId="18680106-976" text="Apigenin treatment also augmented HuR translocation into the cytoplasm.">
            <entity id="DS.d696.s4.e0" origId="5280443" charOffset="0-8" type="compound" text="Apigenin"/>
            <entity id="DS.d696.s4.e1" origId="P70372,Q15717" charOffset="34-37" type="protein" text="HuR"/>
            <pair e1="DS.d696.s4.e0" e2="DS.d696.s4.e1" id="DS.d696.s4.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d696.s5" origId="18680106-979" text="Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which apigenin induces p53 protein expression is enhancement of translation through the RNA binding protein HuR.">
            <entity id="DS.d696.s5.e0" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="65-68" type="protein" text="p53"/>
            <entity id="DS.d696.s5.e1" origId="5280443" charOffset="119-127" type="compound" text="apigenin"/>
            <entity id="DS.d696.s5.e2" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="136-139" type="protein" text="p53"/>
            <entity id="DS.d696.s5.e3" origId="P03526,P04487,P07940,P12002,P56958,P82866" charOffset="201-220" type="protein" text="RNA binding protein"/>
            <entity id="DS.d696.s5.e4" origId="P70372,Q15717" charOffset="221-224" type="protein" text="HuR"/>
            <pair e1="DS.d696.s5.e1" e2="DS.d696.s5.e0" id="DS.d696.s5.i0" interaction="True"/>
            <pair e1="DS.d696.s5.e1" e2="DS.d696.s5.e4" id="DS.d696.s5.i1" interaction="True"/>
            <pair e1="DS.d696.s5.e1" e2="DS.d696.s5.e3" id="DS.d696.s5.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d697" origId="18680156">
        <sentence id="DS.d697.s0" origId="18680156-264" text="Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that thyroxin treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.">
            <entity id="DS.d697.s0.e0" origId="O24006" charOffset="61-64" type="protein" text="AMP"/>
            <entity id="DS.d697.s0.e1" origId="P15337,P16220,P27925,P51984,P51985,Q01147" charOffset="99-103" type="protein" text="CREB"/>
            <entity id="DS.d697.s0.e2" origId="Q00859" charOffset="106-139" type="protein" text="mitogen-activated protein kinases"/>
            <entity id="DS.d697.s0.e3" origId="P27361,P28869,P42525,Q07176" charOffset="153-157" type="protein" text="ERK1"/>
            <entity id="DS.d697.s0.e4" origId="5819" charOffset="188-196" type="compound" text="thyroxin"/>
            <pair e1="DS.d697.s0.e4" e2="DS.d697.s0.e1" id="DS.d697.s0.i0" interaction="True"/>
            <pair e1="DS.d697.s0.e4" e2="DS.d697.s0.e3" id="DS.d697.s0.i1" interaction="True"/>
            <pair e1="DS.d697.s0.e4" e2="DS.d697.s0.e2" id="DS.d697.s0.i2" interaction="True"/>
            <pair e1="DS.d697.s0.e4" e2="DS.d697.s0.e0" id="DS.d697.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d698" origId="18680550">
        <sentence id="DS.d698.s0" origId="18680550-1533" text="Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus ribavirin.">
            <entity id="DS.d698.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="0-7" type="protein" text="Insulin"/>
            <entity id="DS.d698.s0.e1" origId="37542" charOffset="157-166" type="compound" text="ribavirin"/>
            <pair e1="DS.d698.s0.e1" e2="DS.d698.s0.e0" id="DS.d698.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d698.s1" origId="18680550-1535" text="Aim To investigate retrospectively the impact of insulin resistance on treatment response in Chinese genotype 1 CHC patients receiving a 24-week course therapy with peginterferon alpha-2b/ribavirin.">
            <entity id="DS.d698.s1.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="49-56" type="protein" text="insulin"/>
            <entity id="DS.d698.s1.e1" origId="37542" charOffset="188-197" type="compound" text="ribavirin"/>
            <pair e1="DS.d698.s1.e1" e2="DS.d698.s1.e0" id="DS.d698.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d699" origId="18680626">
        <sentence id="DS.d699.s0" origId="18680626-658" text="We hypothesised that OAT could be a limiting step in glutamine-arginine interconversion.">
            <entity id="DS.d699.s0.e0" origId="P04181,Q07805,Q4XWV5,Q6LFH8,Q7RT90" charOffset="21-24" type="protein" text="OAT"/>
            <entity id="DS.d699.s0.e1" origId="738,5961" charOffset="53-62" type="compound" text="glutamine"/>
            <entity id="DS.d699.s0.e2" origId="232,4367,6322" charOffset="63-71" type="compound" text="arginine"/>
            <pair e1="DS.d699.s0.e1" e2="DS.d699.s0.e0" id="DS.d699.s0.i0" interaction="True"/>
            <pair e1="DS.d699.s0.e2" e2="DS.d699.s0.e0" id="DS.d699.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d699.s1" origId="18680626-659" text="OAT overexpression decreased plasma and liver ornithine concentrations but did not affect glutamine or arginine homeostasis.">
            <entity id="DS.d699.s1.e0" origId="P04181,Q07805,Q4XWV5,Q6LFH8,Q7RT90" charOffset="0-3" type="protein" text="OAT"/>
            <entity id="DS.d699.s1.e1" origId="389,6262,71082" charOffset="46-55" type="compound" text="ornithine"/>
            <entity id="DS.d699.s1.e2" origId="738,5961" charOffset="90-99" type="compound" text="glutamine"/>
            <entity id="DS.d699.s1.e3" origId="232,4367,6322" charOffset="103-111" type="compound" text="arginine"/>
            <pair e1="DS.d699.s1.e1" e2="DS.d699.s1.e0" id="DS.d699.s1.i0" interaction="True"/>
            <pair e1="DS.d699.s1.e2" e2="DS.d699.s1.e0" id="DS.d699.s1.i1" interaction="False"/>
            <pair e1="DS.d699.s1.e3" e2="DS.d699.s1.e0" id="DS.d699.s1.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d699.s2" origId="18680626-660" text="There was an inverse relationship between ornithine levels and OAT activity.">
            <entity id="DS.d699.s2.e0" origId="389,6262,71082" charOffset="42-51" type="compound" text="ornithine"/>
            <entity id="DS.d699.s2.e1" origId="P04181,Q07805,Q4XWV5,Q6LFH8,Q7RT90" charOffset="63-66" type="protein" text="OAT"/>
            <pair e1="DS.d699.s2.e0" e2="DS.d699.s2.e1" id="DS.d699.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d700" origId="18681858">
        <sentence id="DS.d700.s0" origId="18681858-1" text="In men there is a large interindividual variation of SHBG levels and consequently of testosterone (T) and E(2) levels.">
            <entity id="DS.d700.s0.e0" origId="P04278,P08689,P15196,P97497,Q62588" charOffset="53-57" type="protein" text="SHBG"/>
            <entity id="DS.d700.s0.e1" origId="6013" charOffset="85-97" type="compound" text="testosterone"/>
            <pair e1="DS.d700.s0.e1" e2="DS.d700.s0.e0" id="DS.d700.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d701" origId="18682334">
        <sentence id="DS.d701.s0" origId="18682334-364" text="Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble RANKL (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL OPG, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/L Ca and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.">
            <entity id="DS.d701.s0.e0" origId="O14788,O35235,Q9ESE2" charOffset="127-132" type="protein" text="RANKL"/>
            <entity id="DS.d701.s0.e1" origId="O00300" charOffset="174-177" type="protein" text="OPG"/>
            <entity id="DS.d701.s0.e2" origId="O00300" charOffset="191-194" type="protein" text="OPG"/>
            <entity id="DS.d701.s0.e3" origId="O00300" charOffset="191-194" type="protein" text="OPG"/>
            <entity id="DS.d701.s0.e4" origId="O00300" charOffset="191-194" type="protein" text="OPG"/>
            <entity id="DS.d701.s0.e5" origId="5281764" charOffset="260-264" type="compound" text="L Ca"/>
            <entity id="DS.d701.s0.e6" origId="O00300" charOffset="191-194" type="protein" text="OPG"/>
            <pair e1="DS.d701.s0.e5" e2="DS.d701.s0.e0" id="DS.d701.s0.i0" interaction="False"/>
            <pair e1="DS.d701.s0.e5" e2="DS.d701.s0.e1" id="DS.d701.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d702" origId="18682988">
        <sentence id="DS.d702.s0" origId="18682988-518" text="Over-expression of GDH decreased the yield of ethanol and 2,3-butanediol, meanwhile it increased the concentration of acetic acid.">
            <entity id="DS.d702.s0.e0" origId="O52310,O59650,O74024,O95479,P00366,P00367,P00368,P0AES2,P0AES3,P10860,P13443,P26443,P28270,P36234,P42174,P42206,P42238,P49448,P52596,P54385,P56201,P80319,P82264,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q53199,Q56304,Q59516,Q64HZ8,Q64HZ9,Q64I00,Q64I01,Q9HFR6,Q9HGU3,Q9HGU4,Q9RDE9,Q9URS1,Q9YC65" charOffset="19-22" type="protein" text="GDH"/>
            <entity id="DS.d702.s0.e1" origId="702" charOffset="46-53" type="compound" text="ethanol"/>
            <entity id="DS.d702.s0.e2" origId="262,225936" charOffset="58-72" type="compound" text="2,3-butanediol"/>
            <entity id="DS.d702.s0.e3" origId="176,286,291512" charOffset="118-129" type="compound" text="acetic acid"/>
            <pair e1="DS.d702.s0.e3" e2="DS.d702.s0.e0" id="DS.d702.s0.i0" interaction="True"/>
            <pair e1="DS.d702.s0.e1" e2="DS.d702.s0.e0" id="DS.d702.s0.i1" interaction="True"/>
            <pair e1="DS.d702.s0.e2" e2="DS.d702.s0.e0" id="DS.d702.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d703" origId="18683011">
        <sentence id="DS.d703.s0" origId="18683011-1547" text="Geranylgeranylacetone prevents acute liver damage after massive hepatectomy in rats through suppression of a CXC chemokine GRO1 and induction of heat shock proteins.">
            <entity id="DS.d703.s0.e0" origId="5282199" charOffset="0-21" type="compound" text="Geranylgeranylacetone"/>
            <entity id="DS.d703.s0.e1" origId="P09341" charOffset="123-127" type="protein" text="GRO1"/>
            <pair e1="DS.d703.s0.e0" e2="DS.d703.s0.e1" id="DS.d703.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d704" origId="18683188">
        <sentence id="DS.d704.s0" origId="18683188-1093" text="Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant vitamin C and Trolox effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/Bax.">
            <entity id="DS.d704.s0.e0" origId="977" charOffset="61-67" type="compound" text="oxygen"/>
            <entity id="DS.d704.s0.e1" origId="54670067" charOffset="113-122" type="compound" text="vitamin C"/>
            <entity id="DS.d704.s0.e2" origId="40634" charOffset="127-133" type="compound" text="Trolox"/>
            <entity id="DS.d704.s0.e3" origId="P10417,P49950" charOffset="200-205" type="protein" text="Bcl-2"/>
            <entity id="DS.d704.s0.e4" origId="P27297,Q07813,Q63690" charOffset="206-209" type="protein" text="Bax"/>
            <pair e1="DS.d704.s0.e0" e2="DS.d704.s0.e3" id="DS.d704.s0.i0" interaction="False"/>
            <pair e1="DS.d704.s0.e2" e2="DS.d704.s0.e4" id="DS.d704.s0.i1" interaction="True"/>
            <pair e1="DS.d704.s0.e2" e2="DS.d704.s0.e3" id="DS.d704.s0.i2" interaction="True"/>
            <pair e1="DS.d704.s0.e1" e2="DS.d704.s0.e3" id="DS.d704.s0.i3" interaction="True"/>
            <pair e1="DS.d704.s0.e1" e2="DS.d704.s0.e4" id="DS.d704.s0.i4" interaction="True"/>
            <pair e1="DS.d704.s0.e0" e2="DS.d704.s0.e4" id="DS.d704.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d705" origId="18683221">
        <sentence id="DS.d705.s0" origId="18683221-1122" text="The adsorption of ovine fibrinogen onto PMA-modified surfaces was reduced relative to unmodified surfaces, and in vitro ovine blood contact through a rocking test revealed marked reductions in platelet deposition and bulk phase platelet activation relative to unmodified TiAl6V4 and polystyrene controls.">
            <entity id="DS.d705.s0.e0" origId="P22775,P81070" charOffset="24-34" type="protein" text="fibrinogen"/>
            <entity id="DS.d705.s0.e1" origId="27924,122634,22833501" charOffset="40-43" type="compound" text="PMA"/>
            <pair e1="DS.d705.s0.e1" e2="DS.d705.s0.e0" id="DS.d705.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d706" origId="18683225">
        <sentence id="DS.d706.s0" origId="18683225-1127" text="When the thrombin concentration was higher than 15 U/mL, the gelation could be finished within 1 min and yielded a composite with evenly suspended and distributed PLGA microspheres.">
            <entity id="DS.d706.s0.e0" origId="P84122" charOffset="9-17" type="protein" text="thrombin"/>
            <entity id="DS.d706.s0.e1" origId="36797" charOffset="163-167" type="compound" text="PLGA"/>
            <pair e1="DS.d706.s0.e1" e2="DS.d706.s0.e0" id="DS.d706.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d707" origId="18683233">
        <sentence id="DS.d707.s0" origId="18683233-58" text="The culture tests using MSCs show that the level of alkaline phosphatase (ALP) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and beta-GP.">
            <entity id="DS.d707.s0.e0" origId="O60109,P81800,P83456" charOffset="52-72" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d707.s0.e1" origId="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0" charOffset="74-77" type="protein" text="ALP"/>
            <entity id="DS.d707.s0.e2" origId="2526" charOffset="183-190" type="compound" text="beta-GP"/>
            <pair e1="DS.d707.s0.e2" e2="DS.d707.s0.e1" id="DS.d707.s0.i0" interaction="True"/>
            <pair e1="DS.d707.s0.e2" e2="DS.d707.s0.e0" id="DS.d707.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d707.s1" origId="18683233-59" text="The level was unchanged in MSCs cultured on PV-H. In the case of supplementing Dex and beta-GP to the medium, the level of ALP activity in MSCs cultured on SPV-H was higher than that on PV-H at all time points during the 21-day culture.">
            <entity id="DS.d707.s1.e0" origId="2526" charOffset="87-94" type="compound" text="beta-GP"/>
            <entity id="DS.d707.s1.e1" origId="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0" charOffset="123-126" type="protein" text="ALP"/>
            <pair e1="DS.d707.s1.e0" e2="DS.d707.s1.e1" id="DS.d707.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d708" origId="18683244">
        <sentence id="DS.d708.s0" origId="18683244-106" text="The combined treatment strategy not only decreased ubiquitin-positive aggregation in striatum, alleviated polyglutamine aggregation formation, and reduced striatal volume, but also extended life span in the R6/2 animal model.">
            <entity id="DS.d708.s0.e0" origId="O46543,P08565,P08618,P0C014,P0C072,P13117,P14624,P14792,P15174,P19848,P20685,P22589,P23324,P23398,P42739,P42740,P46574,P49634,P49635,P59263,P59669,P61862,P61863,P61864,P62972,P62973,P62974,P62975,P62976,P62977,P62988,P62989,P62990,P62991,P63049,P63051,P68195,P68196,P68197,P68198,P68199,P68201,P68204,P69308,P69309,P69310,P69311,P69312,P69313,P69314,P69315,P69316,P69317,P69318,P69319,P69320,P69321,P69322,P69323,P69324,P69325,P69326,P84589,Q05550,Q865C5,Q867C2,Q867C3,Q867C4,Q8MKD1,Q9Y848" charOffset="51-60" type="protein" text="ubiquitin"/>
            <entity id="DS.d708.s0.e1" origId="5961" charOffset="106-119" type="compound" text="polyglutamine"/>
            <pair e1="DS.d708.s0.e1" e2="DS.d708.s0.e0" id="DS.d708.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d709" origId="18683246">
        <sentence id="DS.d709.s0" origId="18683246-1143" text="Vasoactive intestinal peptide inhibits toll-like receptor 3-induced nitric oxide production in Schwann cells and subsequent sensory neuronal cell death in vitro.">
            <entity id="DS.d709.s0.e0" origId="P01282,P01283,P01284,P04566,P09684,P09685,P32648,P32649,P39089,P45644,P48142,P48143,P63289,P63290,P63291,P81016,P81401,P84488,P84771,P84772" charOffset="0-29" type="protein" text="Vasoactive intestinal peptide"/>
            <entity id="DS.d709.s0.e1" origId="145068" charOffset="68-80" type="compound" text="nitric oxide"/>
            <pair e1="DS.d709.s0.e1" e2="DS.d709.s0.e0" id="DS.d709.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d710" origId="18683252">
        <sentence id="DS.d710.s0" origId="18683252-1154" text="The GUS and LUC genes were chosen because they can be used as markers for the easy detection of transgenic plants, while histidine tail better enables the isolation of protein expressed in plant tissue.">
            <entity id="DS.d710.s0.e0" origId="P05804" charOffset="4-7" type="protein" text="GUS"/>
            <entity id="DS.d710.s0.e1" origId="773,6274" charOffset="121-130" type="compound" text="histidine"/>
            <pair e1="DS.d710.s0.e1" e2="DS.d710.s0.e0" id="DS.d710.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d711" origId="18683262">
        <sentence id="DS.d711.s0" origId="18683262-1162" text="Expression was performed in fusion to maltose binding protein using chemically defined minimal medium, followed by a single-step affinity capture and enzymatic cleavage using tobacco etch virus protease.">
            <entity id="DS.d711.s0.e0" origId="294,6255,439186,439341,10991489,45109807" charOffset="38-45" type="compound" text="maltose"/>
            <entity id="DS.d711.s0.e1" origId="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0" charOffset="194-202" type="protein" text="protease"/>
            <pair e1="DS.d711.s0.e0" e2="DS.d711.s0.e1" id="DS.d711.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d712" origId="18683263">
        <sentence id="DS.d712.s0" origId="18683263-1164" text="The amplification of gltA gene encoding citrate synthase of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during vanillin production from ferulic acid, to CoA, which is essential for vanillin production.">
            <entity id="DS.d712.s0.e0" origId="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20902,P20903,P21553,P26491,P39812,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P94325,Q10530,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59977,Q9RWB2,Q9ZN37" charOffset="21-25" type="protein" text="gltA"/>
            <entity id="DS.d712.s0.e1" origId="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20901,P20902,P20903,P21553,P26491,P27660,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P84543,P94325,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59939,Q59977,Q9RWB2,Q9ZN37" charOffset="40-56" type="protein" text="citrate synthase"/>
            <entity id="DS.d712.s0.e2" origId="1183" charOffset="144-152" type="compound" text="vanillin"/>
            <entity id="DS.d712.s0.e3" origId="445858" charOffset="169-181" type="compound" text="ferulic acid"/>
            <entity id="DS.d712.s0.e4" origId="1183" charOffset="214-222" type="compound" text="vanillin"/>
            <pair e1="DS.d712.s0.e3" e2="DS.d712.s0.e1" id="DS.d712.s0.i0" interaction="True"/>
            <pair e1="DS.d712.s0.e3" e2="DS.d712.s0.e0" id="DS.d712.s0.i1" interaction="True"/>
            <pair e1="DS.d712.s0.e2" e2="DS.d712.s0.e1" id="DS.d712.s0.i2" interaction="True"/>
            <pair e1="DS.d712.s0.e2" e2="DS.d712.s0.e0" id="DS.d712.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d712.s1" origId="18683263-1167" text="The gltA amplification of the glyoxylate bypass in the icdA null mutant remarkably increased the production rate of vanillin with a little increase in the amount of vanillin production.">
            <entity id="DS.d712.s1.e0" origId="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20902,P20903,P21553,P26491,P39812,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P94325,Q10530,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59977,Q9RWB2,Q9ZN37" charOffset="4-8" type="protein" text="gltA"/>
            <entity id="DS.d712.s1.e1" origId="1183" charOffset="116-124" type="compound" text="vanillin"/>
            <entity id="DS.d712.s1.e2" origId="1183" charOffset="165-173" type="compound" text="vanillin"/>
            <pair e1="DS.d712.s1.e1" e2="DS.d712.s1.e0" id="DS.d712.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d712.s2" origId="18683263-1168" text="The real synergistic effect of gltA amplification and icdA deletion was observed with use of XAD-2 resin reducing the toxicity of vanillin produced during culture.">
            <entity id="DS.d712.s2.e0" origId="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20902,P20903,P21553,P26491,P39812,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P94325,Q10530,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59977,Q9RWB2,Q9ZN37" charOffset="31-35" type="protein" text="gltA"/>
            <entity id="DS.d712.s2.e1" origId="P08200,P79089" charOffset="54-58" type="protein" text="icdA"/>
            <entity id="DS.d712.s2.e2" origId="1183" charOffset="130-138" type="compound" text="vanillin"/>
            <pair e1="DS.d712.s2.e2" e2="DS.d712.s2.e0" id="DS.d712.s2.i0" interaction="True"/>
            <pair e1="DS.d712.s2.e2" e2="DS.d712.s2.e1" id="DS.d712.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d713" origId="18683889">
        <sentence id="DS.d713.s0" origId="18683889-1688" text="Treatment of dermal fibroblasts with vitamin D(3) induced expression of BMP-4 (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and BMP-6 (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.">
            <entity id="DS.d713.s0.e0" origId="5280795,5283711" charOffset="37-48" type="compound" text="vitamin D(3"/>
            <entity id="DS.d713.s0.e1" origId="O46576,P12644,P21275,P30885,Q06826,Q29607,Q2KJH1,Q8MJV5,Q90752" charOffset="72-77" type="protein" text="BMP-4"/>
            <entity id="DS.d713.s0.e2" origId="P20722,P22004,Q04906" charOffset="143-148" type="protein" text="BMP-6"/>
            <pair e1="DS.d713.s0.e0" e2="DS.d713.s0.e1" id="DS.d713.s0.i0" interaction="True"/>
            <pair e1="DS.d713.s0.e0" e2="DS.d713.s0.e2" id="DS.d713.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d713.s1" origId="18683889-1689" text="Vitamin D(3) was also shown to induce the expression of the osteoblast-specific markers, alkaline phosphatase and osteocalcin, in a dose-dependent manner in human dermal fibroblasts.">
            <entity id="DS.d713.s1.e0" origId="5280795,5283711" charOffset="0-11" type="compound" text="Vitamin D(3"/>
            <entity id="DS.d713.s1.e1" origId="O60109,P81800,P83456" charOffset="89-109" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d713.s1.e2" origId="P02819,P02821,P02823,P0C225,P0C226,P15504,P28317,P39056,P81455,P83005,P83238,P83473,P83489,P84348,P84349,P84350,P84351,Q7LZI4,Q8HYY9" charOffset="114-125" type="protein" text="osteocalcin"/>
            <pair e1="DS.d713.s1.e0" e2="DS.d713.s1.e1" id="DS.d713.s1.i0" interaction="True"/>
            <pair e1="DS.d713.s1.e0" e2="DS.d713.s1.e2" id="DS.d713.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d714" origId="18684212">
        <sentence id="DS.d714.s0" origId="18684212-1656" text="The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (ACTH) and cortisol in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and noradrenaline responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.">
            <entity id="DS.d714.s0.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="108-112" type="protein" text="ACTH"/>
            <entity id="DS.d714.s0.e1" origId="5754" charOffset="118-126" type="compound" text="cortisol"/>
            <entity id="DS.d714.s0.e2" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="182-186" type="protein" text="ACTH"/>
            <entity id="DS.d714.s0.e3" origId="5754" charOffset="188-196" type="compound" text="cortisol"/>
            <entity id="DS.d714.s0.e4" origId="951,439260" charOffset="201-214" type="compound" text="noradrenaline"/>
            <pair e1="DS.d714.s0.e4" e2="DS.d714.s0.e0" id="DS.d714.s0.i0" interaction="False"/>
            <pair e1="DS.d714.s0.e1" e2="DS.d714.s0.e0" id="DS.d714.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d714.s1" origId="18684212-1657" text="In Study 1, basal cortisol levels were analysed in 41 IBS and 25 controls using 24-h collections of plasma ACTH and cortisol (q10 min sampling).">
            <entity id="DS.d714.s1.e0" origId="5754" charOffset="18-26" type="compound" text="cortisol"/>
            <entity id="DS.d714.s1.e1" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="107-111" type="protein" text="ACTH"/>
            <entity id="DS.d714.s1.e2" origId="5754" charOffset="116-124" type="compound" text="cortisol"/>
            <pair e1="DS.d714.s1.e0" e2="DS.d714.s1.e1" id="DS.d714.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d714.s2" origId="18684212-1658" text="Basal ACTH 0.05), while basal and stimulated plasma cortisol levels were higher in patients.">
            <entity id="DS.d714.s2.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="6-10" type="protein" text="ACTH"/>
            <entity id="DS.d714.s2.e1" origId="5754" charOffset="52-60" type="compound" text="cortisol"/>
            <pair e1="DS.d714.s2.e1" e2="DS.d714.s2.e0" id="DS.d714.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d715" origId="18684339">
        <sentence id="DS.d715.s0" origId="18684339-438" text="A 3-fold increase in the expression of the MnSOD gene was associated with decreased CpG methylation of the analysed promoter region in the vegetarian group compared with the age-matched omnivores group.">
            <entity id="DS.d715.s0.e0" origId="P00448,P66828,P66829,Q8Z2V9,Q9RUV2" charOffset="43-48" type="protein" text="MnSOD"/>
            <entity id="DS.d715.s0.e1" origId="6804" charOffset="84-87" type="compound" text="CpG"/>
            <pair e1="DS.d715.s0.e1" e2="DS.d715.s0.e0" id="DS.d715.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d716" origId="18684712">
        <sentence id="DS.d716.s0" origId="18684712-650" text="ALK2 (R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or dorsomorphin.">
            <entity id="DS.d716.s0.e0" origId="Q9Y758" charOffset="0-4" type="protein" text="ALK2"/>
            <entity id="DS.d716.s0.e1" origId="P70340,P97588,Q9I8V2" charOffset="18-23" type="protein" text="Smad1"/>
            <entity id="DS.d716.s0.e2" origId="P97454,Q99717,Q9R1V3,Q9W7E7" charOffset="27-32" type="protein" text="Smad5"/>
            <entity id="DS.d716.s0.e3" origId="O15105,O35253,O88406" charOffset="97-102" type="protein" text="Smad7"/>
            <entity id="DS.d716.s0.e4" origId="11524144" charOffset="106-118" type="compound" text="dorsomorphin"/>
            <pair e1="DS.d716.s0.e4" e2="DS.d716.s0.e1" id="DS.d716.s0.i0" interaction="True"/>
            <pair e1="DS.d716.s0.e4" e2="DS.d716.s0.e3" id="DS.d716.s0.i1" interaction="False"/>
            <pair e1="DS.d716.s0.e4" e2="DS.d716.s0.e2" id="DS.d716.s0.i2" interaction="True"/>
            <pair e1="DS.d716.s0.e4" e2="DS.d716.s0.e0" id="DS.d716.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d717" origId="18685817">
        <sentence id="DS.d717.s0" origId="18685817-1575" text="Combustion products of 1,3-butadiene inhibit catalase activity and induce expression of oxidative DNA damage repair enzymes in human bronchial epithelial cells.">
            <entity id="DS.d717.s0.e0" origId="7845" charOffset="23-36" type="compound" text="1,3-butadiene"/>
            <entity id="DS.d717.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="45-53" type="protein" text="catalase"/>
            <pair e1="DS.d717.s0.e0" e2="DS.d717.s0.e1" id="DS.d717.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d718" origId="18686014">
        <sentence id="DS.d718.s0" origId="18686014-49" text="The aim of the present study was to examine whether increased serum Hsp70 levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (fibronectin), trophoblast debris (cell-free fetal DNA) and oxidative stress (malondialdehyde).">
            <entity id="DS.d718.s0.e0" origId="P30722,P47547,P49463,P75344,Q7YQC6,Q8TQR2,Q9UXR0,Q9WYK6" charOffset="68-73" type="protein" text="Hsp70"/>
            <entity id="DS.d718.s0.e1" origId="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400" charOffset="320-331" type="protein" text="fibronectin"/>
            <entity id="DS.d718.s0.e2" origId="10964" charOffset="397-412" type="compound" text="malondialdehyde"/>
            <pair e1="DS.d718.s0.e2" e2="DS.d718.s0.e1" id="DS.d718.s0.i0" interaction="False"/>
            <pair e1="DS.d718.s0.e2" e2="DS.d718.s0.e0" id="DS.d718.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d718.s1" origId="18686014-50" text="Furthermore, serum levels of blood urea nitrogen, creatinine, bilirubin and CRP, serum alanine aminotransferase and lactate dehydrogenase (LDH) activities, as well as plasma levels of VWF :Ag, fibronectin, cell-free fetal DNA and malondialdehyde were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.">
            <entity id="DS.d718.s1.e0" origId="1176,265993" charOffset="35-39" type="compound" text="urea"/>
            <entity id="DS.d718.s1.e1" origId="947,123329" charOffset="40-48" type="compound" text="nitrogen"/>
            <entity id="DS.d718.s1.e2" origId="588" charOffset="50-60" type="compound" text="creatinine"/>
            <entity id="DS.d718.s1.e3" origId="5280352" charOffset="62-71" type="compound" text="bilirubin"/>
            <entity id="DS.d718.s1.e4" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="76-79" type="protein" text="CRP"/>
            <entity id="DS.d718.s1.e5" origId="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289" charOffset="139-142" type="protein" text="LDH"/>
            <entity id="DS.d718.s1.e6" origId="P04275,P80012,Q28295,Q28833,Q8CIZ8" charOffset="184-187" type="protein" text="VWF"/>
            <entity id="DS.d718.s1.e7" origId="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400" charOffset="193-204" type="protein" text="fibronectin"/>
            <entity id="DS.d718.s1.e8" origId="10964" charOffset="230-245" type="compound" text="malondialdehyde"/>
            <pair e1="DS.d718.s1.e2" e2="DS.d718.s1.e7" id="DS.d718.s1.i0" interaction="False"/>
            <pair e1="DS.d718.s1.e8" e2="DS.d718.s1.e6" id="DS.d718.s1.i1" interaction="False"/>
            <pair e1="DS.d718.s1.e3" e2="DS.d718.s1.e6" id="DS.d718.s1.i2" interaction="False"/>
            <pair e1="DS.d718.s1.e1" e2="DS.d718.s1.e4" id="DS.d718.s1.i3" interaction="False"/>
            <pair e1="DS.d718.s1.e2" e2="DS.d718.s1.e4" id="DS.d718.s1.i4" interaction="False"/>
            <pair e1="DS.d718.s1.e1" e2="DS.d718.s1.e5" id="DS.d718.s1.i5" interaction="False"/>
            <pair e1="DS.d718.s1.e0" e2="DS.d718.s1.e7" id="DS.d718.s1.i6" interaction="False"/>
            <pair e1="DS.d718.s1.e0" e2="DS.d718.s1.e4" id="DS.d718.s1.i7" interaction="False"/>
            <pair e1="DS.d718.s1.e3" e2="DS.d718.s1.e5" id="DS.d718.s1.i8" interaction="False"/>
            <pair e1="DS.d718.s1.e8" e2="DS.d718.s1.e4" id="DS.d718.s1.i9" interaction="False"/>
            <pair e1="DS.d718.s1.e0" e2="DS.d718.s1.e6" id="DS.d718.s1.i10" interaction="False"/>
            <pair e1="DS.d718.s1.e2" e2="DS.d718.s1.e6" id="DS.d718.s1.i11" interaction="False"/>
            <pair e1="DS.d718.s1.e3" e2="DS.d718.s1.e7" id="DS.d718.s1.i12" interaction="False"/>
            <pair e1="DS.d718.s1.e1" e2="DS.d718.s1.e6" id="DS.d718.s1.i13" interaction="False"/>
            <pair e1="DS.d718.s1.e1" e2="DS.d718.s1.e7" id="DS.d718.s1.i14" interaction="False"/>
            <pair e1="DS.d718.s1.e3" e2="DS.d718.s1.e4" id="DS.d718.s1.i15" interaction="False"/>
            <pair e1="DS.d718.s1.e0" e2="DS.d718.s1.e5" id="DS.d718.s1.i16" interaction="False"/>
            <pair e1="DS.d718.s1.e8" e2="DS.d718.s1.e5" id="DS.d718.s1.i17" interaction="False"/>
            <pair e1="DS.d718.s1.e8" e2="DS.d718.s1.e7" id="DS.d718.s1.i18" interaction="False"/>
            <pair e1="DS.d718.s1.e2" e2="DS.d718.s1.e5" id="DS.d718.s1.i19" interaction="False"/>
        </sentence>
        <sentence id="DS.d718.s2" origId="18686014-51" text="In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma malondialdehyde levels (R = 0.25, p = 0.043).">
            <entity id="DS.d718.s2.e0" origId="P30722,P47547,P49463,P75344,Q7YQC6,Q8TQR2,Q9UXR0,Q9WYK6" charOffset="32-37" type="protein" text="Hsp70"/>
            <entity id="DS.d718.s2.e1" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="88-91" type="protein" text="CRP"/>
            <entity id="DS.d718.s2.e2" origId="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56" charOffset="137-163" type="protein" text="aspartate aminotransferase"/>
            <entity id="DS.d718.s2.e3" origId="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289" charOffset="190-193" type="protein" text="LDH"/>
            <entity id="DS.d718.s2.e4" origId="10964" charOffset="226-241" type="compound" text="malondialdehyde"/>
            <pair e1="DS.d718.s2.e4" e2="DS.d718.s2.e1" id="DS.d718.s2.i0" interaction="False"/>
            <pair e1="DS.d718.s2.e4" e2="DS.d718.s2.e0" id="DS.d718.s2.i1" interaction="True"/>
            <pair e1="DS.d718.s2.e4" e2="DS.d718.s2.e2" id="DS.d718.s2.i2" interaction="False"/>
            <pair e1="DS.d718.s2.e4" e2="DS.d718.s2.e3" id="DS.d718.s2.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d719" origId="18686047">
        <sentence id="DS.d719.s0" origId="18686047-887" text="In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, Rapamycin, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the mTOR receptor, is compared to paclitaxel in combination therapy employing monospecific or bispecific oligos.">
            <entity id="DS.d719.s0.e0" origId="5040,478951,5284616,5358081,5374464,5460439,5497196,6436030,16760631,17753749,44295234,53627520,54600319" charOffset="148-157" type="compound" text="Rapamycin"/>
            <entity id="DS.d719.s0.e1" origId="P42345,P42346,Q9JLN9" charOffset="257-261" type="protein" text="mTOR"/>
            <entity id="DS.d719.s0.e2" origId="4666,36314,441276,5352019,6713921,6915727,44155032,53313247" charOffset="287-297" type="compound" text="paclitaxel"/>
            <pair e1="DS.d719.s0.e0" e2="DS.d719.s0.e1" id="DS.d719.s0.i0" interaction="True"/>
            <pair e1="DS.d719.s0.e2" e2="DS.d719.s0.e1" id="DS.d719.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d720" origId="18686136">
        <sentence id="DS.d720.s0" origId="18686136-131" text="In this study we investigated the superoxide radicals scavenging effect and xanthine oxidase inhibitory activity by magnesium lithospermate B, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.">
            <entity id="DS.d720.s0.e0" origId="5359597" charOffset="34-44" type="compound" text="superoxide"/>
            <entity id="DS.d720.s0.e1" origId="P22985,P47989,P47990,P80457,Q00519,Q9MYW6" charOffset="76-92" type="protein" text="xanthine oxidase"/>
            <entity id="DS.d720.s0.e2" origId="6451084" charOffset="116-141" type="compound" text="magnesium lithospermate B"/>
            <pair e1="DS.d720.s0.e2" e2="DS.d720.s0.e1" id="DS.d720.s0.i0" interaction="True"/>
            <pair e1="DS.d720.s0.e0" e2="DS.d720.s0.e1" id="DS.d720.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d720.s1" origId="18686136-132" text="Superoxide radicals were generated both in beta-NADH/PMS system and xanthine/xanthine oxidase system.">
            <entity id="DS.d720.s1.e0" origId="5359597" charOffset="0-10" type="compound" text="Superoxide"/>
            <entity id="DS.d720.s1.e1" origId="928,439153,11250888" charOffset="43-52" type="compound" text="beta-NADH"/>
            <entity id="DS.d720.s1.e2" origId="9286" charOffset="53-56" type="compound" text="PMS"/>
            <entity id="DS.d720.s1.e3" origId="1188" charOffset="68-76" type="compound" text="xanthine"/>
            <entity id="DS.d720.s1.e4" origId="P22985,P47989,P47990,P80457,Q00519,Q9MYW6" charOffset="77-93" type="protein" text="xanthine oxidase"/>
            <pair e1="DS.d720.s1.e2" e2="DS.d720.s1.e4" id="DS.d720.s1.i0" interaction="False"/>
            <pair e1="DS.d720.s1.e1" e2="DS.d720.s1.e4" id="DS.d720.s1.i1" interaction="False"/>
            <pair e1="DS.d720.s1.e3" e2="DS.d720.s1.e4" id="DS.d720.s1.i2" interaction="True"/>
            <pair e1="DS.d720.s1.e0" e2="DS.d720.s1.e4" id="DS.d720.s1.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d720.s2" origId="18686136-133" text="Further study suggested that magnesium lithospermate B can directly inhibit xanthine oxidase and exhibits competitive inhibition.">
            <entity id="DS.d720.s2.e0" origId="6451084" charOffset="29-54" type="compound" text="magnesium lithospermate B"/>
            <entity id="DS.d720.s2.e1" origId="P22985,P47989,P47990,P80457,Q00519,Q9MYW6" charOffset="76-92" type="protein" text="xanthine oxidase"/>
            <pair e1="DS.d720.s2.e0" e2="DS.d720.s2.e1" id="DS.d720.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d720.s3" origId="18686136-134" text="In addition, magnesium lithospermate B significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the xanthine/xanthine oxidase reactions.">
            <entity id="DS.d720.s3.e0" origId="6451084" charOffset="13-38" type="compound" text="magnesium lithospermate B"/>
            <entity id="DS.d720.s3.e1" origId="1188" charOffset="125-133" type="compound" text="xanthine"/>
            <entity id="DS.d720.s3.e2" origId="P22985,P47989,P47990,P80457,Q00519,Q9MYW6" charOffset="134-150" type="protein" text="xanthine oxidase"/>
            <pair e1="DS.d720.s3.e0" e2="DS.d720.s3.e2" id="DS.d720.s3.i0" interaction="True"/>
            <pair e1="DS.d720.s3.e1" e2="DS.d720.s3.e2" id="DS.d720.s3.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d721" origId="18686165">
        <sentence id="DS.d721.s0" origId="18686165-403" text="Four different molecules contain galactofuranose in A. fumigatus: (i) the galactomannan present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O glycan moieties of secreted glycoproteins (iii) a GPI-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an inositol phosphoceramide.">
            <entity id="DS.d721.s0.e0" origId="439336" charOffset="74-87" type="compound" text="galactomannan"/>
            <entity id="DS.d721.s0.e1" origId="871" charOffset="172-178" type="compound" text="glycan"/>
            <entity id="DS.d721.s0.e2" origId="P08163" charOffset="200-213" type="protein" text="glycoproteins"/>
            <entity id="DS.d721.s0.e3" origId="O25781,O51672,O59618,O66954,O82059,O83488,O84382,P06744,P06745,P08059,P0A0T0,P0A0T1,P0A6T1,P0A6T2,P12341,P12709,P13377,P18240,P28718,P29333,P34795,P34796,P34797,P42861,P44312,P46479,P47357,P49105,P50309,P52029,P52030,P52031,P52983,P54234,P54235,P54236,P54237,P54238,P54239,P54240,P54241,P54242,P54243,P57636,P64192,P64193,P64194,P64195,P64196,P77877,P78033,P78917,P80860,P81181,P83194,P83780,P84140,P99078,Q0TA36,Q0VR14,Q11MA0,Q13Z07,Q165T7,Q18FQ4,Q1ASN4,Q1BH79,Q1CSA0,Q1CX51,Q1GAY0,Q1GJQ5,Q1GTU1,Q1H1P4,Q1IYT4,Q1J8N2,Q1JDQ8,Q1JIS1,Q1JNM4,Q1LM68,Q1LU73,Q1MM06,Q1QEK1,Q1R3R3,Q1WUR2,Q21M11,Q21ZD5,Q24VW9,Q255I6,Q28QX4,Q2A2C5,Q2FIB3,Q2FZU0,Q2G7C4,Q2IE39,Q2JH03,Q2JHU0,Q2JX86,Q2KCY8,Q2KYE9,Q2LRD0,Q2NJ38,Q2NR04,Q2P380,Q2RQ51,Q2S8W1,Q2SS24,Q2SWP6,Q2VYV7,Q2YBU4,Q2YPF3,Q2YWS3,Q31AX5,Q31I19,Q31LL0,Q31TX1,Q328X7,Q38WF1,Q39FF4,Q39SU1,Q3A201,Q3AFH3,Q3AJU7,Q3ASZ0,Q3AXV8,Q3B3Q8,Q3BUL3,Q3IKH4,Q3IMS0,Q3J2U4,Q3JCN1,Q3JRE2,Q3K2Y2,Q3K6Q4,Q3KLX6,Q3M6S3,Q3YUW0,Q3ZBD7,Q44407,Q46L16,Q47IJ3,Q48N88,Q48VF9,Q491V0,Q49WA1,Q4A5S9,Q4A7J2,Q4A9F3,Q4FVH5,Q4JCA7,Q4JX51,Q4K5Y1,Q4L4X8,Q4QL07,Q4R591,Q4UTV8,Q4ZY88,Q57F73,Q57H06,Q59000,Q59088,Q5E847,Q5FL04,Q5H0A7,Q5HHC2,Q5HQJ9,Q5JE38,Q5KVS7,Q5L5E1,Q5L9E3,Q5LRS9,Q5M1N9,Q5N0B4,Q5NFC4,Q5P0T4,Q5PL07,Q5QWW0,Q5R4E3,Q5SLL6,Q5UXU0,Q5WDX0,Q5WYE0,Q5X6Y8,Q5XE09,Q5YPP1,Q5ZXH2,Q600A8,Q609I7,Q62JL8,Q632G4,Q63V31,Q64PM7,Q65FL6,Q65TC2,Q660E3,Q664W9,Q67QQ0,Q6A5X5,Q6AQ48,Q6D022,Q6F1L2,Q6FRW1,Q6G0T9,Q6GAW4,Q6GIC6,Q6HC08,Q6KH90,Q6LM51,Q6LXQ4,Q6MD44,Q6MTA3,Q6NIE5,Q6YQU0,Q711G1,Q71X61,Q72GY6,Q72MT7,Q72YI4,Q73K18,Q742E4,Q74DK5,Q74K31,Q758L0,Q7MH97,Q7MUV9,Q7MZB4,Q7NJY9,Q7S986,Q7U6T0,Q7V1I1,Q7V7M6,Q7VBZ6,Q7VNR9,Q7VRI4,Q7VUF4,Q7W197,Q7WP01,Q816G0,Q81K75,Q822E7,Q82SP4,Q835G1,Q83D91,Q83XM3,Q848I4,Q87EV7,Q87L81,Q888Q7,Q88UI4,Q891H2,Q89A35,Q8A5W2,Q8CT80,Q8D1V8,Q8DCK7,Q8DKY2,Q8DN74,Q8EBH1,Q8ENY8,Q8EVU1,Q8EZG6,Q8FB44,Q8FR39,Q8G2N3,Q8G7I6,Q8K8Q6,Q8K910,Q8KDQ7,Q8L1Z9,Q8NS31,Q8NXF1,Q8P2R3,Q8P9S7,Q8R924,Q8RHH5,Q8SRY1,Q8UI94,Q8VVB7,Q8XI54,Q8XYN9,Q8Y4R7,Q8YF86,Q8YY05,Q8Z1U7,Q8ZAS2,Q8ZKI4,Q8ZWV0,Q928R6,Q92SC4,Q96YC2,Q978F3,Q97FP8,Q97NG0,Q97WE5,Q98BV5,Q98R79,Q9A1L1,Q9ABK5,Q9CD75,Q9CNL2,Q9FXM4,Q9FXM5,Q9HGZ2,Q9HIC2,Q9HNQ6,Q9HV67,Q9K7L8,Q9KUY4,Q9KX58,Q9N1E2,Q9PGR6,Q9PK16,Q9PMD4,Q9RDY2,Q9RMC1,Q9RTL8,Q9UXW3,Q9X1A5,Q9X670,Q9YE01,Q9Z6N4,Q9ZK49" charOffset="222-225" type="protein" text="GPI"/>
            <entity id="DS.d721.s0.e4" origId="57339182" charOffset="327-351" type="compound" text="inositol phosphoceramide"/>
            <pair e1="DS.d721.s0.e0" e2="DS.d721.s0.e2" id="DS.d721.s0.i0" interaction="False"/>
            <pair e1="DS.d721.s0.e4" e2="DS.d721.s0.e2" id="DS.d721.s0.i1" interaction="False"/>
            <pair e1="DS.d721.s0.e0" e2="DS.d721.s0.e3" id="DS.d721.s0.i2" interaction="False"/>
            <pair e1="DS.d721.s0.e1" e2="DS.d721.s0.e2" id="DS.d721.s0.i3" interaction="True"/>
            <pair e1="DS.d721.s0.e4" e2="DS.d721.s0.e3" id="DS.d721.s0.i4" interaction="False"/>
            <pair e1="DS.d721.s0.e1" e2="DS.d721.s0.e3" id="DS.d721.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d722" origId="18687549">
        <sentence id="DS.d722.s0" origId="18687549-1315" text="The estimated CRP level and the IMCL content in these patients were correlated with body mass index, percentage of body fat, other measures of abdominal obesity, serum lipoproteins, fasting and post-oral glucose load serum insulin levels and other surrogate markers of insulin resistance.">
            <entity id="DS.d722.s0.e0" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="14-17" type="protein" text="CRP"/>
            <entity id="DS.d722.s0.e1" origId="206,5793,64689,79025" charOffset="204-211" type="compound" text="glucose"/>
            <entity id="DS.d722.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="223-230" type="protein" text="insulin"/>
            <entity id="DS.d722.s0.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="269-276" type="protein" text="insulin"/>
            <pair e1="DS.d722.s0.e1" e2="DS.d722.s0.e0" id="DS.d722.s0.i0" interaction="False"/>
            <pair e1="DS.d722.s0.e1" e2="DS.d722.s0.e2" id="DS.d722.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d723" origId="18687985">
        <sentence id="DS.d723.s0" origId="18687985-1621" text="Studies suggest that DKK1 activation in osteoblasts is the underlying cause of glucocorticoid- and estrogen deficiency-mediated osteoporosis, and at least partially underlies the teratogenic effects of thalidomide on limb development.">
            <entity id="DS.d723.s0.e0" origId="O94907" charOffset="21-25" type="protein" text="DKK1"/>
            <entity id="DS.d723.s0.e1" origId="5426,75792,92142" charOffset="202-213" type="compound" text="thalidomide"/>
            <pair e1="DS.d723.s0.e1" e2="DS.d723.s0.e0" id="DS.d723.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d724" origId="18688040">
        <sentence id="DS.d724.s0" origId="18688040-30" text="The IL-13-induced up-regulation of RhoA was inhibited by leflunomide, an inhibitor of signal transducer and activator of transcription 6 (STAT6).">
            <entity id="DS.d724.s0.e0" origId="P20109,P35225,P42203,P61126,Q5I6E4,Q864V6,Q865W5,Q865X3,Q95J68,Q9N0W9,Q9XSV9" charOffset="4-9" type="protein" text="IL-13"/>
            <entity id="DS.d724.s0.e1" origId="Q9C3Y4" charOffset="35-39" type="protein" text="RhoA"/>
            <entity id="DS.d724.s0.e2" origId="3899" charOffset="57-68" type="compound" text="leflunomide"/>
            <entity id="DS.d724.s0.e3" origId="P42226" charOffset="138-143" type="protein" text="STAT6"/>
            <pair e1="DS.d724.s0.e2" e2="DS.d724.s0.e0" id="DS.d724.s0.i0" interaction="False"/>
            <pair e1="DS.d724.s0.e2" e2="DS.d724.s0.e1" id="DS.d724.s0.i1" interaction="True"/>
            <pair e1="DS.d724.s0.e2" e2="DS.d724.s0.e3" id="DS.d724.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d725" origId="18688042">
        <sentence id="DS.d725.s0" origId="18688042-1313" text="The goal of this study was to determine the mechanisms by which 17beta-estradiol induces MUC5B gene expression in airway epithelial cells.">
            <entity id="DS.d725.s0.e0" origId="5757" charOffset="64-80" type="compound" text="17beta-estradiol"/>
            <entity id="DS.d725.s0.e1" origId="Q9HC84" charOffset="89-94" type="protein" text="MUC5B"/>
            <pair e1="DS.d725.s0.e0" e2="DS.d725.s0.e1" id="DS.d725.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d725.s1" origId="18688042-1314" text="Pretreatment with ER antagonist ICI 182,780 blocked both E2-induced ERK1/2-MAPK activation and MUC5B gene expression.">
            <entity id="DS.d725.s1.e0" origId="104741" charOffset="32-43" type="compound" text="ICI 182,780"/>
            <entity id="DS.d725.s1.e1" origId="P27361,P28869,P42525,Q07176" charOffset="68-72" type="protein" text="ERK1"/>
            <entity id="DS.d725.s1.e2" origId="O42781,P27638,Q00859" charOffset="75-79" type="protein" text="MAPK"/>
            <entity id="DS.d725.s1.e3" origId="Q9HC84" charOffset="95-100" type="protein" text="MUC5B"/>
            <pair e1="DS.d725.s1.e0" e2="DS.d725.s1.e1" id="DS.d725.s1.i0" interaction="True"/>
            <pair e1="DS.d725.s1.e0" e2="DS.d725.s1.e2" id="DS.d725.s1.i1" interaction="True"/>
            <pair e1="DS.d725.s1.e0" e2="DS.d725.s1.e3" id="DS.d725.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d726" origId="18688696">
        <sentence id="DS.d726.s0" origId="18688696-558" text="We here show that calumenin in the presence of Ca(2+) binds to TSP1 with a dissociation constant K (d) around 0.4 muM.">
            <entity id="DS.d726.s0.e0" origId="271" charOffset="47-51" type="compound" text="Ca(2"/>
            <entity id="DS.d726.s0.e1" origId="P07996,P54000,Q28178" charOffset="63-67" type="protein" text="TSP1"/>
            <pair e1="DS.d726.s0.e0" e2="DS.d726.s0.e1" id="DS.d726.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d727" origId="18688816">
        <sentence id="DS.d727.s0" origId="18688816-657" text="It represents transition in sulfur-deprived conditions, known to lead to H2 production in Chlamydomonas reinhardtii, and the two main processes then induced which are an over-accumulation of intracellular starch and a progressive reduction of PSII activity for anoxia achievement.">
            <entity id="DS.d727.s0.e0" origId="402" charOffset="28-34" type="compound" text="sulfur"/>
            <entity id="DS.d727.s0.e1" origId="O47040,O78462,O96813,P12185,P12186,P12187,P13165,P17227,P17228,P28251,P30980,P48116,P49159,P49484,P51387,P52768,P56768,P58214,P69396,P69397,P69398,Q31909,Q5QA78,Q5SCW1,Q68RZ6,Q6B8K8,Q6ENG4,Q6ENV4,Q6EW69,Q6L390,Q6L603,Q6QBN9,Q70XZ3,Q7FNS8,Q7YJW3,Q85CI4,Q85FL2,Q85X26,Q8M9X5,Q8WI10,Q9BBS0,Q9GDV2,Q9MTL2,Q9MUQ4,Q9TL12,Q9TM24" charOffset="243-247" type="protein" text="PSII"/>
            <pair e1="DS.d727.s0.e0" e2="DS.d727.s0.e1" id="DS.d727.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d728" origId="18689429">
        <sentence id="DS.d728.s0" origId="18689429-1187" text="We examined whether aldosterone produced locally in the brain may contribute to the activation of mineralocorticoid receptors in the CNS.">
            <entity id="DS.d728.s0.e0" origId="5839" charOffset="20-31" type="compound" text="aldosterone"/>
            <entity id="DS.d728.s0.e1" origId="P08235,P22199,P79404,Q29131,Q3YC04,Q4JM28,Q8QHI2,Q8VII8,Q91573,Q9BDJ7,Q9IAC6,Q9N0W8" charOffset="98-125" type="protein" text="mineralocorticoid receptors"/>
            <pair e1="DS.d728.s0.e0" e2="DS.d728.s0.e1" id="DS.d728.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d729" origId="18690415">
        <sentence id="DS.d729.s0" origId="18690415-286" text="Macrophages isolated from iron deficient rats, or pregnant rats at day 21 of gestation, either supplemented with a single dose of iron dextran, 10 mg, at the commencement of pregnancy, or not, showed significant increases of macrophage ferroportin mRNA expression, which was paralleled by significant decreases in hepatic Hamp mRNA expression.">
            <entity id="DS.d729.s0.e0" origId="105075" charOffset="130-142" type="compound" text="iron dextran"/>
            <entity id="DS.d729.s0.e1" origId="Q7T273,Q99MH3,Q9EQ21" charOffset="322-326" type="protein" text="Hamp"/>
            <pair e1="DS.d729.s0.e0" e2="DS.d729.s0.e1" id="DS.d729.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d730" origId="18690549">
        <sentence id="DS.d730.s0" origId="18690549-796" text="Rat dicarboxylate transporter (SDCT1), expressed in renal tubular epithelial cells, plays a key role in regulating blood and urinary citrate level by reabsorbing citrate from the lumen.">
            <entity id="DS.d730.s0.e0" origId="Q13183,Q28615" charOffset="31-36" type="protein" text="SDCT1"/>
            <entity id="DS.d730.s0.e1" origId="311,2733526" charOffset="133-140" type="compound" text="citrate"/>
            <entity id="DS.d730.s0.e2" origId="311,2733526" charOffset="162-169" type="compound" text="citrate"/>
            <pair e1="DS.d730.s0.e1" e2="DS.d730.s0.e0" id="DS.d730.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d731" origId="18690792">
        <sentence id="DS.d731.s0" origId="18690792-145" text="However, as opposed to exogenous HS, the continuous use of FGF-2 during in vitro differentiation completely blocked rMSC mineralization.">
            <entity id="DS.d731.s0.e0" origId="5047209,46173182" charOffset="33-35" type="compound" text="HS"/>
            <entity id="DS.d731.s0.e1" origId="P03969,P20003,P48800,Q60487" charOffset="59-64" type="protein" text="FGF-2"/>
            <pair e1="DS.d731.s0.e0" e2="DS.d731.s0.e1" id="DS.d731.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d731.s1" origId="18690792-146" text="We show that the effects of both FGF-2 and HS are mediated through FGF receptor 1 (FGFR1) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.">
            <entity id="DS.d731.s1.e0" origId="P03969,P20003,P48800,Q60487" charOffset="33-38" type="protein" text="FGF-2"/>
            <entity id="DS.d731.s1.e1" origId="5047209,46173182" charOffset="43-45" type="compound" text="HS"/>
            <entity id="DS.d731.s1.e2" origId="O10284,P41444" charOffset="33-36" type="protein" text="FGF"/>
            <entity id="DS.d731.s1.e3" origId="P11362,P21804,Q8MY86,Q91285" charOffset="83-88" type="protein" text="FGFR1"/>
            <pair e1="DS.d731.s1.e1" e2="DS.d731.s1.e2" id="DS.d731.s1.i0" interaction="False"/>
            <pair e1="DS.d731.s1.e1" e2="DS.d731.s1.e0" id="DS.d731.s1.i1" interaction="False"/>
            <pair e1="DS.d731.s1.e1" e2="DS.d731.s1.e3" id="DS.d731.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d732" origId="18691156">
        <sentence id="DS.d732.s0" origId="18691156-926" text="Two related polytopic membrane proteins of the major facilitator family, NarK and NarU, catalyse nitrate uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.">
            <entity id="DS.d732.s0.e0" origId="P16629,P24266,P28991,Q04565,Q07252" charOffset="22-39" type="protein" text="membrane proteins"/>
            <entity id="DS.d732.s0.e1" origId="P10903,P46907" charOffset="73-77" type="protein" text="NarK"/>
            <entity id="DS.d732.s0.e2" origId="P37593,P37758" charOffset="82-86" type="protein" text="NarU"/>
            <entity id="DS.d732.s0.e3" origId="943" charOffset="97-104" type="compound" text="nitrate"/>
            <pair e1="DS.d732.s0.e3" e2="DS.d732.s0.e0" id="DS.d732.s0.i0" interaction="False"/>
            <pair e1="DS.d732.s0.e3" e2="DS.d732.s0.e2" id="DS.d732.s0.i1" interaction="True"/>
            <pair e1="DS.d732.s0.e3" e2="DS.d732.s0.e1" id="DS.d732.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d733" origId="18691343">
        <sentence id="DS.d733.s0" origId="18691343-1073" text="Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and ionomycin using flow cytometry.">
            <entity id="DS.d733.s0.e0" origId="Q9TTB0" charOffset="47-63" type="protein" text="interferon-gamma"/>
            <entity id="DS.d733.s0.e1" origId="Q64279,Q922L6" charOffset="65-68" type="protein" text="Th1"/>
            <entity id="DS.d733.s0.e2" origId="4792,27924,122634,22833501" charOffset="138-169" type="compound" text="phorbol 12-myristate 13-acetate"/>
            <entity id="DS.d733.s0.e3" origId="3733,6434517,6912226,25134244" charOffset="174-183" type="compound" text="ionomycin"/>
            <pair e1="DS.d733.s0.e3" e2="DS.d733.s0.e0" id="DS.d733.s0.i0" interaction="True"/>
            <pair e1="DS.d733.s0.e2" e2="DS.d733.s0.e1" id="DS.d733.s0.i1" interaction="True"/>
            <pair e1="DS.d733.s0.e2" e2="DS.d733.s0.e0" id="DS.d733.s0.i2" interaction="True"/>
            <pair e1="DS.d733.s0.e3" e2="DS.d733.s0.e1" id="DS.d733.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d734" origId="18691603">
        <sentence id="DS.d734.s0" origId="18691603-1685" text="This signaling system is engaged by the active component of cannabis, Delta9-tetrahydrocannabinol (Delta9-THC), which exerts its pharmacological effects by activation of G protein-coupled type-1 (CB1) and type-2 (CB2) cannabinoid receptors.">
            <entity id="DS.d734.s0.e0" origId="16078" charOffset="70-97" type="compound" text="Delta9-tetrahydrocannabinol"/>
            <entity id="DS.d734.s0.e1" origId="16078" charOffset="99-109" type="compound" text="Delta9-THC"/>
            <entity id="DS.d734.s0.e2" origId="O02777,P20272,P21554,P47746,P56971,Q333S9,Q5IS73,Q71SP5,Q801M1,Q9PUI7" charOffset="196-199" type="protein" text="CB1"/>
            <entity id="DS.d734.s0.e3" origId="P34972,P47936,Q9QZN9" charOffset="213-216" type="protein" text="CB2"/>
            <pair e1="DS.d734.s0.e1" e2="DS.d734.s0.e3" id="DS.d734.s0.i0" interaction="True"/>
            <pair e1="DS.d734.s0.e0" e2="DS.d734.s0.e3" id="DS.d734.s0.i1" interaction="True"/>
            <pair e1="DS.d734.s0.e0" e2="DS.d734.s0.e2" id="DS.d734.s0.i2" interaction="True"/>
            <pair e1="DS.d734.s0.e1" e2="DS.d734.s0.e2" id="DS.d734.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d735" origId="18691715">
        <sentence id="DS.d735.s0" origId="18691715-1342" text="Homocysteine stimulates antioxidant response element-mediated expression of glutamate-cysteine ligase in mouse macrophages.">
            <entity id="DS.d735.s0.e0" origId="778" charOffset="0-12" type="compound" text="Homocysteine"/>
            <entity id="DS.d735.s0.e1" origId="O68838,P0A6W9,P0A6X0,P32477,P57485,P58994,P61379,Q09768,Q20117,Q57KV3,Q5E7F8,Q5LYY5,Q5M3J8,Q5PF10,Q65RX0,Q66E64,Q6ANW2,Q6D1T4,Q6LMV1,Q71VZ1,Q72RD4,Q7MHS5,Q7N7A4,Q7W3F2,Q7WES2,Q82ZG8,Q87LS2,Q88AR1,Q88R90,Q88UW5,Q89AD8,Q8D2V5,Q8DC38,Q8DW15,Q8DXM9,Q8E399,Q8EBF9,Q8F4D5,Q8X0X0,Q8X900,Q8XK30,Q8Y3R3,Q8Z4D6,Q8ZBU2,Q926X7,Q97IV1,Q9CM00,Q9HF78,Q9HTY6,Q9KUG5,Q9NFN6,Q9W3K5" charOffset="76-101" type="protein" text="glutamate-cysteine ligase"/>
            <pair e1="DS.d735.s0.e0" e2="DS.d735.s0.e1" id="DS.d735.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d735.s1" origId="18691715-1343" text="The current study investigated whether homocysteine induces transcription of glutamate-cysteine ligase (Gcl), via ARE driven gene expression in mouse macrophages.">
            <entity id="DS.d735.s1.e0" origId="778" charOffset="39-51" type="compound" text="homocysteine"/>
            <entity id="DS.d735.s1.e1" origId="O68838,P0A6W9,P0A6X0,P32477,P57485,P58994,P61379,Q09768,Q20117,Q57KV3,Q5E7F8,Q5LYY5,Q5M3J8,Q5PF10,Q65RX0,Q66E64,Q6ANW2,Q6D1T4,Q6LMV1,Q71VZ1,Q72RD4,Q7MHS5,Q7N7A4,Q7W3F2,Q7WES2,Q82ZG8,Q87LS2,Q88AR1,Q88R90,Q88UW5,Q89AD8,Q8D2V5,Q8DC38,Q8DW15,Q8DXM9,Q8E399,Q8EBF9,Q8F4D5,Q8X0X0,Q8X900,Q8XK30,Q8Y3R3,Q8Z4D6,Q8ZBU2,Q926X7,Q97IV1,Q9CM00,Q9HF78,Q9HTY6,Q9KUG5,Q9NFN6,Q9W3K5" charOffset="77-102" type="protein" text="glutamate-cysteine ligase"/>
            <entity id="DS.d735.s1.e2" origId="P0AEP7,P0AEP8,Q01820,Q920G9" charOffset="104-107" type="protein" text="Gcl"/>
            <pair e1="DS.d735.s1.e0" e2="DS.d735.s1.e1" id="DS.d735.s1.i0" interaction="False"/>
            <pair e1="DS.d735.s1.e0" e2="DS.d735.s1.e2" id="DS.d735.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d735.s2" origId="18691715-1344" text="Treatment of mouse macrophages with d-/l-homocysteine (50microM) induced depletion of intracellular glutathione and a compensatory increase in Gcl activity.">
            <entity id="DS.d735.s2.e0" origId="778" charOffset="41-53" type="compound" text="homocysteine"/>
            <entity id="DS.d735.s2.e1" origId="124886" charOffset="100-111" type="compound" text="glutathione"/>
            <entity id="DS.d735.s2.e2" origId="P0AEP7,P0AEP8,Q01820,Q920G9" charOffset="143-146" type="protein" text="Gcl"/>
            <pair e1="DS.d735.s2.e0" e2="DS.d735.s2.e2" id="DS.d735.s2.i0" interaction="True"/>
            <pair e1="DS.d735.s2.e1" e2="DS.d735.s2.e2" id="DS.d735.s2.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d735.s3" origId="18691715-1345" text="Real-time RT-PCR revealed increased mRNA-expression of the catalytic subunit of Gcl (Gclc) after treatment with homocysteine, and this occurred via increased transcription as demonstrated with luciferase promoter reporter constructs for Gclc.">
            <entity id="DS.d735.s3.e0" origId="778" charOffset="112-124" type="compound" text="homocysteine"/>
            <entity id="DS.d735.s3.e1" origId="P08659,P13129,Q01158,Q26304,Q27757" charOffset="193-203" type="protein" text="luciferase"/>
            <pair e1="DS.d735.s3.e0" e2="DS.d735.s3.e1" id="DS.d735.s3.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d736" origId="18691757">
        <sentence id="DS.d736.s0" origId="18691757-12" text="Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells.">
            <entity id="DS.d736.s0.e0" origId="Q00342" charOffset="15-19" type="protein" text="Flt3"/>
            <entity id="DS.d736.s0.e1" origId="42890" charOffset="109-119" type="compound" text="idarubicin"/>
            <pair e1="DS.d736.s0.e1" e2="DS.d736.s0.e0" id="DS.d736.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d737" origId="18692155">
        <sentence id="DS.d737.s0" origId="18692155-570" text="Only EGF activated ERK signaling and up-regulated early gene expression, while DHT triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.">
            <entity id="DS.d737.s0.e0" origId="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0" charOffset="5-8" type="protein" text="EGF"/>
            <entity id="DS.d737.s0.e1" origId="P29323" charOffset="19-22" type="protein" text="ERK"/>
            <entity id="DS.d737.s0.e2" origId="10635" charOffset="79-82" type="compound" text="DHT"/>
            <entity id="DS.d737.s0.e3" origId="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0" charOffset="167-170" type="protein" text="EGF"/>
            <entity id="DS.d737.s0.e4" origId="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617" charOffset="179-182" type="protein" text="PSA"/>
            <pair e1="DS.d737.s0.e2" e2="DS.d737.s0.e1" id="DS.d737.s0.i0" interaction="False"/>
            <pair e1="DS.d737.s0.e2" e2="DS.d737.s0.e4" id="DS.d737.s0.i1" interaction="False"/>
            <pair e1="DS.d737.s0.e2" e2="DS.d737.s0.e0" id="DS.d737.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d737.s1" origId="18692155-571" text="DHT and EGF up-regulated cyclinD1 (CD1) at both mRNA and protein levels in A549 cells, while in LNCaP cells each mitogen increased only CD1 protein expression.">
            <entity id="DS.d737.s1.e0" origId="10635" charOffset="0-3" type="compound" text="DHT"/>
            <entity id="DS.d737.s1.e1" origId="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0" charOffset="8-11" type="protein" text="EGF"/>
            <entity id="DS.d737.s1.e2" origId="P23043" charOffset="35-38" type="protein" text="CD1"/>
            <entity id="DS.d737.s1.e3" origId="P23043" charOffset="136-139" type="protein" text="CD1"/>
            <pair e1="DS.d737.s1.e0" e2="DS.d737.s1.e1" id="DS.d737.s1.i0" interaction="False"/>
            <pair e1="DS.d737.s1.e0" e2="DS.d737.s1.e2" id="DS.d737.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d738" origId="18692592">
        <sentence id="DS.d738.s0" origId="18692592-835" text="High glucose induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.">
            <entity id="DS.d738.s0.e0" origId="206,5793,64689,79025" charOffset="5-12" type="compound" text="glucose"/>
            <entity id="DS.d738.s0.e1" origId="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6" charOffset="90-98" type="protein" text="TGFbeta1"/>
            <entity id="DS.d738.s0.e2" origId="P03967,P22126,Q07152" charOffset="127-130" type="protein" text="Ras"/>
            <pair e1="DS.d738.s0.e0" e2="DS.d738.s0.e1" id="DS.d738.s0.i0" interaction="True"/>
            <pair e1="DS.d738.s0.e0" e2="DS.d738.s0.e2" id="DS.d738.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d738.s1" origId="18692592-836" text="The influence of the prenylation status of Ras on the observed changes in endothelial cell growth under high glucose conditions has not previously been examined.">
            <entity id="DS.d738.s1.e0" origId="P03967,P22126,Q07152" charOffset="43-46" type="protein" text="Ras"/>
            <entity id="DS.d738.s1.e1" origId="206,5793,64689,79025" charOffset="109-116" type="compound" text="glucose"/>
            <pair e1="DS.d738.s1.e1" e2="DS.d738.s1.e0" id="DS.d738.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d739" origId="18692599">
        <sentence id="DS.d739.s0" origId="18692599-393" text="Calcineurin inhibitors (CsA, FK-506 and pimecrolimus) inhibited NO production and iNOS expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.">
            <entity id="DS.d739.s0.e1" origId="6436007" charOffset="29-35" type="compound" text="FK-506"/>
            <entity id="DS.d739.s0.e2" origId="6447131,6509979,17753757,24847863,53394893,53486290" charOffset="40-52" type="compound" text="pimecrolimus"/>
            <entity id="DS.d739.s0.e3" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="82-86" type="protein" text="iNOS"/>
            <entity id="DS.d739.s0.e4" origId="6436007" charOffset="162-168" type="compound" text="FK-506"/>
            <entity id="DS.d739.s0.e5" origId="6447131,6509979,17753757,24847863,53394893,53486290" charOffset="173-185" type="compound" text="pimecrolimus"/>
            <pair e1="DS.d739.s0.e1" e2="DS.d739.s0.e3" id="DS.d739.s0.i1" interaction="True"/>
            <pair e1="DS.d739.s0.e2" e2="DS.d739.s0.e3" id="DS.d739.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d739.s1" origId="18692599-395" text="In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (FK-506) and pimecrolimus inhibit iNOS expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.">
            <entity id="DS.d739.s1.e1" origId="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938" charOffset="63-76" type="compound" text="cyclosporin A"/>
            <entity id="DS.d739.s1.e2" origId="5372,445643,445647,6426916,6436007,6473866,6536850,9940643,23581796,54611630" charOffset="78-88" type="compound" text="tacrolimus"/>
            <entity id="DS.d739.s1.e3" origId="6436007" charOffset="90-96" type="compound" text="FK-506"/>
            <entity id="DS.d739.s1.e4" origId="6447131,6509979,17753757,24847863,53394893,53486290" charOffset="102-114" type="compound" text="pimecrolimus"/>
            <entity id="DS.d739.s1.e5" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="123-127" type="protein" text="iNOS"/>
            <entity id="DS.d739.s1.e6" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="219-223" type="protein" text="iNOS"/>
            <pair e1="DS.d739.s1.e4" e2="DS.d739.s1.e5" id="DS.d739.s1.i1" interaction="True"/>
            <pair e1="DS.d739.s1.e1" e2="DS.d739.s1.e5" id="DS.d739.s1.i3" interaction="True"/>
            <pair e1="DS.d739.s1.e2" e2="DS.d739.s1.e5" id="DS.d739.s1.i5" interaction="True"/>
            <pair e1="DS.d739.s1.e3" e2="DS.d739.s1.e5" id="DS.d739.s1.i7" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d740" origId="18692849">
        <sentence id="DS.d740.s0" origId="18692849-615" text="An increased activity of ATP-binding cassette transporter A1 (ABCA1) and ABCG5/G8 heterodimer has been proposed as a mechanism underlying the hypocholesterolaemic effect of phytosterols.">
            <entity id="DS.d740.s0.e0" origId="O95477" charOffset="62-67" type="protein" text="ABCA1"/>
            <entity id="DS.d740.s0.e1" origId="Q9H222" charOffset="73-78" type="protein" text="ABCG5"/>
            <entity id="DS.d740.s0.e2" origId="12303662" charOffset="173-185" type="compound" text="phytosterols"/>
            <pair e1="DS.d740.s0.e2" e2="DS.d740.s0.e0" id="DS.d740.s0.i0" interaction="True"/>
            <pair e1="DS.d740.s0.e2" e2="DS.d740.s0.e1" id="DS.d740.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d741" origId="18692896">
        <sentence id="DS.d741.s0" origId="18692896-648" text="In sum, copper exposure lowered TOSC, a result that at least in part can be related to lowering of antioxidant enzymes like CAT.">
            <entity id="DS.d741.s0.e0" origId="23978" charOffset="8-14" type="compound" text="copper"/>
            <entity id="DS.d741.s0.e1" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="124-127" type="protein" text="CAT"/>
            <pair e1="DS.d741.s0.e0" e2="DS.d741.s0.e1" id="DS.d741.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d742" origId="18693051">
        <sentence id="DS.d742.s0" origId="18693051-793" text="Accumulation of glucose in PA was increased by insulin at 10nM and by IGF-I at 1 nM and 10nM.">
            <entity id="DS.d742.s0.e0" origId="206,5793,64689,79025" charOffset="16-23" type="compound" text="glucose"/>
            <entity id="DS.d742.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="47-54" type="protein" text="insulin"/>
            <entity id="DS.d742.s0.e2" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="70-75" type="protein" text="IGF-I"/>
            <pair e1="DS.d742.s0.e0" e2="DS.d742.s0.e1" id="DS.d742.s0.i0" interaction="True"/>
            <pair e1="DS.d742.s0.e0" e2="DS.d742.s0.e2" id="DS.d742.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d743" origId="18693094">
        <sentence id="DS.d743.s0" origId="18693094-1555" text="Glucagon is important to this response because it increases glutamine uptake.">
            <entity id="DS.d743.s0.e0" origId="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9" charOffset="0-8" type="protein" text="Glucagon"/>
            <entity id="DS.d743.s0.e1" origId="738,5961" charOffset="60-69" type="compound" text="glutamine"/>
            <pair e1="DS.d743.s0.e1" e2="DS.d743.s0.e0" id="DS.d743.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d744" origId="18693095">
        <sentence id="DS.d744.s0" origId="18693095-825" text="It was shown that PAR significantly increased serum ALT, AST, ALP, liver MDA levels and significantly decreased liver GSH-Px activity, when compared to the control group (Group 1).">
            <entity id="DS.d744.s0.e0" origId="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67" charOffset="57-60" type="protein" text="AST"/>
            <entity id="DS.d744.s0.e1" origId="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0" charOffset="62-65" type="protein" text="ALP"/>
            <entity id="DS.d744.s0.e2" origId="124886" charOffset="118-121" type="compound" text="GSH"/>
            <pair e1="DS.d744.s0.e2" e2="DS.d744.s0.e0" id="DS.d744.s0.i0" interaction="False"/>
            <pair e1="DS.d744.s0.e2" e2="DS.d744.s0.e1" id="DS.d744.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d745" origId="18693100">
        <sentence id="DS.d745.s0" origId="18693100-829" text="Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood glucose levels and restoring the insulin levels in streptozotocin-induced diabetic rats.">
            <entity id="DS.d745.s0.e0" origId="206,5793,64689,79025" charOffset="115-122" type="compound" text="glucose"/>
            <entity id="DS.d745.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="148-155" type="protein" text="insulin"/>
            <entity id="DS.d745.s0.e2" origId="5300,29327,6420074,6713972,7067772,45357367" charOffset="166-180" type="compound" text="streptozotocin"/>
            <pair e1="DS.d745.s0.e2" e2="DS.d745.s0.e1" id="DS.d745.s0.i0" interaction="False"/>
            <pair e1="DS.d745.s0.e0" e2="DS.d745.s0.e1" id="DS.d745.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d746" origId="18693294">
        <sentence id="DS.d746.s0" origId="18693294-868" text="The activity of guanylyl cyclase was determined by the amount of cGMP generated in responses to sodium nitroprusside (SNP) or ANP.">
            <entity id="DS.d746.s0.e0" origId="O94303,P33734,Q9P4P9,Q9SZ30" charOffset="25-32" type="protein" text="cyclase"/>
            <entity id="DS.d746.s0.e1" origId="24316" charOffset="65-69" type="compound" text="cGMP"/>
            <pair e1="DS.d746.s0.e1" e2="DS.d746.s0.e0" id="DS.d746.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d747" origId="18694296">
        <sentence id="DS.d747.s0" origId="18694296-116" text="Both SAHA and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/Bcl-2 expression.">
            <entity id="DS.d747.s0.e0" origId="5311" charOffset="5-9" type="compound" text="SAHA"/>
            <entity id="DS.d747.s0.e1" origId="4261" charOffset="14-20" type="compound" text="MS-275"/>
            <entity id="DS.d747.s0.e2" origId="P27297,Q07813,Q63690" charOffset="211-214" type="protein" text="Bax"/>
            <entity id="DS.d747.s0.e3" origId="P10417,P49950" charOffset="215-220" type="protein" text="Bcl-2"/>
            <pair e1="DS.d747.s0.e1" e2="DS.d747.s0.e2" id="DS.d747.s0.i0" interaction="True"/>
            <pair e1="DS.d747.s0.e0" e2="DS.d747.s0.e2" id="DS.d747.s0.i1" interaction="True"/>
            <pair e1="DS.d747.s0.e1" e2="DS.d747.s0.e3" id="DS.d747.s0.i2" interaction="True"/>
            <pair e1="DS.d747.s0.e0" e2="DS.d747.s0.e3" id="DS.d747.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d748" origId="18694429">
        <sentence id="DS.d748.s0" origId="18694429-208" text="Immunolocalization of androgen receptor in the boar epididymis: the effect of GnRH agonist deslorelin.">
            <entity id="DS.d748.s0.e0" origId="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90" charOffset="22-39" type="protein" text="androgen receptor"/>
            <entity id="DS.d748.s0.e1" origId="25074999,25077495,25078016" charOffset="91-101" type="compound" text="deslorelin"/>
            <pair e1="DS.d748.s0.e1" e2="DS.d748.s0.e0" id="DS.d748.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d749" origId="18694845">
        <sentence id="DS.d749.s0" origId="18694845-560" text="E(2) increased the expression of caveolin-1 and caveolin-2 mRNA and proteins, but pre-treatment with ICI 182,780 (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.">
            <entity id="DS.d749.s0.e0" origId="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8" charOffset="33-43" type="protein" text="caveolin-1"/>
            <entity id="DS.d749.s0.e1" origId="O46550,P51636,Q07DW0,Q07DX2,Q07DZ3,Q07E26,Q07E39,Q07E50,Q09YH9,Q09YJ1,Q09YK2,Q09YL4,Q09YN7,Q108U8,Q18879,Q2IBA4,Q2IBC2,Q2IBD6,Q2IBF3,Q2IBG9,Q2QL80,Q2QL91,Q2QLB1,Q2QLC2,Q2QLD3,Q2QLE2,Q2QLF3,Q2QLG7,Q2QLH8,Q66WT7,Q9WVC3,Q9YGM9" charOffset="48-58" type="protein" text="caveolin-2"/>
            <entity id="DS.d749.s0.e2" origId="104741" charOffset="101-112" type="compound" text="ICI 182,780"/>
            <entity id="DS.d749.s0.e3" origId="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8" charOffset="187-197" type="protein" text="caveolin-1"/>
            <entity id="DS.d749.s0.e4" origId="O46550,P51636,Q07DW0,Q07DX2,Q07DZ3,Q07E26,Q07E39,Q07E50,Q09YH9,Q09YJ1,Q09YK2,Q09YL4,Q09YN7,Q108U8,Q18879,Q2IBA4,Q2IBC2,Q2IBD6,Q2IBF3,Q2IBG9,Q2QL80,Q2QL91,Q2QLB1,Q2QLC2,Q2QLD3,Q2QLE2,Q2QLF3,Q2QLG7,Q2QLH8,Q66WT7,Q9WVC3,Q9YGM9" charOffset="202-212" type="protein" text="caveolin-2"/>
            <pair e1="DS.d749.s0.e2" e2="DS.d749.s0.e0" id="DS.d749.s0.i0" interaction="True"/>
            <pair e1="DS.d749.s0.e2" e2="DS.d749.s0.e1" id="DS.d749.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d749.s1" origId="18694845-561" text="Phospho-caveolin-1 was significantly blocked by ICI 182,780 or pyrazolopyrimidine 2 (PP2 ; a Src-kinase inhibitor).">
            <entity id="DS.d749.s1.e0" origId="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8" charOffset="8-18" type="protein" text="caveolin-1"/>
            <entity id="DS.d749.s1.e1" origId="104741" charOffset="48-59" type="compound" text="ICI 182,780"/>
            <entity id="DS.d749.s1.e2" origId="15077741,21083976" charOffset="63-81" type="compound" text="pyrazolopyrimidine"/>
            <pair e1="DS.d749.s1.e1" e2="DS.d749.s1.e0" id="DS.d749.s1.i0" interaction="True"/>
            <pair e1="DS.d749.s1.e2" e2="DS.d749.s1.e0" id="DS.d749.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d749.s2" origId="18694845-562" text="LY 294002 (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in caveolin-1 expression and the accompanying ((3)H)-thymidine incorporation.">
            <entity id="DS.d749.s2.e0" origId="3973" charOffset="0-9" type="compound" text="LY 294002"/>
            <entity id="DS.d749.s2.e1" origId="4713" charOffset="32-40" type="compound" text="PD 98059"/>
            <entity id="DS.d749.s2.e2" origId="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8" charOffset="98-108" type="protein" text="caveolin-1"/>
            <entity id="DS.d749.s2.e3" origId="5789" charOffset="148-157" type="compound" text="thymidine"/>
            <pair e1="DS.d749.s2.e3" e2="DS.d749.s2.e2" id="DS.d749.s2.i0" interaction="True"/>
            <pair e1="DS.d749.s2.e1" e2="DS.d749.s2.e2" id="DS.d749.s2.i1" interaction="True"/>
            <pair e1="DS.d749.s2.e0" e2="DS.d749.s2.e2" id="DS.d749.s2.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d749.s3" origId="18694845-563" text="Furthermore, inhibition of caveolin-1 expression using a caveolin-1 siRNA significantly attenuated E(2)-induced up-regulation of proto-oncogenes, cell cycle regulatory proteins, ((3)H)-thymidine incorporation, overall cell number, and percent of the cell population in S phase, while mediating a concomitant increase in the G0/G1 population.">
            <entity id="DS.d749.s3.e0" origId="P18754,Q18211" charOffset="146-176" type="protein" text="cell cycle regulatory proteins"/>
            <entity id="DS.d749.s3.e1" origId="5789" charOffset="185-194" type="compound" text="thymidine"/>
            <pair e1="DS.d749.s3.e1" e2="DS.d749.s3.e0" id="DS.d749.s3.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d750" origId="18694847">
        <sentence id="DS.d750.s0" origId="18694847-1230" text="Almost all Akt kinase that translocates to the nucleus shows a marked phosphorylation on serine 473.">
            <entity id="DS.d750.s0.e0" origId="P31750,Q8INB9" charOffset="11-14" type="protein" text="Akt"/>
            <entity id="DS.d750.s0.e1" origId="5951" charOffset="89-95" type="compound" text="serine"/>
            <pair e1="DS.d750.s0.e1" e2="DS.d750.s0.e0" id="DS.d750.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d751" origId="18695846">
        <sentence id="DS.d751.s0" origId="18695846-1364" text="During the early response in AR, histamine has been found to be the most abundant mediator and it is associated with many symptoms of this disease mediated through the histamine H1 receptor.">
            <entity id="DS.d751.s0.e0" origId="774" charOffset="33-42" type="compound" text="histamine"/>
            <entity id="DS.d751.s0.e1" origId="P30546,P31389,P31390,P35367,P70174,Q9N2B0,Q9N2B1,Q9N2B2" charOffset="168-189" type="protein" text="histamine H1 receptor"/>
            <pair e1="DS.d751.s0.e0" e2="DS.d751.s0.e1" id="DS.d751.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d752" origId="18695937">
        <sentence id="DS.d752.s0" origId="18695937-929" text="During the incubation of L-phenylalanine with para-hydroquinones using laccase as biocatalyst, one or two main products were formed.">
            <entity id="DS.d752.s0.e0" origId="6140" charOffset="25-40" type="compound" text="L-phenylalanine"/>
            <entity id="DS.d752.s0.e1" origId="Q12570" charOffset="71-78" type="protein" text="laccase"/>
            <pair e1="DS.d752.s0.e0" e2="DS.d752.s0.e1" id="DS.d752.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d753" origId="18696104">
        <sentence id="DS.d753.s0" origId="18696104-1256" text="The effect on activation voltage but not that on amplitude was absent when expressing a cAMP-insensitive mutant (HCN2R/E), while a C-terminal truncated form of HCN2 (HCN2DeltaCx) exhibited only the voltage dependent but not the amplitude effect of erbstatin.">
            <entity id="DS.d753.s0.e0" origId="Q9UL51" charOffset="113-117" type="protein" text="HCN2"/>
            <entity id="DS.d753.s0.e1" origId="5328552" charOffset="248-257" type="compound" text="erbstatin"/>
            <pair e1="DS.d753.s0.e1" e2="DS.d753.s0.e0" id="DS.d753.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d753.s1" origId="18696104-1257" text="Thus, the action of erbstatin on the activation relation and current amplitude are distinct and separable in newborn myocytes, and the effect on activation voltage depends on the cAMP status of HCN2 channels.">
            <entity id="DS.d753.s1.e0" origId="5328552" charOffset="20-29" type="compound" text="erbstatin"/>
            <entity id="DS.d753.s1.e1" origId="6076" charOffset="179-183" type="compound" text="cAMP"/>
            <entity id="DS.d753.s1.e2" origId="Q9UL51" charOffset="194-198" type="protein" text="HCN2"/>
            <pair e1="DS.d753.s1.e1" e2="DS.d753.s1.e2" id="DS.d753.s1.i0" interaction="True"/>
            <pair e1="DS.d753.s1.e0" e2="DS.d753.s1.e2" id="DS.d753.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d753.s2" origId="18696104-1258" text="In contrast to newborn myocytes, erbstatin had no effect on HCN2 under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated cAMP was added to the pipette solution.">
            <entity id="DS.d753.s2.e0" origId="5328552" charOffset="33-42" type="compound" text="erbstatin"/>
            <entity id="DS.d753.s2.e1" origId="Q9UL51" charOffset="60-64" type="protein" text="HCN2"/>
            <entity id="DS.d753.s2.e2" origId="6076" charOffset="180-184" type="compound" text="cAMP"/>
            <pair e1="DS.d753.s2.e0" e2="DS.d753.s2.e1" id="DS.d753.s2.i0" interaction="False"/>
            <pair e1="DS.d753.s2.e2" e2="DS.d753.s2.e1" id="DS.d753.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d754" origId="18696216">
        <sentence id="DS.d754.s0" origId="18696216-140" text="Arginine-specific ADP-ribosyltransferase (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.">
            <entity id="DS.d754.s0.e0" origId="232,4367,6322" charOffset="0-8" type="compound" text="Arginine"/>
            <entity id="DS.d754.s0.e1" origId="P14299" charOffset="18-40" type="protein" text="ADP-ribosyltransferase"/>
            <entity id="DS.d754.s0.e2" origId="5893" charOffset="136-139" type="compound" text="NAD"/>
            <entity id="DS.d754.s0.e3" origId="232,4367,6322" charOffset="147-155" type="compound" text="arginine"/>
            <pair e1="DS.d754.s0.e3" e2="DS.d754.s0.e1" id="DS.d754.s0.i0" interaction="True"/>
            <pair e1="DS.d754.s0.e0" e2="DS.d754.s0.e1" id="DS.d754.s0.i1" interaction="True"/>
            <pair e1="DS.d754.s0.e2" e2="DS.d754.s0.e1" id="DS.d754.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d756" origId="18696261">
        <sentence id="DS.d756.s0" origId="18696261-327" text="A D-amino acid oxidase gene (dao) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of DAAO without the use of any inducer such as isopropyl beta-D-1-thiogalactopyranoside which is poisonous to the cells and environment.">
            <entity id="DS.d756.s0.e0" origId="O35078,P18894" charOffset="29-32" type="protein" text="dao"/>
            <entity id="DS.d756.s0.e1" origId="O01739,O35078,P00371,P14920,P18894,P22942,P24552,P80324,Q19564,Q99042,Q9Z1M5,Q9Z302" charOffset="123-127" type="protein" text="DAAO"/>
            <entity id="DS.d756.s0.e2" origId="656894" charOffset="167-207" type="compound" text="isopropyl beta-D-1-thiogalactopyranoside"/>
            <pair e1="DS.d756.s0.e2" e2="DS.d756.s0.e1" id="DS.d756.s0.i0" interaction="True"/>
            <pair e1="DS.d756.s0.e2" e2="DS.d756.s0.e0" id="DS.d756.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d757" origId="18698091">
        <sentence id="DS.d757.s0" origId="18698091-1558" text="In response to a cholesterol-containing atherogenic diet, C57BL/6J mice significantly increased expression of UCP2 in the aorta, while mice lacking UCP2, in the absence of any other genetic modification, displayed significant endothelial dysfunction following the atherogenic diet.">
            <entity id="DS.d757.s0.e0" origId="304,5997,6432564,11025495" charOffset="17-28" type="compound" text="cholesterol"/>
            <entity id="DS.d757.s0.e1" origId="O97562,P55851,Q9N2J1,Q9W725" charOffset="110-114" type="protein" text="UCP2"/>
            <entity id="DS.d757.s0.e2" origId="O97562,P55851,Q9N2J1,Q9W725" charOffset="148-152" type="protein" text="UCP2"/>
            <pair e1="DS.d757.s0.e0" e2="DS.d757.s0.e1" id="DS.d757.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d757.s1" origId="18698091-1559" text="These data establish that in the vasculature UCP2 functions as an adaptive antioxidant defense to protect against the development of atherosclerosis in response to a fat and cholesterol diet.">
            <entity id="DS.d757.s1.e0" origId="O97562,P55851,Q9N2J1,Q9W725" charOffset="45-49" type="protein" text="UCP2"/>
            <entity id="DS.d757.s1.e1" origId="304,5997,6432564,11025495" charOffset="174-185" type="compound" text="cholesterol"/>
            <pair e1="DS.d757.s1.e1" e2="DS.d757.s1.e0" id="DS.d757.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d758" origId="18698130">
        <sentence id="DS.d758.s0" origId="18698130-1197" text="To confirm that mouse DMP1-PG possesses a single GAG chain attached to Ser (89), we substituted Ser (89) by Gly (89).">
            <entity id="DS.d758.s0.e0" origId="Q13316,Q95120" charOffset="22-26" type="protein" text="DMP1"/>
            <entity id="DS.d758.s0.e1" origId="750,5460845" charOffset="108-111" type="compound" text="Gly"/>
            <pair e1="DS.d758.s0.e1" e2="DS.d758.s0.e0" id="DS.d758.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d759" origId="18698132">
        <sentence id="DS.d759.s0" origId="18698132-1603" text="PC-1 is the primary generator of pyrophosphate in osteoblastic cells; therefore, regulated expression of PC-1 by FGFs may be a principal mechanism by which FGF signaling affects bone mineralization.">
            <entity id="DS.d759.s0.e0" origId="644102" charOffset="33-46" type="compound" text="pyrophosphate"/>
            <entity id="DS.d759.s0.e1" origId="O10284,P41444" charOffset="113-117" type="protein" text="FGFs"/>
            <entity id="DS.d759.s0.e2" origId="O10284,P41444" charOffset="113-116" type="protein" text="FGF"/>
            <pair e1="DS.d759.s0.e0" e2="DS.d759.s0.e2" id="DS.d759.s0.i0" interaction="True"/>
            <pair e1="DS.d759.s0.e0" e2="DS.d759.s0.e1" id="DS.d759.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d760" origId="18698333">
        <sentence id="DS.d760.s0" origId="18698333-75" text="In analogy to the reduction of Ca(2+) oscillation frequency, the blockers impaired HCEC contraction, NF-kappaB activation, and VCAM-1 expression.">
            <entity id="DS.d760.s0.e0" origId="271" charOffset="31-35" type="compound" text="Ca(2"/>
            <entity id="DS.d760.s0.e1" origId="P19320,P29533,P29534,Q28260" charOffset="127-133" type="protein" text="VCAM-1"/>
            <pair e1="DS.d760.s0.e0" e2="DS.d760.s0.e1" id="DS.d760.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d760.s1" origId="18698333-76" text="Cisternal SAH-CSF induces cytosolic Ca(2+) oscillations in HCEC that results in cellular constriction, NF-kappaB activation, and VCAM-1 expression.">
            <entity id="DS.d760.s1.e0" origId="271" charOffset="36-40" type="compound" text="Ca(2"/>
            <entity id="DS.d760.s1.e1" origId="P19320,P29533,P29534,Q28260" charOffset="129-135" type="protein" text="VCAM-1"/>
            <pair e1="DS.d760.s1.e0" e2="DS.d760.s1.e1" id="DS.d760.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d761" origId="18698636">
        <sentence id="DS.d761.s0" origId="18698636-309" text="For proof of principle, we use L-lactate and D-lactate as representative pair of enantiomers, L-lactate oxidase as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.">
            <entity id="DS.d761.s0.e0" origId="107689" charOffset="31-40" type="compound" text="L-lactate"/>
            <entity id="DS.d761.s0.e1" origId="61503" charOffset="45-54" type="compound" text="D-lactate"/>
            <entity id="DS.d761.s0.e2" origId="P21795" charOffset="96-111" type="protein" text="lactate oxidase"/>
            <entity id="DS.d761.s0.e3" origId="1060" charOffset="228-236" type="compound" text="pyruvate"/>
            <pair e1="DS.d761.s0.e1" e2="DS.d761.s0.e2" id="DS.d761.s0.i0" interaction="False"/>
            <pair e1="DS.d761.s0.e0" e2="DS.d761.s0.e2" id="DS.d761.s0.i1" interaction="False"/>
            <pair e1="DS.d761.s0.e3" e2="DS.d761.s0.e2" id="DS.d761.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d762" origId="18698648">
        <sentence id="DS.d762.s0" origId="18698648-318" text="Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent xylose reductase from Candida boidinii (CbXR) was previously reported to produce xylitol from xylose while metabolizing glucose (Cirino et al.">
            <entity id="DS.d762.s0.e0" origId="P38715" charOffset="108-124" type="protein" text="xylose reductase"/>
            <entity id="DS.d762.s0.e1" origId="6912" charOffset="189-196" type="compound" text="xylitol"/>
            <entity id="DS.d762.s0.e2" origId="206,5793,64689,79025" charOffset="228-235" type="compound" text="glucose"/>
            <pair e1="DS.d762.s0.e1" e2="DS.d762.s0.e0" id="DS.d762.s0.i0" interaction="True"/>
            <pair e1="DS.d762.s0.e2" e2="DS.d762.s0.e0" id="DS.d762.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d762.s1" origId="18698648-319" text="Studies in which the expression of CbXR or a xylose transporter was increased suggest that enzyme activity and xylose transport are not limiting xylitol production in PC09.">
            <entity id="DS.d762.s1.e0" origId="P96792" charOffset="45-63" type="protein" text="xylose transporter"/>
            <entity id="DS.d762.s1.e1" origId="6912" charOffset="145-152" type="compound" text="xylitol"/>
            <pair e1="DS.d762.s1.e1" e2="DS.d762.s1.e0" id="DS.d762.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d762.s2" origId="18698648-321" text="For the case of xylose-proton symport, omitting the Zwf (glucose-6-phosphate dehydrogenase) or PntAB (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol xylitol (mol glucose)(-1), respectively.">
            <entity id="DS.d762.s2.e0" origId="O51581,O54537,O68282,O83491,O84188,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11411,P21907,P29686,P37986,P44311,P48848,P48992,P54547,P56110,P57405,P73411,P77809,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2" charOffset="52-55" type="protein" text="Zwf"/>
            <entity id="DS.d762.s2.e1" origId="P0C187,P51995,Q2RSB3" charOffset="95-100" type="protein" text="PntAB"/>
            <entity id="DS.d762.s2.e2" origId="6912" charOffset="254-261" type="compound" text="xylitol"/>
            <pair e1="DS.d762.s2.e2" e2="DS.d762.s2.e0" id="DS.d762.s2.i0" interaction="True"/>
            <pair e1="DS.d762.s2.e2" e2="DS.d762.s2.e1" id="DS.d762.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d762.s3" origId="18698648-322" text="Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol xylitol (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.">
            <entity id="DS.d762.s3.e0" origId="O25781,O51672,O83488,O84382,O88015,P0A0T0,P0A0T1,P0A6T1,P0A6T2,P28718,P44312,P47357,P52029,P52030,P52031,P52983,P57636,P64192,P64193,P64194,P64195,P64196,P77877,P78033,P80860,P81181,P96803,P99078,Q0TA36,Q0VR14,Q11MA0,Q13Z07,Q165T7,Q18FQ4,Q1ASN4,Q1BH79,Q1CSA0,Q1CX51,Q1GAY0,Q1GJQ5,Q1GTU1,Q1H1P4,Q1IYT4,Q1J8N2,Q1JDQ8,Q1JIS1,Q1JNM4,Q1LM68,Q1LU73,Q1MM06,Q1QEK1,Q1R3R3,Q1WUR2,Q21M11,Q21ZD5,Q24VW9,Q255I6,Q28QX4,Q2A2C5,Q2FIB3,Q2FZU0,Q2G7C4,Q2IE39,Q2JH03,Q2JHU0,Q2JX86,Q2KCY8,Q2KYE9,Q2LRD0,Q2NJ38,Q2NR04,Q2P380,Q2RQ51,Q2S8W1,Q2SS24,Q2SWP6,Q2VYV7,Q2YBU4,Q2YPF3,Q2YWS3,Q31AX5,Q31I19,Q31LL0,Q31TX1,Q328X7,Q38WF1,Q39FF4,Q39SU1,Q3A201,Q3AFH3,Q3AJU7,Q3ASZ0,Q3AXV8,Q3B3Q8,Q3BUL3,Q3IKH4,Q3IMS0,Q3J2U4,Q3JCN1,Q3JRE2,Q3K2Y2,Q3K6Q4,Q3KLX6,Q3M6S3,Q3YUW0,Q46L16,Q47IJ3,Q48N88,Q48VF9,Q491V0,Q49WA1,Q4A5S9,Q4A7J2,Q4A9F3,Q4FVH5,Q4JX51,Q4K5Y1,Q4L4X8,Q4QL07,Q4UTV8,Q4ZY88,Q57F73,Q57H06,Q59000,Q59088,Q5E847,Q5FL04,Q5H0A7,Q5HHC2,Q5HQJ9,Q5KVS7,Q5L5E1,Q5L9E3,Q5LRS9,Q5M1N9,Q5N0B4,Q5NFC4,Q5P0T4,Q5PL07,Q5QWW0,Q5SLL6,Q5UXU0,Q5WDX0,Q5WYE0,Q5X6Y8,Q5XE09,Q5YPP1,Q5ZXH2,Q600A8,Q609I7,Q62JL8,Q632G4,Q63V31,Q64PM7,Q65FL6,Q65TC2,Q660E3,Q664W9,Q67QQ0,Q6A5X5,Q6AQ48,Q6D022,Q6F1L2,Q6G0T9,Q6GAW4,Q6GIC6,Q6HC08,Q6KH90,Q6LM51,Q6LXQ4,Q6MD44,Q6MTA3,Q6NIE5,Q6YQU0,Q71X61,Q72GY6,Q72MT7,Q72YI4,Q73K18,Q742E4,Q74DK5,Q74K31,Q7MH97,Q7MUV9,Q7MZB4,Q7NJY9,Q7U6T0,Q7V1I1,Q7V7M6,Q7VBZ6,Q7VNR9,Q7VRI4,Q7VUF4,Q7W197,Q7WP01,Q816G0,Q81K75,Q822E7,Q82SP4,Q835G1,Q83D91,Q83XM3,Q848I4,Q87EV7,Q87L81,Q888Q7,Q88UI4,Q891H2,Q89A35,Q8A5W2,Q8CT80,Q8D1V8,Q8DCK7,Q8DKY2,Q8DN74,Q8EBH1,Q8ENY8,Q8EVU1,Q8EZG6,Q8FB44,Q8FR39,Q8G2N3,Q8G7I6,Q8K8Q6,Q8K910,Q8KDQ7,Q8L1Z9,Q8NS31,Q8NXF1,Q8P2R3,Q8P9S7,Q8R924,Q8RHH5,Q8UI94,Q8VVB7,Q8XI54,Q8XYN9,Q8Y4R7,Q8YF86,Q8YY05,Q8Z1U7,Q8ZAS2,Q8ZKI4,Q928R6,Q92SC4,Q97FP8,Q97NG0,Q98BV5,Q98R79,Q9A1L1,Q9ABK5,Q9CD75,Q9CNL2,Q9HNQ6,Q9HV67,Q9K7L8,Q9KUY4,Q9KX58,Q9PGR6,Q9PK16,Q9PMD4,Q9RDY2,Q9RMC1,Q9RTL8,Q9X1A5,Q9X670,Q9Z6N4,Q9ZK49" charOffset="25-28" type="protein" text="pgi"/>
            <entity id="DS.d762.s3.e1" origId="O25781,O51672,O59618,O66954,O82059,O83488,O84382,P06744,P06745,P08059,P0A0T0,P0A0T1,P0A6T1,P0A6T2,P12341,P12709,P13377,P18240,P28718,P29333,P34795,P34796,P34797,P42861,P44312,P46479,P47357,P49105,P50309,P52029,P52030,P52031,P52983,P54234,P54235,P54236,P54237,P54238,P54239,P54240,P54241,P54242,P54243,P57636,P64192,P64193,P64194,P64195,P64196,P77877,P78033,P78917,P80860,P81181,P83194,P83780,P84140,P96803,P99078,Q0TA36,Q0VR14,Q11MA0,Q13Z07,Q165T7,Q18FQ4,Q1ASN4,Q1BH79,Q1CSA0,Q1CX51,Q1GAY0,Q1GJQ5,Q1GTU1,Q1H1P4,Q1IYT4,Q1J8N2,Q1JDQ8,Q1JIS1,Q1JNM4,Q1LM68,Q1LU73,Q1MM06,Q1QEK1,Q1R3R3,Q1WUR2,Q21M11,Q21ZD5,Q24VW9,Q255I6,Q28QX4,Q2A2C5,Q2FIB3,Q2FZU0,Q2G7C4,Q2IE39,Q2JH03,Q2JHU0,Q2JX86,Q2KCY8,Q2KYE9,Q2LRD0,Q2NJ38,Q2NR04,Q2P380,Q2RQ51,Q2S8W1,Q2SS24,Q2SWP6,Q2VYV7,Q2YBU4,Q2YPF3,Q2YWS3,Q31AX5,Q31I19,Q31LL0,Q31TX1,Q328X7,Q38WF1,Q39FF4,Q39SU1,Q3A201,Q3AFH3,Q3AJU7,Q3ASZ0,Q3AXV8,Q3B3Q8,Q3BUL3,Q3IKH4,Q3IMS0,Q3J2U4,Q3JCN1,Q3JRE2,Q3K2Y2,Q3K6Q4,Q3KLX6,Q3M6S3,Q3YUW0,Q3ZBD7,Q44407,Q46L16,Q47IJ3,Q48N88,Q48VF9,Q491V0,Q49WA1,Q4A5S9,Q4A7J2,Q4A9F3,Q4FVH5,Q4JCA7,Q4JX51,Q4K5Y1,Q4L4X8,Q4QL07,Q4R591,Q4UTV8,Q4ZY88,Q57F73,Q57H06,Q59000,Q59088,Q5E847,Q5FL04,Q5H0A7,Q5HHC2,Q5HQJ9,Q5JE38,Q5KVS7,Q5L5E1,Q5L9E3,Q5LRS9,Q5M1N9,Q5N0B4,Q5NFC4,Q5P0T4,Q5PL07,Q5QWW0,Q5R4E3,Q5SLL6,Q5UXU0,Q5WDX0,Q5WYE0,Q5X6Y8,Q5XE09,Q5YPP1,Q5ZXH2,Q600A8,Q609I7,Q62JL8,Q632G4,Q63V31,Q64PM7,Q65FL6,Q65TC2,Q660E3,Q664W9,Q67QQ0,Q6A5X5,Q6AQ48,Q6D022,Q6F1L2,Q6FRW1,Q6G0T9,Q6GAW4,Q6GIC6,Q6HC08,Q6KH90,Q6LM51,Q6LXQ4,Q6MD44,Q6MTA3,Q6NIE5,Q6YQU0,Q711G1,Q71X61,Q72GY6,Q72MT7,Q72YI4,Q73K18,Q742E4,Q74DK5,Q74K31,Q758L0,Q7MH97,Q7MUV9,Q7MZB4,Q7NJY9,Q7S986,Q7U6T0,Q7V1I1,Q7V7M6,Q7VBZ6,Q7VNR9,Q7VRI4,Q7VUF4,Q7W197,Q7WP01,Q816G0,Q81K75,Q822E7,Q82SP4,Q835G1,Q83D91,Q83XM3,Q848I4,Q87EV7,Q87L81,Q888Q7,Q88UI4,Q891H2,Q89A35,Q8A5W2,Q8CT80,Q8D1V8,Q8DCK7,Q8DKY2,Q8DN74,Q8EBH1,Q8ENY8,Q8EVU1,Q8EZG6,Q8FB44,Q8FR39,Q8G2N3,Q8G7I6,Q8K8Q6,Q8K910,Q8KDQ7,Q8L1Z9,Q8NS31,Q8NXF1,Q8P2R3,Q8P9S7,Q8R924,Q8RHH5,Q8SRY1,Q8UI94,Q8VVB7,Q8XI54,Q8XYN9,Q8Y4R7,Q8YF86,Q8YY05,Q8Z1U7,Q8ZAS2,Q8ZKI4,Q8ZWV0,Q928R6,Q92SC4,Q96YC2,Q978F3,Q97FP8,Q97NG0,Q97WE5,Q98BV5,Q98R79,Q9A1L1,Q9ABK5,Q9CD75,Q9CNL2,Q9FXM4,Q9FXM5,Q9HGZ2,Q9HIC2,Q9HNQ6,Q9HV67,Q9K7L8,Q9KUY4,Q9KX58,Q9N1E2,Q9PGR6,Q9PK16,Q9PMD4,Q9RDY2,Q9RMC1,Q9RTL8,Q9UXW3,Q9X1A5,Q9X670,Q9YE01,Q9Z6N4,Q9ZK49" charOffset="39-63" type="protein" text="phosphoglucose isomerase"/>
            <entity id="DS.d762.s3.e2" origId="6912" charOffset="121-128" type="compound" text="xylitol"/>
            <entity id="DS.d762.s3.e4" origId="O05139,P27306,P50529,P57112,P66006,P66007,P66008,P66009,P71317,Q0TA96,Q1CBU5,Q1CNP4,Q1QX78,Q1R3U7,Q2NQZ3,Q2SIP2,Q3K9F5,Q48A14,Q48KI8,Q4KFA6,Q4ZV77,Q57H91,Q5E212,Q5PK71,Q66G61,Q6CZB1,Q6LLT9,Q7MBG9,Q7MQ83,Q83MI1,Q87KN5,Q884I6,Q88KY8,Q8DD46,Q8FB93,Q8X727,Q8ZA97,Q9XBQ9" charOffset="205-209" type="protein" text="sthA"/>
            <entity id="DS.d762.s3.e5" origId="P07001,P43842" charOffset="214-218" type="protein" text="pntA"/>
            <pair e1="DS.d762.s3.e2" e2="DS.d762.s3.e1" id="DS.d762.s3.i1" interaction="True"/>
            <pair e1="DS.d762.s3.e2" e2="DS.d762.s3.e0" id="DS.d762.s3.i2" interaction="True"/>
            <pair e1="DS.d762.s3.e2" e2="DS.d762.s3.e4" id="DS.d762.s3.i3" interaction="False"/>
            <pair e1="DS.d762.s3.e2" e2="DS.d762.s3.e5" id="DS.d762.s3.i7" interaction="False"/>
        </sentence>
        <sentence id="DS.d762.s4" origId="18698648-323" text="Deleting either zwf or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol glucose)(-1), respectively.">
            <entity id="DS.d762.s4.e0" origId="O51581,O54537,O68282,O83491,O84188,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11411,P21907,P29686,P37986,P44311,P48848,P48992,P54547,P56110,P57405,P73411,P77809,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2" charOffset="16-19" type="protein" text="zwf"/>
            <entity id="DS.d762.s4.e1" origId="O05966,O27115,O67546,O84828,O87840,P0A836,P0A837,P0A838,P0A839,P25126,P45101,P53592,P53593,P66867,P66868,P66869,P66870,P66871,P66872,P71559,P80886,P99071,Q49X32,Q4L5U8,Q4ULQ7,Q57663,Q57RL3,Q5HGI7,Q5HPU5,Q5PBI8,Q5PCM7,Q66DA0,Q68WU5,Q6F8L4,Q6G9W8,Q6GHJ0,Q72PA2,Q7MMN3,Q7U0Z1,Q7UKI3,Q822A1,Q87A98,Q87RE8,Q8CPH5,Q8DFQ1,Q8EFN8,Q8F746,Q8KFE7,Q8NMK7,Q8P676,Q8PHL5,Q8UC60,Q8Y1Y3,Q8ZH00,Q8ZVF3,Q92I21,Q98EC5,Q9AB94,Q9CNZ0,Q9EYG9,Q9HPP1,Q9JUT0,Q9JZP4,Q9KA20,Q9KQB5,Q9PAH1,Q9PHY1,Q9PL99,Q9RUY3,Q9Z5H8,Q9Z6T6" charOffset="23-27" type="protein" text="sucC"/>
            <entity id="DS.d762.s4.e2" origId="6912" charOffset="100-107" type="compound" text="xylitol"/>
            <entity id="DS.d762.s4.e3" origId="206,5793,64689,79025" charOffset="113-120" type="compound" text="glucose"/>
            <pair e1="DS.d762.s4.e3" e2="DS.d762.s4.e0" id="DS.d762.s4.i0" interaction="True"/>
            <pair e1="DS.d762.s4.e2" e2="DS.d762.s4.e1" id="DS.d762.s4.i1" interaction="True"/>
            <pair e1="DS.d762.s4.e3" e2="DS.d762.s4.e1" id="DS.d762.s4.i2" interaction="True"/>
            <pair e1="DS.d762.s4.e2" e2="DS.d762.s4.e0" id="DS.d762.s4.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d763" origId="18698649">
        <sentence id="DS.d763.s0" origId="18698649-324" text="In the process studied, the enzyme cellobiose dehydrogenase (CDH) oxidizes lactose at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to lactobionic acid.">
            <entity id="DS.d763.s0.e0" origId="P17444,P54223,P60336,P60337,Q01738,Q0TKW1,Q13NG7,Q1BQE2,Q1C932,Q1CFR7,Q1MJU4,Q1QXE1,Q1RFM3,Q2FDP9,Q2FV11,Q2KB43,Q2T6D0,Q2YWJ5,Q39A44,Q3BXK8,Q3JLL7,Q3K5H3,Q48CM7,Q4A0Q1,Q4K4K7,Q4L9D7,Q4UYN5,Q4ZM63,Q5HCU1,Q5HL11,Q62CH8,Q63KK7,Q66D54,Q6D6D9,Q6FDF9,Q6G664,Q6GDJ1,Q6LGH5,Q7MF12,Q88AE7,Q88CW6,Q8BJ64,Q8CMY2,Q8D3K2,Q8FKI9,Q8G1Z8,Q8NE62,Q8NUM0,Q8P5D7,Q8PPG8,Q8UH55,Q8X6C6,Q8YFY2,Q8ZGW0,Q985M5,Q9HTJ2,Q9L4K0,Q9RA05,Q9X2M2" charOffset="61-64" type="protein" text="CDH"/>
            <entity id="DS.d763.s0.e1" origId="294,6134,84571,440995" charOffset="75-82" type="compound" text="lactose"/>
            <entity id="DS.d763.s0.e2" origId="7314" charOffset="188-204" type="compound" text="lactobionic acid"/>
            <pair e1="DS.d763.s0.e2" e2="DS.d763.s0.e0" id="DS.d763.s0.i0" interaction="True"/>
            <pair e1="DS.d763.s0.e1" e2="DS.d763.s0.e0" id="DS.d763.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d763.s2" origId="18698649-326" text="Oxygen served as the terminal electron acceptor of the reaction and was fully reduced to water by laccase.">
            <entity id="DS.d763.s2.e0" origId="977" charOffset="0-6" type="compound" text="Oxygen"/>
            <entity id="DS.d763.s2.e1" origId="Q12570" charOffset="98-105" type="protein" text="laccase"/>
            <pair e1="DS.d763.s2.e0" e2="DS.d763.s2.e1" id="DS.d763.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d764" origId="18699724">
        <sentence id="DS.d764.s0" origId="18699724-117" text="Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.">
            <entity id="DS.d764.s0.e0" origId="53262342" charOffset="61-67" type="compound" text="SSEA-3"/>
            <entity id="DS.d764.s0.e1" origId="444212" charOffset="77-80" type="compound" text="TRA"/>
            <entity id="DS.d764.s0.e2" origId="444212" charOffset="91-94" type="compound" text="TRA"/>
            <entity id="DS.d764.s0.e3" origId="O60109,P81800,P83456" charOffset="114-134" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d764.s0.e4" origId="P03358,P03554,P03555,P03556,P04323,P05400,P09523,P0A3U0,P0A3U1,P10394,P10399,P10400,P10401,P10978,P11283,P11369,P15629,P16423,P19199,P20825,P21325,P21328,P21329,P23070,P23071,P23072,P27502,Q00962,Q02964,Q03269,Q03270,Q03271,Q03272,Q03273,Q03274,Q03275,Q03276,Q03277,Q03278,Q03279,Q05118,Q8I7P9,Q95SX7,Q9NBX4,Q9QC07" charOffset="139-160" type="protein" text="reverse transcriptase"/>
            <entity id="DS.d764.s0.e5" origId="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1" charOffset="191-194" type="protein" text="PCR"/>
            <pair e1="DS.d764.s0.e1" e2="DS.d764.s0.e4" id="DS.d764.s0.i0" interaction="False"/>
            <pair e1="DS.d764.s0.e0" e2="DS.d764.s0.e4" id="DS.d764.s0.i1" interaction="False"/>
            <pair e1="DS.d764.s0.e1" e2="DS.d764.s0.e3" id="DS.d764.s0.i2" interaction="False"/>
            <pair e1="DS.d764.s0.e1" e2="DS.d764.s0.e5" id="DS.d764.s0.i3" interaction="False"/>
            <pair e1="DS.d764.s0.e0" e2="DS.d764.s0.e5" id="DS.d764.s0.i4" interaction="False"/>
            <pair e1="DS.d764.s0.e0" e2="DS.d764.s0.e3" id="DS.d764.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d765" origId="18699774">
        <sentence id="DS.d765.s0" origId="18699774-1334" text="Solamargine induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of HER2/neu.">
            <entity id="DS.d765.s0.e0" origId="73611" charOffset="0-11" type="compound" text="Solamargine"/>
            <entity id="DS.d765.s0.e1" origId="41867" charOffset="77-87" type="compound" text="epirubicin"/>
            <entity id="DS.d765.s0.e2" origId="P04626" charOffset="149-153" type="protein" text="HER2"/>
            <entity id="DS.d765.s0.e3" origId="O35657,P06494,P29503,P70424,Q24746" charOffset="154-157" type="protein" text="neu"/>
            <pair e1="DS.d765.s0.e1" e2="DS.d765.s0.e3" id="DS.d765.s0.i0" interaction="False"/>
            <pair e1="DS.d765.s0.e0" e2="DS.d765.s0.e2" id="DS.d765.s0.i1" interaction="False"/>
            <pair e1="DS.d765.s0.e1" e2="DS.d765.s0.e2" id="DS.d765.s0.i2" interaction="False"/>
            <pair e1="DS.d765.s0.e0" e2="DS.d765.s0.e3" id="DS.d765.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d765.s1" origId="18699774-1335" text="SM (solamargine), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/neu expression by SM was investigated.">
            <entity id="DS.d765.s1.e0" origId="73611" charOffset="4-15" type="compound" text="solamargine"/>
            <entity id="DS.d765.s1.e1" origId="452975" charOffset="26-44" type="compound" text="steroidal alkaloid"/>
            <entity id="DS.d765.s1.e2" origId="P04626" charOffset="311-315" type="protein" text="HER2"/>
            <entity id="DS.d765.s1.e3" origId="O35657,P06494,P29503,P70424,Q24746" charOffset="316-319" type="protein" text="neu"/>
            <pair e1="DS.d765.s1.e0" e2="DS.d765.s1.e2" id="DS.d765.s1.i0" interaction="False"/>
            <pair e1="DS.d765.s1.e1" e2="DS.d765.s1.e3" id="DS.d765.s1.i1" interaction="False"/>
            <pair e1="DS.d765.s1.e0" e2="DS.d765.s1.e3" id="DS.d765.s1.i2" interaction="False"/>
            <pair e1="DS.d765.s1.e1" e2="DS.d765.s1.e2" id="DS.d765.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d766" origId="18700056">
        <sentence id="DS.d766.s0" origId="18700056-1486" text="Since ondansetron completely reversed the effects of clorgyline on DA neuronal activity, the effects of MAOA inhibition appeared to be mediated by 5-HT3 receptors.">
            <entity id="DS.d766.s0.e0" origId="4595" charOffset="6-17" type="compound" text="ondansetron"/>
            <entity id="DS.d766.s0.e1" origId="4380" charOffset="53-63" type="compound" text="clorgyline"/>
            <entity id="DS.d766.s0.e2" origId="O18851,P21397,P21398,P58027,Q5NU32,Q5RE60,Q6Q2J0" charOffset="104-108" type="protein" text="MAOA"/>
            <entity id="DS.d766.s0.e3" origId="O70212,P23979,P35563,P46098" charOffset="147-152" type="protein" text="5-HT3"/>
            <pair e1="DS.d766.s0.e1" e2="DS.d766.s0.e3" id="DS.d766.s0.i0" interaction="False"/>
            <pair e1="DS.d766.s0.e1" e2="DS.d766.s0.e2" id="DS.d766.s0.i1" interaction="False"/>
            <pair e1="DS.d766.s0.e0" e2="DS.d766.s0.e3" id="DS.d766.s0.i2" interaction="False"/>
            <pair e1="DS.d766.s0.e0" e2="DS.d766.s0.e2" id="DS.d766.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d767" origId="18700057">
        <sentence id="DS.d767.s0" origId="18700057-534" text="The effects of Ipt were reversed by the mitochondrial KATP blocker, 5-hydroxydecanoate, indicating that mitochondrial KATP channels participate in the regulation of astrocyte activation.">
            <entity id="DS.d767.s0.e0" origId="P0A3L5,P0A3L6,P15653,P25018,P46376,Q04590,Q47851,Q80UN9" charOffset="15-18" type="protein" text="Ipt"/>
            <entity id="DS.d767.s0.e1" origId="1825" charOffset="68-86" type="compound" text="5-hydroxydecanoate"/>
            <pair e1="DS.d767.s0.e1" e2="DS.d767.s0.e0" id="DS.d767.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d768" origId="18700809">
        <sentence id="DS.d768.s0" origId="18700809-895" text="The cell proliferation, the up-regulation of pS2, and the down-regulation of ERalpha and ERbeta gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L ICI 182,780.">
            <entity id="DS.d768.s0.e0" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="77-84" type="protein" text="ERalpha"/>
            <entity id="DS.d768.s0.e1" origId="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32" charOffset="89-95" type="protein" text="ERbeta"/>
            <entity id="DS.d768.s0.e2" origId="104741" charOffset="216-227" type="compound" text="ICI 182,780"/>
            <pair e1="DS.d768.s0.e2" e2="DS.d768.s0.e0" id="DS.d768.s0.i0" interaction="True"/>
            <pair e1="DS.d768.s0.e2" e2="DS.d768.s0.e1" id="DS.d768.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d769" origId="18700818">
        <sentence id="DS.d769.s0" origId="18700818-411" text="While bass in all diazinon treatment groups had significantly inhibited brain AChE activity, only the medium and high treatment groups showed a dose- and time-dependent increase in time to capture prey.">
            <entity id="DS.d769.s0.e0" origId="3017" charOffset="18-26" type="compound" text="diazinon"/>
            <entity id="DS.d769.s0.e1" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="78-82" type="protein" text="AChE"/>
            <pair e1="DS.d769.s0.e0" e2="DS.d769.s0.e1" id="DS.d769.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d770" origId="18701427">
        <sentence id="DS.d770.s0" origId="18701427-85" text="The aim of this phase 0 study was to investigate whether gemcitabine passes the blood-tumor barrier, and is phosphorylated in the tumor by deoxycytidine kinase (dCK) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.">
            <entity id="DS.d770.s0.e0" origId="60750" charOffset="57-68" type="compound" text="gemcitabine"/>
            <entity id="DS.d770.s0.e1" origId="P27707,P43346,P48769" charOffset="139-159" type="protein" text="deoxycytidine kinase"/>
            <entity id="DS.d770.s0.e2" origId="P21974,P27707,P43346,P48769,Q9J579" charOffset="161-164" type="protein" text="dCK"/>
            <entity id="DS.d770.s0.e3" origId="60750" charOffset="169-180" type="compound" text="gemcitabine"/>
            <pair e1="DS.d770.s0.e0" e2="DS.d770.s0.e1" id="DS.d770.s0.i0" interaction="True"/>
            <pair e1="DS.d770.s0.e0" e2="DS.d770.s0.e2" id="DS.d770.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d771" origId="18701806">
        <sentence id="DS.d771.s0" origId="18701806-1254" text="The proline mutation at amino acid location 164 significantly reduced the initial hydrolysis of either the amelogenins in solution or the proteins bound on HAP, which was confirmed by amelogenin oligopeptide assays.">
            <entity id="DS.d771.s0.e0" origId="614,8988,145742" charOffset="4-11" type="compound" text="proline"/>
            <entity id="DS.d771.s0.e1" origId="O97646,O97647,Q28462" charOffset="107-118" type="protein" text="amelogenins"/>
            <pair e1="DS.d771.s0.e0" e2="DS.d771.s0.e1" id="DS.d771.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d772" origId="18701809">
        <sentence id="DS.d772.s0" origId="18701809-777" text="In conclusion, dentin mineralization in a corrected phosphate and vitamin D environment compensates the adverse effect of PHEX mutation.">
            <entity id="DS.d772.s0.e0" origId="1061,167704,644102" charOffset="52-61" type="compound" text="phosphate"/>
            <entity id="DS.d772.s0.e1" origId="5280795" charOffset="66-75" type="compound" text="vitamin D"/>
            <entity id="DS.d772.s0.e2" origId="P78562" charOffset="122-126" type="protein" text="PHEX"/>
            <pair e1="DS.d772.s0.e0" e2="DS.d772.s0.e2" id="DS.d772.s0.i0" interaction="False"/>
            <pair e1="DS.d772.s0.e1" e2="DS.d772.s0.e2" id="DS.d772.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d773" origId="18702173">
        <sentence id="DS.d773.s0" origId="18702173-1549" text="The considered biological model system consisted of a coating antibody (goat IgG), bovine serum albumin (BSA) as blocking agent, and a complementary antibody labelled with FITC (anti-goat IgG).">
            <entity id="DS.d773.s0.e0" origId="P21847,P83517" charOffset="90-103" type="protein" text="serum albumin"/>
            <entity id="DS.d773.s0.e1" origId="P02769" charOffset="105-108" type="protein" text="BSA"/>
            <entity id="DS.d773.s0.e2" origId="18730" charOffset="172-176" type="compound" text="FITC"/>
            <pair e1="DS.d773.s0.e2" e2="DS.d773.s0.e1" id="DS.d773.s0.i0" interaction="False"/>
            <pair e1="DS.d773.s0.e2" e2="DS.d773.s0.e0" id="DS.d773.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d774" origId="18702613">
        <sentence id="DS.d774.s0" origId="18702613-201" text="Prolonged L-alanine exposure induces changes in metabolism, Ca(2+) handling and desensitization of insulin secretion in clonal pancreatic beta-cells.">
            <entity id="DS.d774.s0.e0" origId="602,4580,5950,71080" charOffset="12-19" type="compound" text="alanine"/>
            <entity id="DS.d774.s0.e1" origId="271" charOffset="60-64" type="compound" text="Ca(2"/>
            <entity id="DS.d774.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="99-106" type="protein" text="insulin"/>
            <pair e1="DS.d774.s0.e1" e2="DS.d774.s0.e2" id="DS.d774.s0.i0" interaction="False"/>
            <pair e1="DS.d774.s0.e0" e2="DS.d774.s0.e2" id="DS.d774.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d774.s1" origId="18702613-203" text="Collectively, these results illustrate the phenomenon of beta-cell desensitization by amino acids, indicating that prolonged exposure to alanine can induce reversible alterations to metabolic flux, Ca(2+) handling and insulin secretion.">
            <entity id="DS.d774.s1.e0" origId="602,4580,5950,71080" charOffset="137-144" type="compound" text="alanine"/>
            <entity id="DS.d774.s1.e1" origId="271" charOffset="198-202" type="compound" text="Ca(2"/>
            <entity id="DS.d774.s1.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="218-225" type="protein" text="insulin"/>
            <pair e1="DS.d774.s1.e1" e2="DS.d774.s1.e2" id="DS.d774.s1.i0" interaction="False"/>
            <pair e1="DS.d774.s1.e0" e2="DS.d774.s1.e2" id="DS.d774.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d775" origId="18702682">
        <sentence id="DS.d775.s0" origId="18702682-263" text="Acylation-stimulating protein (ASP) has been shown to positively stimulate fatty acid esterification and glucose uptake in adipocytes.">
            <entity id="DS.d775.s0.e0" origId="P32765,P42127,P45381,P79407,Q03288,Q16937,Q1XGU5,Q1XGU6,Q1XGU7,Q1XGU8,Q1XGU9,Q1XGV0,Q1XGV1,Q1XGV2,Q1XGV3,Q1XGV4,Q1XGV5,Q1XGV6,Q1XGV7,Q29414,Q5UK76,Q6ZYM3,Q865F0,Q95MP2,Q99JA2,Q9H1Y0,Q9NQ94" charOffset="31-34" type="protein" text="ASP"/>
            <entity id="DS.d775.s0.e1" origId="206,5793,64689,79025" charOffset="105-112" type="compound" text="glucose"/>
            <pair e1="DS.d775.s0.e1" e2="DS.d775.s0.e0" id="DS.d775.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d776" origId="18703100">
        <sentence id="DS.d776.s0" origId="18703100-623" text="Using a set of experiments aimed at manipulate a putative l-glutamate/NMDA/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of GnRH mRNA in a dose-response manner.">
            <entity id="DS.d776.s0.e0" origId="33032" charOffset="58-69" type="compound" text="l-glutamate"/>
            <entity id="DS.d776.s0.e1" origId="22880" charOffset="70-74" type="compound" text="NMDA"/>
            <entity id="DS.d776.s0.e2" origId="22880" charOffset="165-169" type="compound" text="NMDA"/>
            <entity id="DS.d776.s0.e3" origId="P27429" charOffset="197-201" type="protein" text="GnRH"/>
            <pair e1="DS.d776.s0.e0" e2="DS.d776.s0.e3" id="DS.d776.s0.i0" interaction="True"/>
            <pair e1="DS.d776.s0.e1" e2="DS.d776.s0.e3" id="DS.d776.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d777" origId="18703333">
        <sentence id="DS.d777.s0" origId="18703333-1701" text="Reaction parameters for the production of XOS from corncob using endoxylanase from Aspergillus oryzae MTCC 5154 were optimized and an XOS yield of 10.2+/-0.14 mg ml(-1) corresponding to 81+/-3.9% with 73.5% xylobiose was obtained.">
            <entity id="DS.d777.s0.e0" origId="Q60042" charOffset="65-77" type="protein" text="endoxylanase"/>
            <entity id="DS.d777.s0.e1" origId="439538" charOffset="207-216" type="compound" text="xylobiose"/>
            <pair e1="DS.d777.s0.e1" e2="DS.d777.s0.e0" id="DS.d777.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d778" origId="18703532">
        <sentence id="DS.d778.s0" origId="18703532-1538" text="Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.">
            <entity id="DS.d778.s0.e0" origId="2754" charOffset="0-10" type="compound" text="Cilostazol"/>
            <entity id="DS.d778.s0.e1" origId="P00513,P25848" charOffset="88-102" type="protein" text="protein kinase"/>
            <pair e1="DS.d778.s0.e0" e2="DS.d778.s0.e1" id="DS.d778.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d778.s1" origId="18703532-1539" text="Cilostazol is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic AMP (cAMP) levels and activates protein kinase A, thereby inhibiting platelet aggregation and inducing peripheral vasodilation.">
            <entity id="DS.d778.s1.e0" origId="2754" charOffset="0-10" type="compound" text="Cilostazol"/>
            <entity id="DS.d778.s1.e1" origId="6076" charOffset="100-104" type="compound" text="cAMP"/>
            <entity id="DS.d778.s1.e2" origId="Q05608,Q9RI12" charOffset="127-143" type="protein" text="protein kinase A"/>
            <pair e1="DS.d778.s1.e1" e2="DS.d778.s1.e2" id="DS.d778.s1.i0" interaction="False"/>
            <pair e1="DS.d778.s1.e0" e2="DS.d778.s1.e2" id="DS.d778.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d778.s2" origId="18703532-1540" text="We hypothesized that cilostazol may prevent inflammatory cytokine induced-nuclear factor (NF)-kappaB activation by activating AMP-activated protein kinase (AMPK) in vascular endothelial cells.">
            <entity id="DS.d778.s2.e0" origId="2754" charOffset="21-31" type="compound" text="cilostazol"/>
            <entity id="DS.d778.s2.e1" origId="P00513,P25848" charOffset="140-154" type="protein" text="protein kinase"/>
            <entity id="DS.d778.s2.e2" origId="P54646,Q09136,Q9Y478" charOffset="156-160" type="protein" text="AMPK"/>
            <pair e1="DS.d778.s2.e0" e2="DS.d778.s2.e2" id="DS.d778.s2.i0" interaction="True"/>
            <pair e1="DS.d778.s2.e0" e2="DS.d778.s2.e1" id="DS.d778.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d779" origId="18703622">
        <sentence id="DS.d779.s0" origId="18703622-1294" text="Serum estradiol (E2) levels were not altered at any time point after IGF-I, demonstrating that the increased KiSS-1 expression observed was not caused by an elevation in E2.">
            <entity id="DS.d779.s0.e0" origId="5757" charOffset="6-15" type="compound" text="estradiol"/>
            <entity id="DS.d779.s0.e1" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="69-74" type="protein" text="IGF-I"/>
            <pair e1="DS.d779.s0.e0" e2="DS.d779.s0.e1" id="DS.d779.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d780" origId="18703794">
        <sentence id="DS.d780.s0" origId="18703794-1209" text="A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and MIP-1alpha while simultaneously synergizing with hyaluronan fragments to up-regulate the TH1 cytokine IL-12.">
            <entity id="DS.d780.s0.e0" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="65-74" type="protein" text="TNF-alpha"/>
            <entity id="DS.d780.s0.e1" origId="P06624,P28238,P30301,P35999,P37932,Q01992,Q09734,Q10415,Q6J8I9,Q6RZ07,Q92973,Q99797" charOffset="144-147" type="protein" text="MIP"/>
            <entity id="DS.d780.s0.e2" origId="P10147,P10855,P50229,Q5I1Z0,Q8HYQ3,Q8SQA6" charOffset="156-166" type="protein" text="MIP-1alpha"/>
            <entity id="DS.d780.s0.e3" origId="24759" charOffset="205-215" type="compound" text="hyaluronan"/>
            <pair e1="DS.d780.s0.e3" e2="DS.d780.s0.e0" id="DS.d780.s0.i0" interaction="False"/>
            <pair e1="DS.d780.s0.e3" e2="DS.d780.s0.e1" id="DS.d780.s0.i1" interaction="False"/>
            <pair e1="DS.d780.s0.e3" e2="DS.d780.s0.e2" id="DS.d780.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d781" origId="18703795">
        <sentence id="DS.d781.s0" origId="18703795-1210" text="In addition, treatment of primary mouse lung fibroblasts with ADMA stimulated arginase activity and collagen formation in vitro.">
            <entity id="DS.d781.s0.e0" origId="123831" charOffset="62-66" type="compound" text="ADMA"/>
            <entity id="DS.d781.s0.e1" origId="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3" charOffset="78-86" type="protein" text="arginase"/>
            <pair e1="DS.d781.s0.e0" e2="DS.d781.s0.e1" id="DS.d781.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d781.s1" origId="18703795-1211" text="These data support the idea that ADMA may play a role in airway diseases, including asthma and pulmonary fibrosis, through NOS inhibition and enhancement of arginase activity.">
            <entity id="DS.d781.s1.e0" origId="123831" charOffset="33-37" type="compound" text="ADMA"/>
            <entity id="DS.d781.s1.e1" origId="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2" charOffset="123-126" type="protein" text="NOS"/>
            <entity id="DS.d781.s1.e2" origId="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3" charOffset="157-165" type="protein" text="arginase"/>
            <pair e1="DS.d781.s1.e0" e2="DS.d781.s1.e2" id="DS.d781.s1.i0" interaction="True"/>
            <pair e1="DS.d781.s1.e0" e2="DS.d781.s1.e1" id="DS.d781.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d782" origId="18703867">
        <sentence id="DS.d782.s0" origId="18703867-1272" text="Osteopontin (OPN) inhibits the growth of calcium oxalate monohydrate (COM) and other crystal phases in a phosphorylation-dependent manner.">
            <entity id="DS.d782.s0.e0" origId="P10451,P14287,P31096,Q9XSY9" charOffset="13-16" type="protein" text="OPN"/>
            <entity id="DS.d782.s0.e1" origId="971" charOffset="41-68" type="compound" text="calcium oxalate monohydrate"/>
            <pair e1="DS.d782.s0.e1" e2="DS.d782.s0.e0" id="DS.d782.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d783" origId="18703992">
        <sentence id="DS.d783.s0" origId="18703992-1333" text="Prostaglandins D2, E2, and F2alpha were increased in the tissues from mouse pups exposed to &amp;gt;95% O2 at 7 d indicating a differential expression of cyclooxygenase-2 products.">
            <entity id="DS.d783.s0.e0" origId="977,5359597" charOffset="100-102" type="compound" text="O2"/>
            <entity id="DS.d783.s0.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="150-166" type="protein" text="cyclooxygenase-2"/>
            <pair e1="DS.d783.s0.e0" e2="DS.d783.s0.e1" id="DS.d783.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d784" origId="18704001">
        <sentence id="DS.d784.s0" origId="18704001-1340" text="Glucose replacement to euglycemia causes hypoxia, acidosis, and decreased insulin secretion in fetal sheep with intrauterine growth restriction.">
            <entity id="DS.d784.s0.e0" origId="206,5793,64689,79025" charOffset="0-7" type="compound" text="Glucose"/>
            <entity id="DS.d784.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="74-81" type="protein" text="insulin"/>
            <pair e1="DS.d784.s0.e0" e2="DS.d784.s0.e1" id="DS.d784.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d784.s1" origId="18704001-1341" text="Glucose stimulated insulin secretion (GSIS) was lower in the Glu group.">
            <entity id="DS.d784.s1.e0" origId="206,5793,64689,79025" charOffset="0-7" type="compound" text="Glucose"/>
            <entity id="DS.d784.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="19-26" type="protein" text="insulin"/>
            <pair e1="DS.d784.s1.e0" e2="DS.d784.s1.e1" id="DS.d784.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d785" origId="18704095">
        <sentence id="DS.d785.s0" origId="18704095-238" text="These data confirm that endogenous miR-34a regulates GRM7 levels and supports the notion that miR-34a contributes to the effects of lithium and VPA on GRM7.">
            <entity id="DS.d785.s0.e1" origId="Q14831,Q5RDQ8" charOffset="53-57" type="protein" text="GRM7"/>
            <entity id="DS.d785.s0.e3" origId="28486,3028194" charOffset="132-139" type="compound" text="lithium"/>
            <entity id="DS.d785.s0.e4" origId="Q14831,Q5RDQ8" charOffset="151-155" type="protein" text="GRM7"/>
            <pair e1="DS.d785.s0.e3" e2="DS.d785.s0.e1" id="DS.d785.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d786" origId="18704096">
        <sentence id="DS.d786.s0" origId="18704096-1413" text="These results confirm the therapeutic potential of mGluR5 blockade on motor symptoms induced by reduced striatal dopamine function.">
            <entity id="DS.d786.s0.e0" origId="P31424,P41594" charOffset="51-57" type="protein" text="mGluR5"/>
            <entity id="DS.d786.s0.e1" origId="681" charOffset="113-121" type="compound" text="dopamine"/>
            <pair e1="DS.d786.s0.e1" e2="DS.d786.s0.e0" id="DS.d786.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d786.s1" origId="18704096-1414" text="Further, they demonstrate that mGluR5 blockade may also have beneficial effects on cognitive deficits induced by dopamine depletion.">
            <entity id="DS.d786.s1.e0" origId="P31424,P41594" charOffset="31-37" type="protein" text="mGluR5"/>
            <entity id="DS.d786.s1.e1" origId="681" charOffset="113-121" type="compound" text="dopamine"/>
            <pair e1="DS.d786.s1.e1" e2="DS.d786.s1.e0" id="DS.d786.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d787" origId="18704103">
        <sentence id="DS.d787.s0" origId="18704103-600" text="Here, we found that the addition of glucocorticoids, such as dexamethasone and cortisol, to cultured human keratinocytes increased their TLR2 gene expression.">
            <entity id="DS.d787.s0.e0" origId="5743" charOffset="61-74" type="compound" text="dexamethasone"/>
            <entity id="DS.d787.s0.e1" origId="5754" charOffset="79-87" type="compound" text="cortisol"/>
            <entity id="DS.d787.s0.e2" origId="O60603,Q2V897,Q689D1,Q95LA9,Q95M53,Q9R1F8" charOffset="137-141" type="protein" text="TLR2"/>
            <pair e1="DS.d787.s0.e1" e2="DS.d787.s0.e2" id="DS.d787.s0.i0" interaction="True"/>
            <pair e1="DS.d787.s0.e0" e2="DS.d787.s0.e2" id="DS.d787.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d787.s1" origId="18704103-601" text="Gene expression of mitogen-activated protein kinase (MAPK) phosphatase-1 was also increased by the addition of dexamethasone.">
            <entity id="DS.d787.s1.e0" origId="O42781,P27638,Q00859" charOffset="53-57" type="protein" text="MAPK"/>
            <entity id="DS.d787.s1.e1" origId="5743" charOffset="111-124" type="compound" text="dexamethasone"/>
            <pair e1="DS.d787.s1.e1" e2="DS.d787.s1.e0" id="DS.d787.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d788" origId="18704264">
        <sentence id="DS.d788.s0" origId="18704264-1595" text="Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and vitamin C.">
            <entity id="DS.d788.s0.e0" origId="P06731" charOffset="127-151" type="protein" text="carcinoembryonic antigen"/>
            <entity id="DS.d788.s0.e1" origId="P06731" charOffset="153-156" type="protein" text="CEA"/>
            <entity id="DS.d788.s0.e2" origId="P15557,P19440,P20735,Q05053" charOffset="250-253" type="protein" text="GGT"/>
            <entity id="DS.d788.s0.e3" origId="P07024,P52307,Q56878,Q9I767,Q9RN37,Q9XZ43" charOffset="256-270" type="protein" text="5'nucleotidase"/>
            <entity id="DS.d788.s0.e4" origId="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289" charOffset="305-308" type="protein" text="LDH"/>
            <entity id="DS.d788.s0.e5" origId="O50258" charOffset="378-398" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d788.s0.e6" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="400-403" type="protein" text="SOD"/>
            <entity id="DS.d788.s0.e7" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="406-414" type="protein" text="catalase"/>
            <entity id="DS.d788.s0.e8" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="416-419" type="protein" text="CAT"/>
            <entity id="DS.d788.s0.e9" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="422-444" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d788.s0.e10" origId="124886" charOffset="452-471" type="compound" text="reduced glutathione"/>
            <entity id="DS.d788.s0.e11" origId="124886" charOffset="473-476" type="compound" text="GSH"/>
            <entity id="DS.d788.s0.e12" origId="2116,14985,1548900,1742129" charOffset="479-488" type="compound" text="vitamin E"/>
            <entity id="DS.d788.s0.e13" origId="54670067" charOffset="493-502" type="compound" text="vitamin C"/>
            <pair e1="DS.d788.s0.e11" e2="DS.d788.s0.e6" id="DS.d788.s0.i0" interaction="False"/>
            <pair e1="DS.d788.s0.e10" e2="DS.d788.s0.e6" id="DS.d788.s0.i1" interaction="False"/>
            <pair e1="DS.d788.s0.e13" e2="DS.d788.s0.e1" id="DS.d788.s0.i2" interaction="False"/>
            <pair e1="DS.d788.s0.e13" e2="DS.d788.s0.e8" id="DS.d788.s0.i3" interaction="False"/>
            <pair e1="DS.d788.s0.e11" e2="DS.d788.s0.e2" id="DS.d788.s0.i4" interaction="False"/>
            <pair e1="DS.d788.s0.e10" e2="DS.d788.s0.e4" id="DS.d788.s0.i5" interaction="False"/>
            <pair e1="DS.d788.s0.e13" e2="DS.d788.s0.e7" id="DS.d788.s0.i6" interaction="False"/>
            <pair e1="DS.d788.s0.e10" e2="DS.d788.s0.e2" id="DS.d788.s0.i7" interaction="False"/>
            <pair e1="DS.d788.s0.e12" e2="DS.d788.s0.e1" id="DS.d788.s0.i8" interaction="False"/>
            <pair e1="DS.d788.s0.e12" e2="DS.d788.s0.e8" id="DS.d788.s0.i9" interaction="False"/>
            <pair e1="DS.d788.s0.e11" e2="DS.d788.s0.e1" id="DS.d788.s0.i10" interaction="False"/>
            <pair e1="DS.d788.s0.e12" e2="DS.d788.s0.e6" id="DS.d788.s0.i11" interaction="False"/>
            <pair e1="DS.d788.s0.e12" e2="DS.d788.s0.e7" id="DS.d788.s0.i12" interaction="False"/>
            <pair e1="DS.d788.s0.e11" e2="DS.d788.s0.e0" id="DS.d788.s0.i13" interaction="False"/>
            <pair e1="DS.d788.s0.e12" e2="DS.d788.s0.e2" id="DS.d788.s0.i14" interaction="False"/>
            <pair e1="DS.d788.s0.e11" e2="DS.d788.s0.e8" id="DS.d788.s0.i15" interaction="False"/>
            <pair e1="DS.d788.s0.e10" e2="DS.d788.s0.e8" id="DS.d788.s0.i16" interaction="False"/>
            <pair e1="DS.d788.s0.e12" e2="DS.d788.s0.e0" id="DS.d788.s0.i17" interaction="False"/>
            <pair e1="DS.d788.s0.e13" e2="DS.d788.s0.e0" id="DS.d788.s0.i18" interaction="False"/>
            <pair e1="DS.d788.s0.e12" e2="DS.d788.s0.e3" id="DS.d788.s0.i19" interaction="False"/>
            <pair e1="DS.d788.s0.e13" e2="DS.d788.s0.e2" id="DS.d788.s0.i20" interaction="False"/>
            <pair e1="DS.d788.s0.e11" e2="DS.d788.s0.e9" id="DS.d788.s0.i21" interaction="False"/>
            <pair e1="DS.d788.s0.e10" e2="DS.d788.s0.e3" id="DS.d788.s0.i22" interaction="False"/>
            <pair e1="DS.d788.s0.e10" e2="DS.d788.s0.e5" id="DS.d788.s0.i23" interaction="False"/>
            <pair e1="DS.d788.s0.e11" e2="DS.d788.s0.e5" id="DS.d788.s0.i24" interaction="False"/>
            <pair e1="DS.d788.s0.e12" e2="DS.d788.s0.e9" id="DS.d788.s0.i25" interaction="False"/>
            <pair e1="DS.d788.s0.e12" e2="DS.d788.s0.e5" id="DS.d788.s0.i26" interaction="False"/>
            <pair e1="DS.d788.s0.e11" e2="DS.d788.s0.e4" id="DS.d788.s0.i27" interaction="False"/>
            <pair e1="DS.d788.s0.e10" e2="DS.d788.s0.e1" id="DS.d788.s0.i28" interaction="False"/>
            <pair e1="DS.d788.s0.e10" e2="DS.d788.s0.e9" id="DS.d788.s0.i29" interaction="False"/>
            <pair e1="DS.d788.s0.e10" e2="DS.d788.s0.e7" id="DS.d788.s0.i30" interaction="False"/>
            <pair e1="DS.d788.s0.e11" e2="DS.d788.s0.e7" id="DS.d788.s0.i31" interaction="False"/>
            <pair e1="DS.d788.s0.e11" e2="DS.d788.s0.e3" id="DS.d788.s0.i32" interaction="False"/>
            <pair e1="DS.d788.s0.e13" e2="DS.d788.s0.e5" id="DS.d788.s0.i33" interaction="False"/>
            <pair e1="DS.d788.s0.e13" e2="DS.d788.s0.e9" id="DS.d788.s0.i34" interaction="False"/>
            <pair e1="DS.d788.s0.e13" e2="DS.d788.s0.e4" id="DS.d788.s0.i35" interaction="False"/>
            <pair e1="DS.d788.s0.e13" e2="DS.d788.s0.e3" id="DS.d788.s0.i36" interaction="False"/>
            <pair e1="DS.d788.s0.e13" e2="DS.d788.s0.e6" id="DS.d788.s0.i37" interaction="False"/>
            <pair e1="DS.d788.s0.e10" e2="DS.d788.s0.e0" id="DS.d788.s0.i38" interaction="False"/>
            <pair e1="DS.d788.s0.e12" e2="DS.d788.s0.e4" id="DS.d788.s0.i39" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d789" origId="18704417">
        <sentence id="DS.d789.s0" origId="18704417-141" text="Achieving CCgR within 12 months and maintaining it without an increase in BCR-ABL transcripts might indicate that low-dose imatinib therapy can produce acceptable outcomes without excess toxicity.">
            <entity id="DS.d789.s0.e0" origId="P11274" charOffset="74-77" type="protein" text="BCR"/>
            <entity id="DS.d789.s0.e1" origId="P00519,P00521,P10447,P11681,Q00022" charOffset="78-81" type="protein" text="ABL"/>
            <entity id="DS.d789.s0.e2" origId="5291" charOffset="123-131" type="compound" text="imatinib"/>
            <pair e1="DS.d789.s0.e2" e2="DS.d789.s0.e0" id="DS.d789.s0.i0" interaction="True"/>
            <pair e1="DS.d789.s0.e2" e2="DS.d789.s0.e1" id="DS.d789.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d790" origId="18704487">
        <sentence id="DS.d790.s0" origId="18704487-89" text="Rac1 (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the TxA(2) analog U46619, indicating that impaired GPVI-, but not G-protein signaling, was responsible for the observed defect.">
            <entity id="DS.d790.s0.e0" origId="P40792,P63001,Q6RUV5" charOffset="0-4" type="protein" text="Rac1"/>
            <entity id="DS.d790.s0.e1" origId="5280497" charOffset="154-159" type="compound" text="TxA(2"/>
            <entity id="DS.d790.s0.e2" origId="P0C191,Q9HCN6" charOffset="201-205" type="protein" text="GPVI"/>
            <pair e1="DS.d790.s0.e1" e2="DS.d790.s0.e2" id="DS.d790.s0.i0" interaction="False"/>
            <pair e1="DS.d790.s0.e1" e2="DS.d790.s0.e0" id="DS.d790.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d791" origId="18704543">
        <sentence id="DS.d791.s0" origId="18704543-120" text="LCT 13910 CC genotype is associated with lactose intolerance, a condition often resulting in reduced milk intake.">
            <entity id="DS.d791.s0.e0" origId="P09848,P09849" charOffset="0-3" type="protein" text="LCT"/>
            <entity id="DS.d791.s0.e1" origId="294,6134,84571,440995" charOffset="41-48" type="compound" text="lactose"/>
            <pair e1="DS.d791.s0.e1" e2="DS.d791.s0.e0" id="DS.d791.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d792" origId="18704651">
        <sentence id="DS.d792.s0" origId="18704651-196" text="Osteointegration of titanium or its alloy with bone can be greatly improved by calcium phosphate coatings, and further enhanced by an extracellular matrix protein layer such as collagen.">
            <entity id="DS.d792.s0.e0" origId="23963" charOffset="20-28" type="compound" text="titanium"/>
            <entity id="DS.d792.s0.e1" origId="24441,24456,24632" charOffset="79-96" type="compound" text="calcium phosphate"/>
            <entity id="DS.d792.s0.e2" origId="O12705,O18559,O57299,O89341,P03314,P03344,P03419,P03426,P03519,P04876,P04888,P05769,P06157,P06166,P06446,P06502,P06503,P06935,P06942,P06943,P07564,P07720,P07873,P08325,P08671,P09732,P09866,P11206,P12446,P12823,P13616,P13844,P14335,P14336,P14340,P14403,P15200,P16287,P16628,P16629,P17748,P17763,P18356,P18611,P19110,P19692,P19718,P22046,P22338,P24266,P24615,P25058,P25182,P25223,P25224,P26034,P27019,P27020,P27287,P27395,P27663,P27910,P27912,P27913,P27915,P29165,P29837,P29838,P29983,P29984,P29990,P29991,P30026,P31035,P31620,P32886,P33478,P33482,P33515,P35947,P35976,P36355,P36356,P41358,P52637,P62683,P62684,P62685,P62689,P62690,P63117,P63126,P63128,P63130,P63145,P87577,P87889,Q01299,Q01427,Q04538,Q074N0,Q1X880,Q1X881,Q66112,Q6DV88,Q6J3P1,Q7LDI9,Q84131,Q88266,Q88428,Q89277,Q91B74,Q96PI4,Q98803,Q9HDB9,Q9IK90,Q9JAF2,Q9NRZ4,Q9UKH8,Q9YNA8,Q9YRV3" charOffset="148-162" type="protein" text="matrix protein"/>
            <pair e1="DS.d792.s0.e0" e2="DS.d792.s0.e2" id="DS.d792.s0.i0" interaction="True"/>
            <pair e1="DS.d792.s0.e1" e2="DS.d792.s0.e2" id="DS.d792.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d793" origId="18704653">
        <sentence id="DS.d793.s0" origId="18704653-197" text="Use of tissue transglutaminase and fibronectin to influence osteoblast responses to tricalcium phosphate scaffolds.">
            <entity id="DS.d793.s0.e0" origId="P08587,P21980,P21981,P51176,P52181,Q01841" charOffset="7-30" type="protein" text="tissue transglutaminase"/>
            <entity id="DS.d793.s0.e1" origId="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400" charOffset="35-46" type="protein" text="fibronectin"/>
            <entity id="DS.d793.s0.e2" origId="24456" charOffset="84-104" type="compound" text="tricalcium phosphate"/>
            <pair e1="DS.d793.s0.e2" e2="DS.d793.s0.e0" id="DS.d793.s0.i0" interaction="True"/>
            <pair e1="DS.d793.s0.e2" e2="DS.d793.s0.e1" id="DS.d793.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d793.s1" origId="18704653-198" text="To explore the possibility of controlling cell interaction with biomaterials, tricalcium phosphate scaffolds were modified using the enzyme tissue transglutaminase (tTgase) in conjunction with fibronectin.">
            <entity id="DS.d793.s1.e0" origId="24456" charOffset="78-98" type="compound" text="tricalcium phosphate"/>
            <entity id="DS.d793.s1.e1" origId="P08587,P21980,P21981,P51176,P52181,Q01841" charOffset="140-163" type="protein" text="tissue transglutaminase"/>
            <entity id="DS.d793.s1.e2" origId="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400" charOffset="193-204" type="protein" text="fibronectin"/>
            <pair e1="DS.d793.s1.e0" e2="DS.d793.s1.e1" id="DS.d793.s1.i0" interaction="True"/>
            <pair e1="DS.d793.s1.e0" e2="DS.d793.s1.e2" id="DS.d793.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d796" origId="18704766">
        <sentence id="DS.d796.s0" origId="18704766-300" text="Four MPTP monkeys received L-DOPA/Benserazide plus CI-1041 an NMDA antagonist selective for NR1/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.">
            <entity id="DS.d796.s0.e0" origId="6047" charOffset="27-33" type="compound" text="L-DOPA"/>
            <entity id="DS.d796.s0.e1" origId="2327" charOffset="34-45" type="compound" text="Benserazide"/>
            <entity id="DS.d796.s0.e2" origId="P11605,P11832,P16081,P39865,Q9SML8" charOffset="92-95" type="protein" text="NR1"/>
            <entity id="DS.d796.s0.e3" origId="Q00960,Q01097,Q13224" charOffset="96-100" type="protein" text="NR2B"/>
            <entity id="DS.d796.s0.e4" origId="6047" charOffset="128-134" type="compound" text="L-DOPA"/>
            <entity id="DS.d796.s0.e5" origId="2327" charOffset="135-146" type="compound" text="Benserazide"/>
            <entity id="DS.d796.s0.e6" origId="54746" charOffset="168-179" type="compound" text="cabergoline"/>
            <pair e1="DS.d796.s0.e1" e2="DS.d796.s0.e2" id="DS.d796.s0.i0" interaction="False"/>
            <pair e1="DS.d796.s0.e6" e2="DS.d796.s0.e2" id="DS.d796.s0.i1" interaction="False"/>
            <pair e1="DS.d796.s0.e1" e2="DS.d796.s0.e3" id="DS.d796.s0.i2" interaction="False"/>
            <pair e1="DS.d796.s0.e0" e2="DS.d796.s0.e2" id="DS.d796.s0.i3" interaction="False"/>
            <pair e1="DS.d796.s0.e6" e2="DS.d796.s0.e3" id="DS.d796.s0.i4" interaction="False"/>
            <pair e1="DS.d796.s0.e0" e2="DS.d796.s0.e3" id="DS.d796.s0.i5" interaction="False"/>
        </sentence>
        <sentence id="DS.d796.s1" origId="18704766-304" text="Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and cabergoline, or reduction with Ro 61-8048 were associated with modulation of NR2B/NMDA glutamate receptors.">
            <entity id="DS.d796.s1.e0" origId="6047" charOffset="20-26" type="compound" text="L-DOPA"/>
            <entity id="DS.d796.s1.e1" origId="54746" charOffset="76-87" type="compound" text="cabergoline"/>
            <entity id="DS.d796.s1.e2" origId="5282337" charOffset="107-117" type="compound" text="Ro 61-8048"/>
            <entity id="DS.d796.s1.e3" origId="Q00960,Q01097,Q13224" charOffset="153-157" type="protein" text="NR2B"/>
            <pair e1="DS.d796.s1.e2" e2="DS.d796.s1.e3" id="DS.d796.s1.i0" interaction="True"/>
            <pair e1="DS.d796.s1.e0" e2="DS.d796.s1.e3" id="DS.d796.s1.i1" interaction="True"/>
            <pair e1="DS.d796.s1.e1" e2="DS.d796.s1.e3" id="DS.d796.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d797" origId="18704940">
        <sentence id="DS.d797.s0" origId="18704940-430" text="MurD (UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase), a three-domain bacterial protein, catalyses a highly specific incorporation of D-glutamate to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-alanine (UMA) utilizing ATP hydrolysis to ADP and P(i).">
            <entity id="DS.d797.s0.e0" origId="O06222,O07108,O07669,O25236,O51532,O67852,O83873,O84763,P0A089,P0A090,P0A091,P0C0D7,P0C0D8,P14900,P45063,P57313,P57995,P73668,Q03522,Q0SHR9,Q0SQ91,Q0TLQ1,Q0TMJ3,Q0VS04,Q11GS3,Q11RH3,Q12EL7,Q13TZ0,Q14J05,Q163I6,Q182Y7,Q1AVX1,Q1BZG5,Q1C212,Q1CMM9,Q1CU35,Q1D0S8,Q1GAT6,Q1GIV4,Q1GRX7,Q1GYZ9,Q1IKG8,Q1J147,Q1J5S5,Q1JAT4,Q1JG10,Q1JKY4,Q1LIM4,Q1LSW4,Q1ME31,Q1MPC1,Q1Q883,Q1QNU5,Q1QVG5,Q1RGA7,Q1RI52,Q1WT99,Q216E0,Q21MH1,Q21SW7,Q24TE4,Q255W7,Q28NN2,Q2A1Z9,Q2FHQ4,Q2FZ92,Q2G997,Q2IG29,Q2IYL0,Q2JD52,Q2JHP5,Q2JVR9,Q2K6B9,Q2KVF5,Q2LR50,Q2NVV3,Q2P5V2,Q2RK81,Q2RVU2,Q2S530,Q2S9Z0,Q2SZI5,Q2W0H5,Q2Y636,Q2YM69,Q2YXD9,Q313Q5,Q319C4,Q31I61,Q31MM2,Q326E7,Q32K04,Q38XM9,Q39JX2,Q39YM1,Q3A2G4,Q3AAE4,Q3AHP0,Q3ANV5,Q3AZI5,Q3B127,Q3BR29,Q3IG02,Q3J4M6,Q3J787,Q3JND6,Q3K2P4,Q3K742,Q3KKT4,Q3MF19,Q3SMH5,Q3STT0,Q3Z5S1,Q46JA8,Q46WZ2,Q47AA2,Q47QX1,Q47VQ7,Q48EF6,Q48SK8,Q493Q3,Q49WW5,Q4FQ21,Q4JW97,Q4K6J1,Q4L5N4,Q4QLG0,Q4ULT8,Q4UWX9,Q4ZNY8,Q52953,Q57C76,Q57TD2,Q5E2P8,Q5F6L6,Q5FKV3,Q5FUJ7,Q5GSC8,Q5H2Y1,Q5HGP8,Q5HQ09,Q5HW34,Q5L0X7,Q5L521,Q5LIJ5,Q5LU71,Q5M0D5,Q5M4Y2,Q5MZA8,Q5NHK3,Q5NPA7,Q5P6Z4,Q5PBH9,Q5PDC2,Q5R0M3,Q5SJD2,Q5WFG8,Q5WTI5,Q5X1S4,Q5XB04,Q5YYY1,Q5ZSA3,Q604V5,Q62GS5,Q636B4,Q63QJ5,Q64ZL9,Q65JY2,Q65RY4,Q66EK7,Q67QM7,Q68WW9,Q6A9Q4,Q6AE62,Q6AJ52,Q6D0I1,Q6FFC2,Q6G122,Q6G2Q3,Q6GA29,Q6GHQ2,Q6HEQ2,Q6LMF4,Q6MBS4,Q6MIF8,Q6N409,Q6NGC6,Q71XX7,Q728U6,Q72JQ1,Q72NP4,Q732F6,Q73GT3,Q73YQ6,Q748D4,Q74JY5,Q7MNV3,Q7MWM5,Q7N145,Q7NEZ5,Q7NPZ7,Q7U8T1,Q7V0A5,Q7V5V5,Q7VAM1,Q7VEP7,Q7VP56,Q7VQI9,Q7VUQ1,Q7W4B2,Q7WFS0,Q819Q2,Q81WC9,Q821S1,Q82AD8,Q82VS5,Q83F20,Q83GN2,Q83HK0,Q83MF9,Q879A1,Q87EA7,Q87SG6,Q87WY3,Q88N78,Q88V80,Q899G5,Q89AQ2,Q89FU5,Q8A256,Q8CSX6,Q8D2Z4,Q8DEK8,Q8DMN8,Q8DQM2,Q8DVE3,Q8E186,Q8E6P1,Q8E9P6,Q8ER50,Q8F7V4,Q8FL65,Q8FNT8,Q8FZP2,Q8G4Q6,Q8K9T2,Q8KGD2,Q8NX35,Q8P063,Q8P775,Q8PII9,Q8R9G4,Q8RDQ1,Q8UDM6,Q8X9Y9,Q8XHM4,Q8XVI5,Q8Y5M1,Q8YI68,Q8YPS9,Q8Z9H0,Q8ZIF1,Q8ZRU4,Q929Y1,Q92I60,Q97EB9,Q97RU8,Q98KB1,Q9A597,Q9CF91,Q9CPB0,Q9F1N2,Q9HVZ9,Q9JSZ5,Q9K0Y4,Q9K9S8,Q9KPG5,Q9PEB0,Q9PI73,Q9PLG5,Q9RRJ4,Q9S2W9,Q9WY76,Q9Z705,Q9ZDC2,Q9ZLY0" charOffset="0-4" type="protein" text="MurD"/>
            <entity id="DS.d797.s0.e1" origId="5496796" charOffset="214-217" type="compound" text="UMA"/>
            <pair e1="DS.d797.s0.e1" e2="DS.d797.s0.e0" id="DS.d797.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d797.s1" origId="18704940-431" text="On the basis of structural studies of MurD complexes, a stepwise catalytic mechanism was proposed that commences with a formation of the acyl-phosphate intermediate, followed by a nucleophilic attack of D-glutamate that, through the formation of a tetrahedral reaction intermediate and subsequent phosphate dissociation, affords the final product, UDP-N-acetyl-muramoyl-L-alanine-D-glutamate (UMAG).">
            <entity id="DS.d797.s1.e0" origId="O06222,O07108,O07669,O25236,O51532,O67852,O83873,O84763,P0A089,P0A090,P0A091,P0C0D7,P0C0D8,P14900,P45063,P57313,P57995,P73668,Q03522,Q0SHR9,Q0SQ91,Q0TLQ1,Q0TMJ3,Q0VS04,Q11GS3,Q11RH3,Q12EL7,Q13TZ0,Q14J05,Q163I6,Q182Y7,Q1AVX1,Q1BZG5,Q1C212,Q1CMM9,Q1CU35,Q1D0S8,Q1GAT6,Q1GIV4,Q1GRX7,Q1GYZ9,Q1IKG8,Q1J147,Q1J5S5,Q1JAT4,Q1JG10,Q1JKY4,Q1LIM4,Q1LSW4,Q1ME31,Q1MPC1,Q1Q883,Q1QNU5,Q1QVG5,Q1RGA7,Q1RI52,Q1WT99,Q216E0,Q21MH1,Q21SW7,Q24TE4,Q255W7,Q28NN2,Q2A1Z9,Q2FHQ4,Q2FZ92,Q2G997,Q2IG29,Q2IYL0,Q2JD52,Q2JHP5,Q2JVR9,Q2K6B9,Q2KVF5,Q2LR50,Q2NVV3,Q2P5V2,Q2RK81,Q2RVU2,Q2S530,Q2S9Z0,Q2SZI5,Q2W0H5,Q2Y636,Q2YM69,Q2YXD9,Q313Q5,Q319C4,Q31I61,Q31MM2,Q326E7,Q32K04,Q38XM9,Q39JX2,Q39YM1,Q3A2G4,Q3AAE4,Q3AHP0,Q3ANV5,Q3AZI5,Q3B127,Q3BR29,Q3IG02,Q3J4M6,Q3J787,Q3JND6,Q3K2P4,Q3K742,Q3KKT4,Q3MF19,Q3SMH5,Q3STT0,Q3Z5S1,Q46JA8,Q46WZ2,Q47AA2,Q47QX1,Q47VQ7,Q48EF6,Q48SK8,Q493Q3,Q49WW5,Q4FQ21,Q4JW97,Q4K6J1,Q4L5N4,Q4QLG0,Q4ULT8,Q4UWX9,Q4ZNY8,Q52953,Q57C76,Q57TD2,Q5E2P8,Q5F6L6,Q5FKV3,Q5FUJ7,Q5GSC8,Q5H2Y1,Q5HGP8,Q5HQ09,Q5HW34,Q5L0X7,Q5L521,Q5LIJ5,Q5LU71,Q5M0D5,Q5M4Y2,Q5MZA8,Q5NHK3,Q5NPA7,Q5P6Z4,Q5PBH9,Q5PDC2,Q5R0M3,Q5SJD2,Q5WFG8,Q5WTI5,Q5X1S4,Q5XB04,Q5YYY1,Q5ZSA3,Q604V5,Q62GS5,Q636B4,Q63QJ5,Q64ZL9,Q65JY2,Q65RY4,Q66EK7,Q67QM7,Q68WW9,Q6A9Q4,Q6AE62,Q6AJ52,Q6D0I1,Q6FFC2,Q6G122,Q6G2Q3,Q6GA29,Q6GHQ2,Q6HEQ2,Q6LMF4,Q6MBS4,Q6MIF8,Q6N409,Q6NGC6,Q71XX7,Q728U6,Q72JQ1,Q72NP4,Q732F6,Q73GT3,Q73YQ6,Q748D4,Q74JY5,Q7MNV3,Q7MWM5,Q7N145,Q7NEZ5,Q7NPZ7,Q7U8T1,Q7V0A5,Q7V5V5,Q7VAM1,Q7VEP7,Q7VP56,Q7VQI9,Q7VUQ1,Q7W4B2,Q7WFS0,Q819Q2,Q81WC9,Q821S1,Q82AD8,Q82VS5,Q83F20,Q83GN2,Q83HK0,Q83MF9,Q879A1,Q87EA7,Q87SG6,Q87WY3,Q88N78,Q88V80,Q899G5,Q89AQ2,Q89FU5,Q8A256,Q8CSX6,Q8D2Z4,Q8DEK8,Q8DMN8,Q8DQM2,Q8DVE3,Q8E186,Q8E6P1,Q8E9P6,Q8ER50,Q8F7V4,Q8FL65,Q8FNT8,Q8FZP2,Q8G4Q6,Q8K9T2,Q8KGD2,Q8NX35,Q8P063,Q8P775,Q8PII9,Q8R9G4,Q8RDQ1,Q8UDM6,Q8X9Y9,Q8XHM4,Q8XVI5,Q8Y5M1,Q8YI68,Q8YPS9,Q8Z9H0,Q8ZIF1,Q8ZRU4,Q929Y1,Q92I60,Q97EB9,Q97RU8,Q98KB1,Q9A597,Q9CF91,Q9CPB0,Q9F1N2,Q9HVZ9,Q9JSZ5,Q9K0Y4,Q9K9S8,Q9KPG5,Q9PEB0,Q9PI73,Q9PLG5,Q9RRJ4,Q9S2W9,Q9WY76,Q9Z705,Q9ZDC2,Q9ZLY0" charOffset="38-42" type="protein" text="MurD"/>
            <entity id="DS.d797.s1.e2" origId="23327" charOffset="203-214" type="compound" text="D-glutamate"/>
            <pair e1="DS.d797.s1.e2" e2="DS.d797.s1.e0" id="DS.d797.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d798" origId="18704946">
        <sentence id="DS.d798.s0" origId="18704946-1065" text="Although the overall amino acid identity between SERTs and the LeuT(Aa) is only 17%, it increases to above 50% in the first shell of the putative 5-HT binding site, allowing de novo computational docking of tryptamine derivatives in atomic detail.">
            <entity id="DS.d798.s0.e0" origId="P31645,Q9XT49" charOffset="49-54" type="protein" text="SERTs"/>
            <entity id="DS.d798.s0.e1" origId="1150" charOffset="207-217" type="compound" text="tryptamine"/>
            <pair e1="DS.d798.s0.e1" e2="DS.d798.s0.e0" id="DS.d798.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d799" origId="18704953">
        <sentence id="DS.d799.s0" origId="18704953-1278" text="Mal-sCT, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble palmitic acid derivative at Cys 1 and Cys 7, was reacted with mPEG-succinimide (mPEG-Suc, 5 kDa).">
            <entity id="DS.d799.s0.e0" origId="P56862" charOffset="4-7" type="protein" text="sCT"/>
            <entity id="DS.d799.s0.e1" origId="P56862" charOffset="33-36" type="protein" text="sCT"/>
            <entity id="DS.d799.s0.e3" origId="985" charOffset="79-92" type="compound" text="palmitic acid"/>
            <entity id="DS.d799.s0.e4" origId="8019" charOffset="141-145" type="compound" text="mPEG"/>
            <entity id="DS.d799.s0.e5" origId="11439" charOffset="146-157" type="compound" text="succinimide"/>
            <entity id="DS.d799.s0.e6" origId="8019" charOffset="159-163" type="compound" text="mPEG"/>
            <pair e1="DS.d799.s0.e5" e2="DS.d799.s0.e0" id="DS.d799.s0.i0" interaction="True"/>
            <pair e1="DS.d799.s0.e3" e2="DS.d799.s0.e0" id="DS.d799.s0.i1" interaction="True"/>
            <pair e1="DS.d799.s0.e4" e2="DS.d799.s0.e0" id="DS.d799.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d800" origId="18704955">
        <sentence id="DS.d800.s0" origId="18704955-1137" text="Our findings suggest that GLP-1 substituted with a PEG of an appropriate Mw at Lys (34) could be used as a promising type 2 anti-diabetic agent to timely control postprandial glucose levels.">
            <entity id="DS.d800.s0.e0" origId="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25" charOffset="26-31" type="protein" text="GLP-1"/>
            <entity id="DS.d800.s0.e1" origId="206,5793,64689,79025" charOffset="175-182" type="compound" text="glucose"/>
            <pair e1="DS.d800.s0.e1" e2="DS.d800.s0.e0" id="DS.d800.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d801" origId="18706130">
        <sentence id="DS.d801.s0" origId="18706130-1404" text="The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats.">
            <entity id="DS.d801.s0.e0" origId="82148" charOffset="19-30" type="compound" text="agomelatine"/>
            <entity id="DS.d801.s0.e1" origId="P13591,P13592,P31836" charOffset="158-162" type="protein" text="NCAM"/>
            <pair e1="DS.d801.s0.e0" e2="DS.d801.s0.e1" id="DS.d801.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d802" origId="18706695">
        <sentence id="DS.d802.s0" origId="18706695-1298" text="Phosphatase activity was also inhibited for all the soils treated with triclosan (from 0.1 to 50mg/kg dry soil), but a declining inhibition was observed after 2 days of incubation.">
            <entity id="DS.d802.s0.e0" origId="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7" charOffset="0-11" type="protein" text="Phosphatase"/>
            <entity id="DS.d802.s0.e1" origId="5564" charOffset="71-80" type="compound" text="triclosan"/>
            <pair e1="DS.d802.s0.e1" e2="DS.d802.s0.e0" id="DS.d802.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d804" origId="18706940">
        <sentence id="DS.d804.s0" origId="18706940-826" text="The magnitude of autophagosome formation is tightly regulated by intracellular and extracellular amino acid concentrations and ATP levels via signaling pathways that include the nutrient sensing kinase TOR.">
            <entity id="DS.d804.s0.e0" origId="5957" charOffset="127-130" type="compound" text="ATP"/>
            <entity id="DS.d804.s0.e1" origId="P51450" charOffset="202-205" type="protein" text="TOR"/>
            <pair e1="DS.d804.s0.e0" e2="DS.d804.s0.e1" id="DS.d804.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d805" origId="18707755">
        <sentence id="DS.d805.s0" origId="18707755-1088" text="Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) glucose clamps were maintained for 6 hours by infusion of glucose, insulin and somatostatin.">
            <entity id="DS.d805.s0.e0" origId="2724488,10954115" charOffset="77-87" type="compound" text="L) glucose"/>
            <entity id="DS.d805.s0.e1" origId="206,5793,64689,79025" charOffset="80-87" type="compound" text="glucose"/>
            <entity id="DS.d805.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="147-154" type="protein" text="insulin"/>
            <entity id="DS.d805.s0.e3" origId="16129681,16129706" charOffset="159-171" type="compound" text="somatostatin"/>
            <pair e1="DS.d805.s0.e0" e2="DS.d805.s0.e2" id="DS.d805.s0.i0" interaction="False"/>
            <pair e1="DS.d805.s0.e1" e2="DS.d805.s0.e2" id="DS.d805.s0.i1" interaction="False"/>
            <pair e1="DS.d805.s0.e3" e2="DS.d805.s0.e2" id="DS.d805.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d806" origId="18708066">
        <sentence id="DS.d806.s0" origId="18708066-1324" text="or=6 ng/ml) was associated with increased expression of mrp-1 and pgp-1 and decreased glutathione, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-glycoproteins.">
            <entity id="DS.d806.s0.e0" origId="O24999,O35379,O66946,P0AF08,P0AF09,P28667,P32653,P45135,P50863,P53381,P53382,P53383,P65441,P65442,Q92JA4,Q9RVM9,Q9ZE27,Q9ZMM5" charOffset="56-59" type="protein" text="mrp"/>
            <entity id="DS.d806.s0.e1" origId="P34712" charOffset="66-71" type="protein" text="pgp-1"/>
            <entity id="DS.d806.s0.e2" origId="124886" charOffset="86-97" type="compound" text="glutathione"/>
            <entity id="DS.d806.s0.e3" origId="P08163" charOffset="200-213" type="protein" text="glycoproteins"/>
            <pair e1="DS.d806.s0.e2" e2="DS.d806.s0.e1" id="DS.d806.s0.i0" interaction="False"/>
            <pair e1="DS.d806.s0.e2" e2="DS.d806.s0.e3" id="DS.d806.s0.i1" interaction="False"/>
            <pair e1="DS.d806.s0.e2" e2="DS.d806.s0.e0" id="DS.d806.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d807" origId="18708157">
        <sentence id="DS.d807.s0" origId="18708157-1383" text="Co(2+) also induces the release of the pro-apoptotic factors, cytochrome c and AIF.">
            <entity id="DS.d807.s0.e0" origId="104729" charOffset="0-4" type="compound" text="Co(2"/>
            <entity id="DS.d807.s0.e1" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="62-74" type="protein" text="cytochrome c"/>
            <entity id="DS.d807.s0.e2" origId="O95831" charOffset="79-82" type="protein" text="AIF"/>
            <pair e1="DS.d807.s0.e0" e2="DS.d807.s0.e1" id="DS.d807.s0.i0" interaction="True"/>
            <pair e1="DS.d807.s0.e0" e2="DS.d807.s0.e2" id="DS.d807.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d807.s1" origId="18708157-1384" text="Incubation of rat hepatocyte primary cultures with Co(2+) results in apoptosis induction with caspase activation and increased level of expression of HIF-1alpha.">
            <entity id="DS.d807.s1.e0" origId="104729" charOffset="51-55" type="compound" text="Co(2"/>
            <entity id="DS.d807.s1.e1" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="150-160" type="protein" text="HIF-1alpha"/>
            <pair e1="DS.d807.s1.e0" e2="DS.d807.s1.e1" id="DS.d807.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d808" origId="18708158">
        <sentence id="DS.d808.s0" origId="18708158-1385" text="Roscovitine reduced amounts of the caspase inhibitor XIAP, and API-2 increased amounts of the BH3-only protein Bim.">
            <entity id="DS.d808.s0.e0" origId="160355" charOffset="0-11" type="compound" text="Roscovitine"/>
            <entity id="DS.d808.s0.e1" origId="O54918,O88498" charOffset="111-114" type="protein" text="Bim"/>
            <pair e1="DS.d808.s0.e0" e2="DS.d808.s0.e1" id="DS.d808.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d808.s1" origId="18708158-1386" text="Bax accumulated in mitochondria in response to API-2, whereas release of cytochrome c from mitochondria required both API-2 and roscovitine.">
            <entity id="DS.d808.s1.e0" origId="P27297,Q07813,Q63690" charOffset="0-3" type="protein" text="Bax"/>
            <entity id="DS.d808.s1.e1" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="73-85" type="protein" text="cytochrome c"/>
            <entity id="DS.d808.s1.e2" origId="160355" charOffset="128-139" type="compound" text="roscovitine"/>
            <pair e1="DS.d808.s1.e2" e2="DS.d808.s1.e0" id="DS.d808.s1.i0" interaction="False"/>
            <pair e1="DS.d808.s1.e2" e2="DS.d808.s1.e1" id="DS.d808.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d808.s2" origId="18708158-1387" text="We suggest that roscovitine elicits events that activate Bax once it translocates to mitochondria and that inactivation of cdk9 signals these events and the down-regulation of XIAP.">
            <entity id="DS.d808.s2.e0" origId="160355" charOffset="16-27" type="compound" text="roscovitine"/>
            <entity id="DS.d808.s2.e1" origId="P27297,Q07813,Q63690" charOffset="57-60" type="protein" text="Bax"/>
            <entity id="DS.d808.s2.e2" origId="Q641Z4,Q6GLD8,Q96WV9,Q99J95" charOffset="123-127" type="protein" text="cdk9"/>
            <pair e1="DS.d808.s2.e0" e2="DS.d808.s2.e2" id="DS.d808.s2.i0" interaction="True"/>
            <pair e1="DS.d808.s2.e0" e2="DS.d808.s2.e1" id="DS.d808.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d809" origId="18708191">
        <sentence id="DS.d809.s0" origId="18708191-1226" text="Intravenous glutamine enhances COX-2 activity giving cardioprotection.">
            <entity id="DS.d809.s0.e0" origId="738,5961" charOffset="12-21" type="compound" text="glutamine"/>
            <entity id="DS.d809.s0.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="31-36" type="protein" text="COX-2"/>
            <pair e1="DS.d809.s0.e0" e2="DS.d809.s0.e1" id="DS.d809.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d809.s1" origId="18708191-1227" text="We investigated whether acute intravenous glutamine, through an effect on cyclooxygenase (COX)-2 and heat shock protein (HSP) 72, might induce preconditioning.">
            <entity id="DS.d809.s1.e0" origId="738,5961" charOffset="42-51" type="compound" text="glutamine"/>
            <entity id="DS.d809.s1.e1" origId="P11353,P36551,P36552,Q9UTE2,Q9V3D2" charOffset="90-93" type="protein" text="COX"/>
            <entity id="DS.d809.s1.e2" origId="P32590" charOffset="121-124" type="protein" text="HSP"/>
            <pair e1="DS.d809.s1.e0" e2="DS.d809.s1.e2" id="DS.d809.s1.i0" interaction="True"/>
            <pair e1="DS.d809.s1.e0" e2="DS.d809.s1.e1" id="DS.d809.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d810" origId="18708284">
        <sentence id="DS.d810.s0" origId="18708284-1027" text="Islets from taurine-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.">
            <entity id="DS.d810.s0.e0" origId="1123" charOffset="12-19" type="compound" text="taurine"/>
            <entity id="DS.d810.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="68-75" type="protein" text="insulin"/>
            <entity id="DS.d810.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="100-107" type="protein" text="insulin"/>
            <entity id="DS.d810.s0.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="100-107" type="protein" text="insulin"/>
            <entity id="DS.d810.s0.e4" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="100-107" type="protein" text="insulin"/>
            <entity id="DS.d810.s0.e5" origId="Q09427,Q09428,Q09429" charOffset="471-494" type="protein" text="sulfonylurea receptor-1"/>
            <entity id="DS.d810.s0.e6" origId="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0" charOffset="496-507" type="protein" text="glucokinase"/>
            <entity id="DS.d810.s0.e7" origId="P12336,P14246" charOffset="509-515" type="protein" text="Glut-2"/>
            <entity id="DS.d810.s0.e8" origId="P52945,P52946" charOffset="535-563" type="protein" text="pancreas duodenum homeobox-1"/>
            <entity id="DS.d810.s0.e9" origId="P52945" charOffset="565-570" type="protein" text="PDX-1"/>
            <entity id="DS.d810.s0.e10" origId="P52945" charOffset="608-613" type="protein" text="PDX-1"/>
            <pair e1="DS.d810.s0.e0" e2="DS.d810.s0.e1" id="DS.d810.s0.i0" interaction="True"/>
            <pair e1="DS.d810.s0.e0" e2="DS.d810.s0.e7" id="DS.d810.s0.i1" interaction="True"/>
            <pair e1="DS.d810.s0.e0" e2="DS.d810.s0.e8" id="DS.d810.s0.i2" interaction="True"/>
            <pair e1="DS.d810.s0.e0" e2="DS.d810.s0.e6" id="DS.d810.s0.i3" interaction="True"/>
            <pair e1="DS.d810.s0.e0" e2="DS.d810.s0.e9" id="DS.d810.s0.i4" interaction="True"/>
            <pair e1="DS.d810.s0.e0" e2="DS.d810.s0.e5" id="DS.d810.s0.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d810.s1" origId="18708284-1028" text="Moreover, taurine supplementation significantly increased both basal and insulin stimulated tyrosine phosphorylation of the insulin receptor in skeletal muscle and liver tissues.">
            <entity id="DS.d810.s1.e0" origId="1123" charOffset="10-17" type="compound" text="taurine"/>
            <entity id="DS.d810.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="73-80" type="protein" text="insulin"/>
            <entity id="DS.d810.s1.e2" origId="1153,6057,5460803" charOffset="92-100" type="compound" text="tyrosine"/>
            <entity id="DS.d810.s1.e3" origId="Q28516" charOffset="124-140" type="protein" text="insulin receptor"/>
            <pair e1="DS.d810.s1.e0" e2="DS.d810.s1.e1" id="DS.d810.s1.i0" interaction="False"/>
            <pair e1="DS.d810.s1.e0" e2="DS.d810.s1.e3" id="DS.d810.s1.i1" interaction="True"/>
            <pair e1="DS.d810.s1.e2" e2="DS.d810.s1.e3" id="DS.d810.s1.i2" interaction="True"/>
            <pair e1="DS.d810.s1.e2" e2="DS.d810.s1.e1" id="DS.d810.s1.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d810.s2" origId="18708284-1029" text="These results indicate that taurine controls glucose homeostasis by regulating the expression of genes required for glucose-stimulated insulin secretion.">
            <entity id="DS.d810.s2.e0" origId="1123" charOffset="28-35" type="compound" text="taurine"/>
            <entity id="DS.d810.s2.e1" origId="206,5793,64689,79025" charOffset="45-52" type="compound" text="glucose"/>
            <entity id="DS.d810.s2.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="135-142" type="protein" text="insulin"/>
            <pair e1="DS.d810.s2.e0" e2="DS.d810.s2.e2" id="DS.d810.s2.i0" interaction="True"/>
            <pair e1="DS.d810.s2.e1" e2="DS.d810.s2.e2" id="DS.d810.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d810.s3" origId="18708284-1030" text="In addition, taurine enhances peripheral insulin sensitivity.">
            <entity id="DS.d810.s3.e0" origId="1123" charOffset="13-20" type="compound" text="taurine"/>
            <entity id="DS.d810.s3.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="41-48" type="protein" text="insulin"/>
            <pair e1="DS.d810.s3.e0" e2="DS.d810.s3.e1" id="DS.d810.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d811" origId="18708285">
        <sentence id="DS.d811.s0" origId="18708285-1040" text="Furthermore, treatment of lycopene and EPA also synergistically blocked the activation of downstream mTOR molecule.">
            <entity id="DS.d811.s0.e0" origId="446925" charOffset="26-34" type="compound" text="lycopene"/>
            <entity id="DS.d811.s0.e1" origId="P42345,P42346,Q9JLN9" charOffset="101-105" type="protein" text="mTOR"/>
            <pair e1="DS.d811.s0.e0" e2="DS.d811.s0.e1" id="DS.d811.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d811.s1" origId="18708285-1041" text="Immunocytochemical staining results revealed that lycopene and EPA could also up-regulate the expression of apoptotic proteins such as Bax and Fas ligand to suppress cell survival.">
            <entity id="DS.d811.s1.e0" origId="446925" charOffset="50-58" type="compound" text="lycopene"/>
            <entity id="DS.d811.s1.e1" origId="P27297,Q07813,Q63690" charOffset="135-138" type="protein" text="Bax"/>
            <entity id="DS.d811.s1.e2" origId="P36940,P41047,P48023,P63306,P63307,P63308,Q861W5,Q9BDN1,Q9BEA8" charOffset="143-153" type="protein" text="Fas ligand"/>
            <pair e1="DS.d811.s1.e0" e2="DS.d811.s1.e1" id="DS.d811.s1.i0" interaction="True"/>
            <pair e1="DS.d811.s1.e0" e2="DS.d811.s1.e2" id="DS.d811.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d812" origId="18709446">
        <sentence id="DS.d812.s0" origId="18709446-802" text="Amino acids (alanine, aspartic acid, glutamic acid) and glucose oxidase (GOx) were adsorbed on CNF and the results were compared with those obtained when activated carbon (AC) was used as support.">
            <entity id="DS.d812.s0.e0" origId="602,4580,5950,71080" charOffset="13-20" type="compound" text="alanine"/>
            <entity id="DS.d812.s0.e1" origId="424,5960,83887" charOffset="22-35" type="compound" text="aspartic acid"/>
            <entity id="DS.d812.s0.e2" origId="P81156" charOffset="56-71" type="protein" text="glucose oxidase"/>
            <entity id="DS.d812.s0.e3" origId="297" charOffset="154-170" type="compound" text="activated carbon"/>
            <pair e1="DS.d812.s0.e0" e2="DS.d812.s0.e2" id="DS.d812.s0.i0" interaction="False"/>
            <pair e1="DS.d812.s0.e3" e2="DS.d812.s0.e2" id="DS.d812.s0.i1" interaction="False"/>
            <pair e1="DS.d812.s0.e1" e2="DS.d812.s0.e2" id="DS.d812.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d814" origId="18709646">
        <sentence id="DS.d814.s0" origId="18709646-694" text="The NSCs and neuroblasts had epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor alpha (PDGFRalpha) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker BrdU.">
            <entity id="DS.d814.s0.e0" origId="P55245" charOffset="29-61" type="protein" text="epidermal growth factor receptor"/>
            <entity id="DS.d814.s0.e1" origId="P00533,P13387,P55245" charOffset="63-67" type="protein" text="EGFR"/>
            <entity id="DS.d814.s0.e2" origId="P16234,P20786,P26618,P26619,Q8AXC7,Q9DE49,Q9PUF6" charOffset="120-130" type="protein" text="PDGFRalpha"/>
            <entity id="DS.d814.s0.e3" origId="6035" charOffset="235-239" type="compound" text="BrdU"/>
            <pair e1="DS.d814.s0.e3" e2="DS.d814.s0.e2" id="DS.d814.s0.i0" interaction="False"/>
            <pair e1="DS.d814.s0.e3" e2="DS.d814.s0.e0" id="DS.d814.s0.i1" interaction="False"/>
            <pair e1="DS.d814.s0.e3" e2="DS.d814.s0.e1" id="DS.d814.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d814.s1" origId="18709646-695" text="Ependymal and displaced ependymal cells also expressed EGFR and PDGFRalpha on their cilia but did not incorporate BrdU.">
            <entity id="DS.d814.s1.e0" origId="P00533,P13387,P55245" charOffset="55-59" type="protein" text="EGFR"/>
            <entity id="DS.d814.s1.e1" origId="P16234,P20786,P26618,P26619,Q8AXC7,Q9DE49,Q9PUF6" charOffset="64-74" type="protein" text="PDGFRalpha"/>
            <entity id="DS.d814.s1.e2" origId="6035" charOffset="114-118" type="compound" text="BrdU"/>
            <pair e1="DS.d814.s1.e2" e2="DS.d814.s1.e1" id="DS.d814.s1.i0" interaction="False"/>
            <pair e1="DS.d814.s1.e2" e2="DS.d814.s1.e0" id="DS.d814.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d815" origId="18709647">
        <sentence id="DS.d815.s0" origId="18709647-968" text="Both 17alpha- and 17beta-estradiol elicited rapid phosphorylation of p42/44MAPK, Akt, and GSK-3beta within 8 min.">
            <entity id="DS.d815.s0.e0" origId="5757" charOffset="18-34" type="compound" text="17beta-estradiol"/>
            <entity id="DS.d815.s0.e1" origId="P46672,Q27272,Q8NFH3,Q9SB81" charOffset="69-72" type="protein" text="p42"/>
            <entity id="DS.d815.s0.e2" origId="P31750,Q8INB9" charOffset="81-84" type="protein" text="Akt"/>
            <entity id="DS.d815.s0.e3" origId="P18266,P49841,Q5YJC2,Q9WV60" charOffset="90-99" type="protein" text="GSK-3beta"/>
            <pair e1="DS.d815.s0.e0" e2="DS.d815.s0.e2" id="DS.d815.s0.i0" interaction="True"/>
            <pair e1="DS.d815.s0.e0" e2="DS.d815.s0.e3" id="DS.d815.s0.i1" interaction="True"/>
            <pair e1="DS.d815.s0.e0" e2="DS.d815.s0.e1" id="DS.d815.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d816" origId="18709649">
        <sentence id="DS.d816.s0" origId="18709649-718" text="Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of PBR expression may augment HE development.">
            <entity id="DS.d816.s0.e0" origId="32051" charOffset="8-11" type="compound" text="Zn2"/>
            <entity id="DS.d816.s0.e1" origId="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568" charOffset="39-54" type="protein" text="metallothionein"/>
            <entity id="DS.d816.s0.e2" origId="977" charOffset="134-140" type="compound" text="oxygen"/>
            <entity id="DS.d816.s0.e3" origId="945,948,25352,61526,160954,3609161" charOffset="145-159" type="compound" text="nitrogen oxide"/>
            <entity id="DS.d816.s0.e4" origId="P16257,P30535,P30536,P50637" charOffset="184-187" type="protein" text="PBR"/>
            <pair e1="DS.d816.s0.e3" e2="DS.d816.s0.e1" id="DS.d816.s0.i0" interaction="True"/>
            <pair e1="DS.d816.s0.e3" e2="DS.d816.s0.e4" id="DS.d816.s0.i1" interaction="False"/>
            <pair e1="DS.d816.s0.e0" e2="DS.d816.s0.e4" id="DS.d816.s0.i2" interaction="False"/>
            <pair e1="DS.d816.s0.e2" e2="DS.d816.s0.e1" id="DS.d816.s0.i3" interaction="True"/>
            <pair e1="DS.d816.s0.e2" e2="DS.d816.s0.e4" id="DS.d816.s0.i4" interaction="False"/>
            <pair e1="DS.d816.s0.e0" e2="DS.d816.s0.e1" id="DS.d816.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d817" origId="18709661">
        <sentence id="DS.d817.s0" origId="18709661-989" text="Accordingly, the TLR3 agonist poly(I:C) (PIC) induced higher release of IFN-beta in primary and purified astroglia than in microglia.">
            <entity id="DS.d817.s0.e0" origId="32744,213546,274740" charOffset="30-38" type="compound" text="poly(I:C"/>
            <entity id="DS.d817.s0.e1" origId="1854" charOffset="41-44" type="compound" text="PIC"/>
            <entity id="DS.d817.s0.e2" origId="O77812,P01574,P01575,P05012,P70499,Q6XZW6,Q9N2J0" charOffset="72-80" type="protein" text="IFN-beta"/>
            <pair e1="DS.d817.s0.e0" e2="DS.d817.s0.e2" id="DS.d817.s0.i0" interaction="True"/>
            <pair e1="DS.d817.s0.e1" e2="DS.d817.s0.e2" id="DS.d817.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d817.s1" origId="18709661-990" text="As siRNA, PIC induced IP-10, Stat1, VCAM-1, and Cox-2 and increased TLR3 mRNA expression.">
            <entity id="DS.d817.s1.e0" origId="1854" charOffset="10-13" type="compound" text="PIC"/>
            <entity id="DS.d817.s1.e1" origId="P02778,P17515,P48973" charOffset="22-27" type="protein" text="IP-10"/>
            <entity id="DS.d817.s1.e2" origId="P42225" charOffset="29-34" type="protein" text="Stat1"/>
            <entity id="DS.d817.s1.e3" origId="P19320,P29533,P29534,Q28260" charOffset="36-42" type="protein" text="VCAM-1"/>
            <entity id="DS.d817.s1.e4" origId="P00411,P24894,P35355,Q05769,Q8HEC3,Q8SEM9" charOffset="48-53" type="protein" text="Cox-2"/>
            <entity id="DS.d817.s1.e5" origId="O15455,Q0PV50,Q5TJ59" charOffset="68-72" type="protein" text="TLR3"/>
            <pair e1="DS.d817.s1.e0" e2="DS.d817.s1.e1" id="DS.d817.s1.i0" interaction="True"/>
            <pair e1="DS.d817.s1.e0" e2="DS.d817.s1.e3" id="DS.d817.s1.i1" interaction="True"/>
            <pair e1="DS.d817.s1.e0" e2="DS.d817.s1.e2" id="DS.d817.s1.i2" interaction="True"/>
            <pair e1="DS.d817.s1.e0" e2="DS.d817.s1.e5" id="DS.d817.s1.i3" interaction="True"/>
            <pair e1="DS.d817.s1.e0" e2="DS.d817.s1.e4" id="DS.d817.s1.i4" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d818" origId="18710402">
        <sentence id="DS.d818.s0" origId="18710402-1097" text="Intracellular concentrations of Ca(2+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/CD86 interactions in CD4 (+) T lymphocytes.">
            <entity id="DS.d818.s0.e0" origId="271" charOffset="32-36" type="compound" text="Ca(2"/>
            <entity id="DS.d818.s0.e1" origId="P31522,Q26721,Q56982" charOffset="120-129" type="protein" text="antigen-4"/>
            <entity id="DS.d818.s0.e2" origId="P16410" charOffset="131-136" type="protein" text="CD152"/>
            <entity id="DS.d818.s0.e3" origId="P33681,P42070" charOffset="138-142" type="protein" text="CD80"/>
            <entity id="DS.d818.s0.e4" origId="P42071,P42081" charOffset="143-147" type="protein" text="CD86"/>
            <pair e1="DS.d818.s0.e0" e2="DS.d818.s0.e3" id="DS.d818.s0.i0" interaction="True"/>
            <pair e1="DS.d818.s0.e0" e2="DS.d818.s0.e4" id="DS.d818.s0.i1" interaction="True"/>
            <pair e1="DS.d818.s0.e0" e2="DS.d818.s0.e1" id="DS.d818.s0.i2" interaction="True"/>
            <pair e1="DS.d818.s0.e0" e2="DS.d818.s0.e2" id="DS.d818.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d818.s1" origId="18710402-1099" text="During activation with PMA and low amounts of I, intracellular concentrations of calcium ((Ca(2+))(i)) were greatly reduced upon CTLA-4-CD80/CD86 blockade.">
            <entity id="DS.d818.s1.e0" origId="27924,122634,22833501" charOffset="23-26" type="compound" text="PMA"/>
            <entity id="DS.d818.s1.e1" origId="271" charOffset="91-95" type="compound" text="Ca(2"/>
            <entity id="DS.d818.s1.e2" origId="P09793,P16410,P42072,Q9MYX7,Q9XSI1" charOffset="129-135" type="protein" text="CTLA-4"/>
            <entity id="DS.d818.s1.e3" origId="P33681,P42070" charOffset="136-140" type="protein" text="CD80"/>
            <entity id="DS.d818.s1.e4" origId="P42071,P42081" charOffset="141-145" type="protein" text="CD86"/>
            <pair e1="DS.d818.s1.e0" e2="DS.d818.s1.e3" id="DS.d818.s1.i0" interaction="True"/>
            <pair e1="DS.d818.s1.e1" e2="DS.d818.s1.e4" id="DS.d818.s1.i1" interaction="True"/>
            <pair e1="DS.d818.s1.e0" e2="DS.d818.s1.e4" id="DS.d818.s1.i2" interaction="True"/>
            <pair e1="DS.d818.s1.e0" e2="DS.d818.s1.e2" id="DS.d818.s1.i3" interaction="True"/>
            <pair e1="DS.d818.s1.e1" e2="DS.d818.s1.e3" id="DS.d818.s1.i4" interaction="True"/>
            <pair e1="DS.d818.s1.e1" e2="DS.d818.s1.e2" id="DS.d818.s1.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d818.s2" origId="18710402-1100" text="Further experiments demonstrated that CTLA-4-CD80/CD86 interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).">
            <entity id="DS.d818.s2.e0" origId="P09793,P16410,P42072,Q9MYX7,Q9XSI1" charOffset="38-44" type="protein" text="CTLA-4"/>
            <entity id="DS.d818.s2.e1" origId="P33681,P42070" charOffset="45-49" type="protein" text="CD80"/>
            <entity id="DS.d818.s2.e2" origId="P42071,P42081" charOffset="50-54" type="protein" text="CD86"/>
            <entity id="DS.d818.s2.e3" origId="27924,122634,22833501" charOffset="110-113" type="compound" text="PMA"/>
            <entity id="DS.d818.s2.e4" origId="8885" charOffset="148-151" type="compound" text="SOS"/>
            <entity id="DS.d818.s2.e5" origId="27924,122634,22833501" charOffset="184-187" type="compound" text="PMA"/>
            <entity id="DS.d818.s2.e6" origId="8885" charOffset="220-223" type="compound" text="SOS"/>
            <pair e1="DS.d818.s2.e3" e2="DS.d818.s2.e1" id="DS.d818.s2.i0" interaction="True"/>
            <pair e1="DS.d818.s2.e4" e2="DS.d818.s2.e1" id="DS.d818.s2.i1" interaction="True"/>
            <pair e1="DS.d818.s2.e4" e2="DS.d818.s2.e0" id="DS.d818.s2.i2" interaction="True"/>
            <pair e1="DS.d818.s2.e3" e2="DS.d818.s2.e2" id="DS.d818.s2.i3" interaction="True"/>
            <pair e1="DS.d818.s2.e3" e2="DS.d818.s2.e0" id="DS.d818.s2.i4" interaction="True"/>
            <pair e1="DS.d818.s2.e4" e2="DS.d818.s2.e2" id="DS.d818.s2.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d819" origId="18710604">
        <sentence id="DS.d819.s0" origId="18710604-62" text="FSO decreased fasting glucose by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating insulin, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.">
            <entity id="DS.d819.s0.e0" origId="5288258" charOffset="0-3" type="compound" text="FSO"/>
            <entity id="DS.d819.s0.e1" origId="206,5793,64689,79025" charOffset="22-29" type="compound" text="glucose"/>
            <entity id="DS.d819.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="128-135" type="protein" text="insulin"/>
            <pair e1="DS.d819.s0.e0" e2="DS.d819.s0.e2" id="DS.d819.s0.i0" interaction="True"/>
            <pair e1="DS.d819.s0.e1" e2="DS.d819.s0.e2" id="DS.d819.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d820" origId="18710606">
        <sentence id="DS.d820.s0" origId="18710606-240" text="Animal evidence indicates that green tea may modulate insulin sensitivity, with epigallocatechin-3-gallate (EGCG) proposed as a likely health-promoting component.">
            <entity id="DS.d820.s0.e0" origId="4630" charOffset="31-40" type="compound" text="green tea"/>
            <entity id="DS.d820.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="54-61" type="protein" text="insulin"/>
            <entity id="DS.d820.s0.e2" origId="65064" charOffset="80-106" type="compound" text="epigallocatechin-3-gallate"/>
            <entity id="DS.d820.s0.e3" origId="65064" charOffset="108-112" type="compound" text="EGCG"/>
            <pair e1="DS.d820.s0.e3" e2="DS.d820.s0.e1" id="DS.d820.s0.i0" interaction="False"/>
            <pair e1="DS.d820.s0.e2" e2="DS.d820.s0.e1" id="DS.d820.s0.i1" interaction="False"/>
            <pair e1="DS.d820.s0.e0" e2="DS.d820.s0.e1" id="DS.d820.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d820.s1" origId="18710606-241" text="The purpose of this study was to investigate the effect of dietary supplementation with EGCG on insulin resistance and associated metabolic risk factors in man.">
            <entity id="DS.d820.s1.e0" origId="65064" charOffset="88-92" type="compound" text="EGCG"/>
            <entity id="DS.d820.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="96-103" type="protein" text="insulin"/>
            <pair e1="DS.d820.s1.e0" e2="DS.d820.s1.e1" id="DS.d820.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d820.s2" origId="18710606-242" text="EGCG treatment had no effect on insulin sensitivity, insulin secretion or glucose tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).">
            <entity id="DS.d820.s2.e0" origId="65064" charOffset="0-4" type="compound" text="EGCG"/>
            <entity id="DS.d820.s2.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="32-39" type="protein" text="insulin"/>
            <entity id="DS.d820.s2.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="53-60" type="protein" text="insulin"/>
            <entity id="DS.d820.s2.e3" origId="206,5793,64689,79025" charOffset="74-81" type="compound" text="glucose"/>
            <entity id="DS.d820.s2.e4" origId="65064" charOffset="176-180" type="compound" text="EGCG"/>
            <pair e1="DS.d820.s2.e0" e2="DS.d820.s2.e1" id="DS.d820.s2.i0" interaction="False"/>
            <pair e1="DS.d820.s2.e3" e2="DS.d820.s2.e1" id="DS.d820.s2.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d820.s3" origId="18710606-243" text="In conclusion, regular intake of EGCG had no effect on insulin resistance but did result in a modest reduction in diastolic blood pressure.">
            <entity id="DS.d820.s3.e0" origId="65064" charOffset="33-37" type="compound" text="EGCG"/>
            <entity id="DS.d820.s3.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="55-62" type="protein" text="insulin"/>
            <pair e1="DS.d820.s3.e0" e2="DS.d820.s3.e1" id="DS.d820.s3.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d821" origId="18710702">
        <sentence id="DS.d821.s0" origId="18710702-125" text="We found that postovulatory administration of 1.5 mg of levonorgestrel to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of estrogen receptors (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), androgen receptor (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.">
            <entity id="DS.d821.s0.e0" origId="13109" charOffset="56-70" type="compound" text="levonorgestrel"/>
            <entity id="DS.d821.s0.e1" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="180-198" type="protein" text="estrogen receptors"/>
            <entity id="DS.d821.s0.e2" origId="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90" charOffset="254-271" type="protein" text="androgen receptor"/>
            <pair e1="DS.d821.s0.e0" e2="DS.d821.s0.e1" id="DS.d821.s0.i0" interaction="False"/>
            <pair e1="DS.d821.s0.e0" e2="DS.d821.s0.e2" id="DS.d821.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d822" origId="18710819">
        <sentence id="DS.d822.s0" origId="18710819-1300" text="5-FU effect on HS cell viability was markedly reduced in hypoxic condition without an induction of chemoresistant related protein, P-glycoprotein.">
            <entity id="DS.d822.s0.e0" origId="3385" charOffset="0-4" type="compound" text="5-FU"/>
            <entity id="DS.d822.s0.e1" origId="P08163" charOffset="133-145" type="protein" text="glycoprotein"/>
            <pair e1="DS.d822.s0.e0" e2="DS.d822.s0.e1" id="DS.d822.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d823" origId="18710908">
        <sentence id="DS.d823.s0" origId="18710908-298" text="High-level toxin production occurred after detectable spore germination in all experiments except those with C. difficile PCR ribotype 027 and moxifloxacin, in which marked cytotoxin production preceded detectable germination, which coincided with isolate recovery on fluoroquinolone-containing medium.">
            <entity id="DS.d823.s0.e0" origId="152946" charOffset="143-155" type="compound" text="moxifloxacin"/>
            <entity id="DS.d823.s0.e1" origId="P07845,P81662" charOffset="173-182" type="protein" text="cytotoxin"/>
            <pair e1="DS.d823.s0.e0" e2="DS.d823.s0.e1" id="DS.d823.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d824" origId="18711728">
        <sentence id="DS.d824.s0" origId="18711728-143" text="Furthermore, Ngb overexpression reduced superoxide anion generation after H/R, whereas glutathione levels were significantly improved compared with WT controls.">
            <entity id="DS.d824.s0.e0" origId="Q90YJ2,Q99JA8,Q9ER97" charOffset="13-16" type="protein" text="Ngb"/>
            <entity id="DS.d824.s0.e1" origId="5359597" charOffset="40-50" type="compound" text="superoxide"/>
            <entity id="DS.d824.s0.e2" origId="124886" charOffset="87-98" type="compound" text="glutathione"/>
            <pair e1="DS.d824.s0.e1" e2="DS.d824.s0.e0" id="DS.d824.s0.i0" interaction="True"/>
            <pair e1="DS.d824.s0.e2" e2="DS.d824.s0.e0" id="DS.d824.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d825" origId="18711746">
        <sentence id="DS.d825.s0" origId="18711746-961" text="Our previous studies have shown that serotonin (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after insulin administration.">
            <entity id="DS.d825.s0.e0" origId="5202" charOffset="37-46" type="compound" text="serotonin"/>
            <entity id="DS.d825.s0.e1" origId="5202" charOffset="48-52" type="compound" text="5-HT"/>
            <entity id="DS.d825.s0.e2" origId="P13678,Q25378" charOffset="121-137" type="protein" text="protein kinase C"/>
            <entity id="DS.d825.s0.e3" origId="P04409,P05696,P10102,P17252,P20444" charOffset="145-154" type="protein" text="PKC-alpha"/>
            <entity id="DS.d825.s0.e4" origId="Q00168" charOffset="160-166" type="protein" text="CaMKII"/>
            <entity id="DS.d825.s0.e5" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="210-217" type="protein" text="insulin"/>
            <pair e1="DS.d825.s0.e0" e2="DS.d825.s0.e3" id="DS.d825.s0.i0" interaction="True"/>
            <pair e1="DS.d825.s0.e0" e2="DS.d825.s0.e5" id="DS.d825.s0.i1" interaction="True"/>
            <pair e1="DS.d825.s0.e1" e2="DS.d825.s0.e3" id="DS.d825.s0.i2" interaction="True"/>
            <pair e1="DS.d825.s0.e1" e2="DS.d825.s0.e4" id="DS.d825.s0.i3" interaction="True"/>
            <pair e1="DS.d825.s0.e1" e2="DS.d825.s0.e2" id="DS.d825.s0.i4" interaction="True"/>
            <pair e1="DS.d825.s0.e1" e2="DS.d825.s0.e5" id="DS.d825.s0.i5" interaction="True"/>
            <pair e1="DS.d825.s0.e0" e2="DS.d825.s0.e2" id="DS.d825.s0.i6" interaction="True"/>
            <pair e1="DS.d825.s0.e0" e2="DS.d825.s0.e4" id="DS.d825.s0.i7" interaction="True"/>
        </sentence>
        <sentence id="DS.d825.s1" origId="18711746-962" text="The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.">
            <entity id="DS.d825.s1.e0" origId="5781" charOffset="30-37" type="compound" text="alloxan"/>
            <entity id="DS.d825.s1.e1" origId="5202" charOffset="140-144" type="compound" text="5-HT"/>
            <entity id="DS.d825.s1.e2" origId="P04409,P05696,P10102,P17252,P20444" charOffset="146-155" type="protein" text="PKC-alpha"/>
            <entity id="DS.d825.s1.e3" origId="P05130,P13677,P13678,P34722" charOffset="146-149" type="protein" text="PKC"/>
            <entity id="DS.d825.s1.e4" origId="P52430,P55159" charOffset="229-233" type="protein" text="pons"/>
            <pair e1="DS.d825.s1.e1" e2="DS.d825.s1.e2" id="DS.d825.s1.i0" interaction="False"/>
            <pair e1="DS.d825.s1.e0" e2="DS.d825.s1.e4" id="DS.d825.s1.i1" interaction="False"/>
            <pair e1="DS.d825.s1.e1" e2="DS.d825.s1.e3" id="DS.d825.s1.i2" interaction="False"/>
            <pair e1="DS.d825.s1.e1" e2="DS.d825.s1.e4" id="DS.d825.s1.i3" interaction="False"/>
            <pair e1="DS.d825.s1.e0" e2="DS.d825.s1.e2" id="DS.d825.s1.i4" interaction="True"/>
            <pair e1="DS.d825.s1.e0" e2="DS.d825.s1.e3" id="DS.d825.s1.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d825.s2" origId="18711746-963" text="Although the 5-HT levels in hippocampus (HC) and hypothalamus (HT) were not altered, the PKC-alpha expression and PKC 0.05) in level in HC.">
            <entity id="DS.d825.s2.e0" origId="5202" charOffset="13-17" type="compound" text="5-HT"/>
            <entity id="DS.d825.s2.e1" origId="P04409,P05696,P10102,P17252,P20444" charOffset="89-98" type="protein" text="PKC-alpha"/>
            <entity id="DS.d825.s2.e2" origId="P05130,P13677,P13678,P34722" charOffset="89-92" type="protein" text="PKC"/>
            <pair e1="DS.d825.s2.e0" e2="DS.d825.s2.e1" id="DS.d825.s2.i0" interaction="False"/>
            <pair e1="DS.d825.s2.e0" e2="DS.d825.s2.e2" id="DS.d825.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d826" origId="18711749">
        <sentence id="DS.d826.s0" origId="18711749-1020" text="We tested the hypothesis that a nitric oxide donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.">
            <entity id="DS.d826.s0.e0" origId="145068" charOffset="32-44" type="compound" text="nitric oxide"/>
            <entity id="DS.d826.s0.e1" origId="1606" charOffset="52-64" type="compound" text="DETA-NONOate"/>
            <entity id="DS.d826.s0.e2" origId="O62657,P48061" charOffset="110-114" type="protein" text="SDF1"/>
            <entity id="DS.d826.s0.e3" origId="P21570" charOffset="136-140" type="protein" text="Ang1"/>
            <entity id="DS.d826.s0.e4" origId="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8" charOffset="227-232" type="protein" text="CXCR4"/>
            <entity id="DS.d826.s0.e5" origId="O73791,Q02858" charOffset="238-242" type="protein" text="Tie2"/>
            <pair e1="DS.d826.s0.e1" e2="DS.d826.s0.e4" id="DS.d826.s0.i0" interaction="True"/>
            <pair e1="DS.d826.s0.e1" e2="DS.d826.s0.e2" id="DS.d826.s0.i1" interaction="True"/>
            <pair e1="DS.d826.s0.e0" e2="DS.d826.s0.e5" id="DS.d826.s0.i2" interaction="True"/>
            <pair e1="DS.d826.s0.e0" e2="DS.d826.s0.e2" id="DS.d826.s0.i3" interaction="True"/>
            <pair e1="DS.d826.s0.e0" e2="DS.d826.s0.e3" id="DS.d826.s0.i4" interaction="True"/>
            <pair e1="DS.d826.s0.e1" e2="DS.d826.s0.e5" id="DS.d826.s0.i5" interaction="True"/>
            <pair e1="DS.d826.s0.e1" e2="DS.d826.s0.e3" id="DS.d826.s0.i6" interaction="True"/>
            <pair e1="DS.d826.s0.e0" e2="DS.d826.s0.e4" id="DS.d826.s0.i7" interaction="True"/>
        </sentence>
        <sentence id="DS.d826.s1" origId="18711749-1021" text="To elucidate whether SDF1/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.">
            <entity id="DS.d826.s1.e0" origId="O62657,P48061" charOffset="21-25" type="protein" text="SDF1"/>
            <entity id="DS.d826.s1.e1" origId="1606" charOffset="63-75" type="compound" text="DETA-NONOate"/>
            <entity id="DS.d826.s1.e2" origId="52944803" charOffset="128-138" type="compound" text="peptide, a"/>
            <entity id="DS.d826.s1.e3" origId="65015" charOffset="169-176" type="compound" text="AMD3100"/>
            <pair e1="DS.d826.s1.e3" e2="DS.d826.s1.e0" id="DS.d826.s1.i0" interaction="True"/>
            <pair e1="DS.d826.s1.e1" e2="DS.d826.s1.e0" id="DS.d826.s1.i1" interaction="True"/>
            <pair e1="DS.d826.s1.e2" e2="DS.d826.s1.e0" id="DS.d826.s1.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d826.s2" origId="18711749-1023" text="DETA-NONOate significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.">
            <entity id="DS.d826.s2.e0" origId="1606" charOffset="0-12" type="compound" text="DETA-NONOate"/>
            <entity id="DS.d826.s2.e1" origId="O62657,P48061" charOffset="55-59" type="protein" text="SDF1"/>
            <entity id="DS.d826.s2.e2" origId="P21570" charOffset="64-68" type="protein" text="Ang1"/>
            <entity id="DS.d826.s2.e3" origId="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8" charOffset="109-114" type="protein" text="CXCR4"/>
            <entity id="DS.d826.s2.e4" origId="O73791,Q02858" charOffset="119-123" type="protein" text="Tie2"/>
            <pair e1="DS.d826.s2.e0" e2="DS.d826.s2.e3" id="DS.d826.s2.i0" interaction="True"/>
            <pair e1="DS.d826.s2.e0" e2="DS.d826.s2.e4" id="DS.d826.s2.i1" interaction="True"/>
            <pair e1="DS.d826.s2.e0" e2="DS.d826.s2.e1" id="DS.d826.s2.i2" interaction="True"/>
            <pair e1="DS.d826.s2.e0" e2="DS.d826.s2.e2" id="DS.d826.s2.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d826.s3" origId="18711749-1025" text="Our data indicate that treatment of stroke with a nitric oxide donor up-regulates SDF1/CXCR4 and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.">
            <entity id="DS.d826.s3.e0" origId="145068" charOffset="50-62" type="compound" text="nitric oxide"/>
            <entity id="DS.d826.s3.e1" origId="O62657,P48061" charOffset="82-86" type="protein" text="SDF1"/>
            <entity id="DS.d826.s3.e2" origId="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8" charOffset="87-92" type="protein" text="CXCR4"/>
            <entity id="DS.d826.s3.e3" origId="P21570" charOffset="97-101" type="protein" text="Ang1"/>
            <entity id="DS.d826.s3.e4" origId="O73791,Q02858" charOffset="102-106" type="protein" text="Tie2"/>
            <pair e1="DS.d826.s3.e0" e2="DS.d826.s3.e4" id="DS.d826.s3.i0" interaction="True"/>
            <pair e1="DS.d826.s3.e0" e2="DS.d826.s3.e3" id="DS.d826.s3.i1" interaction="True"/>
            <pair e1="DS.d826.s3.e0" e2="DS.d826.s3.e1" id="DS.d826.s3.i2" interaction="True"/>
            <pair e1="DS.d826.s3.e0" e2="DS.d826.s3.e2" id="DS.d826.s3.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d827" origId="18711750">
        <sentence id="DS.d827.s0" origId="18711750-1026" text="The MEK inhibitor PD98059 did not inhibit neurite outgrowth, and Y-27632 and staurosporine did not induce ERK phosphorylation, suggesting that the inhibitory effect of ODQ on neurite outgrowth is independent of the ERK signaling pathway.">
            <entity id="DS.d827.s0.e0" origId="4713" charOffset="18-25" type="compound" text="PD98059"/>
            <entity id="DS.d827.s0.e1" origId="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148" charOffset="77-90" type="compound" text="staurosporine"/>
            <entity id="DS.d827.s0.e2" origId="P29323" charOffset="106-109" type="protein" text="ERK"/>
            <entity id="DS.d827.s0.e3" origId="1456" charOffset="168-171" type="compound" text="ODQ"/>
            <entity id="DS.d827.s0.e4" origId="P29323" charOffset="215-218" type="protein" text="ERK"/>
            <pair e1="DS.d827.s0.e0" e2="DS.d827.s0.e2" id="DS.d827.s0.i0" interaction="False"/>
            <pair e1="DS.d827.s0.e3" e2="DS.d827.s0.e2" id="DS.d827.s0.i1" interaction="False"/>
            <pair e1="DS.d827.s0.e1" e2="DS.d827.s0.e2" id="DS.d827.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d828" origId="18712272">
        <sentence id="DS.d828.s0" origId="18712272-1403" text="We used this model to identify a potent competitive inhibitor, N1,N7-dihexyl-1,7-diamino-4-azaheptane, and to develop an affinity column, 1,16-diamino4,13-diazahexadecane-linked Sepharose, which was useful for the purification of PAO.">
            <entity id="DS.d828.s0.e0" origId="11966311" charOffset="178-187" type="compound" text="Sepharose"/>
            <entity id="DS.d828.s0.e1" origId="O64411,Q6QHF9,Q865R1,Q9FYC2" charOffset="230-233" type="protein" text="PAO"/>
            <pair e1="DS.d828.s0.e0" e2="DS.d828.s0.e1" id="DS.d828.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d829" origId="18712288">
        <sentence id="DS.d829.s0" origId="18712288-246" text="Rapid determination of L-glutamine using engineered Escherichia coli overexpressing glutamine synthetase.">
            <entity id="DS.d829.s0.e0" origId="5961,145815" charOffset="23-34" type="compound" text="L-glutamine"/>
            <entity id="DS.d829.s0.e1" origId="O00088,O04867,O08467,O27612,O29313,O58097,O59648,O66514,P00964,P04773,P07804,P09606,P0A039,P0A040,P0A1P6,P0A1P7,P0A9C5,P0A9C6,P0A9C7,P0A9C8,P10583,P10656,P11600,P12424,P12425,P13499,P15103,P15104,P15105,P15106,P15124,P15623,P16580,P19064,P19904,P20479,P21154,P22248,P23712,P23794,P25821,P28605,P28786,P32288,P33035,P36205,P43386,P43518,P43794,P45627,P46410,P51120,P51121,P60890,P77961,P94126,P94845,P99095,Q04831,Q05650,Q05907,Q06378,Q09179,Q12613,Q4R7U3,Q5HGC3,Q5HPN2,Q60182,Q6B4U7,Q6C3E0,Q6FMT6,Q6G9Q4,Q6GHC6,Q75BT9,Q86ZF9,Q86ZU6,Q874T6,Q8CSR8,Q8HZM5,Q8J1R3,Q8X169,Q96UG9,Q96UV5,Q96V52,Q9C2U9,Q9CDL9,Q9CLP2,Q9HH09,Q9HNI2,Q9HU65,Q9KNJ2,Q9QY94,Q9UUN6,Q9UY99,Q9ZLW5" charOffset="84-104" type="protein" text="glutamine synthetase"/>
            <pair e1="DS.d829.s0.e0" e2="DS.d829.s0.e1" id="DS.d829.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d830" origId="18712290">
        <sentence id="DS.d830.s0" origId="18712290-619" text="Purification, characterization, and preliminary X-ray diffraction analysis of a lactose-specific lectin from Cymbosema roseum seeds.">
            <entity id="DS.d830.s0.e0" origId="294,6134,84571,440995" charOffset="80-87" type="compound" text="lactose"/>
            <entity id="DS.d830.s0.e1" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="97-103" type="protein" text="lectin"/>
            <pair e1="DS.d830.s0.e0" e2="DS.d830.s0.e1" id="DS.d830.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d830.s1" origId="18712290-620" text="Here, we report the purification, partial primary structure, carbohydrate affinity characterization, crystallization, and preliminary X-ray diffraction analysis of a lactose-specific lectin from Cymbosema roseum seeds (CRLII).">
            <entity id="DS.d830.s1.e0" origId="294,6134,84571,440995" charOffset="166-173" type="compound" text="lactose"/>
            <entity id="DS.d830.s1.e1" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="183-189" type="protein" text="lectin"/>
            <pair e1="DS.d830.s1.e0" e2="DS.d830.s1.e1" id="DS.d830.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d831" origId="18712361">
        <sentence id="DS.d831.s0" origId="18712361-637" text="Effects on haemolytic activity of single proline substitutions in the Bordetella pertussis CyaA pore-forming fragment.">
            <entity id="DS.d831.s0.e0" origId="614,8988,145742" charOffset="41-48" type="compound" text="proline"/>
            <entity id="DS.d831.s0.e1" origId="P00936,P0A1A7,P0A1A8,P15318,P19485,P40127,P40134,P40137,P59739,P98009,Q57506,Q8FBP0,Q8XAP1,Q9WXC3" charOffset="91-95" type="protein" text="CyaA"/>
            <pair e1="DS.d831.s0.e0" e2="DS.d831.s0.e1" id="DS.d831.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d832" origId="18712381">
        <sentence id="DS.d832.s0" origId="18712381-639" text="Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.">
            <entity id="DS.d832.s0.e0" origId="3053" charOffset="41-45" type="compound" text="DTPA"/>
            <entity id="DS.d832.s0.e1" origId="P04626" charOffset="59-63" type="protein" text="HER2"/>
            <pair e1="DS.d832.s0.e0" e2="DS.d832.s0.e1" id="DS.d832.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d832.s1" origId="18712381-640" text="The purpose of the study was to investigate the associations between uptake of (111)In-DTPA-trastuzumab, tumour HER2 density and response to trastuzumab (Herceptin) of human breast cancer (BC) xenografts in athymic mice.">
            <entity id="DS.d832.s1.e0" origId="3053" charOffset="87-91" type="compound" text="DTPA"/>
            <entity id="DS.d832.s1.e1" origId="P04626" charOffset="112-116" type="protein" text="HER2"/>
            <pair e1="DS.d832.s1.e0" e2="DS.d832.s1.e1" id="DS.d832.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d833" origId="18712598">
        <sentence id="DS.d833.s0" origId="18712598-674" text="The adenosine (the final product of ATP hydrolysis by ectonucleotidases), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions.">
            <entity id="DS.d833.s0.e0" origId="60961" charOffset="4-13" type="compound" text="adenosine"/>
            <entity id="DS.d833.s0.e1" origId="P29240" charOffset="54-71" type="protein" text="ectonucleotidases"/>
            <pair e1="DS.d833.s0.e0" e2="DS.d833.s0.e1" id="DS.d833.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d834" origId="18712838">
        <sentence id="DS.d834.s0" origId="18712838-744" text="To this end, the cultured fibroblasts were analyzed for very long chain fatty acid (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, dihydroxyacetone-phosphate acyltransferase (DHAPAT) activity, peroxisomal thiolase, and catalase immunofluorescence.">
            <entity id="DS.d834.s0.e0" origId="284" charOffset="61-82" type="compound" text="long chain fatty acid"/>
            <entity id="DS.d834.s0.e1" origId="O15228,P98192,Q9ES71" charOffset="146-188" type="protein" text="dihydroxyacetone-phosphate acyltransferase"/>
            <entity id="DS.d834.s0.e2" origId="O15228" charOffset="190-196" type="protein" text="DHAPAT"/>
            <entity id="DS.d834.s0.e3" origId="Q6L8K7" charOffset="220-228" type="protein" text="thiolase"/>
            <entity id="DS.d834.s0.e4" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="234-242" type="protein" text="catalase"/>
            <pair e1="DS.d834.s0.e0" e2="DS.d834.s0.e1" id="DS.d834.s0.i0" interaction="False"/>
            <pair e1="DS.d834.s0.e0" e2="DS.d834.s0.e4" id="DS.d834.s0.i1" interaction="False"/>
            <pair e1="DS.d834.s0.e0" e2="DS.d834.s0.e2" id="DS.d834.s0.i2" interaction="False"/>
            <pair e1="DS.d834.s0.e0" e2="DS.d834.s0.e3" id="DS.d834.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d835" origId="18713274">
        <sentence id="DS.d835.s0" origId="18713274-881" text="Also, iNOS induction and concomitant nitric oxide generation appear to participate in the cytotoxicity of excessive portal pressure after extended hepatectomy.">
            <entity id="DS.d835.s0.e0" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="6-10" type="protein" text="iNOS"/>
            <entity id="DS.d835.s0.e1" origId="145068" charOffset="37-49" type="compound" text="nitric oxide"/>
            <pair e1="DS.d835.s0.e1" e2="DS.d835.s0.e0" id="DS.d835.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d836" origId="18713277">
        <sentence id="DS.d836.s0" origId="18713277-882" text="Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.">
            <entity id="DS.d836.s0.e0" origId="O50258" charOffset="0-20" type="protein" text="Superoxide dismutase"/>
            <entity id="DS.d836.s0.e1" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="22-25" type="protein" text="SOD"/>
            <entity id="DS.d836.s0.e2" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="28-50" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d836.s0.e3" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="61-69" type="protein" text="catalase"/>
            <entity id="DS.d836.s0.e4" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="71-74" type="protein" text="CAT"/>
            <entity id="DS.d836.s0.e5" origId="10964" charOffset="130-145" type="compound" text="malondialdehyde"/>
            <entity id="DS.d836.s0.e6" origId="304,5997,6432564,11025495" charOffset="153-164" type="compound" text="cholesterol"/>
            <entity id="DS.d836.s0.e7" origId="304,5997,6432564,11025495" charOffset="220-231" type="compound" text="cholesterol"/>
            <pair e1="DS.d836.s0.e6" e2="DS.d836.s0.e2" id="DS.d836.s0.i0" interaction="False"/>
            <pair e1="DS.d836.s0.e6" e2="DS.d836.s0.e3" id="DS.d836.s0.i1" interaction="False"/>
            <pair e1="DS.d836.s0.e6" e2="DS.d836.s0.e4" id="DS.d836.s0.i2" interaction="False"/>
            <pair e1="DS.d836.s0.e5" e2="DS.d836.s0.e1" id="DS.d836.s0.i3" interaction="False"/>
            <pair e1="DS.d836.s0.e5" e2="DS.d836.s0.e2" id="DS.d836.s0.i4" interaction="False"/>
            <pair e1="DS.d836.s0.e6" e2="DS.d836.s0.e0" id="DS.d836.s0.i5" interaction="False"/>
            <pair e1="DS.d836.s0.e5" e2="DS.d836.s0.e4" id="DS.d836.s0.i6" interaction="False"/>
            <pair e1="DS.d836.s0.e5" e2="DS.d836.s0.e0" id="DS.d836.s0.i7" interaction="False"/>
            <pair e1="DS.d836.s0.e6" e2="DS.d836.s0.e1" id="DS.d836.s0.i8" interaction="False"/>
            <pair e1="DS.d836.s0.e5" e2="DS.d836.s0.e3" id="DS.d836.s0.i9" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d837" origId="18714161">
        <sentence id="DS.d837.s0" origId="18714161-1109" text="Inhibition of apoptotic signaling and neointimal hyperplasia by tempol and nitric oxide synthase following vascular injury.">
            <entity id="DS.d837.s0.e0" origId="137994" charOffset="64-70" type="compound" text="tempol"/>
            <entity id="DS.d837.s0.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="75-96" type="protein" text="nitric oxide synthase"/>
            <pair e1="DS.d837.s0.e0" e2="DS.d837.s0.e1" id="DS.d837.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d838" origId="18715145">
        <sentence id="DS.d838.s0" origId="18715145-1378" text="Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of HMGB1-mediated reactive oxygen species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.">
            <entity id="DS.d838.s0.e0" origId="P14904" charOffset="37-41" type="protein" text="APE1"/>
            <entity id="DS.d838.s0.e1" origId="P07156,P09429,P10103,P12682,P36194,Q4R844,Q6YKA4" charOffset="84-89" type="protein" text="HMGB1"/>
            <entity id="DS.d838.s0.e2" origId="977" charOffset="108-114" type="compound" text="oxygen"/>
            <entity id="DS.d838.s0.e3" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="159-175" type="protein" text="cyclooxygenase-2"/>
            <pair e1="DS.d838.s0.e2" e2="DS.d838.s0.e3" id="DS.d838.s0.i0" interaction="False"/>
            <pair e1="DS.d838.s0.e2" e2="DS.d838.s0.e0" id="DS.d838.s0.i1" interaction="True"/>
            <pair e1="DS.d838.s0.e2" e2="DS.d838.s0.e1" id="DS.d838.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d839" origId="18715148">
        <sentence id="DS.d839.s0" origId="18715148-1380" text="NO, a gas, is produced from L-arginine by different isoforms of nitric oxide synthase (NOS) and serves many normal physiologic purposes, such as promoting vasodilation of blood vessels and mediating communication between nervous system cells.">
            <entity id="DS.d839.s0.e0" origId="232,4367,6322" charOffset="30-38" type="compound" text="arginine"/>
            <entity id="DS.d839.s0.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="64-85" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d839.s0.e2" origId="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2" charOffset="87-90" type="protein" text="NOS"/>
            <pair e1="DS.d839.s0.e0" e2="DS.d839.s0.e1" id="DS.d839.s0.i0" interaction="True"/>
            <pair e1="DS.d839.s0.e0" e2="DS.d839.s0.e2" id="DS.d839.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d840" origId="18715149">
        <sentence id="DS.d840.s0" origId="18715149-1381" text="As one of the very few repair systems for oxidized proteins, MsrA and MsrB enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive oxygen species.">
            <entity id="DS.d840.s0.e0" origId="O25011,O26635,O69761,O83641,P0A081,P0A082,P0A083,P0A084,P0A085,P0A086,P0A3Q9,P0A3R0,P0A5L0,P0A5L1,P0A744,P0A745,P23212,P47648,P54154,P65443,P65444,P75188,Q4J9L3,Q53W34,Q576P8,Q5HG58,Q5HVD4,Q5PJ81,Q5XDH1,Q66F89,Q6D151,Q6L2S4,Q6LV65,Q6LYY1,Q6NEL2,Q71YF6,Q746G0,Q7MYW1,Q87D27,Q87SW6,Q88AI5,Q88QZ8,Q899M3,Q8DE84,Q8DSY4,Q8DYH1,Q8E434,Q8FAG4,Q8FLU6,Q8FUZ0,Q8NLL5,Q8P272,Q8PCA6,Q8PNY8,Q8PUD6,Q8TQV6,Q8VS50,Q8XCG3,Q8XH97,Q8Y1C6,Q8Y640,Q8YDE7,Q8Z150,Q8ZB94,Q8ZK71,Q92AE8,Q93KF3,Q93S39,Q97MV3,Q97Y45,Q98PE5,Q99YT1,Q9A149,Q9AJF7,Q9APY4,Q9CCZ3,Q9CN40,Q9EWF7,Q9HQG0,Q9HUF1,Q9KAN8,Q9KP30,Q9LAM9,Q9PC45,Q9PQK2,Q9RTB6,Q9ZEQ8,Q9ZMK8" charOffset="61-65" type="protein" text="MsrA"/>
            <entity id="DS.d840.s0.e1" origId="O26807,P0A087,P0A088,P0A746,P0A747,P0A748,P47686,P54155,P65447,P65448,P65449,P65450,P65451,P75129,P99065,Q49XN4,Q4L6D3,Q5HPB4,Q5WH73,Q5XCD0,Q66AP6,Q6D4P7,Q6G9D8,Q6GGY4,Q71YF7,Q72NN2,Q7MMC4,Q83L66,Q87AJ9,Q87MS5,Q885Q1,Q88LQ6,Q88W33,Q89EM9,Q8CSK6,Q8D849,Q8DJK9,Q8E026,Q8E5Q9,Q8F7W8,Q8K7M6,Q8P172,Q8UGX7,Q8XJZ6,Q8XYL1,Q8Y641,Q8ZEK7,Q92AE9,Q97IU0,Q99ZV6,Q9A6B1,Q9CJ17,Q9CMB1,Q9I016,Q9KCX2,Q9KQK0,Q9PF29,Q9RUK6,Q9XB39,Q9ZNJ9" charOffset="70-74" type="protein" text="MsrB"/>
            <entity id="DS.d840.s0.e2" origId="977" charOffset="235-241" type="compound" text="oxygen"/>
            <pair e1="DS.d840.s0.e2" e2="DS.d840.s0.e0" id="DS.d840.s0.i0" interaction="True"/>
            <pair e1="DS.d840.s0.e2" e2="DS.d840.s0.e1" id="DS.d840.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d841" origId="18715284">
        <sentence id="DS.d841.s0" origId="18715284-1402" text="High density lipoprotein-cholesterol levels increase with age in American women but not in Hong Kong Chinese women.">
            <entity id="DS.d841.s0.e0" origId="P81182" charOffset="0-24" type="protein" text="High density lipoprotein"/>
            <entity id="DS.d841.s0.e1" origId="304,5997,6432564,11025495" charOffset="25-36" type="compound" text="cholesterol"/>
            <pair e1="DS.d841.s0.e1" e2="DS.d841.s0.e0" id="DS.d841.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d841.s1" origId="18715284-1403" text="High-density lipoprotein (HDL) cholesterol is a powerful cardiovascular risk factor.">
            <entity id="DS.d841.s1.e0" origId="P81182" charOffset="0-24" type="protein" text="High-density lipoprotein"/>
            <entity id="DS.d841.s1.e1" origId="304,5997,6432564,11025495" charOffset="31-42" type="compound" text="cholesterol"/>
            <pair e1="DS.d841.s1.e1" e2="DS.d841.s1.e0" id="DS.d841.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d842" origId="18715643">
        <sentence id="DS.d842.s0" origId="18715643-1517" text="Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of superoxide dismutase, catalase, reduced glutathione content, glutathione reductase and succinate dehydrogenase activities.">
            <entity id="DS.d842.s0.e0" origId="O60109,P81800,P83456" charOffset="209-230" type="protein" text="alkaline phosphatases"/>
            <entity id="DS.d842.s0.e1" origId="O50258" charOffset="275-295" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d842.s0.e2" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="297-305" type="protein" text="catalase"/>
            <entity id="DS.d842.s0.e3" origId="124886" charOffset="307-326" type="compound" text="reduced glutathione"/>
            <entity id="DS.d842.s0.e4" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="336-357" type="protein" text="glutathione reductase"/>
            <pair e1="DS.d842.s0.e3" e2="DS.d842.s0.e1" id="DS.d842.s0.i0" interaction="False"/>
            <pair e1="DS.d842.s0.e3" e2="DS.d842.s0.e0" id="DS.d842.s0.i1" interaction="False"/>
            <pair e1="DS.d842.s0.e3" e2="DS.d842.s0.e2" id="DS.d842.s0.i2" interaction="False"/>
            <pair e1="DS.d842.s0.e3" e2="DS.d842.s0.e4" id="DS.d842.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d842.s1" origId="18715643-1518" text="Hepatoprotective potential of vitamin C was indicated by its ability to restore GSH, SOD, CAT, AcP, AlkP and GRD levels towards near normal.">
            <entity id="DS.d842.s1.e0" origId="124886" charOffset="80-83" type="compound" text="GSH"/>
            <entity id="DS.d842.s1.e1" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="85-88" type="protein" text="SOD"/>
            <entity id="DS.d842.s1.e2" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="90-93" type="protein" text="CAT"/>
            <entity id="DS.d842.s1.e3" origId="P56544" charOffset="95-98" type="protein" text="AcP"/>
            <entity id="DS.d842.s1.e4" origId="Q24352" charOffset="109-112" type="protein" text="GRD"/>
            <pair e1="DS.d842.s1.e0" e2="DS.d842.s1.e2" id="DS.d842.s1.i0" interaction="False"/>
            <pair e1="DS.d842.s1.e0" e2="DS.d842.s1.e1" id="DS.d842.s1.i1" interaction="False"/>
            <pair e1="DS.d842.s1.e0" e2="DS.d842.s1.e3" id="DS.d842.s1.i2" interaction="False"/>
            <pair e1="DS.d842.s1.e0" e2="DS.d842.s1.e4" id="DS.d842.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d843" origId="18715823">
        <sentence id="DS.d843.s0" origId="18715823-1582" text="The interaction of quercetin, which is a bioflavonoid, with bovine serum albumin (BSA) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).">
            <entity id="DS.d843.s0.e0" origId="5280343" charOffset="19-28" type="compound" text="quercetin"/>
            <entity id="DS.d843.s0.e1" origId="5280805" charOffset="41-53" type="compound" text="bioflavonoid"/>
            <entity id="DS.d843.s0.e2" origId="P21847,P83517" charOffset="67-80" type="protein" text="serum albumin"/>
            <entity id="DS.d843.s0.e3" origId="P02769" charOffset="82-85" type="protein" text="BSA"/>
            <pair e1="DS.d843.s0.e1" e2="DS.d843.s0.e2" id="DS.d843.s0.i0" interaction="True"/>
            <pair e1="DS.d843.s0.e0" e2="DS.d843.s0.e2" id="DS.d843.s0.i1" interaction="True"/>
            <pair e1="DS.d843.s0.e1" e2="DS.d843.s0.e3" id="DS.d843.s0.i2" interaction="True"/>
            <pair e1="DS.d843.s0.e0" e2="DS.d843.s0.e3" id="DS.d843.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d843.s1" origId="18715823-1585" text="1x10(-5) mol L(-1)), most of the site marker reacted with the quercetin-BSA, but free warfarin was present at higher concentrations.">
            <entity id="DS.d843.s1.e0" origId="P02769" charOffset="72-75" type="protein" text="BSA"/>
            <entity id="DS.d843.s1.e1" origId="54678486" charOffset="86-94" type="compound" text="warfarin"/>
            <pair e1="DS.d843.s1.e1" e2="DS.d843.s1.e0" id="DS.d843.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d844" origId="18715824">
        <sentence id="DS.d844.s0" origId="18715824-1587" text="Under optimum conditions, the fluorescence intensity of BSA-GNPs is linearly proportional to nickel concentration from 6.0x10(-8)mol/L to 8.0x10(-6)mol/L with a detection limit of 1.0x10(-8)mol/L.">
            <entity id="DS.d844.s0.e0" origId="P02769" charOffset="56-59" type="protein" text="BSA"/>
            <entity id="DS.d844.s0.e1" origId="935" charOffset="93-99" type="compound" text="nickel"/>
            <pair e1="DS.d844.s0.e1" e2="DS.d844.s0.e0" id="DS.d844.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d845" origId="18716315">
        <sentence id="DS.d845.s0" origId="18716315-1771" text="C18 and C20Gb(3) were, in mixtures without C24 :1Gb(3), dominant negative for gp120 vesicle binding.">
            <entity id="DS.d845.s0.e0" origId="446804" charOffset="43-46" type="compound" text="C24"/>
            <entity id="DS.d845.s0.e1" origId="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69" charOffset="78-83" type="protein" text="gp120"/>
            <pair e1="DS.d845.s0.e0" e2="DS.d845.s0.e1" id="DS.d845.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d845.s1" origId="18716315-1772" text="Gp120/VT1bound C18 and C24 :1Gb(3) mixtures, although neither isoform bound alone.">
            <entity id="DS.d845.s1.e0" origId="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69" charOffset="0-5" type="protein" text="Gp120"/>
            <entity id="DS.d845.s1.e1" origId="446804" charOffset="23-26" type="compound" text="C24"/>
            <pair e1="DS.d845.s1.e1" e2="DS.d845.s1.e0" id="DS.d845.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d845.s2" origId="18716315-1773" text="Monolayer surface pressure measurement showed VT1, but not VT2, bound Gb(3) at cellular DRM surface pressures, and confirmed loss of VT1 and gp120 (but not VT2) specific C18Gb(3) binding.">
            <entity id="DS.d845.s2.e0" origId="5353448" charOffset="70-74" type="compound" text="Gb(3"/>
            <entity id="DS.d845.s2.e1" origId="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69" charOffset="141-146" type="protein" text="gp120"/>
            <pair e1="DS.d845.s2.e0" e2="DS.d845.s2.e1" id="DS.d845.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d846" origId="18716607">
        <sentence id="DS.d846.s0" origId="18716607-1835" text="Cholinesterase inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary TCPy.">
            <entity id="DS.d846.s0.e0" origId="P32749,P32750,P32751,P32752,P32753,P81908" charOffset="0-14" type="protein" text="Cholinesterase"/>
            <entity id="DS.d846.s0.e1" origId="62764" charOffset="130-134" type="compound" text="TCPy"/>
            <pair e1="DS.d846.s0.e1" e2="DS.d846.s0.e0" id="DS.d846.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d846.s1" origId="18716607-1836" text="The objective of this study was to evaluate the quantitative relation between measured red blood cell acetylcholinesterase (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to chlorpyrifos (CPF) as assessed by measurement of urinary 3,5,6-trichloro-2-pyridinol (TCPy) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.">
            <entity id="DS.d846.s1.e0" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="102-122" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d846.s1.e1" origId="2730" charOffset="203-215" type="compound" text="chlorpyrifos"/>
            <entity id="DS.d846.s1.e2" origId="23017" charOffset="260-287" type="compound" text="3,5,6-trichloro-2-pyridinol"/>
            <entity id="DS.d846.s1.e3" origId="62764" charOffset="289-293" type="compound" text="TCPy"/>
            <pair e1="DS.d846.s1.e1" e2="DS.d846.s1.e0" id="DS.d846.s1.i0" interaction="True"/>
            <pair e1="DS.d846.s1.e3" e2="DS.d846.s1.e0" id="DS.d846.s1.i1" interaction="True"/>
            <pair e1="DS.d846.s1.e2" e2="DS.d846.s1.e0" id="DS.d846.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d847" origId="18716756">
        <sentence id="DS.d847.s0" origId="18716756-1877" text="Immunofluorescence analysis revealed that two known virulence-associated surface proteins featuring Leu-Pro-X-Thr-Gly motif, muramidase-released protein and surface antigen one, were absent in the DeltasrtA.">
            <entity id="DS.d847.s0.e0" origId="O12164,O41803,O42043,O56861,O70902,O71037,O89292,O91086,P03374,P03375,P03377,P03378,P03379,P03380,P03381,P03383,P03385,P03386,P03387,P03388,P03390,P03391,P03392,P03395,P03396,P03397,P03399,P04027,P04502,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P06445,P06751,P06752,P07575,P08359,P08360,P08810,P0C212,P10259,P10267,P10269,P11261,P11267,P11268,P11306,P12449,P12487,P12488,P12489,P12492,P14075,P14351,P15073,P15831,P16082,P16090,P16899,P17281,P17755,P18040,P18094,P18799,P19030,P19503,P19549,P19550,P19551,P19556,P19557,P20871,P20872,P20888,P21412,P21415,P21436,P21443,P21444,P21445,P22380,P22427,P22428,P22429,P22430,P23064,P23073,P23422,P23423,P24105,P25057,P25504,P25505,P25506,P25507,P26803,P26804,P27399,P27757,P27977,P31621,P31626,P31627,P31789,P31791,P31794,P31796,P31819,P31872,P32536,P32541,P33498,P35954,P35961,P51515,P51519,P51520,P60507,P60508,P60608,P61549,P61550,P61552,P61553,P61554,P61555,P61556,P61557,P61558,P61559,P61561,P61562,P61563,P61564,P61565,P61566,P61567,P61570,Q02076,Q02077,Q02282,Q02837,Q03804,Q03816,Q03817,Q04993,Q04995,Q05312,Q09SZ7,Q0R5Q9,Q14264,Q1A243,Q1A261,Q69384,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q85646,Q89607,Q8AIH5,Q8MIB6,Q902F8,Q902F9,Q96L62,Q9IDV2,Q9N2J8,Q9N2J9,Q9N2K0,Q9NX77,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9TTC0,Q9UKH3,Q9UQF0,Q9WC60,Q9WC69" charOffset="73-89" type="protein" text="surface proteins"/>
            <entity id="DS.d847.s0.e1" origId="3977067" charOffset="100-107" type="compound" text="Leu-Pro"/>
            <entity id="DS.d847.s0.e2" origId="750,5460845" charOffset="114-117" type="compound" text="Gly"/>
            <entity id="DS.d847.s0.e3" origId="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P15057,P19385,P19386,P27359,P33486,P51728,P51771,P62692,P62693,P68920,P68921,P76159,P78285,Q37875,Q37896,Q9T1T5,Q9T1X2,Q9ZXB7" charOffset="125-135" type="protein" text="muramidase"/>
            <pair e1="DS.d847.s0.e1" e2="DS.d847.s0.e3" id="DS.d847.s0.i0" interaction="False"/>
            <pair e1="DS.d847.s0.e1" e2="DS.d847.s0.e0" id="DS.d847.s0.i1" interaction="True"/>
            <pair e1="DS.d847.s0.e2" e2="DS.d847.s0.e0" id="DS.d847.s0.i2" interaction="True"/>
            <pair e1="DS.d847.s0.e2" e2="DS.d847.s0.e3" id="DS.d847.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d848" origId="18716761">
        <sentence id="DS.d848.s0" origId="18716761-1880" text="In addition, neuronal nitric oxide synthase, another component of the NMDA/nitric oxide/cGMP intracellular pathway, has been reported to be dysregulated in schizophrenia patients.">
            <entity id="DS.d848.s0.e0" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="22-43" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d848.s0.e2" origId="145068" charOffset="75-87" type="compound" text="nitric oxide"/>
            <entity id="DS.d848.s0.e3" origId="24316" charOffset="88-92" type="compound" text="cGMP"/>
            <pair e1="DS.d848.s0.e2" e2="DS.d848.s0.e0" id="DS.d848.s0.i0" interaction="True"/>
            <pair e1="DS.d848.s0.e3" e2="DS.d848.s0.e0" id="DS.d848.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d850" origId="18716782">
        <sentence id="DS.d850.s0" origId="18716782-1887" text="A role for natriuretic peptide in lipopolysaccharide-induced fever in Pekin ducks (Anas platyrhynchos): is natriuretic peptide an endogenous antipyretic in birds.">
            <entity id="DS.d850.s0.e0" origId="P28374" charOffset="11-30" type="protein" text="natriuretic peptide"/>
            <entity id="DS.d850.s0.e1" origId="11970143" charOffset="34-52" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d850.s0.e2" origId="P28374" charOffset="107-126" type="protein" text="natriuretic peptide"/>
            <pair e1="DS.d850.s0.e1" e2="DS.d850.s0.e0" id="DS.d850.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d850.s1" origId="18716782-1888" text="We induced fever in Pekin ducks with lipopolysaccharide and, at the same time, treated the animals with natriuretic peptide antiserum at a dose that effectively inhibited the known renal actions of endogenously secreted natriuretic peptide.">
            <entity id="DS.d850.s1.e0" origId="11970143" charOffset="37-55" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d850.s1.e1" origId="P28374" charOffset="104-123" type="protein" text="natriuretic peptide"/>
            <entity id="DS.d850.s1.e2" origId="P28374" charOffset="220-239" type="protein" text="natriuretic peptide"/>
            <pair e1="DS.d850.s1.e0" e2="DS.d850.s1.e1" id="DS.d850.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d851" origId="18716808">
        <sentence id="DS.d851.s0" origId="18716808-1894" text="Among the Gram-negative bacteria, 100% of the Escherichia coli isolates (including extended spectrum beta-lactamase (ESBL)-producers) were tigecycline-susceptible, while about 10% of the Enterobacter cloacae and Klebsiella pneumoniae isolates were resistant.">
            <entity id="DS.d851.s0.e0" origId="P80298,P80545,P81173" charOffset="101-115" type="protein" text="beta-lactamase"/>
            <entity id="DS.d851.s0.e1" origId="54686904" charOffset="139-150" type="compound" text="tigecycline"/>
            <pair e1="DS.d851.s0.e1" e2="DS.d851.s0.e0" id="DS.d851.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d853" origId="18716864">
        <sentence id="DS.d853.s0" origId="18716864-1923" text="The data presented here show that NH4Cl (5 mM) mediates astroglial cell swelling, and that treatment with NH4Cl or lactate (25 mM) causes rearrangements of actin filaments and reduces astroglial glutamate uptake capacity.">
            <entity id="DS.d853.s0.e0" origId="612" charOffset="115-122" type="compound" text="lactate"/>
            <entity id="DS.d853.s0.e1" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="156-161" type="protein" text="actin"/>
            <pair e1="DS.d853.s0.e0" e2="DS.d853.s0.e1" id="DS.d853.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d854" origId="18716881">
        <sentence id="DS.d854.s1" origId="18716881-1940" text="Here, we proposed that Lap4, a vacuolar amino peptidase, is involved in glutathione catabolism under cadmium stress.">
            <entity id="DS.d854.s1.e0" origId="Q80U72" charOffset="23-27" type="protein" text="Lap4"/>
            <entity id="DS.d854.s1.e1" origId="23973" charOffset="101-108" type="compound" text="cadmium"/>
            <pair e1="DS.d854.s1.e1" e2="DS.d854.s1.e0" id="DS.d854.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d854.s3" origId="18716881-1942" text="Thus, under cadmium stress, Lap4 and gamma-glutamyl transferase seem to work together to assure an efficient glutathione turnover stored in the vacuole.">
            <entity id="DS.d854.s3.e0" origId="23973" charOffset="12-19" type="compound" text="cadmium"/>
            <entity id="DS.d854.s3.e1" origId="Q80U72" charOffset="28-32" type="protein" text="Lap4"/>
            <entity id="DS.d854.s3.e2" origId="124886" charOffset="109-120" type="compound" text="glutathione"/>
            <pair e1="DS.d854.s3.e2" e2="DS.d854.s3.e1" id="DS.d854.s3.i0" interaction="True"/>
            <pair e1="DS.d854.s3.e0" e2="DS.d854.s3.e1" id="DS.d854.s3.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d855" origId="18716920">
        <sentence id="DS.d855.s0" origId="18716920-1959" text="In this research, the effects of pH, temperature, and oxygen on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with transglutaminase (TGase) production and cell sporulation were investigated.">
            <entity id="DS.d855.s0.e0" origId="977" charOffset="54-60" type="compound" text="oxygen"/>
            <entity id="DS.d855.s0.e1" origId="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7" charOffset="173-189" type="protein" text="transglutaminase"/>
            <entity id="DS.d855.s0.e2" origId="P40746,P81453,Q05187,Q819L3,Q81MS1,Q8GR90,Q9K5W7" charOffset="191-196" type="protein" text="TGase"/>
            <pair e1="DS.d855.s0.e0" e2="DS.d855.s0.e1" id="DS.d855.s0.i0" interaction="True"/>
            <pair e1="DS.d855.s0.e0" e2="DS.d855.s0.e2" id="DS.d855.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d856" origId="18717617">
        <sentence id="DS.d856.s0" origId="18717617-2177" text="No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and monoamine oxidase enzymes).">
            <entity id="DS.d856.s0.e0" origId="23931" charOffset="37-44" type="compound" text="mercury"/>
            <entity id="DS.d856.s0.e1" origId="6326970" charOffset="46-54" type="compound" text="selenium"/>
            <entity id="DS.d856.s0.e2" origId="681" charOffset="100-108" type="compound" text="dopamine"/>
            <entity id="DS.d856.s0.e3" origId="119" charOffset="112-135" type="compound" text="gamma-aminobutyric acid"/>
            <entity id="DS.d856.s0.e4" origId="P32749,P32750,P32751,P32752,P32753,P81908" charOffset="205-219" type="protein" text="cholinesterase"/>
            <entity id="DS.d856.s0.e5" origId="P49253" charOffset="224-241" type="protein" text="monoamine oxidase"/>
            <pair e1="DS.d856.s0.e3" e2="DS.d856.s0.e4" id="DS.d856.s0.i0" interaction="False"/>
            <pair e1="DS.d856.s0.e1" e2="DS.d856.s0.e4" id="DS.d856.s0.i1" interaction="False"/>
            <pair e1="DS.d856.s0.e2" e2="DS.d856.s0.e4" id="DS.d856.s0.i2" interaction="False"/>
            <pair e1="DS.d856.s0.e1" e2="DS.d856.s0.e5" id="DS.d856.s0.i3" interaction="False"/>
            <pair e1="DS.d856.s0.e2" e2="DS.d856.s0.e5" id="DS.d856.s0.i4" interaction="False"/>
            <pair e1="DS.d856.s0.e3" e2="DS.d856.s0.e5" id="DS.d856.s0.i5" interaction="False"/>
            <pair e1="DS.d856.s0.e0" e2="DS.d856.s0.e5" id="DS.d856.s0.i6" interaction="False"/>
            <pair e1="DS.d856.s0.e0" e2="DS.d856.s0.e4" id="DS.d856.s0.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d857" origId="18717625">
        <sentence id="DS.d857.s0" origId="18717625-2181" text="Despite responsive antioxidative defense (increased activities of superoxide dismutase, ascorbate peroxidase, and pyrogallol peroxidase), Tl+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.">
            <entity id="DS.d857.s0.e0" origId="O50258" charOffset="66-86" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d857.s0.e1" origId="P15984,P16147,P84714" charOffset="98-108" type="protein" text="peroxidase"/>
            <entity id="DS.d857.s0.e2" origId="P15984,P16147,P84714" charOffset="125-135" type="protein" text="peroxidase"/>
            <entity id="DS.d857.s0.e3" origId="105005" charOffset="138-140" type="compound" text="Tl"/>
            <pair e1="DS.d857.s0.e3" e2="DS.d857.s0.e1" id="DS.d857.s0.i0" interaction="False"/>
            <pair e1="DS.d857.s0.e3" e2="DS.d857.s0.e0" id="DS.d857.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d858" origId="18717627">
        <sentence id="DS.d858.s0" origId="18717627-2182" text="However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive oxygen species (ROS) through activation of the components of NADPH oxidase, like p22 (phox), p47 (phox), and Nox4.">
            <entity id="DS.d858.s0.e0" origId="977" charOffset="109-115" type="compound" text="oxygen"/>
            <entity id="DS.d858.s0.e1" origId="O75935,P03304,P11691,P15961,P16342,P17593,P17594,P19751,P23169,P24102,P50629,P50630,P50631,P50632,P50633,P50634,P82796,Q05903,Q66198,Q8V439,Q8V6W7,Q91A29,Q9PYA3" charOffset="190-193" type="protein" text="p22"/>
            <entity id="DS.d858.s0.e2" origId="O10300,P08567,P26642,P34051,Q12802,Q91375,Q9SZB9,Q9Y240" charOffset="202-205" type="protein" text="p47"/>
            <entity id="DS.d858.s0.e3" origId="Q924V1,Q9JHI8" charOffset="218-222" type="protein" text="Nox4"/>
            <pair e1="DS.d858.s0.e0" e2="DS.d858.s0.e2" id="DS.d858.s0.i0" interaction="True"/>
            <pair e1="DS.d858.s0.e0" e2="DS.d858.s0.e1" id="DS.d858.s0.i1" interaction="True"/>
            <pair e1="DS.d858.s0.e0" e2="DS.d858.s0.e3" id="DS.d858.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d859" origId="18717628">
        <sentence id="DS.d859.s0" origId="18717628-2183" text="We conclude that mitochondrial dysfunction can induce alpha-synuclein oligomerization via ATP depletion-driven microtubule depolymerization and via ROS increase-driven protein oxidation.">
            <entity id="DS.d859.s0.e0" origId="O55042,P37377,P37840,P61138,P61139,P61140,P61141,P61142,P61143,P61144,P61145,P61146,P61147,Q3I5G7,Q3T0G8,Q91448" charOffset="54-69" type="protein" text="alpha-synuclein"/>
            <entity id="DS.d859.s0.e1" origId="5957" charOffset="90-93" type="compound" text="ATP"/>
            <pair e1="DS.d859.s0.e1" e2="DS.d859.s0.e0" id="DS.d859.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d860" origId="18717715">
        <sentence id="DS.d860.s0" origId="18717715-2195" text="Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.">
            <entity id="DS.d860.s0.e0" origId="Q02563,Q9JIS5" charOffset="24-51" type="protein" text="synaptic vesicle protein 2A"/>
            <entity id="DS.d860.s0.e1" origId="5284583" charOffset="74-87" type="compound" text="levetiracetam"/>
            <pair e1="DS.d860.s0.e1" e2="DS.d860.s0.e0" id="DS.d860.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d860.s1" origId="18717715-2196" text="We previously showed that gene expression of synaptic vesicle protein 2A (SV2A), the binding site for the antiepileptic drug levetiracetam, is reduced during epileptogenesis in the rat.">
            <entity id="DS.d860.s1.e0" origId="Q02563,Q9JIS5" charOffset="45-72" type="protein" text="synaptic vesicle protein 2A"/>
            <entity id="DS.d860.s1.e1" origId="Q29397,Q4R4X3,Q5R4L9,Q7L0J3" charOffset="74-78" type="protein" text="SV2A"/>
            <entity id="DS.d860.s1.e2" origId="5284583" charOffset="125-138" type="compound" text="levetiracetam"/>
            <pair e1="DS.d860.s1.e2" e2="DS.d860.s1.e0" id="DS.d860.s1.i0" interaction="True"/>
            <pair e1="DS.d860.s1.e2" e2="DS.d860.s1.e1" id="DS.d860.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d862" origId="18718549">
        <sentence id="DS.d862.s0" origId="18718549-2503" text="We also demonstrated that the deletion of the ptsG gene doubled ATP-driven glutathione synthesis and increased cellular ATP synthetic activity.">
            <entity id="DS.d862.s0.e0" origId="P20166,P37439,P42015,P47315,P57437,P69786,P69787,P69788,P75569,Q45298,Q46072,Q89AG6,Q8K9J0" charOffset="46-50" type="protein" text="ptsG"/>
            <entity id="DS.d862.s0.e1" origId="124886" charOffset="75-86" type="compound" text="glutathione"/>
            <pair e1="DS.d862.s0.e1" e2="DS.d862.s0.e0" id="DS.d862.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d863" origId="18718551">
        <sentence id="DS.d863.s0" origId="18718551-2505" text="Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation.">
            <entity id="DS.d863.s0.e0" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="110-113" type="protein" text="p53"/>
            <entity id="DS.d863.s0.e1" origId="977" charOffset="143-149" type="compound" text="oxygen"/>
            <pair e1="DS.d863.s0.e1" e2="DS.d863.s0.e0" id="DS.d863.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d863.s1" origId="18718551-2506" text="In the present study, we showed that selenocystine (SeC), a naturally occurring selenoamino acid, induced caspase-independent apoptosis in MCF-7 breast carcinoma cells, which was accompanied by poly(ADP-ribose) polymerase (PARP) cleavage, caspase activation, DNA fragmentation, phosphatidylserine exposure and nuclear condensation.">
            <entity id="DS.d863.s1.e0" origId="P02783" charOffset="199-202" type="protein" text="ADP"/>
            <entity id="DS.d863.s1.e1" origId="O50017,P08469,P14043,P31669,P35875,P55057,Q08824,Q11208" charOffset="223-227" type="protein" text="PARP"/>
            <entity id="DS.d863.s1.e2" origId="445141,6323481,44147587" charOffset="278-296" type="compound" text="phosphatidylserine"/>
            <pair e1="DS.d863.s1.e2" e2="DS.d863.s1.e1" id="DS.d863.s1.i0" interaction="False"/>
            <pair e1="DS.d863.s1.e2" e2="DS.d863.s1.e0" id="DS.d863.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d863.s2" origId="18718551-2507" text="Silencing and attenuating of p53 activation with RNA interference and pifithrin-alpha treatment, respectively, partially suppressed SeC-induced cell apoptosis.">
            <entity id="DS.d863.s2.e0" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="29-32" type="protein" text="p53"/>
            <entity id="DS.d863.s2.e1" origId="4817" charOffset="70-85" type="compound" text="pifithrin-alpha"/>
            <pair e1="DS.d863.s2.e1" e2="DS.d863.s2.e0" id="DS.d863.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d864" origId="18718660">
        <sentence id="DS.d864.s0" origId="18718660-2524" text="Activation of c-Jun N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by monochloramine.">
            <entity id="DS.d864.s0.e0" origId="P05627,P17325,P18289" charOffset="16-19" type="protein" text="Jun"/>
            <entity id="DS.d864.s0.e1" origId="25423" charOffset="105-119" type="compound" text="monochloramine"/>
            <pair e1="DS.d864.s0.e1" e2="DS.d864.s0.e0" id="DS.d864.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d864.s1" origId="18718660-2525" text="Within 10min of NH(2) Cl treatment, c-Jun N-terminal kinase (JNK) activation and elevation of cytosolic Ca(2+) were observed.">
            <entity id="DS.d864.s1.e0" origId="312" charOffset="22-24" type="compound" text="Cl"/>
            <entity id="DS.d864.s1.e1" origId="P05627,P17325,P18289" charOffset="38-41" type="protein" text="Jun"/>
            <entity id="DS.d864.s1.e2" origId="P92208,Q966Y3" charOffset="61-64" type="protein" text="JNK"/>
            <entity id="DS.d864.s1.e3" origId="271" charOffset="104-108" type="compound" text="Ca(2"/>
            <pair e1="DS.d864.s1.e3" e2="DS.d864.s1.e2" id="DS.d864.s1.i0" interaction="False"/>
            <pair e1="DS.d864.s1.e0" e2="DS.d864.s1.e2" id="DS.d864.s1.i1" interaction="False"/>
            <pair e1="DS.d864.s1.e3" e2="DS.d864.s1.e1" id="DS.d864.s1.i2" interaction="False"/>
            <pair e1="DS.d864.s1.e0" e2="DS.d864.s1.e1" id="DS.d864.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d865" origId="18718713">
        <sentence id="DS.d865.s0" origId="18718713-2535" text="Induction in the activity of lignin peroxidase and azoreductase was observed during decolorization of Reactive Red 2 in the batch culture, which represented their role in degradation.">
            <entity id="DS.d865.s0.e0" origId="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622" charOffset="29-46" type="protein" text="lignin peroxidase"/>
            <entity id="DS.d865.s0.e1" origId="P05982,P15559,Q5RD31,Q64669,Q8CHK7" charOffset="51-63" type="protein" text="azoreductase"/>
            <entity id="DS.d865.s0.e2" origId="6093247" charOffset="102-116" type="compound" text="Reactive Red 2"/>
            <pair e1="DS.d865.s0.e2" e2="DS.d865.s0.e0" id="DS.d865.s0.i0" interaction="True"/>
            <pair e1="DS.d865.s0.e2" e2="DS.d865.s0.e1" id="DS.d865.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d867" origId="18719855">
        <sentence id="DS.d867.s0" origId="18719855-2110" text="Treatment with nimbolide resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC(50) values of 2.01 and 1.19 microM for 7 and 24 h respectively, accompanied by downregulation of proliferating cell nuclear antigen.">
            <entity id="DS.d867.s0.e0" origId="100017" charOffset="15-24" type="compound" text="nimbolide"/>
            <entity id="DS.d867.s0.e1" origId="O01377,O02115,O16852,O82134,O82797,P04961,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00268,Q03392,Q43124,Q43266,Q6B6N4,Q9DDF1,Q9DEA3,Q9MAY3,Q9PTP1,Q9W644" charOffset="202-236" type="protein" text="proliferating cell nuclear antigen"/>
            <pair e1="DS.d867.s0.e0" e2="DS.d867.s0.e1" id="DS.d867.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d868" origId="18719891">
        <sentence id="DS.d868.s0" origId="18719891-434" text="In all cases, the phenotype of SVQ524 was nearly overcome by the addition of methionine or cobalamin to the plant growth media or by the presence of a copy of the cobO gene in cosmid pMUS756.">
            <entity id="DS.d868.s0.e0" origId="876,6137" charOffset="77-87" type="compound" text="methionine"/>
            <entity id="DS.d868.s0.e1" origId="3034082,6713940,25243974" charOffset="91-100" type="compound" text="cobalamin"/>
            <entity id="DS.d868.s0.e2" origId="P29930" charOffset="163-167" type="protein" text="cobO"/>
            <pair e1="DS.d868.s0.e0" e2="DS.d868.s0.e2" id="DS.d868.s0.i0" interaction="False"/>
            <pair e1="DS.d868.s0.e1" e2="DS.d868.s0.e2" id="DS.d868.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d870" origId="18719969">
        <sentence id="DS.d870.s0" origId="18719969-461" text="Obesity increases insulin resistance and glucose intolerance and also exacerbates metabolic abnormalities present in type 2 diabetes.">
            <entity id="DS.d870.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="18-25" type="protein" text="insulin"/>
            <entity id="DS.d870.s0.e1" origId="206,5793,64689,79025" charOffset="41-48" type="compound" text="glucose"/>
            <pair e1="DS.d870.s0.e1" e2="DS.d870.s0.e0" id="DS.d870.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d871" origId="18720192">
        <sentence id="DS.d871.s0" origId="18720192-531" text="Inhibition of glycogen synthase kinase by curcumin : Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.">
            <entity id="DS.d871.s0.e0" origId="O08328,O66935,O84804,P05416,P0A6U8,P0A6U9,P0A6V0,P39125,P45179,P58395,Q21BQ1,Q221N9,Q255S3,Q28MN0,Q2A4U4,Q2G7S7,Q2IM81,Q2J308,Q2K485,Q2P9F6,Q2RH55,Q2RS50,Q2T6R2,Q2W5G0,Q2YB48,Q30Z13,Q31BS5,Q31IB5,Q31VJ4,Q32AV6,Q3A0B8,Q3AKK1,Q3APL6,Q3AVF9,Q3B6C3,Q3BYI1,Q3K1K2,Q3KD65,Q3KKP3,Q3SH79,Q3YW96,Q46LU1,Q47IJ4,Q48JG9,Q4KCP0,Q4QK70,Q4UZL8,Q4ZS46,Q57IU1,Q5DZC1,Q5FL65,Q5H6Q4,Q5L562,Q5N1P1,Q5NHN2,Q5NXZ7,Q5PM09,Q5SMC5,Q632H4,Q65FS7,Q65TI3,Q664I5,Q6CZK3,Q6HC18,Q6KHP2,Q6LKA1,Q6MAS9,Q6NCT7,Q729V4,Q72G68,Q72YJ6,Q73MC7,Q7MJ50,Q7NM37,Q7U7I2,Q7UPY2,Q7V275,Q7V8F0,Q7VBP0,Q7W6L5,Q7WIJ0,Q816G8,Q81K85,Q821W4,Q82SP3,Q83PV4,Q87QX5,Q880M9,Q88FN9,Q890I8,Q8CWX0,Q8DAR0,Q8DKU2,Q8DPS3,Q8E079,Q8E5V5,Q8ET54,Q8KAY6,Q8PDD2,Q8PQA3,Q8RF65,Q8XPA1,Q8XT73,Q8Z232,Q8ZA78,Q935Y7,Q97GX6,Q97QS5,Q985P2,Q9CHM9,Q9CN91,Q9EUT5,Q9I1V0,Q9KDX6,Q9KRB6,Q9PLC3,Q9RNH6,Q9RWS1,Q9WZZ7,Q9Z6V8" charOffset="14-31" type="protein" text="glycogen synthase"/>
            <entity id="DS.d871.s0.e1" origId="969516" charOffset="42-50" type="compound" text="curcumin"/>
            <pair e1="DS.d871.s0.e1" e2="DS.d871.s0.e0" id="DS.d871.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d871.s1" origId="18720192-532" text="The investigation included simulated docking experiments to fit curcumin within the binding pocket of GSK-3beta followed by experimental in vitro and in vivo validations.">
            <entity id="DS.d871.s1.e0" origId="969516" charOffset="64-72" type="compound" text="curcumin"/>
            <entity id="DS.d871.s1.e1" origId="P18266,P49841,Q5YJC2,Q9WV60" charOffset="102-111" type="protein" text="GSK-3beta"/>
            <pair e1="DS.d871.s1.e0" e2="DS.d871.s1.e1" id="DS.d871.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d871.s2" origId="18720192-533" text="Curcumin was found to optimally fit within the binding pocket of GSK-3beta via several attractive interactions with key amino acids.">
            <entity id="DS.d871.s2.e0" origId="969516" charOffset="0-8" type="compound" text="Curcumin"/>
            <entity id="DS.d871.s2.e1" origId="P18266,P49841,Q5YJC2,Q9WV60" charOffset="65-74" type="protein" text="GSK-3beta"/>
            <pair e1="DS.d871.s2.e0" e2="DS.d871.s2.e1" id="DS.d871.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d872" origId="18720446">
        <sentence id="DS.d872.s0" origId="18720446-603" text="A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.">
            <entity id="DS.d872.s0.e0" origId="5328791" charOffset="154-158" type="compound" text="CHCA"/>
            <entity id="DS.d872.s0.e1" origId="243,167551" charOffset="178-190" type="compound" text="benzoic acid"/>
            <entity id="DS.d872.s0.e2" origId="9882105" charOffset="192-195" type="compound" text="DHB"/>
            <entity id="DS.d872.s0.e3" origId="6422" charOffset="200-221" type="compound" text="trifluoro acetic acid"/>
            <entity id="DS.d872.s0.e4" origId="Q27203" charOffset="223-226" type="protein" text="TFA"/>
            <entity id="DS.d872.s0.e5" origId="P02877" charOffset="317-323" type="protein" text="Hevein"/>
            <entity id="DS.d872.s0.e6" origId="P15252,P45951" charOffset="325-328" type="protein" text="REF"/>
            <entity id="DS.d872.s0.e7" origId="P15252,P45951" charOffset="353-356" type="protein" text="REF"/>
            <pair e1="DS.d872.s0.e1" e2="DS.d872.s0.e6" id="DS.d872.s0.i0" interaction="False"/>
            <pair e1="DS.d872.s0.e3" e2="DS.d872.s0.e6" id="DS.d872.s0.i1" interaction="False"/>
            <pair e1="DS.d872.s0.e3" e2="DS.d872.s0.e5" id="DS.d872.s0.i2" interaction="False"/>
            <pair e1="DS.d872.s0.e2" e2="DS.d872.s0.e4" id="DS.d872.s0.i3" interaction="False"/>
            <pair e1="DS.d872.s0.e0" e2="DS.d872.s0.e6" id="DS.d872.s0.i4" interaction="False"/>
            <pair e1="DS.d872.s0.e0" e2="DS.d872.s0.e5" id="DS.d872.s0.i5" interaction="False"/>
            <pair e1="DS.d872.s0.e1" e2="DS.d872.s0.e5" id="DS.d872.s0.i6" interaction="False"/>
            <pair e1="DS.d872.s0.e3" e2="DS.d872.s0.e4" id="DS.d872.s0.i7" interaction="False"/>
            <pair e1="DS.d872.s0.e0" e2="DS.d872.s0.e4" id="DS.d872.s0.i8" interaction="False"/>
            <pair e1="DS.d872.s0.e1" e2="DS.d872.s0.e4" id="DS.d872.s0.i9" interaction="False"/>
            <pair e1="DS.d872.s0.e2" e2="DS.d872.s0.e6" id="DS.d872.s0.i10" interaction="False"/>
            <pair e1="DS.d872.s0.e2" e2="DS.d872.s0.e5" id="DS.d872.s0.i11" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d874" origId="18721153">
        <sentence id="DS.d874.s0" origId="18721153-786" text="Pathological role of CD44 on NKT cells in carbon tetrachloride-mediated liver injury.">
            <entity id="DS.d874.s0.e0" origId="P14745,P16070,P20944,Q05078,Q28284,Q29423,Q60522" charOffset="21-25" type="protein" text="CD44"/>
            <entity id="DS.d874.s0.e1" origId="5943" charOffset="42-62" type="compound" text="carbon tetrachloride"/>
            <pair e1="DS.d874.s0.e1" e2="DS.d874.s0.e0" id="DS.d874.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d874.s1" origId="18721153-787" text="Methods: We injected CD44 knock out (KO) or wild type mice with carbon tetrachloride (CCl(4)) and examined the difference of liver injury by immunological or histological analysis.">
            <entity id="DS.d874.s1.e0" origId="P14745,P16070,P20944,Q05078,Q28284,Q29423,Q60522" charOffset="21-25" type="protein" text="CD44"/>
            <entity id="DS.d874.s1.e1" origId="5943" charOffset="64-84" type="compound" text="carbon tetrachloride"/>
            <pair e1="DS.d874.s1.e1" e2="DS.d874.s1.e0" id="DS.d874.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d875" origId="18721245">
        <sentence id="DS.d875.s0" origId="18721245-809" text="Studies using 1-methyl-tryptophan (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.">
            <entity id="DS.d875.s0.e0" origId="98112" charOffset="16-33" type="compound" text="methyl-tryptophan"/>
            <entity id="DS.d875.s0.e1" origId="98112" charOffset="35-39" type="compound" text="1-MT"/>
            <entity id="DS.d875.s0.e2" origId="Q9TTB0" charOffset="113-129" type="protein" text="interferon-gamma"/>
            <entity id="DS.d875.s0.e3" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="131-140" type="protein" text="IFN-gamma"/>
            <pair e1="DS.d875.s0.e0" e2="DS.d875.s0.e2" id="DS.d875.s0.i0" interaction="False"/>
            <pair e1="DS.d875.s0.e1" e2="DS.d875.s0.e3" id="DS.d875.s0.i1" interaction="True"/>
            <pair e1="DS.d875.s0.e0" e2="DS.d875.s0.e3" id="DS.d875.s0.i2" interaction="True"/>
            <pair e1="DS.d875.s0.e1" e2="DS.d875.s0.e2" id="DS.d875.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d876" origId="18721829">
        <sentence id="DS.d876.s0" origId="18721829-966" text="We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for serotonin, Substance P, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).">
            <entity id="DS.d876.s0.e0" origId="5202" charOffset="111-120" type="compound" text="serotonin"/>
            <entity id="DS.d876.s0.e1" origId="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541" charOffset="122-133" type="protein" text="Substance P"/>
            <entity id="DS.d876.s0.e2" origId="O02777,P20272,P21554,P47746,P56971,Q333S9,Q5IS73,Q71SP5,Q801M1,Q9PUI7" charOffset="135-158" type="protein" text="cannabinoid receptors 1"/>
            <entity id="DS.d876.s0.e3" origId="P01101,P12841,Q56415" charOffset="216-219" type="protein" text="Fos"/>
            <pair e1="DS.d876.s0.e0" e2="DS.d876.s0.e3" id="DS.d876.s0.i0" interaction="False"/>
            <pair e1="DS.d876.s0.e0" e2="DS.d876.s0.e1" id="DS.d876.s0.i1" interaction="False"/>
            <pair e1="DS.d876.s0.e0" e2="DS.d876.s0.e2" id="DS.d876.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d877" origId="18722097">
        <sentence id="DS.d877.s0" origId="18722097-1040" text="To observe the inhibitory effects of TSP-1 functional fragments, critical for CD36 binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after bleomycin administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.">
            <entity id="DS.d877.s0.e0" origId="P11032,Q28178" charOffset="37-42" type="protein" text="TSP-1"/>
            <entity id="DS.d877.s0.e1" origId="P16671,P26201,P70110" charOffset="78-82" type="protein" text="CD36"/>
            <entity id="DS.d877.s0.e2" origId="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6" charOffset="115-124" type="protein" text="TGF-beta1"/>
            <entity id="DS.d877.s0.e3" origId="456190,5360373,5460769" charOffset="194-203" type="compound" text="bleomycin"/>
            <entity id="DS.d877.s0.e4" origId="P11032,Q28178" charOffset="279-284" type="protein" text="TSP-1"/>
            <pair e1="DS.d877.s0.e3" e2="DS.d877.s0.e1" id="DS.d877.s0.i0" interaction="False"/>
            <pair e1="DS.d877.s0.e3" e2="DS.d877.s0.e0" id="DS.d877.s0.i1" interaction="False"/>
            <pair e1="DS.d877.s0.e3" e2="DS.d877.s0.e2" id="DS.d877.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d878" origId="18722104">
        <sentence id="DS.d878.s0" origId="18722104-1045" text="The pEREGFP9 vector was delivered to a single MCF-7 using a nanoneedle and the effect of ICI 182,780, which is an antagonist of estrogen, was observed using the GFP expression level.">
            <entity id="DS.d878.s0.e0" origId="104741" charOffset="89-100" type="compound" text="ICI 182,780"/>
            <entity id="DS.d878.s0.e1" origId="P42212" charOffset="8-11" type="protein" text="GFP"/>
            <pair e1="DS.d878.s0.e0" e2="DS.d878.s0.e1" id="DS.d878.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d878.s1" origId="18722104-1046" text="By ICI 182,780 treatment, the fluorescence intensity of the GFP was decreased by 30-50% within 24h.">
            <entity id="DS.d878.s1.e0" origId="104741" charOffset="3-14" type="compound" text="ICI 182,780"/>
            <entity id="DS.d878.s1.e1" origId="P42212" charOffset="60-63" type="protein" text="GFP"/>
            <pair e1="DS.d878.s1.e0" e2="DS.d878.s1.e1" id="DS.d878.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d879" origId="18722114">
        <sentence id="DS.d879.s0" origId="18722114-1051" text="Effect of different cellulase dosages on cell viability and ethanol production by Kluyveromyces marxianus in SSF processes.">
            <entity id="DS.d879.s0.e0" origId="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7" charOffset="20-29" type="protein" text="cellulase"/>
            <entity id="DS.d879.s0.e1" origId="702" charOffset="60-67" type="compound" text="ethanol"/>
            <pair e1="DS.d879.s0.e1" e2="DS.d879.s0.e0" id="DS.d879.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d879.s1" origId="18722114-1052" text="This study was aimed to study the effect of commercial cellulases (Celluclast 1.5 LFG) on Kluyveromyces marxianus CECT 10875 growth and ethanol production in SSF processes.">
            <entity id="DS.d879.s1.e0" origId="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7" charOffset="55-65" type="protein" text="cellulases"/>
            <entity id="DS.d879.s1.e1" origId="702" charOffset="136-143" type="compound" text="ethanol"/>
            <pair e1="DS.d879.s1.e1" e2="DS.d879.s1.e0" id="DS.d879.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d881" origId="18722490">
        <sentence id="DS.d881.s0" origId="18722490-1167" text="Crustacean hyperglycemic hormone (CHH) not only plays an important role in the modulation of hemolymph glucose level but also functions in other biological events including molting, reproduction and stress response.">
            <entity id="DS.d881.s0.e0" origId="O77220,P14944,P30814,P55845,P56687,P59685,P81032,P83800,Q25588,Q25589,Q25683,Q26181" charOffset="0-32" type="protein" text="Crustacean hyperglycemic hormone"/>
            <entity id="DS.d881.s0.e1" origId="O77220,P14944,P30814,P55845,P56687,P59685,P81032,P83800,Q25588,Q25589,Q25683,Q26181" charOffset="34-37" type="protein" text="CHH"/>
            <entity id="DS.d881.s0.e2" origId="206,5793,64689,79025" charOffset="103-110" type="compound" text="glucose"/>
            <pair e1="DS.d881.s0.e2" e2="DS.d881.s0.e1" id="DS.d881.s0.i0" interaction="True"/>
            <pair e1="DS.d881.s0.e2" e2="DS.d881.s0.e0" id="DS.d881.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d882" origId="18722763">
        <sentence id="DS.d882.s0" origId="18722763-1249" text="As a proof-of-concept, Concanavalin A-coated QDs (ConA-QDs) and dextran-coated AuNPs (Dex-AuNPs) were used to detect the mannosylated proteins.">
            <entity id="DS.d882.s0.e0" origId="P81460,P81461" charOffset="23-37" type="protein" text="Concanavalin A"/>
            <entity id="DS.d882.s0.e1" origId="P02866,P14894,P81460,P81461" charOffset="50-54" type="protein" text="ConA"/>
            <entity id="DS.d882.s0.e2" origId="4125253,5460037" charOffset="64-71" type="compound" text="dextran"/>
            <pair e1="DS.d882.s0.e2" e2="DS.d882.s0.e0" id="DS.d882.s0.i0" interaction="False"/>
            <pair e1="DS.d882.s0.e2" e2="DS.d882.s0.e1" id="DS.d882.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d882.s1" origId="18722763-1250" text="As a result, the PL intensity of QDs was found to be linearly correlated with the concentration and the number of glycan moiety of the glycoprotein.">
            <entity id="DS.d882.s1.e0" origId="871" charOffset="114-120" type="compound" text="glycan"/>
            <entity id="DS.d882.s1.e1" origId="P08163" charOffset="135-147" type="protein" text="glycoprotein"/>
            <pair e1="DS.d882.s1.e0" e2="DS.d882.s1.e1" id="DS.d882.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d883" origId="18723022">
        <sentence id="DS.d883.s0" origId="18723022-1306" text="We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express arginase, which is responsible for the hydrolysis of l-arginine to l-ornithine and urea.">
            <entity id="DS.d883.s0.e0" origId="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3" charOffset="118-126" type="protein" text="arginase"/>
            <entity id="DS.d883.s0.e1" origId="232,4367,6322" charOffset="173-181" type="compound" text="arginine"/>
            <entity id="DS.d883.s0.e2" origId="6262" charOffset="185-196" type="compound" text="l-ornithine"/>
            <entity id="DS.d883.s0.e3" origId="1176,265993" charOffset="201-205" type="compound" text="urea"/>
            <pair e1="DS.d883.s0.e1" e2="DS.d883.s0.e0" id="DS.d883.s0.i0" interaction="True"/>
            <pair e1="DS.d883.s0.e3" e2="DS.d883.s0.e0" id="DS.d883.s0.i1" interaction="True"/>
            <pair e1="DS.d883.s0.e2" e2="DS.d883.s0.e0" id="DS.d883.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d884" origId="18723107">
        <sentence id="DS.d884.s0" origId="18723107-1332" text="To overcome this limitation we turned to the yeast Pichia stipitis, which naturally produces xylitol, as a source of xylulokinase (Xyl3).">
            <entity id="DS.d884.s0.e0" origId="6912" charOffset="93-100" type="compound" text="xylitol"/>
            <entity id="DS.d884.s0.e1" origId="O75191,P09099,P12867,P21939,P26909,P27155,P27156,P29444,P35850,P39211,P42826,P44401,P54271,Q3MIF4,Q3SYZ6,Q3TNA1,Q5R830,Q9CFG8,Q9RK00" charOffset="117-129" type="protein" text="xylulokinase"/>
            <pair e1="DS.d884.s0.e0" e2="DS.d884.s0.e1" id="DS.d884.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d884.s1" origId="18723107-1333" text="We examined the effects of plasmid-based expression of Xyl3 versus XylB on growth and xylitol production by engineered E. coli strains.">
            <entity id="DS.d884.s1.e0" origId="O30360,P09099,P12867,P21939,P26909,P27155,P27156,P29444,P35850,P39211,P39849,P44401,P45982,P54271,Q5HL88,Q8CR47,Q9CFG8,Q9RK00" charOffset="67-71" type="protein" text="XylB"/>
            <entity id="DS.d884.s1.e1" origId="6912" charOffset="86-93" type="compound" text="xylitol"/>
            <pair e1="DS.d884.s1.e1" e2="DS.d884.s1.e0" id="DS.d884.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d885" origId="18723121">
        <sentence id="DS.d885.s0" origId="18723121-1340" text="Behavioral and biochemical responses including filtering rates, key phase I, II and antioxidant enzymes and levels of metallothioneins, glutathione, lipid peroxidation and DNA strand breaks were determined in digestive glands of mussels after being exposed to sublethal levels of mercury chloride, methyl mercury, cadmium and Aroclor 1260 during 5 days.">
            <entity id="DS.d885.s0.e0" origId="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568" charOffset="118-134" type="protein" text="metallothioneins"/>
            <entity id="DS.d885.s0.e1" origId="124886" charOffset="136-147" type="compound" text="glutathione"/>
            <pair e1="DS.d885.s0.e1" e2="DS.d885.s0.e0" id="DS.d885.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d886" origId="18723336">
        <sentence id="DS.d886.s0" origId="18723336-870" text="In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (GFP (2)) acceptor and coelenterazine 400a substrate).">
            <entity id="DS.d886.s0.e0" origId="P27918,Q5RBP8,Q64181" charOffset="45-48" type="protein" text="CFP"/>
            <entity id="DS.d886.s0.e1" origId="P21578" charOffset="59-62" type="protein" text="YFP"/>
            <entity id="DS.d886.s0.e2" origId="P08659,P13129,Q01158,Q26304,Q27757" charOffset="118-128" type="protein" text="luciferase"/>
            <entity id="DS.d886.s0.e3" origId="P42212" charOffset="136-161" type="protein" text="green fluorescent protein"/>
            <entity id="DS.d886.s0.e4" origId="P42212" charOffset="167-170" type="protein" text="GFP"/>
            <entity id="DS.d886.s0.e5" origId="22832089" charOffset="189-208" type="compound" text="coelenterazine 400a"/>
            <pair e1="DS.d886.s0.e5" e2="DS.d886.s0.e0" id="DS.d886.s0.i0" interaction="False"/>
            <pair e1="DS.d886.s0.e5" e2="DS.d886.s0.e4" id="DS.d886.s0.i1" interaction="False"/>
            <pair e1="DS.d886.s0.e5" e2="DS.d886.s0.e2" id="DS.d886.s0.i2" interaction="False"/>
            <pair e1="DS.d886.s0.e5" e2="DS.d886.s0.e1" id="DS.d886.s0.i3" interaction="False"/>
            <pair e1="DS.d886.s0.e5" e2="DS.d886.s0.e3" id="DS.d886.s0.i4" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d887" origId="18723342">
        <sentence id="DS.d887.s0" origId="18723342-981" text="If no pretreatment applied, hydrolyses of the textiles by cellulase and beta-glucosidase for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g ethanol/g textiles, which was 25-26% of the corresponding theoretical yield.">
            <entity id="DS.d887.s0.e0" origId="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7" charOffset="58-67" type="protein" text="cellulase"/>
            <entity id="DS.d887.s0.e1" origId="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684" charOffset="72-88" type="protein" text="beta-glucosidase"/>
            <entity id="DS.d887.s0.e2" origId="702" charOffset="200-207" type="compound" text="ethanol"/>
            <pair e1="DS.d887.s0.e2" e2="DS.d887.s0.e1" id="DS.d887.s0.i0" interaction="True"/>
            <pair e1="DS.d887.s0.e2" e2="DS.d887.s0.e0" id="DS.d887.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d888" origId="18723440">
        <sentence id="DS.d888.s0" origId="18723440-1394" text="In cystic fibrosis, this equilibrium is disrupted by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene resulting in the absence of functional CFTR protein, which in turn results in deficient cAMP-dependent Cl (-) secretion and predominant Na (+) absorption.">
            <entity id="DS.d888.s0.e0" origId="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2" charOffset="70-121" type="protein" text="cystic fibrosis transmembrane conductance regulator"/>
            <entity id="DS.d888.s0.e1" origId="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2" charOffset="123-127" type="protein" text="CFTR"/>
            <entity id="DS.d888.s0.e2" origId="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2" charOffset="173-177" type="protein" text="CFTR"/>
            <entity id="DS.d888.s0.e3" origId="6076" charOffset="222-226" type="compound" text="cAMP"/>
            <entity id="DS.d888.s0.e4" origId="312" charOffset="237-239" type="compound" text="Cl"/>
            <entity id="DS.d888.s0.e5" origId="923,373840" charOffset="270-272" type="compound" text="Na"/>
            <pair e1="DS.d888.s0.e5" e2="DS.d888.s0.e1" id="DS.d888.s0.i0" interaction="True"/>
            <pair e1="DS.d888.s0.e3" e2="DS.d888.s0.e1" id="DS.d888.s0.i1" interaction="True"/>
            <pair e1="DS.d888.s0.e5" e2="DS.d888.s0.e0" id="DS.d888.s0.i2" interaction="True"/>
            <pair e1="DS.d888.s0.e3" e2="DS.d888.s0.e0" id="DS.d888.s0.i3" interaction="True"/>
            <pair e1="DS.d888.s0.e4" e2="DS.d888.s0.e1" id="DS.d888.s0.i4" interaction="True"/>
            <pair e1="DS.d888.s0.e4" e2="DS.d888.s0.e0" id="DS.d888.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d889" origId="18723471">
        <sentence id="DS.d889.s0" origId="18723471-1399" text="Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&amp;gt;G) of the PROKR2, which results in a leucine-to-arginine substitution at codon 173.">
            <entity id="DS.d889.s0.e0" origId="Q8NFJ6,Q8SPN1" charOffset="89-95" type="protein" text="PROKR2"/>
            <entity id="DS.d889.s0.e1" origId="857,6106,439524" charOffset="116-123" type="compound" text="leucine"/>
            <entity id="DS.d889.s0.e2" origId="232,4367,6322" charOffset="127-135" type="compound" text="arginine"/>
            <pair e1="DS.d889.s0.e2" e2="DS.d889.s0.e0" id="DS.d889.s0.i0" interaction="True"/>
            <pair e1="DS.d889.s0.e1" e2="DS.d889.s0.e0" id="DS.d889.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d890" origId="18723570">
        <sentence id="DS.d890.s0" origId="18723570-1420" text="Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells.">
            <entity id="DS.d890.s0.e0" origId="446541" charOffset="0-17" type="compound" text="Mycophenolic acid"/>
            <entity id="DS.d890.s0.e1" origId="P08046" charOffset="97-102" type="protein" text="Egr-1"/>
            <pair e1="DS.d890.s0.e0" e2="DS.d890.s0.e1" id="DS.d890.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d891" origId="18723579">
        <sentence id="DS.d891.s0" origId="18723579-1422" text="Angiotensin II (AngII) stimulation of water and NaCl intake is a classic model of the behavioural effects of hormones.">
            <entity id="DS.d891.s0.e0" origId="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0" charOffset="0-14" type="protein" text="Angiotensin II"/>
            <entity id="DS.d891.s0.e1" origId="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0" charOffset="16-21" type="protein" text="AngII"/>
            <entity id="DS.d891.s0.e2" origId="5234" charOffset="48-52" type="compound" text="NaCl"/>
            <pair e1="DS.d891.s0.e2" e2="DS.d891.s0.e1" id="DS.d891.s0.i0" interaction="True"/>
            <pair e1="DS.d891.s0.e2" e2="DS.d891.s0.e0" id="DS.d891.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d891.s1" origId="18723579-1423" text="Previous studies support the hypotheses that PKC is involved in AngII-induced water, but not NaCl intake and that MAP kinase plays a role in NaCl consumption, but not water intake, after injection of AngII.">
            <entity id="DS.d891.s1.e0" origId="P05130,P13677,P13678,P34722" charOffset="45-48" type="protein" text="PKC"/>
            <entity id="DS.d891.s1.e1" origId="5234" charOffset="93-97" type="compound" text="NaCl"/>
            <entity id="DS.d891.s1.e2" origId="5234" charOffset="141-145" type="compound" text="NaCl"/>
            <pair e1="DS.d891.s1.e1" e2="DS.d891.s1.e0" id="DS.d891.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d891.s2" origId="18723579-1424" text="Pretreatment with the PKC inhibitor chelerythrine attenuated AngII-induced water intake, but NaCl intake was unaffected.">
            <entity id="DS.d891.s2.e0" origId="2703,411938" charOffset="36-49" type="compound" text="chelerythrine"/>
            <entity id="DS.d891.s2.e1" origId="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0" charOffset="61-66" type="protein" text="AngII"/>
            <entity id="DS.d891.s2.e2" origId="5234" charOffset="93-97" type="compound" text="NaCl"/>
            <pair e1="DS.d891.s2.e2" e2="DS.d891.s2.e1" id="DS.d891.s2.i0" interaction="False"/>
            <pair e1="DS.d891.s2.e0" e2="DS.d891.s2.e1" id="DS.d891.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d891.s3" origId="18723579-1425" text="In contrast, pretreatment with U0126, a MAP kinase inhibitor, had no effect on AngII-induced water intake, but attenuated NaCl intake.">
            <entity id="DS.d891.s3.e0" origId="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0" charOffset="79-84" type="protein" text="AngII"/>
            <entity id="DS.d891.s3.e1" origId="5234" charOffset="122-126" type="compound" text="NaCl"/>
            <pair e1="DS.d891.s3.e1" e2="DS.d891.s3.e0" id="DS.d891.s3.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d893" origId="18724397">
        <sentence id="DS.d893.s0" origId="18724397-1741" text="The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood glucose and low high-density lipoprotein cholesterol were not.">
            <entity id="DS.d893.s0.e0" origId="206,5793,64689,79025" charOffset="203-210" type="compound" text="glucose"/>
            <entity id="DS.d893.s0.e1" origId="P81182" charOffset="219-243" type="protein" text="high-density lipoprotein"/>
            <entity id="DS.d893.s0.e2" origId="304,5997,6432564,11025495" charOffset="244-255" type="compound" text="cholesterol"/>
            <pair e1="DS.d893.s0.e0" e2="DS.d893.s0.e1" id="DS.d893.s0.i0" interaction="False"/>
            <pair e1="DS.d893.s0.e2" e2="DS.d893.s0.e1" id="DS.d893.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d894" origId="18725236">
        <sentence id="DS.d894.s0" origId="18725236-2014" text="Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in dopamine and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as corticotropin-releasing factor (CRF), in the extended amygdala.">
            <entity id="DS.d894.s0.e0" origId="681" charOffset="129-137" type="compound" text="dopamine"/>
            <entity id="DS.d894.s0.e1" origId="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1" charOffset="245-275" type="protein" text="corticotropin-releasing factor"/>
            <entity id="DS.d894.s0.e2" origId="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1" charOffset="277-280" type="protein" text="CRF"/>
            <pair e1="DS.d894.s0.e0" e2="DS.d894.s0.e2" id="DS.d894.s0.i0" interaction="True"/>
            <pair e1="DS.d894.s0.e0" e2="DS.d894.s0.e1" id="DS.d894.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d895" origId="18726068">
        <sentence id="DS.d895.s0" origId="18726068-972" text="Neither enzymatic activity of transaminases (AST and ALT) nor urea levels were significantly altered.">
            <entity id="DS.d895.s0.e0" origId="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67" charOffset="45-48" type="protein" text="AST"/>
            <entity id="DS.d895.s0.e1" origId="1176,265993" charOffset="62-66" type="compound" text="urea"/>
            <pair e1="DS.d895.s0.e1" e2="DS.d895.s0.e0" id="DS.d895.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d896" origId="18726117">
        <sentence id="DS.d896.s0" origId="18726117-2302" text="On other hand, EGFR gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to gefitinib or erlotinib.">
            <entity id="DS.d896.s0.e0" origId="P00533,P13387,P55245" charOffset="15-19" type="protein" text="EGFR"/>
            <entity id="DS.d896.s0.e1" origId="123631" charOffset="153-162" type="compound" text="gefitinib"/>
            <entity id="DS.d896.s0.e2" origId="176870" charOffset="166-175" type="compound" text="erlotinib"/>
            <pair e1="DS.d896.s0.e1" e2="DS.d896.s0.e0" id="DS.d896.s0.i0" interaction="True"/>
            <pair e1="DS.d896.s0.e2" e2="DS.d896.s0.e0" id="DS.d896.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d897" origId="18726675">
        <sentence id="DS.d897.s0" origId="18726675-2476" text="Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, monocyte chemotactic protein-1, malondialdehyde, osteopontin, and alkaline phosphatase were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.">
            <entity id="DS.d897.s0.e0" origId="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="134-164" type="protein" text="monocyte chemotactic protein-1"/>
            <entity id="DS.d897.s0.e1" origId="10964" charOffset="166-181" type="compound" text="malondialdehyde"/>
            <entity id="DS.d897.s0.e2" origId="O60109,P81800,P83456" charOffset="200-220" type="protein" text="alkaline phosphatase"/>
            <pair e1="DS.d897.s0.e1" e2="DS.d897.s0.e2" id="DS.d897.s0.i0" interaction="False"/>
            <pair e1="DS.d897.s0.e1" e2="DS.d897.s0.e0" id="DS.d897.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d898" origId="18726677">
        <sentence id="DS.d898.s0" origId="18726677-2477" text="Transitions in the tryptophan microenvironment and secondary structure of two monocot lectins from Sauromatum guttatum and Arisaema tortuosum under different denaturing conditions were studied by steady state and time resolved fluorescence and CD spectroscopy.">
            <entity id="DS.d898.s0.e0" origId="1148,6305,9060,5460840" charOffset="19-29" type="compound" text="tryptophan"/>
            <entity id="DS.d898.s0.e1" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="86-93" type="protein" text="lectins"/>
            <pair e1="DS.d898.s0.e0" e2="DS.d898.s0.e1" id="DS.d898.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d898.s1" origId="18726677-2478" text="The lectins exist as tetramers with a single tryptophan residue estimated per monomer, present in a polar environment.">
            <entity id="DS.d898.s1.e0" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="4-11" type="protein" text="lectins"/>
            <entity id="DS.d898.s1.e1" origId="1148,6305,9060,5460840" charOffset="45-55" type="compound" text="tryptophan"/>
            <pair e1="DS.d898.s1.e1" e2="DS.d898.s1.e0" id="DS.d898.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d898.s2" origId="18726677-2479" text="Similarly, both the lectins showed a drastic loss of secondary structure in 5 M Gdn-HCl or 6 M Urea or at pH 2.0 and below.">
            <entity id="DS.d898.s2.e0" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="20-27" type="protein" text="lectins"/>
            <entity id="DS.d898.s2.e1" origId="97535" charOffset="80-83" type="compound" text="Gdn"/>
            <entity id="DS.d898.s2.e2" origId="313" charOffset="84-87" type="compound" text="HCl"/>
            <entity id="DS.d898.s2.e3" origId="1176,265993" charOffset="95-99" type="compound" text="Urea"/>
            <pair e1="DS.d898.s2.e2" e2="DS.d898.s2.e0" id="DS.d898.s2.i0" interaction="True"/>
            <pair e1="DS.d898.s2.e3" e2="DS.d898.s2.e0" id="DS.d898.s2.i1" interaction="True"/>
            <pair e1="DS.d898.s2.e1" e2="DS.d898.s2.e0" id="DS.d898.s2.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d899" origId="18726687">
        <sentence id="DS.d899.s0" origId="18726687-2490" text="In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1), generation of reactive oxygen species (ROS), and NF-kappaB activation in rat BMECs.">
            <entity id="DS.d899.s0.e0" origId="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132" charOffset="201-207" type="protein" text="ICAM-1"/>
            <entity id="DS.d899.s0.e1" origId="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="213-247" type="protein" text="monocyte chemoattractant protein-1"/>
            <entity id="DS.d899.s0.e2" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="249-254" type="protein" text="MCP-1"/>
            <entity id="DS.d899.s0.e3" origId="977" charOffset="280-286" type="compound" text="oxygen"/>
            <pair e1="DS.d899.s0.e3" e2="DS.d899.s0.e1" id="DS.d899.s0.i0" interaction="False"/>
            <pair e1="DS.d899.s0.e3" e2="DS.d899.s0.e0" id="DS.d899.s0.i1" interaction="False"/>
            <pair e1="DS.d899.s0.e3" e2="DS.d899.s0.e2" id="DS.d899.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d900" origId="18726998">
        <sentence id="DS.d900.s0" origId="18726998-19" text="We examined 1,25 dihydroxyvitamin D (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (CYP24) and apical calcium channel (TRPV6) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.">
            <entity id="DS.d900.s0.e0" origId="5280453" charOffset="12-35" type="compound" text="1,25 dihydroxyvitamin D"/>
            <entity id="DS.d900.s0.e1" origId="Q07973" charOffset="115-120" type="protein" text="CYP24"/>
            <entity id="DS.d900.s0.e2" origId="Q9H1D0" charOffset="150-155" type="protein" text="TRPV6"/>
            <pair e1="DS.d900.s0.e0" e2="DS.d900.s0.e2" id="DS.d900.s0.i0" interaction="True"/>
            <pair e1="DS.d900.s0.e0" e2="DS.d900.s0.e1" id="DS.d900.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d901" origId="18727009">
        <sentence id="DS.d901.s0" origId="18727009-26" text="Here, we tested the hypothesis that interactions with DNA-topoisomerases play a role in the DNA-damaging properties of AOH.">
            <entity id="DS.d901.s0.e0" origId="P38086" charOffset="54-72" type="protein" text="DNA-topoisomerases"/>
            <entity id="DS.d901.s0.e1" origId="5359485" charOffset="119-122" type="compound" text="AOH"/>
            <pair e1="DS.d901.s0.e1" e2="DS.d901.s0.e0" id="DS.d901.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d901.s1" origId="18727009-27" text="Next, we selected AOH as the most DNA-damaging Alternaria metabolite for further studies of interactions with DNA topoisomerases.">
            <entity id="DS.d901.s1.e0" origId="5359485" charOffset="18-21" type="compound" text="AOH"/>
            <entity id="DS.d901.s1.e1" origId="P38086" charOffset="110-128" type="protein" text="DNA topoisomerases"/>
            <pair e1="DS.d901.s1.e0" e2="DS.d901.s1.e1" id="DS.d901.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d901.s2" origId="18727009-28" text="Stabilisation of covalent topoisomerase II-DNA intermediates by AOH was also detectable in cell culture, and here, the IIalpha isoform was preferentially targeted.">
            <entity id="DS.d901.s2.e0" origId="O29238,O51934,O58530,O67037,O67226,P74759,P95479,Q08582,Q58907,Q6F598,Q8R979,Q8ZXT5,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9UZ86,Q9YC75,Q9YCB6" charOffset="26-39" type="protein" text="topoisomerase"/>
            <entity id="DS.d901.s2.e1" origId="5359485" charOffset="64-67" type="compound" text="AOH"/>
            <pair e1="DS.d901.s2.e1" e2="DS.d901.s2.e0" id="DS.d901.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d902" origId="18727113">
        <sentence id="DS.d902.s0" origId="18727113-70" text="Bone formation and maturation processes were evaluated by double staining for alkaline phosphatase and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with calcein, and elemental mapping with an electron probe microanalyzer.">
            <entity id="DS.d902.s0.e0" origId="O60109,P81800,P83456" charOffset="78-98" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d902.s0.e1" origId="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7" charOffset="87-98" type="protein" text="phosphatase"/>
            <entity id="DS.d902.s0.e2" origId="O12705,O18559,O57299,O89341,P03314,P03344,P03419,P03426,P03519,P04876,P04888,P05769,P06157,P06166,P06446,P06502,P06503,P06935,P06942,P06943,P07564,P07720,P07873,P08325,P08671,P09732,P09866,P11206,P12446,P12823,P13616,P13844,P14335,P14336,P14340,P14403,P15200,P16287,P16628,P16629,P17748,P17763,P18356,P18611,P19110,P19692,P19718,P22046,P22338,P24266,P24615,P25058,P25182,P25223,P25224,P26034,P27019,P27020,P27287,P27395,P27663,P27910,P27912,P27913,P27915,P29165,P29837,P29838,P29983,P29984,P29990,P29991,P30026,P31035,P31620,P32886,P33478,P33482,P33515,P35947,P35976,P36355,P36356,P41358,P52637,P62683,P62684,P62685,P62689,P62690,P63117,P63126,P63128,P63130,P63145,P87577,P87889,Q01299,Q01427,Q04538,Q074N0,Q1X880,Q1X881,Q66112,Q6DV88,Q6J3P1,Q7LDI9,Q84131,Q88266,Q88428,Q89277,Q91B74,Q96PI4,Q98803,Q9HDB9,Q9IK90,Q9JAF2,Q9NRZ4,Q9UKH8,Q9YNA8,Q9YRV3" charOffset="170-185" type="protein" text="matrix proteins"/>
            <entity id="DS.d902.s0.e3" origId="65079" charOffset="207-214" type="compound" text="calcein"/>
            <pair e1="DS.d902.s0.e3" e2="DS.d902.s0.e1" id="DS.d902.s0.i0" interaction="False"/>
            <pair e1="DS.d902.s0.e3" e2="DS.d902.s0.e2" id="DS.d902.s0.i1" interaction="False"/>
            <pair e1="DS.d902.s0.e3" e2="DS.d902.s0.e0" id="DS.d902.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d903" origId="18728222">
        <sentence id="DS.d903.s0" origId="18728222-493" text="Phosphorylation of insulin receptor substrate (IRS) proteins on serine residues has emerged as a key step in these control processes under both physiological and pathological conditions.">
            <entity id="DS.d903.s0.e0" origId="Q28516" charOffset="19-35" type="protein" text="insulin receptor"/>
            <entity id="DS.d903.s0.e1" origId="P41252,Q8BU30,Q9XTN2" charOffset="47-50" type="protein" text="IRS"/>
            <entity id="DS.d903.s0.e2" origId="5951" charOffset="64-70" type="compound" text="serine"/>
            <pair e1="DS.d903.s0.e2" e2="DS.d903.s0.e1" id="DS.d903.s0.i0" interaction="True"/>
            <pair e1="DS.d903.s0.e2" e2="DS.d903.s0.e0" id="DS.d903.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d904" origId="18728345">
        <sentence id="DS.d904.s0" origId="18728345-519" text="In contrast, SKI-1 (S1P or site-1) is a membrane-bound serine protease inhibitable by AEBSF.">
            <entity id="DS.d904.s0.e0" origId="Q14703,Q9WTZ2,Q9WTZ3,Q9Z2A8" charOffset="13-18" type="protein" text="SKI-1"/>
            <entity id="DS.d904.s0.e1" origId="Q14703,Q9Z2A8" charOffset="20-23" type="protein" text="S1P"/>
            <entity id="DS.d904.s0.e2" origId="P83290" charOffset="55-70" type="protein" text="serine protease"/>
            <entity id="DS.d904.s0.e3" origId="1701" charOffset="86-91" type="compound" text="AEBSF"/>
            <pair e1="DS.d904.s0.e3" e2="DS.d904.s0.e1" id="DS.d904.s0.i0" interaction="True"/>
            <pair e1="DS.d904.s0.e3" e2="DS.d904.s0.e0" id="DS.d904.s0.i1" interaction="True"/>
            <pair e1="DS.d904.s0.e3" e2="DS.d904.s0.e2" id="DS.d904.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d905" origId="18728347">
        <sentence id="DS.d905.s0" origId="18728347-520" text="The progressive ankylosis gene (ank) is a transmembrane protein that transports intracellular pyrophosphate to the extracellular milieu.">
            <entity id="DS.d905.s0.e1" origId="O12164,O41803,O42043,O56861,O70902,O71037,O89292,O91086,P03374,P03375,P03377,P03378,P03379,P03380,P03381,P03383,P03384,P03385,P03386,P03387,P03388,P03390,P03391,P03392,P03396,P03397,P03398,P03399,P04027,P04502,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P06445,P06751,P06752,P07575,P08359,P08360,P08810,P0C212,P10259,P10267,P10269,P11261,P11267,P11268,P11306,P12449,P12487,P12488,P12489,P12492,P14075,P14351,P15073,P15831,P16082,P16090,P16899,P17281,P17755,P18040,P18094,P18799,P19030,P19503,P19549,P19550,P19551,P19556,P19557,P20871,P20872,P20888,P21412,P21415,P21436,P21443,P21445,P22380,P22427,P22428,P22429,P22430,P23064,P23073,P23422,P23423,P24105,P25057,P25504,P25505,P25506,P25507,P26803,P26804,P27399,P27757,P27977,P31621,P31626,P31627,P31789,P31791,P31794,P31796,P31819,P31872,P32536,P32541,P33498,P35954,P35961,P51515,P51519,P51520,P60507,P60508,P61550,P61552,P61553,P61554,P61555,P61556,P61557,P61558,P61559,P61561,P61562,P61563,P61564,P61565,P61566,P61567,P61570,Q02076,Q02077,Q02282,Q02837,Q03804,Q03816,Q03817,Q04993,Q04995,Q05312,Q09SZ7,Q0R5Q9,Q14264,Q1A243,Q1A261,Q69384,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q85646,Q89607,Q8AIH5,Q8MIB6,Q902F8,Q902F9,Q96L62,Q9IDV2,Q9N2J8,Q9N2J9,Q9N2K0,Q9NX77,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9TTC0,Q9UKH3,Q9UQF0,Q9WC60,Q9WC69" charOffset="42-63" type="protein" text="transmembrane protein"/>
            <entity id="DS.d905.s0.e2" origId="644102" charOffset="94-107" type="compound" text="pyrophosphate"/>
            <pair e1="DS.d905.s0.e2" e2="DS.d905.s0.e1" id="DS.d905.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d906" origId="18728678">
        <sentence id="DS.d906.s0" origId="18728678-624" text="Tumor necrosis factor receptor-1 is essential for LPS-induced sensitization and tolerance to oxygen-glucose deprivation in murine neonatal organotypic hippocampal slices.">
            <entity id="DS.d906.s0.e0" origId="Q8JFG3" charOffset="0-21" type="protein" text="Tumor necrosis factor"/>
            <entity id="DS.d906.s0.e1" origId="977" charOffset="93-99" type="compound" text="oxygen"/>
            <entity id="DS.d906.s0.e2" origId="206,5793,64689,79025" charOffset="100-107" type="compound" text="glucose"/>
            <pair e1="DS.d906.s0.e1" e2="DS.d906.s0.e0" id="DS.d906.s0.i0" interaction="True"/>
            <pair e1="DS.d906.s0.e2" e2="DS.d906.s0.e0" id="DS.d906.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d906.s1" origId="18728678-625" text="The role of tumor necrosis factor (TNF) receptors 1 and 2 in lipopolysaccharide (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.">
            <entity id="DS.d906.s1.e0" origId="Q8JFG3" charOffset="12-33" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d906.s1.e1" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="35-38" type="protein" text="TNF"/>
            <entity id="DS.d906.s1.e2" origId="11970143" charOffset="61-79" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d906.s1.e2" e2="DS.d906.s1.e1" id="DS.d906.s1.i2" interaction="True"/>
            <pair e1="DS.d906.s1.e2" e2="DS.d906.s1.e0" id="DS.d906.s1.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d907" origId="18729103">
        <sentence id="DS.d907.s0" origId="18729103-711" text="The immunoblot, ELISA and EMSA analysis demonstrated that the treatment of HCT116 cells with delphinidin resulted in the inhibition of (i) IKKalpha, (ii) phosphorylation and degradation of IkappaBalpha, (iii) phosphorylation of NF-kappaB/p65 at Ser (536), (iv) nuclear translocation of NF-kappaB/p65, (v) NF-kappaB/p65 DNA binding activity, and (vi) transcriptional activation of NF-kappaB.">
            <entity id="DS.d907.s0.e0" origId="128853" charOffset="93-104" type="compound" text="delphinidin"/>
            <entity id="DS.d907.s0.e1" origId="O15111,Q60680" charOffset="139-147" type="protein" text="IKKalpha"/>
            <entity id="DS.d907.s0.e2" origId="P25963,Q08353,Q63746,Q91974,Q9Z1E3" charOffset="189-201" type="protein" text="IkappaBalpha"/>
            <entity id="DS.d907.s0.e3" origId="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3" charOffset="238-241" type="protein" text="p65"/>
            <entity id="DS.d907.s0.e4" origId="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3" charOffset="296-299" type="protein" text="p65"/>
            <entity id="DS.d907.s0.e5" origId="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3" charOffset="296-299" type="protein" text="p65"/>
            <pair e1="DS.d907.s0.e0" e2="DS.d907.s0.e3" id="DS.d907.s0.i0" interaction="True"/>
            <pair e1="DS.d907.s0.e0" e2="DS.d907.s0.e1" id="DS.d907.s0.i1" interaction="True"/>
            <pair e1="DS.d907.s0.e0" e2="DS.d907.s0.e2" id="DS.d907.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d908" origId="18729824">
        <sentence id="DS.d908.s0" origId="18729824-936" text="Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions.">
            <entity id="DS.d908.s0.e0" origId="5983,14107712" charOffset="17-30" type="compound" text="physostigmine"/>
            <entity id="DS.d908.s0.e1" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="52-72" type="protein" text="acetylcholinesterase"/>
            <pair e1="DS.d908.s0.e0" e2="DS.d908.s0.e1" id="DS.d908.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d908.s1" origId="18729824-937" text="The role of the functional architecture of the HuAChE (human acetylcholinesterase) in reactivity toward the carbamates pyridostigmine, rivastigmine and several analogues of physostigmine, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.">
            <entity id="DS.d908.s1.e0" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="61-81" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d908.s1.e1" origId="4991" charOffset="119-133" type="compound" text="pyridostigmine"/>
            <entity id="DS.d908.s1.e2" origId="77991" charOffset="135-147" type="compound" text="rivastigmine"/>
            <entity id="DS.d908.s1.e3" origId="5983,14107712" charOffset="173-186" type="compound" text="physostigmine"/>
            <pair e1="DS.d908.s1.e2" e2="DS.d908.s1.e0" id="DS.d908.s1.i0" interaction="True"/>
            <pair e1="DS.d908.s1.e3" e2="DS.d908.s1.e0" id="DS.d908.s1.i1" interaction="True"/>
            <pair e1="DS.d908.s1.e1" e2="DS.d908.s1.e0" id="DS.d908.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d909" origId="18751681">
        <sentence id="DS.d909.s0" origId="18751681-68" text="Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (SOD), or ruthenium red (RuR).">
            <entity id="DS.d909.s0.e0" origId="1983" charOffset="31-35" type="compound" text="APAP"/>
            <entity id="DS.d909.s0.e1" origId="550788" charOffset="90-113" type="compound" text="L-arginine methyl ester"/>
            <entity id="DS.d909.s0.e2" origId="O50258" charOffset="124-144" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d909.s0.e3" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="146-149" type="protein" text="SOD"/>
            <entity id="DS.d909.s0.e4" origId="23950" charOffset="155-164" type="compound" text="ruthenium"/>
            <entity id="DS.d909.s0.e5" origId="4971" charOffset="170-173" type="compound" text="RuR"/>
            <pair e1="DS.d909.s0.e4" e2="DS.d909.s0.e2" id="DS.d909.s0.i0" interaction="False"/>
            <pair e1="DS.d909.s0.e4" e2="DS.d909.s0.e3" id="DS.d909.s0.i1" interaction="False"/>
            <pair e1="DS.d909.s0.e5" e2="DS.d909.s0.e2" id="DS.d909.s0.i2" interaction="False"/>
            <pair e1="DS.d909.s0.e1" e2="DS.d909.s0.e3" id="DS.d909.s0.i3" interaction="False"/>
            <pair e1="DS.d909.s0.e5" e2="DS.d909.s0.e3" id="DS.d909.s0.i4" interaction="False"/>
            <pair e1="DS.d909.s0.e0" e2="DS.d909.s0.e2" id="DS.d909.s0.i5" interaction="False"/>
            <pair e1="DS.d909.s0.e1" e2="DS.d909.s0.e2" id="DS.d909.s0.i6" interaction="False"/>
            <pair e1="DS.d909.s0.e0" e2="DS.d909.s0.e3" id="DS.d909.s0.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d910" origId="18751889">
        <sentence id="DS.d910.s0" origId="18751889-128" text="Synaptic vesicle-bound pyruvate kinase can support vesicular glutamate uptake.">
            <entity id="DS.d910.s0.e0" origId="O05118,O06134,O08309,O44006,O51323,O62619,O94122,P19680,P22360,P30614,P31865,P32044,P34038,P43924,P46614,P47458,P51181,P51182,P57404,P70789,P78031,P80885,P81344,P94685,P94939,Q02499,Q04668,Q07637,Q10208,Q12669,Q27686,Q27788,Q44473,Q46078,Q46289,Q56301,Q57572,Q6BS75,Q759A9,Q7RVA8,Q875M9,Q875S4,Q875Z9,Q89AI8,Q8FP04,Q8K9M3,Q9PK61,Q9Z984" charOffset="23-38" type="protein" text="pyruvate kinase"/>
            <entity id="DS.d910.s0.e1" origId="611,23327,33032" charOffset="61-70" type="compound" text="glutamate"/>
            <pair e1="DS.d910.s0.e1" e2="DS.d910.s0.e0" id="DS.d910.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d910.s1" origId="18751889-129" text="We present evidence that ATP generated by synaptic vesicle-associated pyruvate kinase is harnessed to transport glutamate into synaptic vesicles.">
            <entity id="DS.d910.s1.e0" origId="O05118,O06134,O08309,O44006,O51323,O62619,O94122,P19680,P22360,P30614,P31865,P32044,P34038,P43924,P46614,P47458,P51181,P51182,P57404,P70789,P78031,P80885,P81344,P94685,P94939,Q02499,Q04668,Q07637,Q10208,Q12669,Q27686,Q27788,Q44473,Q46078,Q46289,Q56301,Q57572,Q6BS75,Q759A9,Q7RVA8,Q875M9,Q875S4,Q875Z9,Q89AI8,Q8FP04,Q8K9M3,Q9PK61,Q9Z984" charOffset="70-85" type="protein" text="pyruvate kinase"/>
            <entity id="DS.d910.s1.e1" origId="611,23327,33032" charOffset="112-121" type="compound" text="glutamate"/>
            <pair e1="DS.d910.s1.e1" e2="DS.d910.s1.e0" id="DS.d910.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d911" origId="18751891">
        <sentence id="DS.d911.s0" origId="18751891-135" text="We examined the expression of Phgdh and ASCT1 in kainic acid (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.">
            <entity id="DS.d911.s0.e0" origId="O08651,Q61753" charOffset="30-35" type="protein" text="Phgdh"/>
            <entity id="DS.d911.s0.e1" origId="O35874,P43007" charOffset="40-45" type="protein" text="ASCT1"/>
            <entity id="DS.d911.s0.e2" origId="10255" charOffset="49-60" type="compound" text="kainic acid"/>
            <pair e1="DS.d911.s0.e2" e2="DS.d911.s0.e0" id="DS.d911.s0.i0" interaction="True"/>
            <pair e1="DS.d911.s0.e2" e2="DS.d911.s0.e1" id="DS.d911.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d912" origId="18751892">
        <sentence id="DS.d912.s0" origId="18751892-136" text="In the present study the effect of the convulsant drug 3-mercaptopropionic acid (MP) repetitive administration (4-7 days) on the hippocampal NR2B subunit was studied.">
            <entity id="DS.d912.s0.e0" origId="6514" charOffset="55-79" type="compound" text="3-mercaptopropionic acid"/>
            <entity id="DS.d912.s0.e1" origId="Q00960,Q01097,Q13224" charOffset="141-145" type="protein" text="NR2B"/>
            <pair e1="DS.d912.s0.e0" e2="DS.d912.s0.e1" id="DS.d912.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d912.s1" origId="18751892-137" text="A significant decrease in NR2B in the whole hippocampus was observed after MP4 with a tendency to recover to normal values in MP7 by western blot assay.">
            <entity id="DS.d912.s1.e0" origId="Q00960,Q01097,Q13224" charOffset="26-30" type="protein" text="NR2B"/>
            <entity id="DS.d912.s1.e1" origId="49766501" charOffset="126-129" type="compound" text="MP7"/>
            <pair e1="DS.d912.s1.e1" e2="DS.d912.s1.e0" id="DS.d912.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d913" origId="18751894">
        <sentence id="DS.d913.s0" origId="18751894-139" text="Heart glycogen represents a store of glucosyl residues which are mobilized by the catalysis of glycogen phosphorylase (GP) and are mainly destined to serve as substrates for the generation of ATP.">
            <entity id="DS.d913.s0.e0" origId="O66932,O84250,P06738,P0AC86,P0AC87,P39123,P45180,P73511,Q10639,Q7U078,Q9CN90,Q9PKE6,Q9XTL9,Q9Z8N1" charOffset="95-117" type="protein" text="glycogen phosphorylase"/>
            <entity id="DS.d913.s0.e1" origId="5957" charOffset="192-195" type="compound" text="ATP"/>
            <pair e1="DS.d913.s0.e1" e2="DS.d913.s0.e0" id="DS.d913.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d914" origId="18752001">
        <sentence id="DS.d914.s0" origId="18752001-187" text="However, phenformin was equally effective in AMPKalpha1(-/-) and wild-type animals, suggesting additional AMPK-independent action of phenformin.">
            <entity id="DS.d914.s0.e0" origId="8249" charOffset="9-19" type="compound" text="phenformin"/>
            <entity id="DS.d914.s0.e1" origId="P54646,Q09136,Q9Y478" charOffset="45-49" type="protein" text="AMPK"/>
            <entity id="DS.d914.s0.e2" origId="8249" charOffset="133-143" type="compound" text="phenformin"/>
            <pair e1="DS.d914.s0.e0" e2="DS.d914.s0.e1" id="DS.d914.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d915" origId="18752070">
        <sentence id="DS.d915.s0" origId="18752070-205" text="The relationship between prolactin (PRL), leptin, nitric oxide (NO), and cytokines in patients with hyperprolactinemia.">
            <entity id="DS.d915.s0.e0" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="25-34" type="protein" text="prolactin"/>
            <entity id="DS.d915.s0.e1" origId="O62781,O62819,O93337,P01236,P01237,P01238,P01239,P01240,P06879,P09585,P10765,P12420,P14676,P17572,P21993,P22393,P29234,P29235,P33089,P33090,P33091,P33096,P34181,P35395,P37884,P40424,P43001,P43299,P46403,P48096,P48249,P51904,P55151,P87495,Q28318,Q28632,Q3Y4G6,Q6UC74,Q7ZZV3,Q8HXS1,Q9QZL1,Q9YGV6" charOffset="36-39" type="protein" text="PRL"/>
            <entity id="DS.d915.s0.e2" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="42-48" type="protein" text="leptin"/>
            <entity id="DS.d915.s0.e3" origId="145068" charOffset="50-62" type="compound" text="nitric oxide"/>
            <pair e1="DS.d915.s0.e3" e2="DS.d915.s0.e1" id="DS.d915.s0.i0" interaction="False"/>
            <pair e1="DS.d915.s0.e3" e2="DS.d915.s0.e0" id="DS.d915.s0.i1" interaction="False"/>
            <pair e1="DS.d915.s0.e3" e2="DS.d915.s0.e2" id="DS.d915.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d915.s1" origId="18752070-206" text="The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), nitric oxide (NO) levels in patients with hyperprolactinemia.">
            <entity id="DS.d915.s1.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="60-66" type="protein" text="leptin"/>
            <entity id="DS.d915.s1.e1" origId="Q8JFG3" charOffset="68-89" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d915.s1.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="97-106" type="protein" text="TNF-alpha"/>
            <entity id="DS.d915.s1.e3" origId="P41693" charOffset="109-122" type="protein" text="interleukin-6"/>
            <entity id="DS.d915.s1.e4" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="124-128" type="protein" text="IL-6"/>
            <entity id="DS.d915.s1.e5" origId="145068" charOffset="131-143" type="compound" text="nitric oxide"/>
            <pair e1="DS.d915.s1.e5" e2="DS.d915.s1.e0" id="DS.d915.s1.i0" interaction="False"/>
            <pair e1="DS.d915.s1.e5" e2="DS.d915.s1.e4" id="DS.d915.s1.i1" interaction="False"/>
            <pair e1="DS.d915.s1.e5" e2="DS.d915.s1.e1" id="DS.d915.s1.i2" interaction="False"/>
            <pair e1="DS.d915.s1.e5" e2="DS.d915.s1.e2" id="DS.d915.s1.i3" interaction="False"/>
            <pair e1="DS.d915.s1.e5" e2="DS.d915.s1.e3" id="DS.d915.s1.i4" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d916" origId="18752089">
        <sentence id="DS.d916.s0" origId="18752089-210" text="Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant-174G&amp;gt;C with circulating glucose levels, interleukin-6 levels, and body mass index.">
            <entity id="DS.d916.s0.e0" origId="O35736,P05231,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="90-93" type="protein" text="IL6"/>
            <entity id="DS.d916.s0.e1" origId="206,5793,64689,79025" charOffset="129-136" type="compound" text="glucose"/>
            <entity id="DS.d916.s0.e2" origId="P41693" charOffset="145-158" type="protein" text="interleukin-6"/>
            <pair e1="DS.d916.s0.e1" e2="DS.d916.s0.e2" id="DS.d916.s0.i0" interaction="False"/>
            <pair e1="DS.d916.s0.e1" e2="DS.d916.s0.e0" id="DS.d916.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d917" origId="18752284">
        <sentence id="DS.d917.s0" origId="18752284-283" text="Effect of cytochrome P450 3A5 *3 genotype on the stereoselective pharmacokinetics of amlodipine in healthy subjects.">
            <entity id="DS.d917.s0.e0" origId="P20815,P80056" charOffset="10-29" type="protein" text="cytochrome P450 3A5"/>
            <entity id="DS.d917.s0.e1" origId="2162" charOffset="85-95" type="compound" text="amlodipine"/>
            <pair e1="DS.d917.s0.e1" e2="DS.d917.s0.e0" id="DS.d917.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d917.s1" origId="18752284-286" text="In conclusion, the present study showed that despite the evidence that amlodipine is stereoselectively metabolized, CYP3A5 *3 genotype did not affect stereoselective disposition of amlodipine.">
            <entity id="DS.d917.s1.e0" origId="2162" charOffset="71-81" type="compound" text="amlodipine"/>
            <entity id="DS.d917.s1.e1" origId="P20815" charOffset="116-122" type="protein" text="CYP3A5"/>
            <entity id="DS.d917.s1.e2" origId="2162" charOffset="181-191" type="compound" text="amlodipine"/>
            <pair e1="DS.d917.s1.e0" e2="DS.d917.s1.e1" id="DS.d917.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d917.s2" origId="18752284-287" text="It provides the evidence that CYP3A5 *3genotype plays a minor role in the interindividual variability of stereoselective disposition of amlodipine in humans.">
            <entity id="DS.d917.s2.e0" origId="P20815" charOffset="30-36" type="protein" text="CYP3A5"/>
            <entity id="DS.d917.s2.e1" origId="2162" charOffset="136-146" type="compound" text="amlodipine"/>
            <pair e1="DS.d917.s2.e1" e2="DS.d917.s2.e0" id="DS.d917.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d918" origId="18752291">
        <sentence id="DS.d918.s0" origId="18752291-293" text="Tissues were stained for BrdU, Pax-7, vimentin, and haematoxylin and eosin staining.">
            <entity id="DS.d918.s0.e0" origId="6035" charOffset="25-29" type="compound" text="BrdU"/>
            <entity id="DS.d918.s0.e1" origId="P47239" charOffset="31-36" type="protein" text="Pax-7"/>
            <entity id="DS.d918.s0.e2" origId="P02543,P02544,P08670,P09654,P20152,P31000,P48616,P48670,P48674,P84198,Q4R4X4,Q5R1W8,Q92155,Q9MZA9" charOffset="38-46" type="protein" text="vimentin"/>
            <entity id="DS.d918.s0.e3" origId="442514" charOffset="52-64" type="compound" text="haematoxylin"/>
            <pair e1="DS.d918.s0.e3" e2="DS.d918.s0.e1" id="DS.d918.s0.i0" interaction="False"/>
            <pair e1="DS.d918.s0.e0" e2="DS.d918.s0.e1" id="DS.d918.s0.i1" interaction="False"/>
            <pair e1="DS.d918.s0.e0" e2="DS.d918.s0.e2" id="DS.d918.s0.i2" interaction="False"/>
            <pair e1="DS.d918.s0.e3" e2="DS.d918.s0.e2" id="DS.d918.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d919" origId="18752295">
        <sentence id="DS.d919.s0" origId="18752295-295" text="Differences in the expression of inwardly rectifying potassium channels (Kir4.1), glial fibrillary acidic protein (GFAP), and taurine levels in cortical astrocytes were detected using immunohistochemical methods.">
            <entity id="DS.d919.s0.e0" origId="P49655" charOffset="73-79" type="protein" text="Kir4.1"/>
            <entity id="DS.d919.s0.e1" origId="P01538,P01543,P01544,P01545,P08772,P08943,P09617,P09618,P21742,P32032,Q05806,Q42596,Q42597,Q42838,Q8H0Q5,Q8VZK8,Q9C8D6,Q9SBK8" charOffset="99-113" type="protein" text="acidic protein"/>
            <entity id="DS.d919.s0.e2" origId="P03995,P14136,P47819,Q28115" charOffset="115-119" type="protein" text="GFAP"/>
            <entity id="DS.d919.s0.e3" origId="1123" charOffset="126-133" type="compound" text="taurine"/>
            <pair e1="DS.d919.s0.e3" e2="DS.d919.s0.e1" id="DS.d919.s0.i0" interaction="False"/>
            <pair e1="DS.d919.s0.e3" e2="DS.d919.s0.e0" id="DS.d919.s0.i1" interaction="False"/>
            <pair e1="DS.d919.s0.e3" e2="DS.d919.s0.e2" id="DS.d919.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d919.s1" origId="18752295-296" text="Immunohistochemical analysis suggests that the diverse expression of Kir4.1 channels and GFAP as well as differences in the accumulation of taurine might contribute to the distinct ability of astrocytes to regulate their volume.">
            <entity id="DS.d919.s1.e0" origId="P49655" charOffset="69-75" type="protein" text="Kir4.1"/>
            <entity id="DS.d919.s1.e1" origId="P03995,P14136,P47819,Q28115" charOffset="89-93" type="protein" text="GFAP"/>
            <entity id="DS.d919.s1.e2" origId="1123" charOffset="140-147" type="compound" text="taurine"/>
            <pair e1="DS.d919.s1.e2" e2="DS.d919.s1.e0" id="DS.d919.s1.i0" interaction="False"/>
            <pair e1="DS.d919.s1.e2" e2="DS.d919.s1.e1" id="DS.d919.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d920" origId="18752301">
        <sentence id="DS.d920.s0" origId="18752301-300" text="These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by 5'-iodoresiniferatoxin (5 microg) or PKC was inhibited by chelerythrine chloride (5 microg).">
            <entity id="DS.d920.s0.e0" origId="16219535" charOffset="132-154" type="compound" text="5'-iodoresiniferatoxin"/>
            <entity id="DS.d920.s0.e1" origId="P05130,P13677,P13678,P34722" charOffset="169-172" type="protein" text="PKC"/>
            <entity id="DS.d920.s0.e2" origId="2703,411938" charOffset="190-203" type="compound" text="chelerythrine"/>
            <entity id="DS.d920.s0.e3" origId="312" charOffset="204-212" type="compound" text="chloride"/>
            <pair e1="DS.d920.s0.e2" e2="DS.d920.s0.e1" id="DS.d920.s0.i0" interaction="True"/>
            <pair e1="DS.d920.s0.e0" e2="DS.d920.s0.e1" id="DS.d920.s0.i1" interaction="False"/>
            <pair e1="DS.d920.s0.e3" e2="DS.d920.s0.e1" id="DS.d920.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d921" origId="18752305">
        <sentence id="DS.d921.s0" origId="18752305-1438" text="Regulation of the phosphoinositide-3 kinase and mitogen-activated protein kinase signaling pathways by progesterone and its reduced metabolites in the rat brain.">
            <entity id="DS.d921.s0.e0" origId="Q00859" charOffset="48-80" type="protein" text="mitogen-activated protein kinase"/>
            <entity id="DS.d921.s0.e1" origId="5994" charOffset="103-115" type="compound" text="progesterone"/>
            <pair e1="DS.d921.s0.e1" e2="DS.d921.s0.e0" id="DS.d921.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d921.s1" origId="18752305-1439" text="Several growth factors, such as vascular endothelial growth factor, brain-derived neurotrophic factor, and insulin-like growth factor-I are involved in the actions of progesterone in the central nervous system.">
            <entity id="DS.d921.s1.e0" origId="P25430,P25431,P25432,Q06225" charOffset="68-101" type="protein" text="brain-derived neurotrophic factor"/>
            <entity id="DS.d921.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="107-114" type="protein" text="insulin"/>
            <entity id="DS.d921.s1.e2" origId="5994" charOffset="167-179" type="compound" text="progesterone"/>
            <pair e1="DS.d921.s1.e2" e2="DS.d921.s1.e0" id="DS.d921.s1.i0" interaction="True"/>
            <pair e1="DS.d921.s1.e2" e2="DS.d921.s1.e1" id="DS.d921.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d921.s2" origId="18752305-1440" text="Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (p85) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after progesterone administration.">
            <entity id="DS.d921.s2.e0" origId="P29323" charOffset="48-51" type="protein" text="ERK"/>
            <entity id="DS.d921.s2.e1" origId="P07566,P08563,P08564,P14907,P19725,P47825,Q6X2U1,Q6X2U3,Q8VA10,Q99IE6,Q9J6K8" charOffset="89-93" type="protein" text="p110"/>
            <entity id="DS.d921.s2.e2" origId="O43439,P46655,P49846,Q14155" charOffset="115-118" type="protein" text="p85"/>
            <entity id="DS.d921.s2.e3" origId="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0" charOffset="132-136" type="protein" text="PI3K"/>
            <entity id="DS.d921.s2.e4" origId="P31750,Q8INB9" charOffset="167-170" type="protein" text="Akt"/>
            <entity id="DS.d921.s2.e5" origId="5994" charOffset="254-266" type="compound" text="progesterone"/>
            <pair e1="DS.d921.s2.e5" e2="DS.d921.s2.e0" id="DS.d921.s2.i0" interaction="True"/>
            <pair e1="DS.d921.s2.e5" e2="DS.d921.s2.e2" id="DS.d921.s2.i1" interaction="True"/>
            <pair e1="DS.d921.s2.e5" e2="DS.d921.s2.e1" id="DS.d921.s2.i2" interaction="True"/>
            <pair e1="DS.d921.s2.e5" e2="DS.d921.s2.e4" id="DS.d921.s2.i3" interaction="True"/>
            <pair e1="DS.d921.s2.e5" e2="DS.d921.s2.e3" id="DS.d921.s2.i4" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d922" origId="18752414">
        <sentence id="DS.d922.s0" origId="18752414-337" text="In addition, we used PET to evaluate the striatal dopamine transporter availability (DAT) with ((11)C)d-threo-methylphenidate in the patient group.">
            <entity id="DS.d922.s0.e0" origId="P13483,P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6" charOffset="85-88" type="protein" text="DAT"/>
            <entity id="DS.d922.s0.e1" origId="4158" charOffset="110-125" type="compound" text="methylphenidate"/>
            <pair e1="DS.d922.s0.e1" e2="DS.d922.s0.e0" id="DS.d922.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d923" origId="18752468">
        <sentence id="DS.d923.s0" origId="18752468-361" text="Associated with the mitochondrial permeabilization, PdC also induced the release of cytochrome c, which is sensitive to inhibition by DTT.">
            <entity id="DS.d923.s0.e0" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="84-96" type="protein" text="cytochrome c"/>
            <entity id="DS.d923.s0.e1" origId="439352" charOffset="134-137" type="compound" text="DTT"/>
            <pair e1="DS.d923.s0.e1" e2="DS.d923.s0.e0" id="DS.d923.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d924" origId="18752565">
        <sentence id="DS.d924.s0" origId="18752565-399" text="Toll-like receptor 4 (TLR-4)/myeloid differentiation protein-2 complex ligation by lipopolysaccharide induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.">
            <entity id="DS.d924.s0.e0" origId="P23799" charOffset="22-25" type="protein" text="TLR"/>
            <entity id="DS.d924.s0.e1" origId="P03548,P03549,P03550,P05397,P09521,P19818,Q00965,Q01087,Q02966" charOffset="53-62" type="protein" text="protein-2"/>
            <entity id="DS.d924.s0.e2" origId="11970143" charOffset="83-101" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d924.s0.e2" e2="DS.d924.s0.e0" id="DS.d924.s0.i0" interaction="True"/>
            <pair e1="DS.d924.s0.e2" e2="DS.d924.s0.e1" id="DS.d924.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d925" origId="18752633">
        <sentence id="DS.d925.s0" origId="18752633-420" text="Immunohistochemistry was performed on paraffin-embedded sections, using anti-5-methylcytosine (5mc) and anti-Acetyl-Histone H3 (Lys 9).">
            <entity id="DS.d925.s0.e0" origId="65040" charOffset="77-93" type="compound" text="5-methylcytosine"/>
            <entity id="DS.d925.s0.e1" origId="P02299,P07041,P08437,P08898,P22843,P23753,P40285,P50564,P61830,P61831,P61832,P61833,P61834,P61835,P61836,P80553,P83864,P84235,P84236,P84237,P84238,P84239,P90543,Q06196,Q2UCQ0,Q5DWI3,Q757N1,Q7XYZ0,Q98RY4,Q9HDN1,Q9P427,Q9U7D1" charOffset="116-126" type="protein" text="Histone H3"/>
            <pair e1="DS.d925.s0.e0" e2="DS.d925.s0.e1" id="DS.d925.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d926" origId="18752635">
        <sentence id="DS.d926.s0" origId="18752635-423" text="Here, the NCX-mediated (45)Ca(2+) uptake was compared in Na (+)-loaded pig coronary artery smooth muscle and endothelial cells.">
            <entity id="DS.d926.s0.e0" origId="O43763" charOffset="10-13" type="protein" text="NCX"/>
            <entity id="DS.d926.s0.e1" origId="923,373840" charOffset="57-59" type="compound" text="Na"/>
            <pair e1="DS.d926.s0.e1" e2="DS.d926.s0.e0" id="DS.d926.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d926.s1" origId="18752635-425" text="The concept of a linkage between NCX and SERCA in smooth muscle was also confirmed by similar distribution of NCX and SERCA2 proteins when detergent-treated microsomes were fractionated by flotation on sucrose density gradients.">
            <entity id="DS.d926.s1.e0" origId="O43763" charOffset="33-36" type="protein" text="NCX"/>
            <entity id="DS.d926.s1.e1" origId="O43763" charOffset="110-113" type="protein" text="NCX"/>
            <entity id="DS.d926.s1.e2" origId="O46674,O55143,P11507,P11607,P16615,P20647,Q00779,Q03669" charOffset="118-124" type="protein" text="SERCA2"/>
            <entity id="DS.d926.s1.e3" origId="5988" charOffset="202-209" type="compound" text="sucrose"/>
            <pair e1="DS.d926.s1.e3" e2="DS.d926.s1.e2" id="DS.d926.s1.i0" interaction="False"/>
            <pair e1="DS.d926.s1.e3" e2="DS.d926.s1.e0" id="DS.d926.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d927" origId="18752971">
        <sentence id="DS.d927.s0" origId="18752971-536" text="The recent approval of sunitinib, sorafenib, temsirolimus and bevacizumab in combination with IFN-alpha has revolutionized the management of renal cell carcinoma.">
            <entity id="DS.d927.s0.e0" origId="5329102" charOffset="23-32" type="compound" text="sunitinib"/>
            <entity id="DS.d927.s0.e1" origId="216239" charOffset="34-43" type="compound" text="sorafenib"/>
            <entity id="DS.d927.s0.e2" origId="148191,6918289,18293306,23724530,24847874,53486199,54608508" charOffset="45-57" type="compound" text="temsirolimus"/>
            <entity id="DS.d927.s0.e3" origId="P35849" charOffset="94-103" type="protein" text="IFN-alpha"/>
            <pair e1="DS.d927.s0.e2" e2="DS.d927.s0.e3" id="DS.d927.s0.i0" interaction="False"/>
            <pair e1="DS.d927.s0.e1" e2="DS.d927.s0.e3" id="DS.d927.s0.i1" interaction="False"/>
            <pair e1="DS.d927.s0.e0" e2="DS.d927.s0.e3" id="DS.d927.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d928" origId="18753126">
        <sentence id="DS.d928.s0" origId="18753126-578" text="Here we report identification of the first three in vivo non-histone protein substrates of lysine propionylation in eukaryotic cells: p53, p300, and CREB-binding protein.">
            <entity id="DS.d928.s0.e0" origId="866,5962" charOffset="91-97" type="compound" text="lysine"/>
            <entity id="DS.d928.s0.e1" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="134-137" type="protein" text="p53"/>
            <entity id="DS.d928.s0.e2" origId="Q01705,Q09472" charOffset="139-143" type="protein" text="p300"/>
            <entity id="DS.d928.s0.e3" origId="P45481,Q92793" charOffset="149-169" type="protein" text="CREB-binding protein"/>
            <pair e1="DS.d928.s0.e0" e2="DS.d928.s0.e3" id="DS.d928.s0.i0" interaction="True"/>
            <pair e1="DS.d928.s0.e0" e2="DS.d928.s0.e1" id="DS.d928.s0.i1" interaction="True"/>
            <pair e1="DS.d928.s0.e0" e2="DS.d928.s0.e2" id="DS.d928.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d928.s1" origId="18753126-580" text="p300 was able to perform autopropionylation on lysine residues in cells.">
            <entity id="DS.d928.s1.e0" origId="Q01705,Q09472" charOffset="0-4" type="protein" text="p300"/>
            <entity id="DS.d928.s1.e1" origId="866,5962" charOffset="47-53" type="compound" text="lysine"/>
            <pair e1="DS.d928.s1.e1" e2="DS.d928.s1.e0" id="DS.d928.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d929" origId="18753604">
        <sentence id="DS.d929.s0" origId="18753604-688" text="This study determined the effects of the estrous cycle, pregnancy, progesterone (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.">
            <entity id="DS.d929.s0.e0" origId="5994" charOffset="67-79" type="compound" text="progesterone"/>
            <entity id="DS.d929.s0.e1" origId="P10637,P16525,P19332,P58384" charOffset="101-104" type="protein" text="tau"/>
            <entity id="DS.d929.s0.e2" origId="O46633,P28171,P28172,Q95187" charOffset="106-110" type="protein" text="IFNT"/>
            <entity id="DS.d929.s0.e3" origId="P11166,P13355,P20303,P27674,P46896,P79365" charOffset="148-154" type="protein" text="SLC2A1"/>
            <entity id="DS.d929.s0.e4" origId="O62787,P11169,P28568,P47842,P47843,P58352,Q5R608,Q9XSC2" charOffset="156-162" type="protein" text="SLC2A3"/>
            <entity id="DS.d929.s0.e5" origId="P14672,Q27994,Q9XST2,Q9XT10" charOffset="168-174" type="protein" text="SLC2A4"/>
            <entity id="DS.d929.s0.e6" origId="P11170,P13866,P26429,P53791" charOffset="198-204" type="protein" text="SLC5A1"/>
            <entity id="DS.d929.s0.e7" origId="P23586" charOffset="218-238" type="protein" text="glucose transporters"/>
            <pair e1="DS.d929.s0.e0" e2="DS.d929.s0.e3" id="DS.d929.s0.i0" interaction="True"/>
            <pair e1="DS.d929.s0.e0" e2="DS.d929.s0.e4" id="DS.d929.s0.i1" interaction="True"/>
            <pair e1="DS.d929.s0.e0" e2="DS.d929.s0.e6" id="DS.d929.s0.i2" interaction="True"/>
            <pair e1="DS.d929.s0.e0" e2="DS.d929.s0.e7" id="DS.d929.s0.i3" interaction="True"/>
            <pair e1="DS.d929.s0.e0" e2="DS.d929.s0.e5" id="DS.d929.s0.i4" interaction="True"/>
            <pair e1="DS.d929.s0.e0" e2="DS.d929.s0.e2" id="DS.d929.s0.i5" interaction="False"/>
            <pair e1="DS.d929.s0.e0" e2="DS.d929.s0.e1" id="DS.d929.s0.i6" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d930" origId="18753675">
        <sentence id="DS.d930.s0" origId="18753675-708" text="In CD36-D patients, plasma triglycerides, apolipoprotein B-48 (apoB-48), free fatty acids (FFAs), and free glycerol levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.">
            <entity id="DS.d930.s0.e0" origId="P16671,P26201,P70110" charOffset="3-7" type="protein" text="CD36"/>
            <entity id="DS.d930.s0.e1" origId="P04114" charOffset="42-61" type="protein" text="apolipoprotein B-48"/>
            <entity id="DS.d930.s0.e2" origId="P04114" charOffset="63-70" type="protein" text="apoB-48"/>
            <entity id="DS.d930.s0.e3" origId="753" charOffset="107-115" type="compound" text="glycerol"/>
            <pair e1="DS.d930.s0.e3" e2="DS.d930.s0.e0" id="DS.d930.s0.i0" interaction="False"/>
            <pair e1="DS.d930.s0.e3" e2="DS.d930.s0.e2" id="DS.d930.s0.i1" interaction="False"/>
            <pair e1="DS.d930.s0.e3" e2="DS.d930.s0.e1" id="DS.d930.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d931" origId="18753676">
        <sentence id="DS.d931.s0" origId="18753676-709" text="Identification of SMEK2 as a candidate gene for regulation of responsiveness to dietary cholesterol in rats.">
            <entity id="DS.d931.s0.e0" origId="Q5MIZ7" charOffset="18-23" type="protein" text="SMEK2"/>
            <entity id="DS.d931.s0.e1" origId="304,5997,6432564,11025495" charOffset="88-99" type="compound" text="cholesterol"/>
            <pair e1="DS.d931.s0.e1" e2="DS.d931.s0.e0" id="DS.d931.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d931.s1" origId="18753676-710" text="Here we narrowed Dihc2 to a region including 33 genes and predicted transcripts and identified RGD1309450_predicted, a homologous gene of SMEK2, as a strong candidate for responsiveness to dietary cholesterol.">
            <entity id="DS.d931.s1.e0" origId="Q5MIZ7" charOffset="138-143" type="protein" text="SMEK2"/>
            <entity id="DS.d931.s1.e1" origId="304,5997,6432564,11025495" charOffset="197-208" type="compound" text="cholesterol"/>
            <pair e1="DS.d931.s1.e1" e2="DS.d931.s1.e0" id="DS.d931.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d932" origId="18753737">
        <sentence id="DS.d932.s0" origId="18753737-733" text="Testosterone is a strong correlate of ghrelin levels in men and postmenopausal women.">
            <entity id="DS.d932.s0.e0" origId="6013" charOffset="0-12" type="compound" text="Testosterone"/>
            <entity id="DS.d932.s0.e1" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="38-45" type="protein" text="ghrelin"/>
            <pair e1="DS.d932.s0.e0" e2="DS.d932.s0.e1" id="DS.d932.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d933" origId="18754081">
        <sentence id="DS.d933.s0" origId="18754081-829" text="Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% sulfuric acid at 140 degrees C for 30 min and enzymatic hydrolysis with cellulase (15 filter per unit (FPU)/g cellulose) and beta-glucosidase (50 cellobiose units (CBU)/g cellulose).">
            <entity id="DS.d933.s0.e0" origId="1118" charOffset="98-111" type="compound" text="sulfuric acid"/>
            <entity id="DS.d933.s0.e1" origId="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7" charOffset="170-179" type="protein" text="cellulase"/>
            <entity id="DS.d933.s0.e2" origId="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684" charOffset="223-239" type="protein" text="beta-glucosidase"/>
            <pair e1="DS.d933.s0.e0" e2="DS.d933.s0.e2" id="DS.d933.s0.i0" interaction="False"/>
            <pair e1="DS.d933.s0.e0" e2="DS.d933.s0.e1" id="DS.d933.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d934" origId="18754092">
        <sentence id="DS.d934.s0" origId="18754092-832" text="Glutathione (GSH), catalase (CAT), and malondialdehyde (MDA) activities in blood were measured.">
            <entity id="DS.d934.s0.e0" origId="124886" charOffset="0-11" type="compound" text="Glutathione"/>
            <entity id="DS.d934.s0.e1" origId="124886" charOffset="13-16" type="compound" text="GSH"/>
            <entity id="DS.d934.s0.e2" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="19-27" type="protein" text="catalase"/>
            <entity id="DS.d934.s0.e3" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="29-32" type="protein" text="CAT"/>
            <entity id="DS.d934.s0.e4" origId="10964" charOffset="39-54" type="compound" text="malondialdehyde"/>
            <pair e1="DS.d934.s0.e0" e2="DS.d934.s0.e3" id="DS.d934.s0.i0" interaction="False"/>
            <pair e1="DS.d934.s0.e1" e2="DS.d934.s0.e3" id="DS.d934.s0.i1" interaction="False"/>
            <pair e1="DS.d934.s0.e4" e2="DS.d934.s0.e3" id="DS.d934.s0.i2" interaction="False"/>
            <pair e1="DS.d934.s0.e1" e2="DS.d934.s0.e2" id="DS.d934.s0.i3" interaction="False"/>
            <pair e1="DS.d934.s0.e4" e2="DS.d934.s0.e2" id="DS.d934.s0.i4" interaction="False"/>
            <pair e1="DS.d934.s0.e0" e2="DS.d934.s0.e2" id="DS.d934.s0.i5" interaction="False"/>
        </sentence>
        <sentence id="DS.d934.s1" origId="18754092-833" text="Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and nitric oxide (NO) activities were measured from tissue samples.">
            <entity id="DS.d934.s1.e0" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="0-8" type="protein" text="Catalase"/>
            <entity id="DS.d934.s1.e1" origId="P05164,P11247" charOffset="27-30" type="protein" text="MPO"/>
            <entity id="DS.d934.s1.e2" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="33-55" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d934.s1.e3" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="66-87" type="protein" text="glutathione reductase"/>
            <entity id="DS.d934.s1.e4" origId="10964" charOffset="94-109" type="compound" text="malondialdehyde"/>
            <entity id="DS.d934.s1.e5" origId="145068" charOffset="115-127" type="compound" text="nitric oxide"/>
            <pair e1="DS.d934.s1.e4" e2="DS.d934.s1.e1" id="DS.d934.s1.i0" interaction="False"/>
            <pair e1="DS.d934.s1.e5" e2="DS.d934.s1.e3" id="DS.d934.s1.i1" interaction="False"/>
            <pair e1="DS.d934.s1.e5" e2="DS.d934.s1.e0" id="DS.d934.s1.i2" interaction="False"/>
            <pair e1="DS.d934.s1.e4" e2="DS.d934.s1.e2" id="DS.d934.s1.i3" interaction="False"/>
            <pair e1="DS.d934.s1.e5" e2="DS.d934.s1.e2" id="DS.d934.s1.i4" interaction="False"/>
            <pair e1="DS.d934.s1.e4" e2="DS.d934.s1.e0" id="DS.d934.s1.i5" interaction="False"/>
            <pair e1="DS.d934.s1.e4" e2="DS.d934.s1.e3" id="DS.d934.s1.i6" interaction="False"/>
            <pair e1="DS.d934.s1.e5" e2="DS.d934.s1.e1" id="DS.d934.s1.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d935" origId="18754101">
        <sentence id="DS.d935.s0" origId="18754101-836" text="In this study we examined the possible antigenotoxic effect of selenium (Se) in rats chronically exposed to low levels of methylmercury (MeHg) and the association between glutathione peroxidase (GSH-Px) activity and DNA lesions (via comet assay) in the same exposed animals.">
            <entity id="DS.d935.s0.e0" origId="7906" charOffset="122-135" type="compound" text="methylmercury"/>
            <entity id="DS.d935.s0.e1" origId="6860" charOffset="137-141" type="compound" text="MeHg"/>
            <entity id="DS.d935.s0.e2" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="171-193" type="protein" text="glutathione peroxidase"/>
            <pair e1="DS.d935.s0.e0" e2="DS.d935.s0.e2" id="DS.d935.s0.i0" interaction="False"/>
            <pair e1="DS.d935.s0.e1" e2="DS.d935.s0.e2" id="DS.d935.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d936" origId="18754103">
        <sentence id="DS.d936.s0" origId="18754103-838" text="To investigate any similarities in the inhibition of CYP2E1 by quinacrine and disulfiram, molecular modeling techniques were adopted and revealed that quinacrine molecule anchors inside the same binding pocket of the protein where disulfiram is also attached.">
            <entity id="DS.d936.s0.e0" origId="O18963,P05181,P08682,P33266,P51581,P79383,Q6GUQ4" charOffset="53-59" type="protein" text="CYP2E1"/>
            <entity id="DS.d936.s0.e1" origId="3117" charOffset="78-88" type="compound" text="disulfiram"/>
            <entity id="DS.d936.s0.e2" origId="3117" charOffset="231-241" type="compound" text="disulfiram"/>
            <pair e1="DS.d936.s0.e1" e2="DS.d936.s0.e0" id="DS.d936.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d937" origId="18754105">
        <sentence id="DS.d937.s0" origId="18754105-839" text="administered during 7 days at 20 mg/kg per day (subacute treatment), resveratrol abrogated LPS-induced erythrocytes lipoperoxidation and catalase (CAT) activity depression to control levels.">
            <entity id="DS.d937.s0.e0" origId="445154" charOffset="69-80" type="compound" text="resveratrol"/>
            <entity id="DS.d937.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="137-145" type="protein" text="catalase"/>
            <entity id="DS.d937.s0.e2" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="147-150" type="protein" text="CAT"/>
            <pair e1="DS.d937.s0.e0" e2="DS.d937.s0.e2" id="DS.d937.s0.i0" interaction="True"/>
            <pair e1="DS.d937.s0.e0" e2="DS.d937.s0.e1" id="DS.d937.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d938" origId="18754702">
        <sentence id="DS.d938.s0" origId="18754702-986" text="H2S can be produced from cysteine by enzymes such as cystathionine beta-synthase.">
            <entity id="DS.d938.s0.e0" origId="594,5862,5360637" charOffset="25-33" type="compound" text="cysteine"/>
            <entity id="DS.d938.s0.e1" origId="P32232,P32582,P35520,P46794,Q58H57,Q91WT9,Q9N0V7,Q9YBL2" charOffset="53-80" type="protein" text="cystathionine beta-synthase"/>
            <pair e1="DS.d938.s0.e0" e2="DS.d938.s0.e1" id="DS.d938.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d939" origId="18754757">
        <sentence id="DS.d939.s0" origId="18754757-1000" text="The influence of carbon sources on rhGH (recombinant human growth hormone) production by two Pichia pastoris strains having different methanol utilization phenotypes (P. pastoris-hGH-Mut (+) and P. pastoris-hGH-Mut (s)) was investigated using batch bioreactors.">
            <entity id="DS.d939.s0.e0" origId="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8" charOffset="59-73" type="protein" text="growth hormone"/>
            <entity id="DS.d939.s0.e1" origId="19314" charOffset="134-142" type="compound" text="methanol"/>
            <pair e1="DS.d939.s0.e1" e2="DS.d939.s0.e0" id="DS.d939.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d940" origId="18754816">
        <sentence id="DS.d940.s0" origId="18754816-1023" text="The present study was undertaken to test the hypothesis that PPARalpha activator fenofibrate plays a key role in left ventricular hypertrophic remodelling via the formation of c-fos/c-jun heterodimers in spontaneous hypertensive rats (SHRs).">
            <entity id="DS.d940.s0.e0" origId="3339" charOffset="81-92" type="compound" text="fenofibrate"/>
            <entity id="DS.d940.s0.e1" origId="P01101,P12841,Q56415" charOffset="178-181" type="protein" text="fos"/>
            <entity id="DS.d940.s0.e2" origId="P05627,P17325,P18289" charOffset="184-187" type="protein" text="jun"/>
            <pair e1="DS.d940.s0.e0" e2="DS.d940.s0.e1" id="DS.d940.s0.i0" interaction="True"/>
            <pair e1="DS.d940.s0.e0" e2="DS.d940.s0.e2" id="DS.d940.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d941" origId="18755047">
        <sentence id="DS.d941.s0" origId="18755047-1448" text="Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats.">
            <entity id="DS.d941.s0.e0" origId="446284" charOffset="11-32" type="compound" text="eicosapentaenoic acid"/>
            <entity id="DS.d941.s0.e1" origId="8857" charOffset="33-44" type="compound" text="ethyl ester"/>
            <entity id="DS.d941.s0.e2" origId="P43490,Q52I78,Q80Z29,Q99KQ4" charOffset="48-56" type="protein" text="visfatin"/>
            <entity id="DS.d941.s0.e3" origId="56841713" charOffset="61-67" type="compound" text="apelin"/>
            <pair e1="DS.d941.s0.e0" e2="DS.d941.s0.e2" id="DS.d941.s0.i0" interaction="False"/>
            <pair e1="DS.d941.s0.e1" e2="DS.d941.s0.e2" id="DS.d941.s0.i1" interaction="False"/>
            <pair e1="DS.d941.s0.e3" e2="DS.d941.s0.e2" id="DS.d941.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d942" origId="18755051">
        <sentence id="DS.d942.s0" origId="18755051-1093" text="In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), HSF (about 454 %) and P-HSF (about 371 %) when compared with ferrous sulfate or ferritin without AA.">
            <entity id="DS.d942.s0.e0" origId="P10961,P12850,P19875,P22121,P22813,P41154,Q02953" charOffset="112-115" type="protein" text="HSF"/>
            <entity id="DS.d942.s0.e1" origId="P10961,P12850,P19875,P22121,P22813,P41154,Q02953" charOffset="136-139" type="protein" text="HSF"/>
            <entity id="DS.d942.s0.e2" origId="1117" charOffset="181-188" type="compound" text="sulfate"/>
            <entity id="DS.d942.s0.e3" origId="Q26061" charOffset="192-200" type="protein" text="ferritin"/>
            <pair e1="DS.d942.s0.e2" e2="DS.d942.s0.e0" id="DS.d942.s0.i0" interaction="False"/>
            <pair e1="DS.d942.s0.e2" e2="DS.d942.s0.e3" id="DS.d942.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d943" origId="18755266">
        <sentence id="DS.d943.s0" origId="18755266-1173" text="Insulin-like growth factor-I (IGF-I) is neuroprotective against ethanol-related toxicity and promotes white matter production following a number of insults.">
            <entity id="DS.d943.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="0-7" type="protein" text="Insulin"/>
            <entity id="DS.d943.s0.e1" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="30-35" type="protein" text="IGF-I"/>
            <entity id="DS.d943.s0.e2" origId="702" charOffset="64-71" type="compound" text="ethanol"/>
            <pair e1="DS.d943.s0.e2" e2="DS.d943.s0.e1" id="DS.d943.s0.i0" interaction="True"/>
            <pair e1="DS.d943.s0.e2" e2="DS.d943.s0.e0" id="DS.d943.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d943.s1" origId="18755266-1174" text="These data indicate that IGF-I may be a potential treatment for some of ethanol's damaging effects, a finding that has important implications for children of women who drink alcohol during pregnancy.">
            <entity id="DS.d943.s1.e0" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="25-30" type="protein" text="IGF-I"/>
            <entity id="DS.d943.s1.e1" origId="702" charOffset="72-79" type="compound" text="ethanol"/>
            <pair e1="DS.d943.s1.e1" e2="DS.d943.s1.e0" id="DS.d943.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d944" origId="18755506">
        <sentence id="DS.d944.s0" origId="18755506-1246" text="This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.">
            <entity id="DS.d944.s0.e0" origId="7979" charOffset="50-82" type="compound" text="triethyleneglycol dimethacrylate"/>
            <entity id="DS.d944.s0.e1" origId="13360" charOffset="96-123" type="compound" text="2-hydroxyethyl methacrylate"/>
            <entity id="DS.d944.s0.e2" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="148-164" type="protein" text="cyclooxygenase-2"/>
            <entity id="DS.d944.s0.e3" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="166-171" type="protein" text="COX-2"/>
            <entity id="DS.d944.s0.e4" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="187-208" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d944.s0.e5" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="210-214" type="protein" text="iNOS"/>
            <pair e1="DS.d944.s0.e0" e2="DS.d944.s0.e2" id="DS.d944.s0.i0" interaction="True"/>
            <pair e1="DS.d944.s0.e0" e2="DS.d944.s0.e3" id="DS.d944.s0.i1" interaction="True"/>
            <pair e1="DS.d944.s0.e0" e2="DS.d944.s0.e5" id="DS.d944.s0.i2" interaction="True"/>
            <pair e1="DS.d944.s0.e1" e2="DS.d944.s0.e4" id="DS.d944.s0.i3" interaction="True"/>
            <pair e1="DS.d944.s0.e1" e2="DS.d944.s0.e3" id="DS.d944.s0.i4" interaction="True"/>
            <pair e1="DS.d944.s0.e1" e2="DS.d944.s0.e5" id="DS.d944.s0.i5" interaction="True"/>
            <pair e1="DS.d944.s0.e0" e2="DS.d944.s0.e4" id="DS.d944.s0.i6" interaction="True"/>
            <pair e1="DS.d944.s0.e1" e2="DS.d944.s0.e2" id="DS.d944.s0.i7" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d945" origId="18755582">
        <sentence id="DS.d945.s0" origId="18755582-1265" text="SWCNT coatings were thus functionalized with poly(adamantane-pyrrole) and applied to the anchoring of glucose oxidase (GOX), modified with beta-cyclodextrin.">
            <entity id="DS.d945.s0.e0" origId="9238" charOffset="50-60" type="compound" text="adamantane"/>
            <entity id="DS.d945.s0.e1" origId="P81156" charOffset="102-117" type="protein" text="glucose oxidase"/>
            <entity id="DS.d945.s0.e2" origId="P05414,Q92452,Q9UJM8,Q9WU19" charOffset="119-122" type="protein" text="GOX"/>
            <pair e1="DS.d945.s0.e0" e2="DS.d945.s0.e2" id="DS.d945.s0.i0" interaction="True"/>
            <pair e1="DS.d945.s0.e0" e2="DS.d945.s0.e1" id="DS.d945.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d945.s1" origId="18755582-1266" text="This allows the immobilization of adamantane-tagged GOX.">
            <entity id="DS.d945.s1.e0" origId="9238" charOffset="34-44" type="compound" text="adamantane"/>
            <entity id="DS.d945.s1.e1" origId="P05414,Q92452,Q9UJM8,Q9WU19" charOffset="52-55" type="protein" text="GOX"/>
            <pair e1="DS.d945.s1.e0" e2="DS.d945.s1.e1" id="DS.d945.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d946" origId="18755616">
        <sentence id="DS.d946.s0" origId="18755616-1270" text="Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study.">
            <entity id="DS.d946.s0.e0" origId="4677798" charOffset="0-6" type="compound" text="Statin"/>
            <entity id="DS.d946.s0.e1" origId="P07580" charOffset="20-41" type="protein" text="morphogenetic protein"/>
            <entity id="DS.d946.s0.e2" origId="P35855" charOffset="43-46" type="protein" text="BMP"/>
            <pair e1="DS.d946.s0.e0" e2="DS.d946.s0.e1" id="DS.d946.s0.i0" interaction="True"/>
            <pair e1="DS.d946.s0.e0" e2="DS.d946.s0.e2" id="DS.d946.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d946.s1" origId="18755616-1271" text="The purpose of this study was to investigate bone morphogenetic protein (BMP) 2 expression after implantation of a statin and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.">
            <entity id="DS.d946.s1.e0" origId="P07580" charOffset="50-71" type="protein" text="morphogenetic protein"/>
            <entity id="DS.d946.s1.e1" origId="P35855" charOffset="73-76" type="protein" text="BMP"/>
            <entity id="DS.d946.s1.e2" origId="4677798" charOffset="115-121" type="compound" text="statin"/>
            <entity id="DS.d946.s1.e3" origId="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751" charOffset="144-149" type="protein" text="BMP-2"/>
            <pair e1="DS.d946.s1.e2" e2="DS.d946.s1.e3" id="DS.d946.s1.i0" interaction="True"/>
            <pair e1="DS.d946.s1.e2" e2="DS.d946.s1.e0" id="DS.d946.s1.i1" interaction="True"/>
            <pair e1="DS.d946.s1.e2" e2="DS.d946.s1.e1" id="DS.d946.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d947" origId="18755796">
        <sentence id="DS.d947.s0" origId="18755796-1307" text="cAMP, a second messenger in LH signaling, was identified as a factor in hCG-dependent regulation of Cdk5/p35.">
            <entity id="DS.d947.s0.e0" origId="6076" charOffset="0-4" type="compound" text="cAMP"/>
            <entity id="DS.d947.s0.e1" origId="P48609,P49615,P51166,Q03114" charOffset="100-104" type="protein" text="Cdk5"/>
            <entity id="DS.d947.s0.e2" origId="P04083,P07150,P08160,P10107,P12723,P14087,P16342,P19619,P19751,P27920,P30047,P31354,P38626,P46193,P51662,P51948,P51949,P61809,P61810,P70552,P99025,Q03148,Q15078,Q28199,Q66198,Q80YF6,Q864V4,Q8V439,Q8V6W7,Q91A29,Q91QT2,Q92108,Q96510,Q96FF9,Q9BT76,Q9PYA3" charOffset="105-108" type="protein" text="p35"/>
            <pair e1="DS.d947.s0.e0" e2="DS.d947.s0.e2" id="DS.d947.s0.i0" interaction="True"/>
            <pair e1="DS.d947.s0.e0" e2="DS.d947.s0.e1" id="DS.d947.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d948" origId="18755820">
        <sentence id="DS.d948.s0" origId="18755820-1310" text="Intracellular production of TNFalpha and IL-2 after stimulation with phorbol myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.">
            <entity id="DS.d948.s0.e0" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="28-36" type="protein" text="TNFalpha"/>
            <entity id="DS.d948.s0.e1" origId="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84" charOffset="41-45" type="protein" text="IL-2"/>
            <entity id="DS.d948.s0.e2" origId="290670,442070,24832117" charOffset="69-76" type="compound" text="phorbol"/>
            <entity id="DS.d948.s0.e3" origId="11005" charOffset="77-86" type="compound" text="myristate"/>
            <entity id="DS.d948.s0.e4" origId="3733,6434517,6912226,25134244" charOffset="87-96" type="compound" text="ionomycin"/>
            <pair e1="DS.d948.s0.e4" e2="DS.d948.s0.e0" id="DS.d948.s0.i0" interaction="True"/>
            <pair e1="DS.d948.s0.e2" e2="DS.d948.s0.e1" id="DS.d948.s0.i1" interaction="True"/>
            <pair e1="DS.d948.s0.e2" e2="DS.d948.s0.e0" id="DS.d948.s0.i2" interaction="True"/>
            <pair e1="DS.d948.s0.e4" e2="DS.d948.s0.e1" id="DS.d948.s0.i3" interaction="True"/>
            <pair e1="DS.d948.s0.e3" e2="DS.d948.s0.e0" id="DS.d948.s0.i4" interaction="True"/>
            <pair e1="DS.d948.s0.e3" e2="DS.d948.s0.e1" id="DS.d948.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d949" origId="18756496">
        <sentence id="DS.d949.s0" origId="18756496-1463" text="Although we reported that 8-Cl-cAMP induces growth inhibition via p38 mitogen-activated protein kinase (MAPK) and a metabolite of 8-Cl-cAMP, 8-Cl-adenosine mediates this process, the action mechanism of 8-Cl-cAMP is still uncertain.">
            <entity id="DS.d949.s0.e0" origId="O42781,P27638,Q00859" charOffset="104-108" type="protein" text="MAPK"/>
            <entity id="DS.d949.s0.e1" origId="60961" charOffset="146-155" type="compound" text="adenosine"/>
            <pair e1="DS.d949.s0.e1" e2="DS.d949.s0.e0" id="DS.d949.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d950" origId="18756527">
        <sentence id="DS.d950.s0" origId="18756527-1486" text="Certain non-steroidal anti-inflammatory drugs, e.g., the cyclooxygenase 2-specific nonsteroidal anti-inflammatory drugs, celecoxib, raise Abeta(42) levels.">
            <entity id="DS.d950.s0.e0" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="57-73" type="protein" text="cyclooxygenase 2"/>
            <entity id="DS.d950.s0.e1" origId="2662" charOffset="121-130" type="compound" text="celecoxib"/>
            <pair e1="DS.d950.s0.e1" e2="DS.d950.s0.e0" id="DS.d950.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d951" origId="18756589">
        <sentence id="DS.d951.s0" origId="18756589-1515" text="This was significantly in accordance with intracellular oxidative stress levels measured by glutathione depletion, malondialdehyde production, superoxide dismutase inhibition as well as reactive oxygen species generation.">
            <entity id="DS.d951.s0.e0" origId="124886" charOffset="92-103" type="compound" text="glutathione"/>
            <entity id="DS.d951.s0.e1" origId="10964" charOffset="115-130" type="compound" text="malondialdehyde"/>
            <entity id="DS.d951.s0.e2" origId="O50258" charOffset="143-163" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d951.s0.e3" origId="977" charOffset="195-201" type="compound" text="oxygen"/>
            <pair e1="DS.d951.s0.e1" e2="DS.d951.s0.e2" id="DS.d951.s0.i0" interaction="False"/>
            <pair e1="DS.d951.s0.e3" e2="DS.d951.s0.e2" id="DS.d951.s0.i1" interaction="False"/>
            <pair e1="DS.d951.s0.e0" e2="DS.d951.s0.e2" id="DS.d951.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d952" origId="18757054">
        <sentence id="DS.d952.s0" origId="18757054-1690" text="Acrolein, IL-6 and CRP as markers of silent brain infarction.">
            <entity id="DS.d952.s0.e0" origId="7847" charOffset="0-8" type="compound" text="Acrolein"/>
            <entity id="DS.d952.s0.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="10-14" type="protein" text="IL-6"/>
            <entity id="DS.d952.s0.e2" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="19-22" type="protein" text="CRP"/>
            <pair e1="DS.d952.s0.e0" e2="DS.d952.s0.e1" id="DS.d952.s0.i0" interaction="False"/>
            <pair e1="DS.d952.s0.e0" e2="DS.d952.s0.e2" id="DS.d952.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d952.s1" origId="18757054-1691" text="We found previously that increased levels of polyamine oxidase (PAO) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (SMO)), and acrolein (CH(2)CHCHO) are good markers of stroke.">
            <entity id="DS.d952.s1.e0" origId="Q6QHF9,Q865R1,Q8C0L6" charOffset="45-62" type="protein" text="polyamine oxidase"/>
            <entity id="DS.d952.s1.e1" origId="O64411,Q6QHF9,Q865R1,Q9FYC2" charOffset="64-67" type="protein" text="PAO"/>
            <entity id="DS.d952.s1.e2" origId="Q99K82,Q9NWM0" charOffset="107-123" type="protein" text="spermine oxidase"/>
            <entity id="DS.d952.s1.e3" origId="O42224,P56726,P97698,Q99835,Q9NWM0" charOffset="125-128" type="protein" text="SMO"/>
            <entity id="DS.d952.s1.e4" origId="7847" charOffset="136-144" type="compound" text="acrolein"/>
            <pair e1="DS.d952.s1.e4" e2="DS.d952.s1.e3" id="DS.d952.s1.i0" interaction="False"/>
            <pair e1="DS.d952.s1.e4" e2="DS.d952.s1.e1" id="DS.d952.s1.i1" interaction="False"/>
            <pair e1="DS.d952.s1.e4" e2="DS.d952.s1.e0" id="DS.d952.s1.i2" interaction="False"/>
            <pair e1="DS.d952.s1.e4" e2="DS.d952.s1.e2" id="DS.d952.s1.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d952.s2" origId="18757054-1692" text="We then investigated whether silent brain infarction (SBI) can be detected by measuring acrolein, PAO, or other biomarkers.">
            <entity id="DS.d952.s2.e0" origId="7847" charOffset="88-96" type="compound" text="acrolein"/>
            <entity id="DS.d952.s2.e1" origId="O64411,Q6QHF9,Q865R1,Q9FYC2" charOffset="98-101" type="protein" text="PAO"/>
            <pair e1="DS.d952.s2.e0" e2="DS.d952.s2.e1" id="DS.d952.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d952.s3" origId="18757054-1693" text="It was found that the levels of protein-conjugated acrolein (PC-Acro), interleukin-6 (IL-6) and C-reactive protein (CRP) were significantly higher in SBI than in normal subjects.">
            <entity id="DS.d952.s3.e0" origId="7847" charOffset="51-59" type="compound" text="acrolein"/>
            <entity id="DS.d952.s3.e1" origId="P41693" charOffset="71-84" type="protein" text="interleukin-6"/>
            <entity id="DS.d952.s3.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="86-90" type="protein" text="IL-6"/>
            <entity id="DS.d952.s3.e3" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="116-119" type="protein" text="CRP"/>
            <pair e1="DS.d952.s3.e0" e2="DS.d952.s3.e1" id="DS.d952.s3.i0" interaction="False"/>
            <pair e1="DS.d952.s3.e0" e2="DS.d952.s3.e2" id="DS.d952.s3.i1" interaction="False"/>
            <pair e1="DS.d952.s3.e0" e2="DS.d952.s3.e3" id="DS.d952.s3.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d953" origId="18757097">
        <sentence id="DS.d953.s0" origId="18757097-1716" text="Human skin keratinocytes HaCat attacked by Staphylococcus aureus alpha-toxin showed a transient drop of cellular ATP levels whereas in toxin-perforated bovine mammary epithelial cells (BMEC), the ATP levels dropped more slowly.">
            <entity id="DS.d953.s0.e0" origId="P09616,P0C216,Q0TV31,Q9RF12" charOffset="65-76" type="protein" text="alpha-toxin"/>
            <entity id="DS.d953.s0.e1" origId="5957" charOffset="113-116" type="compound" text="ATP"/>
            <entity id="DS.d953.s0.e2" origId="5957" charOffset="196-199" type="compound" text="ATP"/>
            <pair e1="DS.d953.s0.e1" e2="DS.d953.s0.e0" id="DS.d953.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d954" origId="18757185">
        <sentence id="DS.d954.s0" origId="18757185-1747" text="Catalepsy, serum prolactin, receptor binding profile and cortical (PFC), hippocampal (Hip) and dopamine (DA) levels were determined.">
            <entity id="DS.d954.s0.e0" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="17-26" type="protein" text="prolactin"/>
            <entity id="DS.d954.s0.e1" origId="681" charOffset="95-103" type="compound" text="dopamine"/>
            <pair e1="DS.d954.s0.e1" e2="DS.d954.s0.e0" id="DS.d954.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d955" origId="18757188">
        <sentence id="DS.d955.s0" origId="18757188-1748" text="Estrogenic effect was determined by the change of uterine weight, and oxidant effects were determined by the content of SOD, GSH-Px, CAT and MDA.">
            <entity id="DS.d955.s0.e0" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="120-123" type="protein" text="SOD"/>
            <entity id="DS.d955.s0.e1" origId="124886" charOffset="125-128" type="compound" text="GSH"/>
            <entity id="DS.d955.s0.e2" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="133-136" type="protein" text="CAT"/>
            <pair e1="DS.d955.s0.e1" e2="DS.d955.s0.e2" id="DS.d955.s0.i0" interaction="False"/>
            <pair e1="DS.d955.s0.e1" e2="DS.d955.s0.e0" id="DS.d955.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d955.s1" origId="18757188-1749" text="The intake of formononetin increased the uterine weight of the mice significantly as well as the content of SOD, GSH-Px, CAT, and reduced MDA in body.">
            <entity id="DS.d955.s1.e0" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="108-111" type="protein" text="SOD"/>
            <entity id="DS.d955.s1.e1" origId="124886" charOffset="113-116" type="compound" text="GSH"/>
            <entity id="DS.d955.s1.e2" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="121-124" type="protein" text="CAT"/>
            <pair e1="DS.d955.s1.e1" e2="DS.d955.s1.e2" id="DS.d955.s1.i0" interaction="False"/>
            <pair e1="DS.d955.s1.e1" e2="DS.d955.s1.e0" id="DS.d955.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d956" origId="18757189">
        <sentence id="DS.d956.s0" origId="18757189-1750" text="A novel sialic acid-specific lectin from Phaseolus coccineus seeds with potent antineoplastic and antifungal activities.">
            <entity id="DS.d956.s0.e0" origId="906,444885,445063" charOffset="8-19" type="compound" text="sialic acid"/>
            <entity id="DS.d956.s0.e1" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="29-35" type="protein" text="lectin"/>
            <pair e1="DS.d956.s0.e0" e2="DS.d956.s0.e1" id="DS.d956.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d956.s1" origId="18757189-1751" text="A novel lectin (PCL) with specificity towards sialic acid was purified from Phaseolus coccineus L. (P. multiflorus willd) seeds using ion exchange chromatography on CM and DEAE-Sepharose, and gel filtration on Sephacryl S-200 column.">
            <entity id="DS.d956.s1.e0" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="8-14" type="protein" text="lectin"/>
            <entity id="DS.d956.s1.e1" origId="906,444885,445063" charOffset="46-57" type="compound" text="sialic acid"/>
            <pair e1="DS.d956.s1.e1" e2="DS.d956.s1.e0" id="DS.d956.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d957" origId="18757233">
        <sentence id="DS.d957.s0" origId="18757233-1762" text="The characterization for the binding of calcium and terbium to Euplotes octocarinatus centrin.">
            <entity id="DS.d957.s0.e0" origId="23958" charOffset="52-59" type="compound" text="terbium"/>
            <entity id="DS.d957.s0.e1" origId="P05434,P41210,P43645,P43646,P53441,P54213,Q06827,Q24956,Q27177,Q27178,Q27179" charOffset="86-93" type="protein" text="centrin"/>
            <pair e1="DS.d957.s0.e0" e2="DS.d957.s0.e1" id="DS.d957.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d958" origId="18757307">
        <sentence id="DS.d958.s0" origId="18757307-1779" text="We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on hyaluronan depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activation.">
            <entity id="DS.d958.s0.e0" origId="P98088" charOffset="42-48" type="protein" text="MUC5AC"/>
            <entity id="DS.d958.s0.e1" origId="24759" charOffset="90-100" type="compound" text="hyaluronan"/>
            <entity id="DS.d958.s0.e2" origId="P55245" charOffset="122-154" type="protein" text="epidermal growth factor receptor"/>
            <entity id="DS.d958.s0.e3" origId="P00533,P13387,P55245" charOffset="156-160" type="protein" text="EGFR"/>
            <entity id="DS.d958.s0.e4" origId="Q00859" charOffset="162-194" type="protein" text="mitogen-activated protein kinase"/>
            <entity id="DS.d958.s0.e5" origId="O42781,P27638,Q00859" charOffset="196-200" type="protein" text="MAPK"/>
            <pair e1="DS.d958.s0.e1" e2="DS.d958.s0.e5" id="DS.d958.s0.i0" interaction="False"/>
            <pair e1="DS.d958.s0.e1" e2="DS.d958.s0.e4" id="DS.d958.s0.i1" interaction="False"/>
            <pair e1="DS.d958.s0.e1" e2="DS.d958.s0.e0" id="DS.d958.s0.i2" interaction="True"/>
            <pair e1="DS.d958.s0.e1" e2="DS.d958.s0.e2" id="DS.d958.s0.i3" interaction="False"/>
            <pair e1="DS.d958.s0.e1" e2="DS.d958.s0.e3" id="DS.d958.s0.i4" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d959" origId="18757495">
        <sentence id="DS.d959.s0" origId="18757495-1808" text="Alkaline phosphatase activity and osteonectin expression of the osteoblasts cultured on the PLGA scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.">
            <entity id="DS.d959.s0.e0" origId="O60109,P81800,P83456" charOffset="0-20" type="protein" text="Alkaline phosphatase"/>
            <entity id="DS.d959.s0.e1" origId="O93390,P07214,P09486,P13213,P16975,P20112,P34714,P36233,P36377,P36378,P36379" charOffset="34-45" type="protein" text="osteonectin"/>
            <entity id="DS.d959.s0.e2" origId="36797" charOffset="92-96" type="compound" text="PLGA"/>
            <pair e1="DS.d959.s0.e2" e2="DS.d959.s0.e1" id="DS.d959.s0.i0" interaction="False"/>
            <pair e1="DS.d959.s0.e2" e2="DS.d959.s0.e0" id="DS.d959.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d959.s1" origId="18757495-1809" text="The alkaline phosphatase activity of osteoblasts cultured on PLGA scaffolds is comparable with that from two commercially-available scaffolds-OPLA and collagen scaffolds (Becton-Dickinson (BD) Inc., Franklin Lakes, NJ, USA).">
            <entity id="DS.d959.s1.e0" origId="O60109,P81800,P83456" charOffset="4-24" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d959.s1.e1" origId="36797" charOffset="61-65" type="compound" text="PLGA"/>
            <pair e1="DS.d959.s1.e1" e2="DS.d959.s1.e0" id="DS.d959.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d960" origId="18757514">
        <sentence id="DS.d960.s0" origId="18757514-1816" text="The vasodilating effect of acetazolamide and dorzolamide involves mechanisms other than carbonic anhydrase inhibition.">
            <entity id="DS.d960.s0.e0" origId="1986" charOffset="27-40" type="compound" text="acetazolamide"/>
            <entity id="DS.d960.s0.e1" origId="5284549" charOffset="45-56" type="compound" text="dorzolamide"/>
            <entity id="DS.d960.s0.e2" origId="P27134,P46281,P46510,P46511,P54212,P84537,Q54735,Q92051,Q9ZN54" charOffset="88-106" type="protein" text="carbonic anhydrase"/>
            <pair e1="DS.d960.s0.e0" e2="DS.d960.s0.e2" id="DS.d960.s0.i0" interaction="False"/>
            <pair e1="DS.d960.s0.e1" e2="DS.d960.s0.e2" id="DS.d960.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d961" origId="18757837">
        <sentence id="DS.d961.s0" origId="18757837-1932" text="The objective of the present study was to investigate the effects of a high-cholesterol diet on caveolin-1 expression and IR localization and activity in the rat liver.">
            <entity id="DS.d961.s0.e0" origId="304,5997,6432564,11025495" charOffset="76-87" type="compound" text="cholesterol"/>
            <entity id="DS.d961.s0.e1" origId="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8" charOffset="96-106" type="protein" text="caveolin-1"/>
            <pair e1="DS.d961.s0.e0" e2="DS.d961.s0.e1" id="DS.d961.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d962" origId="18758183">
        <sentence id="DS.d962.s0" origId="18758183-2073" text="P27 and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and paclitaxel.">
            <entity id="DS.d962.s0.e0" origId="O11451,O11452,O11453,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P06934,P16342,P19751,P25880,P25881,P25882,P25884,P25989,P26660,P26661,P26662,P26663,P26664,P27958,P29833,P29846,P29996,P29997,P40305,P68763,P68764,P68765,P69180,P69181,P69182,P69183,P69184,P69618,P69619,Q00269,Q43735,Q5I2N3,Q66198,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q81835,Q81842,Q8V439,Q8V6W7,Q913D4,Q91A29,Q91DH7,Q91DH8,Q91DH9,Q99IB8,Q9DHD6,Q9E925,Q9PYA3,Q9QAX1,Q9WMX2" charOffset="0-3" type="protein" text="P27"/>
            <entity id="DS.d962.s0.e1" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="8-11" type="protein" text="P53"/>
            <entity id="DS.d962.s0.e2" origId="5040,478951,5284616,5358081,5374464,5460439,5497196,6436030,16760631,17753749,44295234,53627520,54600319" charOffset="157-166" type="compound" text="rapamycin"/>
            <entity id="DS.d962.s0.e3" origId="4666,36314,441276,5352019,6713921,6915727,44155032,53313247" charOffset="171-181" type="compound" text="paclitaxel"/>
            <pair e1="DS.d962.s0.e3" e2="DS.d962.s0.e0" id="DS.d962.s0.i0" interaction="True"/>
            <pair e1="DS.d962.s0.e2" e2="DS.d962.s0.e1" id="DS.d962.s0.i1" interaction="True"/>
            <pair e1="DS.d962.s0.e2" e2="DS.d962.s0.e0" id="DS.d962.s0.i2" interaction="True"/>
            <pair e1="DS.d962.s0.e3" e2="DS.d962.s0.e1" id="DS.d962.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d963" origId="18758695">
        <sentence id="DS.d963.s0" origId="18758695-2200" text="Immobilization of hemoglobin on the gold colloid modified pretreated glassy carbon electrode for preparing a novel hydrogen peroxide biosensor.">
            <entity id="DS.d963.s0.e0" origId="P15160,P17724,P73925,Q03459" charOffset="18-28" type="protein" text="hemoglobin"/>
            <entity id="DS.d963.s0.e1" origId="23985" charOffset="36-48" type="compound" text="gold colloid"/>
            <pair e1="DS.d963.s0.e1" e2="DS.d963.s0.e0" id="DS.d963.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d963.s1" origId="18758695-2201" text="A novel hydrogen peroxide (H2O2) biosensor was developed by immobilizing hemoglobin on the gold colloid modified electrochemical pretreated glassy carbon electrode (PGCE) via the bridging of an ethylenediamine monolayer.">
            <entity id="DS.d963.s1.e0" origId="P15160,P17724,P73925,Q03459" charOffset="73-83" type="protein" text="hemoglobin"/>
            <entity id="DS.d963.s1.e1" origId="23985" charOffset="91-103" type="compound" text="gold colloid"/>
            <pair e1="DS.d963.s1.e1" e2="DS.d963.s1.e0" id="DS.d963.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d964" origId="18758751">
        <sentence id="DS.d964.s0" origId="18758751-2238" text="Involvement of PKC in TPA-potentiated apoptosis induction during hemin-mediated erythroid differentiation in K562 cells.">
            <entity id="DS.d964.s0.e0" origId="P05130,P13677,P13678,P34722" charOffset="15-18" type="protein" text="PKC"/>
            <entity id="DS.d964.s0.e1" origId="4971" charOffset="65-70" type="compound" text="hemin"/>
            <pair e1="DS.d964.s0.e1" e2="DS.d964.s0.e0" id="DS.d964.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d964.s1" origId="18758751-2239" text="To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of PKC pathway with an activator of the protein kinase C, 12-O-tetradecanoylphorbol-13-acetate (TPA), during hemin-induced erythroid differentiation of K562 erythroleukemia cells.">
            <entity id="DS.d964.s1.e0" origId="P05130,P13677,P13678,P34722" charOffset="128-131" type="protein" text="PKC"/>
            <entity id="DS.d964.s1.e1" origId="27924" charOffset="183-219" type="compound" text="12-O-tetradecanoylphorbol-13-acetate"/>
            <entity id="DS.d964.s1.e2" origId="4971" charOffset="234-239" type="compound" text="hemin"/>
            <pair e1="DS.d964.s1.e2" e2="DS.d964.s1.e0" id="DS.d964.s1.i0" interaction="False"/>
            <pair e1="DS.d964.s1.e1" e2="DS.d964.s1.e0" id="DS.d964.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d964.s2" origId="18758751-2244" text="Taken together, our results suggested the involvement of PKC in TPA-potentiated apoptosis induction during hemin-mediated erythroid differentiation in K562 cells.">
            <entity id="DS.d964.s2.e0" origId="P05130,P13677,P13678,P34722" charOffset="57-60" type="protein" text="PKC"/>
            <entity id="DS.d964.s2.e1" origId="4971" charOffset="107-112" type="compound" text="hemin"/>
            <pair e1="DS.d964.s2.e1" e2="DS.d964.s2.e0" id="DS.d964.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d965" origId="18758757">
        <sentence id="DS.d965.s0" origId="18758757-2247" text="At glutamatergic synapses, increased binding to the glycine-B site located in the N-methyl-D-aspartate receptor (NMDAR) can enhance neurotransmission via NMDARs.">
            <entity id="DS.d965.s0.e0" origId="750" charOffset="52-59" type="compound" text="glycine"/>
            <entity id="DS.d965.s0.e1" origId="P35439,Q9R1M7" charOffset="82-111" type="protein" text="N-methyl-D-aspartate receptor"/>
            <pair e1="DS.d965.s0.e0" e2="DS.d965.s0.e1" id="DS.d965.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d966" origId="18758781">
        <sentence id="DS.d966.s0" origId="18758781-2256" text="The most common adverse events were mild and transient gastrointestinal disturbances, skin rash, nonprogressive transient increases in serum creatinine and urine beta2-microglobulin, and a temporary reduction of the creatinine clearance.">
            <entity id="DS.d966.s0.e0" origId="588" charOffset="141-151" type="compound" text="creatinine"/>
            <entity id="DS.d966.s0.e1" origId="P01885,P01886,P19341,P21612,P30442,P55077,P55078,Q03423,Q04714" charOffset="162-181" type="protein" text="beta2-microglobulin"/>
            <entity id="DS.d966.s0.e2" origId="588" charOffset="216-226" type="compound" text="creatinine"/>
            <pair e1="DS.d966.s0.e0" e2="DS.d966.s0.e1" id="DS.d966.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d967" origId="18758819">
        <sentence id="DS.d967.s0" origId="18758819-2275" text="In vitro effect of radiation, antibody to epidermal growth factor receptor and Docetaxel in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR.">
            <entity id="DS.d967.s0.e0" origId="P55245" charOffset="42-74" type="protein" text="epidermal growth factor receptor"/>
            <entity id="DS.d967.s0.e1" origId="148124" charOffset="79-88" type="compound" text="Docetaxel"/>
            <entity id="DS.d967.s0.e2" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="149-152" type="protein" text="P53"/>
            <entity id="DS.d967.s0.e3" origId="P00533,P13387,P55245" charOffset="172-176" type="protein" text="EGFR"/>
            <pair e1="DS.d967.s0.e1" e2="DS.d967.s0.e2" id="DS.d967.s0.i0" interaction="True"/>
            <pair e1="DS.d967.s0.e1" e2="DS.d967.s0.e3" id="DS.d967.s0.i1" interaction="True"/>
            <pair e1="DS.d967.s0.e1" e2="DS.d967.s0.e0" id="DS.d967.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d968" origId="18758925">
        <sentence id="DS.d968.s0" origId="18758925-2312" text="The optimal condition for the labeling of cypate to L-ASNase was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by HOBt/HBTU.">
            <entity id="DS.d968.s0.e0" origId="O25424,O34482,P06608,P26900,P30363,P43843,P50286,P63627,P63628,Q9RRX9,Q9X7E6,Q9ZLB9" charOffset="52-60" type="protein" text="L-ASNase"/>
            <entity id="DS.d968.s0.e1" origId="75771" charOffset="132-136" type="compound" text="HOBt"/>
            <entity id="DS.d968.s0.e2" origId="130500" charOffset="137-141" type="compound" text="HBTU"/>
            <pair e1="DS.d968.s0.e2" e2="DS.d968.s0.e0" id="DS.d968.s0.i0" interaction="True"/>
            <pair e1="DS.d968.s0.e1" e2="DS.d968.s0.e0" id="DS.d968.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d969" origId="18758938">
        <sentence id="DS.d969.s0" origId="18758938-2315" text="Effects of insulin and ascorbic acid on expression of Bcl-2 family proteins and caspase-3 activity in hippocampus of diabetic rats were evaluated in this study.">
            <entity id="DS.d969.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="11-18" type="protein" text="insulin"/>
            <entity id="DS.d969.s0.e1" origId="54670067,54690394" charOffset="23-36" type="compound" text="ascorbic acid"/>
            <entity id="DS.d969.s0.e2" origId="P10417,P49950" charOffset="54-59" type="protein" text="Bcl-2"/>
            <pair e1="DS.d969.s0.e1" e2="DS.d969.s0.e2" id="DS.d969.s0.i0" interaction="True"/>
            <pair e1="DS.d969.s0.e1" e2="DS.d969.s0.e0" id="DS.d969.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d970" origId="18758940">
        <sentence id="DS.d970.s0" origId="18758940-2316" text="Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-LacNAc) structures and their characterization for CGL2-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces.">
            <entity id="DS.d970.s0.e0" origId="119547" charOffset="29-53" type="compound" text="poly-N-acetyllactosamine"/>
            <entity id="DS.d970.s0.e1" origId="16760443" charOffset="60-66" type="compound" text="LacNAc"/>
            <entity id="DS.d970.s0.e2" origId="P20718" charOffset="110-114" type="protein" text="CGL2"/>
            <entity id="DS.d970.s0.e3" origId="Q801X7" charOffset="115-123" type="protein" text="galectin"/>
            <entity id="DS.d970.s0.e4" origId="P08163" charOffset="148-161" type="protein" text="glycoproteins"/>
            <pair e1="DS.d970.s0.e1" e2="DS.d970.s0.e2" id="DS.d970.s0.i0" interaction="True"/>
            <pair e1="DS.d970.s0.e0" e2="DS.d970.s0.e3" id="DS.d970.s0.i1" interaction="True"/>
            <pair e1="DS.d970.s0.e1" e2="DS.d970.s0.e3" id="DS.d970.s0.i2" interaction="True"/>
            <pair e1="DS.d970.s0.e0" e2="DS.d970.s0.e2" id="DS.d970.s0.i3" interaction="True"/>
            <pair e1="DS.d970.s0.e1" e2="DS.d970.s0.e4" id="DS.d970.s0.i4" interaction="True"/>
            <pair e1="DS.d970.s0.e0" e2="DS.d970.s0.e4" id="DS.d970.s0.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d970.s1" origId="18758940-2317" text="Poly-N-acetyllactosamine (poly-LacNAc) structures have been identified as important ligands for galectin-mediated cell adhesion to extra-cellular matrix (ECM) proteins.">
            <entity id="DS.d970.s1.e0" origId="119547" charOffset="0-24" type="compound" text="Poly-N-acetyllactosamine"/>
            <entity id="DS.d970.s1.e1" origId="16760443" charOffset="31-37" type="compound" text="LacNAc"/>
            <entity id="DS.d970.s1.e2" origId="Q801X7" charOffset="96-104" type="protein" text="galectin"/>
            <pair e1="DS.d970.s1.e0" e2="DS.d970.s1.e2" id="DS.d970.s1.i0" interaction="True"/>
            <pair e1="DS.d970.s1.e1" e2="DS.d970.s1.e2" id="DS.d970.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d970.s2" origId="18758940-2318" text="We here present the biofunctionalization of surfaces with poly-LacNAc structures and subsequent binding of ECM glycoproteins.">
            <entity id="DS.d970.s2.e0" origId="16760443" charOffset="63-69" type="compound" text="LacNAc"/>
            <entity id="DS.d970.s2.e1" origId="P08163" charOffset="111-124" type="protein" text="glycoproteins"/>
            <pair e1="DS.d970.s2.e0" e2="DS.d970.s2.e1" id="DS.d970.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d970.s3" origId="18758940-2319" text="A mixture of poly-LacNAc-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model galectin His(6) CGL2.">
            <entity id="DS.d970.s3.e0" origId="16760443" charOffset="18-24" type="compound" text="LacNAc"/>
            <entity id="DS.d970.s3.e1" origId="Q801X7" charOffset="137-145" type="protein" text="galectin"/>
            <entity id="DS.d970.s3.e2" origId="P20718" charOffset="153-157" type="protein" text="CGL2"/>
            <pair e1="DS.d970.s3.e0" e2="DS.d970.s3.e2" id="DS.d970.s3.i0" interaction="True"/>
            <pair e1="DS.d970.s3.e0" e2="DS.d970.s3.e1" id="DS.d970.s3.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d970.s4" origId="18758940-2320" text="We further demonstrate for the first time that these poly-LacNAc surfaces are suitable for further galectin-mediated binding of the ECM glycoproteins laminin and fibronectin.">
            <entity id="DS.d970.s4.e0" origId="16760443" charOffset="58-64" type="compound" text="LacNAc"/>
            <entity id="DS.d970.s4.e1" origId="Q801X7" charOffset="99-107" type="protein" text="galectin"/>
            <entity id="DS.d970.s4.e2" origId="Q13201" charOffset="132-135" type="protein" text="ECM"/>
            <entity id="DS.d970.s4.e3" origId="P08163" charOffset="136-149" type="protein" text="glycoproteins"/>
            <entity id="DS.d970.s4.e5" origId="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400" charOffset="162-173" type="protein" text="fibronectin"/>
            <pair e1="DS.d970.s4.e0" e2="DS.d970.s4.e1" id="DS.d970.s4.i1" interaction="True"/>
            <pair e1="DS.d970.s4.e0" e2="DS.d970.s4.e5" id="DS.d970.s4.i2" interaction="True"/>
            <pair e1="DS.d970.s4.e0" e2="DS.d970.s4.e3" id="DS.d970.s4.i4" interaction="True"/>
            <pair e1="DS.d970.s4.e0" e2="DS.d970.s4.e2" id="DS.d970.s4.i6" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d971" origId="18758978">
        <sentence id="DS.d971.s0" origId="18758978-2339" text="Seasonal variation of the metal (Zn, Fe, Mn) and metallothionein concentrations in the liver cytosol of the European chub (Squalius cephalus L.).">
            <entity id="DS.d971.s0.e0" origId="23930" charOffset="41-43" type="compound" text="Mn"/>
            <entity id="DS.d971.s0.e1" origId="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568" charOffset="49-64" type="protein" text="metallothionein"/>
            <pair e1="DS.d971.s0.e0" e2="DS.d971.s0.e1" id="DS.d971.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d971.s1" origId="18758978-2340" text="The specimens caught in the spring period had higher biometric (liver mass, condition and hepatosomatic indices) and some biochemical parameters (metallothionein (MT) and Mn) that are characteristic for the reproductive period.">
            <entity id="DS.d971.s1.e0" origId="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568" charOffset="146-161" type="protein" text="metallothionein"/>
            <entity id="DS.d971.s1.e1" origId="23930" charOffset="171-173" type="compound" text="Mn"/>
            <pair e1="DS.d971.s1.e1" e2="DS.d971.s1.e0" id="DS.d971.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d972" origId="18758993">
        <sentence id="DS.d972.s0" origId="18758993-2343" text="Glutamate decarboxylase (GAD) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).">
            <entity id="DS.d972.s0.e0" origId="O30418,P20228,P54767,Q04792,Q07346,Q9CG20" charOffset="0-23" type="protein" text="Glutamate decarboxylase"/>
            <entity id="DS.d972.s0.e1" origId="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20" charOffset="25-28" type="protein" text="GAD"/>
            <entity id="DS.d972.s0.e2" origId="119" charOffset="78-101" type="compound" text="gamma-aminobutyric acid"/>
            <entity id="DS.d972.s0.e3" origId="119" charOffset="103-107" type="compound" text="GABA"/>
            <pair e1="DS.d972.s0.e3" e2="DS.d972.s0.e0" id="DS.d972.s0.i0" interaction="True"/>
            <pair e1="DS.d972.s0.e2" e2="DS.d972.s0.e1" id="DS.d972.s0.i1" interaction="True"/>
            <pair e1="DS.d972.s0.e3" e2="DS.d972.s0.e1" id="DS.d972.s0.i2" interaction="True"/>
            <pair e1="DS.d972.s0.e2" e2="DS.d972.s0.e0" id="DS.d972.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d972.s1" origId="18758993-2344" text="These transcripts were predicted to synthesis of GAD proteins truncated of the binding site for pyridoxal phosphate, an essential cofactor, therefore cannot function as a decarboxylase.">
            <entity id="DS.d972.s1.e0" origId="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20" charOffset="49-52" type="protein" text="GAD"/>
            <entity id="DS.d972.s1.e1" origId="1051" charOffset="96-115" type="compound" text="pyridoxal phosphate"/>
            <pair e1="DS.d972.s1.e1" e2="DS.d972.s1.e0" id="DS.d972.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d973" origId="18759148">
        <sentence id="DS.d973.s0" origId="18759148-2382" text="Loss-of-expression of SSTR2 in tumor tissues has been suggested to correlate with tumor progression and to the relatively poorer outcomes of somatostatin analog treatment in some clinical trials.">
            <entity id="DS.d973.s0.e0" origId="P30874,P34993,P34994" charOffset="22-27" type="protein" text="SSTR2"/>
            <entity id="DS.d973.s0.e1" origId="16129681,16129706" charOffset="141-153" type="compound" text="somatostatin"/>
            <pair e1="DS.d973.s0.e1" e2="DS.d973.s0.e0" id="DS.d973.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d974" origId="18760301">
        <sentence id="DS.d974.s0" origId="18760301-213" text="Cobra venom factor (CVF) is a structural and functional analog of complement C3 isolated from cobra venom.">
            <entity id="DS.d974.s0.e0" origId="56842156" charOffset="0-18" type="compound" text="Cobra venom factor"/>
            <entity id="DS.d974.s0.e1" origId="P23667,P98094" charOffset="66-79" type="protein" text="complement C3"/>
            <pair e1="DS.d974.s0.e0" e2="DS.d974.s0.e1" id="DS.d974.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d975" origId="18760497">
        <sentence id="DS.d975.s0" origId="18760497-301" text="Activities of malate- and succinate-dehydrogenases (MDH, SDH) and NADH- and succinate-cytochrome c reductases (NCCR, SCCR) were rapidly inhibited, while cytochrome c oxidase (CCO) was unaltered by cadmium treatment.">
            <entity id="DS.d975.s0.e0" origId="O24047,P20932,P33216,P46487,P52426,Q04820,Q43744" charOffset="52-55" type="protein" text="MDH"/>
            <entity id="DS.d975.s0.e1" origId="O34607,O34635,O86564,P09367,P20132,P21801,P21912,P21914,P33073,P33074,P38997,P38998,P42630,P43065,P56072,P66773,P66774,P71349,P80212,P80213,Q02912,Q09694,Q48838,Q6FU27,Q75BV4,Q7SFX6,Q870G1,Q8LGI2,Q99K67,Q9SMZ4,Q9SQT8,Q9UDR5,Q9ZMU7" charOffset="57-60" type="protein" text="SDH"/>
            <entity id="DS.d975.s0.e4" origId="23973" charOffset="197-204" type="compound" text="cadmium"/>
            <pair e1="DS.d975.s0.e4" e2="DS.d975.s0.e1" id="DS.d975.s0.i0" interaction="True"/>
            <pair e1="DS.d975.s0.e4" e2="DS.d975.s0.e0" id="DS.d975.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d975.s1" origId="18760497-302" text="However, this stimulated the NADPH-generating enzyme activities of the pentose phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).">
            <entity id="DS.d975.s1.e0" origId="854" charOffset="71-78" type="compound" text="pentose"/>
            <entity id="DS.d975.s1.e1" origId="P37830,P48826" charOffset="158-163" type="protein" text="G6PDH"/>
            <entity id="DS.d975.s1.e2" origId="O31186,P00332,P00334,P06525,P07159,P07162,P0A9Q7,P0A9Q8,P10807,P12311,P14940,P17648,P21518,P21898,P22245,P23277,P23278,P23361,P25139,P25721,P25988,P26719,P28483,P28484,P33744,P37473,P42327,P42328,P48584,P48585,P48977,P51549,P51550,P51551,P51552,P71017,P84328,Q00669,Q00670,Q00671,Q00672,Q03384,Q05114,Q07588,Q09009,Q09010,Q24641,Q24803,Q27404,Q6LCE4,Q9GN94,Q9NAR7,Q9NG40,Q9NG42,Q9U8S9" charOffset="217-238" type="protein" text="alcohol dehydrogenase"/>
            <entity id="DS.d975.s1.e3" origId="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7" charOffset="240-243" type="protein" text="ADH"/>
            <pair e1="DS.d975.s1.e0" e2="DS.d975.s1.e2" id="DS.d975.s1.i0" interaction="False"/>
            <pair e1="DS.d975.s1.e0" e2="DS.d975.s1.e1" id="DS.d975.s1.i1" interaction="False"/>
            <pair e1="DS.d975.s1.e0" e2="DS.d975.s1.e3" id="DS.d975.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d976" origId="18760912">
        <sentence id="DS.d976.s0" origId="18760912-456" text="We also examined cellular impedance responsiveness of PC 12 cells in response to phenotypic alteration especially with regard to modulation of ion fluxes using nerve growth factor (NGF), dexamethasone and forskolin.">
            <entity id="DS.d976.s0.e0" origId="P21617,P34129,Q6YBR5,Q90W38" charOffset="181-184" type="protein" text="NGF"/>
            <entity id="DS.d976.s0.e1" origId="5743" charOffset="187-200" type="compound" text="dexamethasone"/>
            <entity id="DS.d976.s0.e2" origId="47936" charOffset="205-214" type="compound" text="forskolin"/>
            <pair e1="DS.d976.s0.e2" e2="DS.d976.s0.e0" id="DS.d976.s0.i0" interaction="False"/>
            <pair e1="DS.d976.s0.e1" e2="DS.d976.s0.e0" id="DS.d976.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d977" origId="18760952">
        <sentence id="DS.d977.s0" origId="18760952-480" text="This paper investigates the effect of sterilisation by gamma irradiation (dose 2.5Mrad) on the following properties of polycaprolactone (PCL): (1) degradation rate (catalysed by lipase), (2) mechanical properties, (3) the ability of cells to attach and subsequently grow on its surface.">
            <entity id="DS.d977.s0.e0" origId="10401" charOffset="119-135" type="compound" text="polycaprolactone"/>
            <entity id="DS.d977.s0.e1" origId="Q7M4U7" charOffset="178-184" type="protein" text="lipase"/>
            <pair e1="DS.d977.s0.e0" e2="DS.d977.s0.e1" id="DS.d977.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d978" origId="18761029">
        <sentence id="DS.d978.s0" origId="18761029-495" text="Specifically, animals were exposed to one of five dipsetic stimuli: (1) 24-h water deprivation, (2) replacement of drinking water with 2.5% NaCl, (3) peripheral administration of hypertonic saline, (4) ICV injection of angiotensin II (AngII), or (5) the combination of peripheral hypertonic saline and central AngII.">
            <entity id="DS.d978.s0.e0" origId="5234" charOffset="140-144" type="compound" text="NaCl"/>
            <entity id="DS.d978.s0.e1" origId="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0" charOffset="219-233" type="protein" text="angiotensin II"/>
            <entity id="DS.d978.s0.e2" origId="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0" charOffset="235-240" type="protein" text="AngII"/>
            <entity id="DS.d978.s0.e3" origId="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0" charOffset="310-315" type="protein" text="AngII"/>
            <pair e1="DS.d978.s0.e0" e2="DS.d978.s0.e2" id="DS.d978.s0.i0" interaction="False"/>
            <pair e1="DS.d978.s0.e0" e2="DS.d978.s0.e1" id="DS.d978.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d979" origId="18761103">
        <sentence id="DS.d979.s0" origId="18761103-512" text="We therefore propose copper-dependent homodimerization to be an essential step in the regulation of ATOX1-dependent transcription.">
            <entity id="DS.d979.s0.e0" origId="23978" charOffset="21-27" type="compound" text="copper"/>
            <entity id="DS.d979.s0.e1" origId="O00244,Q9TT99,Q9XT28" charOffset="100-105" type="protein" text="ATOX1"/>
            <pair e1="DS.d979.s0.e0" e2="DS.d979.s0.e1" id="DS.d979.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d980" origId="18761380">
        <sentence id="DS.d980.s0" origId="18761380-599" text="In order to investigate the role of spinal opioid peptide in the phenomenon of naloxone-precipitated withdrawal we examined the effect of herpes simplex virus vector-mediated overexpression of proenkephalin in lumbar dorsal root ganglia in rats with neuropathic pain treated with morphine.">
            <entity id="DS.d980.s0.e0" origId="P84814" charOffset="43-57" type="protein" text="opioid peptide"/>
            <entity id="DS.d980.s0.e1" origId="5284596,16395294" charOffset="79-87" type="compound" text="naloxone"/>
            <pair e1="DS.d980.s0.e1" e2="DS.d980.s0.e0" id="DS.d980.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d981" origId="18761426">
        <sentence id="DS.d981.s0" origId="18761426-612" text="The lectins were isolated by ammonium sulphate treatment of crude extracts followed by chromatography on chitin.">
            <entity id="DS.d981.s0.e0" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="4-11" type="protein" text="lectins"/>
            <entity id="DS.d981.s0.e1" origId="6097028" charOffset="29-46" type="compound" text="ammonium sulphate"/>
            <pair e1="DS.d981.s0.e1" e2="DS.d981.s0.e0" id="DS.d981.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d982" origId="18761603">
        <sentence id="DS.d982.s0" origId="18761603-651" text="One hundred and forty-four HCV-2- and HCV-3-infected patients initiated Peg-IFN alpha-2a (180 microg/week) and ribavirin (1000 or 1200 mg/day); those with viral clearance at week 4 were randomized to either Peg-IFN alpha-2a monotherapy (n = 59) or continuing combination therapy (n = 61) until week 12.">
            <entity id="DS.d982.s0.e0" origId="P35849" charOffset="76-85" type="protein" text="IFN alpha"/>
            <entity id="DS.d982.s0.e1" origId="37542" charOffset="111-120" type="compound" text="ribavirin"/>
            <entity id="DS.d982.s0.e2" origId="P35849" charOffset="211-220" type="protein" text="IFN alpha"/>
            <pair e1="DS.d982.s0.e1" e2="DS.d982.s0.e0" id="DS.d982.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d982.s1" origId="18761603-652" text="Thus in HCV-2- and HCV-3-infected patients, withdrawal of ribavirin and continuation of Peg-IFN alpha-2a monotherapy may be appropriate to attain an SVR, providing viraemia is cleared early during therapy and associated with low baseline viral load.">
            <entity id="DS.d982.s1.e0" origId="37542" charOffset="58-67" type="compound" text="ribavirin"/>
            <entity id="DS.d982.s1.e1" origId="P35849" charOffset="92-101" type="protein" text="IFN alpha"/>
            <pair e1="DS.d982.s1.e0" e2="DS.d982.s1.e1" id="DS.d982.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d983" origId="18761779">
        <sentence id="DS.d983.s0" origId="18761779-682" text="The apoE-deficient mouse, which develops atherosclerotic lesions rapidly when fed cholesterol, was used to determine the ability of dried plums to reduce atherosclerosis.">
            <entity id="DS.d983.s0.e0" origId="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8" charOffset="4-8" type="protein" text="apoE"/>
            <entity id="DS.d983.s0.e1" origId="304,5997,6432564,11025495" charOffset="82-93" type="compound" text="cholesterol"/>
            <pair e1="DS.d983.s0.e1" e2="DS.d983.s0.e0" id="DS.d983.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d983.s1" origId="18761779-683" text="Urinary thiobarbituric acid-reactive substances (TBARS) excretion and serum amyloid P-component (SAP) were measured as indicators of oxidative stress and inflammation, respectively.">
            <entity id="DS.d983.s1.e0" origId="2723628" charOffset="8-27" type="compound" text="thiobarbituric acid"/>
            <entity id="DS.d983.s1.e1" origId="P15697,P19095,P20677" charOffset="70-95" type="protein" text="serum amyloid P-component"/>
            <entity id="DS.d983.s1.e2" origId="O19063,O60880,P02743,P07629,P12246,P19095,P20677,P23680,P24047,P35827,P49255,Q9FKH1" charOffset="97-100" type="protein" text="SAP"/>
            <pair e1="DS.d983.s1.e0" e2="DS.d983.s1.e2" id="DS.d983.s1.i0" interaction="False"/>
            <pair e1="DS.d983.s1.e0" e2="DS.d983.s1.e1" id="DS.d983.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d984" origId="18762200">
        <sentence id="DS.d984.s0" origId="18762200-801" text="Inhibition in the brain is dominated by the neurotransmitter gamma-aminobutyric acid (GABA); operating through GABA(A) receptors.">
            <entity id="DS.d984.s0.e0" origId="119" charOffset="61-84" type="compound" text="gamma-aminobutyric acid"/>
            <entity id="DS.d984.s0.e1" origId="119" charOffset="86-90" type="compound" text="GABA"/>
            <entity id="DS.d984.s0.e2" origId="P26714,Q08832,Q9BLY8" charOffset="111-128" type="protein" text="GABA(A) receptors"/>
            <pair e1="DS.d984.s0.e0" e2="DS.d984.s0.e2" id="DS.d984.s0.i0" interaction="True"/>
            <pair e1="DS.d984.s0.e1" e2="DS.d984.s0.e2" id="DS.d984.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d985" origId="18762201">
        <sentence id="DS.d985.s0" origId="18762201-805" text="Thus, in keeping with the ability of neurosteroids to potentiate GABA currents via a broad variety of GABA(A) receptor isoforms in neurons, the potentiation site is structurally highly conserved on this important neurotransmitter receptor family.">
            <entity id="DS.d985.s0.e0" origId="119" charOffset="65-69" type="compound" text="GABA"/>
            <entity id="DS.d985.s0.e1" origId="P26714,Q08832,Q9BLY8" charOffset="102-118" type="protein" text="GABA(A) receptor"/>
            <pair e1="DS.d985.s0.e0" e2="DS.d985.s0.e1" id="DS.d985.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d986" origId="18762202">
        <sentence id="DS.d986.s0" origId="18762202-807" text="The 5-HT2AR response dominated the MAPK signaling pathway when co-expressed with 5-HT1AR, and diminution of the response by the 5-HT2AR antagonist Ketanserin could not be rescued by the 5-HT1AR agonist.">
            <entity id="DS.d986.s0.e0" origId="O42781,P27638,Q00859" charOffset="35-39" type="protein" text="MAPK"/>
            <entity id="DS.d986.s0.e1" origId="3822" charOffset="147-157" type="compound" text="Ketanserin"/>
            <pair e1="DS.d986.s0.e1" e2="DS.d986.s0.e0" id="DS.d986.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d987" origId="18762271">
        <sentence id="DS.d987.s0" origId="18762271-826" text="The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1).">
            <entity id="DS.d987.s0.e0" origId="P05432,Q99JZ7,Q9UJM3" charOffset="49-54" type="protein" text="Mig-6"/>
            <entity id="DS.d987.s0.e1" origId="Q91WJ0" charOffset="159-167" type="protein" text="FRS2beta"/>
            <entity id="DS.d987.s0.e2" origId="O43559,Q52RG8" charOffset="169-213" type="protein" text="suc1-associated neurotrophic factor target-2"/>
            <entity id="DS.d987.s0.e3" origId="O43559,Q52RG8" charOffset="215-220" type="protein" text="SNT-2"/>
            <entity id="DS.d987.s0.e4" origId="O43559" charOffset="222-226" type="protein" text="FRS3"/>
            <entity id="DS.d987.s0.e5" origId="O14543,O35718,O88583,Q68AM8,Q90X67,Q9BEG9" charOffset="228-262" type="protein" text="suppressor of cytokine signaling 3"/>
            <entity id="DS.d987.s0.e6" origId="O14543,Q68AM8,Q90X67,Q9BEG9" charOffset="264-269" type="protein" text="SOCS3"/>
            <entity id="DS.d987.s0.e7" origId="O14544,Q8WXH5" charOffset="271-276" type="protein" text="SOCS4"/>
            <entity id="DS.d987.s0.e8" origId="O75159,Q29RN6" charOffset="277-282" type="protein" text="SOCS5"/>
            <entity id="DS.d987.s0.e9" origId="857,6106,439524" charOffset="288-295" type="compound" text="leucine"/>
            <entity id="DS.d987.s0.e10" origId="Q96JA1" charOffset="344-349" type="protein" text="LRIG1"/>
            <pair e1="DS.d987.s0.e9" e2="DS.d987.s0.e0" id="DS.d987.s0.i0" interaction="False"/>
            <pair e1="DS.d987.s0.e9" e2="DS.d987.s0.e10" id="DS.d987.s0.i1" interaction="False"/>
            <pair e1="DS.d987.s0.e9" e2="DS.d987.s0.e7" id="DS.d987.s0.i2" interaction="False"/>
            <pair e1="DS.d987.s0.e9" e2="DS.d987.s0.e8" id="DS.d987.s0.i3" interaction="False"/>
            <pair e1="DS.d987.s0.e9" e2="DS.d987.s0.e5" id="DS.d987.s0.i4" interaction="False"/>
            <pair e1="DS.d987.s0.e9" e2="DS.d987.s0.e3" id="DS.d987.s0.i5" interaction="False"/>
            <pair e1="DS.d987.s0.e9" e2="DS.d987.s0.e4" id="DS.d987.s0.i6" interaction="False"/>
            <pair e1="DS.d987.s0.e9" e2="DS.d987.s0.e2" id="DS.d987.s0.i7" interaction="False"/>
            <pair e1="DS.d987.s0.e9" e2="DS.d987.s0.e6" id="DS.d987.s0.i8" interaction="False"/>
            <pair e1="DS.d987.s0.e9" e2="DS.d987.s0.e1" id="DS.d987.s0.i9" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d988" origId="18762369">
        <sentence id="DS.d988.s0" origId="18762369-869" text="Novel homo- and hetero-nuclear copper (II) complexes of tetradentate Schiff bases: synthesis, characterization, solvent-extraction and catalase-like activity studies.">
            <entity id="DS.d988.s0.e0" origId="23978" charOffset="31-37" type="compound" text="copper"/>
            <entity id="DS.d988.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="135-143" type="protein" text="catalase"/>
            <pair e1="DS.d988.s0.e0" e2="DS.d988.s0.e1" id="DS.d988.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d989" origId="18762913">
        <sentence id="DS.d989.s0" origId="18762913-991" text="In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma insulin, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.">
            <entity id="DS.d989.s0.e0" origId="Q42665" charOffset="150-162" type="protein" text="hemoglobin A"/>
            <entity id="DS.d989.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="188-195" type="protein" text="insulin"/>
            <entity id="DS.d989.s0.e2" origId="206,5793,64689,79025" charOffset="211-218" type="compound" text="glucose"/>
            <entity id="DS.d989.s0.e3" origId="206,5793,64689,79025" charOffset="227-234" type="compound" text="glucose"/>
            <entity id="DS.d989.s0.e4" origId="304,5997,6432564,11025495" charOffset="325-336" type="compound" text="cholesterol"/>
            <pair e1="DS.d989.s0.e2" e2="DS.d989.s0.e1" id="DS.d989.s0.i0" interaction="False"/>
            <pair e1="DS.d989.s0.e2" e2="DS.d989.s0.e0" id="DS.d989.s0.i1" interaction="False"/>
            <pair e1="DS.d989.s0.e4" e2="DS.d989.s0.e0" id="DS.d989.s0.i2" interaction="False"/>
            <pair e1="DS.d989.s0.e4" e2="DS.d989.s0.e1" id="DS.d989.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d990" origId="18762977">
        <sentence id="DS.d990.s0" origId="18762977-1011" text="The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, PO4 4.4+/-1.3 mg/dL, alkaline phosphatase (ALP) 1,341+/-823, 25-hydroxyvitamin D (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.">
            <entity id="DS.d990.s0.e0" origId="1061" charOffset="100-103" type="compound" text="PO4"/>
            <entity id="DS.d990.s0.e1" origId="O60109,P81800,P83456" charOffset="121-141" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d990.s0.e2" origId="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0" charOffset="143-146" type="protein" text="ALP"/>
            <entity id="DS.d990.s0.e3" origId="5283731,6433735" charOffset="161-180" type="compound" text="25-hydroxyvitamin D"/>
            <pair e1="DS.d990.s0.e3" e2="DS.d990.s0.e2" id="DS.d990.s0.i0" interaction="False"/>
            <pair e1="DS.d990.s0.e3" e2="DS.d990.s0.e1" id="DS.d990.s0.i1" interaction="False"/>
            <pair e1="DS.d990.s0.e0" e2="DS.d990.s0.e2" id="DS.d990.s0.i2" interaction="False"/>
            <pair e1="DS.d990.s0.e0" e2="DS.d990.s0.e1" id="DS.d990.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d991" origId="18763027">
        <sentence id="DS.d991.s0" origId="18763027-1031" text="There are no controlled trials comparing etanercept and acitretin efficacy and therapeutic mechanisms in psoriasis.">
            <entity id="DS.d991.s0.e0" origId="P20333" charOffset="41-51" type="protein" text="etanercept"/>
            <entity id="DS.d991.s0.e1" origId="5284513" charOffset="56-65" type="compound" text="acitretin"/>
            <pair e1="DS.d991.s0.e1" e2="DS.d991.s0.e0" id="DS.d991.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d992" origId="18763047">
        <sentence id="DS.d992.s0" origId="18763047-1035" text="Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As16) of Ascaris suum fused with cholera toxin B subunit.">
            <entity id="DS.d992.s0.e0" origId="10196533" charOffset="117-121" type="compound" text="As16"/>
            <entity id="DS.d992.s0.e1" origId="P01380,P18177,P25669" charOffset="158-165" type="protein" text="toxin B"/>
            <pair e1="DS.d992.s0.e0" e2="DS.d992.s0.e1" id="DS.d992.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d993" origId="18763168">
        <sentence id="DS.d993.s0" origId="18763168-1076" text="Inhibition of human poly(A)-specific ribonuclease (PARN) by purine nucleotides: kinetic analysis.">
            <entity id="DS.d993.s0.e0" origId="P00645,P00646,P04061,P13312,P17999,P35078,P37203,P84784,P84844,P84867" charOffset="37-49" type="protein" text="ribonuclease"/>
            <entity id="DS.d993.s0.e1" origId="O95453,P69341,Q5RC51,Q9LG26" charOffset="51-55" type="protein" text="PARN"/>
            <entity id="DS.d993.s0.e2" origId="1044" charOffset="60-66" type="compound" text="purine"/>
            <pair e1="DS.d993.s0.e2" e2="DS.d993.s0.e0" id="DS.d993.s0.i0" interaction="True"/>
            <pair e1="DS.d993.s0.e2" e2="DS.d993.s0.e1" id="DS.d993.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d994" origId="18764779">
        <sentence id="DS.d994.s0" origId="18764779-1509" text="The aqueous extract was found to be more effective than doxorubicin, a classical anticarcinogenic drug, with respect to its action on antioxidant enzymes and LDH in the liver of mice with developing lymphomas.">
            <entity id="DS.d994.s0.e0" origId="31703" charOffset="56-67" type="compound" text="doxorubicin"/>
            <entity id="DS.d994.s0.e1" origId="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289" charOffset="158-161" type="protein" text="LDH"/>
            <pair e1="DS.d994.s0.e0" e2="DS.d994.s0.e1" id="DS.d994.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d995" origId="18764780">
        <sentence id="DS.d995.s0" origId="18764780-1510" text="Cu,Zn-superoxide dismutase-driven free radical modifications: copper- and carbonate radical anion-initiated protein radical chemistry.">
            <entity id="DS.d995.s0.e0" origId="O50258" charOffset="6-26" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d995.s0.e1" origId="23978" charOffset="62-68" type="compound" text="copper"/>
            <pair e1="DS.d995.s0.e1" e2="DS.d995.s0.e0" id="DS.d995.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d995.s1" origId="18764780-1511" text="The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type SOD1 (Cu,Zn-superoxide dismutase) with H2O2 and their fate is incomplete, but a better understanding of the role of this reaction is needed.">
            <entity id="DS.d995.s1.e0" origId="O42724,O46412,O59924,O94178,P00441,P00442,P00443,P00445,P04178,P09212,P09670,P33431,P60052,P80566,P93258,Q42684,Q52RN5,Q5FB29,Q6C662,Q6CPE2,Q6FWL5,Q6T3B0,Q711T9,Q751L8,Q7M1R5,Q8HXP8,Q8HXP9,Q8HXQ0,Q8HXQ1,Q8HXQ2,Q8HXQ3,Q8HXQ4,Q8J0N2,Q8J0N3,Q8WNN6,Q96VL0,Q9C0N4,Q9SQL5" charOffset="136-140" type="protein" text="SOD1"/>
            <entity id="DS.d995.s1.e1" origId="O50258" charOffset="148-168" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d995.s1.e2" origId="784" charOffset="175-179" type="compound" text="H2O2"/>
            <pair e1="DS.d995.s1.e2" e2="DS.d995.s1.e0" id="DS.d995.s1.i0" interaction="True"/>
            <pair e1="DS.d995.s1.e2" e2="DS.d995.s1.e1" id="DS.d995.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d995.s2" origId="18764780-1512" text="In the absence of (bi)carbonate, site-specific radical-mediated fragmentation is produced by SOD1 active-site copper.">
            <entity id="DS.d995.s2.e0" origId="O42724,O46412,O59924,O94178,P00441,P00442,P00443,P00445,P04178,P09212,P09670,P33431,P60052,P80566,P93258,Q42684,Q52RN5,Q5FB29,Q6C662,Q6CPE2,Q6FWL5,Q6T3B0,Q711T9,Q751L8,Q7M1R5,Q8HXP8,Q8HXP9,Q8HXQ0,Q8HXQ1,Q8HXQ2,Q8HXQ3,Q8HXQ4,Q8J0N2,Q8J0N3,Q8WNN6,Q96VL0,Q9C0N4,Q9SQL5" charOffset="93-97" type="protein" text="SOD1"/>
            <entity id="DS.d995.s2.e1" origId="23978" charOffset="110-116" type="compound" text="copper"/>
            <pair e1="DS.d995.s2.e1" e2="DS.d995.s2.e0" id="DS.d995.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d995.s3" origId="18764780-1513" text="Finally, we propose a biochemical mechanism to explain CO(*-) production from CO2, enhanced protein radical formation and protection by (bi)carbonate against H2O2-induced fragmentation of the SOD1 active site.">
            <entity id="DS.d995.s3.e0" origId="784" charOffset="158-162" type="compound" text="H2O2"/>
            <entity id="DS.d995.s3.e1" origId="O42724,O46412,O59924,O94178,P00441,P00442,P00443,P00445,P04178,P09212,P09670,P33431,P60052,P80566,P93258,Q42684,Q52RN5,Q5FB29,Q6C662,Q6CPE2,Q6FWL5,Q6T3B0,Q711T9,Q751L8,Q7M1R5,Q8HXP8,Q8HXP9,Q8HXQ0,Q8HXQ1,Q8HXQ2,Q8HXQ3,Q8HXQ4,Q8J0N2,Q8J0N3,Q8WNN6,Q96VL0,Q9C0N4,Q9SQL5" charOffset="192-196" type="protein" text="SOD1"/>
            <pair e1="DS.d995.s3.e0" e2="DS.d995.s3.e1" id="DS.d995.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d996" origId="18764784">
        <sentence id="DS.d996.s0" origId="18764784-1516" text="Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (BH3-interacting domain death agonist), a hallmark of lysosome-mediated apoptotic cell death.">
            <entity id="DS.d996.s0.e0" origId="2788" charOffset="65-75" type="compound" text="clioquinol"/>
            <entity id="DS.d996.s0.e1" origId="62344" charOffset="134-149" type="compound" text="Acridine Orange"/>
            <entity id="DS.d996.s0.e2" origId="2788" charOffset="167-177" type="compound" text="Clioquinol"/>
            <entity id="DS.d996.s0.e3" origId="P55957,P70444,Q4JHS0,Q8JGM8,Q9JLT6" charOffset="219-255" type="protein" text="BH3-interacting domain death agonist"/>
            <pair e1="DS.d996.s0.e2" e2="DS.d996.s0.e3" id="DS.d996.s0.i0" interaction="True"/>
            <pair e1="DS.d996.s0.e0" e2="DS.d996.s0.e3" id="DS.d996.s0.i1" interaction="True"/>
            <pair e1="DS.d996.s0.e1" e2="DS.d996.s0.e3" id="DS.d996.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d997" origId="18764864">
        <sentence id="DS.d997.s0" origId="18764864-1538" text="Imidazoline-induced amplification of glucose- and carbachol-stimulated insulin release includes a marked suppression of islet nitric oxide generation in the mouse.">
            <entity id="DS.d997.s0.e0" origId="68156" charOffset="0-11" type="compound" text="Imidazoline"/>
            <entity id="DS.d997.s0.e1" origId="206,5793,64689,79025" charOffset="37-44" type="compound" text="glucose"/>
            <entity id="DS.d997.s0.e2" origId="2551" charOffset="50-59" type="compound" text="carbachol"/>
            <entity id="DS.d997.s0.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="71-78" type="protein" text="insulin"/>
            <pair e1="DS.d997.s0.e2" e2="DS.d997.s0.e3" id="DS.d997.s0.i0" interaction="True"/>
            <pair e1="DS.d997.s0.e1" e2="DS.d997.s0.e3" id="DS.d997.s0.i1" interaction="True"/>
            <pair e1="DS.d997.s0.e0" e2="DS.d997.s0.e3" id="DS.d997.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d998" origId="18764923">
        <sentence id="DS.d998.s0" origId="18764923-1564" text="The picture of signalling mechanisms underlying the wound-regulated FAD7 expression, and potential roles of CPL proteins as attenuators of wound-induced JA biosynthesis, are discussed.">
            <entity id="DS.d998.s0.e0" origId="P46310,P48618,P48620,P48621" charOffset="68-72" type="protein" text="FAD7"/>
            <entity id="DS.d998.s0.e1" origId="P26602,P81711,Q0TA23,Q0VTA8,Q142T1,Q1BUR8,Q1C0T7,Q1CE94,Q1GXB4,Q1LIU6,Q1QE02,Q1QSG3,Q1R3P7,Q21U27,Q2L1H6,Q2NR06,Q2SZY9,Q2Y5S2,Q31DN1,Q31TU7,Q327U6,Q39E37,Q3IHW4,Q3SLJ3,Q3YUU5,Q46XB3,Q47AZ9,Q48AM0,Q48BQ6,Q4FUZ9,Q4K3M0,Q4ZLB5,Q57GZ4,Q5E206,Q5P5L9,Q5PL18,Q5QUP2,Q609A0,Q62ID2,Q63W06,Q66FH1,Q6D9I9,Q6F9N7,Q6FZ67,Q6G5M1,Q6LVS4,Q70C33,Q7MQ88,Q7MZB5,Q7VZD6,Q7WAC9,Q7WJH0,Q82TP3,Q83F94,Q83IP6,Q87KM8,Q87U40,Q88C66,Q8DD50,Q8EKG2,Q8FB35,Q8XEC3,Q8XVQ0,Q8Z1T7,Q8ZJ20,Q8ZKI0,Q9CMB5,Q9FD32,Q9HTK1,Q9KVP6" charOffset="108-111" type="protein" text="CPL"/>
            <entity id="DS.d998.s0.e2" origId="5281166" charOffset="153-155" type="compound" text="JA"/>
            <pair e1="DS.d998.s0.e2" e2="DS.d998.s0.e1" id="DS.d998.s0.i0" interaction="False"/>
            <pair e1="DS.d998.s0.e2" e2="DS.d998.s0.e0" id="DS.d998.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d999" origId="18765263">
        <sentence id="DS.d999.s0" origId="18765263-1705" text="KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by kainate or picrotoxin, while mRNA for GPR54 remained essentially unchanged.">
            <entity id="DS.d999.s0.e0" origId="10255" charOffset="153-160" type="compound" text="kainate"/>
            <entity id="DS.d999.s0.e1" origId="31304,518601,5311359,5458938,6473767,24867522,57402144" charOffset="164-174" type="compound" text="picrotoxin"/>
            <entity id="DS.d999.s0.e2" origId="Q6BD04,Q969F8" charOffset="191-196" type="protein" text="GPR54"/>
            <pair e1="DS.d999.s0.e1" e2="DS.d999.s0.e2" id="DS.d999.s0.i0" interaction="False"/>
            <pair e1="DS.d999.s0.e0" e2="DS.d999.s0.e2" id="DS.d999.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1000" origId="18765295">
        <sentence id="DS.d1000.s0" origId="18765295-1718" text="In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal cytochrome c oxidase (COX) activity after 49 days of MeHg exposure.">
            <entity id="DS.d1000.s0.e0" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="141-153" type="protein" text="cytochrome c"/>
            <entity id="DS.d1000.s0.e1" origId="P11353,P36551,P36552,Q9UTE2,Q9V3D2" charOffset="163-166" type="protein" text="COX"/>
            <entity id="DS.d1000.s0.e2" origId="6860" charOffset="194-198" type="compound" text="MeHg"/>
            <pair e1="DS.d1000.s0.e2" e2="DS.d1000.s0.e1" id="DS.d1000.s0.i0" interaction="True"/>
            <pair e1="DS.d1000.s0.e2" e2="DS.d1000.s0.e0" id="DS.d1000.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1001" origId="18765678">
        <sentence id="DS.d1001.s0" origId="18765678-1803" text="The dominant positive regulator of mTORC1 is the GTP-charged form of the ras-like GTPase Rheb.">
            <entity id="DS.d1001.s0.e0" origId="6830" charOffset="49-52" type="compound" text="GTP"/>
            <entity id="DS.d1001.s0.e1" origId="P03967,P22126,Q07152" charOffset="73-76" type="protein" text="ras"/>
            <entity id="DS.d1001.s0.e2" origId="Q62639,Q921J2,Q9VND8" charOffset="89-93" type="protein" text="Rheb"/>
            <pair e1="DS.d1001.s0.e0" e2="DS.d1001.s0.e1" id="DS.d1001.s0.i0" interaction="True"/>
            <pair e1="DS.d1001.s0.e0" e2="DS.d1001.s0.e2" id="DS.d1001.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1001.s1" origId="18765678-1804" text="In contrast, amino acids, especially leucine, regulate mTORC1 by controlling the ability of Rheb-GTP to activate mTORC1.">
            <entity id="DS.d1001.s1.e0" origId="Q62639,Q921J2,Q9VND8" charOffset="92-96" type="protein" text="Rheb"/>
            <entity id="DS.d1001.s1.e1" origId="6830" charOffset="97-100" type="compound" text="GTP"/>
            <pair e1="DS.d1001.s1.e1" e2="DS.d1001.s1.e0" id="DS.d1001.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1002" origId="18765850">
        <sentence id="DS.d1002.s0" origId="18765850-1867" text="Cortisol, hematocrit, blood urea nitrogen, total protein, albumin, aspartate aminotransferase 0.05) after transport regardless of space allowance.">
            <entity id="DS.d1002.s0.e0" origId="5754" charOffset="0-8" type="compound" text="Cortisol"/>
            <entity id="DS.d1002.s0.e1" origId="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56" charOffset="67-93" type="protein" text="aspartate aminotransferase"/>
            <pair e1="DS.d1002.s0.e0" e2="DS.d1002.s0.e1" id="DS.d1002.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1003" origId="18766172">
        <sentence id="DS.d1003.s0" origId="18766172-2008" text="At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were 7-aminoactinomycin D (7-AAD) positive and annexin V negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.">
            <entity id="DS.d1003.s0.e0" origId="65180" charOffset="123-143" type="compound" text="7-aminoactinomycin D"/>
            <entity id="DS.d1003.s0.e1" origId="P23670,P81336,Q01752,Q7NSA6,Q8XR10,Q9EYI7,Q9RPK1" charOffset="147-150" type="protein" text="AAD"/>
            <entity id="DS.d1003.s0.e2" origId="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0" charOffset="165-174" type="protein" text="annexin V"/>
            <pair e1="DS.d1003.s0.e0" e2="DS.d1003.s0.e1" id="DS.d1003.s0.i0" interaction="False"/>
            <pair e1="DS.d1003.s0.e0" e2="DS.d1003.s0.e2" id="DS.d1003.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1004" origId="18766385">
        <sentence id="DS.d1004.s0" origId="18766385-2075" text="Iron uptake by the ubiquitous iron-storage protein ferritin involves the oxidation of two Fe(II) ions located at the highly conserved dinuclear &quot; ferroxidase centre&quot; in individual subunits.">
            <entity id="DS.d1004.s0.e0" origId="Q26061" charOffset="51-59" type="protein" text="ferritin"/>
            <entity id="DS.d1004.s0.e1" origId="27284" charOffset="90-95" type="compound" text="Fe(II"/>
            <entity id="DS.d1004.s0.e2" origId="P00450,P13635,Q61147,Q9XT27" charOffset="146-157" type="protein" text="ferroxidase"/>
            <pair e1="DS.d1004.s0.e1" e2="DS.d1004.s0.e2" id="DS.d1004.s0.i0" interaction="True"/>
            <pair e1="DS.d1004.s0.e1" e2="DS.d1004.s0.e0" id="DS.d1004.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1004.s1" origId="18766385-2076" text="We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear ferroxidase site) of recombinant human H-chain ferritin (rHuHF) in their complexes with reactive Fe(II) and redox-inactive Zn(II).">
            <entity id="DS.d1004.s1.e0" origId="P00450,P13635,Q61147,Q9XT27" charOffset="185-196" type="protein" text="ferroxidase"/>
            <entity id="DS.d1004.s1.e1" origId="Q26061" charOffset="232-240" type="protein" text="ferritin"/>
            <entity id="DS.d1004.s1.e2" origId="27284" charOffset="282-287" type="compound" text="Fe(II"/>
            <entity id="DS.d1004.s1.e3" origId="32051" charOffset="308-313" type="compound" text="Zn(II"/>
            <pair e1="DS.d1004.s1.e3" e2="DS.d1004.s1.e1" id="DS.d1004.s1.i0" interaction="True"/>
            <pair e1="DS.d1004.s1.e2" e2="DS.d1004.s1.e0" id="DS.d1004.s1.i1" interaction="True"/>
            <pair e1="DS.d1004.s1.e3" e2="DS.d1004.s1.e0" id="DS.d1004.s1.i2" interaction="True"/>
            <pair e1="DS.d1004.s1.e2" e2="DS.d1004.s1.e1" id="DS.d1004.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1005" origId="18766955">
        <sentence id="DS.d1005.s0" origId="18766955-2250" text="The aim of this study was to determine the effect of spironolactone on endothelial function in anti-tumour necrosis factor (TNF)-naive RA patients.">
            <entity id="DS.d1005.s0.e0" origId="5833" charOffset="53-67" type="compound" text="spironolactone"/>
            <entity id="DS.d1005.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="124-127" type="protein" text="TNF"/>
            <pair e1="DS.d1005.s0.e0" e2="DS.d1005.s0.e1" id="DS.d1005.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1006" origId="18767058">
        <sentence id="DS.d1006.s0" origId="18767058-2287" text="Compared with nonperfused constructs, flow perfused constructs demonstrated improved cells proliferation and differentiation according to cell viability, glucose consumption, alkaline phosphatase activity, and osteopontin.">
            <entity id="DS.d1006.s0.e0" origId="206,5793,64689,79025" charOffset="154-161" type="compound" text="glucose"/>
            <entity id="DS.d1006.s0.e1" origId="O60109,P81800,P83456" charOffset="175-195" type="protein" text="alkaline phosphatase"/>
            <pair e1="DS.d1006.s0.e0" e2="DS.d1006.s0.e1" id="DS.d1006.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1007" origId="18767059">
        <sentence id="DS.d1007.s0" origId="18767059-2288" text="Behavior of rat periodontal ligament cells on fibroblast growth factor-2-immobilized titanium surfaces treated by plasma modification.">
            <entity id="DS.d1007.s0.e0" origId="Q60487" charOffset="46-72" type="protein" text="fibroblast growth factor-2"/>
            <entity id="DS.d1007.s0.e1" origId="23963" charOffset="85-93" type="compound" text="titanium"/>
            <pair e1="DS.d1007.s0.e1" e2="DS.d1007.s0.e0" id="DS.d1007.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1007.s1" origId="18767059-2289" text="The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on fibroblast growth factor-2 (FGF-2)-immobilized titanium surfaces treated by oxygen (O2) plasma.">
            <entity id="DS.d1007.s1.e0" origId="Q60487" charOffset="106-132" type="protein" text="fibroblast growth factor-2"/>
            <entity id="DS.d1007.s1.e1" origId="P03969,P20003,P48800,Q60487" charOffset="134-139" type="protein" text="FGF-2"/>
            <entity id="DS.d1007.s1.e2" origId="23963" charOffset="153-161" type="compound" text="titanium"/>
            <entity id="DS.d1007.s1.e3" origId="977" charOffset="182-188" type="compound" text="oxygen"/>
            <entity id="DS.d1007.s1.e4" origId="977,5359597" charOffset="190-192" type="compound" text="O2"/>
            <pair e1="DS.d1007.s1.e3" e2="DS.d1007.s1.e1" id="DS.d1007.s1.i0" interaction="True"/>
            <pair e1="DS.d1007.s1.e4" e2="DS.d1007.s1.e1" id="DS.d1007.s1.i1" interaction="True"/>
            <pair e1="DS.d1007.s1.e3" e2="DS.d1007.s1.e0" id="DS.d1007.s1.i2" interaction="True"/>
            <pair e1="DS.d1007.s1.e2" e2="DS.d1007.s1.e1" id="DS.d1007.s1.i3" interaction="True"/>
            <pair e1="DS.d1007.s1.e4" e2="DS.d1007.s1.e0" id="DS.d1007.s1.i4" interaction="True"/>
            <pair e1="DS.d1007.s1.e2" e2="DS.d1007.s1.e0" id="DS.d1007.s1.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d1007.s2" origId="18767059-2290" text="These were treated with oxygen plasma and dipped in FGF-2 solution.">
            <entity id="DS.d1007.s2.e0" origId="977" charOffset="24-30" type="compound" text="oxygen"/>
            <entity id="DS.d1007.s2.e1" origId="P03969,P20003,P48800,Q60487" charOffset="52-57" type="protein" text="FGF-2"/>
            <pair e1="DS.d1007.s2.e0" e2="DS.d1007.s2.e1" id="DS.d1007.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1007.s3" origId="18767059-2291" text="Cells from fourth subculture were seeded onto the FGF-2-immobilized titanium surface.">
            <entity id="DS.d1007.s3.e0" origId="P03969,P20003,P48800,Q60487" charOffset="50-55" type="protein" text="FGF-2"/>
            <entity id="DS.d1007.s3.e1" origId="23963" charOffset="68-76" type="compound" text="titanium"/>
            <pair e1="DS.d1007.s3.e1" e2="DS.d1007.s3.e0" id="DS.d1007.s3.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1007.s4" origId="18767059-2292" text="These findings suggest that oxygen plasma modification can immobilize FGF-2 onto a titanium surface.">
            <entity id="DS.d1007.s4.e0" origId="977" charOffset="28-34" type="compound" text="oxygen"/>
            <entity id="DS.d1007.s4.e1" origId="P03969,P20003,P48800,Q60487" charOffset="70-75" type="protein" text="FGF-2"/>
            <entity id="DS.d1007.s4.e2" origId="23963" charOffset="83-91" type="compound" text="titanium"/>
            <pair e1="DS.d1007.s4.e0" e2="DS.d1007.s4.e1" id="DS.d1007.s4.i0" interaction="True"/>
            <pair e1="DS.d1007.s4.e2" e2="DS.d1007.s4.e1" id="DS.d1007.s4.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1008" origId="18767063">
        <sentence id="DS.d1008.s0" origId="18767063-2297" text="One of the best triads for bone engineering is bone marrow stromal cells, calcium phosphate ceramics, and bone morphogenetic protein (BMP).">
            <entity id="DS.d1008.s0.e0" origId="24441,24456,24632" charOffset="74-91" type="compound" text="calcium phosphate"/>
            <entity id="DS.d1008.s0.e1" origId="P07580" charOffset="111-132" type="protein" text="morphogenetic protein"/>
            <entity id="DS.d1008.s0.e2" origId="P35855" charOffset="134-137" type="protein" text="BMP"/>
            <pair e1="DS.d1008.s0.e0" e2="DS.d1008.s0.e1" id="DS.d1008.s0.i0" interaction="False"/>
            <pair e1="DS.d1008.s0.e0" e2="DS.d1008.s0.e2" id="DS.d1008.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1008.s1" origId="18767063-2298" text="The cells were mixed with beta-tricalcium phosphate (beta-TCP) granules followed by osteoblast induction with recombinant human BMP-2 (rhBMP-2) (first mixture), or were first induced with rhBMP-2 on plastic dishes and then mixed with the beta-TCP granules (last mixture) just prior to the operation.">
            <entity id="DS.d1008.s1.e0" origId="24456" charOffset="26-51" type="compound" text="beta-tricalcium phosphate"/>
            <entity id="DS.d1008.s1.e1" origId="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751" charOffset="128-133" type="protein" text="BMP-2"/>
            <pair e1="DS.d1008.s1.e0" e2="DS.d1008.s1.e1" id="DS.d1008.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1009" origId="18767136">
        <sentence id="DS.d1009.s0" origId="18767136-1171" text="Effect of short-time exposures to nickel and lead on brain monoamine oxidase from Danio rerio and Poecilia reticulata.">
            <entity id="DS.d1009.s0.e0" origId="935" charOffset="34-40" type="compound" text="nickel"/>
            <entity id="DS.d1009.s0.e1" origId="P49253" charOffset="59-76" type="protein" text="monoamine oxidase"/>
            <pair e1="DS.d1009.s0.e0" e2="DS.d1009.s0.e1" id="DS.d1009.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1009.s1" origId="18767136-1172" text="The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of nickel and lead, on brain monoamine oxidase (MAO), an important neural enzyme.">
            <entity id="DS.d1009.s1.e0" origId="935" charOffset="199-205" type="compound" text="nickel"/>
            <entity id="DS.d1009.s1.e1" origId="P49253" charOffset="225-242" type="protein" text="monoamine oxidase"/>
            <entity id="DS.d1009.s1.e2" origId="P49253" charOffset="244-247" type="protein" text="MAO"/>
            <pair e1="DS.d1009.s1.e0" e2="DS.d1009.s1.e2" id="DS.d1009.s1.i0" interaction="True"/>
            <pair e1="DS.d1009.s1.e0" e2="DS.d1009.s1.e1" id="DS.d1009.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1010" origId="18767138">
        <sentence id="DS.d1010.s0" origId="18767138-2325" text="Methylenetetrahydrofolate dehydrogenase) methenyltetrahydrofolate cyclohydrolase) formyltetrahydrofolate synthetase (MTHFD1) is a trifunctional enzyme that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis.">
            <entity id="DS.d1010.s0.e0" origId="O84081,O96553,P07245,P09440,P11586,P24186,P27653,P44313,P47259,P51696,P54382,P55818,P56467,P57557,P58688,P75096,P96050,Q05213,Q27772,Q60006,Q89A92,Q8K979,Q922D8,Q92HY4,Q9PKW1,Q9Z8K3,Q9ZD32,Q9ZLQ4" charOffset="0-39" type="protein" text="Methylenetetrahydrofolate dehydrogenase"/>
            <entity id="DS.d1010.s0.e1" origId="O84081,O96553,P07245,P09440,P11586,P13995,P18155,P24186,P27653,P44313,P47259,P51696,P54382,P56467,P57557,P58688,P75096,P96050,Q04448,Q05213,Q27772,Q49135,Q5ZKA5,Q60006,Q89A92,Q8K979,Q922D8,Q92HY4,Q9PKW1,Q9Z8K3,Q9ZD32,Q9ZLQ4" charOffset="41-80" type="protein" text="methenyltetrahydrofolate cyclohydrolase"/>
            <entity id="DS.d1010.s0.e2" origId="O66164,O96553,P07245,P09440,P11586,P13419,P21164,P27653,P28723,Q07064,Q27772,Q3Z8K3,Q3ZX40,Q4FL49,Q4JVW2,Q4L776,Q59925,Q5E3V8,Q5FAG1,Q5HF42,Q5HNH4,Q5LD60,Q5LNV0,Q5M083,Q5M4U2,Q5NQC7,Q5V5Y2,Q5XZD9,Q605Q9,Q63C61,Q64U80,Q65IA6,Q67JH9,Q6ABS5,Q6AL19,Q6G8J5,Q6GFX6,Q6HJK9,Q6KZM3,Q6LNJ0,Q6NH87,Q71YD9,Q72GY9,Q739F4,Q73RR6,Q74JC1,Q7A535,Q7MEE8,Q7MUZ8,Q7VLW6,Q81E87,Q81RE1,Q834D6,Q83WS0,Q87HX2,Q88W76,Q891R3,Q8A9S8,Q8CNV9,Q8D7D8,Q8DPL5,Q8DZP5,Q8E5E3,Q8EJA7,Q8EUQ1,Q8G700,Q8NW37,Q8R7L3,Q8RHF4,Q8XHL4,Q8Y624,Q922D8,Q92AD2,Q92N42,Q97CL3,Q97EB3,Q97QI2,Q98HQ4,Q99TD2,Q9CH07,Q9HI67,Q9JVY8,Q9JXY2,Q9KLX7,Q9PQS1,Q9SPK5,Q9X287" charOffset="82-115" type="protein" text="formyltetrahydrofolate synthetase"/>
            <entity id="DS.d1010.s0.e3" origId="P11586" charOffset="117-123" type="protein" text="MTHFD1"/>
            <entity id="DS.d1010.s0.e4" origId="91443" charOffset="9-25" type="compound" text="tetrahydrofolate"/>
            <pair e1="DS.d1010.s0.e4" e2="DS.d1010.s0.e1" id="DS.d1010.s0.i0" interaction="True"/>
            <pair e1="DS.d1010.s0.e4" e2="DS.d1010.s0.e3" id="DS.d1010.s0.i1" interaction="True"/>
            <pair e1="DS.d1010.s0.e4" e2="DS.d1010.s0.e0" id="DS.d1010.s0.i2" interaction="True"/>
            <pair e1="DS.d1010.s0.e4" e2="DS.d1010.s0.e2" id="DS.d1010.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1011" origId="18767147">
        <sentence id="DS.d1011.s0" origId="18767147-1187" text="An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and BRAF genes, methylation at CpG sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.">
            <entity id="DS.d1011.s0.e0" origId="O09185,O12946,O36006,O57538,O93379,P04637,P10360,P13481,P25035,P41685,P51664,P56423,P56424,P61260,P67938,P67939,P79820,P79892,Q00366,Q29480,Q29537,Q64662,Q8SPZ3,Q92143,Q95330,Q9TTA1,Q9TUB2,Q9W678,Q9W679,Q9WUR6" charOffset="63-67" type="protein" text="TP53"/>
            <entity id="DS.d1011.s0.e1" origId="P01116" charOffset="69-74" type="protein" text="KRAS2"/>
            <entity id="DS.d1011.s0.e2" origId="P25054" charOffset="76-79" type="protein" text="APC"/>
            <entity id="DS.d1011.s0.e3" origId="P15056,P34908,Q04982" charOffset="85-89" type="protein" text="BRAF"/>
            <entity id="DS.d1011.s0.e4" origId="6804" charOffset="112-115" type="compound" text="CpG"/>
            <entity id="DS.d1011.s0.e5" origId="P38920,P40692" charOffset="125-129" type="protein" text="MLH1"/>
            <pair e1="DS.d1011.s0.e4" e2="DS.d1011.s0.e3" id="DS.d1011.s0.i0" interaction="False"/>
            <pair e1="DS.d1011.s0.e4" e2="DS.d1011.s0.e2" id="DS.d1011.s0.i1" interaction="False"/>
            <pair e1="DS.d1011.s0.e4" e2="DS.d1011.s0.e5" id="DS.d1011.s0.i2" interaction="True"/>
            <pair e1="DS.d1011.s0.e4" e2="DS.d1011.s0.e1" id="DS.d1011.s0.i3" interaction="False"/>
            <pair e1="DS.d1011.s0.e4" e2="DS.d1011.s0.e0" id="DS.d1011.s0.i4" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1012" origId="18767149">
        <sentence id="DS.d1012.s0" origId="18767149-2331" text="We characterized this selenoprotein MsrA which had a single Sec residue at the catalytic site but no cysteine (Cys) residues in the protein sequence.">
            <entity id="DS.d1012.s0.e0" origId="O25011,O26635,O69761,O83641,P0A081,P0A082,P0A083,P0A084,P0A085,P0A086,P0A3Q9,P0A3R0,P0A5L0,P0A5L1,P0A744,P0A745,P23212,P47648,P54154,P65443,P65444,P75188,Q4J9L3,Q53W34,Q576P8,Q5HG58,Q5HVD4,Q5PJ81,Q5XDH1,Q66F89,Q6D151,Q6L2S4,Q6LV65,Q6LYY1,Q6NEL2,Q71YF6,Q746G0,Q7MYW1,Q87D27,Q87SW6,Q88AI5,Q88QZ8,Q899M3,Q8DE84,Q8DSY4,Q8DYH1,Q8E434,Q8FAG4,Q8FLU6,Q8FUZ0,Q8NLL5,Q8P272,Q8PCA6,Q8PNY8,Q8PUD6,Q8TQV6,Q8VS50,Q8XCG3,Q8XH97,Q8Y1C6,Q8Y640,Q8YDE7,Q8Z150,Q8ZB94,Q8ZK71,Q92AE8,Q93KF3,Q93S39,Q97MV3,Q97Y45,Q98PE5,Q99YT1,Q9A149,Q9AJF7,Q9APY4,Q9CCZ3,Q9CN40,Q9EWF7,Q9HQG0,Q9HUF1,Q9KAN8,Q9KP30,Q9LAM9,Q9PC45,Q9PQK2,Q9RTB6,Q9ZEQ8,Q9ZMK8" charOffset="36-40" type="protein" text="MsrA"/>
            <entity id="DS.d1012.s0.e1" origId="594,5862,5360637" charOffset="101-109" type="compound" text="cysteine"/>
            <pair e1="DS.d1012.s0.e1" e2="DS.d1012.s0.e0" id="DS.d1012.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1013" origId="18767150">
        <sentence id="DS.d1013.s0" origId="18767150-2332" text="Zn2+-linked dimerization of UreG from Helicobacter pylori, a chaperone involved in nickel trafficking and urease activation.">
            <entity id="DS.d1013.s0.e0" origId="O54424,P0A4R7,P0A4R8,P0A664,P0A665,P18319,P42871,P42877,P44396,P69992,P69993,P72955,Q03287,Q06206,Q07403,Q09066,Q55057,Q56561,Q9ZMZ7" charOffset="28-32" type="protein" text="UreG"/>
            <entity id="DS.d1013.s0.e1" origId="935" charOffset="83-89" type="compound" text="nickel"/>
            <entity id="DS.d1013.s0.e2" origId="O00084,O13465,P07374,P08298,Q5KCQ6,Q6A3P9" charOffset="106-112" type="protein" text="urease"/>
            <pair e1="DS.d1013.s0.e1" e2="DS.d1013.s0.e0" id="DS.d1013.s0.i0" interaction="True"/>
            <pair e1="DS.d1013.s0.e1" e2="DS.d1013.s0.e2" id="DS.d1013.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1013.s1" origId="18767150-2333" text="The biosynthesis of the active metal-bound form of the nickel-dependent enzyme urease involves the formation of a lysine-carbamate functional group concomitantly with the delivery of two Ni(2+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.">
            <entity id="DS.d1013.s1.e0" origId="O00084,O13465,P07374,P08298,Q5KCQ6,Q6A3P9" charOffset="79-85" type="protein" text="urease"/>
            <entity id="DS.d1013.s1.e1" origId="866,5962" charOffset="114-120" type="compound" text="lysine"/>
            <entity id="DS.d1013.s1.e2" origId="277" charOffset="121-130" type="compound" text="carbamate"/>
            <entity id="DS.d1013.s1.e3" origId="934" charOffset="187-191" type="compound" text="Ni(2"/>
            <pair e1="DS.d1013.s1.e1" e2="DS.d1013.s1.e0" id="DS.d1013.s1.i0" interaction="True"/>
            <pair e1="DS.d1013.s1.e3" e2="DS.d1013.s1.e0" id="DS.d1013.s1.i1" interaction="True"/>
            <pair e1="DS.d1013.s1.e2" e2="DS.d1013.s1.e0" id="DS.d1013.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1014" origId="18767155">
        <sentence id="DS.d1014.s0" origId="18767155-2335" text="Residue-wise conformational stability of DLC8 dimer from native-state hydrogen exchange.">
            <entity id="DS.d1014.s0.e0" origId="P63167,P63168,P63169,P63170,Q9D0M5" charOffset="41-45" type="protein" text="DLC8"/>
            <entity id="DS.d1014.s0.e1" origId="783" charOffset="70-78" type="compound" text="hydrogen"/>
            <pair e1="DS.d1014.s0.e1" e2="DS.d1014.s0.e0" id="DS.d1014.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1015" origId="18767934">
        <sentence id="DS.d1015.s0" origId="18767934-15" text="Whereas the role of locally produced 1, 25-dihydroxyvitamin D is not yet clear, it is possible that it contributes importantly to vitamin D-mediated inhibition of parathyroid cell growth, so CYP27B1 can be considered a candidate parathyroid tumor suppressor gene in that its acquired inactivation in a parathyroid cell could confer a tumorigenic growth advantage.">
            <entity id="DS.d1015.s0.e0" origId="5283731,6433735" charOffset="40-61" type="compound" text="25-dihydroxyvitamin D"/>
            <entity id="DS.d1015.s0.e1" origId="5280795" charOffset="52-61" type="compound" text="vitamin D"/>
            <entity id="DS.d1015.s0.e2" origId="O15528" charOffset="191-198" type="protein" text="CYP27B1"/>
            <pair e1="DS.d1015.s0.e0" e2="DS.d1015.s0.e2" id="DS.d1015.s0.i0" interaction="False"/>
            <pair e1="DS.d1015.s0.e1" e2="DS.d1015.s0.e2" id="DS.d1015.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1016" origId="18768213">
        <sentence id="DS.d1016.s0" origId="18768213-91" text="Mechanistically, we showed EphA2 knockdown suppressed thrombin-induced serine 536 phosphorylation of NFkappaB, an event critical of ICAM-1 transcriptional upregulation.">
            <entity id="DS.d1016.s0.e0" origId="P84122" charOffset="54-62" type="protein" text="thrombin"/>
            <entity id="DS.d1016.s0.e1" origId="5951" charOffset="71-77" type="compound" text="serine"/>
            <entity id="DS.d1016.s0.e2" origId="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132" charOffset="132-138" type="protein" text="ICAM-1"/>
            <pair e1="DS.d1016.s0.e1" e2="DS.d1016.s0.e0" id="DS.d1016.s0.i0" interaction="True"/>
            <pair e1="DS.d1016.s0.e1" e2="DS.d1016.s0.e2" id="DS.d1016.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1017" origId="18768362">
        <sentence id="DS.d1017.s0" origId="18768362-173" text="Total antioxidant capacity, catalase, thiobarbituric acid-reactive substances, hemoglobin, transferrin saturation and ferritin did not change significantly.">
            <entity id="DS.d1017.s0.e0" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="28-36" type="protein" text="catalase"/>
            <entity id="DS.d1017.s0.e1" origId="2723628" charOffset="38-57" type="compound" text="thiobarbituric acid"/>
            <entity id="DS.d1017.s0.e2" origId="P15160,P17724,P73925,Q03459" charOffset="79-89" type="protein" text="hemoglobin"/>
            <entity id="DS.d1017.s0.e3" origId="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1" charOffset="91-102" type="protein" text="transferrin"/>
            <entity id="DS.d1017.s0.e4" origId="Q26061" charOffset="118-126" type="protein" text="ferritin"/>
            <pair e1="DS.d1017.s0.e1" e2="DS.d1017.s0.e4" id="DS.d1017.s0.i0" interaction="False"/>
            <pair e1="DS.d1017.s0.e1" e2="DS.d1017.s0.e3" id="DS.d1017.s0.i1" interaction="False"/>
            <pair e1="DS.d1017.s0.e1" e2="DS.d1017.s0.e0" id="DS.d1017.s0.i2" interaction="False"/>
            <pair e1="DS.d1017.s0.e1" e2="DS.d1017.s0.e2" id="DS.d1017.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1018" origId="18768916">
        <sentence id="DS.d1018.s0" origId="18768916-385" text="Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of cholesterol to pregnenolone by cholesterol side-chain cleavage enzyme (CYP11A).">
            <entity id="DS.d1018.s0.e0" origId="304,5997,6432564,11025495" charOffset="248-259" type="compound" text="cholesterol"/>
            <entity id="DS.d1018.s0.e1" origId="8955" charOffset="263-275" type="compound" text="pregnenolone"/>
            <entity id="DS.d1018.s0.e2" origId="O46515,P00189,P05108,P10612,P14137,P79153,P79202,Q07217,Q28827,Q2XV99,Q92045,Q9EPT4,Q9QZ82" charOffset="279-317" type="protein" text="cholesterol side-chain cleavage enzyme"/>
            <entity id="DS.d1018.s0.e3" origId="P05108,Q2XV99,Q9EPT4" charOffset="319-325" type="protein" text="CYP11A"/>
            <pair e1="DS.d1018.s0.e1" e2="DS.d1018.s0.e3" id="DS.d1018.s0.i0" interaction="True"/>
            <pair e1="DS.d1018.s0.e0" e2="DS.d1018.s0.e2" id="DS.d1018.s0.i1" interaction="True"/>
            <pair e1="DS.d1018.s0.e0" e2="DS.d1018.s0.e3" id="DS.d1018.s0.i2" interaction="True"/>
            <pair e1="DS.d1018.s0.e1" e2="DS.d1018.s0.e2" id="DS.d1018.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d1018.s1" origId="18768916-386" text="Finally, HA increased nitric oxide synthase (NOS) activity, and the NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME) markedly attenuated the effect of the amine on steroid synthesis.">
            <entity id="DS.d1018.s1.e0" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="22-43" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d1018.s1.e1" origId="550788" charOffset="91-114" type="compound" text="L-arginine methyl ester"/>
            <pair e1="DS.d1018.s1.e1" e2="DS.d1018.s1.e0" id="DS.d1018.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1019" origId="18769443">
        <sentence id="DS.d1019.s0" origId="18769443-565" text="LH, FSH, 17 beta-estradiol, progesterone, aldosterone and PRA were assayed at the seventh, fourteenth, twenty-first and twenty-eighth days of the cycle after 30 min of recumbency.">
            <entity id="DS.d1019.s0.e0" origId="5757" charOffset="12-26" type="compound" text="beta-estradiol"/>
            <entity id="DS.d1019.s0.e1" origId="5994" charOffset="28-40" type="compound" text="progesterone"/>
            <entity id="DS.d1019.s0.e2" origId="P06703,P10977" charOffset="58-61" type="protein" text="PRA"/>
            <pair e1="DS.d1019.s0.e0" e2="DS.d1019.s0.e2" id="DS.d1019.s0.i0" interaction="False"/>
            <pair e1="DS.d1019.s0.e1" e2="DS.d1019.s0.e2" id="DS.d1019.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1019.s1" origId="18769443-566" text="Aldosterone was positively related to PRA and progesterone.">
            <entity id="DS.d1019.s1.e0" origId="P06703,P10977" charOffset="38-41" type="protein" text="PRA"/>
            <entity id="DS.d1019.s1.e1" origId="5994" charOffset="46-58" type="compound" text="progesterone"/>
            <pair e1="DS.d1019.s1.e1" e2="DS.d1019.s1.e0" id="DS.d1019.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1020" origId="18769474">
        <sentence id="DS.d1020.s0" origId="18769474-571" text="COMT activity and proline levels may therefore be altered in 22q11DS individuals.">
            <entity id="DS.d1020.s0.e0" origId="O23760,O81646,O82054,P21964,P28002,P46484,Q06509,Q06528,Q43239,Q43609,Q6ZD89,Q8GU25,Q8LL87,Q8W013,Q99028,Q9FQY8,Q9SWC2" charOffset="0-4" type="protein" text="COMT"/>
            <entity id="DS.d1020.s0.e1" origId="614,8988,145742" charOffset="18-25" type="compound" text="proline"/>
            <pair e1="DS.d1020.s0.e1" e2="DS.d1020.s0.e0" id="DS.d1020.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1020.s1" origId="18769474-572" text="COMT (158) genotype and plasma proline levels were determined in the 22q11DS children.">
            <entity id="DS.d1020.s1.e0" origId="O23760,O81646,O82054,P21964,P28002,P46484,Q06509,Q06528,Q43239,Q43609,Q6ZD89,Q8GU25,Q8LL87,Q8W013,Q99028,Q9FQY8,Q9SWC2" charOffset="0-4" type="protein" text="COMT"/>
            <entity id="DS.d1020.s1.e1" origId="614,8988,145742" charOffset="31-38" type="compound" text="proline"/>
            <pair e1="DS.d1020.s1.e1" e2="DS.d1020.s1.e0" id="DS.d1020.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1021" origId="18769875">
        <sentence id="DS.d1021.s0" origId="18769875-666" text="We have investigated its antibacterial activity and binding activity to pathogenic whole cell antigens, lipopolysaccharide (LPS) and staphylococcal enterotoxin B.">
            <entity id="DS.d1021.s0.e0" origId="11970143" charOffset="104-122" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d1021.s0.e1" origId="P22542" charOffset="148-161" type="protein" text="enterotoxin B"/>
            <pair e1="DS.d1021.s0.e0" e2="DS.d1021.s0.e1" id="DS.d1021.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1022" origId="18770028">
        <sentence id="DS.d1022.s0" origId="18770028-698" text="Quinone formation is closely linked to other representative hypotheses such as mitochondrial dysfunction, inflammation, oxidative stress, and dysfunction of the ubiquitin-proteasome system, in the pathogenesis of neurodegenerative diseases such as Parkinson's disease and methamphetamine-induced neurotoxicity.">
            <entity id="DS.d1022.s0.e0" origId="O46543,P08565,P08618,P0C014,P0C072,P13117,P14624,P14792,P15174,P19848,P20685,P22589,P23324,P23398,P42739,P42740,P46574,P49634,P49635,P59263,P59669,P61862,P61863,P61864,P62972,P62973,P62974,P62975,P62976,P62977,P62988,P62989,P62990,P62991,P63049,P63051,P68195,P68196,P68197,P68198,P68199,P68201,P68204,P69308,P69309,P69310,P69311,P69312,P69313,P69314,P69315,P69316,P69317,P69318,P69319,P69320,P69321,P69322,P69323,P69324,P69325,P69326,P84589,Q05550,Q865C5,Q867C2,Q867C3,Q867C4,Q8MKD1,Q9Y848" charOffset="161-170" type="protein" text="ubiquitin"/>
            <entity id="DS.d1022.s0.e1" origId="1206,10836,36604" charOffset="272-287" type="compound" text="methamphetamine"/>
            <pair e1="DS.d1022.s0.e1" e2="DS.d1022.s0.e0" id="DS.d1022.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1023" origId="18771337">
        <sentence id="DS.d1023.s0" origId="18771337-1073" text="The effect of fenitrothion exposure on birds was examined by measuring aerobic metabolism, blood hemoglobin content, plasma cholinesterases, and body weight for up to 21 d postdose.">
            <entity id="DS.d1023.s0.e0" origId="31200" charOffset="14-26" type="compound" text="fenitrothion"/>
            <entity id="DS.d1023.s0.e1" origId="P15160,P17724,P73925,Q03459" charOffset="97-107" type="protein" text="hemoglobin"/>
            <entity id="DS.d1023.s0.e2" origId="P32749,P32750,P32751,P32752,P32753,P81908" charOffset="124-139" type="protein" text="cholinesterases"/>
            <pair e1="DS.d1023.s0.e0" e2="DS.d1023.s0.e2" id="DS.d1023.s0.i0" interaction="True"/>
            <pair e1="DS.d1023.s0.e0" e2="DS.d1023.s0.e1" id="DS.d1023.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1024" origId="18771515">
        <sentence id="DS.d1024.s0" origId="18771515-1111" text="Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.">
            <entity id="DS.d1024.s0.e0" origId="49837850" charOffset="51-54" type="compound" text="K99"/>
            <entity id="DS.d1024.s0.e1" origId="760826" charOffset="64-67" type="compound" text="F41"/>
            <entity id="DS.d1024.s0.e2" origId="P54355,P80567,P80568" charOffset="89-100" type="protein" text="enterotoxin"/>
            <entity id="DS.d1024.s0.e3" origId="P45629" charOffset="124-131" type="protein" text="toxin 1"/>
            <entity id="DS.d1024.s0.e4" origId="P50279,Q00262" charOffset="165-169" type="protein" text="Stx2"/>
            <entity id="DS.d1024.s0.e5" origId="O31000,P19809,P43261,P52869,Q07591" charOffset="182-189" type="protein" text="intimin"/>
            <entity id="DS.d1024.s0.e6" origId="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1" charOffset="232-235" type="protein" text="PCR"/>
            <pair e1="DS.d1024.s0.e0" e2="DS.d1024.s0.e3" id="DS.d1024.s0.i0" interaction="False"/>
            <pair e1="DS.d1024.s0.e0" e2="DS.d1024.s0.e4" id="DS.d1024.s0.i1" interaction="False"/>
            <pair e1="DS.d1024.s0.e1" e2="DS.d1024.s0.e5" id="DS.d1024.s0.i2" interaction="False"/>
            <pair e1="DS.d1024.s0.e1" e2="DS.d1024.s0.e3" id="DS.d1024.s0.i3" interaction="False"/>
            <pair e1="DS.d1024.s0.e0" e2="DS.d1024.s0.e2" id="DS.d1024.s0.i4" interaction="False"/>
            <pair e1="DS.d1024.s0.e1" e2="DS.d1024.s0.e6" id="DS.d1024.s0.i5" interaction="False"/>
            <pair e1="DS.d1024.s0.e0" e2="DS.d1024.s0.e6" id="DS.d1024.s0.i6" interaction="False"/>
            <pair e1="DS.d1024.s0.e1" e2="DS.d1024.s0.e2" id="DS.d1024.s0.i7" interaction="False"/>
            <pair e1="DS.d1024.s0.e1" e2="DS.d1024.s0.e4" id="DS.d1024.s0.i8" interaction="False"/>
            <pair e1="DS.d1024.s0.e0" e2="DS.d1024.s0.e5" id="DS.d1024.s0.i9" interaction="False"/>
        </sentence>
        <sentence id="DS.d1024.s1" origId="18771515-1112" text="Of the 18 E. coli isolated from healthy calves, K99 (16.6%) and intimin (55.5%) genes were identified by PCR.">
            <entity id="DS.d1024.s1.e0" origId="49837850" charOffset="48-51" type="compound" text="K99"/>
            <entity id="DS.d1024.s1.e1" origId="O31000,P19809,P43261,P52869,Q07591" charOffset="64-71" type="protein" text="intimin"/>
            <entity id="DS.d1024.s1.e2" origId="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1" charOffset="105-108" type="protein" text="PCR"/>
            <pair e1="DS.d1024.s1.e0" e2="DS.d1024.s1.e2" id="DS.d1024.s1.i0" interaction="False"/>
            <pair e1="DS.d1024.s1.e0" e2="DS.d1024.s1.e1" id="DS.d1024.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1024.s2" origId="18771515-1113" text="K99, F41, STa, Stx1 and Stx2 were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.">
            <entity id="DS.d1024.s2.e0" origId="49837850" charOffset="0-3" type="compound" text="K99"/>
            <entity id="DS.d1024.s2.e1" origId="760826" charOffset="5-8" type="compound" text="F41"/>
            <entity id="DS.d1024.s2.e2" origId="P50279,Q00262" charOffset="24-28" type="protein" text="Stx2"/>
            <pair e1="DS.d1024.s2.e0" e2="DS.d1024.s2.e2" id="DS.d1024.s2.i0" interaction="False"/>
            <pair e1="DS.d1024.s2.e1" e2="DS.d1024.s2.e2" id="DS.d1024.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1025" origId="18771570">
        <sentence id="DS.d1025.s0" origId="18771570-1136" text="These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of glucose-dependent insulin secretion, suppression of glucagon secretion, slowing of gastric emptying, and reduction of food intake.">
            <entity id="DS.d1025.s0.e0" origId="206,5793,64689,79025" charOffset="143-150" type="compound" text="glucose"/>
            <entity id="DS.d1025.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="161-168" type="protein" text="insulin"/>
            <entity id="DS.d1025.s0.e2" origId="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9" charOffset="195-203" type="protein" text="glucagon"/>
            <pair e1="DS.d1025.s0.e0" e2="DS.d1025.s0.e1" id="DS.d1025.s0.i0" interaction="True"/>
            <pair e1="DS.d1025.s0.e0" e2="DS.d1025.s0.e2" id="DS.d1025.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1026" origId="18771604">
        <sentence id="DS.d1026.s0" origId="18771604-1158" text="Induction of the spliced form of XBP1 as well as total XBP1 by thapsigargin was significantly attenuated in patients with BD.">
            <entity id="DS.d1026.s0.e0" origId="P17861,P40489" charOffset="33-37" type="protein" text="XBP1"/>
            <entity id="DS.d1026.s0.e1" origId="P17861,P40489" charOffset="55-59" type="protein" text="XBP1"/>
            <entity id="DS.d1026.s0.e2" origId="446378" charOffset="63-75" type="compound" text="thapsigargin"/>
            <pair e1="DS.d1026.s0.e2" e2="DS.d1026.s0.e0" id="DS.d1026.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1026.s1" origId="18771604-1159" text="Induction of GRP94 by thapsigargin was also decreased in the BD group.">
            <entity id="DS.d1026.s1.e0" origId="O18750,P08113,P08712,P14625,P41148,Q29092,Q95M18" charOffset="13-18" type="protein" text="GRP94"/>
            <entity id="DS.d1026.s1.e1" origId="446378" charOffset="22-34" type="compound" text="thapsigargin"/>
            <pair e1="DS.d1026.s1.e1" e2="DS.d1026.s1.e0" id="DS.d1026.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1027" origId="18771683">
        <sentence id="DS.d1027.s0" origId="18771683-1179" text="Efforts in the field of synthetic vaccine carriers are focussing on decorating the particle surface with ligands for DC receptors such as heparan sulphate glycosaminoglycan structures, integrins, Siglecs, galectins, C-type lectins and toll-like receptors.">
            <entity id="DS.d1027.s0.e0" origId="1117" charOffset="146-154" type="compound" text="sulphate"/>
            <entity id="DS.d1027.s0.e1" origId="Q801X7" charOffset="205-214" type="protein" text="galectins"/>
            <entity id="DS.d1027.s0.e2" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="207-214" type="protein" text="lectins"/>
            <pair e1="DS.d1027.s0.e0" e2="DS.d1027.s0.e2" id="DS.d1027.s0.i0" interaction="False"/>
            <pair e1="DS.d1027.s0.e0" e2="DS.d1027.s0.e1" id="DS.d1027.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1028" origId="18771795">
        <sentence id="DS.d1028.s0" origId="18771795-1211" text="Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aPCC and PCC.">
            <entity id="DS.d1028.s0.e0" origId="5282448" charOffset="37-49" type="compound" text="fondaparinux"/>
            <entity id="DS.d1028.s0.e1" origId="P84122" charOffset="53-61" type="protein" text="thrombin"/>
            <entity id="DS.d1028.s0.e2" origId="62529" charOffset="85-88" type="compound" text="PCC"/>
            <pair e1="DS.d1028.s0.e0" e2="DS.d1028.s0.e1" id="DS.d1028.s0.i0" interaction="True"/>
            <pair e1="DS.d1028.s0.e2" e2="DS.d1028.s0.e1" id="DS.d1028.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1029" origId="18771857">
        <sentence id="DS.d1029.s0" origId="18771857-1234" text="It appears that GSTM1 null and GSTT1 null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these GSTs (mostly alkylating agents and platinum compounds).">
            <entity id="DS.d1029.s0.e0" origId="P09488,P16413,Q9N0V4,Q9TSM5" charOffset="16-21" type="protein" text="GSTM1"/>
            <entity id="DS.d1029.s0.e1" origId="P20135,P30711,Q2NL00" charOffset="31-36" type="protein" text="GSTT1"/>
            <entity id="DS.d1029.s0.e2" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="178-182" type="protein" text="GSTs"/>
            <entity id="DS.d1029.s0.e3" origId="23939" charOffset="213-231" type="compound" text="platinum compounds"/>
            <pair e1="DS.d1029.s0.e3" e2="DS.d1029.s0.e2" id="DS.d1029.s0.i0" interaction="True"/>
            <pair e1="DS.d1029.s0.e3" e2="DS.d1029.s0.e1" id="DS.d1029.s0.i1" interaction="True"/>
            <pair e1="DS.d1029.s0.e3" e2="DS.d1029.s0.e0" id="DS.d1029.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1030" origId="18771904">
        <sentence id="DS.d1030.s0" origId="18771904-1247" text="Silibinin attenuates antigen-specific IgE production through the modulation of Th1/Th2 balance in ovalbumin-sensitized BALB/c mice.">
            <entity id="DS.d1030.s0.e0" origId="5213,31553,3086637,16211710" charOffset="0-9" type="compound" text="Silibinin"/>
            <entity id="DS.d1030.s0.e1" origId="Q64279,Q922L6" charOffset="79-82" type="protein" text="Th1"/>
            <pair e1="DS.d1030.s0.e0" e2="DS.d1030.s0.e1" id="DS.d1030.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1030.s1" origId="18771904-1248" text="BALB/c mice were either left untreated or administered daily with vehicle (VH; saline) and/or silibinin (200 or 400 mg/kg) by gavage for 3 consecutive days prior to sensitization with ovalbumin (OVA).">
            <entity id="DS.d1030.s1.e0" origId="5213,31553,3086637,16211710" charOffset="94-103" type="compound" text="silibinin"/>
            <entity id="DS.d1030.s1.e1" origId="O73860,P01012,P19104,Q6V115" charOffset="184-193" type="protein" text="ovalbumin"/>
            <pair e1="DS.d1030.s1.e0" e2="DS.d1030.s1.e1" id="DS.d1030.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1031" origId="18772236">
        <sentence id="DS.d1031.s0" origId="18772236-1315" text="Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.">
            <entity id="DS.d1031.s0.e0" origId="23931" charOffset="15-17" type="compound" text="HG"/>
            <entity id="DS.d1031.s0.e1" origId="6251" charOffset="37-45" type="compound" text="mannitol"/>
            <entity id="DS.d1031.s0.e2" origId="206,5793,64689,79025" charOffset="60-67" type="compound" text="glucose"/>
            <entity id="DS.d1031.s0.e3" origId="O77636,P78536,Q9Z0F8,Q9Z1K9" charOffset="115-142" type="protein" text="TNF-alpha converting enzyme"/>
            <entity id="DS.d1031.s0.e4" origId="O77636,P78536" charOffset="144-148" type="protein" text="TACE"/>
            <entity id="DS.d1031.s0.e5" origId="O77636,P78536" charOffset="151-157" type="protein" text="ADAM17"/>
            <entity id="DS.d1031.s0.e6" origId="337359" charOffset="185-193" type="compound" text="sorbinil"/>
            <pair e1="DS.d1031.s0.e0" e2="DS.d1031.s0.e5" id="DS.d1031.s0.i0" interaction="True"/>
            <pair e1="DS.d1031.s0.e1" e2="DS.d1031.s0.e3" id="DS.d1031.s0.i1" interaction="False"/>
            <pair e1="DS.d1031.s0.e2" e2="DS.d1031.s0.e4" id="DS.d1031.s0.i2" interaction="False"/>
            <pair e1="DS.d1031.s0.e6" e2="DS.d1031.s0.e3" id="DS.d1031.s0.i3" interaction="True"/>
            <pair e1="DS.d1031.s0.e0" e2="DS.d1031.s0.e3" id="DS.d1031.s0.i4" interaction="True"/>
            <pair e1="DS.d1031.s0.e1" e2="DS.d1031.s0.e5" id="DS.d1031.s0.i5" interaction="False"/>
            <pair e1="DS.d1031.s0.e6" e2="DS.d1031.s0.e5" id="DS.d1031.s0.i6" interaction="True"/>
            <pair e1="DS.d1031.s0.e2" e2="DS.d1031.s0.e3" id="DS.d1031.s0.i7" interaction="False"/>
            <pair e1="DS.d1031.s0.e0" e2="DS.d1031.s0.e4" id="DS.d1031.s0.i8" interaction="True"/>
            <pair e1="DS.d1031.s0.e6" e2="DS.d1031.s0.e4" id="DS.d1031.s0.i9" interaction="True"/>
            <pair e1="DS.d1031.s0.e2" e2="DS.d1031.s0.e5" id="DS.d1031.s0.i10" interaction="False"/>
            <pair e1="DS.d1031.s0.e1" e2="DS.d1031.s0.e4" id="DS.d1031.s0.i11" interaction="False"/>
        </sentence>
        <sentence id="DS.d1031.s1" origId="18772236-1316" text="These results indicate that HG-induced TNF-alpha shedding could be attributed to TACE activation, which is regulated, in part, by PKC-delta and AR.">
            <entity id="DS.d1031.s1.e0" origId="23931" charOffset="28-30" type="compound" text="HG"/>
            <entity id="DS.d1031.s1.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="39-48" type="protein" text="TNF-alpha"/>
            <entity id="DS.d1031.s1.e2" origId="O77636,P78536" charOffset="81-85" type="protein" text="TACE"/>
            <entity id="DS.d1031.s1.e3" origId="P10829" charOffset="130-139" type="protein" text="PKC-delta"/>
            <pair e1="DS.d1031.s1.e0" e2="DS.d1031.s1.e2" id="DS.d1031.s1.i0" interaction="True"/>
            <pair e1="DS.d1031.s1.e0" e2="DS.d1031.s1.e1" id="DS.d1031.s1.i1" interaction="True"/>
            <pair e1="DS.d1031.s1.e0" e2="DS.d1031.s1.e3" id="DS.d1031.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1032" origId="18772240">
        <sentence id="DS.d1032.s0" origId="18772240-1321" text="We conclude that gastrocnemius, heart, and liver mitochondria of streptozotocin diabetic rats are not irrevocably altered toward excess superoxide production either by complex I or complex III.">
            <entity id="DS.d1032.s0.e0" origId="5359597" charOffset="136-146" type="compound" text="superoxide"/>
            <entity id="DS.d1032.s0.e1" origId="Q07842" charOffset="168-177" type="protein" text="complex I"/>
            <pair e1="DS.d1032.s0.e0" e2="DS.d1032.s0.e1" id="DS.d1032.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1033" origId="18772354">
        <sentence id="DS.d1033.s0" origId="18772354-1356" text="Consequently, the primary mechanism of resistance to temozolomide is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA methyltransferase (MGMT).">
            <entity id="DS.d1033.s0.e0" origId="5394" charOffset="53-65" type="compound" text="temozolomide"/>
            <entity id="DS.d1033.s0.e1" origId="O40976,P03588,P03589,P06011,P17769,P20122,P27752,P28726,P28931,Q00020,Q66121,Q83264,Q83270" charOffset="144-161" type="protein" text="methyltransferase"/>
            <entity id="DS.d1033.s0.e2" origId="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8" charOffset="163-167" type="protein" text="MGMT"/>
            <pair e1="DS.d1033.s0.e0" e2="DS.d1033.s0.e1" id="DS.d1033.s0.i0" interaction="True"/>
            <pair e1="DS.d1033.s0.e0" e2="DS.d1033.s0.e2" id="DS.d1033.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1034" origId="18772483">
        <sentence id="DS.d1034.s0" origId="18772483-962" text="Despite their inhibitory effects on inflammatory gene expression, loss of PPARs or LXRs in macrophages did not exert major effects on obesity or glucose tolerance induced by a high-fat diet.">
            <entity id="DS.d1034.s0.e0" origId="Q07869" charOffset="74-79" type="protein" text="PPARs"/>
            <entity id="DS.d1034.s0.e1" origId="206,5793,64689,79025" charOffset="145-152" type="compound" text="glucose"/>
            <pair e1="DS.d1034.s0.e1" e2="DS.d1034.s0.e0" id="DS.d1034.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1034.s1" origId="18772483-964" text="Our results do not exclude a contribution of macrophage PPAR and LXR expression to systemic metabolism in certain contexts, but these factors do not appear to be dominant contributors to glucose tolerance in a high-fat-fed Th1-biased bone marrow transplant model.">
            <entity id="DS.d1034.s1.e0" origId="Q07869" charOffset="56-60" type="protein" text="PPAR"/>
            <entity id="DS.d1034.s1.e1" origId="206,5793,64689,79025" charOffset="187-194" type="compound" text="glucose"/>
            <pair e1="DS.d1034.s1.e1" e2="DS.d1034.s1.e0" id="DS.d1034.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1035" origId="18772488">
        <sentence id="DS.d1035.s0" origId="18772488-1372" text="The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance.">
            <entity id="DS.d1035.s0.e0" origId="6013" charOffset="17-29" type="compound" text="testosterone"/>
            <entity id="DS.d1035.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="66-73" type="protein" text="insulin"/>
            <pair e1="DS.d1035.s0.e0" e2="DS.d1035.s0.e1" id="DS.d1035.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1035.s1" origId="18772488-1373" text="A considerable body of evidence exists suggesting a link among reduced testosterone plasma levels, type 2 diabetes (T2D), and insulin resistance (IR).">
            <entity id="DS.d1035.s1.e0" origId="6013" charOffset="71-83" type="compound" text="testosterone"/>
            <entity id="DS.d1035.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="126-133" type="protein" text="insulin"/>
            <pair e1="DS.d1035.s1.e0" e2="DS.d1035.s1.e1" id="DS.d1035.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1035.s2" origId="18772488-1376" text="Androgen therapy of hypogonadal men improves insulin sensitivity, fasting glucose, and HbA1c levels.">
            <entity id="DS.d1035.s2.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="45-52" type="protein" text="insulin"/>
            <entity id="DS.d1035.s2.e1" origId="206,5793,64689,79025" charOffset="74-81" type="compound" text="glucose"/>
            <pair e1="DS.d1035.s2.e1" e2="DS.d1035.s2.e0" id="DS.d1035.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1036" origId="18772894">
        <sentence id="DS.d1036.s0" origId="18772894-1473" text="Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men.">
            <entity id="DS.d1036.s0.e0" origId="5280644,5282796" charOffset="11-35" type="compound" text="conjugated linoleic acid"/>
            <entity id="DS.d1036.s0.e1" origId="56842239" charOffset="45-72" type="compound" text="polyunsaturated fatty acids"/>
            <entity id="DS.d1036.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="76-83" type="protein" text="insulin"/>
            <entity id="DS.d1036.s0.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="108-115" type="protein" text="insulin"/>
            <pair e1="DS.d1036.s0.e1" e2="DS.d1036.s0.e2" id="DS.d1036.s0.i0" interaction="True"/>
            <pair e1="DS.d1036.s0.e0" e2="DS.d1036.s0.e2" id="DS.d1036.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1037" origId="18773149">
        <sentence id="DS.d1037.s0" origId="18773149-1572" text="A mechanism for the bioreduction of H2PtCl6 and PtCl2 into platinum nanoparticles by a hydrogenase enzyme from Fusarium oxysporum is proposed.">
            <entity id="DS.d1037.s0.e0" origId="23939" charOffset="59-67" type="compound" text="platinum"/>
            <entity id="DS.d1037.s0.e1" origId="P80509,P80510" charOffset="87-98" type="protein" text="hydrogenase"/>
            <pair e1="DS.d1037.s0.e0" e2="DS.d1037.s0.e1" id="DS.d1037.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1038" origId="18773198">
        <sentence id="DS.d1038.s0" origId="18773198-1602" text="Responses of limbic and extrapyramidal substance P systems to nicotine treatment.">
            <entity id="DS.d1038.s0.e0" origId="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541" charOffset="39-50" type="protein" text="substance P"/>
            <entity id="DS.d1038.s0.e1" origId="942,89594,157672" charOffset="62-70" type="compound" text="nicotine"/>
            <pair e1="DS.d1038.s0.e1" e2="DS.d1038.s0.e0" id="DS.d1038.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1039" origId="18773247">
        <sentence id="DS.d1039.s0" origId="18773247-1624" text="Radioisotopic localization of (90) Yttrium-ibritumomab tiuxetan in patients with CD20+ non-Hodgkin's lymphoma.">
            <entity id="DS.d1039.s0.e0" origId="23993" charOffset="35-42" type="compound" text="Yttrium"/>
            <entity id="DS.d1039.s0.e1" origId="P11836,Q3C2E2" charOffset="81-85" type="protein" text="CD20"/>
            <pair e1="DS.d1039.s0.e0" e2="DS.d1039.s0.e1" id="DS.d1039.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1040" origId="18773910">
        <sentence id="DS.d1040.s0" origId="18773910-1819" text="We solved the crystal structures of Aquifex aeolicus SPS and its complex with adenosine 5 '-(alpha,beta-methylene) triphosphate (AMPCPP).">
            <entity id="DS.d1040.s0.e0" origId="P31927,P49031,P49903,Q43845,Q43876" charOffset="53-56" type="protein" text="SPS"/>
            <entity id="DS.d1040.s0.e1" origId="123164" charOffset="104-113" type="compound" text="methylene"/>
            <entity id="DS.d1040.s0.e2" origId="92199" charOffset="129-135" type="compound" text="AMPCPP"/>
            <pair e1="DS.d1040.s0.e2" e2="DS.d1040.s0.e0" id="DS.d1040.s0.i0" interaction="True"/>
            <pair e1="DS.d1040.s0.e1" e2="DS.d1040.s0.e0" id="DS.d1040.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1040.s1" origId="18773910-1820" text="To identify the amino-acid residues that contribute to SPS activity, we prepared six mutants of SPS and examined their selenide-dependent ATP consumption.">
            <entity id="DS.d1040.s1.e0" origId="P31927,P49031,P49903,Q43845,Q43876" charOffset="55-58" type="protein" text="SPS"/>
            <entity id="DS.d1040.s1.e1" origId="P31927,P49031,P49903,Q43845,Q43876" charOffset="96-99" type="protein" text="SPS"/>
            <entity id="DS.d1040.s1.e2" origId="107674" charOffset="119-127" type="compound" text="selenide"/>
            <pair e1="DS.d1040.s1.e2" e2="DS.d1040.s1.e0" id="DS.d1040.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1040.s2" origId="18773910-1821" text="In SPS. AMPCPP, the N-terminal loop, including the two residues, assumes different conformations (&quot;open&quot; and &quot;closed&quot;) between the two subunits.">
            <entity id="DS.d1040.s2.e0" origId="P31927,P49031,P49903,Q43845,Q43876" charOffset="3-6" type="protein" text="SPS"/>
            <entity id="DS.d1040.s2.e1" origId="92199" charOffset="8-14" type="compound" text="AMPCPP"/>
            <pair e1="DS.d1040.s2.e1" e2="DS.d1040.s2.e0" id="DS.d1040.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1041" origId="18773925">
        <sentence id="DS.d1041.s0" origId="18773925-1827" text="The results indicated that CB1 receptors within the nucleus accumbens are involved in the acquisition and expression of morphine-induced CPP in sensitized rats.">
            <entity id="DS.d1041.s0.e0" origId="O02777,P20272,P21554,P47746,P56971,Q333S9,Q5IS73,Q71SP5,Q801M1,Q9PUI7" charOffset="27-30" type="protein" text="CB1"/>
            <entity id="DS.d1041.s0.e1" origId="5288826,5479215" charOffset="120-128" type="compound" text="morphine"/>
            <pair e1="DS.d1041.s0.e1" e2="DS.d1041.s0.e0" id="DS.d1041.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1042" origId="18773927">
        <sentence id="DS.d1042.s0" origId="18773927-1828" text="Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas.">
            <entity id="DS.d1042.s0.e0" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9UBU3" charOffset="10-19" type="protein" text="obestatin"/>
            <entity id="DS.d1042.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="23-30" type="protein" text="insulin"/>
            <entity id="DS.d1042.s0.e2" origId="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9" charOffset="32-40" type="protein" text="glucagon"/>
            <entity id="DS.d1042.s0.e3" origId="16129681,16129706" charOffset="45-57" type="compound" text="somatostatin"/>
            <pair e1="DS.d1042.s0.e3" e2="DS.d1042.s0.e2" id="DS.d1042.s0.i0" interaction="False"/>
            <pair e1="DS.d1042.s0.e3" e2="DS.d1042.s0.e0" id="DS.d1042.s0.i1" interaction="True"/>
            <pair e1="DS.d1042.s0.e3" e2="DS.d1042.s0.e1" id="DS.d1042.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d1042.s1" origId="18773927-1829" text="The potentiated effect of obestatin on glucose-induced insulin output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.">
            <entity id="DS.d1042.s1.e0" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9UBU3" charOffset="26-35" type="protein" text="obestatin"/>
            <entity id="DS.d1042.s1.e1" origId="206,5793,64689,79025" charOffset="39-46" type="compound" text="glucose"/>
            <entity id="DS.d1042.s1.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="55-62" type="protein" text="insulin"/>
            <entity id="DS.d1042.s1.e3" origId="3019" charOffset="106-115" type="compound" text="diazoxide"/>
            <pair e1="DS.d1042.s1.e1" e2="DS.d1042.s1.e2" id="DS.d1042.s1.i0" interaction="True"/>
            <pair e1="DS.d1042.s1.e1" e2="DS.d1042.s1.e0" id="DS.d1042.s1.i1" interaction="True"/>
            <pair e1="DS.d1042.s1.e3" e2="DS.d1042.s1.e2" id="DS.d1042.s1.i2" interaction="True"/>
            <pair e1="DS.d1042.s1.e3" e2="DS.d1042.s1.e0" id="DS.d1042.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1043" origId="18773954">
        <sentence id="DS.d1043.s0" origId="18773954-1841" text="Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na (+), K(+), Cl (-)) contents, immunostained for albumin and glial fibrillary acidic protein (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.">
            <entity id="DS.d1043.s0.e0" origId="923,373840" charOffset="125-127" type="compound" text="Na"/>
            <entity id="DS.d1043.s0.e1" origId="312" charOffset="139-141" type="compound" text="Cl"/>
            <entity id="DS.d1043.s0.e2" origId="P01538,P01543,P01544,P01545,P08772,P08943,P09617,P09618,P21742,P32032,Q05806,Q42596,Q42597,Q42838,Q8H0Q5,Q8VZK8,Q9C8D6,Q9SBK8" charOffset="204-218" type="protein" text="acidic protein"/>
            <entity id="DS.d1043.s0.e3" origId="P03995,P14136,P47819,Q28115" charOffset="220-224" type="protein" text="GFAP"/>
            <pair e1="DS.d1043.s0.e0" e2="DS.d1043.s0.e2" id="DS.d1043.s0.i0" interaction="False"/>
            <pair e1="DS.d1043.s0.e0" e2="DS.d1043.s0.e3" id="DS.d1043.s0.i1" interaction="False"/>
            <pair e1="DS.d1043.s0.e1" e2="DS.d1043.s0.e3" id="DS.d1043.s0.i2" interaction="False"/>
            <pair e1="DS.d1043.s0.e1" e2="DS.d1043.s0.e2" id="DS.d1043.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1044" origId="18773955">
        <sentence id="DS.d1044.s0" origId="18773955-1842" text="We administered parathion to newborn rats on postnatal days (PN) 1-4 at doses spanning the threshold for detectable cholinesterase inhibition (0.1 mg/kg/day) and the first signs of loss of viability (0.2 mg/kg/day).">
            <entity id="DS.d1044.s0.e0" origId="991" charOffset="16-25" type="compound" text="parathion"/>
            <entity id="DS.d1044.s0.e1" origId="P32749,P32750,P32751,P32752,P32753,P81908" charOffset="116-130" type="protein" text="cholinesterase"/>
            <pair e1="DS.d1044.s0.e0" e2="DS.d1044.s0.e1" id="DS.d1044.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1045" origId="18774132">
        <sentence id="DS.d1045.s0" origId="18774132-1889" text="The Arg105 in GLUT10 is highly conserved across species and its replacement with cysteine is predicted to be pathogenic.">
            <entity id="DS.d1045.s0.e0" origId="O95528,Q9BYW1" charOffset="14-20" type="protein" text="GLUT10"/>
            <entity id="DS.d1045.s0.e1" origId="594,5862,5360637" charOffset="81-89" type="compound" text="cysteine"/>
            <pair e1="DS.d1045.s0.e1" e2="DS.d1045.s0.e0" id="DS.d1045.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1046" origId="18774203">
        <sentence id="DS.d1046.s0" origId="18774203-1922" text="(Ofloxacin is contraindicated in case of G6PD deficiency: is it evidenced based?).">
            <entity id="DS.d1046.s0.e0" origId="4583,149096,452723" charOffset="0-10" type="compound" text="(Ofloxacin"/>
            <entity id="DS.d1046.s0.e1" origId="O00091,O24357,O51581,O54537,O55044,O68282,O83491,O84188,P05370,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11410,P11411,P11412,P11413,P12646,P15588,P21907,P29686,P37830,P37986,P41571,P41764,P44311,P48826,P48828,P48848,P48992,P54547,P54996,P56110,P57405,P73411,P77809,P80619,P97324,Q00612,Q23711,Q24625,Q25019,Q25537,Q27464,Q27638,Q29492,Q42919,Q43793,Q43839,Q7YS37,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2" charOffset="41-45" type="protein" text="G6PD"/>
            <pair e1="DS.d1046.s0.e1" e2="DS.d1046.s0.e1" id="DS.d1046.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1047" origId="18774319">
        <sentence id="DS.d1047.s0" origId="18774319-1994" text="We also assess prostaglandin (PGE (2)) and thromboxane (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and COX-2.">
            <entity id="DS.d1047.s0.e0" origId="Q29458" charOffset="30-33" type="protein" text="PGE"/>
            <entity id="DS.d1047.s0.e1" origId="114873" charOffset="43-54" type="compound" text="thromboxane"/>
            <entity id="DS.d1047.s0.e2" origId="9548654" charOffset="56-59" type="compound" text="TXB"/>
            <entity id="DS.d1047.s0.e3" origId="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8" charOffset="168-173" type="protein" text="COX-1"/>
            <entity id="DS.d1047.s0.e4" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="178-183" type="protein" text="COX-2"/>
            <pair e1="DS.d1047.s0.e2" e2="DS.d1047.s0.e4" id="DS.d1047.s0.i0" interaction="False"/>
            <pair e1="DS.d1047.s0.e2" e2="DS.d1047.s0.e3" id="DS.d1047.s0.i1" interaction="False"/>
            <pair e1="DS.d1047.s0.e1" e2="DS.d1047.s0.e4" id="DS.d1047.s0.i2" interaction="False"/>
            <pair e1="DS.d1047.s0.e1" e2="DS.d1047.s0.e3" id="DS.d1047.s0.i3" interaction="False"/>
            <pair e1="DS.d1047.s0.e2" e2="DS.d1047.s0.e0" id="DS.d1047.s0.i4" interaction="False"/>
            <pair e1="DS.d1047.s0.e1" e2="DS.d1047.s0.e0" id="DS.d1047.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1048" origId="18774664">
        <sentence id="DS.d1048.s0" origId="18774664-2104" text="High-dose steroid therapy for the former symptoms of AHS, and immunoglobulin, granulocyte colony-stimulating factor, and cefepime for the latter agranulocytosis were successfully performed.">
            <entity id="DS.d1048.s0.e0" origId="P35834,Q28746" charOffset="78-115" type="protein" text="granulocyte colony-stimulating factor"/>
            <entity id="DS.d1048.s0.e1" origId="5491295" charOffset="121-129" type="compound" text="cefepime"/>
            <pair e1="DS.d1048.s0.e1" e2="DS.d1048.s0.e0" id="DS.d1048.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1049" origId="18774689">
        <sentence id="DS.d1049.s0" origId="18774689-2116" text="0.05 vs. aortic IR) plasma levels of malondialdehyde, P-selectin, intercellular adhesion molecule-1 (ICAM-I), and tissue levels of malondialdehyde and catalase.">
            <entity id="DS.d1049.s0.e0" origId="10964" charOffset="37-52" type="compound" text="malondialdehyde"/>
            <entity id="DS.d1049.s0.e1" origId="10964" charOffset="131-146" type="compound" text="malondialdehyde"/>
            <entity id="DS.d1049.s0.e2" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="151-159" type="protein" text="catalase"/>
            <pair e1="DS.d1049.s0.e0" e2="DS.d1049.s0.e2" id="DS.d1049.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1050" origId="18774957">
        <sentence id="DS.d1050.s0" origId="18774957-2175" text="Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of NPC1 or NPC2 proteins, leading to an accumulation of unesterified cholesterol and glycosphingolipids (GSLs) in the lysosomes.">
            <entity id="DS.d1050.s0.e0" origId="O15118,P56941" charOffset="117-121" type="protein" text="NPC1"/>
            <entity id="DS.d1050.s0.e1" origId="O93388,O97763,P61916,P61917,P61918,P79345,Q12408,Q28895,Q4P580,Q52FS9,Q5A8A2,Q5KIR9,Q6BV42,Q6CHU5,Q6CNE0,Q6FNB1,Q756Q3,Q9VQ62" charOffset="125-129" type="protein" text="NPC2"/>
            <entity id="DS.d1050.s0.e2" origId="304,5997,6432564,11025495" charOffset="183-194" type="compound" text="cholesterol"/>
            <pair e1="DS.d1050.s0.e2" e2="DS.d1050.s0.e0" id="DS.d1050.s0.i0" interaction="True"/>
            <pair e1="DS.d1050.s0.e2" e2="DS.d1050.s0.e1" id="DS.d1050.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1051" origId="18775028">
        <sentence id="DS.d1051.s0" origId="18775028-2185" text="arginase-diminished arginine and indolamine 2,3-dioxygenase-diminished tryptophan) or nitric oxide (NO) production.">
            <entity id="DS.d1051.s0.e0" origId="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3" charOffset="0-8" type="protein" text="arginase"/>
            <entity id="DS.d1051.s0.e1" origId="232,4367,6322" charOffset="20-28" type="compound" text="arginine"/>
            <entity id="DS.d1051.s0.e2" origId="1148,6305,9060,5460840" charOffset="71-81" type="compound" text="tryptophan"/>
            <entity id="DS.d1051.s0.e3" origId="145068" charOffset="86-98" type="compound" text="nitric oxide"/>
            <pair e1="DS.d1051.s0.e3" e2="DS.d1051.s0.e0" id="DS.d1051.s0.i0" interaction="False"/>
            <pair e1="DS.d1051.s0.e1" e2="DS.d1051.s0.e0" id="DS.d1051.s0.i1" interaction="True"/>
            <pair e1="DS.d1051.s0.e2" e2="DS.d1051.s0.e0" id="DS.d1051.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1052" origId="18775088">
        <sentence id="DS.d1052.s0" origId="18775088-2206" text="Memory impairment in young women at increased risk of depression: influence of cortisol and 5-HTT genotype.">
            <entity id="DS.d1052.s0.e0" origId="5754" charOffset="79-87" type="compound" text="cortisol"/>
            <entity id="DS.d1052.s0.e1" origId="P31645" charOffset="94-97" type="protein" text="HTT"/>
            <pair e1="DS.d1052.s0.e0" e2="DS.d1052.s0.e1" id="DS.d1052.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1052.s1" origId="18775088-2207" text="The aim of the present study was to determine whether memory impairments were present in young women at increased familial risk of depression and whether memory performance was related either to cortisol secretion or to allelic variation in the promoter region of the serotonin transporter gene (5-HTT).">
            <entity id="DS.d1052.s1.e0" origId="5754" charOffset="195-203" type="compound" text="cortisol"/>
            <entity id="DS.d1052.s1.e1" origId="P31645" charOffset="298-301" type="protein" text="HTT"/>
            <pair e1="DS.d1052.s1.e0" e2="DS.d1052.s1.e1" id="DS.d1052.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1053" origId="18775090">
        <sentence id="DS.d1053.s0" origId="18775090-2208" text="The relative gene expression of cytochrome c 0.05) in-Cu calves compared with+ Cu or-Cu+Mn calves.">
            <entity id="DS.d1053.s0.e0" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="32-44" type="protein" text="cytochrome c"/>
            <entity id="DS.d1053.s0.e1" origId="104815" charOffset="54-56" type="compound" text="Cu"/>
            <entity id="DS.d1053.s0.e2" origId="104815" charOffset="79-81" type="compound" text="Cu"/>
            <entity id="DS.d1053.s0.e3" origId="104815" charOffset="79-81" type="compound" text="Cu"/>
            <pair e1="DS.d1053.s0.e1" e2="DS.d1053.s0.e0" id="DS.d1053.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1054" origId="18775100">
        <sentence id="DS.d1054.s0" origId="18775100-2213" text="Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients.">
            <entity id="DS.d1054.s0.e0" origId="261166" charOffset="30-36" type="compound" text="lignan"/>
            <entity id="DS.d1054.s0.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="71-75" type="protein" text="IL-6"/>
            <entity id="DS.d1054.s0.e2" origId="P09048,P69610,P69611" charOffset="96-105" type="protein" text="protein 4"/>
            <pair e1="DS.d1054.s0.e0" e2="DS.d1054.s0.e1" id="DS.d1054.s0.i0" interaction="True"/>
            <pair e1="DS.d1054.s0.e0" e2="DS.d1054.s0.e2" id="DS.d1054.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1054.s1" origId="18775100-2214" text="The present study explored the effects of flaxseed-derived lignan on inflammatory factors and RBP4 concentrations in type 2 diabetics, who have higher levels of these biomarkers.">
            <entity id="DS.d1054.s1.e0" origId="261166" charOffset="59-65" type="compound" text="lignan"/>
            <entity id="DS.d1054.s1.e1" origId="P02753,P06912,P18902,P27485,P41263,P61641,Q28369" charOffset="94-98" type="protein" text="RBP4"/>
            <pair e1="DS.d1054.s1.e0" e2="DS.d1054.s1.e1" id="DS.d1054.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1054.s2" origId="18775100-2215" text="No between-treatment differences were found with regard to IL-6 or RBP4 ; though IL-6 0.001 following lignan and placebo treatments, respectively).">
            <entity id="DS.d1054.s2.e0" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="59-63" type="protein" text="IL-6"/>
            <entity id="DS.d1054.s2.e1" origId="P02753,P06912,P18902,P27485,P41263,P61641,Q28369" charOffset="67-71" type="protein" text="RBP4"/>
            <entity id="DS.d1054.s2.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="81-85" type="protein" text="IL-6"/>
            <entity id="DS.d1054.s2.e3" origId="261166" charOffset="102-108" type="compound" text="lignan"/>
            <pair e1="DS.d1054.s2.e3" e2="DS.d1054.s2.e1" id="DS.d1054.s2.i0" interaction="False"/>
            <pair e1="DS.d1054.s2.e3" e2="DS.d1054.s2.e0" id="DS.d1054.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1055" origId="18775460">
        <sentence id="DS.d1055.s0" origId="18775460-2359" text="These include typical G-protein (Galphaq/11)-coupled cascades, such as activation of phospholipase C (PLC), and subsequent accumulation of inositol-(1,4,5)-triphosphate (IP3), intracellular Ca(2+) mobilization, and activation of protein kinase C.">
            <entity id="DS.d1055.s0.e0" origId="271" charOffset="190-194" type="compound" text="Ca(2"/>
            <entity id="DS.d1055.s0.e1" origId="P13678,Q25378" charOffset="229-245" type="protein" text="protein kinase C"/>
            <pair e1="DS.d1055.s0.e0" e2="DS.d1055.s0.e1" id="DS.d1055.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1056" origId="18775471">
        <sentence id="DS.d1056.s0" origId="18775471-2362" text="Here we report the discovery of a series of novel adamantyl carboxamides as selective inhibitors of human 11beta-HSD1 in HEK-293 cells transfected with the HSD11B1 gene.">
            <entity id="DS.d1056.s0.e0" origId="713" charOffset="60-72" type="compound" text="carboxamides"/>
            <entity id="DS.d1056.s0.e1" origId="P28845,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4" charOffset="156-163" type="protein" text="HSD11B1"/>
            <pair e1="DS.d1056.s0.e0" e2="DS.d1056.s0.e1" id="DS.d1056.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1057" origId="18775538">
        <sentence id="DS.d1057.s0" origId="18775538-2383" text="Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy.">
            <entity id="DS.d1057.s0.e0" origId="P14417" charOffset="20-37" type="protein" text="apolipoprotein(a)"/>
            <entity id="DS.d1057.s0.e1" origId="2244" charOffset="104-111" type="compound" text="aspirin"/>
            <pair e1="DS.d1057.s0.e1" e2="DS.d1057.s0.e0" id="DS.d1057.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1057.s1" origId="18775538-2384" text="We investigated whether this allele was associated with elevated Lp(a) and cardiovascular risk in the Women's Health Study, a randomized trial of low-dose aspirin, and whether aspirin reduced cardiovascular risk in minor allele carriers.">
            <entity id="DS.d1057.s1.e0" origId="P08519,P14417" charOffset="65-70" type="protein" text="Lp(a)"/>
            <entity id="DS.d1057.s1.e1" origId="2244" charOffset="155-162" type="compound" text="aspirin"/>
            <entity id="DS.d1057.s1.e2" origId="2244" charOffset="176-183" type="compound" text="aspirin"/>
            <pair e1="DS.d1057.s1.e1" e2="DS.d1057.s1.e0" id="DS.d1057.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1058" origId="18775593">
        <sentence id="DS.d1058.s0" origId="18775593-2403" text="The study was prompted to characterize the B-type esterase activities in the terrestrial snail Xeropicta derbentina and to evaluate its sensitivity to organophosphorus and carbamate pesticides.">
            <entity id="DS.d1058.s0.e0" origId="P16397,P18773" charOffset="50-58" type="protein" text="esterase"/>
            <entity id="DS.d1058.s0.e1" origId="277" charOffset="172-181" type="compound" text="carbamate"/>
            <pair e1="DS.d1058.s0.e1" e2="DS.d1058.s0.e0" id="DS.d1058.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1058.s1" origId="18775593-2404" text="Specific cholinesterase and carboxylesterase activities were mainly obtained with acetylthiocholine (K(m)=77.2 mM; V(max)=38.2 mU/mg protein) and 1-naphthyl acetate (K(m)=222 mM, V(max)=1095 mU/mg protein) substrates, respectively.">
            <entity id="DS.d1058.s1.e0" origId="P32749,P32750,P32751,P32752,P32753,P81908" charOffset="9-23" type="protein" text="cholinesterase"/>
            <entity id="DS.d1058.s1.e1" origId="20544" charOffset="82-99" type="compound" text="acetylthiocholine"/>
            <entity id="DS.d1058.s1.e2" origId="13247" charOffset="146-164" type="compound" text="1-naphthyl acetate"/>
            <pair e1="DS.d1058.s1.e1" e2="DS.d1058.s1.e0" id="DS.d1058.s1.i0" interaction="True"/>
            <pair e1="DS.d1058.s1.e2" e2="DS.d1058.s1.e0" id="DS.d1058.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1059" origId="18775733">
        <sentence id="DS.d1059.s0" origId="18775733-2451" text="To distinguish between isoform-specific and context-dependent modulation as possible explanations for this selectivity, the effects of penicillin were evaluated on recombinant GABA(A) receptors expressed in HEK293T cells.">
            <entity id="DS.d1059.s0.e0" origId="5904" charOffset="135-145" type="compound" text="penicillin"/>
            <entity id="DS.d1059.s0.e1" origId="P26714,Q08832,Q9BLY8" charOffset="176-193" type="protein" text="GABA(A) receptors"/>
            <pair e1="DS.d1059.s0.e0" e2="DS.d1059.s0.e1" id="DS.d1059.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1060" origId="18775745">
        <sentence id="DS.d1060.s0" origId="18775745-2455" text="Drosophila responds to detection of diamonopimelic-type microbial peptidoglycan through activation of the immune deficiency (Imd) pathway, a signaling pathway with numerous similarities to the mammalian pro-inflammatory TNF pathway.">
            <entity id="DS.d1060.s0.e0" origId="9816401" charOffset="66-79" type="compound" text="peptidoglycan"/>
            <entity id="DS.d1060.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="220-223" type="protein" text="TNF"/>
            <pair e1="DS.d1060.s0.e0" e2="DS.d1060.s0.e1" id="DS.d1060.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1061" origId="18775894">
        <sentence id="DS.d1061.s0" origId="18775894-2504" text="We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).">
            <entity id="DS.d1061.s0.e0" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="58-61" type="protein" text="CRP"/>
            <entity id="DS.d1061.s0.e1" origId="O70159,P02765,P12763,P24090,P29699,P29700,P29701,P80191,P97515,Q9N2D0" charOffset="64-72" type="protein" text="fetuin-A"/>
            <entity id="DS.d1061.s0.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="74-78" type="protein" text="IL-6"/>
            <entity id="DS.d1061.s0.e3" origId="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0" charOffset="80-85" type="protein" text="IL-18"/>
            <entity id="DS.d1061.s0.e4" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="87-92" type="protein" text="IL-10"/>
            <entity id="DS.d1061.s0.e5" origId="24441,24456,24632" charOffset="162-180" type="compound" text="calcium, phosphate"/>
            <entity id="DS.d1061.s0.e6" origId="24441,24456,24632" charOffset="182-199" type="compound" text="calcium-phosphate"/>
            <entity id="DS.d1061.s0.e7" origId="P22775,P81070" charOffset="218-228" type="protein" text="fibrinogen"/>
            <entity id="DS.d1061.s0.e8" origId="304,5997,6432564,11025495" charOffset="230-241" type="compound" text="cholesterol"/>
            <entity id="DS.d1061.s0.e9" origId="P81182" charOffset="243-267" type="protein" text="high-density lipoprotein"/>
            <entity id="DS.d1061.s0.e10" origId="P01270" charOffset="293-305" type="protein" text="parathormone"/>
            <pair e1="DS.d1061.s0.e8" e2="DS.d1061.s0.e0" id="DS.d1061.s0.i0" interaction="False"/>
            <pair e1="DS.d1061.s0.e6" e2="DS.d1061.s0.e2" id="DS.d1061.s0.i1" interaction="False"/>
            <pair e1="DS.d1061.s0.e8" e2="DS.d1061.s0.e7" id="DS.d1061.s0.i2" interaction="False"/>
            <pair e1="DS.d1061.s0.e5" e2="DS.d1061.s0.e2" id="DS.d1061.s0.i3" interaction="False"/>
            <pair e1="DS.d1061.s0.e8" e2="DS.d1061.s0.e1" id="DS.d1061.s0.i4" interaction="False"/>
            <pair e1="DS.d1061.s0.e6" e2="DS.d1061.s0.e0" id="DS.d1061.s0.i5" interaction="False"/>
            <pair e1="DS.d1061.s0.e5" e2="DS.d1061.s0.e1" id="DS.d1061.s0.i6" interaction="False"/>
            <pair e1="DS.d1061.s0.e8" e2="DS.d1061.s0.e3" id="DS.d1061.s0.i7" interaction="False"/>
            <pair e1="DS.d1061.s0.e8" e2="DS.d1061.s0.e2" id="DS.d1061.s0.i8" interaction="False"/>
            <pair e1="DS.d1061.s0.e5" e2="DS.d1061.s0.e9" id="DS.d1061.s0.i9" interaction="False"/>
            <pair e1="DS.d1061.s0.e8" e2="DS.d1061.s0.e9" id="DS.d1061.s0.i10" interaction="False"/>
            <pair e1="DS.d1061.s0.e5" e2="DS.d1061.s0.e3" id="DS.d1061.s0.i11" interaction="False"/>
            <pair e1="DS.d1061.s0.e6" e2="DS.d1061.s0.e7" id="DS.d1061.s0.i12" interaction="False"/>
            <pair e1="DS.d1061.s0.e6" e2="DS.d1061.s0.e10" id="DS.d1061.s0.i13" interaction="False"/>
            <pair e1="DS.d1061.s0.e6" e2="DS.d1061.s0.e4" id="DS.d1061.s0.i14" interaction="False"/>
            <pair e1="DS.d1061.s0.e8" e2="DS.d1061.s0.e4" id="DS.d1061.s0.i15" interaction="False"/>
            <pair e1="DS.d1061.s0.e6" e2="DS.d1061.s0.e3" id="DS.d1061.s0.i16" interaction="False"/>
            <pair e1="DS.d1061.s0.e6" e2="DS.d1061.s0.e9" id="DS.d1061.s0.i17" interaction="False"/>
            <pair e1="DS.d1061.s0.e8" e2="DS.d1061.s0.e10" id="DS.d1061.s0.i18" interaction="False"/>
            <pair e1="DS.d1061.s0.e5" e2="DS.d1061.s0.e4" id="DS.d1061.s0.i19" interaction="False"/>
            <pair e1="DS.d1061.s0.e5" e2="DS.d1061.s0.e7" id="DS.d1061.s0.i20" interaction="False"/>
            <pair e1="DS.d1061.s0.e5" e2="DS.d1061.s0.e10" id="DS.d1061.s0.i21" interaction="False"/>
            <pair e1="DS.d1061.s0.e5" e2="DS.d1061.s0.e0" id="DS.d1061.s0.i22" interaction="False"/>
            <pair e1="DS.d1061.s0.e6" e2="DS.d1061.s0.e1" id="DS.d1061.s0.i23" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1062" origId="18775944">
        <sentence id="DS.d1062.s0" origId="18775944-2518" text="Serum 25-hydroxyvitamin D (25-OHD), calcium, alkaline phosphatase and phosphorus were measured.">
            <entity id="DS.d1062.s0.e0" origId="5283731,6433735" charOffset="6-25" type="compound" text="25-hydroxyvitamin D"/>
            <entity id="DS.d1062.s0.e1" origId="O60109,P81800,P83456" charOffset="45-65" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d1062.s0.e2" origId="24404,139579" charOffset="70-80" type="compound" text="phosphorus"/>
            <pair e1="DS.d1062.s0.e0" e2="DS.d1062.s0.e1" id="DS.d1062.s0.i0" interaction="False"/>
            <pair e1="DS.d1062.s0.e2" e2="DS.d1062.s0.e1" id="DS.d1062.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1063" origId="18776133">
        <sentence id="DS.d1063.s0" origId="18776133-17" text="In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated dexamethasone (DEX)-induced glucocorticoid receptor (GCR)-alpha nuclear translocation in both CD4 (+) and CD8(+) T cells.">
            <entity id="DS.d1063.s0.e0" origId="5743" charOffset="168-181" type="compound" text="dexamethasone"/>
            <entity id="DS.d1063.s0.e1" origId="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3" charOffset="196-219" type="protein" text="glucocorticoid receptor"/>
            <entity id="DS.d1063.s0.e2" origId="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78" charOffset="262-265" type="protein" text="CD4"/>
            <pair e1="DS.d1063.s0.e0" e2="DS.d1063.s0.e1" id="DS.d1063.s0.i0" interaction="True"/>
            <pair e1="DS.d1063.s0.e0" e2="DS.d1063.s0.e2" id="DS.d1063.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1064" origId="18776170">
        <sentence id="DS.d1064.s0" origId="18776170-42" text="Linear regression analyses showed that cholesterol and phospholipid efflux and cellular apoA-I binding correlated significantly with the ability of ABCA1 to form cell surface lipid domains.">
            <entity id="DS.d1064.s0.e0" origId="304,5997,6432564,11025495" charOffset="39-50" type="compound" text="cholesterol"/>
            <entity id="DS.d1064.s0.e1" origId="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4" charOffset="88-94" type="protein" text="apoA-I"/>
            <entity id="DS.d1064.s0.e2" origId="O95477" charOffset="148-153" type="protein" text="ABCA1"/>
            <pair e1="DS.d1064.s0.e0" e2="DS.d1064.s0.e2" id="DS.d1064.s0.i0" interaction="True"/>
            <pair e1="DS.d1064.s0.e0" e2="DS.d1064.s0.e1" id="DS.d1064.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1065" origId="18776171">
        <sentence id="DS.d1065.s0" origId="18776171-43" text="Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol.">
            <entity id="DS.d1065.s0.e0" origId="5280644,5282796" charOffset="0-24" type="compound" text="Conjugated linoleic acid"/>
            <entity id="DS.d1065.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="51-58" type="protein" text="insulin"/>
            <entity id="DS.d1065.s0.e2" origId="445154" charOffset="108-119" type="compound" text="resveratrol"/>
            <pair e1="DS.d1065.s0.e0" e2="DS.d1065.s0.e1" id="DS.d1065.s0.i0" interaction="False"/>
            <pair e1="DS.d1065.s0.e2" e2="DS.d1065.s0.e1" id="DS.d1065.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1065.s1" origId="18776171-44" text="Inflammation plays a role in trans-10, cis-12 (10,12)-conjugated linoleic acid (CLA)-mediated delipidation and insulin resistance in adipocytes.">
            <entity id="DS.d1065.s1.e0" origId="5280644,5282796" charOffset="54-78" type="compound" text="conjugated linoleic acid"/>
            <entity id="DS.d1065.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="111-118" type="protein" text="insulin"/>
            <pair e1="DS.d1065.s1.e0" e2="DS.d1065.s1.e1" id="DS.d1065.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1065.s2" origId="18776171-45" text="Given the anti-inflammatory role of resveratrol (RSV), we hypothesized that RSV would attenuate inflammation and insulin resistance caused by 10,12 CLA in human adipocytes.">
            <entity id="DS.d1065.s2.e0" origId="445154" charOffset="36-47" type="compound" text="resveratrol"/>
            <entity id="DS.d1065.s2.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="113-120" type="protein" text="insulin"/>
            <pair e1="DS.d1065.s2.e0" e2="DS.d1065.s2.e1" id="DS.d1065.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1066" origId="18777013">
        <sentence id="DS.d1066.s0" origId="18777013-349" text="Near-infrared fluorescence detection of ATP-biotin-mediated phosphoprotein labeling.">
            <entity id="DS.d1066.s0.e0" origId="5957" charOffset="40-43" type="compound" text="ATP"/>
            <entity id="DS.d1066.s0.e1" origId="253,171548" charOffset="44-50" type="compound" text="biotin"/>
            <entity id="DS.d1066.s0.e2" origId="O55778,O57285,P03421,P03422,P03520,P04859,P04860,P04877,P04878,P04879,P04880,P06162,P06163,P06747,P06940,P11208,P12579,P14156,P14251,P14252,P15198,P16072,P16073,P16286,P16380,P16595,P19717,P21299,P21738,P22044,P22363,P23055,P23056,P24567,P24698,P26033,P26668,P28054,P32530,P32531,P32532,P33454,P35939,P35945,P35974,P60166,P69479,P69480,Q00793,Q01769,Q03335,Q06427,Q83956,Q86606,Q9DUE2,Q9IK91,Q9WS39" charOffset="60-74" type="protein" text="phosphoprotein"/>
            <pair e1="DS.d1066.s0.e0" e2="DS.d1066.s0.e2" id="DS.d1066.s0.i0" interaction="True"/>
            <pair e1="DS.d1066.s0.e1" e2="DS.d1066.s0.e2" id="DS.d1066.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1067" origId="18777014">
        <sentence id="DS.d1067.s0" origId="18777014-352" text="Wheat germ lipase had a high activity and enantioselectivity only in n-hexane with a high initial water activity (alpha(w) = 0.97), especially with 1-phenylethanol (C 32%, E &amp;gt; 200).">
            <entity id="DS.d1067.s0.e0" origId="Q7M4U7" charOffset="11-17" type="protein" text="lipase"/>
            <entity id="DS.d1067.s0.e1" origId="7409" charOffset="148-163" type="compound" text="1-phenylethanol"/>
            <pair e1="DS.d1067.s0.e1" e2="DS.d1067.s0.e0" id="DS.d1067.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1068" origId="18777087">
        <sentence id="DS.d1068.s0" origId="18777087-373" text="We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.">
            <entity id="DS.d1068.s0.e0" origId="656629" charOffset="59-70" type="compound" text="omapatrilat"/>
            <entity id="DS.d1068.s0.e1" origId="2541" charOffset="129-140" type="compound" text="candesartan"/>
            <entity id="DS.d1068.s0.e2" origId="P01033" charOffset="356-360" type="protein" text="TIMP"/>
            <entity id="DS.d1068.s0.e3" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="375-396" type="protein" text="nitric-oxide-synthase"/>
            <entity id="DS.d1068.s0.e4" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="398-402" type="protein" text="iNOS"/>
            <entity id="DS.d1068.s0.e5" origId="P05164,P11247" charOffset="441-444" type="protein" text="MPO"/>
            <entity id="DS.d1068.s0.e6" origId="Q8JFG3" charOffset="461-482" type="protein" text="tumor-necrosis-factor"/>
            <entity id="DS.d1068.s0.e7" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="484-487" type="protein" text="TNF"/>
            <entity id="DS.d1068.s0.e8" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="519-524" type="protein" text="IL-10"/>
            <pair e1="DS.d1068.s0.e1" e2="DS.d1068.s0.e6" id="DS.d1068.s0.i0" interaction="False"/>
            <pair e1="DS.d1068.s0.e0" e2="DS.d1068.s0.e6" id="DS.d1068.s0.i1" interaction="False"/>
            <pair e1="DS.d1068.s0.e0" e2="DS.d1068.s0.e3" id="DS.d1068.s0.i2" interaction="False"/>
            <pair e1="DS.d1068.s0.e0" e2="DS.d1068.s0.e4" id="DS.d1068.s0.i3" interaction="False"/>
            <pair e1="DS.d1068.s0.e1" e2="DS.d1068.s0.e5" id="DS.d1068.s0.i4" interaction="False"/>
            <pair e1="DS.d1068.s0.e0" e2="DS.d1068.s0.e2" id="DS.d1068.s0.i5" interaction="False"/>
            <pair e1="DS.d1068.s0.e1" e2="DS.d1068.s0.e7" id="DS.d1068.s0.i6" interaction="False"/>
            <pair e1="DS.d1068.s0.e1" e2="DS.d1068.s0.e4" id="DS.d1068.s0.i7" interaction="False"/>
            <pair e1="DS.d1068.s0.e0" e2="DS.d1068.s0.e8" id="DS.d1068.s0.i8" interaction="False"/>
            <pair e1="DS.d1068.s0.e0" e2="DS.d1068.s0.e5" id="DS.d1068.s0.i9" interaction="False"/>
            <pair e1="DS.d1068.s0.e0" e2="DS.d1068.s0.e7" id="DS.d1068.s0.i10" interaction="False"/>
            <pair e1="DS.d1068.s0.e1" e2="DS.d1068.s0.e2" id="DS.d1068.s0.i11" interaction="False"/>
            <pair e1="DS.d1068.s0.e1" e2="DS.d1068.s0.e8" id="DS.d1068.s0.i12" interaction="False"/>
            <pair e1="DS.d1068.s0.e1" e2="DS.d1068.s0.e3" id="DS.d1068.s0.i13" interaction="False"/>
        </sentence>
        <sentence id="DS.d1068.s1" origId="18777087-374" text="The results suggest that modulation of matrix proteases, oxidants, cytokines, and NOSs with omapatrilat and candesartan contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.">
            <entity id="DS.d1068.s1.e0" origId="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0" charOffset="46-55" type="protein" text="proteases"/>
            <entity id="DS.d1068.s1.e1" origId="656629" charOffset="92-103" type="compound" text="omapatrilat"/>
            <entity id="DS.d1068.s1.e2" origId="2541" charOffset="108-119" type="compound" text="candesartan"/>
            <pair e1="DS.d1068.s1.e2" e2="DS.d1068.s1.e0" id="DS.d1068.s1.i0" interaction="True"/>
            <pair e1="DS.d1068.s1.e1" e2="DS.d1068.s1.e0" id="DS.d1068.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1069" origId="18777088">
        <sentence id="DS.d1069.s0" origId="18777088-375" text="We recently reported homocysteine (Hcy)-induced ERK-phosphorylation was suppressed by pertussis toxin (PTX), which suggested the involvement of GPCRs in initiating signal transduction.">
            <entity id="DS.d1069.s0.e0" origId="778" charOffset="21-33" type="compound" text="homocysteine"/>
            <entity id="DS.d1069.s0.e1" origId="P29323" charOffset="48-51" type="protein" text="ERK"/>
            <pair e1="DS.d1069.s0.e0" e2="DS.d1069.s0.e1" id="DS.d1069.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1070" origId="18777110">
        <sentence id="DS.d1070.s0" origId="18777110-388" text="Other factors prognostic for inferior survival were serum albumin 37 g/L (HR 3.22, 95% CI 1.11-13.22, p = 0.034) and treatment with non-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy (HR 4.89, 95% CI 1.67-14.36, p = 0.004).">
            <entity id="DS.d1070.s0.e0" origId="P21847,P83517" charOffset="52-65" type="protein" text="serum albumin"/>
            <entity id="DS.d1070.s0.e1" origId="2907,9554282" charOffset="136-152" type="compound" text="cyclophosphamide"/>
            <entity id="DS.d1070.s0.e2" origId="31703" charOffset="154-165" type="compound" text="doxorubicin"/>
            <entity id="DS.d1070.s0.e3" origId="5978" charOffset="167-178" type="compound" text="vincristine"/>
            <entity id="DS.d1070.s0.e4" origId="5755" charOffset="184-196" type="compound" text="prednisolone"/>
            <pair e1="DS.d1070.s0.e2" e2="DS.d1070.s0.e0" id="DS.d1070.s0.i0" interaction="False"/>
            <pair e1="DS.d1070.s0.e1" e2="DS.d1070.s0.e0" id="DS.d1070.s0.i1" interaction="False"/>
            <pair e1="DS.d1070.s0.e3" e2="DS.d1070.s0.e0" id="DS.d1070.s0.i2" interaction="False"/>
            <pair e1="DS.d1070.s0.e4" e2="DS.d1070.s0.e0" id="DS.d1070.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1071" origId="18777117">
        <sentence id="DS.d1071.s0" origId="18777117-392" text="Association between Val/Leu (247) polymorphism of apolipoprotein H and cerebral infarction in a Chinese population.">
            <entity id="DS.d1071.s0.e0" origId="107487" charOffset="20-27" type="compound" text="Val/Leu"/>
            <entity id="DS.d1071.s0.e1" origId="P02749,P17690,P26644,P33703,Q01339,Q95LB0" charOffset="50-66" type="protein" text="apolipoprotein H"/>
            <pair e1="DS.d1071.s0.e0" e2="DS.d1071.s0.e1" id="DS.d1071.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1071.s1" origId="18777117-393" text="The purpose of this study was to identify associations between the Val/Leu (247) polymorphism of apoH gene and CI in a Chinese cohort.">
            <entity id="DS.d1071.s1.e0" origId="107487" charOffset="67-74" type="compound" text="Val/Leu"/>
            <entity id="DS.d1071.s1.e1" origId="P02749,P17690,P26644,P33703,Q01339,Q95LB0" charOffset="97-101" type="protein" text="apoH"/>
            <pair e1="DS.d1071.s1.e0" e2="DS.d1071.s1.e1" id="DS.d1071.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1072" origId="18777136">
        <sentence id="DS.d1072.s0" origId="18777136-397" text="We have discovered multiple genetic and biochemical differences between humans and these other hominids, in relation to sialic acids and in Siglecs (Sia-recognizing Ig superfamily lectins).">
            <entity id="DS.d1072.s0.e0" origId="349960" charOffset="120-132" type="compound" text="sialic acids"/>
            <entity id="DS.d1072.s0.e1" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="180-187" type="protein" text="lectins"/>
            <pair e1="DS.d1072.s0.e0" e2="DS.d1072.s0.e1" id="DS.d1072.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1073" origId="18777160">
        <sentence id="DS.d1073.s0" origId="18777160-404" text="Possible binding site for the substrate, prostaglandin H(2) (PGH(2)), was identified by systematically probing the refined molecular structure of mPGES-1.">
            <entity id="DS.d1073.s0.e0" origId="445049" charOffset="61-66" type="compound" text="PGH(2"/>
            <entity id="DS.d1073.s0.e1" origId="Q9JM51" charOffset="146-153" type="protein" text="mPGES-1"/>
            <pair e1="DS.d1073.s0.e0" e2="DS.d1073.s0.e1" id="DS.d1073.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1074" origId="18777180">
        <sentence id="DS.d1074.s0" origId="18777180-406" text="We cloned the zGCAP4 gene, purified non-myristoylated and myristoylated forms of the protein after heterologous expression in Escherichia coli and studied its properties: zGCAP4 was a strong activator of membrane-bound guanylate cyclases from bovine and zebrafish retina, showing half-maximal activation at 520-570 nM free Ca(2+) concentration.">
            <entity id="DS.d1074.s0.e0" origId="O94303,P33734,Q9P4P9,Q9SZ30" charOffset="229-237" type="protein" text="cyclases"/>
            <entity id="DS.d1074.s0.e1" origId="271" charOffset="323-327" type="compound" text="Ca(2"/>
            <pair e1="DS.d1074.s0.e1" e2="DS.d1074.s0.e0" id="DS.d1074.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1074.s1" origId="18777180-408" text="Thus, expression and biochemical properties of zGCAP4 are in agreement with its function as an efficient Ca(2+)-sensitive regulator of guanylate cyclase activity in cone vision.">
            <entity id="DS.d1074.s1.e0" origId="271" charOffset="105-109" type="compound" text="Ca(2"/>
            <entity id="DS.d1074.s1.e1" origId="O94303,P33734,Q9P4P9,Q9SZ30" charOffset="145-152" type="protein" text="cyclase"/>
            <pair e1="DS.d1074.s1.e0" e2="DS.d1074.s1.e1" id="DS.d1074.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1075" origId="18777181">
        <sentence id="DS.d1075.s0" origId="18777181-411" text="The results of the present work show that this replacement does not considerably affect the DNA modifications by this drug, recognition of these modifications by HMGB1 protein, their repair, and reactivity of the platinum complex with GSH.">
            <entity id="DS.d1075.s0.e0" origId="P07156,P09429,P10103,P12682,P36194,Q4R844,Q6YKA4" charOffset="162-167" type="protein" text="HMGB1"/>
            <entity id="DS.d1075.s0.e1" origId="2915" charOffset="213-229" type="compound" text="platinum complex"/>
            <entity id="DS.d1075.s0.e2" origId="124886" charOffset="235-238" type="compound" text="GSH"/>
            <pair e1="DS.d1075.s0.e1" e2="DS.d1075.s0.e0" id="DS.d1075.s0.i0" interaction="False"/>
            <pair e1="DS.d1075.s0.e2" e2="DS.d1075.s0.e0" id="DS.d1075.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1076" origId="18778244">
        <sentence id="DS.d1076.s0" origId="18778244-705" text="However, in addition to GST activity, we discovered that EGST also possesses thiol : disulfide oxidoreductase activity, for which the residue Cys (10) plays an essential role.">
            <entity id="DS.d1076.s0.e0" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="24-27" type="protein" text="GST"/>
            <entity id="DS.d1076.s0.e1" origId="45102689" charOffset="77-82" type="compound" text="thiol"/>
            <entity id="DS.d1076.s0.e2" origId="O84179,P0A6M2,P0A6M3,P44707,P59343,P59346,P59347,P63993,P63994,P94287,Q44856,Q54155,Q56578,Q7MJN7,Q7VKY2,Q822U2,Q83D55,Q87AV3,Q87N03,Q887H2,Q8ERY3,Q8GHM3,Q8PC32,Q8PNQ6,Q8XZM2,Q8ZEM1,Q9JTA9,Q9JYC6,Q9KBI6,Q9KQU6,Q9L6B3,Q9PGG2,Q9PKL7,Q9RWB5,Q9Z8V7" charOffset="85-109" type="protein" text="disulfide oxidoreductase"/>
            <pair e1="DS.d1076.s0.e1" e2="DS.d1076.s0.e0" id="DS.d1076.s0.i0" interaction="False"/>
            <pair e1="DS.d1076.s0.e1" e2="DS.d1076.s0.e2" id="DS.d1076.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1077" origId="18778281">
        <sentence id="DS.d1077.s0" origId="18778281-720" text="Anti-P mAb promoted IL-10 overproduction in a dose- and time-dependent manner in both lipopolysaccharide (LPS)-activated RAW 264.7 cells and primary human macrophages.">
            <entity id="DS.d1077.s0.e0" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="20-25" type="protein" text="IL-10"/>
            <entity id="DS.d1077.s0.e1" origId="11970143" charOffset="86-104" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d1077.s0.e1" e2="DS.d1077.s0.e0" id="DS.d1077.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1078" origId="18778289">
        <sentence id="DS.d1078.s0" origId="18778289-732" text="Increased secretion of hyperimmune antibodies following lipopolysaccharide stimulation of CD40-activated human B cells in vitro.">
            <entity id="DS.d1078.s0.e0" origId="11970143" charOffset="56-74" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d1078.s0.e1" origId="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34" charOffset="90-94" type="protein" text="CD40"/>
            <pair e1="DS.d1078.s0.e0" e2="DS.d1078.s0.e1" id="DS.d1078.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1079" origId="18778316">
        <sentence id="DS.d1079.s0" origId="18778316-735" text="The addition of a bisecting N-acetylglucosamine residue by beta(1,4)-N-acetylglucosaminyltransferase III (GnTIII) is known to control the processing of N-linked glycans in mammals, for example by preventing alpha(1,6)-fucosylation of the core glycan.">
            <entity id="DS.d1079.s0.e0" origId="24139" charOffset="28-47" type="compound" text="N-acetylglucosamine"/>
            <entity id="DS.d1079.s0.e1" origId="Q02527,Q09327,Q10470" charOffset="69-104" type="protein" text="N-acetylglucosaminyltransferase III"/>
            <pair e1="DS.d1079.s0.e0" e2="DS.d1079.s0.e1" id="DS.d1079.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1079.s1" origId="18778316-736" text="Both CTSs targeted enhanced yellow fluorescent protein (eYFP) to a brefeldin A-sensitive compartment, indicative of Golgi localization.">
            <entity id="DS.d1079.s1.e0" origId="P21578" charOffset="28-54" type="protein" text="yellow fluorescent protein"/>
            <entity id="DS.d1079.s1.e1" origId="5287620" charOffset="67-78" type="compound" text="brefeldin A"/>
            <pair e1="DS.d1079.s1.e1" e2="DS.d1079.s1.e0" id="DS.d1079.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1081" origId="18778748">
        <sentence id="DS.d1081.s0" origId="18778748-865" text="We have investigated the pre-receptor metabolism of progesterone in primary hOSE cells and an immortalised hOSE cell line, OSE-C2, focusing on transcriptional regulation of 3beta-hydroxysteroid dehydrogenase (3beta-HSD) by inflammatory, anti-inflammatory and apoptotic factors.">
            <entity id="DS.d1081.s0.e0" origId="5994" charOffset="52-64" type="compound" text="progesterone"/>
            <entity id="DS.d1081.s0.e1" origId="P19871" charOffset="173-207" type="protein" text="3beta-hydroxysteroid dehydrogenase"/>
            <entity id="DS.d1081.s0.e2" origId="O46516,O57245,P14893,P21097,P26670,P27365,Q5IFP1,Q67477,Q9N119" charOffset="209-218" type="protein" text="3beta-HSD"/>
            <pair e1="DS.d1081.s0.e0" e2="DS.d1081.s0.e2" id="DS.d1081.s0.i0" interaction="False"/>
            <pair e1="DS.d1081.s0.e0" e2="DS.d1081.s0.e1" id="DS.d1081.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1082" origId="18778749">
        <sentence id="DS.d1082.s0" origId="18778749-866" text="Coexpression with H6PDH potentiated 11beta-HSD1 reductase activity at high glucose.">
            <entity id="DS.d1082.s0.e0" origId="P16232,P28845,P50172,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4" charOffset="36-47" type="protein" text="11beta-HSD1"/>
            <entity id="DS.d1082.s0.e1" origId="206,5793,64689,79025" charOffset="75-82" type="compound" text="glucose"/>
            <pair e1="DS.d1082.s0.e1" e2="DS.d1082.s0.e0" id="DS.d1082.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1082.s1" origId="18778749-867" text="11beta-HSD1 dehydrogenase activity was observed in H4IIE cells only at subphysiological glucose levels, indicating a highly efficient supply of substrate for H6PDH and NADPH generation in the ER-lumen.">
            <entity id="DS.d1082.s1.e0" origId="P16232,P28845,P50172,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4" charOffset="0-11" type="protein" text="11beta-HSD1"/>
            <entity id="DS.d1082.s1.e1" origId="206,5793,64689,79025" charOffset="88-95" type="compound" text="glucose"/>
            <pair e1="DS.d1082.s1.e1" e2="DS.d1082.s1.e0" id="DS.d1082.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1083" origId="18778768">
        <sentence id="DS.d1083.s0" origId="18778768-874" text="There are data to suggest that psychological intervention can influence neuroendocrine (e.g., cortisol) and immune function indicators, especially lymphocyte proliferation and TH1 cytokine production.">
            <entity id="DS.d1083.s0.e0" origId="5754" charOffset="94-102" type="compound" text="cortisol"/>
            <entity id="DS.d1083.s0.e1" origId="Q24134,Q8IXH7,Q9UVI4" charOffset="176-179" type="protein" text="TH1"/>
            <pair e1="DS.d1083.s0.e0" e2="DS.d1083.s0.e1" id="DS.d1083.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1084" origId="18778874">
        <sentence id="DS.d1084.s0" origId="18778874-903" text="The proteins identified belong to the photosynthesis, carbohydrate and nitrogen metabolism, and stress-related protein functional categories.">
            <entity id="DS.d1084.s0.e0" origId="947,123329" charOffset="71-79" type="compound" text="nitrogen"/>
            <entity id="DS.d1084.s0.e1" origId="Q41112,Q9SW70" charOffset="96-118" type="protein" text="stress-related protein"/>
            <pair e1="DS.d1084.s0.e0" e2="DS.d1084.s0.e1" id="DS.d1084.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1085" origId="18778892">
        <sentence id="DS.d1085.s0" origId="18778892-914" text="In the present study, we investigated whether CD147/basigin is involved, via its association with MCT1 and 4 to transport lactate, in glycolysis and then contributes to the progression of A375 melanoma cells.">
            <entity id="DS.d1085.s0.e0" origId="Q99PA3" charOffset="52-59" type="protein" text="basigin"/>
            <entity id="DS.d1085.s0.e1" origId="O35439,P53985,Q03064,Q12283" charOffset="98-102" type="protein" text="MCT1"/>
            <entity id="DS.d1085.s0.e2" origId="612" charOffset="122-129" type="compound" text="lactate"/>
            <pair e1="DS.d1085.s0.e2" e2="DS.d1085.s0.e1" id="DS.d1085.s0.i0" interaction="True"/>
            <pair e1="DS.d1085.s0.e2" e2="DS.d1085.s0.e0" id="DS.d1085.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1086" origId="18779389">
        <sentence id="DS.d1086.s0" origId="18779389-1017" text="TCblR belongs to the low-density lipoprotein receptor family, with 2 low-density lipoprotein receptor type A domains separated by a complement-like cysteine-rich region.">
            <entity id="DS.d1086.s0.e0" origId="P01131,P20063,Q28832" charOffset="21-53" type="protein" text="low-density lipoprotein receptor"/>
            <entity id="DS.d1086.s0.e1" origId="P02855" charOffset="102-108" type="protein" text="type A"/>
            <entity id="DS.d1086.s0.e2" origId="594,5862,5360637" charOffset="148-156" type="compound" text="cysteine"/>
            <pair e1="DS.d1086.s0.e2" e2="DS.d1086.s0.e0" id="DS.d1086.s0.i0" interaction="True"/>
            <pair e1="DS.d1086.s0.e2" e2="DS.d1086.s0.e1" id="DS.d1086.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1087" origId="18780301">
        <sentence id="DS.d1087.s0" origId="18780301-1284" text="Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine.">
            <entity id="DS.d1087.s0.e0" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="15-19" type="protein" text="AChE"/>
            <entity id="DS.d1087.s0.e1" origId="P07668,P13222,P28329,P32738,P32756,Q03059" charOffset="31-35" type="protein" text="ChAT"/>
            <entity id="DS.d1087.s0.e2" origId="3152" charOffset="138-147" type="compound" text="Donepezil"/>
            <entity id="DS.d1087.s0.e3" origId="77991" charOffset="152-164" type="compound" text="Rivastigmine"/>
            <pair e1="DS.d1087.s0.e2" e2="DS.d1087.s0.e1" id="DS.d1087.s0.i0" interaction="True"/>
            <pair e1="DS.d1087.s0.e3" e2="DS.d1087.s0.e1" id="DS.d1087.s0.i1" interaction="True"/>
            <pair e1="DS.d1087.s0.e3" e2="DS.d1087.s0.e0" id="DS.d1087.s0.i2" interaction="True"/>
            <pair e1="DS.d1087.s0.e2" e2="DS.d1087.s0.e0" id="DS.d1087.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1088" origId="18780328">
        <sentence id="DS.d1088.s0" origId="18780328-1293" text="Extended-release PEG-luciferin allows for long-term imaging of firefly luciferase activity in vivo.">
            <entity id="DS.d1088.s0.e0" origId="5484207" charOffset="21-30" type="compound" text="luciferin"/>
            <entity id="DS.d1088.s0.e1" origId="P08659,P13129,Q01158,Q26304,Q27757" charOffset="71-81" type="protein" text="luciferase"/>
            <pair e1="DS.d1088.s0.e0" e2="DS.d1088.s0.e1" id="DS.d1088.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1089" origId="18780332">
        <sentence id="DS.d1089.s0" origId="18780332-1296" text="Spectrofluorimetric determination of vitamin B(1) using horseradish peroxidase as catalyst in the presence of hydrogen peroxide.">
            <entity id="DS.d1089.s0.e0" origId="P15984,P16147,P84714" charOffset="68-78" type="protein" text="peroxidase"/>
            <entity id="DS.d1089.s0.e1" origId="784" charOffset="110-127" type="compound" text="hydrogen peroxide"/>
            <pair e1="DS.d1089.s0.e1" e2="DS.d1089.s0.e0" id="DS.d1089.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1089.s1" origId="18780332-1297" text="In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish peroxidase (HRP) in the presence of hydrogen peroxide (H2O2), has been developed.">
            <entity id="DS.d1089.s1.e0" origId="P15984,P16147,P84714" charOffset="132-142" type="protein" text="peroxidase"/>
            <entity id="DS.d1089.s1.e1" origId="Q08168" charOffset="144-147" type="protein" text="HRP"/>
            <entity id="DS.d1089.s1.e2" origId="784" charOffset="168-185" type="compound" text="hydrogen peroxide"/>
            <entity id="DS.d1089.s1.e3" origId="784" charOffset="187-191" type="compound" text="H2O2"/>
            <pair e1="DS.d1089.s1.e3" e2="DS.d1089.s1.e1" id="DS.d1089.s1.i0" interaction="True"/>
            <pair e1="DS.d1089.s1.e3" e2="DS.d1089.s1.e0" id="DS.d1089.s1.i1" interaction="True"/>
            <pair e1="DS.d1089.s1.e2" e2="DS.d1089.s1.e1" id="DS.d1089.s1.i2" interaction="True"/>
            <pair e1="DS.d1089.s1.e2" e2="DS.d1089.s1.e0" id="DS.d1089.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1090" origId="18780360">
        <sentence id="DS.d1090.s0" origId="18780360-1305" text="Electrospun polyglyconate (Maxon) and its blends with proteins such as gelatin and elastin, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering.">
            <entity id="DS.d1090.s0.e0" origId="123833" charOffset="12-25" type="compound" text="polyglyconate"/>
            <entity id="DS.d1090.s0.e1" origId="123833" charOffset="27-32" type="compound" text="Maxon"/>
            <entity id="DS.d1090.s0.e2" origId="P11547" charOffset="83-90" type="protein" text="elastin"/>
            <pair e1="DS.d1090.s0.e1" e2="DS.d1090.s0.e2" id="DS.d1090.s0.i0" interaction="True"/>
            <pair e1="DS.d1090.s0.e0" e2="DS.d1090.s0.e2" id="DS.d1090.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1091" origId="18781168">
        <sentence id="DS.d1091.s0" origId="18781168-1823" text="So far, in maize, three classes of mutants involved in phytic acid biosynthesis have been isolated: lpa1, lpa2 and lpa3.">
            <entity id="DS.d1091.s0.e0" origId="890" charOffset="55-66" type="compound" text="phytic acid"/>
            <entity id="DS.d1091.s0.e1" origId="P61793,P61794" charOffset="100-104" type="protein" text="lpa1"/>
            <entity id="DS.d1091.s0.e2" origId="Q9JL06" charOffset="106-110" type="protein" text="lpa2"/>
            <entity id="DS.d1091.s0.e3" origId="Q8K5E0,Q9EQ31" charOffset="115-119" type="protein" text="lpa3"/>
            <pair e1="DS.d1091.s0.e0" e2="DS.d1091.s0.e1" id="DS.d1091.s0.i0" interaction="True"/>
            <pair e1="DS.d1091.s0.e0" e2="DS.d1091.s0.e2" id="DS.d1091.s0.i1" interaction="True"/>
            <pair e1="DS.d1091.s0.e0" e2="DS.d1091.s0.e3" id="DS.d1091.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1092" origId="18781316">
        <sentence id="DS.d1092.s0" origId="18781316-1566" text="Bevacizumab (Avastin), ranibizumab (Lucentis) and pegaptanib sodium (Macugen) are anti-VEGF medications that have been used in the treatment of CNV.">
            <entity id="DS.d1092.s0.e0" origId="158786" charOffset="50-67" type="compound" text="pegaptanib sodium"/>
            <entity id="DS.d1092.s0.e1" origId="158786" charOffset="69-76" type="compound" text="Macugen"/>
            <entity id="DS.d1092.s0.e2" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="87-91" type="protein" text="VEGF"/>
            <pair e1="DS.d1092.s0.e1" e2="DS.d1092.s0.e2" id="DS.d1092.s0.i0" interaction="True"/>
            <pair e1="DS.d1092.s0.e0" e2="DS.d1092.s0.e2" id="DS.d1092.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1093" origId="18781338">
        <sentence id="DS.d1093.s0" origId="18781338-1571" text="Blood samples were collected to assay for biomarkers of oxidative stress (malondialdehyde and carbonyl groups) and antioxidants (glutathione peroxidase, reduced glutathione, alpha-tocopherol, and beta-carotene).">
            <entity id="DS.d1093.s0.e0" origId="10964" charOffset="74-89" type="compound" text="malondialdehyde"/>
            <entity id="DS.d1093.s0.e1" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="129-151" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d1093.s0.e2" origId="124886" charOffset="153-172" type="compound" text="reduced glutathione"/>
            <pair e1="DS.d1093.s0.e2" e2="DS.d1093.s0.e1" id="DS.d1093.s0.i0" interaction="False"/>
            <pair e1="DS.d1093.s0.e0" e2="DS.d1093.s0.e1" id="DS.d1093.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1094" origId="18781385">
        <sentence id="DS.d1094.s0" origId="18781385-1599" text="The low content of sphingomyelin, sulfatide and galactosylceramide is consistent with the immunohistochemical results showing that in the grey-lethal brain significant depletion and disorganization of the myelinated fibres is present, thus supporting the hypothesis that loss of function of the OSTM1 causes neuronal impairment and myelin deficit.">
            <entity id="DS.d1094.s0.e0" origId="52949283" charOffset="48-66" type="compound" text="galactosylceramide"/>
            <entity id="DS.d1094.s0.e1" origId="Q86WC4" charOffset="295-300" type="protein" text="OSTM1"/>
            <pair e1="DS.d1094.s0.e0" e2="DS.d1094.s0.e1" id="DS.d1094.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1095" origId="18781596">
        <sentence id="DS.d1095.s0" origId="18781596-1677" text="Finally and most importantly, our data indicate that a decrease in AKT activity followed by a total decrease in p70 (S6K) phosphorylation reflecting a decrease in mTOR activity occurs during high oxygen consumption, resulting from high cell density.">
            <entity id="DS.d1095.s0.e0" origId="O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P08133,P14824,P26660,P26661,P26662,P26663,P26664,P27694,P27958,P29846,P48037,P51901,P79134,Q00269,Q01588,Q24492,Q5FW17,Q5I2N3,Q5R7Q4,Q5ZJJ2,Q68749,Q68798,Q68801,Q6NY74,Q81258,Q81487,Q81495,Q81754,Q8VEE4,Q913D4,Q99IB8,Q9DHD6,Q9FMI7,Q9QAX1,Q9WMX2" charOffset="112-115" type="protein" text="p70"/>
            <entity id="DS.d1095.s0.e1" origId="P23443,P67998,P67999,Q6TJY3,Q8BSK8" charOffset="117-120" type="protein" text="S6K"/>
            <entity id="DS.d1095.s0.e2" origId="P42345,P42346,Q9JLN9" charOffset="163-167" type="protein" text="mTOR"/>
            <entity id="DS.d1095.s0.e3" origId="977" charOffset="196-202" type="compound" text="oxygen"/>
            <pair e1="DS.d1095.s0.e3" e2="DS.d1095.s0.e1" id="DS.d1095.s0.i0" interaction="True"/>
            <pair e1="DS.d1095.s0.e3" e2="DS.d1095.s0.e0" id="DS.d1095.s0.i1" interaction="True"/>
            <pair e1="DS.d1095.s0.e3" e2="DS.d1095.s0.e2" id="DS.d1095.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1096" origId="18781650">
        <sentence id="DS.d1096.s0" origId="18781650-1708" text="Some of the peptide derivatives inhibited PEPT1-mediated uptake of ((3)H) Gly-Sar.">
            <entity id="DS.d1096.s0.e0" origId="P36836,P46059,Q8WMX5" charOffset="42-47" type="protein" text="PEPT1"/>
            <entity id="DS.d1096.s0.e1" origId="750,5460845" charOffset="74-77" type="compound" text="Gly"/>
            <pair e1="DS.d1096.s0.e1" e2="DS.d1096.s0.e0" id="DS.d1096.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1097" origId="18781688">
        <sentence id="DS.d1097.s0" origId="18781688-1721" text="Effect of enzyme supplementation at moderate cellulase loadings on initial glucose and xylose release from corn stover solids pretreated by leading technologies.">
            <entity id="DS.d1097.s0.e0" origId="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7" charOffset="45-54" type="protein" text="cellulase"/>
            <entity id="DS.d1097.s0.e1" origId="5793" charOffset="75-82" type="compound" text="glucose"/>
            <pair e1="DS.d1097.s0.e1" e2="DS.d1097.s0.e0" id="DS.d1097.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1097.s1" origId="18781688-1722" text="For a combined mass loading of cellulase and beta-glucosidase of 16.1 mg/g original glucan (about 7.5 FPU/g), glucose release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.">
            <entity id="DS.d1097.s1.e0" origId="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7" charOffset="31-40" type="protein" text="cellulase"/>
            <entity id="DS.d1097.s1.e1" origId="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684" charOffset="45-61" type="protein" text="beta-glucosidase"/>
            <entity id="DS.d1097.s1.e2" origId="5793" charOffset="84-90" type="compound" text="glucan"/>
            <entity id="DS.d1097.s1.e3" origId="5793" charOffset="110-117" type="compound" text="glucose"/>
            <pair e1="DS.d1097.s1.e2" e2="DS.d1097.s1.e1" id="DS.d1097.s1.i0" interaction="True"/>
            <pair e1="DS.d1097.s1.e3" e2="DS.d1097.s1.e1" id="DS.d1097.s1.i1" interaction="True"/>
            <pair e1="DS.d1097.s1.e2" e2="DS.d1097.s1.e0" id="DS.d1097.s1.i2" interaction="True"/>
            <pair e1="DS.d1097.s1.e3" e2="DS.d1097.s1.e0" id="DS.d1097.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1098" origId="18782461">
        <sentence id="DS.d1098.s0" origId="18782461-1964" text="PCFT/HCP1 could therefore play a physiological role in Fe nutrition and the data highlight the potential for the interaction of folate and haem at the level of intestinal absorption.">
            <entity id="DS.d1098.s0.e0" origId="Q13946,Q96NT5" charOffset="5-9" type="protein" text="HCP1"/>
            <entity id="DS.d1098.s0.e1" origId="6037" charOffset="128-134" type="compound" text="folate"/>
            <pair e1="DS.d1098.s0.e1" e2="DS.d1098.s0.e0" id="DS.d1098.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1099" origId="18782463">
        <sentence id="DS.d1099.s0" origId="18782463-1965" text="Following an oral glucose challenge, there was a weak trend for glucose-stimulated insulin release to be increased in the offspring of dams fed the folate-deficient diet.">
            <entity id="DS.d1099.s0.e0" origId="206,5793,64689,79025" charOffset="18-25" type="compound" text="glucose"/>
            <entity id="DS.d1099.s0.e1" origId="206,5793,64689,79025" charOffset="64-71" type="compound" text="glucose"/>
            <entity id="DS.d1099.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="83-90" type="protein" text="insulin"/>
            <pair e1="DS.d1099.s0.e0" e2="DS.d1099.s0.e2" id="DS.d1099.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1100" origId="18782570">
        <sentence id="DS.d1100.s0" origId="18782570-2009" text="Association between serum retinol-binding protein 4 and small dense low-density lipoprotein cholesterol levels in young adult women.">
            <entity id="DS.d1100.s0.e0" origId="P09048,P69610,P69611" charOffset="42-51" type="protein" text="protein 4"/>
            <entity id="DS.d1100.s0.e1" origId="304,5997,6432564,11025495" charOffset="92-103" type="compound" text="cholesterol"/>
            <pair e1="DS.d1100.s0.e1" e2="DS.d1100.s0.e0" id="DS.d1100.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1101" origId="18782588">
        <sentence id="DS.d1101.s0" origId="18782588-2018" text="Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine serum albumin (TNP-BSA).">
            <entity id="DS.d1101.s0.e0" origId="P21847,P83517" charOffset="128-141" type="protein" text="serum albumin"/>
            <entity id="DS.d1101.s0.e1" origId="5289486" charOffset="143-146" type="compound" text="TNP"/>
            <entity id="DS.d1101.s0.e2" origId="P02769" charOffset="147-150" type="protein" text="BSA"/>
            <pair e1="DS.d1101.s0.e1" e2="DS.d1101.s0.e0" id="DS.d1101.s0.i0" interaction="True"/>
            <pair e1="DS.d1101.s0.e1" e2="DS.d1101.s0.e2" id="DS.d1101.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1102" origId="18782661">
        <sentence id="DS.d1102.s0" origId="18782661-2054" text="By using the system, we obtained four event timing data sets (stimulation by NGF with and without staurosporine at the concentrations of 0.01, 0.1, and 1 microM).">
            <entity id="DS.d1102.s0.e0" origId="P21617,P34129,Q6YBR5,Q90W38" charOffset="77-80" type="protein" text="NGF"/>
            <entity id="DS.d1102.s0.e1" origId="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148" charOffset="98-111" type="compound" text="staurosporine"/>
            <pair e1="DS.d1102.s0.e1" e2="DS.d1102.s0.e0" id="DS.d1102.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1103" origId="18783254">
        <sentence id="DS.d1103.s1" origId="18783254-2198" text="First, R-state, or allosteric, autocatalysis of nitrite reduction increases the rate of NO generation by deoxyhemoglobin and results in maximal NO production at approximately 50% hemoglobin oxygen saturation, which is physiologically associated with greatest NO-dependent vasodilation.">
            <entity id="DS.d1103.s1.e0" origId="P15160,P17724,P73925,Q03459" charOffset="110-120" type="protein" text="hemoglobin"/>
            <entity id="DS.d1103.s1.e1" origId="977" charOffset="190-196" type="compound" text="oxygen"/>
            <pair e1="DS.d1103.s1.e1" e2="DS.d1103.s1.e0" id="DS.d1103.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1104" origId="18783311">
        <sentence id="DS.d1104.s0" origId="18783311-2231" text="Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells.">
            <entity id="DS.d1104.s0.e0" origId="Q924V1,Q9JHI8" charOffset="8-12" type="protein" text="Nox4"/>
            <entity id="DS.d1104.s0.e1" origId="977" charOffset="52-58" type="compound" text="oxygen"/>
            <pair e1="DS.d1104.s0.e1" e2="DS.d1104.s0.e0" id="DS.d1104.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1104.s1" origId="18783311-2234" text="Downregulation of Nox4, or pretreatment with N-acetylcysteine, attenuated hyperoxia-induced cell migration and capillary tube formation, suggesting that ROS generated by Nox4 regulate endothelial cell motility.">
            <entity id="DS.d1104.s1.e0" origId="Q924V1,Q9JHI8" charOffset="18-22" type="protein" text="Nox4"/>
            <entity id="DS.d1104.s1.e1" origId="12035" charOffset="45-61" type="compound" text="N-acetylcysteine"/>
            <entity id="DS.d1104.s1.e2" origId="Q924V1,Q9JHI8" charOffset="170-174" type="protein" text="Nox4"/>
            <pair e1="DS.d1104.s1.e1" e2="DS.d1104.s1.e0" id="DS.d1104.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1105" origId="18783384">
        <sentence id="DS.d1105.s0" origId="18783384-2267" text="Using newly designed degenerate primers targeting the phnA gene we analysed the potential for phosphonoacetate utilization in DNA and cDNA libraries constructed from a phytoplankton bloom in the Western English Channel during July 2006.">
            <entity id="DS.d1105.s0.e0" origId="P09785,P0AFJ1,P0AFJ2,P0AFJ3,P0AFJ4,P44479,Q02419" charOffset="54-58" type="protein" text="phnA"/>
            <entity id="DS.d1105.s0.e1" origId="546" charOffset="94-110" type="compound" text="phosphonoacetate"/>
            <pair e1="DS.d1105.s0.e1" e2="DS.d1105.s0.e0" id="DS.d1105.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1106" origId="18783774">
        <sentence id="DS.d1106.s0" origId="18783774-2396" text="Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.">
            <entity id="DS.d1106.s0.e0" origId="304,5997,6432564,11025495" charOffset="24-35" type="compound" text="cholesterol"/>
            <entity id="DS.d1106.s0.e1" origId="P81182" charOffset="44-68" type="protein" text="high-density lipoprotein"/>
            <entity id="DS.d1106.s0.e2" origId="304,5997,6432564,11025495" charOffset="69-80" type="compound" text="cholesterol"/>
            <pair e1="DS.d1106.s0.e0" e2="DS.d1106.s0.e1" id="DS.d1106.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1106.s1" origId="18783774-2397" text="Only a small number of population-based cohort studies have directly compared the predictive value of low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDLC) for coronary artery disease in Asian populations, such as Japan.">
            <entity id="DS.d1106.s1.e0" origId="304,5997,6432564,11025495" charOffset="126-137" type="compound" text="cholesterol"/>
            <entity id="DS.d1106.s1.e1" origId="P81182" charOffset="154-178" type="protein" text="high-density lipoprotein"/>
            <entity id="DS.d1106.s1.e2" origId="304,5997,6432564,11025495" charOffset="179-190" type="compound" text="cholesterol"/>
            <pair e1="DS.d1106.s1.e0" e2="DS.d1106.s1.e1" id="DS.d1106.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1107" origId="18783827">
        <sentence id="DS.d1107.s0" origId="18783827-2422" text="Finally, we show that Vcx1 helps return cytosolic Ca(2+) toward resting levels after shock with high extracellular Ca(2+) much more effectively than Pmc1 and that calcineurin, a protein phosphatase regulator of Vcx1 and Pmc1, had no detectable effects on these factors within the first few minutes of its activation.">
            <entity id="DS.d1107.s0.e0" origId="271" charOffset="50-54" type="compound" text="Ca(2"/>
            <entity id="DS.d1107.s0.e1" origId="271" charOffset="115-119" type="compound" text="Ca(2"/>
            <entity id="DS.d1107.s0.e2" origId="Q9P7Y4" charOffset="149-153" type="protein" text="Pmc1"/>
            <entity id="DS.d1107.s0.e3" origId="Q9P7Y4" charOffset="220-224" type="protein" text="Pmc1"/>
            <pair e1="DS.d1107.s0.e0" e2="DS.d1107.s0.e2" id="DS.d1107.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1108" origId="18783828">
        <sentence id="DS.d1108.s0" origId="18783828-2424" text="It is a serious problem that effective treatment choices to T315I, in the ABL kinase domain that shows a strong tolerance in imatinib do not exist clinically.">
            <entity id="DS.d1108.s0.e0" origId="P00519,P00521,P10447,P11681,Q00022" charOffset="74-77" type="protein" text="ABL"/>
            <entity id="DS.d1108.s0.e1" origId="5291" charOffset="125-133" type="compound" text="imatinib"/>
            <pair e1="DS.d1108.s0.e1" e2="DS.d1108.s0.e0" id="DS.d1108.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1109" origId="18783846">
        <sentence id="DS.d1109.s0" origId="18783846-2433" text="Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, tolbutamide- and KCl-induced Egr-1 expression.">
            <entity id="DS.d1109.s0.e0" origId="P13678,Q25378" charOffset="34-50" type="protein" text="protein kinase C"/>
            <entity id="DS.d1109.s0.e1" origId="P00513,P25848" charOffset="34-48" type="protein" text="protein kinase"/>
            <entity id="DS.d1109.s0.e2" origId="P29323" charOffset="127-130" type="protein" text="ERK"/>
            <entity id="DS.d1109.s0.e3" origId="206,5793,64689,79025" charOffset="149-156" type="compound" text="glucose"/>
            <entity id="DS.d1109.s0.e4" origId="5505" charOffset="159-170" type="compound" text="tolbutamide"/>
            <entity id="DS.d1109.s0.e5" origId="P08046" charOffset="188-193" type="protein" text="Egr-1"/>
            <pair e1="DS.d1109.s0.e4" e2="DS.d1109.s0.e2" id="DS.d1109.s0.i0" interaction="True"/>
            <pair e1="DS.d1109.s0.e3" e2="DS.d1109.s0.e0" id="DS.d1109.s0.i1" interaction="True"/>
            <pair e1="DS.d1109.s0.e4" e2="DS.d1109.s0.e0" id="DS.d1109.s0.i2" interaction="True"/>
            <pair e1="DS.d1109.s0.e4" e2="DS.d1109.s0.e5" id="DS.d1109.s0.i3" interaction="True"/>
            <pair e1="DS.d1109.s0.e3" e2="DS.d1109.s0.e5" id="DS.d1109.s0.i4" interaction="True"/>
            <pair e1="DS.d1109.s0.e3" e2="DS.d1109.s0.e2" id="DS.d1109.s0.i5" interaction="True"/>
            <pair e1="DS.d1109.s0.e3" e2="DS.d1109.s0.e1" id="DS.d1109.s0.i6" interaction="True"/>
            <pair e1="DS.d1109.s0.e4" e2="DS.d1109.s0.e1" id="DS.d1109.s0.i7" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1110" origId="18784063">
        <sentence id="DS.d1110.s0" origId="18784063-2498" text="Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance.">
            <entity id="DS.d1110.s0.e0" origId="3686" charOffset="46-54" type="compound" text="SNT-MC17"/>
            <entity id="DS.d1110.s0.e1" origId="3686" charOffset="55-64" type="compound" text="idebenone"/>
            <entity id="DS.d1110.s0.e2" origId="O97592,P11530,P11531,P11532,P11533,Q5GN48" charOffset="72-82" type="protein" text="dystrophin"/>
            <pair e1="DS.d1110.s0.e1" e2="DS.d1110.s0.e2" id="DS.d1110.s0.i0" interaction="True"/>
            <pair e1="DS.d1110.s0.e0" e2="DS.d1110.s0.e2" id="DS.d1110.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1111" origId="18784648">
        <sentence id="DS.d1111.s0" origId="18784648-124" text="Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice.">
            <entity id="DS.d1111.s0.e0" origId="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3" charOffset="0-23" type="protein" text="Glucocorticoid receptor"/>
            <entity id="DS.d1111.s0.e1" origId="5300,29327,6420074,6713972,7067772,45357367" charOffset="96-110" type="compound" text="streptozotocin"/>
            <pair e1="DS.d1111.s0.e1" e2="DS.d1111.s0.e0" id="DS.d1111.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1112" origId="18784734">
        <sentence id="DS.d1112.s0" origId="18784734-168" text="The study aim was to determine whether urine albumin/creatinine ratio (UACR), high-sensitivity C-reactive protein (hsCRP) or N-terminal pro-brain natriuretic peptide (Nt-proBNP) added to risk prediction based on HeartScore and history of diabetes or cardiovascular disease.">
            <entity id="DS.d1112.s0.e0" origId="588" charOffset="53-63" type="compound" text="creatinine"/>
            <entity id="DS.d1112.s0.e1" origId="P40753" charOffset="140-165" type="protein" text="brain natriuretic peptide"/>
            <pair e1="DS.d1112.s0.e0" e2="DS.d1112.s0.e1" id="DS.d1112.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1113" origId="18784749">
        <sentence id="DS.d1113.s0" origId="18784749-176" text="Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.">
            <entity id="DS.d1113.s0.e0" origId="O46522,P04839,P52649,Q61093,Q95L74" charOffset="65-73" type="protein" text="gp91phox"/>
            <entity id="DS.d1113.s0.e1" origId="5359597" charOffset="107-117" type="compound" text="superoxide"/>
            <pair e1="DS.d1113.s0.e1" e2="DS.d1113.s0.e0" id="DS.d1113.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1114" origId="18784906">
        <sentence id="DS.d1114.s0" origId="18784906-222" text="Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats.">
            <entity id="DS.d1114.s0.e0" origId="P36836,P46059,Q8WMX5" charOffset="27-32" type="protein" text="PEPT1"/>
            <entity id="DS.d1114.s0.e1" origId="27447" charOffset="68-78" type="compound" text="cephalexin"/>
            <pair e1="DS.d1114.s0.e1" e2="DS.d1114.s0.e0" id="DS.d1114.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1115" origId="18784908">
        <sentence id="DS.d1115.s0" origId="18784908-224" text="Cu concentration in the liver and in plasma alanine aminotransferase (ALT) and aspartate transaminase (AST) activities were determined.">
            <entity id="DS.d1115.s0.e0" origId="104815" charOffset="0-2" type="compound" text="Cu"/>
            <entity id="DS.d1115.s0.e1" origId="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67" charOffset="103-106" type="protein" text="AST"/>
            <pair e1="DS.d1115.s0.e0" e2="DS.d1115.s0.e1" id="DS.d1115.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1115.s1" origId="18784908-225" text="In brain tissue, Cu concentration, superoxide dismutase (SOD) activities, malondialdehyde (MDA) levels and glutathione (GSH) concentrations were determined.">
            <entity id="DS.d1115.s1.e0" origId="104815" charOffset="17-19" type="compound" text="Cu"/>
            <entity id="DS.d1115.s1.e1" origId="O50258" charOffset="35-55" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1115.s1.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="57-60" type="protein" text="SOD"/>
            <entity id="DS.d1115.s1.e3" origId="10964" charOffset="74-89" type="compound" text="malondialdehyde"/>
            <pair e1="DS.d1115.s1.e3" e2="DS.d1115.s1.e2" id="DS.d1115.s1.i0" interaction="False"/>
            <pair e1="DS.d1115.s1.e3" e2="DS.d1115.s1.e1" id="DS.d1115.s1.i1" interaction="False"/>
            <pair e1="DS.d1115.s1.e0" e2="DS.d1115.s1.e1" id="DS.d1115.s1.i2" interaction="False"/>
            <pair e1="DS.d1115.s1.e0" e2="DS.d1115.s1.e2" id="DS.d1115.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1116" origId="18785000">
        <sentence id="DS.d1116.s0" origId="18785000-243" text="We previously reported that inhibition of Rho-kinase (ROCK) by hydroxyl fasudil improves cognitive deficit and neuronal damage in rats with chronic cerebral ischemia (Huang et al., Cell Mol Neurobiol 28:757-768, 2008).">
            <entity id="DS.d1116.s0.e0" origId="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9" charOffset="42-45" type="protein" text="Rho"/>
            <entity id="DS.d1116.s0.e1" origId="3547" charOffset="72-79" type="compound" text="fasudil"/>
            <pair e1="DS.d1116.s0.e1" e2="DS.d1116.s0.e0" id="DS.d1116.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1116.s1" origId="18785000-244" text="Finally, in the presence of OGD and fasudil mesylate, superoxide dismutase (SOD) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group.">
            <entity id="DS.d1116.s1.e0" origId="3547" charOffset="36-43" type="compound" text="fasudil"/>
            <entity id="DS.d1116.s1.e1" origId="O50258" charOffset="54-74" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1116.s1.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="76-79" type="protein" text="SOD"/>
            <pair e1="DS.d1116.s1.e0" e2="DS.d1116.s1.e2" id="DS.d1116.s1.i0" interaction="True"/>
            <pair e1="DS.d1116.s1.e0" e2="DS.d1116.s1.e1" id="DS.d1116.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1117" origId="18785066">
        <sentence id="DS.d1117.s0" origId="18785066-298" text="Na+/H+ exchanger isoform 3 (NHE-3) is responsible for net uptake of NaCl and water from the gastrointestinal (GI) tract.">
            <entity id="DS.d1117.s0.e0" origId="P26432,P26433,P48764,Q28362,Q84WG1" charOffset="28-33" type="protein" text="NHE-3"/>
            <entity id="DS.d1117.s0.e1" origId="5234" charOffset="68-72" type="compound" text="NaCl"/>
            <pair e1="DS.d1117.s0.e1" e2="DS.d1117.s0.e0" id="DS.d1117.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1118" origId="18785206">
        <sentence id="DS.d1118.s0" origId="18785206-418" text="PDE4B is also important in the regulation of cAMP signaling, a second messenger implicated in learning, memory, and mood.">
            <entity id="DS.d1118.s0.e0" origId="Q07343" charOffset="0-5" type="protein" text="PDE4B"/>
            <entity id="DS.d1118.s0.e1" origId="6076" charOffset="45-49" type="compound" text="cAMP"/>
            <pair e1="DS.d1118.s0.e1" e2="DS.d1118.s0.e0" id="DS.d1118.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1119" origId="18785212">
        <sentence id="DS.d1119.s0" origId="18785212-354" text="Elevated amounts of PGK1, one of the ATP-generating reactions of glycolysis, in wood frog brain during freezing would enhance the glycolytic capacity of the organ and support the maintenance of cellular energetics under the ischemic conditions of the frozen state.">
            <entity id="DS.d1119.s0.e0" origId="P00558,P00559,P00560,P29405,P29407,P29408,P41757,P46273,P50310,Q3T0P6,Q5NVB5,Q60HD8,Q6BLA0,Q6FKY1,Q757Q0,Q7SIB7,Q7ZA46" charOffset="20-24" type="protein" text="PGK1"/>
            <entity id="DS.d1119.s0.e1" origId="5957" charOffset="37-40" type="compound" text="ATP"/>
            <pair e1="DS.d1119.s0.e1" e2="DS.d1119.s0.e0" id="DS.d1119.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1120" origId="18785685">
        <sentence id="DS.d1120.s0" origId="18785685-518" text="SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6), and nitric oxide (NO).">
            <entity id="DS.d1120.s0.e0" origId="53481793" charOffset="69-97" type="compound" text="endotoxin lipopolysaccharide"/>
            <entity id="DS.d1120.s0.e1" origId="Q8JFG3" charOffset="127-148" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d1120.s0.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="156-165" type="protein" text="TNF-alpha"/>
            <entity id="DS.d1120.s0.e3" origId="P41693" charOffset="168-181" type="protein" text="interleukin 6"/>
            <entity id="DS.d1120.s0.e4" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="183-187" type="protein" text="IL-6"/>
            <entity id="DS.d1120.s0.e5" origId="145068" charOffset="194-206" type="compound" text="nitric oxide"/>
            <pair e1="DS.d1120.s0.e0" e2="DS.d1120.s0.e4" id="DS.d1120.s0.i0" interaction="True"/>
            <pair e1="DS.d1120.s0.e5" e2="DS.d1120.s0.e3" id="DS.d1120.s0.i1" interaction="False"/>
            <pair e1="DS.d1120.s0.e5" e2="DS.d1120.s0.e1" id="DS.d1120.s0.i2" interaction="False"/>
            <pair e1="DS.d1120.s0.e5" e2="DS.d1120.s0.e2" id="DS.d1120.s0.i3" interaction="False"/>
            <pair e1="DS.d1120.s0.e0" e2="DS.d1120.s0.e2" id="DS.d1120.s0.i4" interaction="True"/>
            <pair e1="DS.d1120.s0.e0" e2="DS.d1120.s0.e3" id="DS.d1120.s0.i5" interaction="True"/>
            <pair e1="DS.d1120.s0.e5" e2="DS.d1120.s0.e4" id="DS.d1120.s0.i6" interaction="False"/>
            <pair e1="DS.d1120.s0.e0" e2="DS.d1120.s0.e1" id="DS.d1120.s0.i7" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1121" origId="18785878">
        <sentence id="DS.d1121.s0" origId="18785878-575" text="We therefore hypothesized that a diffusible product of the GPI-PLC enzyme reaction (possibly DAG (diacylglycerol)) mediated the biological effects of the protein.">
            <entity id="DS.d1121.s0.e0" origId="O15886,P09194" charOffset="59-66" type="protein" text="GPI-PLC"/>
            <entity id="DS.d1121.s0.e1" origId="6026790" charOffset="98-112" type="compound" text="diacylglycerol"/>
            <pair e1="DS.d1121.s0.e1" e2="DS.d1121.s0.e0" id="DS.d1121.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1122" origId="18786000">
        <sentence id="DS.d1122.s0" origId="18786000-610" text="Silencing of chalcone synthase, the key entry-point enzyme for flavonoid biosynthesis led to flavonoid-deficient roots.">
            <entity id="DS.d1122.s0.e0" origId="O04111,O04220,O22586,O22652,O65872,O82144,P06515,P13114,P16107,P17818,P23569,P30078,P30079,P48385,P48389,P48405,P51075,P51080,P51089,P51090,Q9FUB7,Q9LKP7,Q9MBB1,Q9SEP2,Q9SEP4,Q9ZRR8,Q9ZRS4,Q9ZU06" charOffset="13-30" type="protein" text="chalcone synthase"/>
            <entity id="DS.d1122.s0.e1" origId="10251" charOffset="63-72" type="compound" text="flavonoid"/>
            <pair e1="DS.d1122.s0.e1" e2="DS.d1122.s0.e0" id="DS.d1122.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1123" origId="18786181">
        <sentence id="DS.d1123.s0" origId="18786181-656" text="Nitrilase enzymes have been characterised in plants, bacteria and fungi and are thought to be important in detoxification of nitriles, utilisation of nitrogen and synthesis of plant hormones.">
            <entity id="DS.d1123.s0.e0" origId="P13448,P13449,P27763,P27764,P33036,P82605,P97051,P97052,Q53117,Q53118" charOffset="0-9" type="protein" text="Nitrilase"/>
            <entity id="DS.d1123.s0.e1" origId="947,123329" charOffset="150-158" type="compound" text="nitrogen"/>
            <pair e1="DS.d1123.s0.e1" e2="DS.d1123.s0.e0" id="DS.d1123.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1123.s1" origId="18786181-657" text="In plants cyanide is converted to beta-cyano-L-alanine, which is subsequently detoxified to aspartic acid and ammonia by NIT4.">
            <entity id="DS.d1123.s1.e0" origId="424,5960,83887" charOffset="92-105" type="compound" text="aspartic acid"/>
            <entity id="DS.d1123.s1.e1" origId="222" charOffset="110-117" type="compound" text="ammonia"/>
            <entity id="DS.d1123.s1.e2" origId="P46011,Q42965" charOffset="121-125" type="protein" text="NIT4"/>
            <pair e1="DS.d1123.s1.e1" e2="DS.d1123.s1.e2" id="DS.d1123.s1.i0" interaction="True"/>
            <pair e1="DS.d1123.s1.e0" e2="DS.d1123.s1.e2" id="DS.d1123.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1124" origId="18786182">
        <sentence id="DS.d1124.s0" origId="18786182-658" text="The mitochondrial membrane potential (Delta psi (mit)) was also tested with rhodamine 123 30 min after SI challenge, and was shown to have collapsed in the incompatible pollen tubes after exposure to S-RNase.">
            <entity id="DS.d1124.s0.e0" origId="65218" charOffset="76-89" type="compound" text="rhodamine 123"/>
            <entity id="DS.d1124.s0.e1" origId="P00669" charOffset="200-207" type="protein" text="S-RNase"/>
            <pair e1="DS.d1124.s0.e0" e2="DS.d1124.s0.e1" id="DS.d1124.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1125" origId="18786279">
        <sentence id="DS.d1125.s0" origId="18786279-668" text="In conclusion, female rats undernourished in utero had normophagic obesity as adults but had an absence of serotonin-induced hypophagia and low hypothalamic levels of the 5-HT 2C receptor.">
            <entity id="DS.d1125.s0.e0" origId="5202" charOffset="107-116" type="compound" text="serotonin"/>
            <entity id="DS.d1125.s0.e1" origId="P08909,P28335,P34968,Q5IS66,Q60F97" charOffset="171-178" type="protein" text="5-HT 2C"/>
            <pair e1="DS.d1125.s0.e0" e2="DS.d1125.s0.e1" id="DS.d1125.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1125.s1" origId="18786279-669" text="Compensatory adaptations for the functional serotonergic impairment were evidenced, such as an enhanced release of serotonin in response to a meal allied to up-regulated hypothalamic 5-HT1B and transporter expression.">
            <entity id="DS.d1125.s1.e0" origId="5202" charOffset="115-124" type="compound" text="serotonin"/>
            <entity id="DS.d1125.s1.e1" origId="O08892,P28222,P28286,P28334,P28564,P35404,P46636,P49144,P56496,P60020,P79250,P79399,Q588Y6,Q6XXX8,Q9N2B7" charOffset="183-189" type="protein" text="5-HT1B"/>
            <pair e1="DS.d1125.s1.e0" e2="DS.d1125.s1.e1" id="DS.d1125.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1126" origId="18786604">
        <sentence id="DS.d1126.s0" origId="18786604-753" text="The proliferation of the parental cell line was most efficiently stimulated by 5alpha-dihydrotestosterone (DHT), but the LNCaP(17beta-HSD3) cells were equally stimulated by Adione, indicating that 17beta-HSD3 efficiently converts Adione to T in this model.">
            <entity id="DS.d1126.s0.e0" origId="10635" charOffset="79-105" type="compound" text="5alpha-dihydrotestosterone"/>
            <entity id="DS.d1126.s0.e1" origId="10635" charOffset="107-110" type="compound" text="DHT"/>
            <entity id="DS.d1126.s0.e2" origId="O54939,P37058,P70385" charOffset="127-138" type="protein" text="17beta-HSD3"/>
            <entity id="DS.d1126.s0.e3" origId="O54939,P37058,P70385" charOffset="197-208" type="protein" text="17beta-HSD3"/>
            <pair e1="DS.d1126.s0.e0" e2="DS.d1126.s0.e2" id="DS.d1126.s0.i0" interaction="False"/>
            <pair e1="DS.d1126.s0.e1" e2="DS.d1126.s0.e2" id="DS.d1126.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1127" origId="18786605">
        <sentence id="DS.d1127.s0" origId="18786605-754" text="They potentiate glucose-induced insulin secretion and may be responsible for up to 70% of postprandial insulin secretion.">
            <entity id="DS.d1127.s0.e0" origId="206,5793,64689,79025" charOffset="16-23" type="compound" text="glucose"/>
            <entity id="DS.d1127.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="32-39" type="protein" text="insulin"/>
            <entity id="DS.d1127.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="103-110" type="protein" text="insulin"/>
            <pair e1="DS.d1127.s0.e0" e2="DS.d1127.s0.e1" id="DS.d1127.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1127.s1" origId="18786605-755" text="However, in supraphysiological doses, GLP-1 administration may completely normalize beta as well as alpha cell sensitivity to glucose.">
            <entity id="DS.d1127.s1.e0" origId="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25" charOffset="38-43" type="protein" text="GLP-1"/>
            <entity id="DS.d1127.s1.e1" origId="206,5793,64689,79025" charOffset="126-133" type="compound" text="glucose"/>
            <pair e1="DS.d1127.s1.e1" e2="DS.d1127.s1.e0" id="DS.d1127.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1128" origId="18786649">
        <sentence id="DS.d1128.s0" origId="18786649-767" text="The induction of signal transduction by serum and growth factors significantly increases the level of S6K ubiquitination, while the treatment of cells with UV and staurosporine has the opposite effect.">
            <entity id="DS.d1128.s0.e0" origId="P23443,P67998,P67999,Q6TJY3,Q8BSK8" charOffset="102-105" type="protein" text="S6K"/>
            <entity id="DS.d1128.s0.e1" origId="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148" charOffset="163-176" type="compound" text="staurosporine"/>
            <pair e1="DS.d1128.s0.e1" e2="DS.d1128.s0.e0" id="DS.d1128.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1129" origId="18786760">
        <sentence id="DS.d1129.s0" origId="18786760-796" text="Interaction of malachite green with bovine serum albumin : determination of the binding mechanism and binding site by spectroscopic methods.">
            <entity id="DS.d1129.s0.e0" origId="11295" charOffset="15-30" type="compound" text="malachite green"/>
            <entity id="DS.d1129.s0.e1" origId="P21847,P83517" charOffset="43-56" type="protein" text="serum albumin"/>
            <pair e1="DS.d1129.s0.e0" e2="DS.d1129.s0.e1" id="DS.d1129.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1129.s1" origId="18786760-797" text="The interaction between malachite green (MG) and bovine serum albumin (BSA) under simulative physiological conditions was investigated by the methods of fluorescence spectroscopy, UV-vis absorption and circular dichroism (CD) spectroscopy.">
            <entity id="DS.d1129.s1.e0" origId="11295" charOffset="24-39" type="compound" text="malachite green"/>
            <entity id="DS.d1129.s1.e1" origId="P21847,P83517" charOffset="56-69" type="protein" text="serum albumin"/>
            <entity id="DS.d1129.s1.e2" origId="P02769" charOffset="71-74" type="protein" text="BSA"/>
            <pair e1="DS.d1129.s1.e0" e2="DS.d1129.s1.e1" id="DS.d1129.s1.i0" interaction="True"/>
            <pair e1="DS.d1129.s1.e0" e2="DS.d1129.s1.e2" id="DS.d1129.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1129.s2" origId="18786760-798" text="The binding distance (r) between MG and the tryptophan residue of BSA was obtained to be 4.79 nm according to F&#246;rster theory of non-radioactive energy transfer.">
            <entity id="DS.d1129.s2.e0" origId="1148,6305,9060,5460840" charOffset="44-54" type="compound" text="tryptophan"/>
            <entity id="DS.d1129.s2.e1" origId="P02769" charOffset="66-69" type="protein" text="BSA"/>
            <pair e1="DS.d1129.s2.e0" e2="DS.d1129.s2.e1" id="DS.d1129.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1130" origId="18786974">
        <sentence id="DS.d1130.s0" origId="18786974-878" text="Unlike creatinine, Cystatin C (CysC) is believed to be independent of body composition in both adults and children.">
            <entity id="DS.d1130.s0.e0" origId="588" charOffset="7-17" type="compound" text="creatinine"/>
            <entity id="DS.d1130.s0.e1" origId="P08935,P25973,P81061,P81714,Q06445" charOffset="19-27" type="protein" text="Cystatin"/>
            <entity id="DS.d1130.s0.e2" origId="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6" charOffset="31-35" type="protein" text="CysC"/>
            <pair e1="DS.d1130.s0.e0" e2="DS.d1130.s0.e2" id="DS.d1130.s0.i0" interaction="False"/>
            <pair e1="DS.d1130.s0.e0" e2="DS.d1130.s0.e1" id="DS.d1130.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1131" origId="18787021">
        <sentence id="DS.d1131.s0" origId="18787021-886" text="Levels of endothelial nitric oxide synthase and inducible nitric oxide synthase did not differ among the groups, nor did total nitrite plus nitrate levels.">
            <entity id="DS.d1131.s0.e0" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="22-43" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d1131.s0.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="58-79" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d1131.s0.e2" origId="943" charOffset="140-147" type="compound" text="nitrate"/>
            <pair e1="DS.d1131.s0.e2" e2="DS.d1131.s0.e0" id="DS.d1131.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1132" origId="18787024">
        <sentence id="DS.d1132.s0" origId="18787024-887" text="Glucose controls cytosolic Ca2+ and insulin secretion in mouse islets lacking adenosine triphosphate-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.">
            <entity id="DS.d1132.s0.e0" origId="79025" charOffset="0-7" type="compound" text="Glucose"/>
            <entity id="DS.d1132.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="36-43" type="protein" text="insulin"/>
            <entity id="DS.d1132.s0.e2" origId="5957" charOffset="78-100" type="compound" text="adenosine triphosphate"/>
            <pair e1="DS.d1132.s0.e0" e2="DS.d1132.s0.e1" id="DS.d1132.s0.i0" interaction="True"/>
            <pair e1="DS.d1132.s0.e2" e2="DS.d1132.s0.e1" id="DS.d1132.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1133" origId="18787032">
        <sentence id="DS.d1133.s0" origId="18787032-890" text="Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of MAPK pathway with 50 microM PD98059 but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm wortmannin.">
            <entity id="DS.d1133.s0.e0" origId="O42781,P27638,Q00859" charOffset="99-103" type="protein" text="MAPK"/>
            <entity id="DS.d1133.s0.e1" origId="4713" charOffset="127-134" type="compound" text="PD98059"/>
            <entity id="DS.d1133.s0.e2" origId="312145" charOffset="222-232" type="compound" text="wortmannin"/>
            <pair e1="DS.d1133.s0.e1" e2="DS.d1133.s0.e0" id="DS.d1133.s0.i0" interaction="True"/>
            <pair e1="DS.d1133.s0.e2" e2="DS.d1133.s0.e0" id="DS.d1133.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1134" origId="18787174">
        <sentence id="DS.d1134.s0" origId="18787174-941" text="Lung injury was assessed by measuring vascular permeability (via Evans blue dye), edema, neutrophil infiltration (via myeloperoxidase (MPO), and expression of proinflammatory cytokines.">
            <entity id="DS.d1134.s0.e0" origId="9566058" charOffset="65-79" type="compound" text="Evans blue dye"/>
            <entity id="DS.d1134.s0.e1" origId="P05164,P11247" charOffset="135-138" type="protein" text="MPO"/>
            <pair e1="DS.d1134.s0.e0" e2="DS.d1134.s0.e1" id="DS.d1134.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1135" origId="18787236">
        <sentence id="DS.d1135.s0" origId="18787236-950" text="Cholesterol efflux from ((3)H) cholesterol-oleate-acetyl-LDL-loaded monocyte-derived macrophages to standard apolipoprotein A-I (apoA-I), HDL(2), and serum was measured.">
            <entity id="DS.d1135.s0.e0" origId="304,5997,6432564,11025495" charOffset="0-11" type="compound" text="Cholesterol"/>
            <entity id="DS.d1135.s0.e1" origId="5283632" charOffset="31-49" type="compound" text="cholesterol-oleate"/>
            <entity id="DS.d1135.s0.e2" origId="P18647" charOffset="109-127" type="protein" text="apolipoprotein A-I"/>
            <entity id="DS.d1135.s0.e3" origId="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4" charOffset="129-135" type="protein" text="apoA-I"/>
            <pair e1="DS.d1135.s0.e1" e2="DS.d1135.s0.e3" id="DS.d1135.s0.i0" interaction="True"/>
            <pair e1="DS.d1135.s0.e0" e2="DS.d1135.s0.e3" id="DS.d1135.s0.i1" interaction="True"/>
            <pair e1="DS.d1135.s0.e1" e2="DS.d1135.s0.e2" id="DS.d1135.s0.i2" interaction="True"/>
            <pair e1="DS.d1135.s0.e0" e2="DS.d1135.s0.e2" id="DS.d1135.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d1135.s1" origId="18787236-952" text="Cholesterol efflux to apoA-I, HDL(2), and serum from macrophage foam cells derived from low- and high-HDL subjects was similar.">
            <entity id="DS.d1135.s1.e0" origId="304,5997,6432564,11025495" charOffset="0-11" type="compound" text="Cholesterol"/>
            <entity id="DS.d1135.s1.e1" origId="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4" charOffset="22-28" type="protein" text="apoA-I"/>
            <pair e1="DS.d1135.s1.e0" e2="DS.d1135.s1.e1" id="DS.d1135.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1135.s2" origId="18787236-954" text="Cholesterol efflux from THP-1 macrophages to serum from study subjects correlated with serum apoB (P = 0.033), apoA-I (P = 0.004), apoA-II 0.0001), and the percentage of apoA-I present in the form of prebeta-HDL (P = 0.0001).">
            <entity id="DS.d1135.s2.e0" origId="304,5997,6432564,11025495" charOffset="0-11" type="compound" text="Cholesterol"/>
            <entity id="DS.d1135.s2.e1" origId="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4" charOffset="111-117" type="protein" text="apoA-I"/>
            <entity id="DS.d1135.s2.e2" origId="P02652,P02653,P04638,P09813,P18656,P81644,P83704,Q8MIQ5" charOffset="131-138" type="protein" text="apoA-II"/>
            <entity id="DS.d1135.s2.e3" origId="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4" charOffset="131-137" type="protein" text="apoA-I"/>
            <pair e1="DS.d1135.s2.e0" e2="DS.d1135.s2.e1" id="DS.d1135.s2.i0" interaction="True"/>
            <pair e1="DS.d1135.s2.e0" e2="DS.d1135.s2.e2" id="DS.d1135.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1136" origId="18787748">
        <sentence id="DS.d1136.s0" origId="18787748-1079" text="In this study, the degradation of Rac- and R-metalaxyl under anaerobic conditions was studied.">
            <entity id="DS.d1136.s0.e0" origId="P31750" charOffset="34-37" type="protein" text="Rac"/>
            <entity id="DS.d1136.s0.e1" origId="42586,11150163" charOffset="45-54" type="compound" text="metalaxyl"/>
            <pair e1="DS.d1136.s0.e1" e2="DS.d1136.s0.e0" id="DS.d1136.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1137" origId="18787757">
        <sentence id="DS.d1137.s0" origId="18787757-1084" text="Regulation of muscle protein degradation, not synthesis, by dietary leucine in rats fed a protein-deficient diet.">
            <entity id="DS.d1137.s0.e0" origId="857,6106,439524" charOffset="68-75" type="compound" text="leucine"/>
            <entity id="DS.d1137.s0.e1" origId="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005" charOffset="88-97" type="protein" text="a protein"/>
            <pair e1="DS.d1137.s0.e0" e2="DS.d1137.s0.e1" id="DS.d1137.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1138" origId="18787837">
        <sentence id="DS.d1138.s0" origId="18787837-1099" text="Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified threonine residues in the n-myc downstream-regulated gene 1 protein (NDRG1-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).">
            <entity id="DS.d1138.s0.e0" origId="6288" charOffset="103-112" type="compound" text="threonine"/>
            <entity id="DS.d1138.s0.e1" origId="Q62433,Q92597" charOffset="129-170" type="protein" text="n-myc downstream-regulated gene 1 protein"/>
            <entity id="DS.d1138.s0.e2" origId="Q92597" charOffset="172-177" type="protein" text="NDRG1"/>
            <pair e1="DS.d1138.s0.e0" e2="DS.d1138.s0.e1" id="DS.d1138.s0.i0" interaction="True"/>
            <pair e1="DS.d1138.s0.e0" e2="DS.d1138.s0.e2" id="DS.d1138.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1138.s1" origId="18787837-1100" text="Although G (Na) is negligible in hormone-deprived cells, these cells displayed basal SGK1 activity that was sensitive to LY294002, an inhibitor of 3-phosphatidylinositol phosphate kinase (PI3K).">
            <entity id="DS.d1138.s1.e0" origId="O00141,Q9XT18" charOffset="85-89" type="protein" text="SGK1"/>
            <entity id="DS.d1138.s1.e1" origId="3973" charOffset="121-129" type="compound" text="LY294002"/>
            <pair e1="DS.d1138.s1.e1" e2="DS.d1138.s1.e0" id="DS.d1138.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1139" origId="18787840">
        <sentence id="DS.d1139.s0" origId="18787840-1103" text="Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy.">
            <entity id="DS.d1139.s0.e0" origId="P55245" charOffset="0-32" type="protein" text="Epidermal growth factor receptor"/>
            <entity id="DS.d1139.s0.e1" origId="23939" charOffset="179-187" type="compound" text="platinum"/>
            <pair e1="DS.d1139.s0.e1" e2="DS.d1139.s0.e0" id="DS.d1139.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1140" origId="18787967">
        <sentence id="DS.d1140.s0" origId="18787967-1145" text="The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and selenium, incorporated in conventional treatment regimen.">
            <entity id="DS.d1140.s0.e0" origId="O50258" charOffset="170-190" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1140.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="195-203" type="protein" text="catalase"/>
            <entity id="DS.d1140.s0.e2" origId="2116,14985,1548900,1742129" charOffset="314-323" type="compound" text="vitamin E"/>
            <entity id="DS.d1140.s0.e3" origId="6326970" charOffset="328-336" type="compound" text="selenium"/>
            <pair e1="DS.d1140.s0.e2" e2="DS.d1140.s0.e0" id="DS.d1140.s0.i0" interaction="False"/>
            <pair e1="DS.d1140.s0.e2" e2="DS.d1140.s0.e1" id="DS.d1140.s0.i1" interaction="False"/>
            <pair e1="DS.d1140.s0.e3" e2="DS.d1140.s0.e0" id="DS.d1140.s0.i2" interaction="False"/>
            <pair e1="DS.d1140.s0.e3" e2="DS.d1140.s0.e1" id="DS.d1140.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1141" origId="18787973">
        <sentence id="DS.d1141.s0" origId="18787973-1149" text="This study was designed to determine the effect of molsidomine (MO), a precursor of nitric oxide (NO) donor, on hypoxia inducible factor alpha (HIF-1alpha) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.">
            <entity id="DS.d1141.s0.e0" origId="4239" charOffset="51-62" type="compound" text="molsidomine"/>
            <entity id="DS.d1141.s0.e1" origId="145068" charOffset="84-96" type="compound" text="nitric oxide"/>
            <entity id="DS.d1141.s0.e2" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="144-154" type="protein" text="HIF-1alpha"/>
            <pair e1="DS.d1141.s0.e1" e2="DS.d1141.s0.e2" id="DS.d1141.s0.i0" interaction="True"/>
            <pair e1="DS.d1141.s0.e0" e2="DS.d1141.s0.e2" id="DS.d1141.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1142" origId="18787978">
        <sentence id="DS.d1142.s0" origId="18787978-1152" text="Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and proteinase) and antifungal drug sensitivity (amphotericin B, fluconazole and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.">
            <entity id="DS.d1142.s0.e0" origId="P10265,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63129,P63131,Q9Y6I0" charOffset="205-215" type="protein" text="proteinase"/>
            <entity id="DS.d1142.s0.e1" origId="5280965" charOffset="250-264" type="compound" text="amphotericin B"/>
            <entity id="DS.d1142.s0.e2" origId="3365" charOffset="266-277" type="compound" text="fluconazole"/>
            <entity id="DS.d1142.s0.e3" origId="3793,55283,6917738,14179013" charOffset="282-294" type="compound" text="itraconazole"/>
            <pair e1="DS.d1142.s0.e1" e2="DS.d1142.s0.e0" id="DS.d1142.s0.i0" interaction="False"/>
            <pair e1="DS.d1142.s0.e2" e2="DS.d1142.s0.e0" id="DS.d1142.s0.i1" interaction="False"/>
            <pair e1="DS.d1142.s0.e3" e2="DS.d1142.s0.e0" id="DS.d1142.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1143" origId="18788036">
        <sentence id="DS.d1143.s0" origId="18788036-1175" text="To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((PO4))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine serum albumin (BSA) as a control.">
            <entity id="DS.d1143.s0.e0" origId="1061" charOffset="130-133" type="compound" text="PO4"/>
            <entity id="DS.d1143.s0.e1" origId="P21847,P83517" charOffset="270-283" type="protein" text="serum albumin"/>
            <entity id="DS.d1143.s0.e2" origId="P02769" charOffset="285-288" type="protein" text="BSA"/>
            <pair e1="DS.d1143.s0.e0" e2="DS.d1143.s0.e2" id="DS.d1143.s0.i0" interaction="False"/>
            <pair e1="DS.d1143.s0.e0" e2="DS.d1143.s0.e1" id="DS.d1143.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1144" origId="18789002">
        <sentence id="DS.d1144.s0" origId="18789002-1201" text="Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.">
            <entity id="DS.d1144.s0.e0" origId="1060" charOffset="42-50" type="compound" text="pyruvate"/>
            <entity id="DS.d1144.s0.e1" origId="P56517,P56518,Q13547,Q94517" charOffset="95-100" type="protein" text="HDAC1"/>
            <entity id="DS.d1144.s0.e2" origId="O15379,P56520" charOffset="101-106" type="protein" text="HDAC3"/>
            <pair e1="DS.d1144.s0.e0" e2="DS.d1144.s0.e1" id="DS.d1144.s0.i0" interaction="False"/>
            <pair e1="DS.d1144.s0.e0" e2="DS.d1144.s0.e2" id="DS.d1144.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1144.s1" origId="18789002-1204" text="This process is associated with an increase in intracellular levels of pyruvate, increase in the acetylation status of histone H4, and enhanced cell death.">
            <entity id="DS.d1144.s1.e0" origId="1060" charOffset="71-79" type="compound" text="pyruvate"/>
            <entity id="DS.d1144.s1.e1" origId="P02309,P04914,P04915,P08436,P09322,P27996,P35057,P35059,P40287,P50566,P59259,P62776,P62777,P62778,P62779,P62780,P62781,P62782,P62783,P62784,P62787,P62788,P62789,P62790,P62791,P62792,P62793,P62794,P62795,P62796,P62797,P62798,P62799,P62800,P62801,P62802,P62803,P62804,P62805,P62806,P62887,P80738,P80739,P82888,P83865,P84040,P84041,P84042,P84043,P84044,P84045,P84046,P84047,P84048,P84049,P84050,P90516,P91849,P91882,P91890,Q27443,Q27765,Q43083,Q6LAF1,Q6LAF3,Q6PMI5,Q6V9I2,Q6WV72,Q6WV73,Q6WV74,Q6WV90,Q6WZ83,Q6ZXX3,Q71V09,Q76FD9,Q76FE7,Q76FF1,Q76FF5,Q76H85,Q76MU7,Q7K8C0,Q7KQD1,Q7LKT3,Q7M3Z5,Q8I0Y4,Q8J1L3,Q8MTV8,Q8NIG3,Q8SQP4,Q8T7J8,Q9HDF5,Q9U7D0" charOffset="119-129" type="protein" text="histone H4"/>
            <pair e1="DS.d1144.s1.e0" e2="DS.d1144.s1.e1" id="DS.d1144.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1145" origId="18789341">
        <sentence id="DS.d1145.s0" origId="18789341-1500" text="The cAMP/protein kinase A (PKA) signaling cascade is crucial for synaptic plasticity in a wide variety of species.">
            <entity id="DS.d1145.s0.e0" origId="6076" charOffset="4-8" type="compound" text="cAMP"/>
            <entity id="DS.d1145.s0.e1" origId="Q05608,Q9RI12" charOffset="9-25" type="protein" text="protein kinase A"/>
            <pair e1="DS.d1145.s0.e0" e2="DS.d1145.s0.e1" id="DS.d1145.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1146" origId="18789398">
        <sentence id="DS.d1146.s0" origId="18789398-1523" text="Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.">
            <entity id="DS.d1146.s0.e0" origId="3121" charOffset="51-64" type="compound" text="valproic acid"/>
            <entity id="DS.d1146.s0.e1" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="86-103" type="protein" text="estrogen receptor"/>
            <pair e1="DS.d1146.s0.e0" e2="DS.d1146.s0.e1" id="DS.d1146.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1147" origId="18789440">
        <sentence id="DS.d1147.s0" origId="18789440-1646" text="In the present study, we have investigated the effect of IFN-gamma on ABCA1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells.">
            <entity id="DS.d1147.s0.e0" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="57-66" type="protein" text="IFN-gamma"/>
            <entity id="DS.d1147.s0.e1" origId="O95477" charOffset="70-75" type="protein" text="ABCA1"/>
            <entity id="DS.d1147.s0.e2" origId="304,5997,6432564,11025495" charOffset="91-102" type="compound" text="cholesterol"/>
            <pair e1="DS.d1147.s0.e2" e2="DS.d1147.s0.e0" id="DS.d1147.s0.i0" interaction="True"/>
            <pair e1="DS.d1147.s0.e2" e2="DS.d1147.s0.e1" id="DS.d1147.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1148" origId="18789466">
        <sentence id="DS.d1148.s0" origId="18789466-1548" text="Every 12 weeks intestinal permeability (lactulose/mannitol ratio), haemoglobin, plasma albumin, alpha-1-acid glycoprotein, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.">
            <entity id="DS.d1148.s0.e0" origId="3872,11333,11024312,16217605,16760534" charOffset="40-49" type="compound" text="lactulose"/>
            <entity id="DS.d1148.s0.e1" origId="6251" charOffset="50-58" type="compound" text="mannitol"/>
            <entity id="DS.d1148.s0.e2" origId="Q08398" charOffset="96-103" type="protein" text="alpha-1"/>
            <entity id="DS.d1148.s0.e3" origId="P08163" charOffset="109-121" type="protein" text="glycoprotein"/>
            <pair e1="DS.d1148.s0.e0" e2="DS.d1148.s0.e3" id="DS.d1148.s0.i0" interaction="False"/>
            <pair e1="DS.d1148.s0.e1" e2="DS.d1148.s0.e2" id="DS.d1148.s0.i1" interaction="False"/>
            <pair e1="DS.d1148.s0.e0" e2="DS.d1148.s0.e2" id="DS.d1148.s0.i2" interaction="False"/>
            <pair e1="DS.d1148.s0.e1" e2="DS.d1148.s0.e3" id="DS.d1148.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1149" origId="18789492">
        <sentence id="DS.d1149.s0" origId="18789492-1558" text="As such, the aim of the present study was to investigate whether CETP-inhibition with JTT-705, a molecule distinctly different from torcetrapib, impacts on vascular function, a well-established surrogate of atherosclerotic vascular disease, as well as markers of inflammation and oxidative stress in patients with type II hyperlipidemia.">
            <entity id="DS.d1149.s0.e0" origId="P11597,P22687,P25914,P47896" charOffset="65-69" type="protein" text="CETP"/>
            <entity id="DS.d1149.s0.e1" origId="6918540" charOffset="86-93" type="compound" text="JTT-705"/>
            <pair e1="DS.d1149.s0.e1" e2="DS.d1149.s0.e0" id="DS.d1149.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1150" origId="18789529">
        <sentence id="DS.d1150.s0" origId="18789529-1570" text="In this review we discuss the membrane proteins that transport arsenic and selenium into cells, from bacteria to humans, as well as some of the efflux proteins involved in detoxification.">
            <entity id="DS.d1150.s0.e0" origId="P16629,P24266,P28991,Q04565,Q07252" charOffset="30-47" type="protein" text="membrane proteins"/>
            <entity id="DS.d1150.s0.e1" origId="6326970" charOffset="75-83" type="compound" text="selenium"/>
            <pair e1="DS.d1150.s0.e1" e2="DS.d1150.s0.e0" id="DS.d1150.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1151" origId="18789530">
        <sentence id="DS.d1151.s0" origId="18789530-2169" text="Pathways involved in the hydrolysis of nitrile pollutants (aliphatic nitriles, benzonitrile analogues) and the corresponding enzymes (nitrilase, nitrile hydratase) are described in detail.">
            <entity id="DS.d1151.s0.e0" origId="7505" charOffset="79-91" type="compound" text="benzonitrile"/>
            <entity id="DS.d1151.s0.e1" origId="P13448,P13449,P27763,P27764,P33036,P82605,P97051,P97052,Q53117,Q53118" charOffset="134-143" type="protein" text="nitrilase"/>
            <pair e1="DS.d1151.s0.e0" e2="DS.d1151.s0.e1" id="DS.d1151.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1152" origId="18789597">
        <sentence id="DS.d1152.s0" origId="18789597-659" text="Since stellate cells have been found to express the beta but not the alpha isoform of the estrogen receptor, it can be predicted that nutritional intakes of the soy isoflavone genistein-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.">
            <entity id="DS.d1152.s0.e0" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="90-107" type="protein" text="estrogen receptor"/>
            <entity id="DS.d1152.s0.e1" origId="72304" charOffset="165-175" type="compound" text="isoflavone"/>
            <entity id="DS.d1152.s0.e2" origId="5280961" charOffset="176-185" type="compound" text="genistein"/>
            <pair e1="DS.d1152.s0.e2" e2="DS.d1152.s0.e0" id="DS.d1152.s0.i0" interaction="False"/>
            <pair e1="DS.d1152.s0.e1" e2="DS.d1152.s0.e0" id="DS.d1152.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1153" origId="18789664">
        <sentence id="DS.d1153.s0" origId="18789664-1638" text="We report that the PP inhibition of proteolysis in young rats was mediated by the increased INS secretion and resulted from a down-regulation of both lysosomal and Ca(2+)-dependent proteolysis.">
            <entity id="DS.d1153.s0.e0" origId="P01308,P01310,P01311,P01313,P01314,P01315,P01316,P01317,P01318,P01319,P01320,P01321,P01324,P01327,P01328,P01329,P01330,P01331,P01333,P01334,P01335,P01336,P01340,P01342,P04667,P06306,P07453,P09476,P09477,P0C236,P12703,P12704,P12705,P12708,P13190,P17715,P18109,P21563,P29335,P30406,P30407,P30410,P41522,P42633,P51463,P67968,P67969,P67970,P67971,P67972,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69045,P69046,P69047,P69048,P81025,P81423,P81881,Q62587,Q6YK33,Q8HXV2,Q91XI3,Q98TA8,Q9TQY7,Q9W7R2" charOffset="92-95" type="protein" text="INS"/>
            <entity id="DS.d1153.s0.e1" origId="271" charOffset="164-168" type="compound" text="Ca(2"/>
            <pair e1="DS.d1153.s0.e1" e2="DS.d1153.s0.e0" id="DS.d1153.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1154" origId="18789666">
        <sentence id="DS.d1154.s0" origId="18789666-1639" text="Aqueous extract of cumin was tested for its antiglycating ability against fructose-induced glycation of goat lens total soluble protein (TSP), alpha-crystallin from goat lens and a nonlenticular protein bovine serum albumin (BSA).">
            <entity id="DS.d1154.s0.e0" origId="5984" charOffset="74-82" type="compound" text="fructose"/>
            <entity id="DS.d1154.s0.e1" origId="P07996,P12528,Q9XJP3" charOffset="137-140" type="protein" text="TSP"/>
            <entity id="DS.d1154.s0.e2" origId="P21847,P83517" charOffset="210-223" type="protein" text="serum albumin"/>
            <entity id="DS.d1154.s0.e3" origId="P02769" charOffset="225-228" type="protein" text="BSA"/>
            <pair e1="DS.d1154.s0.e0" e2="DS.d1154.s0.e2" id="DS.d1154.s0.i0" interaction="True"/>
            <pair e1="DS.d1154.s0.e0" e2="DS.d1154.s0.e1" id="DS.d1154.s0.i1" interaction="True"/>
            <pair e1="DS.d1154.s0.e0" e2="DS.d1154.s0.e3" id="DS.d1154.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1155" origId="18789669">
        <sentence id="DS.d1155.s0" origId="18789669-1641" text="To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.">
            <entity id="DS.d1155.s0.e0" origId="6326970" charOffset="30-38" type="compound" text="selenium"/>
            <entity id="DS.d1155.s0.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="102-123" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d1155.s0.e2" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="125-129" type="protein" text="iNOS"/>
            <entity id="DS.d1155.s0.e3" origId="1090" charOffset="313-321" type="compound" text="selenite"/>
            <pair e1="DS.d1155.s0.e3" e2="DS.d1155.s0.e2" id="DS.d1155.s0.i0" interaction="False"/>
            <pair e1="DS.d1155.s0.e3" e2="DS.d1155.s0.e1" id="DS.d1155.s0.i1" interaction="False"/>
            <pair e1="DS.d1155.s0.e0" e2="DS.d1155.s0.e1" id="DS.d1155.s0.i2" interaction="True"/>
            <pair e1="DS.d1155.s0.e0" e2="DS.d1155.s0.e2" id="DS.d1155.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d1155.s1" origId="18789669-1642" text="The results showed that pancreatic selenium content and glutathione peroxidase.05), respectively, in selenite-treated diabetes mellitus group compared with untreated diabetes mellitus group.">
            <entity id="DS.d1155.s1.e0" origId="6326970" charOffset="35-43" type="compound" text="selenium"/>
            <entity id="DS.d1155.s1.e1" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="56-78" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d1155.s1.e2" origId="1090" charOffset="101-109" type="compound" text="selenite"/>
            <pair e1="DS.d1155.s1.e0" e2="DS.d1155.s1.e1" id="DS.d1155.s1.i0" interaction="False"/>
            <pair e1="DS.d1155.s1.e2" e2="DS.d1155.s1.e1" id="DS.d1155.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1155.s2" origId="18789669-1643" text="Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and interferon-gamma ; mRNA expression and activity of iNOS.05), respectively, in selenite-treated diabetes mellitus group compared with untreated diabetes mellitus group.">
            <entity id="DS.d1155.s2.e0" origId="Q8JFG3" charOffset="87-108" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d1155.s2.e1" origId="Q9TTB0" charOffset="119-135" type="protein" text="interferon-gamma"/>
            <entity id="DS.d1155.s2.e2" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="170-174" type="protein" text="iNOS"/>
            <entity id="DS.d1155.s2.e3" origId="1090" charOffset="197-205" type="compound" text="selenite"/>
            <pair e1="DS.d1155.s2.e3" e2="DS.d1155.s2.e0" id="DS.d1155.s2.i0" interaction="True"/>
            <pair e1="DS.d1155.s2.e3" e2="DS.d1155.s2.e2" id="DS.d1155.s2.i1" interaction="True"/>
            <pair e1="DS.d1155.s2.e3" e2="DS.d1155.s2.e1" id="DS.d1155.s2.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1156" origId="18789733">
        <sentence id="DS.d1156.s0" origId="18789733-21" text="Decreases in PNNs, aggrecan and hyaluronic acid were observed only in the terminal stages and correlated with the distribution of PrP (BSE) and activated glial cells.">
            <entity id="DS.d1156.s0.e0" origId="24759,453618,3084050,24728612" charOffset="32-47" type="compound" text="hyaluronic acid"/>
            <entity id="DS.d1156.s0.e1" origId="O18754,O46501,P04156,P04273,P04925,P10279,P13852,P23907,P40242,P40243,P40244,P40245,P40246,P40247,P40248,P40249,P40251,P40252,P40255,P40256,P40257,P40258,P47852,P49927,P51446,P51780,P52113,P52114,P61761,P61762,P61766,P61767,P61768,P67986,P67987,P67988,P67989,P67990,P67991,P67992,P67993,P67994,P67995,P67996,P67997,P79141,Q5UAF1,Q5UJG1,Q5UJG3,Q5UJG7,Q5UJH0,Q5UJH8,Q5UJI7,Q5XVM4,Q60468,Q60506,Q68G95,Q6EH52,Q7JIH3,Q7JIY2,Q7JK02,Q95174,Q95176,Q95211,Q95270,Q95M08,Q9Z0T3" charOffset="130-133" type="protein" text="PrP"/>
            <pair e1="DS.d1156.s0.e0" e2="DS.d1156.s0.e1" id="DS.d1156.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1156.s1" origId="18789733-22" text="This study suggests that the loss of PNNs, aggrecan and hyaluronic acid is a consequence of PrP (BSE) accumulation.">
            <entity id="DS.d1156.s1.e0" origId="P79122,P79149,Q5R5X0,Q9H307" charOffset="37-41" type="protein" text="PNNs"/>
            <entity id="DS.d1156.s1.e1" origId="24759,453618,3084050,24728612" charOffset="56-71" type="compound" text="hyaluronic acid"/>
            <entity id="DS.d1156.s1.e2" origId="O18754,O46501,P04156,P04273,P04925,P10279,P13852,P23907,P40242,P40243,P40244,P40245,P40246,P40247,P40248,P40249,P40251,P40252,P40255,P40256,P40257,P40258,P47852,P49927,P51446,P51780,P52113,P52114,P61761,P61762,P61766,P61767,P61768,P67986,P67987,P67988,P67989,P67990,P67991,P67992,P67993,P67994,P67995,P67996,P67997,P79141,Q5UAF1,Q5UJG1,Q5UJG3,Q5UJG7,Q5UJH0,Q5UJH8,Q5UJI7,Q5XVM4,Q60468,Q60506,Q68G95,Q6EH52,Q7JIH3,Q7JIY2,Q7JK02,Q95174,Q95176,Q95211,Q95270,Q95M08,Q9Z0T3" charOffset="92-95" type="protein" text="PrP"/>
            <pair e1="DS.d1156.s1.e1" e2="DS.d1156.s1.e2" id="DS.d1156.s1.i0" interaction="False"/>
            <pair e1="DS.d1156.s1.e1" e2="DS.d1156.s1.e0" id="DS.d1156.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1157" origId="18789802">
        <sentence id="DS.d1157.s0" origId="18789802-1681" text="Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with copper or ferrous ions or by exposure to auto-oxidation products of arachidonic acid for 16h, and VEGF was then assayed in medium.">
            <entity id="DS.d1157.s0.e0" origId="23978" charOffset="125-131" type="compound" text="copper"/>
            <entity id="DS.d1157.s0.e1" origId="27284" charOffset="135-147" type="compound" text="ferrous ions"/>
            <entity id="DS.d1157.s0.e2" origId="444899" charOffset="193-209" type="compound" text="arachidonic acid"/>
            <entity id="DS.d1157.s0.e3" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="223-227" type="protein" text="VEGF"/>
            <pair e1="DS.d1157.s0.e0" e2="DS.d1157.s0.e3" id="DS.d1157.s0.i0" interaction="False"/>
            <pair e1="DS.d1157.s0.e2" e2="DS.d1157.s0.e3" id="DS.d1157.s0.i1" interaction="False"/>
            <pair e1="DS.d1157.s0.e1" e2="DS.d1157.s0.e3" id="DS.d1157.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1158" origId="18789953">
        <sentence id="DS.d1158.s0" origId="18789953-507" text="In hypersensitive alpha4L9'A mice, injections of a low dose of nicotine (0.1 mg/kg) led to strong c-fos expression in only the ventrolateral region of the MHb, but not in the MHb of wild-type (WT) mice.">
            <entity id="DS.d1158.s0.e0" origId="942,89594,157672" charOffset="63-71" type="compound" text="nicotine"/>
            <entity id="DS.d1158.s0.e1" origId="P01101,P12841,Q56415" charOffset="100-103" type="protein" text="fos"/>
            <pair e1="DS.d1158.s0.e0" e2="DS.d1158.s0.e1" id="DS.d1158.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1159" origId="18790021">
        <sentence id="DS.d1159.s0" origId="18790021-1764" text="To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of 6-hydroxydopamine-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal neuropeptide precursors, GAD67, cytochrome oxidase subunit I) by quantitative in situ hybridization histochemistry.">
            <entity id="DS.d1159.s0.e0" origId="4624" charOffset="90-107" type="compound" text="6-hydroxydopamine"/>
            <entity id="DS.d1159.s0.e1" origId="P21259" charOffset="267-279" type="protein" text="neuropeptide"/>
            <entity id="DS.d1159.s0.e2" origId="P14748,P48319,Q5IS68,Q99259" charOffset="292-297" type="protein" text="GAD67"/>
            <entity id="DS.d1159.s0.e3" origId="P45021" charOffset="299-327" type="protein" text="cytochrome oxidase subunit I"/>
            <pair e1="DS.d1159.s0.e0" e2="DS.d1159.s0.e1" id="DS.d1159.s0.i0" interaction="True"/>
            <pair e1="DS.d1159.s0.e0" e2="DS.d1159.s0.e3" id="DS.d1159.s0.i1" interaction="True"/>
            <pair e1="DS.d1159.s0.e0" e2="DS.d1159.s0.e2" id="DS.d1159.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1160" origId="18790083">
        <sentence id="DS.d1160.s0" origId="18790083-1786" text="Participating in a significant fraction of the fundamental paths connecting the ligands to the phenotypes, cofactor GTP and complex Gbeta/Ggamma were identified as &quot;housekeeping&quot; molecules, through which all pathways of EGFR network are cross-talking.">
            <entity id="DS.d1160.s0.e0" origId="6830" charOffset="116-119" type="compound" text="GTP"/>
            <entity id="DS.d1160.s0.e1" origId="P00533,P13387,P55245" charOffset="220-224" type="protein" text="EGFR"/>
            <pair e1="DS.d1160.s0.e0" e2="DS.d1160.s0.e1" id="DS.d1160.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1161" origId="18790533">
        <sentence id="DS.d1161.s0" origId="18790533-1437" text="These effects were probably associated with the increase of intracellular superoxide in mitochondrial signaling pathway which attributed to the down-regulation of superoxide dismutase (SOD).">
            <entity id="DS.d1161.s0.e0" origId="5359597" charOffset="74-84" type="compound" text="superoxide"/>
            <entity id="DS.d1161.s0.e1" origId="O50258" charOffset="163-183" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1161.s0.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="185-188" type="protein" text="SOD"/>
            <pair e1="DS.d1161.s0.e0" e2="DS.d1161.s0.e1" id="DS.d1161.s0.i0" interaction="True"/>
            <pair e1="DS.d1161.s0.e0" e2="DS.d1161.s0.e2" id="DS.d1161.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1162" origId="18790812">
        <sentence id="DS.d1162.s0" origId="18790812-2041" text="This initiates a cAMP signalling cascade resulting in the translocation of AQP2-bearing vesicles to the apical membrane.">
            <entity id="DS.d1162.s0.e0" origId="6076" charOffset="17-21" type="compound" text="cAMP"/>
            <entity id="DS.d1162.s0.e1" origId="O62735,O77697,O77714,O77722,O77740,P41181,P79099,P79144,P79164,P79165,P79168,P79200,P79213,P79229,P79803" charOffset="75-79" type="protein" text="AQP2"/>
            <pair e1="DS.d1162.s0.e0" e2="DS.d1162.s0.e1" id="DS.d1162.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1163" origId="18790996">
        <sentence id="DS.d1163.s0" origId="18790996-2085" text="The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (ATG8) and ATG12 proteins to their respective targets, phosphatidylethanolamine and the ATG5 protein.">
            <entity id="DS.d1163.s0.e0" origId="P0C075,P38182,P87068,Q4P2U6,Q51MW4,Q5KN30,Q5QFG1,Q6BT31,Q6C794,Q6CMF8,Q6FXR8,Q755X2,Q8H715,Q8J282,Q8NJJ4" charOffset="145-149" type="protein" text="ATG8"/>
            <entity id="DS.d1163.s0.e1" origId="O94817,P38316,Q3T0W7,Q51P78,Q55S70,Q5AKU4,Q5R7W1,Q69NP0,Q6BU30,Q6BZZ1,Q6CUD5,Q6FMM7,Q75EB4" charOffset="155-160" type="protein" text="ATG12"/>
            <entity id="DS.d1163.s0.e2" origId="114944" charOffset="199-223" type="compound" text="phosphatidylethanolamine"/>
            <entity id="DS.d1163.s0.e3" origId="Q12380,Q3MQ04,Q3MQ24,Q525E4,Q59VY1,Q5K6S9,Q5R792,Q6BVI8,Q6C4Q6,Q6CKE2,Q6FJZ6,Q6ZGL4,Q75BY9,Q9FFI2,Q9H1Y0" charOffset="232-236" type="protein" text="ATG5"/>
            <pair e1="DS.d1163.s0.e2" e2="DS.d1163.s0.e0" id="DS.d1163.s0.i0" interaction="True"/>
            <pair e1="DS.d1163.s0.e2" e2="DS.d1163.s0.e1" id="DS.d1163.s0.i1" interaction="True"/>
            <pair e1="DS.d1163.s0.e2" e2="DS.d1163.s0.e3" id="DS.d1163.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d1163.s1" origId="18790996-2086" text="Levels of Atg transcripts and/or the ATG8-phosphatidylethanolamine adduct increase during leaf senescence and nitrogen and fixed-carbon limitations, indicating that autophagy plays a key role in nutrient remobilization.">
            <entity id="DS.d1163.s1.e0" origId="P0C075,P38182,P87068,Q4P2U6,Q51MW4,Q5KN30,Q5QFG1,Q6BT31,Q6C794,Q6CMF8,Q6FXR8,Q755X2,Q8H715,Q8J282,Q8NJJ4" charOffset="37-41" type="protein" text="ATG8"/>
            <entity id="DS.d1163.s1.e1" origId="114944" charOffset="42-66" type="compound" text="phosphatidylethanolamine"/>
            <pair e1="DS.d1163.s1.e1" e2="DS.d1163.s1.e0" id="DS.d1163.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1164" origId="18791141">
        <sentence id="DS.d1164.s0" origId="18791141-99" text="This study confirmed QTL previously identified for pH except those on SSC1, 11, 12, and X, and found 11 new 5% genome-wise significant QTL for glycogen-related traits.">
            <entity id="DS.d1164.s0.e0" origId="O43315,P12398,Q9BW60" charOffset="70-74" type="protein" text="SSC1"/>
            <entity id="DS.d1164.s0.e1" origId="439177" charOffset="143-151" type="compound" text="glycogen"/>
            <pair e1="DS.d1164.s0.e1" e2="DS.d1164.s0.e0" id="DS.d1164.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1165" origId="18791145">
        <sentence id="DS.d1165.s0" origId="18791145-109" text="The objective of this study was to examine the effect of level and duration of feeding of an n-3 PUFA-enriched fish oil (FO) supplement in combination with soybean oil (SO) on the transcriptional regulation of Delta(9)-desaturase gene expression in bovine muscle.">
            <entity id="DS.d1165.s0.e0" origId="46209,69711" charOffset="121-123" type="compound" text="FO"/>
            <entity id="DS.d1165.s0.e1" origId="O00767,O02858,O62849,O94523,Q12618,Q64420,Q92038,Q95MI7,Q9TT94" charOffset="210-229" type="protein" text="Delta(9)-desaturase"/>
            <pair e1="DS.d1165.s0.e0" e2="DS.d1165.s0.e1" id="DS.d1165.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1166" origId="18791154">
        <sentence id="DS.d1166.s0" origId="18791154-2132" text="Whole blood and plasma were analyzed for total Se, glutathione peroxidase activity in whole blood (GPX-1) and plasma, and thyroid hormones (thyroxine and triiodothyronine) in plasma.">
            <entity id="DS.d1166.s0.e0" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="51-73" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d1166.s0.e1" origId="P47236" charOffset="99-104" type="protein" text="GPX-1"/>
            <entity id="DS.d1166.s0.e2" origId="853,5819" charOffset="140-149" type="compound" text="thyroxine"/>
            <entity id="DS.d1166.s0.e3" origId="861,5920,71212" charOffset="154-170" type="compound" text="triiodothyronine"/>
            <pair e1="DS.d1166.s0.e3" e2="DS.d1166.s0.e0" id="DS.d1166.s0.i0" interaction="False"/>
            <pair e1="DS.d1166.s0.e2" e2="DS.d1166.s0.e0" id="DS.d1166.s0.i1" interaction="False"/>
            <pair e1="DS.d1166.s0.e3" e2="DS.d1166.s0.e1" id="DS.d1166.s0.i2" interaction="False"/>
            <pair e1="DS.d1166.s0.e2" e2="DS.d1166.s0.e1" id="DS.d1166.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1167" origId="18791496">
        <sentence id="DS.d1167.s0" origId="18791496-2222" text="Studies have shown that administration of 17beta-estradiol (estrogen) after trauma-hemorrhage normalized cardiac IL-6 levels and restored cardiac functions under those conditions.">
            <entity id="DS.d1167.s0.e0" origId="5757" charOffset="42-58" type="compound" text="17beta-estradiol"/>
            <entity id="DS.d1167.s0.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="113-117" type="protein" text="IL-6"/>
            <pair e1="DS.d1167.s0.e0" e2="DS.d1167.s0.e1" id="DS.d1167.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1168" origId="18791811">
        <sentence id="DS.d1168.s0" origId="18791811-2349" text="Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways.">
            <entity id="DS.d1168.s0.e0" origId="445154" charOffset="29-40" type="compound" text="resveratrol"/>
            <entity id="DS.d1168.s0.e1" origId="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0" charOffset="102-106" type="protein" text="PI3K"/>
            <pair e1="DS.d1168.s0.e0" e2="DS.d1168.s0.e1" id="DS.d1168.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1169" origId="18791821">
        <sentence id="DS.d1169.s0" origId="18791821-2351" text="Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer.">
            <entity id="DS.d1169.s0.e0" origId="41867" charOffset="0-10" type="compound" text="Epirubicin"/>
            <entity id="DS.d1169.s0.e1" origId="P04626" charOffset="40-44" type="protein" text="HER2"/>
            <pair e1="DS.d1169.s0.e0" e2="DS.d1169.s0.e1" id="DS.d1169.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1169.s1" origId="18791821-2352" text="This phase II study, evaluated the activity and cardiotoxicity of first-line epirubicin plus low-dose trastuzumab (LD-T) in patients with HER2 positive MBC.">
            <entity id="DS.d1169.s1.e0" origId="41867" charOffset="77-87" type="compound" text="epirubicin"/>
            <entity id="DS.d1169.s1.e1" origId="P04626" charOffset="138-142" type="protein" text="HER2"/>
            <pair e1="DS.d1169.s1.e0" e2="DS.d1169.s1.e1" id="DS.d1169.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1171" origId="18791914">
        <sentence id="DS.d1171.s0" origId="18791914-2380" text="The DEP-induced increases in peribronchial eosinophils and mucous goblet cells in the lung tissues, and of IL-5 and IL-13 in the BAL fluid, were significantly attenuated by the antioxidant N-acetylcysteine.">
            <entity id="DS.d1171.s0.e0" origId="O02699,O08987,O77515,P04401,P05113,P46685,P48093,P52173,Q08125,Q28586,Q62575,Q95J76,Q9ESI9,Q9XT91" charOffset="107-111" type="protein" text="IL-5"/>
            <entity id="DS.d1171.s0.e1" origId="P20109,P35225,P42203,P61126,Q5I6E4,Q864V6,Q865W5,Q865X3,Q95J68,Q9N0W9,Q9XSV9" charOffset="116-121" type="protein" text="IL-13"/>
            <entity id="DS.d1171.s0.e2" origId="12035" charOffset="189-205" type="compound" text="N-acetylcysteine"/>
            <pair e1="DS.d1171.s0.e2" e2="DS.d1171.s0.e0" id="DS.d1171.s0.i0" interaction="True"/>
            <pair e1="DS.d1171.s0.e2" e2="DS.d1171.s0.e1" id="DS.d1171.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1172" origId="18792056">
        <sentence id="DS.d1172.s0" origId="18792056-2438" text="Each of the developed consortium has a phosphate solubilizer, nitrogen fixer, growth hormone producer, heterotrophic member and an antagonist.">
            <entity id="DS.d1172.s0.e0" origId="1061,167704,644102" charOffset="39-48" type="compound" text="phosphate"/>
            <entity id="DS.d1172.s0.e1" origId="947,123329" charOffset="62-70" type="compound" text="nitrogen"/>
            <entity id="DS.d1172.s0.e2" origId="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8" charOffset="78-92" type="protein" text="growth hormone"/>
            <pair e1="DS.d1172.s0.e1" e2="DS.d1172.s0.e2" id="DS.d1172.s0.i0" interaction="False"/>
            <pair e1="DS.d1172.s0.e0" e2="DS.d1172.s0.e2" id="DS.d1172.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1173" origId="18792785">
        <sentence id="DS.d1173.s0" origId="18792785-89" text="Using cannabinoid receptor antagonists and cannabinoid receptor gene deficient mice (CB(1) (-/-) and CB(2) (-/-)), we showed that both CB(1) and CB(2) receptors were involved in the THC-induced attenuation of serum IL-12 and IFNgamma.">
            <entity id="DS.d1173.s0.e0" origId="134740" charOffset="182-185" type="compound" text="THC"/>
            <entity id="DS.d1173.s0.e1" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="225-233" type="protein" text="IFNgamma"/>
            <pair e1="DS.d1173.s0.e0" e2="DS.d1173.s0.e1" id="DS.d1173.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1174" origId="18792801">
        <sentence id="DS.d1174.s0" origId="18792801-694" text="Promoter analysis of the PSG1, 4, and 11 genes in HeLa cells did not reveal a cis-regulatory element responsive to 5-bromodeoxyuridine in their 5'-flanking sequences.">
            <entity id="DS.d1174.s0.e0" origId="P11464" charOffset="25-29" type="protein" text="PSG1"/>
            <entity id="DS.d1174.s0.e1" origId="6035" charOffset="115-134" type="compound" text="5-bromodeoxyuridine"/>
            <pair e1="DS.d1174.s0.e1" e2="DS.d1174.s0.e0" id="DS.d1174.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1175" origId="18792915">
        <sentence id="DS.d1175.s0" origId="18792915-162" text="p38-MAPK- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by retinoic acid.">
            <entity id="DS.d1175.s0.e0" origId="O62618" charOffset="0-8" type="protein" text="p38-MAPK"/>
            <entity id="DS.d1175.s0.e1" origId="444795" charOffset="105-118" type="compound" text="retinoic acid"/>
            <pair e1="DS.d1175.s0.e1" e2="DS.d1175.s0.e0" id="DS.d1175.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1176" origId="18793216">
        <sentence id="DS.d1176.s0" origId="18793216-256" text="In vivo administration of a synthetic phospholipid, named hereafter phospho-ceramide analogue-1 (PCERA-1), was previously found to suppress lipopolysaccharide (LPS)-induced TNF-alpha blood levels.">
            <entity id="DS.d1176.s0.e0" origId="11970143" charOffset="140-158" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d1176.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="173-182" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d1176.s0.e0" e2="DS.d1176.s0.e1" id="DS.d1176.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1176.s1" origId="18793216-258" text="In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of cAMP production, and eventually TNF-alpha suppression and IL-10 induction.">
            <entity id="DS.d1176.s1.e0" origId="6076" charOffset="119-123" type="compound" text="cAMP"/>
            <entity id="DS.d1176.s1.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="151-160" type="protein" text="TNF-alpha"/>
            <entity id="DS.d1176.s1.e2" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="177-182" type="protein" text="IL-10"/>
            <pair e1="DS.d1176.s1.e0" e2="DS.d1176.s1.e2" id="DS.d1176.s1.i0" interaction="False"/>
            <pair e1="DS.d1176.s1.e0" e2="DS.d1176.s1.e1" id="DS.d1176.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1177" origId="18793341">
        <sentence id="DS.d1177.s0" origId="18793341-327" text="Acylated ghrelin and TNF &#945;, IFN &#947;, IL-1&#946; and IL-6 were measured with bioplex.">
            <entity id="DS.d1177.s0.e0" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="9-16" type="protein" text="ghrelin"/>
            <entity id="DS.d1177.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="21-24" type="protein" text="TNF"/>
            <entity id="DS.d1177.s0.e2" origId="P28172,P51526" charOffset="28-31" type="protein" text="IFN"/>
            <entity id="DS.d1177.s0.e3" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="45-49" type="protein" text="IL-6"/>
            <entity id="DS.d1177.s0.e4" origId="636403" charOffset="69-76" type="compound" text="bioplex"/>
            <pair e1="DS.d1177.s0.e4" e2="DS.d1177.s0.e2" id="DS.d1177.s0.i0" interaction="False"/>
            <pair e1="DS.d1177.s0.e4" e2="DS.d1177.s0.e1" id="DS.d1177.s0.i1" interaction="False"/>
            <pair e1="DS.d1177.s0.e4" e2="DS.d1177.s0.e0" id="DS.d1177.s0.i2" interaction="False"/>
            <pair e1="DS.d1177.s0.e4" e2="DS.d1177.s0.e3" id="DS.d1177.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1178" origId="18793347">
        <sentence id="DS.d1178.s0" origId="18793347-2512" text="Pre-gravid physical activity and reduced risk of glucose intolerance in pregnancy : the role of insulin sensitivity.">
            <entity id="DS.d1178.s0.e0" origId="206,5793,64689,79025" charOffset="49-56" type="compound" text="glucose"/>
            <entity id="DS.d1178.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="96-103" type="protein" text="insulin"/>
            <pair e1="DS.d1178.s0.e0" e2="DS.d1178.s0.e1" id="DS.d1178.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1178.s1" origId="18793347-2513" text="Thus, we sought to study the relationships between types of pre-gravid physical activity and metabolic parameters in pregnancy, including glucose tolerance, insulin sensitivity and beta-cell function.">
            <entity id="DS.d1178.s1.e0" origId="206,5793,64689,79025" charOffset="138-145" type="compound" text="glucose"/>
            <entity id="DS.d1178.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="157-164" type="protein" text="insulin"/>
            <pair e1="DS.d1178.s1.e0" e2="DS.d1178.s1.e1" id="DS.d1178.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1179" origId="18793351">
        <sentence id="DS.d1179.s0" origId="18793351-330" text="Inhibition of autophagy by treating rats with Wortmannin (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, Beclin-1, BAG-1 and cardioprotection.">
            <entity id="DS.d1179.s0.e0" origId="312145" charOffset="46-56" type="compound" text="Wortmannin"/>
            <entity id="DS.d1179.s0.e1" origId="P82160" charOffset="147-150" type="protein" text="LC3"/>
            <entity id="DS.d1179.s0.e2" origId="O88597,Q14457,Q4A1L4,Q4A1L5" charOffset="155-163" type="protein" text="Beclin-1"/>
            <entity id="DS.d1179.s0.e3" origId="Q60739,Q99933" charOffset="165-170" type="protein" text="BAG-1"/>
            <pair e1="DS.d1179.s0.e0" e2="DS.d1179.s0.e1" id="DS.d1179.s0.i0" interaction="True"/>
            <pair e1="DS.d1179.s0.e0" e2="DS.d1179.s0.e3" id="DS.d1179.s0.i1" interaction="True"/>
            <pair e1="DS.d1179.s0.e0" e2="DS.d1179.s0.e2" id="DS.d1179.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1181" origId="18793694">
        <sentence id="DS.d1181.s0" origId="18793694-459" text="When myosin molecules work as an aggregate, the sliding movement of a myosin filament driven by the power strokes of some myosin heads makes other myosin heads that have completed their power strokes detach from the actin without consuming ATP.">
            <entity id="DS.d1181.s0.e0" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="216-221" type="protein" text="actin"/>
            <entity id="DS.d1181.s0.e1" origId="5957" charOffset="240-243" type="compound" text="ATP"/>
            <pair e1="DS.d1181.s0.e1" e2="DS.d1181.s0.e0" id="DS.d1181.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1181.s1" origId="18793694-460" text="A critical requirement for this mechanism is that ATP must preferentially facilitate the detachment of myosins that have completed their power strokes, but are still strongly attached to the actin.">
            <entity id="DS.d1181.s1.e0" origId="5957" charOffset="50-53" type="compound" text="ATP"/>
            <entity id="DS.d1181.s1.e1" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="191-196" type="protein" text="actin"/>
            <pair e1="DS.d1181.s1.e0" e2="DS.d1181.s1.e1" id="DS.d1181.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1183" origId="18794178">
        <sentence id="DS.d1183.s0" origId="18794178-604" text="Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.">
            <entity id="DS.d1183.s0.e0" origId="P20333" charOffset="62-72" type="protein" text="etanercept"/>
            <entity id="DS.d1183.s0.e1" origId="5353980,5359476,5384001" charOffset="77-90" type="compound" text="sulfasalazine"/>
            <entity id="DS.d1183.s0.e2" origId="P20333" charOffset="98-108" type="protein" text="etanercept"/>
            <pair e1="DS.d1183.s0.e1" e2="DS.d1183.s0.e0" id="DS.d1183.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1183.s1" origId="18794178-605" text="To determine the efficacy and safety of etanercept and etanercept plus sulfasalazine versus sulfasalazine in patients with rheumatoid arthritis (RA) despite sulfasalazine therapy.">
            <entity id="DS.d1183.s1.e0" origId="P20333" charOffset="40-50" type="protein" text="etanercept"/>
            <entity id="DS.d1183.s1.e1" origId="P20333" charOffset="55-65" type="protein" text="etanercept"/>
            <entity id="DS.d1183.s1.e2" origId="5353980,5359476,5384001" charOffset="71-84" type="compound" text="sulfasalazine"/>
            <entity id="DS.d1183.s1.e3" origId="5353980,5359476,5384001" charOffset="92-105" type="compound" text="sulfasalazine"/>
            <entity id="DS.d1183.s1.e4" origId="5353980,5359476,5384001" charOffset="92-105" type="compound" text="sulfasalazine"/>
            <pair e1="DS.d1183.s1.e2" e2="DS.d1183.s1.e0" id="DS.d1183.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1184" origId="18794865">
        <sentence id="DS.d1184.s0" origId="18794865-1914" text="A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.">
            <entity id="DS.d1184.s0.e0" origId="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217" charOffset="22-31" type="compound" text="etoposide"/>
            <entity id="DS.d1184.s0.e1" origId="O02708,O02837,P09919,P09920,P35833,P35834,Q28746" charOffset="36-41" type="protein" text="G-CSF"/>
            <pair e1="DS.d1184.s0.e0" e2="DS.d1184.s0.e1" id="DS.d1184.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1184.s1" origId="18794865-1915" text="Twenty seven patients were mobilized with etoposide and G-CSF and 28 with etoposide, G-CSF and rituximab.">
            <entity id="DS.d1184.s1.e0" origId="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217" charOffset="42-51" type="compound" text="etoposide"/>
            <entity id="DS.d1184.s1.e1" origId="O02708,O02837,P09919,P09920,P35833,P35834,Q28746" charOffset="56-61" type="protein" text="G-CSF"/>
            <entity id="DS.d1184.s1.e2" origId="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217" charOffset="74-83" type="compound" text="etoposide"/>
            <entity id="DS.d1184.s1.e3" origId="O02708,O02837,P09919,P09920,P35833,P35834,Q28746" charOffset="85-90" type="protein" text="G-CSF"/>
            <pair e1="DS.d1184.s1.e0" e2="DS.d1184.s1.e1" id="DS.d1184.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1185" origId="18795231">
        <sentence id="DS.d1185.s0" origId="18795231-893" text="Aberrant methylation of the MGMT (O6-methylguanine-DNA methyltransferase) DNA-repair gene is a predictive marker for the response to chemotherapy with alkylating agents (e.g., temozolomide) in malignant gliomas.">
            <entity id="DS.d1185.s0.e0" origId="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8" charOffset="28-32" type="protein" text="MGMT"/>
            <entity id="DS.d1185.s0.e2" origId="5394" charOffset="176-188" type="compound" text="temozolomide"/>
            <pair e1="DS.d1185.s0.e2" e2="DS.d1185.s0.e0" id="DS.d1185.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1186" origId="18795240">
        <sentence id="DS.d1186.s0" origId="18795240-896" text="This work describes the influence of two polar lipids, Sn-1/3 and Sn-2 monopalmitin, on the activity of lipase in biphasic systems and in microemulsions.">
            <entity id="DS.d1186.s0.e0" origId="123409" charOffset="69-83" type="compound" text="2 monopalmitin"/>
            <entity id="DS.d1186.s0.e1" origId="Q7M4U7" charOffset="104-110" type="protein" text="lipase"/>
            <pair e1="DS.d1186.s0.e0" e2="DS.d1186.s0.e1" id="DS.d1186.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1186.s1" origId="18795240-897" text="In previous communications, we have shown that Sn-2 monoglycerides can replace Sn-1,3 regiospecific lipases at the oil-water interface, causing a drastically reduced rate of lipolysis.">
            <entity id="DS.d1186.s1.e0" origId="17756737" charOffset="50-66" type="compound" text="2 monoglycerides"/>
            <entity id="DS.d1186.s1.e1" origId="Q7M4U7" charOffset="100-107" type="protein" text="lipases"/>
            <pair e1="DS.d1186.s1.e0" e2="DS.d1186.s1.e1" id="DS.d1186.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1187" origId="18795263">
        <sentence id="DS.d1187.s0" origId="18795263-905" text="Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on propionate plus fumarate significantly, although the specific activities of hydrogenase and especially formate dehydrogenase were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.">
            <entity id="DS.d1187.s0.e0" origId="1032" charOffset="118-128" type="compound" text="propionate"/>
            <entity id="DS.d1187.s0.e1" origId="444972" charOffset="134-142" type="compound" text="fumarate"/>
            <entity id="DS.d1187.s0.e2" origId="P80509,P80510" charOffset="194-205" type="protein" text="hydrogenase"/>
            <entity id="DS.d1187.s0.e3" origId="P33160,P33677,Q07103" charOffset="221-242" type="protein" text="formate dehydrogenase"/>
            <pair e1="DS.d1187.s0.e0" e2="DS.d1187.s0.e2" id="DS.d1187.s0.i0" interaction="False"/>
            <pair e1="DS.d1187.s0.e0" e2="DS.d1187.s0.e3" id="DS.d1187.s0.i1" interaction="False"/>
            <pair e1="DS.d1187.s0.e1" e2="DS.d1187.s0.e2" id="DS.d1187.s0.i2" interaction="False"/>
            <pair e1="DS.d1187.s0.e1" e2="DS.d1187.s0.e3" id="DS.d1187.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d1187.s1" origId="18795263-906" text="Our results suggest a more prominent role for H2 as electron carrier in the syntrophic conversion of propionate, when the essential trace metals W and Mo for the functioning of formate dehydrogenase are depleted.">
            <entity id="DS.d1187.s1.e0" origId="1032" charOffset="101-111" type="compound" text="propionate"/>
            <entity id="DS.d1187.s1.e1" origId="P33160,P33677,Q07103" charOffset="177-198" type="protein" text="formate dehydrogenase"/>
            <pair e1="DS.d1187.s1.e0" e2="DS.d1187.s1.e1" id="DS.d1187.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1188" origId="18795264">
        <sentence id="DS.d1188.s0" origId="18795264-907" text="Previous studies have demonstrated an association between genetic polymorphisms of the mu opioid receptor gene (OPRM1) and response to naltrexone treatment.">
            <entity id="DS.d1188.s0.e0" origId="P35372,P79350,P97266,Q5IS39,Q5IS84,Q95247,Q95M54,Q9MYW9" charOffset="112-117" type="protein" text="OPRM1"/>
            <entity id="DS.d1188.s0.e1" origId="5360515" charOffset="135-145" type="compound" text="naltrexone"/>
            <pair e1="DS.d1188.s0.e1" e2="DS.d1188.s0.e0" id="DS.d1188.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1189" origId="18795290">
        <sentence id="DS.d1189.s0" origId="18795290-925" text="Based on the preclinical evidence of topoisomerase I (Topo-1) upregulation by mitomycin C (MMC) and decreased NF-kappaB activation by celecoxib, we evaluated combinations of irinotecan/MMC and irinotecan/MMC/celecoxib in patients with advanced solid malignancies.">
            <entity id="DS.d1189.s0.e0" origId="O29238,O51934,O58530,O67037,O67226,P74759,P95479,Q08582,Q58907,Q6F598,Q8R979,Q8ZXT5,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9UZ86,Q9YC75,Q9YCB6" charOffset="37-50" type="protein" text="topoisomerase"/>
            <entity id="DS.d1189.s0.e1" origId="5746" charOffset="78-89" type="compound" text="mitomycin C"/>
            <pair e1="DS.d1189.s0.e1" e2="DS.d1189.s0.e0" id="DS.d1189.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1190" origId="18795320">
        <sentence id="DS.d1190.s0" origId="18795320-932" text="The cells expressed aquaporin-1 sensitive to HgCl (2) and decreased by siRNA, which both reduced fast volume changes.">
            <entity id="DS.d1190.s0.e0" origId="P29972,P29975,P47865,P53386,P56401,P61837,P61838,Q02013,Q5R819,Q6PQZ1,Q9N2J4" charOffset="20-31" type="protein" text="aquaporin-1"/>
            <entity id="DS.d1190.s0.e1" origId="24182" charOffset="45-49" type="compound" text="HgCl"/>
            <pair e1="DS.d1190.s0.e1" e2="DS.d1190.s0.e0" id="DS.d1190.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1191" origId="18795889">
        <sentence id="DS.d1191.s0" origId="18795889-1063" text="Two conserved leucine repeats within the COMM domain were found to be critically required for XIAP binding.">
            <entity id="DS.d1191.s0.e0" origId="857,6106,439524" charOffset="14-21" type="compound" text="leucine"/>
            <entity id="DS.d1191.s0.e1" origId="P98170" charOffset="94-98" type="protein" text="XIAP"/>
            <pair e1="DS.d1191.s0.e0" e2="DS.d1191.s0.e1" id="DS.d1191.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1192" origId="18795892">
        <sentence id="DS.d1192.s0" origId="18795892-1064" text="Functional analysis of rat liver citrate carrier promoter: differential responsiveness to polyunsaturated fatty acids.">
            <entity id="DS.d1192.s0.e0" origId="P0AE74,P0AE75" charOffset="33-48" type="protein" text="citrate carrier"/>
            <entity id="DS.d1192.s0.e1" origId="56842239" charOffset="90-117" type="compound" text="polyunsaturated fatty acids"/>
            <pair e1="DS.d1192.s0.e1" e2="DS.d1192.s0.e0" id="DS.d1192.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1193" origId="18795918">
        <sentence id="DS.d1193.s0" origId="18795918-1074" text="Wet-wrap treatment using dilutions of tacrolimus ointment and fluticasone propionate cream in human APOC1 (+/+) mice with atopic dermatitis.">
            <entity id="DS.d1193.s0.e0" origId="5372,445643,445647,6426916,6436007,6473866,6536850,9940643,23581796,54611630" charOffset="38-48" type="compound" text="tacrolimus"/>
            <entity id="DS.d1193.s0.e1" origId="444036" charOffset="62-84" type="compound" text="fluticasone propionate"/>
            <entity id="DS.d1193.s0.e2" origId="P02654,P18657,P33047,P34929,P56595,Q9XSN5" charOffset="100-105" type="protein" text="APOC1"/>
            <pair e1="DS.d1193.s0.e0" e2="DS.d1193.s0.e2" id="DS.d1193.s0.i0" interaction="False"/>
            <pair e1="DS.d1193.s0.e1" e2="DS.d1193.s0.e2" id="DS.d1193.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1194" origId="18795969">
        <sentence id="DS.d1194.s0" origId="18795969-1090" text="The use of low-dose COCs is preferable in PCOS, especially among patients with glucose intolerance, insulin resistance and uncomplicated diabetes mellitus.">
            <entity id="DS.d1194.s0.e0" origId="206,5793,64689,79025" charOffset="79-86" type="compound" text="glucose"/>
            <entity id="DS.d1194.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="100-107" type="protein" text="insulin"/>
            <pair e1="DS.d1194.s0.e0" e2="DS.d1194.s0.e1" id="DS.d1194.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1195" origId="18796314">
        <sentence id="DS.d1195.s0" origId="18796314-1192" text="Due to its faculty to protect cholinesterase (ChE) activity against irreversible inactivation by OP, pyridostigmine bromide (PB) was used as a prophylaxis treatment during the first Persian Gulf War.">
            <entity id="DS.d1195.s0.e0" origId="P32749,P32750,P32751,P32752,P32753,P81908" charOffset="30-44" type="protein" text="cholinesterase"/>
            <entity id="DS.d1195.s0.e1" origId="4991" charOffset="101-123" type="compound" text="pyridostigmine bromide"/>
            <pair e1="DS.d1195.s0.e1" e2="DS.d1195.s0.e0" id="DS.d1195.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1196" origId="18796403">
        <sentence id="DS.d1196.s0" origId="18796403-1220" text="Mice lacking Niemann-Pick C1-Like 1 (NPC1L1) (NPC1L1 (-/-)mice) exhibit a defect in intestinal absorption of cholesterol and phytosterols.">
            <entity id="DS.d1196.s0.e0" origId="Q9UHC9" charOffset="37-43" type="protein" text="NPC1L1"/>
            <entity id="DS.d1196.s0.e1" origId="Q9UHC9" charOffset="46-52" type="protein" text="NPC1L1"/>
            <entity id="DS.d1196.s0.e2" origId="12303662" charOffset="125-137" type="compound" text="phytosterols"/>
            <pair e1="DS.d1196.s0.e2" e2="DS.d1196.s0.e0" id="DS.d1196.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1196.s1" origId="18796403-1222" text="In this study, we examined the role of NPC1L1 in phytosterol and cholesterol trafficking in mice lacking ATP-binding cassette (ABC) transporters G5 and G8 (G5/G8(-/-) mice).">
            <entity id="DS.d1196.s1.e0" origId="Q9UHC9" charOffset="39-45" type="protein" text="NPC1L1"/>
            <entity id="DS.d1196.s1.e1" origId="222284,457801" charOffset="49-60" type="compound" text="phytosterol"/>
            <pair e1="DS.d1196.s1.e1" e2="DS.d1196.s1.e0" id="DS.d1196.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1196.s2" origId="18796403-1223" text="We found that mice lacking ABCG5/G8 and NPC1L1 (triple knockout (TKO) mice) did not accumulate phytosterols in plasma and the liver.">
            <entity id="DS.d1196.s2.e0" origId="Q9H222" charOffset="27-32" type="protein" text="ABCG5"/>
            <entity id="DS.d1196.s2.e1" origId="Q9UHC9" charOffset="40-46" type="protein" text="NPC1L1"/>
            <entity id="DS.d1196.s2.e2" origId="12303662" charOffset="95-107" type="compound" text="phytosterols"/>
            <pair e1="DS.d1196.s2.e2" e2="DS.d1196.s2.e1" id="DS.d1196.s2.i0" interaction="False"/>
            <pair e1="DS.d1196.s2.e2" e2="DS.d1196.s2.e0" id="DS.d1196.s2.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1196.s3" origId="18796403-1224" text="In conclusion, NPC1L1 is essential for phytosterols to enter the body in mice.">
            <entity id="DS.d1196.s3.e0" origId="Q9UHC9" charOffset="15-21" type="protein" text="NPC1L1"/>
            <entity id="DS.d1196.s3.e1" origId="12303662" charOffset="39-51" type="compound" text="phytosterols"/>
            <pair e1="DS.d1196.s3.e1" e2="DS.d1196.s3.e0" id="DS.d1196.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1197" origId="18796561">
        <sentence id="DS.d1197.s0" origId="18796561-1268" text="The slow BSO-induced GSH depletion allows separation of two redox-related phases, namely, early thiol disequilibrium and late frank oxidative stress; each phase contributes to the progressive activation of a p50-p50 homodimer.">
            <entity id="DS.d1197.s0.e0" origId="124886" charOffset="21-24" type="compound" text="GSH"/>
            <entity id="DS.d1197.s0.e1" origId="P23061,P38644,P83939,Q05894,Q28618,Q43731" charOffset="208-211" type="protein" text="p50"/>
            <entity id="DS.d1197.s0.e2" origId="P23061,P38644,P83939,Q05894,Q28618,Q43731" charOffset="212-215" type="protein" text="p50"/>
            <pair e1="DS.d1197.s0.e0" e2="DS.d1197.s0.e1" id="DS.d1197.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1198" origId="18796623">
        <sentence id="DS.d1198.s0" origId="18796623-1276" text="In contrast, Notch-signaling inhibition by the gamma-secretase inhibitor I (GSI ; z-Leu-Leu-Nle-CHO) and the specific Notch2 down-regulation by small-interfering RNA accelerate spontaneous B-CLL cell apoptosis.">
            <entity id="DS.d1198.s0.e0" origId="16760646" charOffset="47-74" type="compound" text="gamma-secretase inhibitor I"/>
            <entity id="DS.d1198.s0.e1" origId="O35516,Q9QW30" charOffset="118-124" type="protein" text="Notch2"/>
            <pair e1="DS.d1198.s0.e0" e2="DS.d1198.s0.e1" id="DS.d1198.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1199" origId="18797825">
        <sentence id="DS.d1199.s0" origId="18797825-1625" text="Effects of exhaustion and calcium supplementation on adrenocorticotropic hormone and cortisol levels in athletes.">
            <entity id="DS.d1199.s0.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="53-80" type="protein" text="adrenocorticotropic hormone"/>
            <entity id="DS.d1199.s0.e1" origId="5754" charOffset="85-93" type="compound" text="cortisol"/>
            <pair e1="DS.d1199.s0.e1" e2="DS.d1199.s0.e0" id="DS.d1199.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1199.s1" origId="18797825-1626" text="The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on cortisol and adrenocorticotropic hormone levels in athletes at rest and exhaustion.">
            <entity id="DS.d1199.s1.e0" origId="5754" charOffset="112-120" type="compound" text="cortisol"/>
            <entity id="DS.d1199.s1.e1" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="125-152" type="protein" text="adrenocorticotropic hormone"/>
            <pair e1="DS.d1199.s1.e0" e2="DS.d1199.s1.e1" id="DS.d1199.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1199.s2" origId="18797825-1627" text="One-month supplementation with calcium does not influence the cortisol and adrenocorticotropic hormone 0.05).">
            <entity id="DS.d1199.s2.e0" origId="5754" charOffset="62-70" type="compound" text="cortisol"/>
            <entity id="DS.d1199.s2.e1" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="75-102" type="protein" text="adrenocorticotropic hormone"/>
            <pair e1="DS.d1199.s2.e0" e2="DS.d1199.s2.e1" id="DS.d1199.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1200" origId="18797870">
        <sentence id="DS.d1200.s0" origId="18797870-1649" text="Effects of nonspecific targeting of FLT3 were evaluated with addition of imatinib (Gleevec) to cell cultures.">
            <entity id="DS.d1200.s0.e0" origId="P36888" charOffset="36-40" type="protein" text="FLT3"/>
            <entity id="DS.d1200.s0.e1" origId="5291" charOffset="83-90" type="compound" text="Gleevec"/>
            <pair e1="DS.d1200.s0.e1" e2="DS.d1200.s0.e0" id="DS.d1200.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1201" origId="18797914">
        <sentence id="DS.d1201.s0" origId="18797914-1664" text="In the pericentral necrotic zone after CCl4-treatment, no induction of Thy-1 was found.">
            <entity id="DS.d1201.s0.e0" origId="5943" charOffset="39-43" type="compound" text="CCl4"/>
            <entity id="DS.d1201.s0.e1" origId="P01830,P01831" charOffset="71-76" type="protein" text="Thy-1"/>
            <pair e1="DS.d1201.s0.e0" e2="DS.d1201.s0.e1" id="DS.d1201.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1202" origId="18797943">
        <sentence id="DS.d1202.s0" origId="18797943-1672" text="Sixty-one percent of the isolates were beta-lactamase producers, which explains the poor activity of penicillin.">
            <entity id="DS.d1202.s0.e0" origId="P80298,P80545,P81173" charOffset="39-53" type="protein" text="beta-lactamase"/>
            <entity id="DS.d1202.s0.e1" origId="5904" charOffset="101-111" type="compound" text="penicillin"/>
            <pair e1="DS.d1202.s0.e1" e2="DS.d1202.s0.e0" id="DS.d1202.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1204" origId="18798281">
        <sentence id="DS.d1204.s0" origId="18798281-1790" text="In contrast, chelating intracellular calcium ((Ca(2+))(i)) by BAPTA-AM abolished BDNF-mediated Arc up-regulation.">
            <entity id="DS.d1204.s0.e0" origId="271" charOffset="47-51" type="compound" text="Ca(2"/>
            <entity id="DS.d1204.s0.e1" origId="2293" charOffset="62-70" type="compound" text="BAPTA-AM"/>
            <entity id="DS.d1204.s0.e2" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="81-85" type="protein" text="BDNF"/>
            <pair e1="DS.d1204.s0.e1" e2="DS.d1204.s0.e2" id="DS.d1204.s0.i0" interaction="False"/>
            <pair e1="DS.d1204.s0.e0" e2="DS.d1204.s0.e2" id="DS.d1204.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1204.s1" origId="18798281-1791" text="These data suggested novel functions of (Ca(2+))(i) and CaM in BDNF signaling.">
            <entity id="DS.d1204.s1.e0" origId="271" charOffset="41-45" type="compound" text="Ca(2"/>
            <entity id="DS.d1204.s1.e1" origId="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0" charOffset="56-59" type="protein" text="CaM"/>
            <entity id="DS.d1204.s1.e2" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="63-67" type="protein" text="BDNF"/>
            <pair e1="DS.d1204.s1.e0" e2="DS.d1204.s1.e2" id="DS.d1204.s1.i0" interaction="True"/>
            <pair e1="DS.d1204.s1.e0" e2="DS.d1204.s1.e1" id="DS.d1204.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1204.s2" origId="18798281-1792" text="Comparison of the Arc transcription profiles between Ca(2+)-stimulated and BDNF-stimulated neurons demonstrated that the regulatory mechanisms were distinctively tailored to the complex features of neuronal activity.">
            <entity id="DS.d1204.s2.e0" origId="271" charOffset="53-57" type="compound" text="Ca(2"/>
            <entity id="DS.d1204.s2.e1" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="75-79" type="protein" text="BDNF"/>
            <pair e1="DS.d1204.s2.e0" e2="DS.d1204.s2.e1" id="DS.d1204.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1205" origId="18798567">
        <sentence id="DS.d1205.s0" origId="18798567-1853" text="Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (GalNAc)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II RIPs, SNA-V), found in the same species.">
            <entity id="DS.d1205.s0.e0" origId="35717,84265" charOffset="86-92" type="compound" text="GalNAc"/>
            <entity id="DS.d1205.s0.e1" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="103-109" type="protein" text="lectin"/>
            <entity id="DS.d1205.s0.e2" origId="P10297,P21326,P23339,P24475,P24476,P24477,P80750,Q03464,Q40772" charOffset="185-214" type="protein" text="ribosome-inactivating protein"/>
            <entity id="DS.d1205.s0.e3" origId="P24817,P52594,P56626,Q13546,Q2TA45,Q86UA6" charOffset="224-228" type="protein" text="RIPs"/>
            <pair e1="DS.d1205.s0.e0" e2="DS.d1205.s0.e1" id="DS.d1205.s0.i3" interaction="True"/>
            <pair e1="DS.d1205.s0.e0" e2="DS.d1205.s0.e2" id="DS.d1205.s0.i4" interaction="False"/>
            <pair e1="DS.d1205.s0.e0" e2="DS.d1205.s0.e3" id="DS.d1205.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1206" origId="18798730">
        <sentence id="DS.d1206.s0" origId="18798730-1896" text="Infusion of each receptor antagonist alone similarly reduced basal unstressed volume and blood flow in ACEI-treated CHF patients, but not in healthy volunteers or ARB-treated CHF patients.">
            <entity id="DS.d1206.s0.e0" origId="Q9P8W3" charOffset="103-107" type="protein" text="ACEI"/>
            <entity id="DS.d1206.s0.e1" origId="439764" charOffset="163-166" type="compound" text="ARB"/>
            <pair e1="DS.d1206.s0.e1" e2="DS.d1206.s0.e0" id="DS.d1206.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1206.s1" origId="18798730-1897" text="In ARB-treated heart failure, venous responses to bradykinin are preserved but arterial responses are reduced compared with healthy controls.">
            <entity id="DS.d1206.s1.e0" origId="439764" charOffset="3-6" type="compound" text="ARB"/>
            <entity id="DS.d1206.s1.e1" origId="O08677,P01042,P01044,P01045,P08934,P83055,P83060,P83856,P83857,P84697,P84825,P84895,Q7T3L1,Q90W88,Q90WZ1" charOffset="50-60" type="protein" text="bradykinin"/>
            <pair e1="DS.d1206.s1.e0" e2="DS.d1206.s1.e1" id="DS.d1206.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1207" origId="18798833">
        <sentence id="DS.d1207.s0" origId="18798833-1679" text="Later-onset congenital central hypoventilation syndrome due to a heterozygous 24-polyalanine repeat expansion mutation in the PHOX2B gene.">
            <entity id="DS.d1207.s0.e0" origId="5950" charOffset="81-92" type="compound" text="polyalanine"/>
            <entity id="DS.d1207.s0.e1" origId="Q99453" charOffset="126-132" type="protein" text="PHOX2B"/>
            <pair e1="DS.d1207.s0.e0" e2="DS.d1207.s0.e1" id="DS.d1207.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1207.s1" origId="18798833-1680" text="to describe a family with later onset congenital central hypoventilation syndrome (LO-CCHS) and heterozygosity for a 24-polyalanine repeat expansion mutation in the PHOX2B gene, rendered phenotypically apparent with exposure to anesthetics.">
            <entity id="DS.d1207.s1.e0" origId="5950" charOffset="120-131" type="compound" text="polyalanine"/>
            <entity id="DS.d1207.s1.e1" origId="Q99453" charOffset="165-171" type="protein" text="PHOX2B"/>
            <pair e1="DS.d1207.s1.e0" e2="DS.d1207.s1.e1" id="DS.d1207.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1208" origId="18798864">
        <sentence id="DS.d1208.s0" origId="18798864-1974" text="Effects of raloxifene on breast cancer cell migration and invasion through the actin cytoskeleton.">
            <entity id="DS.d1208.s0.e0" origId="5035" charOffset="11-21" type="compound" text="raloxifene"/>
            <entity id="DS.d1208.s0.e1" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="79-84" type="protein" text="actin"/>
            <pair e1="DS.d1208.s0.e0" e2="DS.d1208.s0.e1" id="DS.d1208.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1209" origId="18798867">
        <sentence id="DS.d1209.s0" origId="18798867-1982" text="High glucose attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.">
            <entity id="DS.d1209.s0.e0" origId="206,5793,64689,79025" charOffset="5-12" type="compound" text="glucose"/>
            <entity id="DS.d1209.s0.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="24-28" type="protein" text="VEGF"/>
            <entity id="DS.d1209.s0.e2" origId="O60674" charOffset="116-120" type="protein" text="JAK2"/>
            <entity id="DS.d1209.s0.e3" origId="P40763,P61635" charOffset="121-126" type="protein" text="STAT3"/>
            <pair e1="DS.d1209.s0.e0" e2="DS.d1209.s0.e3" id="DS.d1209.s0.i0" interaction="False"/>
            <pair e1="DS.d1209.s0.e0" e2="DS.d1209.s0.e2" id="DS.d1209.s0.i1" interaction="False"/>
            <pair e1="DS.d1209.s0.e0" e2="DS.d1209.s0.e1" id="DS.d1209.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d1209.s1" origId="18798867-1983" text="This study was to investigate the effect of high glucose (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/STAT-3 signalling.">
            <entity id="DS.d1209.s1.e0" origId="206,5793,64689,79025" charOffset="49-56" type="compound" text="glucose"/>
            <entity id="DS.d1209.s1.e1" origId="23931" charOffset="58-60" type="compound" text="HG"/>
            <entity id="DS.d1209.s1.e2" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="101-105" type="protein" text="VEGF"/>
            <entity id="DS.d1209.s1.e3" origId="O60674" charOffset="148-152" type="protein" text="JAK2"/>
            <entity id="DS.d1209.s1.e4" origId="P08457,P35610,Q7QDU4" charOffset="153-157" type="protein" text="STAT"/>
            <pair e1="DS.d1209.s1.e0" e2="DS.d1209.s1.e4" id="DS.d1209.s1.i0" interaction="False"/>
            <pair e1="DS.d1209.s1.e0" e2="DS.d1209.s1.e3" id="DS.d1209.s1.i1" interaction="False"/>
            <pair e1="DS.d1209.s1.e1" e2="DS.d1209.s1.e2" id="DS.d1209.s1.i2" interaction="False"/>
            <pair e1="DS.d1209.s1.e1" e2="DS.d1209.s1.e3" id="DS.d1209.s1.i3" interaction="False"/>
            <pair e1="DS.d1209.s1.e1" e2="DS.d1209.s1.e4" id="DS.d1209.s1.i4" interaction="False"/>
            <pair e1="DS.d1209.s1.e0" e2="DS.d1209.s1.e2" id="DS.d1209.s1.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1211" origId="18799187">
        <sentence id="DS.d1211.s0" origId="18799187-2083" text="Hepatic stellate cell activation in focal nodular hyperplasia with a central scar was accompanied by the expression of 8-hydroxy-2'-deoxyguanosine and inducible nitric oxide synthase in the liver.">
            <entity id="DS.d1211.s0.e0" origId="73318" charOffset="119-146" type="compound" text="8-hydroxy-2'-deoxyguanosine"/>
            <entity id="DS.d1211.s0.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="161-182" type="protein" text="nitric oxide synthase"/>
            <pair e1="DS.d1211.s0.e0" e2="DS.d1211.s0.e1" id="DS.d1211.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1211.s1" origId="18799187-2084" text="Expression of 8-hydroxy-2'-deoxyguanosine and inducible nitric oxide synthase was rarely seen in focal nodular hyperplasia without a central scar, focal nodular hyperplasia-like nodules, or nodular regenerative hyperplasia.">
            <entity id="DS.d1211.s1.e0" origId="73318" charOffset="14-41" type="compound" text="8-hydroxy-2'-deoxyguanosine"/>
            <entity id="DS.d1211.s1.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="56-77" type="protein" text="nitric oxide synthase"/>
            <pair e1="DS.d1211.s1.e0" e2="DS.d1211.s1.e1" id="DS.d1211.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1212" origId="18799201">
        <sentence id="DS.d1212.s0" origId="18799201-2087" text="The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and insulin.">
            <entity id="DS.d1212.s0.e0" origId="5202" charOffset="379-388" type="compound" text="serotonin"/>
            <entity id="DS.d1212.s0.e1" origId="5202" charOffset="390-394" type="compound" text="5-HT"/>
            <entity id="DS.d1212.s0.e2" origId="16129681,16129706" charOffset="397-409" type="compound" text="somatostatin"/>
            <entity id="DS.d1212.s0.e3" origId="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9" charOffset="421-429" type="protein" text="glucagon"/>
            <entity id="DS.d1212.s0.e4" origId="O18811,O18845,O46617,O62820,P01307,P12872,P19863,P27114,Q99MP5,Q9PRP6,Q9XSE2" charOffset="431-438" type="protein" text="motilin"/>
            <entity id="DS.d1212.s0.e5" origId="P09641,P10082,P10631,P29203,P29204,P29205,P29206,P48098,P51694,P68004,P68005,P69092,P69093,P69094,P69095,P69096,P81028,Q76CL2,Q9EPS2,Q9PT99,Q9TR93" charOffset="456-459" type="protein" text="PYY"/>
            <entity id="DS.d1212.s0.e6" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="465-472" type="protein" text="insulin"/>
            <pair e1="DS.d1212.s0.e2" e2="DS.d1212.s0.e5" id="DS.d1212.s0.i0" interaction="False"/>
            <pair e1="DS.d1212.s0.e0" e2="DS.d1212.s0.e3" id="DS.d1212.s0.i1" interaction="False"/>
            <pair e1="DS.d1212.s0.e1" e2="DS.d1212.s0.e6" id="DS.d1212.s0.i2" interaction="False"/>
            <pair e1="DS.d1212.s0.e0" e2="DS.d1212.s0.e4" id="DS.d1212.s0.i3" interaction="False"/>
            <pair e1="DS.d1212.s0.e1" e2="DS.d1212.s0.e4" id="DS.d1212.s0.i4" interaction="False"/>
            <pair e1="DS.d1212.s0.e2" e2="DS.d1212.s0.e3" id="DS.d1212.s0.i5" interaction="False"/>
            <pair e1="DS.d1212.s0.e0" e2="DS.d1212.s0.e6" id="DS.d1212.s0.i6" interaction="False"/>
            <pair e1="DS.d1212.s0.e0" e2="DS.d1212.s0.e5" id="DS.d1212.s0.i7" interaction="False"/>
            <pair e1="DS.d1212.s0.e1" e2="DS.d1212.s0.e3" id="DS.d1212.s0.i8" interaction="False"/>
            <pair e1="DS.d1212.s0.e2" e2="DS.d1212.s0.e6" id="DS.d1212.s0.i9" interaction="False"/>
            <pair e1="DS.d1212.s0.e1" e2="DS.d1212.s0.e5" id="DS.d1212.s0.i10" interaction="False"/>
            <pair e1="DS.d1212.s0.e2" e2="DS.d1212.s0.e4" id="DS.d1212.s0.i11" interaction="False"/>
        </sentence>
        <sentence id="DS.d1212.s1" origId="18799201-2088" text="In the gizzard, endocrine cells secreting somatostatin, 5-HT and PYY were detected, while those secreting glucagon and insulin were not.">
            <entity id="DS.d1212.s1.e0" origId="16129681,16129706" charOffset="42-54" type="compound" text="somatostatin"/>
            <entity id="DS.d1212.s1.e1" origId="5202" charOffset="56-60" type="compound" text="5-HT"/>
            <entity id="DS.d1212.s1.e2" origId="P09641,P10082,P10631,P29203,P29204,P29205,P29206,P48098,P51694,P68004,P68005,P69092,P69093,P69094,P69095,P69096,P81028,Q76CL2,Q9EPS2,Q9PT99,Q9TR93" charOffset="65-68" type="protein" text="PYY"/>
            <entity id="DS.d1212.s1.e3" origId="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9" charOffset="106-114" type="protein" text="glucagon"/>
            <entity id="DS.d1212.s1.e4" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="119-126" type="protein" text="insulin"/>
            <pair e1="DS.d1212.s1.e0" e2="DS.d1212.s1.e2" id="DS.d1212.s1.i0" interaction="False"/>
            <pair e1="DS.d1212.s1.e1" e2="DS.d1212.s1.e4" id="DS.d1212.s1.i1" interaction="False"/>
            <pair e1="DS.d1212.s1.e0" e2="DS.d1212.s1.e3" id="DS.d1212.s1.i2" interaction="False"/>
            <pair e1="DS.d1212.s1.e1" e2="DS.d1212.s1.e3" id="DS.d1212.s1.i3" interaction="False"/>
            <pair e1="DS.d1212.s1.e1" e2="DS.d1212.s1.e2" id="DS.d1212.s1.i4" interaction="False"/>
            <pair e1="DS.d1212.s1.e0" e2="DS.d1212.s1.e4" id="DS.d1212.s1.i5" interaction="False"/>
        </sentence>
        <sentence id="DS.d1212.s2" origId="18799201-2089" text="In the final part of the gizzard, endocrine cells secreting 5-HT were more frequent, and cells secreting somatostatin and insulin were not detected.">
            <entity id="DS.d1212.s2.e0" origId="5202" charOffset="60-64" type="compound" text="5-HT"/>
            <entity id="DS.d1212.s2.e1" origId="16129681,16129706" charOffset="105-117" type="compound" text="somatostatin"/>
            <entity id="DS.d1212.s2.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="122-129" type="protein" text="insulin"/>
            <pair e1="DS.d1212.s2.e0" e2="DS.d1212.s2.e2" id="DS.d1212.s2.i0" interaction="False"/>
            <pair e1="DS.d1212.s2.e1" e2="DS.d1212.s2.e2" id="DS.d1212.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1213" origId="18799634">
        <sentence id="DS.d1213.s0" origId="18799634-2193" text="Cell fractionation by sucrose gradient and differential centrifugation demonstrated that in bradykinin-stimulated cells, TRPM7 localized in fractions corresponding to caveolae.">
            <entity id="DS.d1213.s0.e0" origId="5988" charOffset="22-29" type="compound" text="sucrose"/>
            <entity id="DS.d1213.s0.e1" origId="Q96QT4" charOffset="121-126" type="protein" text="TRPM7"/>
            <pair e1="DS.d1213.s0.e0" e2="DS.d1213.s0.e1" id="DS.d1213.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1214" origId="18799753">
        <sentence id="DS.d1214.s0" origId="18799753-2260" text="However, there are conflicting data regarding the role of Gpr30 as an estrogen receptor (ER): several laboratories were unable to demonstrate estradiol binding to GPR30 or estradiol-activated signal transduction in Gpr30-expressing cells.">
            <entity id="DS.d1214.s0.e0" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="70-87" type="protein" text="estrogen receptor"/>
            <entity id="DS.d1214.s0.e1" origId="5757" charOffset="142-151" type="compound" text="estradiol"/>
            <entity id="DS.d1214.s0.e2" origId="5757" charOffset="172-181" type="compound" text="estradiol"/>
            <pair e1="DS.d1214.s0.e1" e2="DS.d1214.s0.e0" id="DS.d1214.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1214.s1" origId="18799753-2261" text="Our data demonstrate that in vivo Gpr30 is dispensable for the mediation of estradiol effects in reproductive organs.">
            <entity id="DS.d1214.s1.e0" origId="O08878,Q8BMP4" charOffset="34-39" type="protein" text="Gpr30"/>
            <entity id="DS.d1214.s1.e1" origId="5757" charOffset="76-85" type="compound" text="estradiol"/>
            <pair e1="DS.d1214.s1.e1" e2="DS.d1214.s1.e0" id="DS.d1214.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1215" origId="18799757">
        <sentence id="DS.d1215.s0" origId="18799757-2262" text="Sorbitol can fuel mouse sperm motility and protein tyrosine phosphorylation via sorbitol dehydrogenase.">
            <entity id="DS.d1215.s0.e0" origId="5780" charOffset="0-8" type="compound" text="Sorbitol"/>
            <entity id="DS.d1215.s0.e1" origId="1153,6057,5460803" charOffset="51-59" type="compound" text="tyrosine"/>
            <entity id="DS.d1215.s0.e2" origId="P07846,P27867,Q00796,Q02912,Q06004,Q29318,Q4R639,Q58D31,Q59787,Q64442,Q9Z9U1" charOffset="80-102" type="protein" text="sorbitol dehydrogenase"/>
            <pair e1="DS.d1215.s0.e1" e2="DS.d1215.s0.e2" id="DS.d1215.s0.i0" interaction="False"/>
            <pair e1="DS.d1215.s0.e0" e2="DS.d1215.s0.e2" id="DS.d1215.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1215.s1" origId="18799757-2263" text="Here we characterize Sord mRNA and SORD expression during mouse spermatogenesis and examine the ability of sorbitol to support epididymal sperm motility and tyrosine phosphorylation.">
            <entity id="DS.d1215.s1.e0" origId="P27867,Q64442" charOffset="21-25" type="protein" text="Sord"/>
            <entity id="DS.d1215.s1.e1" origId="P07846,Q00796,Q29318,Q4R639,Q58D31" charOffset="35-39" type="protein" text="SORD"/>
            <entity id="DS.d1215.s1.e2" origId="5780" charOffset="107-115" type="compound" text="sorbitol"/>
            <entity id="DS.d1215.s1.e3" origId="1153,6057,5460803" charOffset="157-165" type="compound" text="tyrosine"/>
            <pair e1="DS.d1215.s1.e2" e2="DS.d1215.s1.e0" id="DS.d1215.s1.i0" interaction="False"/>
            <pair e1="DS.d1215.s1.e2" e2="DS.d1215.s1.e1" id="DS.d1215.s1.i1" interaction="False"/>
            <pair e1="DS.d1215.s1.e3" e2="DS.d1215.s1.e1" id="DS.d1215.s1.i2" interaction="False"/>
            <pair e1="DS.d1215.s1.e3" e2="DS.d1215.s1.e0" id="DS.d1215.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1216" origId="18800037">
        <sentence id="DS.d1216.s0" origId="18800037-1366" text="Increase in sildenafil clearance in the early postnatal period likely reflects maturation of CYP-mediated N-demethylation.">
            <entity id="DS.d1216.s0.e0" origId="5212" charOffset="12-22" type="compound" text="sildenafil"/>
            <entity id="DS.d1216.s0.e1" origId="P21568,P21569,P24525,P34887,Q26551" charOffset="93-96" type="protein" text="CYP"/>
            <pair e1="DS.d1216.s0.e0" e2="DS.d1216.s0.e1" id="DS.d1216.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1217" origId="18800064">
        <sentence id="DS.d1217.s0" origId="18800064-2365" text="Desipramine modulation of alpha-, gamma-synuclein, and the norepinephrine transporter in an animal model of depression.">
            <entity id="DS.d1217.s0.e0" origId="2995" charOffset="0-11" type="compound" text="Desipramine"/>
            <entity id="DS.d1217.s0.e1" origId="O76070,Q2PFW6,Q63544,Q9NZ50,Q9Z0F7" charOffset="34-49" type="protein" text="gamma-synuclein"/>
            <entity id="DS.d1217.s0.e2" origId="O55192,P23975,P51143" charOffset="59-85" type="protein" text="norepinephrine transporter"/>
            <pair e1="DS.d1217.s0.e0" e2="DS.d1217.s0.e1" id="DS.d1217.s0.i0" interaction="True"/>
            <pair e1="DS.d1217.s0.e0" e2="DS.d1217.s0.e2" id="DS.d1217.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1217.s1" origId="18800064-2366" text="The NET-selective antidepressant desipramine (DMI) was chronically administered for 14 days to WKY rats and the strain from which it was outbred that does not show depressive-like behavior, the Wistar rat.">
            <entity id="DS.d1217.s1.e0" origId="O55192,P23975,P41970,P51143,P54762" charOffset="4-7" type="protein" text="NET"/>
            <entity id="DS.d1217.s1.e1" origId="2995" charOffset="33-44" type="compound" text="desipramine"/>
            <pair e1="DS.d1217.s1.e1" e2="DS.d1217.s1.e0" id="DS.d1217.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1218" origId="18800198">
        <sentence id="DS.d1218.s0" origId="18800198-2413" text="The present study was designed to evaluate the impact of zinc status before burn on the recovery of injury with focus on plasma insulin and glucose levels.">
            <entity id="DS.d1218.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="128-135" type="protein" text="insulin"/>
            <entity id="DS.d1218.s0.e1" origId="206,5793,64689,79025" charOffset="140-147" type="compound" text="glucose"/>
            <pair e1="DS.d1218.s0.e1" e2="DS.d1218.s0.e0" id="DS.d1218.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1218.s1" origId="18800198-2414" text="Blood and tissue samples were collected 3, 6, and 24 h after injury in order to study biochemical parameters and the glucose/insulin response in relation with the zinc status.">
            <entity id="DS.d1218.s1.e0" origId="206,5793,64689,79025" charOffset="117-124" type="compound" text="glucose"/>
            <entity id="DS.d1218.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="125-132" type="protein" text="insulin"/>
            <pair e1="DS.d1218.s1.e0" e2="DS.d1218.s1.e1" id="DS.d1218.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1218.s2" origId="18800198-2415" text="In addition, the burn-induced insulin resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, glucose, and leptin levels in zinc-deficient animals versus normal-fed rats.">
            <entity id="DS.d1218.s2.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="30-37" type="protein" text="insulin"/>
            <entity id="DS.d1218.s2.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="116-123" type="protein" text="insulin"/>
            <entity id="DS.d1218.s2.e2" origId="206,5793,64689,79025" charOffset="125-132" type="compound" text="glucose"/>
            <entity id="DS.d1218.s2.e3" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="138-144" type="protein" text="leptin"/>
            <pair e1="DS.d1218.s2.e2" e2="DS.d1218.s2.e3" id="DS.d1218.s2.i0" interaction="False"/>
            <pair e1="DS.d1218.s2.e2" e2="DS.d1218.s2.e0" id="DS.d1218.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1219" origId="18800204">
        <sentence id="DS.d1219.s0" origId="18800204-2418" text="methoxyphenoxy)benzyl) morpholine) is a positron emission tomography (PET) radioligand recently applied in clinical studies of norepinephrine transporters (NETs) in the human brain in vivo.">
            <entity id="DS.d1219.s0.e0" origId="8083" charOffset="23-33" type="compound" text="morpholine"/>
            <entity id="DS.d1219.s0.e1" origId="O55192,P23975,P51143" charOffset="127-154" type="protein" text="norepinephrine transporters"/>
            <entity id="DS.d1219.s0.e2" origId="O55192,P23975,P41970,P51143,P54762" charOffset="156-160" type="protein" text="NETs"/>
            <pair e1="DS.d1219.s0.e0" e2="DS.d1219.s0.e2" id="DS.d1219.s0.i0" interaction="True"/>
            <pair e1="DS.d1219.s0.e0" e2="DS.d1219.s0.e1" id="DS.d1219.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1220" origId="18800231">
        <sentence id="DS.d1220.s0" origId="18800231-631" text="The most predictive model of EPO response for the pediatric cohort had, as the major variables, urea clearance x dialysis duration/total body water (Kt/V), urea reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and folate deficiencies as the dominant variables.">
            <entity id="DS.d1220.s0.e0" origId="P01588,P07865,P11678,P33707,P33708,P33709,P48617,P49157,P49290,P80550,Q28513,Q6H8S9,Q6H8T1,Q6H8T2,Q867B1,Q9GKA2" charOffset="29-32" type="protein" text="EPO"/>
            <entity id="DS.d1220.s0.e1" origId="1176,265993" charOffset="96-100" type="compound" text="urea"/>
            <entity id="DS.d1220.s0.e2" origId="1176,265993" charOffset="156-160" type="compound" text="urea"/>
            <entity id="DS.d1220.s0.e3" origId="6037" charOffset="347-353" type="compound" text="folate"/>
            <pair e1="DS.d1220.s0.e1" e2="DS.d1220.s0.e0" id="DS.d1220.s0.i0" interaction="True"/>
            <pair e1="DS.d1220.s0.e3" e2="DS.d1220.s0.e0" id="DS.d1220.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1220.s1" origId="18800231-632" text="In summary EPO resistance in the pediatric dialysis cohort was predicted by nutritional deficits, inflammation, poor dialysis, and hyperparathyroidism, while iron and folate deficits were the major determinants in adults.">
            <entity id="DS.d1220.s1.e0" origId="P01588,P07865,P11678,P33707,P33708,P33709,P48617,P49157,P49290,P80550,Q28513,Q6H8S9,Q6H8T1,Q6H8T2,Q867B1,Q9GKA2" charOffset="11-14" type="protein" text="EPO"/>
            <entity id="DS.d1220.s1.e1" origId="6037" charOffset="167-173" type="compound" text="folate"/>
            <pair e1="DS.d1220.s1.e1" e2="DS.d1220.s1.e0" id="DS.d1220.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1222" origId="18800351">
        <sentence id="DS.d1222.s0" origId="18800351-2001" text="Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells.">
            <entity id="DS.d1222.s0.e0" origId="16315" charOffset="0-18" type="compound" text="Diallyl trisulfide"/>
            <entity id="DS.d1222.s0.e1" origId="P27297,Q07813,Q63690" charOffset="38-41" type="protein" text="Bax"/>
            <entity id="DS.d1222.s0.e2" origId="O08734" charOffset="47-50" type="protein" text="Bak"/>
            <pair e1="DS.d1222.s0.e0" e2="DS.d1222.s0.e2" id="DS.d1222.s0.i0" interaction="True"/>
            <pair e1="DS.d1222.s0.e0" e2="DS.d1222.s0.e1" id="DS.d1222.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1222.s1" origId="18800351-2002" text="The DATS-mediated G2-M phase cell cycle arrest was explained by down-regulation of cyclin-dependent kinase 1 (Cdk1) and cell division cycle 25C protein expression leading to accumulation of Tyr15 phosphorylated (inactive) Cdk1.">
            <entity id="DS.d1222.s1.e0" origId="75552" charOffset="4-8" type="compound" text="DATS"/>
            <entity id="DS.d1222.s1.e1" origId="P06493,P11440,P13863,P39951,P48734,P51958,Q5RCH1,Q9DG98,Q9DGA2,Q9DGA5,Q9DGD3" charOffset="83-108" type="protein" text="cyclin-dependent kinase 1"/>
            <entity id="DS.d1222.s1.e2" origId="P34556" charOffset="110-114" type="protein" text="Cdk1"/>
            <entity id="DS.d1222.s1.e3" origId="P34556" charOffset="222-226" type="protein" text="Cdk1"/>
            <pair e1="DS.d1222.s1.e0" e2="DS.d1222.s1.e2" id="DS.d1222.s1.i0" interaction="True"/>
            <pair e1="DS.d1222.s1.e0" e2="DS.d1222.s1.e1" id="DS.d1222.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1222.s2" origId="18800351-2003" text="Knockdown of Bax and Bak proteins conferred significant protection against DATS-induced apoptotic cytoplasmic histone-associated DNA fragmentation.">
            <entity id="DS.d1222.s2.e0" origId="P27297,Q07813,Q63690" charOffset="13-16" type="protein" text="Bax"/>
            <entity id="DS.d1222.s2.e1" origId="O08734" charOffset="21-24" type="protein" text="Bak"/>
            <entity id="DS.d1222.s2.e2" origId="75552" charOffset="75-79" type="compound" text="DATS"/>
            <pair e1="DS.d1222.s2.e2" e2="DS.d1222.s2.e1" id="DS.d1222.s2.i0" interaction="False"/>
            <pair e1="DS.d1222.s2.e2" e2="DS.d1222.s2.e0" id="DS.d1222.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1223" origId="18800985">
        <sentence id="DS.d1223.s0" origId="18800985-2514" text="In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (CpG) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both arginase and inducible nitric oxide synthase (iNOS) in murine Mphi.">
            <entity id="DS.d1223.s0.e2" origId="6804" charOffset="136-139" type="compound" text="CpG"/>
            <entity id="DS.d1223.s0.e3" origId="Q9TTB0" charOffset="183-199" type="protein" text="interferon-gamma"/>
            <entity id="DS.d1223.s0.e4" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="201-210" type="protein" text="IFN-gamma"/>
            <entity id="DS.d1223.s0.e5" origId="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3" charOffset="218-226" type="protein" text="arginase"/>
            <entity id="DS.d1223.s0.e6" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="241-262" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d1223.s0.e7" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="264-268" type="protein" text="iNOS"/>
            <pair e1="DS.d1223.s0.e2" e2="DS.d1223.s0.e4" id="DS.d1223.s0.i4" interaction="False"/>
            <pair e1="DS.d1223.s0.e2" e2="DS.d1223.s0.e5" id="DS.d1223.s0.i5" interaction="True"/>
            <pair e1="DS.d1223.s0.e2" e2="DS.d1223.s0.e3" id="DS.d1223.s0.i7" interaction="False"/>
            <pair e1="DS.d1223.s0.e2" e2="DS.d1223.s0.e6" id="DS.d1223.s0.i10" interaction="True"/>
            <pair e1="DS.d1223.s0.e2" e2="DS.d1223.s0.e7" id="DS.d1223.s0.i14" interaction="True"/>
        </sentence>
        <sentence id="DS.d1223.s1" origId="18800985-2515" text="A significant increase in arginase activity was observed upon a short pre-incubation (1 hr) with IFN-gamma and subsequent CpG stimulation.">
            <entity id="DS.d1223.s1.e0" origId="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3" charOffset="26-34" type="protein" text="arginase"/>
            <entity id="DS.d1223.s1.e1" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="97-106" type="protein" text="IFN-gamma"/>
            <entity id="DS.d1223.s1.e2" origId="6804" charOffset="122-125" type="compound" text="CpG"/>
            <pair e1="DS.d1223.s1.e2" e2="DS.d1223.s1.e0" id="DS.d1223.s1.i0" interaction="True"/>
            <pair e1="DS.d1223.s1.e2" e2="DS.d1223.s1.e1" id="DS.d1223.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1223.s2" origId="18800985-2516" text="Therefore, a very interesting observation of this study was that the CpG-mediated arginase activity is dependent on IFN-gamma priming.">
            <entity id="DS.d1223.s2.e0" origId="6804" charOffset="69-72" type="compound" text="CpG"/>
            <entity id="DS.d1223.s2.e1" origId="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3" charOffset="82-90" type="protein" text="arginase"/>
            <entity id="DS.d1223.s2.e2" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="116-125" type="protein" text="IFN-gamma"/>
            <pair e1="DS.d1223.s2.e0" e2="DS.d1223.s2.e2" id="DS.d1223.s2.i0" interaction="True"/>
            <pair e1="DS.d1223.s2.e0" e2="DS.d1223.s2.e1" id="DS.d1223.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1223.s3" origId="18800985-2517" text="This report reveals a singular effect of the combination of CpG and IFN-gamma, one of the mayor cytokines produced in response to CpG administration in vivo.">
            <entity id="DS.d1223.s3.e0" origId="6804" charOffset="60-63" type="compound" text="CpG"/>
            <entity id="DS.d1223.s3.e1" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="68-77" type="protein" text="IFN-gamma"/>
            <entity id="DS.d1223.s3.e2" origId="6804" charOffset="130-133" type="compound" text="CpG"/>
            <pair e1="DS.d1223.s3.e0" e2="DS.d1223.s3.e1" id="DS.d1223.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1224" origId="18801207">
        <sentence id="DS.d1224.s0" origId="18801207-197" text="Bakuchiol has a three-fold higher binding affinity for ERalpha than for ERbeta.">
            <entity id="DS.d1224.s0.e0" origId="5321439,5468522" charOffset="0-9" type="compound" text="Bakuchiol"/>
            <entity id="DS.d1224.s0.e1" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="55-62" type="protein" text="ERalpha"/>
            <entity id="DS.d1224.s0.e2" origId="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32" charOffset="72-78" type="protein" text="ERbeta"/>
            <pair e1="DS.d1224.s0.e0" e2="DS.d1224.s0.e2" id="DS.d1224.s0.i0" interaction="True"/>
            <pair e1="DS.d1224.s0.e0" e2="DS.d1224.s0.e1" id="DS.d1224.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1226" origId="18801483">
        <sentence id="DS.d1226.s0" origId="18801483-309" text="In the present study, we examined the effect of gliclazide, a second generation sulfonylurea with antioxidant properties, on LOX-1 expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).">
            <entity id="DS.d1226.s0.e0" origId="3475" charOffset="48-58" type="compound" text="gliclazide"/>
            <entity id="DS.d1226.s0.e1" origId="104818" charOffset="80-92" type="compound" text="sulfonylurea"/>
            <entity id="DS.d1226.s0.e2" origId="O70156,P78380,P79391,Q9EQ09,Q9TTK7,Q9XTA8" charOffset="125-130" type="protein" text="LOX-1"/>
            <entity id="DS.d1226.s0.e3" origId="O70156,P78380,P79391,Q9EQ09,Q9TTK7,Q9XTA8" charOffset="146-151" type="protein" text="LOX-1"/>
            <entity id="DS.d1226.s0.e4" origId="O18733,P14780,P41245,P41246,P50282,P52176" charOffset="161-166" type="protein" text="MMP-9"/>
            <pair e1="DS.d1226.s0.e1" e2="DS.d1226.s0.e4" id="DS.d1226.s0.i0" interaction="False"/>
            <pair e1="DS.d1226.s0.e0" e2="DS.d1226.s0.e4" id="DS.d1226.s0.i1" interaction="True"/>
            <pair e1="DS.d1226.s0.e0" e2="DS.d1226.s0.e2" id="DS.d1226.s0.i2" interaction="True"/>
            <pair e1="DS.d1226.s0.e1" e2="DS.d1226.s0.e2" id="DS.d1226.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1227" origId="18801573">
        <sentence id="DS.d1227.s0" origId="18801573-338" text="The phenolics: anthocyanin (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.">
            <entity id="DS.d1227.s0.e0" origId="145858" charOffset="15-26" type="compound" text="anthocyanin"/>
            <entity id="DS.d1227.s0.e1" origId="O50258" charOffset="87-107" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1227.s0.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="109-112" type="protein" text="SOD"/>
            <entity id="DS.d1227.s0.e3" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="115-123" type="protein" text="catalase"/>
            <entity id="DS.d1227.s0.e4" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="125-128" type="protein" text="CAT"/>
            <entity id="DS.d1227.s0.e5" origId="P15984,P16147,P84714" charOffset="140-150" type="protein" text="peroxidase"/>
            <entity id="DS.d1227.s0.e6" origId="P07003,P37063,P92983,Q54970" charOffset="152-155" type="protein" text="POX"/>
            <entity id="DS.d1227.s0.e7" origId="P15984,P16147,P84714" charOffset="168-178" type="protein" text="peroxidase"/>
            <entity id="DS.d1227.s0.e8" origId="P27695,Q01613,Q42564" charOffset="180-183" type="protein" text="APX"/>
            <entity id="DS.d1227.s0.e9" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="186-208" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d1227.s0.e10" origId="O77834,P83564,Q00277" charOffset="210-213" type="protein" text="GPX"/>
            <entity id="DS.d1227.s0.e11" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="219-240" type="protein" text="glutathione reductase"/>
            <pair e1="DS.d1227.s0.e0" e2="DS.d1227.s0.e6" id="DS.d1227.s0.i0" interaction="False"/>
            <pair e1="DS.d1227.s0.e0" e2="DS.d1227.s0.e3" id="DS.d1227.s0.i1" interaction="False"/>
            <pair e1="DS.d1227.s0.e0" e2="DS.d1227.s0.e4" id="DS.d1227.s0.i2" interaction="False"/>
            <pair e1="DS.d1227.s0.e0" e2="DS.d1227.s0.e10" id="DS.d1227.s0.i3" interaction="False"/>
            <pair e1="DS.d1227.s0.e0" e2="DS.d1227.s0.e11" id="DS.d1227.s0.i4" interaction="False"/>
            <pair e1="DS.d1227.s0.e0" e2="DS.d1227.s0.e9" id="DS.d1227.s0.i5" interaction="False"/>
            <pair e1="DS.d1227.s0.e0" e2="DS.d1227.s0.e2" id="DS.d1227.s0.i6" interaction="False"/>
            <pair e1="DS.d1227.s0.e0" e2="DS.d1227.s0.e8" id="DS.d1227.s0.i7" interaction="False"/>
            <pair e1="DS.d1227.s0.e0" e2="DS.d1227.s0.e1" id="DS.d1227.s0.i8" interaction="False"/>
            <pair e1="DS.d1227.s0.e0" e2="DS.d1227.s0.e5" id="DS.d1227.s0.i9" interaction="False"/>
        </sentence>
        <sentence id="DS.d1227.s1" origId="18801573-339" text="It could results from the fact that phenolic compounds (PhC), which could be also substrates for different peroxidases, were the first line of defence against metal stress.">
            <entity id="DS.d1227.s1.e0" origId="444567" charOffset="56-59" type="compound" text="PhC"/>
            <entity id="DS.d1227.s1.e1" origId="P15984,P16147,P84714" charOffset="107-118" type="protein" text="peroxidases"/>
            <pair e1="DS.d1227.s1.e0" e2="DS.d1227.s1.e1" id="DS.d1227.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1228" origId="18801652">
        <sentence id="DS.d1228.s0" origId="18801652-367" text="The affinity characteristics of developed immunosensors were investigated in reaction with microcystin-LR, and PSA.">
            <entity id="DS.d1228.s0.e0" origId="445434,6437057" charOffset="91-105" type="compound" text="microcystin-LR"/>
            <entity id="DS.d1228.s0.e1" origId="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617" charOffset="111-114" type="protein" text="PSA"/>
            <pair e1="DS.d1228.s0.e0" e2="DS.d1228.s0.e1" id="DS.d1228.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1228.s1" origId="18801652-368" text="The detection limit for microcystin-LR was 10 ngmL(-1) and for PSA 0.01 ngmL(-1).">
            <entity id="DS.d1228.s1.e0" origId="445434,6437057" charOffset="24-38" type="compound" text="microcystin-LR"/>
            <entity id="DS.d1228.s1.e1" origId="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617" charOffset="63-66" type="protein" text="PSA"/>
            <pair e1="DS.d1228.s1.e0" e2="DS.d1228.s1.e1" id="DS.d1228.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1229" origId="18801682">
        <sentence id="DS.d1229.s0" origId="18801682-382" text="This was achieved by (1) direct comparison of the sensitivity of ASIC1, ASIC2, ASIC3 and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or formalin.">
            <entity id="DS.d1229.s0.e0" origId="P55926,P78348,Q7T1N4" charOffset="65-70" type="protein" text="ASIC1"/>
            <entity id="DS.d1229.s0.e1" origId="Q16515" charOffset="72-77" type="protein" text="ASIC2"/>
            <entity id="DS.d1229.s0.e2" origId="O35240,Q6X1Y6,Q9UHC3" charOffset="79-84" type="protein" text="ASIC3"/>
            <entity id="DS.d1229.s0.e3" origId="Q697L1,Q8NER1" charOffset="89-94" type="protein" text="TRPV1"/>
            <entity id="DS.d1229.s0.e4" origId="712" charOffset="327-335" type="compound" text="formalin"/>
            <pair e1="DS.d1229.s0.e4" e2="DS.d1229.s0.e2" id="DS.d1229.s0.i0" interaction="False"/>
            <pair e1="DS.d1229.s0.e4" e2="DS.d1229.s0.e1" id="DS.d1229.s0.i1" interaction="False"/>
            <pair e1="DS.d1229.s0.e4" e2="DS.d1229.s0.e0" id="DS.d1229.s0.i2" interaction="False"/>
            <pair e1="DS.d1229.s0.e4" e2="DS.d1229.s0.e3" id="DS.d1229.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d1229.s1" origId="18801682-383" text="Following formalin injection, ASIC1 (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.">
            <entity id="DS.d1229.s1.e0" origId="712" charOffset="10-18" type="compound" text="formalin"/>
            <entity id="DS.d1229.s1.e1" origId="P55926,P78348,Q7T1N4" charOffset="30-35" type="protein" text="ASIC1"/>
            <entity id="DS.d1229.s1.e2" origId="Q16515" charOffset="46-51" type="protein" text="ASIC2"/>
            <entity id="DS.d1229.s1.e3" origId="O35240,Q6X1Y6,Q9UHC3" charOffset="67-72" type="protein" text="ASIC3"/>
            <entity id="DS.d1229.s1.e4" origId="Q697L1,Q8NER1" charOffset="82-87" type="protein" text="TRPV1"/>
            <pair e1="DS.d1229.s1.e0" e2="DS.d1229.s1.e3" id="DS.d1229.s1.i0" interaction="False"/>
            <pair e1="DS.d1229.s1.e0" e2="DS.d1229.s1.e2" id="DS.d1229.s1.i1" interaction="True"/>
            <pair e1="DS.d1229.s1.e0" e2="DS.d1229.s1.e4" id="DS.d1229.s1.i2" interaction="False"/>
            <pair e1="DS.d1229.s1.e0" e2="DS.d1229.s1.e1" id="DS.d1229.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1230" origId="18801894">
        <sentence id="DS.d1230.s0" origId="18801894-463" text="The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.">
            <entity id="DS.d1230.s0.e0" origId="O35090,P02768,P02769,P08835,P14639,P19121,P21847,P35747,P49064,P49065,P49822,Q28522,Q5XLE4" charOffset="49-52" type="protein" text="ALB"/>
            <entity id="DS.d1230.s0.e1" origId="Q9BXS0" charOffset="96-99" type="protein" text="AMY"/>
            <entity id="DS.d1230.s0.e2" origId="5280352" charOffset="108-117" type="compound" text="bilirubin"/>
            <entity id="DS.d1230.s0.e3" origId="588" charOffset="152-162" type="compound" text="creatinine"/>
            <entity id="DS.d1230.s0.e4" origId="206,5793,64689,79025" charOffset="170-177" type="compound" text="glucose"/>
            <entity id="DS.d1230.s0.e5" origId="24404,139579" charOffset="232-242" type="compound" text="phosphorus"/>
            <pair e1="DS.d1230.s0.e2" e2="DS.d1230.s0.e1" id="DS.d1230.s0.i0" interaction="False"/>
            <pair e1="DS.d1230.s0.e5" e2="DS.d1230.s0.e1" id="DS.d1230.s0.i1" interaction="False"/>
            <pair e1="DS.d1230.s0.e2" e2="DS.d1230.s0.e0" id="DS.d1230.s0.i2" interaction="False"/>
            <pair e1="DS.d1230.s0.e5" e2="DS.d1230.s0.e0" id="DS.d1230.s0.i3" interaction="False"/>
            <pair e1="DS.d1230.s0.e3" e2="DS.d1230.s0.e1" id="DS.d1230.s0.i4" interaction="False"/>
            <pair e1="DS.d1230.s0.e4" e2="DS.d1230.s0.e0" id="DS.d1230.s0.i5" interaction="False"/>
            <pair e1="DS.d1230.s0.e3" e2="DS.d1230.s0.e0" id="DS.d1230.s0.i6" interaction="False"/>
            <pair e1="DS.d1230.s0.e4" e2="DS.d1230.s0.e1" id="DS.d1230.s0.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1231" origId="18801899">
        <sentence id="DS.d1231.s0" origId="18801899-465" text="In addition, serum levels of glucose, adiponectin, and insulin were measured.">
            <entity id="DS.d1231.s0.e0" origId="206,5793,64689,79025" charOffset="29-36" type="compound" text="glucose"/>
            <entity id="DS.d1231.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="55-62" type="protein" text="insulin"/>
            <pair e1="DS.d1231.s0.e0" e2="DS.d1231.s0.e1" id="DS.d1231.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1231.s1" origId="18801899-466" text="In addition, adenosine monophosphate-activated protein kinase levels were high during fasting and low during HF diet.">
            <entity id="DS.d1231.s1.e0" origId="6083" charOffset="13-36" type="compound" text="adenosine monophosphate"/>
            <entity id="DS.d1231.s1.e1" origId="P00513,P25848" charOffset="47-61" type="protein" text="protein kinase"/>
            <pair e1="DS.d1231.s1.e0" e2="DS.d1231.s1.e1" id="DS.d1231.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1232" origId="18801901">
        <sentence id="DS.d1232.s0" origId="18801901-901" text="This action of IGF-I was abolished by SB 212090 but not by wortmannin.">
            <entity id="DS.d1232.s0.e0" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="15-20" type="protein" text="IGF-I"/>
            <entity id="DS.d1232.s0.e1" origId="312145" charOffset="59-69" type="compound" text="wortmannin"/>
            <pair e1="DS.d1232.s0.e1" e2="DS.d1232.s0.e0" id="DS.d1232.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1233" origId="18801905">
        <sentence id="DS.d1233.s0" origId="18801905-473" text="After 7 d central leptin treatment, the total content of ceramides was analyzed by quantitative shotgun lipidomics mass spectrometry.">
            <entity id="DS.d1233.s0.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="18-24" type="protein" text="leptin"/>
            <entity id="DS.d1233.s0.e1" origId="5283565" charOffset="57-66" type="compound" text="ceramides"/>
            <pair e1="DS.d1233.s0.e1" e2="DS.d1233.s0.e0" id="DS.d1233.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1234" origId="18801908">
        <sentence id="DS.d1234.s0" origId="18801908-476" text="Previously we have shown that rosiglitazone has antiinflammatory actions not explicable by activation of PPARgamma,but possibly by the glucocorticoid receptor (GR).">
            <entity id="DS.d1234.s0.e0" origId="77999" charOffset="30-43" type="compound" text="rosiglitazone"/>
            <entity id="DS.d1234.s0.e1" origId="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4" charOffset="105-114" type="protein" text="PPARgamma"/>
            <entity id="DS.d1234.s0.e2" origId="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3" charOffset="135-158" type="protein" text="glucocorticoid receptor"/>
            <pair e1="DS.d1234.s0.e0" e2="DS.d1234.s0.e1" id="DS.d1234.s0.i0" interaction="False"/>
            <pair e1="DS.d1234.s0.e0" e2="DS.d1234.s0.e2" id="DS.d1234.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1234.s1" origId="18801908-477" text="Rosiglitazone drives luciferase expression from a simple glucocorticoid-response element containing reporter gene in a GR-dependent manner (EC50 4 microm), with a similar amplitude response to the partial GR agonist RU486.">
            <entity id="DS.d1234.s1.e0" origId="77999" charOffset="0-13" type="compound" text="Rosiglitazone"/>
            <entity id="DS.d1234.s1.e1" origId="P08659,P13129,Q01158,Q26304,Q27757" charOffset="21-31" type="protein" text="luciferase"/>
            <pair e1="DS.d1234.s1.e0" e2="DS.d1234.s1.e1" id="DS.d1234.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1235" origId="18801909">
        <sentence id="DS.d1235.s0" origId="18801909-478" text="To begin to understand the mechanisms for the development of acute insulin resistance, serine phosphorylation of insulin receptor substrate (IRS)-1 and c-Jun N-terminal kinase phosphorylation/activation was investigated.">
            <entity id="DS.d1235.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="67-74" type="protein" text="insulin"/>
            <entity id="DS.d1235.s0.e1" origId="5951" charOffset="87-93" type="compound" text="serine"/>
            <entity id="DS.d1235.s0.e3" origId="P41252,Q8BU30,Q9XTN2" charOffset="141-144" type="protein" text="IRS"/>
            <entity id="DS.d1235.s0.e4" origId="P05627,P17325,P18289" charOffset="154-157" type="protein" text="Jun"/>
            <pair e1="DS.d1235.s0.e1" e2="DS.d1235.s0.e3" id="DS.d1235.s0.i0" interaction="True"/>
            <pair e1="DS.d1235.s0.e1" e2="DS.d1235.s0.e0" id="DS.d1235.s0.i1" interaction="False"/>
            <pair e1="DS.d1235.s0.e1" e2="DS.d1235.s0.e4" id="DS.d1235.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1236" origId="18802196">
        <sentence id="DS.d1236.s0" origId="18802196-558" text="Circulating oxidized LDL (oxLDL) levels are strongly correlated to LDL-cholesterol (LDL-c) and apolipoprotein-B100 (apoB100), making it difficult to disentangle their independent contributions to cardiovascular risk.">
            <entity id="DS.d1236.s0.e0" origId="304,5997,6432564,11025495" charOffset="71-82" type="compound" text="cholesterol"/>
            <entity id="DS.d1236.s0.e1" origId="P04114" charOffset="116-123" type="protein" text="apoB100"/>
            <pair e1="DS.d1236.s0.e0" e2="DS.d1236.s0.e1" id="DS.d1236.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1236.s1" origId="18802196-559" text="FMD of the brachial artery and plasma concentrations of oxLDL, LDL-cholesterol, and apoB100 were measured in 624 men and women (age range 50 to 87 years), participating in a population-based cohort study.">
            <entity id="DS.d1236.s1.e0" origId="304,5997,6432564,11025495" charOffset="67-78" type="compound" text="cholesterol"/>
            <entity id="DS.d1236.s1.e1" origId="P04114" charOffset="84-91" type="protein" text="apoB100"/>
            <pair e1="DS.d1236.s1.e0" e2="DS.d1236.s1.e1" id="DS.d1236.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1236.s2" origId="18802196-560" text="After adjustment for age, sex, glucose tolerance status, and Framingham risk score, the oxLDL/apoB100 ratio was negatively related to FMD (P = 0.017).">
            <entity id="DS.d1236.s2.e0" origId="206,5793,64689,79025" charOffset="31-38" type="compound" text="glucose"/>
            <entity id="DS.d1236.s2.e1" origId="P04114" charOffset="94-101" type="protein" text="apoB100"/>
            <pair e1="DS.d1236.s2.e0" e2="DS.d1236.s2.e1" id="DS.d1236.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1237" origId="18802325">
        <sentence id="DS.d1237.s0" origId="18802325-593" text="The fibrillin-1 isolated from the youngest group had the highest capacity to form fructosamine and AGEs under glycation in vitro.">
            <entity id="DS.d1237.s0.e0" origId="O81439" charOffset="4-15" type="protein" text="fibrillin-1"/>
            <entity id="DS.d1237.s0.e1" origId="20484" charOffset="82-94" type="compound" text="fructosamine"/>
            <pair e1="DS.d1237.s0.e1" e2="DS.d1237.s0.e0" id="DS.d1237.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1238" origId="18802724">
        <sentence id="DS.d1238.s0" origId="18802724-681" text="The patterns of nerves immunoreactive (IR) to antibodies towards serotonin (5-HT) and the invertebrate neuropeptide FMRFamide are described in relation to the musculature.">
            <entity id="DS.d1238.s0.e0" origId="5202" charOffset="65-74" type="compound" text="serotonin"/>
            <entity id="DS.d1238.s0.e1" origId="5202" charOffset="76-80" type="compound" text="5-HT"/>
            <entity id="DS.d1238.s0.e2" origId="P21259" charOffset="103-115" type="protein" text="neuropeptide"/>
            <entity id="DS.d1238.s0.e3" origId="P08020,P08021,P08022,P69145,P69146,P69147,P69148" charOffset="116-125" type="protein" text="FMRFamide"/>
            <pair e1="DS.d1238.s0.e1" e2="DS.d1238.s0.e2" id="DS.d1238.s0.i0" interaction="False"/>
            <pair e1="DS.d1238.s0.e0" e2="DS.d1238.s0.e3" id="DS.d1238.s0.i1" interaction="False"/>
            <pair e1="DS.d1238.s0.e0" e2="DS.d1238.s0.e2" id="DS.d1238.s0.i2" interaction="False"/>
            <pair e1="DS.d1238.s0.e1" e2="DS.d1238.s0.e3" id="DS.d1238.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1239" origId="18802750">
        <sentence id="DS.d1239.s0" origId="18802750-687" text="Based on these results we analyzed the expression of either M1 receptors or BDNF following PMA treatment of retinal cell cultures.">
            <entity id="DS.d1239.s0.e0" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="76-80" type="protein" text="BDNF"/>
            <entity id="DS.d1239.s0.e1" origId="27924,122634,22833501" charOffset="91-94" type="compound" text="PMA"/>
            <pair e1="DS.d1239.s0.e1" e2="DS.d1239.s0.e0" id="DS.d1239.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1240" origId="18802816">
        <sentence id="DS.d1240.s0" origId="18802816-701" text="Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha.">
            <entity id="DS.d1240.s0.e0" origId="1099" charOffset="61-70" type="compound" text="sulfonate"/>
            <entity id="DS.d1240.s0.e1" origId="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78" charOffset="87-135" type="protein" text="peroxisome proliferator-activated receptor alpha"/>
            <pair e1="DS.d1240.s0.e0" e2="DS.d1240.s0.e1" id="DS.d1240.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1241" origId="18803227">
        <sentence id="DS.d1241.s0" origId="18803227-822" text="Inhibitory activities of Cassia tora and its anthraquinone constituents on angiotensin-converting enzyme.">
            <entity id="DS.d1241.s0.e0" origId="6780" charOffset="45-58" type="compound" text="anthraquinone"/>
            <entity id="DS.d1241.s0.e1" origId="Q10751" charOffset="75-104" type="protein" text="angiotensin-converting enzyme"/>
            <pair e1="DS.d1241.s0.e0" e2="DS.d1241.s0.e1" id="DS.d1241.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1242" origId="18803284">
        <sentence id="DS.d1242.s0" origId="18803284-847" text="The results obtained from the Fluo-3 image experiments showed that VEGF pretreatment of cultured neurons at a final concentration of 50, 100, or 200 ng/ml acutely and dose dependently attenuated the Ca(2+) influx induced by application of KCl (60 mM) or glutamate (50 microM).">
            <entity id="DS.d1242.s0.e0" origId="104978" charOffset="30-36" type="compound" text="Fluo-3"/>
            <entity id="DS.d1242.s0.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="67-71" type="protein" text="VEGF"/>
            <entity id="DS.d1242.s0.e2" origId="271" charOffset="199-203" type="compound" text="Ca(2"/>
            <pair e1="DS.d1242.s0.e2" e2="DS.d1242.s0.e1" id="DS.d1242.s0.i0" interaction="True"/>
            <pair e1="DS.d1242.s0.e0" e2="DS.d1242.s0.e1" id="DS.d1242.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1243" origId="18803286">
        <sentence id="DS.d1243.s0" origId="18803286-849" text="5-Bromo-2'-deoxyuridine (BrdU) was injected into pregnant mice 3 hr after the NT3 administration to label the neural progenitor cells.">
            <entity id="DS.d1243.s0.e0" origId="6035" charOffset="0-29" type="compound" text="5-Bromo-2'-deoxyuridine (BrdU"/>
            <entity id="DS.d1243.s0.e1" origId="P59275,P80958,Q99523" charOffset="78-81" type="protein" text="NT3"/>
            <pair e1="DS.d1243.s0.e0" e2="DS.d1243.s0.e1" id="DS.d1243.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1244" origId="18803297">
        <sentence id="DS.d1244.s0" origId="18803297-852" text="A vitreous fraction showing growth-promoting activity 1000 Da, consistent with ascorbic acid.">
            <entity id="DS.d1244.s0.e0" origId="Q02011" charOffset="28-53" type="protein" text="growth-promoting activity"/>
            <entity id="DS.d1244.s0.e1" origId="54670067,54690394" charOffset="79-92" type="compound" text="ascorbic acid"/>
            <pair e1="DS.d1244.s0.e1" e2="DS.d1244.s0.e0" id="DS.d1244.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1245" origId="18803462">
        <sentence id="DS.d1245.s0" origId="18803462-1385" text="The secretion of endorphins, progesterone (P(4)), human chorionic gonadotropin, 17beta-estradiol, and gonadotropin-releasing hormone by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.">
            <entity id="DS.d1245.s0.e0" origId="5994" charOffset="29-41" type="compound" text="progesterone"/>
            <entity id="DS.d1245.s0.e1" origId="5757" charOffset="80-96" type="compound" text="17beta-estradiol"/>
            <entity id="DS.d1245.s0.e2" origId="P27429" charOffset="102-132" type="protein" text="gonadotropin-releasing hormone"/>
            <pair e1="DS.d1245.s0.e0" e2="DS.d1245.s0.e2" id="DS.d1245.s0.i0" interaction="False"/>
            <pair e1="DS.d1245.s0.e1" e2="DS.d1245.s0.e2" id="DS.d1245.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1246" origId="18803582">
        <sentence id="DS.d1246.s0" origId="18803582-1273" text="A specific digoxigenin-labelled probe, obtained by PCR amplification of a 270-bp fragment of the gene coding the LCDV major capsid protein, was used for ISH.">
            <entity id="DS.d1246.s0.e0" origId="15478" charOffset="11-22" type="compound" text="digoxigenin"/>
            <entity id="DS.d1246.s0.e1" origId="O39163,O39164,P03226,P03530,P03531,P04509,P04535,P06491,P08035,P09245,P14162,P16487,P16488,P16592,P16593,P16729,P17499,P17500,P17887,P18162,P18610,P22166,P22176,P22535,P22776,P26596,P28920,P30328,P35840,P51720,P52347,P69481,P69482,P69483,Q00705,Q00734,Q00999,Q04754,Q04755,Q05815,Q06386,Q38055,Q67473,Q6S6S9,Q91QZ8,Q9ZXI0" charOffset="118-138" type="protein" text="major capsid protein"/>
            <pair e1="DS.d1246.s0.e0" e2="DS.d1246.s0.e1" id="DS.d1246.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1247" origId="18803655">
        <sentence id="DS.d1247.s0" origId="18803655-955" text="In particular, a Cimicifuga heracleifolia extract (CHE) was reported to inhibit the formation of glutamate and the glutamate dehydrogenase activity in cultured rat islet.">
            <entity id="DS.d1247.s0.e0" origId="611,23327,33032" charOffset="97-106" type="compound" text="glutamate"/>
            <entity id="DS.d1247.s0.e1" origId="O52310,O59650,O74024,P28270,P52596,P80319,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q56304,Q9YC65" charOffset="115-138" type="protein" text="glutamate dehydrogenase"/>
            <pair e1="DS.d1247.s0.e0" e2="DS.d1247.s0.e1" id="DS.d1247.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1248" origId="18804292">
        <sentence id="DS.d1248.s0" origId="18804292-1116" text="No differences in estradiol, testosterone, or vitellogenin plasma concentrations were observed in exposed males or females compared to controls.">
            <entity id="DS.d1248.s0.e0" origId="5757" charOffset="18-27" type="compound" text="estradiol"/>
            <entity id="DS.d1248.s0.e1" origId="6013" charOffset="29-41" type="compound" text="testosterone"/>
            <entity id="DS.d1248.s0.e2" origId="P19615" charOffset="46-58" type="protein" text="vitellogenin"/>
            <pair e1="DS.d1248.s0.e1" e2="DS.d1248.s0.e2" id="DS.d1248.s0.i0" interaction="False"/>
            <pair e1="DS.d1248.s0.e0" e2="DS.d1248.s0.e2" id="DS.d1248.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1249" origId="18804314">
        <sentence id="DS.d1249.s0" origId="18804314-557" text="Macrophages located in the media differentiate into giant cells and/or produce reactive oxygen species, nitric oxide and matrix metallo-proteinases.">
            <entity id="DS.d1249.s0.e0" origId="977" charOffset="88-94" type="compound" text="oxygen"/>
            <entity id="DS.d1249.s0.e1" origId="145068" charOffset="104-116" type="compound" text="nitric oxide"/>
            <entity id="DS.d1249.s0.e2" origId="P10265,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63129,P63131,Q9Y6I0" charOffset="136-147" type="protein" text="proteinases"/>
            <pair e1="DS.d1249.s0.e1" e2="DS.d1249.s0.e2" id="DS.d1249.s0.i0" interaction="False"/>
            <pair e1="DS.d1249.s0.e0" e2="DS.d1249.s0.e2" id="DS.d1249.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1250" origId="18804365">
        <sentence id="DS.d1250.s0" origId="18804365-1156" text="Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with protein A on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-MUA) and 6-mercaptohexan-1-ol (6-MHO) as adhesive layer.">
            <entity id="DS.d1250.s0.e0" origId="P02810,P03064,P07602,P18164,P26779,Q66929,Q96631,Q992J0,Q993M1,Q9DIC5,Q9IMM4,Q9J7Z2,Q9QAZ8" charOffset="134-143" type="protein" text="protein A"/>
            <entity id="DS.d1250.s0.e1" origId="543502" charOffset="189-215" type="compound" text="11-mercaptoundecanoic acid"/>
            <entity id="DS.d1250.s0.e2" origId="108714" charOffset="220-223" type="compound" text="MUA"/>
            <entity id="DS.d1250.s0.e3" origId="560126" charOffset="229-249" type="compound" text="6-mercaptohexan-1-ol"/>
            <entity id="DS.d1250.s0.e4" origId="10062737" charOffset="253-256" type="compound" text="MHO"/>
            <pair e1="DS.d1250.s0.e1" e2="DS.d1250.s0.e0" id="DS.d1250.s0.i0" interaction="False"/>
            <pair e1="DS.d1250.s0.e2" e2="DS.d1250.s0.e0" id="DS.d1250.s0.i1" interaction="False"/>
            <pair e1="DS.d1250.s0.e4" e2="DS.d1250.s0.e0" id="DS.d1250.s0.i2" interaction="False"/>
            <pair e1="DS.d1250.s0.e3" e2="DS.d1250.s0.e0" id="DS.d1250.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1251" origId="18804521">
        <sentence id="DS.d1251.s0" origId="18804521-2419" text="Budesonide is a potent glucocorticoid with high affinity for the glucocorticoid receptor, which is now used for the treatment of inflammatory bowel diseases.">
            <entity id="DS.d1251.s0.e0" origId="2462,40000,63006,3033890,5281004,5702148,24867460" charOffset="0-10" type="compound" text="Budesonide"/>
            <entity id="DS.d1251.s0.e1" origId="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3" charOffset="65-88" type="protein" text="glucocorticoid receptor"/>
            <pair e1="DS.d1251.s0.e0" e2="DS.d1251.s0.e1" id="DS.d1251.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1252" origId="18804525">
        <sentence id="DS.d1252.s0" origId="18804525-2139" text="Studies on the antioxidant effect and interaction of diphenyl diselenide and dicholesteroyl diselenide with hepatic delta-aminolevulinic acid dehydratase and isoforms of lactate dehydrogenase.">
            <entity id="DS.d1252.s0.e0" origId="15460" charOffset="53-72" type="compound" text="diphenyl diselenide"/>
            <entity id="DS.d1252.s0.e1" origId="O26839,O28305,O33357,O42768,O67876,O84638,P05373,P06214,P0ACB2,P0ACB3,P0C1R9,P10518,P13716,P30950,P42504,P43087,P45622,P46723,P54919,P56074,P64333,P64334,P64335,P77923,P77969,P78974,Q02250,Q2FXR3,Q59295,Q59334,Q59643,Q5HFA4,Q5HNN5,Q5R971,Q60178,Q60HH9,Q6G8Q7,Q6GG37,Q750E0,Q8CNZ0,Q8KCJ0,Q9K8G2,Q9PLU4,Q9Z7G1,Q9ZMR8" charOffset="116-153" type="protein" text="delta-aminolevulinic acid dehydratase"/>
            <pair e1="DS.d1252.s0.e0" e2="DS.d1252.s0.e1" id="DS.d1252.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1252.s1" origId="18804525-2140" text="Studies on the interaction of dicholesteroyl diselenide (DCDS) and diphenyl diselenide (DPDS) with hepatic delta-aminolevulinic acid dehydratase (ALA-D) and different isoforms of lactate dehydrogenase (LDH) from different tissues were investigated.">
            <entity id="DS.d1252.s1.e0" origId="15460" charOffset="67-86" type="compound" text="diphenyl diselenide"/>
            <entity id="DS.d1252.s1.e1" origId="O26839,O28305,O33357,O42768,O67876,O84638,P05373,P06214,P0ACB2,P0ACB3,P0C1R9,P10518,P13716,P30950,P42504,P43087,P45622,P46723,P54919,P56074,P64333,P64334,P64335,P77923,P77969,P78974,Q02250,Q2FXR3,Q59295,Q59334,Q59643,Q5HFA4,Q5HNN5,Q5R971,Q60178,Q60HH9,Q6G8Q7,Q6GG37,Q750E0,Q8CNZ0,Q8KCJ0,Q9K8G2,Q9PLU4,Q9Z7G1,Q9ZMR8" charOffset="107-144" type="protein" text="delta-aminolevulinic acid dehydratase"/>
            <entity id="DS.d1252.s1.e2" origId="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289" charOffset="202-205" type="protein" text="LDH"/>
            <pair e1="DS.d1252.s1.e0" e2="DS.d1252.s1.e1" id="DS.d1252.s1.i0" interaction="False"/>
            <pair e1="DS.d1252.s1.e0" e2="DS.d1252.s1.e2" id="DS.d1252.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1253" origId="18804848">
        <sentence id="DS.d1253.s0" origId="18804848-1280" text="A single guanosine insertion/deletion (4G/5G) polymorphism in the promoter region of the PAI-1 gene, may play an important role in the regulation of PAI-1 expression.">
            <entity id="DS.d1253.s0.e0" origId="6802" charOffset="9-18" type="compound" text="guanosine"/>
            <entity id="DS.d1253.s0.e1" origId="2763225" charOffset="42-44" type="compound" text="5G"/>
            <entity id="DS.d1253.s0.e2" origId="P05121,P13909,P20961,P22777,P50449,P79335" charOffset="89-94" type="protein" text="PAI-1"/>
            <entity id="DS.d1253.s0.e3" origId="P05121,P13909,P20961,P22777,P50449,P79335" charOffset="149-154" type="protein" text="PAI-1"/>
            <pair e1="DS.d1253.s0.e0" e2="DS.d1253.s0.e2" id="DS.d1253.s0.i0" interaction="True"/>
            <pair e1="DS.d1253.s0.e1" e2="DS.d1253.s0.e2" id="DS.d1253.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1254" origId="18804908">
        <sentence id="DS.d1254.s0" origId="18804908-377" text="Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.">
            <entity id="DS.d1254.s0.e0" origId="18897,439213,441477,445621,45933887" charOffset="0-11" type="compound" text="Glucosamine"/>
            <entity id="DS.d1254.s0.e1" origId="P08587,P21980,P21981,P51176,P52181,Q01841" charOffset="49-67" type="protein" text="transglutaminase 2"/>
            <pair e1="DS.d1254.s0.e0" e2="DS.d1254.s0.e1" id="DS.d1254.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1254.s1" origId="18804908-379" text="Glucosamine also recovered the depletion of I-kappaBalpha via TGase 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.">
            <entity id="DS.d1254.s1.e0" origId="18897,439213,441477,445621,45933887" charOffset="0-11" type="compound" text="Glucosamine"/>
            <entity id="DS.d1254.s1.e1" origId="P25963,Q08353,Q63746,Q91974,Q9Z1E3" charOffset="44-57" type="protein" text="I-kappaBalpha"/>
            <entity id="DS.d1254.s1.e2" origId="P40746,P81453,Q05187,Q819L3,Q81MS1,Q8GR90,Q9K5W7" charOffset="62-67" type="protein" text="TGase"/>
            <pair e1="DS.d1254.s1.e0" e2="DS.d1254.s1.e2" id="DS.d1254.s1.i0" interaction="True"/>
            <pair e1="DS.d1254.s1.e0" e2="DS.d1254.s1.e1" id="DS.d1254.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1255" origId="18804927">
        <sentence id="DS.d1255.s0" origId="18804927-1300" text="Influence of IGF-I on buffalo (Bubalus bubalis) spermatozoa motility, membrane integrity, lipid peroxidation and fructose uptake in vitro.">
            <entity id="DS.d1255.s0.e0" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="13-18" type="protein" text="IGF-I"/>
            <entity id="DS.d1255.s0.e1" origId="5984" charOffset="113-121" type="compound" text="fructose"/>
            <pair e1="DS.d1255.s0.e1" e2="DS.d1255.s0.e0" id="DS.d1255.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1255.s1" origId="18804927-1301" text="The objective of the present experiment was to examine the influence of mean physiological concentration of insulin-like growth factor-I (IGF-I) on frozen-thawed Surti buffalo (Bubalus bubalis) spermatozoa functional parameters, i.e., motility, plasmalemma integrity, acrosomal integrity, functional membrane integrity, lipid peroxidation and fructose uptake in vitro.">
            <entity id="DS.d1255.s1.e1" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="138-143" type="protein" text="IGF-I"/>
            <entity id="DS.d1255.s1.e2" origId="5984" charOffset="343-351" type="compound" text="fructose"/>
            <pair e1="DS.d1255.s1.e2" e2="DS.d1255.s1.e1" id="DS.d1255.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1255.s2" origId="18804927-1302" text="Frozen-thawed semen samples (n=6) were washed in tris buffer and divided into two equal parts (control and IGF-I groups).">
            <entity id="DS.d1255.s2.e0" origId="6503" charOffset="49-60" type="compound" text="tris buffer"/>
            <entity id="DS.d1255.s2.e1" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="107-112" type="protein" text="IGF-I"/>
            <pair e1="DS.d1255.s2.e0" e2="DS.d1255.s2.e1" id="DS.d1255.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1255.s3" origId="18804927-1303" text="Fructose utilization was significantly higher in IGF-I 0.01) of incubation.">
            <entity id="DS.d1255.s3.e0" origId="5984" charOffset="0-8" type="compound" text="Fructose"/>
            <entity id="DS.d1255.s3.e1" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="49-54" type="protein" text="IGF-I"/>
            <pair e1="DS.d1255.s3.e0" e2="DS.d1255.s3.e1" id="DS.d1255.s3.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1256" origId="18804950">
        <sentence id="DS.d1256.s0" origId="18804950-1309" text="This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the COL3A1 gene, c.2545G--&amp;gt;C, leading to a codon encoding for arginine instead of glycine (p.Gly849Arg).">
            <entity id="DS.d1256.s0.e0" origId="P02461,P04258,P12105" charOffset="94-100" type="protein" text="COL3A1"/>
            <entity id="DS.d1256.s0.e1" origId="232,4367,6322" charOffset="155-163" type="compound" text="arginine"/>
            <entity id="DS.d1256.s0.e2" origId="750" charOffset="175-182" type="compound" text="glycine"/>
            <pair e1="DS.d1256.s0.e1" e2="DS.d1256.s0.e0" id="DS.d1256.s0.i0" interaction="True"/>
            <pair e1="DS.d1256.s0.e2" e2="DS.d1256.s0.e0" id="DS.d1256.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1257" origId="18804984">
        <sentence id="DS.d1257.s0" origId="18804984-1311" text="Animal studies show that ecosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are effective for the prevention and treatment of insulin resistance (IR).">
            <entity id="DS.d1257.s0.e0" origId="445580" charOffset="56-76" type="compound" text="docosahexaenoic acid"/>
            <entity id="DS.d1257.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="133-140" type="protein" text="insulin"/>
            <pair e1="DS.d1257.s0.e0" e2="DS.d1257.s0.e1" id="DS.d1257.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1258" origId="18805402">
        <sentence id="DS.d1258.s0" origId="18805402-1407" text="Signaling involving cAMP is organized in subcellular compartments and a distinct cAMP compartment might be required for proper AHR mobility and function.">
            <entity id="DS.d1258.s0.e0" origId="6076" charOffset="20-24" type="compound" text="cAMP"/>
            <entity id="DS.d1258.s0.e1" origId="6076" charOffset="81-85" type="compound" text="cAMP"/>
            <entity id="DS.d1258.s0.e2" origId="O02747,P35869,Q95LD9" charOffset="127-130" type="protein" text="AHR"/>
            <pair e1="DS.d1258.s0.e0" e2="DS.d1258.s0.e2" id="DS.d1258.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1259" origId="18805433">
        <sentence id="DS.d1259.s0" origId="18805433-1411" text="We also found an inhibitory effect of lenalidomide on the associations between cadherin 5, beta-catenin and CD31, adherens junction proteins whose interaction is critical for endothelial cell cord formation.">
            <entity id="DS.d1259.s0.e0" origId="216326" charOffset="38-50" type="compound" text="lenalidomide"/>
            <entity id="DS.d1259.s0.e1" origId="P26233,P35222,P35223,P35224,Q02248,Q9WU82" charOffset="91-103" type="protein" text="beta-catenin"/>
            <pair e1="DS.d1259.s0.e0" e2="DS.d1259.s0.e1" id="DS.d1259.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1259.s1" origId="18805433-1412" text="We also found a strong inhibitory effect of lenalidomide on hypoxia-induced endothelial cell formation of cords and HIF-1 alpha expression, the main mediator of hypoxia-mediated effects and a key driver of angiogenesis and metastasis.">
            <entity id="DS.d1259.s1.e0" origId="216326" charOffset="44-56" type="compound" text="lenalidomide"/>
            <entity id="DS.d1259.s1.e1" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="116-127" type="protein" text="HIF-1 alpha"/>
            <pair e1="DS.d1259.s1.e0" e2="DS.d1259.s1.e1" id="DS.d1259.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1260" origId="18805442">
        <sentence id="DS.d1260.s0" origId="18805442-1416" text="Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.">
            <entity id="DS.d1260.s0.e0" origId="P08909,P28335,P34968,Q5IS66,Q60F97" charOffset="24-30" type="protein" text="5-HT2C"/>
            <entity id="DS.d1260.s0.e1" origId="942,89594,157672" charOffset="68-76" type="compound" text="nicotine"/>
            <pair e1="DS.d1260.s0.e1" e2="DS.d1260.s0.e0" id="DS.d1260.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1261" origId="18805484">
        <sentence id="DS.d1261.s0" origId="18805484-1419" text="Control loperamide-loaded HSA nanoparticles with IgG2a antibodies yielded only marginal effects.">
            <entity id="DS.d1261.s0.e0" origId="3955" charOffset="8-18" type="compound" text="loperamide"/>
            <entity id="DS.d1261.s0.e1" origId="P24807,Q07490" charOffset="26-29" type="protein" text="HSA"/>
            <pair e1="DS.d1261.s0.e0" e2="DS.d1261.s0.e1" id="DS.d1261.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1262" origId="18805505">
        <sentence id="DS.d1262.s0" origId="18805505-1370" text="Engineered selenium-containing glutaredoxin displays strong glutathione peroxidase activity rivaling natural enzyme.">
            <entity id="DS.d1262.s0.e0" origId="6326970" charOffset="11-19" type="compound" text="selenium"/>
            <entity id="DS.d1262.s0.e1" origId="O81187,P00276,P45242,P55142,P55143,Q9HU55,Q9JVU9,Q9JY15,Q9KSW0,Q9ZDW1,Q9ZR41" charOffset="31-43" type="protein" text="glutaredoxin"/>
            <entity id="DS.d1262.s0.e2" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="60-82" type="protein" text="glutathione peroxidase"/>
            <pair e1="DS.d1262.s0.e0" e2="DS.d1262.s0.e2" id="DS.d1262.s0.i0" interaction="False"/>
            <pair e1="DS.d1262.s0.e0" e2="DS.d1262.s0.e1" id="DS.d1262.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1262.s1" origId="18805505-1371" text="The use of a common thioredoxin fold with a high affinity for glutathione in glutaredoxin (Grx) and glutathione peroxidase (GPx) suggests a possibility of engineering Grx into GPx and vice versa.">
            <entity id="DS.d1262.s1.e0" origId="124886" charOffset="62-73" type="compound" text="glutathione"/>
            <entity id="DS.d1262.s1.e1" origId="O81187,P00276,P45242,P55142,P55143,Q9HU55,Q9JVU9,Q9JY15,Q9KSW0,Q9ZDW1,Q9ZR41" charOffset="77-89" type="protein" text="glutaredoxin"/>
            <entity id="DS.d1262.s1.e2" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="100-122" type="protein" text="glutathione peroxidase"/>
            <pair e1="DS.d1262.s1.e0" e2="DS.d1262.s1.e2" id="DS.d1262.s1.i0" interaction="True"/>
            <pair e1="DS.d1262.s1.e0" e2="DS.d1262.s1.e1" id="DS.d1262.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1263" origId="18805508">
        <sentence id="DS.d1263.s0" origId="18805508-1434" text="The potassium channels blockade by either tetraethylammonium or charybdotoxin also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas apamine only slightly reduced it.">
            <entity id="DS.d1263.s0.e0" origId="5413" charOffset="42-60" type="compound" text="tetraethylammonium"/>
            <entity id="DS.d1263.s0.e1" origId="P13487" charOffset="64-77" type="protein" text="charybdotoxin"/>
            <entity id="DS.d1263.s0.e2" origId="16129677" charOffset="158-165" type="compound" text="apamine"/>
            <pair e1="DS.d1263.s0.e0" e2="DS.d1263.s0.e1" id="DS.d1263.s0.i0" interaction="False"/>
            <pair e1="DS.d1263.s0.e2" e2="DS.d1263.s0.e1" id="DS.d1263.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1264" origId="18805632">
        <sentence id="DS.d1264.s0" origId="18805632-1457" text="ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways p38, ERK and JNK (their activation was abrogated by the antioxidant N-acetylcysteine).">
            <entity id="DS.d1264.s0.e0" origId="O42781,P27638,Q00859" charOffset="83-87" type="protein" text="MAPK"/>
            <entity id="DS.d1264.s0.e1" origId="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7" charOffset="97-100" type="protein" text="p38"/>
            <entity id="DS.d1264.s0.e2" origId="P29323" charOffset="102-105" type="protein" text="ERK"/>
            <entity id="DS.d1264.s0.e3" origId="P92208,Q966Y3" charOffset="110-113" type="protein" text="JNK"/>
            <entity id="DS.d1264.s0.e4" origId="12035" charOffset="165-181" type="compound" text="N-acetylcysteine"/>
            <pair e1="DS.d1264.s0.e4" e2="DS.d1264.s0.e3" id="DS.d1264.s0.i0" interaction="True"/>
            <pair e1="DS.d1264.s0.e4" e2="DS.d1264.s0.e2" id="DS.d1264.s0.i1" interaction="True"/>
            <pair e1="DS.d1264.s0.e4" e2="DS.d1264.s0.e0" id="DS.d1264.s0.i2" interaction="True"/>
            <pair e1="DS.d1264.s0.e4" e2="DS.d1264.s0.e1" id="DS.d1264.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1265" origId="18805639">
        <sentence id="DS.d1265.s0" origId="18805639-1461" text="Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (AChE) using only their empirical formulas (elemental composition) and molecular weights.">
            <entity id="DS.d1265.s0.e0" origId="223" charOffset="173-181" type="compound" text="ammonium"/>
            <entity id="DS.d1265.s0.e1" origId="795" charOffset="183-194" type="compound" text="imidazolium"/>
            <entity id="DS.d1265.s0.e2" origId="8083" charOffset="196-208" type="compound" text="morpholinium"/>
            <entity id="DS.d1265.s0.e3" origId="5460504" charOffset="210-221" type="compound" text="phosphonium"/>
            <entity id="DS.d1265.s0.e4" origId="8082" charOffset="223-235" type="compound" text="piperidinium"/>
            <entity id="DS.d1265.s0.e5" origId="1049" charOffset="237-247" type="compound" text="pyridinium"/>
            <entity id="DS.d1265.s0.e6" origId="31268" charOffset="249-262" type="compound" text="pyrrolidinium"/>
            <entity id="DS.d1265.s0.e7" origId="7047" charOffset="267-278" type="compound" text="quinolinium"/>
            <entity id="DS.d1265.s0.e8" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="341-361" type="protein" text="Acetylcholinesterase"/>
            <entity id="DS.d1265.s0.e9" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="363-367" type="protein" text="AChE"/>
            <pair e1="DS.d1265.s0.e5" e2="DS.d1265.s0.e9" id="DS.d1265.s0.i0" interaction="False"/>
            <pair e1="DS.d1265.s0.e0" e2="DS.d1265.s0.e9" id="DS.d1265.s0.i1" interaction="False"/>
            <pair e1="DS.d1265.s0.e6" e2="DS.d1265.s0.e8" id="DS.d1265.s0.i2" interaction="False"/>
            <pair e1="DS.d1265.s0.e3" e2="DS.d1265.s0.e8" id="DS.d1265.s0.i3" interaction="False"/>
            <pair e1="DS.d1265.s0.e3" e2="DS.d1265.s0.e9" id="DS.d1265.s0.i4" interaction="False"/>
            <pair e1="DS.d1265.s0.e4" e2="DS.d1265.s0.e9" id="DS.d1265.s0.i5" interaction="False"/>
            <pair e1="DS.d1265.s0.e4" e2="DS.d1265.s0.e8" id="DS.d1265.s0.i6" interaction="False"/>
            <pair e1="DS.d1265.s0.e1" e2="DS.d1265.s0.e8" id="DS.d1265.s0.i7" interaction="False"/>
            <pair e1="DS.d1265.s0.e7" e2="DS.d1265.s0.e8" id="DS.d1265.s0.i8" interaction="False"/>
            <pair e1="DS.d1265.s0.e0" e2="DS.d1265.s0.e8" id="DS.d1265.s0.i9" interaction="False"/>
            <pair e1="DS.d1265.s0.e2" e2="DS.d1265.s0.e9" id="DS.d1265.s0.i10" interaction="False"/>
            <pair e1="DS.d1265.s0.e6" e2="DS.d1265.s0.e9" id="DS.d1265.s0.i11" interaction="False"/>
            <pair e1="DS.d1265.s0.e2" e2="DS.d1265.s0.e8" id="DS.d1265.s0.i12" interaction="False"/>
            <pair e1="DS.d1265.s0.e5" e2="DS.d1265.s0.e8" id="DS.d1265.s0.i13" interaction="False"/>
            <pair e1="DS.d1265.s0.e7" e2="DS.d1265.s0.e9" id="DS.d1265.s0.i14" interaction="False"/>
            <pair e1="DS.d1265.s0.e1" e2="DS.d1265.s0.e9" id="DS.d1265.s0.i15" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1266" origId="18805685">
        <sentence id="DS.d1266.s0" origId="18805685-1489" text="The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, malondialdehyde (MDA) production, inflammatory cell infiltration, interleukin-6 (IL-6) expression and caspase-3 activity.">
            <entity id="DS.d1266.s0.e0" origId="10964" charOffset="130-145" type="compound" text="malondialdehyde"/>
            <entity id="DS.d1266.s0.e1" origId="P41693" charOffset="196-209" type="protein" text="interleukin-6"/>
            <entity id="DS.d1266.s0.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="211-215" type="protein" text="IL-6"/>
            <pair e1="DS.d1266.s0.e0" e2="DS.d1266.s0.e2" id="DS.d1266.s0.i0" interaction="False"/>
            <pair e1="DS.d1266.s0.e0" e2="DS.d1266.s0.e1" id="DS.d1266.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1266.s1" origId="18805685-1490" text="Elevation of antioxidative capacity, as evidenced by decreased MDA level and increased superoxide dismutase activity and glutathione level, was detected only in the chronic daily-administration group.">
            <entity id="DS.d1266.s1.e0" origId="O50258" charOffset="87-107" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1266.s1.e1" origId="124886" charOffset="121-132" type="compound" text="glutathione"/>
            <pair e1="DS.d1266.s1.e1" e2="DS.d1266.s1.e0" id="DS.d1266.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1267" origId="18806218">
        <sentence id="DS.d1267.s0" origId="18806218-232" text="Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol.">
            <entity id="DS.d1267.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="0-7" type="protein" text="Insulin"/>
            <entity id="DS.d1267.s0.e1" origId="304,5997,6432564,11025495" charOffset="71-82" type="compound" text="cholesterol"/>
            <pair e1="DS.d1267.s0.e1" e2="DS.d1267.s0.e0" id="DS.d1267.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1268" origId="18806296">
        <sentence id="DS.d1268.s0" origId="18806296-1733" text="Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.">
            <entity id="DS.d1268.s0.e0" origId="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4" charOffset="23-71" type="protein" text="peroxisome proliferator-activated receptor gamma"/>
            <entity id="DS.d1268.s0.e1" origId="977" charOffset="101-107" type="compound" text="oxygen"/>
            <pair e1="DS.d1268.s0.e1" e2="DS.d1268.s0.e0" id="DS.d1268.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1269" origId="18806930">
        <sentence id="DS.d1269.s0" origId="18806930-1949" text="TKTL 1 was highest expressed in cell lines derived from more invasive tumors but the expression level was not strongly correlated to proliferation rate, to GLUT-1 expression or to the response to oxythiamine.">
            <entity id="DS.d1269.s0.e0" origId="P79365" charOffset="156-162" type="protein" text="GLUT-1"/>
            <entity id="DS.d1269.s0.e1" origId="8682" charOffset="196-207" type="compound" text="oxythiamine"/>
            <pair e1="DS.d1269.s0.e1" e2="DS.d1269.s0.e0" id="DS.d1269.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1270" origId="18806932">
        <sentence id="DS.d1270.s0" origId="18806932-1906" text="Magnesium (Mg), interleukin 8 (IL-8), and malondialdehyde levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.">
            <entity id="DS.d1270.s0.e0" origId="5462224" charOffset="0-9" type="compound" text="Magnesium"/>
            <entity id="DS.d1270.s0.e1" origId="P10145" charOffset="16-29" type="protein" text="interleukin 8"/>
            <entity id="DS.d1270.s0.e2" origId="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5" charOffset="31-35" type="protein" text="IL-8"/>
            <entity id="DS.d1270.s0.e3" origId="10964" charOffset="42-57" type="compound" text="malondialdehyde"/>
            <pair e1="DS.d1270.s0.e3" e2="DS.d1270.s0.e1" id="DS.d1270.s0.i0" interaction="False"/>
            <pair e1="DS.d1270.s0.e3" e2="DS.d1270.s0.e2" id="DS.d1270.s0.i1" interaction="False"/>
            <pair e1="DS.d1270.s0.e0" e2="DS.d1270.s0.e1" id="DS.d1270.s0.i2" interaction="False"/>
            <pair e1="DS.d1270.s0.e0" e2="DS.d1270.s0.e2" id="DS.d1270.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1271" origId="18807018">
        <sentence id="DS.d1271.s0" origId="18807018-1954" text="Study of multiple binding constants of dexamethasone with human serum albumin by capillary electrophoresis-frontal analysis and multivariate regression.">
            <entity id="DS.d1271.s0.e0" origId="5743" charOffset="39-52" type="compound" text="dexamethasone"/>
            <entity id="DS.d1271.s0.e1" origId="P21847,P83517" charOffset="64-77" type="protein" text="serum albumin"/>
            <pair e1="DS.d1271.s0.e0" e2="DS.d1271.s0.e1" id="DS.d1271.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1271.s1" origId="18807018-1955" text="In this paper, to evaluate the pharmacokinetic and pharmacodynamic properties of dexamethasone (DXM), the interaction between DXM and HSA was studied by capillary electrophoresis-frontal analysis (CE-FA).">
            <entity id="DS.d1271.s1.e0" origId="5743" charOffset="81-94" type="compound" text="dexamethasone"/>
            <entity id="DS.d1271.s1.e1" origId="P24807,Q07490" charOffset="134-137" type="protein" text="HSA"/>
            <pair e1="DS.d1271.s1.e0" e2="DS.d1271.s1.e1" id="DS.d1271.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1272" origId="18807050">
        <sentence id="DS.d1272.s0" origId="18807050-1745" text="Arthropod hemocyanins transport and store oxygen and are composed of six subunits, or multiples thereof depending on the species.">
            <entity id="DS.d1272.s0.e0" origId="P80888" charOffset="10-21" type="protein" text="hemocyanins"/>
            <entity id="DS.d1272.s0.e1" origId="977" charOffset="42-48" type="compound" text="oxygen"/>
            <pair e1="DS.d1272.s0.e1" e2="DS.d1272.s0.e0" id="DS.d1272.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1272.s1" origId="18807050-1746" text="The protein is insensitive to lactate, but affected by urate which markedly increased hemocyanin-oxygen affinity, acting as the physiological major positive effector.">
            <entity id="DS.d1272.s1.e0" origId="P80888" charOffset="86-96" type="protein" text="hemocyanin"/>
            <entity id="DS.d1272.s1.e1" origId="977" charOffset="97-103" type="compound" text="oxygen"/>
            <pair e1="DS.d1272.s1.e1" e2="DS.d1272.s1.e0" id="DS.d1272.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1273" origId="18807177">
        <sentence id="DS.d1273.s0" origId="18807177-2028" text="The estrogen-induced increase in CXCR4 protein in MCF-7-HER2 cells was abrogated by the antiestrogen ICI 182780 and by gefitinib (Iressa ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.">
            <entity id="DS.d1273.s0.e0" origId="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8" charOffset="33-38" type="protein" text="CXCR4"/>
            <entity id="DS.d1273.s0.e1" origId="104741" charOffset="101-111" type="compound" text="ICI 182780"/>
            <entity id="DS.d1273.s0.e2" origId="123631" charOffset="119-128" type="compound" text="gefitinib"/>
            <entity id="DS.d1273.s0.e3" origId="123631" charOffset="130-136" type="compound" text="Iressa"/>
            <pair e1="DS.d1273.s0.e3" e2="DS.d1273.s0.e0" id="DS.d1273.s0.i0" interaction="True"/>
            <pair e1="DS.d1273.s0.e2" e2="DS.d1273.s0.e0" id="DS.d1273.s0.i1" interaction="True"/>
            <pair e1="DS.d1273.s0.e1" e2="DS.d1273.s0.e0" id="DS.d1273.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1274" origId="18807200">
        <sentence id="DS.d1274.s0" origId="18807200-2046" text="Enzymatic activities of an H(2)O(2) independent oxidase along with laccase and an azoreductase suggest their prominent role during the decolorization of reactive yellow 84A.">
            <entity id="DS.d1274.s0.e0" origId="Q12570" charOffset="67-74" type="protein" text="laccase"/>
            <entity id="DS.d1274.s0.e1" origId="P05982,P15559,Q5RD31,Q64669,Q8CHK7" charOffset="82-94" type="protein" text="azoreductase"/>
            <entity id="DS.d1274.s0.e2" origId="24180624" charOffset="169-172" type="compound" text="84A"/>
            <pair e1="DS.d1274.s0.e2" e2="DS.d1274.s0.e0" id="DS.d1274.s0.i0" interaction="True"/>
            <pair e1="DS.d1274.s0.e2" e2="DS.d1274.s0.e1" id="DS.d1274.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1274.s1" origId="18807200-2047" text="Azoreductase activity was prominent in presence of cofactors NADH and NADP in mineral salt medium.">
            <entity id="DS.d1274.s1.e0" origId="P05982,P15559,Q5RD31,Q64669,Q8CHK7" charOffset="0-12" type="protein" text="Azoreductase"/>
            <entity id="DS.d1274.s1.e1" origId="439153" charOffset="61-65" type="compound" text="NADH"/>
            <entity id="DS.d1274.s1.e2" origId="5886" charOffset="70-74" type="compound" text="NADP"/>
            <pair e1="DS.d1274.s1.e1" e2="DS.d1274.s1.e0" id="DS.d1274.s1.i0" interaction="True"/>
            <pair e1="DS.d1274.s1.e2" e2="DS.d1274.s1.e0" id="DS.d1274.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1275" origId="18807214">
        <sentence id="DS.d1275.s0" origId="18807214-2051" text="The increase of oxygen availability caused the induction of the antioxidant enzyme superoxide dismutase, which indicates that the defensive mechanisms of the cells against oxidative stress were effective and cells could cope with increased pressure.">
            <entity id="DS.d1275.s0.e0" origId="977" charOffset="16-22" type="compound" text="oxygen"/>
            <entity id="DS.d1275.s0.e1" origId="O50258" charOffset="83-103" type="protein" text="superoxide dismutase"/>
            <pair e1="DS.d1275.s0.e0" e2="DS.d1275.s0.e1" id="DS.d1275.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1276" origId="18808217">
        <sentence id="DS.d1276.s0" origId="18808217-2356" text="Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (HRP), hydrogen peroxide, and a phenolic cosubstrate (4-methoxyphenol).">
            <entity id="DS.d1276.s0.e0" origId="P15984,P16147,P84714" charOffset="187-197" type="protein" text="peroxidase"/>
            <entity id="DS.d1276.s0.e1" origId="Q08168" charOffset="199-202" type="protein" text="HRP"/>
            <entity id="DS.d1276.s0.e2" origId="784" charOffset="205-222" type="compound" text="hydrogen peroxide"/>
            <entity id="DS.d1276.s0.e3" origId="9015" charOffset="252-267" type="compound" text="4-methoxyphenol"/>
            <pair e1="DS.d1276.s0.e3" e2="DS.d1276.s0.e1" id="DS.d1276.s0.i0" interaction="True"/>
            <pair e1="DS.d1276.s0.e3" e2="DS.d1276.s0.e0" id="DS.d1276.s0.i1" interaction="True"/>
            <pair e1="DS.d1276.s0.e2" e2="DS.d1276.s0.e0" id="DS.d1276.s0.i2" interaction="True"/>
            <pair e1="DS.d1276.s0.e2" e2="DS.d1276.s0.e1" id="DS.d1276.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d1276.s1" origId="18808217-2357" text="Approximately 68% depletion of the parent compound and 98% depletion of its related acute aquatic toxicity are achieved in 6 h. Because no PFOA removal is observed in the absence of cosubstrate and/or following consumption thereof, we conclude that radical intermediate species generated during reaction between HRP and 4-methoxyphenol mediate nonspecific depletion of PFOA and that these intermediates may be sufficiently reactive to sever the extremely stable C-F bonds of PFOA.">
            <entity id="DS.d1276.s1.e0" origId="Q08168" charOffset="312-315" type="protein" text="HRP"/>
            <entity id="DS.d1276.s1.e1" origId="9015" charOffset="320-335" type="compound" text="4-methoxyphenol"/>
            <pair e1="DS.d1276.s1.e1" e2="DS.d1276.s1.e0" id="DS.d1276.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1277" origId="18808365">
        <sentence id="DS.d1277.s0" origId="18808365-2406" text="In the present study, the mRNA expression and promoter CpG methylation of ERalpha isoforms (i.e.">
            <entity id="DS.d1277.s0.e0" origId="6804" charOffset="55-58" type="compound" text="CpG"/>
            <entity id="DS.d1277.s0.e1" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="74-81" type="protein" text="ERalpha"/>
            <pair e1="DS.d1277.s0.e0" e2="DS.d1277.s0.e1" id="DS.d1277.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1277.s1" origId="18808365-2407" text="The present study is the first report that demonstrates selective inactivation of ERalpha isoforms through the promoter CpG methylation pathway in leukaemias.">
            <entity id="DS.d1277.s1.e0" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="82-89" type="protein" text="ERalpha"/>
            <entity id="DS.d1277.s1.e1" origId="6804" charOffset="120-123" type="compound" text="CpG"/>
            <pair e1="DS.d1277.s1.e1" e2="DS.d1277.s1.e0" id="DS.d1277.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1278" origId="18808455">
        <sentence id="DS.d1278.s0" origId="18808455-2441" text="Type-B monogalactosyldiacylglycerol synthases are involved in phosphate starvation-induced lipid remodeling, and are crucial for low-phosphate adaptation.">
            <entity id="DS.d1278.s0.e0" origId="P02854" charOffset="0-6" type="protein" text="Type-B"/>
            <entity id="DS.d1278.s0.e1" origId="1061,167704,644102" charOffset="62-71" type="compound" text="phosphate"/>
            <entity id="DS.d1278.s0.e2" origId="1061,167704,644102" charOffset="133-142" type="compound" text="phosphate"/>
            <pair e1="DS.d1278.s0.e1" e2="DS.d1278.s0.e0" id="DS.d1278.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1279" origId="18809244">
        <sentence id="DS.d1279.s0" origId="18809244-141" text="This study was performed to evaluate the effects of imatinib on breast cancer cell lines with respect to the activity of PDGFR beta and Akt : a downstream modulator of cell growth and survival.">
            <entity id="DS.d1279.s0.e0" origId="5291" charOffset="52-60" type="compound" text="imatinib"/>
            <entity id="DS.d1279.s0.e1" origId="P05622,P09619,P79749,Q05030,Q6QNF3" charOffset="121-131" type="protein" text="PDGFR beta"/>
            <entity id="DS.d1279.s0.e2" origId="P31750,Q8INB9" charOffset="136-139" type="protein" text="Akt"/>
            <pair e1="DS.d1279.s0.e0" e2="DS.d1279.s0.e1" id="DS.d1279.s0.i0" interaction="True"/>
            <pair e1="DS.d1279.s0.e0" e2="DS.d1279.s0.e2" id="DS.d1279.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1280" origId="18809262">
        <sentence id="DS.d1280.s0" origId="18809262-150" text="The mechanisms may include the recently revealed anti-inflammatory effects of insulin as well as its conventional glucose and free fatty acids lowering effects, and possibly may also include changes in body fat distribution and plasma adiponectin level.">
            <entity id="DS.d1280.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="78-85" type="protein" text="insulin"/>
            <entity id="DS.d1280.s0.e1" origId="206,5793,64689,79025" charOffset="114-121" type="compound" text="glucose"/>
            <pair e1="DS.d1280.s0.e1" e2="DS.d1280.s0.e0" id="DS.d1280.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1281" origId="18809347">
        <sentence id="DS.d1281.s0" origId="18809347-188" text="Recently, we reported stimulatory effect of ghrelin alone and in combination with growth hormone (GH) on estradiol secretion, aromatase activity in parallel with inhibitory effect on cell apoptosis.">
            <entity id="DS.d1281.s0.e0" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="44-51" type="protein" text="ghrelin"/>
            <entity id="DS.d1281.s0.e1" origId="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8" charOffset="82-96" type="protein" text="growth hormone"/>
            <entity id="DS.d1281.s0.e2" origId="5757" charOffset="105-114" type="compound" text="estradiol"/>
            <entity id="DS.d1281.s0.e3" origId="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28" charOffset="126-135" type="protein" text="aromatase"/>
            <pair e1="DS.d1281.s0.e2" e2="DS.d1281.s0.e3" id="DS.d1281.s0.i0" interaction="False"/>
            <pair e1="DS.d1281.s0.e2" e2="DS.d1281.s0.e1" id="DS.d1281.s0.i1" interaction="True"/>
            <pair e1="DS.d1281.s0.e2" e2="DS.d1281.s0.e0" id="DS.d1281.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d1281.s1" origId="18809347-189" text="In cultures treated together ghrelin and (D-Lys-3)-GHRP-6, estradiol secretion, aromatase activity and cell proliferation returned to control levels.">
            <entity id="DS.d1281.s1.e0" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="29-36" type="protein" text="ghrelin"/>
            <entity id="DS.d1281.s1.e1" origId="5757" charOffset="59-68" type="compound" text="estradiol"/>
            <entity id="DS.d1281.s1.e2" origId="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28" charOffset="80-89" type="protein" text="aromatase"/>
            <pair e1="DS.d1281.s1.e1" e2="DS.d1281.s1.e2" id="DS.d1281.s1.i0" interaction="False"/>
            <pair e1="DS.d1281.s1.e1" e2="DS.d1281.s1.e0" id="DS.d1281.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1282" origId="18809364">
        <sentence id="DS.d1282.s0" origId="18809364-192" text="Expression levels of the functional activities (albumin secretion and ammonia removal) and the cell-cell adhesion molecules (cadherin and connexin-32) were higher in the hepatocytes that formed spheroids compared to those which assumed a monolayer configuration, and these levels were maintained for at least 10 days.">
            <entity id="DS.d1282.s0.e0" origId="222" charOffset="70-77" type="compound" text="ammonia"/>
            <entity id="DS.d1282.s0.e1" origId="O18968,P08033,P08034,P28230,Q60HF7,Q6WGK6" charOffset="138-149" type="protein" text="connexin-32"/>
            <pair e1="DS.d1282.s0.e0" e2="DS.d1282.s0.e1" id="DS.d1282.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1283" origId="18809367">
        <sentence id="DS.d1283.s0" origId="18809367-193" text="Nevertheless, certain clinical cases manifest themselves with the onset of acute renal failure bought upon by the administration of blockers of the rennin-angiotensin-aldosterone system, or by some other causes responsible for a sudden drop in renal plasma flow (e.g., thrombosis of the renal artery).">
            <entity id="DS.d1283.s0.e0" origId="Q10757" charOffset="155-166" type="protein" text="angiotensin"/>
            <entity id="DS.d1283.s0.e1" origId="5839" charOffset="167-178" type="compound" text="aldosterone"/>
            <pair e1="DS.d1283.s0.e1" e2="DS.d1283.s0.e0" id="DS.d1283.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1284" origId="18809432">
        <sentence id="DS.d1284.s0" origId="18809432-1105" text="The function of rhamnose-binding lectin in innate immunity by restricted binding to Gb3.">
            <entity id="DS.d1284.s0.e0" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="33-39" type="protein" text="lectin"/>
            <entity id="DS.d1284.s0.e1" origId="11963508" charOffset="84-87" type="compound" text="Gb3"/>
            <pair e1="DS.d1284.s0.e1" e2="DS.d1284.s0.e0" id="DS.d1284.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1284.s1" origId="18809432-1106" text="This is the first finding that Gb3 plays a role in innate immunity by cooperating with natural ligands, RBLs.">
            <entity id="DS.d1284.s1.e0" origId="11963508" charOffset="31-34" type="compound" text="Gb3"/>
            <entity id="DS.d1284.s1.e1" origId="Q9PVW8" charOffset="104-108" type="protein" text="RBLs"/>
            <pair e1="DS.d1284.s1.e0" e2="DS.d1284.s1.e1" id="DS.d1284.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1285" origId="18809481">
        <sentence id="DS.d1285.s0" origId="18809481-220" text="Effect of polyols on the solubility of bovine serum albumin (BSA) in the presence of polyethylene glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.">
            <entity id="DS.d1285.s0.e0" origId="P21847,P83517" charOffset="46-59" type="protein" text="serum albumin"/>
            <entity id="DS.d1285.s0.e1" origId="P02769" charOffset="61-64" type="protein" text="BSA"/>
            <entity id="DS.d1285.s0.e2" origId="6325" charOffset="85-97" type="compound" text="polyethylene"/>
            <pair e1="DS.d1285.s0.e2" e2="DS.d1285.s0.e1" id="DS.d1285.s0.i0" interaction="False"/>
            <pair e1="DS.d1285.s0.e2" e2="DS.d1285.s0.e0" id="DS.d1285.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1286" origId="18810331">
        <sentence id="DS.d1286.s0" origId="18810331-544" text="After 2 and 6 weeks of treatment, parotid gland was removed and total protein and sialic acid (free and total) concentration and amylase and peroxidase activities were determined.">
            <entity id="DS.d1286.s0.e0" origId="906,444885,445063" charOffset="82-93" type="compound" text="sialic acid"/>
            <entity id="DS.d1286.s0.e1" origId="P15984,P16147,P84714" charOffset="141-151" type="protein" text="peroxidase"/>
            <pair e1="DS.d1286.s0.e0" e2="DS.d1286.s0.e1" id="DS.d1286.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1286.s1" origId="18810331-545" text="At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and peroxidase (160%) activities, free (150%) and total (170%) sialic acid concentration.">
            <entity id="DS.d1286.s1.e0" origId="P15984,P16147,P84714" charOffset="152-162" type="protein" text="peroxidase"/>
            <entity id="DS.d1286.s1.e1" origId="906,444885,445063" charOffset="211-222" type="compound" text="sialic acid"/>
            <pair e1="DS.d1286.s1.e1" e2="DS.d1286.s1.e0" id="DS.d1286.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1287" origId="18810466">
        <sentence id="DS.d1287.s0" origId="18810466-577" text="To investigate the change pattern of substance P (SP) and nitric oxide (NO) in the portal vein during the recto-anal inhibitory reflex (RAIR), and its physiological significance; the influence of external splanchnic nerve (ESN) of rectum and anus to the RAIR.">
            <entity id="DS.d1287.s0.e0" origId="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541" charOffset="37-48" type="protein" text="substance P"/>
            <entity id="DS.d1287.s0.e1" origId="145068" charOffset="58-70" type="compound" text="nitric oxide"/>
            <pair e1="DS.d1287.s0.e1" e2="DS.d1287.s0.e0" id="DS.d1287.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1288" origId="18810510">
        <sentence id="DS.d1288.s0" origId="18810510-591" text="Considering the common metabolic pathway and synergism between dopamine and serotonin, the role of dopamine transporter (SLC6A3, DAT) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.">
            <entity id="DS.d1288.s0.e0" origId="5202" charOffset="76-85" type="compound" text="serotonin"/>
            <entity id="DS.d1288.s0.e1" origId="P27922,Q01959,Q9GJT6" charOffset="121-127" type="protein" text="SLC6A3"/>
            <entity id="DS.d1288.s0.e2" origId="P13483,P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6" charOffset="129-132" type="protein" text="DAT"/>
            <entity id="DS.d1288.s0.e3" origId="P49253" charOffset="138-155" type="protein" text="monoamine oxidase"/>
            <entity id="DS.d1288.s0.e4" origId="O18851,P21397,P21398,P58027,Q5NU32,Q5RE60,Q6Q2J0" charOffset="159-163" type="protein" text="MAOA"/>
            <pair e1="DS.d1288.s0.e0" e2="DS.d1288.s0.e3" id="DS.d1288.s0.i0" interaction="False"/>
            <pair e1="DS.d1288.s0.e0" e2="DS.d1288.s0.e4" id="DS.d1288.s0.i1" interaction="False"/>
            <pair e1="DS.d1288.s0.e0" e2="DS.d1288.s0.e1" id="DS.d1288.s0.i2" interaction="False"/>
            <pair e1="DS.d1288.s0.e0" e2="DS.d1288.s0.e2" id="DS.d1288.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1289" origId="18810517">
        <sentence id="DS.d1289.s0" origId="18810517-648" text="A lipase (F2) and lipase-like materials (F1) were purified from the culture supernatant of P. monteilii TKU009 with soybean powder as the sole carbon/nitrogen source.">
            <entity id="DS.d1289.s0.e0" origId="Q7M4U7" charOffset="2-8" type="protein" text="lipase"/>
            <entity id="DS.d1289.s0.e1" origId="Q7M4U7" charOffset="18-24" type="protein" text="lipase"/>
            <entity id="DS.d1289.s0.e2" origId="947,123329" charOffset="150-158" type="compound" text="nitrogen"/>
            <pair e1="DS.d1289.s0.e2" e2="DS.d1289.s0.e0" id="DS.d1289.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1290" origId="18810712">
        <sentence id="DS.d1290.s0" origId="18810712-643" text="DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.">
            <entity id="DS.d1290.s0.e0" origId="12594" charOffset="6-12" type="compound" text="DHEA-S"/>
            <entity id="DS.d1290.s0.e1" origId="10635" charOffset="14-33" type="compound" text="dihydrotestosterone"/>
            <entity id="DS.d1290.s0.e2" origId="6013" charOffset="21-33" type="compound" text="testosterone"/>
            <entity id="DS.d1290.s0.e3" origId="6013" charOffset="41-53" type="compound" text="testosterone"/>
            <entity id="DS.d1290.s0.e4" origId="5870" charOffset="104-111" type="compound" text="estrone"/>
            <entity id="DS.d1290.s0.e5" origId="5757" charOffset="113-122" type="compound" text="estradiol"/>
            <entity id="DS.d1290.s0.e6" origId="5754" charOffset="124-132" type="compound" text="cortisol"/>
            <entity id="DS.d1290.s0.e7" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="134-141" type="protein" text="insulin"/>
            <entity id="DS.d1290.s0.e8" origId="Q95222" charOffset="143-148" type="protein" text="IGF-1"/>
            <entity id="DS.d1290.s0.e9" origId="P08833,P21743,P24591,P47876,Q6Q484,Q75ZP3" charOffset="150-157" type="protein" text="IGFBP-1"/>
            <entity id="DS.d1290.s0.e10" origId="P15473,P16611,P17936,P20959,P47878" charOffset="159-166" type="protein" text="IGFBP-3"/>
            <pair e1="DS.d1290.s0.e1" e2="DS.d1290.s0.e8" id="DS.d1290.s0.i0" interaction="False"/>
            <pair e1="DS.d1290.s0.e4" e2="DS.d1290.s0.e8" id="DS.d1290.s0.i1" interaction="False"/>
            <pair e1="DS.d1290.s0.e6" e2="DS.d1290.s0.e10" id="DS.d1290.s0.i2" interaction="False"/>
            <pair e1="DS.d1290.s0.e2" e2="DS.d1290.s0.e10" id="DS.d1290.s0.i3" interaction="False"/>
            <pair e1="DS.d1290.s0.e0" e2="DS.d1290.s0.e8" id="DS.d1290.s0.i4" interaction="False"/>
            <pair e1="DS.d1290.s0.e0" e2="DS.d1290.s0.e7" id="DS.d1290.s0.i5" interaction="False"/>
            <pair e1="DS.d1290.s0.e1" e2="DS.d1290.s0.e7" id="DS.d1290.s0.i6" interaction="False"/>
            <pair e1="DS.d1290.s0.e6" e2="DS.d1290.s0.e7" id="DS.d1290.s0.i7" interaction="False"/>
            <pair e1="DS.d1290.s0.e5" e2="DS.d1290.s0.e9" id="DS.d1290.s0.i8" interaction="False"/>
            <pair e1="DS.d1290.s0.e2" e2="DS.d1290.s0.e8" id="DS.d1290.s0.i9" interaction="False"/>
            <pair e1="DS.d1290.s0.e0" e2="DS.d1290.s0.e10" id="DS.d1290.s0.i10" interaction="False"/>
            <pair e1="DS.d1290.s0.e5" e2="DS.d1290.s0.e7" id="DS.d1290.s0.i11" interaction="False"/>
            <pair e1="DS.d1290.s0.e5" e2="DS.d1290.s0.e8" id="DS.d1290.s0.i12" interaction="False"/>
            <pair e1="DS.d1290.s0.e0" e2="DS.d1290.s0.e9" id="DS.d1290.s0.i13" interaction="False"/>
            <pair e1="DS.d1290.s0.e6" e2="DS.d1290.s0.e9" id="DS.d1290.s0.i14" interaction="False"/>
            <pair e1="DS.d1290.s0.e4" e2="DS.d1290.s0.e7" id="DS.d1290.s0.i15" interaction="False"/>
            <pair e1="DS.d1290.s0.e1" e2="DS.d1290.s0.e9" id="DS.d1290.s0.i16" interaction="False"/>
            <pair e1="DS.d1290.s0.e2" e2="DS.d1290.s0.e7" id="DS.d1290.s0.i17" interaction="False"/>
            <pair e1="DS.d1290.s0.e1" e2="DS.d1290.s0.e10" id="DS.d1290.s0.i18" interaction="False"/>
            <pair e1="DS.d1290.s0.e2" e2="DS.d1290.s0.e9" id="DS.d1290.s0.i19" interaction="False"/>
            <pair e1="DS.d1290.s0.e4" e2="DS.d1290.s0.e9" id="DS.d1290.s0.i20" interaction="False"/>
            <pair e1="DS.d1290.s0.e6" e2="DS.d1290.s0.e8" id="DS.d1290.s0.i21" interaction="False"/>
            <pair e1="DS.d1290.s0.e5" e2="DS.d1290.s0.e10" id="DS.d1290.s0.i22" interaction="False"/>
            <pair e1="DS.d1290.s0.e4" e2="DS.d1290.s0.e10" id="DS.d1290.s0.i23" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1291" origId="18812013">
        <sentence id="DS.d1291.s0" origId="18812013-984" text="Our data indicate that genetic differences in S100B gene expression may predispose individual differences in the responsivity to repeated intake of MDMA.">
            <entity id="DS.d1291.s0.e0" origId="P02638,P04271,Q6YNR6" charOffset="46-51" type="protein" text="S100B"/>
            <entity id="DS.d1291.s0.e1" origId="1615" charOffset="148-152" type="compound" text="MDMA"/>
            <pair e1="DS.d1291.s0.e1" e2="DS.d1291.s0.e0" id="DS.d1291.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1292" origId="18812209">
        <sentence id="DS.d1292.s0" origId="18812209-396" text="Angiotensin II (Ang II) is the key peptide hormone in the renin-angiotensin-aldosterone system (RAAS).">
            <entity id="DS.d1292.s0.e0" origId="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0" charOffset="0-14" type="protein" text="Angiotensin II"/>
            <entity id="DS.d1292.s0.e1" origId="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0" charOffset="16-22" type="protein" text="Ang II"/>
            <entity id="DS.d1292.s0.e2" origId="P81626" charOffset="35-50" type="protein" text="peptide hormone"/>
            <entity id="DS.d1292.s0.e3" origId="Q10757" charOffset="64-75" type="protein" text="angiotensin"/>
            <entity id="DS.d1292.s0.e4" origId="5839" charOffset="76-87" type="compound" text="aldosterone"/>
            <pair e1="DS.d1292.s0.e4" e2="DS.d1292.s0.e1" id="DS.d1292.s0.i0" interaction="True"/>
            <pair e1="DS.d1292.s0.e4" e2="DS.d1292.s0.e2" id="DS.d1292.s0.i1" interaction="True"/>
            <pair e1="DS.d1292.s0.e4" e2="DS.d1292.s0.e3" id="DS.d1292.s0.i2" interaction="True"/>
            <pair e1="DS.d1292.s0.e4" e2="DS.d1292.s0.e0" id="DS.d1292.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1293" origId="18812225">
        <sentence id="DS.d1293.s0" origId="18812225-1232" text="The enzyme responsible for D-serine biosynthesis, serine racemase (SR), is therefore a promising target for treatment of neuropathologies related to glutamate receptor excitotoxicity, such as stroke or Alzheimer's disease.">
            <entity id="DS.d1293.s0.e0" origId="5951" charOffset="29-35" type="compound" text="serine"/>
            <entity id="DS.d1293.s0.e1" origId="Q9GZT4,Q9QZX7" charOffset="50-65" type="protein" text="serine racemase"/>
            <pair e1="DS.d1293.s0.e0" e2="DS.d1293.s0.e1" id="DS.d1293.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1294" origId="18812229">
        <sentence id="DS.d1294.s0" origId="18812229-1054" text="Hepatocyte apoptosis was estimated morphologically using Annexin-V combined with propidium iodide, or toluidine blue staining.">
            <entity id="DS.d1294.s0.e0" origId="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0" charOffset="57-66" type="protein" text="Annexin-V"/>
            <entity id="DS.d1294.s0.e1" origId="4939" charOffset="81-97" type="compound" text="propidium iodide"/>
            <entity id="DS.d1294.s0.e2" origId="7084" charOffset="102-116" type="compound" text="toluidine blue"/>
            <pair e1="DS.d1294.s0.e1" e2="DS.d1294.s0.e0" id="DS.d1294.s0.i0" interaction="False"/>
            <pair e1="DS.d1294.s0.e2" e2="DS.d1294.s0.e0" id="DS.d1294.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1295" origId="18812233">
        <sentence id="DS.d1295.s0" origId="18812233-1056" text="To investigate the metabolism of NADA through the cytochrome P450 (CYP450) metabolic pathway, we studied the in vitro rat liver microsomal production of hydroxylated metabolites and their activity at recombinant human TRPV(1) receptors.">
            <entity id="DS.d1295.s0.e0" origId="5282105" charOffset="33-37" type="compound" text="NADA"/>
            <entity id="DS.d1295.s0.e1" origId="O08469" charOffset="50-65" type="protein" text="cytochrome P450"/>
            <pair e1="DS.d1295.s0.e0" e2="DS.d1295.s0.e1" id="DS.d1295.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1296" origId="18812596">
        <sentence id="DS.d1296.s0" origId="18812596-1164" text="The FFA fractions elicited pro-inflammatory responses inducing TNFalpha and intracellular adhesion molecule expression and reactive oxygen species (ROS) production in human aortic endothelial cells (HAECs).">
            <entity id="DS.d1296.s0.e0" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="63-71" type="protein" text="TNFalpha"/>
            <entity id="DS.d1296.s0.e1" origId="977" charOffset="132-138" type="compound" text="oxygen"/>
            <pair e1="DS.d1296.s0.e1" e2="DS.d1296.s0.e0" id="DS.d1296.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1297" origId="18812689">
        <sentence id="DS.d1297.s0" origId="18812689-1190" text="MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer.">
            <entity id="DS.d1297.s0.e0" origId="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72" charOffset="0-4" type="protein" text="MDR1"/>
            <entity id="DS.d1297.s0.e1" origId="148124" charOffset="91-100" type="compound" text="docetaxel"/>
            <pair e1="DS.d1297.s0.e1" e2="DS.d1297.s0.e0" id="DS.d1297.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1298" origId="18814142">
        <sentence id="DS.d1298.s0" origId="18814142-2252" text="Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells.">
            <entity id="DS.d1298.s0.e0" origId="O70431,P04274,P07550,P10608,P18762,P54833,Q28044,Q28509,Q28997,Q4KWL2,Q8UUY8,Q9TST5" charOffset="25-51" type="protein" text="beta2 adrenergic receptors"/>
            <entity id="DS.d1298.s0.e1" origId="124886" charOffset="125-136" type="compound" text="glutathione"/>
            <entity id="DS.d1298.s0.e2" origId="O54968,Q60795" charOffset="153-157" type="protein" text="Nrf2"/>
            <pair e1="DS.d1298.s0.e1" e2="DS.d1298.s0.e0" id="DS.d1298.s0.i0" interaction="True"/>
            <pair e1="DS.d1298.s0.e1" e2="DS.d1298.s0.e2" id="DS.d1298.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1298.s1" origId="18814142-2253" text="Exposure to adrenaline not only increased cAMP formation, phosphorylation of cAMP responsive element (CRE) binding protein (CREB) on serine133 and CRE reporter activity in a manner sensitive to propranolol, but also rendered C3H10T1/2 cells resistant to the cytotoxicity of hydrogen peroxide, but not of either 2,4-dinitirophenol or tunicamycin.">
            <entity id="DS.d1298.s1.e0" origId="P15337,P16220,P27925,P51984,P51985,Q01147" charOffset="124-128" type="protein" text="CREB"/>
            <entity id="DS.d1298.s1.e1" origId="4946,21138,91536" charOffset="194-205" type="compound" text="propranolol"/>
            <entity id="DS.d1298.s1.e2" origId="784" charOffset="274-291" type="compound" text="hydrogen peroxide"/>
            <pair e1="DS.d1298.s1.e1" e2="DS.d1298.s1.e0" id="DS.d1298.s1.i0" interaction="True"/>
            <pair e1="DS.d1298.s1.e2" e2="DS.d1298.s1.e0" id="DS.d1298.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1298.s2" origId="18814142-2254" text="These results suggest that adrenaline may selectively protect mesenchymal C3H10T1/2 cells from oxidative stress through a mechanism related to the promoted biosynthesis of glutathione in association with transient Nrf2 expression after activation of beta(2)AdR.">
            <entity id="DS.d1298.s2.e0" origId="124886" charOffset="172-183" type="compound" text="glutathione"/>
            <entity id="DS.d1298.s2.e1" origId="O54968,Q60795" charOffset="214-218" type="protein" text="Nrf2"/>
            <pair e1="DS.d1298.s2.e0" e2="DS.d1298.s2.e1" id="DS.d1298.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1299" origId="18814181">
        <sentence id="DS.d1299.s0" origId="18814181-1610" text="Two principal signaling pathways that regulate proliferation are PI3K/PI(3,4,5)P3/Akt and Shc/Ras/ERK1/2.">
            <entity id="DS.d1299.s0.e0" origId="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0" charOffset="65-69" type="protein" text="PI3K"/>
            <entity id="DS.d1299.s0.e1" origId="643963" charOffset="70-81" type="compound" text="PI(3,4,5)P3"/>
            <entity id="DS.d1299.s0.e2" origId="P31750,Q8INB9" charOffset="82-85" type="protein" text="Akt"/>
            <entity id="DS.d1299.s0.e3" origId="P33247,P33990,P54924,P55348,P98083" charOffset="90-93" type="protein" text="Shc"/>
            <entity id="DS.d1299.s0.e4" origId="P03967,P22126,Q07152" charOffset="94-97" type="protein" text="Ras"/>
            <entity id="DS.d1299.s0.e5" origId="P27361,P28869,P42525,Q07176" charOffset="98-102" type="protein" text="ERK1"/>
            <pair e1="DS.d1299.s0.e1" e2="DS.d1299.s0.e3" id="DS.d1299.s0.i0" interaction="False"/>
            <pair e1="DS.d1299.s0.e1" e2="DS.d1299.s0.e4" id="DS.d1299.s0.i1" interaction="False"/>
            <pair e1="DS.d1299.s0.e1" e2="DS.d1299.s0.e0" id="DS.d1299.s0.i2" interaction="True"/>
            <pair e1="DS.d1299.s0.e1" e2="DS.d1299.s0.e2" id="DS.d1299.s0.i3" interaction="True"/>
            <pair e1="DS.d1299.s0.e1" e2="DS.d1299.s0.e5" id="DS.d1299.s0.i4" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1300" origId="18814266">
        <sentence id="DS.d1300.s0" origId="18814266-2509" text="However, lovastatin treatment resulted in intracellular accumulation of PLP and prevented its translocation to the cell surface.">
            <entity id="DS.d1300.s0.e0" origId="53232" charOffset="9-19" type="compound" text="lovastatin"/>
            <entity id="DS.d1300.s0.e1" origId="P04116,P13085,P22858,P23289,P23294,P30044,P47789,P47790,P60201,P60202,P60203,P79826,P80145,P99029,Q8HXW7,Q96GD0,Q9R063" charOffset="72-75" type="protein" text="PLP"/>
            <pair e1="DS.d1300.s0.e0" e2="DS.d1300.s0.e1" id="DS.d1300.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1301" origId="18814279">
        <sentence id="DS.d1301.s0" origId="18814279-1660" text="Imatinib mesylate (imatinib) is a potent and selective inhibitor of the tyrosine kinases, Bcr-Abl, c-Kit and platelet-derived growth factor receptors (PDGFRs).">
            <entity id="DS.d1301.s0.e0" origId="5291" charOffset="0-17" type="compound" text="Imatinib mesylate"/>
            <entity id="DS.d1301.s0.e1" origId="5291" charOffset="19-27" type="compound" text="imatinib"/>
            <entity id="DS.d1301.s0.e2" origId="P28246,P45123" charOffset="90-93" type="protein" text="Bcr"/>
            <entity id="DS.d1301.s0.e3" origId="P00520,P00522" charOffset="94-97" type="protein" text="Abl"/>
            <entity id="DS.d1301.s0.e4" origId="O97799,P05532,P10721,P43481,Q08156,Q28317,Q28889,Q2HWD6,Q76II0,Q8AXC6" charOffset="99-104" type="protein" text="c-Kit"/>
            <pair e1="DS.d1301.s0.e0" e2="DS.d1301.s0.e4" id="DS.d1301.s0.i0" interaction="True"/>
            <pair e1="DS.d1301.s0.e1" e2="DS.d1301.s0.e3" id="DS.d1301.s0.i1" interaction="True"/>
            <pair e1="DS.d1301.s0.e0" e2="DS.d1301.s0.e2" id="DS.d1301.s0.i2" interaction="True"/>
            <pair e1="DS.d1301.s0.e1" e2="DS.d1301.s0.e4" id="DS.d1301.s0.i3" interaction="True"/>
            <pair e1="DS.d1301.s0.e1" e2="DS.d1301.s0.e2" id="DS.d1301.s0.i4" interaction="True"/>
            <pair e1="DS.d1301.s0.e0" e2="DS.d1301.s0.e3" id="DS.d1301.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1302" origId="18814300">
        <sentence id="DS.d1302.s0" origId="18814300-1665" text="The large and diverse family of cytochrome P450 monooxygenases (CYPs) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the heme center.">
            <entity id="DS.d1302.s0.e0" origId="O08469" charOffset="32-47" type="protein" text="cytochrome P450"/>
            <entity id="DS.d1302.s0.e1" origId="P21568,P21569,P24525,P34887,Q26551" charOffset="64-68" type="protein" text="CYPs"/>
            <entity id="DS.d1302.s0.e2" origId="4971" charOffset="239-243" type="compound" text="heme"/>
            <pair e1="DS.d1302.s0.e2" e2="DS.d1302.s0.e0" id="DS.d1302.s0.i0" interaction="True"/>
            <pair e1="DS.d1302.s0.e2" e2="DS.d1302.s0.e1" id="DS.d1302.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1302.s1" origId="18814300-1666" text="In 98.4% of all CYP sequences a preferentially hydrophobic residue is located at position 5 after the ExxR motif that is predicted to point close to the heme center.">
            <entity id="DS.d1302.s1.e0" origId="P21568,P21569,P24525,P34887,Q26551" charOffset="16-19" type="protein" text="CYP"/>
            <entity id="DS.d1302.s1.e1" origId="4971" charOffset="153-157" type="compound" text="heme"/>
            <pair e1="DS.d1302.s1.e1" e2="DS.d1302.s1.e0" id="DS.d1302.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1303" origId="18814316">
        <sentence id="DS.d1303.s0" origId="18814316-53" text="We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (IOC) with human serum albumin (HSA) using various biophysical methods.">
            <entity id="DS.d1303.s0.e0" origId="969516" charOffset="62-70" type="compound" text="curcumin"/>
            <entity id="DS.d1303.s0.e1" origId="446240" charOffset="90-93" type="compound" text="IOC"/>
            <entity id="DS.d1303.s0.e2" origId="P21847,P83517" charOffset="106-119" type="protein" text="serum albumin"/>
            <entity id="DS.d1303.s0.e3" origId="P24807,Q07490" charOffset="121-124" type="protein" text="HSA"/>
            <pair e1="DS.d1303.s0.e0" e2="DS.d1303.s0.e3" id="DS.d1303.s0.i0" interaction="True"/>
            <pair e1="DS.d1303.s0.e1" e2="DS.d1303.s0.e2" id="DS.d1303.s0.i1" interaction="True"/>
            <pair e1="DS.d1303.s0.e0" e2="DS.d1303.s0.e2" id="DS.d1303.s0.i2" interaction="True"/>
            <pair e1="DS.d1303.s0.e1" e2="DS.d1303.s0.e3" id="DS.d1303.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d1303.s1" origId="18814316-54" text="The observed fluorescence quenching of HSA by IOC is due to a complex formation by a static quenching process with a quenching constant of the order of 10(5) M(-1).">
            <entity id="DS.d1303.s1.e0" origId="P24807,Q07490" charOffset="39-42" type="protein" text="HSA"/>
            <entity id="DS.d1303.s1.e1" origId="446240" charOffset="46-49" type="compound" text="IOC"/>
            <pair e1="DS.d1303.s1.e1" e2="DS.d1303.s1.e0" id="DS.d1303.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1303.s2" origId="18814316-55" text="From the observed F&#246;rster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in HSA) to acceptor (IOC) distance is calculated to be 3.2 nm.">
            <entity id="DS.d1303.s2.e0" origId="P24807,Q07490" charOffset="100-103" type="protein" text="HSA"/>
            <entity id="DS.d1303.s2.e1" origId="446240" charOffset="118-121" type="compound" text="IOC"/>
            <pair e1="DS.d1303.s2.e1" e2="DS.d1303.s2.e0" id="DS.d1303.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1303.s3" origId="18814316-56" text="The preferred binding site of IOC was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and warfarin-bound HSA.">
            <entity id="DS.d1303.s3.e0" origId="446240" charOffset="30-33" type="compound" text="IOC"/>
            <entity id="DS.d1303.s3.e1" origId="1369" charOffset="87-119" type="compound" text="1-anilino-8-naphthalenesulfonate"/>
            <entity id="DS.d1303.s3.e2" origId="54678486" charOffset="130-138" type="compound" text="warfarin"/>
            <entity id="DS.d1303.s3.e3" origId="P24807,Q07490" charOffset="145-148" type="protein" text="HSA"/>
            <pair e1="DS.d1303.s3.e2" e2="DS.d1303.s3.e3" id="DS.d1303.s3.i0" interaction="True"/>
            <pair e1="DS.d1303.s3.e1" e2="DS.d1303.s3.e3" id="DS.d1303.s3.i1" interaction="True"/>
            <pair e1="DS.d1303.s3.e0" e2="DS.d1303.s3.e3" id="DS.d1303.s3.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1304" origId="18814864">
        <sentence id="DS.d1304.s0" origId="18814864-1818" text="A number of site-specific modifications of the nucleosome core histones-including the trimethylated forms of histone H3 lysines K4, K9, and K27-are of particular interest for postmortem research, because these marks differentiate between active and inactive chromatin and seem to remain relatively stable during tissue autolysis.">
            <entity id="DS.d1304.s0.e0" origId="P02299,P07041,P08437,P08898,P22843,P23753,P40285,P50564,P61830,P61831,P61832,P61833,P61834,P61835,P61836,P80553,P83864,P84235,P84236,P84237,P84238,P84239,P90543,Q06196,Q2UCQ0,Q5DWI3,Q757N1,Q7XYZ0,Q98RY4,Q9HDN1,Q9P427,Q9U7D1" charOffset="109-119" type="protein" text="histone H3"/>
            <entity id="DS.d1304.s0.e1" origId="5492535" charOffset="140-143" type="compound" text="K27"/>
            <pair e1="DS.d1304.s0.e1" e2="DS.d1304.s0.e0" id="DS.d1304.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1305" origId="18814910">
        <sentence id="DS.d1305.s0" origId="18814910-1833" text="We here demonstrate that TRPA1 confers a sensitivity towards near ultraviolet (UVA) light, which rapidly causes Ca(2+) entry.">
            <entity id="DS.d1305.s0.e0" origId="O75762" charOffset="25-30" type="protein" text="TRPA1"/>
            <entity id="DS.d1305.s0.e1" origId="271" charOffset="112-116" type="compound" text="Ca(2"/>
            <pair e1="DS.d1305.s0.e1" e2="DS.d1305.s0.e0" id="DS.d1305.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1305.s1" origId="18814910-1834" text="In the presence of the photosensitising agents acridine orange (100 nM) or hypericin (10 nM), the sensitivity of light-induced TRPA1 activation was increased and extended towards the visible spectrum.">
            <entity id="DS.d1305.s1.e0" origId="62344" charOffset="47-62" type="compound" text="acridine orange"/>
            <entity id="DS.d1305.s1.e1" origId="5281051" charOffset="75-84" type="compound" text="hypericin"/>
            <entity id="DS.d1305.s1.e2" origId="O75762" charOffset="127-132" type="protein" text="TRPA1"/>
            <pair e1="DS.d1305.s1.e0" e2="DS.d1305.s1.e2" id="DS.d1305.s1.i0" interaction="True"/>
            <pair e1="DS.d1305.s1.e1" e2="DS.d1305.s1.e2" id="DS.d1305.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1306" origId="18814934">
        <sentence id="DS.d1306.s0" origId="18814934-1845" text="To verify the possible involvement of lipids and several other compounds including hydrogen peroxide (H(2)O(2)) and glyceraldehyde-3-phosphate dehydrogenase (G3PDH) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).">
            <entity id="DS.d1306.s0.e0" origId="784" charOffset="83-100" type="compound" text="hydrogen peroxide"/>
            <entity id="DS.d1306.s0.e1" origId="O01360,O13507,O27090,O28542,O32755,O42259,O52631,O57479,O57672,O59494,O59841,O67161,O83816,P00355,P00356,P00357,P00361,P00362,P04406,P04797,P08439,P09316,P09317,P0A1P0,P0A1P1,P0C0G6,P0C0G7,P10096,P10618,P15115,P16858,P17244,P17721,P19089,P19314,P19315,P20287,P20445,P23722,P24163,P24164,P24166,P24746,P24748,P24749,P24750,P24751,P24753,P26988,P27726,P28844,P29497,P32637,P32638,P34783,P35143,P39460,P44304,P46406,P46713,P46795,P46796,P47543,P48812,P51009,P51469,P51640,P52694,P52987,P53430,P54117,P54118,P54226,P55070,P55071,P55971,P56649,P57384,P58839,P61879,P61880,P64178,P64179,P68777,P70685,P75358,P83601,P87197,P94915,Q00301,Q00584,Q00640,Q01597,Q01651,Q01982,Q05025,Q07234,Q12552,Q1DTF9,Q27652,Q28259,Q28554,Q2NEN0,Q3IUT3,Q46450,Q48335,Q4J940,Q4KYY3,Q58546,Q59199,Q59309,Q59800,Q59906,Q5JHB5,Q5R2J2,Q5RAB4,Q5V061,Q5XDW3,Q6BMK0,Q6CCU7,Q6L125,Q6M0E6,Q757I2,Q89AK1,Q8J1H3,Q8K8M9,Q8NK47,Q8PTD3,Q8TFJ2,Q8WZN0,Q8X1X3,Q8ZWK7,Q92211,Q92243,Q92263,Q94469,Q96US8,Q971K2,Q97BJ8,Q9HFX1,Q9HGY7,Q9HJ69,Q9HSS7,Q9N2D5,Q9N655,Q9P8C0,Q9PJN6,Q9UR38,Q9UVC0,Q9UW96,Q9V1P1,Q9Y796,Q9Y8E9,Q9YFS9,Q9Z518,Q9Z7T0,Q9ZKT0" charOffset="116-156" type="protein" text="glyceraldehyde-3-phosphate dehydrogenase"/>
            <entity id="DS.d1306.s0.e2" origId="P51640,Q28554" charOffset="158-163" type="protein" text="G3PDH"/>
            <pair e1="DS.d1306.s0.e0" e2="DS.d1306.s0.e2" id="DS.d1306.s0.i0" interaction="False"/>
            <pair e1="DS.d1306.s0.e0" e2="DS.d1306.s0.e1" id="DS.d1306.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1307" origId="18815024">
        <sentence id="DS.d1307.s0" origId="18815024-1868" text="A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two alpha,d-glucose molecules, and a GOD (glucose oxidase) amperometric biosensor is employed for the glucose determination.">
            <entity id="DS.d1307.s0.e0" origId="206,79025" charOffset="172-187" type="compound" text="alpha,d-glucose"/>
            <entity id="DS.d1307.s0.e1" origId="P13006,P81156,Q92452" charOffset="205-208" type="protein" text="GOD"/>
            <entity id="DS.d1307.s0.e2" origId="P81156" charOffset="210-225" type="protein" text="glucose oxidase"/>
            <pair e1="DS.d1307.s0.e0" e2="DS.d1307.s0.e2" id="DS.d1307.s0.i0" interaction="False"/>
            <pair e1="DS.d1307.s0.e0" e2="DS.d1307.s0.e1" id="DS.d1307.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1308" origId="18815084">
        <sentence id="DS.d1308.s0" origId="18815084-1886" text="The angiogenic potential of vascular endothelial growth factor (VEGF) and its oxygen pressure-dependent regulation suggest a strong connection between this growth factor and the 'delay phenomenon'.">
            <entity id="DS.d1308.s0.e0" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="64-68" type="protein" text="VEGF"/>
            <entity id="DS.d1308.s0.e1" origId="977" charOffset="78-84" type="compound" text="oxygen"/>
            <pair e1="DS.d1308.s0.e1" e2="DS.d1308.s0.e0" id="DS.d1308.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1309" origId="18815123">
        <sentence id="DS.d1309.s0" origId="18815123-1901" text="Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated ERK activation in response to lipopolysaccharide.">
            <entity id="DS.d1309.s0.e0" origId="P29323" charOffset="135-138" type="protein" text="ERK"/>
            <entity id="DS.d1309.s0.e1" origId="11970143" charOffset="165-183" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d1309.s0.e1" e2="DS.d1309.s0.e0" id="DS.d1309.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1310" origId="18815141">
        <sentence id="DS.d1310.s0" origId="18815141-1912" text="Methylmercury toxicity and Nrf2-dependent detoxification in astrocytes.">
            <entity id="DS.d1310.s0.e0" origId="7906" charOffset="0-13" type="compound" text="Methylmercury"/>
            <entity id="DS.d1310.s0.e1" origId="O54968,Q60795" charOffset="27-31" type="protein" text="Nrf2"/>
            <pair e1="DS.d1310.s0.e0" e2="DS.d1310.s0.e1" id="DS.d1310.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1311" origId="18815243">
        <sentence id="DS.d1311.s0" origId="18815243-1973" text="After serum creatinine reached a stable nadir in the transplant recipients, GFR and its hemodynamic determinants were evaluated and the whole allograft K(f) was computed.">
            <entity id="DS.d1311.s0.e0" origId="588" charOffset="12-22" type="compound" text="creatinine"/>
            <entity id="DS.d1311.s0.e1" origId="Q92565" charOffset="76-79" type="protein" text="GFR"/>
            <pair e1="DS.d1311.s0.e0" e2="DS.d1311.s0.e1" id="DS.d1311.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1312" origId="18815356">
        <sentence id="DS.d1312.s0" origId="18815356-1953" text="Lower expression of IGFBP1 and prolactin mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to 8-Br-cAMP, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.">
            <entity id="DS.d1312.s0.e0" origId="P08833,P24591,Q6Q484,Q75ZP3" charOffset="20-26" type="protein" text="IGFBP1"/>
            <entity id="DS.d1312.s0.e1" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="31-40" type="protein" text="prolactin"/>
            <entity id="DS.d1312.s0.e2" origId="32014" charOffset="142-151" type="compound" text="8-Br-cAMP"/>
            <pair e1="DS.d1312.s0.e2" e2="DS.d1312.s0.e1" id="DS.d1312.s0.i0" interaction="True"/>
            <pair e1="DS.d1312.s0.e2" e2="DS.d1312.s0.e0" id="DS.d1312.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1313" origId="18815358">
        <sentence id="DS.d1313.s0" origId="18815358-2022" text="Furthermore, constitutive expression of an oxygen-insensitive, active form of HIF1A protein mimicked the effects of low oxygen, inhibiting the differentiation of trophoblast giant cells.">
            <entity id="DS.d1313.s0.e0" origId="977" charOffset="43-49" type="compound" text="oxygen"/>
            <entity id="DS.d1313.s0.e1" origId="Q0PGG7,Q16665,Q309Z6,Q98SW2,Q9XTA5,Q9YIB9" charOffset="78-83" type="protein" text="HIF1A"/>
            <entity id="DS.d1313.s0.e2" origId="977" charOffset="120-126" type="compound" text="oxygen"/>
            <pair e1="DS.d1313.s0.e0" e2="DS.d1313.s0.e1" id="DS.d1313.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1314" origId="18815782">
        <sentence id="DS.d1314.s0" origId="18815782-2147" text="Finally, the results showed that the lipase covalently attached onto epoxy resin exhibited the highest enantioselectivity and operational stability.">
            <entity id="DS.d1314.s0.e0" origId="Q7M4U7" charOffset="37-43" type="protein" text="lipase"/>
            <entity id="DS.d1314.s0.e1" origId="169944" charOffset="69-80" type="compound" text="epoxy resin"/>
            <pair e1="DS.d1314.s0.e1" e2="DS.d1314.s0.e0" id="DS.d1314.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1315" origId="18815831">
        <sentence id="DS.d1315.s0" origId="18815831-2150" text="Effect of the inoculum size on carbapenem susceptibilities of beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae.">
            <entity id="DS.d1315.s0.e0" origId="P80298,P80545,P81173" charOffset="62-76" type="protein" text="beta-lactamase"/>
            <entity id="DS.d1315.s0.e1" origId="6249" charOffset="87-97" type="compound" text="ampicillin"/>
            <pair e1="DS.d1315.s0.e1" e2="DS.d1315.s0.e0" id="DS.d1315.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1315.s1" origId="18815831-2151" text="However, the effect of inoculum size of beta-lactamase-negative, ampicillin-resistant H. influenzae (BLNAR) on MICs for carbapenems has not been investigated.">
            <entity id="DS.d1315.s1.e0" origId="P80298,P80545,P81173" charOffset="40-54" type="protein" text="beta-lactamase"/>
            <entity id="DS.d1315.s1.e1" origId="6249" charOffset="65-75" type="compound" text="ampicillin"/>
            <pair e1="DS.d1315.s1.e1" e2="DS.d1315.s1.e0" id="DS.d1315.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1316" origId="18815849">
        <sentence id="DS.d1316.s0" origId="18815849-2155" text="It has been proposed that there is improvement in glucose and insulin metabolism after weight loss in patients who underwent diet restriction and bariatric surgery.">
            <entity id="DS.d1316.s0.e0" origId="206,5793,64689,79025" charOffset="50-57" type="compound" text="glucose"/>
            <entity id="DS.d1316.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="62-69" type="protein" text="insulin"/>
            <pair e1="DS.d1316.s0.e0" e2="DS.d1316.s0.e1" id="DS.d1316.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1317" origId="18815869">
        <sentence id="DS.d1317.s0" origId="18815869-2158" text="Folate deficiency due to the methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.">
            <entity id="DS.d1317.s0.e0" origId="6037" charOffset="0-6" type="compound" text="Folate"/>
            <entity id="DS.d1317.s0.e1" origId="P42898,Q5I598,Q60HE5,Q9WU20" charOffset="29-64" type="protein" text="methylenetetrahydrofolate reductase"/>
            <entity id="DS.d1317.s0.e2" origId="P42898,Q5I598,Q60HE5" charOffset="66-71" type="protein" text="MTHFR"/>
            <entity id="DS.d1317.s0.e3" origId="O26869,O33259,O33465,O58816,P13009,P37586,P55299,P57704,Q49775,Q4JAI4,Q4JIJ3,Q55786,Q58868,Q5E814,Q5JH51,Q7MHB1,Q87L95,Q8DCJ7,Q8TH63,Q975N4,Q979L4,Q980A9,Q99707,Q9AJQ8,Q9KUW9,Q9V085,Q9YA91" charOffset="77-96" type="protein" text="methionine synthase"/>
            <pair e1="DS.d1317.s0.e0" e2="DS.d1317.s0.e2" id="DS.d1317.s0.i0" interaction="True"/>
            <pair e1="DS.d1317.s0.e0" e2="DS.d1317.s0.e3" id="DS.d1317.s0.i1" interaction="True"/>
            <pair e1="DS.d1317.s0.e0" e2="DS.d1317.s0.e1" id="DS.d1317.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1318" origId="18815881">
        <sentence id="DS.d1318.s0" origId="18815881-2160" text="Tamoxifen has been the mainstay of endocrine therapy for estrogen receptor-positive breast cancer.">
            <entity id="DS.d1318.s0.e0" origId="2733526" charOffset="0-9" type="compound" text="Tamoxifen"/>
            <entity id="DS.d1318.s0.e1" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="57-74" type="protein" text="estrogen receptor"/>
            <pair e1="DS.d1318.s0.e0" e2="DS.d1318.s0.e1" id="DS.d1318.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1319" origId="18815882">
        <sentence id="DS.d1319.s0" origId="18815882-2164" text="The bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) is the key enzyme for the biosynthesis of sialic acids, terminal components of glycoconjugates associated with a variety of physiological and pathological processes.">
            <entity id="DS.d1319.s0.e0" origId="O35826,P27828,P39131,P52642,Q7TQ49,Q8XAR8,Q8Z388,Q8ZAE3,Q91WG8,Q9L6R5,Q9Y223" charOffset="24-59" type="protein" text="UDP-N-acetylglucosamine 2-epimerase"/>
            <entity id="DS.d1319.s0.e1" origId="Q7TQ49,Q9Y223" charOffset="88-91" type="protein" text="GNE"/>
            <entity id="DS.d1319.s0.e2" origId="349960" charOffset="135-147" type="compound" text="sialic acids"/>
            <pair e1="DS.d1319.s0.e2" e2="DS.d1319.s0.e0" id="DS.d1319.s0.i0" interaction="True"/>
            <pair e1="DS.d1319.s0.e2" e2="DS.d1319.s0.e1" id="DS.d1319.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1320" origId="18816186">
        <sentence id="DS.d1320.s0" origId="18816186-2283" text="A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal Cx36 and glial Cx43 hemichannel activity, favoring ATP release and generation of preconditioning.">
            <entity id="DS.d1320.s0.e0" origId="O54851,O70610,Q866T7,Q9UKL4" charOffset="142-146" type="protein" text="Cx36"/>
            <entity id="DS.d1320.s0.e1" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="157-161" type="protein" text="Cx43"/>
            <entity id="DS.d1320.s0.e2" origId="5957" charOffset="193-196" type="compound" text="ATP"/>
            <pair e1="DS.d1320.s0.e2" e2="DS.d1320.s0.e0" id="DS.d1320.s0.i0" interaction="True"/>
            <pair e1="DS.d1320.s0.e2" e2="DS.d1320.s0.e1" id="DS.d1320.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1321" origId="18816698">
        <sentence id="DS.d1321.s0" origId="18816698-2452" text="A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.">
            <entity id="DS.d1321.s0.e0" origId="3690,9588020" charOffset="25-35" type="compound" text="ifosfamide"/>
            <entity id="DS.d1321.s0.e1" origId="2568" charOffset="37-48" type="compound" text="carboplatin"/>
            <entity id="DS.d1321.s0.e2" origId="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217" charOffset="54-63" type="compound" text="etoposide"/>
            <entity id="DS.d1321.s0.e3" origId="P11836,Q3C2E2" charOffset="123-127" type="protein" text="CD20"/>
            <pair e1="DS.d1321.s0.e2" e2="DS.d1321.s0.e3" id="DS.d1321.s0.i0" interaction="True"/>
            <pair e1="DS.d1321.s0.e1" e2="DS.d1321.s0.e3" id="DS.d1321.s0.i1" interaction="True"/>
            <pair e1="DS.d1321.s0.e0" e2="DS.d1321.s0.e3" id="DS.d1321.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1322" origId="18816790">
        <sentence id="DS.d1322.s0" origId="18816790-2482" text="4) PKA regulates neurotransmission without PKC involvement because, after PMA or CaC modulation of the PKC activity, coupling to the ACh release of PKA can normally be stimulated with Sp-8-BrcAMP or inhibited with H-89.">
            <entity id="DS.d1322.s0.e0" origId="P05130,P13677,P13678,P34722" charOffset="43-46" type="protein" text="PKC"/>
            <entity id="DS.d1322.s0.e1" origId="27924,122634,22833501" charOffset="74-77" type="compound" text="PMA"/>
            <entity id="DS.d1322.s0.e2" origId="P05130,P13677,P13678,P34722" charOffset="103-106" type="protein" text="PKC"/>
            <pair e1="DS.d1322.s0.e1" e2="DS.d1322.s0.e0" id="DS.d1322.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1322.s1" origId="18816790-2483" text="5) After PKA inhibition with H-89, PKC stimulation with PMA (or inhibition with CaC) does not lead to any change in evoked ACh release.">
            <entity id="DS.d1322.s1.e0" origId="P05130,P13677,P13678,P34722" charOffset="35-38" type="protein" text="PKC"/>
            <entity id="DS.d1322.s1.e1" origId="27924,122634,22833501" charOffset="56-59" type="compound" text="PMA"/>
            <pair e1="DS.d1322.s1.e1" e2="DS.d1322.s1.e0" id="DS.d1322.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1322.s2" origId="18816790-2484" text="In contrast, PKA inhibition prevent PKC stimulation (with the phorbol ester) and coupling to ACh output.">
            <entity id="DS.d1322.s2.e0" origId="P05130,P13677,P13678,P34722" charOffset="36-39" type="protein" text="PKC"/>
            <entity id="DS.d1322.s2.e1" origId="27924,22833501" charOffset="62-75" type="compound" text="phorbol ester"/>
            <pair e1="DS.d1322.s2.e1" e2="DS.d1322.s2.e0" id="DS.d1322.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1323" origId="18817778">
        <sentence id="DS.d1323.s0" origId="18817778-252" text="The inhibition of female rabbit sexual behavior by progesterone : progesterone receptor-dependent and-independent effects.">
            <entity id="DS.d1323.s0.e0" origId="5994" charOffset="51-63" type="compound" text="progesterone"/>
            <entity id="DS.d1323.s0.e1" origId="P06186,P06401,P07812,P79373,Q00175,Q28590,Q63449,Q8AYI2,Q9GLW0" charOffset="66-87" type="protein" text="progesterone receptor"/>
            <pair e1="DS.d1323.s0.e0" e2="DS.d1323.s0.e1" id="DS.d1323.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1324" origId="18817795">
        <sentence id="DS.d1324.s0" origId="18817795-259" text="Reproductive experience alters corticosterone and CBG levels in the rat dam.">
            <entity id="DS.d1324.s0.e0" origId="5753" charOffset="31-45" type="compound" text="corticosterone"/>
            <entity id="DS.d1324.s0.e1" origId="P08185,P23775,P31211,P49920,P50451,Q06770,Q5R9E3,Q5RF65,Q60543,Q9H227" charOffset="50-53" type="protein" text="CBG"/>
            <pair e1="DS.d1324.s0.e0" e2="DS.d1324.s0.e1" id="DS.d1324.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1324.s1" origId="18817795-260" text="The present study investigated whether the levels of circulating corticosterone and its binding protein, corticosteroid binding globulin (CBG), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.">
            <entity id="DS.d1324.s1.e0" origId="5753" charOffset="65-79" type="compound" text="corticosterone"/>
            <entity id="DS.d1324.s1.e1" origId="P23775" charOffset="105-136" type="protein" text="corticosteroid binding globulin"/>
            <entity id="DS.d1324.s1.e2" origId="P08185,P23775,P31211,P49920,P50451,Q06770,Q5R9E3,Q5RF65,Q60543,Q9H227" charOffset="138-141" type="protein" text="CBG"/>
            <pair e1="DS.d1324.s1.e0" e2="DS.d1324.s1.e1" id="DS.d1324.s1.i0" interaction="True"/>
            <pair e1="DS.d1324.s1.e0" e2="DS.d1324.s1.e2" id="DS.d1324.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1324.s2" origId="18817795-261" text="Total serum corticosterone and CBG were assayed from five groups; multiparous, primiparous, nulliparous, primip-no-pups, and sensitized rats during gestation (days 14 and 19) and the postpartum period (days 1, 5, 14, 21, and 35).">
            <entity id="DS.d1324.s2.e0" origId="5753" charOffset="12-26" type="compound" text="corticosterone"/>
            <entity id="DS.d1324.s2.e1" origId="P08185,P23775,P31211,P49920,P50451,Q06770,Q5R9E3,Q5RF65,Q60543,Q9H227" charOffset="31-34" type="protein" text="CBG"/>
            <pair e1="DS.d1324.s2.e0" e2="DS.d1324.s2.e1" id="DS.d1324.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1325" origId="18817797">
        <sentence id="DS.d1325.s0" origId="18817797-263" text="The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain.">
            <entity id="DS.d1325.s0.e0" origId="54454,4677798" charOffset="17-28" type="compound" text="simvastatin"/>
            <entity id="DS.d1325.s0.e1" origId="60823" charOffset="30-42" type="compound" text="atorvastatin"/>
            <entity id="DS.d1325.s0.e2" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="72-92" type="protein" text="acetylcholinesterase"/>
            <pair e1="DS.d1325.s0.e0" e2="DS.d1325.s0.e2" id="DS.d1325.s0.i0" interaction="False"/>
            <pair e1="DS.d1325.s0.e1" e2="DS.d1325.s0.e2" id="DS.d1325.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1326" origId="18817816">
        <sentence id="DS.d1326.s0" origId="18817816-1059" text="The expressions of serotonin receptors (5-hydroxytryptamine receptor), corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA in the hypothalamus were detected by real time PCR.">
            <entity id="DS.d1326.s0.e0" origId="Q17239,Q25190,Q25414" charOffset="19-38" type="protein" text="serotonin receptors"/>
            <entity id="DS.d1326.s0.e1" origId="O46635,Q17239,Q25190,Q25414" charOffset="40-68" type="protein" text="5-hydroxytryptamine receptor"/>
            <entity id="DS.d1326.s0.e2" origId="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1" charOffset="71-102" type="protein" text="corticotropin-releasing hormone"/>
            <entity id="DS.d1326.s0.e3" origId="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1" charOffset="104-107" type="protein" text="CRH"/>
            <entity id="DS.d1326.s0.e4" origId="8230,644077,44285245" charOffset="113-133" type="compound" text="arginine vasopressin"/>
            <pair e1="DS.d1326.s0.e4" e2="DS.d1326.s0.e3" id="DS.d1326.s0.i0" interaction="False"/>
            <pair e1="DS.d1326.s0.e4" e2="DS.d1326.s0.e2" id="DS.d1326.s0.i1" interaction="False"/>
            <pair e1="DS.d1326.s0.e4" e2="DS.d1326.s0.e1" id="DS.d1326.s0.i2" interaction="False"/>
            <pair e1="DS.d1326.s0.e4" e2="DS.d1326.s0.e0" id="DS.d1326.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1327" origId="18817841">
        <sentence id="DS.d1327.s0" origId="18817841-391" text="After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, estrone (E1) and estradiol (E2), detected suggesting that the pathway of aromatase is not important in these cell lines.">
            <entity id="DS.d1327.s0.e0" origId="5870" charOffset="82-89" type="compound" text="estrone"/>
            <entity id="DS.d1327.s0.e1" origId="5757" charOffset="99-108" type="compound" text="estradiol"/>
            <entity id="DS.d1327.s0.e2" origId="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28" charOffset="155-164" type="protein" text="aromatase"/>
            <pair e1="DS.d1327.s0.e1" e2="DS.d1327.s0.e2" id="DS.d1327.s0.i0" interaction="False"/>
            <pair e1="DS.d1327.s0.e0" e2="DS.d1327.s0.e2" id="DS.d1327.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1328" origId="18817845">
        <sentence id="DS.d1328.s0" origId="18817845-305" text="The aim of this study was to investigate the effects of acute and chronic exercise on thiobarbituric acid reactive substances, as an indicator of lipid peroxidation, in the hippocampus, which has a high concentration of glucocorticoid receptors, and prefrontal cortex and striatum, which have high dopamine content.">
            <entity id="DS.d1328.s0.e0" origId="2723628" charOffset="86-105" type="compound" text="thiobarbituric acid"/>
            <entity id="DS.d1328.s0.e1" origId="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3" charOffset="220-244" type="protein" text="glucocorticoid receptors"/>
            <entity id="DS.d1328.s0.e2" origId="681" charOffset="298-306" type="compound" text="dopamine"/>
            <pair e1="DS.d1328.s0.e0" e2="DS.d1328.s0.e1" id="DS.d1328.s0.i0" interaction="False"/>
            <pair e1="DS.d1328.s0.e2" e2="DS.d1328.s0.e1" id="DS.d1328.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1328.s1" origId="18817845-306" text="Additionally we examined antioxidant enzyme activities, superoxide dismutase and glutathione peroxidase and nitrite-nitrate levels to assess the effects of reactive oxygen and nitrogen species.">
            <entity id="DS.d1328.s1.e0" origId="O50258" charOffset="56-76" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1328.s1.e1" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="81-103" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d1328.s1.e2" origId="943" charOffset="116-123" type="compound" text="nitrate"/>
            <pair e1="DS.d1328.s1.e2" e2="DS.d1328.s1.e0" id="DS.d1328.s1.i0" interaction="False"/>
            <pair e1="DS.d1328.s1.e2" e2="DS.d1328.s1.e1" id="DS.d1328.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1329" origId="18818063">
        <sentence id="DS.d1329.s0" origId="18818063-283" text="Oral administration of (PhSe)(2) in rats did not change plasma alanine and aspartate aminotransferase activities (AST and ALT) as well as urea and creatinine levels.">
            <entity id="DS.d1329.s0.e0" origId="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56" charOffset="75-101" type="protein" text="aspartate aminotransferase"/>
            <entity id="DS.d1329.s0.e1" origId="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67" charOffset="114-117" type="protein" text="AST"/>
            <entity id="DS.d1329.s0.e2" origId="1176,265993" charOffset="138-142" type="compound" text="urea"/>
            <entity id="DS.d1329.s0.e3" origId="588" charOffset="147-157" type="compound" text="creatinine"/>
            <pair e1="DS.d1329.s0.e2" e2="DS.d1329.s0.e0" id="DS.d1329.s0.i0" interaction="False"/>
            <pair e1="DS.d1329.s0.e2" e2="DS.d1329.s0.e1" id="DS.d1329.s0.i1" interaction="False"/>
            <pair e1="DS.d1329.s0.e3" e2="DS.d1329.s0.e0" id="DS.d1329.s0.i2" interaction="False"/>
            <pair e1="DS.d1329.s0.e3" e2="DS.d1329.s0.e1" id="DS.d1329.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1330" origId="18818229">
        <sentence id="DS.d1330.s0" origId="18818229-311" text="Total plasma homocysteine level, MTHFR C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and cobalamin levels were determined.">
            <entity id="DS.d1330.s0.e0" origId="778" charOffset="13-25" type="compound" text="homocysteine"/>
            <entity id="DS.d1330.s0.e1" origId="P42898,Q5I598,Q60HE5" charOffset="33-38" type="protein" text="MTHFR"/>
            <entity id="DS.d1330.s0.e2" origId="6037" charOffset="137-143" type="compound" text="folate"/>
            <entity id="DS.d1330.s0.e3" origId="3034082,6713940,25243974" charOffset="148-157" type="compound" text="cobalamin"/>
            <pair e1="DS.d1330.s0.e0" e2="DS.d1330.s0.e1" id="DS.d1330.s0.i0" interaction="False"/>
            <pair e1="DS.d1330.s0.e3" e2="DS.d1330.s0.e1" id="DS.d1330.s0.i1" interaction="False"/>
            <pair e1="DS.d1330.s0.e2" e2="DS.d1330.s0.e1" id="DS.d1330.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1331" origId="18818289">
        <sentence id="DS.d1331.s0" origId="18818289-2648" text="Immunohistochemical colabeling for nesfatin-1 and ghrelin, histidine decarboxylase, or somatostatin revealed two subtypes of nesfatin-1-positive endocrine cells.">
            <entity id="DS.d1331.s0.e0" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="50-57" type="protein" text="ghrelin"/>
            <entity id="DS.d1331.s0.e1" origId="P05034,P16453,P19113,P23738,P28577,P28578,P54772,P95477,Q05733,Q56581,Q5EA83,Q8L0Z4,Q98A07" charOffset="59-82" type="protein" text="histidine decarboxylase"/>
            <entity id="DS.d1331.s0.e2" origId="16129681,16129706" charOffset="87-99" type="compound" text="somatostatin"/>
            <pair e1="DS.d1331.s0.e2" e2="DS.d1331.s0.e0" id="DS.d1331.s0.i0" interaction="False"/>
            <pair e1="DS.d1331.s0.e2" e2="DS.d1331.s0.e1" id="DS.d1331.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1331.s1" origId="18818289-2649" text="Cells in the midportion of the glands coexpressed nesfatin-1 and ghrelin, whereas few cells in the glandular base coexpressed nesfatin-1 and somatostatin or histidine decarboxylase.">
            <entity id="DS.d1331.s1.e0" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="65-72" type="protein" text="ghrelin"/>
            <entity id="DS.d1331.s1.e1" origId="16129681,16129706" charOffset="141-153" type="compound" text="somatostatin"/>
            <entity id="DS.d1331.s1.e2" origId="P05034,P16453,P19113,P23738,P28577,P28578,P54772,P95477,Q05733,Q56581,Q5EA83,Q8L0Z4,Q98A07" charOffset="157-180" type="protein" text="histidine decarboxylase"/>
            <pair e1="DS.d1331.s1.e1" e2="DS.d1331.s1.e0" id="DS.d1331.s1.i0" interaction="False"/>
            <pair e1="DS.d1331.s1.e1" e2="DS.d1331.s1.e2" id="DS.d1331.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1332" origId="18818294">
        <sentence id="DS.d1332.s0" origId="18818294-345" text="Importantly, tPA and PAI-1 proteins and tPA activity were low/nondetectable in granulosa cells obtained after treatment with hCG and the PG synthesis inhibitor celecoxib.">
            <entity id="DS.d1332.s0.e0" origId="P00750,P11214,P19637,Q28198" charOffset="13-16" type="protein" text="tPA"/>
            <entity id="DS.d1332.s0.e1" origId="P05121,P13909,P20961,P22777,P50449,P79335" charOffset="21-26" type="protein" text="PAI-1"/>
            <entity id="DS.d1332.s0.e2" origId="P00750,P11214,P19637,Q28198" charOffset="40-43" type="protein" text="tPA"/>
            <entity id="DS.d1332.s0.e3" origId="2662" charOffset="160-169" type="compound" text="celecoxib"/>
            <pair e1="DS.d1332.s0.e3" e2="DS.d1332.s0.e0" id="DS.d1332.s0.i0" interaction="True"/>
            <pair e1="DS.d1332.s0.e3" e2="DS.d1332.s0.e1" id="DS.d1332.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1332.s1" origId="18818294-346" text="To determine whether hCG stimulation of tPA and PAI-1 requires PGE2, granulosa cells obtained at 0 h were cultured with hCG plus indomethacin to inhibit PG production; some cells also received PGE2 or an agonist selective for one PGE2 receptor (EP).">
            <entity id="DS.d1332.s1.e0" origId="P00750,P11214,P19637,Q28198" charOffset="40-43" type="protein" text="tPA"/>
            <entity id="DS.d1332.s1.e1" origId="P05121,P13909,P20961,P22777,P50449,P79335" charOffset="48-53" type="protein" text="PAI-1"/>
            <entity id="DS.d1332.s1.e2" origId="3715" charOffset="129-141" type="compound" text="indomethacin"/>
            <pair e1="DS.d1332.s1.e2" e2="DS.d1332.s1.e1" id="DS.d1332.s1.i0" interaction="False"/>
            <pair e1="DS.d1332.s1.e2" e2="DS.d1332.s1.e0" id="DS.d1332.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1333" origId="18818299">
        <sentence id="DS.d1333.s0" origId="18818299-354" text="The role of tanshinone IIA in the treatment of obesity through peroxisome proliferator-activated receptor gamma antagonism.">
            <entity id="DS.d1333.s0.e0" origId="164676" charOffset="12-26" type="compound" text="tanshinone IIA"/>
            <entity id="DS.d1333.s0.e1" origId="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4" charOffset="63-111" type="protein" text="peroxisome proliferator-activated receptor gamma"/>
            <pair e1="DS.d1333.s0.e0" e2="DS.d1333.s0.e1" id="DS.d1333.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1334" origId="18818375">
        <sentence id="DS.d1334.s0" origId="18818375-367" text="In conclusion, the enhanced H(2)O(2) contraction in resistance arteries from SHRs seems to be mediated by increased TXA(2) release from COX-1 followed by elevations in vascular smooth muscle (Ca(2+))(i) levels and O(2)(.">
            <entity id="DS.d1334.s0.e0" origId="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8" charOffset="136-141" type="protein" text="COX-1"/>
            <entity id="DS.d1334.s0.e1" origId="271" charOffset="192-196" type="compound" text="Ca(2"/>
            <pair e1="DS.d1334.s0.e1" e2="DS.d1334.s0.e0" id="DS.d1334.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1335" origId="18818396">
        <sentence id="DS.d1335.s0" origId="18818396-379" text="The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells.">
            <entity id="DS.d1335.s0.e0" origId="P01103,P06876,P10242,P46200" charOffset="4-9" type="protein" text="c-myb"/>
            <entity id="DS.d1335.s0.e1" origId="10036366" charOffset="38-41" type="compound" text="15a"/>
            <pair e1="DS.d1335.s0.e1" e2="DS.d1335.s0.e0" id="DS.d1335.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1335.s1" origId="18818396-380" text="Herein we show that c-Myb expression is subject to posttranscriptional regulation by microRNA (miRNA)-15a.">
            <entity id="DS.d1335.s1.e0" origId="P01103,P06876,P10242,P46200" charOffset="20-25" type="protein" text="c-Myb"/>
            <entity id="DS.d1335.s1.e1" origId="10036366" charOffset="102-105" type="compound" text="15a"/>
            <pair e1="DS.d1335.s1.e1" e2="DS.d1335.s1.e0" id="DS.d1335.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1335.s2" origId="18818396-381" text="Exogenous expression of c-myb mRNA lacking the 3'-UTR partially rescued the miR-15a induced cell-cycle block.">
            <entity id="DS.d1335.s2.e0" origId="P01103,P06876,P10242,P46200" charOffset="24-29" type="protein" text="c-myb"/>
            <entity id="DS.d1335.s2.e1" origId="10036366" charOffset="80-83" type="compound" text="15a"/>
            <pair e1="DS.d1335.s2.e1" e2="DS.d1335.s2.e0" id="DS.d1335.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1335.s3" origId="18818396-382" text="Occupancy of one canonical c-Myb binding site was demonstrated by chromatin immunoprecipitation analysis and shown to be required for miR-15a expression in K562 cells.">
            <entity id="DS.d1335.s3.e0" origId="P01103,P06876,P10242,P46200" charOffset="27-32" type="protein" text="c-Myb"/>
            <entity id="DS.d1335.s3.e1" origId="10036366" charOffset="138-141" type="compound" text="15a"/>
            <pair e1="DS.d1335.s3.e1" e2="DS.d1335.s3.e0" id="DS.d1335.s3.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1335.s4" origId="18818396-384" text="In aggregate, these findings suggest the presence of a c-Myb-miR-15a autoregulatory feedback loop of potential importance in human hematopoiesis.">
            <entity id="DS.d1335.s4.e0" origId="P01103,P06876,P10242,P46200" charOffset="55-60" type="protein" text="c-Myb"/>
            <entity id="DS.d1335.s4.e1" origId="10036366" charOffset="65-68" type="compound" text="15a"/>
            <pair e1="DS.d1335.s4.e1" e2="DS.d1335.s4.e0" id="DS.d1335.s4.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1336" origId="18818486">
        <sentence id="DS.d1336.s0" origId="18818486-396" text="The central homeostasis is characterized by increased cerebrocortical synaptosomal T(3) content, deiodinase type II (DII) activity, and cAMP content.">
            <entity id="DS.d1336.s0.e0" origId="P0C187,Q2RSB3" charOffset="117-120" type="protein" text="DII"/>
            <entity id="DS.d1336.s0.e1" origId="6076" charOffset="136-140" type="compound" text="cAMP"/>
            <pair e1="DS.d1336.s0.e1" e2="DS.d1336.s0.e0" id="DS.d1336.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1337" origId="18818687">
        <sentence id="DS.d1337.s0" origId="18818687-454" text="This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for aldosterone signaling and the control of epithelial Na(+) channel-alpha (ENaCalpha) subunit gene expression in the collecting duct.">
            <entity id="DS.d1337.s0.e0" origId="5839" charOffset="148-159" type="compound" text="aldosterone"/>
            <entity id="DS.d1337.s0.e1" origId="P02719" charOffset="200-213" type="protein" text="Na(+) channel"/>
            <pair e1="DS.d1337.s0.e0" e2="DS.d1337.s0.e1" id="DS.d1337.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1338" origId="18818710">
        <sentence id="DS.d1338.s0" origId="18818710-2729" text="We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (GCV) therapy directed by the carcinoembryonic antigen (CEA) promoter.">
            <entity id="DS.d1338.s0.e1" origId="3454" charOffset="237-248" type="compound" text="ganciclovir"/>
            <entity id="DS.d1338.s0.e2" origId="445994" charOffset="250-253" type="compound" text="GCV"/>
            <entity id="DS.d1338.s0.e3" origId="P06731" charOffset="279-303" type="protein" text="carcinoembryonic antigen"/>
            <entity id="DS.d1338.s0.e4" origId="P06731" charOffset="305-308" type="protein" text="CEA"/>
            <pair e1="DS.d1338.s0.e1" e2="DS.d1338.s0.e3" id="DS.d1338.s0.i0" interaction="True"/>
            <pair e1="DS.d1338.s0.e2" e2="DS.d1338.s0.e4" id="DS.d1338.s0.i1" interaction="True"/>
            <pair e1="DS.d1338.s0.e1" e2="DS.d1338.s0.e4" id="DS.d1338.s0.i2" interaction="True"/>
            <pair e1="DS.d1338.s0.e2" e2="DS.d1338.s0.e3" id="DS.d1338.s0.i4" interaction="True"/>
        </sentence>
        <sentence id="DS.d1338.s1" origId="18818710-2730" text="Cytopathic effects of AxdAdB-3 plus AxCEAprTK (an adenovirus expressing HSVtk directed by CEA promoter) or AxCAHSVtk (an adenovirus expressing HSVtk directed by a nonspecific CAG promoter) with GCV administration were examined in several GBC lines and normal cells.">
            <entity id="DS.d1338.s1.e1" origId="Q00398" charOffset="175-178" type="protein" text="CAG"/>
            <entity id="DS.d1338.s1.e2" origId="445994" charOffset="194-197" type="compound" text="GCV"/>
            <pair e1="DS.d1338.s1.e2" e2="DS.d1338.s1.e1" id="DS.d1338.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1340" origId="18818946">
        <sentence id="DS.d1340.s0" origId="18818946-557" text="This mutation in the SLC2A10 gene replaces a cysteine encoding codon with a stop signal.">
            <entity id="DS.d1340.s0.e0" origId="O95528" charOffset="21-28" type="protein" text="SLC2A10"/>
            <entity id="DS.d1340.s0.e1" origId="594,5862,5360637" charOffset="45-53" type="compound" text="cysteine"/>
            <pair e1="DS.d1340.s0.e1" e2="DS.d1340.s0.e0" id="DS.d1340.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1341" origId="18819019">
        <sentence id="DS.d1341.s0" origId="18819019-595" text="Cyclophilin A (CypA), a receptor for the immunosuppressive agent cyclosporin A (CsA), is a cis-trans peptidyl-prolyl isomerase (PPIase) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.">
            <entity id="DS.d1341.s0.e0" origId="O53021,P0AFL3,P0AFL4,P0AFL5,P10111,P14851,P17742,P62935,P62936,P62937,P62938,P62940,P62941,Q0ZQK3,Q0ZQK6,Q0ZQK7,Q0ZQK8,Q0ZQL0,Q0ZQL1,Q0ZQL2,Q59641,Q5R8S7,Q6DTV9,Q8HXS3,Q9TTC6" charOffset="0-13" type="protein" text="Cyclophilin A"/>
            <entity id="DS.d1341.s0.e1" origId="O08469" charOffset="15-19" type="protein" text="CypA"/>
            <entity id="DS.d1341.s0.e2" origId="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938" charOffset="65-78" type="compound" text="cyclosporin A"/>
            <entity id="DS.d1341.s0.e3" origId="O00060,O00845,O04287,O07046,O08437,O22870,O25748,O25982,O42123,O46638,O49886,O52980,O54998,O60046,O66105,O74191,O75344,O83369,O94746,O95302,P0A9K9,P0A9L0,P0A9L1,P0A9L2,P0A9L3,P0A9L4,P0ABZ6,P0ABZ7,P0ABZ8,P0ABZ9,P0AEM0,P0AEM1,P0AEM2,P0AEM3,P0C196,P0C1B0,P0C1I4,P0C1I5,P0C1I6,P0C1J1,P0C1J3,P0C1J4,P0C1J5,P0C1J6,P0C1J7,P10255,P14088,P14832,P15425,P18203,P18253,P21568,P21569,P21863,P22011,P23284,P23285,P24367,P24368,P24369,P24525,P25007,P25334,P25719,P26623,P26882,P26883,P26884,P26885,P27124,P28517,P28870,P29117,P29820,P30404,P30405,P30412,P30416,P30417,P31106,P32472,P34887,P35176,P35627,P38911,P42693,P44760,P44830,P45523,P45877,P45878,P47103,P48375,P51752,P52009,P52010,P52011,P52012,P52013,P52014,P52015,P52016,P52017,P52018,P53605,P53691,P53728,P54397,P54985,P57599,P59024,P59724,P62942,P62943,P65764,P65765,P69059,P72704,P73789,P80311,P81104,P81531,P82536,P84342,P84343,P91791,Q00688,Q01490,Q02790,Q06205,Q08752,Q09637,Q09734,Q10175,Q11004,Q13356,Q13451,Q26486,Q26551,Q26565,Q2KJC8,Q2U256,Q2U316,Q2U5W8,Q2U6U0,Q2UN37,Q2UPT7,Q38931,Q38935,Q38936,Q39613,Q41649,Q41651,Q43207,Q4HZB8,Q4I1Y1,Q4IBK5,Q4IE79,Q4IN00,Q4INZ9,Q4IPB8,Q4P555,Q4PCH8,Q4PIN7,Q4W9R2,Q4WAQ9,Q4WCR3,Q4WHX4,Q4WLV6,Q4WMB6,Q4WMV5,Q4WVU5,Q57726,Q58235,Q59VR3,Q5ARI5,Q5ASQ0,Q5ATN7,Q5AXD5,Q5AXT6,Q5BAH7,Q5E992,Q5KAW8,Q5KGT9,Q5KHA8,Q5KIJ5,Q5KKX7,Q5KMG3,Q5KNY5,Q5R941,Q5RET2,Q5RF88,Q5UP71,Q5ZLV2,Q5ZXE0,Q61576,Q62446,Q62658,Q64378,Q66H94,Q6BP84,Q6BSE7,Q6BX45,Q6C4C9,Q6CF41,Q6CGG3,Q6CUZ8,Q6CWE8,Q6CX30,Q6DGG0,Q6FK71,Q6FKH7,Q6FMA3,Q6FSC1,Q6KBA8,Q6M981,Q6MWS8,Q754K8,Q756V1,Q7DMA9,Q7RXA6,Q7SCN0,Q7SF72,Q812D3,Q86ZF2,Q871A4,Q89A61,Q8K943,Q8LGG0,Q8WUA2,Q8X191,Q91XW8,Q96AY3,Q99KR7,Q9CR16,Q9CXG3,Q9D0W5,Q9D1M7,Q9D6L8,Q9D787,Q9H2H8,Q9LDC0,Q9LM71,Q9NWM8,Q9NYL4,Q9P3X9,Q9PJK1,Q9QVC8,Q9SCY2,Q9SCY3,Q9TRY0,Q9VL78,Q9Y3C6,Q9Y680,Q9Z247,Q9Z7P3,Q9ZJH5,Q9ZK89" charOffset="128-134" type="protein" text="PPIase"/>
            <pair e1="DS.d1341.s0.e2" e2="DS.d1341.s0.e3" id="DS.d1341.s0.i0" interaction="False"/>
            <pair e1="DS.d1341.s0.e2" e2="DS.d1341.s0.e1" id="DS.d1341.s0.i1" interaction="True"/>
            <pair e1="DS.d1341.s0.e2" e2="DS.d1341.s0.e0" id="DS.d1341.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1342" origId="18819053">
        <sentence id="DS.d1342.s0" origId="18819053-613" text="While studies have shown that eplerenone does not exhibit nonspecific actions on androgen receptor, its effects on steroid hormone production have not been reported.">
            <entity id="DS.d1342.s0.e0" origId="443872" charOffset="30-40" type="compound" text="eplerenone"/>
            <entity id="DS.d1342.s0.e1" origId="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90" charOffset="81-98" type="protein" text="androgen receptor"/>
            <pair e1="DS.d1342.s0.e0" e2="DS.d1342.s0.e1" id="DS.d1342.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1343" origId="18819705">
        <sentence id="DS.d1343.s0" origId="18819705-825" text="New treatments for type 2 diabetes mellitus are needed to retain insulin-glucose coupling and lower the risk of weight gain and hypoglycaemia.">
            <entity id="DS.d1343.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="65-72" type="protein" text="insulin"/>
            <entity id="DS.d1343.s0.e1" origId="206,5793,64689,79025" charOffset="73-80" type="compound" text="glucose"/>
            <pair e1="DS.d1343.s0.e1" e2="DS.d1343.s0.e0" id="DS.d1343.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1344" origId="18819713">
        <sentence id="DS.d1344.s0" origId="18819713-827" text="The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total glutathione (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).">
            <entity id="DS.d1344.s0.e0" origId="124886" charOffset="87-98" type="compound" text="glutathione"/>
            <entity id="DS.d1344.s0.e1" origId="O50258" charOffset="144-164" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1344.s0.e2" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="166-169" type="protein" text="SOD"/>
            <entity id="DS.d1344.s0.e3" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="172-180" type="protein" text="catalase"/>
            <entity id="DS.d1344.s0.e4" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="182-185" type="protein" text="CAT"/>
            <entity id="DS.d1344.s0.e5" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="188-209" type="protein" text="glutathione reductase"/>
            <entity id="DS.d1344.s0.e6" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="216-238" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d1344.s0.e7" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="249-274" type="protein" text="glutathione S-transferase"/>
            <entity id="DS.d1344.s0.e8" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="276-279" type="protein" text="GST"/>
            <pair e1="DS.d1344.s0.e0" e2="DS.d1344.s0.e4" id="DS.d1344.s0.i0" interaction="False"/>
            <pair e1="DS.d1344.s0.e0" e2="DS.d1344.s0.e8" id="DS.d1344.s0.i1" interaction="False"/>
            <pair e1="DS.d1344.s0.e0" e2="DS.d1344.s0.e2" id="DS.d1344.s0.i2" interaction="False"/>
            <pair e1="DS.d1344.s0.e0" e2="DS.d1344.s0.e7" id="DS.d1344.s0.i3" interaction="False"/>
            <pair e1="DS.d1344.s0.e0" e2="DS.d1344.s0.e1" id="DS.d1344.s0.i4" interaction="False"/>
            <pair e1="DS.d1344.s0.e0" e2="DS.d1344.s0.e5" id="DS.d1344.s0.i5" interaction="False"/>
            <pair e1="DS.d1344.s0.e0" e2="DS.d1344.s0.e6" id="DS.d1344.s0.i6" interaction="False"/>
            <pair e1="DS.d1344.s0.e0" e2="DS.d1344.s0.e3" id="DS.d1344.s0.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1345" origId="18819820">
        <sentence id="DS.d1345.s0" origId="18819820-872" text="Augmentation of antibody responses by retinoic acid and costimulatory molecules.">
            <entity id="DS.d1345.s0.e0" origId="444795" charOffset="38-51" type="compound" text="retinoic acid"/>
            <entity id="DS.d1345.s0.e1" origId="Q5ZPR3,Q7TPB4,Q8VE98" charOffset="56-79" type="protein" text="costimulatory molecules"/>
            <pair e1="DS.d1345.s0.e0" e2="DS.d1345.s0.e1" id="DS.d1345.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1346" origId="18820127">
        <sentence id="DS.d1346.s0" origId="18820127-944" text="In accord with published results, we could show that treatment with 17AAG resulted in depletion of Chk1, a known Hsp90 client protein.">
            <entity id="DS.d1346.s0.e0" origId="6440175" charOffset="68-73" type="compound" text="17AAG"/>
            <entity id="DS.d1346.s0.e1" origId="O35280,P34208,Q6DE87,Q91ZN7" charOffset="99-103" type="protein" text="Chk1"/>
            <entity id="DS.d1346.s0.e2" origId="P40292,P41887,Q90474" charOffset="113-118" type="protein" text="Hsp90"/>
            <pair e1="DS.d1346.s0.e0" e2="DS.d1346.s0.e1" id="DS.d1346.s0.i0" interaction="True"/>
            <pair e1="DS.d1346.s0.e0" e2="DS.d1346.s0.e2" id="DS.d1346.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1346.s1" origId="18820127-945" text="In addition, we observed a time- and dose-dependent decrease in Wee1 kinase level, a negative regulator of mitosis, after 17AAG treatment in gastrointestinal cancer cells.">
            <entity id="DS.d1346.s1.e0" origId="P07527,P47810,Q63802" charOffset="64-68" type="protein" text="Wee1"/>
            <entity id="DS.d1346.s1.e1" origId="6440175" charOffset="122-127" type="compound" text="17AAG"/>
            <pair e1="DS.d1346.s1.e1" e2="DS.d1346.s1.e0" id="DS.d1346.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1347" origId="18820134">
        <sentence id="DS.d1347.s0" origId="18820134-953" text="Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.">
            <entity id="DS.d1347.s0.e0" origId="Q8JFG3" charOffset="0-21" type="protein" text="Tumor necrosis factor"/>
            <entity id="DS.d1347.s0.e1" origId="62959" charOffset="86-99" type="compound" text="trovafloxacin"/>
            <pair e1="DS.d1347.s0.e1" e2="DS.d1347.s0.e0" id="DS.d1347.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1348" origId="18820153">
        <sentence id="DS.d1348.s0" origId="18820153-959" text="A small cytoplasmic protein, MURR1, has been identified in human hepatic tissue, but its role in Cu metabolism is unknown.">
            <entity id="DS.d1348.s0.e0" origId="Q8N668,Q8WMD0" charOffset="29-34" type="protein" text="MURR1"/>
            <entity id="DS.d1348.s0.e1" origId="104815" charOffset="97-99" type="compound" text="Cu"/>
            <pair e1="DS.d1348.s0.e1" e2="DS.d1348.s0.e0" id="DS.d1348.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1348.s1" origId="18820153-962" text="As with CCS, they are involved in making Cu available to apo-enzymes inside the cell.">
            <entity id="DS.d1348.s1.e0" origId="O14618,Q42435,Q6PWT7,Q9SEA0" charOffset="8-11" type="protein" text="CCS"/>
            <entity id="DS.d1348.s1.e1" origId="104815" charOffset="41-43" type="compound" text="Cu"/>
            <pair e1="DS.d1348.s1.e1" e2="DS.d1348.s1.e0" id="DS.d1348.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1349" origId="18820175">
        <sentence id="DS.d1349.s0" origId="18820175-973" text="BrdU proliferation assays showed that in vivo proliferation of CD8+ T cells was reduced in ethanol-fed mice, and IL-2-dependent in vitro proliferation of naive CD8+ T cells was also reduced.">
            <entity id="DS.d1349.s0.e0" origId="702" charOffset="91-98" type="compound" text="ethanol"/>
            <entity id="DS.d1349.s0.e1" origId="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84" charOffset="113-117" type="protein" text="IL-2"/>
            <pair e1="DS.d1349.s0.e0" e2="DS.d1349.s0.e1" id="DS.d1349.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1350" origId="18820241">
        <sentence id="DS.d1350.s0" origId="18820241-987" text="Multiple studies suggest increased conversion of cholesterol to bile acids by cholesterol 7alpha-hydroxylase (CYP7A1) protects against dyslipidemia and atherosclerosis.">
            <entity id="DS.d1350.s0.e0" origId="304,5997,6432564,11025495" charOffset="49-60" type="compound" text="cholesterol"/>
            <entity id="DS.d1350.s0.e1" origId="O46491,P18125,P22680,P46634,P51542,Q64505" charOffset="78-108" type="protein" text="cholesterol 7alpha-hydroxylase"/>
            <entity id="DS.d1350.s0.e2" origId="O46491,P22680,P46634,P51542" charOffset="110-116" type="protein" text="CYP7A1"/>
            <pair e1="DS.d1350.s0.e0" e2="DS.d1350.s0.e1" id="DS.d1350.s0.i0" interaction="True"/>
            <pair e1="DS.d1350.s0.e0" e2="DS.d1350.s0.e2" id="DS.d1350.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1351" origId="18820279">
        <sentence id="DS.d1351.s0" origId="18820279-997" text="Therefore, we queried whether rosuvastatin is prosurvival in podocytes through a p21-dependent pathway.">
            <entity id="DS.d1351.s0.e0" origId="446157" charOffset="30-42" type="compound" text="rosuvastatin"/>
            <entity id="DS.d1351.s0.e1" origId="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2" charOffset="81-84" type="protein" text="p21"/>
            <pair e1="DS.d1351.s0.e0" e2="DS.d1351.s0.e1" id="DS.d1351.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1352" origId="18820825">
        <sentence id="DS.d1352.s0" origId="18820825-2189" text="Treatment with pioglitazone, associated with metformin, showed a reduction of IL-6 monocyte production after their in vitro activation with LPS.">
            <entity id="DS.d1352.s0.e0" origId="4091" charOffset="45-54" type="compound" text="metformin"/>
            <entity id="DS.d1352.s0.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="78-82" type="protein" text="IL-6"/>
            <pair e1="DS.d1352.s0.e0" e2="DS.d1352.s0.e1" id="DS.d1352.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1353" origId="18820838">
        <sentence id="DS.d1353.s0" origId="18820838-1229" text="Regulation of T-type Cav3.1 channels expression by synthetic glucocorticoid dexamethasone in neonatal cardiac myocytes.">
            <entity id="DS.d1353.s0.e0" origId="P51637,P51638" charOffset="21-25" type="protein" text="Cav3"/>
            <entity id="DS.d1353.s0.e1" origId="5743" charOffset="76-89" type="compound" text="dexamethasone"/>
            <pair e1="DS.d1353.s0.e1" e2="DS.d1353.s0.e0" id="DS.d1353.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1354" origId="18820905">
        <sentence id="DS.d1354.s0" origId="18820905-1243" text="The supernatant of the majority of the strains did not release the aglycone from daidzin, suggesting that cell-associated beta-glucosidases (beta-Glu) are mainly responsible for the metabolism of soybean glyco-conjugates.">
            <entity id="DS.d1354.s0.e0" origId="107971,1023571,4183640,11992452,44257214" charOffset="81-88" type="compound" text="daidzin"/>
            <entity id="DS.d1354.s0.e1" origId="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684" charOffset="122-139" type="protein" text="beta-glucosidases"/>
            <entity id="DS.d1354.s0.e2" origId="P00864" charOffset="146-149" type="protein" text="Glu"/>
            <pair e1="DS.d1354.s0.e0" e2="DS.d1354.s0.e2" id="DS.d1354.s0.i0" interaction="False"/>
            <pair e1="DS.d1354.s0.e0" e2="DS.d1354.s0.e1" id="DS.d1354.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1355" origId="18820913">
        <sentence id="DS.d1355.s0" origId="18820913-1250" text="Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.">
            <entity id="DS.d1355.s0.e0" origId="Q9UNQ0" charOffset="8-12" type="protein" text="BCRP"/>
            <entity id="DS.d1355.s0.e1" origId="3385" charOffset="57-71" type="compound" text="5-fluorouracil"/>
            <pair e1="DS.d1355.s0.e1" e2="DS.d1355.s0.e0" id="DS.d1355.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1356" origId="18821018">
        <sentence id="DS.d1356.s0" origId="18821018-1286" text="Acute regulation is mediated by the steroidogenic acute regulatory protein (StAR), which facilitates the rapid influx of cholesterol into mitochondria, where P450scc resides.">
            <entity id="DS.d1356.s0.e0" origId="P58864,Q9DG08" charOffset="36-74" type="protein" text="steroidogenic acute regulatory protein"/>
            <entity id="DS.d1356.s0.e1" origId="O46689,P49675,P51557,P58864,P70114,P79245,P97826,Q28918,Q28996,Q9DE06,Q9DEB4,Q9DG08,Q9DG09,Q9DG10" charOffset="76-80" type="protein" text="StAR"/>
            <entity id="DS.d1356.s0.e2" origId="304,5997,6432564,11025495" charOffset="121-132" type="compound" text="cholesterol"/>
            <pair e1="DS.d1356.s0.e2" e2="DS.d1356.s0.e0" id="DS.d1356.s0.i0" interaction="True"/>
            <pair e1="DS.d1356.s0.e2" e2="DS.d1356.s0.e1" id="DS.d1356.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1356.s1" origId="18821018-1287" text="In the absence of P450c17 in the zona glomerulosa, C21 deoxy steroids are produced, leading to the mineralocorticoid, aldosterone.">
            <entity id="DS.d1356.s1.e0" origId="O57525,O73853,P05093,P05185,P11715,P12394,P19100,P27786,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q91Z85,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7" charOffset="18-25" type="protein" text="P450c17"/>
            <entity id="DS.d1356.s1.e1" origId="5839" charOffset="118-129" type="compound" text="aldosterone"/>
            <pair e1="DS.d1356.s1.e1" e2="DS.d1356.s1.e0" id="DS.d1356.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1356.s2" origId="18821018-1288" text="In the presence of the 17alpha-hydroxylase but not the 17,20 lyase activity of P450c17 in the zona fasciculata, C21, 17-hydroxy steroids are produced, leading to the glucocorticoid, cortisol.">
            <entity id="DS.d1356.s2.e0" origId="O57525,O73853,P05093,P05185,P11715,P12394,P19100,P27786,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q91Z85,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7" charOffset="79-86" type="protein" text="P450c17"/>
            <entity id="DS.d1356.s2.e1" origId="5754" charOffset="182-190" type="compound" text="cortisol"/>
            <pair e1="DS.d1356.s2.e1" e2="DS.d1356.s2.e0" id="DS.d1356.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1356.s3" origId="18821018-1289" text="When both the 17alpha-hydroxylase and 17,20 lyase activities of P450c17 are present in the zona reticularis, the androgen precursor DHEA is produced.">
            <entity id="DS.d1356.s3.e0" origId="O57525,O73853,P05093,P05185,P11715,P12394,P19100,P27786,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q91Z85,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7" charOffset="64-71" type="protein" text="P450c17"/>
            <entity id="DS.d1356.s3.e1" origId="5881" charOffset="132-136" type="compound" text="DHEA"/>
            <pair e1="DS.d1356.s3.e1" e2="DS.d1356.s3.e0" id="DS.d1356.s3.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1356.s4" origId="18821018-1291" text="In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and cytochrome b5, and the low expression of 3beta-hydroxysteroid dehydrogenase (HSD3B2) result in the production of the large amounts of DHEA that characterize adrenarche.">
            <entity id="DS.d1356.s4.e0" origId="O04354,P00167,P00168,P00169,P00170,P00171,P00172,P00173,P00174,P40312,P40934,P49096,P49097,P49098,P49100,P56395,Q874I5,Q9HFV1,Q9V4N3,Q9Y706" charOffset="84-97" type="protein" text="cytochrome b5"/>
            <entity id="DS.d1356.s4.e1" origId="P19871" charOffset="125-159" type="protein" text="3beta-hydroxysteroid dehydrogenase"/>
            <entity id="DS.d1356.s4.e2" origId="P26439,Q64421" charOffset="161-167" type="protein" text="HSD3B2"/>
            <entity id="DS.d1356.s4.e3" origId="5881" charOffset="218-222" type="compound" text="DHEA"/>
            <pair e1="DS.d1356.s4.e3" e2="DS.d1356.s4.e1" id="DS.d1356.s4.i0" interaction="True"/>
            <pair e1="DS.d1356.s4.e3" e2="DS.d1356.s4.e0" id="DS.d1356.s4.i1" interaction="True"/>
            <pair e1="DS.d1356.s4.e3" e2="DS.d1356.s4.e2" id="DS.d1356.s4.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1357" origId="18821058">
        <sentence id="DS.d1357.s0" origId="18821058-2709" text="These were mutated in onion vacuolar invertase (acINV) according to the residue in festuca sucrose : sucrose 1-fructosyltransferase (saSST) and vice versa.">
            <entity id="DS.d1357.s0.e0" origId="O24509,P29000,P29001,Q43857" charOffset="28-46" type="protein" text="vacuolar invertase"/>
            <entity id="DS.d1357.s0.e1" origId="5988" charOffset="91-98" type="compound" text="sucrose"/>
            <entity id="DS.d1357.s0.e2" origId="P49175" charOffset="101-110" type="protein" text="sucrose 1"/>
            <pair e1="DS.d1357.s0.e1" e2="DS.d1357.s0.e0" id="DS.d1357.s0.i0" interaction="False"/>
            <pair e1="DS.d1357.s0.e1" e2="DS.d1357.s0.e2" id="DS.d1357.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1359" origId="18821127">
        <sentence id="DS.d1359.s0" origId="18821127-1366" text="Optimization of chitosan succinate and chitosan phthalate microspheres for oral delivery of insulin using response surface methodology.">
            <entity id="DS.d1359.s0.e0" origId="1017" charOffset="48-57" type="compound" text="phthalate"/>
            <entity id="DS.d1359.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="92-99" type="protein" text="insulin"/>
            <pair e1="DS.d1359.s0.e0" e2="DS.d1359.s0.e1" id="DS.d1359.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1359.s1" origId="18821127-1367" text="The relative pharmacological efficacy for chitosan phthalate and chitosan succinate microspheres (18.66+/-3.84%, 16.24+/-4%) was almost three-fold higher than the efficacy of the oral insulin administration (4.68+/-1.52%).">
            <entity id="DS.d1359.s1.e0" origId="1017" charOffset="51-60" type="compound" text="phthalate"/>
            <entity id="DS.d1359.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="184-191" type="protein" text="insulin"/>
            <pair e1="DS.d1359.s1.e0" e2="DS.d1359.s1.e1" id="DS.d1359.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1360" origId="18821579">
        <sentence id="DS.d1360.s0" origId="18821579-1511" text="Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor FK228 through AIF translocation.">
            <entity id="DS.d1360.s0.e0" origId="5352062" charOffset="94-99" type="compound" text="FK228"/>
            <entity id="DS.d1360.s0.e1" origId="O95831" charOffset="108-111" type="protein" text="AIF"/>
            <pair e1="DS.d1360.s0.e0" e2="DS.d1360.s0.e1" id="DS.d1360.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1360.s1" origId="18821579-1513" text="FK228 converted unconjugated microtubule-associated protein light chain 3 (LC3-I) to conjugated light chain 3 (LC3-II) and induced localization of LC3 to autophagosomes.">
            <entity id="DS.d1360.s1.e0" origId="5352062" charOffset="0-5" type="compound" text="FK228"/>
            <entity id="DS.d1360.s1.e1" origId="Q00285" charOffset="29-73" type="protein" text="microtubule-associated protein light chain 3"/>
            <entity id="DS.d1360.s1.e2" origId="P82160" charOffset="75-80" type="protein" text="LC3-I"/>
            <entity id="DS.d1360.s1.e3" origId="P82160" charOffset="111-117" type="protein" text="LC3-II"/>
            <entity id="DS.d1360.s1.e4" origId="P82160" charOffset="147-150" type="protein" text="LC3"/>
            <pair e1="DS.d1360.s1.e0" e2="DS.d1360.s1.e1" id="DS.d1360.s1.i0" interaction="True"/>
            <pair e1="DS.d1360.s1.e0" e2="DS.d1360.s1.e2" id="DS.d1360.s1.i1" interaction="True"/>
            <pair e1="DS.d1360.s1.e0" e2="DS.d1360.s1.e3" id="DS.d1360.s1.i2" interaction="True"/>
            <pair e1="DS.d1360.s1.e0" e2="DS.d1360.s1.e4" id="DS.d1360.s1.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d1360.s2" origId="18821579-1514" text="Apoptosis inducing factor (AIF), which plays a role in caspase-independent cell death, translocated to the nucleus in response to FK228 treatment.">
            <entity id="DS.d1360.s2.e0" origId="O95831,Q9JM53,Q9Z0X1" charOffset="0-25" type="protein" text="Apoptosis inducing factor"/>
            <entity id="DS.d1360.s2.e1" origId="O95831" charOffset="27-30" type="protein" text="AIF"/>
            <entity id="DS.d1360.s2.e2" origId="5352062" charOffset="130-135" type="compound" text="FK228"/>
            <pair e1="DS.d1360.s2.e2" e2="DS.d1360.s2.e0" id="DS.d1360.s2.i0" interaction="True"/>
            <pair e1="DS.d1360.s2.e2" e2="DS.d1360.s2.e1" id="DS.d1360.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1361" origId="18821853">
        <sentence id="DS.d1361.s0" origId="18821853-1612" text="Furthermore, the effect of HBO on DDR2 has not been reported previously.">
            <entity id="DS.d1361.s0.e0" origId="445228" charOffset="27-30" type="compound" text="HBO"/>
            <entity id="DS.d1361.s0.e1" origId="P89113,Q16832" charOffset="34-38" type="protein" text="DDR2"/>
            <pair e1="DS.d1361.s0.e0" e2="DS.d1361.s0.e1" id="DS.d1361.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1361.s1" origId="18821853-1613" text="In the present study, we investigated the cellular and molecular mechanisms of DDR2 regulation by HBO in VSMCs (vascular SMCs).">
            <entity id="DS.d1361.s1.e0" origId="P89113,Q16832" charOffset="79-83" type="protein" text="DDR2"/>
            <entity id="DS.d1361.s1.e1" origId="445228" charOffset="98-101" type="compound" text="HBO"/>
            <pair e1="DS.d1361.s1.e1" e2="DS.d1361.s1.e0" id="DS.d1361.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1363" origId="18822099">
        <sentence id="DS.d1363.s0" origId="18822099-1671" text="The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.">
            <entity id="DS.d1363.s0.e1" origId="O75907,Q8MK44,Q9GMF1" charOffset="119-124" type="protein" text="DGAT1"/>
            <entity id="DS.d1363.s0.e2" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="127-133" type="protein" text="leptin"/>
            <entity id="DS.d1363.s0.e3" origId="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8" charOffset="138-152" type="protein" text="growth hormone"/>
            <entity id="DS.d1363.s0.e4" origId="441" charOffset="311-331" type="compound" text="beta-hydroxybutyrate"/>
            <entity id="DS.d1363.s0.e5" origId="206,5793,64689,79025" charOffset="333-340" type="compound" text="glucose"/>
            <pair e1="DS.d1363.s0.e4" e2="DS.d1363.s0.e2" id="DS.d1363.s0.i0" interaction="False"/>
            <pair e1="DS.d1363.s0.e4" e2="DS.d1363.s0.e1" id="DS.d1363.s0.i1" interaction="False"/>
            <pair e1="DS.d1363.s0.e5" e2="DS.d1363.s0.e3" id="DS.d1363.s0.i2" interaction="False"/>
            <pair e1="DS.d1363.s0.e5" e2="DS.d1363.s0.e2" id="DS.d1363.s0.i3" interaction="False"/>
            <pair e1="DS.d1363.s0.e5" e2="DS.d1363.s0.e1" id="DS.d1363.s0.i5" interaction="False"/>
            <pair e1="DS.d1363.s0.e4" e2="DS.d1363.s0.e3" id="DS.d1363.s0.i6" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1364" origId="18822105">
        <sentence id="DS.d1364.s0" origId="18822105-1672" text="Pretransplant conditioning consisted of fludarabine, l-PAM and TBI (2 Gy).">
            <entity id="DS.d1364.s0.e0" origId="657237" charOffset="40-51" type="compound" text="fludarabine"/>
            <entity id="DS.d1364.s0.e1" origId="O75592,P10731,P14925,P19021,P83388,P97467" charOffset="55-58" type="protein" text="PAM"/>
            <pair e1="DS.d1364.s0.e0" e2="DS.d1364.s0.e1" id="DS.d1364.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1365" origId="18822107">
        <sentence id="DS.d1365.s0" origId="18822107-1673" text="Despite pre- and post-operative PP and immunosuppressive treatment consisting of steroids, CycA, daclizumab, and MMF, daily protein excretion and serum creatinine increased.">
            <entity id="DS.d1365.s0.e0" origId="P00083,P00090,P00091,P00094,P00096,P00149,P00154,P04164,P0AAE0,P0AAE1,P0C0X8,P0C189,P38091,P42426,P43302,P56205,Q2RVM4,Q3J164,Q45233,Q57142,Q5SME3,Q9RQB9" charOffset="91-95" type="protein" text="CycA"/>
            <entity id="DS.d1365.s0.e1" origId="P15513" charOffset="113-116" type="protein" text="MMF"/>
            <entity id="DS.d1365.s0.e2" origId="588" charOffset="152-162" type="compound" text="creatinine"/>
            <pair e1="DS.d1365.s0.e2" e2="DS.d1365.s0.e1" id="DS.d1365.s0.i0" interaction="False"/>
            <pair e1="DS.d1365.s0.e2" e2="DS.d1365.s0.e0" id="DS.d1365.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1366" origId="18822278">
        <sentence id="DS.d1366.s0" origId="18822278-1745" text="Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.">
            <entity id="DS.d1366.s0.e0" origId="O14313,O22711,O30973,O32823,O43099,O66790,O69777,O83790,O84101,P0A9P4,P0A9P5,P0AE52,P0AE53,P0AE54,P0AE55,P14292,P14293,P21762,P26830,P30044,P34227,P39916,P40553,P43496,P43788,P44411,P44758,P46843,P47348,P49537,P50971,P51272,P51978,P52213,P52214,P52215,P55979,P56431,P56577,P56578,P56876,P57279,P57399,P61076,P65688,P65689,P66010,P66011,P73728,P75531,P80880,P80892,P81433,P94284,P99029,P99101,Q01116,Q05741,Q25861,Q53212,Q55624,Q5HHQ4,Q5HQW4,Q6BIS1,Q6C7L4,Q6FR39,Q6GB66,Q6GIM7,Q75CM8,Q7Z7S3,Q89AJ2,Q89AS1,Q8CPY8,Q8J0U0,Q8K9W0,Q8T6Z1,Q92375,Q928B5,Q92I02,Q98PK9,Q9BGI1,Q9GLW7,Q9GLW9,Q9KSS4,Q9M7T0,Q9PKT7,Q9PR71,Q9R063,Q9Z8M4,Q9ZD97,Q9ZHF0,Q9ZL18,Q9ZMU4" charOffset="14-35" type="protein" text="thioredoxin reductase"/>
            <entity id="DS.d1366.s0.e1" origId="94304" charOffset="39-50" type="compound" text="mansonone F"/>
            <pair e1="DS.d1366.s0.e1" e2="DS.d1366.s0.e0" id="DS.d1366.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1367" origId="18822413">
        <sentence id="DS.d1367.s0" origId="18822413-1812" text="High-density-lipoproteins-cholesterol (HDL-C) is invertedly related to the incidence of cardiovascular events.">
            <entity id="DS.d1367.s0.e0" origId="P81182" charOffset="0-25" type="protein" text="High-density-lipoproteins"/>
            <entity id="DS.d1367.s0.e1" origId="304,5997,6432564,11025495" charOffset="26-37" type="compound" text="cholesterol"/>
            <pair e1="DS.d1367.s0.e1" e2="DS.d1367.s0.e0" id="DS.d1367.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1368" origId="18823071">
        <sentence id="DS.d1368.s0" origId="18823071-2096" text="An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.">
            <entity id="DS.d1368.s0.e0" origId="O88202,P26900,P30363,P50286,Q9U518" charOffset="59-73" type="protein" text="l-asparaginase"/>
            <entity id="DS.d1368.s0.e1" origId="236,6267,342043,439600" charOffset="89-99" type="compound" text="asparagine"/>
            <pair e1="DS.d1368.s0.e1" e2="DS.d1368.s0.e0" id="DS.d1368.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1369" origId="18823430">
        <sentence id="DS.d1369.s0" origId="18823430-2181" text="Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.">
            <entity id="DS.d1369.s0.e0" origId="P33261" charOffset="11-18" type="protein" text="CYP2C19"/>
            <entity id="DS.d1369.s0.e1" origId="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72" charOffset="23-27" type="protein" text="MDR1"/>
            <entity id="DS.d1369.s0.e2" origId="54688,84029,4663848,5284534,5311050,6426662,11969952,13048687,44629879" charOffset="147-161" type="compound" text="clarithromycin"/>
            <pair e1="DS.d1369.s0.e2" e2="DS.d1369.s0.e1" id="DS.d1369.s0.i0" interaction="False"/>
            <pair e1="DS.d1369.s0.e2" e2="DS.d1369.s0.e0" id="DS.d1369.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1370" origId="18823436">
        <sentence id="DS.d1370.s0" origId="18823436-2183" text="Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling.">
            <entity id="DS.d1370.s0.e0" origId="2662" charOffset="31-40" type="compound" text="celecoxib"/>
            <entity id="DS.d1370.s0.e1" origId="P31750,Q8INB9" charOffset="93-96" type="protein" text="Akt"/>
            <pair e1="DS.d1370.s0.e0" e2="DS.d1370.s0.e1" id="DS.d1370.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1371" origId="18823687">
        <sentence id="DS.d1371.s0" origId="18823687-2243" text="Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.">
            <entity id="DS.d1371.s0.e0" origId="5839" charOffset="28-39" type="compound" text="aldosterone"/>
            <entity id="DS.d1371.s0.e1" origId="O54947" charOffset="115-139" type="protein" text="kidney injury molecule 1"/>
            <pair e1="DS.d1371.s0.e0" e2="DS.d1371.s0.e1" id="DS.d1371.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1372" origId="18823722">
        <sentence id="DS.d1372.s0" origId="18823722-2255" text="Among the R-Nx strains, a substitution of Gly to Cys at position 81 (Gly81&#224; Cys) of the gyrA gene in 10 strains isolated from wild birds and ovine foetuses, and of Asp to Tyr at position 87 (Asp87&#224; Tyr) in one strain isolated from ewe faeces, were revealed by sequencing the gene.">
            <entity id="DS.d1372.s0.e0" origId="750,5460845" charOffset="42-45" type="compound" text="Gly"/>
            <entity id="DS.d1372.s0.e1" origId="O33149,O33926,O50628,O51396,O67108,O83051,O84192,P05653,P0AES4,P0AES5,P0C0Q9,P0C0R0,P14829,P20831,P21557,P22446,P34030,P35810,P35885,P37411,P41080,P41513,P43700,P47235,P47250,P47719,P48354,P48369,P48370,P48371,P48372,P50071,P57277,P72065,P72524,P94605,Q03470,Q07702,Q2FKQ0,Q2G2Q0,Q49166,Q49467,Q49608,Q55738,Q57532,Q5HJZ0,Q5HK04,Q5XC58,Q6GD84,Q6GKT9,Q89AS3,Q8DPM2,Q8K7H2,Q8K9W2,Q8NKW8,Q8P116,Q92IZ6,Q932M0,Q99XG5,Q9L7Q5,Q9PKK4,Q9PR63,Q9Z8R4,Q9ZLD9" charOffset="88-92" type="protein" text="gyrA"/>
            <pair e1="DS.d1372.s0.e0" e2="DS.d1372.s0.e1" id="DS.d1372.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1373" origId="18823727">
        <sentence id="DS.d1373.s0" origId="18823727-2261" text="Expansion of the first polyalanine tract of the ARX gene in a boy presenting with generalized dystonia in the absence of infantile spasms.">
            <entity id="DS.d1373.s0.e0" origId="5950" charOffset="23-34" type="compound" text="polyalanine"/>
            <entity id="DS.d1373.s0.e1" origId="O42115,Q96QS3" charOffset="48-51" type="protein" text="ARX"/>
            <pair e1="DS.d1373.s0.e0" e2="DS.d1373.s0.e1" id="DS.d1373.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1373.s1" origId="18823727-2262" text="Gene sequencing detected an additional seven GCG repeats in the first polyalanine tract of the ARX gene, a mutation which leads to an expansion of the normal 16 alanine residues to 23.">
            <entity id="DS.d1373.s1.e0" origId="5950" charOffset="70-81" type="compound" text="polyalanine"/>
            <entity id="DS.d1373.s1.e1" origId="O42115,Q96QS3" charOffset="95-98" type="protein" text="ARX"/>
            <pair e1="DS.d1373.s1.e0" e2="DS.d1373.s1.e1" id="DS.d1373.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1375" origId="18823877">
        <sentence id="DS.d1375.s0" origId="18823877-2298" text="Emerging evidence that both brain-derived neurotrophic factor (BDNF) and lithium suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.">
            <entity id="DS.d1375.s0.e0" origId="P25430,P25431,P25432,Q06225" charOffset="28-61" type="protein" text="brain-derived neurotrophic factor"/>
            <entity id="DS.d1375.s0.e1" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="63-67" type="protein" text="BDNF"/>
            <entity id="DS.d1375.s0.e2" origId="28486,3028194" charOffset="73-80" type="compound" text="lithium"/>
            <pair e1="DS.d1375.s0.e2" e2="DS.d1375.s0.e0" id="DS.d1375.s0.i0" interaction="False"/>
            <pair e1="DS.d1375.s0.e2" e2="DS.d1375.s0.e1" id="DS.d1375.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1376" origId="18823890">
        <sentence id="DS.d1376.s0" origId="18823890-2301" text="We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.">
            <entity id="DS.d1376.s0.e0" origId="1148,6305,9060,5460840" charOffset="43-53" type="compound" text="tryptophan"/>
            <entity id="DS.d1376.s0.e1" origId="161166" charOffset="61-64" type="compound" text="KYN"/>
            <entity id="DS.d1376.s0.e2" origId="89" charOffset="66-85" type="compound" text="3-hydroxykynurenine"/>
            <entity id="DS.d1376.s0.e3" origId="O50258" charOffset="128-148" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1376.s0.e4" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="156-159" type="protein" text="SOD"/>
            <entity id="DS.d1376.s0.e5" origId="784" charOffset="130-138" type="compound" text="peroxide"/>
            <entity id="DS.d1376.s0.e6" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="226-229" type="protein" text="CRP"/>
            <pair e1="DS.d1376.s0.e1" e2="DS.d1376.s0.e3" id="DS.d1376.s0.i0" interaction="False"/>
            <pair e1="DS.d1376.s0.e0" e2="DS.d1376.s0.e4" id="DS.d1376.s0.i1" interaction="False"/>
            <pair e1="DS.d1376.s0.e0" e2="DS.d1376.s0.e3" id="DS.d1376.s0.i2" interaction="False"/>
            <pair e1="DS.d1376.s0.e1" e2="DS.d1376.s0.e6" id="DS.d1376.s0.i3" interaction="False"/>
            <pair e1="DS.d1376.s0.e5" e2="DS.d1376.s0.e6" id="DS.d1376.s0.i4" interaction="False"/>
            <pair e1="DS.d1376.s0.e2" e2="DS.d1376.s0.e4" id="DS.d1376.s0.i5" interaction="False"/>
            <pair e1="DS.d1376.s0.e1" e2="DS.d1376.s0.e4" id="DS.d1376.s0.i6" interaction="False"/>
            <pair e1="DS.d1376.s0.e2" e2="DS.d1376.s0.e3" id="DS.d1376.s0.i7" interaction="False"/>
            <pair e1="DS.d1376.s0.e0" e2="DS.d1376.s0.e6" id="DS.d1376.s0.i8" interaction="False"/>
            <pair e1="DS.d1376.s0.e5" e2="DS.d1376.s0.e3" id="DS.d1376.s0.i9" interaction="False"/>
            <pair e1="DS.d1376.s0.e5" e2="DS.d1376.s0.e4" id="DS.d1376.s0.i10" interaction="False"/>
            <pair e1="DS.d1376.s0.e2" e2="DS.d1376.s0.e6" id="DS.d1376.s0.i11" interaction="False"/>
        </sentence>
        <sentence id="DS.d1376.s1" origId="18823890-2304" text="ESRD patients showed a significant increase in Cu/Zn SOD, total peroxide and hs CRP levels between controls and all patients group.">
            <entity id="DS.d1376.s1.e0" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="53-56" type="protein" text="SOD"/>
            <entity id="DS.d1376.s1.e1" origId="784" charOffset="64-72" type="compound" text="peroxide"/>
            <entity id="DS.d1376.s1.e2" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="80-83" type="protein" text="CRP"/>
            <pair e1="DS.d1376.s1.e1" e2="DS.d1376.s1.e0" id="DS.d1376.s1.i0" interaction="False"/>
            <pair e1="DS.d1376.s1.e1" e2="DS.d1376.s1.e2" id="DS.d1376.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1377" origId="18823964">
        <sentence id="DS.d1377.s0" origId="18823964-2330" text="Diabetes is characterized by elevated fasting blood glucose (FBG) resulting from improper insulin regulation and/or insulin resistance.">
            <entity id="DS.d1377.s0.e0" origId="206,5793,64689,79025" charOffset="52-59" type="compound" text="glucose"/>
            <entity id="DS.d1377.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="90-97" type="protein" text="insulin"/>
            <entity id="DS.d1377.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="116-123" type="protein" text="insulin"/>
            <pair e1="DS.d1377.s0.e0" e2="DS.d1377.s0.e1" id="DS.d1377.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1377.s1" origId="18823964-2332" text="THII significantly diminished these changes in glucose and insulin.">
            <entity id="DS.d1377.s1.e0" origId="206,5793,64689,79025" charOffset="47-54" type="compound" text="glucose"/>
            <entity id="DS.d1377.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="59-66" type="protein" text="insulin"/>
            <pair e1="DS.d1377.s1.e0" e2="DS.d1377.s1.e1" id="DS.d1377.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1378" origId="18824011">
        <sentence id="DS.d1378.s0" origId="18824011-260" text="Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.">
            <entity id="DS.d1378.s0.e0" origId="951,439260" charOffset="87-100" type="compound" text="noradrenaline"/>
            <entity id="DS.d1378.s0.e1" origId="923,373840" charOffset="102-104" type="compound" text="NA"/>
            <entity id="DS.d1378.s0.e2" origId="5893" charOffset="145-183" type="compound" text="beta-nicotinamide adenine dinucleotide"/>
            <entity id="DS.d1378.s0.e3" origId="5893" charOffset="185-193" type="compound" text="beta-NAD"/>
            <entity id="DS.d1378.s0.e4" origId="P83301,P83390" charOffset="252-261" type="protein" text="conotoxin"/>
            <entity id="DS.d1378.s0.e5" origId="P30288" charOffset="270-288" type="protein" text="omega-agatoxin IVA"/>
            <pair e1="DS.d1378.s0.e2" e2="DS.d1378.s0.e5" id="DS.d1378.s0.i0" interaction="False"/>
            <pair e1="DS.d1378.s0.e1" e2="DS.d1378.s0.e4" id="DS.d1378.s0.i1" interaction="False"/>
            <pair e1="DS.d1378.s0.e3" e2="DS.d1378.s0.e4" id="DS.d1378.s0.i2" interaction="False"/>
            <pair e1="DS.d1378.s0.e1" e2="DS.d1378.s0.e5" id="DS.d1378.s0.i3" interaction="False"/>
            <pair e1="DS.d1378.s0.e2" e2="DS.d1378.s0.e4" id="DS.d1378.s0.i4" interaction="False"/>
            <pair e1="DS.d1378.s0.e0" e2="DS.d1378.s0.e4" id="DS.d1378.s0.i5" interaction="False"/>
            <pair e1="DS.d1378.s0.e0" e2="DS.d1378.s0.e5" id="DS.d1378.s0.i6" interaction="False"/>
            <pair e1="DS.d1378.s0.e3" e2="DS.d1378.s0.e5" id="DS.d1378.s0.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1379" origId="18824106">
        <sentence id="DS.d1379.s0" origId="18824106-2403" text="An extensive kinetic profile towards a plethora of purines and mutational analyses have established models on how UapA recognizes the purine ring and revealed specific amino acid residues involved in proper folding, topogenesis, function and specificity.">
            <entity id="DS.d1379.s0.e0" origId="Q07307" charOffset="114-118" type="protein" text="UapA"/>
            <entity id="DS.d1379.s0.e1" origId="1044" charOffset="134-145" type="compound" text="purine ring"/>
            <pair e1="DS.d1379.s0.e1" e2="DS.d1379.s0.e0" id="DS.d1379.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1379.s1" origId="18824106-2404" text="The present work describes for the first time the purification of the UapA transporter of A. nidulans through overexpression via the strong, ethanol-inducible, glucose-repressible, alcA promoter.">
            <entity id="DS.d1379.s1.e0" origId="Q07307" charOffset="70-74" type="protein" text="UapA"/>
            <entity id="DS.d1379.s1.e1" origId="702" charOffset="141-148" type="compound" text="ethanol"/>
            <entity id="DS.d1379.s1.e2" origId="206,5793,64689,79025" charOffset="160-167" type="compound" text="glucose"/>
            <entity id="DS.d1379.s1.e3" origId="P08843,P65199,P65200,Q44740" charOffset="181-185" type="protein" text="alcA"/>
            <pair e1="DS.d1379.s1.e1" e2="DS.d1379.s1.e0" id="DS.d1379.s1.i0" interaction="True"/>
            <pair e1="DS.d1379.s1.e2" e2="DS.d1379.s1.e0" id="DS.d1379.s1.i1" interaction="True"/>
            <pair e1="DS.d1379.s1.e1" e2="DS.d1379.s1.e3" id="DS.d1379.s1.i2" interaction="True"/>
            <pair e1="DS.d1379.s1.e2" e2="DS.d1379.s1.e3" id="DS.d1379.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1380" origId="18824121">
        <sentence id="DS.d1380.s0" origId="18824121-2411" text="Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).">
            <entity id="DS.d1380.s0.e1" origId="18950" charOffset="46-53" type="compound" text="mannose"/>
            <entity id="DS.d1380.s0.e2" origId="69507" charOffset="87-107" type="compound" text="fructose 6-phosphate"/>
            <entity id="DS.d1380.s0.e3" origId="O66954,P00946,P07874,P25081,P29951,P29952,P29954,P29956,P34650,P34948,P34949,P39841,P59785,Q3SZI0,Q44407,Q4JCA7,Q59935,Q66WM4,Q68FX1,Q75AB5,Q76IQ2,Q83KZ1,Q870Y1,Q887Q9,Q88ND5,Q8HXX2,Q8J093,Q8ZWV0,Q924M7,Q96YC2,Q978F3,Q97WE5,Q9GP38,Q9HFU4,Q9HIC2,Q9YE01" charOffset="110-134" type="protein" text="phosphomannose isomerase"/>
            <entity id="DS.d1380.s0.e4" origId="O66954,P00946,P07874,P25081,P29951,P29952,P29954,P29956,P34650,P34948,P34949,P39841,P59785,Q3SZI0,Q44407,Q4JCA7,Q59935,Q66WM4,Q68FX1,Q75AB5,Q76IQ2,Q83KZ1,Q870Y1,Q887Q9,Q88ND5,Q8HXX2,Q8J093,Q8ZWV0,Q924M7,Q96YC2,Q978F3,Q97WE5,Q9GP38,Q9HFU4,Q9HIC2,Q9YE01" charOffset="136-139" type="protein" text="PMI"/>
            <entity id="DS.d1380.s0.e5" origId="O43976,O85343,P07283,P24175,P26341,P26405,P29955,P31353,P37742,P37755,P45632,P47299,P47723,P55356,P75050,Q00330,Q01411,Q06951,Q48463,Q9UTJ2" charOffset="142-160" type="protein" text="phosphomannomutase"/>
            <entity id="DS.d1380.s0.e6" origId="O43976,O80840,O85343,P07283,P18159,P24175,P26341,P26405,P29955,P31353,P37742,P37755,P45632,P47299,P47723,P55356,P75050,Q00330,Q01411,Q06951,Q48463,Q57290,Q57842,Q9UTJ2,Q9VTZ6,Q9XUE6" charOffset="162-165" type="protein" text="PMM"/>
            <entity id="DS.d1380.s0.e7" origId="O74484,O74624,O85342,O93827,P07874,P24174,P26340,P26404,P29956,P37741,P37753,P37820,P41940,P55357,P59785,Q00473,Q01410,Q07024,Q2UJU5,Q48462,Q4I1Y5,Q4U3E8,Q5B1J4,Q5KKH2,Q6BN12,Q6CCU3,Q70SJ2,Q752H4,Q7RVR8,Q887Q9,Q88ND5,Q9P8N0" charOffset="171-200" type="protein" text="GDP-mannose pyrophosphorylase"/>
            <pair e1="DS.d1380.s0.e2" e2="DS.d1380.s0.e7" id="DS.d1380.s0.i1" interaction="True"/>
            <pair e1="DS.d1380.s0.e2" e2="DS.d1380.s0.e5" id="DS.d1380.s0.i3" interaction="True"/>
            <pair e1="DS.d1380.s0.e2" e2="DS.d1380.s0.e3" id="DS.d1380.s0.i4" interaction="True"/>
            <pair e1="DS.d1380.s0.e1" e2="DS.d1380.s0.e3" id="DS.d1380.s0.i5" interaction="True"/>
            <pair e1="DS.d1380.s0.e1" e2="DS.d1380.s0.e6" id="DS.d1380.s0.i6" interaction="True"/>
            <pair e1="DS.d1380.s0.e1" e2="DS.d1380.s0.e7" id="DS.d1380.s0.i7" interaction="True"/>
            <pair e1="DS.d1380.s0.e2" e2="DS.d1380.s0.e4" id="DS.d1380.s0.i10" interaction="True"/>
            <pair e1="DS.d1380.s0.e2" e2="DS.d1380.s0.e6" id="DS.d1380.s0.i11" interaction="True"/>
            <pair e1="DS.d1380.s0.e1" e2="DS.d1380.s0.e4" id="DS.d1380.s0.i12" interaction="True"/>
            <pair e1="DS.d1380.s0.e1" e2="DS.d1380.s0.e5" id="DS.d1380.s0.i13" interaction="True"/>
        </sentence>
        <sentence id="DS.d1380.s1" origId="18824121-2412" text="Synthesis of GDP-mannose from exogenous mannose requires hexokinase or phosphotransferase enzymes together with PMM and GMPP.">
            <entity id="DS.d1380.s1.e1" origId="18950" charOffset="17-24" type="compound" text="mannose"/>
            <entity id="DS.d1380.s1.e2" origId="18950" charOffset="40-47" type="compound" text="mannose"/>
            <entity id="DS.d1380.s1.e3" origId="P33284,P50506,P80581,Q02155,Q26609,Q969A8" charOffset="57-67" type="protein" text="hexokinase"/>
            <entity id="DS.d1380.s1.e4" origId="O43976,O80840,O85343,P07283,P18159,P24175,P26341,P26405,P29955,P31353,P37742,P37755,P45632,P47299,P47723,P55356,P75050,Q00330,Q01411,Q06951,Q48463,Q57290,Q57842,Q9UTJ2,Q9VTZ6,Q9XUE6" charOffset="112-115" type="protein" text="PMM"/>
            <pair e1="DS.d1380.s1.e1" e2="DS.d1380.s1.e3" id="DS.d1380.s1.i1" interaction="True"/>
            <pair e1="DS.d1380.s1.e1" e2="DS.d1380.s1.e4" id="DS.d1380.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1381" origId="18824341">
        <sentence id="DS.d1381.s0" origId="18824341-1648" text="Preincubation of airway epithelial cells with lycopene (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.">
            <entity id="DS.d1381.s0.e0" origId="446925" charOffset="46-54" type="compound" text="lycopene"/>
            <entity id="DS.d1381.s0.e1" origId="8028" charOffset="69-84" type="compound" text="tetrahydrofuran"/>
            <entity id="DS.d1381.s0.e2" origId="446925" charOffset="96-104" type="compound" text="lycopene"/>
            <entity id="DS.d1381.s0.e3" origId="P41693" charOffset="155-168" type="protein" text="interleukin-6"/>
            <entity id="DS.d1381.s0.e4" origId="P02778,P17515,P48973" charOffset="217-222" type="protein" text="IP-10"/>
            <pair e1="DS.d1381.s0.e0" e2="DS.d1381.s0.e4" id="DS.d1381.s0.i0" interaction="True"/>
            <pair e1="DS.d1381.s0.e1" e2="DS.d1381.s0.e4" id="DS.d1381.s0.i1" interaction="False"/>
            <pair e1="DS.d1381.s0.e0" e2="DS.d1381.s0.e3" id="DS.d1381.s0.i2" interaction="True"/>
            <pair e1="DS.d1381.s0.e1" e2="DS.d1381.s0.e3" id="DS.d1381.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1382" origId="18824415">
        <sentence id="DS.d1382.s0" origId="18824415-2564" text="Thrombin, vascular endothelial growth factor, and hydrogen peroxide increased EC permeability, disrupted cell junctions, and induced stress fiber formation.">
            <entity id="DS.d1382.s0.e0" origId="P84122" charOffset="0-8" type="protein" text="Thrombin"/>
            <entity id="DS.d1382.s0.e1" origId="784" charOffset="50-67" type="compound" text="hydrogen peroxide"/>
            <pair e1="DS.d1382.s0.e1" e2="DS.d1382.s0.e0" id="DS.d1382.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1383" origId="18824476">
        <sentence id="DS.d1383.s0" origId="18824476-2583" text="Clarified glycomic and protemic information combined with publicly available microarray data sets allowed us to identify galectin-3 as a receptor of Galalpha1-3Gal epitope.">
            <entity id="DS.d1383.s0.e0" origId="P08699,P16110,P17931,P38486,P47845,P47953" charOffset="121-131" type="protein" text="galectin-3"/>
            <entity id="DS.d1383.s0.e1" origId="16219440" charOffset="149-163" type="compound" text="Galalpha1-3Gal"/>
            <pair e1="DS.d1383.s0.e1" e2="DS.d1383.s0.e0" id="DS.d1383.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1384" origId="18824496">
        <sentence id="DS.d1384.s0" origId="18824496-2592" text="Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by polyglutamine expansion mutation in the androgen receptor (AR).">
            <entity id="DS.d1384.s0.e0" origId="5961" charOffset="78-91" type="compound" text="polyglutamine"/>
            <entity id="DS.d1384.s0.e1" origId="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90" charOffset="118-135" type="protein" text="androgen receptor"/>
            <pair e1="DS.d1384.s0.e0" e2="DS.d1384.s0.e1" id="DS.d1384.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1385" origId="18824518">
        <sentence id="DS.d1385.s0" origId="18824518-2598" text="Also, our previous studies implicated the SphK1/S1P pathway in the induction of the arachidonic acid cascade, a major inflammatory pathway involved in colon carcinogenesis.">
            <entity id="DS.d1385.s0.e0" origId="Q14703,Q9Z2A8" charOffset="48-51" type="protein" text="S1P"/>
            <entity id="DS.d1385.s0.e1" origId="444899" charOffset="84-100" type="compound" text="arachidonic acid"/>
            <pair e1="DS.d1385.s0.e1" e2="DS.d1385.s0.e0" id="DS.d1385.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1385.s1" origId="18824518-2599" text="In the azoxymethane (AOM) murine model of colon cancer, SphK1 and S1P were significantly elevated in colon cancer tissues compared to normal mucosa.">
            <entity id="DS.d1385.s1.e0" origId="33184" charOffset="7-19" type="compound" text="azoxymethane"/>
            <entity id="DS.d1385.s1.e1" origId="33184" charOffset="21-24" type="compound" text="AOM"/>
            <entity id="DS.d1385.s1.e2" origId="Q14703,Q9Z2A8" charOffset="66-69" type="protein" text="S1P"/>
            <pair e1="DS.d1385.s1.e1" e2="DS.d1385.s1.e2" id="DS.d1385.s1.i0" interaction="True"/>
            <pair e1="DS.d1385.s1.e0" e2="DS.d1385.s1.e2" id="DS.d1385.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1386" origId="18824524">
        <sentence id="DS.d1386.s0" origId="18824524-2604" text="Uptake of valsartan, losartan, and cefadroxil was quantified in HeLa cells after heterologous expression of human PEPT1 (hPEPT1).">
            <entity id="DS.d1386.s0.e0" origId="60846" charOffset="10-19" type="compound" text="valsartan"/>
            <entity id="DS.d1386.s0.e1" origId="3961" charOffset="21-29" type="compound" text="losartan"/>
            <entity id="DS.d1386.s0.e2" origId="47965" charOffset="35-45" type="compound" text="cefadroxil"/>
            <entity id="DS.d1386.s0.e3" origId="P36836,P46059,Q8WMX5" charOffset="114-119" type="protein" text="PEPT1"/>
            <pair e1="DS.d1386.s0.e0" e2="DS.d1386.s0.e3" id="DS.d1386.s0.i0" interaction="False"/>
            <pair e1="DS.d1386.s0.e1" e2="DS.d1386.s0.e3" id="DS.d1386.s0.i1" interaction="False"/>
            <pair e1="DS.d1386.s0.e2" e2="DS.d1386.s0.e3" id="DS.d1386.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d1386.s1" origId="18824524-2605" text="In contrast to cefadroxil, no PEPT1-specific uptake of valsartan and losartan was found.">
            <entity id="DS.d1386.s1.e0" origId="47965" charOffset="15-25" type="compound" text="cefadroxil"/>
            <entity id="DS.d1386.s1.e1" origId="P36836,P46059,Q8WMX5" charOffset="30-35" type="protein" text="PEPT1"/>
            <entity id="DS.d1386.s1.e2" origId="60846" charOffset="55-64" type="compound" text="valsartan"/>
            <entity id="DS.d1386.s1.e3" origId="3961" charOffset="69-77" type="compound" text="losartan"/>
            <pair e1="DS.d1386.s1.e2" e2="DS.d1386.s1.e1" id="DS.d1386.s1.i0" interaction="False"/>
            <pair e1="DS.d1386.s1.e3" e2="DS.d1386.s1.e1" id="DS.d1386.s1.i1" interaction="False"/>
            <pair e1="DS.d1386.s1.e0" e2="DS.d1386.s1.e1" id="DS.d1386.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1387" origId="18824527">
        <sentence id="DS.d1387.s0" origId="18824527-2607" text="The 2-(acylamino)-3-thiophenecarboxylates suppressed CFTR-mediated Cl (-) current in T84 colonic cells in response to cholera and Escherichia coli (STa) toxins, and prevented intestinal fluid accumulation in a closed-loop mouse model of secretory diarrhea.">
            <entity id="DS.d1387.s0.e0" origId="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2" charOffset="53-57" type="protein" text="CFTR"/>
            <entity id="DS.d1387.s0.e1" origId="312" charOffset="67-69" type="compound" text="Cl"/>
            <pair e1="DS.d1387.s0.e1" e2="DS.d1387.s0.e0" id="DS.d1387.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1388" origId="18824596">
        <sentence id="DS.d1388.s0" origId="18824596-2638" text="We investigated the hypothesis that modulation of EPC biology and attenuation of allograft vasculopathy by increased high-density lipoprotein cholesterol after human apo A-I (AdA-I) transfer requires scavenger receptor (SR)-BI expression in bone marrow-derived EPCs.">
            <entity id="DS.d1388.s0.e0" origId="P81182" charOffset="117-141" type="protein" text="high-density lipoprotein"/>
            <entity id="DS.d1388.s0.e1" origId="304,5997,6432564,11025495" charOffset="142-153" type="compound" text="cholesterol"/>
            <pair e1="DS.d1388.s0.e1" e2="DS.d1388.s0.e0" id="DS.d1388.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1389" origId="18824635">
        <sentence id="DS.d1389.s0" origId="18824635-2654" text="Hormone-sensitive lipase (HSL) is a key regulator of cholesterol esters metabolism.">
            <entity id="DS.d1389.s0.e0" origId="P15304,P16386,P54310,Q05469,Q68J42,Q9R101" charOffset="0-24" type="protein" text="Hormone-sensitive lipase"/>
            <entity id="DS.d1389.s0.e1" origId="P15304,P16386,P54310,Q05469,Q68J42,Q9R101" charOffset="26-29" type="protein" text="HSL"/>
            <entity id="DS.d1389.s0.e2" origId="304,5997,6432564,11025495" charOffset="53-64" type="compound" text="cholesterol"/>
            <pair e1="DS.d1389.s0.e2" e2="DS.d1389.s0.e1" id="DS.d1389.s0.i0" interaction="True"/>
            <pair e1="DS.d1389.s0.e2" e2="DS.d1389.s0.e0" id="DS.d1389.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1390" origId="18825162">
        <sentence id="DS.d1390.s0" origId="18825162-2817" text="We found associations between the midazolam phenotype and age, diagnosis of hypertension and one htSNP (141689) located upstream of CYP3A4.">
            <entity id="DS.d1390.s0.e0" origId="4192" charOffset="34-43" type="compound" text="midazolam"/>
            <entity id="DS.d1390.s0.e1" origId="P08684" charOffset="132-138" type="protein" text="CYP3A4"/>
            <pair e1="DS.d1390.s0.e0" e2="DS.d1390.s0.e1" id="DS.d1390.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1391" origId="18825163">
        <sentence id="DS.d1391.s0" origId="18825163-2818" text="Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia.">
            <entity id="DS.d1391.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="0-7" type="protein" text="Insulin"/>
            <entity id="DS.d1391.s0.e1" origId="5757" charOffset="17-27" type="compound" text="oestradiol"/>
            <pair e1="DS.d1391.s0.e1" e2="DS.d1391.s0.e0" id="DS.d1391.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1391.s1" origId="18825163-2819" text="The objective of the present study was to test the insulin, oestradiol and metabolic syndrome hypotheses as promoters of BPH.">
            <entity id="DS.d1391.s1.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="51-58" type="protein" text="insulin"/>
            <entity id="DS.d1391.s1.e1" origId="5757" charOffset="60-70" type="compound" text="oestradiol"/>
            <pair e1="DS.d1391.s1.e1" e2="DS.d1391.s1.e0" id="DS.d1391.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1391.s2" origId="18825163-2820" text="Using a multivariate analysis, BPH as measured by the total prostate gland volume correlated statistically significantly with fasting serum insulin (beta=0.200, P=0.028), free oestradiol (beta=0.233, P=0.008) and lean body mass (beta=0.257, P=0.034).">
            <entity id="DS.d1391.s2.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="140-147" type="protein" text="insulin"/>
            <entity id="DS.d1391.s2.e1" origId="5757" charOffset="176-186" type="compound" text="oestradiol"/>
            <pair e1="DS.d1391.s2.e1" e2="DS.d1391.s2.e0" id="DS.d1391.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1391.s3" origId="18825163-2821" text="Insulin and free oestradiol appear to be independent risk factors for BPH, confirming both the insulin and the oestradiol hypotheses.">
            <entity id="DS.d1391.s3.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="0-7" type="protein" text="Insulin"/>
            <entity id="DS.d1391.s3.e1" origId="5757" charOffset="17-27" type="compound" text="oestradiol"/>
            <entity id="DS.d1391.s3.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="95-102" type="protein" text="insulin"/>
            <entity id="DS.d1391.s3.e3" origId="5757" charOffset="111-121" type="compound" text="oestradiol"/>
            <pair e1="DS.d1391.s3.e1" e2="DS.d1391.s3.e0" id="DS.d1391.s3.i0" interaction="False"/>
            <pair e1="DS.d1391.s3.e1" e2="DS.d1391.s3.e2" id="DS.d1391.s3.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1392" origId="18825302">
        <sentence id="DS.d1392.s0" origId="18825302-18" text="Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.">
            <entity id="DS.d1392.s0.e0" origId="65981" charOffset="0-11" type="compound" text="Repaglinide"/>
            <entity id="DS.d1392.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="29-36" type="protein" text="insulin"/>
            <pair e1="DS.d1392.s0.e0" e2="DS.d1392.s0.e1" id="DS.d1392.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1393" origId="18825335">
        <sentence id="DS.d1393.s0" origId="18825335-25" text="Much interest has been directed to the study of the TRPV1, because capsaicin has been instrumental in discovering the unique role of a subset of primary sensory neurons in causing nociceptive responses, in activating reflex pathways including cough, and in producing neurogenic inflammation.">
            <entity id="DS.d1393.s0.e0" origId="Q697L1,Q8NER1" charOffset="52-57" type="protein" text="TRPV1"/>
            <entity id="DS.d1393.s0.e1" origId="1548943" charOffset="67-76" type="compound" text="capsaicin"/>
            <pair e1="DS.d1393.s0.e1" e2="DS.d1393.s0.e0" id="DS.d1393.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1394" origId="18825368">
        <sentence id="DS.d1394.s0" origId="18825368-41" text="To evaluate arginine vasopressin (AVP) and copeptin plasma concentrations in patients with vasodilatory shock after cardiac surgery.">
            <entity id="DS.d1394.s0.e0" origId="8230,644077,44285245" charOffset="12-32" type="compound" text="arginine vasopressin"/>
            <entity id="DS.d1394.s0.e1" origId="P01180,P01181,P01183,P01185,P01186,P10769,P35455" charOffset="43-51" type="protein" text="copeptin"/>
            <pair e1="DS.d1394.s0.e0" e2="DS.d1394.s0.e1" id="DS.d1394.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1395" origId="18825380">
        <sentence id="DS.d1395.s0" origId="18825380-47" text="In this study, we report a novel GPIbbeta defect in a Tunisian family, in which Serine 23 is substituted by a Stop codon causing a premature termination of translation.">
            <entity id="DS.d1395.s0.e0" origId="P13224,P56400,Q04785" charOffset="33-41" type="protein" text="GPIbbeta"/>
            <entity id="DS.d1395.s0.e1" origId="5951" charOffset="80-86" type="compound" text="Serine"/>
            <pair e1="DS.d1395.s0.e1" e2="DS.d1395.s0.e0" id="DS.d1395.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1396" origId="18825527">
        <sentence id="DS.d1396.s0" origId="18825527-114" text="Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte acetylcholinesterase (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.">
            <entity id="DS.d1396.s0.e0" origId="1702" charOffset="79-82" type="compound" text="NHP"/>
            <entity id="DS.d1396.s0.e1" origId="11852" charOffset="113-116" type="compound" text="pBr"/>
            <entity id="DS.d1396.s0.e2" origId="134601" charOffset="139-142" type="compound" text="pMe"/>
            <entity id="DS.d1396.s0.e3" origId="1702" charOffset="161-164" type="compound" text="NHP"/>
            <entity id="DS.d1396.s0.e4" origId="11852" charOffset="195-198" type="compound" text="pBr"/>
            <entity id="DS.d1396.s0.e5" origId="134601" charOffset="217-220" type="compound" text="pMe"/>
            <entity id="DS.d1396.s0.e6" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="332-352" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d1396.s0.e7" origId="398803" charOffset="449-460" type="compound" text="compound 2a"/>
            <pair e1="DS.d1396.s0.e7" e2="DS.d1396.s0.e6" id="DS.d1396.s0.i0" interaction="False"/>
            <pair e1="DS.d1396.s0.e0" e2="DS.d1396.s0.e6" id="DS.d1396.s0.i1" interaction="False"/>
            <pair e1="DS.d1396.s0.e1" e2="DS.d1396.s0.e6" id="DS.d1396.s0.i2" interaction="False"/>
            <pair e1="DS.d1396.s0.e2" e2="DS.d1396.s0.e6" id="DS.d1396.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1397" origId="18825528">
        <sentence id="DS.d1397.s0" origId="18825528-117" text="The presented study is aimed at reactivation of trichlorfon-inhibited butyrylcholinesterase since this enzyme play an important role in Alzheimer's disease as deputy for acetylcholinesterase and furthermore it could be applied as a scavenger in case of overdosing.">
            <entity id="DS.d1397.s0.e0" origId="5853" charOffset="48-59" type="compound" text="trichlorfon"/>
            <entity id="DS.d1397.s0.e1" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="170-190" type="protein" text="acetylcholinesterase"/>
            <pair e1="DS.d1397.s0.e0" e2="DS.d1397.s0.e1" id="DS.d1397.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1398" origId="18825531">
        <sentence id="DS.d1398.s0" origId="18825531-118" text="Among them, compound 3 and 5 had significant calpain inhibitory activities.">
            <entity id="DS.d1398.s0.e0" origId="5858639" charOffset="12-22" type="compound" text="compound 3"/>
            <entity id="DS.d1398.s0.e1" origId="P27730" charOffset="45-52" type="protein" text="calpain"/>
            <pair e1="DS.d1398.s0.e0" e2="DS.d1398.s0.e1" id="DS.d1398.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1399" origId="18825537">
        <sentence id="DS.d1399.s0" origId="18825537-122" text="Here we report the docking study of four green tea catechins and four alkylating anticancer drugs into the GST P1-1 model, as GSTs were found to be affected by tea catechins.">
            <entity id="DS.d1399.s0.e0" origId="4630" charOffset="41-50" type="compound" text="green tea"/>
            <entity id="DS.d1399.s0.e1" origId="P80031" charOffset="107-115" type="protein" text="GST P1-1"/>
            <entity id="DS.d1399.s0.e2" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="126-130" type="protein" text="GSTs"/>
            <pair e1="DS.d1399.s0.e0" e2="DS.d1399.s0.e1" id="DS.d1399.s0.i0" interaction="True"/>
            <pair e1="DS.d1399.s0.e0" e2="DS.d1399.s0.e2" id="DS.d1399.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1400" origId="18825553">
        <sentence id="DS.d1400.s0" origId="18825553-139" text="The protein glycation inhibitory activity of ethanolic extract of Lawsonia inermis (henna) plant tissues was evaluated in vitro using the model system of bovine serum albumin and glucose.">
            <entity id="DS.d1400.s0.e0" origId="P21847,P83517" charOffset="161-174" type="protein" text="serum albumin"/>
            <entity id="DS.d1400.s0.e1" origId="206,5793,64689,79025" charOffset="179-186" type="compound" text="glucose"/>
            <pair e1="DS.d1400.s0.e1" e2="DS.d1400.s0.e0" id="DS.d1400.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1401" origId="18825555">
        <sentence id="DS.d1401.s0" origId="18825555-141" text="In vitro effects of peroxynitrite treatment on fish liver catalase activity.">
            <entity id="DS.d1401.s0.e0" origId="104806" charOffset="20-33" type="compound" text="peroxynitrite"/>
            <entity id="DS.d1401.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="58-66" type="protein" text="catalase"/>
            <pair e1="DS.d1401.s0.e0" e2="DS.d1401.s0.e1" id="DS.d1401.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1401.s1" origId="18825555-142" text="The effect of peroxynitrite (PN), a highly toxic agent, on catalase (CAT) activity in fish liver microsomal homogenates was determined.">
            <entity id="DS.d1401.s1.e0" origId="104806" charOffset="14-27" type="compound" text="peroxynitrite"/>
            <entity id="DS.d1401.s1.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="59-67" type="protein" text="catalase"/>
            <entity id="DS.d1401.s1.e2" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="69-72" type="protein" text="CAT"/>
            <pair e1="DS.d1401.s1.e0" e2="DS.d1401.s1.e1" id="DS.d1401.s1.i0" interaction="True"/>
            <pair e1="DS.d1401.s1.e0" e2="DS.d1401.s1.e2" id="DS.d1401.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1402" origId="18825778">
        <sentence id="DS.d1402.s0" origId="18825778-209" text="NMR-derived folate-bound structure of dihydrofolate reductase 1 from the halophile Haloferax volcanii.">
            <entity id="DS.d1402.s0.e0" origId="6037" charOffset="12-18" type="compound" text="folate"/>
            <entity id="DS.d1402.s0.e1" origId="Q5V3R2" charOffset="38-63" type="protein" text="dihydrofolate reductase 1"/>
            <pair e1="DS.d1402.s0.e0" e2="DS.d1402.s0.e1" id="DS.d1402.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1403" origId="18826375">
        <sentence id="DS.d1403.s0" origId="18826375-301" text="Histidine-regulated activity of M-ficolin.">
            <entity id="DS.d1403.s0.e0" origId="773,6274" charOffset="0-9" type="compound" text="Histidine"/>
            <entity id="DS.d1403.s0.e1" origId="O00602,O70165,Q9WTS8" charOffset="32-41" type="protein" text="M-ficolin"/>
            <pair e1="DS.d1403.s0.e0" e2="DS.d1403.s0.e1" id="DS.d1403.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1403.s1" origId="18826375-305" text="The biological roles of the histidine-regulated conformational equilibrium of M-ficolin are discussed in terms of the self and non-self discrimination mechanism.">
            <entity id="DS.d1403.s1.e0" origId="773,6274" charOffset="28-37" type="compound" text="histidine"/>
            <entity id="DS.d1403.s1.e1" origId="O00602,O70165,Q9WTS8" charOffset="78-87" type="protein" text="M-ficolin"/>
            <pair e1="DS.d1403.s1.e0" e2="DS.d1403.s1.e1" id="DS.d1403.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1404" origId="18826425">
        <sentence id="DS.d1404.s0" origId="18826425-314" text="The Iowa Gambling Task (IGT) was used to examine (i) social decision-making in women with borderline personality disorder (BPD), and (ii) the relationship between impaired decision-making and the tryptophan hydroxylase-1 (TPH-1) gene, involved in serotonin synthesis.">
            <entity id="DS.d1404.s0.e0" origId="P90697" charOffset="222-227" type="protein" text="TPH-1"/>
            <entity id="DS.d1404.s0.e1" origId="5202" charOffset="247-256" type="compound" text="serotonin"/>
            <pair e1="DS.d1404.s0.e1" e2="DS.d1404.s0.e0" id="DS.d1404.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1405" origId="18826485">
        <sentence id="DS.d1405.s0" origId="18826485-2656" text="These results underscore the differential regulation of GPX expression in response to cadmium, aluminium and nitric oxide, and strongly support a role for GPX6 and possibly other GPX genes in stress and/or metabolic signalling.">
            <entity id="DS.d1405.s0.e0" origId="O77834,P83564,Q00277" charOffset="56-59" type="protein" text="GPX"/>
            <entity id="DS.d1405.s0.e1" origId="5359268" charOffset="95-104" type="compound" text="aluminium"/>
            <entity id="DS.d1405.s0.e2" origId="145068" charOffset="109-121" type="compound" text="nitric oxide"/>
            <entity id="DS.d1405.s0.e3" origId="O48646,P59796,Q96SL4" charOffset="155-159" type="protein" text="GPX6"/>
            <entity id="DS.d1405.s0.e4" origId="O77834,P83564,Q00277" charOffset="155-158" type="protein" text="GPX"/>
            <pair e1="DS.d1405.s0.e2" e2="DS.d1405.s0.e3" id="DS.d1405.s0.i0" interaction="True"/>
            <pair e1="DS.d1405.s0.e1" e2="DS.d1405.s0.e0" id="DS.d1405.s0.i1" interaction="True"/>
            <pair e1="DS.d1405.s0.e1" e2="DS.d1405.s0.e3" id="DS.d1405.s0.i2" interaction="True"/>
            <pair e1="DS.d1405.s0.e2" e2="DS.d1405.s0.e0" id="DS.d1405.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1406" origId="18827283">
        <sentence id="DS.d1406.s0" origId="18827283-620" text="Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux.">
            <entity id="DS.d1406.s0.e0" origId="P45844" charOffset="49-54" type="protein" text="ABCG1"/>
            <entity id="DS.d1406.s0.e1" origId="304,5997,6432564,11025495" charOffset="78-89" type="compound" text="cholesterol"/>
            <pair e1="DS.d1406.s0.e1" e2="DS.d1406.s0.e0" id="DS.d1406.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1406.s1" origId="18827283-621" text="Among the known mechanisms of reverse cholesterol transport (RCT), ATP binding cassette transporter G1 (ABCG1)-mediated free cholesterol (FC) transport is the most recent and least studied.">
            <entity id="DS.d1406.s1.e0" origId="P45844" charOffset="104-109" type="protein" text="ABCG1"/>
            <entity id="DS.d1406.s1.e1" origId="304,5997,6432564,11025495" charOffset="38-49" type="compound" text="cholesterol"/>
            <pair e1="DS.d1406.s1.e1" e2="DS.d1406.s1.e0" id="DS.d1406.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1406.s2" origId="18827283-622" text="Here, we have characterized the efficiencies of different acceptors using baby hamster kidney (BHK) cells transfected with human ABCG1 cDNA, which is inducible upon treatment with mifepristone.">
            <entity id="DS.d1406.s2.e0" origId="P45844" charOffset="129-134" type="protein" text="ABCG1"/>
            <entity id="DS.d1406.s2.e1" origId="55245" charOffset="180-192" type="compound" text="mifepristone"/>
            <pair e1="DS.d1406.s2.e1" e2="DS.d1406.s2.e0" id="DS.d1406.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1407" origId="18827741">
        <sentence id="DS.d1407.s0" origId="18827741-766" text="Losartan treatment significantly attenuated TNF-alpha, IL-6, and IL-1beta 6 h after CLP.">
            <entity id="DS.d1407.s0.e0" origId="3961" charOffset="0-8" type="compound" text="Losartan"/>
            <entity id="DS.d1407.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="44-53" type="protein" text="TNF-alpha"/>
            <entity id="DS.d1407.s0.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="55-59" type="protein" text="IL-6"/>
            <entity id="DS.d1407.s0.e3" origId="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77" charOffset="65-73" type="protein" text="IL-1beta"/>
            <pair e1="DS.d1407.s0.e0" e2="DS.d1407.s0.e3" id="DS.d1407.s0.i0" interaction="True"/>
            <pair e1="DS.d1407.s0.e0" e2="DS.d1407.s0.e2" id="DS.d1407.s0.i1" interaction="True"/>
            <pair e1="DS.d1407.s0.e0" e2="DS.d1407.s0.e1" id="DS.d1407.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1408" origId="18827742">
        <sentence id="DS.d1408.s0" origId="18827742-767" text="Hemoglobin vesicles and red blood cells as carriers of carbon monoxide prior to oxygen for resuscitation after hemorrhagic shock in a rat model.">
            <entity id="DS.d1408.s0.e0" origId="P15160,P17724,P73925,Q03459" charOffset="0-10" type="protein" text="Hemoglobin"/>
            <entity id="DS.d1408.s0.e1" origId="281" charOffset="55-70" type="compound" text="carbon monoxide"/>
            <entity id="DS.d1408.s0.e2" origId="977" charOffset="80-86" type="compound" text="oxygen"/>
            <pair e1="DS.d1408.s0.e1" e2="DS.d1408.s0.e0" id="DS.d1408.s0.i0" interaction="True"/>
            <pair e1="DS.d1408.s0.e2" e2="DS.d1408.s0.e0" id="DS.d1408.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1409" origId="18827746">
        <sentence id="DS.d1409.s0" origId="18827746-775" text="Reduced responses of alpha-MSH or Nac-beta-END IRM to CRH and the invalid suppression by dexamethasone reflect a state of dysfunction of the melanotroph-type POMC system in nonsurvivors.">
            <entity id="DS.d1409.s0.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P41589,P61280,P61281,P68000,P68001,P87352,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="21-30" type="protein" text="alpha-MSH"/>
            <entity id="DS.d1409.s0.e1" origId="O26279,O30024,O59193,P0C0K9,Q01631,Q08597,Q47005,Q4J6D8,Q57728,Q5JGB7,Q5V5C9,Q6L1N3,Q6M0I0,Q8PVF0,Q8TSA1,Q8TWS7,Q8U0P1,Q96YI2,Q97CI3,Q9HI94,Q9HS36,Q9V0Z2,Q9YFQ1" charOffset="34-37" type="protein" text="Nac"/>
            <entity id="DS.d1409.s0.e2" origId="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1" charOffset="54-57" type="protein" text="CRH"/>
            <entity id="DS.d1409.s0.e3" origId="5743" charOffset="89-102" type="compound" text="dexamethasone"/>
            <entity id="DS.d1409.s0.e4" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01201,P06297,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q91082,Q9YGK2" charOffset="158-162" type="protein" text="POMC"/>
            <pair e1="DS.d1409.s0.e3" e2="DS.d1409.s0.e1" id="DS.d1409.s0.i0" interaction="False"/>
            <pair e1="DS.d1409.s0.e3" e2="DS.d1409.s0.e4" id="DS.d1409.s0.i1" interaction="False"/>
            <pair e1="DS.d1409.s0.e3" e2="DS.d1409.s0.e2" id="DS.d1409.s0.i2" interaction="False"/>
            <pair e1="DS.d1409.s0.e3" e2="DS.d1409.s0.e0" id="DS.d1409.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1410" origId="18827747">
        <sentence id="DS.d1410.s0" origId="18827747-776" text="Systemic, hepatosplanchnic, and renal hemodynamics; oxygen exchange; energy metabolism (lactate/pyruvate and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (TNF-alpha, IL-6); nitrosative/oxidative stress (thiobarbituric acid reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (asymmetric dimethylarginine, von Willebrand factor, thrombin-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.">
            <entity id="DS.d1410.s0.e0" origId="977" charOffset="52-58" type="compound" text="oxygen"/>
            <entity id="DS.d1410.s0.e1" origId="612" charOffset="88-95" type="compound" text="lactate"/>
            <entity id="DS.d1410.s0.e2" origId="1060" charOffset="96-104" type="compound" text="pyruvate"/>
            <entity id="DS.d1410.s0.e3" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="202-211" type="protein" text="TNF-alpha"/>
            <entity id="DS.d1410.s0.e4" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="213-217" type="protein" text="IL-6"/>
            <entity id="DS.d1410.s0.e5" origId="2723628" charOffset="250-269" type="compound" text="thiobarbituric acid"/>
            <entity id="DS.d1410.s0.e6" origId="123831" charOffset="350-377" type="compound" text="asymmetric dimethylarginine"/>
            <entity id="DS.d1410.s0.e7" origId="Q62935" charOffset="379-400" type="protein" text="von Willebrand factor"/>
            <entity id="DS.d1410.s0.e8" origId="P84122" charOffset="402-410" type="protein" text="thrombin"/>
            <pair e1="DS.d1410.s0.e5" e2="DS.d1410.s0.e3" id="DS.d1410.s0.i0" interaction="False"/>
            <pair e1="DS.d1410.s0.e0" e2="DS.d1410.s0.e7" id="DS.d1410.s0.i1" interaction="False"/>
            <pair e1="DS.d1410.s0.e5" e2="DS.d1410.s0.e4" id="DS.d1410.s0.i2" interaction="False"/>
            <pair e1="DS.d1410.s0.e2" e2="DS.d1410.s0.e4" id="DS.d1410.s0.i3" interaction="False"/>
            <pair e1="DS.d1410.s0.e1" e2="DS.d1410.s0.e7" id="DS.d1410.s0.i4" interaction="False"/>
            <pair e1="DS.d1410.s0.e2" e2="DS.d1410.s0.e8" id="DS.d1410.s0.i5" interaction="False"/>
            <pair e1="DS.d1410.s0.e2" e2="DS.d1410.s0.e7" id="DS.d1410.s0.i6" interaction="False"/>
            <pair e1="DS.d1410.s0.e0" e2="DS.d1410.s0.e4" id="DS.d1410.s0.i7" interaction="False"/>
            <pair e1="DS.d1410.s0.e5" e2="DS.d1410.s0.e8" id="DS.d1410.s0.i8" interaction="False"/>
            <pair e1="DS.d1410.s0.e0" e2="DS.d1410.s0.e3" id="DS.d1410.s0.i9" interaction="False"/>
            <pair e1="DS.d1410.s0.e6" e2="DS.d1410.s0.e8" id="DS.d1410.s0.i10" interaction="False"/>
            <pair e1="DS.d1410.s0.e1" e2="DS.d1410.s0.e8" id="DS.d1410.s0.i11" interaction="False"/>
            <pair e1="DS.d1410.s0.e1" e2="DS.d1410.s0.e3" id="DS.d1410.s0.i12" interaction="False"/>
            <pair e1="DS.d1410.s0.e6" e2="DS.d1410.s0.e7" id="DS.d1410.s0.i13" interaction="False"/>
            <pair e1="DS.d1410.s0.e6" e2="DS.d1410.s0.e3" id="DS.d1410.s0.i14" interaction="False"/>
            <pair e1="DS.d1410.s0.e5" e2="DS.d1410.s0.e7" id="DS.d1410.s0.i15" interaction="False"/>
            <pair e1="DS.d1410.s0.e6" e2="DS.d1410.s0.e4" id="DS.d1410.s0.i16" interaction="False"/>
            <pair e1="DS.d1410.s0.e1" e2="DS.d1410.s0.e4" id="DS.d1410.s0.i17" interaction="False"/>
            <pair e1="DS.d1410.s0.e2" e2="DS.d1410.s0.e3" id="DS.d1410.s0.i18" interaction="False"/>
            <pair e1="DS.d1410.s0.e0" e2="DS.d1410.s0.e8" id="DS.d1410.s0.i19" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1411" origId="18827975">
        <sentence id="DS.d1411.s0" origId="18827975-862" text="The purpose of this retrospective study was to compare the effects of lepirudin and argatroban in the management of HIT.">
            <entity id="DS.d1411.s0.e0" origId="P01050" charOffset="70-79" type="protein" text="lepirudin"/>
            <entity id="DS.d1411.s0.e1" origId="2232,92722,152951,440542,445156" charOffset="84-94" type="compound" text="argatroban"/>
            <pair e1="DS.d1411.s0.e1" e2="DS.d1411.s0.e0" id="DS.d1411.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1412" origId="18828007">
        <sentence id="DS.d1412.s0" origId="18828007-864" text="The outer membrane TolC is involved in cysteine tolerance and overproduction in Escherichia coli.">
            <entity id="DS.d1412.s0.e0" origId="P02930,Q54001,Q9K2Y1" charOffset="19-23" type="protein" text="TolC"/>
            <entity id="DS.d1412.s0.e1" origId="594,5862,5360637" charOffset="39-47" type="compound" text="cysteine"/>
            <pair e1="DS.d1412.s0.e1" e2="DS.d1412.s0.e0" id="DS.d1412.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1412.s1" origId="18828007-866" text="Gene expression analysis revealed that the tolC gene encoding the outer membrane channel is essential for L-cysteine tolerance in E. coli cells.">
            <entity id="DS.d1412.s1.e0" origId="P02930,Q54001,Q9K2Y1" charOffset="43-47" type="protein" text="tolC"/>
            <entity id="DS.d1412.s1.e1" origId="581,5862,5460838" charOffset="106-116" type="compound" text="L-cysteine"/>
            <pair e1="DS.d1412.s1.e1" e2="DS.d1412.s1.e0" id="DS.d1412.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1413" origId="18828019">
        <sentence id="DS.d1413.s0" origId="18828019-168" text="The present study was performed to elucidate the relationship between the expression of ABCB1/MDR1 and ABCC1/MRP1 with resistance to either ET-743 or PM00104.">
            <entity id="DS.d1413.s0.e0" origId="P08183,P21448" charOffset="88-93" type="protein" text="ABCB1"/>
            <entity id="DS.d1413.s0.e1" origId="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72" charOffset="94-98" type="protein" text="MDR1"/>
            <entity id="DS.d1413.s0.e2" origId="P33527,Q5F364" charOffset="103-108" type="protein" text="ABCC1"/>
            <entity id="DS.d1413.s0.e3" origId="P10662,P20585,P33527,Q5F364,Q6UR05,Q864R9,Q8HXQ5,Q9C8G9" charOffset="109-113" type="protein" text="MRP1"/>
            <entity id="DS.d1413.s0.e4" origId="108150,44584244" charOffset="140-146" type="compound" text="ET-743"/>
            <pair e1="DS.d1413.s0.e4" e2="DS.d1413.s0.e3" id="DS.d1413.s0.i0" interaction="True"/>
            <pair e1="DS.d1413.s0.e4" e2="DS.d1413.s0.e2" id="DS.d1413.s0.i1" interaction="True"/>
            <pair e1="DS.d1413.s0.e4" e2="DS.d1413.s0.e0" id="DS.d1413.s0.i2" interaction="True"/>
            <pair e1="DS.d1413.s0.e4" e2="DS.d1413.s0.e1" id="DS.d1413.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1414" origId="18828793">
        <sentence id="DS.d1414.s0" origId="18828793-1124" text="The previous amphotericin B, granulocyte colony-stimulating factor, hyperbaric oxygen and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.">
            <entity id="DS.d1414.s0.e0" origId="5280965" charOffset="13-27" type="compound" text="amphotericin B"/>
            <entity id="DS.d1414.s0.e1" origId="P35834,Q28746" charOffset="29-66" type="protein" text="granulocyte colony-stimulating factor"/>
            <entity id="DS.d1414.s0.e2" origId="977" charOffset="79-85" type="compound" text="oxygen"/>
            <pair e1="DS.d1414.s0.e2" e2="DS.d1414.s0.e1" id="DS.d1414.s0.i0" interaction="False"/>
            <pair e1="DS.d1414.s0.e0" e2="DS.d1414.s0.e1" id="DS.d1414.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1416" origId="18829132">
        <sentence id="DS.d1416.s0" origId="18829132-1261" text="Bacterial strains differed in their ability to synthesize auxin and hydrogen cyanide compounds, as well as in their ACC deaminase activity.">
            <entity id="DS.d1416.s0.e0" origId="802" charOffset="58-63" type="compound" text="auxin"/>
            <entity id="DS.d1416.s0.e1" origId="768" charOffset="68-84" type="compound" text="hydrogen cyanide"/>
            <entity id="DS.d1416.s0.e2" origId="O57809,P30297,Q00740,Q51813,Q5KMX3,Q5PWZ8,Q62CE3,Q63KN7,Q6J256,Q7M523,Q87YW7,Q89XR6,Q8U4R3,Q8XS35,Q93AG0,Q98AM7,Q9AHF0,Q9URX3,Q9V2L2,Q9WY68,Q9ZHW3" charOffset="116-129" type="protein" text="ACC deaminase"/>
            <pair e1="DS.d1416.s0.e0" e2="DS.d1416.s0.e2" id="DS.d1416.s0.i0" interaction="False"/>
            <pair e1="DS.d1416.s0.e1" e2="DS.d1416.s0.e2" id="DS.d1416.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1417" origId="18829266">
        <sentence id="DS.d1417.s0" origId="18829266-1329" text="Toll-like receptor (TLR) 4 is a critical receptor and signal transducer for lipopolysaccharide (LPS), a major component of Gram-negative bacteria.">
            <entity id="DS.d1417.s0.e0" origId="P23799" charOffset="20-23" type="protein" text="TLR"/>
            <entity id="DS.d1417.s0.e1" origId="11970143" charOffset="76-94" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d1417.s0.e1" e2="DS.d1417.s0.e0" id="DS.d1417.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1418" origId="18829281">
        <sentence id="DS.d1418.s0" origId="18829281-1345" text="Postprandial glucose and CRP.05) in HTAG.">
            <entity id="DS.d1418.s0.e0" origId="206,5793,64689,79025" charOffset="13-20" type="compound" text="glucose"/>
            <entity id="DS.d1418.s0.e1" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="25-28" type="protein" text="CRP"/>
            <pair e1="DS.d1418.s0.e0" e2="DS.d1418.s0.e1" id="DS.d1418.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1419" origId="18829286">
        <sentence id="DS.d1419.s0" origId="18829286-1353" text="Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the selenium-dependent glutathione peroxidases, GPx2.">
            <entity id="DS.d1419.s0.e0" origId="6326970" charOffset="94-102" type="compound" text="selenium"/>
            <entity id="DS.d1419.s0.e1" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="113-136" type="protein" text="glutathione peroxidases"/>
            <entity id="DS.d1419.s0.e2" origId="P18283,P83645,Q4AEH7,Q4AEH8,Q4AEH9,Q4AEI0,Q9JHC0" charOffset="138-142" type="protein" text="GPx2"/>
            <pair e1="DS.d1419.s0.e0" e2="DS.d1419.s0.e2" id="DS.d1419.s0.i0" interaction="True"/>
            <pair e1="DS.d1419.s0.e0" e2="DS.d1419.s0.e1" id="DS.d1419.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1420" origId="18829287">
        <sentence id="DS.d1420.s0" origId="18829287-2771" text="The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (BDNF), nitric oxide (NO) and dopamine (DA) in aged mice.">
            <entity id="DS.d1420.s0.e0" origId="445580" charOffset="72-92" type="compound" text="docosahexaenoic acid"/>
            <entity id="DS.d1420.s0.e1" origId="P25430,P25431,P25432,Q06225" charOffset="156-189" type="protein" text="brain-derived neurotrophic factor"/>
            <entity id="DS.d1420.s0.e2" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="191-195" type="protein" text="BDNF"/>
            <entity id="DS.d1420.s0.e3" origId="145068" charOffset="198-210" type="compound" text="nitric oxide"/>
            <entity id="DS.d1420.s0.e4" origId="681" charOffset="220-228" type="compound" text="dopamine"/>
            <pair e1="DS.d1420.s0.e3" e2="DS.d1420.s0.e2" id="DS.d1420.s0.i0" interaction="False"/>
            <pair e1="DS.d1420.s0.e4" e2="DS.d1420.s0.e1" id="DS.d1420.s0.i1" interaction="False"/>
            <pair e1="DS.d1420.s0.e0" e2="DS.d1420.s0.e2" id="DS.d1420.s0.i2" interaction="False"/>
            <pair e1="DS.d1420.s0.e3" e2="DS.d1420.s0.e1" id="DS.d1420.s0.i3" interaction="False"/>
            <pair e1="DS.d1420.s0.e0" e2="DS.d1420.s0.e1" id="DS.d1420.s0.i4" interaction="True"/>
            <pair e1="DS.d1420.s0.e4" e2="DS.d1420.s0.e2" id="DS.d1420.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1421" origId="18829372">
        <sentence id="DS.d1421.s0" origId="18829372-151" text="Model analysis of local oxygen delivery with liposome-encapsulated hemoglobin.">
            <entity id="DS.d1421.s0.e0" origId="977" charOffset="24-30" type="compound" text="oxygen"/>
            <entity id="DS.d1421.s0.e1" origId="P15160,P17724,P73925,Q03459" charOffset="67-77" type="protein" text="hemoglobin"/>
            <pair e1="DS.d1421.s0.e0" e2="DS.d1421.s0.e1" id="DS.d1421.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1421.s1" origId="18829372-152" text="Liposome-encapsulated hemoglobins (LHs) are comparable to red blood cells (RBCs) in terms of oxygen (O(2))-carrying capacity.">
            <entity id="DS.d1421.s1.e0" origId="P15160,P17724,P73925,Q03459" charOffset="22-33" type="protein" text="hemoglobins"/>
            <entity id="DS.d1421.s1.e1" origId="977" charOffset="93-99" type="compound" text="oxygen"/>
            <pair e1="DS.d1421.s1.e1" e2="DS.d1421.s1.e0" id="DS.d1421.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1422" origId="18829677">
        <sentence id="DS.d1422.s0" origId="18829677-1475" text="Moreover, both lung and plasma concentrations of the pro-inflammatory cytokines tumour necrosis factor-alpha and interferon-gamma were higher in nicotine-treated animals at this time-point.">
            <entity id="DS.d1422.s0.e0" origId="Q9TTB0" charOffset="113-129" type="protein" text="interferon-gamma"/>
            <entity id="DS.d1422.s0.e1" origId="942,89594,157672" charOffset="145-153" type="compound" text="nicotine"/>
            <pair e1="DS.d1422.s0.e1" e2="DS.d1422.s0.e0" id="DS.d1422.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1423" origId="18829704">
        <sentence id="DS.d1423.s0" origId="18829704-1495" text="The role of Hg(2+)-insensitive AQP7, if any, in sperm volume regulation was studied in transgenic mice.">
            <entity id="DS.d1423.s0.e0" origId="26623" charOffset="12-16" type="compound" text="Hg(2"/>
            <entity id="DS.d1423.s0.e1" origId="O14520" charOffset="31-35" type="protein" text="AQP7"/>
            <pair e1="DS.d1423.s0.e0" e2="DS.d1423.s0.e1" id="DS.d1423.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1423.s1" origId="18829704-1496" text="Therefore, the Hg(2+)-sensitive AQP8, which was localized in elongated spermatids and spermatozoa, is a likely candidate for a water channel responsible for physiological sperm volume regulation crucial to in vivo fertilization.">
            <entity id="DS.d1423.s1.e0" origId="26623" charOffset="15-19" type="compound" text="Hg(2"/>
            <entity id="DS.d1423.s1.e1" origId="O94778,Q5I4F8" charOffset="32-36" type="protein" text="AQP8"/>
            <pair e1="DS.d1423.s1.e0" e2="DS.d1423.s1.e1" id="DS.d1423.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1424" origId="18829979">
        <sentence id="DS.d1424.s0" origId="18829979-1580" text="Increased intrahepatic vascular tone in cirrhosis has been attributed to a decrease of hepatic nitric oxide (NO) secondary to disturbances in the post-translational regulation of the enzyme eNOS.">
            <entity id="DS.d1424.s0.e0" origId="145068" charOffset="95-107" type="compound" text="nitric oxide"/>
            <entity id="DS.d1424.s0.e1" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="190-194" type="protein" text="eNOS"/>
            <pair e1="DS.d1424.s0.e0" e2="DS.d1424.s0.e1" id="DS.d1424.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1425" origId="18830228">
        <sentence id="DS.d1425.s0" origId="18830228-1650" text="Adenylosuccinate lyase deficiency is a rare autosomal disorder of de novo purine synthesis, which results in the accumulation of succinylpurines in body fluids.">
            <entity id="DS.d1425.s0.e0" origId="O27580,O28041,O58582,O60105,O66856,P0AB89,P0AB90,P12047,P21265,P30566,P44797,P52201,P54822,P56468,P57351,P72478,P74384,Q05911,Q21774,Q2FFI7,Q2G2S0,Q2YU66,Q49YV3,Q4L7M3,Q58339,Q5HEL4,Q5HN26,Q60Q90,Q6G825,Q6GFE9,Q7A0G9,Q7A4Q3,Q89AM3,Q8CRT6,Q8HXY5,Q8K9Q7,Q99SX9,Q9RSE6,Q9UZ99,Q9X0I0,Q9ZKA2" charOffset="0-22" type="protein" text="Adenylosuccinate lyase"/>
            <entity id="DS.d1425.s0.e1" origId="1044" charOffset="74-80" type="compound" text="purine"/>
            <pair e1="DS.d1425.s0.e1" e2="DS.d1425.s0.e0" id="DS.d1425.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1425.s1" origId="18830228-1651" text="Both patients had an increased succinyladenosine/SAICAr ratio of 1.6, and exhibited a novel homozygous missense mutation (c.674T&amp;gt;C; p.Met225Thr) in the exon 6 of the ADSL gene.">
            <entity id="DS.d1425.s1.e0" origId="165243,20849086" charOffset="31-48" type="compound" text="succinyladenosine"/>
            <entity id="DS.d1425.s1.e1" origId="P21265,P30566,Q8HXY5" charOffset="169-173" type="protein" text="ADSL"/>
            <pair e1="DS.d1425.s1.e0" e2="DS.d1425.s1.e1" id="DS.d1425.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1426" origId="18830381">
        <sentence id="DS.d1426.s0" origId="18830381-1696" text="The profile of global DNA and estrogen receptor (ER)-alpha gene methylation during cancer development was determined by analysis of 5-methylcytosine (5-MeC) using immunohistochemical (IHC) staining, dot blot analysis or a quantitative gene methylation assay (QGMA).">
            <entity id="DS.d1426.s0.e0" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="30-47" type="protein" text="estrogen receptor"/>
            <entity id="DS.d1426.s0.e1" origId="65040" charOffset="132-148" type="compound" text="5-methylcytosine"/>
            <entity id="DS.d1426.s0.e2" origId="448166" charOffset="152-155" type="compound" text="MeC"/>
            <pair e1="DS.d1426.s0.e1" e2="DS.d1426.s0.e0" id="DS.d1426.s0.i0" interaction="False"/>
            <pair e1="DS.d1426.s0.e2" e2="DS.d1426.s0.e0" id="DS.d1426.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1427" origId="18830594">
        <sentence id="DS.d1427.s0" origId="18830594-1807" text="Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cells.">
            <entity id="DS.d1427.s0.e0" origId="3385" charOffset="49-63" type="compound" text="5-fluorouracil"/>
            <entity id="DS.d1427.s0.e1" origId="6076" charOffset="68-72" type="compound" text="cAMP"/>
            <entity id="DS.d1427.s0.e2" origId="P15337,P16220,P27925,P51984,P51985,Q01147" charOffset="77-81" type="protein" text="CREB"/>
            <pair e1="DS.d1427.s0.e0" e2="DS.d1427.s0.e2" id="DS.d1427.s0.i0" interaction="True"/>
            <pair e1="DS.d1427.s0.e1" e2="DS.d1427.s0.e2" id="DS.d1427.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1428" origId="18830620">
        <sentence id="DS.d1428.s0" origId="18830620-1813" text="Complex modulation of L-type Ca(2+) current inactivation by sorcin in isolated rabbit cardiomyocytes.">
            <entity id="DS.d1428.s0.e0" origId="271" charOffset="29-33" type="compound" text="Ca(2"/>
            <entity id="DS.d1428.s0.e1" origId="P05044,P30626,Q5R4U9,Q6P069,Q94743" charOffset="60-66" type="protein" text="sorcin"/>
            <pair e1="DS.d1428.s0.e0" e2="DS.d1428.s0.e1" id="DS.d1428.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1429" origId="18830680">
        <sentence id="DS.d1429.s0" origId="18830680-1821" text="Donor testicular cells were prepared from heterozygous chicken beta actin (CAG)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with busulfan to remove endogenous spermatogonia.">
            <entity id="DS.d1429.s0.e0" origId="O18840,O42161,O93400,P15475,P29751,P48975,P60706,P60707,P60708,P60709,P60710,P60711,P60712,P60713,P68143,P79818,P83750,P83751,P84336,P84856,Q0PGG4,Q4L0Y2,Q5R1X3,Q711N9,Q71FK5,Q76N69,Q91ZK5,Q9Y702" charOffset="63-73" type="protein" text="beta actin"/>
            <entity id="DS.d1429.s0.e1" origId="Q00398" charOffset="75-78" type="protein" text="CAG"/>
            <entity id="DS.d1429.s0.e2" origId="P42212" charOffset="89-114" type="protein" text="green fluorescent protein"/>
            <entity id="DS.d1429.s0.e3" origId="2478" charOffset="309-317" type="compound" text="busulfan"/>
            <pair e1="DS.d1429.s0.e3" e2="DS.d1429.s0.e2" id="DS.d1429.s0.i0" interaction="False"/>
            <pair e1="DS.d1429.s0.e3" e2="DS.d1429.s0.e1" id="DS.d1429.s0.i1" interaction="False"/>
            <pair e1="DS.d1429.s0.e3" e2="DS.d1429.s0.e0" id="DS.d1429.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1430" origId="18830721">
        <sentence id="DS.d1430.s0" origId="18830721-1832" text="Models of noncoupled dinuclear copper centers in azurin.">
            <entity id="DS.d1430.s0.e0" origId="23978" charOffset="31-37" type="compound" text="copper"/>
            <entity id="DS.d1430.s0.e1" origId="P00279,P00281,P00283,P00284,P00285,P00286,P34097,P80546" charOffset="49-55" type="protein" text="azurin"/>
            <pair e1="DS.d1430.s0.e0" e2="DS.d1430.s0.e1" id="DS.d1430.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1430.s1" origId="18830721-1833" text="Toward this goal, models of the noncoupled copper centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.">
            <entity id="DS.d1430.s1.e0" origId="23978" charOffset="43-49" type="compound" text="copper"/>
            <entity id="DS.d1430.s1.e1" origId="P10731,P14925,P19021,P83388,P97467,Q95XM2" charOffset="123-126" type="protein" text="PHM"/>
            <entity id="DS.d1430.s1.e2" origId="P09172,P15101,Q05754,Q64237" charOffset="129-156" type="protein" text="dopamine beta-monooxygenase"/>
            <entity id="DS.d1430.s1.e3" origId="Q39161,Q43090" charOffset="187-190" type="protein" text="NiR"/>
            <entity id="DS.d1430.s1.e4" origId="P00279,P00281,P00283,P00284,P00285,P00286,P34097,P80546" charOffset="237-243" type="protein" text="azurin"/>
            <pair e1="DS.d1430.s1.e0" e2="DS.d1430.s1.e1" id="DS.d1430.s1.i0" interaction="True"/>
            <pair e1="DS.d1430.s1.e0" e2="DS.d1430.s1.e4" id="DS.d1430.s1.i1" interaction="True"/>
            <pair e1="DS.d1430.s1.e0" e2="DS.d1430.s1.e3" id="DS.d1430.s1.i2" interaction="True"/>
            <pair e1="DS.d1430.s1.e0" e2="DS.d1430.s1.e2" id="DS.d1430.s1.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d1430.s2" origId="18830721-1834" text="The models are significant because they maintain the existing type 1 (T1) copper, electron transfer site of azurin while including the second designed type 2 (T2) copper center that mimics the T2 catalytic sites in the target enzymes.">
            <entity id="DS.d1430.s2.e0" origId="23978" charOffset="74-80" type="compound" text="copper"/>
            <entity id="DS.d1430.s2.e1" origId="P00279,P00281,P00283,P00284,P00285,P00286,P34097,P80546" charOffset="108-114" type="protein" text="azurin"/>
            <entity id="DS.d1430.s2.e2" origId="23978" charOffset="163-169" type="compound" text="copper"/>
            <pair e1="DS.d1430.s2.e0" e2="DS.d1430.s2.e1" id="DS.d1430.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1431" origId="18830722">
        <sentence id="DS.d1431.s0" origId="18830722-1835" text="Intraprotein electron transfer (IET) from flavin mononucleotide (FMN) to heme is essential in NO synthesis by NO synthase (NOS).">
            <entity id="DS.d1431.s0.e0" origId="710,8965,643976" charOffset="42-63" type="compound" text="flavin mononucleotide"/>
            <entity id="DS.d1431.s0.e1" origId="710,8965,643976" charOffset="65-68" type="compound" text="FMN"/>
            <entity id="DS.d1431.s0.e2" origId="4971" charOffset="73-77" type="compound" text="heme"/>
            <entity id="DS.d1431.s0.e3" origId="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2" charOffset="123-126" type="protein" text="NOS"/>
            <pair e1="DS.d1431.s0.e0" e2="DS.d1431.s0.e3" id="DS.d1431.s0.i0" interaction="True"/>
            <pair e1="DS.d1431.s0.e2" e2="DS.d1431.s0.e3" id="DS.d1431.s0.i1" interaction="True"/>
            <pair e1="DS.d1431.s0.e1" e2="DS.d1431.s0.e3" id="DS.d1431.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1432" origId="18830729">
        <sentence id="DS.d1432.s0" origId="18830729-1841" text="The esterase and lipase activities were determined by the hydrolysis of pNPB and pNPP, respectively.">
            <entity id="DS.d1432.s0.e0" origId="P16397,P18773" charOffset="4-12" type="protein" text="esterase"/>
            <entity id="DS.d1432.s0.e1" origId="Q7M4U7" charOffset="17-23" type="protein" text="lipase"/>
            <entity id="DS.d1432.s0.e2" origId="378" charOffset="81-85" type="compound" text="pNPP"/>
            <pair e1="DS.d1432.s0.e2" e2="DS.d1432.s0.e1" id="DS.d1432.s0.i0" interaction="True"/>
            <pair e1="DS.d1432.s0.e2" e2="DS.d1432.s0.e0" id="DS.d1432.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1433" origId="18830730">
        <sentence id="DS.d1433.s0" origId="18830730-1843" text="In the present work, the activity of the enzymes xylose reductase (XR); xylitol dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (G6PD) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).">
            <entity id="DS.d1433.s0.e0" origId="P38715" charOffset="49-65" type="protein" text="xylose reductase"/>
            <entity id="DS.d1433.s0.e1" origId="P22144,P83049,Q59545,Q8U7Y1,Q92MT4,Q98D10" charOffset="72-93" type="protein" text="xylitol dehydrogenase"/>
            <entity id="DS.d1433.s0.e2" origId="O00091,O24357,O51581,O54537,O55044,O68282,O83491,O84188,P05370,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11410,P11411,P11412,P11413,P12646,P15588,P21907,P29686,P37830,P37986,P41571,P41764,P44311,P48826,P48828,P48848,P48992,P54547,P54996,P56110,P57405,P73411,P77809,P80619,P97324,Q00612,Q23711,Q24625,Q25019,Q25537,Q27464,Q27638,Q29492,Q42919,Q43793,Q43839,Q7YS37,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2" charOffset="139-143" type="protein" text="G6PD"/>
            <entity id="DS.d1433.s0.e3" origId="6912" charOffset="72-79" type="compound" text="xylitol"/>
            <pair e1="DS.d1433.s0.e3" e2="DS.d1433.s0.e2" id="DS.d1433.s0.i0" interaction="True"/>
            <pair e1="DS.d1433.s0.e3" e2="DS.d1433.s0.e0" id="DS.d1433.s0.i1" interaction="True"/>
            <pair e1="DS.d1433.s0.e3" e2="DS.d1433.s0.e1" id="DS.d1433.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1434" origId="18830873">
        <sentence id="DS.d1434.s0" origId="18830873-1896" text="QSAR studies for the inhibition of the transmembrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software.">
            <entity id="DS.d1434.s0.e0" origId="P27134,P46281,P46510,P46511,P54212,P84537,Q54735,Q92051,Q9ZN54" charOffset="53-71" type="protein" text="carbonic anhydrase"/>
            <entity id="DS.d1434.s0.e1" origId="12145736" charOffset="89-101" type="compound" text="sulfonamides"/>
            <pair e1="DS.d1434.s0.e1" e2="DS.d1434.s0.e0" id="DS.d1434.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1434.s1" origId="18830873-1897" text="QSAR studies for the inhibition of isozyme XIV of human carbonic anhydrase (CA, EC 4.2.1.1) by a series of sulfonamides including clinically used derivatives (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, benzolamide, and zonisamide) are presented.">
            <entity id="DS.d1434.s1.e0" origId="P27134,P46281,P46510,P46511,P54212,P84537,Q54735,Q92051,Q9ZN54" charOffset="56-74" type="protein" text="carbonic anhydrase"/>
            <entity id="DS.d1434.s1.e1" origId="12145736" charOffset="107-119" type="compound" text="sulfonamides"/>
            <pair e1="DS.d1434.s1.e1" e2="DS.d1434.s1.e0" id="DS.d1434.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1435" origId="18830874">
        <sentence id="DS.d1435.s0" origId="18830874-1898" text="Inhibition of human muscle-specific enolase by methylglyoxal and irreversible formation of advanced glycation end products.">
            <entity id="DS.d1435.s0.e0" origId="P13929,P15429,P21550,P25704" charOffset="20-43" type="protein" text="muscle-specific enolase"/>
            <entity id="DS.d1435.s0.e1" origId="880" charOffset="47-60" type="compound" text="methylglyoxal"/>
            <pair e1="DS.d1435.s0.e1" e2="DS.d1435.s0.e0" id="DS.d1435.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1435.s1" origId="18830874-1900" text="The affinity of enolase for gluconeogenic substrate phosphoenolpyruvate altered after preincubation with MG in the same manner, but less intensively.">
            <entity id="DS.d1435.s1.e0" origId="O02654,O26149,O29133,O30885,O32513,O51312,O52191,O59605,O66778,O69174,O74286,O84591,O85348,P0A6P9,P0A6Q0,P0A6Q1,P0A6Q2,P15007,P25696,P26300,P29201,P31683,P33675,P33676,P37869,P42040,P42448,P42848,P42894,P42896,P42897,P43806,P47647,P48285,P56252,P57492,P57975,P59566,P64074,P64075,P64076,P64077,P64078,P64079,P64080,P64081,P69949,P69950,P69951,P74934,P75189,P77972,P84208,P84541,P96377,P99088,Q12560,Q27527,Q27655,Q27727,Q27877,Q42971,Q43130,Q43321,Q4J920,Q5E326,Q5F8Z2,Q5FKM6,Q5FNN5,Q5GYK4,Q5HHP1,Q5HQV0,Q5HSC1,Q5JEV6,Q5KVE7,Q5LQL4,Q5M0M5,Q5M561,Q5N3P4,Q5NGW8,Q5NZ69,Q5PEH4,Q5R143,Q5SME1,Q5WDK9,Q5WV02,Q5X3L4,Q5XD01,Q5YQ30,Q5ZTX1,Q60173,Q601S2,Q62J10,Q631M2,Q63SQ0,Q65VZ7,Q661T0,Q66ED8,Q67SV9,Q6AAB8,Q6ADR6,Q6AM97,Q6C1F3,Q6D182,Q6F0Z7,Q6FAT9,Q6G173,Q6GB54,Q6GIL4,Q6HBF3,Q6KIB0,Q6LMT1,Q6M075,Q6MEY2,Q6MPQ2,Q6MTZ2,Q6N5U6,Q6NI61,Q6RG04,Q6W3C0,Q6YQT9,Q70CP7,Q71WX1,Q72F92,Q72H85,Q72QZ8,Q72XY5,Q73HQ2,Q73P50,Q741U7,Q74AR6,Q756H2,Q76KF9,Q7M8Q0,Q7MHQ1,Q7MTV8,Q7N835,Q7NAY0,Q7NIR1,Q7RA60,Q7RV85,Q7U0U6,Q7U3T1,Q7UIR2,Q7V377,Q7V483,Q7VDY0,Q7VIH4,Q7VNM6,Q7VQH3,Q7VW79,Q7W5N9,Q7WD75,Q815K8,Q81X78,Q821H7,Q82HH5,Q83B44,Q83FF7,Q83H73,Q870B9,Q87DY6,Q87LQ0,Q88MF9,Q898R0,Q89KV6,Q89Z05,Q8CPY3,Q8D2K1,Q8DC62,Q8DL40,Q8DPS0,Q8DTS9,Q8EBR0,Q8ENP5,Q8EW32,Q8F4T8,Q8FQS7,Q8G0G3,Q8G5I9,Q8GE63,Q8GR70,Q8IJN7,Q8K9E0,Q8KNX9,Q8L202,Q8NRS1,Q8P9Z3,Q8PLS0,Q8PT81,Q8R967,Q8RI55,Q8TQ79,Q8TUV6,Q8U477,Q8UFH1,Q8XKU4,Q8Y0B5,Q8YHF0,Q8YRB0,Q8ZBN2,Q8ZYE7,Q92Q98,Q967Y8,Q96VP4,Q96X30,Q96X46,Q972B6,Q979Z9,Q97L52,Q97QS2,Q97ZJ3,Q98MZ3,Q98Q50,Q9A7J9,Q9CD42,Q9HDT3,Q9HJT1,Q9HQI9,Q9HXZ5,Q9JU46,Q9JZ53,Q9K596,Q9K717,Q9KPC5,Q9PDT8,Q9PJF3,Q9PQV9,Q9RR60,Q9U615,Q9UAL5,Q9UXZ0,Q9XDS7,Q9Y927,Q9Z7A6,Q9ZMS6" charOffset="16-23" type="protein" text="enolase"/>
            <entity id="DS.d1435.s1.e1" origId="1005" charOffset="52-71" type="compound" text="phosphoenolpyruvate"/>
            <pair e1="DS.d1435.s1.e1" e2="DS.d1435.s1.e0" id="DS.d1435.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1436" origId="18830875">
        <sentence id="DS.d1436.s0" origId="18830875-307" text="Inhibitory effects of Cefazolin and Cefodizime on the activity of mushroom tyrosinase.">
            <entity id="DS.d1436.s0.e0" origId="33255" charOffset="22-31" type="compound" text="Cefazolin"/>
            <entity id="DS.d1436.s0.e1" origId="5361871" charOffset="36-46" type="compound" text="Cefodizime"/>
            <entity id="DS.d1436.s0.e2" origId="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396" charOffset="75-85" type="protein" text="tyrosinase"/>
            <pair e1="DS.d1436.s0.e1" e2="DS.d1436.s0.e2" id="DS.d1436.s0.i0" interaction="True"/>
            <pair e1="DS.d1436.s0.e0" e2="DS.d1436.s0.e2" id="DS.d1436.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1437" origId="18830876">
        <sentence id="DS.d1437.s0" origId="18830876-308" text="The order of the cytotoxicity of the compounds was; IV &amp;gt; III &amp;gt; II &amp;gt; I &amp;gt; V. Compound IV, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest DNA topoisomerase I inhibition.">
            <entity id="DS.d1437.s0.e0" origId="55717" charOffset="87-98" type="compound" text="Compound IV"/>
            <entity id="DS.d1437.s0.e1" origId="O27661,O28469,O34204,O51768,O58356,O66893,O69548,O73954,O83409,P04786,P06612,P07799,P0A2I1,P0A2I2,P0A620,P0A621,P11387,P16472,P30181,P30189,P32989,P34184,P34185,P39814,P40114,P41511,P41512,P43012,P46155,P46799,P47368,P55991,P57371,P68697,P68698,P73810,P78032,P93119,Q00313,Q04750,Q07050,Q59046,Q76ZS7,Q7YR26,Q87AQ6,Q8K9P7,Q92IH1,Q9CG80,Q9CN30,Q9HM08,Q9HZJ5,Q9JN65,Q9KA23,Q9KRB2,Q9PEV8,Q9PLZ2,Q9UYS8,Q9WUL0,Q9X3X7,Q9X909,Q9YB01,Q9ZDK2,Q9ZMV7" charOffset="223-242" type="protein" text="DNA topoisomerase I"/>
            <pair e1="DS.d1437.s0.e0" e2="DS.d1437.s0.e1" id="DS.d1437.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1438" origId="18830877">
        <sentence id="DS.d1438.s0" origId="18830877-1907" text="Tests were carried out on cell cultures of human keratinocytes and mouse 3T3 fibroblasts incubated with radiolabeled acetate, and on homogenates prepared from yeast cells expressing human lanosterol synthase, incubated with radiolabeled oxidosqualene.">
            <entity id="DS.d1438.s0.e0" origId="P38604,P48449,P48450,P84466,Q04782,Q10231,Q8BLN5,Q96WJ0" charOffset="188-207" type="protein" text="lanosterol synthase"/>
            <entity id="DS.d1438.s0.e1" origId="5280395" charOffset="237-250" type="compound" text="oxidosqualene"/>
            <pair e1="DS.d1438.s0.e1" e2="DS.d1438.s0.e0" id="DS.d1438.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1439" origId="18830880">
        <sentence id="DS.d1439.s0" origId="18830880-1910" text="Hepatic antioxidant status viz, reduced glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (CAT 0.001).">
            <entity id="DS.d1439.s0.e0" origId="124886" charOffset="32-51" type="compound" text="reduced glutathione"/>
            <entity id="DS.d1439.s0.e1" origId="124886" charOffset="53-56" type="compound" text="GSH"/>
            <entity id="DS.d1439.s0.e2" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="59-80" type="protein" text="glutathione reductase"/>
            <entity id="DS.d1439.s0.e3" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="87-109" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d1439.s0.e4" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="141-149" type="protein" text="catalase"/>
            <entity id="DS.d1439.s0.e5" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="151-154" type="protein" text="CAT"/>
            <pair e1="DS.d1439.s0.e0" e2="DS.d1439.s0.e4" id="DS.d1439.s0.i0" interaction="False"/>
            <pair e1="DS.d1439.s0.e0" e2="DS.d1439.s0.e2" id="DS.d1439.s0.i1" interaction="False"/>
            <pair e1="DS.d1439.s0.e1" e2="DS.d1439.s0.e3" id="DS.d1439.s0.i2" interaction="False"/>
            <pair e1="DS.d1439.s0.e0" e2="DS.d1439.s0.e3" id="DS.d1439.s0.i3" interaction="False"/>
            <pair e1="DS.d1439.s0.e1" e2="DS.d1439.s0.e5" id="DS.d1439.s0.i4" interaction="False"/>
            <pair e1="DS.d1439.s0.e1" e2="DS.d1439.s0.e4" id="DS.d1439.s0.i5" interaction="False"/>
            <pair e1="DS.d1439.s0.e1" e2="DS.d1439.s0.e2" id="DS.d1439.s0.i6" interaction="False"/>
            <pair e1="DS.d1439.s0.e0" e2="DS.d1439.s0.e5" id="DS.d1439.s0.i7" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1440" origId="18830882">
        <sentence id="DS.d1440.s0" origId="18830882-1911" text="Inhibition of rat liver cathepsins B and L by the peptide aldehyde benzyloxycarbonyl-leucyl-leucyl-leucinal and its analogues.">
            <entity id="DS.d1440.s0.e0" origId="P81494,P83205" charOffset="24-36" type="protein" text="cathepsins B"/>
            <entity id="DS.d1440.s0.e1" origId="107707" charOffset="67-107" type="compound" text="benzyloxycarbonyl-leucyl-leucyl-leucinal"/>
            <pair e1="DS.d1440.s0.e1" e2="DS.d1440.s0.e0" id="DS.d1440.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1440.s1" origId="18830882-1913" text="The concentration required for 50% inhibition (IC(50)) by ZLLLal was 88 nM for cathepsin B and 163 nM for cathepsin L.">
            <entity id="DS.d1440.s1.e0" origId="107707" charOffset="58-64" type="compound" text="ZLLLal"/>
            <entity id="DS.d1440.s1.e1" origId="P81494,P83205" charOffset="79-90" type="protein" text="cathepsin B"/>
            <entity id="DS.d1440.s1.e2" origId="P09648,P25773,Q10991" charOffset="106-117" type="protein" text="cathepsin L"/>
            <pair e1="DS.d1440.s1.e0" e2="DS.d1440.s1.e2" id="DS.d1440.s1.i0" interaction="True"/>
            <pair e1="DS.d1440.s1.e0" e2="DS.d1440.s1.e1" id="DS.d1440.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1441" origId="18830885">
        <sentence id="DS.d1441.s0" origId="18830885-1914" text="Preliminary structure-activity relationships and a molecular modeling study for 9a have revealed that the isoflavone moiety plays a key role in the interaction of this series of derivatives with AChE by acting as an anchor in its peripheral anionic site.">
            <entity id="DS.d1441.s0.e0" origId="72304" charOffset="106-116" type="compound" text="isoflavone"/>
            <entity id="DS.d1441.s0.e1" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="195-199" type="protein" text="AChE"/>
            <pair e1="DS.d1441.s0.e0" e2="DS.d1441.s0.e1" id="DS.d1441.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1442" origId="18830972">
        <sentence id="DS.d1442.s0" origId="18830972-1951" text="Heme oxygenase-1 (HO-1) and Nitric oxide (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.">
            <entity id="DS.d1442.s0.e0" origId="P06762,P09601,P14791,P14901,P32394,P72849,Q5E9F2" charOffset="0-16" type="protein" text="Heme oxygenase-1"/>
            <entity id="DS.d1442.s0.e1" origId="P06762,P09601,P14791,P14901,P32394,Q5E9F2" charOffset="18-22" type="protein" text="HO-1"/>
            <entity id="DS.d1442.s0.e2" origId="145068" charOffset="28-40" type="compound" text="Nitric oxide"/>
            <pair e1="DS.d1442.s0.e2" e2="DS.d1442.s0.e1" id="DS.d1442.s0.i0" interaction="False"/>
            <pair e1="DS.d1442.s0.e2" e2="DS.d1442.s0.e0" id="DS.d1442.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1443" origId="18831007">
        <sentence id="DS.d1443.s0" origId="18831007-1971" text="One potential target for reducing T cell migration is inhibition of the Ca(2+)-activated neutral protease calpain.">
            <entity id="DS.d1443.s0.e0" origId="271" charOffset="72-76" type="compound" text="Ca(2"/>
            <entity id="DS.d1443.s0.e1" origId="P05806,P06832,P29148,P43133,P43263,P68734,P68735,P68736,Q00891" charOffset="89-105" type="protein" text="neutral protease"/>
            <entity id="DS.d1443.s0.e2" origId="P27730" charOffset="106-113" type="protein" text="calpain"/>
            <pair e1="DS.d1443.s0.e0" e2="DS.d1443.s0.e2" id="DS.d1443.s0.i0" interaction="True"/>
            <pair e1="DS.d1443.s0.e0" e2="DS.d1443.s0.e1" id="DS.d1443.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1444" origId="18831010">
        <sentence id="DS.d1444.s0" origId="18831010-1974" text="A shift toward proinflammatory microglial activation is indicated by the release of interleukin-6, tumor necrosis factor-alpha, and nitric oxide and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.">
            <entity id="DS.d1444.s0.e0" origId="P41693" charOffset="84-97" type="protein" text="interleukin-6"/>
            <entity id="DS.d1444.s0.e1" origId="Q8JFG3" charOffset="99-120" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d1444.s0.e2" origId="145068" charOffset="132-144" type="compound" text="nitric oxide"/>
            <pair e1="DS.d1444.s0.e2" e2="DS.d1444.s0.e1" id="DS.d1444.s0.i0" interaction="False"/>
            <pair e1="DS.d1444.s0.e2" e2="DS.d1444.s0.e0" id="DS.d1444.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1445" origId="18831033">
        <sentence id="DS.d1445.s0" origId="18831033-1984" text="Levetiracetam, a newer anticonvulsant, does not undergo CYP metabolism and does not alter the pharmacokinetics of chemotherapy, antiemetics, and corticosteroids, which are metabolized by the liver.">
            <entity id="DS.d1445.s0.e0" origId="5284583" charOffset="0-13" type="compound" text="Levetiracetam"/>
            <entity id="DS.d1445.s0.e1" origId="P21568,P21569,P24525,P34887,Q26551" charOffset="56-59" type="protein" text="CYP"/>
            <pair e1="DS.d1445.s0.e0" e2="DS.d1445.s0.e1" id="DS.d1445.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1447" origId="18831052">
        <sentence id="DS.d1447.s0" origId="18831052-2002" text="The human AU RNA binding protein/enoyl-Coenzyme A hydratase (AUH) is a 3-hydroxy-3-methylglutaconyl-CoA dehydratase in the leucine degradation pathway.">
            <entity id="DS.d1447.s0.e0" origId="P03526,P04487,P07940,P12002,P56958,P82866" charOffset="13-32" type="protein" text="RNA binding protein"/>
            <entity id="DS.d1447.s0.e1" origId="O42887,P60651,P60652,P60653,P60654,P60655,P60656,P60657,P70999,Q10088,Q13825,Q57K36,Q5F6R3,Q5PJH7,Q7N122,Q7P0S6,Q7VRG4,Q7X3P1,Q814Q2,Q81JT1,Q8FE36,Q90XD2,Q9BSE5,Q9K6B9" charOffset="61-64" type="protein" text="AUH"/>
            <entity id="DS.d1447.s0.e2" origId="857,6106,439524" charOffset="123-130" type="compound" text="leucine"/>
            <pair e1="DS.d1447.s0.e2" e2="DS.d1447.s0.e0" id="DS.d1447.s0.i0" interaction="True"/>
            <pair e1="DS.d1447.s0.e2" e2="DS.d1447.s0.e1" id="DS.d1447.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1448" origId="18831980">
        <sentence id="DS.d1448.s0" origId="18831980-2703" text="SULT1E1 is responsible for the sulfation and inactivation of beta-estradiol (E2) at physiological concentrations.">
            <entity id="DS.d1448.s0.e0" origId="P19217,P49887,P49888" charOffset="0-7" type="protein" text="SULT1E1"/>
            <entity id="DS.d1448.s0.e1" origId="5757" charOffset="61-75" type="compound" text="beta-estradiol"/>
            <pair e1="DS.d1448.s0.e1" e2="DS.d1448.s0.e0" id="DS.d1448.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1449" origId="18832050">
        <sentence id="DS.d1449.s0" origId="18832050-2295" text="The main mechanism of resistance to methotrexate was extra-chromosomal amplification of the dihydrofolate reductase gene.">
            <entity id="DS.d1449.s0.e0" origId="126941" charOffset="36-48" type="compound" text="methotrexate"/>
            <entity id="DS.d1449.s0.e1" origId="O02604,O62583,O81395,P00374,P00375,P00376,P00377,P00378,P00380,P00381,P04174,P04382,P04753,P07382,P07807,P0A016,P0A017,P0A546,P0A547,P0ABQ4,P0ABQ5,P0ABQ6,P0C0P0,P0C0P1,P11045,P13922,P15093,P16126,P16184,P17719,P20712,P22906,P27498,P28019,P31073,P31074,P36591,P43791,P45350,P46103,P47470,P51820,P57243,P78028,P99079,Q05762,Q05763,Q07422,Q07801,Q23695,Q27713,Q27783,Q27793,Q27828,Q2QRX6,Q54277,Q54801,Q59487,Q5HFZ7,Q5HPB1,Q5UQG3,Q60034,Q6G9D5,Q6GGY1,Q89AV2,Q8K9Z8,Q8NWQ9,Q920D2,Q98Q32,Q9CBW1,Q9JSQ9,Q9K168,Q9PR30,Q9U8B8" charOffset="92-115" type="protein" text="dihydrofolate reductase"/>
            <pair e1="DS.d1449.s0.e0" e2="DS.d1449.s0.e1" id="DS.d1449.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1450" origId="18832097">
        <sentence id="DS.d1450.s0" origId="18832097-2311" text="In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and VDR protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.">
            <entity id="DS.d1450.s0.e0" origId="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148" charOffset="93-106" type="compound" text="staurosporine"/>
            <entity id="DS.d1450.s0.e1" origId="9547243" charOffset="130-154" type="compound" text="1,25-dihydroxy vitamin D"/>
            <entity id="DS.d1450.s0.e2" origId="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5" charOffset="171-174" type="protein" text="VDR"/>
            <entity id="DS.d1450.s0.e3" origId="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5" charOffset="204-207" type="protein" text="VDR"/>
            <pair e1="DS.d1450.s0.e1" e2="DS.d1450.s0.e2" id="DS.d1450.s0.i0" interaction="False"/>
            <pair e1="DS.d1450.s0.e0" e2="DS.d1450.s0.e2" id="DS.d1450.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1451" origId="18832102">
        <sentence id="DS.d1451.s0" origId="18832102-2313" text="The use of lipoproteins as a substrate for progesterone synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (VLDLR), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.">
            <entity id="DS.d1451.s0.e0" origId="5994" charOffset="43-55" type="compound" text="progesterone"/>
            <entity id="DS.d1451.s0.e1" origId="P01131,P20063,Q28832" charOffset="133-165" type="protein" text="low-density lipoprotein receptor"/>
            <entity id="DS.d1451.s0.e2" origId="P35953,P98155,P98165" charOffset="167-172" type="protein" text="VLDLR"/>
            <entity id="DS.d1451.s0.e3" origId="P01131,P20063,Q28832" charOffset="175-207" type="protein" text="low-density lipoprotein receptor"/>
            <entity id="DS.d1451.s0.e4" origId="P01130,P01131,P20063,P35950,Q28832" charOffset="168-172" type="protein" text="LDLR"/>
            <entity id="DS.d1451.s0.e5" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="243-248" type="protein" text="SR-BI"/>
            <pair e1="DS.d1451.s0.e0" e2="DS.d1451.s0.e2" id="DS.d1451.s0.i0" interaction="False"/>
            <pair e1="DS.d1451.s0.e0" e2="DS.d1451.s0.e1" id="DS.d1451.s0.i1" interaction="False"/>
            <pair e1="DS.d1451.s0.e0" e2="DS.d1451.s0.e5" id="DS.d1451.s0.i2" interaction="False"/>
            <pair e1="DS.d1451.s0.e0" e2="DS.d1451.s0.e4" id="DS.d1451.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d1451.s1" origId="18832102-2314" text="These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a progesterone substrate and that as these are depleted, new cholesterol esters are obtained through an LDLR- and/or SR-BI-mediated mechanism.">
            <entity id="DS.d1451.s1.e0" origId="5994" charOffset="103-115" type="compound" text="progesterone"/>
            <entity id="DS.d1451.s1.e1" origId="P01130,P01131,P20063,P35950,Q28832" charOffset="205-209" type="protein" text="LDLR"/>
            <entity id="DS.d1451.s1.e2" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="218-223" type="protein" text="SR-BI"/>
            <pair e1="DS.d1451.s1.e0" e2="DS.d1451.s1.e2" id="DS.d1451.s1.i0" interaction="False"/>
            <pair e1="DS.d1451.s1.e0" e2="DS.d1451.s1.e1" id="DS.d1451.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1452" origId="18832185">
        <sentence id="DS.d1452.s0" origId="18832185-2341" text="The 2,2',4,4',5,5'-hexachlorobiphenyl-enhanced degradation of connexin 43 involves both proteasomal and lysosomal activities.">
            <entity id="DS.d1452.s0.e0" origId="37034" charOffset="4-37" type="compound" text="2,2',4,4',5,5'-hexachlorobiphenyl"/>
            <entity id="DS.d1452.s0.e1" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="62-73" type="protein" text="connexin 43"/>
            <pair e1="DS.d1452.s0.e0" e2="DS.d1452.s0.e1" id="DS.d1452.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1452.s1" origId="18832185-2343" text="As this effect might be related to deregulation of connexin 43 (Cx43) synthesis, trafficking, or degradation, we investigated the impact of PCB 153 on these events.">
            <entity id="DS.d1452.s1.e0" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="51-62" type="protein" text="connexin 43"/>
            <entity id="DS.d1452.s1.e1" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="64-68" type="protein" text="Cx43"/>
            <entity id="DS.d1452.s1.e2" origId="37034" charOffset="140-147" type="compound" text="PCB 153"/>
            <pair e1="DS.d1452.s1.e2" e2="DS.d1452.s1.e0" id="DS.d1452.s1.i0" interaction="True"/>
            <pair e1="DS.d1452.s1.e2" e2="DS.d1452.s1.e1" id="DS.d1452.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1452.s2" origId="18832185-2345" text="Inhibition of either proteasomes or lysosomes with their specific inhibitors largely restored total Cx43 protein levels, thus suggesting that both proteasomes and lysosomes may participate in the PCB 153-enhanced Cx43 internalization and degradation.">
            <entity id="DS.d1452.s2.e0" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="100-104" type="protein" text="Cx43"/>
            <entity id="DS.d1452.s2.e1" origId="37034" charOffset="196-203" type="compound" text="PCB 153"/>
            <entity id="DS.d1452.s2.e2" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="213-217" type="protein" text="Cx43"/>
            <pair e1="DS.d1452.s2.e1" e2="DS.d1452.s2.e0" id="DS.d1452.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1452.s3" origId="18832185-2346" text="Finally, PCB 153 also interfered with restoration of gap junction plaques following the inhibition of Cx43 transport to plasma membrane.">
            <entity id="DS.d1452.s3.e0" origId="37034" charOffset="9-16" type="compound" text="PCB 153"/>
            <entity id="DS.d1452.s3.e1" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="102-106" type="protein" text="Cx43"/>
            <pair e1="DS.d1452.s3.e0" e2="DS.d1452.s3.e1" id="DS.d1452.s3.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1452.s4" origId="18832185-2347" text="Taken together, multiple modes of action seem to contribute to downregulation of Cx43 in PCB 153-treated rat liver epithelial cells.">
            <entity id="DS.d1452.s4.e0" origId="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0" charOffset="81-85" type="protein" text="Cx43"/>
            <entity id="DS.d1452.s4.e1" origId="37034" charOffset="89-96" type="compound" text="PCB 153"/>
            <pair e1="DS.d1452.s4.e1" e2="DS.d1452.s4.e0" id="DS.d1452.s4.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1453" origId="18832295">
        <sentence id="DS.d1453.s0" origId="18832295-2399" text="Vildagliptin demonstrates potent inhibition of DPP-4 activity with excellent tolerability at doses of up to and including 200 mg qd.">
            <entity id="DS.d1453.s0.e0" origId="6918537" charOffset="0-12" type="compound" text="Vildagliptin"/>
            <entity id="DS.d1453.s0.e1" origId="P97399,Q62598,Q9NZW4" charOffset="47-50" type="protein" text="DPP"/>
            <pair e1="DS.d1453.s0.e0" e2="DS.d1453.s0.e1" id="DS.d1453.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1454" origId="18832330">
        <sentence id="DS.d1454.s0" origId="18832330-479" text="The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or mGluR5 receptor with 2-methyl-6-(phenylethynyl)-pyridine (MPEP).">
            <entity id="DS.d1454.s0.e0" origId="6442441" charOffset="118-124" type="compound" text="MK-801"/>
            <entity id="DS.d1454.s0.e1" origId="P31424,P41594" charOffset="128-134" type="protein" text="mGluR5"/>
            <entity id="DS.d1454.s0.e2" origId="3025961" charOffset="149-184" type="compound" text="2-methyl-6-(phenylethynyl)-pyridine"/>
            <entity id="DS.d1454.s0.e3" origId="3025961" charOffset="186-190" type="compound" text="MPEP"/>
            <pair e1="DS.d1454.s0.e0" e2="DS.d1454.s0.e1" id="DS.d1454.s0.i0" interaction="False"/>
            <pair e1="DS.d1454.s0.e3" e2="DS.d1454.s0.e1" id="DS.d1454.s0.i1" interaction="True"/>
            <pair e1="DS.d1454.s0.e2" e2="DS.d1454.s0.e1" id="DS.d1454.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1455" origId="18832453">
        <sentence id="DS.d1455.s0" origId="18832453-2471" text="Here, PCA is applied to three problems in GAG research: (i) distinguishing origins of heparin preparations, (ii) structural analysis of heparin derivatives, and (iii) classification of chondroitin sulfates (CS).">
            <entity id="DS.d1455.s0.e0" origId="P01105,P32503" charOffset="42-45" type="protein" text="GAG"/>
            <entity id="DS.d1455.s0.e1" origId="24766" charOffset="185-205" type="compound" text="chondroitin sulfates"/>
            <pair e1="DS.d1455.s0.e1" e2="DS.d1455.s0.e0" id="DS.d1455.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1457" origId="18832476">
        <sentence id="DS.d1457.s0" origId="18832476-2484" text="The CL(int) was obtained using either individual or combined cofactors for cytochrome P450 (P450) and UGT enzymes with alamethicin activation and in the presence and absence of 2% bovine serum albumin (BSA).">
            <entity id="DS.d1457.s0.e0" origId="16132042,16132684" charOffset="119-130" type="compound" text="alamethicin"/>
            <entity id="DS.d1457.s0.e1" origId="P21847,P83517" charOffset="187-200" type="protein" text="serum albumin"/>
            <entity id="DS.d1457.s0.e2" origId="P02769" charOffset="202-205" type="protein" text="BSA"/>
            <pair e1="DS.d1457.s0.e0" e2="DS.d1457.s0.e2" id="DS.d1457.s0.i0" interaction="False"/>
            <pair e1="DS.d1457.s0.e0" e2="DS.d1457.s0.e1" id="DS.d1457.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1458" origId="18832480">
        <sentence id="DS.d1458.s0" origId="18832480-801" text="By using purified bovine xanthine oxidase, the reduction was observed in the presence of NAD (P)H. These results suggest that FLU-1 N-OH is involved in flutamide-induced hepatotoxicity and that cytosolic reduction of FLU-1 N-OH plays a major role in protection against flutamide-induced hepatotoxicity.">
            <entity id="DS.d1458.s0.e0" origId="P22985,P47989,P47990,P80457,Q00519,Q9MYW6" charOffset="25-41" type="protein" text="xanthine oxidase"/>
            <entity id="DS.d1458.s0.e1" origId="5893" charOffset="89-92" type="compound" text="NAD"/>
            <pair e1="DS.d1458.s0.e1" e2="DS.d1458.s0.e0" id="DS.d1458.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1459" origId="18832589">
        <sentence id="DS.d1459.s0" origId="18832589-2551" text="Recent studies have provided important insight into the homeoprotein LIM homeobox transcription factor 1alpha (Lmx1a) and its role in the commitment of cells to a midbrain dopamine (mDA) fate in the developing mouse.">
            <entity id="DS.d1459.s0.e0" origId="Q25132" charOffset="69-72" type="protein" text="LIM"/>
            <entity id="DS.d1459.s0.e1" origId="Q9JKU8" charOffset="111-116" type="protein" text="Lmx1a"/>
            <entity id="DS.d1459.s0.e2" origId="681" charOffset="172-180" type="compound" text="dopamine"/>
            <pair e1="DS.d1459.s0.e2" e2="DS.d1459.s0.e1" id="DS.d1459.s0.i0" interaction="True"/>
            <pair e1="DS.d1459.s0.e2" e2="DS.d1459.s0.e0" id="DS.d1459.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1460" origId="18832593">
        <sentence id="DS.d1460.s0" origId="18832593-1025" text="An acute increase in oxygen tension led to Smad activation within 30 minutes, even in the absence of exogenous BMP treatment.">
            <entity id="DS.d1460.s0.e0" origId="977" charOffset="21-27" type="compound" text="oxygen"/>
            <entity id="DS.d1460.s0.e1" origId="P35855" charOffset="111-114" type="protein" text="BMP"/>
            <pair e1="DS.d1460.s0.e0" e2="DS.d1460.s0.e1" id="DS.d1460.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1461" origId="18832596">
        <sentence id="DS.d1461.s0" origId="18832596-2558" text="Recognition of galactan components of pectin by galectin-3.">
            <entity id="DS.d1461.s0.e0" origId="16218585,20758205" charOffset="15-23" type="compound" text="galactan"/>
            <entity id="DS.d1461.s0.e1" origId="P08699,P16110,P17931,P38486,P47845,P47953" charOffset="48-58" type="protein" text="galectin-3"/>
            <pair e1="DS.d1461.s0.e0" e2="DS.d1461.s0.e1" id="DS.d1461.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1461.s1" origId="18832596-2559" text="By using a combination of fluorescence microscopy, flow cytometry, and force spectroscopy, it has been possible to demonstrate, for the first time, specific binding of a pectin galactan to the recombinant form of human Gal3.">
            <entity id="DS.d1461.s1.e0" origId="16218585,20758205" charOffset="177-185" type="compound" text="galactan"/>
            <entity id="DS.d1461.s1.e1" origId="Q9DG58" charOffset="219-223" type="protein" text="Gal3"/>
            <pair e1="DS.d1461.s1.e0" e2="DS.d1461.s1.e1" id="DS.d1461.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1462" origId="18832659">
        <sentence id="DS.d1462.s0" origId="18832659-2578" text="STIM1 has been identified as an endoplasmic reticulum (ER)-resident Ca(2+) sensor that regulates store-operated calcium entry (SOCE) in immune cells and platelets, but the identity of the platelet SOC channel has remained elusive.">
            <entity id="DS.d1462.s0.e0" origId="Q13586,Q58CP9" charOffset="0-5" type="protein" text="STIM1"/>
            <entity id="DS.d1462.s0.e1" origId="271" charOffset="68-72" type="compound" text="Ca(2"/>
            <pair e1="DS.d1462.s0.e1" e2="DS.d1462.s0.e0" id="DS.d1462.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1463" origId="18832772">
        <sentence id="DS.d1463.s0" origId="18832772-2632" text="A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL.">
            <entity id="DS.d1463.s0.e0" origId="847" charOffset="39-59" type="compound" text="methionine sulfoxide"/>
            <entity id="DS.d1463.s0.e1" origId="P18647" charOffset="71-89" type="protein" text="apolipoprotein A-I"/>
            <pair e1="DS.d1463.s0.e0" e2="DS.d1463.s0.e1" id="DS.d1463.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1463.s1" origId="18832772-2633" text="A wide range of reactive intermediates oxidizes methionine residues to methionine sulfoxide (MetO) in apolipoprotein A-I (apoA-I), the major HDL protein.">
            <entity id="DS.d1463.s1.e0" origId="847" charOffset="71-91" type="compound" text="methionine sulfoxide"/>
            <entity id="DS.d1463.s1.e1" origId="P18647" charOffset="102-120" type="protein" text="apolipoprotein A-I"/>
            <entity id="DS.d1463.s1.e2" origId="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4" charOffset="122-128" type="protein" text="apoA-I"/>
            <pair e1="DS.d1463.s1.e0" e2="DS.d1463.s1.e1" id="DS.d1463.s1.i0" interaction="True"/>
            <pair e1="DS.d1463.s1.e0" e2="DS.d1463.s1.e2" id="DS.d1463.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1464" origId="18832826">
        <sentence id="DS.d1464.s0" origId="18832826-1553" text="The renin-angiotensin-aldosterone system: approaches to guide angiotensin-converting enzyme inhibition in patients with coronary artery disease.">
            <entity id="DS.d1464.s0.e0" origId="5839" charOffset="22-33" type="compound" text="aldosterone"/>
            <entity id="DS.d1464.s0.e1" origId="Q10751" charOffset="62-91" type="protein" text="angiotensin-converting enzyme"/>
            <pair e1="DS.d1464.s0.e0" e2="DS.d1464.s0.e1" id="DS.d1464.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1465" origId="18834674">
        <sentence id="DS.d1465.s0" origId="18834674-2651" text="It was identified as producer of extended-spectrum beta-lactamases (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, ceftazidime and aztreonam.">
            <entity id="DS.d1465.s0.e0" origId="P80298,P80545,P81173" charOffset="51-66" type="protein" text="beta-lactamases"/>
            <entity id="DS.d1465.s0.e1" origId="33613" charOffset="110-121" type="compound" text="amoxicillin"/>
            <entity id="DS.d1465.s0.e2" origId="5280980" charOffset="122-133" type="compound" text="clavulanate"/>
            <entity id="DS.d1465.s0.e3" origId="5479527,5742673,6540461" charOffset="138-148" type="compound" text="cefotaxime"/>
            <entity id="DS.d1465.s0.e4" origId="5479530" charOffset="150-161" type="compound" text="ceftriaxone"/>
            <entity id="DS.d1465.s0.e5" origId="6321415" charOffset="163-174" type="compound" text="ceftazidime"/>
            <entity id="DS.d1465.s0.e6" origId="5742832" charOffset="179-188" type="compound" text="aztreonam"/>
            <pair e1="DS.d1465.s0.e1" e2="DS.d1465.s0.e0" id="DS.d1465.s0.i0" interaction="True"/>
            <pair e1="DS.d1465.s0.e5" e2="DS.d1465.s0.e0" id="DS.d1465.s0.i1" interaction="True"/>
            <pair e1="DS.d1465.s0.e3" e2="DS.d1465.s0.e0" id="DS.d1465.s0.i2" interaction="True"/>
            <pair e1="DS.d1465.s0.e4" e2="DS.d1465.s0.e0" id="DS.d1465.s0.i3" interaction="True"/>
            <pair e1="DS.d1465.s0.e6" e2="DS.d1465.s0.e0" id="DS.d1465.s0.i4" interaction="True"/>
            <pair e1="DS.d1465.s0.e2" e2="DS.d1465.s0.e0" id="DS.d1465.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1466" origId="18834690">
        <sentence id="DS.d1466.s0" origId="18834690-355" text="The binding of diazepam to human serum albumin was used as the model system in order to evaluate the performance of automated SPME.">
            <entity id="DS.d1466.s0.e0" origId="3016" charOffset="15-23" type="compound" text="diazepam"/>
            <entity id="DS.d1466.s0.e1" origId="P21847,P83517" charOffset="33-46" type="protein" text="serum albumin"/>
            <pair e1="DS.d1466.s0.e0" e2="DS.d1466.s0.e1" id="DS.d1466.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1467" origId="18834707">
        <sentence id="DS.d1467.s0" origId="18834707-357" text="Nitric oxide (NO) and interlukin-6 (IL-6) are highly reactive mediators that have been shown to play different roles in a variety of different biological process.">
            <entity id="DS.d1467.s0.e0" origId="145068" charOffset="0-12" type="compound" text="Nitric oxide"/>
            <entity id="DS.d1467.s0.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="36-40" type="protein" text="IL-6"/>
            <pair e1="DS.d1467.s0.e0" e2="DS.d1467.s0.e1" id="DS.d1467.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1468" origId="18834868">
        <sentence id="DS.d1468.s0" origId="18834868-391" text="Mitochondrial aldehyde dehydrogenase (ALDH-2)--maker of and marker for nitrate tolerance in response to nitroglycerin treatment.">
            <entity id="DS.d1468.s0.e0" origId="O74187,P08157,P12693,P23240,P40108,P41751,P42041,P45959,Q27640,Q8VXQ2,Q9RYG9,Q9ZA11" charOffset="14-36" type="protein" text="aldehyde dehydrogenase"/>
            <entity id="DS.d1468.s0.e1" origId="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2" charOffset="38-42" type="protein" text="ALDH"/>
            <entity id="DS.d1468.s0.e2" origId="943" charOffset="71-78" type="compound" text="nitrate"/>
            <entity id="DS.d1468.s0.e3" origId="4510" charOffset="104-117" type="compound" text="nitroglycerin"/>
            <pair e1="DS.d1468.s0.e3" e2="DS.d1468.s0.e0" id="DS.d1468.s0.i0" interaction="True"/>
            <pair e1="DS.d1468.s0.e3" e2="DS.d1468.s0.e1" id="DS.d1468.s0.i1" interaction="True"/>
            <pair e1="DS.d1468.s0.e2" e2="DS.d1468.s0.e1" id="DS.d1468.s0.i2" interaction="True"/>
            <pair e1="DS.d1468.s0.e2" e2="DS.d1468.s0.e0" id="DS.d1468.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d1468.s1" origId="18834868-392" text="According to the oxidative stress concept, increased vascular superoxide and peroxynitrite production as well as an increased sensitivity to vasoconstrictors secondary to activation of protein kinase C as well as vascular NADPH oxidases contribute to the development of tolerance.">
            <entity id="DS.d1468.s1.e0" origId="5359597" charOffset="62-72" type="compound" text="superoxide"/>
            <entity id="DS.d1468.s1.e1" origId="104806" charOffset="77-90" type="compound" text="peroxynitrite"/>
            <entity id="DS.d1468.s1.e2" origId="P13678,Q25378" charOffset="185-201" type="protein" text="protein kinase C"/>
            <pair e1="DS.d1468.s1.e0" e2="DS.d1468.s1.e2" id="DS.d1468.s1.i0" interaction="False"/>
            <pair e1="DS.d1468.s1.e1" e2="DS.d1468.s1.e2" id="DS.d1468.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1468.s2" origId="18834868-393" text="mitochondrial aldehyde dehydrogenase (ALDH-2)) and mitochondria as potential sources of reactive oxygen species (ROS).">
            <entity id="DS.d1468.s2.e0" origId="O74187,P08157,P12693,P23240,P40108,P41751,P42041,P45959,Q27640,Q8VXQ2,Q9RYG9,Q9ZA11" charOffset="14-36" type="protein" text="aldehyde dehydrogenase"/>
            <entity id="DS.d1468.s2.e1" origId="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2" charOffset="38-42" type="protein" text="ALDH"/>
            <entity id="DS.d1468.s2.e2" origId="977" charOffset="97-103" type="compound" text="oxygen"/>
            <pair e1="DS.d1468.s2.e2" e2="DS.d1468.s2.e1" id="DS.d1468.s2.i0" interaction="False"/>
            <pair e1="DS.d1468.s2.e2" e2="DS.d1468.s2.e0" id="DS.d1468.s2.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1468.s3" origId="18834868-395" text="Finally, we will address the question whether ALDH-2 inactivation by nitroglycerin could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.">
            <entity id="DS.d1468.s3.e0" origId="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2" charOffset="46-50" type="protein" text="ALDH"/>
            <entity id="DS.d1468.s3.e1" origId="4510" charOffset="69-82" type="compound" text="nitroglycerin"/>
            <entity id="DS.d1468.s3.e2" origId="943" charOffset="121-128" type="compound" text="nitrate"/>
            <entity id="DS.d1468.s3.e3" origId="421" charOffset="211-229" type="compound" text="dihydrolipoic acid"/>
            <pair e1="DS.d1468.s3.e3" e2="DS.d1468.s3.e0" id="DS.d1468.s3.i0" interaction="False"/>
            <pair e1="DS.d1468.s3.e1" e2="DS.d1468.s3.e0" id="DS.d1468.s3.i1" interaction="False"/>
            <pair e1="DS.d1468.s3.e2" e2="DS.d1468.s3.e0" id="DS.d1468.s3.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1469" origId="18834871">
        <sentence id="DS.d1469.s0" origId="18834871-397" text="Sex steroids enhance insulin receptors and glucose oxidation in Chang liver cells.">
            <entity id="DS.d1469.s0.e0" origId="Q28516" charOffset="21-38" type="protein" text="insulin receptors"/>
            <entity id="DS.d1469.s0.e1" origId="206,5793,64689,79025" charOffset="43-50" type="compound" text="glucose"/>
            <pair e1="DS.d1469.s0.e1" e2="DS.d1469.s0.e0" id="DS.d1469.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1469.s1" origId="18834871-398" text="The present study was designed to assess the effect of sex steroids (testosterone and 17beta-estradiol) on insulin receptor expression, insulin binding and glucose oxidation in human liver cell line.">
            <entity id="DS.d1469.s1.e0" origId="6013" charOffset="69-81" type="compound" text="testosterone"/>
            <entity id="DS.d1469.s1.e1" origId="5757" charOffset="86-102" type="compound" text="17beta-estradiol"/>
            <entity id="DS.d1469.s1.e2" origId="Q28516" charOffset="107-123" type="protein" text="insulin receptor"/>
            <entity id="DS.d1469.s1.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="107-114" type="protein" text="insulin"/>
            <entity id="DS.d1469.s1.e4" origId="206,5793,64689,79025" charOffset="156-163" type="compound" text="glucose"/>
            <pair e1="DS.d1469.s1.e4" e2="DS.d1469.s1.e3" id="DS.d1469.s1.i0" interaction="False"/>
            <pair e1="DS.d1469.s1.e0" e2="DS.d1469.s1.e3" id="DS.d1469.s1.i1" interaction="True"/>
            <pair e1="DS.d1469.s1.e1" e2="DS.d1469.s1.e3" id="DS.d1469.s1.i2" interaction="True"/>
            <pair e1="DS.d1469.s1.e0" e2="DS.d1469.s1.e2" id="DS.d1469.s1.i3" interaction="True"/>
            <pair e1="DS.d1469.s1.e4" e2="DS.d1469.s1.e2" id="DS.d1469.s1.i4" interaction="False"/>
            <pair e1="DS.d1469.s1.e1" e2="DS.d1469.s1.e2" id="DS.d1469.s1.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1470" origId="18834900">
        <sentence id="DS.d1470.s0" origId="18834900-402" text="It is predicted to possess all the expected features of proPO members, including two putative tyrosinase copper-binding motifs with six histidine residues and a thiol ester-like motif, sharing 67% amino acid sequence identity with PmproPO1.">
            <entity id="DS.d1470.s0.e0" origId="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396" charOffset="94-104" type="protein" text="tyrosinase"/>
            <entity id="DS.d1470.s0.e1" origId="773,6274" charOffset="136-145" type="compound" text="histidine"/>
            <entity id="DS.d1470.s0.e2" origId="519335" charOffset="161-172" type="compound" text="thiol ester"/>
            <pair e1="DS.d1470.s0.e1" e2="DS.d1470.s0.e0" id="DS.d1470.s0.i0" interaction="False"/>
            <pair e1="DS.d1470.s0.e2" e2="DS.d1470.s0.e0" id="DS.d1470.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1471" origId="18834946">
        <sentence id="DS.d1471.s0" origId="18834946-408" text="Examination of cadmium-induced expression of the small heat shock protein gene, hsp30, in Xenopus laevis A6 kidney epithelial cells.">
            <entity id="DS.d1471.s0.e0" origId="23973" charOffset="15-22" type="compound" text="cadmium"/>
            <entity id="DS.d1471.s0.e1" origId="P19752,P40920" charOffset="80-85" type="protein" text="hsp30"/>
            <pair e1="DS.d1471.s0.e0" e2="DS.d1471.s0.e1" id="DS.d1471.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1471.s1" origId="18834946-409" text="In the present study, we have characterized the effect of cadmium on the accumulation of the small heat shock protein (HSP), HSP30, in Xenopus laevis A6 kidney epithelial cells.">
            <entity id="DS.d1471.s1.e0" origId="23973" charOffset="58-65" type="compound" text="cadmium"/>
            <entity id="DS.d1471.s1.e1" origId="P32590" charOffset="119-122" type="protein" text="HSP"/>
            <entity id="DS.d1471.s1.e2" origId="P25619,P42931" charOffset="125-130" type="protein" text="HSP30"/>
            <pair e1="DS.d1471.s1.e0" e2="DS.d1471.s1.e1" id="DS.d1471.s1.i0" interaction="True"/>
            <pair e1="DS.d1471.s1.e0" e2="DS.d1471.s1.e2" id="DS.d1471.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1471.s2" origId="18834946-410" text="Immunocytochemical analysis of cadmium chloride-treated A6 cells revealed HSP30 accumulation primarily in the cytoplasm in a punctate pattern supplemented with larger HSP30 staining structures.">
            <entity id="DS.d1471.s2.e0" origId="24633,24947" charOffset="31-47" type="compound" text="cadmium chloride"/>
            <entity id="DS.d1471.s2.e1" origId="P25619,P42931" charOffset="74-79" type="protein" text="HSP30"/>
            <entity id="DS.d1471.s2.e2" origId="P25619,P42931" charOffset="167-172" type="protein" text="HSP30"/>
            <pair e1="DS.d1471.s2.e0" e2="DS.d1471.s2.e1" id="DS.d1471.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1471.s3" origId="18834946-411" text="Also, HSP30 co-localized with the F-actin cytoskeleton at higher cadmium chloride concentrations.">
            <entity id="DS.d1471.s3.e0" origId="P25619,P42931" charOffset="6-11" type="protein" text="HSP30"/>
            <entity id="DS.d1471.s3.e1" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="36-41" type="protein" text="actin"/>
            <entity id="DS.d1471.s3.e2" origId="24633,24947" charOffset="65-81" type="compound" text="cadmium chloride"/>
            <pair e1="DS.d1471.s3.e2" e2="DS.d1471.s3.e0" id="DS.d1471.s3.i0" interaction="True"/>
            <pair e1="DS.d1471.s3.e2" e2="DS.d1471.s3.e1" id="DS.d1471.s3.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1472" origId="18834950">
        <sentence id="DS.d1472.s0" origId="18834950-413" text="In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, glutamic acid (E) and lysine (K), at the solvent accessible site of C34.">
            <entity id="DS.d1472.s0.e0" origId="611,23327,33032" charOffset="114-127" type="compound" text="glutamic acid"/>
            <entity id="DS.d1472.s0.e1" origId="866,5962" charOffset="136-142" type="compound" text="lysine"/>
            <entity id="DS.d1472.s0.e2" origId="P32910" charOffset="182-185" type="protein" text="C34"/>
            <pair e1="DS.d1472.s0.e0" e2="DS.d1472.s0.e2" id="DS.d1472.s0.i0" interaction="True"/>
            <pair e1="DS.d1472.s0.e1" e2="DS.d1472.s0.e2" id="DS.d1472.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1473" origId="18834958">
        <sentence id="DS.d1473.s0" origId="18834958-415" text="Cloning, expression, and characterization of cadmium-induced metallothionein-2 from the earthworms Metaphire posthuma and Polypheretima elongata.">
            <entity id="DS.d1473.s0.e0" origId="23973" charOffset="45-52" type="compound" text="cadmium"/>
            <entity id="DS.d1473.s0.e1" origId="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P67981,P68041,P68301,P68302,P68303,P68304,P80394,Q5NVS0,Q7ZSY6,Q9I9I0,Q9XST5" charOffset="61-78" type="protein" text="metallothionein-2"/>
            <pair e1="DS.d1473.s0.e0" e2="DS.d1473.s0.e1" id="DS.d1473.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1473.s1" origId="18834958-416" text="In this study we report the sequences of MT-2 cDNA from two species of Megascoleidae earthworms, Metaphire posthuma and Polypheretima elongata, by mRNA differential display after exposure of the organisms to cadmium.">
            <entity id="DS.d1473.s1.e0" origId="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P43392,P55943,P67981,P68041,P68301,P68302,P68303,P68304,P80394,P94029,Q39459,Q5NVS0,Q7ZSY6,Q9I9I0,Q9VG55,Q9XST5" charOffset="41-45" type="protein" text="MT-2"/>
            <entity id="DS.d1473.s1.e1" origId="23973" charOffset="208-215" type="compound" text="cadmium"/>
            <pair e1="DS.d1473.s1.e1" e2="DS.d1473.s1.e0" id="DS.d1473.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1473.s2" origId="18834958-417" text="Complementary (c)DNA was verified as the MT-2 gene by the characteristics of its predicted translation product, namely a high cysteine content, conserved CXC motifs, and a molecular weight of around 8 kDa.">
            <entity id="DS.d1473.s2.e0" origId="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P43392,P55943,P67981,P68041,P68301,P68302,P68303,P68304,P80394,P94029,Q39459,Q5NVS0,Q7ZSY6,Q9I9I0,Q9VG55,Q9XST5" charOffset="41-45" type="protein" text="MT-2"/>
            <entity id="DS.d1473.s2.e1" origId="594,5862,5360637" charOffset="126-134" type="compound" text="cysteine"/>
            <pair e1="DS.d1473.s2.e1" e2="DS.d1473.s2.e0" id="DS.d1473.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1473.s3" origId="18834958-420" text="These earthworms could be used to evaluate heavy-metal pollution in soil due to the inducible MT-2 by cadmium exposure.">
            <entity id="DS.d1473.s3.e0" origId="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P43392,P55943,P67981,P68041,P68301,P68302,P68303,P68304,P80394,P94029,Q39459,Q5NVS0,Q7ZSY6,Q9I9I0,Q9VG55,Q9XST5" charOffset="94-98" type="protein" text="MT-2"/>
            <entity id="DS.d1473.s3.e1" origId="23973" charOffset="102-109" type="compound" text="cadmium"/>
            <pair e1="DS.d1473.s3.e1" e2="DS.d1473.s3.e0" id="DS.d1473.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1474" origId="18834983">
        <sentence id="DS.d1474.s0" origId="18834983-429" text="Despite the reciprocal relationship that exists between inflammation and thrombosis, we asked whether thrombosis can develop without inflammation, and whether stress-related hormones (ACTH and cortisol) influence platelet-mediated thrombosis.">
            <entity id="DS.d1474.s0.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="184-188" type="protein" text="ACTH"/>
            <entity id="DS.d1474.s0.e1" origId="5754" charOffset="193-201" type="compound" text="cortisol"/>
            <pair e1="DS.d1474.s0.e1" e2="DS.d1474.s0.e0" id="DS.d1474.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1475" origId="18835067">
        <sentence id="DS.d1475.s0" origId="18835067-453" text="The most active compound to emerge from the in vitro and in vivo murine studies was 2b, suggesting an antimalarial activity via inhibition of hemoglobin hydrolysis, however, not as efficient as chloroquine.">
            <entity id="DS.d1475.s0.e0" origId="P15160,P17724,P73925,Q03459" charOffset="142-152" type="protein" text="hemoglobin"/>
            <entity id="DS.d1475.s0.e1" origId="2719" charOffset="194-205" type="compound" text="chloroquine"/>
            <pair e1="DS.d1475.s0.e1" e2="DS.d1475.s0.e0" id="DS.d1475.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1476" origId="18835228">
        <sentence id="DS.d1476.s0" origId="18835228-501" text="The culture medium was analyzed for pH value, concentration of free calcium and phosphate ions and osteocalcin.">
            <entity id="DS.d1476.s0.e0" origId="1061" charOffset="80-94" type="compound" text="phosphate ions"/>
            <entity id="DS.d1476.s0.e1" origId="P02819,P02821,P02823,P0C225,P0C226,P15504,P28317,P39056,P81455,P83005,P83238,P83473,P83489,P84348,P84349,P84350,P84351,Q7LZI4,Q8HYY9" charOffset="99-110" type="protein" text="osteocalcin"/>
            <pair e1="DS.d1476.s0.e0" e2="DS.d1476.s0.e1" id="DS.d1476.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1477" origId="18835260">
        <sentence id="DS.d1477.s0" origId="18835260-516" text="Surprisingly, no role of ERK1/2 or STAT-3 was found in the protein-mediated protection of hepatocytes during acetaminophen exposure.">
            <entity id="DS.d1477.s0.e0" origId="P27361,P28869,P42525,Q07176" charOffset="25-29" type="protein" text="ERK1"/>
            <entity id="DS.d1477.s0.e1" origId="P08457,P35610,Q7QDU4" charOffset="35-39" type="protein" text="STAT"/>
            <entity id="DS.d1477.s0.e2" origId="1983" charOffset="109-122" type="compound" text="acetaminophen"/>
            <pair e1="DS.d1477.s0.e2" e2="DS.d1477.s0.e0" id="DS.d1477.s0.i0" interaction="False"/>
            <pair e1="DS.d1477.s0.e2" e2="DS.d1477.s0.e1" id="DS.d1477.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1478" origId="18835277">
        <sentence id="DS.d1478.s0" origId="18835277-527" text="Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in uracil or xanthine, cause substantial reductions in XDG and UDG activities.">
            <entity id="DS.d1478.s0.e0" origId="977" charOffset="124-130" type="compound" text="oxygen"/>
            <entity id="DS.d1478.s0.e1" origId="1174" charOffset="134-140" type="compound" text="uracil"/>
            <entity id="DS.d1478.s0.e2" origId="1188" charOffset="144-152" type="compound" text="xanthine"/>
            <entity id="DS.d1478.s0.e3" origId="O51082,O74834,O84613,P04303,P09307,P0A4P3,P0A4P4,P0A4P5,P10186,P12295,P12887,P12888,P13051,P13158,P16769,P20536,P21968,P23379,P28275,P28866,P29950,P32941,P32988,P39615,P43731,P47343,P50639,P52345,P52447,P52506,P52507,P53764,P53765,P53766,P56397,P57280,P57807,P59465,P67071,P67072,P67073,P67074,P67075,P67076,P67077,P67078,P67079,P69859,P75536,P97931,Q01019,Q5FL46,Q5HI95,Q5HRG5,Q5HX80,Q5KUD0,Q5L4Q4,Q5NEP2,Q5R080,Q5UPT2,Q5WAZ9,Q5XCK3,Q65DN9,Q662W1,Q6D208,Q6F9Y2,Q6GBQ6,Q6GJ88,Q6HAN7,Q72X51,Q74K70,Q7MA00,Q7MNR0,Q7MXF6,Q7N1U8,Q7P1I1,Q7VGS1,Q7VMC0,Q7VRQ7,Q7VUM8,Q7W1Y7,Q7WQW5,Q814M9,Q81JQ4,Q821F7,Q836Z5,Q83CW4,Q879Z0,Q87SC4,Q87XE2,Q88N05,Q88YG1,Q8A5V6,Q8CQ65,Q8DEP7,Q8DPQ4,Q8DTV8,Q8EB78,Q8EPH6,Q8FF08,Q8FPQ4,Q8G3E9,Q8K7U9,Q8NQU9,Q8P1B6,Q8P4D7,Q8PFZ6,Q8R634,Q8UCM8,Q8X444,Q8XNR7,Q8XVE4,Q8ZD85,Q91UM2,Q92LU5,Q98PV4,Q9A072,Q9CBS3,Q9CIX2,Q9I5H9,Q9JUC4,Q9JZA1,Q9K682,Q9KPK8,Q9PA28,Q9PJ40,Q9PJD2,Q9PPU2,Q9RWH9,Q9Z7D3,Q9ZJN9" charOffset="194-197" type="protein" text="UDG"/>
            <pair e1="DS.d1478.s0.e2" e2="DS.d1478.s0.e3" id="DS.d1478.s0.i0" interaction="False"/>
            <pair e1="DS.d1478.s0.e0" e2="DS.d1478.s0.e3" id="DS.d1478.s0.i1" interaction="False"/>
            <pair e1="DS.d1478.s0.e1" e2="DS.d1478.s0.e3" id="DS.d1478.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d1478.s1" origId="18835277-528" text="Most interestingly, a proline substitution at the G63 position switches the Gme SMUG1 enzyme to an exclusive UDG as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.">
            <entity id="DS.d1478.s1.e0" origId="614,8988,145742" charOffset="22-29" type="compound" text="proline"/>
            <entity id="DS.d1478.s1.e1" origId="Q51061" charOffset="76-79" type="protein" text="Gme"/>
            <entity id="DS.d1478.s1.e2" origId="Q53HV7,Q59I47" charOffset="80-85" type="protein" text="SMUG1"/>
            <entity id="DS.d1478.s1.e3" origId="O51082,O74834,O84613,P04303,P09307,P0A4P3,P0A4P4,P0A4P5,P10186,P12295,P12887,P12888,P13051,P13158,P16769,P20536,P21968,P23379,P28275,P28866,P29950,P32941,P32988,P39615,P43731,P47343,P50639,P52345,P52447,P52506,P52507,P53764,P53765,P53766,P56397,P57280,P57807,P59465,P67071,P67072,P67073,P67074,P67075,P67076,P67077,P67078,P67079,P69859,P75536,P97931,Q01019,Q5FL46,Q5HI95,Q5HRG5,Q5HX80,Q5KUD0,Q5L4Q4,Q5NEP2,Q5R080,Q5UPT2,Q5WAZ9,Q5XCK3,Q65DN9,Q662W1,Q6D208,Q6F9Y2,Q6GBQ6,Q6GJ88,Q6HAN7,Q72X51,Q74K70,Q7MA00,Q7MNR0,Q7MXF6,Q7N1U8,Q7P1I1,Q7VGS1,Q7VMC0,Q7VRQ7,Q7VUM8,Q7W1Y7,Q7WQW5,Q814M9,Q81JQ4,Q821F7,Q836Z5,Q83CW4,Q879Z0,Q87SC4,Q87XE2,Q88N05,Q88YG1,Q8A5V6,Q8CQ65,Q8DEP7,Q8DPQ4,Q8DTV8,Q8EB78,Q8EPH6,Q8FF08,Q8FPQ4,Q8G3E9,Q8K7U9,Q8NQU9,Q8P1B6,Q8P4D7,Q8PFZ6,Q8R634,Q8UCM8,Q8X444,Q8XNR7,Q8XVE4,Q8ZD85,Q91UM2,Q92LU5,Q98PV4,Q9A072,Q9CBS3,Q9CIX2,Q9I5H9,Q9JUC4,Q9JZA1,Q9K682,Q9KPK8,Q9PA28,Q9PJ40,Q9PJD2,Q9PPU2,Q9RWH9,Q9Z7D3,Q9ZJN9" charOffset="109-112" type="protein" text="UDG"/>
            <entity id="DS.d1478.s1.e4" origId="1174" charOffset="156-162" type="compound" text="uracil"/>
            <pair e1="DS.d1478.s1.e4" e2="DS.d1478.s1.e3" id="DS.d1478.s1.i0" interaction="True"/>
            <pair e1="DS.d1478.s1.e4" e2="DS.d1478.s1.e2" id="DS.d1478.s1.i1" interaction="True"/>
            <pair e1="DS.d1478.s1.e0" e2="DS.d1478.s1.e2" id="DS.d1478.s1.i2" interaction="True"/>
            <pair e1="DS.d1478.s1.e4" e2="DS.d1478.s1.e1" id="DS.d1478.s1.i3" interaction="True"/>
            <pair e1="DS.d1478.s1.e0" e2="DS.d1478.s1.e3" id="DS.d1478.s1.i4" interaction="True"/>
            <pair e1="DS.d1478.s1.e0" e2="DS.d1478.s1.e1" id="DS.d1478.s1.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1479" origId="18835344">
        <sentence id="DS.d1479.s0" origId="18835344-566" text="Serum albumin-alginate coated microspheres: role of the inner gel in binding and release of the KRFK peptide.">
            <entity id="DS.d1479.s0.e0" origId="P21847,P83517" charOffset="0-13" type="protein" text="Serum albumin"/>
            <entity id="DS.d1479.s0.e1" origId="6850754" charOffset="14-22" type="compound" text="alginate"/>
            <pair e1="DS.d1479.s0.e1" e2="DS.d1479.s0.e0" id="DS.d1479.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1480" origId="18835350">
        <sentence id="DS.d1480.s0" origId="18835350-570" text="Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of copper and cholesterol co-treated mice by immunohistochemical analysis.">
            <entity id="DS.d1480.s0.e0" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="52-73" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d1480.s0.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="75-79" type="protein" text="iNOS"/>
            <entity id="DS.d1480.s0.e2" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="85-101" type="protein" text="cyclooxygenase 2"/>
            <entity id="DS.d1480.s0.e3" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="103-108" type="protein" text="COX-2"/>
            <entity id="DS.d1480.s0.e4" origId="23978" charOffset="178-184" type="compound" text="copper"/>
            <pair e1="DS.d1480.s0.e4" e2="DS.d1480.s0.e2" id="DS.d1480.s0.i0" interaction="True"/>
            <pair e1="DS.d1480.s0.e4" e2="DS.d1480.s0.e0" id="DS.d1480.s0.i1" interaction="True"/>
            <pair e1="DS.d1480.s0.e4" e2="DS.d1480.s0.e3" id="DS.d1480.s0.i2" interaction="True"/>
            <pair e1="DS.d1480.s0.e4" e2="DS.d1480.s0.e1" id="DS.d1480.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1481" origId="18835362">
        <sentence id="DS.d1481.s0" origId="18835362-575" text="We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and 3-morpholinosydnonimine hydrochloride (SIN-1)-mediated oxidation and nitration reactions of glutamate dehydrogenase (GDH).">
            <entity id="DS.d1481.s0.e1" origId="5219" charOffset="74-111" type="compound" text="3-morpholinosydnonimine hydrochloride"/>
            <entity id="DS.d1481.s0.e2" origId="O52310,O59650,O74024,P28270,P52596,P80319,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q56304,Q9YC65" charOffset="166-189" type="protein" text="glutamate dehydrogenase"/>
            <entity id="DS.d1481.s0.e3" origId="O52310,O59650,O74024,O95479,P00366,P00367,P00368,P0AES2,P0AES3,P10860,P13443,P26443,P28270,P36234,P42174,P42206,P42238,P49448,P52596,P54385,P56201,P80319,P82264,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q53199,Q56304,Q59516,Q64HZ8,Q64HZ9,Q64I00,Q64I01,Q9HFR6,Q9HGU3,Q9HGU4,Q9RDE9,Q9URS1,Q9YC65" charOffset="191-194" type="protein" text="GDH"/>
            <pair e1="DS.d1481.s0.e1" e2="DS.d1481.s0.e3" id="DS.d1481.s0.i1" interaction="True"/>
            <pair e1="DS.d1481.s0.e1" e2="DS.d1481.s0.e2" id="DS.d1481.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1482" origId="18835442">
        <sentence id="DS.d1482.s0" origId="18835442-614" text="After intravenous administration of either DOTAP/cholesterol or DOTMA/cholesterol liposomes, serum TNFalpha and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.">
            <entity id="DS.d1482.s0.e0" origId="6437371" charOffset="43-48" type="compound" text="DOTAP"/>
            <entity id="DS.d1482.s0.e1" origId="304,5997,6432564,11025495" charOffset="49-60" type="compound" text="cholesterol"/>
            <entity id="DS.d1482.s0.e2" origId="6913074" charOffset="64-69" type="compound" text="DOTMA"/>
            <entity id="DS.d1482.s0.e3" origId="304,5997,6432564,11025495" charOffset="70-81" type="compound" text="cholesterol"/>
            <entity id="DS.d1482.s0.e4" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="99-107" type="protein" text="TNFalpha"/>
            <pair e1="DS.d1482.s0.e1" e2="DS.d1482.s0.e4" id="DS.d1482.s0.i0" interaction="False"/>
            <pair e1="DS.d1482.s0.e2" e2="DS.d1482.s0.e4" id="DS.d1482.s0.i1" interaction="False"/>
            <pair e1="DS.d1482.s0.e0" e2="DS.d1482.s0.e4" id="DS.d1482.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1483" origId="18835585">
        <sentence id="DS.d1483.s0" origId="18835585-659" text="GTP was the most potent regulator of hemoglobin affinity, with concentrations of 5 mmol L(-1) causing an increase in p(50) from 5 to 19 mm Hg at pH 7.5, while the order of potency of the other phosphates was IHP&amp;gt;ATP&amp;gt;BPG.">
            <entity id="DS.d1483.s0.e0" origId="6830" charOffset="0-3" type="compound" text="GTP"/>
            <entity id="DS.d1483.s0.e1" origId="P15160,P17724,P73925,Q03459" charOffset="37-47" type="protein" text="hemoglobin"/>
            <pair e1="DS.d1483.s0.e0" e2="DS.d1483.s0.e1" id="DS.d1483.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1484" origId="18835652">
        <sentence id="DS.d1484.s0" origId="18835652-693" text="Functional inactivation of NF2/merlin in human mesothelioma.">
            <entity id="DS.d1484.s0.e0" origId="P35240,P59750" charOffset="27-30" type="protein" text="NF2"/>
            <entity id="DS.d1484.s0.e1" origId="84098" charOffset="31-37" type="compound" text="merlin"/>
            <pair e1="DS.d1484.s0.e1" e2="DS.d1484.s0.e0" id="DS.d1484.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1484.s1" origId="18835652-694" text="The tumor suppressor merlin is encoded by the neurofibromatosis type 2 gene (NF2) which is located on chromosome 22q12 and mutations in this gene have been found in 40% of mesothelioma.">
            <entity id="DS.d1484.s1.e0" origId="84098" charOffset="21-27" type="compound" text="merlin"/>
            <entity id="DS.d1484.s1.e1" origId="P35240,P59750" charOffset="77-80" type="protein" text="NF2"/>
            <pair e1="DS.d1484.s1.e0" e2="DS.d1484.s1.e1" id="DS.d1484.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1485" origId="18835662">
        <sentence id="DS.d1485.s0" origId="18835662-698" text="No main effect of group assignment on TSST responses was found for IL-6, cortisol or POMS scores.">
            <entity id="DS.d1485.s0.e0" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="67-71" type="protein" text="IL-6"/>
            <entity id="DS.d1485.s0.e1" origId="5754" charOffset="73-81" type="compound" text="cortisol"/>
            <pair e1="DS.d1485.s0.e1" e2="DS.d1485.s0.e0" id="DS.d1485.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1486" origId="18835763">
        <sentence id="DS.d1486.s0" origId="18835763-723" text="The objective of this study was to determine: (i) the prevalence of resistance in current clinical isolates of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis and Klebsiella pneumoniae; (ii) the prevalence of production of extended-spectrum beta-lactamases (ESBLs) and methicillin resistance in S. aureus; and (iii) regional differences in the prevalence of ESBL production and clonality of K. pneumoniae isolates.">
            <entity id="DS.d1486.s0.e0" origId="P80298,P80545,P81173" charOffset="288-303" type="protein" text="beta-lactamases"/>
            <entity id="DS.d1486.s0.e1" origId="6087" charOffset="316-327" type="compound" text="methicillin"/>
            <pair e1="DS.d1486.s0.e1" e2="DS.d1486.s0.e0" id="DS.d1486.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1487" origId="18835829">
        <sentence id="DS.d1487.s0" origId="18835829-730" text="cAMP-induced expression of the orphan nuclear receptor Nur77 in MA-10 Leydig cells involves a CaMKI pathway.">
            <entity id="DS.d1487.s0.e0" origId="6076" charOffset="0-4" type="compound" text="cAMP"/>
            <entity id="DS.d1487.s0.e1" origId="P12813" charOffset="55-60" type="protein" text="Nur77"/>
            <entity id="DS.d1487.s0.e2" origId="Q9P7I2" charOffset="94-99" type="protein" text="CaMKI"/>
            <pair e1="DS.d1487.s0.e0" e2="DS.d1487.s0.e1" id="DS.d1487.s0.i0" interaction="True"/>
            <pair e1="DS.d1487.s0.e0" e2="DS.d1487.s0.e2" id="DS.d1487.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1487.s1" origId="18835829-731" text="In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the adenylate cyclase/cyclic adenosine monophosphate (cAMP) signaling pathway.">
            <entity id="DS.d1487.s1.e0" origId="P00936,P08678,P0A1A7,P0A1A8,P0A4Y0,P0A4Y1,P14605,P23466,P27580,P30528,P40127,P40130,P40134,P40135,P43524,P49606,P59739,Q01513,Q01631,Q05766,Q59119,Q59685,Q8FBP0,Q8XAP1,Q9WXC3" charOffset="178-195" type="protein" text="adenylate cyclase"/>
            <entity id="DS.d1487.s1.e1" origId="188955" charOffset="196-226" type="compound" text="cyclic adenosine monophosphate"/>
            <entity id="DS.d1487.s1.e2" origId="6076" charOffset="228-232" type="compound" text="cAMP"/>
            <pair e1="DS.d1487.s1.e1" e2="DS.d1487.s1.e0" id="DS.d1487.s1.i0" interaction="True"/>
            <pair e1="DS.d1487.s1.e2" e2="DS.d1487.s1.e0" id="DS.d1487.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1487.s2" origId="18835829-732" text="Here, we report that cAMP-mediated induction of Nur77 expression at the protein, mRNA, and promoter levels in MA-10 cells involves different mechanisms.">
            <entity id="DS.d1487.s2.e0" origId="6076" charOffset="21-25" type="compound" text="cAMP"/>
            <entity id="DS.d1487.s2.e1" origId="P12813" charOffset="48-53" type="protein" text="Nur77"/>
            <pair e1="DS.d1487.s2.e0" e2="DS.d1487.s2.e1" id="DS.d1487.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1487.s3" origId="18835829-733" text="In addition, our detailed analysis of the Nur77 promoter in MA-10 cells revealed that distinct regulatory elements are involved in basal and cAMP-induced Nur77 transcription.">
            <entity id="DS.d1487.s3.e0" origId="P12813" charOffset="42-47" type="protein" text="Nur77"/>
            <entity id="DS.d1487.s3.e1" origId="6076" charOffset="141-145" type="compound" text="cAMP"/>
            <entity id="DS.d1487.s3.e2" origId="P12813" charOffset="154-159" type="protein" text="Nur77"/>
            <pair e1="DS.d1487.s3.e1" e2="DS.d1487.s3.e0" id="DS.d1487.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1488" origId="18835830">
        <sentence id="DS.d1488.s0" origId="18835830-734" text="Expression of nitric oxide synthase during germ cell apoptosis in testis of cynomolgus monkey after testosterone and heat treatment.">
            <entity id="DS.d1488.s0.e0" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="14-35" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d1488.s0.e1" origId="6013" charOffset="100-112" type="compound" text="testosterone"/>
            <pair e1="DS.d1488.s0.e1" e2="DS.d1488.s0.e0" id="DS.d1488.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1489" origId="18835831">
        <sentence id="DS.d1489.s0" origId="18835831-735" text="Comparing expression of progesterone and estrogen receptors in testicular tissue from men with obstructive and nonobstructive azoospermia.">
            <entity id="DS.d1489.s0.e0" origId="5994" charOffset="24-36" type="compound" text="progesterone"/>
            <entity id="DS.d1489.s0.e1" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="41-59" type="protein" text="estrogen receptors"/>
            <pair e1="DS.d1489.s0.e0" e2="DS.d1489.s0.e1" id="DS.d1489.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1490" origId="18835926">
        <sentence id="DS.d1490.s0" origId="18835926-762" text="Together, these results provide compelling evidence that Fgf23 does not have a klotho-independent role in the regulation of systemic phosphate and vitamin D homeostasis.">
            <entity id="DS.d1490.s0.e0" origId="Q8VI82,Q9EPC2" charOffset="57-62" type="protein" text="Fgf23"/>
            <entity id="DS.d1490.s0.e1" origId="5280795" charOffset="147-156" type="compound" text="vitamin D"/>
            <pair e1="DS.d1490.s0.e1" e2="DS.d1490.s0.e0" id="DS.d1490.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1491" origId="18835976">
        <sentence id="DS.d1491.s0" origId="18835976-780" text="Based on fasting insulin and glucose, several indices of insulin sensitivity have been developed in adults.">
            <entity id="DS.d1491.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="17-24" type="protein" text="insulin"/>
            <entity id="DS.d1491.s0.e1" origId="206,5793,64689,79025" charOffset="29-36" type="compound" text="glucose"/>
            <entity id="DS.d1491.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="57-64" type="protein" text="insulin"/>
            <pair e1="DS.d1491.s0.e1" e2="DS.d1491.s0.e0" id="DS.d1491.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1492" origId="18835979">
        <sentence id="DS.d1492.s0" origId="18835979-782" text="LDL from all subjects stimulated both the basal and AngII-induced aldosterone and cortisol release from adrenocortical cells.">
            <entity id="DS.d1492.s0.e0" origId="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0" charOffset="52-57" type="protein" text="AngII"/>
            <entity id="DS.d1492.s0.e1" origId="5839" charOffset="66-77" type="compound" text="aldosterone"/>
            <entity id="DS.d1492.s0.e2" origId="5754" charOffset="82-90" type="compound" text="cortisol"/>
            <pair e1="DS.d1492.s0.e1" e2="DS.d1492.s0.e0" id="DS.d1492.s0.i0" interaction="True"/>
            <pair e1="DS.d1492.s0.e2" e2="DS.d1492.s0.e0" id="DS.d1492.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1493" origId="18835981">
        <sentence id="DS.d1493.s0" origId="18835981-786" text="Here we present evidence of distinct STI571-induced modulation of abl functions using high-resolution live-cell imaging approaches.">
            <entity id="DS.d1493.s0.e0" origId="5291" charOffset="37-43" type="compound" text="STI571"/>
            <entity id="DS.d1493.s0.e1" origId="P00520,P00522" charOffset="66-69" type="protein" text="abl"/>
            <pair e1="DS.d1493.s0.e0" e2="DS.d1493.s0.e1" id="DS.d1493.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1493.s1" origId="18835981-787" text="Quantitative analysis yielded 0.81 and 1.8 microM for EC(50) values of STI571-induced cell edge translocation of abl-KD-green fluorescent protein (GFP) and wild-type abl-GFP, respectively.">
            <entity id="DS.d1493.s1.e0" origId="5291" charOffset="71-77" type="compound" text="STI571"/>
            <entity id="DS.d1493.s1.e2" origId="P42212" charOffset="120-145" type="protein" text="green fluorescent protein"/>
            <pair e1="DS.d1493.s1.e0" e2="DS.d1493.s1.e2" id="DS.d1493.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1494" origId="18836089">
        <sentence id="DS.d1494.s0" origId="18836089-2732" text="Association of the ABCB1 gene polymorphisms 2677G&amp;gt;T/A and 3435C&amp;gt;T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients.">
            <entity id="DS.d1494.s0.e0" origId="P08183,P21448" charOffset="19-24" type="protein" text="ABCB1"/>
            <entity id="DS.d1494.s0.e1" origId="4666,36314,441276,5352019,6713921,6915727,44155032,53313247" charOffset="98-108" type="compound" text="paclitaxel"/>
            <pair e1="DS.d1494.s0.e1" e2="DS.d1494.s0.e0" id="DS.d1494.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1494.s1" origId="18836089-2733" text="We evaluated the association between clinical outcome (safety and efficacy) of paclitaxel monotherapy in metastatic breast cancer patients with ABCB1 gene polymorphisms 2677G&amp;gt;T/A or 3435C&amp;gt;T.">
            <entity id="DS.d1494.s1.e0" origId="4666,36314,441276,5352019,6713921,6915727,44155032,53313247" charOffset="79-89" type="compound" text="paclitaxel"/>
            <entity id="DS.d1494.s1.e1" origId="P08183,P21448" charOffset="144-149" type="protein" text="ABCB1"/>
            <pair e1="DS.d1494.s1.e0" e2="DS.d1494.s1.e1" id="DS.d1494.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1495" origId="18836137">
        <sentence id="DS.d1495.s0" origId="18836137-847" text="CXCL1/KC was detected as early as 6 hours after bleomycin instillation and returned to basal levels after Day 8.">
            <entity id="DS.d1495.s0.e0" origId="O46678,O55235,P09340,P09341,P12850,P14095" charOffset="0-5" type="protein" text="CXCL1"/>
            <entity id="DS.d1495.s0.e1" origId="456190,5360373,5460769" charOffset="48-57" type="compound" text="bleomycin"/>
            <pair e1="DS.d1495.s0.e1" e2="DS.d1495.s0.e0" id="DS.d1495.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1495.s1" origId="18836137-848" text="DF2162 treatment reduced bleomycin-induced expression of von Willebrand Factor, a marker of angiogenesis, in the lung.">
            <entity id="DS.d1495.s1.e0" origId="456190,5360373,5460769" charOffset="25-34" type="compound" text="bleomycin"/>
            <entity id="DS.d1495.s1.e1" origId="Q62935" charOffset="57-78" type="protein" text="von Willebrand Factor"/>
            <pair e1="DS.d1495.s1.e0" e2="DS.d1495.s1.e1" id="DS.d1495.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1496" origId="18836482">
        <sentence id="DS.d1496.s0" origId="18836482-927" text="This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 or pharmacological inhibition of PKB.">
            <entity id="DS.d1496.s0.e0" origId="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0" charOffset="84-88" type="protein" text="PI3K"/>
            <entity id="DS.d1496.s0.e1" origId="3973" charOffset="100-108" type="compound" text="LY294002"/>
            <entity id="DS.d1496.s0.e2" origId="P31749,P31750,P47196,Q01314,Q8INB9" charOffset="142-145" type="protein" text="PKB"/>
            <pair e1="DS.d1496.s0.e1" e2="DS.d1496.s0.e0" id="DS.d1496.s0.i0" interaction="True"/>
            <pair e1="DS.d1496.s0.e1" e2="DS.d1496.s0.e2" id="DS.d1496.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1497" origId="18836681">
        <sentence id="DS.d1497.s0" origId="18836681-1004" text="Kynurenic acid (KYNA) is an agonist of the G-protein-coupled receptor GPR35, which is predominantly expressed in gastrointestinal tissues.">
            <entity id="DS.d1497.s0.e0" origId="3845" charOffset="0-14" type="compound" text="Kynurenic acid"/>
            <entity id="DS.d1497.s0.e1" origId="3845" charOffset="16-20" type="compound" text="KYNA"/>
            <entity id="DS.d1497.s0.e2" origId="Q9HC97" charOffset="70-75" type="protein" text="GPR35"/>
            <pair e1="DS.d1497.s0.e0" e2="DS.d1497.s0.e2" id="DS.d1497.s0.i0" interaction="True"/>
            <pair e1="DS.d1497.s0.e1" e2="DS.d1497.s0.e2" id="DS.d1497.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1498" origId="18836710">
        <sentence id="DS.d1498.s0" origId="18836710-1021" text="Molecular dynamics simulation techniques have been used to study the unbinding pathways of 1alpha,25-dihydroxyvitamin D(3) from the ligand-binding pocket of the vitamin D receptor (VDR).">
            <entity id="DS.d1498.s0.e0" origId="22811021" charOffset="91-121" type="compound" text="1alpha,25-dihydroxyvitamin D(3"/>
            <entity id="DS.d1498.s0.e1" origId="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5" charOffset="181-184" type="protein" text="VDR"/>
            <pair e1="DS.d1498.s0.e0" e2="DS.d1498.s0.e1" id="DS.d1498.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1499" origId="18836740">
        <sentence id="DS.d1499.s0" origId="18836740-1043" text="Activation of the Na+/K+-ATPase by insulin and glucose as a putative negative feedback mechanism in pancreatic beta-cells.">
            <entity id="DS.d1499.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="35-42" type="protein" text="insulin"/>
            <entity id="DS.d1499.s0.e1" origId="206,5793,64689,79025" charOffset="47-54" type="compound" text="glucose"/>
            <pair e1="DS.d1499.s0.e1" e2="DS.d1499.s0.e0" id="DS.d1499.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1499.s1" origId="18836740-1046" text="Inhibiting insulin signalling in SUR1 (-/-) beta-cells blunted the glucose-induced decrease of (Ca(2+))(c).">
            <entity id="DS.d1499.s1.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="11-18" type="protein" text="insulin"/>
            <entity id="DS.d1499.s1.e1" origId="206,5793,64689,79025" charOffset="67-74" type="compound" text="glucose"/>
            <pair e1="DS.d1499.s1.e1" e2="DS.d1499.s1.e0" id="DS.d1499.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1500" origId="18836843">
        <sentence id="DS.d1500.s0" origId="18836843-1091" text="Relaxation to CGRP (10(-8) M) was unaffected by L-NAME (3 x 10(-4) M) and indomethacin (10(-6) M) suggesting no involvement of nitric oxide or prostaglandins in the CGRP-induced relaxation.">
            <entity id="DS.d1500.s0.e0" origId="P10286,P30880,P30881,P31888,P80511" charOffset="14-18" type="protein" text="CGRP"/>
            <entity id="DS.d1500.s0.e1" origId="3715" charOffset="74-86" type="compound" text="indomethacin"/>
            <entity id="DS.d1500.s0.e2" origId="145068" charOffset="127-139" type="compound" text="nitric oxide"/>
            <entity id="DS.d1500.s0.e3" origId="P10286,P30880,P30881,P31888,P80511" charOffset="165-169" type="protein" text="CGRP"/>
            <pair e1="DS.d1500.s0.e2" e2="DS.d1500.s0.e0" id="DS.d1500.s0.i0" interaction="False"/>
            <pair e1="DS.d1500.s0.e1" e2="DS.d1500.s0.e0" id="DS.d1500.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1501" origId="18836851">
        <sentence id="DS.d1501.s0" origId="18836851-1099" text="In the mouse model of demyelination-remyelination induced by oral administration of cuprizone, in situ hybridization showed an upregulation of the DDR1 gene in three different white matter areas (corpus callosum, dorsal fornix, and external capsule) during the remyelination period.">
            <entity id="DS.d1501.s0.e0" origId="9723" charOffset="84-93" type="compound" text="cuprizone"/>
            <entity id="DS.d1501.s0.e1" origId="Q08345,Q7YR43" charOffset="147-151" type="protein" text="DDR1"/>
            <pair e1="DS.d1501.s0.e0" e2="DS.d1501.s0.e1" id="DS.d1501.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1501.s1" origId="18836851-1100" text="Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, carnosine, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).">
            <entity id="DS.d1501.s1.e0" origId="Q08345,Q7YR43" charOffset="19-23" type="protein" text="DDR1"/>
            <entity id="DS.d1501.s1.e1" origId="Q13516,Q90XB3" charOffset="77-82" type="protein" text="OLIG2"/>
            <entity id="DS.d1501.s1.e2" origId="9369,439224" charOffset="84-93" type="compound" text="carnosine"/>
            <entity id="DS.d1501.s1.e3" origId="P25054" charOffset="99-102" type="protein" text="APC"/>
            <entity id="DS.d1501.s1.e4" origId="Q99942" charOffset="155-158" type="protein" text="NG2"/>
            <entity id="DS.d1501.s1.e5" origId="P06623,P09543,P13233,P16330" charOffset="177-183" type="protein" text="CNPase"/>
            <entity id="DS.d1501.s1.e6" origId="P03995,P14136,P47819,Q28115" charOffset="223-227" type="protein" text="GFAP"/>
            <pair e1="DS.d1501.s1.e2" e2="DS.d1501.s1.e3" id="DS.d1501.s1.i0" interaction="False"/>
            <pair e1="DS.d1501.s1.e2" e2="DS.d1501.s1.e5" id="DS.d1501.s1.i1" interaction="False"/>
            <pair e1="DS.d1501.s1.e2" e2="DS.d1501.s1.e6" id="DS.d1501.s1.i2" interaction="False"/>
            <pair e1="DS.d1501.s1.e2" e2="DS.d1501.s1.e0" id="DS.d1501.s1.i3" interaction="True"/>
            <pair e1="DS.d1501.s1.e2" e2="DS.d1501.s1.e4" id="DS.d1501.s1.i4" interaction="False"/>
            <pair e1="DS.d1501.s1.e2" e2="DS.d1501.s1.e1" id="DS.d1501.s1.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1502" origId="18836996">
        <sentence id="DS.d1502.s0" origId="18836996-1126" text="By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to 5-azadC/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, Dusp2, FoxJ1 and Smpd3) silenced in this line.">
            <entity id="DS.d1502.s0.e0" origId="451668" charOffset="159-166" type="compound" text="5-azadC"/>
            <entity id="DS.d1502.s0.e1" origId="O73746,P39876,P48032" charOffset="235-240" type="protein" text="Timp3"/>
            <entity id="DS.d1502.s0.e2" origId="Q05922" charOffset="283-288" type="protein" text="Dusp2"/>
            <entity id="DS.d1502.s0.e3" origId="Q5M7N6" charOffset="290-295" type="protein" text="FoxJ1"/>
            <entity id="DS.d1502.s0.e4" origId="O35049,Q9JJY3" charOffset="300-305" type="protein" text="Smpd3"/>
            <pair e1="DS.d1502.s0.e0" e2="DS.d1502.s0.e2" id="DS.d1502.s0.i0" interaction="True"/>
            <pair e1="DS.d1502.s0.e0" e2="DS.d1502.s0.e1" id="DS.d1502.s0.i1" interaction="True"/>
            <pair e1="DS.d1502.s0.e0" e2="DS.d1502.s0.e3" id="DS.d1502.s0.i2" interaction="True"/>
            <pair e1="DS.d1502.s0.e0" e2="DS.d1502.s0.e4" id="DS.d1502.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1503" origId="18837008">
        <sentence id="DS.d1503.s0" origId="18837008-1129" text="Therapeutic strategy to rescue mutation-induced exon skipping in rhodopsin by adaptation of U1 snRNA.">
            <entity id="DS.d1503.s0.e0" origId="O16005,O16017,O16018,O16019,O16020,O18312,O18315,O18481,O18485,O18486,O18766,O42268,O42294,O42300,O42301,O42307,O42327,O42328,O42330,O42427,O42431,O42451,O42452,O42466,O42604,O62791,O62792,O62793,O62794,O62795,O62796,O62798,O93441,O93459,P02699,P02700,P08100,P09241,P15409,P22328,P22671,P24603,P28681,P29403,P31355,P31356,P32308,P32309,P35356,P35359,P35362,P35403,P41590,P41591,P49912,P51470,P51488,P51489,P52202,P56514,P56515,P56516,P79756,P79798,P79807,P79808,P79809,P79812,P79848,P79863,P79898,P79901,P79902,P79903,P79911,P79914,P87369,Q17094,Q17292,Q17296,Q28886,Q68J47,Q6W3E1,Q769E8,Q8HY69,Q90245,Q90305,Q90373,Q95KU1,Q98980,Q9DGG4,Q9YGY9,Q9YGZ0,Q9YGZ1,Q9YGZ2,Q9YGZ3,Q9YGZ4,Q9YGZ5,Q9YGZ6,Q9YGZ7,Q9YGZ8,Q9YGZ9,Q9YH00,Q9YH01,Q9YH02,Q9YH03,Q9YH04,Q9YH05" charOffset="65-74" type="protein" text="rhodopsin"/>
            <entity id="DS.d1503.s0.e1" origId="23989" charOffset="92-94" type="compound" text="U1"/>
            <pair e1="DS.d1503.s0.e1" e2="DS.d1503.s0.e0" id="DS.d1503.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1503.s1" origId="18837008-1130" text="As a therapeutic strategy, U1 snRNAs were adapted to the novel RHO mutation and tested for its potential to reverse missplicing.">
            <entity id="DS.d1503.s1.e0" origId="23989" charOffset="27-29" type="compound" text="U1"/>
            <entity id="DS.d1503.s1.e1" origId="O16005,O16017,O16018,O16019,O16020,O18312,O18315,O18481,O18485,O18486,O18766,O42268,O42294,O42300,O42301,O42307,O42327,O42328,O42330,O42427,O42431,O42451,O42452,O42466,O42604,O62791,O62792,O62793,O62794,O62795,O62796,O62798,O93441,O93459,P01122,P02699,P02700,P08100,P09241,P22328,P22671,P24603,P28681,P30403,P31355,P31356,P32308,P32309,P35356,P35403,P41590,P41591,P49912,P51470,P51488,P52202,P56514,P56515,P56516,P79756,P79798,P79807,P79808,P79809,P79812,P79848,P79863,P79898,P79901,P79902,P79903,P79911,P79914,P87369,Q17094,Q28886,Q68J47,Q6W3E1,Q769E8,Q8HY69,Q90245,Q90305,Q90373,Q95KU1,Q98980,Q9DGG4,Q9YGY9,Q9YGZ0,Q9YGZ1,Q9YGZ2,Q9YGZ3,Q9YGZ4,Q9YGZ5,Q9YGZ6,Q9YGZ7,Q9YGZ8,Q9YGZ9,Q9YH00,Q9YH01,Q9YH02,Q9YH03,Q9YH04,Q9YH05" charOffset="63-66" type="protein" text="RHO"/>
            <pair e1="DS.d1503.s1.e0" e2="DS.d1503.s1.e1" id="DS.d1503.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1504" origId="18837469">
        <sentence id="DS.d1504.s0" origId="18837469-2746" text="Urinary concentrations of dihydrodaidzein, dihydrogenistein, O-desmethylangolensin, and equol exceeded IFN aglycone equivalents.">
            <entity id="DS.d1504.s0.e0" origId="176907" charOffset="26-41" type="compound" text="dihydrodaidzein"/>
            <entity id="DS.d1504.s0.e1" origId="9838356" charOffset="43-59" type="compound" text="dihydrogenistein"/>
            <entity id="DS.d1504.s0.e2" origId="89472" charOffset="61-82" type="compound" text="O-desmethylangolensin"/>
            <entity id="DS.d1504.s0.e3" origId="91469,382975" charOffset="88-93" type="compound" text="equol"/>
            <entity id="DS.d1504.s0.e4" origId="P28172,P51526" charOffset="103-106" type="protein" text="IFN"/>
            <pair e1="DS.d1504.s0.e0" e2="DS.d1504.s0.e4" id="DS.d1504.s0.i0" interaction="False"/>
            <pair e1="DS.d1504.s0.e3" e2="DS.d1504.s0.e4" id="DS.d1504.s0.i1" interaction="False"/>
            <pair e1="DS.d1504.s0.e2" e2="DS.d1504.s0.e4" id="DS.d1504.s0.i2" interaction="False"/>
            <pair e1="DS.d1504.s0.e1" e2="DS.d1504.s0.e4" id="DS.d1504.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1505" origId="18837470">
        <sentence id="DS.d1505.s0" origId="18837470-2752" text="Concentrations of glucose, insulin, C-peptide, nonesterified fatty acids, triacylglycerol, total and exogenous glucose kinetics were assessed for 6 h postprandially.">
            <entity id="DS.d1505.s0.e0" origId="206,5793,64689,79025" charOffset="18-25" type="compound" text="glucose"/>
            <entity id="DS.d1505.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="27-34" type="protein" text="insulin"/>
            <entity id="DS.d1505.s0.e2" origId="206,5793,64689,79025" charOffset="111-118" type="compound" text="glucose"/>
            <pair e1="DS.d1505.s0.e0" e2="DS.d1505.s0.e1" id="DS.d1505.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1505.s1" origId="18837470-2754" text="After 120 min, glucose and insulin responses declined, but remained higher after the Pol 0.05) in parallel to the inhibition of lipolysis.">
            <entity id="DS.d1505.s1.e0" origId="206,5793,64689,79025" charOffset="15-22" type="compound" text="glucose"/>
            <entity id="DS.d1505.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="27-34" type="protein" text="insulin"/>
            <pair e1="DS.d1505.s1.e0" e2="DS.d1505.s1.e1" id="DS.d1505.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1506" origId="18837522">
        <sentence id="DS.d1506.s0" origId="18837522-1374" text="Keeping uracil out of DNA: physiological role, structure and catalytic mechanism of dUTPases.">
            <entity id="DS.d1506.s0.e0" origId="1174" charOffset="8-14" type="compound" text="uracil"/>
            <entity id="DS.d1506.s0.e1" origId="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3" charOffset="84-92" type="protein" text="dUTPases"/>
            <pair e1="DS.d1506.s0.e0" e2="DS.d1506.s0.e1" id="DS.d1506.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1506.s1" origId="18837522-1375" text="To prevent uracil incorporation into DNA, representatives of the dUTP nucleotidohydrolase (dUTPase) enzyme family eliminate excess dUTP.">
            <entity id="DS.d1506.s1.e0" origId="1174" charOffset="11-17" type="compound" text="uracil"/>
            <entity id="DS.d1506.s1.e1" origId="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3" charOffset="91-98" type="protein" text="dUTPase"/>
            <pair e1="DS.d1506.s1.e0" e2="DS.d1506.s1.e1" id="DS.d1506.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1506.s2" origId="18837522-1376" text="The dUTPase binding pocket is highly specific for uracil.">
            <entity id="DS.d1506.s2.e0" origId="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3" charOffset="4-11" type="protein" text="dUTPase"/>
            <entity id="DS.d1506.s2.e1" origId="1174" charOffset="50-56" type="compound" text="uracil"/>
            <pair e1="DS.d1506.s2.e1" e2="DS.d1506.s2.e0" id="DS.d1506.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1506.s3" origId="18837522-1377" text="Phosphate chain coordination involves Mg2+ and is analogous to that of DNA polymerases.">
            <entity id="DS.d1506.s3.e0" origId="1061,167704,644102" charOffset="0-9" type="compound" text="Phosphate"/>
            <entity id="DS.d1506.s3.e1" origId="O27276,O29753,O33845,O57191,O59610,O64235,O70736,O71121,O72539,O72540,P00581,P03158,P03198,P03261,P03680,P04292,P04293,P04415,P04495,P05468,P05664,P06225,P06538,P06856,P06950,P07917,P07918,P08546,P09252,P09804,P09854,P10479,P10582,P18131,P19822,P19894,P20311,P20509,P21402,P24907,P27172,P28857,P28858,P28859,P30314,P30317,P30318,P30319,P30320,P30321,P33793,P41712,P42489,P43139,P48311,P52025,P52342,P52367,P56689,P61875,P61876,P74918,P77933,P87503,P87553,Q05254,Q37882,Q37989,Q38087,Q51334,Q56366,Q58295,Q5UQR0,Q64751,Q65946,Q69025,Q6S6P1,Q83948,Q84173,Q85428,Q88469,Q90162,Q9HH05,Q9HH84,Q9YUS2,Q9YUS3" charOffset="71-86" type="protein" text="DNA polymerases"/>
            <pair e1="DS.d1506.s3.e0" e2="DS.d1506.s3.e1" id="DS.d1506.s3.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1506.s4" origId="18837522-1378" text="In these respective pathogens, Plasmodium falciparum and Mycobacterium tuberculosis, the biosynthesis of dTMP relies exclusively on dUTPase activity.">
            <entity id="DS.d1506.s4.e0" origId="9700" charOffset="105-109" type="compound" text="dTMP"/>
            <entity id="DS.d1506.s4.e1" origId="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3" charOffset="132-139" type="protein" text="dUTPase"/>
            <pair e1="DS.d1506.s4.e0" e2="DS.d1506.s4.e1" id="DS.d1506.s4.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1507" origId="18837652">
        <sentence id="DS.d1507.s0" origId="18837652-1413" text="Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.">
            <entity id="DS.d1507.s0.e0" origId="2214" charOffset="49-57" type="compound" text="apocynin"/>
            <entity id="DS.d1507.s0.e1" origId="12035" charOffset="59-78" type="compound" text="N-acetyl-l-cysteine"/>
            <entity id="DS.d1507.s0.e2" origId="124886" charOffset="86-105" type="compound" text="reduced glutathione"/>
            <entity id="DS.d1507.s0.e3" origId="124886" charOffset="107-110" type="compound" text="GSH"/>
            <entity id="DS.d1507.s0.e4" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="113-121" type="protein" text="catalase"/>
            <entity id="DS.d1507.s0.e5" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="123-126" type="protein" text="CAT"/>
            <entity id="DS.d1507.s0.e6" origId="O50258" charOffset="129-149" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1507.s0.e7" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="151-154" type="protein" text="SOD"/>
            <entity id="DS.d1507.s0.e8" origId="550788" charOffset="170-193" type="compound" text="l-arginine methyl ester"/>
            <pair e1="DS.d1507.s0.e8" e2="DS.d1507.s0.e5" id="DS.d1507.s0.i0" interaction="False"/>
            <pair e1="DS.d1507.s0.e1" e2="DS.d1507.s0.e7" id="DS.d1507.s0.i1" interaction="False"/>
            <pair e1="DS.d1507.s0.e0" e2="DS.d1507.s0.e7" id="DS.d1507.s0.i2" interaction="False"/>
            <pair e1="DS.d1507.s0.e2" e2="DS.d1507.s0.e4" id="DS.d1507.s0.i3" interaction="False"/>
            <pair e1="DS.d1507.s0.e3" e2="DS.d1507.s0.e7" id="DS.d1507.s0.i4" interaction="False"/>
            <pair e1="DS.d1507.s0.e0" e2="DS.d1507.s0.e4" id="DS.d1507.s0.i5" interaction="False"/>
            <pair e1="DS.d1507.s0.e2" e2="DS.d1507.s0.e7" id="DS.d1507.s0.i6" interaction="False"/>
            <pair e1="DS.d1507.s0.e0" e2="DS.d1507.s0.e5" id="DS.d1507.s0.i7" interaction="False"/>
            <pair e1="DS.d1507.s0.e3" e2="DS.d1507.s0.e6" id="DS.d1507.s0.i8" interaction="False"/>
            <pair e1="DS.d1507.s0.e0" e2="DS.d1507.s0.e6" id="DS.d1507.s0.i9" interaction="False"/>
            <pair e1="DS.d1507.s0.e2" e2="DS.d1507.s0.e6" id="DS.d1507.s0.i10" interaction="False"/>
            <pair e1="DS.d1507.s0.e3" e2="DS.d1507.s0.e5" id="DS.d1507.s0.i11" interaction="False"/>
            <pair e1="DS.d1507.s0.e1" e2="DS.d1507.s0.e6" id="DS.d1507.s0.i12" interaction="False"/>
            <pair e1="DS.d1507.s0.e1" e2="DS.d1507.s0.e4" id="DS.d1507.s0.i13" interaction="False"/>
            <pair e1="DS.d1507.s0.e2" e2="DS.d1507.s0.e5" id="DS.d1507.s0.i14" interaction="False"/>
            <pair e1="DS.d1507.s0.e8" e2="DS.d1507.s0.e7" id="DS.d1507.s0.i15" interaction="False"/>
            <pair e1="DS.d1507.s0.e3" e2="DS.d1507.s0.e4" id="DS.d1507.s0.i16" interaction="False"/>
            <pair e1="DS.d1507.s0.e1" e2="DS.d1507.s0.e5" id="DS.d1507.s0.i17" interaction="False"/>
            <pair e1="DS.d1507.s0.e8" e2="DS.d1507.s0.e4" id="DS.d1507.s0.i18" interaction="False"/>
            <pair e1="DS.d1507.s0.e8" e2="DS.d1507.s0.e6" id="DS.d1507.s0.i19" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1508" origId="18837698">
        <sentence id="DS.d1508.s0" origId="18837698-1429" text="It controls the expression of a total of 11 genes, the CopR regulon, in a copper-dependent manner.">
            <entity id="DS.d1508.s0.e0" origId="P24716,Q02540" charOffset="55-59" type="protein" text="CopR"/>
            <entity id="DS.d1508.s0.e1" origId="23978" charOffset="74-80" type="compound" text="copper"/>
            <pair e1="DS.d1508.s0.e1" e2="DS.d1508.s0.e0" id="DS.d1508.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1509" origId="18838074">
        <sentence id="DS.d1509.s0" origId="18838074-1535" text="In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including GTH-releasing hormones, pituitary adenylate cyclase-activating polypeptide, dopamine, ghrelin, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.">
            <entity id="DS.d1509.s0.e0" origId="P47744" charOffset="127-130" type="protein" text="GTH"/>
            <entity id="DS.d1509.s0.e1" origId="P41585,P48144,P81039" charOffset="151-201" type="protein" text="pituitary adenylate cyclase-activating polypeptide"/>
            <entity id="DS.d1509.s0.e2" origId="681" charOffset="203-211" type="compound" text="dopamine"/>
            <entity id="DS.d1509.s0.e3" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="213-220" type="protein" text="ghrelin"/>
            <pair e1="DS.d1509.s0.e2" e2="DS.d1509.s0.e1" id="DS.d1509.s0.i0" interaction="False"/>
            <pair e1="DS.d1509.s0.e2" e2="DS.d1509.s0.e3" id="DS.d1509.s0.i1" interaction="False"/>
            <pair e1="DS.d1509.s0.e2" e2="DS.d1509.s0.e0" id="DS.d1509.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d1509.s1" origId="18838074-1536" text="Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, arachidonic acid, NO, protein kinase A, ERK/MAPK, and Smads allows for integrated control by different neuroendocrine factors.">
            <entity id="DS.d1509.s1.e0" origId="P13678,Q25378" charOffset="163-179" type="protein" text="protein kinase C"/>
            <entity id="DS.d1509.s1.e1" origId="444899" charOffset="181-197" type="compound" text="arachidonic acid"/>
            <entity id="DS.d1509.s1.e2" origId="Q05608,Q9RI12" charOffset="203-219" type="protein" text="protein kinase A"/>
            <entity id="DS.d1509.s1.e3" origId="P29323" charOffset="221-224" type="protein" text="ERK"/>
            <entity id="DS.d1509.s1.e4" origId="O42781,P27638,Q00859" charOffset="225-229" type="protein" text="MAPK"/>
            <pair e1="DS.d1509.s1.e1" e2="DS.d1509.s1.e4" id="DS.d1509.s1.i0" interaction="False"/>
            <pair e1="DS.d1509.s1.e1" e2="DS.d1509.s1.e3" id="DS.d1509.s1.i1" interaction="False"/>
            <pair e1="DS.d1509.s1.e1" e2="DS.d1509.s1.e0" id="DS.d1509.s1.i2" interaction="False"/>
            <pair e1="DS.d1509.s1.e1" e2="DS.d1509.s1.e2" id="DS.d1509.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1510" origId="18838089">
        <sentence id="DS.d1510.s0" origId="18838089-1541" text="An enzymatic reaction between hydrogen peroxide and catalase produced oxygen bubbles and thus many internal pores within microsphere were naturally developed.">
            <entity id="DS.d1510.s0.e0" origId="784" charOffset="30-47" type="compound" text="hydrogen peroxide"/>
            <entity id="DS.d1510.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="52-60" type="protein" text="catalase"/>
            <pair e1="DS.d1510.s0.e0" e2="DS.d1510.s0.e1" id="DS.d1510.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1511" origId="18838102">
        <sentence id="DS.d1511.s0" origId="18838102-1545" text="The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH) and testosterone/estradiol (Te/E(2)).">
            <entity id="DS.d1511.s0.e0" origId="P27429" charOffset="126-156" type="protein" text="gonadotropin-releasing hormone"/>
            <entity id="DS.d1511.s0.e1" origId="P27429" charOffset="158-162" type="protein" text="GnRH"/>
            <entity id="DS.d1511.s0.e2" origId="6013" charOffset="194-206" type="compound" text="testosterone"/>
            <entity id="DS.d1511.s0.e3" origId="5757" charOffset="207-216" type="compound" text="estradiol"/>
            <pair e1="DS.d1511.s0.e3" e2="DS.d1511.s0.e1" id="DS.d1511.s0.i0" interaction="False"/>
            <pair e1="DS.d1511.s0.e3" e2="DS.d1511.s0.e0" id="DS.d1511.s0.i1" interaction="False"/>
            <pair e1="DS.d1511.s0.e2" e2="DS.d1511.s0.e0" id="DS.d1511.s0.i2" interaction="False"/>
            <pair e1="DS.d1511.s0.e2" e2="DS.d1511.s0.e1" id="DS.d1511.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1512" origId="18838266">
        <sentence id="DS.d1512.s0" origId="18838266-1623" text="We present a robust and simple method for the direct detection of multiple point mutations in the Mycobacterium tuberculosis rpoB gene during the development of rifampin (RIF) resistance using an electrochemical genosensor.">
            <entity id="DS.d1512.s0.e0" origId="O52271,O67762,O78485,O83269,O84317,O86094,O87903,P06173,P06271,P06272,P08036,P0A680,P0A681,P0A8V2,P0A8V3,P0A8V4,P0A8V5,P0C151,P11513,P11703,P12091,P16023,P19175,P21421,P22703,P23579,P27059,P29398,P30760,P31814,P36251,P36440,P37870,P41184,P41187,P41557,P41607,P43738,P46818,P47583,P47715,P47767,P47768,P48119,P49466,P50546,P51252,P56299,P56869,P57009,P57146,P59642,P59643,P60278,P60279,P60280,P60281,P60282,P60283,P77941,P77965,P78013,Q03587,Q1XDN5,Q20EX1,Q2FJ98,Q2GCD7,Q2GD90,Q2GJ68,Q2II86,Q2JFI5,Q2JJ19,Q2JX64,Q2L2M3,Q2L8Z9,Q2LQ87,Q2MIA8,Q2MIJ5,Q2NJ15,Q2NWR6,Q2NZX8,Q2RFN9,Q2RQV3,Q2S1Q5,Q2S905,Q2ST48,Q2SU19,Q2VEI4,Q2W2I1,Q2YB05,Q2YM15,Q2YSB9,Q30TP7,Q30X05,Q318Q7,Q31IY9,Q31N17,Q31U10,Q32AF9,Q32RG0,Q32RW5,Q33C46,Q38UQ2,Q39KH5,Q39Y13,Q3A6Q4,Q3A9Q7,Q3AHX5,Q3ATP5,Q3AZA4,Q3B1H7,Q3BAP8,Q3BWZ1,Q3C1G7,Q3ILP9,Q3J5T0,Q3J8Q7,Q3JMQ3,Q3K3L2,Q3K5Y1,Q3KM47,Q3M5D0,Q3SLQ6,Q3SSY0,Q3V542,Q3YST5,Q3YUZ7,Q3Z8V4,Q3ZJ93,Q3ZX01,Q46124,Q46J22,Q46WD4,Q47JB0,Q47LI5,Q47UV9,Q48D29,Q48VR1,Q492B9,Q49L06,Q49V52,Q4A5S7,Q4A7A9,Q4A969,Q4FLL2,Q4FQH3,Q4G3A7,Q4JT32,Q4K526,Q4L3K3,Q4MY95,Q4QN33,Q4UKD4,Q4URD2,Q4VZP1,Q4ZMN7,Q50388,Q51561,Q56P13,Q57CP8,Q57H69,Q589C0,Q59191,Q59622,Q5E238,Q5F5R5,Q5FFD9,Q5FM97,Q5FTX7,Q5GWS6,Q5HC05,Q5HID3,Q5HRL0,Q5HVY9,Q5L405,Q5L5I3,Q5L897,Q5LMQ5,Q5LXV3,Q5M2F5,Q5MZ23,Q5NID2,Q5NPK5,Q5P339,Q5PBG4,Q5PK93,Q5QA72,Q5QWA5,Q5SCX8,Q5WLS0,Q5WZL9,Q5X866,Q5XE97,Q5ZYQ0,Q5ZZS1,Q60A06,Q63H98,Q63Q03,Q64NJ7,Q65PB5,Q65W41,Q661M9,Q66FQ2,Q67JT3,Q68S14,Q6A6K6,Q6ACX5,Q6AP78,Q6B8R8,Q6DAN0,Q6ENI4,Q6ENX3,Q6EW56,Q6F0L7,Q6FF90,Q6GBU5,Q6GJC6,Q6HPR6,Q6KI09,Q6L3A7,Q6LLW2,Q6MDM1,Q6MJ09,Q6MRX6,Q6N4R9,Q6YQW3,Q724F0,Q727C7,Q72HM5,Q72UA8,Q73FA4,Q73JJ7,Q73SE4,Q748Y6,Q74L95,Q7MGR8,Q7MX27,Q7N9A4,Q7NIA0,Q7NQE6,Q7U8K4,Q7URW6,Q7V006,Q7V5P1,Q7VA29,Q7VKL7,Q7VRP7,Q7W0R9,Q7W2G9,Q7WRD9,Q7YJX8,Q81J48,Q81VT8,Q822J1,Q82DQ5,Q82T75,Q82Z40,Q85BW1,Q85FM7,Q85FR7,Q85X54,Q87A32,Q87KQ4,Q889X8,Q88QP2,Q88XZ3,Q890N4,Q89B20,Q89J74,Q8A469,Q8CQ84,Q8D233,Q8DD20,Q8DL55,Q8DNF0,Q8DS46,Q8E239,Q8E7J8,Q8EK74,Q8ETY8,Q8EWX1,Q8F0S2,Q8FS97,Q8G069,Q8G514,Q8GCR3,Q8GCR4,Q8GCR5,Q8GCR6,Q8HVY5,Q8K8W3,Q8KG15,Q8KWX2,Q8KWX4,Q8MA12,Q8NT26,Q8P2Y3,Q8PC56,Q8PNT0,Q8R7U6,Q8RHI6,Q8RQE9,Q8S8X9,Q8UE08,Q8WI24,Q8XUZ8,Q8YHP8,Q8Z320,Q8ZAP5,Q92F22,Q92QH7,Q932F8,Q93GF2,Q93MK7,Q93MK8,Q93MK9,Q93R88,Q97EG9,Q97NQ7,Q98N66,Q98Q23,Q9A1U1,Q9AAU2,Q9AIU3,Q9BBS9,Q9CEN6,Q9CK91,Q9F3X8,Q9KJG4,Q9KJM5,Q9KK59,Q9KV30,Q9KW14,Q9KWU7,Q9L0L0,Q9L637,Q9MTM5,Q9MUS5,Q9PA86,Q9PQV6,Q9RH41,Q9RH43,Q9RLT9,Q9RQZ7,Q9RVV9,Q9TL06,Q9TM35,Q9X6Y1,Q9XPS7,Q9Z9A0,Q9Z9M2" charOffset="125-129" type="protein" text="rpoB"/>
            <entity id="DS.d1512.s0.e1" origId="5381226" charOffset="161-169" type="compound" text="rifampin"/>
            <pair e1="DS.d1512.s0.e1" e2="DS.d1512.s0.e0" id="DS.d1512.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1513" origId="18838482">
        <sentence id="DS.d1513.s0" origId="18838482-1670" text="The main source of extracellular adenosine stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (CD39) and the ecto-5'-nucleotidase (CD73).">
            <entity id="DS.d1513.s0.e0" origId="60961" charOffset="33-42" type="compound" text="adenosine"/>
            <entity id="DS.d1513.s0.e1" origId="O18956,O75355,O93295,P49961,P55772,P97687,Q9MYU4" charOffset="131-143" type="protein" text="ecto-apyrase"/>
            <entity id="DS.d1513.s0.e2" origId="O18956,O93295,P49961,Q9MYU4" charOffset="145-149" type="protein" text="CD39"/>
            <entity id="DS.d1513.s0.e3" origId="P21588,P21589,Q05927,Q61503" charOffset="159-179" type="protein" text="ecto-5'-nucleotidase"/>
            <pair e1="DS.d1513.s0.e0" e2="DS.d1513.s0.e1" id="DS.d1513.s0.i0" interaction="True"/>
            <pair e1="DS.d1513.s0.e0" e2="DS.d1513.s0.e2" id="DS.d1513.s0.i1" interaction="True"/>
            <pair e1="DS.d1513.s0.e0" e2="DS.d1513.s0.e3" id="DS.d1513.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1514" origId="18838483">
        <sentence id="DS.d1514.s0" origId="18838483-2012" text="Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone.">
            <entity id="DS.d1514.s0.e0" origId="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8" charOffset="17-22" type="protein" text="COX-1"/>
            <entity id="DS.d1514.s0.e1" origId="5280427,5282411,6434194" charOffset="26-38" type="compound" text="prostacyclin"/>
            <entity id="DS.d1514.s0.e2" origId="784" charOffset="99-112" type="compound" text="hydroperoxide"/>
            <pair e1="DS.d1514.s0.e2" e2="DS.d1514.s0.e0" id="DS.d1514.s0.i0" interaction="False"/>
            <pair e1="DS.d1514.s0.e1" e2="DS.d1514.s0.e0" id="DS.d1514.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1514.s1" origId="18838483-2013" text="We aimed at evaluating the relative contribution of cyclooxygenase (COX)-1 and COX-2 to the synthesis of prostacyclin in endothelial cells under static conditions in the presence or absence of exogenous arachidonic acid and/or altered intracellular redox balance.">
            <entity id="DS.d1514.s1.e0" origId="P11353,P36551,P36552,Q9UTE2,Q9V3D2" charOffset="68-71" type="protein" text="COX"/>
            <entity id="DS.d1514.s1.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="79-84" type="protein" text="COX-2"/>
            <entity id="DS.d1514.s1.e2" origId="5280427,5282411,6434194" charOffset="105-117" type="compound" text="prostacyclin"/>
            <entity id="DS.d1514.s1.e3" origId="444899" charOffset="203-219" type="compound" text="arachidonic acid"/>
            <pair e1="DS.d1514.s1.e3" e2="DS.d1514.s1.e0" id="DS.d1514.s1.i0" interaction="False"/>
            <pair e1="DS.d1514.s1.e3" e2="DS.d1514.s1.e1" id="DS.d1514.s1.i1" interaction="False"/>
            <pair e1="DS.d1514.s1.e2" e2="DS.d1514.s1.e1" id="DS.d1514.s1.i2" interaction="True"/>
            <pair e1="DS.d1514.s1.e2" e2="DS.d1514.s1.e0" id="DS.d1514.s1.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1515" origId="18838503">
        <sentence id="DS.d1515.s0" origId="18838503-1683" text="In contrast, CYP2D6.24, CYP2D6.26, and CYP2D6.27 allelic isoforms all showed active drug-metabolizing activities toward both codeine and dextromethorphan O-demethylation.">
            <entity id="DS.d1515.s0.e0" origId="P10635,Q2XNC8,Q2XNC9" charOffset="13-19" type="protein" text="CYP2D6"/>
            <entity id="DS.d1515.s0.e1" origId="P10635,Q2XNC8,Q2XNC9" charOffset="24-30" type="protein" text="CYP2D6"/>
            <entity id="DS.d1515.s0.e2" origId="P10635,Q2XNC8,Q2XNC9" charOffset="24-30" type="protein" text="CYP2D6"/>
            <entity id="DS.d1515.s0.e3" origId="5284371" charOffset="125-132" type="compound" text="codeine"/>
            <entity id="DS.d1515.s0.e4" origId="3008,5360696,5362449,12305042" charOffset="137-153" type="compound" text="dextromethorphan"/>
            <pair e1="DS.d1515.s0.e4" e2="DS.d1515.s0.e0" id="DS.d1515.s0.i0" interaction="True"/>
            <pair e1="DS.d1515.s0.e3" e2="DS.d1515.s0.e0" id="DS.d1515.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1516" origId="18838506">
        <sentence id="DS.d1516.s0" origId="18838506-1689" text="Mechanism-based inactivation of cytochrome P450 2C9 by tienilic acid and (+/-)-suprofen : a comparison of kinetics and probe substrate selection.">
            <entity id="DS.d1516.s0.e0" origId="P11712" charOffset="32-51" type="protein" text="cytochrome P450 2C9"/>
            <entity id="DS.d1516.s0.e1" origId="38409" charOffset="55-68" type="compound" text="tienilic acid"/>
            <entity id="DS.d1516.s0.e2" origId="5359" charOffset="79-87" type="compound" text="suprofen"/>
            <pair e1="DS.d1516.s0.e2" e2="DS.d1516.s0.e0" id="DS.d1516.s0.i0" interaction="True"/>
            <pair e1="DS.d1516.s0.e1" e2="DS.d1516.s0.e0" id="DS.d1516.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1516.s1" origId="18838506-1690" text="In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of cytochrome P450 (P450) 2C9 by tienilic acid and (+/-)-suprofen using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.">
            <entity id="DS.d1516.s1.e0" origId="O08469" charOffset="109-124" type="protein" text="cytochrome P450"/>
            <entity id="DS.d1516.s1.e1" origId="38409" charOffset="139-152" type="compound" text="tienilic acid"/>
            <entity id="DS.d1516.s1.e2" origId="5359" charOffset="163-171" type="compound" text="suprofen"/>
            <pair e1="DS.d1516.s1.e1" e2="DS.d1516.s1.e0" id="DS.d1516.s1.i0" interaction="True"/>
            <pair e1="DS.d1516.s1.e2" e2="DS.d1516.s1.e0" id="DS.d1516.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1517" origId="18838523">
        <sentence id="DS.d1517.s0" origId="18838523-1691" text="Leukotoxin activity was evaluated by measuring Ca(2+) entry or pore formation using spectrofluorometry or flow cytometry.">
            <entity id="DS.d1517.s0.e0" origId="P0C081,P0C082,P0C083,P0C084,P0C085,P16462,P16535,P55117,P55118,P55123,Q7BHI8,Q9ETX2,Q9EV27,Q9EV29,Q9EV30,Q9EV31,Q9EV32,Q9EV33,Q9EV34" charOffset="0-10" type="protein" text="Leukotoxin"/>
            <entity id="DS.d1517.s0.e1" origId="271" charOffset="47-51" type="compound" text="Ca(2"/>
            <pair e1="DS.d1517.s0.e1" e2="DS.d1517.s0.e0" id="DS.d1517.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1518" origId="18838739">
        <sentence id="DS.d1518.s0" origId="18838739-1780" text="These Ca2+-independent phospholipases A2 display remarkable specificity for the length of the sn-2 residue, but this selectivity is lost as the residue gains oxygen functions.">
            <entity id="DS.d1518.s0.e0" origId="O77793,P00608,P00609,P00610,P00620,P00622,P04362,P14419,P14420,P14556,P18999,P20258,P20259,P20260,P20474,P21789,P31854,P47712,P47713,P49147,P50392,P50393,P51972,P59066,P81166,P81167,P81236,P81237,P81243,P82971,P84651,P84736,Q10756,Q7M3V3,Q7M4I5,Q7M4I6,Q99289,Q9BMK4,Q9I8F8" charOffset="23-40" type="protein" text="phospholipases A2"/>
            <entity id="DS.d1518.s0.e1" origId="977" charOffset="158-164" type="compound" text="oxygen"/>
            <pair e1="DS.d1518.s0.e1" e2="DS.d1518.s0.e0" id="DS.d1518.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1519" origId="18839053">
        <sentence id="DS.d1519.s0" origId="18839053-1886" text="At the end of treatment, BMI, WHR, HbA1c, fasting glucose, leptin, HOMA-IR, alanine aminotransferase values decreased in both groups.">
            <entity id="DS.d1519.s0.e0" origId="206,5793,64689,79025" charOffset="50-57" type="compound" text="glucose"/>
            <entity id="DS.d1519.s0.e1" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="59-65" type="protein" text="leptin"/>
            <pair e1="DS.d1519.s0.e0" e2="DS.d1519.s0.e1" id="DS.d1519.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1521" origId="18839068">
        <sentence id="DS.d1521.s0" origId="18839068-1905" text="Among these indicators is phosphatidylserine (PS) translocation from the inner to the outer leaflet of the plasma membrane, which can be detected by annexinV (ANXA5) conjugation.">
            <entity id="DS.d1521.s0.e0" origId="445141,6323481,44147587" charOffset="26-44" type="compound" text="phosphatidylserine"/>
            <entity id="DS.d1521.s0.e1" origId="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0" charOffset="149-157" type="protein" text="annexinV"/>
            <entity id="DS.d1521.s0.e2" origId="P08758,P17153,P81287,Q4R4H7,Q5R1W0" charOffset="159-164" type="protein" text="ANXA5"/>
            <pair e1="DS.d1521.s0.e0" e2="DS.d1521.s0.e2" id="DS.d1521.s0.i0" interaction="True"/>
            <pair e1="DS.d1521.s0.e0" e2="DS.d1521.s0.e1" id="DS.d1521.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1522" origId="18839150">
        <sentence id="DS.d1522.s0" origId="18839150-1938" text="Effects of chronic inflammation and morphine tolerance on the expression of phospho-ERK 1/2 and phospho-P38 in the injured tissue.">
            <entity id="DS.d1522.s0.e0" origId="5288826,5479215" charOffset="36-44" type="compound" text="morphine"/>
            <entity id="DS.d1522.s0.e1" origId="P21708,P27361,Q63844" charOffset="84-89" type="protein" text="ERK 1"/>
            <entity id="DS.d1522.s0.e2" origId="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7" charOffset="104-107" type="protein" text="P38"/>
            <pair e1="DS.d1522.s0.e0" e2="DS.d1522.s0.e2" id="DS.d1522.s0.i0" interaction="True"/>
            <pair e1="DS.d1522.s0.e0" e2="DS.d1522.s0.e1" id="DS.d1522.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1522.s1" origId="18839150-1940" text="The results of the present study show that ERKs phosphorylation is unaltered by inflammation or morphine tolerance, each one individually, in the plantar tissue.">
            <entity id="DS.d1522.s1.e0" origId="P29323" charOffset="43-47" type="protein" text="ERKs"/>
            <entity id="DS.d1522.s1.e1" origId="5288826,5479215" charOffset="96-104" type="compound" text="morphine"/>
            <pair e1="DS.d1522.s1.e1" e2="DS.d1522.s1.e0" id="DS.d1522.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1522.s2" origId="18839150-1941" text="In contrast, no significant differences in phospho-p38 expression were observed between na&#239;ve and tolerant animals acutely injected with saline or morphine in presence of CFA inflammation.">
            <entity id="DS.d1522.s2.e0" origId="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7" charOffset="51-54" type="protein" text="p38"/>
            <entity id="DS.d1522.s2.e1" origId="5288826,5479215" charOffset="147-155" type="compound" text="morphine"/>
            <pair e1="DS.d1522.s2.e1" e2="DS.d1522.s2.e0" id="DS.d1522.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1522.s3" origId="18839150-1942" text="These results suggest that ERK but not p38 could be implicated in the development of morphine tolerance during peripheral inflammation.">
            <entity id="DS.d1522.s3.e0" origId="P29323" charOffset="27-30" type="protein" text="ERK"/>
            <entity id="DS.d1522.s3.e1" origId="5288826,5479215" charOffset="85-93" type="compound" text="morphine"/>
            <pair e1="DS.d1522.s3.e1" e2="DS.d1522.s3.e0" id="DS.d1522.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1523" origId="18839155">
        <sentence id="DS.d1523.s0" origId="18839155-1946" text="The anterior pituitary gland contains five types of cells secreting specific hormones (growth hormone, adrenocorticotropic hormone (ACTH), gonadotropic hormone, prolactin, and thyroid-stimulating hormone), and the double staining results indicated that D:-Ala is localized to the ACTH-secreting cells.">
            <entity id="DS.d1523.s0.e0" origId="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8" charOffset="87-101" type="protein" text="growth hormone"/>
            <entity id="DS.d1523.s0.e1" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="103-130" type="protein" text="adrenocorticotropic hormone"/>
            <entity id="DS.d1523.s0.e2" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="161-170" type="protein" text="prolactin"/>
            <entity id="DS.d1523.s0.e3" origId="71080" charOffset="253-259" type="compound" text="D:-Ala"/>
            <pair e1="DS.d1523.s0.e3" e2="DS.d1523.s0.e1" id="DS.d1523.s0.i0" interaction="False"/>
            <pair e1="DS.d1523.s0.e3" e2="DS.d1523.s0.e2" id="DS.d1523.s0.i1" interaction="False"/>
            <pair e1="DS.d1523.s0.e3" e2="DS.d1523.s0.e0" id="DS.d1523.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1524" origId="18839173">
        <sentence id="DS.d1524.s0" origId="18839173-1953" text="In addition to rifampicin and hyperforin, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (PXR).">
            <entity id="DS.d1524.s0.e0" origId="5381226,5388984,5458213,6243627,6842115,6913622,16043998,17753751,25141428,45356263,56947149" charOffset="15-25" type="compound" text="rifampicin"/>
            <entity id="DS.d1524.s0.e1" origId="3662,441298,5288591,6426795,46835064" charOffset="30-40" type="compound" text="hyperforin"/>
            <entity id="DS.d1524.s0.e2" origId="4666,36314,441276,5352019,6713921,6915727,44155032,53313247" charOffset="62-72" type="compound" text="paclitaxel"/>
            <entity id="DS.d1524.s0.e3" origId="O54915,O75469,Q8SQ01,Q9R1A7" charOffset="142-161" type="protein" text="pregnane X receptor"/>
            <entity id="DS.d1524.s0.e4" origId="O75469,Q8SQ01" charOffset="163-166" type="protein" text="PXR"/>
            <pair e1="DS.d1524.s0.e0" e2="DS.d1524.s0.e4" id="DS.d1524.s0.i0" interaction="False"/>
            <pair e1="DS.d1524.s0.e1" e2="DS.d1524.s0.e4" id="DS.d1524.s0.i1" interaction="False"/>
            <pair e1="DS.d1524.s0.e2" e2="DS.d1524.s0.e3" id="DS.d1524.s0.i2" interaction="True"/>
            <pair e1="DS.d1524.s0.e1" e2="DS.d1524.s0.e3" id="DS.d1524.s0.i3" interaction="False"/>
            <pair e1="DS.d1524.s0.e0" e2="DS.d1524.s0.e3" id="DS.d1524.s0.i4" interaction="False"/>
            <pair e1="DS.d1524.s0.e2" e2="DS.d1524.s0.e4" id="DS.d1524.s0.i5" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1525" origId="18839216">
        <sentence id="DS.d1525.s0" origId="18839216-1978" text="A comprehensive literature review of clinical studies in children evaluating s-CysC or CysC-based formulas and plasma creatinine or creatinine-based formulas against an exogenous reference method using receiver operating characteristics (ROC) curves or Bland-Altman plots is presented.">
            <entity id="DS.d1525.s0.e0" origId="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6" charOffset="79-83" type="protein" text="CysC"/>
            <entity id="DS.d1525.s0.e1" origId="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6" charOffset="87-91" type="protein" text="CysC"/>
            <entity id="DS.d1525.s0.e2" origId="588" charOffset="118-128" type="compound" text="creatinine"/>
            <entity id="DS.d1525.s0.e3" origId="588" charOffset="132-142" type="compound" text="creatinine"/>
            <pair e1="DS.d1525.s0.e2" e2="DS.d1525.s0.e0" id="DS.d1525.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1525.s1" origId="18839216-1979" text="The comparison of s-CysC with plasma creatinine indicated that s-CysC was superior to plasma creatinine in five of 13 studies; four studies showed no difference, and, in four studies, no statistical comparison was made.">
            <entity id="DS.d1525.s1.e0" origId="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6" charOffset="20-24" type="protein" text="CysC"/>
            <entity id="DS.d1525.s1.e1" origId="588" charOffset="37-47" type="compound" text="creatinine"/>
            <entity id="DS.d1525.s1.e2" origId="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6" charOffset="65-69" type="protein" text="CysC"/>
            <entity id="DS.d1525.s1.e3" origId="588" charOffset="93-103" type="compound" text="creatinine"/>
            <pair e1="DS.d1525.s1.e1" e2="DS.d1525.s1.e0" id="DS.d1525.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1525.s2" origId="18839216-1980" text="S-CysC is most likely superior to plasma creatinine and at least equal to creatinine-based formulas.">
            <entity id="DS.d1525.s2.e0" origId="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6" charOffset="2-6" type="protein" text="CysC"/>
            <entity id="DS.d1525.s2.e1" origId="588" charOffset="41-51" type="compound" text="creatinine"/>
            <entity id="DS.d1525.s2.e2" origId="588" charOffset="74-84" type="compound" text="creatinine"/>
            <pair e1="DS.d1525.s2.e1" e2="DS.d1525.s2.e0" id="DS.d1525.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1525.s3" origId="18839216-1981" text="CysC-based prediction equations are at least as good as creatinine-based formulas but cannot replace exogenous methods.">
            <entity id="DS.d1525.s3.e0" origId="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6" charOffset="0-4" type="protein" text="CysC"/>
            <entity id="DS.d1525.s3.e1" origId="588" charOffset="56-66" type="compound" text="creatinine"/>
            <pair e1="DS.d1525.s3.e1" e2="DS.d1525.s3.e0" id="DS.d1525.s3.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1526" origId="18839315">
        <sentence id="DS.d1526.s0" origId="18839315-2028" text="By combining endosperm LKR/SDH suppression with embryo LKR/SDH suppression through crosses, the saccharopine level in embryo was reduced and resulted in higher lysine accumulation in mature kernels.">
            <entity id="DS.d1526.s0.e0" origId="Q99K67,Q9SMZ4,Q9UDR5" charOffset="23-26" type="protein" text="LKR"/>
            <entity id="DS.d1526.s0.e1" origId="O34607,O34635,O86564,P09367,P20132,P21801,P21912,P21914,P33073,P33074,P38997,P38998,P42630,P43065,P56072,P66773,P66774,P71349,P80212,P80213,Q02912,Q09694,Q48838,Q6FU27,Q75BV4,Q7SFX6,Q870G1,Q8LGI2,Q99K67,Q9SMZ4,Q9SQT8,Q9UDR5,Q9ZMU7" charOffset="27-30" type="protein" text="SDH"/>
            <entity id="DS.d1526.s0.e2" origId="Q99K67,Q9SMZ4,Q9UDR5" charOffset="55-58" type="protein" text="LKR"/>
            <entity id="DS.d1526.s0.e3" origId="O34607,O34635,O86564,P09367,P20132,P21801,P21912,P21914,P33073,P33074,P38997,P38998,P42630,P43065,P56072,P66773,P66774,P71349,P80212,P80213,Q02912,Q09694,Q48838,Q6FU27,Q75BV4,Q7SFX6,Q870G1,Q8LGI2,Q99K67,Q9SMZ4,Q9SQT8,Q9UDR5,Q9ZMU7" charOffset="59-62" type="protein" text="SDH"/>
            <entity id="DS.d1526.s0.e4" origId="160556" charOffset="96-108" type="compound" text="saccharopine"/>
            <pair e1="DS.d1526.s0.e4" e2="DS.d1526.s0.e0" id="DS.d1526.s0.i0" interaction="True"/>
            <pair e1="DS.d1526.s0.e4" e2="DS.d1526.s0.e1" id="DS.d1526.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1527" origId="18839328">
        <sentence id="DS.d1527.s0" origId="18839328-2042" text="We examined the relationship between FGF23 and serum calcium, phosphate, 1,25(OH)(2)D(3), and PTH levels in haemodialysis patients.">
            <entity id="DS.d1527.s0.e0" origId="Q5MK86,Q9GZV9" charOffset="37-42" type="protein" text="FGF23"/>
            <entity id="DS.d1527.s0.e1" origId="1061,167704,644102" charOffset="62-71" type="compound" text="phosphate"/>
            <pair e1="DS.d1527.s0.e1" e2="DS.d1527.s0.e0" id="DS.d1527.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1528" origId="18839335">
        <sentence id="DS.d1528.s0" origId="18839335-2050" text="Resistin, an adipokine-linked obesity with type 2 diabetes, impairs glucose-stimulated insulin secretion (GSIS) in beta-cells.">
            <entity id="DS.d1528.s0.e0" origId="206,5793,64689,79025" charOffset="68-75" type="compound" text="glucose"/>
            <entity id="DS.d1528.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="87-94" type="protein" text="insulin"/>
            <pair e1="DS.d1528.s0.e0" e2="DS.d1528.s0.e1" id="DS.d1528.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1529" origId="18839360">
        <sentence id="DS.d1529.s0" origId="18839360-2057" text="Intracellular Cl (-) is required for the motor function of prestin, a unique plasma membrane molecular motor of these cells.">
            <entity id="DS.d1529.s0.e0" origId="312" charOffset="14-16" type="compound" text="Cl"/>
            <entity id="DS.d1529.s0.e1" origId="P58743,Q99NH7,Q9EPH0,Q9JKQ2" charOffset="59-66" type="protein" text="prestin"/>
            <pair e1="DS.d1529.s0.e0" e2="DS.d1529.s0.e1" id="DS.d1529.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1530" origId="18839361">
        <sentence id="DS.d1530.s0" origId="18839361-2058" text="Prestin was immunostained with mouse anti-FLAG primary antibody and FITC-conjugated goat anti-mouse IgG secondary antibody.">
            <entity id="DS.d1530.s0.e0" origId="P58743,Q99NH7,Q9EPH0,Q9JKQ2" charOffset="0-7" type="protein" text="Prestin"/>
            <entity id="DS.d1530.s0.e1" origId="18730" charOffset="68-72" type="compound" text="FITC"/>
            <pair e1="DS.d1530.s0.e1" e2="DS.d1530.s0.e0" id="DS.d1530.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1531" origId="18839419">
        <sentence id="DS.d1531.s0" origId="18839419-2085" text="Intramuscular triacylglycerol does not appear to be a ubiquitous marker of insulin resistance, although specific IMCL intermediates such as long-chain fatty acyl-CoAs, ceramide, and diacylglycerol may inhibit insulin signal transduction.">
            <entity id="DS.d1531.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="75-82" type="protein" text="insulin"/>
            <entity id="DS.d1531.s0.e1" origId="6026790" charOffset="182-196" type="compound" text="diacylglycerol"/>
            <entity id="DS.d1531.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="209-216" type="protein" text="insulin"/>
            <pair e1="DS.d1531.s0.e1" e2="DS.d1531.s0.e0" id="DS.d1531.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1532" origId="18840097">
        <sentence id="DS.d1532.s0" origId="18840097-2250" text="Light stimulates cGMP hydrolysis via the G-protein transducin, which directly binds to and activates phosphodiesterase.">
            <entity id="DS.d1532.s0.e0" origId="24316" charOffset="17-21" type="compound" text="cGMP"/>
            <entity id="DS.d1532.s0.e1" origId="P49177" charOffset="51-61" type="protein" text="transducin"/>
            <pair e1="DS.d1532.s0.e0" e2="DS.d1532.s0.e1" id="DS.d1532.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1533" origId="18840413">
        <sentence id="DS.d1533.s0" origId="18840413-2365" text="Inhibition of gamma-glutamyl transferase (GGT1, EC 2.3.2.2)-catalyzed extracellular GSH degradation with acivicin significantly blocked GSH efflux, suggesting that GSH breakdown is a driving force for GSH export.">
            <entity id="DS.d1533.s0.e0" origId="P19440,P20735" charOffset="42-46" type="protein" text="GGT1"/>
            <entity id="DS.d1533.s0.e1" origId="294641" charOffset="105-113" type="compound" text="acivicin"/>
            <pair e1="DS.d1533.s0.e1" e2="DS.d1533.s0.e0" id="DS.d1533.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1534" origId="18840446">
        <sentence id="DS.d1534.s0" origId="18840446-2377" text="We injected females with human chorionic gonadotropin (HCG), estradiol, estradiol plus progesterone, saline, or HCG plus fadrozole (an aromatase blocker) and tested their responses to mating calls.">
            <entity id="DS.d1534.s0.e0" origId="Q9NFL4" charOffset="55-58" type="protein" text="HCG"/>
            <entity id="DS.d1534.s0.e1" origId="5757" charOffset="61-70" type="compound" text="estradiol"/>
            <entity id="DS.d1534.s0.e2" origId="5757" charOffset="72-81" type="compound" text="estradiol"/>
            <entity id="DS.d1534.s0.e3" origId="5994" charOffset="87-99" type="compound" text="progesterone"/>
            <entity id="DS.d1534.s0.e4" origId="Q9NFL4" charOffset="112-115" type="protein" text="HCG"/>
            <entity id="DS.d1534.s0.e5" origId="59693" charOffset="121-130" type="compound" text="fadrozole"/>
            <pair e1="DS.d1534.s0.e5" e2="DS.d1534.s0.e0" id="DS.d1534.s0.i0" interaction="False"/>
            <pair e1="DS.d1534.s0.e1" e2="DS.d1534.s0.e0" id="DS.d1534.s0.i1" interaction="False"/>
            <pair e1="DS.d1534.s0.e3" e2="DS.d1534.s0.e0" id="DS.d1534.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1535" origId="18840462">
        <sentence id="DS.d1535.s0" origId="18840462-2386" text="Here we use an array of flow cytometric analyses to characterize silkworm hemocytes with various molecular probes, such as propidium iodide, green fluorescence protein, monoclonal antibodies, and fluorescent lectins.">
            <entity id="DS.d1535.s0.e0" origId="4939" charOffset="123-139" type="compound" text="propidium iodide"/>
            <entity id="DS.d1535.s0.e1" origId="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114" charOffset="208-215" type="protein" text="lectins"/>
            <pair e1="DS.d1535.s0.e0" e2="DS.d1535.s0.e1" id="DS.d1535.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1536" origId="18840470">
        <sentence id="DS.d1536.s0" origId="18840470-2387" text="Amino acid 1092 (AA1092) in capsid protein 1 of coxsackievirus B3 (CVB3) is located in close vicinity to the central phenoxy group of capsid binders (i.e.">
            <entity id="DS.d1536.s0.e0" origId="O39831,O40980,O40981,O40983,O56129,O72620,O90369,O90371,P03314,P03315,P03316,P03590,P03591,P03598,P03601,P03602,P03605,P03607,P03641,P03642,P04866,P05070,P05072,P05673,P05674,P07566,P07699,P07931,P08491,P08563,P08564,P08767,P08768,P09502,P09592,P10468,P11333,P11642,P13890,P13897,P14340,P14849,P15100,P15406,P15892,P16486,P16489,P16596,P16653,P17529,P17782,P18027,P19725,P21368,P22056,P22116,P22172,P22955,P23627,P24147,P24264,P24402,P27284,P27285,P27334,P27335,P28899,P29165,P31798,P36329,P36330,P36331,P36332,P37991,P37993,P54087,P54088,P54089,P54090,P54635,P62406,P62683,P62684,P62685,P62690,P63117,P63126,P63128,P63130,P63145,P69466,P69467,P69470,P69471,P87889,P89946,Q00259,Q00260,Q00261,Q00467,Q00556,Q01669,Q02106,Q04542,Q04572,Q05142,Q06934,Q074N0,Q07506,Q07626,Q1X880,Q1X881,Q306W5,Q306W7,Q38041,Q4QXJ7,Q5WQY5,Q5XXP3,Q5Y388,Q66114,Q66120,Q66135,Q66138,Q66140,Q66141,Q66143,Q66154,Q6DV88,Q6J3P1,Q6X2U1,Q6X2U3,Q7LDI9,Q80QL5,Q80S27,Q83251,Q83253,Q83269,Q83271,Q86925,Q86993,Q87012,Q87019,Q88305,Q88894,Q89277,Q8JJX0,Q8JUX5,Q8QL52,Q8QZ72,Q8V987,Q8VA10,Q98803,Q99153,Q99IE6,Q9HDB9,Q9J6K8,Q9JGK8,Q9NRZ4,Q9WIJ8,Q9YNA8,Q9YRV3,Q9Z035" charOffset="28-42" type="protein" text="capsid protein"/>
            <entity id="DS.d1536.s0.e1" origId="123143" charOffset="117-124" type="compound" text="phenoxy"/>
            <pair e1="DS.d1536.s0.e1" e2="DS.d1536.s0.e0" id="DS.d1536.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1537" origId="18840474">
        <sentence id="DS.d1537.s0" origId="18840474-2388" text="Insulin is a polypeptide hormone that is present in mammals and its main function is the maintenance of adequate blood sugar level.">
            <entity id="DS.d1537.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="0-7" type="protein" text="Insulin"/>
            <entity id="DS.d1537.s0.e1" origId="107526" charOffset="113-124" type="compound" text="blood sugar"/>
            <pair e1="DS.d1537.s0.e1" e2="DS.d1537.s0.e0" id="DS.d1537.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1538" origId="18840497">
        <sentence id="DS.d1538.s0" origId="18840497-2407" text="In vivo assays confirmed that the three resulting genotypes differed in their ability to produce cortisol in response to intravenous insulin injection implicating CYP17 as the primary cause of the observed hypocortisolism.">
            <entity id="DS.d1538.s0.e0" origId="5754" charOffset="97-105" type="compound" text="cortisol"/>
            <entity id="DS.d1538.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="133-140" type="protein" text="insulin"/>
            <entity id="DS.d1538.s0.e2" origId="O57525,O73853,P05093,P05185,P12394,P19100,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7" charOffset="163-168" type="protein" text="CYP17"/>
            <pair e1="DS.d1538.s0.e0" e2="DS.d1538.s0.e2" id="DS.d1538.s0.i0" interaction="True"/>
            <pair e1="DS.d1538.s0.e0" e2="DS.d1538.s0.e1" id="DS.d1538.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1539" origId="18840501">
        <sentence id="DS.d1539.s0" origId="18840501-434" text="In addition, SR-BI facilitates bi-directional flux of cholesterol by modifying the phospholipid content of the plasma membrane.">
            <entity id="DS.d1539.s0.e0" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="13-18" type="protein" text="SR-BI"/>
            <entity id="DS.d1539.s0.e1" origId="304,5997,6432564,11025495" charOffset="54-65" type="compound" text="cholesterol"/>
            <pair e1="DS.d1539.s0.e1" e2="DS.d1539.s0.e0" id="DS.d1539.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1539.s1" origId="18840501-435" text="Overall, SR-BI is the cell surface receptor responsible for selective uptake of lipoprotein cholesterol and its ultimate delivery to sites of hormone synthesis in steroidogenic tissues.">
            <entity id="DS.d1539.s1.e0" origId="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0" charOffset="9-14" type="protein" text="SR-BI"/>
            <entity id="DS.d1539.s1.e1" origId="304,5997,6432564,11025495" charOffset="92-103" type="compound" text="cholesterol"/>
            <pair e1="DS.d1539.s1.e1" e2="DS.d1539.s1.e0" id="DS.d1539.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1540" origId="18840514">
        <sentence id="DS.d1540.s0" origId="18840514-2413" text="Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the folate metabolic pathway, such as methylenetetrahydrofolate reductase (MTHFR).">
            <entity id="DS.d1540.s0.e0" origId="6037" charOffset="99-105" type="compound" text="folate"/>
            <entity id="DS.d1540.s0.e1" origId="P42898,Q5I598,Q60HE5,Q9WU20" charOffset="133-168" type="protein" text="methylenetetrahydrofolate reductase"/>
            <entity id="DS.d1540.s0.e2" origId="P42898,Q5I598,Q60HE5" charOffset="170-175" type="protein" text="MTHFR"/>
            <pair e1="DS.d1540.s0.e0" e2="DS.d1540.s0.e2" id="DS.d1540.s0.i0" interaction="True"/>
            <pair e1="DS.d1540.s0.e0" e2="DS.d1540.s0.e1" id="DS.d1540.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1541" origId="18840516">
        <sentence id="DS.d1541.s0" origId="18840516-2417" text="We looked at the toxicity of non-drug-containing liposomes on (3)H-thymidine incorporation by concanavalin A (Con A)-stimulated human lymphocytes, splenocytes and Epstein-Barr virus (EBV)-transformed human B-cell lymphoblastoid cell line (LCL).">
            <entity id="DS.d1541.s0.e0" origId="5789" charOffset="67-76" type="compound" text="thymidine"/>
            <entity id="DS.d1541.s0.e1" origId="P81460,P81461" charOffset="94-108" type="protein" text="concanavalin A"/>
            <entity id="DS.d1541.s0.e2" origId="P02866,P14894,P81460,P81461" charOffset="110-115" type="protein" text="Con A"/>
            <pair e1="DS.d1541.s0.e0" e2="DS.d1541.s0.e1" id="DS.d1541.s0.i0" interaction="True"/>
            <pair e1="DS.d1541.s0.e0" e2="DS.d1541.s0.e2" id="DS.d1541.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1542" origId="18840548">
        <sentence id="DS.d1542.s0" origId="18840548-2430" text="The anti-inflammatory effect of these compounds and a coumarin control, scopoletin, on interleukin-6 (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.">
            <entity id="DS.d1542.s0.e0" origId="323,94381" charOffset="54-62" type="compound" text="coumarin"/>
            <entity id="DS.d1542.s0.e1" origId="5280460" charOffset="72-82" type="compound" text="scopoletin"/>
            <entity id="DS.d1542.s0.e2" origId="P41693" charOffset="87-100" type="protein" text="interleukin-6"/>
            <entity id="DS.d1542.s0.e3" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="102-106" type="protein" text="IL-6"/>
            <entity id="DS.d1542.s0.e4" origId="Q8JFG3" charOffset="109-130" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d1542.s0.e5" origId="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="132-135" type="protein" text="TNF"/>
            <entity id="DS.d1542.s0.e6" origId="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3" charOffset="176-181" type="protein" text="MCP-1"/>
            <pair e1="DS.d1542.s0.e0" e2="DS.d1542.s0.e4" id="DS.d1542.s0.i0" interaction="False"/>
            <pair e1="DS.d1542.s0.e0" e2="DS.d1542.s0.e2" id="DS.d1542.s0.i1" interaction="True"/>
            <pair e1="DS.d1542.s0.e0" e2="DS.d1542.s0.e6" id="DS.d1542.s0.i2" interaction="False"/>
            <pair e1="DS.d1542.s0.e1" e2="DS.d1542.s0.e5" id="DS.d1542.s0.i3" interaction="False"/>
            <pair e1="DS.d1542.s0.e0" e2="DS.d1542.s0.e3" id="DS.d1542.s0.i4" interaction="False"/>
            <pair e1="DS.d1542.s0.e1" e2="DS.d1542.s0.e4" id="DS.d1542.s0.i5" interaction="False"/>
            <pair e1="DS.d1542.s0.e1" e2="DS.d1542.s0.e2" id="DS.d1542.s0.i6" interaction="False"/>
            <pair e1="DS.d1542.s0.e1" e2="DS.d1542.s0.e6" id="DS.d1542.s0.i7" interaction="False"/>
            <pair e1="DS.d1542.s0.e0" e2="DS.d1542.s0.e5" id="DS.d1542.s0.i8" interaction="False"/>
            <pair e1="DS.d1542.s0.e1" e2="DS.d1542.s0.e3" id="DS.d1542.s0.i9" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1543" origId="18840610">
        <sentence id="DS.d1543.s0" origId="18840610-2455" text="We previously determined that BLIP Tyr51 is a canonical and Trp150 an anti-canonical TEM-1-contact residue, where canonical refers to the alanine substitution resulting in a matched change in the hydrophobicity of binding free energy.">
            <entity id="DS.d1543.s0.e0" origId="P35804" charOffset="30-34" type="protein" text="BLIP"/>
            <entity id="DS.d1543.s0.e1" origId="P62593" charOffset="85-90" type="protein" text="TEM-1"/>
            <entity id="DS.d1543.s0.e2" origId="602,4580,5950,71080" charOffset="138-145" type="compound" text="alanine"/>
            <pair e1="DS.d1543.s0.e2" e2="DS.d1543.s0.e0" id="DS.d1543.s0.i0" interaction="True"/>
            <pair e1="DS.d1543.s0.e2" e2="DS.d1543.s0.e1" id="DS.d1543.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1543.s1" origId="18840610-2456" text="This explains the anti-canonical nature of the Trp150 to alanine substitution, and also reveals a strong long distance coupling between Trp150 and Asp49 of BLIP, because these two residues are more than 25 angstroms apart.">
            <entity id="DS.d1543.s1.e0" origId="602,4580,5950,71080" charOffset="57-64" type="compound" text="alanine"/>
            <entity id="DS.d1543.s1.e1" origId="P35804" charOffset="156-160" type="protein" text="BLIP"/>
            <pair e1="DS.d1543.s1.e0" e2="DS.d1543.s1.e1" id="DS.d1543.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1544" origId="18840670">
        <sentence id="DS.d1544.s0" origId="18840670-2486" text="This effect is independent of any change in neutrophil adhesion or adhesion molecule expression but is related to the ability of statins to reduce fMLP-induced Rho activity in neutrophils.">
            <entity id="DS.d1544.s0.e0" origId="443295" charOffset="147-151" type="compound" text="fMLP"/>
            <entity id="DS.d1544.s0.e1" origId="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9" charOffset="160-163" type="protein" text="Rho"/>
            <pair e1="DS.d1544.s0.e0" e2="DS.d1544.s0.e1" id="DS.d1544.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1544.s1" origId="18840670-2487" text="This was confirmed by the ability of the Rho precursor geranylgeranyl pyrophosphate to rescue the statin-mediated reduction in neutrophil transendothelial migration.">
            <entity id="DS.d1544.s1.e0" origId="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9" charOffset="41-44" type="protein" text="Rho"/>
            <entity id="DS.d1544.s1.e1" origId="447277" charOffset="55-83" type="compound" text="geranylgeranyl pyrophosphate"/>
            <pair e1="DS.d1544.s1.e1" e2="DS.d1544.s1.e0" id="DS.d1544.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1545" origId="18840677">
        <sentence id="DS.d1545.s0" origId="18840677-1304" text="Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nitric-oxide synthase 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis.">
            <entity id="DS.d1545.s0.e0" origId="1388" charOffset="15-59" type="compound" text="1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"/>
            <entity id="DS.d1545.s0.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="68-89" type="protein" text="nitric-oxide synthase"/>
            <entity id="DS.d1545.s0.e2" origId="3071" charOffset="128-144" type="compound" text="diindolylmethane"/>
            <pair e1="DS.d1545.s0.e0" e2="DS.d1545.s0.e1" id="DS.d1545.s0.i0" interaction="True"/>
            <pair e1="DS.d1545.s0.e2" e2="DS.d1545.s0.e1" id="DS.d1545.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1546" origId="18840759">
        <sentence id="DS.d1546.s0" origId="18840759-2541" text="We hypothesized that conditioned medium from macrophages pretreated with palmitate or LPS would directly affect insulin action and glucose uptake in muscle cells.">
            <entity id="DS.d1546.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="112-119" type="protein" text="insulin"/>
            <entity id="DS.d1546.s0.e1" origId="206,5793,64689,79025" charOffset="131-138" type="compound" text="glucose"/>
            <pair e1="DS.d1546.s0.e1" e2="DS.d1546.s0.e0" id="DS.d1546.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1546.s1" origId="18840759-2542" text="Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast insulin-stimulated glucose uptake, GLUT4 translocation, and Akt phosphorylation without affecting stress kinases or inflammation indexes.">
            <entity id="DS.d1546.s1.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="128-135" type="protein" text="insulin"/>
            <entity id="DS.d1546.s1.e1" origId="206,5793,64689,79025" charOffset="147-154" type="compound" text="glucose"/>
            <entity id="DS.d1546.s1.e2" origId="P14672,Q27994,Q9XST2,Q9XT10" charOffset="163-168" type="protein" text="GLUT4"/>
            <entity id="DS.d1546.s1.e3" origId="P31750,Q8INB9" charOffset="188-191" type="protein" text="Akt"/>
            <pair e1="DS.d1546.s1.e1" e2="DS.d1546.s1.e2" id="DS.d1546.s1.i0" interaction="False"/>
            <pair e1="DS.d1546.s1.e1" e2="DS.d1546.s1.e0" id="DS.d1546.s1.i1" interaction="True"/>
            <pair e1="DS.d1546.s1.e1" e2="DS.d1546.s1.e3" id="DS.d1546.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1547" origId="18840763">
        <sentence id="DS.d1547.s0" origId="18840763-2544" text="The essential role of glucagon and insulin and the importance of distributed control of glucose fluxes are highlighted in this review.">
            <entity id="DS.d1547.s0.e0" origId="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9" charOffset="22-30" type="protein" text="glucagon"/>
            <entity id="DS.d1547.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="35-42" type="protein" text="insulin"/>
            <entity id="DS.d1547.s0.e2" origId="206,5793,64689,79025" charOffset="88-95" type="compound" text="glucose"/>
            <pair e1="DS.d1547.s0.e2" e2="DS.d1547.s0.e1" id="DS.d1547.s0.i0" interaction="True"/>
            <pair e1="DS.d1547.s0.e2" e2="DS.d1547.s0.e0" id="DS.d1547.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1548" origId="18840765">
        <sentence id="DS.d1548.s0" origId="18840765-2545" text="Because both TCDD and HFD are associated with increased breast cancer risk, we examined their effects on metabolic syndrome-associated phenotypes in three mouse models of breast cancer: 7,12-dimethylbenz(a) anthracene (DMBA), Tg(MMTV-Neu)202Mul/J (HER2), and TgN(MMTV-PyMT)634Mul/J (PyMT), all on an FVB/N genetic background.">
            <entity id="DS.d1548.s0.e0" origId="8418" charOffset="207-217" type="compound" text="anthracene"/>
            <entity id="DS.d1548.s0.e1" origId="6001" charOffset="219-223" type="compound" text="DMBA"/>
            <entity id="DS.d1548.s0.e2" origId="P04626" charOffset="248-252" type="protein" text="HER2"/>
            <pair e1="DS.d1548.s0.e0" e2="DS.d1548.s0.e2" id="DS.d1548.s0.i0" interaction="False"/>
            <pair e1="DS.d1548.s0.e1" e2="DS.d1548.s0.e2" id="DS.d1548.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1549" origId="18840783">
        <sentence id="DS.d1549.s0" origId="18840783-2553" text="Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.">
            <entity id="DS.d1549.s0.e0" origId="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9" charOffset="0-3" type="protein" text="Rho"/>
            <entity id="DS.d1549.s0.e1" origId="3547" charOffset="25-32" type="compound" text="fasudil"/>
            <pair e1="DS.d1549.s0.e1" e2="DS.d1549.s0.e0" id="DS.d1549.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1549.s1" origId="18840783-2554" text="Involvement of the Rho/Rho kinase (ROCK) pathway in diabetic microvasculopathy and therapeutic potential of fasudil, a selective ROCK inhibitor, are investigated.">
            <entity id="DS.d1549.s1.e0" origId="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9" charOffset="19-22" type="protein" text="Rho"/>
            <entity id="DS.d1549.s1.e1" origId="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9" charOffset="23-26" type="protein" text="Rho"/>
            <entity id="DS.d1549.s1.e2" origId="3547" charOffset="108-115" type="compound" text="fasudil"/>
            <pair e1="DS.d1549.s1.e2" e2="DS.d1549.s1.e0" id="DS.d1549.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1550" origId="18840785">
        <sentence id="DS.d1550.s0" origId="18840785-2556" text="This study investigated the acute effects of treatment with vildagliptin on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.">
            <entity id="DS.d1550.s0.e0" origId="6918537" charOffset="60-72" type="compound" text="vildagliptin"/>
            <entity id="DS.d1550.s0.e1" origId="P14740,P22411,P27487,P28843,P81425,Q9N2I7" charOffset="76-98" type="protein" text="dipeptidyl peptidase-4"/>
            <entity id="DS.d1550.s0.e2" origId="P97399,Q62598,Q9NZW4" charOffset="100-103" type="protein" text="DPP"/>
            <entity id="DS.d1550.s0.e3" origId="O12956,P01272,P01273,P01274,P01275,P01278,P05110,P06883,P15438,P22890,P29794,P55095,P68259,Q8MJ25" charOffset="117-140" type="protein" text="glucagon-like peptide 1"/>
            <entity id="DS.d1550.s0.e4" origId="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25" charOffset="142-147" type="protein" text="GLP-1"/>
            <entity id="DS.d1550.s0.e5" origId="P01298,P01299,P01301,P01302,P06303,P06304,P06305,P06884,P10601,P11967,P13083,P15427,P18107,P31229,P33684,P37999,P39659,P41335,P41336,P41337,P41519,P68009,P68010,P68249" charOffset="164-182" type="protein" text="pancreatic hormone"/>
            <pair e1="DS.d1550.s0.e0" e2="DS.d1550.s0.e4" id="DS.d1550.s0.i0" interaction="False"/>
            <pair e1="DS.d1550.s0.e0" e2="DS.d1550.s0.e1" id="DS.d1550.s0.i1" interaction="False"/>
            <pair e1="DS.d1550.s0.e0" e2="DS.d1550.s0.e5" id="DS.d1550.s0.i2" interaction="False"/>
            <pair e1="DS.d1550.s0.e0" e2="DS.d1550.s0.e3" id="DS.d1550.s0.i3" interaction="False"/>
            <pair e1="DS.d1550.s0.e0" e2="DS.d1550.s0.e2" id="DS.d1550.s0.i4" interaction="False"/>
        </sentence>
        <sentence id="DS.d1550.s1" origId="18840785-2557" text="The primary aims were to determine the effects of DPP-4 inhibition on GLP-1 clearance and on hepatic glucose uptake.">
            <entity id="DS.d1550.s1.e0" origId="P97399,Q62598,Q9NZW4" charOffset="50-53" type="protein" text="DPP"/>
            <entity id="DS.d1550.s1.e1" origId="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25" charOffset="70-75" type="protein" text="GLP-1"/>
            <entity id="DS.d1550.s1.e2" origId="206,5793,64689,79025" charOffset="101-108" type="compound" text="glucose"/>
            <pair e1="DS.d1550.s1.e2" e2="DS.d1550.s1.e0" id="DS.d1550.s1.i0" interaction="False"/>
            <pair e1="DS.d1550.s1.e2" e2="DS.d1550.s1.e1" id="DS.d1550.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1551" origId="18840871">
        <sentence id="DS.d1551.s0" origId="18840871-2587" text="In the present study we determined the effect of insulin on the secretome by comparing incorporation rates of (13)C-labeled lysine in the presence and absence of insulin.">
            <entity id="DS.d1551.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="49-56" type="protein" text="insulin"/>
            <entity id="DS.d1551.s0.e1" origId="866,5962" charOffset="124-130" type="compound" text="lysine"/>
            <entity id="DS.d1551.s0.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="162-169" type="protein" text="insulin"/>
            <pair e1="DS.d1551.s0.e1" e2="DS.d1551.s0.e0" id="DS.d1551.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1552" origId="18840995">
        <sentence id="DS.d1552.s0" origId="18840995-2643" text="Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.">
            <entity id="DS.d1552.s0.e0" origId="P33716" charOffset="0-14" type="protein" text="Chromogranin A"/>
            <entity id="DS.d1552.s0.e1" origId="1826" charOffset="36-62" type="compound" text="5-hydroxyindoleacetic acid"/>
            <pair e1="DS.d1552.s0.e1" e2="DS.d1552.s0.e0" id="DS.d1552.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1553" origId="18841321">
        <sentence id="DS.d1553.s0" origId="18841321-2736" text="Th1 cytokine profile may be related to the risk of the vaginal erosions following placement of polypropylene meshes.">
            <entity id="DS.d1553.s0.e0" origId="Q64279,Q922L6" charOffset="0-3" type="protein" text="Th1"/>
            <entity id="DS.d1553.s0.e1" origId="8252" charOffset="95-108" type="compound" text="polypropylene"/>
            <pair e1="DS.d1553.s0.e1" e2="DS.d1553.s0.e0" id="DS.d1553.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1554" origId="18841385">
        <sentence id="DS.d1554.s0" origId="18841385-2745" text="However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and glutathione increased.">
            <entity id="DS.d1554.s0.e0" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="187-207" type="protein" text="nitricoxide synthase"/>
            <entity id="DS.d1554.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="209-217" type="protein" text="catalase"/>
            <entity id="DS.d1554.s0.e2" origId="P15984,P16147,P84714" charOffset="219-229" type="protein" text="peroxidase"/>
            <entity id="DS.d1554.s0.e3" origId="O50258" charOffset="231-251" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1554.s0.e4" origId="145068" charOffset="277-289" type="compound" text="nitric oxide"/>
            <entity id="DS.d1554.s0.e5" origId="54670067,54690394" charOffset="291-304" type="compound" text="ascorbic acid"/>
            <entity id="DS.d1554.s0.e6" origId="124886" charOffset="309-320" type="compound" text="glutathione"/>
            <pair e1="DS.d1554.s0.e5" e2="DS.d1554.s0.e2" id="DS.d1554.s0.i0" interaction="False"/>
            <pair e1="DS.d1554.s0.e4" e2="DS.d1554.s0.e2" id="DS.d1554.s0.i1" interaction="False"/>
            <pair e1="DS.d1554.s0.e5" e2="DS.d1554.s0.e1" id="DS.d1554.s0.i2" interaction="False"/>
            <pair e1="DS.d1554.s0.e4" e2="DS.d1554.s0.e3" id="DS.d1554.s0.i3" interaction="False"/>
            <pair e1="DS.d1554.s0.e4" e2="DS.d1554.s0.e1" id="DS.d1554.s0.i4" interaction="False"/>
            <pair e1="DS.d1554.s0.e5" e2="DS.d1554.s0.e0" id="DS.d1554.s0.i5" interaction="False"/>
            <pair e1="DS.d1554.s0.e6" e2="DS.d1554.s0.e0" id="DS.d1554.s0.i6" interaction="False"/>
            <pair e1="DS.d1554.s0.e5" e2="DS.d1554.s0.e3" id="DS.d1554.s0.i7" interaction="False"/>
            <pair e1="DS.d1554.s0.e6" e2="DS.d1554.s0.e3" id="DS.d1554.s0.i8" interaction="False"/>
            <pair e1="DS.d1554.s0.e6" e2="DS.d1554.s0.e2" id="DS.d1554.s0.i9" interaction="False"/>
            <pair e1="DS.d1554.s0.e4" e2="DS.d1554.s0.e0" id="DS.d1554.s0.i10" interaction="False"/>
            <pair e1="DS.d1554.s0.e6" e2="DS.d1554.s0.e1" id="DS.d1554.s0.i11" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1555" origId="18841409">
        <sentence id="DS.d1555.s0" origId="18841409-2761" text="The oxidative stress in the mollusk was observed at the U site during spring and at the R site during summer and autumn according to the differences in Mn-superoxide dismutase and catalase activities, O (2) (*-) production, lipid peroxidation, and glutathione levels.">
            <entity id="DS.d1555.s0.e0" origId="O50258" charOffset="155-175" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1555.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="180-188" type="protein" text="catalase"/>
            <entity id="DS.d1555.s0.e2" origId="124886" charOffset="248-259" type="compound" text="glutathione"/>
            <pair e1="DS.d1555.s0.e2" e2="DS.d1555.s0.e1" id="DS.d1555.s0.i0" interaction="False"/>
            <pair e1="DS.d1555.s0.e2" e2="DS.d1555.s0.e0" id="DS.d1555.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1556" origId="18841465">
        <sentence id="DS.d1556.s0" origId="18841465-2774" text="These results suggest that ugonin K by activation of ERK1/2 and PI3K/Akt signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.">
            <entity id="DS.d1556.s0.e0" origId="21576577" charOffset="27-35" type="compound" text="ugonin K"/>
            <entity id="DS.d1556.s0.e1" origId="P27361,P28869,P42525,Q07176" charOffset="53-57" type="protein" text="ERK1"/>
            <entity id="DS.d1556.s0.e2" origId="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0" charOffset="64-68" type="protein" text="PI3K"/>
            <entity id="DS.d1556.s0.e3" origId="P31750,Q8INB9" charOffset="69-72" type="protein" text="Akt"/>
            <pair e1="DS.d1556.s0.e0" e2="DS.d1556.s0.e2" id="DS.d1556.s0.i0" interaction="True"/>
            <pair e1="DS.d1556.s0.e0" e2="DS.d1556.s0.e1" id="DS.d1556.s0.i1" interaction="True"/>
            <pair e1="DS.d1556.s0.e0" e2="DS.d1556.s0.e3" id="DS.d1556.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1557" origId="18841468">
        <sentence id="DS.d1557.s0" origId="18841468-2776" text="This decrease was not modified by catalase or Trolox, demonstrating that ONOO (-) was responsible for the effect.">
            <entity id="DS.d1557.s0.e0" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="34-42" type="protein" text="catalase"/>
            <entity id="DS.d1557.s0.e1" origId="40634" charOffset="46-52" type="compound" text="Trolox"/>
            <entity id="DS.d1557.s0.e2" origId="5460609" charOffset="73-77" type="compound" text="ONOO"/>
            <pair e1="DS.d1557.s0.e1" e2="DS.d1557.s0.e0" id="DS.d1557.s0.i0" interaction="False"/>
            <pair e1="DS.d1557.s0.e2" e2="DS.d1557.s0.e0" id="DS.d1557.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1558" origId="18841470">
        <sentence id="DS.d1558.s0" origId="18841470-2778" text="Cell viability (MTT colorimetric determination) and transmembrane mitochondrial potential (J-C1 fluorescence) were concentration-dependently reduced 24 h after NaN (3); neither nuclear fragmentation by DAPI, nor Annexin V positivity by flow cytometry were detected, ruling out the occurrence of apoptosis.">
            <entity id="DS.d1558.s0.e0" origId="2954" charOffset="202-206" type="compound" text="DAPI"/>
            <entity id="DS.d1558.s0.e1" origId="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0" charOffset="212-221" type="protein" text="Annexin V"/>
            <pair e1="DS.d1558.s0.e0" e2="DS.d1558.s0.e1" id="DS.d1558.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1559" origId="18841471">
        <sentence id="DS.d1559.s0" origId="18841471-2779" text="Plasma homovanillic acid and prolactin in Huntington's disease.">
            <entity id="DS.d1559.s0.e0" origId="1738" charOffset="7-24" type="compound" text="homovanillic acid"/>
            <entity id="DS.d1559.s0.e1" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="29-38" type="protein" text="prolactin"/>
            <pair e1="DS.d1559.s0.e0" e2="DS.d1559.s0.e1" id="DS.d1559.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1559.s1" origId="18841471-2780" text="We assessed plasma homovanillic acid (pHVA) and plasma prolactin (pPRL), two correlates of dopaminergic activity, in 116 subjects with CAG repeats expansion in the HD gene, 26 presymptomatic (18 females) and 90 with overt symptomatology (43 females).">
            <entity id="DS.d1559.s1.e0" origId="1738" charOffset="19-36" type="compound" text="homovanillic acid"/>
            <entity id="DS.d1559.s1.e1" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="55-64" type="protein" text="prolactin"/>
            <pair e1="DS.d1559.s1.e0" e2="DS.d1559.s1.e1" id="DS.d1559.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1560" origId="18841529">
        <sentence id="DS.d1560.s0" origId="18841529-2811" text="Profile of serum IL-1beta and IL-10 shortly after ovariectomy and estradiol replacement in rats.">
            <entity id="DS.d1560.s0.e0" origId="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77" charOffset="17-25" type="protein" text="IL-1beta"/>
            <entity id="DS.d1560.s0.e1" origId="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5" charOffset="30-35" type="protein" text="IL-10"/>
            <entity id="DS.d1560.s0.e2" origId="5757" charOffset="66-75" type="compound" text="estradiol"/>
            <pair e1="DS.d1560.s0.e2" e2="DS.d1560.s0.e0" id="DS.d1560.s0.i0" interaction="False"/>
            <pair e1="DS.d1560.s0.e2" e2="DS.d1560.s0.e1" id="DS.d1560.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1561" origId="18842264">
        <sentence id="DS.d1561.s0" origId="18842264-225" text="A low plasma high-density lipoprotein cholesterol (HDL-c) concentration is an important risk factor for the development of atherosclerotic cardiovascular disease.">
            <entity id="DS.d1561.s0.e0" origId="P81182" charOffset="13-37" type="protein" text="high-density lipoprotein"/>
            <entity id="DS.d1561.s0.e1" origId="304,5997,6432564,11025495" charOffset="38-49" type="compound" text="cholesterol"/>
            <pair e1="DS.d1561.s0.e1" e2="DS.d1561.s0.e0" id="DS.d1561.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1562" origId="18842297">
        <sentence id="DS.d1562.s0" origId="18842297-227" text="A hydrogel was fabricated by chemically crosslinking alpha-elastin with glutaraldehyde at high pressure CO(2).">
            <entity id="DS.d1562.s0.e0" origId="P11547" charOffset="59-66" type="protein" text="elastin"/>
            <entity id="DS.d1562.s0.e1" origId="3485" charOffset="72-86" type="compound" text="glutaraldehyde"/>
            <pair e1="DS.d1562.s0.e1" e2="DS.d1562.s0.e0" id="DS.d1562.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1563" origId="18842335">
        <sentence id="DS.d1563.s0" origId="18842335-233" text="We evaluated whether inhibition of heat shock protein 90 (hsp90) function by novobiocin derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.">
            <entity id="DS.d1563.s0.e0" origId="O44001,O61998,P24724,P40292,Q18688,Q4UDU8,Q61W58,Q69QQ6" charOffset="35-56" type="protein" text="heat shock protein 90"/>
            <entity id="DS.d1563.s0.e1" origId="P40292,P41887,Q90474" charOffset="58-63" type="protein" text="hsp90"/>
            <entity id="DS.d1563.s0.e2" origId="54675769" charOffset="77-87" type="compound" text="novobiocin"/>
            <pair e1="DS.d1563.s0.e2" e2="DS.d1563.s0.e0" id="DS.d1563.s0.i0" interaction="True"/>
            <pair e1="DS.d1563.s0.e2" e2="DS.d1563.s0.e1" id="DS.d1563.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1564" origId="18842348">
        <sentence id="DS.d1564.s0" origId="18842348-234" text="The cancer cells could find an alternate pathway to make this protein that does not require progesterone secretion, or the cancer cells may actually utilize progesterone and thus make PIBF in a similar fashion to normal pregnancy.">
            <entity id="DS.d1564.s0.e0" origId="5994" charOffset="92-104" type="compound" text="progesterone"/>
            <entity id="DS.d1564.s0.e1" origId="Q8WXW3" charOffset="184-188" type="protein" text="PIBF"/>
            <pair e1="DS.d1564.s0.e0" e2="DS.d1564.s0.e1" id="DS.d1564.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1565" origId="18842620">
        <sentence id="DS.d1565.s0" origId="18842620-268" text="Cytochrome P450 (CYP) 1A1 and CYP1B1 are inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) in the human breast cancer cell line, MCF-7.">
            <entity id="DS.d1565.s0.e0" origId="O08469" charOffset="0-15" type="protein" text="Cytochrome P450"/>
            <entity id="DS.d1565.s0.e1" origId="P21568,P21569,P24525,P34887,Q26551" charOffset="17-20" type="protein" text="CYP"/>
            <entity id="DS.d1565.s0.e2" origId="Q16678" charOffset="30-36" type="protein" text="CYP1B1"/>
            <entity id="DS.d1565.s0.e3" origId="15625" charOffset="54-89" type="compound" text="2,3,7,8-tetrachlorodibenzo-p-dioxin"/>
            <pair e1="DS.d1565.s0.e3" e2="DS.d1565.s0.e2" id="DS.d1565.s0.i0" interaction="True"/>
            <pair e1="DS.d1565.s0.e3" e2="DS.d1565.s0.e1" id="DS.d1565.s0.i4" interaction="True"/>
            <pair e1="DS.d1565.s0.e3" e2="DS.d1565.s0.e0" id="DS.d1565.s0.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d1565.s1" origId="18842620-269" text="Dioxin treatment leads to recruitment of the aryl hydrocarbon receptor to the enhancer regions but not to the proximal promoter regions of both the CYP1A1 and CYP1B1 genes.">
            <entity id="DS.d1565.s1.e0" origId="15625" charOffset="0-6" type="compound" text="Dioxin"/>
            <entity id="DS.d1565.s1.e1" origId="O02747" charOffset="45-70" type="protein" text="aryl hydrocarbon receptor"/>
            <entity id="DS.d1565.s1.e2" origId="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64" charOffset="148-154" type="protein" text="CYP1A1"/>
            <entity id="DS.d1565.s1.e3" origId="Q16678" charOffset="159-165" type="protein" text="CYP1B1"/>
            <pair e1="DS.d1565.s1.e0" e2="DS.d1565.s1.e2" id="DS.d1565.s1.i0" interaction="False"/>
            <pair e1="DS.d1565.s1.e0" e2="DS.d1565.s1.e3" id="DS.d1565.s1.i1" interaction="False"/>
            <pair e1="DS.d1565.s1.e0" e2="DS.d1565.s1.e1" id="DS.d1565.s1.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d1565.s2" origId="18842620-270" text="These results suggest that nucleosomal remodeling is less significant for dioxin-mediated induction of CYP1B1 than that of CYP1A1 and may be related to the more modest inducibility of the former.">
            <entity id="DS.d1565.s2.e0" origId="15625" charOffset="74-80" type="compound" text="dioxin"/>
            <entity id="DS.d1565.s2.e1" origId="Q16678" charOffset="103-109" type="protein" text="CYP1B1"/>
            <entity id="DS.d1565.s2.e2" origId="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64" charOffset="123-129" type="protein" text="CYP1A1"/>
            <pair e1="DS.d1565.s2.e0" e2="DS.d1565.s2.e1" id="DS.d1565.s2.i0" interaction="True"/>
            <pair e1="DS.d1565.s2.e0" e2="DS.d1565.s2.e2" id="DS.d1565.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1565.s3" origId="18842620-271" text="These observations provide novel insights into the functional roles of the endogenous coactivators in dioxin induction of the human CYP1A1 and CYP1B1 genes in their natural chromosomal configurations.">
            <entity id="DS.d1565.s3.e0" origId="15625" charOffset="102-108" type="compound" text="dioxin"/>
            <entity id="DS.d1565.s3.e1" origId="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64" charOffset="132-138" type="protein" text="CYP1A1"/>
            <entity id="DS.d1565.s3.e2" origId="Q16678" charOffset="143-149" type="protein" text="CYP1B1"/>
            <pair e1="DS.d1565.s3.e0" e2="DS.d1565.s3.e2" id="DS.d1565.s3.i0" interaction="True"/>
            <pair e1="DS.d1565.s3.e0" e2="DS.d1565.s3.e1" id="DS.d1565.s3.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1566" origId="18842703">
        <sentence id="DS.d1566.s0" origId="18842703-297" text="Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.">
            <entity id="DS.d1566.s0.e0" origId="2909,5280754,5284373,5497195,6435893,49867938" charOffset="29-43" type="compound" text="cyclosporine A"/>
            <entity id="DS.d1566.s0.e1" origId="P08163" charOffset="125-137" type="protein" text="glycoprotein"/>
            <pair e1="DS.d1566.s0.e0" e2="DS.d1566.s0.e1" id="DS.d1566.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1567" origId="18842954">
        <sentence id="DS.d1567.s0" origId="18842954-373" text="The different mechanisms might be explained by the different sensitivity of synaptotagmin isoforms to Ca2+, Sr2+, and Ba2+.">
            <entity id="DS.d1567.s0.e0" origId="P21521" charOffset="76-89" type="protein" text="synaptotagmin"/>
            <entity id="DS.d1567.s0.e1" origId="104798" charOffset="108-111" type="compound" text="Sr2"/>
            <pair e1="DS.d1567.s0.e1" e2="DS.d1567.s0.e0" id="DS.d1567.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1568" origId="18842962">
        <sentence id="DS.d1568.s0" origId="18842962-374" text="Each residue was modified with one to three hexose units, and the most dominant SodC glycoform was modified with nine hexose units.">
            <entity id="DS.d1568.s0.e0" origId="206,439357" charOffset="44-50" type="compound" text="hexose"/>
            <entity id="DS.d1568.s0.e1" origId="O68901,P00446,P0A608,P0A609,P0AGD1,P0AGD2,P15453,P20379,P24702,P25841,P25842,P53636,P57005,P66826,P66827,P69049,Q12548,Q51853,Q59081,Q59448,Q59452,Q59623,Q59689,Q5ZT17,Q877B5,Q8X1S6,Q9AGW2,Q9CBI6,Q9RU48,Q9Y8D9" charOffset="80-84" type="protein" text="SodC"/>
            <entity id="DS.d1568.s0.e2" origId="206,439357" charOffset="118-124" type="compound" text="hexose"/>
            <pair e1="DS.d1568.s0.e0" e2="DS.d1568.s0.e1" id="DS.d1568.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1569" origId="18843259">
        <sentence id="DS.d1569.s0" origId="18843259-489" text="Following dDAVP there was a time-dependent redistribution of total aquaporin-2 from predominantly intracellular vesicles to the apical plasma membrane, clathrin-coated vesicles, early endosomal compartments, and lysosomes.">
            <entity id="DS.d1569.s0.e0" origId="27991" charOffset="10-15" type="compound" text="dDAVP"/>
            <entity id="DS.d1569.s0.e1" origId="O62735,O77697,O77714,O77722,O77740,O93938,P34080,P41181,P56402,P79099,P79144,P79164,P79165,P79168,P79200,P79213,P79229,P79803" charOffset="67-78" type="protein" text="aquaporin-2"/>
            <pair e1="DS.d1569.s0.e0" e2="DS.d1569.s0.e1" id="DS.d1569.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1570" origId="18843273">
        <sentence id="DS.d1570.s0" origId="18843273-456" text="The relationships among obesity, metabolic syndrome, ED, sex hormone-binding globulin (SHBG) and serum total and free testosterone levels are complex and often confusing to the physician.">
            <entity id="DS.d1570.s0.e0" origId="P04278,P08689,P15196,P97497,Q62588" charOffset="87-91" type="protein" text="SHBG"/>
            <entity id="DS.d1570.s0.e1" origId="6013" charOffset="118-130" type="compound" text="testosterone"/>
            <pair e1="DS.d1570.s0.e1" e2="DS.d1570.s0.e0" id="DS.d1570.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1571" origId="18843482">
        <sentence id="DS.d1571.s0" origId="18843482-535" text="The transcription factors Nur77 and retinoid X receptors participate in amphetamine-induced locomotor activities.">
            <entity id="DS.d1571.s0.e0" origId="P12813" charOffset="26-31" type="protein" text="Nur77"/>
            <entity id="DS.d1571.s0.e1" origId="3007,5826,32893" charOffset="72-83" type="compound" text="amphetamine"/>
            <pair e1="DS.d1571.s0.e1" e2="DS.d1571.s0.e0" id="DS.d1571.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1573" origId="18844213">
        <sentence id="DS.d1573.s0" origId="18844213-796" text="We now show that treatment of cells with phosphomimic uPA (uPA138E/303E, serine 138 and 303 substituted with glutamic acid) strongly inhibits matrix-induced cell migration.">
            <entity id="DS.d1573.s0.e0" origId="P00749,P04185,P06869,P15120,P16227,P29598,Q05589" charOffset="54-57" type="protein" text="uPA"/>
            <entity id="DS.d1573.s0.e1" origId="5951" charOffset="73-79" type="compound" text="serine"/>
            <pair e1="DS.d1573.s0.e1" e2="DS.d1573.s0.e0" id="DS.d1573.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1574" origId="18844219">
        <sentence id="DS.d1574.s0" origId="18844219-799" text="When cells were subjected to hypoxia (1% O2), the expression of HSP70-2 had a significant increase in cancer cells.">
            <entity id="DS.d1574.s0.e0" origId="977,5359597" charOffset="41-43" type="compound" text="O2"/>
            <entity id="DS.d1574.s0.e1" origId="P12794,P22358,P22954,P50021,Q27965,Q47XI6,Q5E3A7,Q5N1J4,Q6LS31,Q7U3C4,Q7UZG3,Q7V3T5,Q7V9G2,Q826F6,Q8DI58,Q8YW74" charOffset="64-71" type="protein" text="HSP70-2"/>
            <pair e1="DS.d1574.s0.e0" e2="DS.d1574.s0.e1" id="DS.d1574.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1575" origId="18844235">
        <sentence id="DS.d1575.s0" origId="18844235-806" text="We further demonstrate that loss of actin stress fibers is due to a cyclic adenosine monophosphate, protein kinase A-mediated pathway that results in Rho inhibition.">
            <entity id="DS.d1575.s0.e0" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="36-41" type="protein" text="actin"/>
            <entity id="DS.d1575.s0.e1" origId="188955" charOffset="68-98" type="compound" text="cyclic adenosine monophosphate"/>
            <entity id="DS.d1575.s0.e2" origId="Q05608,Q9RI12" charOffset="100-116" type="protein" text="protein kinase A"/>
            <entity id="DS.d1575.s0.e3" origId="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9" charOffset="150-153" type="protein" text="Rho"/>
            <pair e1="DS.d1575.s0.e1" e2="DS.d1575.s0.e0" id="DS.d1575.s0.i0" interaction="True"/>
            <pair e1="DS.d1575.s0.e1" e2="DS.d1575.s0.e2" id="DS.d1575.s0.i1" interaction="True"/>
            <pair e1="DS.d1575.s0.e1" e2="DS.d1575.s0.e3" id="DS.d1575.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1576" origId="18844240">
        <sentence id="DS.d1576.s0" origId="18844240-810" text="The nuclear NF-kappaB p65 expression after treatment with the SFN-5-Fu combination was also evaluated by western blot analysis.">
            <entity id="DS.d1576.s0.e0" origId="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3" charOffset="22-25" type="protein" text="p65"/>
            <entity id="DS.d1576.s0.e1" origId="3385" charOffset="66-70" type="compound" text="5-Fu"/>
            <pair e1="DS.d1576.s0.e1" e2="DS.d1576.s0.e0" id="DS.d1576.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1576.s1" origId="18844240-812" text="Treatment ACCs cells with SFN and 5-Fu in combination, led to synergistic inhibition on cell growth and a decreased expression in nuclear NF-kappaB p65 protein.">
            <entity id="DS.d1576.s1.e0" origId="3385" charOffset="34-38" type="compound" text="5-Fu"/>
            <entity id="DS.d1576.s1.e1" origId="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3" charOffset="148-151" type="protein" text="p65"/>
            <pair e1="DS.d1576.s1.e0" e2="DS.d1576.s1.e1" id="DS.d1576.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1576.s2" origId="18844240-813" text="Our results demonstrate synergism between SFN and 5-Fu at higher doses against the ACC-M and ACC-2 cells, which was associated with the decreased expression of nuclear NF-kappaB p65 protein.">
            <entity id="DS.d1576.s2.e0" origId="3385" charOffset="50-54" type="compound" text="5-Fu"/>
            <entity id="DS.d1576.s2.e1" origId="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3" charOffset="178-181" type="protein" text="p65"/>
            <pair e1="DS.d1576.s2.e0" e2="DS.d1576.s2.e1" id="DS.d1576.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1577" origId="18844290">
        <sentence id="DS.d1577.s0" origId="18844290-828" text="In order to further analyse the protective mode of action, the superoxide anion scavenging activity of two extracts was evaluated in a xanthine/xanthine oxidase system.">
            <entity id="DS.d1577.s0.e0" origId="5359597" charOffset="63-73" type="compound" text="superoxide"/>
            <entity id="DS.d1577.s0.e1" origId="1188" charOffset="135-143" type="compound" text="xanthine"/>
            <entity id="DS.d1577.s0.e2" origId="P22985,P47989,P47990,P80457,Q00519,Q9MYW6" charOffset="144-160" type="protein" text="xanthine oxidase"/>
            <pair e1="DS.d1577.s0.e1" e2="DS.d1577.s0.e2" id="DS.d1577.s0.i0" interaction="True"/>
            <pair e1="DS.d1577.s0.e0" e2="DS.d1577.s0.e2" id="DS.d1577.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1578" origId="18844296">
        <sentence id="DS.d1578.s0" origId="18844296-833" text="Human genetic diseases that affect N-glycosylation result from the defective synthesis of the N-linked sugar moiety (glycan) of glycoproteins.">
            <entity id="DS.d1578.s0.e0" origId="871" charOffset="117-123" type="compound" text="glycan"/>
            <entity id="DS.d1578.s0.e1" origId="P08163" charOffset="128-141" type="protein" text="glycoproteins"/>
            <pair e1="DS.d1578.s0.e0" e2="DS.d1578.s0.e1" id="DS.d1578.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1579" origId="18844325">
        <sentence id="DS.d1579.s0" origId="18844325-840" text="Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, glutathione peroxidase, glutathione-S-transferase and reduced glutathione).">
            <entity id="DS.d1579.s0.e0" origId="O50258" charOffset="249-269" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1579.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="271-279" type="protein" text="catalase"/>
            <entity id="DS.d1579.s0.e2" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="281-303" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d1579.s0.e3" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="305-330" type="protein" text="glutathione-S-transferase"/>
            <entity id="DS.d1579.s0.e4" origId="124886" charOffset="335-354" type="compound" text="reduced glutathione"/>
            <pair e1="DS.d1579.s0.e4" e2="DS.d1579.s0.e0" id="DS.d1579.s0.i0" interaction="False"/>
            <pair e1="DS.d1579.s0.e4" e2="DS.d1579.s0.e3" id="DS.d1579.s0.i1" interaction="False"/>
            <pair e1="DS.d1579.s0.e4" e2="DS.d1579.s0.e1" id="DS.d1579.s0.i2" interaction="False"/>
            <pair e1="DS.d1579.s0.e4" e2="DS.d1579.s0.e2" id="DS.d1579.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1580" origId="18844326">
        <sentence id="DS.d1580.s0" origId="18844326-841" text="Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways.">
            <entity id="DS.d1580.s0.e0" origId="9918693,12901617,44202122,45479443" charOffset="22-37" type="compound" text="ginsenoside Rg3"/>
            <entity id="DS.d1580.s0.e1" origId="P54646,Q09136,Q9Y478" charOffset="51-55" type="protein" text="AMPK"/>
            <entity id="DS.d1580.s0.e2" origId="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4" charOffset="60-70" type="protein" text="PPAR-gamma"/>
            <pair e1="DS.d1580.s0.e0" e2="DS.d1580.s0.e1" id="DS.d1580.s0.i0" interaction="True"/>
            <pair e1="DS.d1580.s0.e0" e2="DS.d1580.s0.e2" id="DS.d1580.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1580.s1" origId="18844326-842" text="This inhibitory effect of ginsenoside Rg3 on adipocyte differentiation was accompanied by PPAR-gamma inhibition in rosiglitazone-treated cells.">
            <entity id="DS.d1580.s1.e0" origId="9918693,12901617,44202122,45479443" charOffset="26-41" type="compound" text="ginsenoside Rg3"/>
            <entity id="DS.d1580.s1.e1" origId="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4" charOffset="90-100" type="protein" text="PPAR-gamma"/>
            <pair e1="DS.d1580.s1.e0" e2="DS.d1580.s1.e1" id="DS.d1580.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1580.s2" origId="18844326-843" text="Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, ginsenoside Rg3, involves the AMPK signaling pathway and PPAR-gamma inhibition.">
            <entity id="DS.d1580.s2.e0" origId="9918693,12901617,44202122,45479443" charOffset="99-114" type="compound" text="ginsenoside Rg3"/>
            <entity id="DS.d1580.s2.e1" origId="P54646,Q09136,Q9Y478" charOffset="129-133" type="protein" text="AMPK"/>
            <entity id="DS.d1580.s2.e2" origId="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4" charOffset="156-166" type="protein" text="PPAR-gamma"/>
            <pair e1="DS.d1580.s2.e0" e2="DS.d1580.s2.e1" id="DS.d1580.s2.i0" interaction="True"/>
            <pair e1="DS.d1580.s2.e0" e2="DS.d1580.s2.e2" id="DS.d1580.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1581" origId="18845121">
        <sentence id="DS.d1581.s0" origId="18845121-1115" text="They can be oxidized by semicarbazide-sensitive amine oxidase (SSAO), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as hydrogen peroxide and ammonia.">
            <entity id="DS.d1581.s0.e0" origId="O08590,O70423,Q16853,Q5R9I0,Q9TTK6" charOffset="24-61" type="protein" text="semicarbazide-sensitive amine oxidase"/>
            <entity id="DS.d1581.s0.e1" origId="O08590,O70423,Q16853,Q5R9I0,Q9TTK6" charOffset="63-67" type="protein" text="SSAO"/>
            <entity id="DS.d1581.s0.e2" origId="712" charOffset="123-135" type="compound" text="formaldehyde"/>
            <entity id="DS.d1581.s0.e3" origId="880" charOffset="140-153" type="compound" text="methylglyoxal"/>
            <entity id="DS.d1581.s0.e4" origId="784" charOffset="165-182" type="compound" text="hydrogen peroxide"/>
            <entity id="DS.d1581.s0.e5" origId="222" charOffset="187-194" type="compound" text="ammonia"/>
            <pair e1="DS.d1581.s0.e3" e2="DS.d1581.s0.e0" id="DS.d1581.s0.i0" interaction="True"/>
            <pair e1="DS.d1581.s0.e4" e2="DS.d1581.s0.e0" id="DS.d1581.s0.i1" interaction="True"/>
            <pair e1="DS.d1581.s0.e5" e2="DS.d1581.s0.e0" id="DS.d1581.s0.i2" interaction="True"/>
            <pair e1="DS.d1581.s0.e2" e2="DS.d1581.s0.e0" id="DS.d1581.s0.i3" interaction="True"/>
            <pair e1="DS.d1581.s0.e4" e2="DS.d1581.s0.e1" id="DS.d1581.s0.i4" interaction="True"/>
            <pair e1="DS.d1581.s0.e2" e2="DS.d1581.s0.e1" id="DS.d1581.s0.i5" interaction="True"/>
            <pair e1="DS.d1581.s0.e3" e2="DS.d1581.s0.e1" id="DS.d1581.s0.i6" interaction="True"/>
            <pair e1="DS.d1581.s0.e5" e2="DS.d1581.s0.e1" id="DS.d1581.s0.i7" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1582" origId="18845132">
        <sentence id="DS.d1582.s0" origId="18845132-1120" text="Selenocystine is taken up well by the b(0,+) rBAT system, while selenobetaine is a low-affinity substrate only for SIT1 and PAT1.">
            <entity id="DS.d1582.s0.e0" origId="152157" charOffset="64-77" type="compound" text="selenobetaine"/>
            <entity id="DS.d1582.s0.e1" origId="P39980,Q9Y3P8" charOffset="115-119" type="protein" text="SIT1"/>
            <entity id="DS.d1582.s0.e2" origId="P25644,P34230,P43577,Q02166,Q6L8K7,Q7Z2H8,Q92624" charOffset="124-128" type="protein" text="PAT1"/>
            <pair e1="DS.d1582.s0.e0" e2="DS.d1582.s0.e1" id="DS.d1582.s0.i0" interaction="True"/>
            <pair e1="DS.d1582.s0.e0" e2="DS.d1582.s0.e2" id="DS.d1582.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1583" origId="18845148">
        <sentence id="DS.d1583.s0" origId="18845148-1121" text="Experiments using a classical inhibitor of phosphotyrosine phosphatase, sodium orthovanadate, also showed that the ecto-phosphatase activity was inhibited in a dose-dependent manner.">
            <entity id="DS.d1583.s0.e0" origId="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7" charOffset="59-70" type="protein" text="phosphatase"/>
            <entity id="DS.d1583.s0.e1" origId="61671" charOffset="72-92" type="compound" text="sodium orthovanadate"/>
            <entity id="DS.d1583.s0.e2" origId="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7" charOffset="120-131" type="protein" text="phosphatase"/>
            <pair e1="DS.d1583.s0.e1" e2="DS.d1583.s0.e0" id="DS.d1583.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1584" origId="18845237">
        <sentence id="DS.d1584.s1" origId="18845237-1145" text="Both promoters are partially regulated by all-trans retinoic acid via RARA and other RARs.">
            <entity id="DS.d1584.s1.e0" origId="444795" charOffset="42-65" type="compound" text="all-trans retinoic acid"/>
            <entity id="DS.d1584.s1.e1" origId="P10276,P18514,Q5FBR4,Q90966,Q9W5Z3" charOffset="70-74" type="protein" text="RARA"/>
            <pair e1="DS.d1584.s1.e0" e2="DS.d1584.s1.e1" id="DS.d1584.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1585" origId="18845277">
        <sentence id="DS.d1585.s0" origId="18845277-1178" text="Our data suggest a developmental role of PBRs in erythropoiesis in chickens, possibly via the regulation of heme availability for the assembly of functional hemoglobins.">
            <entity id="DS.d1585.s0.e0" origId="P16257,P30535,P30536,P50637" charOffset="41-45" type="protein" text="PBRs"/>
            <entity id="DS.d1585.s0.e1" origId="4971" charOffset="108-112" type="compound" text="heme"/>
            <entity id="DS.d1585.s0.e2" origId="P15160,P17724,P73925,Q03459" charOffset="157-168" type="protein" text="hemoglobins"/>
            <pair e1="DS.d1585.s0.e1" e2="DS.d1585.s0.e2" id="DS.d1585.s0.i0" interaction="True"/>
            <pair e1="DS.d1585.s0.e1" e2="DS.d1585.s0.e0" id="DS.d1585.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1586" origId="18845302">
        <sentence id="DS.d1586.s0" origId="18845302-1193" text="Circulating apelin, adiponectin, leptin, TNF-alpha, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.">
            <entity id="DS.d1586.s0.e0" origId="56841713" charOffset="12-18" type="compound" text="apelin"/>
            <entity id="DS.d1586.s0.e1" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="33-39" type="protein" text="leptin"/>
            <entity id="DS.d1586.s0.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="41-50" type="protein" text="TNF-alpha"/>
            <entity id="DS.d1586.s0.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="62-69" type="protein" text="insulin"/>
            <pair e1="DS.d1586.s0.e0" e2="DS.d1586.s0.e2" id="DS.d1586.s0.i0" interaction="False"/>
            <pair e1="DS.d1586.s0.e0" e2="DS.d1586.s0.e3" id="DS.d1586.s0.i1" interaction="False"/>
            <pair e1="DS.d1586.s0.e0" e2="DS.d1586.s0.e1" id="DS.d1586.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1587" origId="18845357">
        <sentence id="DS.d1587.s0" origId="18845357-1202" text="VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.">
            <entity id="DS.d1587.s0.e0" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="0-4" type="protein" text="VEGF"/>
            <entity id="DS.d1587.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="6-15" type="protein" text="TNF-alpha"/>
            <entity id="DS.d1587.s0.e2" origId="107873" charOffset="20-33" type="compound" text="8-isoprostane"/>
            <pair e1="DS.d1587.s0.e2" e2="DS.d1587.s0.e1" id="DS.d1587.s0.i0" interaction="False"/>
            <pair e1="DS.d1587.s0.e2" e2="DS.d1587.s0.e0" id="DS.d1587.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1587.s1" origId="18845357-1203" text="The aim of the present study was to evaluate the levels of VEGF, 8-isoprostane and TNF-alpha in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible diagnostic role.">
            <entity id="DS.d1587.s1.e0" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="59-63" type="protein" text="VEGF"/>
            <entity id="DS.d1587.s1.e1" origId="107873" charOffset="65-78" type="compound" text="8-isoprostane"/>
            <entity id="DS.d1587.s1.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="83-92" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d1587.s1.e1" e2="DS.d1587.s1.e2" id="DS.d1587.s1.i0" interaction="False"/>
            <pair e1="DS.d1587.s1.e1" e2="DS.d1587.s1.e0" id="DS.d1587.s1.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1587.s2" origId="18845357-1204" text="Furthermore, associations between VEGF, 8-isoprostane and TNF-alpha levels in EBC and serum with clinicopathologic factors were investigated.">
            <entity id="DS.d1587.s2.e0" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="34-38" type="protein" text="VEGF"/>
            <entity id="DS.d1587.s2.e1" origId="107873" charOffset="40-53" type="compound" text="8-isoprostane"/>
            <entity id="DS.d1587.s2.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="58-67" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d1587.s2.e1" e2="DS.d1587.s2.e2" id="DS.d1587.s2.i0" interaction="False"/>
            <pair e1="DS.d1587.s2.e1" e2="DS.d1587.s2.e0" id="DS.d1587.s2.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1587.s3" origId="18845357-1205" text="TNF-alpha, VEGF and 8-isoprostane levels in EBC and serum were analyzed by an immunoenzymatic method (ELISA).">
            <entity id="DS.d1587.s3.e0" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="0-9" type="protein" text="TNF-alpha"/>
            <entity id="DS.d1587.s3.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="11-15" type="protein" text="VEGF"/>
            <entity id="DS.d1587.s3.e2" origId="107873" charOffset="20-33" type="compound" text="8-isoprostane"/>
            <pair e1="DS.d1587.s3.e2" e2="DS.d1587.s3.e0" id="DS.d1587.s3.i0" interaction="False"/>
            <pair e1="DS.d1587.s3.e2" e2="DS.d1587.s3.e1" id="DS.d1587.s3.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1588" origId="18845383">
        <sentence id="DS.d1588.s0" origId="18845383-1219" text="Currently, adreno-corticotrophic hormone (ACTH), steroids and vigabatrin (VGB) form the mainstay of its treatment.">
            <entity id="DS.d1588.s0.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="42-46" type="protein" text="ACTH"/>
            <entity id="DS.d1588.s0.e1" origId="5665" charOffset="62-72" type="compound" text="vigabatrin"/>
            <pair e1="DS.d1588.s0.e1" e2="DS.d1588.s0.e0" id="DS.d1588.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1589" origId="18845389">
        <sentence id="DS.d1589.s0" origId="18845389-1221" text="The addition of a protein kinase C (PKC) activator, phorbol 12-myristate 13-acetate, rescued PhIP-inhibited TNF-alpha expression in LTA-stimulated cells.">
            <entity id="DS.d1589.s0.e1" origId="4792,27924,122634,22833501" charOffset="52-83" type="compound" text="phorbol 12-myristate 13-acetate"/>
            <entity id="DS.d1589.s0.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="108-117" type="protein" text="TNF-alpha"/>
            <pair e1="DS.d1589.s0.e1" e2="DS.d1589.s0.e2" id="DS.d1589.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1590" origId="18845486">
        <sentence id="DS.d1590.s0" origId="18845486-1248" text="Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood glucose level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.">
            <entity id="DS.d1590.s0.e0" origId="206,5793,64689,79025" charOffset="95-102" type="compound" text="glucose"/>
            <entity id="DS.d1590.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="128-135" type="protein" text="insulin"/>
            <entity id="DS.d1590.s0.e2" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="203-212" type="protein" text="TNF-alpha"/>
            <entity id="DS.d1590.s0.e3" origId="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9" charOffset="214-223" type="protein" text="IFN-gamma"/>
            <entity id="DS.d1590.s0.e4" origId="Q16552,Q60I29,Q61453,Q62386,Q687Y7" charOffset="225-230" type="protein" text="IL-17"/>
            <entity id="DS.d1590.s0.e5" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="236-240" type="protein" text="iNOS"/>
            <pair e1="DS.d1590.s0.e0" e2="DS.d1590.s0.e2" id="DS.d1590.s0.i0" interaction="False"/>
            <pair e1="DS.d1590.s0.e0" e2="DS.d1590.s0.e1" id="DS.d1590.s0.i1" interaction="False"/>
            <pair e1="DS.d1590.s0.e0" e2="DS.d1590.s0.e4" id="DS.d1590.s0.i2" interaction="False"/>
            <pair e1="DS.d1590.s0.e0" e2="DS.d1590.s0.e5" id="DS.d1590.s0.i3" interaction="False"/>
            <pair e1="DS.d1590.s0.e0" e2="DS.d1590.s0.e3" id="DS.d1590.s0.i4" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1591" origId="18845629">
        <sentence id="DS.d1591.s0" origId="18845629-1303" text="They secreted insulin in response to glucose and could correct hyperglycemia in vivo when cotransplanted with vascular cells.">
            <entity id="DS.d1591.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="14-21" type="protein" text="insulin"/>
            <entity id="DS.d1591.s0.e1" origId="206,5793,64689,79025" charOffset="37-44" type="compound" text="glucose"/>
            <pair e1="DS.d1591.s0.e1" e2="DS.d1591.s0.e0" id="DS.d1591.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1592" origId="18845633">
        <sentence id="DS.d1592.s0" origId="18845633-1305" text="This action was mimicked solely by 100 nm CH-275, a selective agonist at the somatostatin type 1 receptor (SSTR1), but not by 100 nm BIM-23027, L-362855, or NNC-269100 ; agonists selective for the other four SSTRs known to exist in MIN6.">
            <entity id="DS.d1592.s0.e0" origId="P30872" charOffset="107-112" type="protein" text="SSTR1"/>
            <entity id="DS.d1592.s0.e1" origId="5311371" charOffset="157-167" type="compound" text="NNC-269100"/>
            <pair e1="DS.d1592.s0.e1" e2="DS.d1592.s0.e0" id="DS.d1592.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1593" origId="18845634">
        <sentence id="DS.d1593.s0" origId="18845634-1306" text="A functional leptin system is essential for sodium tungstate antiobesity action.">
            <entity id="DS.d1593.s0.e0" origId="O02750,O93416,Q28603,Q95189,Q95234" charOffset="13-19" type="protein" text="leptin"/>
            <entity id="DS.d1593.s0.e1" origId="26052" charOffset="44-60" type="compound" text="sodium tungstate"/>
            <pair e1="DS.d1593.s0.e1" e2="DS.d1593.s0.e0" id="DS.d1593.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1594" origId="18845638">
        <sentence id="DS.d1594.s0" origId="18845638-1311" text="Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice.">
            <entity id="DS.d1594.s0.e0" origId="5757" charOffset="135-144" type="compound" text="estradiol"/>
            <entity id="DS.d1594.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="156-163" type="protein" text="insulin"/>
            <pair e1="DS.d1594.s0.e0" e2="DS.d1594.s0.e1" id="DS.d1594.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1595" origId="18845639">
        <sentence id="DS.d1595.s0" origId="18845639-1312" text="The aim of this study was to assess in rats the effect of protein feeding on the: 1) distribution of endogenous glucose production (EGP) among gluconeogenic organs, and 2) repercussion on the insulin sensitivity of glucose metabolism.">
            <entity id="DS.d1595.s0.e0" origId="206,5793,64689,79025" charOffset="112-119" type="compound" text="glucose"/>
            <entity id="DS.d1595.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="192-199" type="protein" text="insulin"/>
            <pair e1="DS.d1595.s0.e0" e2="DS.d1595.s0.e1" id="DS.d1595.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1596" origId="18845640">
        <sentence id="DS.d1596.s0" origId="18845640-1315" text="Transcription of steroidogenic acute regulatory protein in the rodent ovary and placenta: alternative modes of cyclic adenosine 3', 5'-monophosphate dependent and independent regulation.">
            <entity id="DS.d1596.s0.e0" origId="P58864,Q9DG08" charOffset="17-55" type="protein" text="steroidogenic acute regulatory protein"/>
            <entity id="DS.d1596.s0.e1" origId="6076" charOffset="111-148" type="compound" text="cyclic adenosine 3', 5'-monophosphate"/>
            <pair e1="DS.d1596.s0.e1" e2="DS.d1596.s0.e0" id="DS.d1596.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1596.s1" origId="18845640-1316" text="The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, pregnenolone, by the cholesterol side-chain cleavage cytochrome P450 (CYP11A1) enzyme complex takes place in the inner mitochondrial membranes.">
            <entity id="DS.d1596.s1.e0" origId="8955" charOffset="113-125" type="compound" text="pregnenolone"/>
            <entity id="DS.d1596.s1.e1" origId="O08469" charOffset="166-181" type="protein" text="cytochrome P450"/>
            <entity id="DS.d1596.s1.e2" origId="O46515,P00189,P05108,P10612,P79153,P79202,Q07217,Q28827,Q2XV99,Q92045,Q9EPT4" charOffset="183-190" type="protein" text="CYP11A1"/>
            <pair e1="DS.d1596.s1.e0" e2="DS.d1596.s1.e2" id="DS.d1596.s1.i0" interaction="True"/>
            <pair e1="DS.d1596.s1.e0" e2="DS.d1596.s1.e1" id="DS.d1596.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1597" origId="18845643">
        <sentence id="DS.d1597.s0" origId="18845643-1319" text="Collectively, these studies identify a novel role for 1,25-dihydroxyvitamin D (3) and the VDR in the control of adipocyte metabolism and lipid storage in vivo.">
            <entity id="DS.d1597.s0.e0" origId="5280453" charOffset="54-77" type="compound" text="1,25-dihydroxyvitamin D"/>
            <entity id="DS.d1597.s0.e1" origId="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5" charOffset="90-93" type="protein" text="VDR"/>
            <pair e1="DS.d1597.s0.e0" e2="DS.d1597.s0.e1" id="DS.d1597.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1598" origId="18845645">
        <sentence id="DS.d1598.s0" origId="18845645-1323" text="Direct mineralocorticoid receptor (MR) activation with deoxycorticosterone acetate has deleterious effects on the cerebral vasculature.">
            <entity id="DS.d1598.s0.e0" origId="P08235,P22199,P79404,Q29131,Q3YC04,Q4JM28,Q8QHI2,Q8VII8,Q91573,Q9BDJ7,Q9IAC6,Q9N0W8" charOffset="7-33" type="protein" text="mineralocorticoid receptor"/>
            <entity id="DS.d1598.s0.e1" origId="5952" charOffset="55-82" type="compound" text="deoxycorticosterone acetate"/>
            <pair e1="DS.d1598.s0.e1" e2="DS.d1598.s0.e0" id="DS.d1598.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1598.s1" origId="18845645-1325" text="Therefore, we hypothesized that systemic 11betaHSD2 inhibition with carbenoxolone (CBX) would cause remodeling of the middle cerebral artery (MCA) and increase the damage caused by cerebral ischemia.">
            <entity id="DS.d1598.s1.e0" origId="O77667,P50168,P50233,P51661,P51976,P80365" charOffset="41-51" type="protein" text="11betaHSD2"/>
            <entity id="DS.d1598.s1.e1" origId="21913,636403,5311038" charOffset="68-81" type="compound" text="carbenoxolone"/>
            <pair e1="DS.d1598.s1.e1" e2="DS.d1598.s1.e0" id="DS.d1598.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1599" origId="18845661">
        <sentence id="DS.d1599.s0" origId="18845661-1336" text="In this study, we attempted to evaluate the effects of ketamine on F-actin and microtubular cytoskeletons in human hepatoma HepG2 cells and its possible molecular mechanisms.">
            <entity id="DS.d1599.s0.e0" origId="3821,182137,644025" charOffset="55-63" type="compound" text="ketamine"/>
            <entity id="DS.d1599.s0.e1" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="69-74" type="protein" text="actin"/>
            <pair e1="DS.d1599.s0.e0" e2="DS.d1599.s0.e1" id="DS.d1599.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1599.s1" origId="18845661-1337" text="Consequently, ketamine-caused cytoskeletal interruption led to suppression of CYP3A4 expression and its metabolizing activity.">
            <entity id="DS.d1599.s1.e0" origId="3821,182137,644025" charOffset="14-22" type="compound" text="ketamine"/>
            <entity id="DS.d1599.s1.e1" origId="P08684" charOffset="78-84" type="protein" text="CYP3A4"/>
            <pair e1="DS.d1599.s1.e0" e2="DS.d1599.s1.e1" id="DS.d1599.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1600" origId="18845662">
        <sentence id="DS.d1600.s0" origId="18845662-1339" text="Because many drug-drug interactions may occur at the level of drug transporting proteins, we studied interactions of diclofenac with apical ATP-binding cassette (ABC) multidrug efflux transporters.">
            <entity id="DS.d1600.s0.e0" origId="3033" charOffset="117-127" type="compound" text="diclofenac"/>
            <entity id="DS.d1600.s0.e1" origId="O31855,O82855,P37340,P45272,P58163,P58164,Q55364,Q57PL1,Q5E4Y6,Q5KZL2,Q5MZD9,Q5NYX9,Q5PH16,Q5QWR6,Q62LW6,Q63DZ4,Q63S57,Q65IG9,Q65SY9,Q66A27,Q6D5W6,Q6FEY7,Q6HLG9,Q6LQ49,Q6NB79,Q71YH0,Q73BB8,Q7MKP8,Q7N1G0,Q7N3V2,Q7NXN3,Q7UAH8,Q7VMB5,Q7WAK9,Q7WJR0,Q7WTR3,Q81G28,Q81T85,Q879Z5,Q88BA2,Q88CB9,Q89AX2,Q89W72,Q8CUL5,Q8D9N8,Q8DPQ6,Q8EES3,Q8FH68,Q8G2I1,Q8P4E6,Q8PG07,Q8UDF5,Q8Y654,Q8YFD7,Q8Z6N7,Q8ZDZ8,Q8ZPP2,Q92AG2,Q92PZ0,Q97QN5,Q98D15,Q9CMZ9,Q9F5N7,Q9HTR0,Q9I3Y3,Q9JV27,Q9K015,Q9KEJ2,Q9KRU4,Q9PA34,Q9RY44,Q9WZS2" charOffset="167-196" type="protein" text="multidrug efflux transporters"/>
            <pair e1="DS.d1600.s0.e0" e2="DS.d1600.s0.e1" id="DS.d1600.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1600.s1" origId="18845662-1341" text="Furthermore, in Sf9-BCRP membrane vesicles diclofenac inhibited transport of methotrexate in a concentration-dependent manner.">
            <entity id="DS.d1600.s1.e0" origId="Q9UNQ0" charOffset="20-24" type="protein" text="BCRP"/>
            <entity id="DS.d1600.s1.e1" origId="3033" charOffset="43-53" type="compound" text="diclofenac"/>
            <pair e1="DS.d1600.s1.e1" e2="DS.d1600.s1.e0" id="DS.d1600.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1601" origId="18845675">
        <sentence id="DS.d1601.s0" origId="18845675-1354" text="To test this hypothesis, we measured the effect of AMT on RyR2 channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator Fura-2 acetoxymethyl ester.">
            <entity id="DS.d1601.s0.e0" origId="P25285,P28337,P48728,Q9TSZ7" charOffset="51-54" type="protein" text="AMT"/>
            <entity id="DS.d1601.s0.e1" origId="P30957,Q92736" charOffset="58-62" type="protein" text="RyR2"/>
            <entity id="DS.d1601.s0.e2" origId="57054" charOffset="172-178" type="compound" text="Fura-2"/>
            <entity id="DS.d1601.s0.e3" origId="53627513" charOffset="179-192" type="compound" text="acetoxymethyl"/>
            <pair e1="DS.d1601.s0.e2" e2="DS.d1601.s0.e0" id="DS.d1601.s0.i0" interaction="False"/>
            <pair e1="DS.d1601.s0.e2" e2="DS.d1601.s0.e1" id="DS.d1601.s0.i1" interaction="False"/>
            <pair e1="DS.d1601.s0.e3" e2="DS.d1601.s0.e0" id="DS.d1601.s0.i2" interaction="False"/>
            <pair e1="DS.d1601.s0.e3" e2="DS.d1601.s0.e1" id="DS.d1601.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1602" origId="18845767">
        <sentence id="DS.d1602.s0" origId="18845767-1393" text="Most cells contain methionine sulfoxide reductases, which catalyze a thioredoxin-dependent reduction of methionine sulfoxide back to methionine.">
            <entity id="DS.d1602.s0.e0" origId="O14463,O17486,O22022,O30974,O51088,O51890,O83889,O84544,O96952,O97508,O97680,P00276,P08058,P08628,P08629,P09857,P0A0K4,P0A0K5,P0A0K6,P0A4L3,P0A4L4,P0A616,P0A617,P10472,P10473,P10599,P10639,P11232,P14930,P14949,P21609,P21610,P29429,P29451,P33791,P34723,P37395,P42115,P43785,P46843,P47370,P50254,P50338,P50413,P51225,P52227,P52230,P52231,P52233,P57653,P59527,P66928,P66929,P75512,P80579,P81108,P81109,P81110,P82460,P96132,P99122,P99505,Q05739,Q57755,Q5HGT9,Q5HQ29,Q5R9M3,Q6GA69,Q6GHU0,Q7KQL8,Q7M1B9,Q8CPL5,Q92JR5,Q98PL5,Q98TX1,Q9BDJ3,Q9CM49,Q9DGI3,Q9JWM8,Q9K1N8,Q9PJK3,Q9R6P9,Q9UW02,Q9X2T1,Q9Z7P5,Q9ZEE0" charOffset="69-80" type="protein" text="thioredoxin"/>
            <entity id="DS.d1602.s0.e1" origId="876,6137" charOffset="19-29" type="compound" text="methionine"/>
            <entity id="DS.d1602.s0.e2" origId="876,6137" charOffset="104-114" type="compound" text="methionine"/>
            <pair e1="DS.d1602.s0.e1" e2="DS.d1602.s0.e0" id="DS.d1602.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1602.s1" origId="18845767-1394" text="The intracellular free methionine and S-adenosylmethionine pools were not altered, nor was the specific activity of the key enzyme, glutamine synthetase.">
            <entity id="DS.d1602.s1.e0" origId="876,6137" charOffset="23-33" type="compound" text="methionine"/>
            <entity id="DS.d1602.s1.e1" origId="34756" charOffset="38-58" type="compound" text="S-adenosylmethionine"/>
            <entity id="DS.d1602.s1.e2" origId="O00088,O04867,O08467,O27612,O29313,O58097,O59648,O66514,P00964,P04773,P07804,P09606,P0A039,P0A040,P0A1P6,P0A1P7,P0A9C5,P0A9C6,P0A9C7,P0A9C8,P10583,P10656,P11600,P12424,P12425,P13499,P15103,P15104,P15105,P15106,P15124,P15623,P16580,P19064,P19904,P20479,P21154,P22248,P23712,P23794,P25821,P28605,P28786,P32288,P33035,P36205,P43386,P43518,P43794,P45627,P46410,P51120,P51121,P60890,P77961,P94126,P94845,P99095,Q04831,Q05650,Q05907,Q06378,Q09179,Q12613,Q4R7U3,Q5HGC3,Q5HPN2,Q60182,Q6B4U7,Q6C3E0,Q6FMT6,Q6G9Q4,Q6GHC6,Q75BT9,Q86ZF9,Q86ZU6,Q874T6,Q8CSR8,Q8HZM5,Q8J1R3,Q8X169,Q96UG9,Q96UV5,Q96V52,Q9C2U9,Q9CDL9,Q9CLP2,Q9HH09,Q9HNI2,Q9HU65,Q9KNJ2,Q9QY94,Q9UUN6,Q9UY99,Q9ZLW5" charOffset="132-152" type="protein" text="glutamine synthetase"/>
            <pair e1="DS.d1602.s1.e1" e2="DS.d1602.s1.e2" id="DS.d1602.s1.i0" interaction="False"/>
            <pair e1="DS.d1602.s1.e0" e2="DS.d1602.s1.e2" id="DS.d1602.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1603" origId="18845781">
        <sentence id="DS.d1603.s0" origId="18845781-1399" text="Activity of muscle citrate synthase and 3-hydroxyacyl-CoA dehydrogenase, as well as maximal oxygen uptake and 10-km performance time, remained unaltered in both groups.">
            <entity id="DS.d1603.s0.e0" origId="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20901,P20902,P20903,P21553,P26491,P27660,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P84543,P94325,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59939,Q59977,Q9RWB2,Q9ZN37" charOffset="19-35" type="protein" text="citrate synthase"/>
            <entity id="DS.d1603.s0.e1" origId="O49809,P07896,P21177,P28793,P51659,P51660,P55100,P77399,P97852,Q08426,Q0TAL0,Q1C2C4,Q1CN99,Q1Q8J9,Q1R466,Q32A21,Q39659,Q3K9D8,Q3YVC1,Q489W3,Q48GW3,Q4FQC6,Q4KFC4,Q4ZRA0,Q57HM6,Q57LW6,Q5E3U1,Q5E8X6,Q5PCX6,Q5PKQ2,Q5QXH7,Q5QXM1,Q668V1,Q66FR8,Q6D2L7,Q6DAP5,Q6FF68,Q6LTK3,Q6LW06,Q7MIS5,Q7MQH9,Q7MZ92,Q7N288,Q83PG1,Q83QQ0,Q87MM3,Q87TN9,Q87ZB2,Q88L02,Q8DB47,Q8DDK6,Q8ECP7,Q8EKR9,Q8FBI2,Q8FFG4,Q8W1L6,Q8X8I2,Q8XCP2,Q8Z3C6,Q8Z4Z0,Q8ZAN0,Q8ZD45,Q8ZNA7,Q93Q12,Q9AHY3,Q9DBM2,Q9F0Y7,Q9HZJ2,Q9KNI1,Q9KT58,Q9L6L5" charOffset="40-71" type="protein" text="3-hydroxyacyl-CoA dehydrogenase"/>
            <entity id="DS.d1603.s0.e2" origId="977" charOffset="92-98" type="compound" text="oxygen"/>
            <pair e1="DS.d1603.s0.e2" e2="DS.d1603.s0.e1" id="DS.d1603.s0.i0" interaction="False"/>
            <pair e1="DS.d1603.s0.e2" e2="DS.d1603.s0.e0" id="DS.d1603.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1604" origId="18845907">
        <sentence id="DS.d1604.s0" origId="18845907-1434" text="MIN6 cells excreted insulin, glucagon, somatostatin and ghrelin.">
            <entity id="DS.d1604.s0.e0" origId="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9" charOffset="29-37" type="protein" text="glucagon"/>
            <entity id="DS.d1604.s0.e1" origId="16129681,16129706" charOffset="39-51" type="compound" text="somatostatin"/>
            <entity id="DS.d1604.s0.e2" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="56-63" type="protein" text="ghrelin"/>
            <pair e1="DS.d1604.s0.e1" e2="DS.d1604.s0.e0" id="DS.d1604.s0.i0" interaction="False"/>
            <pair e1="DS.d1604.s0.e1" e2="DS.d1604.s0.e2" id="DS.d1604.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1604.s1" origId="18845907-1435" text="They expressed mRNAs of insulin I and II, proglucagon, somatostatin, pancreatic polypeptide (PP) and ghrelin which were shown in the mouse pancreatic islet core and periphery obtained by LCM.">
            <entity id="DS.d1604.s1.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="24-31" type="protein" text="insulin"/>
            <entity id="DS.d1604.s1.e1" origId="16129681,16129706" charOffset="55-67" type="compound" text="somatostatin"/>
            <entity id="DS.d1604.s1.e2" origId="P01298,P01299,P01300,P01301,P01302,P06303,P06304,P06305,P06884,P10601,P11967,P13083,P15427,P18107,P31229,P33684,P37999,P39659,P41335,P41336,P41337,P41519,P68009,P68010,P68248,P68249" charOffset="69-91" type="protein" text="pancreatic polypeptide"/>
            <entity id="DS.d1604.s1.e3" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="101-108" type="protein" text="ghrelin"/>
            <pair e1="DS.d1604.s1.e1" e2="DS.d1604.s1.e2" id="DS.d1604.s1.i0" interaction="False"/>
            <pair e1="DS.d1604.s1.e1" e2="DS.d1604.s1.e3" id="DS.d1604.s1.i1" interaction="False"/>
            <pair e1="DS.d1604.s1.e1" e2="DS.d1604.s1.e0" id="DS.d1604.s1.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d1604.s2" origId="18845907-1436" text="Glucagon, somatostatin and ghrelin were detectable in the culture medium.">
            <entity id="DS.d1604.s2.e0" origId="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9" charOffset="0-8" type="protein" text="Glucagon"/>
            <entity id="DS.d1604.s2.e1" origId="16129681,16129706" charOffset="10-22" type="compound" text="somatostatin"/>
            <entity id="DS.d1604.s2.e2" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="27-34" type="protein" text="ghrelin"/>
            <pair e1="DS.d1604.s2.e1" e2="DS.d1604.s2.e0" id="DS.d1604.s2.i0" interaction="False"/>
            <pair e1="DS.d1604.s2.e1" e2="DS.d1604.s2.e2" id="DS.d1604.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1605" origId="18846314">
        <sentence id="DS.d1605.s0" origId="18846314-1555" text="Metallothioneins (MTs) are cysteine-rich, metal-binding proteins that are useful biomarkers for monitoring pollution by heavy metals.">
            <entity id="DS.d1605.s0.e0" origId="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568" charOffset="0-16" type="protein" text="Metallothioneins"/>
            <entity id="DS.d1605.s0.e1" origId="594,5862,5360637" charOffset="27-35" type="compound" text="cysteine"/>
            <pair e1="DS.d1605.s0.e1" e2="DS.d1605.s0.e0" id="DS.d1605.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1605.s1" origId="18846314-1558" text="The deduced amino acid sequence has 18 cysteine residues, implying that S. henanense CdMT binds six equivalents of bivalent metal ions (Cd) as opposed to the seven in its mammalian counterparts.">
            <entity id="DS.d1605.s1.e0" origId="594,5862,5360637" charOffset="39-47" type="compound" text="cysteine"/>
            <entity id="DS.d1605.s1.e1" origId="Q8WSW3" charOffset="85-89" type="protein" text="CdMT"/>
            <pair e1="DS.d1605.s1.e0" e2="DS.d1605.s1.e1" id="DS.d1605.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1606" origId="18846317">
        <sentence id="DS.d1606.s0" origId="18846317-1559" text="Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, alkaline phosphatase, phosphorus, HbA1C, PTH, Mg and creatinine analysis.">
            <entity id="DS.d1606.s0.e0" origId="O60109,P81800,P83456" charOffset="137-157" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d1606.s0.e1" origId="24404,139579" charOffset="159-169" type="compound" text="phosphorus"/>
            <entity id="DS.d1606.s0.e2" origId="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3" charOffset="178-181" type="protein" text="PTH"/>
            <entity id="DS.d1606.s0.e3" origId="588" charOffset="190-200" type="compound" text="creatinine"/>
            <pair e1="DS.d1606.s0.e1" e2="DS.d1606.s0.e0" id="DS.d1606.s0.i0" interaction="False"/>
            <pair e1="DS.d1606.s0.e3" e2="DS.d1606.s0.e2" id="DS.d1606.s0.i1" interaction="False"/>
            <pair e1="DS.d1606.s0.e1" e2="DS.d1606.s0.e2" id="DS.d1606.s0.i2" interaction="False"/>
            <pair e1="DS.d1606.s0.e3" e2="DS.d1606.s0.e0" id="DS.d1606.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1607" origId="18846318">
        <sentence id="DS.d1607.s0" origId="18846318-1561" text="Treatment of Platelet Rich Plasma (PRP) with the dialyzed supernatant from the leucocyte suspension incubated with 80 microM aspirin resulted in parallel syntheses of NO and IFN-alpha as determined by methemoglobin assay and enzyme linked immunosorbent assay respectively.">
            <entity id="DS.d1607.s0.e0" origId="2244" charOffset="125-132" type="compound" text="aspirin"/>
            <entity id="DS.d1607.s0.e1" origId="P35849" charOffset="174-183" type="protein" text="IFN-alpha"/>
            <pair e1="DS.d1607.s0.e0" e2="DS.d1607.s0.e1" id="DS.d1607.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1608" origId="18846383">
        <sentence id="DS.d1608.s0" origId="18846383-1582" text="Muscular oxidative stress and inflammation induced by H2O2 or MS were assessed by measurements of isoprostanes and IL-6 levels.">
            <entity id="DS.d1608.s0.e0" origId="784" charOffset="54-58" type="compound" text="H2O2"/>
            <entity id="DS.d1608.s0.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="115-119" type="protein" text="IL-6"/>
            <pair e1="DS.d1608.s0.e0" e2="DS.d1608.s0.e1" id="DS.d1608.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1608.s1" origId="18846383-1583" text="In control rats, H2O2, bradykinin and MS significantly enhanced the HFV response.">
            <entity id="DS.d1608.s1.e0" origId="784" charOffset="17-21" type="compound" text="H2O2"/>
            <entity id="DS.d1608.s1.e1" origId="O08677,P01042,P01044,P01045,P08934,P83055,P83060,P83856,P83857,P84697,P84825,P84895,Q7T3L1,Q90W88,Q90WZ1" charOffset="23-33" type="protein" text="bradykinin"/>
            <pair e1="DS.d1608.s1.e0" e2="DS.d1608.s1.e1" id="DS.d1608.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1608.s2" origId="18846383-1584" text="Pre-treatment with SOD abolished the post-MS-enhanced HFV response whereas diclofenac lowered the peak HFV response to MS and H2O2.">
            <entity id="DS.d1608.s2.e0" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="19-22" type="protein" text="SOD"/>
            <entity id="DS.d1608.s2.e1" origId="3033" charOffset="75-85" type="compound" text="diclofenac"/>
            <entity id="DS.d1608.s2.e2" origId="784" charOffset="126-130" type="compound" text="H2O2"/>
            <pair e1="DS.d1608.s2.e2" e2="DS.d1608.s2.e0" id="DS.d1608.s2.i0" interaction="False"/>
            <pair e1="DS.d1608.s2.e1" e2="DS.d1608.s2.e0" id="DS.d1608.s2.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1608.s3" origId="18846383-1585" text="H2O2 injection and MS elicited significant and similar increases in isoprostanes and IL-6.">
            <entity id="DS.d1608.s3.e0" origId="784" charOffset="0-4" type="compound" text="H2O2"/>
            <entity id="DS.d1608.s3.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="85-89" type="protein" text="IL-6"/>
            <pair e1="DS.d1608.s3.e0" e2="DS.d1608.s3.e1" id="DS.d1608.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1609" origId="18846462">
        <sentence id="DS.d1609.s0" origId="18846462-1626" text="The decreased level of GSH as well as SOD and GSH-Px activities in haloperidol-treated mice were significantly increased by NTA pretreatment.">
            <entity id="DS.d1609.s0.e0" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="38-41" type="protein" text="SOD"/>
            <entity id="DS.d1609.s0.e1" origId="3559" charOffset="67-78" type="compound" text="haloperidol"/>
            <pair e1="DS.d1609.s0.e1" e2="DS.d1609.s0.e0" id="DS.d1609.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1611" origId="18847291">
        <sentence id="DS.d1611.s0" origId="18847291-1916" text="In this study, fluorescence microscopy and elemental analysis were exploited to show that the 3,4-dihydroxyphenyl-L-alanine (dopa) residues of mussel foot protein-1 colocalize with Fe and Ca distributions in the cuticle of Mytilus galloprovincialis mussel byssal threads.">
            <entity id="DS.d1611.s0.e1" origId="6047" charOffset="125-129" type="compound" text="dopa"/>
            <entity id="DS.d1611.s0.e2" origId="Q25434,Q25460,Q27409" charOffset="150-164" type="protein" text="foot protein-1"/>
            <pair e1="DS.d1611.s0.e1" e2="DS.d1611.s0.e2" id="DS.d1611.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1612" origId="18847329">
        <sentence id="DS.d1612.s0" origId="18847329-1933" text="We measured pain using a visual analog pain scale at five time points in 0-48 h, oxycodone use for pain, acetaminophen for fever, C-reactive protein (CRP), and total and percent gammadeltaT-cells.">
            <entity id="DS.d1612.s0.e0" origId="1983" charOffset="105-118" type="compound" text="acetaminophen"/>
            <entity id="DS.d1612.s0.e1" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="150-153" type="protein" text="CRP"/>
            <pair e1="DS.d1612.s0.e0" e2="DS.d1612.s0.e1" id="DS.d1612.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1613" origId="18847384">
        <sentence id="DS.d1613.s0" origId="18847384-1963" text="Association between insulin resistance, glucose intolerance, and hypertension in pregnancy.">
            <entity id="DS.d1613.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="20-27" type="protein" text="insulin"/>
            <entity id="DS.d1613.s0.e1" origId="206,5793,64689,79025" charOffset="40-47" type="compound" text="glucose"/>
            <pair e1="DS.d1613.s0.e1" e2="DS.d1613.s0.e0" id="DS.d1613.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1613.s1" origId="18847384-1966" text="These results suggest that insulin resistance and relative glucose intolerance are associated with an increased risk of new-onset hypertension in pregnancy, particularly preeclampsia, and support the hypothesis that insulin resistance may play a role in the pathogenesis of this disorder.">
            <entity id="DS.d1613.s1.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="27-34" type="protein" text="insulin"/>
            <entity id="DS.d1613.s1.e1" origId="206,5793,64689,79025" charOffset="59-66" type="compound" text="glucose"/>
            <entity id="DS.d1613.s1.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="216-223" type="protein" text="insulin"/>
            <pair e1="DS.d1613.s1.e1" e2="DS.d1613.s1.e0" id="DS.d1613.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1615" origId="18848532">
        <sentence id="DS.d1615.s0" origId="18848532-2325" text="These ADHs are likely to perform similar functions to those reported for other mammalian ADHs in the metabolism of ingested and endogenous alcohols and aldehydes.">
            <entity id="DS.d1615.s0.e0" origId="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7" charOffset="6-10" type="protein" text="ADHs"/>
            <entity id="DS.d1615.s0.e1" origId="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7" charOffset="89-93" type="protein" text="ADHs"/>
            <entity id="DS.d1615.s0.e2" origId="702" charOffset="139-147" type="compound" text="alcohols"/>
            <pair e1="DS.d1615.s0.e2" e2="DS.d1615.s0.e0" id="DS.d1615.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1616" origId="18848584">
        <sentence id="DS.d1616.s0" origId="18848584-2351" text="Glyoxalase I and II form a ubiquitous glutathione-dependent pathway for the detoxification of reactive and mutagenic ketoaldehydes.">
            <entity id="DS.d1616.s0.e0" origId="O04885,O49818,P0A0T2,P0A0T3,P0A1Q2,P0A1Q3,P0AC81,P0AC82,P0AC83,P16635,P44638,P46235,P46417,P50107,P84719,Q04760,Q09751,Q39366,Q42891,Q4R5F2,Q55595,Q6P7Q4,Q8H0V3,Q948T6,Q9CPU0,Q9KT93" charOffset="0-12" type="protein" text="Glyoxalase I"/>
            <entity id="DS.d1616.s0.e1" origId="124886" charOffset="38-49" type="compound" text="glutathione"/>
            <pair e1="DS.d1616.s0.e1" e2="DS.d1616.s0.e0" id="DS.d1616.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1617" origId="18848601">
        <sentence id="DS.d1617.s0" origId="18848601-2359" text="17beta-Hydroxysteroid dehydrogenase type 1 (17beta-HSD1) is responsible for the catalytic reduction of the weak estrogen estrone (E1) into the highly potent 17beta-estradiol (E2).">
            <entity id="DS.d1617.s0.e0" origId="P14061,P51656,P51657,Q1WNP0" charOffset="0-42" type="protein" text="17beta-Hydroxysteroid dehydrogenase type 1"/>
            <entity id="DS.d1617.s0.e1" origId="P14061,P51656,P51657,Q1WNP0" charOffset="44-55" type="protein" text="17beta-HSD1"/>
            <entity id="DS.d1617.s0.e3" origId="5757" charOffset="157-173" type="compound" text="17beta-estradiol"/>
            <pair e1="DS.d1617.s0.e3" e2="DS.d1617.s0.e0" id="DS.d1617.s0.i1" interaction="True"/>
            <pair e1="DS.d1617.s0.e3" e2="DS.d1617.s0.e1" id="DS.d1617.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1618" origId="18848620">
        <sentence id="DS.d1618.s0" origId="18848620-2373" text="Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, cortisol, norepinephrine, and in vitro-stimulated IL-6 production.">
            <entity id="DS.d1618.s0.e0" origId="5754" charOffset="119-127" type="compound" text="cortisol"/>
            <entity id="DS.d1618.s0.e1" origId="951,439260" charOffset="129-143" type="compound" text="norepinephrine"/>
            <entity id="DS.d1618.s0.e2" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="169-173" type="protein" text="IL-6"/>
            <pair e1="DS.d1618.s0.e0" e2="DS.d1618.s0.e2" id="DS.d1618.s0.i0" interaction="False"/>
            <pair e1="DS.d1618.s0.e1" e2="DS.d1618.s0.e2" id="DS.d1618.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1618.s1" origId="18848620-2374" text="Higher NF-kappaB stress responses were associated with lower cortisol stress responses (beta=-.37, p=.05), higher pre-stress IL-6 production (beta=.38, p=.043), and high chronic in combination with low acute stress, or vice versa (beta=-.61, p=.06).">
            <entity id="DS.d1618.s1.e0" origId="5754" charOffset="61-69" type="compound" text="cortisol"/>
            <entity id="DS.d1618.s1.e1" origId="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80" charOffset="125-129" type="protein" text="IL-6"/>
            <pair e1="DS.d1618.s1.e0" e2="DS.d1618.s1.e1" id="DS.d1618.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1620" origId="18848646">
        <sentence id="DS.d1620.s0" origId="18848646-2382" text="The combination of leucine-rich repeat (LRR) and immunoglobulin-like (Ig) domains is found in the domain architecture of the Trk neurotrophin receptor protein.">
            <entity id="DS.d1620.s0.e0" origId="857,6106,439524" charOffset="19-26" type="compound" text="leucine"/>
            <entity id="DS.d1620.s0.e1" origId="P35739,P47946,Q24155" charOffset="125-128" type="protein" text="Trk"/>
            <pair e1="DS.d1620.s0.e0" e2="DS.d1620.s0.e1" id="DS.d1620.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1620.s1" origId="18848646-2383" text="Given the significant biological roles of Trk and such newly identified proteins, we have searched the public database for human proteins with LRR and Ig domains (collectively termed the leucine-rich repeat and Ig domain-containing protein, LRRIG protein, in this study), and have analyzed the mRNA expression pattern of mouse orthologs of obtained human LRRIG proteins at embryonic day 10.">
            <entity id="DS.d1620.s1.e0" origId="P35739,P47946,Q24155" charOffset="42-45" type="protein" text="Trk"/>
            <entity id="DS.d1620.s1.e1" origId="857,6106,439524" charOffset="187-194" type="compound" text="leucine"/>
            <pair e1="DS.d1620.s1.e1" e2="DS.d1620.s1.e0" id="DS.d1620.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1621" origId="18848727">
        <sentence id="DS.d1621.s0" origId="18848727-2425" text="Quantum chemical studies for oxidation of morpholine by Cytochrome P450.">
            <entity id="DS.d1621.s0.e0" origId="8083" charOffset="42-52" type="compound" text="morpholine"/>
            <entity id="DS.d1621.s0.e1" origId="O08469" charOffset="56-71" type="protein" text="Cytochrome P450"/>
            <pair e1="DS.d1621.s0.e0" e2="DS.d1621.s0.e1" id="DS.d1621.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1621.s1" origId="18848727-2426" text="Since morpholine oxidation has recently been shown to involve Cytochrome P450, the study on its mechanism at molecular level using quantum chemical calculations for the model of cytochrome active site is reported here.">
            <entity id="DS.d1621.s1.e0" origId="8083" charOffset="6-16" type="compound" text="morpholine"/>
            <entity id="DS.d1621.s1.e1" origId="O08469" charOffset="62-77" type="protein" text="Cytochrome P450"/>
            <pair e1="DS.d1621.s1.e0" e2="DS.d1621.s1.e1" id="DS.d1621.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1622" origId="18848748">
        <sentence id="DS.d1622.s0" origId="18848748-2442" text="Pretreatment with oligonol diminished the levels of proliferating cell nuclear antigen and expression of COX-2 in papillomas and carcinomas, respectively, as compared to DMBA plus TPA treatment alone.">
            <entity id="DS.d1622.s0.e0" origId="O01377,O02115,O16852,O82134,O82797,P04961,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00268,Q03392,Q43124,Q43266,Q6B6N4,Q9DDF1,Q9DEA3,Q9MAY3,Q9PTP1,Q9W644" charOffset="52-86" type="protein" text="proliferating cell nuclear antigen"/>
            <entity id="DS.d1622.s0.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="105-110" type="protein" text="COX-2"/>
            <entity id="DS.d1622.s0.e2" origId="6001" charOffset="170-174" type="compound" text="DMBA"/>
            <pair e1="DS.d1622.s0.e2" e2="DS.d1622.s0.e1" id="DS.d1622.s0.i0" interaction="True"/>
            <pair e1="DS.d1622.s0.e2" e2="DS.d1622.s0.e0" id="DS.d1622.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1623" origId="18848782">
        <sentence id="DS.d1623.s0" origId="18848782-2443" text="TnBP (tri-n-butyl phosphate) and polysorbate 20 during the manufacture of the factor VIII/VWF concentrate Optivate has been investigated.">
            <entity id="DS.d1623.s0.e0" origId="31357" charOffset="6-27" type="compound" text="tri-n-butyl phosphate"/>
            <entity id="DS.d1623.s0.e1" origId="P04275,P80012,Q28295,Q28833,Q8CIZ8" charOffset="90-93" type="protein" text="VWF"/>
            <pair e1="DS.d1623.s0.e0" e2="DS.d1623.s0.e1" id="DS.d1623.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1624" origId="18848797">
        <sentence id="DS.d1624.s0" origId="18848797-2450" text="Euthyroid animals with a palpation score &amp;gt;or=3 were significantly older, had higher body weights, lower alkaline phosphatase, alanine aminotransferase, phosphate, and urine specific gravity, but higher lipase and creatinine concentrations than hyperthyroid cats.">
            <entity id="DS.d1624.s0.e0" origId="O60109,P81800,P83456" charOffset="107-127" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d1624.s0.e1" origId="1061,167704,644102" charOffset="155-164" type="compound" text="phosphate"/>
            <entity id="DS.d1624.s0.e2" origId="Q7M4U7" charOffset="205-211" type="protein" text="lipase"/>
            <entity id="DS.d1624.s0.e3" origId="588" charOffset="216-226" type="compound" text="creatinine"/>
            <pair e1="DS.d1624.s0.e3" e2="DS.d1624.s0.e2" id="DS.d1624.s0.i0" interaction="False"/>
            <pair e1="DS.d1624.s0.e1" e2="DS.d1624.s0.e2" id="DS.d1624.s0.i1" interaction="False"/>
            <pair e1="DS.d1624.s0.e1" e2="DS.d1624.s0.e0" id="DS.d1624.s0.i2" interaction="False"/>
            <pair e1="DS.d1624.s0.e3" e2="DS.d1624.s0.e0" id="DS.d1624.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1625" origId="18848818">
        <sentence id="DS.d1625.s0" origId="18848818-2462" text="A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.">
            <entity id="DS.d1625.s0.e0" origId="P34972,P47936,Q9QZN9" charOffset="11-14" type="protein" text="CB2"/>
            <entity id="DS.d1625.s0.e1" origId="5281969" charOffset="28-38" type="compound" text="anandamide"/>
            <pair e1="DS.d1625.s0.e1" e2="DS.d1625.s0.e0" id="DS.d1625.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1627" origId="18848878">
        <sentence id="DS.d1627.s0" origId="18848878-2491" text="2-Deoxyglucose decreased NADH/NAD (+) and NADPH/NADP(+) ratios by 59 and 50%, respectively, and intact cell NQO1 activity by 74%; lactate restored NADH/NAD (+), but not NADPH/NADP(+) or NQO1 activity.">
            <entity id="DS.d1627.s0.e0" origId="5893" charOffset="25-28" type="compound" text="NAD"/>
            <entity id="DS.d1627.s0.e1" origId="P15559,Q5RD31,Q8CHK7" charOffset="108-112" type="protein" text="NQO1"/>
            <entity id="DS.d1627.s0.e2" origId="5893" charOffset="30-33" type="compound" text="NAD"/>
            <entity id="DS.d1627.s0.e3" origId="P15559,Q5RD31,Q8CHK7" charOffset="186-190" type="protein" text="NQO1"/>
            <pair e1="DS.d1627.s0.e0" e2="DS.d1627.s0.e1" id="DS.d1627.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1628" origId="18848894">
        <sentence id="DS.d1628.s0" origId="18848894-880" text="We propose that the coordinated regulation of actin cytoskeletal reorganization and macropinocytosis-mediated retrograde membrane trafficking may contribute to Ca(2+)-induced axon growth inhibition.">
            <entity id="DS.d1628.s0.e0" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="46-51" type="protein" text="actin"/>
            <entity id="DS.d1628.s0.e1" origId="271" charOffset="160-164" type="compound" text="Ca(2"/>
            <pair e1="DS.d1628.s0.e1" e2="DS.d1628.s0.e0" id="DS.d1628.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1629" origId="18848957">
        <sentence id="DS.d1629.s0" origId="18848957-982" text="Cocaine stimulated ACTH, cortisol, and LH, whereas cocaine+nalbuphine in combination produced a smaller increase in ACTH, and decreased cortisol and LH.">
            <entity id="DS.d1629.s0.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="19-23" type="protein" text="ACTH"/>
            <entity id="DS.d1629.s0.e1" origId="5754" charOffset="25-33" type="compound" text="cortisol"/>
            <entity id="DS.d1629.s0.e2" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="116-120" type="protein" text="ACTH"/>
            <entity id="DS.d1629.s0.e3" origId="5754" charOffset="136-144" type="compound" text="cortisol"/>
            <pair e1="DS.d1629.s0.e1" e2="DS.d1629.s0.e0" id="DS.d1629.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1629.s1" origId="18848957-983" text="Thus it appears that nalbuphine attenuated cocaine's effects on ACTH, cortisol, and LH.">
            <entity id="DS.d1629.s1.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="64-68" type="protein" text="ACTH"/>
            <entity id="DS.d1629.s1.e1" origId="5754" charOffset="70-78" type="compound" text="cortisol"/>
            <pair e1="DS.d1629.s1.e1" e2="DS.d1629.s1.e0" id="DS.d1629.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1630" origId="18848961">
        <sentence id="DS.d1630.s0" origId="18848961-2547" text="In this work we show that in FaO rat hepatoma cells inhibition of the epidermal growth factor receptor (EGFR) with the tyrphostin AG1478 enhances TGF-beta-induced cell death, coincident with an elevated increase in ROS production and GSH depletion.">
            <entity id="DS.d1630.s0.e0" origId="P55245" charOffset="70-102" type="protein" text="epidermal growth factor receptor"/>
            <entity id="DS.d1630.s0.e1" origId="P00533,P13387,P55245" charOffset="104-108" type="protein" text="EGFR"/>
            <entity id="DS.d1630.s0.e2" origId="2051" charOffset="130-136" type="compound" text="AG1478"/>
            <pair e1="DS.d1630.s0.e2" e2="DS.d1630.s0.e0" id="DS.d1630.s0.i0" interaction="True"/>
            <pair e1="DS.d1630.s0.e2" e2="DS.d1630.s0.e1" id="DS.d1630.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1631" origId="18848984">
        <sentence id="DS.d1631.s0" origId="18848984-2561" text="Membrane inlet mass spectrometry was used to observe nitric oxide in the well-studied reaction of nitrite with hemoglobin.">
            <entity id="DS.d1631.s0.e0" origId="145068" charOffset="53-65" type="compound" text="nitric oxide"/>
            <entity id="DS.d1631.s0.e1" origId="P15160,P17724,P73925,Q03459" charOffset="111-121" type="protein" text="hemoglobin"/>
            <pair e1="DS.d1631.s0.e0" e2="DS.d1631.s0.e1" id="DS.d1631.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1632" origId="18849028">
        <sentence id="DS.d1632.s0" origId="18849028-2571" text="Diminished levels of L-arginine and endothelial nitric oxide synthase (eNOS) uncoupling through deficiency of tetrahydrobiopterin (BH(4)) may contribute to endothelial dysfunction.">
            <entity id="DS.d1632.s0.e0" origId="232,4367,6322" charOffset="23-31" type="compound" text="arginine"/>
            <entity id="DS.d1632.s0.e1" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="48-69" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d1632.s0.e2" origId="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600" charOffset="71-75" type="protein" text="eNOS"/>
            <entity id="DS.d1632.s0.e3" origId="44257,9816201" charOffset="110-129" type="compound" text="tetrahydrobiopterin"/>
            <pair e1="DS.d1632.s0.e3" e2="DS.d1632.s0.e1" id="DS.d1632.s0.i0" interaction="True"/>
            <pair e1="DS.d1632.s0.e0" e2="DS.d1632.s0.e2" id="DS.d1632.s0.i1" interaction="False"/>
            <pair e1="DS.d1632.s0.e3" e2="DS.d1632.s0.e2" id="DS.d1632.s0.i2" interaction="True"/>
            <pair e1="DS.d1632.s0.e0" e2="DS.d1632.s0.e1" id="DS.d1632.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1633" origId="18849030">
        <sentence id="DS.d1633.s0" origId="18849030-2572" text="Serum testosterone, estradiol, sex hormone binding globulin (SHBG), and dehydroepiandrosterone levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.">
            <entity id="DS.d1633.s0.e0" origId="5757" charOffset="20-29" type="compound" text="estradiol"/>
            <entity id="DS.d1633.s0.e1" origId="P04278,P08689,P15196,P97497,Q62588" charOffset="61-65" type="protein" text="SHBG"/>
            <entity id="DS.d1633.s0.e2" origId="5881" charOffset="72-94" type="compound" text="dehydroepiandrosterone"/>
            <pair e1="DS.d1633.s0.e2" e2="DS.d1633.s0.e1" id="DS.d1633.s0.i0" interaction="False"/>
            <pair e1="DS.d1633.s0.e0" e2="DS.d1633.s0.e1" id="DS.d1633.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1633.s1" origId="18849030-2573" text="Total and bioavailable testosterone were positively associated with common cIMT independent of age, BMI, hypertension, smoking, HDL-cholesterol, LDL-cholesterol and insulin sensitivity (p=0.009 and p=0.002, respectively).">
            <entity id="DS.d1633.s1.e0" origId="304,5997,6432564,11025495" charOffset="132-143" type="compound" text="cholesterol"/>
            <entity id="DS.d1633.s1.e1" origId="304,5997,6432564,11025495" charOffset="149-160" type="compound" text="cholesterol"/>
            <entity id="DS.d1633.s1.e2" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="165-172" type="protein" text="insulin"/>
            <pair e1="DS.d1633.s1.e0" e2="DS.d1633.s1.e2" id="DS.d1633.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1634" origId="18849055">
        <sentence id="DS.d1634.s0" origId="18849055-2585" text="In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.">
            <entity id="DS.d1634.s0.e0" origId="O50258" charOffset="81-101" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1634.s0.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="103-111" type="protein" text="catalase"/>
            <entity id="DS.d1634.s0.e2" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="113-135" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d1634.s0.e3" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="137-158" type="protein" text="glutathione reductase"/>
            <entity id="DS.d1634.s0.e4" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="163-188" type="protein" text="glutathione S-transferase"/>
            <entity id="DS.d1634.s0.e5" origId="54670067,54690394" charOffset="225-238" type="compound" text="ascorbic acid"/>
            <entity id="DS.d1634.s0.e6" origId="124886" charOffset="243-262" type="compound" text="reduced glutathione"/>
            <pair e1="DS.d1634.s0.e6" e2="DS.d1634.s0.e1" id="DS.d1634.s0.i0" interaction="False"/>
            <pair e1="DS.d1634.s0.e6" e2="DS.d1634.s0.e3" id="DS.d1634.s0.i1" interaction="False"/>
            <pair e1="DS.d1634.s0.e6" e2="DS.d1634.s0.e0" id="DS.d1634.s0.i2" interaction="False"/>
            <pair e1="DS.d1634.s0.e5" e2="DS.d1634.s0.e4" id="DS.d1634.s0.i3" interaction="False"/>
            <pair e1="DS.d1634.s0.e5" e2="DS.d1634.s0.e1" id="DS.d1634.s0.i4" interaction="False"/>
            <pair e1="DS.d1634.s0.e5" e2="DS.d1634.s0.e3" id="DS.d1634.s0.i5" interaction="False"/>
            <pair e1="DS.d1634.s0.e6" e2="DS.d1634.s0.e2" id="DS.d1634.s0.i6" interaction="False"/>
            <pair e1="DS.d1634.s0.e5" e2="DS.d1634.s0.e0" id="DS.d1634.s0.i7" interaction="False"/>
            <pair e1="DS.d1634.s0.e5" e2="DS.d1634.s0.e2" id="DS.d1634.s0.i8" interaction="False"/>
            <pair e1="DS.d1634.s0.e6" e2="DS.d1634.s0.e4" id="DS.d1634.s0.i9" interaction="False"/>
        </sentence>
        <sentence id="DS.d1634.s1" origId="18849055-2586" text="This study shows that changes in lipid peroxidation, superoxide dismutase, catalase, glutathione reductase, glutathione S-transferase and reduced glutathione in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.">
            <entity id="DS.d1634.s1.e0" origId="O50258" charOffset="53-73" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1634.s1.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="75-83" type="protein" text="catalase"/>
            <entity id="DS.d1634.s1.e2" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="85-106" type="protein" text="glutathione reductase"/>
            <entity id="DS.d1634.s1.e3" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="108-133" type="protein" text="glutathione S-transferase"/>
            <entity id="DS.d1634.s1.e4" origId="124886" charOffset="138-157" type="compound" text="reduced glutathione"/>
            <pair e1="DS.d1634.s1.e4" e2="DS.d1634.s1.e0" id="DS.d1634.s1.i0" interaction="False"/>
            <pair e1="DS.d1634.s1.e4" e2="DS.d1634.s1.e1" id="DS.d1634.s1.i1" interaction="False"/>
            <pair e1="DS.d1634.s1.e4" e2="DS.d1634.s1.e2" id="DS.d1634.s1.i2" interaction="False"/>
            <pair e1="DS.d1634.s1.e4" e2="DS.d1634.s1.e3" id="DS.d1634.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1635" origId="18849069">
        <sentence id="DS.d1635.s0" origId="18849069-2591" text="At the same time, both types of conduits were permeable to three compounds tested including glucose, lysozyme and bovine serum albumin, indicating the suitability of the conduits for free exchanges of nutrients.">
            <entity id="DS.d1635.s0.e0" origId="206,5793,64689,79025" charOffset="92-99" type="compound" text="glucose"/>
            <entity id="DS.d1635.s0.e1" origId="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7" charOffset="101-109" type="protein" text="lysozyme"/>
            <entity id="DS.d1635.s0.e2" origId="P21847,P83517" charOffset="121-134" type="protein" text="serum albumin"/>
            <pair e1="DS.d1635.s0.e0" e2="DS.d1635.s0.e2" id="DS.d1635.s0.i0" interaction="False"/>
            <pair e1="DS.d1635.s0.e0" e2="DS.d1635.s0.e1" id="DS.d1635.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1636" origId="18849110">
        <sentence id="DS.d1636.s0" origId="18849110-2608" text="The inhibitory effect of norepinephrine on the migration of ES-2 ovarian carcinoma cells involves a Rap1-dependent pathway.">
            <entity id="DS.d1636.s0.e0" origId="951,439260" charOffset="25-39" type="compound" text="norepinephrine"/>
            <entity id="DS.d1636.s0.e1" origId="P08645,P18613,Q91VL8,Q96TL7" charOffset="100-104" type="protein" text="Rap1"/>
            <pair e1="DS.d1636.s0.e0" e2="DS.d1636.s0.e1" id="DS.d1636.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1636.s1" origId="18849110-2609" text="This inhibitory effect is possibly mediated by a cAMP-dependent activation of the small GTPase Rap1 via Epac.">
            <entity id="DS.d1636.s1.e0" origId="6076" charOffset="49-53" type="compound" text="cAMP"/>
            <entity id="DS.d1636.s1.e1" origId="P08645,P18613,Q91VL8,Q96TL7" charOffset="95-99" type="protein" text="Rap1"/>
            <entity id="DS.d1636.s1.e2" origId="Q8VCC8,Q9Z1C8" charOffset="104-108" type="protein" text="Epac"/>
            <pair e1="DS.d1636.s1.e0" e2="DS.d1636.s1.e1" id="DS.d1636.s1.i0" interaction="True"/>
            <pair e1="DS.d1636.s1.e0" e2="DS.d1636.s1.e2" id="DS.d1636.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1637" origId="18849120">
        <sentence id="DS.d1637.s0" origId="18849120-2614" text="Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.">
            <entity id="DS.d1637.s0.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="22-35" type="protein" text="corticotropin"/>
            <entity id="DS.d1637.s0.e1" origId="5753" charOffset="40-54" type="compound" text="corticosterone"/>
            <entity id="DS.d1637.s0.e2" origId="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1" charOffset="69-99" type="protein" text="corticotropin-releasing factor"/>
            <pair e1="DS.d1637.s0.e1" e2="DS.d1637.s0.e2" id="DS.d1637.s0.i0" interaction="False"/>
            <pair e1="DS.d1637.s0.e1" e2="DS.d1637.s0.e0" id="DS.d1637.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1637.s1" origId="18849120-2615" text="Although females in both proestrus and diestrus showed significant increases in plasma ACTH and corticosterone and CRF mRNA expression in the PVN in response to PS, no significant responses of the HPA axis to PS were found in males.">
            <entity id="DS.d1637.s1.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="87-91" type="protein" text="ACTH"/>
            <entity id="DS.d1637.s1.e1" origId="5753" charOffset="96-110" type="compound" text="corticosterone"/>
            <entity id="DS.d1637.s1.e2" origId="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1" charOffset="115-118" type="protein" text="CRF"/>
            <pair e1="DS.d1637.s1.e1" e2="DS.d1637.s1.e0" id="DS.d1637.s1.i0" interaction="False"/>
            <pair e1="DS.d1637.s1.e1" e2="DS.d1637.s1.e2" id="DS.d1637.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1638" origId="18849121">
        <sentence id="DS.d1638.s0" origId="18849121-2616" text="BDNF, NGF, adrenocorticotropic hormone (ACTH), cortisol and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.">
            <entity id="DS.d1638.s0.e0" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="0-4" type="protein" text="BDNF"/>
            <entity id="DS.d1638.s0.e1" origId="P21617,P34129,Q6YBR5,Q90W38" charOffset="6-9" type="protein" text="NGF"/>
            <entity id="DS.d1638.s0.e2" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="11-38" type="protein" text="adrenocorticotropic hormone"/>
            <entity id="DS.d1638.s0.e3" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="40-44" type="protein" text="ACTH"/>
            <entity id="DS.d1638.s0.e4" origId="5754" charOffset="47-55" type="compound" text="cortisol"/>
            <entity id="DS.d1638.s0.e5" origId="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8" charOffset="60-74" type="protein" text="growth hormone"/>
            <entity id="DS.d1638.s0.e6" origId="P01160" charOffset="127-130" type="protein" text="PND"/>
            <entity id="DS.d1638.s0.e7" origId="P13304" charOffset="177-180" type="protein" text="RIA"/>
            <pair e1="DS.d1638.s0.e4" e2="DS.d1638.s0.e6" id="DS.d1638.s0.i0" interaction="False"/>
            <pair e1="DS.d1638.s0.e4" e2="DS.d1638.s0.e0" id="DS.d1638.s0.i1" interaction="False"/>
            <pair e1="DS.d1638.s0.e4" e2="DS.d1638.s0.e2" id="DS.d1638.s0.i2" interaction="False"/>
            <pair e1="DS.d1638.s0.e4" e2="DS.d1638.s0.e7" id="DS.d1638.s0.i3" interaction="False"/>
            <pair e1="DS.d1638.s0.e4" e2="DS.d1638.s0.e1" id="DS.d1638.s0.i4" interaction="False"/>
            <pair e1="DS.d1638.s0.e4" e2="DS.d1638.s0.e3" id="DS.d1638.s0.i5" interaction="False"/>
            <pair e1="DS.d1638.s0.e4" e2="DS.d1638.s0.e5" id="DS.d1638.s0.i6" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1639" origId="18849159">
        <sentence id="DS.d1639.s0" origId="18849159-2635" text="A substrate regeneration cycle coupling GOD with l-ascorbic acid (AsA: 0, 1.0, 3.0, 10.0 and 50.0 mmol/l; as reducing reagent system) was applied to the chemo-mechanical reaction unit in order to amplify the output signal of the tonometric biosensor.">
            <entity id="DS.d1639.s0.e0" origId="P13006,P81156,Q92452" charOffset="40-43" type="protein" text="GOD"/>
            <entity id="DS.d1639.s0.e1" origId="54670067,54690394" charOffset="51-64" type="compound" text="ascorbic acid"/>
            <pair e1="DS.d1639.s0.e1" e2="DS.d1639.s0.e0" id="DS.d1639.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1640" origId="18849171">
        <sentence id="DS.d1640.s0" origId="18849171-2637" text="In vitro and in vivo models simulating the bee sting have been developed using live honeybees and, as the envenomation sites, pig ears and rat legs; MALDI MSI has been used to map, over time, the diffusion and distribution of three venom allergens (Api m 1, Api m 4, and Api m 6) and two venom toxins (apamine and mast cell degranulating peptide).">
            <entity id="DS.d1640.s0.e0" origId="99290" charOffset="249-252" type="compound" text="Api"/>
            <entity id="DS.d1640.s0.e1" origId="99290" charOffset="258-261" type="compound" text="Api"/>
            <entity id="DS.d1640.s0.e2" origId="99290" charOffset="258-261" type="compound" text="Api"/>
            <entity id="DS.d1640.s0.e3" origId="P04205,P04567" charOffset="314-345" type="protein" text="mast cell degranulating peptide"/>
            <pair e1="DS.d1640.s0.e0" e2="DS.d1640.s0.e3" id="DS.d1640.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1641" origId="18849325">
        <sentence id="DS.d1641.s0" origId="18849325-2674" text="The effect was lactose-inhibitable and required galectin-3 affinity for N-acetyllactosamine, a saccharide typically found on cell surface glycoproteins, since a mutant lacking this activity was without effect.">
            <entity id="DS.d1641.s0.e0" origId="P08699,P16110,P17931,P38486,P47845,P47953" charOffset="48-58" type="protein" text="galectin-3"/>
            <entity id="DS.d1641.s0.e1" origId="245,439271,9800166,25203095" charOffset="72-91" type="compound" text="N-acetyllactosamine"/>
            <entity id="DS.d1641.s0.e2" origId="Q50833,Q58232" charOffset="125-151" type="protein" text="cell surface glycoproteins"/>
            <pair e1="DS.d1641.s0.e1" e2="DS.d1641.s0.e2" id="DS.d1641.s0.i0" interaction="True"/>
            <pair e1="DS.d1641.s0.e1" e2="DS.d1641.s0.e0" id="DS.d1641.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1642" origId="18849352">
        <sentence id="DS.d1642.s0" origId="18849352-2679" text="Despite widespread expression of epidermal growth factor (EGF) receptors (EGFRs) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as gefitinib exhibit limited activity in this cancer.">
            <entity id="DS.d1642.s0.e0" origId="P01132,P01133,P07522,Q00968,Q95ND4,Q9BEA0" charOffset="33-56" type="protein" text="epidermal growth factor"/>
            <entity id="DS.d1642.s0.e1" origId="P00533,P13387,P55245" charOffset="74-79" type="protein" text="EGFRs"/>
            <entity id="DS.d1642.s0.e2" origId="123631" charOffset="199-208" type="compound" text="gefitinib"/>
            <pair e1="DS.d1642.s0.e2" e2="DS.d1642.s0.e0" id="DS.d1642.s0.i0" interaction="False"/>
            <pair e1="DS.d1642.s0.e2" e2="DS.d1642.s0.e1" id="DS.d1642.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1642.s1" origId="18849352-2680" text="It is noteworthy that FGF2 and FGF9 as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to gefitinib.">
            <entity id="DS.d1642.s1.e0" origId="P03969,P09038,P20003,P48798,P48799,P48800,Q60487" charOffset="22-26" type="protein" text="FGF2"/>
            <entity id="DS.d1642.s1.e1" origId="P31371" charOffset="31-35" type="protein" text="FGF9"/>
            <entity id="DS.d1642.s1.e2" origId="P11362,P21804,Q8MY86,Q91285" charOffset="47-52" type="protein" text="FGFR1"/>
            <entity id="DS.d1642.s1.e3" origId="P18461,P21802,Q8MY85,Q91147,Q91286" charOffset="65-70" type="protein" text="FGFR2"/>
            <entity id="DS.d1642.s1.e4" origId="123631" charOffset="182-191" type="compound" text="gefitinib"/>
            <pair e1="DS.d1642.s1.e4" e2="DS.d1642.s1.e2" id="DS.d1642.s1.i0" interaction="False"/>
            <pair e1="DS.d1642.s1.e4" e2="DS.d1642.s1.e0" id="DS.d1642.s1.i1" interaction="False"/>
            <pair e1="DS.d1642.s1.e4" e2="DS.d1642.s1.e1" id="DS.d1642.s1.i2" interaction="False"/>
            <pair e1="DS.d1642.s1.e4" e2="DS.d1642.s1.e3" id="DS.d1642.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1643" origId="18849389">
        <sentence id="DS.d1643.s0" origId="18849389-2687" text="Preprandial concentrations of glucose, NEFA, lactate, and IGF-I fluctuated over time without significant treatment effect.">
            <entity id="DS.d1643.s0.e0" origId="206,5793,64689,79025" charOffset="30-37" type="compound" text="glucose"/>
            <entity id="DS.d1643.s0.e1" origId="P80303" charOffset="39-43" type="protein" text="NEFA"/>
            <entity id="DS.d1643.s0.e2" origId="612" charOffset="45-52" type="compound" text="lactate"/>
            <entity id="DS.d1643.s0.e3" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="58-63" type="protein" text="IGF-I"/>
            <pair e1="DS.d1643.s0.e2" e2="DS.d1643.s0.e1" id="DS.d1643.s0.i0" interaction="False"/>
            <pair e1="DS.d1643.s0.e0" e2="DS.d1643.s0.e3" id="DS.d1643.s0.i1" interaction="False"/>
            <pair e1="DS.d1643.s0.e2" e2="DS.d1643.s0.e3" id="DS.d1643.s0.i2" interaction="False"/>
            <pair e1="DS.d1643.s0.e0" e2="DS.d1643.s0.e1" id="DS.d1643.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d1643.s1" origId="18849389-2688" text="In late gestation, the postprandial increases in glucose and insulin were delayed, and smaller, after a high-fiber meal than after a control meal.">
            <entity id="DS.d1643.s1.e0" origId="206,5793,64689,79025" charOffset="49-56" type="compound" text="glucose"/>
            <entity id="DS.d1643.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="61-68" type="protein" text="insulin"/>
            <pair e1="DS.d1643.s1.e0" e2="DS.d1643.s1.e1" id="DS.d1643.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1643.s2" origId="18849389-2689" text="During lactation, glucose and insulin profiles after a standard meal did not differ between sows from treatment groups.">
            <entity id="DS.d1643.s2.e0" origId="206,5793,64689,79025" charOffset="18-25" type="compound" text="glucose"/>
            <entity id="DS.d1643.s2.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="30-37" type="protein" text="insulin"/>
            <pair e1="DS.d1643.s2.e0" e2="DS.d1643.s2.e1" id="DS.d1643.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1644" origId="18849391">
        <sentence id="DS.d1644.s0" origId="18849391-1967" text="Effects of gram-negative bacterial lipopolysaccharide (LPS) and supplemental dietary Met on N balance, serum hormones and haptoglobin, and plasma urea-N and AA were evaluated in 20 Angus-cross steers (BW = 262+/-6.3 kg).">
            <entity id="DS.d1644.s0.e0" origId="11970143" charOffset="35-53" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d1644.s0.e1" origId="P19006" charOffset="122-133" type="protein" text="haptoglobin"/>
            <entity id="DS.d1644.s0.e2" origId="1176,265993" charOffset="146-150" type="compound" text="urea"/>
            <pair e1="DS.d1644.s0.e0" e2="DS.d1644.s0.e1" id="DS.d1644.s0.i0" interaction="False"/>
            <pair e1="DS.d1644.s0.e2" e2="DS.d1644.s0.e1" id="DS.d1644.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1644.s1" origId="18849391-1968" text="Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of cortisol, prolactin, tumor necrosis factor-alpha, and haptoglobin 0.01).">
            <entity id="DS.d1644.s1.e0" origId="5754" charOffset="123-131" type="compound" text="cortisol"/>
            <entity id="DS.d1644.s1.e1" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="133-142" type="protein" text="prolactin"/>
            <entity id="DS.d1644.s1.e2" origId="Q8JFG3" charOffset="144-165" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d1644.s1.e3" origId="P19006" charOffset="177-188" type="protein" text="haptoglobin"/>
            <pair e1="DS.d1644.s1.e0" e2="DS.d1644.s1.e3" id="DS.d1644.s1.i0" interaction="False"/>
            <pair e1="DS.d1644.s1.e0" e2="DS.d1644.s1.e2" id="DS.d1644.s1.i1" interaction="False"/>
            <pair e1="DS.d1644.s1.e0" e2="DS.d1644.s1.e1" id="DS.d1644.s1.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d1644.s2" origId="18849391-1969" text="Plasma urea-N was greater for+LPS than-LPS steers (LPS; P = 0.03), and serum IGF-1 was not affected (P &amp;gt; or = 0.26) by LPS or Met.">
            <entity id="DS.d1644.s2.e0" origId="1176,265993" charOffset="7-11" type="compound" text="urea"/>
            <entity id="DS.d1644.s2.e1" origId="Q95222" charOffset="77-82" type="protein" text="IGF-1"/>
            <pair e1="DS.d1644.s2.e0" e2="DS.d1644.s2.e1" id="DS.d1644.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1645" origId="18849413">
        <sentence id="DS.d1645.s0" origId="18849413-2041" text="Domain shape annealing is observed from branched to rounded shapes after SMase activity quenching by EDTA, with a decay halftime of approximately 10 min.">
            <entity id="DS.d1645.s0.e0" origId="P09599,P09978,P11889,P17627,P33377,P69502,Q2FWP1,Q5HEI1,Q9RLV9" charOffset="73-78" type="protein" text="SMase"/>
            <entity id="DS.d1645.s0.e1" origId="6049" charOffset="101-105" type="compound" text="EDTA"/>
            <pair e1="DS.d1645.s0.e1" e2="DS.d1645.s0.e0" id="DS.d1645.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1647" origId="18849420">
        <sentence id="DS.d1647.s0" origId="18849420-2060" text="Using neighborhood approaches, we were able to assign seven novel functional partners in luciferase synthesis, nitrogen metabolism, and quorum sensing to BLUF domain-containing proteins (involved in light sensing).">
            <entity id="DS.d1647.s0.e0" origId="P08659,P13129,Q01158,Q26304,Q27757" charOffset="89-99" type="protein" text="luciferase"/>
            <entity id="DS.d1647.s0.e1" origId="947,123329" charOffset="111-119" type="compound" text="nitrogen"/>
            <pair e1="DS.d1647.s0.e1" e2="DS.d1647.s0.e0" id="DS.d1647.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1648" origId="18849565">
        <sentence id="DS.d1648.s0" origId="18849565-2744" text="Chondroitin lyases (or chondroitinases) are a family of enzymes that depolymerize chondroitin sulfate (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.">
            <entity id="DS.d1648.s0.e0" origId="P34059" charOffset="23-38" type="protein" text="chondroitinases"/>
            <entity id="DS.d1648.s0.e1" origId="24766,21873177" charOffset="82-101" type="compound" text="chondroitin sulfate"/>
            <pair e1="DS.d1648.s0.e1" e2="DS.d1648.s0.e0" id="DS.d1648.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1649" origId="18849890">
        <sentence id="DS.d1649.s0" origId="18849890-22" text="We have assessed the impact of the functional C-1019G variant of the 5-HT1A receptor on the response to risperidone or haloperidol in a prospective, randomized, double-blind study.">
            <entity id="DS.d1649.s0.e0" origId="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298" charOffset="69-75" type="protein" text="5-HT1A"/>
            <entity id="DS.d1649.s0.e1" origId="5073" charOffset="104-115" type="compound" text="risperidone"/>
            <entity id="DS.d1649.s0.e2" origId="3559" charOffset="119-130" type="compound" text="haloperidol"/>
            <pair e1="DS.d1649.s0.e1" e2="DS.d1649.s0.e0" id="DS.d1649.s0.i0" interaction="True"/>
            <pair e1="DS.d1649.s0.e2" e2="DS.d1649.s0.e0" id="DS.d1649.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1650" origId="18850007">
        <sentence id="DS.d1650.s0" origId="18850007-61" text="This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) and cytosine methylation inhibitor 5-aza-2-deoxycytidine (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in RUNX3 silencing by hypoxia.">
            <entity id="DS.d1650.s0.e0" origId="444732" charOffset="100-114" type="compound" text="trichostatin A"/>
            <entity id="DS.d1650.s0.e2" origId="451668" charOffset="156-177" type="compound" text="5-aza-2-deoxycytidine"/>
            <entity id="DS.d1650.s0.e3" origId="Q13761" charOffset="257-262" type="protein" text="RUNX3"/>
            <pair e1="DS.d1650.s0.e2" e2="DS.d1650.s0.e3" id="DS.d1650.s0.i1" interaction="True"/>
            <pair e1="DS.d1650.s0.e0" e2="DS.d1650.s0.e3" id="DS.d1650.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1651" origId="18850009">
        <sentence id="DS.d1651.s0" origId="18850009-63" text="Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma.">
            <entity id="DS.d1651.s0.e0" origId="387447" charOffset="0-10" type="compound" text="Bortezomib"/>
            <entity id="DS.d1651.s0.e1" origId="P13612,Q00651,Q91687" charOffset="86-91" type="protein" text="VLA-4"/>
            <pair e1="DS.d1651.s0.e0" e2="DS.d1651.s0.e1" id="DS.d1651.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1652" origId="18850074">
        <sentence id="DS.d1652.s0" origId="18850074-89" text="Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells.">
            <entity id="DS.d1652.s0.e0" origId="31703" charOffset="0-11" type="compound" text="Doxorubicin"/>
            <entity id="DS.d1652.s0.e1" origId="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1" charOffset="12-23" type="protein" text="transferrin"/>
            <pair e1="DS.d1652.s0.e0" e2="DS.d1652.s0.e1" id="DS.d1652.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1652.s1" origId="18850074-90" text="The purpose of this study was to examine the distribution and action of doxorubicin-transferrin conjugate (DOXTRF) in a leukaemia cell line (HL60), a multidrug-resistant leukaemia cell line (HL60ADR) and a normal tissue cell line (human fibroblasts).">
            <entity id="DS.d1652.s1.e0" origId="31703" charOffset="72-83" type="compound" text="doxorubicin"/>
            <entity id="DS.d1652.s1.e1" origId="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1" charOffset="84-95" type="protein" text="transferrin"/>
            <pair e1="DS.d1652.s1.e0" e2="DS.d1652.s1.e1" id="DS.d1652.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1653" origId="18850096">
        <sentence id="DS.d1653.s0" origId="18850096-105" text="Purification of an alcohol dehydrogenase involved in the conversion of methional to methionol in Oenococcus oeni IOEB 8406.">
            <entity id="DS.d1653.s0.e0" origId="O31186,P00332,P00334,P06525,P07159,P07162,P0A9Q7,P0A9Q8,P10807,P12311,P14940,P17648,P21518,P21898,P22245,P23277,P23278,P23361,P25139,P25721,P25988,P26719,P28483,P28484,P33744,P37473,P42327,P42328,P48584,P48585,P48977,P51549,P51550,P51551,P51552,P71017,P84328,Q00669,Q00670,Q00671,Q00672,Q03384,Q05114,Q07588,Q09009,Q09010,Q24641,Q24803,Q27404,Q6LCE4,Q9GN94,Q9NAR7,Q9NG40,Q9NG42,Q9U8S9" charOffset="19-40" type="protein" text="alcohol dehydrogenase"/>
            <entity id="DS.d1653.s0.e1" origId="18635" charOffset="71-80" type="compound" text="methional"/>
            <entity id="DS.d1653.s0.e2" origId="10448" charOffset="84-93" type="compound" text="methionol"/>
            <pair e1="DS.d1653.s0.e2" e2="DS.d1653.s0.e0" id="DS.d1653.s0.i0" interaction="True"/>
            <pair e1="DS.d1653.s0.e1" e2="DS.d1653.s0.e0" id="DS.d1653.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1653.s1" origId="18850096-106" text="An NAD (P)H-dependent ADH involved in the reduction of methional was then purified to homogeneity.">
            <entity id="DS.d1653.s1.e0" origId="5893" charOffset="3-6" type="compound" text="NAD"/>
            <entity id="DS.d1653.s1.e1" origId="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7" charOffset="22-25" type="protein" text="ADH"/>
            <entity id="DS.d1653.s1.e2" origId="18635" charOffset="55-64" type="compound" text="methional"/>
            <pair e1="DS.d1653.s1.e0" e2="DS.d1653.s1.e1" id="DS.d1653.s1.i0" interaction="True"/>
            <pair e1="DS.d1653.s1.e2" e2="DS.d1653.s1.e1" id="DS.d1653.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1653.s2" origId="18850096-107" text="Sequencing of the purified enzyme and amino acid sequence comparison with the database revealed the presence of a conserved sequence motif specific to the medium-chain zinc-containing NAD (P)H-dependent ADHs.">
            <entity id="DS.d1653.s2.e0" origId="5893" charOffset="184-187" type="compound" text="NAD"/>
            <entity id="DS.d1653.s2.e1" origId="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7" charOffset="203-207" type="protein" text="ADHs"/>
            <pair e1="DS.d1653.s2.e0" e2="DS.d1653.s2.e1" id="DS.d1653.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1653.s3" origId="18850096-108" text="The purified ADH does not seem to be involved in the modification of buttery and lactic notes or to be involved in the specific formation of volatile alcohols during MLF.">
            <entity id="DS.d1653.s3.e0" origId="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7" charOffset="13-16" type="protein" text="ADH"/>
            <entity id="DS.d1653.s3.e1" origId="702" charOffset="150-158" type="compound" text="alcohols"/>
            <pair e1="DS.d1653.s3.e1" e2="DS.d1653.s3.e0" id="DS.d1653.s3.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1653.s4" origId="18850096-109" text="The function of the purified ADH remains unclear, although the role of the sulfur atom in methional molecules in the interaction between enzyme and substrate was evidenced.">
            <entity id="DS.d1653.s4.e0" origId="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7" charOffset="29-32" type="protein" text="ADH"/>
            <entity id="DS.d1653.s4.e1" origId="402" charOffset="75-86" type="compound" text="sulfur atom"/>
            <entity id="DS.d1653.s4.e2" origId="18635" charOffset="90-99" type="compound" text="methional"/>
            <pair e1="DS.d1653.s4.e2" e2="DS.d1653.s4.e0" id="DS.d1653.s4.i0" interaction="False"/>
            <pair e1="DS.d1653.s4.e1" e2="DS.d1653.s4.e0" id="DS.d1653.s4.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1654" origId="18850241">
        <sentence id="DS.d1654.s0" origId="18850241-169" text="All strains tested positive for cellulase activity while none where capable of xylan degradation.">
            <entity id="DS.d1654.s0.e0" origId="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7" charOffset="32-41" type="protein" text="cellulase"/>
            <entity id="DS.d1654.s0.e1" origId="50909243" charOffset="79-84" type="compound" text="xylan"/>
            <pair e1="DS.d1654.s0.e1" e2="DS.d1654.s0.e0" id="DS.d1654.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1655" origId="18850267">
        <sentence id="DS.d1655.s0" origId="18850267-174" text="In the present work we studied the effect of endothelin-1 and-3 on neuronal norepinephrine release and the short-term regulation of tyrosine hydroxylase in the olfactory bulb.">
            <entity id="DS.d1655.s0.e0" origId="P05305,Q28469" charOffset="45-57" type="protein" text="endothelin-1"/>
            <entity id="DS.d1655.s0.e1" origId="951,439260" charOffset="76-90" type="compound" text="norepinephrine"/>
            <pair e1="DS.d1655.s0.e1" e2="DS.d1655.s0.e0" id="DS.d1655.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1655.s1" origId="18850267-175" text="Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of protein kinase A and C, as well as Ca(2+)/calmodulin-dependent protein kinase II.">
            <entity id="DS.d1655.s1.e0" origId="Q05608,Q9RI12" charOffset="191-207" type="protein" text="protein kinase A"/>
            <entity id="DS.d1655.s1.e1" origId="271" charOffset="226-230" type="compound" text="Ca(2"/>
            <entity id="DS.d1655.s1.e2" origId="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0" charOffset="233-243" type="protein" text="calmodulin"/>
            <entity id="DS.d1655.s1.e3" origId="P00513,P25848" charOffset="191-205" type="protein" text="protein kinase"/>
            <pair e1="DS.d1655.s1.e1" e2="DS.d1655.s1.e0" id="DS.d1655.s1.i0" interaction="False"/>
            <pair e1="DS.d1655.s1.e1" e2="DS.d1655.s1.e3" id="DS.d1655.s1.i1" interaction="False"/>
            <pair e1="DS.d1655.s1.e1" e2="DS.d1655.s1.e2" id="DS.d1655.s1.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1656" origId="18850490">
        <sentence id="DS.d1656.s0" origId="18850490-228" text="The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (GSH) and serum urate.">
            <entity id="DS.d1656.s0.e0" origId="O50258" charOffset="226-246" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1656.s0.e1" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="248-251" type="protein" text="SOD"/>
            <entity id="DS.d1656.s0.e2" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="254-262" type="protein" text="catalase"/>
            <entity id="DS.d1656.s0.e3" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="264-267" type="protein" text="CAT"/>
            <entity id="DS.d1656.s0.e4" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="270-295" type="protein" text="glutathione S-transferase"/>
            <entity id="DS.d1656.s0.e5" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="297-300" type="protein" text="GST"/>
            <entity id="DS.d1656.s0.e6" origId="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655" charOffset="306-327" type="protein" text="glutathione reductase"/>
            <entity id="DS.d1656.s0.e8" origId="124886" charOffset="389-392" type="compound" text="GSH"/>
            <pair e1="DS.d1656.s0.e8" e2="DS.d1656.s0.e4" id="DS.d1656.s0.i1" interaction="False"/>
            <pair e1="DS.d1656.s0.e8" e2="DS.d1656.s0.e1" id="DS.d1656.s0.i2" interaction="False"/>
            <pair e1="DS.d1656.s0.e8" e2="DS.d1656.s0.e0" id="DS.d1656.s0.i5" interaction="False"/>
            <pair e1="DS.d1656.s0.e8" e2="DS.d1656.s0.e3" id="DS.d1656.s0.i7" interaction="False"/>
            <pair e1="DS.d1656.s0.e8" e2="DS.d1656.s0.e2" id="DS.d1656.s0.i10" interaction="False"/>
            <pair e1="DS.d1656.s0.e8" e2="DS.d1656.s0.e6" id="DS.d1656.s0.i11" interaction="False"/>
            <pair e1="DS.d1656.s0.e8" e2="DS.d1656.s0.e5" id="DS.d1656.s0.i12" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1657" origId="18851707">
        <sentence id="DS.d1657.s0" origId="18851707-551" text="P2X receptors are membrane cation channels gated by extracellular ATP.">
            <entity id="DS.d1657.s0.e0" origId="P13900,P16604" charOffset="0-3" type="protein" text="P2X"/>
            <entity id="DS.d1657.s0.e1" origId="5957" charOffset="66-69" type="compound" text="ATP"/>
            <pair e1="DS.d1657.s0.e1" e2="DS.d1657.s0.e0" id="DS.d1657.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1658" origId="18851710">
        <sentence id="DS.d1658.s0" origId="18851710-552" text="End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers (hsCRP (high-sensitivity C-reactive protein)) and endothelial function (FMD (flow-mediated dilation), ADMA (asymmetric dimethylarginine), PAI-1 (plasminogen activator inhibitor-1) and vWF (von Willebrand factor)).">
            <entity id="DS.d1658.s0.e0" origId="123831" charOffset="207-211" type="compound" text="ADMA"/>
            <entity id="DS.d1658.s0.e1" origId="123831" charOffset="213-240" type="compound" text="asymmetric dimethylarginine"/>
            <entity id="DS.d1658.s0.e2" origId="Q62935" charOffset="294-315" type="protein" text="von Willebrand factor"/>
            <pair e1="DS.d1658.s0.e1" e2="DS.d1658.s0.e2" id="DS.d1658.s0.i0" interaction="False"/>
            <pair e1="DS.d1658.s0.e0" e2="DS.d1658.s0.e2" id="DS.d1658.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1659" origId="18851713">
        <sentence id="DS.d1659.s0" origId="18851713-556" text="Addition of SOD (superoxide dismutase) doubled the amount of HOBr detected.">
            <entity id="DS.d1659.s0.e0" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="12-15" type="protein" text="SOD"/>
            <entity id="DS.d1659.s0.e1" origId="O50258" charOffset="17-37" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1659.s0.e2" origId="83547" charOffset="61-65" type="compound" text="HOBr"/>
            <pair e1="DS.d1659.s0.e2" e2="DS.d1659.s0.e1" id="DS.d1659.s0.i0" interaction="True"/>
            <pair e1="DS.d1659.s0.e2" e2="DS.d1659.s0.e0" id="DS.d1659.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1660" origId="18851895">
        <sentence id="DS.d1660.s0" origId="18851895-635" text="Drug-resistant cancer cells became sensitive to doxorubicin treatment when nucleophosmin was expressed in cytosol.">
            <entity id="DS.d1660.s0.e0" origId="31703" charOffset="48-59" type="compound" text="doxorubicin"/>
            <entity id="DS.d1660.s0.e1" origId="P06748,P07222,P13084,P16039,Q3T160,Q61937" charOffset="75-88" type="protein" text="nucleophosmin"/>
            <pair e1="DS.d1660.s0.e0" e2="DS.d1660.s0.e1" id="DS.d1660.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1661" origId="18851927">
        <sentence id="DS.d1661.s0" origId="18851927-647" text="All the analyzed resistant mutants exhibited both increased econazole efflux and increased transcription of mmpS5-mmpL5 genes, encoding a hypothetical efflux system belonging to the resistance-nodulation-division (RND) family of transporters.">
            <entity id="DS.d1661.s0.e0" origId="3198" charOffset="60-69" type="compound" text="econazole"/>
            <entity id="DS.d1661.s0.e1" origId="P65380,P65381" charOffset="108-113" type="protein" text="mmpS5"/>
            <entity id="DS.d1661.s0.e2" origId="O53784" charOffset="114-119" type="protein" text="mmpL5"/>
            <pair e1="DS.d1661.s0.e0" e2="DS.d1661.s0.e2" id="DS.d1661.s0.i0" interaction="False"/>
            <pair e1="DS.d1661.s0.e0" e2="DS.d1661.s0.e1" id="DS.d1661.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1662" origId="18851956">
        <sentence id="DS.d1662.s0" origId="18851956-1598" text="This study investigated the effects of atorvastatin on ABCB1 and ABCC1 mRNA expression on peripheral blood mononuclear cells (PBMC) and their relationship with gene polymorphisms and lowering-cholesterol response.">
            <entity id="DS.d1662.s0.e0" origId="P08183,P21448" charOffset="55-60" type="protein" text="ABCB1"/>
            <entity id="DS.d1662.s0.e1" origId="P33527,Q5F364" charOffset="65-70" type="protein" text="ABCC1"/>
            <entity id="DS.d1662.s0.e2" origId="304,5997,6432564,11025495" charOffset="192-203" type="compound" text="cholesterol"/>
            <pair e1="DS.d1662.s0.e2" e2="DS.d1662.s0.e0" id="DS.d1662.s0.i0" interaction="False"/>
            <pair e1="DS.d1662.s0.e2" e2="DS.d1662.s0.e1" id="DS.d1662.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1663" origId="18851994">
        <sentence id="DS.d1663.s0" origId="18851994-2766" text="While the three SAT isotypes showed comparable Km and k(cat) for L-serine and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by L-cysteine.">
            <entity id="DS.d1663.s0.e0" origId="O06736,O07308,O07309,O28606,O33580,O33581,O34764,O43252,O50273,O50274,O54820,O66036,O67174,O76156,O88428,O95340,P08536,P0A951,P0A952,P0A9D4,P0A9D5,P0A9D6,P0A9D7,P13441,P13442,P21156,P21673,P23145,P23845,P28603,P28604,P29847,P32003,P43886,P52978,P52995,P56862,P56863,P56864,P56892,P56893,P57162,P57498,P57499,P59740,P65670,P65671,P65672,P65673,P67764,P67765,P67766,P71405,P72338,P72339,P74089,P74241,P77985,P78937,P84547,Q01612,Q06750,Q10600,Q12555,Q12650,Q27128,Q28999,Q3T0Q0,Q54506,Q56002,Q59967,Q5HIE6,Q5HL01,Q5HRM4,Q60967,Q60FC6,Q6GBV9,Q6GJE0,Q7MPF2,Q7MPF3,Q7N8L0,Q7NVN5,Q7UMW2,Q83JX8,Q87DG7,Q87DG8,Q87SX9,Q87SY0,Q87WW0,Q88NA9,Q89B11,Q8AAP9,Q8AXL1,Q8CR03,Q8CTU2,Q8DE72,Q8DE73,Q8EB10,Q8FEJ0,Q8FEJ1,Q8UH69,Q8X7X4,Q8X7X7,Q8Z470,Q8ZBP1,Q8ZBP2,Q8ZMF5,Q9JHW6,Q9KP19,Q9KP20,Q9PD78,Q9PD79,Q9X5U0,Q9Y872,Q9YCR4,Q9ZK14" charOffset="16-19" type="protein" text="SAT"/>
            <entity id="DS.d1663.s0.e1" origId="5951" charOffset="65-73" type="compound" text="L-serine"/>
            <entity id="DS.d1663.s0.e2" origId="581,5862,5460838" charOffset="163-173" type="compound" text="L-cysteine"/>
            <pair e1="DS.d1663.s0.e2" e2="DS.d1663.s0.e0" id="DS.d1663.s0.i0" interaction="True"/>
            <pair e1="DS.d1663.s0.e1" e2="DS.d1663.s0.e0" id="DS.d1663.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1663.s1" origId="18851994-2767" text="We propose that multiple SAT isotypes with different properties may play complementary roles in the regulation of the cysteine biosynthetic pathway in E. histolytica under different conditions, e.g.">
            <entity id="DS.d1663.s1.e0" origId="O06736,O07308,O07309,O28606,O33580,O33581,O34764,O43252,O50273,O50274,O54820,O66036,O67174,O76156,O88428,O95340,P08536,P0A951,P0A952,P0A9D4,P0A9D5,P0A9D6,P0A9D7,P13441,P13442,P21156,P21673,P23145,P23845,P28603,P28604,P29847,P32003,P43886,P52978,P52995,P56862,P56863,P56864,P56892,P56893,P57162,P57498,P57499,P59740,P65670,P65671,P65672,P65673,P67764,P67765,P67766,P71405,P72338,P72339,P74089,P74241,P77985,P78937,P84547,Q01612,Q06750,Q10600,Q12555,Q12650,Q27128,Q28999,Q3T0Q0,Q54506,Q56002,Q59967,Q5HIE6,Q5HL01,Q5HRM4,Q60967,Q60FC6,Q6GBV9,Q6GJE0,Q7MPF2,Q7MPF3,Q7N8L0,Q7NVN5,Q7UMW2,Q83JX8,Q87DG7,Q87DG8,Q87SX9,Q87SY0,Q87WW0,Q88NA9,Q89B11,Q8AAP9,Q8AXL1,Q8CR03,Q8CTU2,Q8DE72,Q8DE73,Q8EB10,Q8FEJ0,Q8FEJ1,Q8UH69,Q8X7X4,Q8X7X7,Q8Z470,Q8ZBP1,Q8ZBP2,Q8ZMF5,Q9JHW6,Q9KP19,Q9KP20,Q9PD78,Q9PD79,Q9X5U0,Q9Y872,Q9YCR4,Q9ZK14" charOffset="25-28" type="protein" text="SAT"/>
            <entity id="DS.d1663.s1.e1" origId="594,5862,5360637" charOffset="118-126" type="compound" text="cysteine"/>
            <pair e1="DS.d1663.s1.e1" e2="DS.d1663.s1.e0" id="DS.d1663.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1664" origId="18852015">
        <sentence id="DS.d1664.s0" origId="18852015-684" text="At 1 min before the exposure rats were treated with one of the following: intravenous aprotinin, 4.4 mg/kg; intraperitoneal (ip) ilomastat, 25mg/kg; or ip trolox, 500 microg/kg.">
            <entity id="DS.d1664.s0.e0" origId="P00974" charOffset="86-95" type="protein" text="aprotinin"/>
            <entity id="DS.d1664.s0.e1" origId="132519" charOffset="129-138" type="compound" text="ilomastat"/>
            <entity id="DS.d1664.s0.e2" origId="40634" charOffset="155-161" type="compound" text="trolox"/>
            <pair e1="DS.d1664.s0.e1" e2="DS.d1664.s0.e0" id="DS.d1664.s0.i0" interaction="False"/>
            <pair e1="DS.d1664.s0.e2" e2="DS.d1664.s0.e0" id="DS.d1664.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1664.s1" origId="18852015-685" text="Treatment with aprotinin or ilomastat eliminated these PF changes, yielding results comparable with controls for each of these parameters.">
            <entity id="DS.d1664.s1.e0" origId="P00974" charOffset="15-24" type="protein" text="aprotinin"/>
            <entity id="DS.d1664.s1.e1" origId="132519" charOffset="28-37" type="compound" text="ilomastat"/>
            <pair e1="DS.d1664.s1.e1" e2="DS.d1664.s1.e0" id="DS.d1664.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1664.s2" origId="18852015-686" text="While aprotinin and ilomastat both alleviated the PF perturbations, surprisingly only aprotinin reduced the observed pathology, both grossly and histologically.">
            <entity id="DS.d1664.s2.e0" origId="P00974" charOffset="6-15" type="protein" text="aprotinin"/>
            <entity id="DS.d1664.s2.e1" origId="132519" charOffset="20-29" type="compound" text="ilomastat"/>
            <entity id="DS.d1664.s2.e2" origId="P00974" charOffset="86-95" type="protein" text="aprotinin"/>
            <pair e1="DS.d1664.s2.e1" e2="DS.d1664.s2.e0" id="DS.d1664.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1664.s3" origId="18852015-687" text="These early results indicate that treatment with aprotinin and to a lesser extent ilomastat reduces some of the direct inflammatory response and damage associated with SM-induced lung injury.">
            <entity id="DS.d1664.s3.e0" origId="P00974" charOffset="49-58" type="protein" text="aprotinin"/>
            <entity id="DS.d1664.s3.e1" origId="132519" charOffset="82-91" type="compound" text="ilomastat"/>
            <pair e1="DS.d1664.s3.e1" e2="DS.d1664.s3.e0" id="DS.d1664.s3.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1666" origId="18852063">
        <sentence id="DS.d1666.s0" origId="18852063-706" text="Spermine oxidase (SMO) is a FAD-containing enzyme involved in animal cell polyamines (PA) homeostasis, selectively active on spermine and producing H(2)O(2), spermidine, and the 3-aminopropanal.">
            <entity id="DS.d1666.s0.e0" origId="Q99K82,Q9NWM0" charOffset="0-16" type="protein" text="Spermine oxidase"/>
            <entity id="DS.d1666.s0.e1" origId="O42224,P56726,P97698,Q99835,Q9NWM0" charOffset="18-21" type="protein" text="SMO"/>
            <entity id="DS.d1666.s0.e2" origId="1103" charOffset="125-133" type="compound" text="spermine"/>
            <pair e1="DS.d1666.s0.e2" e2="DS.d1666.s0.e1" id="DS.d1666.s0.i0" interaction="True"/>
            <pair e1="DS.d1666.s0.e2" e2="DS.d1666.s0.e0" id="DS.d1666.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1667" origId="18852217">
        <sentence id="DS.d1667.s0" origId="18852217-740" text="Pretreatment with DEX abrogated calcitonin inhibition by sst (2)-preferring analogue octreotide in TT.">
            <entity id="DS.d1667.s0.e0" origId="P01258,P01259,P01260,P01262,P0C234" charOffset="32-42" type="protein" text="calcitonin"/>
            <entity id="DS.d1667.s0.e1" origId="383414,448601" charOffset="85-95" type="compound" text="octreotide"/>
            <pair e1="DS.d1667.s0.e1" e2="DS.d1667.s0.e0" id="DS.d1667.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1668" origId="18852255">
        <sentence id="DS.d1668.s0" origId="18852255-2230" text="Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.">
            <entity id="DS.d1668.s0.e0" origId="5280492" charOffset="0-14" type="compound" text="Leukotriene B4"/>
            <entity id="DS.d1668.s0.e1" origId="Q15722" charOffset="78-82" type="protein" text="BLT1"/>
            <pair e1="DS.d1668.s0.e0" e2="DS.d1668.s0.e1" id="DS.d1668.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1669" origId="18853098">
        <sentence id="DS.d1669.s0" origId="18853098-1027" text="Semicarbazide-sensitive amine oxidase activity and total nitrite and nitrate concentrations in serum: novel biochemical markers for type 2 diabetes.">
            <entity id="DS.d1669.s0.e0" origId="O08590,O70423,Q16853,Q5R9I0,Q9TTK6" charOffset="0-37" type="protein" text="Semicarbazide-sensitive amine oxidase"/>
            <entity id="DS.d1669.s0.e1" origId="943" charOffset="69-76" type="compound" text="nitrate"/>
            <pair e1="DS.d1669.s0.e1" e2="DS.d1669.s0.e0" id="DS.d1669.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1669.s1" origId="18853098-1028" text="The aim of this study was to evaluate the activity of semicarbazide-sensitive amine oxidase (SSAO) and the total nitrite and nitrate (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.">
            <entity id="DS.d1669.s1.e0" origId="O08590,O70423,Q16853,Q5R9I0,Q9TTK6" charOffset="54-91" type="protein" text="semicarbazide-sensitive amine oxidase"/>
            <entity id="DS.d1669.s1.e1" origId="O08590,O70423,Q16853,Q5R9I0,Q9TTK6" charOffset="93-97" type="protein" text="SSAO"/>
            <entity id="DS.d1669.s1.e2" origId="943" charOffset="125-132" type="compound" text="nitrate"/>
            <pair e1="DS.d1669.s1.e2" e2="DS.d1669.s1.e1" id="DS.d1669.s1.i0" interaction="False"/>
            <pair e1="DS.d1669.s1.e2" e2="DS.d1669.s1.e0" id="DS.d1669.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1670" origId="18853099">
        <sentence id="DS.d1670.s0" origId="18853099-1030" text="Serum lipid, creatinine, uric acid, CRP, HbA(1C) and urinary albumin concentration were measured.">
            <entity id="DS.d1670.s0.e0" origId="588" charOffset="13-23" type="compound" text="creatinine"/>
            <entity id="DS.d1670.s0.e1" origId="1175" charOffset="25-34" type="compound" text="uric acid"/>
            <entity id="DS.d1670.s0.e2" origId="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203" charOffset="36-39" type="protein" text="CRP"/>
            <pair e1="DS.d1670.s0.e1" e2="DS.d1670.s0.e2" id="DS.d1670.s0.i0" interaction="False"/>
            <pair e1="DS.d1670.s0.e0" e2="DS.d1670.s0.e2" id="DS.d1670.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1671" origId="18853102">
        <sentence id="DS.d1671.s0" origId="18853102-1107" text="Cryptolepine activity showed highest correlations to topoisomerase II and microtubule targeting drugs.">
            <entity id="DS.d1671.s0.e0" origId="82143" charOffset="0-12" type="compound" text="Cryptolepine"/>
            <entity id="DS.d1671.s0.e1" origId="O29238,O51934,O58530,O67037,O67226,P74759,P95479,Q08582,Q58907,Q6F598,Q8R979,Q8ZXT5,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9UZ86,Q9YC75,Q9YCB6" charOffset="53-66" type="protein" text="topoisomerase"/>
            <pair e1="DS.d1671.s0.e0" e2="DS.d1671.s0.e1" id="DS.d1671.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1672" origId="18853145">
        <sentence id="DS.d1672.s0" origId="18853145-1060" text="Ulcerated tissues were processed to assess ulcer area, malondialdehyde, proliferating cell nuclear antigen (PCNA) and cleaved caspase-3.">
            <entity id="DS.d1672.s0.e0" origId="10964" charOffset="55-70" type="compound" text="malondialdehyde"/>
            <entity id="DS.d1672.s0.e1" origId="O01377,O02115,O16852,O82134,O82797,P04961,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00268,Q03392,Q43124,Q43266,Q6B6N4,Q9DDF1,Q9DEA3,Q9MAY3,Q9PTP1,Q9W644" charOffset="72-106" type="protein" text="proliferating cell nuclear antigen"/>
            <entity id="DS.d1672.s0.e2" origId="O01377,O02115,O10308,O16852,O27367,O29912,O58398,O73947,O82134,O82797,P04961,P11038,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00265,Q00268,Q03392,Q43124,Q43266,Q57697,Q6B6N4,Q6KZF1,Q6LWJ8,Q74MV1,Q7T6Y0,Q8PX25,Q8TUF7,Q8TWK3,Q979S2,Q9DDF1,Q9DEA3,Q9HJQ0,Q9HN45,Q9M7Q7,Q9MAY3,Q9P9H8,Q9PTP1,Q9UWR9,Q9UYX8,Q9W644" charOffset="108-112" type="protein" text="PCNA"/>
            <pair e1="DS.d1672.s0.e0" e2="DS.d1672.s0.e1" id="DS.d1672.s0.i0" interaction="False"/>
            <pair e1="DS.d1672.s0.e0" e2="DS.d1672.s0.e2" id="DS.d1672.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1673" origId="18853166">
        <sentence id="DS.d1673.s0" origId="18853166-1068" text="Serum NO, catalase and glutathione were measured.">
            <entity id="DS.d1673.s0.e0" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="10-18" type="protein" text="catalase"/>
            <entity id="DS.d1673.s0.e1" origId="124886" charOffset="23-34" type="compound" text="glutathione"/>
            <pair e1="DS.d1673.s0.e1" e2="DS.d1673.s0.e0" id="DS.d1673.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1673.s1" origId="18853166-1069" text="Serum glutathione and catalase levels were significantly lower in FM patients than controls.">
            <entity id="DS.d1673.s1.e0" origId="124886" charOffset="6-17" type="compound" text="glutathione"/>
            <entity id="DS.d1673.s1.e1" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="22-30" type="protein" text="catalase"/>
            <pair e1="DS.d1673.s1.e0" e2="DS.d1673.s1.e1" id="DS.d1673.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1674" origId="18853182">
        <sentence id="DS.d1674.s0" origId="18853182-1073" text="This article discusses the physiology of proximal Na (+)/H(+) exchange, the multiple mechanisms of NHE3 regulation, and the reciprocal relationship between NHE3 and NHE8 at the lumen of the proximal tubule.">
            <entity id="DS.d1674.s0.e0" origId="923,373840" charOffset="50-52" type="compound" text="Na"/>
            <entity id="DS.d1674.s0.e1" origId="P26432,P48764,Q28362" charOffset="99-103" type="protein" text="NHE3"/>
            <entity id="DS.d1674.s0.e2" origId="P26432,P48764,Q28362" charOffset="156-160" type="protein" text="NHE3"/>
            <entity id="DS.d1674.s0.e3" origId="Q9Y2E8" charOffset="165-169" type="protein" text="NHE8"/>
            <pair e1="DS.d1674.s0.e0" e2="DS.d1674.s0.e1" id="DS.d1674.s0.i0" interaction="False"/>
            <pair e1="DS.d1674.s0.e0" e2="DS.d1674.s0.e3" id="DS.d1674.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1675" origId="18853185">
        <sentence id="DS.d1675.s0" origId="18853185-1077" text="Cortisol and DHEA-sulfate response to rapid adrenocorticotropic hormone (ACTH) stimulation was inadequate.">
            <entity id="DS.d1675.s0.e0" origId="5754" charOffset="0-8" type="compound" text="Cortisol"/>
            <entity id="DS.d1675.s0.e1" origId="12594" charOffset="13-25" type="compound" text="DHEA-sulfate"/>
            <entity id="DS.d1675.s0.e2" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="44-71" type="protein" text="adrenocorticotropic hormone"/>
            <entity id="DS.d1675.s0.e3" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="73-77" type="protein" text="ACTH"/>
            <pair e1="DS.d1675.s0.e0" e2="DS.d1675.s0.e3" id="DS.d1675.s0.i0" interaction="False"/>
            <pair e1="DS.d1675.s0.e1" e2="DS.d1675.s0.e2" id="DS.d1675.s0.i1" interaction="False"/>
            <pair e1="DS.d1675.s0.e1" e2="DS.d1675.s0.e3" id="DS.d1675.s0.i2" interaction="False"/>
            <pair e1="DS.d1675.s0.e0" e2="DS.d1675.s0.e2" id="DS.d1675.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1676" origId="18853207">
        <sentence id="DS.d1676.s0" origId="18853207-1083" text="The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.">
            <entity id="DS.d1676.s0.e0" origId="O31186,P00332,P00334,P06525,P07159,P07162,P0A9Q7,P0A9Q8,P10807,P12311,P14940,P17648,P21518,P21898,P22245,P23277,P23278,P23361,P25139,P25721,P25988,P26719,P28483,P28484,P33744,P37473,P42327,P42328,P48584,P48585,P48977,P51549,P51550,P51551,P51552,P71017,P84328,Q00669,Q00670,Q00671,Q00672,Q03384,Q05114,Q07588,Q09009,Q09010,Q24641,Q24803,Q27404,Q6LCE4,Q9GN94,Q9NAR7,Q9NG40,Q9NG42,Q9U8S9" charOffset="107-128" type="protein" text="alcohol dehydrogenase"/>
            <entity id="DS.d1676.s0.e1" origId="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7" charOffset="130-133" type="protein" text="ADH"/>
            <entity id="DS.d1676.s0.e2" origId="P37830,P48826" charOffset="174-179" type="protein" text="G6PDH"/>
            <entity id="DS.d1676.s0.e3" origId="8868" charOffset="256-276" type="compound" text="ethyl-3-oxobutanoate"/>
            <entity id="DS.d1676.s0.e4" origId="9547937" charOffset="278-281" type="compound" text="EOB"/>
            <entity id="DS.d1676.s0.e5" origId="94318" charOffset="293-314" type="compound" text="S)-3-hydroxybutanoate"/>
            <entity id="DS.d1676.s0.e6" origId="46942358" charOffset="320-323" type="compound" text="EHB"/>
            <pair e1="DS.d1676.s0.e4" e2="DS.d1676.s0.e1" id="DS.d1676.s0.i0" interaction="True"/>
            <pair e1="DS.d1676.s0.e5" e2="DS.d1676.s0.e1" id="DS.d1676.s0.i1" interaction="True"/>
            <pair e1="DS.d1676.s0.e3" e2="DS.d1676.s0.e2" id="DS.d1676.s0.i2" interaction="True"/>
            <pair e1="DS.d1676.s0.e3" e2="DS.d1676.s0.e0" id="DS.d1676.s0.i3" interaction="True"/>
            <pair e1="DS.d1676.s0.e6" e2="DS.d1676.s0.e1" id="DS.d1676.s0.i4" interaction="True"/>
            <pair e1="DS.d1676.s0.e6" e2="DS.d1676.s0.e0" id="DS.d1676.s0.i5" interaction="True"/>
            <pair e1="DS.d1676.s0.e4" e2="DS.d1676.s0.e0" id="DS.d1676.s0.i6" interaction="True"/>
            <pair e1="DS.d1676.s0.e6" e2="DS.d1676.s0.e2" id="DS.d1676.s0.i7" interaction="True"/>
            <pair e1="DS.d1676.s0.e5" e2="DS.d1676.s0.e2" id="DS.d1676.s0.i8" interaction="True"/>
            <pair e1="DS.d1676.s0.e5" e2="DS.d1676.s0.e0" id="DS.d1676.s0.i9" interaction="True"/>
            <pair e1="DS.d1676.s0.e4" e2="DS.d1676.s0.e2" id="DS.d1676.s0.i10" interaction="True"/>
            <pair e1="DS.d1676.s0.e3" e2="DS.d1676.s0.e1" id="DS.d1676.s0.i11" interaction="True"/>
        </sentence>
        <sentence id="DS.d1676.s1" origId="18853207-1084" text="The intracellular levels of ADH and G6PDH after permeabilization of these stored cells with cetyltrimetylammonium bromide (CTAB) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.">
            <entity id="DS.d1676.s1.e0" origId="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7" charOffset="28-31" type="protein" text="ADH"/>
            <entity id="DS.d1676.s1.e1" origId="P37830,P48826" charOffset="36-41" type="protein" text="G6PDH"/>
            <entity id="DS.d1676.s1.e2" origId="2681" charOffset="123-127" type="compound" text="CTAB"/>
            <pair e1="DS.d1676.s1.e2" e2="DS.d1676.s1.e0" id="DS.d1676.s1.i0" interaction="True"/>
            <pair e1="DS.d1676.s1.e2" e2="DS.d1676.s1.e1" id="DS.d1676.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1677" origId="18853234">
        <sentence id="DS.d1677.s0" origId="18853234-1098" text="Streptokinase (SK), glucose oxidase (GOx) and phosphorylcholine (PC) were immobilized onto PGLD to obtain a blood compatible bioconjugate with glucose sensing properties.">
            <entity id="DS.d1677.s0.e0" origId="P81156" charOffset="20-35" type="protein" text="glucose oxidase"/>
            <entity id="DS.d1677.s0.e1" origId="1014" charOffset="46-63" type="compound" text="phosphorylcholine"/>
            <pair e1="DS.d1677.s0.e1" e2="DS.d1677.s0.e0" id="DS.d1677.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1678" origId="18854222">
        <sentence id="DS.d1678.s0" origId="18854222-1462" text="Treatment of RPE cells with high glucose-induced a significant increased of iNOS, accompanied by an increase in cell damage, NO and nitrotyrosine levels.">
            <entity id="DS.d1678.s0.e0" origId="206,64689" charOffset="33-40" type="compound" text="glucose"/>
            <entity id="DS.d1678.s0.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="76-80" type="protein" text="iNOS"/>
            <pair e1="DS.d1678.s0.e0" e2="DS.d1678.s0.e1" id="DS.d1678.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1678.s1" origId="18854222-1464" text="High glucose causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of p38MAPK and ERK.">
            <entity id="DS.d1678.s1.e0" origId="206,64689" charOffset="5-12" type="compound" text="glucose"/>
            <entity id="DS.d1678.s1.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="89-93" type="protein" text="iNOS"/>
            <entity id="DS.d1678.s1.e2" origId="O62618" charOffset="137-144" type="protein" text="p38MAPK"/>
            <entity id="DS.d1678.s1.e3" origId="P29323" charOffset="149-152" type="protein" text="ERK"/>
            <pair e1="DS.d1678.s1.e0" e2="DS.d1678.s1.e1" id="DS.d1678.s1.i0" interaction="True"/>
            <pair e1="DS.d1678.s1.e0" e2="DS.d1678.s1.e3" id="DS.d1678.s1.i1" interaction="False"/>
            <pair e1="DS.d1678.s1.e0" e2="DS.d1678.s1.e2" id="DS.d1678.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1679" origId="18854226">
        <sentence id="DS.d1679.s0" origId="18854226-1467" text="A crude peel extract and purified fraction of Flemingia vestita, as well as a crude rhizome extract of Stephania glabra and fractions were tested with respect to the activity of NOS, NO efflux and cGMP concentration in the cestode Raillietina echinobothrida in order to find out the possible mode of anthelmintic action of these plant-derived components.">
            <entity id="DS.d1679.s0.e0" origId="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2" charOffset="178-181" type="protein" text="NOS"/>
            <entity id="DS.d1679.s0.e1" origId="24316" charOffset="197-201" type="compound" text="cGMP"/>
            <pair e1="DS.d1679.s0.e1" e2="DS.d1679.s0.e0" id="DS.d1679.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1680" origId="18854307">
        <sentence id="DS.d1680.s0" origId="18854307-761" text="Our data suggest that PKCalpha translocates to the contractile system and anchors to TnI in a Ca(2+)-dependent manner in the human heart, contributing to the maintenance of contractile force.">
            <entity id="DS.d1680.s0.e0" origId="P04409,P05696,P10102,P17252,P20444" charOffset="22-30" type="protein" text="PKCalpha"/>
            <entity id="DS.d1680.s0.e1" origId="P05547,P36188,Q7M3Y3" charOffset="85-88" type="protein" text="TnI"/>
            <entity id="DS.d1680.s0.e2" origId="271" charOffset="94-98" type="compound" text="Ca(2"/>
            <pair e1="DS.d1680.s0.e2" e2="DS.d1680.s0.e0" id="DS.d1680.s0.i0" interaction="True"/>
            <pair e1="DS.d1680.s0.e2" e2="DS.d1680.s0.e1" id="DS.d1680.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1681" origId="18854368">
        <sentence id="DS.d1681.s0" origId="18854368-1518" text="In this study, we describe the crystal structure of yeast PNGase in complex with N,N'-diacetylchitobiose (chitobiose).">
            <entity id="DS.d1681.s0.e0" origId="O74739,Q02890,Q4R6F3,Q503I8,Q59Q38,Q5XI55,Q5ZJM3,Q6BNI6,Q6CAX5,Q6CLZ6,Q6FRU8,Q75D29,Q7KRR5,Q96IV0,Q9JI78" charOffset="58-64" type="protein" text="PNGase"/>
            <entity id="DS.d1681.s0.e1" origId="439544" charOffset="81-104" type="compound" text="N,N'-diacetylchitobiose"/>
            <pair e1="DS.d1681.s0.e1" e2="DS.d1681.s0.e0" id="DS.d1681.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1681.s1" origId="18854368-1519" text="Mutagenesis studies confirm the critical role of the chitobiose-interacting residues in substrate binding and suggest that efficient oligosaccharide binding is required for PNGase activity.">
            <entity id="DS.d1681.s1.e0" origId="439544" charOffset="53-63" type="compound" text="chitobiose"/>
            <entity id="DS.d1681.s1.e1" origId="O74739,Q02890,Q4R6F3,Q503I8,Q59Q38,Q5XI55,Q5ZJM3,Q6BNI6,Q6CAX5,Q6CLZ6,Q6FRU8,Q75D29,Q7KRR5,Q96IV0,Q9JI78" charOffset="173-179" type="protein" text="PNGase"/>
            <pair e1="DS.d1681.s1.e0" e2="DS.d1681.s1.e1" id="DS.d1681.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1682" origId="18854379">
        <sentence id="DS.d1682.s0" origId="18854379-1521" text="Prediction of the effect of erythromycin, diltiazem, and their metabolites, alone and in combination, on CYP3A4 inhibition.">
            <entity id="DS.d1682.s0.e0" origId="12560" charOffset="28-40" type="compound" text="erythromycin"/>
            <entity id="DS.d1682.s0.e1" origId="39186" charOffset="42-51" type="compound" text="diltiazem"/>
            <entity id="DS.d1682.s0.e2" origId="P08684" charOffset="105-111" type="protein" text="CYP3A4"/>
            <pair e1="DS.d1682.s0.e1" e2="DS.d1682.s0.e2" id="DS.d1682.s0.i0" interaction="False"/>
            <pair e1="DS.d1682.s0.e0" e2="DS.d1682.s0.e2" id="DS.d1682.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1683" origId="18854401">
        <sentence id="DS.d1683.s0" origId="18854401-1524" text="Previous studies have suggested a regulatory relationship between serum phosphorus, vitamin D, and fibroblast growth factor 23 (FGF23), a hormone that promotes renal excretion of phosphate.">
            <entity id="DS.d1683.s0.e0" origId="24404,139579" charOffset="72-82" type="compound" text="phosphorus"/>
            <entity id="DS.d1683.s0.e1" origId="5280795" charOffset="84-93" type="compound" text="vitamin D"/>
            <entity id="DS.d1683.s0.e2" origId="Q5MK86,Q9GZV9" charOffset="128-133" type="protein" text="FGF23"/>
            <pair e1="DS.d1683.s0.e0" e2="DS.d1683.s0.e2" id="DS.d1683.s0.i0" interaction="True"/>
            <pair e1="DS.d1683.s0.e1" e2="DS.d1683.s0.e2" id="DS.d1683.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1683.s1" origId="18854401-1525" text="This condition is caused by mutations in the PTH/PTHrP receptor that result in ligand-independent cAMP accumulation, thus rendering the receptor constitutively active.">
            <entity id="DS.d1683.s1.e0" origId="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3" charOffset="45-48" type="protein" text="PTH"/>
            <entity id="DS.d1683.s1.e1" origId="P12272,P13085,P17251,P22858,P52211,P58073,Q9GK30,Q9GLC7,Q9GMB7" charOffset="49-54" type="protein" text="PTHrP"/>
            <entity id="DS.d1683.s1.e2" origId="6076" charOffset="98-102" type="compound" text="cAMP"/>
            <pair e1="DS.d1683.s1.e2" e2="DS.d1683.s1.e1" id="DS.d1683.s1.i0" interaction="True"/>
            <pair e1="DS.d1683.s1.e2" e2="DS.d1683.s1.e0" id="DS.d1683.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1684" origId="18854421">
        <sentence id="DS.d1684.s0" origId="18854421-1530" text="Adiponectin, an adipokine secreted by the white adipose tissue, plays an important role in regulating glucose and lipid metabolism and controlling energy homeostasis in insulin-sensitive tissues.">
            <entity id="DS.d1684.s0.e0" origId="206,5793,64689,79025" charOffset="102-109" type="compound" text="glucose"/>
            <entity id="DS.d1684.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="169-176" type="protein" text="insulin"/>
            <pair e1="DS.d1684.s0.e0" e2="DS.d1684.s0.e1" id="DS.d1684.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1685" origId="18854429">
        <sentence id="DS.d1685.s0" origId="18854429-993" text="Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.">
            <entity id="DS.d1685.s0.e0" origId="Q8VCC8,Q9Z1C8" charOffset="0-4" type="protein" text="Epac"/>
            <entity id="DS.d1685.s0.e1" origId="6076" charOffset="20-24" type="compound" text="cAMP"/>
            <pair e1="DS.d1685.s0.e1" e2="DS.d1685.s0.e0" id="DS.d1685.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1685.s1" origId="18854429-994" text="Both Epac and PKA are effectors of the second messenger cAMP.">
            <entity id="DS.d1685.s1.e0" origId="Q8VCC8,Q9Z1C8" charOffset="5-9" type="protein" text="Epac"/>
            <entity id="DS.d1685.s1.e1" origId="6076" charOffset="56-60" type="compound" text="cAMP"/>
            <pair e1="DS.d1685.s1.e1" e2="DS.d1685.s1.e0" id="DS.d1685.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1686" origId="18854435">
        <sentence id="DS.d1686.s0" origId="18854435-1007" text="Since a polypeptide lacking the proline-rich region (P-region) of huntingtin (103Q) cannot form aggresomes, this domain serves as an aggresome-targeting signal.">
            <entity id="DS.d1686.s0.e0" origId="614,8988,145742" charOffset="32-39" type="compound" text="proline"/>
            <entity id="DS.d1686.s0.e1" origId="P42858,P42859,P51111,P51112" charOffset="66-76" type="protein" text="huntingtin"/>
            <pair e1="DS.d1686.s0.e0" e2="DS.d1686.s0.e1" id="DS.d1686.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1687" origId="18854599">
        <sentence id="DS.d1687.s0" origId="18854599-1421" text="Expression of UDP-N-acetyl-D-galactosamine : polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma.">
            <entity id="DS.d1687.s0.e0" origId="1167,439185,23724461" charOffset="14-42" type="compound" text="UDP-N-acetyl-D-galactosamine"/>
            <entity id="DS.d1687.s0.e1" origId="Q5EA41,Q8C7U7,Q8NCL4" charOffset="45-92" type="protein" text="polypeptide N-acetylgalactosaminyltransferase-6"/>
            <pair e1="DS.d1687.s0.e0" e2="DS.d1687.s0.e1" id="DS.d1687.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1687.s1" origId="18854599-1422" text="UDP-N-acetyl-d-galactosamine : polypeptide N-acetylgalactosaminyltransferase-6 (ppGalNAc-T6) is one of the enzymes responsible for the initial step in O-glycosylation.">
            <entity id="DS.d1687.s1.e0" origId="1167,439185,23724461" charOffset="0-28" type="compound" text="UDP-N-acetyl-d-galactosamine"/>
            <entity id="DS.d1687.s1.e1" origId="Q5EA41,Q8C7U7,Q8NCL4" charOffset="31-78" type="protein" text="polypeptide N-acetylgalactosaminyltransferase-6"/>
            <pair e1="DS.d1687.s1.e0" e2="DS.d1687.s1.e1" id="DS.d1687.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1688" origId="18854840">
        <sentence id="DS.d1688.s0" origId="18854840-1661" text="In addition, SAH caused large increases in markers of inflammation, including TNFalpha and NFkappaB, and markers of cell injury or cell death, including IgG endocytosis and caspase-3 activation, with glibenclamide significantly reducing these effects.">
            <entity id="DS.d1688.s0.e0" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="78-86" type="protein" text="TNFalpha"/>
            <entity id="DS.d1688.s0.e1" origId="3488" charOffset="200-213" type="compound" text="glibenclamide"/>
            <pair e1="DS.d1688.s0.e1" e2="DS.d1688.s0.e0" id="DS.d1688.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1688.s1" origId="18854840-1662" text="We conclude that block of SUR1 by glibenclamide may ameliorate several pathologic effects associated with inflammation that lead to cortical dysfunction after SAH.">
            <entity id="DS.d1688.s1.e0" origId="P33300,Q09428" charOffset="26-30" type="protein" text="SUR1"/>
            <entity id="DS.d1688.s1.e1" origId="3488" charOffset="34-47" type="compound" text="glibenclamide"/>
            <pair e1="DS.d1688.s1.e1" e2="DS.d1688.s1.e0" id="DS.d1688.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1689" origId="18854981">
        <sentence id="DS.d1689.s0" origId="18854981-1711" text="Intrinsic fluorescence of tryptophan-214 in HSA was monitored upon addition of the chemicals.">
            <entity id="DS.d1689.s0.e0" origId="1148,6305,9060,5460840" charOffset="26-36" type="compound" text="tryptophan"/>
            <entity id="DS.d1689.s0.e1" origId="P24807,Q07490" charOffset="44-47" type="protein" text="HSA"/>
            <pair e1="DS.d1689.s0.e0" e2="DS.d1689.s0.e1" id="DS.d1689.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1690" origId="18854987">
        <sentence id="DS.d1690.s0" origId="18854987-1716" text="The COMT enzyme breaks down extracellular dopamine (DA) and has a particularly important role in the prefrontal cortex (PFC) where DA transporters are sparse.">
            <entity id="DS.d1690.s0.e0" origId="O23760,O81646,O82054,P21964,P28002,P46484,Q06509,Q06528,Q43239,Q43609,Q6ZD89,Q8GU25,Q8LL87,Q8W013,Q99028,Q9FQY8,Q9SWC2" charOffset="4-8" type="protein" text="COMT"/>
            <entity id="DS.d1690.s0.e1" origId="681" charOffset="42-50" type="compound" text="dopamine"/>
            <entity id="DS.d1690.s0.e2" origId="P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6" charOffset="131-146" type="protein" text="DA transporters"/>
            <pair e1="DS.d1690.s0.e1" e2="DS.d1690.s0.e2" id="DS.d1690.s0.i0" interaction="True"/>
            <pair e1="DS.d1690.s0.e1" e2="DS.d1690.s0.e0" id="DS.d1690.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1692" origId="18854999">
        <sentence id="DS.d1692.s0" origId="18854999-1723" text="CYP719A subfamily of cytochrome P450 oxygenases and isoquinoline alkaloid biosynthesis in Eschscholzia californica.">
            <entity id="DS.d1692.s0.e0" origId="O08469" charOffset="21-36" type="protein" text="cytochrome P450"/>
            <entity id="DS.d1692.s0.e1" origId="8405" charOffset="52-64" type="compound" text="isoquinoline"/>
            <pair e1="DS.d1692.s0.e1" e2="DS.d1692.s0.e0" id="DS.d1692.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1693" origId="18855021">
        <sentence id="DS.d1693.s0" origId="18855021-1734" text="The metal-thiolate connectivity of recombinant Cd(7)-MT10 metallothionein from the sea mussel Mytilus galloprovincialis has been investigated for the first time by means of multinuclear, multidimensional NMR spectroscopy.">
            <entity id="DS.d1693.s0.e0" origId="5047209" charOffset="10-18" type="compound" text="thiolate"/>
            <entity id="DS.d1693.s0.e1" origId="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568" charOffset="58-73" type="protein" text="metallothionein"/>
            <pair e1="DS.d1693.s0.e0" e2="DS.d1693.s0.e1" id="DS.d1693.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1694" origId="18855035">
        <sentence id="DS.d1694.s0" origId="18855035-1741" text="Radical scavenging activity of lipophilized products from lipase-catalyzed transesterification of triolein with cinnamic and ferulic acids.">
            <entity id="DS.d1694.s0.e0" origId="Q7M4U7" charOffset="58-64" type="protein" text="lipase"/>
            <entity id="DS.d1694.s0.e1" origId="5497163" charOffset="98-106" type="compound" text="triolein"/>
            <pair e1="DS.d1694.s0.e1" e2="DS.d1694.s0.e0" id="DS.d1694.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1694.s1" origId="18855035-1742" text="Lipase-catalyzed transesterification of triolein with cinnamic and ferulic acids using an immobilized lipase from Candida antarctica (E.C.">
            <entity id="DS.d1694.s1.e0" origId="Q7M4U7" charOffset="0-6" type="protein" text="Lipase"/>
            <entity id="DS.d1694.s1.e1" origId="5497163" charOffset="40-48" type="compound" text="triolein"/>
            <entity id="DS.d1694.s1.e2" origId="Q7M4U7" charOffset="102-108" type="protein" text="lipase"/>
            <pair e1="DS.d1694.s1.e1" e2="DS.d1694.s1.e2" id="DS.d1694.s1.i0" interaction="True"/>
            <pair e1="DS.d1694.s1.e1" e2="DS.d1694.s1.e0" id="DS.d1694.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1695" origId="18855107">
        <sentence id="DS.d1695.s0" origId="18855107-1775" text="Validation of a food frequency questionnaire measurement of dietary acrylamide intake using hemoglobin adducts of acrylamide and glycidamide.">
            <entity id="DS.d1695.s0.e0" origId="P15160,P17724,P73925,Q03459" charOffset="92-102" type="protein" text="hemoglobin"/>
            <entity id="DS.d1695.s0.e1" origId="91550" charOffset="129-140" type="compound" text="glycidamide"/>
            <pair e1="DS.d1695.s0.e1" e2="DS.d1695.s0.e0" id="DS.d1695.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1696" origId="18855190">
        <sentence id="DS.d1696.s0" origId="18855190-2056" text="Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.">
            <entity id="DS.d1696.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="92-99" type="protein" text="insulin"/>
            <entity id="DS.d1696.s0.e1" origId="206,5793,64689,79025" charOffset="109-116" type="compound" text="glucose"/>
            <pair e1="DS.d1696.s0.e1" e2="DS.d1696.s0.e0" id="DS.d1696.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1697" origId="18855521">
        <sentence id="DS.d1697.s0" origId="18855521-439" text="The study established that SPZ attenuated myocardial I/R injury through overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.">
            <entity id="DS.d1697.s0.e0" origId="16069453" charOffset="27-30" type="compound" text="SPZ"/>
            <entity id="DS.d1697.s0.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="90-94" type="protein" text="iNOS"/>
            <entity id="DS.d1697.s0.e2" origId="145068" charOffset="122-134" type="compound" text="nitric oxide"/>
            <pair e1="DS.d1697.s0.e2" e2="DS.d1697.s0.e1" id="DS.d1697.s0.i0" interaction="True"/>
            <pair e1="DS.d1697.s0.e0" e2="DS.d1697.s0.e1" id="DS.d1697.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1698" origId="18855522">
        <sentence id="DS.d1698.s0" origId="18855522-1934" text="Currently, pyridoxal-5'-phosphate (PLP)-dependent cystathionine beta-synthase (CBS) is thought to be the major H(2)S-producing enzyme in the brain.">
            <entity id="DS.d1698.s0.e0" origId="1051" charOffset="11-33" type="compound" text="pyridoxal-5'-phosphate"/>
            <entity id="DS.d1698.s0.e1" origId="P32232,P32582,P35520,P46794,Q58H57,Q91WT9,Q9N0V7,Q9YBL2" charOffset="50-77" type="protein" text="cystathionine beta-synthase"/>
            <pair e1="DS.d1698.s0.e0" e2="DS.d1698.s0.e1" id="DS.d1698.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1700" origId="18855911">
        <sentence id="DS.d1700.s1" origId="18855911-2115" text="The purpose of this study was to propose a new preparation method to fabricate insulin-loaded poly(lactic-coglycolic acid) (PLGA) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein.">
            <entity id="DS.d1700.s1.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="79-86" type="protein" text="insulin"/>
            <entity id="DS.d1700.s1.e1" origId="36797" charOffset="124-128" type="compound" text="PLGA"/>
            <pair e1="DS.d1700.s1.e1" e2="DS.d1700.s1.e0" id="DS.d1700.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1702" origId="18855936">
        <sentence id="DS.d1702.s0" origId="18855936-2128" text="This injury induces central sensitization leading to tactile allodynia and is mediated by activation of Ca(2+) permeable AMPA/kainate receptors through PKC and PKA.">
            <entity id="DS.d1702.s0.e0" origId="271" charOffset="104-108" type="compound" text="Ca(2"/>
            <entity id="DS.d1702.s0.e1" origId="P05130,P13677,P13678,P34722" charOffset="152-155" type="protein" text="PKC"/>
            <pair e1="DS.d1702.s0.e0" e2="DS.d1702.s0.e1" id="DS.d1702.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1703" origId="18855942">
        <sentence id="DS.d1703.s0" origId="18855942-2132" text="Stimulation of choline acetyltransferase by C3d, a neural cell adhesion molecule ligand.">
            <entity id="DS.d1703.s0.e0" origId="P16966" charOffset="23-40" type="protein" text="acetyltransferase"/>
            <entity id="DS.d1703.s0.e1" origId="216416" charOffset="44-47" type="compound" text="C3d"/>
            <pair e1="DS.d1703.s0.e1" e2="DS.d1703.s0.e0" id="DS.d1703.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1704" origId="18855943">
        <sentence id="DS.d1704.s0" origId="18855943-2134" text="Transport properties of PIs by the drug efflux transporters P-gp and multidrug resistance protein 1 (MRP1) were assessed by measuring the cellular uptake of (3)H-atazanavir or (3)H-ritonavir in P-gp and MRP1 overexpressing cells as well as hCMEC/D3.">
            <entity id="DS.d1704.s0.e0" origId="P06795,P08183,P16875,P21448,P33449,P34712,P43245,Q06034,Q9ZR72" charOffset="69-99" type="protein" text="multidrug resistance protein 1"/>
            <entity id="DS.d1704.s0.e1" origId="148192" charOffset="162-172" type="compound" text="atazanavir"/>
            <entity id="DS.d1704.s0.e2" origId="392622" charOffset="181-190" type="compound" text="ritonavir"/>
            <pair e1="DS.d1704.s0.e1" e2="DS.d1704.s0.e0" id="DS.d1704.s0.i0" interaction="True"/>
            <pair e1="DS.d1704.s0.e2" e2="DS.d1704.s0.e0" id="DS.d1704.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1705" origId="18922131">
        <sentence id="DS.d1705.s0" origId="18922131-2288" text="Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces insulin-stimulated PKB activation and glucose uptake.">
            <entity id="DS.d1705.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="100-107" type="protein" text="insulin"/>
            <entity id="DS.d1705.s0.e1" origId="P31749,P31750,P47196,Q01314,Q8INB9" charOffset="119-122" type="protein" text="PKB"/>
            <entity id="DS.d1705.s0.e2" origId="206,5793,64689,79025" charOffset="138-145" type="compound" text="glucose"/>
            <pair e1="DS.d1705.s0.e2" e2="DS.d1705.s0.e0" id="DS.d1705.s0.i0" interaction="False"/>
            <pair e1="DS.d1705.s0.e2" e2="DS.d1705.s0.e1" id="DS.d1705.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1706" origId="18922514">
        <sentence id="DS.d1706.s0" origId="18922514-2447" text="This is the first cyclodextrin glycosyltransferase with a known primary structure and a glutamine instead of glycine residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.">
            <entity id="DS.d1706.s0.e0" origId="O30565,P04830,P05618,P08704,P09121,P14014,P17692,P26827,P27036,P30920,P30921,P31746,P31747,P31797,P31835,P43379" charOffset="18-50" type="protein" text="cyclodextrin glycosyltransferase"/>
            <entity id="DS.d1706.s0.e1" origId="738,5961" charOffset="88-97" type="compound" text="glutamine"/>
            <entity id="DS.d1706.s0.e2" origId="750" charOffset="109-116" type="compound" text="glycine"/>
            <pair e1="DS.d1706.s0.e2" e2="DS.d1706.s0.e0" id="DS.d1706.s0.i0" interaction="True"/>
            <pair e1="DS.d1706.s0.e1" e2="DS.d1706.s0.e0" id="DS.d1706.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1707" origId="18922527">
        <sentence id="DS.d1707.s0" origId="18922527-2451" text="Functional LCAT is not required for macrophage cholesterol efflux to human serum.">
            <entity id="DS.d1707.s0.e0" origId="O35502,O35573,O35724,O35840,P04180,P30930,P53760,P53761,Q08758" charOffset="11-15" type="protein" text="LCAT"/>
            <entity id="DS.d1707.s0.e1" origId="304,5997,6432564,11025495" charOffset="47-58" type="compound" text="cholesterol"/>
            <pair e1="DS.d1707.s0.e1" e2="DS.d1707.s0.e0" id="DS.d1707.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1708" origId="18922794">
        <sentence id="DS.d1708.s0" origId="18922794-2589" text="The AbfR/S two-component system is required to activate the expression of the suite of enzymes that remove the numerous side chains from xylan, but not the xylanases that hydrolyze the beta1,4-linked xylose polymeric backbone of this polysaccharide.">
            <entity id="DS.d1708.s0.e0" origId="50909243" charOffset="137-142" type="compound" text="xylan"/>
            <entity id="DS.d1708.s0.e1" origId="O43097,O59859,O60206,P07529,P09850,P17137,P23360,P23557,P29417,P40943,P45703,P48793,P56588,P81536,Q53317" charOffset="156-165" type="protein" text="xylanases"/>
            <pair e1="DS.d1708.s0.e0" e2="DS.d1708.s0.e1" id="DS.d1708.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1709" origId="18922879">
        <sentence id="DS.d1709.s0" origId="18922879-2629" text="In agreement with molecular modeling predictions, the inhibitory action of pPTME and PTME toward intracellular ODC of LN229 cells exceeded that of the previous designed lead compound POB.">
            <entity id="DS.d1709.s0.e0" origId="O22616,P00860,P07805,P08432,P09057,P11926,P14019,P27116,P27117,P27118,P27119,P27121,P40807,P40808,P41931,P43099,P49725,P50134,P78599,Q5RFB7,Q8S3N2,Q92445,Q9BQT8,Q9UQW9" charOffset="111-114" type="protein" text="ODC"/>
            <entity id="DS.d1709.s0.e1" origId="9543438" charOffset="183-186" type="compound" text="POB"/>
            <pair e1="DS.d1709.s0.e1" e2="DS.d1709.s0.e0" id="DS.d1709.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1710" origId="18922958">
        <sentence id="DS.d1710.s0" origId="18922958-2662" text="Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood glucose, or plasma concentrations of catecholamines, ACTH, and cortisol.">
            <entity id="DS.d1710.s0.e0" origId="206,5793,64689,79025" charOffset="143-150" type="compound" text="glucose"/>
            <entity id="DS.d1710.s0.e1" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="196-200" type="protein" text="ACTH"/>
            <entity id="DS.d1710.s0.e2" origId="5754" charOffset="206-214" type="compound" text="cortisol"/>
            <pair e1="DS.d1710.s0.e0" e2="DS.d1710.s0.e1" id="DS.d1710.s0.i0" interaction="False"/>
            <pair e1="DS.d1710.s0.e2" e2="DS.d1710.s0.e1" id="DS.d1710.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1710.s1" origId="18922958-2663" text="During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, ACTH, and cortisol.">
            <entity id="DS.d1710.s1.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="249-253" type="protein" text="ACTH"/>
            <entity id="DS.d1710.s1.e1" origId="5754" charOffset="259-267" type="compound" text="cortisol"/>
            <pair e1="DS.d1710.s1.e1" e2="DS.d1710.s1.e0" id="DS.d1710.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1711" origId="18923065">
        <sentence id="DS.d1711.s0" origId="18923065-2678" text="The induction of HO-1 by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase pyrimidin-4-ylamine (BAY 41-2272).">
            <entity id="DS.d1711.s0.e0" origId="P06762,P09601,P14791,P14901,P32394,Q5E9F2" charOffset="17-21" type="protein" text="HO-1"/>
            <entity id="DS.d1711.s0.e1" origId="5712" charOffset="25-29" type="compound" text="YC-1"/>
            <entity id="DS.d1711.s0.e2" origId="1456" charOffset="115-118" type="compound" text="ODQ"/>
            <entity id="DS.d1711.s0.e3" origId="68958" charOffset="145-164" type="compound" text="pyrimidin-4-ylamine"/>
            <entity id="DS.d1711.s0.e4" origId="9798973" charOffset="166-177" type="compound" text="BAY 41-2272"/>
            <pair e1="DS.d1711.s0.e4" e2="DS.d1711.s0.e0" id="DS.d1711.s0.i0" interaction="False"/>
            <pair e1="DS.d1711.s0.e1" e2="DS.d1711.s0.e0" id="DS.d1711.s0.i1" interaction="True"/>
            <pair e1="DS.d1711.s0.e3" e2="DS.d1711.s0.e0" id="DS.d1711.s0.i2" interaction="False"/>
            <pair e1="DS.d1711.s0.e2" e2="DS.d1711.s0.e0" id="DS.d1711.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1712" origId="18923087">
        <sentence id="DS.d1712.s1" origId="18923087-1871" text="The potentiation was not altered by the beta(1) subunit or mediated by ARA-S metabolites, stimulation of known cannabinoid receptors, G proteins, protein kinases, or Ca(2+)-dependent processes; it was lost after patch excision or after membrane cholesterol depletion but was restored after cholesterol reconstitution.">
            <entity id="DS.d1712.s1.e0" origId="P00513,P25848" charOffset="146-161" type="protein" text="protein kinases"/>
            <entity id="DS.d1712.s1.e1" origId="271" charOffset="166-170" type="compound" text="Ca(2"/>
            <entity id="DS.d1712.s1.e2" origId="304,5997,6432564,11025495" charOffset="245-256" type="compound" text="cholesterol"/>
            <entity id="DS.d1712.s1.e3" origId="304,5997,6432564,11025495" charOffset="290-301" type="compound" text="cholesterol"/>
            <pair e1="DS.d1712.s1.e1" e2="DS.d1712.s1.e0" id="DS.d1712.s1.i0" interaction="False"/>
            <pair e1="DS.d1712.s1.e2" e2="DS.d1712.s1.e0" id="DS.d1712.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1713" origId="18923147">
        <sentence id="DS.d1713.s0" origId="18923147-2705" text="Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function.">
            <entity id="DS.d1713.s0.e0" origId="P40792,P63001,Q6RUV5" charOffset="14-18" type="protein" text="Rac1"/>
            <entity id="DS.d1713.s0.e1" origId="123831" charOffset="31-35" type="compound" text="ADMA"/>
            <entity id="DS.d1713.s0.e2" origId="O94760,O95865" charOffset="36-40" type="protein" text="DDAH"/>
            <pair e1="DS.d1713.s0.e1" e2="DS.d1713.s0.e2" id="DS.d1713.s0.i0" interaction="False"/>
            <pair e1="DS.d1713.s0.e1" e2="DS.d1713.s0.e0" id="DS.d1713.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1714" origId="18923157">
        <sentence id="DS.d1714.s0" origId="18923157-2713" text="Endometriosis is associated with progesterone resistance in the baboon (Papio anubis) oviduct: evidence based on the localization of oviductal glycoprotein 1 (OVGP1).">
            <entity id="DS.d1714.s0.e0" origId="5994" charOffset="33-45" type="compound" text="progesterone"/>
            <entity id="DS.d1714.s0.e1" origId="P36718,Q12889,Q28042,Q28542,Q28990,Q60557,Q62010" charOffset="133-155" type="protein" text="oviductal glycoprotein"/>
            <entity id="DS.d1714.s0.e2" origId="P36718,Q12889,Q28042,Q28542,Q28990,Q60557" charOffset="159-164" type="protein" text="OVGP1"/>
            <pair e1="DS.d1714.s0.e0" e2="DS.d1714.s0.e1" id="DS.d1714.s0.i0" interaction="False"/>
            <pair e1="DS.d1714.s0.e0" e2="DS.d1714.s0.e2" id="DS.d1714.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1714.s1" origId="18923157-2714" text="In this study we evaluated OVGP1 and steroid receptor expression in oviducts of baboons with endometriosis during the midsecretory phase and determined whether progesterone resistance associated with endometriosis also occurs in the oviduct.">
            <entity id="DS.d1714.s1.e0" origId="P36718,Q12889,Q28042,Q28542,Q28990,Q60557" charOffset="27-32" type="protein" text="OVGP1"/>
            <entity id="DS.d1714.s1.e1" origId="5994" charOffset="160-172" type="compound" text="progesterone"/>
            <pair e1="DS.d1714.s1.e1" e2="DS.d1714.s1.e0" id="DS.d1714.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1714.s2" origId="18923157-2715" text="These data imply that the normal antagonism of progesterone on ESR and OVGP1, which results in their downregulation during the window of implantation, is absent in animals with endometriosis.">
            <entity id="DS.d1714.s2.e0" origId="5994" charOffset="47-59" type="compound" text="progesterone"/>
            <entity id="DS.d1714.s2.e1" origId="O42132,P03372,P06212,P16058,P49884,P49885,P49886,P50240,P50241,P50242,P57753,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHZ7" charOffset="63-66" type="protein" text="ESR"/>
            <entity id="DS.d1714.s2.e2" origId="P36718,Q12889,Q28042,Q28542,Q28990,Q60557" charOffset="71-76" type="protein" text="OVGP1"/>
            <pair e1="DS.d1714.s2.e0" e2="DS.d1714.s2.e2" id="DS.d1714.s2.i0" interaction="True"/>
            <pair e1="DS.d1714.s2.e0" e2="DS.d1714.s2.e1" id="DS.d1714.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1715" origId="18923162">
        <sentence id="DS.d1715.s1" origId="18923162-2719" text="In this study, we evaluated the distribution of the principal CD44 ligand hyaluronan (HA) and the expressions of HA synthases (HAS: HAS1, HAS2, and HAS3) during atresia in pig ovaries.">
            <entity id="DS.d1715.s1.e0" origId="24759" charOffset="74-84" type="compound" text="hyaluronan"/>
            <entity id="DS.d1715.s1.e1" origId="P0C0H0,P0C0H1,Q5X9A9,Q8K5G6,Q8NKX1" charOffset="113-125" type="protein" text="HA synthases"/>
            <entity id="DS.d1715.s1.e2" origId="Q03532,Q0UR48,Q1EA54,Q2GMX1,Q4IEK8,Q4P6N0,Q5AK59,Q5KMN6,Q6BH93,Q6C7D2,Q6CXB7,Q6FIL3,Q74Z73,Q92839" charOffset="132-136" type="protein" text="HAS1"/>
            <entity id="DS.d1715.s1.e3" origId="O57424,O97711,Q92819" charOffset="138-142" type="protein" text="HAS2"/>
            <entity id="DS.d1715.s1.e4" origId="O00219,O57425" charOffset="148-152" type="protein" text="HAS3"/>
            <pair e1="DS.d1715.s1.e0" e2="DS.d1715.s1.e2" id="DS.d1715.s1.i0" interaction="False"/>
            <pair e1="DS.d1715.s1.e0" e2="DS.d1715.s1.e1" id="DS.d1715.s1.i1" interaction="False"/>
            <pair e1="DS.d1715.s1.e0" e2="DS.d1715.s1.e4" id="DS.d1715.s1.i2" interaction="False"/>
            <pair e1="DS.d1715.s1.e0" e2="DS.d1715.s1.e3" id="DS.d1715.s1.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1717" origId="18923387">
        <sentence id="DS.d1717.s0" origId="18923387-2775" text="Transgenic mice that overexpress rat angiotensinogen in their proximal tubule cells were given either apocynin, perindopril, or hydralazine while untreated or apocynin-treated non-transgenic littermates served as controls.">
            <entity id="DS.d1717.s0.e0" origId="P01016,P01017,P67885,P67886" charOffset="37-52" type="protein" text="angiotensinogen"/>
            <entity id="DS.d1717.s0.e1" origId="2214" charOffset="102-110" type="compound" text="apocynin"/>
            <entity id="DS.d1717.s0.e2" origId="107807" charOffset="112-123" type="compound" text="perindopril"/>
            <entity id="DS.d1717.s0.e3" origId="3637" charOffset="128-139" type="compound" text="hydralazine"/>
            <entity id="DS.d1717.s0.e4" origId="2214" charOffset="159-167" type="compound" text="apocynin"/>
            <pair e1="DS.d1717.s0.e1" e2="DS.d1717.s0.e0" id="DS.d1717.s0.i0" interaction="False"/>
            <pair e1="DS.d1717.s0.e2" e2="DS.d1717.s0.e0" id="DS.d1717.s0.i1" interaction="False"/>
            <pair e1="DS.d1717.s0.e3" e2="DS.d1717.s0.e0" id="DS.d1717.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1719" origId="18923397">
        <sentence id="DS.d1719.s0" origId="18923397-2783" text="Requirement of AQP4 for antidepressive efficiency of fluoxetine : implication in adult hippocampal neurogenesis.">
            <entity id="DS.d1719.s0.e0" origId="O77750,P55087,Q5I4F9,Q923J4" charOffset="15-19" type="protein" text="AQP4"/>
            <entity id="DS.d1719.s0.e1" origId="3386" charOffset="53-63" type="compound" text="fluoxetine"/>
            <pair e1="DS.d1719.s0.e1" e2="DS.d1719.s0.e0" id="DS.d1719.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1719.s1" origId="18923397-2785" text="Collectively, these findings suggest that AQP4 is required for the antidepressive action of fluoxetine via regulating adult hippocampal neurogenesis.">
            <entity id="DS.d1719.s1.e0" origId="O77750,P55087,Q5I4F9,Q923J4" charOffset="42-46" type="protein" text="AQP4"/>
            <entity id="DS.d1719.s1.e1" origId="3386" charOffset="92-102" type="compound" text="fluoxetine"/>
            <pair e1="DS.d1719.s1.e1" e2="DS.d1719.s1.e0" id="DS.d1719.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1720" origId="18923398">
        <sentence id="DS.d1720.s0" origId="18923398-2787" text="Although no significant change in the apparent K(m) was revealed in animals that exhibited an escalation in the rate of cocaine intake, an increased dopamine uptake rate was found suggesting an upregulation of DAT number in response to a history of high cocaine intake.">
            <entity id="DS.d1720.s0.e0" origId="681" charOffset="149-157" type="compound" text="dopamine"/>
            <entity id="DS.d1720.s0.e1" origId="P13483,P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6" charOffset="210-213" type="protein" text="DAT"/>
            <pair e1="DS.d1720.s0.e0" e2="DS.d1720.s0.e1" id="DS.d1720.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1721" origId="18923402">
        <sentence id="DS.d1721.s0" origId="18923402-2788" text="Previous work has shown that repeated desipramine treatment causes downregulation of the norepinephrine transporter (NET) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.">
            <entity id="DS.d1721.s0.e0" origId="2995" charOffset="38-49" type="compound" text="desipramine"/>
            <entity id="DS.d1721.s0.e1" origId="O55192,P23975,P51143" charOffset="89-115" type="protein" text="norepinephrine transporter"/>
            <entity id="DS.d1721.s0.e2" origId="O55192,P23975,P41970,P51143,P54762" charOffset="117-120" type="protein" text="NET"/>
            <pair e1="DS.d1721.s0.e0" e2="DS.d1721.s0.e2" id="DS.d1721.s0.i0" interaction="True"/>
            <pair e1="DS.d1721.s0.e0" e2="DS.d1721.s0.e1" id="DS.d1721.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1721.s1" origId="18923402-2790" text="Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the NET and SERT, or 10 mg/kg per day phenelzine, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering NET or SERT expression.">
            <entity id="DS.d1721.s1.e0" origId="O55192,P23975,P41970,P51143,P54762" charOffset="81-84" type="protein" text="NET"/>
            <entity id="DS.d1721.s1.e1" origId="P31645,Q9XT49" charOffset="89-93" type="protein" text="SERT"/>
            <entity id="DS.d1721.s1.e2" origId="3675" charOffset="115-125" type="compound" text="phenelzine"/>
            <entity id="DS.d1721.s1.e3" origId="O55192,P23975,P41970,P51143,P54762" charOffset="224-227" type="protein" text="NET"/>
            <entity id="DS.d1721.s1.e4" origId="P31645,Q9XT49" charOffset="231-235" type="protein" text="SERT"/>
            <pair e1="DS.d1721.s1.e2" e2="DS.d1721.s1.e0" id="DS.d1721.s1.i0" interaction="False"/>
            <pair e1="DS.d1721.s1.e2" e2="DS.d1721.s1.e1" id="DS.d1721.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1722" origId="18923405">
        <sentence id="DS.d1722.s0" origId="18923405-2791" text="Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, glutamate transport and GluRs, BDNF and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.">
            <entity id="DS.d1722.s0.e0" origId="P49773,P62958,P80912,Q5RF69" charOffset="118-123" type="protein" text="HINT1"/>
            <entity id="DS.d1722.s0.e1" origId="611,23327,33032" charOffset="125-134" type="compound" text="glutamate"/>
            <entity id="DS.d1722.s0.e2" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="156-160" type="protein" text="BDNF"/>
            <entity id="DS.d1722.s0.e3" origId="P45522" charOffset="165-169" type="protein" text="TrkB"/>
            <entity id="DS.d1722.s0.e4" origId="O96436" charOffset="180-194" type="protein" text="14-3-3 protein"/>
            <entity id="DS.d1722.s0.e5" origId="5957" charOffset="304-307" type="compound" text="ATP"/>
            <pair e1="DS.d1722.s0.e1" e2="DS.d1722.s0.e3" id="DS.d1722.s0.i0" interaction="False"/>
            <pair e1="DS.d1722.s0.e5" e2="DS.d1722.s0.e2" id="DS.d1722.s0.i1" interaction="False"/>
            <pair e1="DS.d1722.s0.e1" e2="DS.d1722.s0.e4" id="DS.d1722.s0.i2" interaction="False"/>
            <pair e1="DS.d1722.s0.e5" e2="DS.d1722.s0.e3" id="DS.d1722.s0.i3" interaction="False"/>
            <pair e1="DS.d1722.s0.e5" e2="DS.d1722.s0.e0" id="DS.d1722.s0.i4" interaction="False"/>
            <pair e1="DS.d1722.s0.e1" e2="DS.d1722.s0.e0" id="DS.d1722.s0.i5" interaction="False"/>
            <pair e1="DS.d1722.s0.e5" e2="DS.d1722.s0.e4" id="DS.d1722.s0.i6" interaction="False"/>
            <pair e1="DS.d1722.s0.e1" e2="DS.d1722.s0.e2" id="DS.d1722.s0.i7" interaction="False"/>
        </sentence>
        <sentence id="DS.d1722.s1" origId="18923405-2792" text="Brains from persons with major depressive disorder reveal decreased expression for genes in glutamate transport and metabolism, neurotrophic signaling (eg, FGF, BDNF and VGF), and MAP kinase pathways.">
            <entity id="DS.d1722.s1.e0" origId="611,23327,33032" charOffset="92-101" type="compound" text="glutamate"/>
            <entity id="DS.d1722.s1.e1" origId="O10284,P41444" charOffset="156-159" type="protein" text="FGF"/>
            <entity id="DS.d1722.s1.e2" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="161-165" type="protein" text="BDNF"/>
            <entity id="DS.d1722.s1.e3" origId="O15240,O57166,P20494,Q86607,Q9JFH4" charOffset="170-173" type="protein" text="VGF"/>
            <pair e1="DS.d1722.s1.e0" e2="DS.d1722.s1.e1" id="DS.d1722.s1.i0" interaction="False"/>
            <pair e1="DS.d1722.s1.e0" e2="DS.d1722.s1.e2" id="DS.d1722.s1.i1" interaction="False"/>
            <pair e1="DS.d1722.s1.e0" e2="DS.d1722.s1.e3" id="DS.d1722.s1.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1724" origId="18923823">
        <sentence id="DS.d1724.s0" origId="18923823-499" text="However, detection of Cu and Zn in superoxide dismutase after PAGE-LA-ICP-MS depends on the conditions of the PAGE method because possible metal losses can occur (either with SDS-PAGE or with native PAGE).">
            <entity id="DS.d1724.s0.e0" origId="104815" charOffset="22-24" type="compound" text="Cu"/>
            <entity id="DS.d1724.s0.e1" origId="O50258" charOffset="35-55" type="protein" text="superoxide dismutase"/>
            <pair e1="DS.d1724.s0.e0" e2="DS.d1724.s0.e1" id="DS.d1724.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1725" origId="18923827">
        <sentence id="DS.d1725.s0" origId="18923827-111" text="Recent studies have suggested that a decrease in the specific activity of the 2-oxoglutarate dehydrogenase complex (ODHC) is important for glutamate overproduction by Corynebacterium glutamicum.">
            <entity id="DS.d1725.s0.e0" origId="Q89AJ7" charOffset="80-106" type="protein" text="oxoglutarate dehydrogenase"/>
            <entity id="DS.d1725.s0.e1" origId="611,23327,33032" charOffset="139-148" type="compound" text="glutamate"/>
            <pair e1="DS.d1725.s0.e1" e2="DS.d1725.s0.e0" id="DS.d1725.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1726" origId="18923851">
        <sentence id="DS.d1726.s0" origId="18923851-130" text="To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (NP1) as a template for protein engineering, we have replaced the native axial heme-coordinating histidine residue with glycine, alanine, and cysteine.">
            <entity id="DS.d1726.s0.e0" origId="P47971,Q15818,Q26239,Q62443" charOffset="76-79" type="protein" text="NP1"/>
            <entity id="DS.d1726.s0.e2" origId="773,6274" charOffset="172-181" type="compound" text="histidine"/>
            <entity id="DS.d1726.s0.e3" origId="750" charOffset="195-202" type="compound" text="glycine"/>
            <entity id="DS.d1726.s0.e4" origId="602,4580,5950,71080" charOffset="204-211" type="compound" text="alanine"/>
            <entity id="DS.d1726.s0.e5" origId="594,5862,5360637" charOffset="217-225" type="compound" text="cysteine"/>
            <pair e1="DS.d1726.s0.e2" e2="DS.d1726.s0.e0" id="DS.d1726.s0.i1" interaction="False"/>
            <pair e1="DS.d1726.s0.e4" e2="DS.d1726.s0.e0" id="DS.d1726.s0.i3" interaction="False"/>
            <pair e1="DS.d1726.s0.e3" e2="DS.d1726.s0.e0" id="DS.d1726.s0.i6" interaction="False"/>
            <pair e1="DS.d1726.s0.e5" e2="DS.d1726.s0.e0" id="DS.d1726.s0.i7" interaction="False"/>
        </sentence>
        <sentence id="DS.d1726.s1" origId="18923851-133" text="Two crystal structures of the H60C_ NP1 in complex with imidazole and histamine were solved to 1.7- and 1.96-A resolution, respectively.">
            <entity id="DS.d1726.s1.e0" origId="P47971,Q15818,Q26239,Q62443" charOffset="36-39" type="protein" text="NP1"/>
            <entity id="DS.d1726.s1.e1" origId="795" charOffset="56-65" type="compound" text="imidazole"/>
            <entity id="DS.d1726.s1.e2" origId="774" charOffset="70-79" type="compound" text="histamine"/>
            <pair e1="DS.d1726.s1.e1" e2="DS.d1726.s1.e0" id="DS.d1726.s1.i0" interaction="True"/>
            <pair e1="DS.d1726.s1.e2" e2="DS.d1726.s1.e0" id="DS.d1726.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1726.s2" origId="18923851-134" text="Both structures show that the H60C mutation is well tolerated by the protein scaffold and suggest that heme-thiolate coordination in H60C_ NP1 requires some movement of the heme within its binding cavity.">
            <entity id="DS.d1726.s2.e0" origId="4971" charOffset="103-107" type="compound" text="heme"/>
            <entity id="DS.d1726.s2.e1" origId="5047209" charOffset="108-116" type="compound" text="thiolate"/>
            <entity id="DS.d1726.s2.e2" origId="P47971,Q15818,Q26239,Q62443" charOffset="139-142" type="protein" text="NP1"/>
            <entity id="DS.d1726.s2.e3" origId="4971" charOffset="173-177" type="compound" text="heme"/>
            <pair e1="DS.d1726.s2.e1" e2="DS.d1726.s2.e2" id="DS.d1726.s2.i0" interaction="False"/>
            <pair e1="DS.d1726.s2.e0" e2="DS.d1726.s2.e2" id="DS.d1726.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1727" origId="18923901">
        <sentence id="DS.d1727.s0" origId="18923901-159" text="Anticancer effect of celecoxib via COX-2 dependent and independent mechanisms in human gastric cancers cells.">
            <entity id="DS.d1727.s0.e0" origId="2662" charOffset="21-30" type="compound" text="celecoxib"/>
            <entity id="DS.d1727.s0.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="35-40" type="protein" text="COX-2"/>
            <pair e1="DS.d1727.s0.e0" e2="DS.d1727.s0.e1" id="DS.d1727.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1728" origId="18924134">
        <sentence id="DS.d1728.s0" origId="18924134-216" text="Real-time polymerase chain reaction analysis of hypoxic, NO-sulindac treated PC-3 cells showed downregulation of lysyl oxidase and carbonic anhydrase IX mRNA expression.">
            <entity id="DS.d1728.s0.e0" origId="5352,1548885,1548887" charOffset="60-68" type="compound" text="sulindac"/>
            <entity id="DS.d1728.s0.e1" origId="P16636,P28300,P28301,P33072,P45845,Q05063" charOffset="113-126" type="protein" text="lysyl oxidase"/>
            <entity id="DS.d1728.s0.e2" origId="Q16790,Q8VHB5" charOffset="131-152" type="protein" text="carbonic anhydrase IX"/>
            <pair e1="DS.d1728.s0.e0" e2="DS.d1728.s0.e2" id="DS.d1728.s0.i0" interaction="True"/>
            <pair e1="DS.d1728.s0.e0" e2="DS.d1728.s0.e1" id="DS.d1728.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1729" origId="18925358">
        <sentence id="DS.d1729.s0" origId="18925358-887" text="Established risk cardiovascular factors like hypertension, atherogenic dyslipidaemia, and glucose intolerance occur in the setting of insulin resistance and central adiposity, with genetic and environmental influences modulating the ultimate risk.">
            <entity id="DS.d1729.s0.e0" origId="206,5793,64689,79025" charOffset="90-97" type="compound" text="glucose"/>
            <entity id="DS.d1729.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="134-141" type="protein" text="insulin"/>
            <pair e1="DS.d1729.s0.e0" e2="DS.d1729.s0.e1" id="DS.d1729.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1730" origId="18925359">
        <sentence id="DS.d1730.s0" origId="18925359-508" text="Despite this lack of oxidative and cytotoxic action, exposure of hepatoma cells to Ni(2+) resulted in a significant activation of Akt that was abrogated by inhibitors of PI3K.">
            <entity id="DS.d1730.s0.e0" origId="934" charOffset="83-87" type="compound" text="Ni(2"/>
            <entity id="DS.d1730.s0.e1" origId="P31750,Q8INB9" charOffset="130-133" type="protein" text="Akt"/>
            <pair e1="DS.d1730.s0.e0" e2="DS.d1730.s0.e1" id="DS.d1730.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1731" origId="18925413">
        <sentence id="DS.d1731.s0" origId="18925413-539" text="Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, insulin, and blood glucose and lactate determination.">
            <entity id="DS.d1731.s0.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="84-88" type="protein" text="ACTH"/>
            <entity id="DS.d1731.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="90-97" type="protein" text="insulin"/>
            <entity id="DS.d1731.s0.e2" origId="206,5793,64689,79025" charOffset="109-116" type="compound" text="glucose"/>
            <entity id="DS.d1731.s0.e3" origId="612" charOffset="121-128" type="compound" text="lactate"/>
            <pair e1="DS.d1731.s0.e3" e2="DS.d1731.s0.e0" id="DS.d1731.s0.i0" interaction="False"/>
            <pair e1="DS.d1731.s0.e2" e2="DS.d1731.s0.e1" id="DS.d1731.s0.i1" interaction="False"/>
            <pair e1="DS.d1731.s0.e3" e2="DS.d1731.s0.e1" id="DS.d1731.s0.i2" interaction="False"/>
            <pair e1="DS.d1731.s0.e2" e2="DS.d1731.s0.e0" id="DS.d1731.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1732" origId="18925649">
        <sentence id="DS.d1732.s0" origId="18925649-643" text="The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by nickel ions and chlorogenic acid, characteristics of PP2B not of PP1.">
            <entity id="DS.d1732.s0.e0" origId="934" charOffset="102-113" type="compound" text="nickel ions"/>
            <entity id="DS.d1732.s0.e1" origId="1794427" charOffset="118-134" type="compound" text="chlorogenic acid"/>
            <entity id="DS.d1732.s0.e2" origId="P07978" charOffset="155-159" type="protein" text="PP2B"/>
            <entity id="DS.d1732.s0.e3" origId="P22198,P30366,P48487,P48488,P50391,P80074,Q61041,Q63447" charOffset="167-170" type="protein" text="PP1"/>
            <pair e1="DS.d1732.s0.e1" e2="DS.d1732.s0.e2" id="DS.d1732.s0.i0" interaction="True"/>
            <pair e1="DS.d1732.s0.e0" e2="DS.d1732.s0.e2" id="DS.d1732.s0.i1" interaction="True"/>
            <pair e1="DS.d1732.s0.e0" e2="DS.d1732.s0.e3" id="DS.d1732.s0.i2" interaction="False"/>
            <pair e1="DS.d1732.s0.e1" e2="DS.d1732.s0.e3" id="DS.d1732.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1733" origId="18925653">
        <sentence id="DS.d1733.s0" origId="18925653-646" text="Because o-quinones are very unstable, we used an oxymetric method to characterize the kinetics of this substrate, based on measurements of the oxygen consumed in the tyrosinase reaction.">
            <entity id="DS.d1733.s0.e0" origId="977" charOffset="143-149" type="compound" text="oxygen"/>
            <entity id="DS.d1733.s0.e1" origId="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396" charOffset="166-176" type="protein" text="tyrosinase"/>
            <pair e1="DS.d1733.s0.e0" e2="DS.d1733.s0.e1" id="DS.d1733.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1734" origId="18925655">
        <sentence id="DS.d1734.s0" origId="18925655-1527" text="Plasma levels of citalopram, cortisol, and prolactin were measured.">
            <entity id="DS.d1734.s0.e0" origId="2771,146570" charOffset="17-27" type="compound" text="citalopram"/>
            <entity id="DS.d1734.s0.e1" origId="5754" charOffset="29-37" type="compound" text="cortisol"/>
            <entity id="DS.d1734.s0.e2" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="43-52" type="protein" text="prolactin"/>
            <pair e1="DS.d1734.s0.e0" e2="DS.d1734.s0.e2" id="DS.d1734.s0.i0" interaction="False"/>
            <pair e1="DS.d1734.s0.e1" e2="DS.d1734.s0.e2" id="DS.d1734.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1734.s1" origId="18925655-1528" text="An increase in cortisol and prolactin concentrations was observed from the EOI until 60 min after the EOI.">
            <entity id="DS.d1734.s1.e0" origId="5754" charOffset="15-23" type="compound" text="cortisol"/>
            <entity id="DS.d1734.s1.e1" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="28-37" type="protein" text="prolactin"/>
            <pair e1="DS.d1734.s1.e0" e2="DS.d1734.s1.e1" id="DS.d1734.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1735" origId="18925830">
        <sentence id="DS.d1735.s0" origId="18925830-712" text="Different lag-time of pulse-released nerve growth factor (NGF) from genipin-crosslinked gelatin within polycaprolactone (PCL) conduits was evaluated in large-gap peripheral nerve repair.">
            <entity id="DS.d1735.s0.e0" origId="P21617,P34129,Q6YBR5,Q90W38" charOffset="58-61" type="protein" text="NGF"/>
            <entity id="DS.d1735.s0.e1" origId="23340,442424,44144320" charOffset="68-75" type="compound" text="genipin"/>
            <entity id="DS.d1735.s0.e2" origId="10401" charOffset="103-119" type="compound" text="polycaprolactone"/>
            <pair e1="DS.d1735.s0.e2" e2="DS.d1735.s0.e0" id="DS.d1735.s0.i0" interaction="False"/>
            <pair e1="DS.d1735.s0.e1" e2="DS.d1735.s0.e0" id="DS.d1735.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1735.s1" origId="18925830-713" text="In this study, 10% (w/v) gelatin was mixed with NGF, crosslinked with 0%, 0.1%, 0.5%, and 1% (w/v) genipin, and then sucked into the wall of PCL conduits.">
            <entity id="DS.d1735.s1.e0" origId="P21617,P34129,Q6YBR5,Q90W38" charOffset="48-51" type="protein" text="NGF"/>
            <entity id="DS.d1735.s1.e1" origId="23340,442424,44144320" charOffset="99-106" type="compound" text="genipin"/>
            <pair e1="DS.d1735.s1.e1" e2="DS.d1735.s1.e0" id="DS.d1735.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1737" origId="18926542">
        <sentence id="DS.d1737.s0" origId="18926542-922" text="It was found from this group that 4-hydroxycoumarin was the best alternative to warfarin for examining the interactions of drugs at Sudlow site I on HSA.">
            <entity id="DS.d1737.s0.e0" origId="54682930" charOffset="34-51" type="compound" text="4-hydroxycoumarin"/>
            <entity id="DS.d1737.s0.e1" origId="P24807,Q07490" charOffset="149-152" type="protein" text="HSA"/>
            <pair e1="DS.d1737.s0.e0" e2="DS.d1737.s0.e1" id="DS.d1737.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1738" origId="18926547">
        <sentence id="DS.d1738.s0" origId="18926547-923" text="Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.">
            <entity id="DS.d1738.s0.e0" origId="O73810,P14416,P20288,P52702,P60026,Q6TLI9,Q9GJU1" charOffset="11-15" type="protein" text="DRD2"/>
            <entity id="DS.d1738.s0.e1" origId="Q8NFD2" charOffset="16-21" type="protein" text="ANKK1"/>
            <entity id="DS.d1738.s0.e2" origId="60795" charOffset="62-74" type="compound" text="aripiprazole"/>
            <pair e1="DS.d1738.s0.e2" e2="DS.d1738.s0.e0" id="DS.d1738.s0.i0" interaction="True"/>
            <pair e1="DS.d1738.s0.e2" e2="DS.d1738.s0.e1" id="DS.d1738.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1739" origId="18926641">
        <sentence id="DS.d1739.s0" origId="18926641-955" text="The majority of patients with acute depression shows an exaggerated plasma corticotrophin (ACTH) and cortisol response to this test that normalizes gradually during successful antidepressant therapy.">
            <entity id="DS.d1739.s0.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="91-95" type="protein" text="ACTH"/>
            <entity id="DS.d1739.s0.e1" origId="5754" charOffset="101-109" type="compound" text="cortisol"/>
            <pair e1="DS.d1739.s0.e1" e2="DS.d1739.s0.e0" id="DS.d1739.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1739.s1" origId="18926641-956" text="We examined plasma ACTH and cortisol responses to the dex/CRH test in acutely depressed inpatients treated either with mirtazapine (n=55) or a monoamine reuptake inhibitor (n=105) according to doctor's choice and compared the test results with healthy controls (n=40).">
            <entity id="DS.d1739.s1.e0" origId="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5" charOffset="19-23" type="protein" text="ACTH"/>
            <entity id="DS.d1739.s1.e1" origId="5754" charOffset="28-36" type="compound" text="cortisol"/>
            <pair e1="DS.d1739.s1.e1" e2="DS.d1739.s1.e0" id="DS.d1739.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1740" origId="18926682">
        <sentence id="DS.d1740.s0" origId="18926682-975" text="Both extracts increased AMP-kinase phosphorylation and HMG-CoA reductase phosphorylation by 2.5-to 4-fold, but with different time courses: maximal phosphorylation with green tea was evident within 30 min of treatment, whereas with black tea phosphorylation was slower to develop, with maximal phosphorylation occurring &amp;gt; or =3 hours after treatment.">
            <entity id="DS.d1740.s0.e1" origId="O08424,O24594,O26662,O28538,O51628,O59469,O74164,O76819,P00347,P04035,P09610,P13702,P14773,P16237,P16393,P20715,P48021,P51639,P54960,Q01237,Q01559,Q03163,Q10283,Q12577,Q12649,Q1W675,Q29512,Q58116,Q59468,Q5R6N3,Q9V1R3,Q9Y7D2,Q9YAS4" charOffset="55-72" type="protein" text="HMG-CoA reductase"/>
            <entity id="DS.d1740.s0.e2" origId="4630" charOffset="169-178" type="compound" text="green tea"/>
            <pair e1="DS.d1740.s0.e2" e2="DS.d1740.s0.e1" id="DS.d1740.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1741" origId="18926687">
        <sentence id="DS.d1741.s0" origId="18926687-978" text="However, the ethyl ester of commipheric acid (150 mg/kg, twice daily) lowered fasting blood glucose and plasma insulin, and plasma triglycerides without affecting food intake or body weight.">
            <entity id="DS.d1741.s0.e0" origId="206,5793,64689,79025" charOffset="92-99" type="compound" text="glucose"/>
            <entity id="DS.d1741.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="111-118" type="protein" text="insulin"/>
            <pair e1="DS.d1741.s0.e0" e2="DS.d1741.s0.e1" id="DS.d1741.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1743" origId="18926804">
        <sentence id="DS.d1743.s0" origId="18926804-1008" text="This finding led the authors to propose that RDH-E2 may be involved in the pathogenesis of psoriasis through its potential role in retinoic acid biosynthesis and stimulation of keratinocyte proliferation.">
            <entity id="DS.d1743.s0.e0" origId="Q9BPW9" charOffset="45-51" type="protein" text="RDH-E2"/>
            <entity id="DS.d1743.s0.e1" origId="444795" charOffset="131-144" type="compound" text="retinoic acid"/>
            <pair e1="DS.d1743.s0.e1" e2="DS.d1743.s0.e0" id="DS.d1743.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1743.s1" origId="18926804-1010" text="In this study, we began the characterization of RDH-E2 protein in order to determine whether it might play a role in retinoic acid biosynthesis.">
            <entity id="DS.d1743.s1.e0" origId="Q9BPW9" charOffset="48-54" type="protein" text="RDH-E2"/>
            <entity id="DS.d1743.s1.e1" origId="444795" charOffset="117-130" type="compound" text="retinoic acid"/>
            <pair e1="DS.d1743.s1.e1" e2="DS.d1743.s1.e0" id="DS.d1743.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1743.s2" origId="18926804-1011" text="The preference for NAD(+) suggests that RDH-E2 is likely to function in the oxidative direction in vivo, further supporting its potential role in the oxidation of retinol to retinaldehyde for retinoic acid biosynthesis in human keratinocytes.">
            <entity id="DS.d1743.s2.e0" origId="Q9BPW9" charOffset="40-46" type="protein" text="RDH-E2"/>
            <entity id="DS.d1743.s2.e1" origId="444795" charOffset="192-205" type="compound" text="retinoic acid"/>
            <pair e1="DS.d1743.s2.e1" e2="DS.d1743.s2.e0" id="DS.d1743.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1744" origId="18926806">
        <sentence id="DS.d1744.s0" origId="18926806-1012" text="Identification of Aldh1a, Cyp26 and RAR orthologs in protostomes pushes back the retinoic acid genetic machinery in evolutionary time to the bilaterian ancestor.">
            <entity id="DS.d1744.s0.e0" origId="O55127,O93323,P79739" charOffset="26-31" type="protein" text="Cyp26"/>
            <entity id="DS.d1744.s0.e1" origId="444795" charOffset="81-94" type="compound" text="retinoic acid"/>
            <pair e1="DS.d1744.s0.e1" e2="DS.d1744.s0.e0" id="DS.d1744.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1745" origId="18926807">
        <sentence id="DS.d1745.s1" origId="18926807-1161" text="As release of NADH can be a rate-limiting step for ALDH activity, NADH binding was evaluated for R166wt and R166H enzymes.">
            <entity id="DS.d1745.s1.e0" origId="439153" charOffset="14-18" type="compound" text="NADH"/>
            <entity id="DS.d1745.s1.e1" origId="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2" charOffset="51-55" type="protein" text="ALDH"/>
            <pair e1="DS.d1745.s1.e0" e2="DS.d1745.s1.e1" id="DS.d1745.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1747" origId="18926849">
        <sentence id="DS.d1747.s0" origId="18926849-1039" text="GSH is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (GST) and glutathione peroxidases (GPx).">
            <entity id="DS.d1747.s0.e0" origId="124886" charOffset="0-3" type="compound" text="GSH"/>
            <entity id="DS.d1747.s0.e1" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="161-187" type="protein" text="glutathione-S-transferases"/>
            <entity id="DS.d1747.s0.e2" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="189-192" type="protein" text="GST"/>
            <entity id="DS.d1747.s0.e3" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="198-221" type="protein" text="glutathione peroxidases"/>
            <pair e1="DS.d1747.s0.e0" e2="DS.d1747.s0.e2" id="DS.d1747.s0.i0" interaction="True"/>
            <pair e1="DS.d1747.s0.e0" e2="DS.d1747.s0.e3" id="DS.d1747.s0.i1" interaction="True"/>
            <pair e1="DS.d1747.s0.e0" e2="DS.d1747.s0.e1" id="DS.d1747.s0.i2" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1748" origId="18926859">
        <sentence id="DS.d1748.s0" origId="18926859-1152" text="Peripheral GLP-1 gastroprotection against ethanol : the role of exendin, NO, CGRP, prostaglandins and blood flow.">
            <entity id="DS.d1748.s0.e0" origId="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25" charOffset="11-16" type="protein" text="GLP-1"/>
            <entity id="DS.d1748.s0.e1" origId="702" charOffset="42-49" type="compound" text="ethanol"/>
            <entity id="DS.d1748.s0.e2" origId="P10286,P30880,P30881,P31888,P80511" charOffset="77-81" type="protein" text="CGRP"/>
            <pair e1="DS.d1748.s0.e1" e2="DS.d1748.s0.e0" id="DS.d1748.s0.i0" interaction="False"/>
            <pair e1="DS.d1748.s0.e1" e2="DS.d1748.s0.e2" id="DS.d1748.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1748.s1" origId="18926859-1154" text="Absolute ethanol was administered through an orogastric cannula right after the injection of GLP-1 (1, 10, 100, 1000 or 10,000 ng/kg; i.p.).">
            <entity id="DS.d1748.s1.e0" origId="702" charOffset="0-16" type="compound" text="Absolute ethanol"/>
            <entity id="DS.d1748.s1.e1" origId="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25" charOffset="93-98" type="protein" text="GLP-1"/>
            <pair e1="DS.d1748.s1.e0" e2="DS.d1748.s1.e1" id="DS.d1748.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1749" origId="18926889">
        <sentence id="DS.d1749.s0" origId="18926889-1065" text="It inhibited Trypanosoma brucei GAPDH with an IC(50) value of 240 microM and has been shown to be a competitive reversible inhibitor (Ki=200+/-10 microM) of this enzyme with respect to its cofactor NAD (+).">
            <entity id="DS.d1749.s0.e0" origId="O01360,O13507,O27090,O28542,O32755,O34425,O42259,O52631,O57479,O57672,O59494,O59841,O67161,O83816,O96423,P00355,P00356,P00357,P00361,P00362,P04406,P04797,P08439,P09124,P09316,P09317,P0A1P0,P0A1P1,P0C0G6,P0C0G7,P10096,P10097,P10618,P15115,P16858,P17244,P17721,P19089,P19314,P19315,P20287,P20445,P22512,P22513,P23722,P24163,P24164,P24166,P24746,P24748,P24749,P24750,P24751,P24753,P25861,P26518,P26519,P26520,P26521,P26988,P27726,P28844,P29272,P29497,P32637,P32638,P34783,P35143,P39460,P44304,P46406,P46713,P46795,P46796,P47543,P48812,P51009,P51469,P51640,P52694,P52987,P53429,P53430,P54117,P54118,P54226,P55070,P55071,P55971,P56649,P57384,P58839,P61879,P61880,P64178,P64179,P68777,P70685,P75358,P80447,P80534,P83601,P87197,P94915,Q00301,Q00584,Q00640,Q01558,Q01597,Q01651,Q01982,Q05025,Q07234,Q12552,Q1DTF9,Q27652,Q27890,Q28259,Q28554,Q2NEN0,Q3IUT3,Q46450,Q48335,Q4J940,Q4KYY3,Q58546,Q59199,Q59309,Q59800,Q59906,Q5JHB5,Q5R2J2,Q5RAB4,Q5V061,Q5XDW3,Q6BMK0,Q6CCU7,Q6L125,Q6M0E6,Q757I2,Q89AK1,Q8J1H3,Q8K8M9,Q8NK47,Q8PTD3,Q8TFJ2,Q8WZN0,Q8X1X3,Q8ZWK7,Q92211,Q92243,Q92263,Q94469,Q96US8,Q971K2,Q97BJ8,Q9HFX1,Q9HGY7,Q9HJ69,Q9HSS7,Q9N2D5,Q9N655,Q9P8C0,Q9PJN6,Q9UR38,Q9UVC0,Q9UW96,Q9V1P1,Q9Y796,Q9Y8E9,Q9YFS9,Q9Z518,Q9Z7T0,Q9ZKT0" charOffset="32-37" type="protein" text="GAPDH"/>
            <entity id="DS.d1749.s0.e1" origId="5893" charOffset="198-201" type="compound" text="NAD"/>
            <pair e1="DS.d1749.s0.e1" e2="DS.d1749.s0.e0" id="DS.d1749.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1750" origId="18926911">
        <sentence id="DS.d1750.s0" origId="18926911-1076" text="We have also described LD between HLA-G alleles and HLA class II DRB1 allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-G0103, DRB103-G0101A and DRB103-G01B.">
            <entity id="DS.d1750.s0.e0" origId="P17693,Q95IT1" charOffset="34-39" type="protein" text="HLA-G"/>
            <entity id="DS.d1750.s0.e1" origId="Q8IUH3" charOffset="65-69" type="protein" text="DRB1"/>
            <entity id="DS.d1750.s0.e2" origId="750" charOffset="170-175" type="compound" text="G0103"/>
            <pair e1="DS.d1750.s0.e2" e2="DS.d1750.s0.e0" id="DS.d1750.s0.i0" interaction="False"/>
            <pair e1="DS.d1750.s0.e2" e2="DS.d1750.s0.e1" id="DS.d1750.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1751" origId="18927146">
        <sentence id="DS.d1751.s0" origId="18927146-1139" text="Morpholino oligonucleotide-induced expression of truncated dystrophin in the brains of mdx mice, but not in the muscle, ameliorated the abnormal freezing response to restraint.">
            <entity id="DS.d1751.s0.e0" origId="5476374" charOffset="0-10" type="compound" text="Morpholino"/>
            <entity id="DS.d1751.s0.e1" origId="O97592,P11530,P11531,P11532,P11533,Q5GN48" charOffset="59-69" type="protein" text="dystrophin"/>
            <pair e1="DS.d1751.s0.e0" e2="DS.d1751.s0.e1" id="DS.d1751.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1752" origId="18927216">
        <sentence id="DS.d1752.s0" origId="18927216-1186" text="It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of iNOS, resulting in superoxide generation, accounts for an impaired NO availability.">
            <entity id="DS.d1752.s0.e0" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="142-146" type="protein" text="iNOS"/>
            <entity id="DS.d1752.s0.e1" origId="5359597" charOffset="161-171" type="compound" text="superoxide"/>
            <pair e1="DS.d1752.s0.e1" e2="DS.d1752.s0.e0" id="DS.d1752.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1753" origId="18927219">
        <sentence id="DS.d1753.s0" origId="18927219-1190" text="Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice.">
            <entity id="DS.d1753.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="112-119" type="protein" text="insulin"/>
            <entity id="DS.d1753.s0.e1" origId="206,5793,64689,79025" charOffset="135-142" type="compound" text="glucose"/>
            <pair e1="DS.d1753.s0.e1" e2="DS.d1753.s0.e0" id="DS.d1753.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1753.s1" origId="18927219-1192" text="These changes were associated with an alleviation of hyperglycemia, glucose intolerance, and insulin resistance.">
            <entity id="DS.d1753.s1.e0" origId="206,5793,64689,79025" charOffset="68-75" type="compound" text="glucose"/>
            <entity id="DS.d1753.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="93-100" type="protein" text="insulin"/>
            <pair e1="DS.d1753.s1.e0" e2="DS.d1753.s1.e1" id="DS.d1753.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1754" origId="18927241">
        <sentence id="DS.d1754.s0" origId="18927241-1195" text="Vernakalant was metabolized rapidly via 4-O-demethylation by cytochrome P450 (CYP)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive glucuronide conjugate.">
            <entity id="DS.d1754.s0.e0" origId="O08469" charOffset="61-76" type="protein" text="cytochrome P450"/>
            <entity id="DS.d1754.s0.e1" origId="P21568,P21569,P24525,P34887,Q26551" charOffset="78-81" type="protein" text="CYP"/>
            <entity id="DS.d1754.s0.e2" origId="5281877" charOffset="170-181" type="compound" text="glucuronide"/>
            <pair e1="DS.d1754.s0.e2" e2="DS.d1754.s0.e0" id="DS.d1754.s0.i0" interaction="False"/>
            <pair e1="DS.d1754.s0.e2" e2="DS.d1754.s0.e1" id="DS.d1754.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1755" origId="18927268">
        <sentence id="DS.d1755.s0" origId="18927268-1200" text="We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused NMDA, and in response to infused endothelin-1 (ET-1) with and without MK-801, an NMDA receptor blocker.">
            <entity id="DS.d1755.s0.e0" origId="22880" charOffset="122-126" type="compound" text="NMDA"/>
            <entity id="DS.d1755.s0.e1" origId="P05305,Q28469" charOffset="155-167" type="protein" text="endothelin-1"/>
            <entity id="DS.d1755.s0.e2" origId="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76" charOffset="169-173" type="protein" text="ET-1"/>
            <pair e1="DS.d1755.s0.e0" e2="DS.d1755.s0.e2" id="DS.d1755.s0.i0" interaction="False"/>
            <pair e1="DS.d1755.s0.e0" e2="DS.d1755.s0.e1" id="DS.d1755.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1756" origId="18927347">
        <sentence id="DS.d1756.s0" origId="18927347-1235" text="Thus, CS-mediated down-regulation of HDAC2 in human macrophages and lung epithelial cells in vitro and in mouse lung in vivo involves the induction of serine/threonine phosphorylation and proteasomal degradation, which may have implications for steroid resistance and abnormal inflammation caused by cigarette smoke.">
            <entity id="DS.d1756.s0.e0" origId="P56519,Q92769" charOffset="37-42" type="protein" text="HDAC2"/>
            <entity id="DS.d1756.s0.e1" origId="5951" charOffset="151-157" type="compound" text="serine"/>
            <entity id="DS.d1756.s0.e2" origId="6288" charOffset="158-167" type="compound" text="threonine"/>
            <pair e1="DS.d1756.s0.e1" e2="DS.d1756.s0.e0" id="DS.d1756.s0.i0" interaction="False"/>
            <pair e1="DS.d1756.s0.e2" e2="DS.d1756.s0.e0" id="DS.d1756.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1757" origId="18927433">
        <sentence id="DS.d1757.s0" origId="18927433-1257" text="Immunofluorescence microscopy of live human umbilical vein endothelial cells showed that VWF multimers rapidly formed strings several hundred micrometers long on the cell surface after stimulation with histamine.">
            <entity id="DS.d1757.s0.e0" origId="P04275,P80012,Q28295,Q28833,Q8CIZ8" charOffset="89-92" type="protein" text="VWF"/>
            <entity id="DS.d1757.s0.e1" origId="774" charOffset="202-211" type="compound" text="histamine"/>
            <pair e1="DS.d1757.s0.e1" e2="DS.d1757.s0.e0" id="DS.d1757.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1757.s1" origId="18927433-1258" text="Soluble P-selectin reduced the number of platelet-decorated VWF strings in the absence of Ca(2+) and Mg(2+) but had no effect in the presence of these cations.">
            <entity id="DS.d1757.s1.e0" origId="P04275,P80012,Q28295,Q28833,Q8CIZ8" charOffset="60-63" type="protein" text="VWF"/>
            <entity id="DS.d1757.s1.e1" origId="271" charOffset="90-94" type="compound" text="Ca(2"/>
            <pair e1="DS.d1757.s1.e1" e2="DS.d1757.s1.e0" id="DS.d1757.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1758" origId="18927435">
        <sentence id="DS.d1758.s0" origId="18927435-1259" text="To examine the relationship of functional expression of VLA-4 to prognosis in AML, we studied marrow samples from 175 adult AML patients who underwent induction chemotherapy with anthracycline and cytarabine on Southwest Oncology Group trials.">
            <entity id="DS.d1758.s0.e0" origId="P13612,Q00651,Q91687" charOffset="56-61" type="protein" text="VLA-4"/>
            <entity id="DS.d1758.s0.e1" origId="6253" charOffset="197-207" type="compound" text="cytarabine"/>
            <pair e1="DS.d1758.s0.e1" e2="DS.d1758.s0.e0" id="DS.d1758.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1759" origId="18928402">
        <sentence id="DS.d1759.s0" origId="18928402-1632" text="Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules Akt and glycogen synthase kinase-3 (GSK3) in the regulation of behavior by dopamine and serotonin (5-HT).">
            <entity id="DS.d1759.s0.e0" origId="P31750,Q8INB9" charOffset="195-198" type="protein" text="Akt"/>
            <entity id="DS.d1759.s0.e2" origId="P38615" charOffset="231-235" type="protein" text="GSK3"/>
            <entity id="DS.d1759.s0.e3" origId="681" charOffset="270-278" type="compound" text="dopamine"/>
            <entity id="DS.d1759.s0.e4" origId="5202" charOffset="283-292" type="compound" text="serotonin"/>
            <entity id="DS.d1759.s0.e5" origId="5202" charOffset="294-298" type="compound" text="5-HT"/>
            <pair e1="DS.d1759.s0.e5" e2="DS.d1759.s0.e2" id="DS.d1759.s0.i0" interaction="True"/>
            <pair e1="DS.d1759.s0.e4" e2="DS.d1759.s0.e0" id="DS.d1759.s0.i1" interaction="True"/>
            <pair e1="DS.d1759.s0.e4" e2="DS.d1759.s0.e2" id="DS.d1759.s0.i2" interaction="True"/>
            <pair e1="DS.d1759.s0.e3" e2="DS.d1759.s0.e0" id="DS.d1759.s0.i3" interaction="True"/>
            <pair e1="DS.d1759.s0.e3" e2="DS.d1759.s0.e2" id="DS.d1759.s0.i7" interaction="True"/>
            <pair e1="DS.d1759.s0.e5" e2="DS.d1759.s0.e0" id="DS.d1759.s0.i8" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1760" origId="18929413">
        <sentence id="DS.d1760.s0" origId="18929413-2021" text="Inhibition of GSK3beta by lithium in vivo suppressed the inflammatory response in mice infected with F. tularensis LVS and conferred a survival advantage.">
            <entity id="DS.d1760.s0.e0" origId="P18266,P49841,Q5YJC2,Q9WV60" charOffset="14-22" type="protein" text="GSK3beta"/>
            <entity id="DS.d1760.s0.e1" origId="28486,3028194" charOffset="26-33" type="compound" text="lithium"/>
            <pair e1="DS.d1760.s0.e1" e2="DS.d1760.s0.e0" id="DS.d1760.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1761" origId="18929429">
        <sentence id="DS.d1761.s0" origId="18929429-2031" text="The capacity for osmotic adjustment, superoxide dismutase (SOD) and ascorbate peroxidase (APX) activities and proline content were also elevated in the transgenic Arabidopsis plants.">
            <entity id="DS.d1761.s0.e0" origId="O50258" charOffset="37-57" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1761.s0.e1" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="59-62" type="protein" text="SOD"/>
            <entity id="DS.d1761.s0.e2" origId="P15984,P16147,P84714" charOffset="78-88" type="protein" text="peroxidase"/>
            <entity id="DS.d1761.s0.e3" origId="P27695,Q01613,Q42564" charOffset="90-93" type="protein" text="APX"/>
            <entity id="DS.d1761.s0.e4" origId="614,8988,145742" charOffset="110-117" type="compound" text="proline"/>
            <pair e1="DS.d1761.s0.e4" e2="DS.d1761.s0.e1" id="DS.d1761.s0.i1" interaction="False"/>
            <pair e1="DS.d1761.s0.e4" e2="DS.d1761.s0.e3" id="DS.d1761.s0.i2" interaction="False"/>
            <pair e1="DS.d1761.s0.e4" e2="DS.d1761.s0.e0" id="DS.d1761.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1762" origId="18929477">
        <sentence id="DS.d1762.s0" origId="18929477-2059" text="To prevent the effects of interfering anionic species, such as uric acid and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then glucose oxidase was immobilized on the coated electrode.">
            <entity id="DS.d1762.s0.e0" origId="1175" charOffset="63-72" type="compound" text="uric acid"/>
            <entity id="DS.d1762.s0.e1" origId="54670067,54690394" charOffset="77-90" type="compound" text="ascorbic acid"/>
            <entity id="DS.d1762.s0.e2" origId="61890" charOffset="152-158" type="compound" text="Nafion"/>
            <entity id="DS.d1762.s0.e3" origId="P81156" charOffset="169-184" type="protein" text="glucose oxidase"/>
            <pair e1="DS.d1762.s0.e2" e2="DS.d1762.s0.e3" id="DS.d1762.s0.i0" interaction="False"/>
            <pair e1="DS.d1762.s0.e0" e2="DS.d1762.s0.e3" id="DS.d1762.s0.i1" interaction="False"/>
            <pair e1="DS.d1762.s0.e1" e2="DS.d1762.s0.e3" id="DS.d1762.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1765" origId="18929666">
        <sentence id="DS.d1765.s0" origId="18929666-2130" text="A naturally occurring glycine to aspartic acid mutation at position 169 (G169D) in the putative transmembrane domain 4 (TM4) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.">
            <entity id="DS.d1765.s0.e0" origId="750" charOffset="22-29" type="compound" text="glycine"/>
            <entity id="DS.d1765.s0.e1" origId="424,5960,83887" charOffset="33-46" type="compound" text="aspartic acid"/>
            <entity id="DS.d1765.s0.e2" origId="Q40170" charOffset="120-123" type="protein" text="TM4"/>
            <pair e1="DS.d1765.s0.e1" e2="DS.d1765.s0.e2" id="DS.d1765.s0.i0" interaction="True"/>
            <pair e1="DS.d1765.s0.e0" e2="DS.d1765.s0.e2" id="DS.d1765.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1766" origId="18930039">
        <sentence id="DS.d1766.s0" origId="18930039-2213" text="Serum free L-carnitine in association with myoglobin as a diagnostic marker of acute myocardial infarction.">
            <entity id="DS.d1766.s0.e0" origId="10918" charOffset="11-22" type="compound" text="L-carnitine"/>
            <entity id="DS.d1766.s0.e1" origId="O77003,P02144,P02145,P02147,P02148,P02150,P02151,P02152,P02153,P02154,P02155,P02156,P02157,P02159,P02160,P02161,P02163,P02164,P02165,P02166,P02167,P02168,P02169,P02170,P02171,P02173,P02174,P02177,P02178,P02179,P02180,P02181,P02182,P02183,P02184,P02185,P02186,P02187,P02189,P02190,P02191,P02192,P02193,P02194,P02195,P02196,P02197,P02199,P02200,P02201,P02202,P02203,P02204,P02205,P02206,P02210,P02211,P02214,P02215,P04247,P04248,P04249,P04250,P09965,P0C227,P11343,P14393,P14396,P14397,P14398,P14399,P15160,P17724,P20856,P29287,P30562,P31331,P32428,P49672,P51535,P51537,P56208,P56532,P62734,P62735,P63113,P63114,P68080,P68081,P68082,P68083,P68084,P68085,P68086,P68189,P68190,P68276,P68277,P68278,P68279,P80721,P80722,P83682,P84997,P87497,Q01966,Q03459,Q0KIY0,Q0KIY1,Q0KIY2,Q0KIY3,Q0KIY5,Q0KIY9,Q2MJN4,Q6I7B0,Q6PL31,Q6VN46,Q701N9,Q76G09,Q7LZM1,Q7LZM2,Q7LZM3,Q7LZM4,Q7LZM5,Q7M3C1,Q7M424,Q7T044,Q9DEN8,Q9DEN9,Q9DEP0,Q9DEP1,Q9DGI8,Q9DGI9,Q9DGJ0,Q9DGJ1,Q9DGJ2,Q9QZ76" charOffset="43-52" type="protein" text="myoglobin"/>
            <pair e1="DS.d1766.s0.e0" e2="DS.d1766.s0.e1" id="DS.d1766.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1766.s1" origId="18930039-2214" text="The aim of this study was to monitor the level of serum free L-carnitine in combination with myoglobin (Myo) and creatine kinase (total activity and CK-MB level) for usefulness as a predictor of AMI in ICU patients.">
            <entity id="DS.d1766.s1.e0" origId="10918" charOffset="61-72" type="compound" text="L-carnitine"/>
            <entity id="DS.d1766.s1.e1" origId="O77003,P02144,P02145,P02147,P02148,P02150,P02151,P02152,P02153,P02154,P02155,P02156,P02157,P02159,P02160,P02161,P02163,P02164,P02165,P02166,P02167,P02168,P02169,P02170,P02171,P02173,P02174,P02177,P02178,P02179,P02180,P02181,P02182,P02183,P02184,P02185,P02186,P02187,P02189,P02190,P02191,P02192,P02193,P02194,P02195,P02196,P02197,P02199,P02200,P02201,P02202,P02203,P02204,P02205,P02206,P02210,P02211,P02214,P02215,P04247,P04248,P04249,P04250,P09965,P0C227,P11343,P14393,P14396,P14397,P14398,P14399,P15160,P17724,P20856,P29287,P30562,P31331,P32428,P49672,P51535,P51537,P56208,P56532,P62734,P62735,P63113,P63114,P68080,P68081,P68082,P68083,P68084,P68085,P68086,P68189,P68190,P68276,P68277,P68278,P68279,P80721,P80722,P83682,P84997,P87497,Q01966,Q03459,Q0KIY0,Q0KIY1,Q0KIY2,Q0KIY3,Q0KIY5,Q0KIY9,Q2MJN4,Q6I7B0,Q6PL31,Q6VN46,Q701N9,Q76G09,Q7LZM1,Q7LZM2,Q7LZM3,Q7LZM4,Q7LZM5,Q7M3C1,Q7M424,Q7T044,Q9DEN8,Q9DEN9,Q9DEP0,Q9DEP1,Q9DGI8,Q9DGI9,Q9DGJ0,Q9DGJ1,Q9DGJ2,Q9QZ76" charOffset="93-102" type="protein" text="myoglobin"/>
            <pair e1="DS.d1766.s1.e0" e2="DS.d1766.s1.e1" id="DS.d1766.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1767" origId="18930076">
        <sentence id="DS.d1767.s0" origId="18930076-2223" text="Curcuminoids inhibited AChE in the in-vitro assay with IC(50) value of 19.67, bisdemethoxycurcumin 16.84, demethoxycurcumin 33.14 and curcumin 67.69 microM.">
            <entity id="DS.d1767.s0.e0" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="23-27" type="protein" text="AChE"/>
            <entity id="DS.d1767.s0.e1" origId="5315472" charOffset="78-98" type="compound" text="bisdemethoxycurcumin"/>
            <pair e1="DS.d1767.s0.e1" e2="DS.d1767.s0.e0" id="DS.d1767.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1768" origId="18930084">
        <sentence id="DS.d1768.s0" origId="18930084-2225" text="L-penetratin was the most effective promoter of insulin absorption compared with others CPPs.">
            <entity id="DS.d1768.s0.e0" origId="25242319" charOffset="2-12" type="compound" text="penetratin"/>
            <entity id="DS.d1768.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="48-55" type="protein" text="insulin"/>
            <pair e1="DS.d1768.s0.e0" e2="DS.d1768.s0.e1" id="DS.d1768.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1768.s1" origId="18930084-2226" text="A dose-dependent relationship of L-penetratin and insulin bioavailability was statically significant.">
            <entity id="DS.d1768.s1.e0" origId="25242319" charOffset="35-45" type="compound" text="penetratin"/>
            <entity id="DS.d1768.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="50-57" type="protein" text="insulin"/>
            <pair e1="DS.d1768.s1.e0" e2="DS.d1768.s1.e1" id="DS.d1768.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1768.s2" origId="18930084-2227" text="There was no significant difference in the release of LDH in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-penetratin was present.">
            <entity id="DS.d1768.s2.e0" origId="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289" charOffset="54-57" type="protein" text="LDH"/>
            <entity id="DS.d1768.s2.e1" origId="25242319" charOffset="137-147" type="compound" text="penetratin"/>
            <pair e1="DS.d1768.s2.e1" e2="DS.d1768.s2.e0" id="DS.d1768.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1770" origId="18930122">
        <sentence id="DS.d1770.s0" origId="18930122-2233" text="Osteoblasts up-regulate the expression of extracellular proteases following attachment to Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate).">
            <entity id="DS.d1770.s0.e0" origId="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0" charOffset="56-65" type="protein" text="proteases"/>
            <entity id="DS.d1770.s0.e1" origId="107801" charOffset="90-139" type="compound" text="Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate"/>
            <pair e1="DS.d1770.s0.e1" e2="DS.d1770.s0.e0" id="DS.d1770.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1771" origId="18930149">
        <sentence id="DS.d1771.s0" origId="18930149-2366" text="Pharmacological stimulation of TRPV1 channels with capsaicin (10 nM) selectively enhanced the frequency of glutamate-mediated spontaneous (sEPSCs) and miniature excitatory postsynaptic currents (mEPSCs) recorded from putative striatal medium spiny neurons.">
            <entity id="DS.d1771.s0.e0" origId="Q697L1,Q8NER1" charOffset="31-36" type="protein" text="TRPV1"/>
            <entity id="DS.d1771.s0.e1" origId="1548943" charOffset="51-60" type="compound" text="capsaicin"/>
            <pair e1="DS.d1771.s0.e1" e2="DS.d1771.s0.e0" id="DS.d1771.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1771.s1" origId="18930149-2367" text="Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of TRPV1 channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA).">
            <entity id="DS.d1771.s1.e0" origId="1548943" charOffset="60-69" type="compound" text="capsaicin"/>
            <entity id="DS.d1771.s1.e1" origId="Q697L1,Q8NER1" charOffset="130-135" type="protein" text="TRPV1"/>
            <entity id="DS.d1771.s1.e2" origId="4792,27924,122634,22833501" charOffset="187-218" type="compound" text="phorbol 12-myristate 13-acetate"/>
            <entity id="DS.d1771.s1.e3" origId="27924,122634,22833501" charOffset="220-223" type="compound" text="PMA"/>
            <pair e1="DS.d1771.s1.e3" e2="DS.d1771.s1.e1" id="DS.d1771.s1.i0" interaction="True"/>
            <pair e1="DS.d1771.s1.e0" e2="DS.d1771.s1.e1" id="DS.d1771.s1.i1" interaction="True"/>
            <pair e1="DS.d1771.s1.e2" e2="DS.d1771.s1.e1" id="DS.d1771.s1.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d1771.s2" origId="18930149-2368" text="The effects of capsaicin and of PMA were absent after pharmacological or genetic inactivation of TRPV1 channels.">
            <entity id="DS.d1771.s2.e0" origId="1548943" charOffset="15-24" type="compound" text="capsaicin"/>
            <entity id="DS.d1771.s2.e1" origId="27924,122634,22833501" charOffset="32-35" type="compound" text="PMA"/>
            <entity id="DS.d1771.s2.e2" origId="Q697L1,Q8NER1" charOffset="97-102" type="protein" text="TRPV1"/>
            <pair e1="DS.d1771.s2.e1" e2="DS.d1771.s2.e2" id="DS.d1771.s2.i0" interaction="True"/>
            <pair e1="DS.d1771.s2.e0" e2="DS.d1771.s2.e2" id="DS.d1771.s2.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1771.s3" origId="18930149-2369" text="Finally, we provided evidence for anandamide as an endovanilloid substance in the striatum, since genetic inhibition of anandamide degradation resulted in a tonic activation of TRPV1 channels modulating glutamate but not GABA release.">
            <entity id="DS.d1771.s3.e0" origId="5281969" charOffset="34-44" type="compound" text="anandamide"/>
            <entity id="DS.d1771.s3.e1" origId="5281969" charOffset="120-130" type="compound" text="anandamide"/>
            <entity id="DS.d1771.s3.e2" origId="Q697L1,Q8NER1" charOffset="177-182" type="protein" text="TRPV1"/>
            <pair e1="DS.d1771.s3.e0" e2="DS.d1771.s3.e2" id="DS.d1771.s3.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1772" origId="18930474">
        <sentence id="DS.d1772.s0" origId="18930474-2338" text="With the exception of significantly elevated serum prolactin after escitalopram, no effects in the secondary outcome measures were detected.">
            <entity id="DS.d1772.s0.e0" origId="P10765,P22393,P33089,P33090,P33091,P43001" charOffset="51-60" type="protein" text="prolactin"/>
            <entity id="DS.d1772.s0.e1" origId="146570" charOffset="67-79" type="compound" text="escitalopram"/>
            <pair e1="DS.d1772.s0.e1" e2="DS.d1772.s0.e0" id="DS.d1772.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1773" origId="18930547">
        <sentence id="DS.d1773.s0" origId="18930547-2375" text="The cellular response to dsRNA or its synthetic analog polyinosinic-polycytidylic acid (poly I:C) results in IRF-3-, IRF-7- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.">
            <entity id="DS.d1773.s0.e0" origId="32744,274740" charOffset="55-86" type="compound" text="polyinosinic-polycytidylic acid"/>
            <entity id="DS.d1773.s0.e1" origId="32744,213546,274740" charOffset="88-96" type="compound" text="poly I:C"/>
            <entity id="DS.d1773.s0.e2" origId="P70671,Q14653,Q4JF28,Q764M6,Q90643" charOffset="109-114" type="protein" text="IRF-3"/>
            <entity id="DS.d1773.s0.e3" origId="P70434,Q92985" charOffset="117-122" type="protein" text="IRF-7"/>
            <pair e1="DS.d1773.s0.e0" e2="DS.d1773.s0.e3" id="DS.d1773.s0.i0" interaction="True"/>
            <pair e1="DS.d1773.s0.e1" e2="DS.d1773.s0.e2" id="DS.d1773.s0.i1" interaction="True"/>
            <pair e1="DS.d1773.s0.e0" e2="DS.d1773.s0.e2" id="DS.d1773.s0.i2" interaction="True"/>
            <pair e1="DS.d1773.s0.e1" e2="DS.d1773.s0.e3" id="DS.d1773.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1774" origId="18930565">
        <sentence id="DS.d1774.s0" origId="18930565-2381" text="Primaquine toxicity is aggravated in people deficient of 6-glucose phosphate dehydrogenase or glutathione synthetase.">
            <entity id="DS.d1774.s0.e0" origId="4908" charOffset="0-10" type="compound" text="Primaquine"/>
            <entity id="DS.d1774.s0.e1" origId="O32463,P04425,P35667,P35668,P45480,P46413,P48637,P51855,P57612,P58578,P58579,P58580,P58581,P58582,P59495,P61396,P73493,Q08220,Q5EAC2,Q5LYY5,Q5M3J8,Q65RX0,Q6ANW2,Q71VZ1,Q7M7H8,Q7MHK1,Q7NF44,Q7NQ65,Q7TUG9,Q7TUK9,Q7TVB0,Q7U3W8,Q7VY62,Q7W910,Q7WKF5,Q82V16,Q82ZG8,Q83AL0,Q83Q91,Q87D42,Q87LK1,Q87VA4,Q88D35,Q88UW5,Q89WL0,Q8D335,Q8DCA9,Q8DKF1,Q8DW15,Q8DXM9,Q8E399,Q8EIK8,Q8FE30,Q8FXW6,Q8HXX5,Q8K931,Q8P6P1,Q8PHZ5,Q8UII5,Q8XK30,Q8Y3R3,Q8YE82,Q926X7,Q92SN3,Q98DE8,Q9ABS9,Q9CM00,Q9I697,Q9JTJ6,Q9JYJ3,Q9KUP7,Q9PC29" charOffset="94-116" type="protein" text="glutathione synthetase"/>
            <pair e1="DS.d1774.s0.e0" e2="DS.d1774.s0.e1" id="DS.d1774.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1775" origId="18930648">
        <sentence id="DS.d1775.s0" origId="18930648-795" text="Levels of interleukin-8 (IL-8) and 8-isoprostane were measured in epithelial lining fluid (ELF) from central and peripheral airways separately collected using a bronchoscopic microsampling technique.">
            <entity id="DS.d1775.s0.e0" origId="P10145" charOffset="10-23" type="protein" text="interleukin-8"/>
            <entity id="DS.d1775.s0.e1" origId="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5" charOffset="25-29" type="protein" text="IL-8"/>
            <entity id="DS.d1775.s0.e2" origId="107873" charOffset="35-48" type="compound" text="8-isoprostane"/>
            <pair e1="DS.d1775.s0.e2" e2="DS.d1775.s0.e1" id="DS.d1775.s0.i0" interaction="False"/>
            <pair e1="DS.d1775.s0.e2" e2="DS.d1775.s0.e0" id="DS.d1775.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1776" origId="18930650">
        <sentence id="DS.d1776.s0" origId="18930650-823" text="Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like N-hydroxysuccinimide (NHS) to alkaline phosphatase (ALP) which was in turn conjugated to 2,4-D molecule.">
            <entity id="DS.d1776.s0.e0" origId="80170" charOffset="272-292" type="compound" text="N-hydroxysuccinimide"/>
            <entity id="DS.d1776.s0.e1" origId="O60109,P81800,P83456" charOffset="302-322" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d1776.s0.e2" origId="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0" charOffset="324-327" type="protein" text="ALP"/>
            <pair e1="DS.d1776.s0.e0" e2="DS.d1776.s0.e2" id="DS.d1776.s0.i0" interaction="True"/>
            <pair e1="DS.d1776.s0.e0" e2="DS.d1776.s0.e1" id="DS.d1776.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1777" origId="18930705">
        <sentence id="DS.d1777.s0" origId="18930705-2444" text="The SoxN protein is proposed to harbor the heme b of lower reduction potential and the heme a (s), and CbsA the other heme b.">
            <entity id="DS.d1777.s0.e0" origId="5326705,5942915" charOffset="87-93" type="compound" text="heme a"/>
            <entity id="DS.d1777.s0.e1" origId="O54088,P58029" charOffset="103-107" type="protein" text="CbsA"/>
            <pair e1="DS.d1777.s0.e0" e2="DS.d1777.s0.e1" id="DS.d1777.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1778" origId="18930712">
        <sentence id="DS.d1778.s0" origId="18930712-2448" text="Seleno-L-methionine (SeMet) can be oxidized to L-methionine selenoxide (MetSeO) by flavin-containing monooxygenase 3 (FMO3) and rat liver microsomes in the presence of NADPH.">
            <entity id="DS.d1778.s0.e0" origId="P31513,P32417,Q7YS44,Q8HYJ9,Q8SPQ7,Q95LA1" charOffset="118-122" type="protein" text="FMO3"/>
            <entity id="DS.d1778.s0.e1" origId="5884" charOffset="168-173" type="compound" text="NADPH"/>
            <pair e1="DS.d1778.s0.e1" e2="DS.d1778.s0.e0" id="DS.d1778.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1779" origId="18930714">
        <sentence id="DS.d1779.s0" origId="18930714-667" text="Regulatory roles for Tiam1, a guanine nucleotide exchange factor for Rac1, in glucose-stimulated insulin secretion in pancreatic beta-cells.">
            <entity id="DS.d1779.s0.e0" origId="Q60610" charOffset="21-26" type="protein" text="Tiam1"/>
            <entity id="DS.d1779.s0.e1" origId="P40792,P63001,Q6RUV5" charOffset="69-73" type="protein" text="Rac1"/>
            <entity id="DS.d1779.s0.e2" origId="206,5793,64689,79025" charOffset="78-85" type="compound" text="glucose"/>
            <entity id="DS.d1779.s0.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="97-104" type="protein" text="insulin"/>
            <pair e1="DS.d1779.s0.e2" e2="DS.d1779.s0.e1" id="DS.d1779.s0.i0" interaction="False"/>
            <pair e1="DS.d1779.s0.e2" e2="DS.d1779.s0.e3" id="DS.d1779.s0.i1" interaction="True"/>
            <pair e1="DS.d1779.s0.e2" e2="DS.d1779.s0.e0" id="DS.d1779.s0.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d1779.s1" origId="18930714-668" text="Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for Rac1, a small G-protein, in glucose-stimulated insulin secretion (GSIS).">
            <entity id="DS.d1779.s1.e0" origId="P40792,P63001,Q6RUV5" charOffset="127-131" type="protein" text="Rac1"/>
            <entity id="DS.d1779.s1.e1" origId="P15153" charOffset="135-150" type="protein" text="small G-protein"/>
            <entity id="DS.d1779.s1.e2" origId="206,5793,64689,79025" charOffset="155-162" type="compound" text="glucose"/>
            <entity id="DS.d1779.s1.e3" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="174-181" type="protein" text="insulin"/>
            <pair e1="DS.d1779.s1.e2" e2="DS.d1779.s1.e1" id="DS.d1779.s1.i0" interaction="False"/>
            <pair e1="DS.d1779.s1.e2" e2="DS.d1779.s1.e3" id="DS.d1779.s1.i1" interaction="True"/>
            <pair e1="DS.d1779.s1.e2" e2="DS.d1779.s1.e0" id="DS.d1779.s1.i2" interaction="False"/>
        </sentence>
        <sentence id="DS.d1779.s2" origId="18930714-670" text="GTP-bound form) and membrane association of Rac1 in INS 832/13 cells and rat islets.">
            <entity id="DS.d1779.s2.e0" origId="6830" charOffset="0-3" type="compound" text="GTP"/>
            <entity id="DS.d1779.s2.e1" origId="P40792,P63001,Q6RUV5" charOffset="44-48" type="protein" text="Rac1"/>
            <pair e1="DS.d1779.s2.e0" e2="DS.d1779.s2.e1" id="DS.d1779.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1779.s3" origId="18930714-671" text="Interestingly, however, in contrast to the inhibitory effects of NSC23766, Tiam1 gene depletion potentiated GSIS in these cells; such a potentiation of GSIS was sensitive to extracellular calcium.">
            <entity id="DS.d1779.s3.e0" origId="409805" charOffset="65-73" type="compound" text="NSC23766"/>
            <entity id="DS.d1779.s3.e1" origId="Q60610" charOffset="75-80" type="protein" text="Tiam1"/>
            <pair e1="DS.d1779.s3.e0" e2="DS.d1779.s3.e1" id="DS.d1779.s3.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1780" origId="18930760">
        <sentence id="DS.d1780.s0" origId="18930760-2475" text="This vector allows the co-expression of alpha-Hb as a fusion protein with Glutathione S-Transferase (GST-alpha-Hb) and beta-Hb with an additional methionine at the N-terminal extremity (rbeta-Hb).">
            <entity id="DS.d1780.s0.e0" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="74-99" type="protein" text="Glutathione S-Transferase"/>
            <entity id="DS.d1780.s0.e1" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="101-104" type="protein" text="GST"/>
            <entity id="DS.d1780.s0.e2" origId="876,6137" charOffset="146-156" type="compound" text="methionine"/>
            <pair e1="DS.d1780.s0.e2" e2="DS.d1780.s0.e0" id="DS.d1780.s0.i0" interaction="False"/>
            <pair e1="DS.d1780.s0.e2" e2="DS.d1780.s0.e1" id="DS.d1780.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1781" origId="18930779">
        <sentence id="DS.d1781.s0" origId="18930779-791" text="Superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.">
            <entity id="DS.d1781.s0.e0" origId="O50258" charOffset="0-20" type="protein" text="Superoxide dismutase"/>
            <entity id="DS.d1781.s0.e1" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="22-25" type="protein" text="SOD"/>
            <entity id="DS.d1781.s0.e2" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="28-36" type="protein" text="catalase"/>
            <entity id="DS.d1781.s0.e3" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="38-41" type="protein" text="CAT"/>
            <entity id="DS.d1781.s0.e4" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="48-70" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d1781.s0.e5" origId="2723628" charOffset="102-121" type="compound" text="thiobarbituric acid"/>
            <entity id="DS.d1781.s0.e6" origId="145068" charOffset="155-167" type="compound" text="nitric oxide"/>
            <pair e1="DS.d1781.s0.e6" e2="DS.d1781.s0.e0" id="DS.d1781.s0.i0" interaction="False"/>
            <pair e1="DS.d1781.s0.e6" e2="DS.d1781.s0.e2" id="DS.d1781.s0.i1" interaction="False"/>
            <pair e1="DS.d1781.s0.e5" e2="DS.d1781.s0.e0" id="DS.d1781.s0.i2" interaction="False"/>
            <pair e1="DS.d1781.s0.e5" e2="DS.d1781.s0.e4" id="DS.d1781.s0.i3" interaction="False"/>
            <pair e1="DS.d1781.s0.e6" e2="DS.d1781.s0.e4" id="DS.d1781.s0.i4" interaction="False"/>
            <pair e1="DS.d1781.s0.e5" e2="DS.d1781.s0.e2" id="DS.d1781.s0.i5" interaction="False"/>
            <pair e1="DS.d1781.s0.e6" e2="DS.d1781.s0.e1" id="DS.d1781.s0.i6" interaction="False"/>
            <pair e1="DS.d1781.s0.e5" e2="DS.d1781.s0.e1" id="DS.d1781.s0.i7" interaction="False"/>
            <pair e1="DS.d1781.s0.e5" e2="DS.d1781.s0.e3" id="DS.d1781.s0.i8" interaction="False"/>
            <pair e1="DS.d1781.s0.e6" e2="DS.d1781.s0.e3" id="DS.d1781.s0.i9" interaction="False"/>
        </sentence>
        <sentence id="DS.d1781.s1" origId="18930779-793" text="The erythrocyte CAT activity was higher in erdosteine group and there was a statistically significant increase, when compared with the erdosteine plus ischemia/reperfusion group.">
            <entity id="DS.d1781.s1.e0" origId="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7" charOffset="16-19" type="protein" text="CAT"/>
            <entity id="DS.d1781.s1.e1" origId="65632" charOffset="43-53" type="compound" text="erdosteine"/>
            <entity id="DS.d1781.s1.e2" origId="65632" charOffset="135-145" type="compound" text="erdosteine"/>
            <pair e1="DS.d1781.s1.e1" e2="DS.d1781.s1.e0" id="DS.d1781.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1782" origId="18930802">
        <sentence id="DS.d1782.s0" origId="18930802-2496" text="The ethidium bromide (EB) demyelinating model was associated with vitamin E (Vit E) and ebselen (Ebs) treatment to evaluate acetylcholinesterase (AChE) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.">
            <entity id="DS.d1782.s0.e0" origId="2116,14985,1548900,1742129" charOffset="66-75" type="compound" text="vitamin E"/>
            <entity id="DS.d1782.s0.e1" origId="3194" charOffset="88-95" type="compound" text="ebselen"/>
            <entity id="DS.d1782.s0.e2" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="124-144" type="protein" text="acetylcholinesterase"/>
            <entity id="DS.d1782.s0.e3" origId="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3" charOffset="146-150" type="protein" text="AChE"/>
            <pair e1="DS.d1782.s0.e1" e2="DS.d1782.s0.e2" id="DS.d1782.s0.i0" interaction="False"/>
            <pair e1="DS.d1782.s0.e1" e2="DS.d1782.s0.e3" id="DS.d1782.s0.i1" interaction="False"/>
            <pair e1="DS.d1782.s0.e0" e2="DS.d1782.s0.e2" id="DS.d1782.s0.i2" interaction="False"/>
            <pair e1="DS.d1782.s0.e0" e2="DS.d1782.s0.e3" id="DS.d1782.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1784" origId="18930813">
        <sentence id="DS.d1784.s0" origId="18930813-875" text="A search of publicly available microarray data reveals that expression of mitochondrial manganese superoxide dismutase (Sod2), responsible for the conversion of superoxide (O(2)(-)) to hydrogen peroxide (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.">
            <entity id="DS.d1784.s0.e0" origId="O50258" charOffset="98-118" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1784.s0.e1" origId="O08460,P07895,P09224,P09671,P36606,P80733,Q00637,Q03301,Q07449,Q9UQX0" charOffset="120-124" type="protein" text="Sod2"/>
            <entity id="DS.d1784.s0.e3" origId="784" charOffset="185-202" type="compound" text="hydrogen peroxide"/>
            <pair e1="DS.d1784.s0.e3" e2="DS.d1784.s0.e1" id="DS.d1784.s0.i0" interaction="True"/>
            <pair e1="DS.d1784.s0.e3" e2="DS.d1784.s0.e0" id="DS.d1784.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1785" origId="18930826">
        <sentence id="DS.d1785.s0" origId="18930826-2517" text="In vivo TASK blockade by anandamide significantly increased infarct volumes at 24 h in mice undergoing 30 min of transient middle cerebral artery occlusion (tMCAO).">
            <entity id="DS.d1785.s0.e0" origId="O14649" charOffset="8-12" type="protein" text="TASK"/>
            <entity id="DS.d1785.s0.e1" origId="5281969" charOffset="25-35" type="compound" text="anandamide"/>
            <pair e1="DS.d1785.s0.e1" e2="DS.d1785.s0.e0" id="DS.d1785.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1786" origId="18930833">
        <sentence id="DS.d1786.s0" origId="18930833-2520" text="Glutathione S-transferases (GSTs) are multifunctional phase II detoxification enzymes that catalyze the attachment of electrophilic substrates to glutathione.">
            <entity id="DS.d1786.s0.e0" origId="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324" charOffset="0-26" type="protein" text="Glutathione S-transferases"/>
            <entity id="DS.d1786.s0.e1" origId="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52" charOffset="28-32" type="protein" text="GSTs"/>
            <entity id="DS.d1786.s0.e2" origId="124886" charOffset="146-157" type="compound" text="glutathione"/>
            <pair e1="DS.d1786.s0.e2" e2="DS.d1786.s0.e1" id="DS.d1786.s0.i0" interaction="True"/>
            <pair e1="DS.d1786.s0.e2" e2="DS.d1786.s0.e0" id="DS.d1786.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1787" origId="18930846">
        <sentence id="DS.d1787.s0" origId="18930846-916" text="It can use a dithiol-disulfide active-site to transfer reducing equivalents from NADPH to thioredoxin (Trx), via the cofactor FAD.">
            <entity id="DS.d1787.s0.e0" origId="5884" charOffset="81-86" type="compound" text="NADPH"/>
            <entity id="DS.d1787.s0.e1" origId="O14463,O17486,O22022,O30974,O51088,O51890,O83889,O84544,O96952,O97508,O97680,P00276,P08058,P08628,P08629,P09857,P0A0K4,P0A0K5,P0A0K6,P0A4L3,P0A4L4,P0A616,P0A617,P10472,P10473,P10599,P10639,P11232,P14930,P14949,P21609,P21610,P29429,P29451,P33791,P34723,P37395,P42115,P43785,P46843,P47370,P50254,P50338,P50413,P51225,P52227,P52230,P52231,P52233,P57653,P59527,P66928,P66929,P75512,P80579,P81108,P81109,P81110,P82460,P96132,P99122,P99505,Q05739,Q57755,Q5HGT9,Q5HQ29,Q5R9M3,Q6GA69,Q6GHU0,Q7KQL8,Q7M1B9,Q8CPL5,Q92JR5,Q98PL5,Q98TX1,Q9BDJ3,Q9CM49,Q9DGI3,Q9JWM8,Q9K1N8,Q9PJK3,Q9R6P9,Q9UW02,Q9X2T1,Q9Z7P5,Q9ZEE0" charOffset="90-101" type="protein" text="thioredoxin"/>
            <entity id="DS.d1787.s0.e2" origId="O97508,O97680,P08628,P08629,P0A4L3,P0A4L4,P0A616,P0A617,P10599,P10639,P11232,P14949,P20659,P29451,P37395,P42115,P46843,P47370,P50413,P52227,P75512,P82460,P99505,Q24742,Q57755,Q5R9M3,Q98TX1,Q9BDJ3,Q9DGI3,Q9R6P9,Q9X2T1" charOffset="103-106" type="protein" text="Trx"/>
            <pair e1="DS.d1787.s0.e0" e2="DS.d1787.s0.e2" id="DS.d1787.s0.i0" interaction="True"/>
            <pair e1="DS.d1787.s0.e0" e2="DS.d1787.s0.e1" id="DS.d1787.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1788" origId="18930903">
        <sentence id="DS.d1788.s0" origId="18930903-626" text="Hypoxia-inducible factor-1alpha (HIF-1alpha) is a transcription factor that plays an essential role in oxygen homeostasis.">
            <entity id="DS.d1788.s0.e0" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="0-31" type="protein" text="Hypoxia-inducible factor-1alpha"/>
            <entity id="DS.d1788.s0.e1" origId="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9" charOffset="33-43" type="protein" text="HIF-1alpha"/>
            <entity id="DS.d1788.s0.e2" origId="977" charOffset="103-109" type="compound" text="oxygen"/>
            <pair e1="DS.d1788.s0.e2" e2="DS.d1788.s0.e0" id="DS.d1788.s0.i0" interaction="True"/>
            <pair e1="DS.d1788.s0.e2" e2="DS.d1788.s0.e1" id="DS.d1788.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1789" origId="18930948">
        <sentence id="DS.d1789.s0" origId="18930948-1088" text="However, transferrin, a protein with no active site serine, was covalently modified in vitro by 0.5mM 10-fluoroethoxyphosphinyl-N-biotinamido pentyldecanamide, chlorpyrifos oxon, diisopropylfluorophosphate, dichlorvos, sarin, and soman.">
            <entity id="DS.d1789.s0.e0" origId="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1" charOffset="9-20" type="protein" text="transferrin"/>
            <entity id="DS.d1789.s0.e2" origId="5951" charOffset="52-58" type="compound" text="serine"/>
            <pair e1="DS.d1789.s0.e2" e2="DS.d1789.s0.e0" id="DS.d1789.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1792" origId="18931035">
        <sentence id="DS.d1792.s0" origId="18931035-2612" text="The mechanism of lysoPAF-mediated inhibition of neutrophils involves an elevation in the intracellular cAMP level, and pharmacological blockade of adenylyl cyclase completely reverses the inhibitory effect of lysoPAF.">
            <entity id="DS.d1792.s0.e0" origId="6076" charOffset="103-107" type="compound" text="cAMP"/>
            <entity id="DS.d1792.s0.e1" origId="P00936,P08678,P0A1A7,P0A1A8,P0A4Y0,P0A4Y1,P14605,P15318,P23466,P26338,P27580,P30528,P40127,P40130,P40134,P40135,P40136,P43524,P49606,P59739,Q01513,Q01631,Q03100,Q03101,Q05766,Q25263,Q26721,Q26896,Q27675,Q57506,Q59119,Q59685,Q8FBP0,Q8XAP1,Q99279,Q99280,Q99396,Q9WXC3" charOffset="147-163" type="protein" text="adenylyl cyclase"/>
            <pair e1="DS.d1792.s0.e0" e2="DS.d1792.s0.e1" id="DS.d1792.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1793" origId="18931047">
        <sentence id="DS.d1793.s0" origId="18931047-2620" text="Sympathetic neurogenic Ca2+ signalling in rat arteries: ATP, noradrenaline and neuropeptide Y.">
            <entity id="DS.d1793.s0.e0" origId="5957" charOffset="56-59" type="compound" text="ATP"/>
            <entity id="DS.d1793.s0.e1" origId="951,439260" charOffset="61-74" type="compound" text="noradrenaline"/>
            <entity id="DS.d1793.s0.e2" origId="P01303,P01304,P07808,P14765,P28672,P28673,P28674,P29071,P33689,P57774,P68006,P68007,P68008,P69101,P69102,P80167,Q27441,Q6RUW3,Q90WF4,Q9DGK7,Q9I8P3,Q9I9D3,Q9PTA0,Q9PW68,Q9XSW6" charOffset="79-93" type="protein" text="neuropeptide Y"/>
            <pair e1="DS.d1793.s0.e1" e2="DS.d1793.s0.e2" id="DS.d1793.s0.i0" interaction="False"/>
            <pair e1="DS.d1793.s0.e0" e2="DS.d1793.s0.e2" id="DS.d1793.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1794" origId="18931108">
        <sentence id="DS.d1794.s0" origId="18931108-2645" text="DnaB (BA) demonstrated a strong DNA helicase activity that required ATP or dATP.">
            <entity id="DS.d1794.s0.e0" origId="O25916,O30477,O78411,O83097,P07908,P0A1Q4,P0A1Q5,P0ACB0,P0ACB1,P45256,P46394,P47340,P49519,P51333,P57611,P59966,P71715,P75539,Q55418,Q6ABX1,Q89A52,Q8FB22,Q8K932,Q8X5V3,Q8YZA1,Q92HG8,Q9CNL6,Q9F5P4,Q9ZD08,Q9ZJM5" charOffset="0-4" type="protein" text="DnaB"/>
            <entity id="DS.d1794.s0.e1" origId="O29238,O51934,O58530,O67037,O67226,P09395,P09498,P15095,P15402,P16342,P17779,P17965,P18458,P19751,P19811,P20951,P22168,P22591,P22657,P27327,P27328,P27407,P27409,P27410,P27411,P27920,P28726,P28897,P36286,P37987,P54634,P59641,P74759,P95479,Q04544,Q04561,Q04575,Q05002,Q06502,Q07518,Q07630,Q08582,Q3I5J6,Q58907,Q66198,Q66914,Q68772,Q69014,Q6F598,Q83017,Q86117,Q86119,Q89273,Q8B912,Q8R979,Q8V439,Q8V6W7,Q8V736,Q8ZXT5,Q91A29,Q91AV2,Q91QT2,Q96725,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9IW06,Q9PYA3,Q9UZ86,Q9WJB2,Q9YC75,Q9YCB6,Q9YN02" charOffset="36-44" type="protein" text="helicase"/>
            <entity id="DS.d1794.s0.e2" origId="5957" charOffset="68-71" type="compound" text="ATP"/>
            <entity id="DS.d1794.s0.e3" origId="15993" charOffset="75-79" type="compound" text="dATP"/>
            <pair e1="DS.d1794.s0.e3" e2="DS.d1794.s0.e1" id="DS.d1794.s0.i0" interaction="True"/>
            <pair e1="DS.d1794.s0.e3" e2="DS.d1794.s0.e0" id="DS.d1794.s0.i1" interaction="True"/>
            <pair e1="DS.d1794.s0.e2" e2="DS.d1794.s0.e0" id="DS.d1794.s0.i2" interaction="True"/>
            <pair e1="DS.d1794.s0.e2" e2="DS.d1794.s0.e1" id="DS.d1794.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1795" origId="18931130">
        <sentence id="DS.d1795.s0" origId="18931130-230" text="MerH was found to transport mercuric ions in Escherichia coli via a pair of essential cysteine residues but only when coexpressed with the mercuric reductase.">
            <entity id="DS.d1795.s0.e0" origId="594,5862,5360637" charOffset="86-94" type="compound" text="cysteine"/>
            <entity id="DS.d1795.s0.e1" origId="P00392,P08332,P08662,P0A0E4,P0A0E5,P16171,P17239,P30341,P94188,P94702,Q51772,Q52109,Q54465" charOffset="139-157" type="protein" text="mercuric reductase"/>
            <pair e1="DS.d1795.s0.e0" e2="DS.d1795.s0.e1" id="DS.d1795.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1796" origId="18931136">
        <sentence id="DS.d1796.s0" origId="18931136-2657" text="HmuY and HmuR are hemin binding proteins required for P. gingivalis growth.">
            <entity id="DS.d1796.s0.e0" origId="Q56989" charOffset="9-13" type="protein" text="HmuR"/>
            <entity id="DS.d1796.s0.e1" origId="4971" charOffset="18-23" type="compound" text="hemin"/>
            <pair e1="DS.d1796.s0.e1" e2="DS.d1796.s0.e0" id="DS.d1796.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1797" origId="18931257">
        <sentence id="DS.d1797.s0" origId="18931257-1820" text="The effect of tropomyosin on actin filaments was independent of ionic strength, but became stronger as the magnesium concentration increased.">
            <entity id="DS.d1797.s0.e0" origId="O01673,O02389,O16127,O18416,O44119,O61379,O96764,O97162,O97192,P31816,P91958,Q02088,Q23758,Q23939,Q25145,Q25456,Q25457,Q25632,Q26503,Q26519,Q7M3Y8,Q8IT89,Q8T380,Q8T6L5,Q8WR63,Q95PU1,Q95VA8,Q9GZ69,Q9GZ70,Q9GZ71,Q9N2R3,Q9NAS5,Q9NDS0,Q9NFZ4,Q9NG56,Q9UB83" charOffset="14-25" type="protein" text="tropomyosin"/>
            <entity id="DS.d1797.s0.e1" origId="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8" charOffset="29-34" type="protein" text="actin"/>
            <entity id="DS.d1797.s0.e2" origId="5462224" charOffset="107-116" type="compound" text="magnesium"/>
            <pair e1="DS.d1797.s0.e2" e2="DS.d1797.s0.e1" id="DS.d1797.s0.i0" interaction="True"/>
            <pair e1="DS.d1797.s0.e2" e2="DS.d1797.s0.e0" id="DS.d1797.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1798" origId="18931328">
        <sentence id="DS.d1798.s0" origId="18931328-2696" text="We showed that, compared with the untreated CF serous cells, a 24-hour pre-incubation period with 200 nM salmeterol induced an 83% increase in delF508-CFTR-mediated chloride efflux.">
            <entity id="DS.d1798.s0.e0" origId="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2" charOffset="151-155" type="protein" text="CFTR"/>
            <entity id="DS.d1798.s0.e1" origId="312" charOffset="165-173" type="compound" text="chloride"/>
            <pair e1="DS.d1798.s0.e1" e2="DS.d1798.s0.e0" id="DS.d1798.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1799" origId="18931344">
        <sentence id="DS.d1799.s0" origId="18931344-2072" text="Activation of Bax and Bak was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall obatoclax exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.">
            <entity id="DS.d1799.s0.e0" origId="P27297,Q07813,Q63690" charOffset="14-17" type="protein" text="Bax"/>
            <entity id="DS.d1799.s0.e1" origId="O08734" charOffset="22-25" type="protein" text="Bak"/>
            <entity id="DS.d1799.s0.e2" origId="11404337,45356963" charOffset="132-141" type="compound" text="obatoclax"/>
            <pair e1="DS.d1799.s0.e2" e2="DS.d1799.s0.e1" id="DS.d1799.s0.i0" interaction="False"/>
            <pair e1="DS.d1799.s0.e2" e2="DS.d1799.s0.e0" id="DS.d1799.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1800" origId="18931380">
        <sentence id="DS.d1800.s0" origId="18931380-2724" text="Liver glycidamide DNA adducts and acrylamide and glycidamide N-terminal valine hemoglobin adducts were also determined.">
            <entity id="DS.d1800.s0.e0" origId="91550" charOffset="6-17" type="compound" text="glycidamide"/>
            <entity id="DS.d1800.s0.e1" origId="6579" charOffset="34-44" type="compound" text="acrylamide"/>
            <entity id="DS.d1800.s0.e2" origId="91550" charOffset="49-60" type="compound" text="glycidamide"/>
            <entity id="DS.d1800.s0.e3" origId="6287" charOffset="72-78" type="compound" text="valine"/>
            <entity id="DS.d1800.s0.e4" origId="P15160,P17724,P73925,Q03459" charOffset="79-89" type="protein" text="hemoglobin"/>
            <pair e1="DS.d1800.s0.e0" e2="DS.d1800.s0.e4" id="DS.d1800.s0.i0" interaction="False"/>
            <pair e1="DS.d1800.s0.e3" e2="DS.d1800.s0.e4" id="DS.d1800.s0.i1" interaction="True"/>
            <pair e1="DS.d1800.s0.e1" e2="DS.d1800.s0.e4" id="DS.d1800.s0.i2" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1801" origId="18931475">
        <sentence id="DS.d1801.s0" origId="18931475-2743" text="The acyl ghrelin peptide features a unique post-translational modification of O-n-octanoylation at serine 3, and is the only gastrointestinal signal that increases meal size.">
            <entity id="DS.d1801.s0.e0" origId="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3" charOffset="9-16" type="protein" text="ghrelin"/>
            <entity id="DS.d1801.s0.e1" origId="5951" charOffset="99-105" type="compound" text="serine"/>
            <pair e1="DS.d1801.s0.e1" e2="DS.d1801.s0.e0" id="DS.d1801.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1802" origId="18931618">
        <sentence id="DS.d1802.s0" origId="18931618-2800" text="Tests of the blood samples obtained at the ED revealed leucocytosis (11 070.6+/-4302.5/microl), increased blood glucose, LDH, CK and CK-MB levels.">
            <entity id="DS.d1802.s0.e0" origId="206,5793,64689,79025" charOffset="112-119" type="compound" text="glucose"/>
            <entity id="DS.d1802.s0.e1" origId="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289" charOffset="121-124" type="protein" text="LDH"/>
            <pair e1="DS.d1802.s0.e0" e2="DS.d1802.s0.e1" id="DS.d1802.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1803" origId="18931836">
        <sentence id="DS.d1803.s0" origId="18931836-26" text="Molecular and biochemical characterization of a distinct tyrosinase involved in melanin production from Aeromonas media.">
            <entity id="DS.d1803.s0.e0" origId="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396" charOffset="57-67" type="protein" text="tyrosinase"/>
            <entity id="DS.d1803.s0.e1" origId="6325610" charOffset="80-87" type="compound" text="melanin"/>
            <pair e1="DS.d1803.s0.e1" e2="DS.d1803.s0.e0" id="DS.d1803.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1803.s1" origId="18931836-28" text="TyrA had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (L-dopa) than many other tyrosinases.">
            <entity id="DS.d1803.s1.e0" origId="P07023,P20692,P43901,P43902,Q02287,Q9CET9" charOffset="0-4" type="protein" text="TyrA"/>
            <entity id="DS.d1803.s1.e1" origId="33665" charOffset="41-49" type="compound" text="diphenol"/>
            <entity id="DS.d1803.s1.e2" origId="836" charOffset="62-84" type="compound" text="dihydroxyphenylalanine"/>
            <entity id="DS.d1803.s1.e3" origId="6047" charOffset="86-92" type="compound" text="L-dopa"/>
            <entity id="DS.d1803.s1.e4" origId="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396" charOffset="110-121" type="protein" text="tyrosinases"/>
            <pair e1="DS.d1803.s1.e1" e2="DS.d1803.s1.e4" id="DS.d1803.s1.i0" interaction="False"/>
            <pair e1="DS.d1803.s1.e3" e2="DS.d1803.s1.e4" id="DS.d1803.s1.i1" interaction="False"/>
            <pair e1="DS.d1803.s1.e1" e2="DS.d1803.s1.e0" id="DS.d1803.s1.i2" interaction="False"/>
            <pair e1="DS.d1803.s1.e2" e2="DS.d1803.s1.e4" id="DS.d1803.s1.i3" interaction="False"/>
            <pair e1="DS.d1803.s1.e3" e2="DS.d1803.s1.e0" id="DS.d1803.s1.i4" interaction="True"/>
            <pair e1="DS.d1803.s1.e2" e2="DS.d1803.s1.e0" id="DS.d1803.s1.i5" interaction="True"/>
        </sentence>
        <sentence id="DS.d1803.s2" origId="18931836-29" text="EDTA or glutathione notably inhibited the enzymatic activities of TyrA, whereas Triton X-100 and SDS activated them.">
            <entity id="DS.d1803.s2.e0" origId="P07023,P20692,P43901,P43902,Q02287,Q9CET9" charOffset="66-70" type="protein" text="TyrA"/>
            <entity id="DS.d1803.s2.e1" origId="5590" charOffset="80-92" type="compound" text="Triton X-100"/>
            <pair e1="DS.d1803.s2.e1" e2="DS.d1803.s2.e0" id="DS.d1803.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1803.s3" origId="18931836-30" text="These results suggest that TyrA is the first reported distinct tyrosinase involved in melanin production in the genus Aeromonas.">
            <entity id="DS.d1803.s3.e0" origId="P07023,P20692,P43901,P43902,Q02287,Q9CET9" charOffset="27-31" type="protein" text="TyrA"/>
            <entity id="DS.d1803.s3.e1" origId="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396" charOffset="63-73" type="protein" text="tyrosinase"/>
            <entity id="DS.d1803.s3.e2" origId="6325610" charOffset="86-93" type="compound" text="melanin"/>
            <pair e1="DS.d1803.s3.e2" e2="DS.d1803.s3.e0" id="DS.d1803.s3.i0" interaction="True"/>
            <pair e1="DS.d1803.s3.e2" e2="DS.d1803.s3.e1" id="DS.d1803.s3.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1804" origId="18931932">
        <sentence id="DS.d1804.s0" origId="18931932-360" text="AMP-deaminase from goldfish white muscle: regulatory properties and redistribution under exposure to high environmental oxygen level.">
            <entity id="DS.d1804.s0.e0" origId="O80452,P15274,P50998" charOffset="0-13" type="protein" text="AMP-deaminase"/>
            <entity id="DS.d1804.s0.e1" origId="977" charOffset="120-126" type="compound" text="oxygen"/>
            <pair e1="DS.d1804.s0.e1" e2="DS.d1804.s0.e0" id="DS.d1804.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1804.s1" origId="18931932-361" text="Both sodium and potassium ions activated goldfish AMPD at low concentrations, with maximal activation at about 80 mM of each chloride salt, whereas higher concentrations became inhibitory.">
            <entity id="DS.d1804.s1.e0" origId="O80452,Q84NP7" charOffset="50-54" type="protein" text="AMPD"/>
            <entity id="DS.d1804.s1.e1" origId="312" charOffset="125-133" type="compound" text="chloride"/>
            <pair e1="DS.d1804.s1.e1" e2="DS.d1804.s1.e0" id="DS.d1804.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1804.s2" origId="18931932-362" text="Magnesium and calcium ions also inhibited goldfish muscle AMPD, as did phosphate and fluoride ; at a concentration of 8 mM, each anion reduced activity by about 66%.">
            <entity id="DS.d1804.s2.e0" origId="O80452,Q84NP7" charOffset="58-62" type="protein" text="AMPD"/>
            <entity id="DS.d1804.s2.e1" origId="1061,167704,644102" charOffset="71-80" type="compound" text="phosphate"/>
            <entity id="DS.d1804.s2.e2" origId="28179" charOffset="85-93" type="compound" text="fluoride"/>
            <pair e1="DS.d1804.s2.e2" e2="DS.d1804.s2.e0" id="DS.d1804.s2.i0" interaction="True"/>
            <pair e1="DS.d1804.s2.e1" e2="DS.d1804.s2.e0" id="DS.d1804.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1805" origId="18931933">
        <sentence id="DS.d1805.s0" origId="18931933-364" text="Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by alpha-lipoic acid through PI3 kinase, PTEN, and PP2A.">
            <entity id="DS.d1805.s0.e0" origId="P31750,Q8INB9" charOffset="29-32" type="protein" text="Akt"/>
            <entity id="DS.d1805.s0.e1" origId="864,6112" charOffset="93-110" type="compound" text="alpha-lipoic acid"/>
            <entity id="DS.d1805.s0.e2" origId="P42347,P42348,P54673,P54674,P54675,P54676" charOffset="119-129" type="protein" text="PI3 kinase"/>
            <entity id="DS.d1805.s0.e3" origId="P60483,P60484" charOffset="131-135" type="protein" text="PTEN"/>
            <entity id="DS.d1805.s0.e4" origId="P23696,Q06009,Q9ZSE4" charOffset="141-145" type="protein" text="PP2A"/>
            <pair e1="DS.d1805.s0.e1" e2="DS.d1805.s0.e0" id="DS.d1805.s0.i0" interaction="True"/>
            <pair e1="DS.d1805.s0.e1" e2="DS.d1805.s0.e3" id="DS.d1805.s0.i1" interaction="True"/>
            <pair e1="DS.d1805.s0.e1" e2="DS.d1805.s0.e2" id="DS.d1805.s0.i2" interaction="True"/>
            <pair e1="DS.d1805.s0.e1" e2="DS.d1805.s0.e4" id="DS.d1805.s0.i3" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1806" origId="18931946">
        <sentence id="DS.d1806.s0" origId="18931946-74" text="Unfolding and inactivation of abalone (Haliotis diversicolor) alkaline phosphatase during denaturation by guanidine hydrochloride.">
            <entity id="DS.d1806.s0.e0" origId="O60109,P81800,P83456" charOffset="62-82" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d1806.s0.e1" origId="3520" charOffset="106-129" type="compound" text="guanidine hydrochloride"/>
            <pair e1="DS.d1806.s0.e1" e2="DS.d1806.s0.e0" id="DS.d1806.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1806.s1" origId="18931946-75" text="Unfolding and inactivation of ALPase from abalone (Haliotis diversicolor) during denaturation by guanidine hydrochloride (GuHCl) of different concentrations has first been studied.">
            <entity id="DS.d1806.s1.e0" origId="P81800" charOffset="30-36" type="protein" text="ALPase"/>
            <entity id="DS.d1806.s1.e1" origId="3520" charOffset="97-120" type="compound" text="guanidine hydrochloride"/>
            <pair e1="DS.d1806.s1.e1" e2="DS.d1806.s1.e0" id="DS.d1806.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1807" origId="18931948">
        <sentence id="DS.d1807.s0" origId="18931948-76" text="We aim to study a possible benefit of a common nitrogen oxide donor, anti-anginal drug, nicorandil (N-(2-hydroxyethyl) nicotinamide nitrate ester), in managing acute gastric ulcers through studying its effect on some relevant intermediates to ulcerogenesis as lipid peroxidation, tumor necrosis factor-alpha (TNF-alpha), and nitric oxide (NO).">
            <entity id="DS.d1807.s0.e0" origId="Q8JFG3" charOffset="280-301" type="protein" text="tumor necrosis factor"/>
            <entity id="DS.d1807.s0.e1" origId="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1" charOffset="309-318" type="protein" text="TNF-alpha"/>
            <entity id="DS.d1807.s0.e2" origId="145068" charOffset="325-337" type="compound" text="nitric oxide"/>
            <pair e1="DS.d1807.s0.e2" e2="DS.d1807.s0.e1" id="DS.d1807.s0.i0" interaction="False"/>
            <pair e1="DS.d1807.s0.e2" e2="DS.d1807.s0.e0" id="DS.d1807.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1808" origId="18932012">
        <sentence id="DS.d1808.s1" origId="18932012-102" text="NADH/NAD (+) ratio can be normalized by the activation or overexpression of nicotinamide nucleotide transhydrogenase (NNT--&amp;gt; NADPH+ NAD (+).">
            <entity id="DS.d1808.s1.e0" origId="439153" charOffset="0-4" type="compound" text="NADH"/>
            <entity id="DS.d1808.s1.e2" origId="P11024,Q13423,Q61941" charOffset="76-116" type="protein" text="nicotinamide nucleotide transhydrogenase"/>
            <entity id="DS.d1808.s1.e3" origId="O93474,P11024,Q13423" charOffset="118-121" type="protein" text="NNT"/>
            <entity id="DS.d1808.s1.e4" origId="5884" charOffset="128-133" type="compound" text="NADPH"/>
            <entity id="DS.d1808.s1.e5" origId="5893" charOffset="5-8" type="compound" text="NAD"/>
            <pair e1="DS.d1808.s1.e4" e2="DS.d1808.s1.e3" id="DS.d1808.s1.i0" interaction="True"/>
            <pair e1="DS.d1808.s1.e4" e2="DS.d1808.s1.e2" id="DS.d1808.s1.i1" interaction="True"/>
            <pair e1="DS.d1808.s1.e0" e2="DS.d1808.s1.e3" id="DS.d1808.s1.i2" interaction="True"/>
            <pair e1="DS.d1808.s1.e0" e2="DS.d1808.s1.e2" id="DS.d1808.s1.i4" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1809" origId="18932024">
        <sentence id="DS.d1809.s0" origId="18932024-913" text="An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing sulfite oxidase and cytochrome c with polyaniline sulfonic acid in a layer-by-layer assembly.">
            <entity id="DS.d1809.s0.e0" origId="P07850,Q9S850" charOffset="95-110" type="protein" text="sulfite oxidase"/>
            <entity id="DS.d1809.s0.e1" origId="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3" charOffset="115-127" type="protein" text="cytochrome c"/>
            <entity id="DS.d1809.s0.e2" origId="104748" charOffset="145-158" type="compound" text="sulfonic acid"/>
            <pair e1="DS.d1809.s0.e2" e2="DS.d1809.s0.e1" id="DS.d1809.s0.i0" interaction="False"/>
            <pair e1="DS.d1809.s0.e2" e2="DS.d1809.s0.e0" id="DS.d1809.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1810" origId="18932046">
        <sentence id="DS.d1810.s0" origId="18932046-599" text="After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as superoxide dismutase, nitrite/nitrate, glutathione peroxidase and malondialdehyde were performed.">
            <entity id="DS.d1810.s0.e0" origId="O50258" charOffset="131-151" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1810.s0.e1" origId="O32770,O59858,Q00277,Q9CFV1" charOffset="170-192" type="protein" text="glutathione peroxidase"/>
            <entity id="DS.d1810.s0.e2" origId="10964" charOffset="197-212" type="compound" text="malondialdehyde"/>
            <pair e1="DS.d1810.s0.e2" e2="DS.d1810.s0.e0" id="DS.d1810.s0.i0" interaction="False"/>
            <pair e1="DS.d1810.s0.e2" e2="DS.d1810.s0.e1" id="DS.d1810.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1810.s1" origId="18932046-600" text="The levels of malondialdehyde and superoxide dismutase were lower in ginkgo groups but not significantly.">
            <entity id="DS.d1810.s1.e0" origId="10964" charOffset="14-29" type="compound" text="malondialdehyde"/>
            <entity id="DS.d1810.s1.e1" origId="O50258" charOffset="34-54" type="protein" text="superoxide dismutase"/>
            <pair e1="DS.d1810.s1.e0" e2="DS.d1810.s1.e1" id="DS.d1810.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1811" origId="18932201">
        <sentence id="DS.d1811.s0" origId="18932201-188" text="These results indicate that cloned embryos have aberrant DNA methylation in the CpG sites of the PE region of Oct-4, and this may contribute directly to abnormal expression of this gene in cloned embryos.">
            <entity id="DS.d1811.s0.e0" origId="6804" charOffset="80-83" type="compound" text="CpG"/>
            <entity id="DS.d1811.s0.e1" origId="O97552,P20263,Q01860,Q9TSV5" charOffset="110-115" type="protein" text="Oct-4"/>
            <pair e1="DS.d1811.s0.e0" e2="DS.d1811.s0.e1" id="DS.d1811.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1812" origId="18932209">
        <sentence id="DS.d1812.s0" origId="18932209-190" text="Xenopus follicle-enclosed oocytes are endowed with purinergic receptors located in the follicular cell membrane ; their stimulation by ATP elicits an electrical response that includes generation of a fast inward current (F(Cl)) carried by Cl(-).">
            <entity id="DS.d1812.s0.e0" origId="O15547,O54803,O70397,P34996,P35383,P41231,P41232,P47824,P47900,P48042,P49650,P49651,P49652,P49653,P49654,P51575,P51576,P51577,P51578,P51579,P56373,P59902,Q64663,Q93086,Q99571,Q99572,Q9UBL9,Q9Z1M0" charOffset="51-71" type="protein" text="purinergic receptors"/>
            <entity id="DS.d1812.s0.e1" origId="5957" charOffset="135-138" type="compound" text="ATP"/>
            <pair e1="DS.d1812.s0.e1" e2="DS.d1812.s0.e0" id="DS.d1812.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1813" origId="18932227">
        <sentence id="DS.d1813.s0" origId="18932227-940" text="Moreover, the dopaminergic and glutamatergic regulation of Homer1 gene activation by cocaine was investigated.">
            <entity id="DS.d1813.s0.e0" origId="Q9Z214,Q9Z2Y3" charOffset="59-65" type="protein" text="Homer1"/>
            <entity id="DS.d1813.s0.e1" origId="2826,5760,439497,446220,644017,54613779" charOffset="85-92" type="compound" text="cocaine"/>
            <pair e1="DS.d1813.s0.e1" e2="DS.d1813.s0.e0" id="DS.d1813.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1813.s1" origId="18932227-941" text="The acute cocaine-mediated activation of Homer1 gene was regulated by D1 but not D2 dopamine receptors.">
            <entity id="DS.d1813.s1.e0" origId="2826,5760,439497,446220,644017,54613779" charOffset="10-17" type="compound" text="cocaine"/>
            <entity id="DS.d1813.s1.e1" origId="Q9Z214,Q9Z2Y3" charOffset="41-47" type="protein" text="Homer1"/>
            <pair e1="DS.d1813.s1.e0" e2="DS.d1813.s1.e1" id="DS.d1813.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1813.s2" origId="18932227-942" text="Activation of Homer1 gene may contribute to the cocaine-mediated synaptic and behavioral plasticity.">
            <entity id="DS.d1813.s2.e0" origId="Q9Z214,Q9Z2Y3" charOffset="14-20" type="protein" text="Homer1"/>
            <entity id="DS.d1813.s2.e1" origId="2826,5760,439497,446220,644017,54613779" charOffset="48-55" type="compound" text="cocaine"/>
            <pair e1="DS.d1813.s2.e1" e2="DS.d1813.s2.e0" id="DS.d1813.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1815" origId="18935970">
        <sentence id="DS.d1815.s0" origId="18935970-1419" text="Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein peptidoglycan by N-linked glycoproteins, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-ether lipids of archaebacteria.">
            <entity id="DS.d1815.s0.e0" origId="9816401" charOffset="208-221" type="compound" text="peptidoglycan"/>
            <entity id="DS.d1815.s0.e1" origId="P08163" charOffset="234-247" type="protein" text="glycoproteins"/>
            <entity id="DS.d1815.s0.e2" origId="3283,5382654" charOffset="364-369" type="compound" text="ether"/>
            <pair e1="DS.d1815.s0.e2" e2="DS.d1815.s0.e1" id="DS.d1815.s0.i0" interaction="False"/>
            <pair e1="DS.d1815.s0.e0" e2="DS.d1815.s0.e1" id="DS.d1815.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1816" origId="18935973">
        <sentence id="DS.d1816.s0" origId="18935973-1420" text="Necrostatin-1, a new inhibitor of non-apoptotic death, rescued cells from death by RIPs, although the effect was also partial and temporary.">
            <entity id="DS.d1816.s0.e0" origId="2828334" charOffset="0-13" type="compound" text="Necrostatin-1"/>
            <entity id="DS.d1816.s0.e1" origId="P24817,P52594,P56626,Q13546,Q2TA45,Q86UA6" charOffset="83-87" type="protein" text="RIPs"/>
            <pair e1="DS.d1816.s0.e0" e2="DS.d1816.s0.e1" id="DS.d1816.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1817" origId="18935985">
        <sentence id="DS.d1817.s0" origId="18935985-1424" text="Here we show the first direct quantitative evidence for PAP binding to the cap analog m(7)GTP.">
            <entity id="DS.d1817.s0.e0" origId="O32449,O43150,O74326,O74518,O83041,O96690,P09274,P0ABF1,P0ABF2,P0ABF3,P10226,P16790,P25500,P27417,P28958,P29468,P36322,P36702,P42786,P44439,P46541,P46542,P46544,P46547,P47266,P51003,P51004,P51005,P51006,P52278,P52279,P52439,P52440,P75092,P80366,P84399,P93732,P96084,Q06141,Q09131,Q10295,Q13442,Q38924,Q3UHX2,Q51D88,Q61183,Q62785,Q7SIG6,Q87DF8,Q8Z9C3,Q8ZRQ8,Q97A76,Q97UA2,Q9D0D3,Q9JUV1,Q9JZR6,Q9NVV4,Q9PD69,Q9S2L4,Q9UT49,Q9UTN3,Q9ZWQ8" charOffset="56-59" type="protein" text="PAP"/>
            <entity id="DS.d1817.s0.e1" origId="444378" charOffset="86-93" type="compound" text="m(7)GTP"/>
            <pair e1="DS.d1817.s0.e1" e2="DS.d1817.s0.e0" id="DS.d1817.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1817.s1" origId="18935985-1425" text="van't Hoff analysis of m(7)GTP-PAP equilibrium reveals a binding reaction that is enthalpy driven and entropy favored with TDeltaS degrees contributing 15% to the overall value of DeltaG degrees.">
            <entity id="DS.d1817.s1.e0" origId="444378" charOffset="23-30" type="compound" text="m(7)GTP"/>
            <entity id="DS.d1817.s1.e1" origId="O32449,O43150,O74326,O74518,O83041,O96690,P09274,P0ABF1,P0ABF2,P0ABF3,P10226,P16790,P25500,P27417,P28958,P29468,P36322,P36702,P42786,P44439,P46541,P46542,P46544,P46547,P47266,P51003,P51004,P51005,P51006,P52278,P52279,P52439,P52440,P75092,P80366,P84399,P93732,P96084,Q06141,Q09131,Q10295,Q13442,Q38924,Q3UHX2,Q51D88,Q61183,Q62785,Q7SIG6,Q87DF8,Q8Z9C3,Q8ZRQ8,Q97A76,Q97UA2,Q9D0D3,Q9JUV1,Q9JZR6,Q9NVV4,Q9PD69,Q9S2L4,Q9UT49,Q9UTN3,Q9ZWQ8" charOffset="31-34" type="protein" text="PAP"/>
            <pair e1="DS.d1817.s1.e0" e2="DS.d1817.s1.e1" id="DS.d1817.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1817.s2" origId="18935985-1426" text="eIFiso4G was shown to enhance the interaction of PAP with m(7)GTP cap analog by 2.4-fold.">
            <entity id="DS.d1817.s2.e0" origId="O32449,O43150,O74326,O74518,O83041,O96690,P09274,P0ABF1,P0ABF2,P0ABF3,P10226,P16790,P25500,P27417,P28958,P29468,P36322,P36702,P42786,P44439,P46541,P46542,P46544,P46547,P47266,P51003,P51004,P51005,P51006,P52278,P52279,P52439,P52440,P75092,P80366,P84399,P93732,P96084,Q06141,Q09131,Q10295,Q13442,Q38924,Q3UHX2,Q51D88,Q61183,Q62785,Q7SIG6,Q87DF8,Q8Z9C3,Q8ZRQ8,Q97A76,Q97UA2,Q9D0D3,Q9JUV1,Q9JZR6,Q9NVV4,Q9PD69,Q9S2L4,Q9UT49,Q9UTN3,Q9ZWQ8" charOffset="49-52" type="protein" text="PAP"/>
            <entity id="DS.d1817.s2.e1" origId="444378" charOffset="58-65" type="compound" text="m(7)GTP"/>
            <pair e1="DS.d1817.s2.e1" e2="DS.d1817.s2.e0" id="DS.d1817.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1819" origId="18936084">
        <sentence id="DS.d1819.s0" origId="18936084-1443" text="In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas forskolin-induced expression of CYP11A1, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.">
            <entity id="DS.d1819.s0.e0" origId="P22004" charOffset="73-77" type="protein" text="BMP6"/>
            <entity id="DS.d1819.s0.e1" origId="47936" charOffset="87-96" type="compound" text="forskolin"/>
            <entity id="DS.d1819.s0.e2" origId="O46515,P00189,P05108,P10612,P79153,P79202,Q07217,Q28827,Q2XV99,Q92045,Q9EPT4" charOffset="119-126" type="protein" text="CYP11A1"/>
            <entity id="DS.d1819.s0.e3" origId="P14060,Q60555" charOffset="128-134" type="protein" text="HSD3B1"/>
            <entity id="DS.d1819.s0.e4" origId="O46512,P11511,P19098,P46194,P70091,P79690,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28" charOffset="136-143" type="protein" text="CYP19A1"/>
            <entity id="DS.d1819.s0.e5" origId="P01175,P01176,P01177,P01178,P01179,P13389,P32005,P35454,P69043,P69044,P69056,P69057,P69058" charOffset="148-156" type="protein" text="oxytocin"/>
            <pair e1="DS.d1819.s0.e1" e2="DS.d1819.s0.e4" id="DS.d1819.s0.i0" interaction="True"/>
            <pair e1="DS.d1819.s0.e1" e2="DS.d1819.s0.e2" id="DS.d1819.s0.i1" interaction="True"/>
            <pair e1="DS.d1819.s0.e1" e2="DS.d1819.s0.e3" id="DS.d1819.s0.i2" interaction="True"/>
            <pair e1="DS.d1819.s0.e1" e2="DS.d1819.s0.e0" id="DS.d1819.s0.i3" interaction="True"/>
            <pair e1="DS.d1819.s0.e1" e2="DS.d1819.s0.e5" id="DS.d1819.s0.i4" interaction="True"/>
        </sentence>
        <sentence id="DS.d1819.s1" origId="18936084-1444" text="In both cell types, follistatin attenuated the suppressive effect of activin A and BMP6 on forskolin-induced P4 secretion but had no effect alone.">
            <entity id="DS.d1819.s1.e0" origId="P22004" charOffset="83-87" type="protein" text="BMP6"/>
            <entity id="DS.d1819.s1.e1" origId="47936" charOffset="91-100" type="compound" text="forskolin"/>
            <pair e1="DS.d1819.s1.e1" e2="DS.d1819.s1.e0" id="DS.d1819.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1820" origId="18936109">
        <sentence id="DS.d1820.s0" origId="18936109-1448" text="1-Aminobenzotriazole (1-ABT) is generally considered to be a nonselective mechanism-based inactivator of both human and non-human cytochrome P450 (P450) enzymes.">
            <entity id="DS.d1820.s0.e0" origId="1367" charOffset="0-20" type="compound" text="1-Aminobenzotriazole"/>
            <entity id="DS.d1820.s0.e1" origId="O08469" charOffset="130-145" type="protein" text="cytochrome P450"/>
            <pair e1="DS.d1820.s0.e0" e2="DS.d1820.s0.e1" id="DS.d1820.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1821" origId="18936140">
        <sentence id="DS.d1821.s0" origId="18936140-1459" text="7-Ketocholesterol is present in lipid deposits in the primate retina: potential implication in the induction of VEGF and CNV formation.">
            <entity id="DS.d1821.s0.e0" origId="91474" charOffset="0-17" type="compound" text="7-Ketocholesterol"/>
            <entity id="DS.d1821.s0.e1" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="112-116" type="protein" text="VEGF"/>
            <pair e1="DS.d1821.s0.e0" e2="DS.d1821.s0.e1" id="DS.d1821.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1822" origId="18936181">
        <sentence id="DS.d1822.s0" origId="18936181-1478" text="ETEC infection also caused a drastic inhibition of host esterase activity, as measured by calcein fluorescence.">
            <entity id="DS.d1822.s0.e0" origId="P16397,P18773" charOffset="56-64" type="protein" text="esterase"/>
            <entity id="DS.d1822.s0.e1" origId="65079" charOffset="90-97" type="compound" text="calcein"/>
            <pair e1="DS.d1822.s0.e1" e2="DS.d1822.s0.e0" id="DS.d1822.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1823" origId="18936191">
        <sentence id="DS.d1823.s0" origId="18936191-1737" text="HCV-796 is a nonnucleoside inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (NS5B) polymerase, and boceprevir is an inhibitor of the NS3 serine protease.">
            <entity id="DS.d1823.s0.e0" origId="11561383" charOffset="0-7" type="compound" text="HCV-796"/>
            <entity id="DS.d1823.s0.e2" origId="O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P19711,P19712,P19741,P21530,P26660,P26661,P26662,P26663,P26664,P27958,P29846,Q00269,Q01499,Q5I2N3,Q68749,Q68798,Q68801,Q69422,Q81258,Q81487,Q81495,Q81754,Q913D4,Q96662,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2" charOffset="94-98" type="protein" text="NS5B"/>
            <pair e1="DS.d1823.s0.e0" e2="DS.d1823.s0.e2" id="DS.d1823.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1823.s2" origId="18936191-1739" text="Mutations known to confer resistance to HCV-796 (NS5B C316Y) and boceprevir (NS3 V170A) were present in the combination-resistant replicons.">
            <entity id="DS.d1823.s2.e0" origId="11561383" charOffset="40-47" type="compound" text="HCV-796"/>
            <entity id="DS.d1823.s2.e1" origId="O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P19711,P19712,P19741,P21530,P26660,P26661,P26662,P26663,P26664,P27958,P29846,Q00269,Q01499,Q5I2N3,Q68749,Q68798,Q68801,Q69422,Q81258,Q81487,Q81495,Q81754,Q913D4,Q96662,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2" charOffset="49-53" type="protein" text="NS5B"/>
            <entity id="DS.d1823.s2.e2" origId="O71152,P06591,P15775,P15779,P29076,Q04854,Q90056" charOffset="77-80" type="protein" text="NS3"/>
            <pair e1="DS.d1823.s2.e0" e2="DS.d1823.s2.e1" id="DS.d1823.s2.i0" interaction="True"/>
            <pair e1="DS.d1823.s2.e0" e2="DS.d1823.s2.e2" id="DS.d1823.s2.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1825" origId="18936772">
        <sentence id="DS.d1825.s0" origId="18936772-1665" text="Increased apoptosis of a human salivary gland (HSG) cell line occurred only in the presence of lipopolysaccharide (LPS-) and interferon (IFN)-gamma-stimulated human monocytic THP-1 cells, which was reversed when caspase-1 in THP-1 cells was targeted by siRNA.">
            <entity id="DS.d1825.s0.e0" origId="11970143" charOffset="95-113" type="compound" text="lipopolysaccharide"/>
            <entity id="DS.d1825.s0.e1" origId="P28172,P51526" charOffset="137-140" type="protein" text="IFN"/>
            <pair e1="DS.d1825.s0.e0" e2="DS.d1825.s0.e1" id="DS.d1825.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1826" origId="18936912">
        <sentence id="DS.d1826.s0" origId="18936912-1717" text="A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.">
            <entity id="DS.d1826.s0.e0" origId="60823" charOffset="11-23" type="compound" text="atorvastatin"/>
            <entity id="DS.d1826.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="28-35" type="protein" text="insulin"/>
            <pair e1="DS.d1826.s0.e0" e2="DS.d1826.s0.e1" id="DS.d1826.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1826.s1" origId="18936912-1718" text="Genetic type 2 diabetic Goto-Kakizaki rats were fed with a high-fat diet to test hepatic effects of type 2 diabetes with hyperlipidemia and the effect of atorvastatin and insulin, individually and in combination, in systemic and hepatic inflammatory and oxidative stress markers.">
            <entity id="DS.d1826.s1.e0" origId="60823" charOffset="154-166" type="compound" text="atorvastatin"/>
            <entity id="DS.d1826.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="171-178" type="protein" text="insulin"/>
            <pair e1="DS.d1826.s1.e0" e2="DS.d1826.s1.e1" id="DS.d1826.s1.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1826.s2" origId="18936912-1719" text="Combination of insulin and atorvastatin further improved glycemic and lipid profiles and decreased circulating C-reactive protein levels and liver inflammatory and oxidative stress markers.">
            <entity id="DS.d1826.s2.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="15-22" type="protein" text="insulin"/>
            <entity id="DS.d1826.s2.e1" origId="60823" charOffset="27-39" type="compound" text="atorvastatin"/>
            <pair e1="DS.d1826.s2.e1" e2="DS.d1826.s2.e0" id="DS.d1826.s2.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1826.s3" origId="18936912-1720" text="Insulin and atorvastatin combination leads to better glycaemic and lipid profiles and to better protection against liver inflammation and oxidative stress, giving a superior level of liver protection in type 2 diabetic with hyperlipidemia.">
            <entity id="DS.d1826.s3.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="0-7" type="protein" text="Insulin"/>
            <entity id="DS.d1826.s3.e1" origId="60823" charOffset="12-24" type="compound" text="atorvastatin"/>
            <pair e1="DS.d1826.s3.e1" e2="DS.d1826.s3.e0" id="DS.d1826.s3.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1827" origId="18936931">
        <sentence id="DS.d1827.s0" origId="18936931-1732" text="Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.">
            <entity id="DS.d1827.s0.e0" origId="P20815" charOffset="35-41" type="protein" text="CYP3A5"/>
            <entity id="DS.d1827.s0.e1" origId="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72" charOffset="46-50" type="protein" text="MDR1"/>
            <entity id="DS.d1827.s0.e2" origId="5280754,5284373,5497195,6435893,24883466,25246316" charOffset="54-66" type="compound" text="cyclosporine"/>
            <entity id="DS.d1827.s0.e3" origId="39186" charOffset="168-177" type="compound" text="diltiazem"/>
            <pair e1="DS.d1827.s0.e2" e2="DS.d1827.s0.e0" id="DS.d1827.s0.i0" interaction="False"/>
            <pair e1="DS.d1827.s0.e3" e2="DS.d1827.s0.e0" id="DS.d1827.s0.i1" interaction="False"/>
            <pair e1="DS.d1827.s0.e3" e2="DS.d1827.s0.e1" id="DS.d1827.s0.i2" interaction="False"/>
            <pair e1="DS.d1827.s0.e2" e2="DS.d1827.s0.e1" id="DS.d1827.s0.i3" interaction="False"/>
        </sentence>
        <sentence id="DS.d1827.s1" origId="18936931-1733" text="The aim of this study was to assess the influence of the cytochrome (CYP450)3A5 and multidrug resistance (MDR1) gene polymorphisms on cyclosporine A (CsA) trough concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.">
            <entity id="DS.d1827.s1.e0" origId="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72" charOffset="106-110" type="protein" text="MDR1"/>
            <entity id="DS.d1827.s1.e1" origId="2909,5280754,5284373,5497195,6435893,49867938" charOffset="134-148" type="compound" text="cyclosporine A"/>
            <entity id="DS.d1827.s1.e2" origId="39186" charOffset="263-272" type="compound" text="diltiazem"/>
            <pair e1="DS.d1827.s1.e1" e2="DS.d1827.s1.e0" id="DS.d1827.s1.i0" interaction="False"/>
            <pair e1="DS.d1827.s1.e2" e2="DS.d1827.s1.e0" id="DS.d1827.s1.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1828" origId="18936963">
        <sentence id="DS.d1828.s0" origId="18936963-1743" text="The-417- and-593 bp promoter regions were sufficient for GUS gene activation by ethylene and methyl jasmonate treatments, respectively.">
            <entity id="DS.d1828.s0.e0" origId="P05804" charOffset="57-60" type="protein" text="GUS"/>
            <entity id="DS.d1828.s0.e1" origId="6325,21159546" charOffset="80-88" type="compound" text="ethylene"/>
            <entity id="DS.d1828.s0.e2" origId="62388,5281929,5319693,5367719,6432008" charOffset="93-109" type="compound" text="methyl jasmonate"/>
            <pair e1="DS.d1828.s0.e2" e2="DS.d1828.s0.e0" id="DS.d1828.s0.i0" interaction="True"/>
            <pair e1="DS.d1828.s0.e1" e2="DS.d1828.s0.e0" id="DS.d1828.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1829" origId="18936983">
        <sentence id="DS.d1829.s0" origId="18936983-1746" text="Reversible two-step unfolding of heme-human serum albumin : a (1)H-NMR relaxometric and circular dichroism study.">
            <entity id="DS.d1829.s0.e0" origId="4971" charOffset="33-37" type="compound" text="heme"/>
            <entity id="DS.d1829.s0.e1" origId="P21847,P83517" charOffset="44-57" type="protein" text="serum albumin"/>
            <pair e1="DS.d1829.s0.e0" e2="DS.d1829.s0.e1" id="DS.d1829.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1829.s1" origId="18936983-1747" text="Human serum albumin (HSA) participates in heme scavenging, the bound heme turning out to be a reactivity center and a powerful spectroscopic probe.">
            <entity id="DS.d1829.s1.e0" origId="P21847,P83517" charOffset="6-19" type="protein" text="serum albumin"/>
            <entity id="DS.d1829.s1.e1" origId="P24807,Q07490" charOffset="21-24" type="protein" text="HSA"/>
            <entity id="DS.d1829.s1.e2" origId="4971" charOffset="42-46" type="compound" text="heme"/>
            <entity id="DS.d1829.s1.e3" origId="4971" charOffset="69-73" type="compound" text="heme"/>
            <pair e1="DS.d1829.s1.e2" e2="DS.d1829.s1.e1" id="DS.d1829.s1.i0" interaction="True"/>
            <pair e1="DS.d1829.s1.e2" e2="DS.d1829.s1.e0" id="DS.d1829.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1829.s2" origId="18936983-1748" text="Here, the reversible unfolding of heme-HSA has been investigated by (1)H-NMR relaxometry, circular dichroism, and absorption spectroscopy.">
            <entity id="DS.d1829.s2.e0" origId="4971" charOffset="34-38" type="compound" text="heme"/>
            <entity id="DS.d1829.s2.e1" origId="P24807,Q07490" charOffset="39-42" type="protein" text="HSA"/>
            <pair e1="DS.d1829.s2.e0" e2="DS.d1829.s2.e1" id="DS.d1829.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1830" origId="18936994">
        <sentence id="DS.d1830.s0" origId="18936994-1754" text="The purified enzymes were a monomer with an apparent molecular mass of 32 kDa (Chi32) and 46 kDa (Chi46), respectively, and showed chitinase activity bands with 0.01% glycol chitin as a substrate after SDS-PAGE.">
            <entity id="DS.d1830.s0.e0" origId="P13656,P14529,P23472,P23473,P81241,P84754" charOffset="131-140" type="protein" text="chitinase"/>
            <entity id="DS.d1830.s0.e1" origId="174" charOffset="167-173" type="compound" text="glycol"/>
            <pair e1="DS.d1830.s0.e1" e2="DS.d1830.s0.e0" id="DS.d1830.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1833" origId="18937073">
        <sentence id="DS.d1833.s0" origId="18937073-2436" text="Possible relation of hemin-induced HO-1 expression to the upregulation of VEGF and BDNF mRNA levels in rat C6 glioma cells.">
            <entity id="DS.d1833.s0.e0" origId="4971" charOffset="21-26" type="compound" text="hemin"/>
            <entity id="DS.d1833.s0.e1" origId="P06762,P09601,P14791,P14901,P32394,Q5E9F2" charOffset="35-39" type="protein" text="HO-1"/>
            <entity id="DS.d1833.s0.e2" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="74-78" type="protein" text="VEGF"/>
            <entity id="DS.d1833.s0.e3" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="83-87" type="protein" text="BDNF"/>
            <pair e1="DS.d1833.s0.e0" e2="DS.d1833.s0.e1" id="DS.d1833.s0.i0" interaction="True"/>
            <pair e1="DS.d1833.s0.e0" e2="DS.d1833.s0.e2" id="DS.d1833.s0.i1" interaction="True"/>
            <pair e1="DS.d1833.s0.e0" e2="DS.d1833.s0.e3" id="DS.d1833.s0.i2" interaction="True"/>
        </sentence>
        <sentence id="DS.d1833.s1" origId="18937073-2437" text="Based on this hypothetical idea, the direct effect of hemin on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.">
            <entity id="DS.d1833.s1.e0" origId="4971" charOffset="54-59" type="compound" text="hemin"/>
            <entity id="DS.d1833.s1.e1" origId="P06762,P09601,P14791,P14901,P32394,P72849,Q5E9F2" charOffset="96-112" type="protein" text="heme oxygenase-1"/>
            <entity id="DS.d1833.s1.e2" origId="P06762,P09601,P14791,P14901,P32394,Q5E9F2" charOffset="114-118" type="protein" text="HO-1"/>
            <entity id="DS.d1833.s1.e3" origId="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3" charOffset="157-161" type="protein" text="VEGF"/>
            <entity id="DS.d1833.s1.e4" origId="P25430,P25431,P25432,Q06225" charOffset="168-201" type="protein" text="brain-derived neurotrophic factor"/>
            <entity id="DS.d1833.s1.e5" origId="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3" charOffset="203-207" type="protein" text="BDNF"/>
            <pair e1="DS.d1833.s1.e0" e2="DS.d1833.s1.e1" id="DS.d1833.s1.i0" interaction="True"/>
            <pair e1="DS.d1833.s1.e0" e2="DS.d1833.s1.e2" id="DS.d1833.s1.i1" interaction="True"/>
            <pair e1="DS.d1833.s1.e0" e2="DS.d1833.s1.e4" id="DS.d1833.s1.i2" interaction="True"/>
            <pair e1="DS.d1833.s1.e0" e2="DS.d1833.s1.e3" id="DS.d1833.s1.i3" interaction="True"/>
            <pair e1="DS.d1833.s1.e0" e2="DS.d1833.s1.e5" id="DS.d1833.s1.i4" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1834" origId="18937079">
        <sentence id="DS.d1834.s0" origId="18937079-1799" text="Furthermore, we study the Akt activation after As(2)O(3) treatment and the HCC cells proliferation after combination of As(2)O(3) with PI3K inhibitor Wortmannin.">
            <entity id="DS.d1834.s0.e0" origId="P31750,Q8INB9" charOffset="26-29" type="protein" text="Akt"/>
            <entity id="DS.d1834.s0.e1" origId="312145" charOffset="150-160" type="compound" text="Wortmannin"/>
            <pair e1="DS.d1834.s0.e1" e2="DS.d1834.s0.e0" id="DS.d1834.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1835" origId="18937214">
        <sentence id="DS.d1835.s0" origId="18937214-1831" text="Carbofuran is a pesticide whose acute toxicity is due to inhibition of acetylcholinesterase.">
            <entity id="DS.d1835.s0.e0" origId="2566" charOffset="0-10" type="compound" text="Carbofuran"/>
            <entity id="DS.d1835.s0.e1" origId="Q867X2,Q867X3,Q86GC9,Q92081" charOffset="71-91" type="protein" text="acetylcholinesterase"/>
            <pair e1="DS.d1835.s0.e0" e2="DS.d1835.s0.e1" id="DS.d1835.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1836" origId="18937289">
        <sentence id="DS.d1836.s0" origId="18937289-1865" text="The interaction of propafenone (PPF) enantiomers with human plasma, human serum albumin (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.">
            <entity id="DS.d1836.s0.e0" origId="4932" charOffset="19-30" type="compound" text="propafenone"/>
            <entity id="DS.d1836.s0.e1" origId="70387" charOffset="32-35" type="compound" text="PPF"/>
            <entity id="DS.d1836.s0.e2" origId="P21847,P83517" charOffset="74-87" type="protein" text="serum albumin"/>
            <entity id="DS.d1836.s0.e3" origId="P24807,Q07490" charOffset="89-92" type="protein" text="HSA"/>
            <pair e1="DS.d1836.s0.e1" e2="DS.d1836.s0.e2" id="DS.d1836.s0.i0" interaction="False"/>
            <pair e1="DS.d1836.s0.e1" e2="DS.d1836.s0.e3" id="DS.d1836.s0.i3" interaction="False"/>
            <pair e1="DS.d1836.s0.e0" e2="DS.d1836.s0.e3" id="DS.d1836.s0.i4" interaction="False"/>
            <pair e1="DS.d1836.s0.e0" e2="DS.d1836.s0.e2" id="DS.d1836.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1837" origId="18937323">
        <sentence id="DS.d1837.s0" origId="18937323-1876" text="cAMP-Epac2-mediated activation of Rap1 in developing male germ cells: RA-RhoGAP as a possible direct down-stream effector.">
            <entity id="DS.d1837.s0.e0" origId="6076" charOffset="0-4" type="compound" text="cAMP"/>
            <entity id="DS.d1837.s0.e1" origId="Q9EQZ6,Q9Z1C7" charOffset="5-10" type="protein" text="Epac2"/>
            <entity id="DS.d1837.s0.e2" origId="P08645,P18613,Q91VL8,Q96TL7" charOffset="34-38" type="protein" text="Rap1"/>
            <pair e1="DS.d1837.s0.e0" e2="DS.d1837.s0.e2" id="DS.d1837.s0.i0" interaction="True"/>
            <pair e1="DS.d1837.s0.e0" e2="DS.d1837.s0.e1" id="DS.d1837.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1837.s1" origId="18937323-1878" text="Taken together, our results, obtained with endogenously expressed proteins, are consistent with a cAMP/Epac2/Rap1-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.">
            <entity id="DS.d1837.s1.e0" origId="6076" charOffset="98-102" type="compound" text="cAMP"/>
            <entity id="DS.d1837.s1.e1" origId="Q9EQZ6,Q9Z1C7" charOffset="103-108" type="protein" text="Epac2"/>
            <entity id="DS.d1837.s1.e2" origId="P08645,P18613,Q91VL8,Q96TL7" charOffset="109-113" type="protein" text="Rap1"/>
            <pair e1="DS.d1837.s1.e0" e2="DS.d1837.s1.e2" id="DS.d1837.s1.i0" interaction="True"/>
            <pair e1="DS.d1837.s1.e0" e2="DS.d1837.s1.e1" id="DS.d1837.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1838" origId="18937360">
        <sentence id="DS.d1838.s0" origId="18937360-1888" text="Cholesterol promotes basal and verapamil-induced ATPase activity of P-glycoprotein (P-gp).">
            <entity id="DS.d1838.s0.e0" origId="2520" charOffset="31-40" type="compound" text="verapamil"/>
            <entity id="DS.d1838.s0.e1" origId="P08163" charOffset="70-82" type="protein" text="glycoprotein"/>
            <pair e1="DS.d1838.s0.e0" e2="DS.d1838.s0.e1" id="DS.d1838.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1839" origId="18937368">
        <sentence id="DS.d1839.s0" origId="18937368-1889" text="Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals.">
            <entity id="DS.d1839.s0.e0" origId="P21847,P83517" charOffset="25-38" type="protein" text="serum albumin"/>
            <entity id="DS.d1839.s0.e1" origId="P24807,Q07490" charOffset="40-43" type="protein" text="HSA"/>
            <entity id="DS.d1839.s0.e2" origId="9552058" charOffset="66-73" type="compound" text="Cu-PTSM"/>
            <entity id="DS.d1839.s0.e3" origId="6409958" charOffset="78-85" type="compound" text="Cu-ATSM"/>
            <pair e1="DS.d1839.s0.e3" e2="DS.d1839.s0.e0" id="DS.d1839.s0.i0" interaction="True"/>
            <pair e1="DS.d1839.s0.e2" e2="DS.d1839.s0.e0" id="DS.d1839.s0.i1" interaction="True"/>
            <pair e1="DS.d1839.s0.e2" e2="DS.d1839.s0.e1" id="DS.d1839.s0.i2" interaction="True"/>
            <pair e1="DS.d1839.s0.e3" e2="DS.d1839.s0.e1" id="DS.d1839.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d1839.s1" origId="18937368-1891" text="This study examines the structural basis for HSA binding of Cu-PTSM and Cu-ATSM via competition with drugs having known albumin binding sites.">
            <entity id="DS.d1839.s1.e0" origId="P24807,Q07490" charOffset="45-48" type="protein" text="HSA"/>
            <entity id="DS.d1839.s1.e1" origId="9552058" charOffset="60-67" type="compound" text="Cu-PTSM"/>
            <entity id="DS.d1839.s1.e2" origId="6409958" charOffset="72-79" type="compound" text="Cu-ATSM"/>
            <pair e1="DS.d1839.s1.e1" e2="DS.d1839.s1.e0" id="DS.d1839.s1.i0" interaction="True"/>
            <pair e1="DS.d1839.s1.e2" e2="DS.d1839.s1.e0" id="DS.d1839.s1.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1839.s2" origId="18937368-1892" text="Cu-ATSM from HSA.">
            <entity id="DS.d1839.s2.e0" origId="6409958" charOffset="0-7" type="compound" text="Cu-ATSM"/>
            <entity id="DS.d1839.s2.e1" origId="P24807,Q07490" charOffset="13-16" type="protein" text="HSA"/>
            <pair e1="DS.d1839.s2.e0" e2="DS.d1839.s2.e1" id="DS.d1839.s2.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1839.s3" origId="18937368-1893" text="At 8:1 warfarin: HSA Cu-ATSM levels increased 300-500%.">
            <entity id="DS.d1839.s3.e0" origId="P24807,Q07490" charOffset="17-20" type="protein" text="HSA"/>
            <entity id="DS.d1839.s3.e1" origId="6409958" charOffset="21-28" type="compound" text="Cu-ATSM"/>
            <pair e1="DS.d1839.s3.e1" e2="DS.d1839.s3.e0" id="DS.d1839.s3.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1839.s4" origId="18937368-1894" text="Cu-ATSM was observed except at high ibuprofen: HSA ratios, where secondary ibuprofen binding to the IIA site may cause modest radiopharmaceutical displacement.">
            <entity id="DS.d1839.s4.e0" origId="6409958" charOffset="0-7" type="compound" text="Cu-ATSM"/>
            <entity id="DS.d1839.s4.e1" origId="P24807,Q07490" charOffset="47-50" type="protein" text="HSA"/>
            <pair e1="DS.d1839.s4.e0" e2="DS.d1839.s4.e1" id="DS.d1839.s4.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1841" origId="18937625">
        <sentence id="DS.d1841.s0" origId="18937625-2531" text="0.05) in the overall glucose-mediated insulin response.">
            <entity id="DS.d1841.s0.e0" origId="206,5793,64689,79025" charOffset="21-28" type="compound" text="glucose"/>
            <entity id="DS.d1841.s0.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="38-45" type="protein" text="insulin"/>
            <pair e1="DS.d1841.s0.e0" e2="DS.d1841.s0.e1" id="DS.d1841.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1841.s1" origId="18937625-2532" text="Glucose-stimulated insulin levels were not significantly different from controls.">
            <entity id="DS.d1841.s1.e0" origId="206,5793,64689,79025" charOffset="0-7" type="compound" text="Glucose"/>
            <entity id="DS.d1841.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="19-26" type="protein" text="insulin"/>
            <pair e1="DS.d1841.s1.e0" e2="DS.d1841.s1.e1" id="DS.d1841.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1842" origId="18937643">
        <sentence id="DS.d1842.s0" origId="18937643-2052" text="The inducible form of nitric oxide synthase (NOS2) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate endotoxin.">
            <entity id="DS.d1842.s0.e0" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="22-43" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d1842.s0.e1" origId="O19114,O46660,O54705,O62699,P35228,P60321,P79290,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="45-49" type="protein" text="NOS2"/>
            <entity id="DS.d1842.s0.e2" origId="44268108" charOffset="162-171" type="compound" text="endotoxin"/>
            <pair e1="DS.d1842.s0.e2" e2="DS.d1842.s0.e0" id="DS.d1842.s0.i0" interaction="True"/>
            <pair e1="DS.d1842.s0.e2" e2="DS.d1842.s0.e1" id="DS.d1842.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1843" origId="18937645">
        <sentence id="DS.d1843.s0" origId="18937645-884" text="Atypical sialylated N-glycan structures are attached to neuronal voltage-gated potassium channels.">
            <entity id="DS.d1843.s0.e0" origId="871" charOffset="22-28" type="compound" text="glycan"/>
            <entity id="DS.d1843.s0.e1" origId="P0A333,P0A334,Q9YDF8" charOffset="65-97" type="protein" text="voltage-gated potassium channels"/>
            <pair e1="DS.d1843.s0.e0" e2="DS.d1843.s0.e1" id="DS.d1843.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1843.s1" origId="18937645-885" text="Sialic acid linkages were identified for voltage-gated potassium channels, Kv3.1, 3.3, 3.4, 1.1, 1.2 and 1.4, by evaluating their electrophoretic migration patterns in adult rat brain membranes digested with various glycosidases.">
            <entity id="DS.d1843.s1.e0" origId="906,444885,445063" charOffset="0-11" type="compound" text="Sialic acid"/>
            <entity id="DS.d1843.s1.e1" origId="P0A333,P0A334,Q9YDF8" charOffset="41-73" type="protein" text="voltage-gated potassium channels"/>
            <pair e1="DS.d1843.s1.e0" e2="DS.d1843.s1.e1" id="DS.d1843.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1844" origId="18937879">
        <sentence id="DS.d1844.s0" origId="18937879-2138" text="No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: a positron emission tomography study.">
            <entity id="DS.d1844.s0.e0" origId="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1" charOffset="26-46" type="protein" text="dopamine D2 receptor"/>
            <entity id="DS.d1844.s0.e1" origId="5073" charOffset="101-112" type="compound" text="risperidone"/>
            <pair e1="DS.d1844.s0.e1" e2="DS.d1844.s0.e0" id="DS.d1844.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1844.s1" origId="18937879-2139" text="In this study, regional distribution of dopamine D2 receptor occupancy by risperidone was determined in order to elucidate the limbic and cortical selectivity of second-generation antipsychotics.">
            <entity id="DS.d1844.s1.e0" origId="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1" charOffset="40-60" type="protein" text="dopamine D2 receptor"/>
            <entity id="DS.d1844.s1.e1" origId="5073" charOffset="74-85" type="compound" text="risperidone"/>
            <pair e1="DS.d1844.s1.e1" e2="DS.d1844.s1.e0" id="DS.d1844.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1844.s2" origId="18937879-2140" text="Striatal and extrastriatal dopamine D2 receptor binding FLB 457, respectively.">
            <entity id="DS.d1844.s2.e0" origId="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1" charOffset="27-47" type="protein" text="dopamine D2 receptor"/>
            <entity id="DS.d1844.s2.e1" origId="129497" charOffset="56-63" type="compound" text="FLB 457"/>
            <pair e1="DS.d1844.s2.e1" e2="DS.d1844.s2.e0" id="DS.d1844.s2.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1845" origId="18937971">
        <sentence id="DS.d1845.s0" origId="18937971-2150" text="TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens.">
            <entity id="DS.d1845.s0.e0" origId="O09185,O12946,O36006,O57538,O93379,P04637,P10360,P13481,P25035,P41685,P51664,P56423,P56424,P61260,P67938,P67939,P79820,P79892,Q00366,Q29480,Q29537,Q64662,Q8SPZ3,Q92143,Q95330,Q9TTA1,Q9TUB2,Q9W678,Q9W679,Q9WUR6" charOffset="0-4" type="protein" text="TP53"/>
            <entity id="DS.d1845.s0.e1" origId="Q00709" charOffset="6-11" type="protein" text="BCL-2"/>
            <entity id="DS.d1845.s0.e2" origId="O02703,P55269,Q07812,Q07814,Q07815" charOffset="16-19" type="protein" text="BAX"/>
            <entity id="DS.d1845.s0.e3" origId="108169,9548828" charOffset="73-79" type="compound" text="taxane"/>
            <entity id="DS.d1845.s0.e4" origId="23939" charOffset="80-88" type="compound" text="platinum"/>
            <pair e1="DS.d1845.s0.e3" e2="DS.d1845.s0.e2" id="DS.d1845.s0.i0" interaction="False"/>
            <pair e1="DS.d1845.s0.e4" e2="DS.d1845.s0.e1" id="DS.d1845.s0.i1" interaction="False"/>
            <pair e1="DS.d1845.s0.e4" e2="DS.d1845.s0.e2" id="DS.d1845.s0.i2" interaction="False"/>
            <pair e1="DS.d1845.s0.e3" e2="DS.d1845.s0.e1" id="DS.d1845.s0.i3" interaction="False"/>
            <pair e1="DS.d1845.s0.e4" e2="DS.d1845.s0.e0" id="DS.d1845.s0.i4" interaction="False"/>
            <pair e1="DS.d1845.s0.e3" e2="DS.d1845.s0.e0" id="DS.d1845.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1846" origId="18938111">
        <sentence id="DS.d1846.s0" origId="18938111-2180" text="NOD2, an intracellular sensor of bacteria-derived muramyl dipeptide (MDP) has been implicated as a key player in intestinal immune health and disease.">
            <entity id="DS.d1846.s0.e0" origId="Q9HC29" charOffset="0-4" type="protein" text="NOD2"/>
            <entity id="DS.d1846.s0.e1" origId="40846,451714,11620162" charOffset="50-67" type="compound" text="muramyl dipeptide"/>
            <pair e1="DS.d1846.s0.e1" e2="DS.d1846.s0.e0" id="DS.d1846.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1849" origId="18938142">
        <sentence id="DS.d1849.s0" origId="18938142-2192" text="Exposure of HEK293 cells to BK produced a concentration-dependent rise in intracellular Ca(2+) (EC(50)=36.5+/-8.0 x 10(-9)M), a rapid increase in tyrosine phosphorylation of ERK (EC(50)=9.8+/-0.4 x 10(-9)M), and elevation in ECAR by approximately 20%.">
            <entity id="DS.d1849.s0.e0" origId="1153,6057,5460803" charOffset="146-154" type="compound" text="tyrosine"/>
            <entity id="DS.d1849.s0.e1" origId="P29323" charOffset="174-177" type="protein" text="ERK"/>
            <pair e1="DS.d1849.s0.e0" e2="DS.d1849.s0.e1" id="DS.d1849.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1850" origId="18938163">
        <sentence id="DS.d1850.s0" origId="18938163-2196" text="IGF-I expression coupled with infusion of the IGF binding protein inhibitor NBI-31772 significantly prevented corticospinal motor neuron death 0.05), but did not promote corticospinal axon regeneration.">
            <entity id="DS.d1850.s0.e0" origId="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222" charOffset="0-5" type="protein" text="IGF-I"/>
            <entity id="DS.d1850.s0.e1" origId="54684689" charOffset="76-85" type="compound" text="NBI-31772"/>
            <pair e1="DS.d1850.s0.e1" e2="DS.d1850.s0.e0" id="DS.d1850.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1851" origId="18938187">
        <sentence id="DS.d1851.s0" origId="18938187-2204" text="A significant decrease was observed in GABA (A) alpha(1), GAD (67), and CRF, but not NR2A, mRNAs in adult rats that consumed ethanol in comparison to controls.">
            <entity id="DS.d1851.s0.e0" origId="119" charOffset="39-43" type="compound" text="GABA"/>
            <entity id="DS.d1851.s0.e1" origId="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20" charOffset="58-61" type="protein" text="GAD"/>
            <entity id="DS.d1851.s0.e2" origId="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1" charOffset="72-75" type="protein" text="CRF"/>
            <entity id="DS.d1851.s0.e3" origId="P35436,Q00959,Q12879,Q5IS45" charOffset="85-89" type="protein" text="NR2A"/>
            <entity id="DS.d1851.s0.e4" origId="702" charOffset="125-132" type="compound" text="ethanol"/>
            <pair e1="DS.d1851.s0.e4" e2="DS.d1851.s0.e1" id="DS.d1851.s0.i0" interaction="True"/>
            <pair e1="DS.d1851.s0.e4" e2="DS.d1851.s0.e3" id="DS.d1851.s0.i1" interaction="False"/>
            <pair e1="DS.d1851.s0.e0" e2="DS.d1851.s0.e3" id="DS.d1851.s0.i2" interaction="False"/>
            <pair e1="DS.d1851.s0.e4" e2="DS.d1851.s0.e2" id="DS.d1851.s0.i3" interaction="True"/>
            <pair e1="DS.d1851.s0.e0" e2="DS.d1851.s0.e2" id="DS.d1851.s0.i4" interaction="False"/>
            <pair e1="DS.d1851.s0.e0" e2="DS.d1851.s0.e1" id="DS.d1851.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1852" origId="18938240">
        <sentence id="DS.d1852.s0" origId="18938240-2219" text="We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to c-Src-dependent tyrosine phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor AP-2.">
            <entity id="DS.d1852.s0.e1" origId="P00523,P05480,P12931,Q9WUD9" charOffset="152-157" type="protein" text="c-Src"/>
            <entity id="DS.d1852.s0.e2" origId="1153,6057,5460803" charOffset="168-176" type="compound" text="tyrosine"/>
            <entity id="DS.d1852.s0.e3" origId="P05549,P34056,P58197,Q9N0N3" charOffset="245-249" type="protein" text="AP-2"/>
            <pair e1="DS.d1852.s0.e2" e2="DS.d1852.s0.e3" id="DS.d1852.s0.i0" interaction="True"/>
            <pair e1="DS.d1852.s0.e2" e2="DS.d1852.s0.e1" id="DS.d1852.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1854" origId="18939895">
        <sentence id="DS.d1854.s0" origId="18939895-2826" text="Genotoxic effect of 2,4,6-trichlorophenol on p53 gene in zebrafish liver.">
            <entity id="DS.d1854.s0.e0" origId="6914" charOffset="26-41" type="compound" text="trichlorophenol"/>
            <entity id="DS.d1854.s0.e1" origId="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679" charOffset="45-48" type="protein" text="p53"/>
            <pair e1="DS.d1854.s0.e0" e2="DS.d1854.s0.e1" id="DS.d1854.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1855" origId="18940183">
        <sentence id="DS.d1855.s0" origId="18940183-691" text="Extensive neutrophil infiltration and chemoattractant factor interleukin 8 (IL-8) expression in IL-10 KO mice were observed after halothane administration.">
            <entity id="DS.d1855.s0.e0" origId="P10145" charOffset="61-74" type="protein" text="interleukin 8"/>
            <entity id="DS.d1855.s0.e1" origId="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5" charOffset="76-80" type="protein" text="IL-8"/>
            <entity id="DS.d1855.s0.e2" origId="3562" charOffset="130-139" type="compound" text="halothane"/>
            <pair e1="DS.d1855.s0.e2" e2="DS.d1855.s0.e1" id="DS.d1855.s0.i0" interaction="True"/>
            <pair e1="DS.d1855.s0.e2" e2="DS.d1855.s0.e0" id="DS.d1855.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1855.s1" origId="18940183-692" text="In addition, increased signal transducer and activator of transcription factors (STAT) 1 and STAT3 were observed in halothane treated IL-10 KO mice.">
            <entity id="DS.d1855.s1.e0" origId="P08457,P35610,Q7QDU4" charOffset="81-85" type="protein" text="STAT"/>
            <entity id="DS.d1855.s1.e1" origId="P40763,P61635" charOffset="93-98" type="protein" text="STAT3"/>
            <entity id="DS.d1855.s1.e2" origId="3562" charOffset="116-125" type="compound" text="halothane"/>
            <pair e1="DS.d1855.s1.e2" e2="DS.d1855.s1.e0" id="DS.d1855.s1.i0" interaction="True"/>
            <pair e1="DS.d1855.s1.e2" e2="DS.d1855.s1.e1" id="DS.d1855.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1857" origId="18940188">
        <sentence id="DS.d1857.s0" origId="18940188-92" text="Interaction of glutathione peroxidase-1 and selenium in endemic dilated cardiomyopathy.">
            <entity id="DS.d1857.s0.e0" origId="O23970,P00435,P04041,P07203,P11352,P11909,P36014,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14" charOffset="15-39" type="protein" text="glutathione peroxidase-1"/>
            <entity id="DS.d1857.s0.e1" origId="6326970" charOffset="44-52" type="compound" text="selenium"/>
            <pair e1="DS.d1857.s0.e1" e2="DS.d1857.s0.e0" id="DS.d1857.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1857.s1" origId="18940188-93" text="We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood selenium and polymorphisms in glutathione peroxidase-1 (GPx-1) gene.">
            <entity id="DS.d1857.s1.e0" origId="6326970" charOffset="112-120" type="compound" text="selenium"/>
            <entity id="DS.d1857.s1.e1" origId="O23970,P00435,P04041,P07203,P11352,P11909,P36014,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14" charOffset="142-166" type="protein" text="glutathione peroxidase-1"/>
            <entity id="DS.d1857.s1.e2" origId="P00435,P04041,P07203,P11352,P11909,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14" charOffset="168-173" type="protein" text="GPx-1"/>
            <pair e1="DS.d1857.s1.e0" e2="DS.d1857.s1.e1" id="DS.d1857.s1.i0" interaction="True"/>
            <pair e1="DS.d1857.s1.e0" e2="DS.d1857.s1.e2" id="DS.d1857.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1858" origId="18940204">
        <sentence id="DS.d1858.s0" origId="18940204-495" text="However, under the pressure of a death stimulus such as edelfosine treatment, L. infantum EndoG is released from the single mitochondrion and translocates to the nucleus, where it is thought to participate in the process of DNA degradation that is associated with programmed cell death.">
            <entity id="DS.d1858.s0.e0" origId="1393" charOffset="56-66" type="compound" text="edelfosine"/>
            <entity id="DS.d1858.s0.e1" origId="O08600,P38447,Q14249,Q95NM6" charOffset="90-95" type="protein" text="EndoG"/>
            <pair e1="DS.d1858.s0.e0" e2="DS.d1858.s0.e1" id="DS.d1858.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1859" origId="18940228">
        <sentence id="DS.d1859.s0" origId="18940228-124" text="Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (GSH), activity of superoxide dismutase (SOD), catalase and glucose-6-phosphate dehydrogenase.">
            <entity id="DS.d1859.s0.e0" origId="124886" charOffset="131-142" type="compound" text="glutathione"/>
            <entity id="DS.d1859.s0.e1" origId="124886" charOffset="144-147" type="compound" text="GSH"/>
            <entity id="DS.d1859.s0.e2" origId="O50258" charOffset="162-182" type="protein" text="superoxide dismutase"/>
            <entity id="DS.d1859.s0.e3" origId="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64" charOffset="184-187" type="protein" text="SOD"/>
            <entity id="DS.d1859.s0.e4" origId="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99" charOffset="190-198" type="protein" text="catalase"/>
            <pair e1="DS.d1859.s0.e1" e2="DS.d1859.s0.e3" id="DS.d1859.s0.i0" interaction="False"/>
            <pair e1="DS.d1859.s0.e0" e2="DS.d1859.s0.e3" id="DS.d1859.s0.i1" interaction="False"/>
            <pair e1="DS.d1859.s0.e1" e2="DS.d1859.s0.e2" id="DS.d1859.s0.i2" interaction="False"/>
            <pair e1="DS.d1859.s0.e0" e2="DS.d1859.s0.e2" id="DS.d1859.s0.i3" interaction="False"/>
            <pair e1="DS.d1859.s0.e1" e2="DS.d1859.s0.e4" id="DS.d1859.s0.i4" interaction="False"/>
            <pair e1="DS.d1859.s0.e0" e2="DS.d1859.s0.e4" id="DS.d1859.s0.i5" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1860" origId="18940247">
        <sentence id="DS.d1860.s0" origId="18940247-147" text="However, these events were blocked by treatment with the antioxidant, N-acetyl-cysteine (NAC), as well as GCK overexpression.">
            <entity id="DS.d1860.s0.e0" origId="581" charOffset="70-87" type="compound" text="N-acetyl-cysteine"/>
            <entity id="DS.d1860.s0.e1" origId="P35557,Q12851,Q61161" charOffset="106-109" type="protein" text="GCK"/>
            <pair e1="DS.d1860.s0.e0" e2="DS.d1860.s0.e1" id="DS.d1860.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1862" origId="18940267">
        <sentence id="DS.d1862.s0" origId="18940267-156" text="It decreased TG levels in tyloxapol-induced hyperlipidemia and increased high-density lipoprotein cholesterol (HDL-C) and reduced atherogenic index in normotensive rats.">
            <entity id="DS.d1862.s0.e0" origId="P81182" charOffset="73-97" type="protein" text="high-density lipoprotein"/>
            <entity id="DS.d1862.s0.e1" origId="304,5997,6432564,11025495" charOffset="98-109" type="compound" text="cholesterol"/>
            <pair e1="DS.d1862.s0.e1" e2="DS.d1862.s0.e0" id="DS.d1862.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1863" origId="18940894">
        <sentence id="DS.d1863.s0" origId="18940894-262" text="This analysis reveals TRPCs as major and unsuspected gates of Ca(2+) entry that contribute, depending on context, to activation of transcription factors, apoptosis, vascular contractility, platelet activation, and cardiac hypertrophy, as well as to normal and abnormal cell proliferation.">
            <entity id="DS.d1863.s0.e0" origId="P25170" charOffset="22-27" type="protein" text="TRPCs"/>
            <entity id="DS.d1863.s0.e1" origId="271" charOffset="62-66" type="compound" text="Ca(2"/>
            <pair e1="DS.d1863.s0.e1" e2="DS.d1863.s0.e0" id="DS.d1863.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1864" origId="18940938">
        <sentence id="DS.d1864.s0" origId="18940938-278" text="A single bout of exercise increases glucose uptake and fatty acid oxidation in skeletal muscle, with a corresponding activation of AMP-activated protein kinase (AMPK).">
            <entity id="DS.d1864.s0.e0" origId="206,5793,64689,79025" charOffset="36-43" type="compound" text="glucose"/>
            <entity id="DS.d1864.s0.e1" origId="P00513,P25848" charOffset="145-159" type="protein" text="protein kinase"/>
            <entity id="DS.d1864.s0.e2" origId="P54646,Q09136,Q9Y478" charOffset="161-165" type="protein" text="AMPK"/>
            <pair e1="DS.d1864.s0.e0" e2="DS.d1864.s0.e1" id="DS.d1864.s0.i0" interaction="True"/>
            <pair e1="DS.d1864.s0.e0" e2="DS.d1864.s0.e2" id="DS.d1864.s0.i1" interaction="True"/>
        </sentence>
        <sentence id="DS.d1864.s1" origId="18940938-280" text="Changes in oxygen consumption and the RQ ratio during sedentary and low-intensity exercise were not different between alpha(1)-AMPK-DN and WT.">
            <entity id="DS.d1864.s1.e0" origId="977" charOffset="11-17" type="compound" text="oxygen"/>
            <entity id="DS.d1864.s1.e1" origId="P54646,Q09136,Q9Y478" charOffset="127-131" type="protein" text="AMPK"/>
            <pair e1="DS.d1864.s1.e0" e2="DS.d1864.s1.e1" id="DS.d1864.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1865" origId="18941142">
        <sentence id="DS.d1865.s0" origId="18941142-329" text="ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity.">
            <entity id="DS.d1865.s0.e0" origId="O95477" charOffset="0-5" type="protein" text="ABCA1"/>
            <entity id="DS.d1865.s0.e1" origId="304,5997,6432564,11025495" charOffset="15-26" type="compound" text="cholesterol"/>
            <pair e1="DS.d1865.s0.e1" e2="DS.d1865.s0.e0" id="DS.d1865.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1866" origId="18941467">
        <sentence id="DS.d1866.s0" origId="18941467-423" text="DHT treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS).">
            <entity id="DS.d1866.s0.e0" origId="10635" charOffset="0-3" type="compound" text="DHT"/>
            <entity id="DS.d1866.s0.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="171-187" type="protein" text="cyclooxygenase-2"/>
            <entity id="DS.d1866.s0.e2" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="189-194" type="protein" text="COX-2"/>
            <entity id="DS.d1866.s0.e3" origId="O61309,O61608,Q27571,Q9I9M2" charOffset="210-231" type="protein" text="nitric oxide synthase"/>
            <entity id="DS.d1866.s0.e4" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="233-237" type="protein" text="iNOS"/>
            <pair e1="DS.d1866.s0.e0" e2="DS.d1866.s0.e1" id="DS.d1866.s0.i0" interaction="True"/>
            <pair e1="DS.d1866.s0.e0" e2="DS.d1866.s0.e4" id="DS.d1866.s0.i1" interaction="True"/>
            <pair e1="DS.d1866.s0.e0" e2="DS.d1866.s0.e3" id="DS.d1866.s0.i2" interaction="True"/>
            <pair e1="DS.d1866.s0.e0" e2="DS.d1866.s0.e2" id="DS.d1866.s0.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d1866.s1" origId="18941467-424" text="Effects of DHT on COX-2 and iNOS were attenuated by flutamide.">
            <entity id="DS.d1866.s1.e0" origId="10635" charOffset="11-14" type="compound" text="DHT"/>
            <entity id="DS.d1866.s1.e1" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="18-23" type="protein" text="COX-2"/>
            <entity id="DS.d1866.s1.e2" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="28-32" type="protein" text="iNOS"/>
            <entity id="DS.d1866.s1.e3" origId="3397" charOffset="52-61" type="compound" text="flutamide"/>
            <pair e1="DS.d1866.s1.e3" e2="DS.d1866.s1.e2" id="DS.d1866.s1.i0" interaction="False"/>
            <pair e1="DS.d1866.s1.e0" e2="DS.d1866.s1.e2" id="DS.d1866.s1.i1" interaction="True"/>
            <pair e1="DS.d1866.s1.e3" e2="DS.d1866.s1.e1" id="DS.d1866.s1.i2" interaction="False"/>
            <pair e1="DS.d1866.s1.e0" e2="DS.d1866.s1.e1" id="DS.d1866.s1.i3" interaction="True"/>
        </sentence>
        <sentence id="DS.d1866.s2" origId="18941467-426" text="In conclusion, activation of the NFkappaB-mediated COX-2/iNOS pathway by the selective androgen receptor agonist, DHT, results in a state of vascular inflammation.">
            <entity id="DS.d1866.s2.e0" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="51-56" type="protein" text="COX-2"/>
            <entity id="DS.d1866.s2.e1" origId="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091" charOffset="57-61" type="protein" text="iNOS"/>
            <entity id="DS.d1866.s2.e2" origId="10635" charOffset="114-117" type="compound" text="DHT"/>
            <pair e1="DS.d1866.s2.e2" e2="DS.d1866.s2.e1" id="DS.d1866.s2.i0" interaction="True"/>
            <pair e1="DS.d1866.s2.e2" e2="DS.d1866.s2.e0" id="DS.d1866.s2.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1867" origId="18941468">
        <sentence id="DS.d1867.s0" origId="18941468-399" text="After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had Evans blue (EB) injected for fluorescent microscopy for MMP-2, MMP-9, tight junction proteins (TJPs), and in situ zymography.">
            <entity id="DS.d1867.s0.e0" origId="5988" charOffset="83-90" type="compound" text="sucrose"/>
            <entity id="DS.d1867.s0.e1" origId="5356750,6913958,9566058" charOffset="108-118" type="compound" text="Evans blue"/>
            <entity id="DS.d1867.s0.e2" origId="P08253,P33434,P33436,P50757,Q90611,Q9GLE5" charOffset="164-169" type="protein" text="MMP-2"/>
            <entity id="DS.d1867.s0.e3" origId="O18733,P14780,P41245,P41246,P50282,P52176" charOffset="171-176" type="protein" text="MMP-9"/>
            <pair e1="DS.d1867.s0.e0" e2="DS.d1867.s0.e3" id="DS.d1867.s0.i0" interaction="False"/>
            <pair e1="DS.d1867.s0.e1" e2="DS.d1867.s0.e2" id="DS.d1867.s0.i1" interaction="False"/>
            <pair e1="DS.d1867.s0.e1" e2="DS.d1867.s0.e3" id="DS.d1867.s0.i2" interaction="False"/>
            <pair e1="DS.d1867.s0.e0" e2="DS.d1867.s0.e2" id="DS.d1867.s0.i3" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1868" origId="18941714">
        <sentence id="DS.d1868.s0" origId="18941714-1885" text="The electrons released from NADPH by CPR were transferred to CTC in the reaction medium, and CTC reduction activity could be assessed spectrophotometrically and spectrofluorometrically.">
            <entity id="DS.d1868.s0.e0" origId="5884" charOffset="28-33" type="compound" text="NADPH"/>
            <entity id="DS.d1868.s0.e1" origId="P00388,P00389,P04175,P16435,P16603,P19618,P36587,P37039,P37040,P37116,P37201,P50126,Q00141,Q05001,Q07994,Q27597,Q3SYT8,Q9EQV9,Q9HDG2,Q9JHH6" charOffset="37-40" type="protein" text="CPR"/>
            <pair e1="DS.d1868.s0.e0" e2="DS.d1868.s0.e1" id="DS.d1868.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1870" origId="18941797">
        <sentence id="DS.d1870.s0" origId="18941797-421" text="Effects of dissolved oxygen tension and agitation rate on the production of heat-shock protein glycoprotein 96 by MethA tumor cell suspension culture in stirred-tank bioreactors.">
            <entity id="DS.d1870.s0.e0" origId="977" charOffset="21-27" type="compound" text="oxygen"/>
            <entity id="DS.d1870.s0.e1" origId="P08163" charOffset="95-107" type="protein" text="glycoprotein"/>
            <pair e1="DS.d1870.s0.e0" e2="DS.d1870.s0.e1" id="DS.d1870.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1871" origId="18941818">
        <sentence id="DS.d1871.s0" origId="18941818-549" text="Goldfish scales were incubated either with 20:3n-9 or with oleic acid at 15 degrees C for 6 and 18 h. Both osteoblastic and osteoclastic activities in the scale were assessed by measuring alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase, respectively.">
            <entity id="DS.d1871.s0.e0" origId="445639" charOffset="59-69" type="compound" text="oleic acid"/>
            <entity id="DS.d1871.s0.e1" origId="O60109,P81800,P83456" charOffset="188-208" type="protein" text="alkaline phosphatase"/>
            <entity id="DS.d1871.s0.e2" origId="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0" charOffset="210-213" type="protein" text="ALP"/>
            <pair e1="DS.d1871.s0.e0" e2="DS.d1871.s0.e2" id="DS.d1871.s0.i0" interaction="False"/>
            <pair e1="DS.d1871.s0.e0" e2="DS.d1871.s0.e1" id="DS.d1871.s0.i1" interaction="False"/>
        </sentence>
        <sentence id="DS.d1871.s1" origId="18941818-550" text="MC3T3-E1 cells (an osteoblast cell line derived from the mouse) were incubated with 20:3n-9 or oleic acid at 37 degrees C for 6 and 18 h. ALP activity in cell lysate was measured.">
            <entity id="DS.d1871.s1.e0" origId="445639" charOffset="95-105" type="compound" text="oleic acid"/>
            <entity id="DS.d1871.s1.e1" origId="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0" charOffset="138-141" type="protein" text="ALP"/>
            <pair e1="DS.d1871.s1.e0" e2="DS.d1871.s1.e1" id="DS.d1871.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1872" origId="18941890">
        <sentence id="DS.d1872.s0" origId="18941890-590" text="Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.">
            <entity id="DS.d1872.s0.e0" origId="5951" charOffset="50-56" type="compound" text="serine"/>
            <entity id="DS.d1872.s0.e1" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="72-89" type="protein" text="estrogen receptor"/>
            <pair e1="DS.d1872.s0.e0" e2="DS.d1872.s0.e1" id="DS.d1872.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1872.s1" origId="18941890-591" text="Both kinases have been implicated in the phosphorylation of serine 118 and serine 167 on ERalpha, respectively.">
            <entity id="DS.d1872.s1.e0" origId="5951" charOffset="60-66" type="compound" text="serine"/>
            <entity id="DS.d1872.s1.e1" origId="5951" charOffset="75-81" type="compound" text="serine"/>
            <entity id="DS.d1872.s1.e2" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="89-96" type="protein" text="ERalpha"/>
            <pair e1="DS.d1872.s1.e0" e2="DS.d1872.s1.e2" id="DS.d1872.s1.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1872.s2" origId="18941890-592" text="Our data show for the first time that ROS can induce post-translational modifications of ERalpha at serine 118 and serine 167, and may lead to ERalpha down-regulation in human breast cancer cells.">
            <entity id="DS.d1872.s2.e0" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="89-96" type="protein" text="ERalpha"/>
            <entity id="DS.d1872.s2.e1" origId="5951" charOffset="100-106" type="compound" text="serine"/>
            <entity id="DS.d1872.s2.e2" origId="5951" charOffset="115-121" type="compound" text="serine"/>
            <entity id="DS.d1872.s2.e3" origId="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7" charOffset="143-150" type="protein" text="ERalpha"/>
            <pair e1="DS.d1872.s2.e1" e2="DS.d1872.s2.e0" id="DS.d1872.s2.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1873" origId="18942092">
        <sentence id="DS.d1873.s0" origId="18942092-662" text="Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.">
            <entity id="DS.d1873.s0.e0" origId="P00533,P13387,P55245" charOffset="104-108" type="protein" text="EGFR"/>
            <entity id="DS.d1873.s0.e1" origId="148124" charOffset="123-132" type="compound" text="docetaxel"/>
            <pair e1="DS.d1873.s0.e1" e2="DS.d1873.s0.e0" id="DS.d1873.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1874" origId="18942097">
        <sentence id="DS.d1874.s0" origId="18942097-665" text="Expression of the histone H2B-GFP fusion protein was observed exclusively upon doxycycline induction and was uniformly distributed throughout the intestinal epithelium.">
            <entity id="DS.d1874.s0.e0" origId="O22582,O49118,O97484,P02280,P02283,P14001,P17271,P19374,P21897,P23754,P27326,P27795,P27893,P30757,P35067,P37210,P40284,P48557,P59781,P59782,P69069,P69070,P78567,P82887,P83837,P83863,P93354,Q27442,Q2HH38,Q2U5A9,Q4HTT2,Q4PEF8,Q4WWC5,Q5G577,Q5KMT4,Q6C4I7,Q75VN4,Q76FD7,Q76FE5,Q76FE9,Q76FF3,Q7M400,Q7M4G7,Q7Z9J4,Q875B7,Q8I1N0,Q8J1K2,Q8SRE2,Q99285" charOffset="18-29" type="protein" text="histone H2B"/>
            <entity id="DS.d1874.s0.e2" origId="54671203" charOffset="79-90" type="compound" text="doxycycline"/>
            <pair e1="DS.d1874.s0.e2" e2="DS.d1874.s0.e0" id="DS.d1874.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1875" origId="18942140">
        <sentence id="DS.d1875.s0" origId="18942140-690" text="On hexanoamide the amidase exhibited a K(m) value of 5.5 mM compared to 0.07 mM for p-nitroacetanilide.">
            <entity id="DS.d1875.s0.e0" origId="12332" charOffset="3-14" type="compound" text="hexanoamide"/>
            <entity id="DS.d1875.s0.e1" origId="O69768,P22984,P27765,P95896" charOffset="19-26" type="protein" text="amidase"/>
            <entity id="DS.d1875.s0.e2" origId="7691" charOffset="84-102" type="compound" text="p-nitroacetanilide"/>
            <pair e1="DS.d1875.s0.e2" e2="DS.d1875.s0.e1" id="DS.d1875.s0.i0" interaction="True"/>
            <pair e1="DS.d1875.s0.e0" e2="DS.d1875.s0.e1" id="DS.d1875.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1876" origId="18942727">
        <sentence id="DS.d1876.s0" origId="18942727-207" text="Recoverin is an important neuronal calcium sensor (NCS) protein, which have been implicated in a wide range of Ca(2+) signaling events in neurons and photoreceptors.">
            <entity id="DS.d1876.s0.e0" origId="P21457,P34057,P35243" charOffset="0-9" type="protein" text="Recoverin"/>
            <entity id="DS.d1876.s0.e1" origId="P0A3R9,P0A3S0" charOffset="51-54" type="protein" text="NCS"/>
            <entity id="DS.d1876.s0.e2" origId="271" charOffset="111-115" type="compound" text="Ca(2"/>
            <pair e1="DS.d1876.s0.e2" e2="DS.d1876.s0.e0" id="DS.d1876.s0.i0" interaction="True"/>
            <pair e1="DS.d1876.s0.e2" e2="DS.d1876.s0.e1" id="DS.d1876.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1877" origId="18942747">
        <sentence id="DS.d1877.s1" origId="18942747-893" text="A decrease in P2X (7)R expression was observed in cultured OPCs after exposure to oxygen-glucose deprivation (OGD) for 2 h in vitro.">
            <entity id="DS.d1877.s1.e0" origId="P13900,P16604" charOffset="14-17" type="protein" text="P2X"/>
            <entity id="DS.d1877.s1.e2" origId="206,5793,64689,79025" charOffset="89-96" type="compound" text="glucose"/>
            <pair e1="DS.d1877.s1.e2" e2="DS.d1877.s1.e0" id="DS.d1877.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1878" origId="18945212">
        <sentence id="DS.d1878.s0" origId="18945212-1760" text="Reactivity of nitric oxide with the (4Fe-4S) cluster of dihydroxyacid dehydratase from Escherichia coli.">
            <entity id="DS.d1878.s0.e0" origId="145068" charOffset="14-26" type="compound" text="nitric oxide"/>
            <entity id="DS.d1878.s0.e2" origId="O06069,O27498,O29248,O51887,O67009,O69198,P05791,P31874,P31959,P40810,P44851,P51785,P55186,P57656,P57957,P59426,P65154,P65155,P65156,P65157,P65158,P65159,P65160,P74689,Q02139,Q317H9,Q31UL3,Q329V0,Q3A3A5,Q3AER0,Q3APB9,Q3BYS5,Q3IMV2,Q3IXP4,Q3J9N3,Q3JV12,Q3K559,Q3SW60,Q3YVJ3,Q3Z888,Q3ZXH9,Q46AU2,Q46LF6,Q47JC0,Q47MS7,Q47UN7,Q48PA6,Q491Z0,Q4FM19,Q4FS54,Q4J860,Q4JUN3,Q4K498,Q4L7T6,Q4QMF8,Q4UZT2,Q4ZZ83,Q57FS2,Q57HU7,Q58672,Q5E1P2,Q5F8G6,Q5FN26,Q5GUY8,Q5HEE8,Q5HMG3,Q5HXE4,Q5KYA5,Q5L9I8,Q5LN98,Q5LYH1,Q5M334,Q5N3N2,Q5NH32,Q5NLJ4,Q5PK00,Q5SIY0,Q5V545,Q5WEM9,Q606D6,Q62LG7,Q63CV3,Q63WB9,Q64PS6,Q65IB0,Q65QD4,Q66G45,Q67KX6,Q6AEN9,Q6CZC7,Q6G543,Q6G7Q4,Q6GF19,Q6HKA0,Q6KZ30,Q6LLH7,Q6M0F3,Q6N9S5,Q6NHN6,Q71Y38,Q725Q1,Q72JA8,Q72TC0,Q73TT7,Q74BW7,Q7MAN4,Q7MGI8,Q7MYJ5,Q7NGK1,Q7NYJ7,Q7TV16,Q7U763,Q7UJ69,Q7V1T1,Q7VC95,Q7VHW3,Q7VRL8,Q81F26,Q81S26,Q82E99,Q82XY7,Q83GP9,Q83HI6,Q83PI6,Q87F63,Q87KB6,Q87V83,Q88CQ2,Q8A608,Q8CNL6,Q8DDG1,Q8DK13,Q8DRT7,Q8E9D9,Q8EN63,Q8F219,Q8FBR5,Q8G353,Q8G3H2,Q8KER4,Q8KTS9,Q8NQZ9,Q8PDJ3,Q8PQI0,Q8Q078,Q8RDJ9,Q8TW40,Q8U297,Q8UE43,Q8XAV1,Q8XWR1,Q8Y5S2,Q8YEN0,Q8YTE6,Q8Z377,Q8ZAB3,Q8ZYU6,Q92A32,Q92M28,Q96YK0,Q97EE3,Q97UB2,Q9I6E0,Q9JS61,Q9JUE0,Q9K8E4,Q9KVW0,Q9PH47,Q9PJ98,Q9RQ48,Q9RQ52,Q9RQ56,Q9RV97,Q9UZ03,Q9WZ21,Q9XBI3,Q9YG88" charOffset="56-81" type="protein" text="dihydroxyacid dehydratase"/>
            <pair e1="DS.d1878.s0.e0" e2="DS.d1878.s0.e2" id="DS.d1878.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1878.s1" origId="18945212-1763" text="The rate constant for the initial reaction between NO and the IlvD (4Fe-4S) cluster is estimated to be (7.0+/-2.0)x10(6) M(-2) x s(-1) at 25 degrees C, which is approx.">
            <entity id="DS.d1878.s1.e0" origId="O06069,O27498,O29248,O51887,O67009,O69198,P05791,P31874,P31959,P40810,P44851,P51785,P55186,P57656,P57957,P59426,P65154,P65155,P65156,P65157,P65158,P65159,P65160,P74689,Q02139,Q317H9,Q31UL3,Q329V0,Q3A3A5,Q3AER0,Q3APB9,Q3BYS5,Q3IMV2,Q3IXP4,Q3J9N3,Q3JV12,Q3K559,Q3SW60,Q3YVJ3,Q3Z888,Q3ZXH9,Q46AU2,Q46LF6,Q47JC0,Q47MS7,Q47UN7,Q48PA6,Q491Z0,Q4FM19,Q4FS54,Q4J860,Q4JUN3,Q4K498,Q4L7T6,Q4QMF8,Q4UZT2,Q4ZZ83,Q57FS2,Q57HU7,Q58672,Q5E1P2,Q5F8G6,Q5FN26,Q5GUY8,Q5HEE8,Q5HMG3,Q5HXE4,Q5KYA5,Q5L9I8,Q5LN98,Q5LYH1,Q5M334,Q5N3N2,Q5NH32,Q5NLJ4,Q5PK00,Q5SIY0,Q5V545,Q5WEM9,Q606D6,Q62LG7,Q63CV3,Q63WB9,Q64PS6,Q65IB0,Q65QD4,Q66G45,Q67KX6,Q6AEN9,Q6CZC7,Q6G543,Q6G7Q4,Q6GF19,Q6HKA0,Q6KZ30,Q6LLH7,Q6M0F3,Q6N9S5,Q6NHN6,Q71Y38,Q725Q1,Q72JA8,Q72TC0,Q73TT7,Q74BW7,Q7MAN4,Q7MGI8,Q7MYJ5,Q7NGK1,Q7NYJ7,Q7TV16,Q7U763,Q7UJ69,Q7V1T1,Q7VC95,Q7VHW3,Q7VRL8,Q81F26,Q81S26,Q82E99,Q82XY7,Q83GP9,Q83HI6,Q83PI6,Q87F63,Q87KB6,Q87V83,Q88CQ2,Q8A608,Q8CNL6,Q8DDG1,Q8DK13,Q8DRT7,Q8E9D9,Q8EN63,Q8F219,Q8FBR5,Q8FPX6,Q8G353,Q8G3H2,Q8KER4,Q8KTS9,Q8NQZ9,Q8PDJ3,Q8PQI0,Q8Q078,Q8RDJ9,Q8TW40,Q8U297,Q8UE43,Q8XAV1,Q8XWR1,Q8Y5S2,Q8YEN0,Q8YTE6,Q8Z377,Q8ZAB3,Q8ZYU6,Q92A32,Q92M28,Q96YK0,Q97EE3,Q97UB2,Q98BZ8,Q9I6E0,Q9JUE0,Q9K8E4,Q9KVW0,Q9PH47,Q9PJ98,Q9RQ48,Q9RQ52,Q9RQ56,Q9RV97,Q9UZ03,Q9WZ21,Q9XBI3,Q9YG88" charOffset="62-66" type="protein" text="IlvD"/>
            <entity id="DS.d1878.s1.e1" origId="6398953" charOffset="68-83" type="compound" text="4Fe-4S) cluster"/>
            <pair e1="DS.d1878.s1.e1" e2="DS.d1878.s1.e0" id="DS.d1878.s1.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1880" origId="18945215">
        <sentence id="DS.d1880.s0" origId="18945215-1768" text="Acylcarnitines have been suggested to play a role in insulin resistance, as well as other long-chain fatty acid metabolites.">
            <entity id="DS.d1880.s0.e0" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="53-60" type="protein" text="insulin"/>
            <entity id="DS.d1880.s0.e1" origId="284" charOffset="90-111" type="compound" text="long-chain fatty acid"/>
            <pair e1="DS.d1880.s0.e1" e2="DS.d1880.s0.e0" id="DS.d1880.s0.i0" interaction="False"/>
        </sentence>
        <sentence id="DS.d1880.s1" origId="18945215-1769" text="In the present study we investigated whether muscle long-chain acylcarnitines increase during fasting and we investigated their relationship with glucose/fat oxidation and insulin sensitivity in lean healthy humans.">
            <entity id="DS.d1880.s1.e0" origId="206,5793,64689,79025" charOffset="146-153" type="compound" text="glucose"/>
            <entity id="DS.d1880.s1.e1" origId="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7" charOffset="172-179" type="protein" text="insulin"/>
            <pair e1="DS.d1880.s1.e0" e2="DS.d1880.s1.e1" id="DS.d1880.s1.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1881" origId="18945217">
        <sentence id="DS.d1881.s0" origId="18945217-1773" text="Ethanol attenuates the HFS-induced, ERK-mediated LTP in a dose-dependent manner in rat striatum.">
            <entity id="DS.d1881.s0.e0" origId="702" charOffset="0-7" type="compound" text="Ethanol"/>
            <entity id="DS.d1881.s0.e1" origId="P29323" charOffset="36-39" type="protein" text="ERK"/>
            <pair e1="DS.d1881.s0.e0" e2="DS.d1881.s0.e1" id="DS.d1881.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1882" origId="18945429">
        <sentence id="DS.d1882.s0" origId="18945429-1846" text="These results suggest that StAR delivers cholesterol to mitochondria where regulatory oxysterols are generated.">
            <entity id="DS.d1882.s0.e0" origId="O46689,P49675,P51557,P58864,P70114,P79245,P97826,Q28918,Q28996,Q9DE06,Q9DEB4,Q9DG08,Q9DG09,Q9DG10" charOffset="27-31" type="protein" text="StAR"/>
            <entity id="DS.d1882.s0.e1" origId="304,5997,6432564,11025495" charOffset="41-52" type="compound" text="cholesterol"/>
            <pair e1="DS.d1882.s0.e1" e2="DS.d1882.s0.e0" id="DS.d1882.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1883" origId="18945563">
        <sentence id="DS.d1883.s0" origId="18945563-2825" text="17beta-Hydroxysteroid dehydrogenase type 1 (HSD17B1) is a key enzyme of 17beta-estradiol biosynthesis, which might play an important role in follicular development of the ovary.">
            <entity id="DS.d1883.s0.e0" origId="P14061,P51656,P51657,Q1WNP0" charOffset="0-42" type="protein" text="17beta-Hydroxysteroid dehydrogenase type 1"/>
            <entity id="DS.d1883.s0.e1" origId="P14061,Q1WNP0" charOffset="44-51" type="protein" text="HSD17B1"/>
            <entity id="DS.d1883.s0.e2" origId="5757" charOffset="72-88" type="compound" text="17beta-estradiol"/>
            <pair e1="DS.d1883.s0.e2" e2="DS.d1883.s0.e1" id="DS.d1883.s0.i0" interaction="True"/>
            <pair e1="DS.d1883.s0.e2" e2="DS.d1883.s0.e0" id="DS.d1883.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1885" origId="18945611">
        <sentence id="DS.d1885.s0" origId="18945611-1922" text="MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma.">
            <entity id="DS.d1885.s0.e0" origId="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8" charOffset="0-4" type="protein" text="MGMT"/>
            <entity id="DS.d1885.s0.e1" origId="5394" charOffset="71-83" type="compound" text="temozolomide"/>
            <pair e1="DS.d1885.s0.e1" e2="DS.d1885.s0.e0" id="DS.d1885.s0.i0" interaction="True"/>
        </sentence>
        <sentence id="DS.d1885.s1" origId="18945611-1923" text="To investigate the correlation between O(6)-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and benefit from temozolomide in patients with recurrent high-grade glioma.">
            <entity id="DS.d1885.s1.e1" origId="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8" charOffset="81-85" type="protein" text="MGMT"/>
            <entity id="DS.d1885.s1.e2" origId="5394" charOffset="125-137" type="compound" text="temozolomide"/>
            <pair e1="DS.d1885.s1.e2" e2="DS.d1885.s1.e1" id="DS.d1885.s1.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1886" origId="18945624">
        <sentence id="DS.d1886.s0" origId="18945624-1926" text="Betulinic acid binding to human serum albumin : a study of protein conformation and binding affinity.">
            <entity id="DS.d1886.s0.e0" origId="64971" charOffset="0-14" type="compound" text="Betulinic acid"/>
            <entity id="DS.d1886.s0.e1" origId="P21847,P83517" charOffset="32-45" type="protein" text="serum albumin"/>
            <pair e1="DS.d1886.s0.e0" e2="DS.d1886.s0.e1" id="DS.d1886.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1887" origId="18945756">
        <sentence id="DS.d1887.s0" origId="18945756-2007" text="Adenosine nucleotide translocase (ANT) translocates ADP/ATP across the inner mitochondrial membrane.">
            <entity id="DS.d1887.s0.e0" origId="P02723,P25083,P27080,P27081,P31691,P31692,P49382,Q09188,Q26365,Q38914" charOffset="34-37" type="protein" text="ANT"/>
            <entity id="DS.d1887.s0.e1" origId="5957" charOffset="56-59" type="compound" text="ATP"/>
            <pair e1="DS.d1887.s0.e1" e2="DS.d1887.s0.e0" id="DS.d1887.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1888" origId="18945757">
        <sentence id="DS.d1888.s0" origId="18945757-720" text="This review will focus on recent evidence that nitric oxide, natriuretic peptides and neuropeptide Y act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.">
            <entity id="DS.d1888.s0.e0" origId="145068" charOffset="47-59" type="compound" text="nitric oxide"/>
            <entity id="DS.d1888.s0.e1" origId="P28374" charOffset="61-81" type="protein" text="natriuretic peptides"/>
            <entity id="DS.d1888.s0.e2" origId="P01303,P01304,P07808,P14765,P28672,P28673,P28674,P29071,P33689,P57774,P68006,P68007,P68008,P69101,P69102,P80167,Q27441,Q6RUW3,Q90WF4,Q9DGK7,Q9I8P3,Q9I9D3,Q9PTA0,Q9PW68,Q9XSW6" charOffset="86-100" type="protein" text="neuropeptide Y"/>
            <pair e1="DS.d1888.s0.e0" e2="DS.d1888.s0.e1" id="DS.d1888.s0.i0" interaction="True"/>
            <pair e1="DS.d1888.s0.e0" e2="DS.d1888.s0.e2" id="DS.d1888.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1889" origId="18945783">
        <sentence id="DS.d1889.s0" origId="18945783-756" text="Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.">
            <entity id="DS.d1889.s0.e0" origId="594,5862,5360637" charOffset="22-30" type="compound" text="cysteine"/>
            <entity id="DS.d1889.s0.e1" origId="P18345" charOffset="73-87" type="protein" text="glycoprotein E"/>
            <pair e1="DS.d1889.s0.e0" e2="DS.d1889.s0.e1" id="DS.d1889.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1890" origId="18945810">
        <sentence id="DS.d1890.s0" origId="18945810-2026" text="Glucocorticoid-activated GR repressed COX-2 gene induction by lipopolysaccharide (LPS).">
            <entity id="DS.d1890.s0.e0" origId="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769" charOffset="38-43" type="protein" text="COX-2"/>
            <entity id="DS.d1890.s0.e1" origId="11970143" charOffset="62-80" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS.d1890.s0.e1" e2="DS.d1890.s0.e0" id="DS.d1890.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1891" origId="18945821">
        <sentence id="DS.d1891.s0" origId="18945821-2039" text="Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimers.">
            <entity id="DS.d1891.s0.e0" origId="P08163" charOffset="16-28" type="protein" text="glycoprotein"/>
            <entity id="DS.d1891.s0.e1" origId="4666,5352019,6713921,6915727,44155032,53313247" charOffset="38-48" type="compound" text="paclitaxel"/>
            <pair e1="DS.d1891.s0.e1" e2="DS.d1891.s0.e0" id="DS.d1891.s0.i0" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1892" origId="18945824">
        <sentence id="DS.d1892.s0" origId="18945824-860" text="The data provide the first demonstration for the presence of V2R in primary cilia of renal epithelial cells, and a functional cAMP-signaling pathway, which targets ciliary channel function and may help control the sensory function of the primary cilium.">
            <entity id="DS.d1892.s0.e0" origId="O77808,P30518" charOffset="61-64" type="protein" text="V2R"/>
            <entity id="DS.d1892.s0.e1" origId="6076" charOffset="126-130" type="compound" text="cAMP"/>
            <pair e1="DS.d1892.s0.e1" e2="DS.d1892.s0.e0" id="DS.d1892.s0.i0" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1893" origId="18945826">
        <sentence id="DS.d1893.s0" origId="18945826-2045" text="The endothelial (Ca(2+))(CYT) response to bradykinin (100 nM) was significantly attenuated.">
            <entity id="DS.d1893.s0.e0" origId="271" charOffset="17-21" type="compound" text="Ca(2"/>
            <entity id="DS.d1893.s0.e1" origId="597" charOffset="25-28" type="compound" text="CYT"/>
            <entity id="DS.d1893.s0.e2" origId="O08677,P01042,P01044,P01045,P08934,P83055,P83060,P83856,P83857,P84697,P84825,P84895,Q7T3L1,Q90W88,Q90WZ1" charOffset="42-52" type="protein" text="bradykinin"/>
            <pair e1="DS.d1893.s0.e1" e2="DS.d1893.s0.e2" id="DS.d1893.s0.i0" interaction="True"/>
            <pair e1="DS.d1893.s0.e0" e2="DS.d1893.s0.e2" id="DS.d1893.s0.i1" interaction="True"/>
        </sentence>
    </document>
    <document id="DS.d1894" origId="18945930">
        <sentence id="DS.d1894.s0" origId="18945930-874" text="The purpose of this research was to enhance intranasal drug targeting to the CNS by incorporating a vasoconstrictor (phenylephrine (PHE)) into nasal formulations containing therapeutic neuropeptides (hypocretin-1 (HC) or the dipeptide L-Tyr-D-Arg (D-KTP)).">
            <entity id="DS.d1894.s0.e0" origId="P21259" charOffset="185-198" type="protein" text="neuropeptides"/>
            <entity id="DS.d1894.s0.e1" origId="O43612,O55232,O55241,O77668,P56717,Q9GLF6" charOffset="200-212" type="protein" text="hypocretin-1"/>
            <entity id="DS.d1894.s0.e2" origId="446833" charOffset="250-253" type="compound" text="KTP"/>
            <pair e1="DS.d1894.s0.e2" e2="DS.d1894.s0.e0" id="DS.d1894.s0.i0" interaction="False"/>
            <pair e1="DS.d1894.s0.e2" e2="DS.d1894.s0.e1" id="DS.d1894.s0.i1" interaction="False"/>
        </sentence>
    </document>
    <document id="DS.d1895" origId="18945988">
        <sentence id="DS.d1895.s0" origId="18945988-1510" text="CpG dinucleotides identified in Bhlhb2, Pparg, E2f, and Egr1 binding sites at the Prkce gene promoter were densely methylated in males and females and were unaffected by cocaine exposure.">
            <entity id="DS.d1895.s0.e0" origId="6804" charOffset="0-3" type="compound" text="CpG"/>
            <entity id="DS.d1895.s0.e1" origId="O35185,O35780" charOffset="32-38" type="protein" text="Bhlhb2"/>
            <entity id="DS.d1895.s0.e2" origId="O88275,P37234,P37238" charOffset="40-45" type="protein" text="Pparg"/>
            <entity id="DS.d1895.s0.e3" origId="Q27368" charOffset="47-50" type="protein" text="E2f"/>
            <entity id="DS.d1895.s0.e4" origId="P08046,P08154,P26632" charOffset="56-60" type="protein" text="Egr1"/>
            <entity id="DS.d1895.s0.e5" origId="P09216,P16054" charOffset="82-87" type="protein" text="Prkce"/>
            <pair e1="DS.d1895.s0.e0" e2="DS.d1895.s0.e3" id="DS.d1895.s0.i0" interaction="True"/>
            <pair e1="DS.d1895.s0.e0" e2="DS.d1895.s0.e2" id="DS.d1895.s0.i1" interaction="True"/>
            <pair e1="DS.d1895.s0.e0" e2="DS.d1895.s0.e5" id="DS.d1895.s0.i2" interaction="True"/>
            <pair e1="DS.d1895.s0.e0" e2="DS.d1895.s0.e1" id="DS.d1895.s0.i3" interaction="True"/>
            <pair e1="DS.d1895.s0.e0" e2="DS.d1895.s0.e4" id="DS.d1895.s0.i4" interaction="True"/>
        </sentence>
</document>
</corpus>
